data_6amr_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6amr _Structure_validation_residue.Date_analyzed 2017-09-15 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.585 ' HG3' HG13 ' A' ' 23' ' ' ILE . 22.1 ptp . . . . . 0 N--CA 1.464 0.23 0 CA-C-O 120.762 0.315 . . . . 73.25 110.379 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.585 HG13 ' HG3' ' A' ' 22' ' ' MET . 60.8 mt -104.97 99.65 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 115.982 -0.553 . . . . 74.4 110.226 177.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.549 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 10.6 tp10 -101.22 155.23 18.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.83 -0.623 . . . . 71.41 109.699 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -106.69 134.7 49.44 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.025 -0.361 . . . . 65.14 110.025 176.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.505 HD13 ' HA ' ' A' ' 31' ' ' PHE . 32.1 pt -129.19 157.01 42.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-O 120.971 0.415 . . . . 73.54 111.134 -175.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -106.81 -171.45 22.63 Favored Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.93 -0.577 . . . . 13.31 112.284 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -67.92 -50.34 56.62 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.27 0.47 . . . . 75.21 112.27 -176.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.5 p -73.34 -11.95 60.66 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.425 0.528 . . . . 64.12 112.425 -171.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.407 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 1.7 pm0 -117.09 -6.71 11.37 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 116.668 -0.242 . . . . 71.55 111.069 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.505 ' HA ' HD13 ' A' ' 26' ' ' ILE . 93.4 t80 -51.77 -70.58 0.08 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.293 -0.412 . . . . 65.21 110.327 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -62.43 -35.18 78.46 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.136 0.493 . . . . 71.43 109.771 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -51.88 -47.6 64.46 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.104 -0.953 . . . . 73.12 111.565 -176.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.483 ' HZ1' ' HB2' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -102.52 -18.32 15.35 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.981 0.363 . . . . 53.44 111.981 -177.137 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.1 t -88.39 -59.74 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 111.947 0.351 . . . . 63.51 111.947 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 34.3 p -78.05 -33.08 51.12 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.818 0.342 . . . . 74.43 111.168 -172.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.9 m -84.57 11.84 8.08 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.253 -0.431 . . . . 73.22 111.351 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.516 ' SG ' HG21 ' A' ' 42' ' ' ILE . 44.9 t -75.76 103.07 5.68 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 120.863 0.363 . . . . 62.14 110.339 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -103.15 12.3 35.93 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.137 0.494 . . . . 70.23 110.327 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -81.7 1.65 33.34 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.082 -0.508 . . . . 63.24 111.256 -178.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 59.22 13.42 3.03 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.495 0.554 . . . . 71.21 112.495 -178.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.516 HG21 ' SG ' ' A' ' 38' ' ' CYS . 10.5 tt -78.85 153.09 4.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.182 -0.673 . . . . 74.52 109.182 176.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.772 HD23 ' HE3' ' A' ' 101' ' ' MET . 57.2 tp -93.4 111.55 23.23 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.281 0.562 . . . . 74.32 110.425 -177.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 101' ' ' MET . 71.6 mt -96.39 129.46 46.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.496 -0.774 . . . . 75.35 110.429 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 5.3 mp -117.72 103.83 10.4 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.923 -0.399 . . . . 72.54 109.923 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.521 HG12 ' HB2' ' A' ' 77' ' ' TYR . 29.6 m -93.78 127.88 45.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 110.242 -0.281 . . . . 71.44 110.242 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.488 ' CG ' ' HZ1' ' A' ' 78' ' ' LYS . 2.0 p-10 -125.07 153.24 43.22 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.925 0.393 . . . . 64.5 110.779 -177.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 . . . . . 0 CA--C 1.539 0.522 0 CA-C-N 116.006 -0.543 . . . . 73.03 111.51 178.224 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.447 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 61.5 Cg_endo . . . . . 0 N--CA 1.453 -0.895 0 CA-C-O 121.261 0.442 . . . . 71.23 112.186 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.8 mp0 -62.32 -33.71 75.21 Favored 'General case' 0 C--O 1.248 1.01 0 CA-C-O 122.105 0.955 . . . . 74.1 109.598 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -56.98 -48.6 78.02 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-N 113.906 -1.497 . . . . 74.22 110.952 -174.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.447 ' HG3' ' HG2' ' A' ' 61' ' ' PRO . 45.2 mt-10 -59.31 -51.64 69.05 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.051 0.453 . . . . 74.41 109.886 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -51.28 -50.87 58.44 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.184 -0.916 . . . . 71.31 111.633 -176.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.586 HD13 HD12 ' A' ' 123' ' ' ILE . 13.2 mt -80.25 -39.22 29.4 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.024 -0.67 . . . . 73.24 112.346 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.56 -38.54 90.45 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.654 0.264 . . . . 61.5 111.31 -176.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.415 ' HA ' ' HE2' ' A' ' 22' ' ' MET . 73.2 mt-30 -54.6 -30.46 54.73 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.788 0.328 . . . . 70.24 111.177 178.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -90.45 -48.51 7.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.311 0.577 . . . . 65.55 110.837 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.512 ' O ' HG22 ' A' ' 74' ' ' VAL . 16.9 m-85 -98.31 23.18 8.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.547 -0.751 . . . . 75.23 112.118 -170.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.4 t -52.37 -42.01 63.58 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 112.234 0.457 . . . . 74.33 112.234 -172.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -72.99 -16.85 61.5 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.032 -0.418 . . . . 53.34 111.382 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.31 -8.04 16.5 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.536 -0.302 . . . . 72.31 111.225 -176.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.512 HG22 ' O ' ' A' ' 70' ' ' TYR . 28.3 m -133.73 151.17 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 O-C-N 121.923 -0.485 . . . . 73.54 111.032 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -140.58 116.17 10.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.011 -0.54 . . . . 63.31 109.941 175.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.488 ' N ' HD12 ' A' ' 76' ' ' ILE . 2.7 mp -92.85 130.22 42.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.253 -0.647 . . . . 74.42 109.253 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.549 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 22.2 m-85 -124.46 128.81 49.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.745 0.307 . . . . 72.2 111.049 -178.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.488 ' HZ1' ' CG ' ' A' ' 47' ' ' ASP . 0.3 OUTLIER -77.96 114.07 16.47 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.273 -0.64 . . . . 72.22 109.273 174.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.486 HG22 ' O ' ' A' ' 47' ' ' ASP . 10.6 tt . . . . . 0 C--N 1.326 -0.433 0 CA-C-O 121.028 0.442 . . . . 72.5 110.058 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.206 0 CA-C-O 120.827 0.346 . . . . 73.53 110.311 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.6 m -69.6 -32.95 71.98 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.907 -0.588 . . . . 71.01 109.756 176.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -63.17 -46.15 88.48 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.839 -0.619 . . . . 72.23 109.616 176.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.441 ' OH ' ' HE2' ' A' ' 107' ' ' LYS . 31.1 m-85 -77.11 -17.08 58.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.716 -0.675 . . . . 74.44 110.955 175.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 62.94 37.77 95.48 Favored Glycine 0 C--N 1.331 0.279 0 CA-C-N 116.203 -0.453 . . . . 71.21 112.197 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.7 p -86.23 144.73 8.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.889 0.376 . . . . 73.5 111.16 -175.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 31.9 t -136.58 84.66 2.09 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.868 -0.79 . . . . 73.31 108.868 173.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -163.85 161.6 23.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.659 -0.7 . . . . 73.13 109.975 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.435 ' HA ' ' HA ' ' A' ' 97' ' ' PRO . 0.0 OUTLIER -129.64 113.41 17.85 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 109.333 -0.617 . . . . 72.43 109.333 178.58 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 96' ' ' ILE . 35.0 Cg_endo -98.6 -155.09 0.27 Allowed 'Cis proline' 0 C--N 1.348 0.544 0 C-N-CA 124.359 -1.101 . . . . 65.31 112.146 -2.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 37.7 m -145.26 139.52 27.18 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 109.256 -0.646 . . . . 71.12 109.256 174.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.701 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 3.6 mp -122.96 132.94 70.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 109.442 -0.577 . . . . 75.35 109.442 -178.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 7.9 mp -110.82 146.48 36.36 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.497 0.189 . . . . 74.23 110.602 178.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.772 ' HE3' HD23 ' A' ' 43' ' ' LEU . 59.0 mtp -115.82 118.5 33.19 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.995 -0.548 . . . . 74.11 111.256 -176.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -118.9 150.72 39.4 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.934 -0.575 . . . . 74.43 110.683 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.788 ' HB3' HD22 ' A' ' 108' ' ' LEU . 13.8 ttmm -165.58 125.67 1.8 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.75 -0.659 . . . . 63.31 109.474 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 63.34 27.1 15.27 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.514 0.673 . . . . 65.24 110.329 175.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 75.31 13.84 82.46 Favored Glycine 0 C--N 1.333 0.379 0 CA-C-N 115.683 -0.69 . . . . 53.51 111.991 -178.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -113.01 156.67 22.64 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 122.83 0.452 . . . . 51.24 110.232 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.441 ' HE2' ' OH ' ' A' ' 91' ' ' TYR . 14.7 ptmm? -101.22 125.39 47.84 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.287 -0.634 . . . . 60.31 109.287 176.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.788 HD22 ' HB3' ' A' ' 103' ' ' LYS . 2.1 mm? -104.87 -53.2 2.72 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 111.909 0.337 . . . . 72.55 111.909 -173.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.687 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 50.4 m -162.97 172.14 15.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.192 -0.458 . . . . 74.54 110.247 -172.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -147.59 127.14 13.26 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.016 0.436 . . . . 75.32 110.797 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.701 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 84.4 t -81.57 107.36 13.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 115.97 -0.559 . . . . 64.25 109.924 178.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.495 ' H ' ' HE3' ' A' ' 118' ' ' LYS . 65.6 mt -107.95 115.19 48.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 116.029 -0.532 . . . . 75.11 110.131 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.07 -135.57 13.19 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 116.097 -0.502 . . . . 74.41 112.108 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -145.39 77.05 1.5 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.182 0.515 . . . . 71.33 110.767 -178.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.529 ' O ' HG22 ' A' ' 119' ' ' ILE . 1.7 m-20 -124.21 91.11 3.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.789 -0.642 . . . . 74.42 109.895 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.435 ' O ' HG13 ' A' ' 119' ' ' ILE . 6.8 tp -54.45 -41.34 53.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 120.798 0.332 . . . . 73.12 111.187 -176.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 43.8 t -59.32 -34.8 72.78 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.17 0.51 . . . . 71.15 111.07 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.495 ' HE3' ' H ' ' A' ' 112' ' ' ILE . 2.4 tmtm? -79.38 -44.14 22.08 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.92 -0.582 . . . . 71.04 110.715 -178.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.529 HG22 ' O ' ' A' ' 115' ' ' ASP . 1.5 pp -66.41 -38.53 81.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 71.22 110.862 -175.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.428 HD12 ' N ' ' A' ' 121' ' ' SER . 2.7 pp -67.39 -31.81 54.51 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.078 0 C-N-CA 120.569 -0.452 . . . . 75.31 109.788 177.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.428 ' N ' HD12 ' A' ' 120' ' ' ILE . 34.7 t -67.48 -47.04 71.21 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.928 -0.578 . . . . 62.24 110.152 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.475 ' CD ' ' HZ2' ' A' ' 118' ' ' LYS . 15.0 pt-20 -76.74 -42.31 41.67 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.27 -0.423 . . . . 74.32 111.765 -177.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.586 HD12 HD13 ' A' ' 66' ' ' LEU . 68.3 mt -66.3 -52.23 49.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 O-C-N 122.335 -0.228 . . . . 72.53 111.046 -178.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -62.64 -20.28 64.64 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.927 0.394 . . . . 72.01 111.035 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -68.58 -34.14 75.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.075 -0.512 . . . . 63.32 110.423 176.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -103.9 -8.14 19.92 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.474 0.546 . . . . 73.11 112.474 -172.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 43.0 pt -139.11 167.85 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 120.796 0.332 . . . . 71.04 110.647 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.371 -0.823 . . . . 74.44 111.122 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 C--O 1.238 0.451 0 N-CA-C 109.729 -0.471 . . . . 73.25 109.729 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.3 mm -107.55 89.66 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 108.142 -1.059 . . . . 74.4 108.142 171.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.633 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 9.3 tp10 -108.78 155.46 20.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.566 -0.288 . . . . 71.41 110.483 -174.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.407 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 29.7 pt20 -105.29 147.65 27.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.919 0.39 . . . . 65.14 110.481 176.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 30.5 pt -129.56 -178.93 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.979 -0.555 . . . . 73.54 109.97 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.31 175.34 18.92 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.841 -0.695 . . . . 13.31 113.514 -175.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -67.76 -34.68 77.29 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.626 0.77 . . . . 75.21 110.949 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.2 t -79.88 -39.21 31.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 64.12 111.285 -171.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -95.12 0.25 54.07 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.998 -0.546 . . . . 71.55 111.304 -175.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -47.84 -71.19 0.07 Allowed 'General case' 0 CA--C 1.53 0.189 0 O-C-N 123.418 0.448 . . . . 65.21 111.186 -177.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -65.86 -32.88 74.65 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.375 -0.602 . . . . 71.43 109.375 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 37' ' ' SER . 3.4 t-20 -51.85 -39.17 58.44 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 114.762 -1.108 . . . . 73.12 111.333 -175.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.9 ptmt -109.76 -25.8 10.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 53.44 112.122 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.5 t -80.11 -53.23 13.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 111.721 0.267 . . . . 63.51 111.721 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.0 p -83.75 -36.2 23.81 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.342 0.591 . . . . 74.43 110.067 -175.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 39.0 m -83.89 12.73 5.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.478 -0.783 . . . . 73.22 111.134 178.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 40.1 t -53.63 91.92 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.133 0.492 . . . . 62.14 110.979 176.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -80.84 -7.23 59.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.771 -0.65 . . . . 70.23 110.962 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -73.5 -16.54 61.28 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.247 -0.433 . . . . 63.24 110.643 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 65.89 21.69 11.4 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.744 -0.662 . . . . 71.21 111.443 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.546 HD12 ' HG2' ' A' ' 75' ' ' LYS . 17.6 tt -94.96 151.71 3.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.113 -0.699 . . . . 74.52 109.113 175.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.714 HD23 ' HE3' ' A' ' 101' ' ' MET . 64.8 tp -79.71 111.76 16.32 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.976 0.417 . . . . 74.32 110.474 -176.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 49.4 mt -91.31 122.91 43.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.615 -0.72 . . . . 75.35 110.498 177.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.571 HD13 HD11 ' A' ' 63' ' ' LEU . 58.8 mt -103.8 102.04 11.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.628 -0.715 . . . . 72.54 109.475 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 74.2 t -86.66 120.2 35.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.209 -0.451 . . . . 71.44 110.844 -177.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.487 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 13.7 t70 -95.24 154.91 16.96 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.925 0.393 . . . . 64.5 110.695 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 72.7 t80 . . . . . 0 CA--C 1.535 0.39 0 CA-C-N 115.762 -0.654 . . . . 73.03 112.301 -174.834 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo . . . . . 0 N--CA 1.463 -0.291 0 CA-C-O 120.89 0.287 . . . . 71.23 112.571 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.553 ' NE2' ' HA ' ' A' ' 114' ' ' ALA . 12.1 mp0 -52.15 -38.62 58.18 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.468 -0.787 . . . . 74.1 110.179 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.571 HD11 HD13 ' A' ' 45' ' ' LEU . 2.7 mm? -60.36 -48.7 80.62 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.672 -1.149 . . . . 74.22 110.326 -173.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -74.16 -36.54 64.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.179 -0.464 . . . . 74.41 109.997 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -52.33 -45.95 65.83 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.752 -0.658 . . . . 71.31 109.822 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.704 HD11 HD12 ' A' ' 123' ' ' ILE . 25.7 mt -84.78 -38.82 19.15 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 111.741 0.275 . . . . 73.24 111.741 177.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.517 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -55.98 -37.34 68.95 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.572 0.225 . . . . 61.5 111.464 -176.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -50.61 -32.35 18.62 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.948 0.404 . . . . 70.24 110.898 178.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -94.44 -59.02 2.04 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.833 -0.622 . . . . 65.55 111.27 175.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.533 ' O ' HG21 ' A' ' 74' ' ' VAL . 17.1 m-85 -91.1 21.03 4.51 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.156 0.798 . . . . 75.23 113.156 -168.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.517 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 11.2 t -54.52 -26.82 34.06 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.174 0.512 . . . . 74.33 110.976 -178.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -62.72 -20.13 64.6 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.752 -0.658 . . . . 53.34 112.239 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -131.93 7.78 4.39 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 111.661 0.245 . . . . 72.31 111.661 -175.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.533 HG21 ' O ' ' A' ' 70' ' ' TYR . 34.4 m -137.04 140.34 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 120.958 0.409 . . . . 73.54 110.992 177.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.546 ' HG2' HD12 ' A' ' 42' ' ' ILE . 33.6 mmtp -129.85 123.15 30.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.776 -0.647 . . . . 63.31 109.312 176.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.519 HG13 ' HB2' ' A' ' 45' ' ' LEU . 2.8 mp -98.99 132.48 44.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.694 -0.484 . . . . 74.42 109.694 -178.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.633 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 52.2 m-85 -134.52 129.34 34.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.076 -0.511 . . . . 72.2 109.786 -178.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.487 ' HB3' ' HB3' ' A' ' 47' ' ' ASP . 57.1 pttt -125.4 170.55 11.26 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.037 -0.357 . . . . 72.22 110.037 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 50.7 mt . . . . . 0 C--N 1.327 -0.385 0 N-CA-C 109.485 -0.561 . . . . 72.5 109.485 176.829 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.366 0 CA-C-O 120.968 0.413 . . . . 73.53 110.589 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 45.2 m -62.3 -42.52 99.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.754 -0.657 . . . . 71.01 110.661 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -65.1 -49.86 68.34 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.187 -0.46 . . . . 72.23 110.972 -176.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -74.0 -17.31 61.01 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.5 -0.318 . . . . 74.44 110.92 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.97 49.27 10.01 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.174 -0.536 . . . . 71.21 112.139 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 46.5 t -90.77 143.03 12.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 110.218 -0.289 . . . . 73.5 110.218 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.9 p -117.04 -58.48 2.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.299 -0.41 . . . . 73.31 110.996 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.59 108.35 2.41 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.105 -0.498 . . . . 73.13 111.479 -178.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.463 ' HB ' ' HA ' ' A' ' 97' ' ' PRO . 2.9 pp -107.42 158.38 33.34 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 116.11 -0.496 . . . . 72.43 109.876 176.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.463 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 61.3 Cg_endo -70.23 153.96 94.36 Favored 'Cis proline' 0 C--N 1.355 0.912 0 C-N-CA 124.039 -1.234 . . . . 65.31 113.03 2.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 28.7 m -120.17 135.3 55.02 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.381 -0.827 . . . . 71.12 109.799 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.583 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 3.8 mp -118.24 138.04 50.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.764 -0.458 . . . . 75.35 109.764 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.486 HD21 ' H ' ' A' ' 101' ' ' MET . 1.1 tt -121.79 137.23 54.85 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.115 -0.698 . . . . 74.23 109.115 176.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.756 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 61.4 mtp -101.62 118.47 37.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.065 -0.516 . . . . 74.11 110.879 -173.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -121.21 147.32 45.77 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.574 -0.284 . . . . 74.43 110.607 178.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.57 ' HB3' HD21 ' A' ' 108' ' ' LEU . 39.7 ttpt -159.16 116.09 2.69 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.099 -0.5 . . . . 63.31 110.137 176.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 48.64 54.75 10.09 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.73 -0.668 . . . . 65.24 111.309 177.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 80.82 -12.76 33.89 Favored Glycine 0 CA--C 1.519 0.328 0 CA-C-N 115.671 -0.695 . . . . 53.51 113.901 175.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -100.98 131.83 46.67 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 117.357 0.579 . . . . 51.24 110.735 -177.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -91.26 112.58 24.55 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.0 -0.741 . . . . 60.31 109.0 173.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.57 HD21 ' HB3' ' A' ' 103' ' ' LYS . 2.3 mm? -80.95 -53.37 6.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.126 -0.488 . . . . 72.55 111.26 -170.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.756 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 56.1 m -161.15 171.72 18.01 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.857 -0.61 . . . . 74.54 110.343 -172.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.492 HE21 HD13 ' A' ' 112' ' ' ILE . 29.5 tt0 -141.82 126.65 18.15 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 120.579 0.228 . . . . 75.32 110.704 -177.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.583 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 59.6 t -91.19 125.53 43.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 123.025 0.53 . . . . 64.25 110.633 178.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.492 HD13 HE21 ' A' ' 110' ' ' GLN . 62.0 mt -126.58 106.82 16.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.468 -0.333 . . . . 75.11 110.113 176.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 99.91 -143.34 16.37 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 121.082 -0.58 . . . . 74.41 112.388 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.553 ' HA ' ' NE2' ' A' ' 62' ' ' GLN . . . -126.49 56.85 1.44 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.251 0.548 . . . . 71.33 111.03 -176.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.492 ' O ' HG23 ' A' ' 119' ' ' ILE . 4.4 m-20 -93.38 71.15 4.39 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.022 -0.535 . . . . 74.42 110.147 179.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.576 ' O ' HG13 ' A' ' 119' ' ' ILE . 6.3 tp -54.57 -44.66 69.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 121.065 0.459 . . . . 73.12 111.432 -177.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.4 p -63.86 -28.89 70.16 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-O 121.212 0.529 . . . . 71.15 111.378 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.497 ' HZ2' ' CD ' ' A' ' 122' ' ' GLU . 14.5 tmtt? -80.03 -45.03 19.08 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 116.062 -0.517 . . . . 71.04 110.84 177.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 116' ' ' ILE . 2.0 pp -64.6 -38.09 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.47 -0.332 . . . . 71.22 111.01 -175.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.544 HG21 HD21 ' A' ' 66' ' ' LEU . 2.9 pp -60.5 -31.72 49.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-O 121.195 0.521 . . . . 75.31 110.051 176.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.422 ' N ' HD11 ' A' ' 120' ' ' ILE . 23.6 m -70.47 -51.68 27.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.977 -0.556 . . . . 62.24 110.734 177.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.567 ' HG2' ' HA ' ' A' ' 119' ' ' ILE . 15.6 pt-20 -72.38 -42.04 65.67 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.387 0.514 . . . . 74.32 112.387 -173.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.704 HD12 HD11 ' A' ' 66' ' ' LEU . 70.6 mt -64.07 -59.05 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 O-C-N 122.113 -0.367 . . . . 72.53 110.498 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -58.91 -20.75 54.66 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.046 -0.525 . . . . 72.01 110.943 -178.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -70.63 -39.14 73.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.811 -0.632 . . . . 63.32 110.885 176.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -103.61 -2.26 26.92 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.355 0.502 . . . . 73.11 112.355 -173.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 123' ' ' ILE . 29.6 pt -109.01 167.92 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 110.018 -0.364 . . . . 71.04 110.018 171.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.403 ' N ' HD21 ' A' ' 128' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.582 -0.723 . . . . 74.44 111.036 -175.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.603 ' HG2' HG12 ' A' ' 23' ' ' ILE . 1.4 pmm? . . . . . 0 C--O 1.236 0.373 0 N-CA-C 108.437 -0.949 . . . . 73.25 108.437 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.603 HG12 ' HG2' ' A' ' 22' ' ' MET . 22.8 mm -121.18 84.07 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 108.06 -1.089 . . . . 74.4 108.06 173.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -86.25 154.74 21.06 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.102 0.477 . . . . 71.41 111.177 -172.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.419 ' HA ' ' HG2' ' A' ' 78' ' ' LYS . 8.6 pt20 -101.44 126.42 48.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.862 -0.608 . . . . 65.14 110.696 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.494 HD11 ' HA ' ' A' ' 31' ' ' PHE . 35.1 pt -131.86 174.62 12.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 120.736 0.303 . . . . 73.54 110.259 175.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -121.11 -166.8 13.09 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 116.016 -0.538 . . . . 13.31 112.486 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.79 -50.3 57.7 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 122.893 0.477 . . . . 75.21 112.023 -176.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 39.7 m -76.67 -31.44 57.29 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 120.901 0.381 . . . . 64.12 111.928 -169.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.481 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 2.1 pm0 -89.93 -15.29 32.37 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.967 -0.56 . . . . 71.55 110.882 -178.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.494 ' HA ' HD11 ' A' ' 26' ' ' ILE . 46.3 t80 -48.77 -70.86 0.08 Allowed 'General case' 0 C--O 1.226 -0.159 0 O-C-N 123.399 0.437 . . . . 65.21 110.285 178.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -56.45 -43.3 79.39 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-O 121.146 0.498 . . . . 71.43 109.748 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.62 ' O ' ' HB3' ' A' ' 37' ' ' SER . 23.1 t-20 -52.3 -41.28 62.79 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 114.209 -1.36 . . . . 73.12 112.449 -171.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.542 ' HZ1' ' HB2' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -112.96 -20.15 11.66 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.257 0.466 . . . . 53.44 112.257 -176.802 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 77.6 t -81.05 -48.97 18.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 O-C-N 122.331 -0.231 . . . . 63.51 111.233 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.8 p -88.2 -35.83 17.13 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.218 0.532 . . . . 74.43 110.242 -177.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.62 ' HB3' ' O ' ' A' ' 33' ' ' ASN . 33.9 t -84.67 12.38 7.27 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.875 -0.602 . . . . 73.22 110.904 178.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.452 ' SG ' ' HB2' ' A' ' 40' ' ' ASP . 43.6 t -53.71 103.24 0.07 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.955 0.407 . . . . 62.14 111.369 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -82.23 -8.9 59.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.871 -0.604 . . . . 70.23 110.372 176.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.452 ' HB2' ' SG ' ' A' ' 38' ' ' CYS . 21.2 m-20 -63.69 -30.76 71.82 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.219 -0.446 . . . . 63.24 110.561 -179.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 40' ' ' ASP . 17.9 m120 71.52 12.9 6.48 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.509 -0.768 . . . . 71.21 110.99 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.5 tt -88.62 161.57 2.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 109.223 -0.658 . . . . 74.52 109.223 177.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.4 HD11 HG23 ' A' ' 127' ' ' ILE . 26.9 mt -78.93 109.24 13.03 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.06 0.457 . . . . 74.32 110.662 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.603 HG21 ' CD2' ' A' ' 77' ' ' TYR . 45.2 mt -94.27 107.61 19.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.649 -0.705 . . . . 75.35 110.163 175.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.572 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 6.4 mp -97.2 107.18 19.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.934 -0.575 . . . . 72.54 109.583 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.5 m -94.97 129.92 44.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 110.091 -0.337 . . . . 71.44 110.091 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -104.29 139.78 38.81 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.11 0.481 . . . . 64.5 110.208 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.465 ' HE2' HD13 ' A' ' 100' ' ' LEU . 40.8 m-85 . . . . . 0 C--N 1.324 -0.512 0 CA-C-N 115.842 -0.617 . . . . 73.03 110.066 176.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo . . . . . 0 N--CA 1.462 -0.382 0 CA-C-O 121.06 0.358 . . . . 71.23 112.408 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.576 ' HB3' HG12 ' A' ' 119' ' ' ILE . 13.8 mp0 -63.12 -48.32 79.0 Favored 'General case' 0 C--O 1.247 0.932 0 CA-C-O 121.583 0.706 . . . . 74.1 110.574 -174.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.552 HD13 ' N ' ' A' ' 64' ' ' GLU . 4.0 pp -57.38 -39.56 76.32 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 114.844 -1.071 . . . . 74.22 111.33 -176.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.552 ' N ' HD13 ' A' ' 63' ' ' LEU . 29.7 mt-10 -70.45 -43.25 70.26 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 120.809 -0.356 . . . . 74.41 110.048 177.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.2 mmtt -50.81 -52.95 36.24 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.133 -0.485 . . . . 71.31 111.528 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.738 HD12 HD12 ' A' ' 123' ' ' ILE . 14.8 mt -85.72 -42.83 13.9 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.198 0.814 . . . . 73.24 113.198 -176.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.18 -32.38 72.12 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.195 0.443 . . . . 61.5 112.195 -172.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -53.28 -33.44 53.2 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.884 0.373 . . . . 70.24 110.764 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -94.0 -53.4 4.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.005 -0.543 . . . . 65.55 110.85 176.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.516 ' O ' HG21 ' A' ' 74' ' ' VAL . 22.7 m-85 -85.35 14.83 4.89 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 113.149 0.796 . . . . 75.23 113.149 -169.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.8 t -52.94 -31.6 41.1 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.344 0.52 . . . . 74.33 111.441 -177.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -66.65 -16.9 64.53 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.283 -0.417 . . . . 53.34 111.553 -178.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -125.1 -7.04 7.15 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.375 -0.375 . . . . 72.31 110.627 -176.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.516 HG21 ' O ' ' A' ' 70' ' ' TYR . 19.6 m -141.83 150.69 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 109.979 -0.378 . . . . 73.54 109.979 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.9 tppt? -144.9 127.25 15.85 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.845 -0.428 . . . . 63.31 109.845 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.572 ' HA ' ' O ' ' A' ' 45' ' ' LEU . 1.9 mp -95.94 142.82 13.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.583 0.23 . . . . 74.42 110.398 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.603 ' CD2' HG21 ' A' ' 44' ' ' ILE . 83.6 m-85 -135.46 131.56 36.29 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.211 -0.45 . . . . 72.2 110.339 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.419 ' HG2' ' HA ' ' A' ' 25' ' ' GLN . 22.3 ptmt -87.21 134.56 33.52 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 120.734 0.302 . . . . 72.22 110.477 177.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.8 tp . . . . . 0 CA--C 1.534 0.351 0 CA-C-N 115.819 -0.628 . . . . 72.5 110.769 -179.133 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.128 0 CA-C-O 121.025 0.441 . . . . 73.53 110.168 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.9 m -67.86 -31.24 70.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.805 -0.634 . . . . 71.01 110.406 178.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -65.4 -55.83 15.92 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.492 -0.776 . . . . 72.23 110.67 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -80.12 -9.01 59.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.32 -0.4 . . . . 74.44 111.153 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.26 47.82 21.66 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.165 -0.54 . . . . 71.21 112.6 176.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.5 t -65.32 105.55 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.948 0.404 . . . . 73.5 110.42 178.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.2 p -107.49 0.43 22.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.082 -0.508 . . . . 73.31 111.06 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.62 125.98 10.83 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.61 -0.268 . . . . 73.13 110.847 -177.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 32.4 pt -100.1 150.94 37.33 Favored Pre-proline 0 C--O 1.238 0.466 0 CA-C-N 116.113 -0.494 . . . . 72.43 110.193 177.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -79.82 178.61 32.57 Favored 'Cis proline' 0 C--N 1.352 0.722 0 C-N-CA 123.663 -1.39 . . . . 65.31 112.507 0.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 27.6 m -148.03 133.3 18.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.194 -0.457 . . . . 71.12 110.243 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 62.2 mt -119.76 134.25 63.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.752 -0.462 . . . . 75.35 109.752 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.465 HD13 ' HE2' ' A' ' 48' ' ' PHE . 11.2 mp -118.0 130.81 56.41 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 120.619 0.247 . . . . 74.23 110.402 177.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 87.0 mtp -95.42 108.46 20.66 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.846 -0.616 . . . . 74.11 110.327 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -110.04 146.95 34.46 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.869 0.366 . . . . 74.43 110.989 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -153.37 108.13 3.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.73 -0.668 . . . . 63.31 109.595 174.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.61 29.78 18.36 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.009 -0.541 . . . . 65.24 110.424 177.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.04 -10.69 74.34 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.235 -0.507 . . . . 53.51 112.741 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -96.74 119.43 35.2 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.761 -0.459 . . . . 51.24 109.761 177.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.21 128.34 34.5 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.508 -0.553 . . . . 60.31 109.508 177.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.48 HD23 ' N ' ' A' ' 108' ' ' LEU . 2.4 mm? -87.89 -47.26 8.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.983 0.421 . . . . 72.55 110.54 -176.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.5 t -160.22 171.81 18.53 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.869 -0.605 . . . . 74.54 110.678 -175.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -149.04 129.73 14.09 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.718 -0.674 . . . . 75.32 110.906 -175.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.44 ' CG2' HG21 ' A' ' 119' ' ' ILE . 22.2 t -96.66 111.49 26.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 123.158 0.583 . . . . 64.25 110.067 178.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 59.8 mt -107.57 106.79 21.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.856 -0.424 . . . . 75.11 109.856 177.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 105.68 -112.39 3.93 Favored Glycine 0 C--N 1.33 0.226 0 N-CA-C 111.399 -0.68 . . . . 74.41 111.399 -176.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.51 57.16 0.5 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.396 0.617 . . . . 71.33 110.685 177.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.56 ' O ' HG23 ' A' ' 119' ' ' ILE . 3.0 m-20 -85.17 75.63 10.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.801 -0.636 . . . . 74.42 110.601 -179.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.547 ' O ' HG13 ' A' ' 119' ' ' ILE . 5.8 tp -52.56 -41.88 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 116.315 -0.402 . . . . 73.12 111.316 -178.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.9 p -62.15 -29.51 70.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.47 . . . . 71.15 111.075 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.418 ' HB2' ' HB3' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -79.41 -42.0 26.44 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.341 -0.614 . . . . 71.04 109.341 178.669 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.576 HG12 ' HB3' ' A' ' 62' ' ' GLN . 1.3 pp -64.68 -43.03 96.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.324 -0.398 . . . . 71.22 111.002 -174.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.504 HD11 ' N ' ' A' ' 121' ' ' SER . 2.9 pp -63.47 -32.26 56.0 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.096 0 C-N-CA 120.623 -0.431 . . . . 75.31 110.39 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.504 ' N ' HD11 ' A' ' 120' ' ' ILE . 47.9 m -71.15 -51.53 24.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.037 -0.529 . . . . 62.24 111.08 177.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.461 ' HG2' ' HA ' ' A' ' 119' ' ' ILE . 10.7 pt-20 -69.44 -41.13 76.71 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.526 -0.306 . . . . 74.32 111.458 -171.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.738 HD12 HD12 ' A' ' 66' ' ' LEU . 74.9 mt -67.33 -57.7 8.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 110.409 -0.219 . . . . 72.53 110.409 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -59.77 -23.39 63.22 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.952 0.406 . . . . 72.01 110.866 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -67.48 -29.29 68.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.943 -0.571 . . . . 63.32 111.391 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -111.82 -1.17 15.65 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.154 0.428 . . . . 73.11 112.154 -174.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 123' ' ' ILE . 47.5 pt -131.83 168.32 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 121.236 0.541 . . . . 71.04 111.299 177.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.1 p30 . . . . . 0 C--O 1.25 1.113 0 CA-C-N 115.116 -0.947 . . . . 74.44 110.485 -178.039 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.474 ' N ' ' SD ' ' A' ' 22' ' ' MET . 3.6 mpp? . . . . . 0 C--O 1.236 0.36 0 CA-C-O 120.925 0.393 . . . . 73.25 110.065 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.466 HG21 ' HE3' ' A' ' 78' ' ' LYS . 7.9 mm -101.08 92.48 2.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 108.595 -0.891 . . . . 74.4 108.595 175.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.601 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 34.4 tt0 -112.9 148.39 35.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.899 -0.591 . . . . 71.41 110.788 -168.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.545 ' HB3' ' HZ2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -99.4 147.56 25.11 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 110.092 -0.336 . . . . 65.14 110.092 179.341 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.429 HD11 ' HA ' ' A' ' 31' ' ' PHE . 31.8 pt -137.91 162.36 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 121.012 0.434 . . . . 73.54 111.409 -176.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.62 171.23 19.97 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.335 -0.848 . . . . 13.31 111.758 177.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -67.78 -30.05 69.39 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.707 0.253 . . . . 75.21 111.459 -177.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 28.8 t -68.7 -36.66 78.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.713 0.292 . . . . 64.12 111.044 -177.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.434 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 4.3 pm0 -98.35 -9.85 24.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 71.55 111.188 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.483 ' HE1' HG11 ' A' ' 46' ' ' VAL . 93.3 t80 -46.75 -71.11 0.08 Allowed 'General case' 0 N--CA 1.467 0.399 0 O-C-N 123.317 0.385 . . . . 65.21 111.259 -175.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -65.79 -35.63 81.24 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 109.593 -0.521 . . . . 71.43 109.593 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -53.59 -33.75 55.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.807 -1.088 . . . . 73.12 111.881 -174.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 0.2 OUTLIER -114.82 -18.53 11.31 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 121.03 -0.268 . . . . 53.44 111.68 -179.822 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 72.7 t -88.44 -57.09 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 111.746 0.276 . . . . 63.51 111.746 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 58.2 p -76.32 -23.33 54.29 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.107 0.48 . . . . 74.43 110.537 -175.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.8 m -86.27 11.68 11.59 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.676 -0.693 . . . . 73.22 111.083 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.482 ' HB2' HD12 ' A' ' 44' ' ' ILE . 41.8 t -57.96 91.11 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.037 0.446 . . . . 62.14 110.962 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -101.33 -6.7 23.77 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.816 -0.629 . . . . 70.23 109.989 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -77.91 -5.23 50.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.361 -0.836 . . . . 63.24 111.778 -174.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.571 ' ND2' HD22 ' A' ' 104' ' ' ASN . 20.6 m120 66.83 16.56 10.4 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.336 -0.393 . . . . 71.21 110.856 -176.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.0 tt -87.18 142.87 12.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.33 -0.619 . . . . 74.52 109.33 177.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.769 HD22 ' HE2' ' A' ' 101' ' ' MET . 68.1 tp -82.46 116.91 22.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.889 0.376 . . . . 74.32 110.314 -178.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.482 HD12 ' HB2' ' A' ' 38' ' ' CYS . 56.3 mt -102.61 117.67 48.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.872 -0.603 . . . . 75.35 110.533 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.508 ' HB2' HG13 ' A' ' 76' ' ' ILE . 4.1 mp -106.06 103.84 13.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.051 -0.522 . . . . 72.54 109.748 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.499 HG21 ' HB2' ' A' ' 77' ' ' TYR . 45.7 t -109.41 123.76 65.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 111.43 0.159 . . . . 71.44 111.43 -177.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.466 ' HB2' HG13 ' A' ' 99' ' ' ILE . 14.2 t70 -91.82 149.52 21.54 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.661 -0.866 . . . . 64.5 108.661 170.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 . . . . . 0 C--N 1.326 -0.444 0 N-CA-C 111.46 0.17 . . . . 73.03 111.46 -177.457 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo . . . . . 0 CA--C 1.533 0.458 0 N-CA-C 110.931 -0.45 . . . . 71.23 110.931 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.523 ' HB3' HG12 ' A' ' 119' ' ' ILE . 6.8 mp0 -48.99 -57.62 6.21 Favored 'General case' 0 C--O 1.247 0.974 0 CA-C-O 121.627 0.727 . . . . 74.1 111.491 -173.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.585 HD11 ' N ' ' A' ' 64' ' ' GLU . 2.1 pp -62.31 -38.81 90.85 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.117 -0.947 . . . . 74.22 111.654 -174.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.585 ' N ' HD11 ' A' ' 63' ' ' LEU . 37.8 mt-10 -70.9 -35.47 72.32 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 110.003 -0.369 . . . . 74.41 110.003 177.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -57.37 -56.73 18.09 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.004 -0.544 . . . . 71.31 110.642 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.642 HD12 HD12 ' A' ' 123' ' ' ILE . 28.5 mt -80.1 -30.79 39.2 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.364 0.505 . . . . 73.24 112.364 -175.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.413 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -62.38 -33.27 74.42 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 111.585 0.217 . . . . 61.5 111.585 -177.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.553 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 78.6 mt-30 -64.07 -30.92 71.96 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.003 0.43 . . . . 70.24 110.657 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 68.8 mm-40 -89.28 -59.11 2.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.009 -0.541 . . . . 65.55 110.776 -176.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.498 ' O ' HG23 ' A' ' 74' ' ' VAL . 17.1 m-85 -87.8 23.49 2.0 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.56 -0.746 . . . . 75.23 111.892 -173.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.413 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 6.6 t -52.0 -38.79 58.01 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.063 0.764 . . . . 74.33 113.063 -167.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -73.45 -16.52 61.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.774 0.321 . . . . 53.34 111.181 -176.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -113.14 -4.31 13.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.317 -0.402 . . . . 72.31 110.951 -177.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 70' ' ' TYR . 32.8 m -133.19 137.15 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.254 0.55 . . . . 73.54 111.072 178.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.434 ' HD2' ' CZ ' ' A' ' 77' ' ' TYR . 7.7 mmtt -128.79 115.13 17.47 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.96 -0.755 . . . . 63.31 108.96 177.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.508 HG13 ' HB2' ' A' ' 45' ' ' LEU . 2.3 mp -99.68 134.68 38.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.411 -0.588 . . . . 74.42 109.411 -177.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.601 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 71.3 m-85 -132.49 155.58 48.33 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.393 -0.367 . . . . 72.2 110.363 -178.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.545 ' HZ2' ' HB3' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -144.02 128.59 18.09 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.722 -0.844 . . . . 72.22 108.722 170.635 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.1 tt . . . . . 0 C--N 1.325 -0.457 0 CA-C-N 116.102 -0.499 . . . . 72.5 110.023 -175.466 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.38 0 CA-C-O 120.986 0.422 . . . . 73.53 110.934 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.9 m -73.9 -31.38 63.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.795 -0.638 . . . . 71.01 110.683 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -63.97 -43.94 94.24 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.765 -0.652 . . . . 72.23 110.573 -178.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -86.58 -14.3 43.27 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.196 -0.456 . . . . 74.44 110.48 175.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 65.03 55.59 20.97 Favored Glycine 0 C--O 1.237 0.282 0 CA-C-N 116.002 -0.545 . . . . 71.21 112.182 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.434 HG23 ' OG1' ' A' ' 98' ' ' THR . 7.9 p -73.93 131.73 34.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.766 0.317 . . . . 73.5 110.728 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.6 t -121.83 -0.88 9.5 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.456 -0.338 . . . . 73.31 111.141 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.456 ' HB1' HG23 ' A' ' 112' ' ' ILE . . . -135.98 128.73 30.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.697 0.285 . . . . 73.13 110.904 -177.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.697 HD11 ' H ' ' A' ' 96' ' ' ILE . 0.2 OUTLIER -113.06 154.85 44.95 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 115.866 -0.606 . . . . 72.43 109.938 179.781 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.67 177.54 28.29 Favored 'Cis proline' 0 C--N 1.356 0.967 0 C-N-CA 124.183 -1.174 . . . . 65.31 112.442 1.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.434 ' OG1' HG23 ' A' ' 93' ' ' VAL . 18.5 m -146.99 115.19 6.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.072 0.463 . . . . 71.12 110.521 -176.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.5 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 3.7 mp -117.88 129.55 74.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.5 -0.773 . . . . 75.35 110.095 -176.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.9 mp -104.54 132.57 50.63 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.835 -0.431 . . . . 74.23 109.835 174.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.769 ' HE2' HD22 ' A' ' 43' ' ' LEU . 53.0 mtp -101.46 112.91 25.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.959 -0.564 . . . . 74.11 110.696 -176.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -112.49 147.51 36.39 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.879 0.371 . . . . 74.43 110.861 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.805 ' HB3' HD23 ' A' ' 108' ' ' LEU . 28.2 ttpp -161.5 131.96 5.05 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.849 -0.614 . . . . 63.31 109.344 176.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.571 HD22 ' ND2' ' A' ' 41' ' ' ASN . 18.6 m120 58.34 32.33 21.95 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.238 0.542 . . . . 65.24 110.703 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.31 21.36 75.83 Favored Glycine 0 C--N 1.334 0.417 0 CA-C-N 115.509 -0.769 . . . . 53.51 112.727 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -137.05 133.53 35.54 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.436 -0.579 . . . . 51.24 109.436 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.9 pptp? -82.8 137.15 34.44 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.68 -0.489 . . . . 60.31 109.68 -177.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.805 HD23 ' HB3' ' A' ' 103' ' ' LYS . 2.1 mm? -99.13 -52.97 3.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.128 -0.487 . . . . 72.55 110.47 -177.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.634 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 16.8 m -150.31 172.1 15.92 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 115.679 -0.691 . . . . 74.54 110.795 -170.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.29 122.15 11.27 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.171 0.51 . . . . 75.32 110.858 -174.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.52 HG23 HG23 ' A' ' 119' ' ' ILE . 49.6 t -85.46 107.17 15.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.062 -0.517 . . . . 64.25 109.905 176.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.456 HG23 ' HB1' ' A' ' 95' ' ' ALA . 54.2 mt -106.32 106.95 21.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-O 120.987 0.423 . . . . 75.11 110.349 178.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.06 -134.76 12.65 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.766 -0.652 . . . . 74.41 112.096 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -132.82 81.67 1.96 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.87 0.367 . . . . 71.33 110.919 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.44 ' HB3' ' HB2' ' A' ' 118' ' ' LYS . 1.0 OUTLIER -122.53 94.41 4.28 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.928 -0.578 . . . . 74.42 110.519 -179.712 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.532 ' O ' HG13 ' A' ' 119' ' ' ILE . 7.8 tp -62.24 -41.38 91.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 CA-C-N 116.306 -0.406 . . . . 73.12 110.927 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.1 t -65.37 -28.9 69.6 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.12 -0.491 . . . . 71.15 110.449 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.44 ' HB2' ' HB3' ' A' ' 115' ' ' ASP . 0.2 OUTLIER -72.71 -55.36 6.9 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 108.689 -0.856 . . . . 71.04 108.689 176.879 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.532 HG13 ' O ' ' A' ' 116' ' ' ILE . 2.2 pp -60.92 -38.49 79.39 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-N 115.757 -0.656 . . . . 71.22 112.065 -171.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.508 HD12 ' N ' ' A' ' 121' ' ' SER . 2.9 pp -64.96 -33.01 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 C-N-CA 120.216 -0.594 . . . . 75.31 110.538 179.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.508 ' N ' HD12 ' A' ' 120' ' ' ILE . 42.0 t -70.92 -51.94 23.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.801 0.334 . . . . 62.24 110.258 177.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.511 ' HG2' ' HA ' ' A' ' 119' ' ' ILE . 15.6 pt-20 -71.78 -35.3 69.98 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.29 -0.413 . . . . 74.32 111.833 -170.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.642 HD12 HD12 ' A' ' 66' ' ' LEU . 71.4 mt -71.02 -53.91 19.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.628 0.251 . . . . 72.53 110.638 177.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -61.87 -23.03 66.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.328 -0.396 . . . . 72.01 111.386 -177.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -62.86 -48.96 76.79 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.461 -0.336 . . . . 63.32 111.361 176.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.559 ' OD1' HD21 ' A' ' 43' ' ' LEU . 9.3 p30 -88.38 -30.37 19.56 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 112.189 0.44 . . . . 73.11 112.189 -170.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.495 HG21 ' OD1' ' A' ' 126' ' ' ASN . 41.8 pt -106.59 168.14 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.864 0.364 . . . . 71.04 110.98 177.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.251 1.138 0 CA-C-O 118.376 -0.821 . . . . 74.44 110.985 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.573 ' HG3' HG13 ' A' ' 23' ' ' ILE . 24.6 ptp . . . . . 0 C--O 1.233 0.197 0 CA-C-O 120.674 0.273 . . . . 73.25 110.293 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.573 HG13 ' HG3' ' A' ' 22' ' ' MET . 65.1 mt -134.3 118.98 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 116.28 -0.418 . . . . 74.4 109.881 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.543 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 8.4 tp10 -131.89 155.13 48.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.908 0.385 . . . . 71.41 111.019 -178.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -109.7 129.2 55.63 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.425 -0.583 . . . . 65.14 109.425 174.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.491 HG21 ' HD3' ' A' ' 34' ' ' LYS . 22.0 pt -122.59 173.65 8.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 116.5 -0.318 . . . . 73.54 111.438 -175.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -112.14 -176.48 19.93 Favored Glycine 0 C--N 1.333 0.371 0 CA-C-N 115.85 -0.614 . . . . 13.31 112.859 -176.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -58.62 -49.94 75.65 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.454 0.702 . . . . 75.21 112.339 -175.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.0 m -74.03 -16.99 61.03 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.657 0.614 . . . . 64.12 112.657 -168.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.401 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 2.1 pm0 -113.52 -7.89 13.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.575 -0.284 . . . . 71.55 111.471 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.486 ' HA ' HD12 ' A' ' 26' ' ' ILE . 30.5 t80 -49.25 -70.79 0.08 Allowed 'General case' 0 N--CA 1.461 0.106 0 O-C-N 123.32 0.387 . . . . 65.21 110.743 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -62.63 -37.67 87.25 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.644 -0.502 . . . . 71.43 109.644 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.508 ' O ' ' HB2' ' A' ' 37' ' ' SER . 20.7 t-20 -52.59 -42.9 64.95 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.789 -1.096 . . . . 73.12 112.051 -173.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.491 ' HD3' HG21 ' A' ' 26' ' ' ILE . 12.7 ptmt -111.52 -15.38 13.52 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.326 0.491 . . . . 53.44 112.326 -177.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.1 t -88.51 -56.37 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 111.681 0.252 . . . . 63.51 111.681 177.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 39.9 p -84.38 -32.09 24.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.911 0.386 . . . . 74.43 110.882 -173.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.508 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 18.0 m -83.81 8.92 13.26 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.083 -0.508 . . . . 73.22 111.516 -177.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.444 ' SG ' HG23 ' A' ' 42' ' ' ILE . 50.2 t -72.27 95.58 1.72 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.946 0.403 . . . . 62.14 110.449 -178.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -76.41 -9.32 58.56 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.934 -0.575 . . . . 70.23 110.796 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -59.05 -25.35 63.64 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.122 -0.49 . . . . 63.24 111.257 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.469 ' HA ' ' HB2' ' A' ' 103' ' ' LYS . 66.4 m-20 65.47 15.92 10.26 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.755 -0.657 . . . . 71.21 111.074 -176.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.444 HG23 ' SG ' ' A' ' 38' ' ' CYS . 10.6 tt -65.33 166.26 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 108.669 -0.863 . . . . 74.52 108.669 172.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.512 HD23 ' HE1' ' A' ' 101' ' ' MET . 49.7 tp -92.35 101.65 14.13 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 121.651 -0.656 . . . . 74.32 110.677 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 50.5 mt -87.32 131.89 34.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.522 -0.763 . . . . 75.35 109.795 174.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.521 ' HB2' HG13 ' A' ' 76' ' ' ILE . 89.0 mt -117.44 104.6 11.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.129 -0.487 . . . . 72.54 109.701 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 23.5 m -95.43 119.53 43.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.965 -0.294 . . . . 71.44 110.72 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.676 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 31.8 t70 -99.27 161.5 13.59 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 116.18 -0.464 . . . . 64.5 110.25 -178.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 25.9 p90 . . . . . 0 C--O 1.239 0.546 0 CA-C-O 121.397 0.617 . . . . 73.03 112.07 -174.06 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo . . . . . 0 C--O 1.234 0.322 0 N-CA-C 110.259 -0.708 . . . . 71.23 110.259 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.528 ' HB3' HG12 ' A' ' 119' ' ' ILE . 10.3 mp0 -51.46 -43.93 62.25 Favored 'General case' 0 C--O 1.246 0.918 0 CA-C-O 121.608 0.718 . . . . 74.1 110.294 -173.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.429 HD12 HG12 ' A' ' 99' ' ' ILE . 6.4 mp -56.92 -48.74 77.56 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 114.488 -1.233 . . . . 74.22 110.491 -175.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.424 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 49.0 mt-10 -70.74 -42.51 70.41 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 123.212 0.32 . . . . 74.41 110.249 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.5 tmtp? -50.76 -46.17 59.23 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.807 -0.633 . . . . 71.31 109.834 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.64 HD12 HD11 ' A' ' 123' ' ' ILE . 17.6 mt -86.18 -41.87 14.31 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.571 0.582 . . . . 73.24 112.571 177.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.87 -39.88 78.87 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 111.934 0.346 . . . . 61.5 111.934 -173.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 97.9 mt-30 -53.69 -33.2 54.61 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.269 0.557 . . . . 70.24 110.313 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 53.1 mm-40 -93.82 -41.39 9.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.445 -0.798 . . . . 65.55 111.465 -177.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.544 ' O ' HG23 ' A' ' 74' ' ' VAL . 17.3 m-85 -107.17 22.38 16.07 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.748 0.647 . . . . 75.23 112.748 -169.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.1 t -52.8 -34.05 51.75 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.13 0.419 . . . . 74.33 112.13 -176.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -68.3 -16.5 63.97 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 111.576 0.213 . . . . 53.34 111.576 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -122.52 -4.77 8.76 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.539 0.209 . . . . 72.31 111.047 -177.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 70' ' ' TYR . 27.7 m -136.82 147.48 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 O-C-N 122.071 -0.393 . . . . 73.54 110.444 178.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.434 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 7.0 tppt? -142.13 116.59 9.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.718 0.295 . . . . 63.31 110.208 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.521 HG13 ' HB2' ' A' ' 45' ' ' LEU . 2.0 mp -93.14 134.23 31.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.078 -0.51 . . . . 74.42 110.762 -175.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.543 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 97.1 m-85 -129.12 128.6 43.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.885 -0.598 . . . . 72.2 109.616 174.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.676 ' HG2' ' HB3' ' A' ' 47' ' ' ASP . 25.6 mtpp -103.29 143.2 32.97 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.787 -0.449 . . . . 72.22 109.787 176.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 40.9 mm . . . . . 0 C--N 1.326 -0.453 0 CA-C-N 115.848 -0.615 . . . . 72.5 111.059 -175.507 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.291 0 CA-C-O 120.916 0.389 . . . . 73.53 110.845 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.9 m -67.69 -30.72 70.32 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.259 -0.428 . . . . 71.01 110.727 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -59.56 -55.99 27.52 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.929 -0.578 . . . . 72.23 110.341 178.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -75.33 -15.82 60.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.391 -0.368 . . . . 74.44 110.937 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.46 61.01 2.39 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.306 -0.473 . . . . 71.21 112.661 175.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.432 HG22 HG22 ' A' ' 98' ' ' THR . 59.7 t -69.51 85.32 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-O 121.361 0.601 . . . . 73.5 110.137 176.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.2 t -116.03 9.76 14.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.507 -0.77 . . . . 73.31 110.144 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.443 ' HB1' HG21 ' A' ' 112' ' ' ILE . . . -152.66 142.63 22.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 73.13 109.973 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 29.9 pt -113.43 149.62 41.85 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.375 -0.375 . . . . 72.43 110.774 -177.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -76.54 -176.02 17.76 Favored 'Cis proline' 0 C--N 1.353 0.792 0 C-N-CA 124.005 -1.248 . . . . 65.31 112.442 -1.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 43.6 m -142.54 115.36 8.69 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.091 -0.337 . . . . 71.12 110.091 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.481 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 4.0 mp -129.14 142.84 42.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.979 -0.555 . . . . 75.35 109.837 -178.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.6 mp -118.92 140.84 49.32 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.697 0.284 . . . . 74.23 110.361 174.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.824 ' SD ' ' HB3' ' A' ' 109' ' ' SER . 89.8 mtp -96.72 114.11 25.73 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.841 -0.618 . . . . 74.11 110.46 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -115.12 144.5 43.57 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.072 0.463 . . . . 74.43 112.13 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.769 ' HG2' HD23 ' A' ' 108' ' ' LEU . 0.4 OUTLIER -157.8 119.23 3.59 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 108.913 -0.773 . . . . 63.31 108.913 163.617 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 58.94 25.03 13.23 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.543 0.687 . . . . 65.24 110.207 -176.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 87.45 -6.21 83.77 Favored Glycine 0 CA--C 1.52 0.349 0 CA-C-N 115.798 -0.637 . . . . 53.51 112.511 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -77.84 128.97 34.83 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.511 -0.552 . . . . 51.24 109.511 177.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 101' ' ' MET . 3.1 mppt? -90.49 109.41 20.55 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.32 -0.622 . . . . 60.31 109.32 174.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.769 HD23 ' HG2' ' A' ' 103' ' ' LYS . 2.3 mm? -77.92 -36.63 49.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.142 -0.481 . . . . 72.55 110.545 -175.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.824 ' HB3' ' SD ' ' A' ' 101' ' ' MET . 17.2 t -178.64 171.9 1.46 Allowed 'General case' 0 C--O 1.24 0.598 0 CA-C-N 115.593 -0.731 . . . . 74.54 109.05 -176.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.04 141.14 36.28 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.251 0.548 . . . . 75.32 111.106 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 98' ' ' THR . 46.6 t -103.57 107.1 21.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.169 -0.923 . . . . 64.25 109.772 176.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.443 HG21 ' HB1' ' A' ' 95' ' ' ALA . 45.1 mt -118.84 106.31 19.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.466 -0.938 . . . . 75.11 108.466 172.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 108.65 174.26 21.58 Favored Glycine 0 CA--C 1.519 0.322 0 N-CA-C 111.041 -0.824 . . . . 74.41 111.041 -170.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -96.59 56.99 1.57 Allowed 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.179 0.514 . . . . 71.33 110.77 -177.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.545 ' O ' HG23 ' A' ' 119' ' ' ILE . 1.9 m-20 -90.19 73.78 7.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.875 -0.602 . . . . 74.42 110.906 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.534 ' O ' HG13 ' A' ' 119' ' ' ILE . 6.3 tp -54.74 -40.37 51.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 CA-C-O 121.108 0.48 . . . . 73.12 110.823 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.2 p -62.62 -29.08 70.36 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.853 -0.612 . . . . 71.15 111.182 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.457 ' HB2' ' HB3' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -79.28 -48.66 13.75 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.306 -0.627 . . . . 71.04 109.306 177.409 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.545 HG23 ' O ' ' A' ' 115' ' ' ASP . 1.6 pp -61.84 -40.77 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 116.132 -0.486 . . . . 71.22 111.421 -172.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.532 HD12 ' N ' ' A' ' 121' ' ' SER . 2.9 pp -63.19 -31.97 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 C-N-CA 120.437 -0.505 . . . . 75.31 110.399 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.532 ' N ' HD12 ' A' ' 120' ' ' ILE . 33.6 t -70.46 -51.92 25.78 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.994 -0.548 . . . . 62.24 110.854 178.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.495 ' HG2' ' HA ' ' A' ' 119' ' ' ILE . 12.8 pt-20 -70.75 -43.67 68.36 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.085 -0.507 . . . . 74.32 111.325 -172.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.64 HD11 HD12 ' A' ' 66' ' ' LEU . 78.8 mt -64.41 -53.86 37.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.352 0.12 . . . . 72.53 110.958 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -59.79 -26.65 65.9 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.775 0.322 . . . . 72.01 111.263 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -77.34 -14.87 59.64 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 111.741 0.274 . . . . 63.32 111.741 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -118.14 9.72 12.74 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 111.656 0.243 . . . . 73.11 111.656 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.506 HG12 ' O ' ' A' ' 123' ' ' ILE . 43.6 pt -134.74 168.33 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 109.921 -0.4 . . . . 71.04 109.921 173.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.366 -0.826 . . . . 74.44 110.969 -176.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.625 ' HG3' HG13 ' A' ' 23' ' ' ILE . 21.2 ptp . . . . . 0 N--CA 1.467 0.376 0 N-CA-C 109.764 -0.458 . . . . 73.25 109.764 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.625 HG13 ' HG3' ' A' ' 22' ' ' MET . 23.2 mt -127.09 101.65 8.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 108.673 -0.862 . . . . 74.4 108.673 174.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 9.4 tp10 -124.01 149.64 45.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.813 0.34 . . . . 71.41 110.377 -175.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -82.15 149.74 27.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.169 -0.468 . . . . 65.14 110.26 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.47 HD12 ' HA ' ' A' ' 31' ' ' PHE . 25.4 pt -130.01 177.4 6.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.603 -0.271 . . . . 73.54 110.512 178.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.18 158.55 18.21 Favored Glycine 0 C--O 1.237 0.32 0 CA-C-N 116.102 -0.499 . . . . 13.31 112.324 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -59.81 -39.15 84.07 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.203 0.525 . . . . 75.21 110.433 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.4 t -63.33 -32.83 74.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.424 -0.807 . . . . 64.12 111.529 -176.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.413 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 10.0 pt-20 -105.28 -1.06 25.71 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 112.324 0.49 . . . . 71.55 112.324 -174.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.47 ' HA ' HD12 ' A' ' 26' ' ' ILE . 57.9 t80 -47.15 -71.61 0.07 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.793 0.33 . . . . 65.21 111.192 -178.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -64.43 -36.43 84.15 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.351 -0.611 . . . . 71.43 109.351 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -52.43 -38.55 59.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.436 -1.256 . . . . 73.12 111.891 -173.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 15.8 ptmt -114.34 -18.27 11.6 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.094 0.405 . . . . 53.44 112.094 -177.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 72.7 t -85.22 -49.59 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 111.851 0.315 . . . . 63.51 111.851 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 64.9 p -83.06 -28.83 29.28 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.075 0.464 . . . . 74.43 111.04 -173.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.1 m -80.1 12.02 3.08 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.914 -0.585 . . . . 73.22 111.992 -177.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 24.6 p -76.8 87.33 3.4 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.824 0.345 . . . . 62.14 111.817 -176.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -75.22 -5.93 47.04 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.14 0.495 . . . . 70.23 110.397 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.522 ' O ' ' HB2' ' A' ' 41' ' ' ASN . 2.1 m-20 -52.82 -30.26 32.43 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.633 -0.712 . . . . 63.24 112.062 -177.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.522 ' HB2' ' O ' ' A' ' 40' ' ' ASP . 0.9 OUTLIER 75.11 11.47 3.55 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 123.691 0.619 . . . . 71.21 110.34 -171.669 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.454 HG23 ' HB2' ' A' ' 40' ' ' ASP . 10.0 tt -81.94 158.53 4.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 115.624 -0.716 . . . . 74.52 109.113 176.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.459 HD12 ' HB2' ' A' ' 126' ' ' ASN . 54.5 mt -84.92 112.53 20.65 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 120.916 -0.314 . . . . 74.32 110.604 179.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 20.0 mt -102.41 105.91 18.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.036 0.446 . . . . 75.35 109.945 173.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.5 ' HB2' HG12 ' A' ' 76' ' ' ILE . 5.1 mp -93.38 136.96 33.15 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.988 -0.745 . . . . 72.54 108.988 177.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.485 HG13 ' HB2' ' A' ' 77' ' ' TYR . 27.4 m -130.17 138.67 53.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.749 -0.463 . . . . 71.44 109.749 178.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -111.33 143.75 41.63 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.857 0.36 . . . . 64.5 111.036 177.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.559 ' HZ ' HG21 ' A' ' 96' ' ' ILE . 13.7 p90 . . . . . 0 C--O 1.234 0.263 0 N-CA-C 109.543 -0.54 . . . . 73.03 109.543 176.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo . . . . . 0 N--CA 1.459 -0.543 0 CA-C-O 120.929 0.304 . . . . 71.23 112.314 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.576 ' HB3' HG12 ' A' ' 119' ' ' ILE . 9.6 mp0 -61.9 -57.51 11.49 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.351 0.596 . . . . 74.1 111.097 -173.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.478 ' HB2' HD11 ' A' ' 76' ' ' ILE . 2.3 pt? -54.37 -47.17 72.93 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.068 -0.969 . . . . 74.22 111.611 -174.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.511 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 37.2 mt-10 -65.66 -43.72 88.53 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 120.888 -0.325 . . . . 74.41 110.255 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -53.14 -48.66 67.73 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.891 -0.595 . . . . 71.31 110.982 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.554 HD11 HD11 ' A' ' 123' ' ' ILE . 17.7 mt -79.43 -37.73 36.37 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 111.967 0.358 . . . . 73.24 111.967 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.4 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -59.81 -31.42 69.69 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.457 0.17 . . . . 61.5 111.307 -176.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.511 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 74.8 mt-30 -54.52 -34.95 62.62 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.951 0.405 . . . . 70.24 111.051 177.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -94.1 -45.23 7.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.192 0.52 . . . . 65.55 111.019 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.558 ' O ' HG22 ' A' ' 74' ' ' VAL . 20.4 m-85 -92.85 14.92 15.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.807 -0.633 . . . . 75.23 112.285 -171.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.4 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 8.8 t -52.48 -35.99 53.92 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.05 0.452 . . . . 74.33 111.442 -174.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -63.96 -28.43 69.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.83 -0.623 . . . . 53.34 111.841 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -116.48 3.19 13.21 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.52 -0.309 . . . . 72.31 111.17 -173.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 70' ' ' TYR . 23.6 m -133.68 141.34 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 121.088 0.47 . . . . 73.54 110.556 177.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.709 ' HE3' ' HA ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -128.15 116.53 20.07 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.523 -0.762 . . . . 63.31 108.969 174.925 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.527 ' HB ' HG12 ' A' ' 23' ' ' ILE . 39.9 mt -109.49 134.7 50.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.725 0.298 . . . . 74.42 110.413 -177.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.485 ' HB2' HG13 ' A' ' 46' ' ' VAL . 51.3 m-85 -120.72 134.5 55.28 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 115.982 -0.554 . . . . 72.2 110.08 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.0 ptmm? -112.89 161.5 16.91 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.25 -0.886 . . . . 72.22 110.62 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 30.9 mt . . . . . 0 N--CA 1.464 0.24 0 CA-C-N 115.561 -0.745 . . . . 72.5 109.892 -174.111 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.187 0 CA-C-O 121.089 0.471 . . . . 73.53 109.876 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.8 m -60.67 -32.05 71.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.83 -0.623 . . . . 71.01 110.53 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -66.12 -37.83 86.7 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.036 -0.529 . . . . 72.23 110.592 177.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -77.26 -5.66 50.22 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.463 -0.335 . . . . 74.44 111.099 176.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.85 21.0 64.33 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 121.082 -0.58 . . . . 71.21 112.077 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 97.9 t -65.93 102.92 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.045 0.45 . . . . 73.5 110.309 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.7 t -143.79 21.03 1.81 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.61 0.719 . . . . 73.31 109.174 178.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -129.01 160.9 31.28 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.567 -0.742 . . . . 73.13 110.29 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.559 HG21 ' HZ ' ' A' ' 48' ' ' PHE . 26.8 pt -118.67 130.61 24.7 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.304 -0.407 . . . . 72.43 110.603 -178.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 96' ' ' ILE . 47.7 Cg_endo -91.62 -170.05 3.96 Favored 'Cis proline' 0 C--N 1.35 0.616 0 C-N-CA 124.05 -1.229 . . . . 65.31 112.336 -4.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.558 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 88.5 m -147.83 139.81 24.12 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.034 -0.53 . . . . 71.12 109.677 175.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 36.9 mt -136.83 114.49 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 115.957 -0.565 . . . . 75.35 110.019 -176.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.2 mp -91.5 146.36 23.86 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.019 0.437 . . . . 74.23 111.152 178.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.478 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 90.5 mtp -108.63 118.97 38.16 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.994 -0.548 . . . . 74.11 110.663 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.419 ' CE2' ' HG2' ' A' ' 107' ' ' LYS . 79.3 m-85 -115.55 149.05 38.8 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.231 0.539 . . . . 74.43 111.482 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.617 ' HB3' HD23 ' A' ' 108' ' ' LEU . 30.8 ttmt -155.65 111.1 3.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.933 -1.031 . . . . 63.31 109.078 177.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.9 t30 60.7 25.06 14.87 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.458 0.647 . . . . 65.24 110.192 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.88 -14.89 62.06 Favored Glycine 0 C--N 1.334 0.458 0 CA-C-N 115.572 -0.74 . . . . 53.51 112.259 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -81.11 144.43 31.7 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.836 -0.431 . . . . 51.24 109.836 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.419 ' HG2' ' CE2' ' A' ' 102' ' ' PHE . 46.2 mttp -102.56 115.3 30.3 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.803 -0.444 . . . . 60.31 109.803 -176.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.617 HD23 ' HB3' ' A' ' 103' ' ' LYS . 2.8 mm? -85.85 -53.4 5.14 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.857 0.361 . . . . 72.55 111.249 -174.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.478 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 20.5 m -160.02 171.89 18.52 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.882 -0.599 . . . . 74.54 110.205 -172.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -143.88 124.04 13.71 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.024 -0.535 . . . . 75.32 110.568 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.563 HG21 HG21 ' A' ' 119' ' ' ILE . 61.2 t -80.43 107.13 12.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.83 -0.623 . . . . 64.25 109.471 175.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 58.7 mt -108.28 107.03 21.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 109.865 -0.42 . . . . 75.11 109.865 178.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.32 -132.53 10.98 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.811 -0.631 . . . . 74.41 111.604 -178.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -142.37 75.74 1.5 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.92 0.39 . . . . 71.33 110.387 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.487 ' O ' HG23 ' A' ' 119' ' ' ILE . 2.6 m-20 -115.47 97.5 6.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.917 -0.583 . . . . 74.42 110.611 -177.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.521 ' O ' HG13 ' A' ' 119' ' ' ILE . 6.7 tp -64.5 -41.08 91.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 116.411 -0.358 . . . . 73.12 111.342 -176.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 15.1 m -64.58 -29.85 70.87 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.454 0.645 . . . . 71.15 110.456 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.452 ' HG3' ' OE2' ' A' ' 122' ' ' GLU . 27.9 tptp -73.88 -50.64 19.29 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.453 -0.794 . . . . 71.04 110.453 178.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.576 HG12 ' HB3' ' A' ' 62' ' ' GLN . 2.1 pp -65.34 -41.32 91.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.814 -0.63 . . . . 71.22 111.519 -174.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.463 HG23 HD12 ' A' ' 66' ' ' LEU . 2.8 pp -62.32 -31.82 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 121.127 0.489 . . . . 75.31 109.837 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.535 ' O ' ' HB2' ' A' ' 125' ' ' ASN . 23.0 t -70.44 -51.56 28.47 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.85 -0.614 . . . . 62.24 110.55 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.452 ' OE2' ' HG3' ' A' ' 118' ' ' LYS . 10.7 pt-20 -73.52 -33.41 64.75 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 111.924 0.342 . . . . 74.32 111.924 -172.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.554 HD11 HD11 ' A' ' 66' ' ' LEU . 71.7 mt -73.59 -57.37 6.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-O 120.567 0.223 . . . . 72.53 110.654 178.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -63.67 -20.12 65.45 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.115 0.483 . . . . 72.01 110.609 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.535 ' HB2' ' O ' ' A' ' 121' ' ' SER . 26.7 t-20 -54.04 -29.8 45.3 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.717 -0.674 . . . . 63.32 110.76 176.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.459 ' HB2' HD12 ' A' ' 43' ' ' LEU . 33.8 m-80 -107.99 -45.21 4.02 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.872 -0.604 . . . . 73.11 111.233 -176.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 48.4 pt -105.46 167.78 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 120.819 0.343 . . . . 71.04 111.274 -175.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.543 ' N ' HD21 ' A' ' 128' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.38 -0.819 . . . . 74.44 112.137 -177.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.515 ' SD ' ' HA ' ' A' ' 68' ' ' GLN . 49.5 mtm . . . . . 0 N--CA 1.473 0.697 0 CA-C-O 121.638 0.733 . . . . 73.25 109.475 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.4 mm -92.67 128.83 43.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 114.38 -1.282 . . . . 74.4 108.641 171.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.401 ' HG2' ' CE1' ' A' ' 77' ' ' TYR . 9.1 tp10 -124.84 153.15 43.0 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.746 0.308 . . . . 71.41 110.426 -176.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.29 124.4 40.26 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.503 -0.554 . . . . 65.14 109.503 177.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.516 ' O ' HD12 ' A' ' 79' ' ' ILE . 32.5 pt -131.69 -176.93 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.047 -0.524 . . . . 73.54 110.533 -172.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -111.79 170.55 13.72 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 121.506 -0.378 . . . . 13.31 112.219 178.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -67.5 -38.15 83.9 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 122.575 0.35 . . . . 75.21 111.71 -178.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.2 m -60.32 -39.09 85.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.003 0.43 . . . . 64.12 111.177 -176.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.456 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 1.7 pm0 -103.38 -0.98 29.35 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.779 -0.646 . . . . 71.55 111.159 -177.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -53.04 -70.55 0.09 Allowed 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 109.775 -0.454 . . . . 65.21 109.775 177.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -49.75 -42.78 47.17 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 116.074 -0.512 . . . . 71.43 110.03 176.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.403 ' O ' ' HB2' ' A' ' 37' ' ' SER . 66.1 t30 -52.19 -54.32 32.29 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 114.655 -1.157 . . . . 73.12 111.481 -172.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.526 ' HZ3' ' HB2' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -101.23 -15.93 17.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.245 -0.434 . . . . 53.44 111.936 -172.921 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 73.1 t -88.58 -57.06 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 111.962 0.356 . . . . 63.51 111.962 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.9 p -88.01 -42.09 12.67 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.047 0.451 . . . . 74.43 110.716 -171.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 18.4 m -76.73 12.07 1.46 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.823 -0.626 . . . . 73.22 111.473 -178.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.427 ' SG ' ' HB2' ' A' ' 40' ' ' ASP . 50.1 t -81.21 99.96 8.86 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.999 0.428 . . . . 62.14 110.334 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -87.25 14.87 7.02 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.181 0.515 . . . . 70.23 110.661 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.427 ' HB2' ' SG ' ' A' ' 38' ' ' CYS . 5.5 m-20 -75.36 -8.8 57.64 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.066 -0.515 . . . . 63.24 111.041 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.1 m120 68.47 0.05 2.42 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.483 0.549 . . . . 71.21 112.483 177.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.9 tt -71.49 145.42 12.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 109.095 -0.706 . . . . 74.52 109.095 177.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.672 HD22 ' HE2' ' A' ' 101' ' ' MET . 61.1 tp -80.76 109.74 15.61 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.263 0.554 . . . . 74.32 110.071 -177.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.48 HG23 ' CD2' ' A' ' 77' ' ' TYR . 61.5 mt -94.99 114.54 31.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.357 -0.838 . . . . 75.35 110.386 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.454 HD13 ' N ' ' A' ' 45' ' ' LEU . 5.5 mp -98.6 101.99 13.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.04 -0.527 . . . . 72.54 110.114 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.603 HG23 ' HB2' ' A' ' 100' ' ' LEU . 16.3 m -96.9 109.92 23.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.685 -0.487 . . . . 71.44 109.685 176.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . 3.9 p30 -101.36 146.77 27.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.465 0.65 . . . . 64.5 111.79 -174.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 66.4 t80 . . . . . 0 C--N 1.323 -0.548 0 N-CA-C 107.614 -1.254 . . . . 73.03 107.614 169.581 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.738 ' HG2' ' HB2' ' A' ' 64' ' ' GLU . 56.4 Cg_endo . . . . . 0 N--CA 1.464 -0.222 0 N-CA-C 109.633 -0.949 . . . . 71.23 109.633 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.52 ' HB3' HG12 ' A' ' 119' ' ' ILE . 9.6 mp0 -57.21 -50.57 72.45 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-O 121.254 0.549 . . . . 74.1 110.401 -170.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.649 HD11 ' N ' ' A' ' 64' ' ' GLU . 3.4 pp -54.33 -40.36 67.95 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.142 -0.935 . . . . 74.22 111.282 -177.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.738 ' HB2' ' HG2' ' A' ' 61' ' ' PRO . 2.3 mm-40 -75.61 -39.89 57.21 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.101 0.477 . . . . 74.41 110.005 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -53.54 -45.81 69.97 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.409 -0.814 . . . . 71.31 109.427 -177.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.496 HD12 HD11 ' A' ' 123' ' ' ILE . 16.1 mt -84.69 -37.86 20.45 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.129 -0.487 . . . . 73.24 111.661 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -53.97 -46.03 71.55 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.783 0.325 . . . . 61.5 111.048 -177.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.515 ' HA ' ' SD ' ' A' ' 22' ' ' MET . 73.1 mt-30 -49.3 -34.86 16.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.724 -0.671 . . . . 70.24 111.516 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -94.01 -57.93 2.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.227 0.537 . . . . 65.55 111.088 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.507 ' O ' HG22 ' A' ' 74' ' ' VAL . 16.6 m-85 -90.44 21.26 4.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.679 -0.691 . . . . 75.23 112.731 -171.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.8 t -52.71 -28.49 22.17 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.167 0.508 . . . . 74.33 111.424 -177.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -65.71 -16.76 64.07 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.73 -0.668 . . . . 53.34 111.127 -177.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -129.05 -5.35 4.99 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.182 -0.463 . . . . 72.31 110.438 -176.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 70' ' ' TYR . 22.9 m -132.66 140.43 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.089 0.471 . . . . 73.54 110.659 178.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -137.25 123.18 20.16 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.813 -0.63 . . . . 63.31 109.475 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.452 HD13 ' N ' ' A' ' 76' ' ' ILE . 2.0 mp -95.62 141.06 15.83 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-O 120.537 0.208 . . . . 74.42 110.65 -175.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.518 ' HB2' HG11 ' A' ' 46' ' ' VAL . 88.2 m-85 -141.06 157.77 44.85 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.347 0.659 . . . . 72.2 109.638 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.39 166.67 16.38 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.935 0.398 . . . . 72.22 110.964 170.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.516 HD12 ' O ' ' A' ' 26' ' ' ILE . 3.9 tp . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 115.106 -0.952 . . . . 72.5 108.669 174.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.551 0 CA-C-O 121.385 0.612 . . . . 73.53 110.58 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 51.3 m -70.77 -29.49 65.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.719 -0.673 . . . . 71.01 109.955 176.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -70.66 -35.63 72.96 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.171 -0.468 . . . . 72.23 110.151 177.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -68.78 -17.2 63.99 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.387 -0.598 . . . . 74.44 109.387 171.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.86 42.22 9.95 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.397 -0.819 . . . . 71.21 112.417 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.525 HG22 ' OG1' ' A' ' 98' ' ' THR . 14.9 p -67.95 131.83 33.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.983 0.391 . . . . 73.5 110.385 177.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.3 p -101.82 -36.43 8.68 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.177 -0.465 . . . . 73.31 111.65 -177.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -127.98 143.6 51.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.649 0.262 . . . . 73.13 111.062 -175.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.457 ' HB ' ' HA ' ' A' ' 97' ' ' PRO . 2.5 pp -100.02 160.84 26.11 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 115.957 -0.565 . . . . 72.43 110.669 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.457 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 98.6 Cg_endo -82.36 -177.96 20.11 Favored 'Cis proline' 0 C--N 1.353 0.813 0 C-N-CA 124.03 -1.238 . . . . 65.31 112.223 -0.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.66 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 17.7 m -144.06 115.41 8.03 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.439 -0.346 . . . . 71.12 110.567 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.488 ' N ' HD13 ' A' ' 99' ' ' ILE . 3.3 mp -108.06 115.22 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.673 -0.24 . . . . 75.35 110.365 -177.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.603 ' HB2' HG23 ' A' ' 46' ' ' VAL . 8.9 mp -91.89 139.98 30.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.826 0.346 . . . . 74.23 110.54 178.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.672 ' HE2' HD22 ' A' ' 43' ' ' LEU . 81.7 mtp -109.37 116.44 31.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.921 -0.581 . . . . 74.11 110.534 -177.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -116.99 154.04 31.6 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.952 0.406 . . . . 74.43 111.035 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.811 ' HB3' HD22 ' A' ' 108' ' ' LEU . 16.1 ttmm -169.27 115.37 0.58 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.437 -0.801 . . . . 63.31 109.617 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.9 t30 60.35 31.08 20.29 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.334 0.588 . . . . 65.24 110.987 172.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.91 -14.45 63.28 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 121.314 -0.47 . . . . 53.51 113.163 178.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -97.04 146.11 25.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.598 0.237 . . . . 51.24 110.589 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -99.06 126.02 44.69 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.242 -0.651 . . . . 60.31 109.242 174.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.811 HD22 ' HB3' ' A' ' 103' ' ' LYS . 3.1 mm? -87.07 -47.39 8.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.525 -0.307 . . . . 72.55 111.15 -174.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.608 ' HB3' ' SD ' ' A' ' 101' ' ' MET . 27.9 t -167.01 171.8 10.77 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.738 0.304 . . . . 74.54 110.927 -175.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -136.69 130.82 32.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.702 -0.681 . . . . 75.32 110.014 175.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.702 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 60.2 t -94.43 107.3 19.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.991 -0.549 . . . . 64.25 110.292 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 61.6 mt -104.26 109.87 28.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 110.022 -0.362 . . . . 75.11 110.022 176.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 106.87 -142.85 15.74 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 121.204 -0.522 . . . . 74.41 112.093 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -138.96 80.16 1.77 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.03 0.443 . . . . 71.33 110.595 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.48 ' O ' HG22 ' A' ' 119' ' ' ILE . 3.0 m-20 -118.67 94.29 4.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.799 -0.637 . . . . 74.42 110.595 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.549 HD12 HD11 ' A' ' 119' ' ' ILE . 7.2 tp -65.07 -39.01 84.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.186 -0.461 . . . . 73.12 111.088 -176.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 27.0 t -64.81 -39.77 94.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.242 0.544 . . . . 71.15 110.445 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.702 ' HE3' ' HA ' ' A' ' 111' ' ' VAL . 0.7 OUTLIER -64.68 -51.7 61.11 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 115.779 -0.646 . . . . 71.04 110.629 178.326 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.549 HD11 HD12 ' A' ' 116' ' ' ILE . 2.2 pp -63.61 -42.04 94.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 116.209 -0.45 . . . . 71.22 111.51 -175.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.493 HG22 HD23 ' A' ' 66' ' ' LEU . 2.8 pp -64.33 -31.76 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 120.738 -0.385 . . . . 75.31 110.254 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.441 ' N ' HD12 ' A' ' 120' ' ' ILE . 23.0 t -69.75 -51.65 32.26 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.187 -0.46 . . . . 62.24 110.523 -178.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.409 ' OE1' ' NZ ' ' A' ' 118' ' ' LYS . 7.9 pt-20 -77.12 -40.68 44.86 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.806 0.669 . . . . 74.32 112.806 -176.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.496 HD11 HD12 ' A' ' 66' ' ' LEU . 69.5 mt -62.7 -53.7 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 O-C-N 122.046 -0.409 . . . . 72.53 110.696 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -59.86 -20.23 55.85 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.117 0.484 . . . . 72.01 110.85 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -78.81 -12.84 60.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.915 -0.584 . . . . 63.32 111.144 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -126.42 9.47 7.22 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.547 -0.297 . . . . 73.11 111.554 -178.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.486 HG12 ' O ' ' A' ' 123' ' ' ILE . 45.7 pt -138.99 168.09 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 109.871 -0.418 . . . . 71.04 109.871 175.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.418 ' N ' HD21 ' A' ' 128' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.163 0 CA-C-O 118.585 -0.722 . . . . 74.44 111.094 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.701 ' SD ' HG13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.382 0 CA-C-O 121.195 0.521 . . . . 73.25 110.231 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.701 HG13 ' SD ' ' A' ' 22' ' ' MET . 49.7 mt -115.82 106.36 20.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-N 115.283 -0.871 . . . . 74.4 109.321 175.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 11.3 tp10 -105.7 136.92 44.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.737 0.303 . . . . 71.41 110.791 -176.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -90.6 128.46 36.6 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 122.379 0.272 . . . . 65.14 110.383 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.456 HG21 ' HD3' ' A' ' 34' ' ' LYS . 33.9 pt -128.0 149.9 33.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 120.851 0.358 . . . . 73.54 111.243 -178.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.51 179.09 53.23 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.616 -0.72 . . . . 13.31 112.789 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -63.7 -50.36 69.47 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 122.767 0.427 . . . . 75.21 111.262 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.9 m -64.43 -39.12 93.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.994 -0.548 . . . . 64.12 111.803 -172.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.531 ' HA ' ' HB3' ' A' ' 33' ' ' ASN . 16.3 pt-20 -85.37 -9.33 57.72 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 116.507 -0.315 . . . . 71.55 111.691 -174.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -47.8 -71.0 0.08 Allowed 'General case' 0 N--CA 1.464 0.25 0 O-C-N 123.192 0.307 . . . . 65.21 111.088 -177.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -66.57 -34.58 78.21 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.276 -0.638 . . . . 71.43 109.276 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.531 ' HB3' ' HA ' ' A' ' 30' ' ' GLU . 7.7 t30 -52.42 -33.82 45.59 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 114.487 -1.233 . . . . 73.12 111.989 -176.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.456 ' HD3' HG21 ' A' ' 26' ' ' ILE . 14.4 ptmt -114.95 -19.35 10.98 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.214 0.45 . . . . 53.44 112.214 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.4 t -88.43 -55.25 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 111.973 0.36 . . . . 63.51 111.973 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 39.9 p -72.83 -18.52 61.45 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.11 0.481 . . . . 74.43 111.033 -173.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.9 p -90.8 11.93 20.9 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.704 -0.68 . . . . 73.22 111.028 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 51.8 t -59.63 117.01 4.43 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.258 -0.428 . . . . 62.14 111.292 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -117.43 3.73 12.5 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.548 0.69 . . . . 70.23 109.349 172.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.59 ' HB2' HG22 ' A' ' 42' ' ' ILE . 1.8 m-20 -70.64 -31.85 68.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.963 -1.017 . . . . 63.24 110.684 -176.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 40' ' ' ASP . 27.7 m-80 73.26 13.4 4.7 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.301 -0.863 . . . . 71.21 111.04 -175.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.59 HG22 ' HB2' ' A' ' 40' ' ' ASP . 15.1 tt -85.99 146.64 6.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 108.828 -0.804 . . . . 74.52 108.828 172.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.698 HD23 ' HE1' ' A' ' 101' ' ' MET . 63.4 tp -79.52 106.59 11.66 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-O 121.556 0.693 . . . . 74.32 110.312 -177.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.481 HG22 ' CD2' ' A' ' 77' ' ' TYR . 65.6 mt -88.68 107.53 17.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.801 -1.09 . . . . 75.35 110.364 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 70.3 mt -90.56 101.82 14.56 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.963 -0.562 . . . . 72.54 109.787 178.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.459 HG13 HG23 ' A' ' 44' ' ' ILE . 27.6 m -95.96 121.53 46.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.031 0.443 . . . . 71.44 110.849 -178.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -95.49 133.71 39.16 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.915 -0.584 . . . . 64.5 111.02 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 . . . . . 0 C--N 1.33 -0.269 0 CA-C-O 121.436 0.636 . . . . 73.03 111.495 -178.924 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo . . . . . 0 CA--C 1.528 0.216 0 N-CA-C 111.104 -0.383 . . . . 71.23 111.104 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.462 ' NE2' ' HA ' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -45.3 -49.7 12.5 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 116.162 -0.472 . . . . 74.1 111.469 -171.813 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.705 ' HB3' HG12 ' A' ' 76' ' ' ILE . 71.6 mt -56.78 -48.88 76.9 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.225 -0.898 . . . . 74.22 111.012 -175.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.542 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 34.4 mt-10 -70.6 -44.33 67.5 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.24 -0.437 . . . . 74.41 109.959 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.3 tptp -54.57 -42.74 71.36 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.378 -0.828 . . . . 71.31 110.986 -174.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.502 HD22 HG21 ' A' ' 120' ' ' ILE . 13.9 mt -81.51 -39.5 24.62 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 120.795 -0.362 . . . . 73.24 111.171 176.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.479 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -55.19 -33.49 63.07 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.587 0.232 . . . . 61.5 111.295 -178.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.542 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 96.4 mt-30 -51.06 -42.46 60.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.99 0.424 . . . . 70.24 110.794 177.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -94.02 -55.17 3.31 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.684 -0.689 . . . . 65.55 111.592 -177.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.533 ' O ' HG21 ' A' ' 74' ' ' VAL . 12.0 m-85 -94.86 22.17 6.75 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.727 0.639 . . . . 75.23 112.727 -167.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.479 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 8.2 t -52.5 -27.33 15.9 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.9 0.381 . . . . 74.33 111.585 -177.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -63.58 -24.25 67.72 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.246 -0.434 . . . . 53.34 111.832 -178.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.55 9.2 5.97 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.485 0.183 . . . . 72.31 111.183 -177.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.533 HG21 ' O ' ' A' ' 70' ' ' TYR . 27.2 m -138.33 140.29 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 O-C-N 121.779 -0.575 . . . . 73.54 110.565 175.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -141.07 135.25 30.82 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.135 -0.484 . . . . 63.31 110.031 174.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.705 HG12 ' HB3' ' A' ' 63' ' ' LEU . 3.4 mp -103.94 144.49 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.391 -0.368 . . . . 74.42 110.146 -176.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.481 ' CD2' HG22 ' A' ' 44' ' ' ILE . 81.2 m-85 -129.38 138.46 51.53 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.276 0.56 . . . . 72.2 111.537 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.463 ' HE2' ' HA ' ' A' ' 78' ' ' LYS . 9.6 mmpt? -99.01 100.22 11.36 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.284 -0.871 . . . . 72.22 108.804 174.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.587 ' N ' HD12 ' A' ' 79' ' ' ILE . 2.4 mp . . . . . 0 C--N 1.323 -0.568 0 N-CA-C 110.249 -0.278 . . . . 72.5 110.249 -175.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.29 0 CA-C-O 121.058 0.456 . . . . 73.53 110.919 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.0 m -74.32 -30.18 61.94 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.71 -0.677 . . . . 71.01 110.554 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -61.64 -55.49 29.98 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.677 -0.692 . . . . 72.23 110.445 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.42 ' HE2' ' HE2' ' A' ' 107' ' ' LYS . 97.4 m-85 -77.08 -13.31 59.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.956 -0.565 . . . . 74.44 110.343 178.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.46 39.25 61.55 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 115.748 -0.66 . . . . 71.21 112.875 174.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 14.6 p -72.43 -37.37 57.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.657 0.265 . . . . 73.5 110.502 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.8 t 67.43 -67.43 0.18 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.67 -0.696 . . . . 73.31 111.294 -178.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.58 134.9 48.06 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.49 -0.323 . . . . 73.13 111.057 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.455 ' HB ' ' HA ' ' A' ' 97' ' ' PRO . 29.4 pt -113.87 158.67 38.5 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 116.062 -0.517 . . . . 72.43 110.107 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.455 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 95.4 Cg_endo -82.96 177.55 31.45 Favored 'Cis proline' 0 C--N 1.35 0.645 0 C-N-CA 123.889 -1.296 . . . . 65.31 112.352 -1.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.1 m -140.8 131.22 25.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.113 -0.494 . . . . 71.12 109.843 178.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.59 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 26.6 mt -109.33 116.93 53.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.333 -0.394 . . . . 75.35 109.999 -176.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.2 mp -94.55 144.57 25.48 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.144 0.497 . . . . 74.23 110.777 -178.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.764 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 70.3 mtp -106.38 114.58 28.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.606 -0.725 . . . . 74.11 109.923 -179.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -115.83 140.63 49.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.76 0.314 . . . . 74.43 110.453 177.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.722 ' HB3' HD21 ' A' ' 108' ' ' LEU . 38.1 ttpt -156.79 128.32 7.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.997 -0.547 . . . . 63.31 109.561 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.7 t30 60.0 24.84 14.01 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.324 0.583 . . . . 65.24 110.686 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.28 -1.13 82.08 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 116.058 -0.519 . . . . 53.51 113.266 177.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -108.2 160.92 15.45 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.99 0.395 . . . . 51.24 110.49 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.42 ' HE2' ' HE2' ' A' ' 91' ' ' TYR . 20.2 pttp -92.69 139.92 30.07 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.472 -0.936 . . . . 60.31 108.472 170.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.722 HD21 ' HB3' ' A' ' 103' ' ' LYS . 3.0 mm? -105.72 -52.98 2.72 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 110.087 -0.338 . . . . 72.55 110.087 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.764 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 23.4 m -157.59 170.96 21.21 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.865 -0.607 . . . . 74.54 110.171 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.7 pm0 -128.85 123.87 33.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.932 -0.576 . . . . 75.32 109.831 172.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.59 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 63.6 t -80.66 113.93 20.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.822 -0.626 . . . . 64.25 110.25 176.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 42.1 mt -100.2 123.06 52.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.427 -0.583 . . . . 75.11 109.427 175.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.76 -129.89 14.0 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.957 -0.639 . . . . 74.41 111.985 -179.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.462 ' HA ' ' NE2' ' A' ' 62' ' ' GLN . . . -142.65 57.36 1.43 Allowed 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.012 0.434 . . . . 71.33 111.117 -178.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.539 ' O ' ' HG3' ' A' ' 118' ' ' LYS . 7.7 m-20 -88.32 86.42 7.06 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-O 121.681 0.753 . . . . 74.42 110.21 177.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.551 ' O ' HG13 ' A' ' 119' ' ' ILE . 7.9 tp -53.09 -35.68 23.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.003 -0.999 . . . . 73.12 110.636 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.6 m -67.07 -37.0 83.22 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.846 -0.615 . . . . 71.15 111.215 -177.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.539 ' HG3' ' O ' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -76.04 -41.62 50.22 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.642 -0.503 . . . . 71.04 109.642 -179.325 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.551 HG13 ' O ' ' A' ' 116' ' ' ILE . 1.9 pp -65.7 -42.35 92.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 116.286 -0.415 . . . . 71.22 110.943 -176.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.502 HG21 HD22 ' A' ' 66' ' ' LEU . 2.8 pp -66.8 -31.85 55.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 121.123 0.487 . . . . 75.31 109.957 177.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.408 ' N ' HD11 ' A' ' 120' ' ' ILE . 47.2 t -63.58 -51.01 67.2 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.73 -0.668 . . . . 62.24 110.686 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 11.6 pt-20 -77.85 -46.17 22.2 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.14 0.422 . . . . 74.32 112.14 -178.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.508 ' O ' HG12 ' A' ' 127' ' ' ILE . 67.5 mt -60.04 -51.0 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 117.903 0.319 . . . . 72.53 111.555 -176.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -59.11 -30.86 68.42 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.073 0.463 . . . . 72.01 110.922 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -83.17 -20.82 33.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.413 0.625 . . . . 63.32 110.282 177.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 1.8 t-20 -88.61 -37.37 15.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.689 -0.687 . . . . 73.11 111.524 -173.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 123' ' ' ILE . 46.8 pt -100.99 168.61 1.87 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 116.266 -0.424 . . . . 71.04 111.159 -177.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.3 p30 . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.432 -0.794 . . . . 74.44 111.297 -174.921 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.521 ' N ' ' SD ' ' A' ' 22' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.341 0 CA-C-O 120.901 0.381 . . . . 73.25 110.165 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.519 HG12 ' HG2' ' A' ' 22' ' ' MET . 14.3 mm -115.66 78.33 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 115.532 -0.758 . . . . 74.4 109.092 174.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.623 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 10.8 tp10 -96.99 153.17 18.07 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.21 -0.45 . . . . 71.41 110.016 -176.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.84 138.88 34.53 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.613 -0.514 . . . . 65.14 109.613 177.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 39.2 pt -122.76 153.75 27.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-O 121.189 0.518 . . . . 73.54 111.095 -177.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.58 150.71 38.62 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.408 -0.815 . . . . 13.31 111.729 176.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -63.64 -34.98 79.05 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.981 0.419 . . . . 75.21 110.469 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.1 m -72.99 -16.38 61.51 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.734 -0.667 . . . . 64.12 111.63 -176.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -113.79 3.02 15.34 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.398 -0.364 . . . . 71.55 110.907 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -47.08 -71.15 0.08 Allowed 'General case' 0 N--CA 1.464 0.241 0 O-C-N 123.46 0.475 . . . . 65.21 110.951 -177.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -65.15 -34.82 79.3 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.861 -0.422 . . . . 71.43 109.861 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -52.04 -41.06 61.98 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.221 -0.9 . . . . 73.12 111.215 -174.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -106.81 -25.2 11.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.195 -0.457 . . . . 53.44 112.104 -177.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 79.1 t -84.12 -50.83 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 112.073 0.397 . . . . 63.51 112.073 -175.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.3 p -76.83 -32.54 57.65 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.987 0.422 . . . . 74.43 110.81 -175.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.8 m -80.59 12.41 3.11 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.765 -0.652 . . . . 73.22 111.695 -177.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.624 ' SG ' HG23 ' A' ' 42' ' ' ILE . 37.1 t -59.24 90.9 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.879 0.371 . . . . 62.14 111.182 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -80.58 -22.0 41.12 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.944 0.402 . . . . 70.23 111.185 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -72.86 2.57 6.52 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.535 -0.302 . . . . 63.24 111.742 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 63.0 21.91 13.17 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.422 -0.354 . . . . 71.21 111.777 172.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.624 HG23 ' SG ' ' A' ' 38' ' ' CYS . 6.8 tt -87.9 144.63 8.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 109.388 -0.597 . . . . 74.52 109.388 177.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 42.1 tp -81.14 115.53 20.61 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.008 0.433 . . . . 74.32 109.979 -177.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 62.1 mt -102.58 123.28 55.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.91 -0.586 . . . . 75.35 110.263 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.536 ' HG ' ' HG2' ' A' ' 101' ' ' MET . 3.3 mp -114.23 106.02 13.86 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.049 -0.523 . . . . 72.54 109.753 -178.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.511 HG21 ' HB2' ' A' ' 77' ' ' TYR . 43.5 t -102.12 125.54 56.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.598 -0.274 . . . . 71.44 110.566 -178.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -98.01 138.49 35.25 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.17 0.51 . . . . 64.5 109.894 178.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 . . . . . 0 C--N 1.324 -0.505 0 CA-C-N 115.578 -0.737 . . . . 73.03 110.009 179.406 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.526 ' HG2' ' HB2' ' A' ' 64' ' ' GLU . 85.4 Cg_endo . . . . . 0 CA--C 1.531 0.325 0 CA-C-O 120.802 0.251 . . . . 71.23 112.485 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.598 ' HB3' HG12 ' A' ' 119' ' ' ILE . 9.9 mp0 -55.34 -55.93 25.94 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-O 121.592 0.711 . . . . 74.1 111.27 -173.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.501 HD11 HG23 ' A' ' 111' ' ' VAL . 3.2 mm? -59.33 -48.39 81.82 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 114.844 -1.071 . . . . 74.22 110.952 -171.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.576 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 48.4 mt-10 -68.38 -32.48 72.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.067 -0.515 . . . . 74.41 110.427 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 61' ' ' PRO . 2.8 tmtm? -59.09 -52.46 65.63 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.803 -0.443 . . . . 71.31 109.803 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.682 HD13 HD12 ' A' ' 123' ' ' ILE . 29.3 mt -70.88 -33.46 70.62 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 120.903 -0.319 . . . . 73.24 111.347 177.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.19 -27.13 66.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.334 -0.394 . . . . 61.5 111.47 -178.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.576 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 76.1 mt-30 -56.93 -35.79 69.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.843 0.354 . . . . 70.24 110.738 177.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -93.83 -55.94 3.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.401 0.619 . . . . 65.55 110.468 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.5 ' O ' HG22 ' A' ' 74' ' ' VAL . 23.4 m-85 -84.74 22.51 1.33 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.58 -0.736 . . . . 75.23 112.69 -172.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.433 ' O ' ' NZ ' ' A' ' 75' ' ' LYS . 4.4 t -52.28 -44.54 65.05 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.369 0.507 . . . . 74.33 112.369 -170.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -73.14 -16.21 61.45 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 122.04 -0.412 . . . . 53.34 111.316 -176.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -101.6 -20.47 15.03 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 110.078 -0.342 . . . . 72.31 110.078 178.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 70' ' ' TYR . 25.4 m -136.91 122.06 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 121.298 0.571 . . . . 73.54 110.64 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.433 ' NZ ' ' O ' ' A' ' 71' ' ' THR . 38.0 mmtm -119.29 124.75 47.44 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.639 -0.504 . . . . 63.31 109.639 177.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.519 HG13 ' HB2' ' A' ' 45' ' ' LEU . 2.1 mp -97.37 137.48 24.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 74.42 110.054 -175.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.623 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 20.2 m-85 -126.58 134.45 50.81 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.116 -0.493 . . . . 72.2 110.368 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 19.1 mtpp -96.31 122.51 39.26 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.181 -0.674 . . . . 72.22 109.181 176.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.6 tp . . . . . 0 CA--C 1.534 0.356 0 CA-C-O 120.908 0.385 . . . . 72.5 111.18 -176.531 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.355 0 CA-C-O 121.064 0.459 . . . . 73.53 110.76 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.4 m -74.52 -28.11 60.83 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.741 -0.663 . . . . 71.01 110.964 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -64.49 -51.11 64.67 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.067 0.46 . . . . 72.23 109.928 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -79.01 -6.71 57.03 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.684 -0.689 . . . . 74.44 110.36 176.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 61.95 53.32 43.85 Favored Glycine 0 C--N 1.331 0.281 0 CA-C-N 115.84 -0.618 . . . . 71.21 113.19 172.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.409 HG22 ' H ' ' A' ' 95' ' ' ALA . 10.0 p -80.01 133.67 29.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.908 0.385 . . . . 73.5 110.671 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.4 t -128.17 27.12 5.68 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.107 0.48 . . . . 73.31 110.329 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.418 ' HB3' HG22 ' A' ' 112' ' ' ILE . . . -145.03 130.38 18.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.01 -0.541 . . . . 73.13 110.157 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.708 ' H ' HD13 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -110.37 148.14 37.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 72.43 110.242 -178.153 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -77.07 -178.12 23.21 Favored 'Cis proline' 0 C--N 1.351 0.687 0 C-N-CA 123.758 -1.351 . . . . 65.31 112.512 -1.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.0 m -137.81 115.64 11.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.105 -0.498 . . . . 71.12 110.039 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.451 HD11 ' N ' ' A' ' 99' ' ' ILE . 3.9 mp -121.6 123.16 68.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-N 116.216 -0.447 . . . . 75.35 109.84 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.5 mp -101.24 141.77 33.64 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.243 -0.28 . . . . 74.23 110.243 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.733 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 56.5 mtp -116.91 115.48 25.58 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 116.398 -0.364 . . . . 74.11 110.872 -175.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -117.38 154.29 31.58 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.049 -0.523 . . . . 74.43 110.511 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.758 ' HB3' HD23 ' A' ' 108' ' ' LEU . 28.1 ttpp -168.23 122.89 0.94 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.747 -0.661 . . . . 63.31 109.78 178.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.2 t30 53.82 45.95 26.77 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.545 0.688 . . . . 65.24 110.845 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 73.87 3.83 65.07 Favored Glycine 0 CA--C 1.52 0.392 0 CA-C-N 115.578 -0.737 . . . . 53.51 113.719 176.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -111.41 142.87 43.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 117.134 0.467 . . . . 51.24 110.589 -178.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.474 ' O ' ' HG3' ' A' ' 107' ' ' LYS . 12.5 ptmm? -95.51 112.39 24.12 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.082 -0.71 . . . . 60.31 109.082 172.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.758 HD23 ' HB3' ' A' ' 103' ' ' LYS . 1.5 mm? -89.33 -53.18 4.67 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.088 0.471 . . . . 72.55 110.904 -172.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.733 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 22.8 m -150.08 172.02 15.93 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.517 -0.765 . . . . 74.54 110.458 -169.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.27 121.28 2.65 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.092 0.472 . . . . 75.32 111.116 -177.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.501 HG23 HD11 ' A' ' 63' ' ' LEU . 59.8 t -80.43 107.47 12.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.607 -0.724 . . . . 64.25 110.037 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.418 HG22 ' HB3' ' A' ' 95' ' ' ALA . 65.7 mt -110.58 106.91 21.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.344 -0.613 . . . . 75.11 109.344 177.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 96.51 -141.33 15.55 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 111.398 -0.681 . . . . 74.41 111.398 -176.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -141.54 88.58 2.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.914 0.357 . . . . 71.33 110.65 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.535 ' O ' HG22 ' A' ' 119' ' ' ILE . 11.7 m-20 -132.9 97.08 3.93 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.101 -0.499 . . . . 74.42 110.14 178.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.511 ' O ' HG13 ' A' ' 119' ' ' ILE . 7.1 tp -58.49 -40.25 77.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 120.846 0.355 . . . . 73.12 111.13 -177.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.3 t -67.24 -28.64 68.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.164 0.507 . . . . 71.15 110.74 -178.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.525 ' HZ1' ' CD ' ' A' ' 122' ' ' GLU . 1.9 tmtm? -79.27 -43.77 23.05 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.985 -0.552 . . . . 71.04 110.75 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.598 HG12 ' HB3' ' A' ' 62' ' ' GLN . 1.8 pp -67.64 -41.53 85.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 71.22 110.613 -177.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.64 HG23 HD11 ' A' ' 66' ' ' LEU . 2.7 pp -62.21 -31.64 52.17 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 109.693 -0.484 . . . . 75.31 109.693 177.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 23.1 t -69.71 -51.23 36.25 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.712 -0.676 . . . . 62.24 110.083 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.525 ' CD ' ' HZ1' ' A' ' 118' ' ' LYS . 16.4 pt-20 -74.12 -33.93 63.73 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 112.109 0.411 . . . . 74.32 112.109 -175.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.682 HD12 HD13 ' A' ' 66' ' ' LEU . 64.6 mt -67.13 -58.05 7.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 O-C-N 122.264 -0.272 . . . . 72.53 110.518 178.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -63.16 -19.98 64.97 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.073 0.463 . . . . 72.01 110.932 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.404 ' HB3' ' O ' ' A' ' 122' ' ' GLU . 7.3 t30 -60.69 -31.45 70.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.067 -0.515 . . . . 63.32 111.219 176.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -114.22 -3.15 13.22 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.075 0.398 . . . . 73.11 112.075 -173.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.43 HG12 ' O ' ' A' ' 123' ' ' ILE . 33.9 pt -135.64 168.56 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 110.372 -0.233 . . . . 71.04 110.372 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.383 -0.818 . . . . 74.44 111.104 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 C--O 1.23 0.069 0 N-CA-C 109.7 -0.481 . . . . 73.25 109.7 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.443 HG12 ' HB ' ' A' ' 76' ' ' ILE . 51.1 mt -133.79 106.6 9.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 108.927 -0.768 . . . . 74.4 108.927 173.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.415 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 36.9 tt0 -131.94 118.61 20.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.604 -0.271 . . . . 71.41 111.083 -171.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.498 ' NE2' ' H ' ' A' ' 25' ' ' GLN . 0.6 OUTLIER -81.62 132.73 35.31 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.209 -0.664 . . . . 65.14 109.209 173.454 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.46 HG22 ' HZ2' ' A' ' 34' ' ' LYS . 25.8 pt -126.44 175.32 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 120.983 0.42 . . . . 73.54 111.952 -170.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.45 154.13 26.97 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.646 -0.707 . . . . 13.31 112.369 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -67.41 -31.2 71.24 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.961 0.41 . . . . 75.21 110.957 -177.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.3 p -71.02 -39.29 72.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.999 -0.546 . . . . 64.12 110.877 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.415 ' HA ' ' HB3' ' A' ' 33' ' ' ASN . 13.1 pt-20 -91.48 -3.77 56.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.999 -0.546 . . . . 71.55 110.991 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -46.34 -71.02 0.08 Allowed 'General case' 0 N--CA 1.464 0.26 0 O-C-N 123.622 0.576 . . . . 65.21 111.161 -176.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.552 ' HB2' ' HG1' ' A' ' 36' ' ' THR . 5.9 p-10 -68.04 -35.17 77.81 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 109.396 -0.594 . . . . 71.43 109.396 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.415 ' HB3' ' HA ' ' A' ' 30' ' ' GLU . 6.2 t30 -52.53 -34.27 49.08 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 114.586 -1.188 . . . . 73.12 111.816 -175.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.46 ' HZ2' HG22 ' A' ' 26' ' ' ILE . 16.2 ptmt -111.69 -27.52 8.49 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.774 -0.194 . . . . 53.44 111.426 -178.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 71.7 t -84.57 -56.66 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 111.745 0.276 . . . . 63.51 111.745 -177.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.552 ' HG1' ' HB2' ' A' ' 32' ' ' ASP . 75.8 p -80.01 -23.77 41.29 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.011 0.434 . . . . 74.43 110.444 -173.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.1 m -83.66 6.08 22.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.733 -0.667 . . . . 73.22 111.027 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.616 ' SG ' HG22 ' A' ' 42' ' ' ILE . 48.0 t -66.88 98.92 0.58 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.887 0.375 . . . . 62.14 110.427 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -88.9 -2.94 58.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.102 -0.499 . . . . 70.23 110.318 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -71.56 -6.62 42.05 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.175 -0.466 . . . . 63.24 110.67 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 60.54 23.3 12.99 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.88 -0.6 . . . . 71.21 111.42 176.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.616 HG22 ' SG ' ' A' ' 38' ' ' CYS . 12.4 tt -84.9 152.61 3.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.754 -0.832 . . . . 74.52 108.754 174.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.643 HD23 ' HE3' ' A' ' 101' ' ' MET . 58.9 tp -85.09 110.2 18.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.606 0.241 . . . . 74.32 110.45 -175.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 101' ' ' MET . 54.4 mt -100.62 136.68 31.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.472 -0.331 . . . . 75.35 110.591 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.537 ' HG ' ' HG2' ' A' ' 101' ' ' MET . 3.7 mp -122.67 109.45 14.28 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.572 -0.529 . . . . 72.54 109.572 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 30.1 m -95.27 127.35 47.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.717 0.294 . . . . 71.44 110.606 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.419 ' HB3' ' HE2' ' A' ' 78' ' ' LYS . 3.1 t70 -125.63 149.42 48.43 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.322 0.582 . . . . 64.5 112.231 -171.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.525 ' CZ ' ' HB ' ' A' ' 98' ' ' THR . 22.5 p90 . . . . . 0 C--N 1.327 -0.389 0 N-CA-C 108.493 -0.929 . . . . 73.03 108.493 164.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo . . . . . 0 C--O 1.233 0.249 0 N-CA-C 111.396 -0.271 . . . . 71.23 111.396 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.556 ' HB3' HG12 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -49.9 -50.21 46.92 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 121.359 0.6 . . . . 74.1 110.966 -176.734 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.675 HD21 HG23 ' A' ' 99' ' ' ILE . 8.8 mp -60.36 -48.85 79.99 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.258 -0.883 . . . . 74.22 111.524 -174.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.609 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 40.2 mt-10 -67.92 -36.35 80.01 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.804 -0.443 . . . . 74.41 109.804 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -54.93 -51.13 67.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.797 -0.638 . . . . 71.31 110.23 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.472 HD12 HG22 ' A' ' 120' ' ' ILE . 22.9 mt -78.3 -34.79 48.58 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.517 -0.31 . . . . 73.24 111.802 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.487 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.37 -28.05 69.73 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 111.345 0.128 . . . . 61.5 111.345 -175.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.609 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 78.9 mt-30 -53.0 -32.4 46.36 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.284 0.564 . . . . 70.24 109.993 175.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -93.55 -59.08 2.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.562 -0.745 . . . . 65.55 110.427 175.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.572 ' O ' HG22 ' A' ' 74' ' ' VAL . 19.0 m-85 -87.55 17.78 4.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.32 -0.855 . . . . 75.23 113.134 -168.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.487 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 9.3 t -52.95 -36.08 59.57 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.147 0.43 . . . . 74.33 111.552 -176.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -70.8 -17.18 62.78 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.826 0.346 . . . . 53.34 111.493 -178.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -112.21 -10.57 13.84 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.269 -0.423 . . . . 72.31 110.6 -176.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.572 HG22 ' O ' ' A' ' 70' ' ' TYR . 32.6 m -131.08 151.07 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 O-C-N 122.174 -0.329 . . . . 73.54 110.872 -179.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.606 ' HE3' ' HA ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -134.1 127.04 31.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.912 -0.585 . . . . 63.31 109.484 177.662 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.443 ' HB ' HG12 ' A' ' 23' ' ' ILE . 51.6 mt -102.21 130.31 52.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 120.788 0.328 . . . . 74.42 110.232 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 74.7 m-85 -131.13 151.44 51.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 72.2 109.779 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.419 ' HE2' ' HB3' ' A' ' 47' ' ' ASP . 1.3 mptm? -126.28 173.07 9.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.751 0.31 . . . . 72.22 111.302 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 61.7 mt . . . . . 0 N--CA 1.463 0.192 0 CA-C-N 114.992 -1.004 . . . . 72.5 109.824 -174.292 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.269 0 CA-C-O 120.714 0.293 . . . . 73.53 110.839 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.3 m -65.03 -32.67 74.5 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.281 -0.418 . . . . 71.01 111.081 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -66.32 -40.05 89.67 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.978 0.418 . . . . 72.23 110.202 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -81.88 -17.07 48.55 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.187 -0.461 . . . . 74.44 110.321 175.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.47 23.26 60.87 Favored Glycine 0 CA--C 1.519 0.327 0 CA-C-N 115.986 -0.552 . . . . 71.21 112.821 177.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.1 t -61.03 133.56 26.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 120.59 0.233 . . . . 73.5 110.721 -178.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 29.2 t -137.37 11.98 3.01 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.194 -0.457 . . . . 73.31 110.72 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -134.49 140.18 46.01 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.355 -0.384 . . . . 73.13 110.49 -177.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.424 ' O ' HD13 ' A' ' 96' ' ' ILE . 2.7 pp -112.63 155.05 44.47 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 116.102 -0.499 . . . . 72.43 111.156 -176.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -79.04 165.31 81.81 Favored 'Cis proline' 0 C--N 1.354 0.848 0 C-N-CA 123.611 -1.412 . . . . 65.31 111.582 -3.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.525 ' HB ' ' CZ ' ' A' ' 48' ' ' PHE . 22.8 m -117.54 120.79 39.14 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.817 -0.438 . . . . 71.12 109.817 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.691 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 27.6 mt -126.24 112.54 30.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.715 -0.675 . . . . 75.35 109.734 -175.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.39 134.18 42.62 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.056 -0.35 . . . . 74.23 110.056 -176.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.756 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 61.8 mtp -101.82 117.54 35.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.448 . . . . 74.11 110.912 -175.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -115.39 156.49 25.46 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 120.972 0.415 . . . . 74.43 111.235 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.73 ' HB3' HD22 ' A' ' 108' ' ' LEU . 37.7 ttmt -169.55 122.38 0.74 Allowed 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.279 -0.873 . . . . 63.31 109.598 177.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 60.56 26.08 15.75 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.327 0.584 . . . . 65.24 111.099 174.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.8 -14.45 61.65 Favored Glycine 0 CA--C 1.52 0.368 0 CA-C-N 115.971 -0.559 . . . . 53.51 112.681 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -94.73 139.54 31.1 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 122.591 0.356 . . . . 51.24 110.071 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.53 ' H ' ' HD3' ' A' ' 107' ' ' LYS . 0.1 OUTLIER -93.93 130.41 40.03 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.002 -0.74 . . . . 60.31 109.002 173.069 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.73 HD22 ' HB3' ' A' ' 103' ' ' LYS . 2.1 mm? -94.42 -53.16 4.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.166 -0.47 . . . . 72.55 110.737 -174.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.756 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 49.6 m -151.25 171.94 16.63 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.551 -0.75 . . . . 74.54 110.345 -172.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -145.15 114.87 7.29 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.153 0.502 . . . . 75.32 110.685 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.691 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 51.5 t -80.15 107.42 12.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.623 -0.717 . . . . 64.25 109.98 178.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 60.5 mt -110.18 106.73 21.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.243 -0.435 . . . . 75.11 110.202 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 93.3 -134.55 12.19 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 116.109 -0.496 . . . . 74.41 112.051 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -137.81 76.53 1.58 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.149 0.499 . . . . 71.33 110.78 -177.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -114.03 97.48 6.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.912 -0.586 . . . . 74.42 110.336 177.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.584 HD11 HD11 ' A' ' 119' ' ' ILE . 7.9 tp -62.54 -39.86 86.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-O 121.089 0.471 . . . . 73.12 110.038 178.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.4 m -63.27 -39.71 95.34 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.571 -0.741 . . . . 71.15 110.554 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -64.49 -56.17 15.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.757 -0.656 . . . . 71.04 110.617 177.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.584 HD11 HD11 ' A' ' 116' ' ' ILE . 2.4 pp -62.68 -39.94 86.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.121 -0.491 . . . . 71.22 111.816 -171.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.472 HG22 HD12 ' A' ' 66' ' ' LEU . 2.8 pp -64.08 -31.82 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 120.314 -0.554 . . . . 75.31 110.078 178.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.427 ' N ' HD13 ' A' ' 120' ' ' ILE . 33.1 t -70.67 -51.8 25.35 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.717 -0.674 . . . . 62.24 110.797 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -77.53 -43.11 33.08 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.544 0.572 . . . . 74.32 112.544 -174.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.424 HD12 HD11 ' A' ' 66' ' ' LEU . 79.7 mt -60.72 -57.62 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 O-C-N 122.187 -0.321 . . . . 72.53 110.813 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -59.58 -20.16 53.86 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.379 -0.373 . . . . 72.01 111.293 -177.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -76.24 -33.63 59.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.993 0.425 . . . . 63.32 110.349 176.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -98.73 -0.34 42.97 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.222 -0.445 . . . . 73.11 112.087 -175.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.413 HG12 ' O ' ' A' ' 123' ' ' ILE . 37.2 pt -133.71 168.27 24.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.763 -0.458 . . . . 71.04 109.763 172.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.481 -0.771 . . . . 74.44 110.861 -174.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 21.8 mmt . . . . . 0 C--O 1.242 0.666 0 CA-C-O 121.234 0.54 . . . . 73.25 110.94 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.2 mm -89.08 86.98 2.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-N 115.233 -0.894 . . . . 74.4 108.597 172.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.534 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 9.6 tp10 -95.06 134.87 37.28 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.376 -0.374 . . . . 71.41 110.726 -176.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.93 132.14 43.78 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.753 -0.462 . . . . 65.14 109.753 177.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.484 HD13 ' HA ' ' A' ' 31' ' ' PHE . 34.4 pt -123.97 175.14 6.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.417 -0.356 . . . . 73.54 111.383 -172.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.44 170.87 33.01 Favored Glycine 0 C--N 1.331 0.265 0 CA-C-N 115.802 -0.635 . . . . 13.31 112.998 -177.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -67.5 -42.37 82.97 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.058 0.543 . . . . 75.21 111.286 -177.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 24.7 t -76.44 -47.32 23.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 64.12 111.188 -174.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -73.47 -9.43 58.68 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.543 -0.299 . . . . 71.55 111.401 -179.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.59 ' HE1' HG13 ' A' ' 46' ' ' VAL . 50.8 t80 -44.21 -71.09 0.08 Allowed 'General case' 0 CA--C 1.529 0.163 0 O-C-N 123.451 0.47 . . . . 65.21 111.136 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -65.69 -32.87 74.67 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.04 -0.356 . . . . 71.43 110.04 -178.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.499 ' O ' ' HB3' ' A' ' 37' ' ' SER . 7.1 t30 -52.35 -41.02 62.68 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.232 -0.894 . . . . 73.12 111.16 -177.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 38' ' ' CYS . 13.1 ptmt -108.83 -15.89 14.29 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.227 -0.442 . . . . 53.44 111.905 -176.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.6 t -88.52 -60.99 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 111.867 0.321 . . . . 63.51 111.867 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.9 p -81.88 -28.85 32.73 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.814 0.34 . . . . 74.43 111.093 -172.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.499 ' HB3' ' O ' ' A' ' 33' ' ' ASN . 46.5 t -91.16 12.29 20.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.959 -0.564 . . . . 73.22 110.191 177.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 34' ' ' LYS . 51.2 t -67.48 95.65 0.47 Allowed 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 120.96 0.409 . . . . 62.14 111.157 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -89.71 14.41 11.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.33 0.586 . . . . 70.23 109.811 174.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -74.74 -6.02 46.55 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.858 -0.61 . . . . 63.24 110.392 -179.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.431 ' HA ' ' HB2' ' A' ' 104' ' ' ASN . 2.1 t-20 62.82 4.96 1.6 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.989 0.737 . . . . 71.21 112.989 174.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.652 HG22 ' HE2' ' A' ' 75' ' ' LYS . 13.2 tt -90.12 159.13 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.983 -0.377 . . . . 74.52 109.983 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.437 HD11 ' HB3' ' A' ' 101' ' ' MET . 64.7 tp -85.41 107.71 17.52 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.264 0.554 . . . . 74.32 109.94 178.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.482 HD12 ' HG ' ' A' ' 38' ' ' CYS . 65.6 mt -92.97 132.06 38.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.37 -0.832 . . . . 75.35 110.309 177.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.634 HD13 HD12 ' A' ' 63' ' ' LEU . 40.3 mt -111.04 101.84 10.35 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.267 -0.642 . . . . 72.54 109.267 177.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.59 HG13 ' HE1' ' A' ' 31' ' ' PHE . 61.3 t -91.5 116.3 32.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.564 -0.532 . . . . 71.44 109.564 178.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -97.1 148.34 23.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.199 0.523 . . . . 64.5 111.351 -173.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 . . . . . 0 C--O 1.235 0.333 0 CA-C-N 115.323 -0.853 . . . . 73.03 109.803 175.045 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 N--CA 1.463 -0.318 0 N-CA-C 111.25 -0.327 . . . . 71.23 111.25 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.412 ' CD ' ' H ' ' A' ' 62' ' ' GLN . 11.7 mp0 -55.09 -48.29 73.76 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-O 121.871 0.843 . . . . 74.1 110.366 -178.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.634 HD12 HD13 ' A' ' 45' ' ' LEU . 2.9 mm? -61.39 -47.97 83.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.449 -1.251 . . . . 74.22 110.449 -174.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.54 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 45.9 tt0 -63.69 -44.05 94.86 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.235 -0.439 . . . . 74.41 109.941 178.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.642 ' HA ' ' HE3' ' A' ' 65' ' ' LYS . 0.1 OUTLIER -50.89 -51.66 49.6 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.602 -0.726 . . . . 71.31 111.033 -179.874 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.601 HD11 HG22 ' A' ' 120' ' ' ILE . 32.9 mt -71.99 -35.29 69.44 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.646 -0.422 . . . . 73.24 110.851 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.41 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -57.27 -40.06 76.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.026 -0.534 . . . . 61.5 111.227 -178.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.54 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 86.9 mt-30 -50.2 -33.4 19.19 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.983 0.42 . . . . 70.24 110.85 -177.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -94.09 -56.47 2.84 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.75 -0.659 . . . . 65.55 111.067 178.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.465 ' O ' HG23 ' A' ' 74' ' ' VAL . 17.3 m-85 -88.79 20.33 3.56 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.684 -0.689 . . . . 75.23 112.671 -170.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 13.8 t -53.35 -30.47 39.6 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.11 0.481 . . . . 74.33 112.28 -176.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -70.21 -16.78 63.11 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.381 -0.372 . . . . 53.34 111.324 -177.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -118.6 -6.5 10.67 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.489 -0.323 . . . . 72.31 110.458 -178.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 70' ' ' TYR . 30.1 m -137.1 135.39 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 121.143 0.497 . . . . 73.54 110.879 178.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.652 ' HE2' HG22 ' A' ' 42' ' ' ILE . 64.8 mttm -112.46 158.57 19.71 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.972 -0.751 . . . . 63.31 108.972 174.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.501 HG13 ' HB2' ' A' ' 45' ' ' LEU . 3.7 mp -125.56 139.4 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 C-N-CA 120.333 -0.547 . . . . 74.42 110.117 171.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.534 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 12.4 m-85 -125.04 129.1 49.6 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.9 -0.591 . . . . 72.2 110.094 177.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.45 ' HD3' ' N ' ' A' ' 79' ' ' ILE . 5.7 tmtm? -111.77 124.33 52.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.194 -0.912 . . . . 72.22 109.201 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.68 ' H ' HD13 ' A' ' 79' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.41 0 N-CA-C 109.775 -0.454 . . . . 72.5 109.775 176.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.137 0 CA-C-O 120.822 0.344 . . . . 73.53 110.367 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.0 m -64.22 -35.04 79.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.269 -0.423 . . . . 71.01 110.454 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -57.65 -38.6 75.35 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.766 -0.652 . . . . 72.23 110.389 178.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -88.76 -17.2 30.35 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.502 -0.317 . . . . 74.44 111.501 176.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.55 25.25 39.69 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 121.018 -0.61 . . . . 71.21 112.223 -177.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 70.7 t -64.26 127.19 24.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.724 0.297 . . . . 73.5 110.296 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.5 p -91.3 -17.0 26.63 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.393 0.516 . . . . 73.31 112.393 -174.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -157.89 146.86 19.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.83 0.348 . . . . 73.13 111.572 -176.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.56 ' HB ' ' HA ' ' A' ' 97' ' ' PRO . 2.7 pp -98.71 162.04 23.03 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 115.923 -0.58 . . . . 72.43 110.036 176.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.56 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 98.5 Cg_endo -80.95 174.25 47.74 Favored 'Cis proline' 0 C--N 1.355 0.87 0 C-N-CA 124.133 -1.195 . . . . 65.31 112.83 2.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.541 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 27.8 m -145.68 134.18 22.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.951 -0.568 . . . . 71.12 110.042 179.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.593 HG23 ' HG ' ' A' ' 63' ' ' LEU . 3.5 mp -116.44 125.2 73.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 N-CA-C 109.71 -0.478 . . . . 75.35 109.71 178.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.7 mp -91.49 134.18 34.86 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.815 0.34 . . . . 74.23 110.738 -178.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.531 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 72.2 mtp -108.98 114.38 28.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.926 -0.579 . . . . 74.11 110.231 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -118.91 148.36 43.01 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.179 0.3 . . . . 74.43 110.271 178.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.6 ' HB3' HD22 ' A' ' 108' ' ' LEU . 62.4 tttm -152.56 115.22 4.54 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.025 -0.731 . . . . 63.31 109.025 176.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.431 ' HB2' ' HA ' ' A' ' 41' ' ' ASN . 5.8 t30 58.52 30.28 19.54 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.362 0.601 . . . . 65.24 110.279 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.18 -9.08 78.55 Favored Glycine 0 CA--C 1.521 0.434 0 CA-C-N 115.696 -0.684 . . . . 53.51 113.355 177.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -95.2 131.17 41.54 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 117.053 0.426 . . . . 51.24 111.031 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.722 ' HZ1' ' HB2' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -80.39 116.87 20.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 60.31 110.043 174.77 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.6 HD22 ' HB3' ' A' ' 103' ' ' LYS . 3.1 mm? -82.06 -52.57 6.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.442 -0.344 . . . . 72.55 110.317 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.531 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 74.6 m -159.35 171.82 19.09 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.81 -0.632 . . . . 74.54 110.759 -176.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 8.4 pm0 -133.35 119.12 19.3 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.428 -0.805 . . . . 75.32 109.346 172.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 98' ' ' THR . 61.3 t -79.99 110.33 15.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 64.25 110.048 -178.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 59.0 mt -107.98 118.54 55.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 110.036 -0.357 . . . . 75.11 110.036 -177.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.36 -115.36 4.21 Favored Glycine 0 N--CA 1.453 -0.206 0 N-CA-C 111.682 -0.567 . . . . 74.41 111.682 -178.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.55 89.19 1.02 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.89 0.345 . . . . 71.33 111.017 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.452 ' O ' HG23 ' A' ' 119' ' ' ILE . 12.5 m-20 -118.99 88.76 2.99 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.41 -0.359 . . . . 74.42 110.448 178.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.497 HD11 HD11 ' A' ' 119' ' ' ILE . 8.2 tp -62.73 -44.89 99.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 120.814 0.34 . . . . 73.12 110.902 -178.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.2 m -68.55 -27.06 65.75 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.34 -0.391 . . . . 71.15 111.336 -176.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.439 ' HZ2' ' CD ' ' A' ' 122' ' ' GLU . 0.8 OUTLIER -79.32 -45.27 19.98 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 120.839 0.352 . . . . 71.04 110.076 178.822 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.508 ' HA ' ' HG2' ' A' ' 122' ' ' GLU . 2.4 pp -68.43 -37.37 77.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.384 -0.371 . . . . 71.22 111.601 -176.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.601 HG22 HD11 ' A' ' 66' ' ' LEU . 2.7 pp -63.66 -31.79 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 121.3 0.571 . . . . 75.31 109.681 176.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.8 t -70.47 -47.89 58.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.446 -0.797 . . . . 62.24 110.568 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.508 ' HG2' ' HA ' ' A' ' 119' ' ' ILE . 21.1 pt-20 -76.96 -44.75 30.14 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.235 0.457 . . . . 74.32 112.235 -176.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.549 HD12 HD13 ' A' ' 66' ' ' LEU . 67.2 mt -61.43 -57.23 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 O-C-N 122.185 -0.322 . . . . 72.53 110.992 -178.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -60.59 -20.37 60.36 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.068 0.461 . . . . 72.01 111.227 -176.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -77.66 -34.49 53.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.753 -0.658 . . . . 63.32 110.576 176.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -83.27 -39.38 20.93 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.077 -0.51 . . . . 73.11 111.012 -177.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.431 HG12 ' O ' ' A' ' 123' ' ' ILE . 47.2 pt -91.78 168.15 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.283 -0.417 . . . . 71.04 110.2 178.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 6.4 p30 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.499 -0.762 . . . . 74.44 110.716 -172.651 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 16.0 tpt . . . . . 0 C--O 1.238 0.487 0 CA-C-O 120.994 0.426 . . . . 73.25 110.508 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.5 HD13 ' HB ' ' A' ' 76' ' ' ILE . 16.9 mm -117.17 124.8 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 115.726 -0.67 . . . . 74.4 110.427 -177.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 45.6 tt0 -131.97 140.93 49.13 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.693 0.282 . . . . 71.41 110.316 173.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -95.8 126.85 41.35 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.786 -0.45 . . . . 65.14 109.786 176.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.487 HD12 ' HA ' ' A' ' 31' ' ' PHE . 44.5 pt -129.26 165.3 29.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-O 121.075 0.464 . . . . 73.54 111.525 -174.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.5 164.07 18.91 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.52 -0.764 . . . . 13.31 111.575 176.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -63.58 -29.88 71.07 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.575 0.226 . . . . 75.21 110.704 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.9 t -62.06 -22.33 65.67 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.17 -0.468 . . . . 64.12 111.627 -178.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -121.29 -3.23 9.48 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.788 -0.187 . . . . 71.55 110.836 -178.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.487 ' HA ' HD12 ' A' ' 26' ' ' ILE . 90.6 t80 -51.29 -70.96 0.07 Allowed 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.232 -0.44 . . . . 65.21 110.363 -177.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -62.71 -34.35 76.99 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.431 -0.581 . . . . 71.43 109.431 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.464 ' O ' ' HB3' ' A' ' 37' ' ' SER . 6.6 t30 -52.18 -39.71 60.48 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.116 -0.947 . . . . 73.12 111.477 -176.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.485 ' HD3' HG23 ' A' ' 26' ' ' ILE . 14.1 ptmt -110.23 -18.04 13.39 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 111.793 0.294 . . . . 53.44 111.793 -177.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 72.2 t -87.58 -54.4 8.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 111.661 0.245 . . . . 63.51 111.661 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 72.0 p -77.47 -27.33 52.0 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.302 0.572 . . . . 74.43 110.0 -176.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.464 ' HB3' ' O ' ' A' ' 33' ' ' ASN . 34.3 t -89.71 12.59 16.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.249 -0.887 . . . . 73.22 110.828 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.421 ' HB2' HD12 ' A' ' 44' ' ' ILE . 43.9 t -46.02 99.58 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.949 0.404 . . . . 62.14 111.672 -178.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -95.4 9.05 41.37 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.804 -0.635 . . . . 70.23 110.296 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -86.28 -15.39 40.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.011 -0.54 . . . . 63.24 110.774 -178.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.4 m120 62.99 16.54 9.35 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.482 0.658 . . . . 71.21 109.673 -171.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 21.7 mt -96.66 141.4 15.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 115.147 -0.933 . . . . 74.52 110.46 -177.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.609 HD23 ' HE2' ' A' ' 101' ' ' MET . 62.7 tp -71.56 103.92 3.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.85 -0.614 . . . . 74.32 110.087 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.421 HD12 ' HB2' ' A' ' 38' ' ' CYS . 44.3 mt -84.7 116.59 28.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.928 -0.578 . . . . 75.35 110.695 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.787 HD12 HD12 ' A' ' 63' ' ' LEU . 44.9 mt -100.63 109.98 22.08 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.475 -0.784 . . . . 72.54 109.217 179.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.3 m -100.97 115.02 41.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-O 120.866 0.365 . . . . 71.44 110.309 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.5 121.03 32.83 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.786 -0.643 . . . . 64.5 111.049 -175.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 . . . . . 0 C--O 1.239 0.534 0 N-CA-C 109.593 -0.521 . . . . 73.03 109.593 175.366 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo . . . . . 0 N--CA 1.463 -0.323 0 N-CA-C 111.59 -0.196 . . . . 71.23 111.59 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.653 ' HB3' HG12 ' A' ' 119' ' ' ILE . 8.2 mp0 -52.47 -48.34 65.96 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 121.551 0.691 . . . . 74.1 110.986 -176.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.787 HD12 HD12 ' A' ' 45' ' ' LEU . 3.0 mm? -57.89 -48.07 80.93 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.655 -1.157 . . . . 74.22 110.35 -173.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.543 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 41.2 mt-10 -71.73 -34.94 69.98 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.432 -0.349 . . . . 74.41 110.9 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 49.6 mmtt -52.85 -52.96 55.26 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.768 0.318 . . . . 71.31 110.52 177.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.577 HD12 HD12 ' A' ' 123' ' ' ILE . 25.5 mt -76.51 -30.22 57.12 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.532 -0.467 . . . . 73.24 111.091 178.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.472 ' HB3' ' HA ' ' A' ' 64' ' ' GLU . . . -59.58 -37.68 79.16 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.743 -0.208 . . . . 61.5 111.412 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.543 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 79.2 mt-30 -54.09 -35.46 62.13 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.989 0.423 . . . . 70.24 110.982 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 66.8 mm-40 -93.86 -53.09 4.14 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.99 -0.55 . . . . 65.55 111.262 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.472 ' O ' HG21 ' A' ' 74' ' ' VAL . 14.3 m-85 -92.74 22.58 4.67 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.815 -0.63 . . . . 75.23 112.047 -171.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.441 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 9.5 t -52.91 -31.52 40.38 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.722 0.296 . . . . 74.33 111.775 -177.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -70.6 -16.47 62.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.991 0.425 . . . . 53.34 111.155 -177.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -123.43 0.79 8.92 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.164 -0.471 . . . . 72.31 110.761 -175.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.472 HG21 ' O ' ' A' ' 70' ' ' TYR . 29.1 m -131.29 147.55 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 120.939 0.4 . . . . 73.54 110.469 177.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -141.86 116.73 9.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.964 -0.562 . . . . 63.31 109.723 -178.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.5 ' HB ' HD13 ' A' ' 23' ' ' ILE . 3.0 mp -99.05 143.44 13.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 120.633 0.254 . . . . 74.42 110.811 -173.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.446 ' OH ' ' HE2' ' A' ' 34' ' ' LYS . 21.0 m-85 -130.75 130.05 43.27 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.988 0.423 . . . . 72.2 111.655 -179.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -96.21 115.17 27.01 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.69 -0.856 . . . . 72.22 108.69 170.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.421 HD13 ' CD1' ' A' ' 31' ' ' PHE . 12.1 tt . . . . . 0 C--N 1.325 -0.469 0 N-CA-C 109.864 -0.421 . . . . 72.5 109.864 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.185 0 CA-C-O 121.031 0.444 . . . . 73.53 110.283 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.3 m -60.06 -37.07 78.77 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.786 -0.643 . . . . 71.01 110.89 178.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -62.44 -47.0 85.99 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.566 -0.743 . . . . 72.23 110.683 -177.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -87.77 6.58 34.48 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.177 -0.465 . . . . 74.44 111.523 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.01 27.65 73.52 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 116.106 -0.497 . . . . 71.21 112.965 175.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 77.7 t -69.27 98.35 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.247 0.546 . . . . 73.5 110.732 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.2 m -101.98 -14.3 17.23 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.059 -0.519 . . . . 73.31 110.51 176.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -123.1 115.85 22.49 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.778 -0.647 . . . . 73.13 110.494 -177.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.585 ' HB ' ' HA ' ' A' ' 97' ' ' PRO . 30.3 pt -96.26 162.2 24.47 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 115.936 -0.574 . . . . 72.43 110.153 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.585 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 83.7 Cg_endo -81.71 171.91 54.9 Favored 'Cis proline' 0 C--N 1.353 0.794 0 C-N-CA 124.136 -1.193 . . . . 65.31 112.986 0.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 97.9 m -147.34 129.25 15.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.913 -0.585 . . . . 71.12 110.474 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.528 HD11 ' N ' ' A' ' 99' ' ' ILE . 3.6 mp -110.46 145.83 16.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.88 -0.785 . . . . 75.35 108.88 177.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.472 HD21 ' H ' ' A' ' 101' ' ' MET . 0.8 OUTLIER -121.56 137.81 54.57 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.755 -0.461 . . . . 74.23 109.755 178.825 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.695 ' SD ' ' HB3' ' A' ' 109' ' ' SER . 64.0 mtp -103.14 111.68 24.17 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.892 -0.594 . . . . 74.11 111.039 -174.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -115.46 153.72 30.59 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.736 0.303 . . . . 74.43 110.655 177.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.475 ' HB3' HD21 ' A' ' 108' ' ' LEU . 39.3 ttpt -166.77 116.92 0.91 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.314 -0.403 . . . . 63.31 110.051 175.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 8.1 t30 50.92 52.14 15.58 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.622 0.725 . . . . 65.24 110.957 178.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 76.46 -14.95 6.18 Favored Glycine 0 CA--C 1.521 0.43 0 CA-C-N 115.436 -0.802 . . . . 53.51 113.666 176.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -100.29 123.47 44.55 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 117.08 0.44 . . . . 51.24 110.398 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 30.6 pttt -89.24 122.61 32.68 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.517 -0.549 . . . . 60.31 109.517 174.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.48 HD23 ' N ' ' A' ' 108' ' ' LEU . 2.5 mm? -82.63 -52.62 6.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.612 -0.722 . . . . 72.55 111.281 -172.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.695 ' HB3' ' SD ' ' A' ' 101' ' ' MET . 22.0 t -162.42 172.01 16.24 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.995 -0.548 . . . . 74.54 110.845 -171.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -133.41 129.26 37.1 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.199 -0.455 . . . . 75.32 110.369 178.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.687 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 83.7 t -92.64 107.11 18.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.994 -0.548 . . . . 64.25 110.28 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 59.9 mt -110.32 119.19 58.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.722 -0.473 . . . . 75.11 109.722 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 95.74 -126.9 8.95 Favored Glycine 0 CA--C 1.519 0.322 0 N-CA-C 111.922 -0.471 . . . . 74.41 111.922 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.47 83.73 0.91 Allowed 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.895 0.379 . . . . 71.33 110.305 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.403 ' O ' HG22 ' A' ' 119' ' ' ILE . 4.9 m-20 -125.7 97.42 5.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.06 -0.518 . . . . 74.42 110.407 -178.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.509 ' O ' HG13 ' A' ' 119' ' ' ILE . 7.7 tp -60.64 -41.67 88.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-N 116.511 -0.313 . . . . 73.12 111.158 -177.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 30.4 t -62.74 -33.04 74.32 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.302 0.572 . . . . 71.15 110.853 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.687 ' HE3' ' HA ' ' A' ' 111' ' ' VAL . 0.9 OUTLIER -75.94 -47.67 24.25 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.648 -0.706 . . . . 71.04 110.656 -179.188 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.653 HG12 ' HB3' ' A' ' 62' ' ' GLN . 2.1 pp -64.97 -40.82 90.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.227 -0.442 . . . . 71.22 111.066 -177.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.455 HG22 HD13 ' A' ' 66' ' ' LEU . 2.8 pp -65.73 -31.71 54.94 Favored 'Isoleucine or valine' 0 C--N 1.34 0.169 0 N-CA-C 109.65 -0.5 . . . . 75.31 109.65 178.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 43.2 t -65.15 -51.62 60.05 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.632 -0.713 . . . . 62.24 110.482 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.439 ' CD ' ' HZ3' ' A' ' 118' ' ' LYS . 5.1 pt-20 -77.15 -38.73 51.24 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.635 0.605 . . . . 74.32 112.635 -176.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.577 HD12 HD12 ' A' ' 66' ' ' LEU . 56.8 mt -66.02 -53.2 40.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 O-C-N 122.167 -0.333 . . . . 72.53 111.011 -178.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -61.85 -20.34 63.59 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.14 0.495 . . . . 72.01 110.499 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -70.73 -32.58 69.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.981 -0.554 . . . . 63.32 111.436 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.533 ' OD1' HD22 ' A' ' 43' ' ' LEU . 9.3 p30 -106.39 -17.97 14.12 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.083 0.401 . . . . 73.11 112.083 -174.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.526 HG21 ' OD1' ' A' ' 126' ' ' ASN . 42.2 pt -125.39 167.69 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 120.846 0.355 . . . . 71.04 111.135 177.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.406 ' N ' HD21 ' A' ' 128' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.353 -0.832 . . . . 74.44 110.781 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.475 ' N ' ' SD ' ' A' ' 22' ' ' MET . 3.7 mpp? . . . . . 0 C--O 1.232 0.155 0 N-CA-C 111.57 0.211 . . . . 73.25 111.57 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.1 mt -108.44 123.59 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 121.018 0.437 . . . . 74.4 111.626 -174.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.633 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 8.7 tp10 -131.97 155.22 48.35 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.834 -0.802 . . . . 71.41 108.834 174.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -100.59 147.83 25.5 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.71 0.29 . . . . 65.14 110.263 174.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.504 HD12 ' HA ' ' A' ' 31' ' ' PHE . 34.9 pt -131.07 -176.95 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.464 -0.334 . . . . 73.54 110.691 -176.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -141.03 -173.83 13.77 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.403 -0.427 . . . . 13.31 112.902 -177.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -55.03 -50.73 68.34 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.92 0.888 . . . . 75.21 112.605 -175.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 24.9 t -73.4 -19.09 61.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.102 -0.499 . . . . 64.12 111.807 -169.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.502 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 1.7 pm0 -111.74 -15.24 13.46 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 111.874 0.324 . . . . 71.55 111.874 -177.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.504 ' HA ' HD12 ' A' ' 26' ' ' ILE . 61.6 t80 -48.2 -71.01 0.08 Allowed 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.41 0.444 . . . . 65.21 111.239 -176.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -63.44 -40.09 96.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.358 0.599 . . . . 71.43 109.636 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.514 ' O ' ' HB3' ' A' ' 37' ' ' SER . 1.8 m-80 -53.13 -34.08 55.18 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.445 -1.252 . . . . 73.12 112.58 -172.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.545 ' HZ3' ' HB2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -114.84 -25.02 8.39 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.577 -0.449 . . . . 53.44 112.16 179.754 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.4 t -82.74 -51.62 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 N-CA-C 111.51 0.189 . . . . 63.51 111.51 -178.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 44.3 p -85.86 -23.03 27.27 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.025 0.44 . . . . 74.43 110.265 -176.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.514 ' HB3' ' O ' ' A' ' 33' ' ' ASN . 28.5 t -92.76 12.05 24.82 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.679 -0.691 . . . . 73.22 110.384 177.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 41.3 t -60.19 90.73 0.02 OUTLIER 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.128 0.489 . . . . 62.14 110.961 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -90.27 -4.0 57.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.872 -0.604 . . . . 70.23 110.543 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -71.02 -8.2 51.71 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.075 -0.511 . . . . 63.24 110.875 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 57.15 22.68 7.76 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.961 -0.563 . . . . 71.21 111.246 -176.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.9 tt -94.16 148.68 4.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.951 -0.759 . . . . 74.52 108.951 177.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.535 HD11 ' HB3' ' A' ' 101' ' ' MET . 63.7 tp -82.46 113.25 20.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.04 0.448 . . . . 74.32 110.634 -175.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.41 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 58.2 mt -98.34 123.97 51.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.522 -0.763 . . . . 75.35 110.58 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.429 HD11 ' N ' ' A' ' 45' ' ' LEU . 5.1 mp -106.71 112.11 24.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.221 -0.445 . . . . 72.54 109.867 177.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 27.5 m -98.04 121.87 49.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-O 121.031 0.444 . . . . 71.44 110.957 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.433 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 2.3 t70 -96.87 128.05 43.44 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.684 -0.689 . . . . 64.5 110.819 -179.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.434 ' CE1' HD13 ' A' ' 100' ' ' LEU . 44.2 m-85 . . . . . 0 C--N 1.328 -0.352 0 CA-C-O 121.07 0.462 . . . . 73.03 110.43 175.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo . . . . . 0 C--O 1.235 0.358 0 CA-C-O 120.446 0.103 . . . . 71.23 111.837 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.613 ' HB3' HG12 ' A' ' 119' ' ' ILE . 8.9 mp0 -51.13 -49.47 60.73 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-O 121.566 0.698 . . . . 74.1 110.533 -176.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.735 HD23 HG12 ' A' ' 99' ' ' ILE . 10.3 mp -54.44 -48.87 71.19 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.617 -1.174 . . . . 74.22 111.49 -175.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -73.42 -32.79 64.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.818 0.342 . . . . 74.41 110.296 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.0 tptp -60.31 -46.77 88.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.752 -0.658 . . . . 71.31 110.358 -176.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.528 HD13 HD11 ' A' ' 123' ' ' ILE . 17.4 mt -85.79 -40.69 15.77 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.082 0.401 . . . . 73.24 112.082 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.26 -37.15 69.41 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.193 0.442 . . . . 61.5 112.193 -173.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -58.47 -30.84 67.29 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.766 0.317 . . . . 70.24 111.201 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 19.2 mm-40 -90.55 -54.2 4.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.09 0.472 . . . . 65.55 110.595 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.513 ' O ' HG21 ' A' ' 74' ' ' VAL . 19.4 m-85 -88.1 22.48 2.4 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.762 -0.654 . . . . 75.23 112.043 -172.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.9 t -52.63 -32.71 43.21 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.175 0.435 . . . . 74.33 112.175 -172.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -72.03 -22.62 61.37 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 121.225 -0.19 . . . . 53.34 111.487 -175.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.04 -4.14 16.04 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.636 -0.256 . . . . 72.31 110.751 -177.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.513 HG21 ' O ' ' A' ' 70' ' ' TYR . 23.2 m -135.46 148.1 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.134 0.493 . . . . 73.54 111.568 -178.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 75' ' ' LYS . 36.6 mmtm -140.81 131.43 25.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.706 -0.679 . . . . 63.31 109.259 171.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.476 HD13 ' HB3' ' A' ' 63' ' ' LEU . 61.5 mt -110.24 127.68 67.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.366 -0.379 . . . . 74.42 110.521 -175.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.633 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 57.7 m-85 -124.84 128.74 49.17 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.592 -0.521 . . . . 72.2 109.592 178.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.433 ' HG2' ' HB3' ' A' ' 47' ' ' ASP . 9.2 mtmp? -100.52 142.74 31.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.874 0.369 . . . . 72.22 110.636 -177.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 32.8 mm . . . . . 0 C--N 1.326 -0.436 0 CA-C-N 115.42 -0.809 . . . . 72.5 110.789 -174.651 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.233 0 CA-C-O 121.119 0.485 . . . . 73.53 109.95 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.9 m -59.33 -37.6 78.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.652 -0.704 . . . . 71.01 110.34 176.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -65.92 -36.56 83.72 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.068 -0.515 . . . . 72.23 110.064 177.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -73.42 -4.2 32.14 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.384 -0.371 . . . . 74.44 111.123 175.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.0 9.33 82.67 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 121.276 -0.488 . . . . 71.21 112.099 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 89.2 t -75.24 83.76 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.425 0.631 . . . . 73.5 110.653 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.0 p -117.85 12.07 13.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.45 -0.795 . . . . 73.31 109.727 174.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -83.34 -68.39 0.71 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.695 -0.684 . . . . 73.13 110.978 -178.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 69.2 mt 68.44 128.1 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.554 0 O-C-N 123.506 0.503 . . . . 72.43 110.362 -178.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -79.38 156.94 90.39 Favored 'Cis proline' 0 C--N 1.353 0.794 0 C-N-CA 123.923 -1.282 . . . . 65.31 112.686 2.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 39.6 m -149.27 134.08 17.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.985 -0.552 . . . . 71.12 109.858 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.735 HG12 HD23 ' A' ' 63' ' ' LEU . 3.5 mp -114.99 124.96 72.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.381 -0.372 . . . . 75.35 110.265 -176.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.434 HD13 ' CE1' ' A' ' 48' ' ' PHE . 10.3 mp -103.3 141.87 35.16 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.654 -0.499 . . . . 74.23 109.654 175.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.681 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 53.4 mtp -112.6 116.13 29.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.517 -0.31 . . . . 74.11 110.724 -173.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -114.07 152.57 30.85 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.212 -0.449 . . . . 74.43 110.851 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.637 ' HB3' HD21 ' A' ' 108' ' ' LEU . 39.1 ttpt -168.38 133.09 1.67 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.304 -0.628 . . . . 63.31 109.304 176.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 56.7 29.17 15.35 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.251 0.548 . . . . 65.24 109.817 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 87.79 -14.49 58.36 Favored Glycine 0 CA--C 1.52 0.358 0 CA-C-N 115.862 -0.608 . . . . 53.51 113.331 177.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -96.52 150.91 20.1 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 117.072 0.436 . . . . 51.24 110.803 -177.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 10.0 ptpt -91.96 118.2 30.54 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.07 -0.715 . . . . 60.31 109.07 171.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.637 HD21 ' HB3' ' A' ' 103' ' ' LYS . 2.2 mm? -89.8 -52.96 4.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.024 0.44 . . . . 72.55 111.057 -173.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.681 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 15.8 m -151.75 171.77 17.18 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 115.731 -0.668 . . . . 74.54 110.329 -170.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -149.89 123.44 9.12 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.286 0.565 . . . . 75.32 111.488 -176.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.424 HG23 HG22 ' A' ' 119' ' ' ILE . 40.4 t -86.26 107.08 16.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.674 -0.694 . . . . 64.25 109.618 175.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 12.8 mt -116.8 106.83 20.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 109.296 -0.631 . . . . 75.11 109.296 178.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 115.52 -127.25 7.51 Favored Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 111.574 -0.61 . . . . 74.41 111.574 -176.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.61 57.27 0.49 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.486 0.66 . . . . 71.33 109.651 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.448 ' O ' HG21 ' A' ' 119' ' ' ILE . 1.6 m-20 -105.58 99.54 9.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.384 -0.825 . . . . 74.42 110.882 -174.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.567 ' O ' HG13 ' A' ' 119' ' ' ILE . 7.0 tp -63.37 -38.87 83.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.171 -0.468 . . . . 73.12 111.079 -178.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.5 m -68.14 -26.85 65.98 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.11 0.481 . . . . 71.15 110.621 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 24.6 tptp -73.2 -52.02 15.64 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.678 -0.692 . . . . 71.04 110.041 176.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.613 HG12 ' HB3' ' A' ' 62' ' ' GLN . 2.0 pp -63.9 -40.81 90.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 115.68 -0.691 . . . . 71.22 111.461 -175.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.433 HD12 ' N ' ' A' ' 121' ' ' SER . 2.8 pp -63.14 -33.13 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 120.434 -0.506 . . . . 75.31 110.284 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.433 ' N ' HD12 ' A' ' 120' ' ' ILE . 35.9 t -70.71 -51.57 26.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.029 -0.532 . . . . 62.24 110.78 179.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.434 ' OE2' ' HB3' ' A' ' 109' ' ' SER . 15.9 pt-20 -75.86 -38.43 57.96 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.082 0.401 . . . . 74.32 112.082 -172.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.533 ' O ' HG12 ' A' ' 127' ' ' ILE . 69.9 mt -65.1 -55.8 18.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 O-C-N 122.32 -0.238 . . . . 72.53 110.442 178.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -60.37 -27.32 67.31 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.281 -0.418 . . . . 72.01 110.728 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -65.36 -31.48 72.62 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.28 -0.418 . . . . 63.32 110.74 176.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -104.43 -4.61 22.57 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.979 -0.555 . . . . 73.11 111.975 -172.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.533 HG12 ' O ' ' A' ' 123' ' ' ILE . 48.5 pt -131.56 168.94 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 122.166 0.186 . . . . 71.04 110.59 178.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.252 1.185 0 CA-C-O 118.462 -0.78 . . . . 74.44 112.796 -176.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 67.1 mtt . . . . . 0 N--CA 1.463 0.192 0 N-CA-C 109.995 -0.372 . . . . 73.25 109.995 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.8 mt -113.89 122.62 68.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 109.218 -0.66 . . . . 74.4 109.218 176.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 -125.54 124.76 42.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.834 0.35 . . . . 71.41 111.056 -174.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.431 ' HG3' ' HB3' ' A' ' 78' ' ' LYS . 1.1 mp0 -81.49 125.97 31.11 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.464 -0.569 . . . . 65.14 109.464 178.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.497 HG21 ' HD3' ' A' ' 34' ' ' LYS . 33.8 pt -131.58 176.39 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.744 0.307 . . . . 73.54 110.936 -176.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -108.86 174.83 18.86 Favored Glycine 0 C--N 1.331 0.278 0 N-CA-C 111.629 -0.588 . . . . 13.31 111.629 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -67.84 -33.43 74.75 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.58 0.229 . . . . 75.21 111.34 -176.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.0 t -68.79 -34.62 75.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.769 0.319 . . . . 64.12 111.145 -174.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -101.35 -6.11 24.52 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.145 -0.479 . . . . 71.55 110.799 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.464 ' HA ' HD13 ' A' ' 26' ' ' ILE . 59.5 t80 -50.45 -70.81 0.08 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.359 -0.382 . . . . 65.21 110.248 177.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -59.67 -36.93 77.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.095 0.474 . . . . 71.43 109.969 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.508 ' O ' ' HB2' ' A' ' 37' ' ' SER . 24.7 t-20 -52.41 -47.73 66.13 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.118 -0.946 . . . . 73.12 111.782 -175.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.497 ' HD3' HG21 ' A' ' 26' ' ' ILE . 0.2 OUTLIER -101.93 -19.18 15.36 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.687 0.255 . . . . 53.44 111.687 -176.01 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.7 t -88.25 -59.54 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 112.038 0.385 . . . . 63.51 112.038 -179.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 66.1 p -79.99 -28.1 39.53 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.135 0.493 . . . . 74.43 110.66 -172.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.508 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 39.8 m -94.6 12.48 27.4 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.69 -0.686 . . . . 73.22 110.958 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.547 ' SG ' HG21 ' A' ' 42' ' ' ILE . 50.9 t -53.68 92.1 0.01 OUTLIER 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.047 0.451 . . . . 62.14 112.043 -177.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -67.47 -19.28 65.32 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.04 -0.527 . . . . 70.23 110.951 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -62.46 -25.27 67.9 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.356 -0.384 . . . . 63.24 111.372 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.436 ' N ' HD21 ' A' ' 41' ' ' ASN . 0.9 OUTLIER 62.49 23.67 14.06 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.972 -0.558 . . . . 71.21 110.235 -175.305 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.547 HG21 ' SG ' ' A' ' 38' ' ' CYS . 12.3 tt -82.38 157.76 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.757 -0.656 . . . . 74.52 109.291 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.434 ' HB3' HG12 ' A' ' 74' ' ' VAL . 48.7 tp -78.21 102.7 7.72 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 109.586 -0.524 . . . . 74.32 109.586 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 101' ' ' MET . 32.5 mt -90.5 126.34 43.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.889 -0.596 . . . . 75.35 111.108 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.526 ' HG ' ' HG2' ' A' ' 101' ' ' MET . 3.5 mp -115.05 101.91 9.44 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.263 -0.644 . . . . 72.54 109.263 177.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.524 HG11 ' HB2' ' A' ' 77' ' ' TYR . 29.1 m -94.79 120.9 44.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.725 -0.472 . . . . 71.44 109.725 178.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -98.09 121.36 39.92 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.527 0.68 . . . . 64.5 109.385 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 . . . . . 0 C--N 1.321 -0.641 0 CA-C-N 115.285 -0.87 . . . . 73.03 109.242 178.992 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.406 ' HG2' ' HB2' ' A' ' 64' ' ' GLU . 72.6 Cg_endo . . . . . 0 N--CA 1.463 -0.318 0 CA-C-O 121.18 0.408 . . . . 71.23 112.674 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.582 ' HB3' HG12 ' A' ' 119' ' ' ILE . 15.7 mp0 -56.16 -40.89 74.59 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.353 -0.84 . . . . 74.1 110.758 -177.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.621 HD13 HG22 ' A' ' 111' ' ' VAL . 2.3 mm? -61.93 -41.0 97.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.87 -1.059 . . . . 74.22 109.868 -176.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.406 ' HB2' ' HG2' ' A' ' 61' ' ' PRO . 8.7 tm-20 -70.53 -36.66 73.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.63 -0.714 . . . . 74.41 109.174 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -56.87 -51.53 68.68 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.433 -0.803 . . . . 71.31 109.909 178.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.607 HD11 HD11 ' A' ' 123' ' ' ILE . 22.3 mt -80.63 -30.61 36.69 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.073 0.397 . . . . 73.24 112.073 -178.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.47 -34.95 69.55 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.789 0.328 . . . . 61.5 110.892 -178.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -56.57 -30.83 63.61 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.163 -0.471 . . . . 70.24 111.372 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -93.62 -48.37 6.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.235 -0.439 . . . . 65.55 110.886 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.533 ' O ' HG23 ' A' ' 74' ' ' VAL . 21.9 m-85 -93.92 21.21 6.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.033 -0.531 . . . . 75.23 112.154 -174.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.1 t -53.01 -36.38 60.43 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.035 0.383 . . . . 74.33 112.035 -174.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -71.24 -16.98 62.52 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.505 -0.316 . . . . 53.34 111.455 -177.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -117.16 -1.37 11.87 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.404 -0.362 . . . . 72.31 111.036 -175.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 70' ' ' TYR . 26.4 m -135.16 150.65 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 121.008 0.432 . . . . 73.54 111.55 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -137.57 115.2 11.27 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.094 -0.706 . . . . 63.31 109.094 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 45' ' ' LEU . 61.0 mt -98.21 140.63 17.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.692 0.282 . . . . 74.42 110.326 -178.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.524 ' HB2' HG11 ' A' ' 46' ' ' VAL . 95.1 m-85 -129.35 138.21 51.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.409 -0.359 . . . . 72.2 110.487 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.431 ' HB3' ' HG3' ' A' ' 25' ' ' GLN . 53.3 tptt -101.24 114.76 29.02 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.402 -0.817 . . . . 72.22 110.115 -178.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.44 ' N ' HD13 ' A' ' 79' ' ' ILE . 2.3 mp . . . . . 0 N--CA 1.468 0.431 0 CA-C-O 120.765 0.317 . . . . 72.5 110.374 178.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.327 0 CA-C-O 121.168 0.508 . . . . 73.53 110.777 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.2 m -66.88 -33.48 75.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.802 -0.635 . . . . 71.01 110.413 178.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -66.6 -36.3 82.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.658 -0.701 . . . . 72.23 110.82 -178.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -89.29 -0.77 57.72 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.844 0.354 . . . . 74.44 110.857 176.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.65 41.66 42.42 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-N 115.787 -0.642 . . . . 71.21 113.7 170.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.0 p -98.45 152.79 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.978 0.389 . . . . 73.5 110.076 176.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.9 t -148.01 35.54 0.83 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.184 0.516 . . . . 73.31 109.806 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -133.21 149.34 52.01 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.009 -0.541 . . . . 73.13 110.813 -178.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 68.6 mt -118.96 128.48 25.93 Favored Pre-proline 0 C--O 1.237 0.42 0 CA-C-N 115.826 -0.625 . . . . 72.43 109.88 176.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -92.98 167.03 23.0 Favored 'Cis proline' 0 C--N 1.349 0.575 0 C-N-CA 124.177 -1.176 . . . . 65.31 112.966 -1.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 62.1 m -120.48 128.63 53.32 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.017 -0.538 . . . . 71.12 110.906 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.665 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 3.4 mp -106.85 138.91 30.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.46 -0.57 . . . . 75.35 109.46 178.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.512 HD11 ' HB3' ' A' ' 110' ' ' GLN . 34.5 tp -127.56 145.93 50.7 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.797 -0.446 . . . . 74.23 109.797 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.792 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 72.7 mtp -118.26 116.21 26.31 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 120.874 0.368 . . . . 74.11 111.979 -173.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -109.41 157.78 18.59 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.736 -0.665 . . . . 74.43 111.363 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.478 ' CB ' HD23 ' A' ' 108' ' ' LEU . 39.4 ttmt -151.22 102.86 2.97 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.566 -0.901 . . . . 63.31 108.566 169.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.8 t30 53.73 38.76 29.18 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.394 0.616 . . . . 65.24 110.762 -177.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.81 -6.48 81.95 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 116.107 -0.497 . . . . 53.51 113.272 177.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -90.15 134.86 34.02 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 122.434 0.293 . . . . 51.24 110.248 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 40.2 tttm -89.42 120.95 31.19 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 110.013 -0.366 . . . . 60.31 110.013 176.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.528 ' N ' HD22 ' A' ' 108' ' ' LEU . 2.0 mm? -98.49 -53.11 3.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.244 -0.434 . . . . 72.55 110.514 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.792 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 16.7 m -156.78 172.41 18.68 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 115.172 -0.922 . . . . 74.54 110.007 -169.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.512 ' HB3' HD11 ' A' ' 100' ' ' LEU . 12.4 pt20 -158.4 131.57 7.39 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.88 0.371 . . . . 75.32 110.452 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.665 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 38.8 t -98.5 107.21 19.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.957 -0.565 . . . . 64.25 110.242 -176.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 68.6 mt -95.46 114.4 31.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.335 -0.393 . . . . 75.11 109.973 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.36 -109.9 2.9 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.726 -0.749 . . . . 74.41 111.966 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.61 104.22 1.97 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.658 0.229 . . . . 71.33 111.264 -178.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.505 ' O ' HG23 ' A' ' 119' ' ' ILE . 37.3 m-20 -140.55 96.05 2.97 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.624 0.25 . . . . 74.42 110.43 176.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.513 HD12 HD11 ' A' ' 119' ' ' ILE . 6.6 tp -60.15 -42.48 90.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 CA-C-O 120.933 0.397 . . . . 73.12 110.503 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 36.8 t -61.62 -30.18 70.53 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.715 -0.675 . . . . 71.15 110.694 -178.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.05 -53.73 6.72 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.183 -0.673 . . . . 71.04 109.183 179.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.582 HG12 ' HB3' ' A' ' 62' ' ' GLN . 2.1 pp -59.08 -40.41 80.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.692 -0.685 . . . . 71.22 111.701 -172.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.524 HD13 ' N ' ' A' ' 121' ' ' SER . 2.8 pp -59.2 -36.89 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 C-N-CA 119.935 -0.706 . . . . 75.31 110.142 178.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.524 ' N ' HD13 ' A' ' 120' ' ' ILE . 28.1 t -70.69 -50.62 34.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.19 -0.459 . . . . 62.24 110.865 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.551 ' HG2' ' HA ' ' A' ' 119' ' ' ILE . 16.4 pt-20 -76.36 -29.02 57.02 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 112.081 0.4 . . . . 74.32 112.081 -170.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.607 HD11 HD11 ' A' ' 66' ' ' LEU . 65.2 mt -72.08 -56.86 8.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-O 120.903 0.382 . . . . 72.53 110.004 174.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -61.88 -20.31 63.59 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.847 -0.615 . . . . 72.01 110.993 -178.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -66.87 -27.99 67.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.08 -0.509 . . . . 63.32 111.231 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -120.46 -1.12 10.2 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.497 0.554 . . . . 73.11 112.497 -171.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 31.4 pt -139.27 167.65 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 110.237 -0.283 . . . . 71.04 110.237 170.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.458 ' N ' HD21 ' A' ' 128' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.327 -0.845 . . . . 74.44 110.869 -179.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.728 ' HG2' HG13 ' A' ' 23' ' ' ILE . 1.6 pmm? . . . . . 0 N--CA 1.461 0.108 0 N-CA-C 109.786 -0.45 . . . . 73.25 109.786 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.728 HG13 ' HG2' ' A' ' 22' ' ' MET . 47.1 mt -129.04 118.15 45.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 115.729 -0.669 . . . . 74.4 109.408 177.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 13.7 tp10 -131.83 155.11 48.37 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.275 -0.269 . . . . 71.41 110.275 -176.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.414 ' HG3' ' HE3' ' A' ' 78' ' ' LYS . 0.7 OUTLIER -92.2 147.67 22.75 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 110.399 -0.223 . . . . 65.14 110.399 -178.759 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 42.7 pt -135.02 -176.76 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 120.638 0.256 . . . . 73.54 110.401 176.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -118.41 167.17 12.94 Favored Glycine 0 C--N 1.331 0.281 0 N-CA-C 111.847 -0.501 . . . . 13.31 111.847 177.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -67.41 -40.79 85.61 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.864 0.32 . . . . 75.21 111.864 -174.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 83.4 p -80.16 -28.77 38.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.919 0.39 . . . . 64.12 111.43 -176.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.426 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 2.3 pm0 -91.48 -6.79 52.07 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 116.379 -0.373 . . . . 71.55 110.484 178.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.442 ' HE1' HG21 ' A' ' 46' ' ' VAL . 37.9 t80 -49.13 -70.8 0.08 Allowed 'General case' 0 C--O 1.227 -0.12 0 CA-C-N 115.871 -0.604 . . . . 65.21 110.174 175.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -58.22 -38.49 76.9 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 109.65 -0.5 . . . . 71.43 109.65 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -51.7 -46.43 63.91 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.035 -0.984 . . . . 73.12 111.321 -172.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.517 ' HZ2' ' HB2' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -108.04 -21.16 12.92 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.107 0.41 . . . . 53.44 112.107 -176.643 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 89.7 t -88.17 -50.57 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 N-CA-C 111.722 0.268 . . . . 63.51 111.722 -177.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 66.4 p -80.18 -25.61 39.64 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 120.244 -0.582 . . . . 74.43 109.834 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.6 m -88.3 11.99 15.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.452 -0.795 . . . . 73.22 110.867 177.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.559 ' O ' ' HA ' ' A' ' 104' ' ' ASN . 44.2 t -59.3 104.49 0.26 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.66 0.267 . . . . 62.14 110.916 -178.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.55 -17.65 47.69 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.879 0.371 . . . . 70.23 110.293 176.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -65.92 -20.74 66.32 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.842 -0.617 . . . . 63.24 111.349 -177.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 64.44 11.48 6.57 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.058 0.543 . . . . 71.21 111.86 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.4 tt -73.35 163.29 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 109.442 -0.577 . . . . 74.52 109.442 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.637 HD21 ' HE1' ' A' ' 101' ' ' MET . 62.6 tp -87.65 110.61 20.53 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.109 0.48 . . . . 74.32 110.202 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.3 mt -96.0 119.66 44.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.747 -0.661 . . . . 75.35 110.204 178.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.676 HD12 HD11 ' A' ' 63' ' ' LEU . 71.5 mt -98.87 109.61 22.34 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.696 -0.853 . . . . 72.54 108.696 177.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.442 HG21 ' HE1' ' A' ' 31' ' ' PHE . 47.1 t -103.04 109.33 26.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.874 -0.148 . . . . 71.44 111.119 -176.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.21 134.28 35.59 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.586 -0.524 . . . . 64.5 109.586 173.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.41 ' HE2' ' HA ' ' A' ' 97' ' ' PRO . 10.7 p90 . . . . . 0 CA--C 1.533 0.301 0 CA-C-O 121.517 0.675 . . . . 73.03 110.169 178.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 CA--C 1.531 0.345 0 CA-C-O 120.511 0.129 . . . . 71.23 112.138 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.497 ' HB3' HG12 ' A' ' 119' ' ' ILE . 14.1 mp0 -47.06 -56.09 7.13 Favored 'General case' 0 C--O 1.249 1.067 0 CA-C-O 121.927 0.87 . . . . 74.1 110.953 -178.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.676 HD11 HD12 ' A' ' 45' ' ' LEU . 3.2 mm? -57.48 -48.14 80.0 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 114.215 -1.357 . . . . 74.22 110.758 -172.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 35.7 mt-10 -69.77 -38.92 76.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.601 -0.272 . . . . 74.41 110.853 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 26.7 mmtm -50.75 -50.18 56.24 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.852 0.358 . . . . 71.31 110.408 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.628 HD13 HD12 ' A' ' 123' ' ' ILE . 32.4 mt -77.73 -37.34 49.53 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 120.542 -0.463 . . . . 73.24 111.695 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.87 -31.32 72.33 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 111.729 0.27 . . . . 61.5 111.729 -175.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.464 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 75.4 mt-30 -54.44 -37.55 65.3 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.861 0.362 . . . . 70.24 110.882 178.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -93.57 -46.22 7.39 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.924 -0.58 . . . . 65.55 110.803 -177.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.516 ' O ' HG23 ' A' ' 74' ' ' VAL . 17.6 m-85 -93.32 22.32 5.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.761 -0.654 . . . . 75.23 112.366 -173.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.4 t -52.17 -38.55 58.05 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.206 0.447 . . . . 74.33 112.206 -173.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -71.06 -22.53 62.11 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 122.183 -0.323 . . . . 53.34 111.832 -177.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.34 -8.63 21.03 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.579 0.228 . . . . 72.31 110.773 -175.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 70' ' ' TYR . 35.2 m -133.11 151.16 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 O-C-N 121.944 -0.472 . . . . 73.54 111.412 -178.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.441 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 35.9 mmtm -139.09 115.34 10.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.773 -0.649 . . . . 63.31 109.563 174.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.515 ' HB ' HG12 ' A' ' 23' ' ' ILE . 56.4 mt -90.12 109.96 21.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.857 -0.61 . . . . 74.42 110.386 -178.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.459 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 7.7 m-85 -97.79 134.03 41.5 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.799 -0.445 . . . . 72.2 109.799 176.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.461 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 57.1 mtmt -107.28 155.6 19.78 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.845 -0.616 . . . . 72.22 110.677 -176.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.461 ' HB ' ' O ' ' A' ' 78' ' ' LYS . 41.4 mm . . . . . 0 N--CA 1.47 0.571 0 O-C-N 124.47 1.106 . . . . 72.5 111.665 178.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.627 0 CA-C-O 120.905 0.383 . . . . 73.53 110.533 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.5 m -64.02 -40.67 96.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.364 -0.835 . . . . 71.01 110.297 176.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 54.7 tp60 -63.93 -43.65 95.26 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.841 -0.618 . . . . 72.23 110.207 178.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -70.68 -17.25 62.85 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.311 -0.404 . . . . 74.44 110.82 175.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 58.87 42.16 96.51 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 110.819 -0.912 . . . . 71.21 110.819 -175.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.6 p -93.65 17.6 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-O 120.973 0.416 . . . . 73.5 111.43 -171.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.6 m -66.81 81.27 0.11 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.264 0.554 . . . . 73.31 110.873 178.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -157.3 91.1 1.15 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.513 -0.921 . . . . 73.13 108.513 176.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.7 pp -83.52 149.32 57.37 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.426 -0.807 . . . . 72.43 111.52 -171.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.437 ' HD2' ' O ' ' A' ' 113' ' ' GLY . 15.5 Cg_exo -69.94 161.08 87.44 Favored 'Cis proline' 0 C--N 1.357 0.995 0 C-N-CA 124.268 -1.138 . . . . 65.31 112.657 -3.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.6 m -141.1 118.36 11.36 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.07 -0.514 . . . . 71.12 110.97 -175.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.659 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 3.2 mp -120.93 133.71 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.884 -0.598 . . . . 75.35 109.977 178.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.7 mp -109.95 139.61 44.86 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 110.182 -0.303 . . . . 74.23 110.182 176.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.657 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 71.7 mtp -104.65 116.2 31.65 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.305 -0.407 . . . . 74.11 110.492 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -114.96 142.16 47.0 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.165 0.507 . . . . 74.43 111.536 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.529 ' CB ' HD21 ' A' ' 108' ' ' LEU . 23.2 ttmm -143.09 107.08 4.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.17 -0.923 . . . . 63.31 109.036 174.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.559 ' HA ' ' O ' ' A' ' 38' ' ' CYS . 3.8 t-20 59.74 28.45 17.91 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.471 0.653 . . . . 65.24 110.461 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.25 -14.41 63.77 Favored Glycine 0 C--N 1.332 0.356 0 CA-C-N 115.819 -0.628 . . . . 53.51 113.181 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.484 ' HD2' HD13 ' A' ' 108' ' ' LEU . 0.9 OUTLIER -87.7 116.97 26.21 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.703 -0.851 . . . . 51.24 108.703 176.425 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 101' ' ' MET . 25.5 pttm -77.84 119.34 21.19 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.69 -0.485 . . . . 60.31 109.69 177.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.529 HD21 ' CB ' ' A' ' 103' ' ' LYS . 1.8 mm? -78.06 -52.06 9.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.335 0.588 . . . . 72.55 109.951 -175.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.657 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 72.1 m -160.69 172.47 17.04 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 114.944 -1.025 . . . . 74.54 110.11 -170.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.02 126.56 17.84 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.124 -0.489 . . . . 75.32 111.044 -174.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.659 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 44.2 t -85.88 106.97 15.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.316 -0.624 . . . . 64.25 109.316 174.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 32.7 mt -113.66 109.89 30.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.509 -0.552 . . . . 75.11 109.509 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.437 ' O ' ' HD2' ' A' ' 97' ' ' PRO . . . 100.74 -121.27 7.18 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.147 -0.549 . . . . 74.41 111.867 -177.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.21 57.37 0.51 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.349 0.595 . . . . 71.33 110.276 -177.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.528 ' O ' HG23 ' A' ' 119' ' ' ILE . 2.5 m-20 -103.51 95.54 6.14 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.719 -0.673 . . . . 74.42 110.86 -173.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.572 ' O ' HG13 ' A' ' 119' ' ' ILE . 6.0 tp -63.24 -43.99 99.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 116.126 -0.488 . . . . 73.12 112.074 -175.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.8 t -65.69 -28.2 68.9 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.13 0.49 . . . . 71.15 110.139 -178.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -75.67 -46.74 29.63 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.884 -0.598 . . . . 71.04 109.529 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.634 ' HA ' ' HG2' ' A' ' 122' ' ' GLU . 2.2 pp -66.67 -39.42 83.73 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.095 0 CA-C-N 116.325 -0.398 . . . . 71.22 111.713 -175.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.442 HD13 ' N ' ' A' ' 121' ' ' SER . 2.8 pp -62.5 -31.75 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 C-N-CA 120.385 -0.526 . . . . 75.31 109.768 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.442 ' N ' HD13 ' A' ' 120' ' ' ILE . 35.0 t -70.62 -51.37 28.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.877 -0.601 . . . . 62.24 110.657 176.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.634 ' HG2' ' HA ' ' A' ' 119' ' ' ILE . 16.7 pt-20 -71.28 -40.82 70.68 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 112.025 0.38 . . . . 74.32 112.025 -172.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.628 HD12 HD13 ' A' ' 66' ' ' LEU . 82.1 mt -70.71 -59.67 3.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.607 -0.27 . . . . 72.53 111.101 -177.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -58.02 -26.26 62.2 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.148 0.499 . . . . 72.01 111.022 -176.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -63.58 -28.94 70.27 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.859 -0.61 . . . . 63.32 111.223 178.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -115.0 9.92 16.13 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.244 0.461 . . . . 73.11 112.244 -174.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.452 HG12 ' O ' ' A' ' 123' ' ' ILE . 42.7 pt -139.08 168.92 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 110.212 -0.292 . . . . 71.04 110.212 175.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.252 1.214 0 CA-C-O 118.444 -0.788 . . . . 74.44 111.983 -176.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.559 ' N ' ' SD ' ' A' ' 22' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.352 0 CA-C-O 121.031 0.443 . . . . 73.25 109.885 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.0 mt -103.32 84.55 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 115.365 -0.834 . . . . 74.4 108.966 172.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.491 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 10.0 tp10 -86.74 155.44 20.35 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.14 -0.482 . . . . 71.41 110.549 -175.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -97.34 143.79 27.75 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.742 0.306 . . . . 65.14 110.294 178.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.505 HD11 ' HA ' ' A' ' 31' ' ' PHE . 29.9 pt -133.65 163.67 36.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-N 116.324 -0.398 . . . . 73.54 110.639 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -98.12 155.6 20.34 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.899 -0.591 . . . . 13.31 111.654 176.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -60.3 -30.35 69.42 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.896 0.379 . . . . 75.21 110.902 -178.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.7 p -61.84 -30.98 71.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.879 -0.601 . . . . 64.12 111.337 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.408 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 10.8 pt-20 -114.24 4.14 15.38 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.216 -0.447 . . . . 71.55 111.954 -175.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.505 ' HA ' HD11 ' A' ' 26' ' ' ILE . 81.3 t80 -52.85 -71.63 0.07 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.733 0.301 . . . . 65.21 110.703 -177.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.538 ' O ' HG23 ' A' ' 36' ' ' THR . 7.3 p-10 -65.27 -34.06 77.46 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.617 -0.512 . . . . 71.43 109.617 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -52.28 -44.72 65.14 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.7 -1.136 . . . . 73.12 111.55 -176.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.421 ' HZ2' HG21 ' A' ' 26' ' ' ILE . 16.7 ptmt -100.9 -25.79 13.97 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.568 -0.287 . . . . 53.44 111.139 -177.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.3 t -78.49 -61.45 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 112.12 0.415 . . . . 63.51 112.12 -176.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 32' ' ' ASP . 11.9 t -84.32 0.35 49.47 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.005 0.431 . . . . 74.43 110.889 -170.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.6 m -98.82 -4.74 32.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.339 -0.392 . . . . 73.22 111.044 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.538 ' SG ' HG23 ' A' ' 42' ' ' ILE . 47.8 t -71.97 100.06 2.38 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.024 0.44 . . . . 62.14 111.034 -175.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -93.18 2.32 56.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.391 0.615 . . . . 70.23 109.548 176.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -63.09 -14.56 49.92 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.479 -0.782 . . . . 63.24 111.168 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.573 ' O ' ' HE3' ' A' ' 103' ' ' LYS . 32.8 m-80 69.21 19.63 7.81 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.749 -0.659 . . . . 71.21 110.946 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.538 HG23 ' SG ' ' A' ' 38' ' ' CYS . 10.9 tt -88.97 146.63 5.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 108.495 -0.928 . . . . 74.52 108.495 172.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.652 HD11 ' HB3' ' A' ' 101' ' ' MET . 68.7 tp -85.6 113.6 21.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.251 0.548 . . . . 74.32 110.648 -176.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 57.4 mt -94.64 123.62 46.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.199 -0.909 . . . . 75.35 110.331 177.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.504 ' HB2' HG12 ' A' ' 76' ' ' ILE . 2.2 mm? -104.74 104.36 14.15 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.334 -0.617 . . . . 72.54 109.334 178.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 35.9 m -99.1 130.29 48.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 110.357 -0.238 . . . . 71.44 110.357 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.492 ' HB2' HG13 ' A' ' 99' ' ' ILE . 27.0 t70 -122.62 141.29 51.88 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 120.923 0.392 . . . . 64.5 111.434 -177.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 C--N 1.329 -0.319 0 N-CA-C 108.699 -0.852 . . . . 73.03 108.699 172.774 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.433 ' HD2' ' HB2' ' A' ' 64' ' ' GLU . 86.4 Cg_endo . . . . . 0 N--CA 1.459 -0.514 0 N-CA-C 111.4 -0.269 . . . . 71.23 111.4 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.666 ' NE2' ' HA ' ' A' ' 114' ' ' ALA . 0.4 OUTLIER -45.15 -57.56 3.83 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.179 0.592 . . . . 74.1 111.931 -173.636 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.422 ' HG ' HG12 ' A' ' 99' ' ' ILE . 3.5 mm? -60.71 -48.6 81.07 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.392 -0.822 . . . . 74.22 111.25 -172.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.501 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 39.7 mt-10 -66.0 -37.66 86.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.965 0.412 . . . . 74.41 110.221 178.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 42.2 tptt -60.71 -45.07 95.63 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.501 -0.772 . . . . 71.31 110.405 -174.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.715 HD13 HD12 ' A' ' 123' ' ' ILE . 23.9 mt -79.95 -30.31 39.83 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.515 -0.312 . . . . 73.24 110.988 176.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.68 -33.62 74.31 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.699 0.285 . . . . 61.5 110.847 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.501 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 78.4 mt-30 -56.07 -31.79 63.53 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.048 0.452 . . . . 70.24 110.547 177.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -93.9 -53.78 3.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.74 -0.663 . . . . 65.55 111.041 -178.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.494 ' O ' HG23 ' A' ' 74' ' ' VAL . 14.4 m-85 -95.73 23.11 6.48 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.604 -0.725 . . . . 75.23 112.822 -168.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.7 t -52.78 -28.64 23.34 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.77 0.319 . . . . 74.33 111.69 -176.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -71.03 -18.71 62.57 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.603 -0.272 . . . . 53.34 111.642 -177.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -120.65 1.07 10.54 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.654 0.264 . . . . 72.31 110.554 -176.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 70' ' ' TYR . 27.9 m -133.57 145.79 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 O-C-N 122.019 -0.426 . . . . 73.54 111.312 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -141.09 124.43 16.6 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.143 -0.688 . . . . 63.31 109.143 172.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.504 HG12 ' HB2' ' A' ' 45' ' ' LEU . 49.5 mt -103.26 135.14 42.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 110.084 -0.339 . . . . 74.42 110.084 -175.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.491 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 74.1 m-85 -126.29 128.68 47.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.884 0.374 . . . . 72.2 110.242 178.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -97.54 139.29 33.67 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.719 -0.845 . . . . 72.22 108.719 176.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 20.6 tt . . . . . 0 C--N 1.321 -0.641 0 N-CA-C 109.862 -0.422 . . . . 72.5 109.862 176.024 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.296 0 CA-C-O 121.21 0.528 . . . . 73.53 110.398 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 29.7 m -67.44 -28.32 67.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.748 -0.66 . . . . 71.01 110.389 178.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -63.41 -42.69 98.76 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.875 -0.602 . . . . 72.23 110.19 178.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -74.89 -17.19 60.62 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.274 -0.421 . . . . 74.44 110.725 176.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 86.9 36.73 8.93 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 121.226 -0.512 . . . . 71.21 112.395 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 99.3 t -70.34 92.52 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-O 121.126 0.488 . . . . 73.5 110.028 176.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.7 m -70.53 -33.39 71.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.56 -0.745 . . . . 73.31 111.367 -178.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -148.11 145.8 28.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.881 0.372 . . . . 73.13 111.187 -176.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.538 ' HB ' ' HA ' ' A' ' 97' ' ' PRO . 17.3 pt -101.43 161.68 22.83 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 115.46 -0.791 . . . . 72.43 109.626 177.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.538 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 93.9 Cg_endo -74.49 169.97 72.62 Favored 'Cis proline' 0 C--N 1.357 0.999 0 C-N-CA 124.585 -1.006 . . . . 65.31 113.243 3.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 96.7 m -155.29 122.03 5.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.483 -0.781 . . . . 71.12 109.699 -175.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.505 HD11 ' N ' ' A' ' 99' ' ' ILE . 3.5 mp -106.7 108.95 26.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.123 -0.489 . . . . 75.35 110.277 -174.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.438 HD23 ' H ' ' A' ' 101' ' ' MET . 1.0 OUTLIER -92.9 136.49 33.21 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.88 -0.785 . . . . 74.23 108.88 177.755 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.886 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 69.0 mtp -101.34 117.52 35.13 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.244 -0.434 . . . . 74.11 110.943 -174.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -117.55 146.9 43.27 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 122.657 0.383 . . . . 74.43 110.524 178.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.808 ' HB3' HD22 ' A' ' 108' ' ' LEU . 84.1 tttt -166.68 135.37 2.84 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.973 -0.751 . . . . 63.31 108.973 -179.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 12.1 t30 60.24 24.91 14.3 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.575 0.702 . . . . 65.24 110.508 177.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.93 17.61 76.73 Favored Glycine 0 CA--C 1.517 0.16 0 CA-C-N 115.789 -0.641 . . . . 53.51 113.392 178.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -136.44 157.53 46.56 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 117.059 0.429 . . . . 51.24 110.265 178.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.636 ' HD2' ' H ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -83.36 142.47 31.01 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.363 -0.38 . . . . 60.31 110.085 176.62 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.808 HD22 ' HB3' ' A' ' 103' ' ' LYS . 2.9 mm? -111.47 -53.03 2.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.308 -0.406 . . . . 72.55 110.928 -178.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.886 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 14.2 m -158.26 172.17 18.87 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.949 -0.569 . . . . 74.54 110.124 -171.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -142.82 140.32 31.26 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.157 0.503 . . . . 75.32 111.76 -175.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.563 HG23 HG23 ' A' ' 119' ' ' ILE . 32.8 t -115.81 134.44 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 115.613 -0.721 . . . . 64.25 109.677 178.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 43.2 mt -126.15 106.89 16.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.899 0.381 . . . . 75.11 109.987 178.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 71.96 -85.86 0.47 Allowed Glycine 0 CA--C 1.521 0.425 0 CA-C-N 116.109 -0.496 . . . . 74.41 112.98 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.666 ' HA ' ' NE2' ' A' ' 62' ' ' GLN . . . -151.49 103.08 2.94 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 122.723 -0.28 . . . . 71.33 111.292 -174.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.449 ' O ' HG22 ' A' ' 119' ' ' ILE . 20.3 m-20 -132.49 63.28 1.63 Allowed 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 109.596 -0.52 . . . . 74.42 109.596 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.545 ' O ' HG13 ' A' ' 119' ' ' ILE . 6.8 tp -53.49 -51.57 40.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 N-CA-C 112.359 0.503 . . . . 73.12 112.359 -172.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.3 p -63.87 -28.1 69.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.33 0.586 . . . . 71.15 111.193 -178.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.412 ' HE2' ' HB2' ' A' ' 115' ' ' ASP . 3.0 tmmm? -79.47 -45.34 19.58 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.628 -0.715 . . . . 71.04 109.865 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.563 HG23 HG23 ' A' ' 111' ' ' VAL . 2.5 pp -69.26 -37.37 75.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 115.778 -0.647 . . . . 71.22 111.204 -174.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.466 HD12 ' N ' ' A' ' 121' ' ' SER . 2.9 pp -63.28 -31.92 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 C-N-CA 120.08 -0.648 . . . . 75.31 110.036 177.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.466 ' N ' HD12 ' A' ' 120' ' ' ILE . 45.0 t -70.52 -51.51 28.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.98 -0.555 . . . . 62.24 110.916 178.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.563 ' HG2' ' HA ' ' A' ' 119' ' ' ILE . 24.2 pt-20 -72.1 -48.93 40.28 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.151 0.426 . . . . 74.32 112.151 -174.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.715 HD12 HD13 ' A' ' 66' ' ' LEU . 83.4 mt -59.38 -55.81 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.597 0.237 . . . . 72.53 110.852 -177.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -58.77 -20.31 48.58 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.991 0.425 . . . . 72.01 111.044 -178.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -84.12 -35.55 23.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.032 -0.531 . . . . 63.32 111.06 177.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -91.69 -9.34 44.22 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.192 -0.458 . . . . 73.11 111.929 -172.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 123' ' ' ILE . 45.4 pt -133.94 168.19 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 120.689 0.28 . . . . 71.04 110.691 175.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.245 0.857 0 CA-C-O 118.802 -0.618 . . . . 74.44 110.624 -175.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.512 ' N ' ' SD ' ' A' ' 22' ' ' MET . 1.4 mpt? . . . . . 0 C--O 1.235 0.302 0 CA-C-O 120.799 0.333 . . . . 73.25 111.105 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.9 mt -111.66 128.11 68.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 115.898 -0.592 . . . . 74.4 110.337 -175.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.455 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 0.9 OUTLIER -122.0 144.22 49.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.326 -0.397 . . . . 71.41 109.952 -179.556 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.41 137.79 33.13 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 110.223 -0.288 . . . . 65.14 110.223 177.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.477 HG21 ' HD3' ' A' ' 34' ' ' LYS . 36.2 pt -140.22 172.96 11.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 121.337 0.589 . . . . 73.54 111.399 -176.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -110.73 173.91 16.61 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.236 -0.893 . . . . 13.31 111.809 177.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -67.29 -33.68 75.81 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.684 0.253 . . . . 75.21 111.684 -177.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 44.6 m -64.48 -47.56 78.52 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.091 0.472 . . . . 64.12 110.804 -178.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.514 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 3.8 pm0 -84.29 -14.46 49.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.762 -0.654 . . . . 71.55 111.072 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.591 ' HE1' HG13 ' A' ' 46' ' ' VAL . 92.4 t80 -46.23 -70.08 0.11 Allowed 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.384 0.427 . . . . 65.21 110.726 -178.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -61.68 -39.85 92.9 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 121.128 0.489 . . . . 71.43 109.726 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.421 ' O ' ' HB2' ' A' ' 37' ' ' SER . 9.4 t-20 -56.35 -33.76 65.98 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.617 -1.174 . . . . 73.12 112.216 -171.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 18.7 ptmt -115.16 -21.85 9.76 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.711 0.263 . . . . 53.44 111.711 -177.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 93.6 t -88.5 -55.63 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 111.727 0.269 . . . . 63.51 111.727 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 30.8 p -85.87 -25.24 26.32 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.076 0.465 . . . . 74.43 110.796 -173.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 16.0 m -84.67 12.03 7.91 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.997 -0.547 . . . . 73.22 110.547 176.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 43.5 t -75.22 94.73 3.02 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.868 0.366 . . . . 62.14 110.548 178.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -91.88 1.31 57.26 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.138 -0.483 . . . . 70.23 110.563 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -72.22 -7.79 51.22 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.197 -0.456 . . . . 63.24 111.499 -176.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 64.39 15.82 9.77 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.18 -0.464 . . . . 71.21 111.397 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.9 tt -85.04 147.82 5.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 108.507 -0.923 . . . . 74.52 108.507 173.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.716 HD21 ' HE3' ' A' ' 101' ' ' MET . 61.2 tp -85.31 120.68 27.07 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.338 0.589 . . . . 74.32 110.682 -175.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 51.1 mt -106.98 126.02 63.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.379 -0.828 . . . . 75.35 110.392 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.423 HD11 ' N ' ' A' ' 45' ' ' LEU . 5.8 mp -108.81 110.13 21.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.317 -0.401 . . . . 72.54 110.067 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.591 HG13 ' HE1' ' A' ' 31' ' ' PHE . 59.3 t -96.96 111.26 26.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.812 -0.44 . . . . 71.44 109.812 176.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.424 ' OD1' ' NZ ' ' A' ' 78' ' ' LYS . 1.7 p30 -91.24 154.64 19.14 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.077 0.465 . . . . 64.5 110.62 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.7 t80 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 115.664 -0.698 . . . . 73.03 110.173 178.824 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo . . . . . 0 C--O 1.235 0.329 0 CA-C-O 120.763 0.235 . . . . 71.23 111.911 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.408 ' HB3' ' CD1' ' A' ' 119' ' ' ILE . 13.9 mp0 -57.74 -48.45 79.58 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.599 0.714 . . . . 74.1 110.466 -175.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.579 HD23 HG12 ' A' ' 99' ' ' ILE . 8.1 mp -55.55 -49.08 73.61 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 114.586 -1.188 . . . . 74.22 111.627 -174.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -71.15 -36.45 72.06 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.224 -0.287 . . . . 74.41 110.224 -177.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 65' ' ' LYS . 41.3 mmtt -55.58 -51.67 66.33 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.234 -0.439 . . . . 71.31 111.248 178.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.619 HD12 HD12 ' A' ' 123' ' ' ILE . 28.5 mt -76.38 -40.9 49.75 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 120.368 -0.533 . . . . 73.24 111.493 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.417 ' HB3' ' HB3' ' A' ' 22' ' ' MET . . . -59.68 -38.3 81.13 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 111.714 0.265 . . . . 61.5 111.714 -175.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -53.93 -33.07 55.71 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.751 0.31 . . . . 70.24 110.901 179.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 70.5 mm-40 -93.89 -41.09 9.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.031 -0.531 . . . . 65.55 111.17 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.478 ' O ' HG21 ' A' ' 74' ' ' VAL . 19.3 m-85 -107.42 17.46 22.75 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.957 0.725 . . . . 75.23 112.957 -168.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.0 t -53.95 -32.73 54.71 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.312 0.506 . . . . 74.33 112.188 -174.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -68.43 -16.69 64.0 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.804 0.335 . . . . 53.34 111.302 -178.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -114.47 -13.96 12.18 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.173 -0.467 . . . . 72.31 110.321 -178.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.478 HG21 ' O ' ' A' ' 70' ' ' TYR . 26.8 m -134.98 127.31 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 120.934 0.397 . . . . 73.54 110.688 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -118.42 122.83 43.75 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.57 -0.53 . . . . 63.31 109.57 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.446 HD12 ' HB3' ' A' ' 63' ' ' LEU . 60.7 mt -98.97 141.0 17.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.911 0.386 . . . . 74.42 110.913 -175.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.455 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 87.6 m-85 -133.63 157.93 44.52 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.076 -0.713 . . . . 72.2 109.076 175.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.424 ' NZ ' ' OD1' ' A' ' 47' ' ' ASP . 0.4 OUTLIER -141.33 148.82 40.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.872 0.367 . . . . 72.22 110.799 179.244 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.4 pp . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 115.525 -0.761 . . . . 72.5 110.423 -179.181 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.387 0 CA-C-O 120.815 0.34 . . . . 73.53 111.431 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.1 m -72.3 -28.16 62.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 71.01 110.931 -179.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -65.6 -40.78 93.03 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.97 -0.559 . . . . 72.23 110.092 -178.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . 0.502 ' HH ' HD13 ' A' ' 100' ' ' LEU . 80.4 m-85 -88.23 -17.17 31.37 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.564 -0.744 . . . . 74.44 110.363 175.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 63.43 50.56 61.38 Favored Glycine 0 C--N 1.333 0.412 0 N-CA-C 111.19 -0.764 . . . . 71.21 111.19 -175.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.7 p -56.25 115.18 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.242 0.544 . . . . 73.5 111.187 -176.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.9 m -96.96 -14.26 21.82 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.813 -0.631 . . . . 73.31 110.855 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.77 131.66 15.15 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.705 0.288 . . . . 73.13 111.208 -177.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.521 ' HB ' ' HA ' ' A' ' 97' ' ' PRO . 2.8 pp -96.11 161.7 26.29 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 116.038 -0.528 . . . . 72.43 110.123 175.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.521 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 3.3 Cg_exo -76.83 176.52 43.59 Favored 'Cis proline' 0 C--N 1.355 0.888 0 C-N-CA 124.389 -1.088 . . . . 65.31 112.314 -0.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 15.9 m -134.32 121.35 21.11 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.221 -0.445 . . . . 71.12 110.098 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.632 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 3.7 mp -117.07 125.8 74.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.331 -0.618 . . . . 75.35 109.331 179.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.502 HD13 ' HH ' ' A' ' 91' ' ' TYR . 0.8 OUTLIER -106.92 128.9 54.72 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.794 0.331 . . . . 74.23 110.129 -177.566 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.741 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 65.9 mtp -100.74 113.26 25.99 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.117 -0.492 . . . . 74.11 110.772 -177.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -111.42 146.61 36.88 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.076 -0.511 . . . . 74.43 110.749 178.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.783 ' HB3' HD21 ' A' ' 108' ' ' LEU . 33.9 ttpt -160.06 130.89 5.68 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.889 -0.782 . . . . 63.31 108.889 177.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 31.5 t-20 55.11 31.61 16.63 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.681 0.753 . . . . 65.24 110.101 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 74.84 20.93 79.26 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.313 -0.858 . . . . 53.51 113.42 176.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -129.3 155.2 45.97 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.758 0.279 . . . . 51.24 110.663 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.53 120.14 32.69 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.765 0.317 . . . . 60.31 110.168 177.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.783 HD21 ' HB3' ' A' ' 103' ' ' LYS . 2.0 mm? -92.89 -51.87 4.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.332 -0.395 . . . . 72.55 110.323 -178.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.741 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 49.7 m -153.96 171.54 18.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.59 -0.732 . . . . 74.54 110.592 -175.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -146.16 124.89 12.57 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.992 -0.549 . . . . 75.32 110.546 176.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.632 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 52.5 t -82.55 107.12 14.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.697 -0.483 . . . . 64.25 109.697 176.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 64.5 mt -109.18 108.67 25.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.813 -0.44 . . . . 75.11 109.813 178.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.0 -122.9 7.74 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.18 -0.534 . . . . 74.41 111.783 -178.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.24 88.15 1.0 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.779 0.323 . . . . 71.33 110.27 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.471 ' O ' HG21 ' A' ' 119' ' ' ILE . 3.6 m-20 -126.7 86.58 2.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.274 -0.421 . . . . 74.42 110.282 -177.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.512 ' O ' HG13 ' A' ' 119' ' ' ILE . 7.7 tp -55.57 -44.76 77.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 116.242 -0.435 . . . . 73.12 111.807 -176.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.5 t -68.09 -26.48 65.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.07 0.462 . . . . 71.15 110.655 -175.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.485 ' HZ1' ' CD ' ' A' ' 122' ' ' GLU . 14.7 tmtt? -79.71 -45.6 18.64 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 116.086 -0.506 . . . . 71.04 110.269 179.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 116' ' ' ILE . 2.1 pp -67.87 -40.27 83.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 115.853 -0.612 . . . . 71.22 111.088 -175.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.467 HG21 HD13 ' A' ' 66' ' ' LEU . 2.8 pp -61.79 -32.23 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 120.439 -0.505 . . . . 75.31 110.029 178.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.465 ' N ' HD13 ' A' ' 120' ' ' ILE . 27.9 t -70.29 -51.77 27.89 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.867 -0.606 . . . . 62.24 110.379 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.522 ' HB2' ' HG ' ' A' ' 109' ' ' SER . 21.0 pt-20 -72.02 -34.33 68.75 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.186 0.439 . . . . 74.32 112.186 -175.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.619 HD12 HD12 ' A' ' 66' ' ' LEU . 66.8 mt -71.02 -47.97 58.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-O 120.661 0.267 . . . . 72.53 110.795 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -66.77 -20.12 65.89 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.948 0.404 . . . . 72.01 111.247 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -74.02 -6.13 45.57 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.458 -0.337 . . . . 63.32 111.172 174.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -113.93 -49.0 2.88 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.826 0.346 . . . . 73.11 110.648 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 33.6 pt -100.38 168.03 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.779 -0.646 . . . . 71.04 110.665 -177.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.449 ' N ' HD21 ' A' ' 128' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.161 0 CA-C-O 118.355 -0.831 . . . . 74.44 110.723 178.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.718 ' HG3' HG12 ' A' ' 23' ' ' ILE . 25.3 ptt? . . . . . 0 N--CA 1.463 0.208 0 CA-C-O 120.666 0.27 . . . . 73.25 110.655 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.718 HG12 ' HG3' ' A' ' 22' ' ' MET . 14.6 mm -113.78 108.82 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 N-CA-C 109.043 -0.725 . . . . 74.4 109.043 178.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.567 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 36.1 tt0 -122.73 131.98 54.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.733 0.301 . . . . 71.41 110.536 -172.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -90.22 128.89 36.5 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.641 -0.503 . . . . 65.14 109.641 178.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.454 HG21 ' HD3' ' A' ' 34' ' ' LYS . 47.5 pt -130.9 165.94 29.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-O 121.056 0.455 . . . . 73.54 111.492 -175.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -111.79 169.26 13.07 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.576 -0.738 . . . . 13.31 112.845 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -52.25 -38.85 59.35 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 122.824 0.45 . . . . 75.21 111.407 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.5 t -59.36 -21.88 60.5 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.821 -0.627 . . . . 64.12 112.251 -175.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.465 ' HA ' ' HB2' ' A' ' 33' ' ' ASN . 11.3 pt-20 -125.64 -3.34 7.24 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 111.679 0.251 . . . . 71.55 111.679 -175.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -51.61 -70.8 0.08 Allowed 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.192 0.308 . . . . 65.21 111.152 -177.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -58.8 -42.71 89.75 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.638 0.733 . . . . 71.43 109.429 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.465 ' HB2' ' HA ' ' A' ' 30' ' ' GLU . 1.5 m-80 -52.44 -38.25 58.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 113.829 -1.532 . . . . 73.12 112.795 -172.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.454 ' HD3' HG21 ' A' ' 26' ' ' ILE . 16.1 ptmt -111.31 -19.58 12.59 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.023 0.379 . . . . 53.44 112.023 -177.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.6 t -88.26 -55.32 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 111.928 0.344 . . . . 63.51 111.928 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 45.7 p -77.92 -38.3 45.89 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.171 0.51 . . . . 74.43 110.78 -173.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.7 m -79.89 9.29 5.47 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.854 -0.612 . . . . 73.22 111.511 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 53.2 t -75.44 111.38 10.66 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.798 0.332 . . . . 62.14 111.066 -178.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -116.69 15.1 15.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.026 -0.534 . . . . 70.23 110.317 178.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -68.96 -2.46 9.87 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.828 -0.624 . . . . 63.24 112.08 -177.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . 0.435 ' O ' ' HE3' ' A' ' 103' ' ' LYS . 18.3 m120 70.18 6.26 5.69 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 122.954 0.502 . . . . 71.21 111.071 -177.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.3 tt -89.09 157.08 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.331 -0.618 . . . . 74.52 109.331 178.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.446 HD22 ' HE3' ' A' ' 101' ' ' MET . 63.7 tp -96.26 118.23 32.41 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.155 -0.313 . . . . 74.32 110.155 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 101' ' ' MET . 48.8 mt -97.96 124.79 51.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.163 -0.471 . . . . 75.35 110.703 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.514 ' HB2' HG13 ' A' ' 76' ' ' ILE . 3.3 mp -115.7 105.77 13.12 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.654 -0.499 . . . . 72.54 109.654 178.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.52 HG12 ' HB2' ' A' ' 77' ' ' TYR . 30.9 m -97.01 121.69 47.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 CA-C-N 116.625 -0.261 . . . . 71.44 110.32 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.414 ' OD1' ' HG2' ' A' ' 78' ' ' LYS . 5.8 p-10 -104.63 125.42 50.73 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.391 0.615 . . . . 64.5 109.823 176.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.414 -0.812 . . . . 73.03 111.497 -176.735 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo . . . . . 0 CA--C 1.534 0.502 0 CA-C-O 121.15 0.396 . . . . 71.23 112.952 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.693 ' HB3' HG12 ' A' ' 119' ' ' ILE . 11.5 mp0 -51.18 -49.03 61.74 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 115.316 -0.857 . . . . 74.1 111.65 -173.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.511 HD13 HG21 ' A' ' 111' ' ' VAL . 2.5 mm? -64.25 -46.13 85.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.852 -1.067 . . . . 74.22 110.124 -172.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.574 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 55.0 mt-10 -68.0 -32.51 72.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.747 -0.66 . . . . 74.41 110.449 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -58.41 -56.66 19.23 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.342 -0.39 . . . . 71.31 110.634 176.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.565 HD13 HD13 ' A' ' 123' ' ' ILE . 22.5 mt -69.13 -30.11 68.29 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 120.825 -0.35 . . . . 73.24 110.861 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.21 -36.35 70.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.419 -0.355 . . . . 61.5 111.278 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.574 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 84.2 mt-30 -56.25 -32.98 65.0 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.286 -0.415 . . . . 70.24 111.006 -178.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -94.01 -56.59 2.81 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.322 0.582 . . . . 65.55 110.826 178.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.515 ' O ' HG23 ' A' ' 74' ' ' VAL . 22.2 m-85 -82.52 21.69 0.94 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.645 -0.707 . . . . 75.23 112.336 -173.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.445 ' OG1' ' HB3' ' A' ' 22' ' ' MET . 8.8 t -52.46 -31.26 33.92 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.976 0.417 . . . . 74.33 111.698 -176.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -70.13 -18.96 63.25 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.103 -0.498 . . . . 53.34 111.542 -175.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.41 6.24 8.35 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.732 0.301 . . . . 72.31 110.815 -173.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 70' ' ' TYR . 23.1 m -137.46 145.07 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 121.117 0.484 . . . . 73.54 111.583 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.5 mmtt -129.14 114.86 16.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.528 -0.76 . . . . 63.31 108.959 174.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.514 HG13 ' HB2' ' A' ' 45' ' ' LEU . 2.3 mp -100.5 138.43 24.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.559 -0.534 . . . . 74.42 109.559 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.567 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 41.2 m-85 -130.55 134.26 46.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.247 -0.433 . . . . 72.2 110.885 -177.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.414 ' HG2' ' OD1' ' A' ' 47' ' ' ASP . 55.9 mttm -109.19 111.86 23.7 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.257 -0.646 . . . . 72.22 109.257 174.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 32.0 pt . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 115.958 -0.564 . . . . 72.5 111.25 -175.882 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.554 0 CA-C-O 120.915 0.388 . . . . 73.53 111.001 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 88.5 m -65.76 -36.43 83.53 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.209 -0.45 . . . . 71.01 110.118 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -65.77 -37.34 86.05 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.159 -0.473 . . . . 72.23 110.228 177.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -70.72 -15.25 62.68 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.192 -0.458 . . . . 74.44 110.656 174.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.07 38.88 46.84 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.192 -0.528 . . . . 71.21 112.059 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.8 p -51.98 120.22 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 121.104 0.478 . . . . 73.5 111.168 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.4 m -124.37 6.57 8.37 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.782 -0.645 . . . . 73.31 110.609 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -156.38 126.77 6.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.09 -0.505 . . . . 73.13 110.606 -179.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.435 ' HB ' ' HA ' ' A' ' 97' ' ' PRO . 29.7 pt -101.69 156.14 35.55 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.986 -0.552 . . . . 72.43 109.755 177.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.435 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 84.5 Cg_endo -79.47 163.04 84.98 Favored 'Cis proline' 0 C--N 1.352 0.721 0 C-N-CA 123.822 -1.324 . . . . 65.31 112.709 1.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.469 HG23 HG12 ' A' ' 112' ' ' ILE . 30.6 m -128.19 115.62 18.65 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.733 -0.667 . . . . 71.12 109.36 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.602 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 3.4 mp -110.36 124.13 66.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.364 -0.38 . . . . 75.35 110.502 -176.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.4 mp -103.5 133.81 47.92 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.793 -0.447 . . . . 74.23 109.793 176.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.752 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 66.3 mtp -112.04 108.56 17.91 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.312 -0.404 . . . . 74.11 110.595 -175.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -108.76 154.83 21.49 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.162 -0.472 . . . . 74.43 111.272 -178.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.754 ' HB3' HD21 ' A' ' 108' ' ' LEU . 87.7 tttt -162.86 117.32 1.73 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.401 -0.962 . . . . 63.31 108.401 179.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 62.42 25.19 15.02 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.528 0.68 . . . . 65.24 110.416 -178.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.69 -0.44 89.19 Favored Glycine 0 C--N 1.331 0.291 0 CA-C-N 115.881 -0.599 . . . . 53.51 112.763 179.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -100.62 137.56 38.85 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.829 -0.434 . . . . 51.24 109.829 177.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.86 126.92 33.88 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.306 -0.627 . . . . 60.31 109.306 174.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.754 HD21 ' HB3' ' A' ' 103' ' ' LYS . 2.0 mm? -98.16 -51.09 4.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.224 -0.443 . . . . 72.55 110.108 -178.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.752 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 18.8 m -149.47 155.68 40.78 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.655 -0.702 . . . . 74.54 111.122 -171.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -131.04 118.85 21.16 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.802 -0.635 . . . . 75.32 109.835 175.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.602 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 50.4 t -89.78 107.09 17.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.707 -0.479 . . . . 64.25 109.707 176.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.469 HG12 HG23 ' A' ' 98' ' ' THR . 60.9 mt -112.72 117.33 55.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.613 -0.514 . . . . 75.11 109.613 179.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.75 -126.04 8.78 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 111.687 -0.565 . . . . 74.41 111.687 -178.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.52 91.46 1.16 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.711 0.291 . . . . 71.33 110.861 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -132.54 99.74 4.75 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.1 0.476 . . . . 74.42 111.155 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.628 HD12 HD12 ' A' ' 119' ' ' ILE . 7.1 tp -62.97 -40.39 88.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 115.671 -0.695 . . . . 73.12 110.58 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 32.3 t -64.8 -32.04 73.55 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.132 0.491 . . . . 71.15 110.257 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.99 -53.66 10.61 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 109.266 -0.642 . . . . 71.04 109.266 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.693 HG12 ' HB3' ' A' ' 62' ' ' GLN . 2.4 pp -62.07 -39.42 83.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 115.661 -0.7 . . . . 71.22 111.566 -173.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.443 HD13 ' N ' ' A' ' 121' ' ' SER . 2.8 pp -62.52 -31.52 52.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 120.087 -0.645 . . . . 75.31 110.208 178.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.443 ' N ' HD13 ' A' ' 120' ' ' ILE . 29.2 m -70.89 -51.43 26.29 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.194 -0.457 . . . . 62.24 110.806 178.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.477 ' OE2' ' HB3' ' A' ' 109' ' ' SER . 13.1 pt-20 -77.32 -41.91 38.82 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.603 0.594 . . . . 74.32 112.603 -173.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.565 HD13 HD13 ' A' ' 66' ' ' LEU . 74.2 mt -61.82 -55.14 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 O-C-N 122.144 -0.347 . . . . 72.53 110.611 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -59.26 -20.05 51.01 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.094 0.473 . . . . 72.01 110.816 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -79.08 -34.17 43.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.917 -0.583 . . . . 63.32 110.87 176.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -93.43 -20.87 19.9 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.372 -0.377 . . . . 73.11 111.611 -173.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . 0.422 HG12 ' O ' ' A' ' 123' ' ' ILE . 48.5 pt -120.32 168.36 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 110.173 -0.306 . . . . 71.04 110.173 175.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . 0.514 ' N ' HD21 ' A' ' 128' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.224 -0.893 . . . . 74.44 111.977 -176.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.578 ' HG3' ' HB2' ' A' ' 67' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.521 0 N-CA-C 109.176 -0.676 . . . . 73.25 109.176 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.412 HD11 ' HB ' ' A' ' 76' ' ' ILE . 8.6 mm -110.57 106.44 20.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 114.797 -1.092 . . . . 74.4 108.923 178.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.46 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 7.9 tp10 -121.1 141.4 50.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.888 0.375 . . . . 71.41 111.058 -178.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -95.58 124.15 39.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.886 -0.597 . . . . 65.14 109.535 177.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.51 HD12 ' HA ' ' A' ' 31' ' ' PHE . 27.0 pt -121.67 157.53 25.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 116.221 -0.445 . . . . 73.54 111.214 -175.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.25 170.15 37.05 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.875 -0.602 . . . . 13.31 112.107 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -66.2 -30.17 70.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.23 0.538 . . . . 75.21 110.449 -176.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.1 m -70.29 -48.76 55.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.575 -0.739 . . . . 64.12 111.156 -177.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -87.64 -13.55 42.4 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.45 -0.341 . . . . 71.55 111.274 -177.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.51 ' HA ' HD12 ' A' ' 26' ' ' ILE . 47.8 t80 -48.8 -70.15 0.1 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.873 0.368 . . . . 65.21 110.298 175.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -53.75 -43.26 68.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.946 -0.57 . . . . 71.43 109.663 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.557 ' O ' ' HB2' ' A' ' 37' ' ' SER . 0.2 OUTLIER -53.16 -50.11 65.24 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 114.734 -1.121 . . . . 73.12 111.762 -173.45 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.17 -17.08 17.56 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.195 0.443 . . . . 53.44 112.195 -173.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.5 t -88.29 -52.14 11.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 111.655 0.243 . . . . 63.51 111.655 -178.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.0 p -75.49 -45.27 39.38 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.545 0.688 . . . . 74.43 109.806 -177.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.557 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 19.9 m -77.06 12.78 1.27 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.47 -0.786 . . . . 73.22 111.107 176.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 36.1 t -28.93 101.17 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.184 0.993 . . . . 62.14 113.061 -178.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -89.62 -18.21 26.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.622 -0.717 . . . . 70.23 109.556 175.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.489 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . 2.8 m-20 -53.91 -40.33 66.57 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.685 -0.688 . . . . 63.24 110.833 -179.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 60.8 19.48 9.66 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.903 0.859 . . . . 71.21 109.636 -170.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.489 ' HB ' ' HB3' ' A' ' 40' ' ' ASP . 7.8 mt -101.02 154.24 4.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 114.086 -1.415 . . . . 74.52 108.613 175.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.717 HD22 ' HE3' ' A' ' 101' ' ' MET . 49.3 tp -70.15 104.9 2.74 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.505 -0.554 . . . . 74.32 109.505 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 48.1 mt -93.09 105.05 16.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.864 -0.607 . . . . 75.35 110.664 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.548 HD23 HD22 ' A' ' 63' ' ' LEU . 2.0 mp -100.28 102.98 14.38 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.434 -0.58 . . . . 72.54 109.434 178.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.499 HG21 ' HB2' ' A' ' 77' ' ' TYR . 33.2 t -99.66 123.74 52.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.422 -0.584 . . . . 71.44 109.422 178.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -108.75 131.6 54.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.529 0.681 . . . . 64.5 110.959 -178.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 115.091 -0.959 . . . . 73.03 109.312 -179.614 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo . . . . . 0 N--CA 1.464 -0.254 0 N-CA-C 110.923 -0.453 . . . . 71.23 110.923 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.458 ' HB3' HG12 ' A' ' 119' ' ' ILE . 7.3 mp0 -50.84 -57.46 8.4 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 121.165 0.507 . . . . 74.1 111.493 -172.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.795 HD11 HD12 ' A' ' 99' ' ' ILE . 21.7 mt -57.71 -48.84 78.45 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.461 -0.79 . . . . 74.22 111.437 -172.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.57 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 51.0 mt-10 -71.71 -32.49 67.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.961 -0.563 . . . . 74.41 110.244 -177.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -61.17 -46.23 91.35 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.974 -0.557 . . . . 71.31 110.051 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.436 HD13 HD12 ' A' ' 123' ' ' ILE . 37.6 mt -74.56 -37.22 63.03 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.447 -0.342 . . . . 73.24 110.919 175.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.578 ' HB2' ' HG3' ' A' ' 22' ' ' MET . . . -58.14 -31.11 66.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 61.5 111.603 -177.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.57 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 77.9 mt-30 -54.56 -33.26 59.86 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.862 0.363 . . . . 70.24 110.712 177.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -94.36 -42.25 8.99 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.051 -0.522 . . . . 65.55 111.592 177.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.525 ' O ' HG22 ' A' ' 74' ' ' VAL . 11.5 m-85 -103.41 22.34 14.39 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.461 0.541 . . . . 75.23 112.461 -168.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.44 ' OG1' ' HB3' ' A' ' 22' ' ' MET . 5.3 t -52.28 -35.04 49.14 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.412 0.523 . . . . 74.33 112.412 -172.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -71.35 -16.11 62.42 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.212 0.449 . . . . 53.34 112.212 -175.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.428 ' O ' HG21 ' A' ' 42' ' ' ILE . 0.2 OUTLIER -125.77 11.5 7.83 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.587 0.232 . . . . 72.31 111.218 -176.743 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 70' ' ' TYR . 34.1 m -136.76 137.43 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 O-C-N 121.733 -0.604 . . . . 73.54 111.275 176.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 28.1 mmtp -119.98 115.26 23.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.538 -0.755 . . . . 63.31 109.511 177.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.469 HD13 ' N ' ' A' ' 76' ' ' ILE . 2.9 mp -105.27 122.79 58.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 108.869 -0.789 . . . . 74.42 108.869 177.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.499 ' HB2' HG21 ' A' ' 46' ' ' VAL . 39.5 m-85 -119.37 132.32 55.83 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.229 0.538 . . . . 72.2 111.667 -174.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -91.19 110.22 21.49 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.711 -1.132 . . . . 72.22 108.696 173.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.6 tp . . . . . 0 C--N 1.323 -0.579 0 CA-C-O 120.845 0.355 . . . . 72.5 110.999 -177.168 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.156 0 CA-C-O 121.092 0.473 . . . . 73.53 110.242 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.5 m -64.19 -33.6 76.16 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.818 -0.628 . . . . 71.01 110.387 179.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -63.04 -46.95 85.13 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.823 -0.626 . . . . 72.23 110.306 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 22.4 m-30 -83.01 5.24 22.85 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.062 -0.517 . . . . 74.44 111.324 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 65.0 34.72 90.63 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 121.31 -0.471 . . . . 71.21 112.8 175.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.44 HG11 ' OG1' ' A' ' 98' ' ' THR . 64.7 t -61.71 98.9 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.978 0.418 . . . . 73.5 110.068 177.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.3 m -100.49 8.75 43.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.898 -0.592 . . . . 73.31 111.553 -174.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -147.6 164.82 32.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.601 0.238 . . . . 73.13 110.631 -178.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 pp -129.93 156.89 78.37 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.225 -0.443 . . . . 72.43 110.596 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.17 169.35 74.45 Favored 'Cis proline' 0 C--N 1.354 0.827 0 C-N-CA 123.784 -1.34 . . . . 65.31 112.213 -0.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.44 ' OG1' HG11 ' A' ' 93' ' ' VAL . 15.0 m -112.15 124.5 52.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.108 -0.496 . . . . 71.12 110.502 -179.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.828 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 36.0 mt -126.62 135.75 62.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.341 -0.614 . . . . 75.35 109.341 178.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.19 133.77 52.64 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.964 -0.384 . . . . 74.23 109.964 -178.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.768 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 50.1 mtp -106.1 117.93 35.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.896 -0.593 . . . . 74.11 110.776 -176.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -118.34 155.72 30.16 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 122.646 0.378 . . . . 74.43 110.677 178.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.576 ' HB3' HD21 ' A' ' 108' ' ' LEU . 38.1 ttpt -166.31 123.04 1.32 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.844 -0.616 . . . . 63.31 109.774 176.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 46.2 t30 58.04 25.02 11.82 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.771 0.795 . . . . 65.24 110.812 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.85 -2.34 79.64 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 115.991 -0.549 . . . . 53.51 113.381 175.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 54.0 tttm -102.77 145.07 30.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.908 0.354 . . . . 51.24 110.135 177.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -82.19 139.22 34.43 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.804 -0.813 . . . . 60.31 108.804 171.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.576 HD21 ' HB3' ' A' ' 103' ' ' LYS . 2.7 mm? -107.14 -53.26 2.64 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.885 0.374 . . . . 72.55 110.231 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.768 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 54.5 m -153.72 164.46 38.27 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 116.019 -0.537 . . . . 74.54 111.086 -175.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -129.48 106.44 8.76 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.715 -0.675 . . . . 75.32 109.298 177.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.828 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 77.0 t -84.04 107.28 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.463 -0.569 . . . . 64.25 109.463 -179.304 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 62.5 mt -120.15 108.76 23.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.858 -0.61 . . . . 75.11 110.19 -176.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 108.67 -117.33 4.97 Favored Glycine 0 CA--C 1.518 0.265 0 N-CA-C 111.831 -0.508 . . . . 74.41 111.831 -178.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.41 57.22 0.5 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.392 0.615 . . . . 71.33 110.032 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.73 81.8 5.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.464 -0.789 . . . . 74.42 110.399 -178.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.525 HD12 HD12 ' A' ' 119' ' ' ILE . 6.3 tp -61.89 -42.58 95.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 115.847 -0.615 . . . . 73.12 110.928 -177.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 45.4 t -62.67 -31.59 72.51 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.036 0.446 . . . . 71.15 110.633 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -74.05 -52.2 13.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.971 -0.559 . . . . 71.04 110.225 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.525 HD12 HD12 ' A' ' 116' ' ' ILE . 2.3 pp -63.84 -39.3 84.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.159 -0.473 . . . . 71.22 111.552 -173.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.482 HD13 ' N ' ' A' ' 121' ' ' SER . 2.9 pp -64.81 -33.86 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 C-N-CA 120.303 -0.559 . . . . 75.31 109.946 178.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.482 ' N ' HD13 ' A' ' 120' ' ' ILE . 23.1 t -70.42 -47.62 59.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.933 -0.576 . . . . 62.24 110.584 -178.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.485 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 13.0 pt-20 -77.2 -43.06 35.09 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.676 -0.238 . . . . 74.32 111.48 -175.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.436 HD12 HD13 ' A' ' 66' ' ' LEU . 82.4 mt -64.11 -51.59 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 117.657 0.208 . . . . 72.53 111.143 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -58.65 -24.07 60.41 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.065 0.459 . . . . 72.01 110.609 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -91.94 -21.25 20.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.943 -0.571 . . . . 63.32 110.963 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 3.7 t-20 -85.81 -36.78 19.85 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.086 -0.506 . . . . 73.11 111.152 -175.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 47.2 pt -107.93 168.77 3.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 115.759 -0.655 . . . . 71.04 110.032 178.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.2 p30 . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.409 -0.805 . . . . 74.44 110.638 -173.533 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.706 ' HG3' ' HB3' ' A' ' 67' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.524 0 CA-C-O 120.587 0.232 . . . . 73.25 111.362 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.501 HD11 ' HG2' ' A' ' 64' ' ' GLU . 22.9 mm -104.65 126.15 59.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.972 -0.558 . . . . 74.4 109.536 178.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.473 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 9.7 tp10 -129.23 137.29 51.01 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.025 -0.361 . . . . 71.41 110.025 178.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.647 ' NE2' ' H ' ' A' ' 25' ' ' GLN . 0.6 OUTLIER -105.81 114.62 28.88 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.614 -0.514 . . . . 65.14 109.614 176.771 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.528 HG23 ' HD3' ' A' ' 34' ' ' LYS . 28.2 pt -114.45 154.22 15.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.044 -0.526 . . . . 73.54 111.476 -172.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.56 178.22 45.66 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.455 -0.793 . . . . 13.31 112.115 176.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -63.25 -36.47 83.76 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.18 0.514 . . . . 75.21 111.213 -176.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.7 m -69.61 -42.67 74.05 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.756 -0.656 . . . . 64.12 111.525 -173.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -85.38 -12.31 52.42 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.562 -0.29 . . . . 71.55 111.692 -176.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.511 ' HA ' HD12 ' A' ' 26' ' ' ILE . 90.1 t80 -47.36 -69.9 0.11 Allowed 'General case' 0 N--CA 1.462 0.173 0 O-C-N 123.425 0.453 . . . . 65.21 110.263 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -55.63 -43.78 76.5 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 116.46 -0.336 . . . . 71.43 110.78 177.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.414 ' O ' ' HB2' ' A' ' 37' ' ' SER . 0.2 OUTLIER -52.22 -44.39 64.76 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.113 -0.949 . . . . 73.12 111.399 -170.557 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.528 ' HD3' HG23 ' A' ' 26' ' ' ILE . 0.2 OUTLIER -110.94 -21.71 11.88 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.326 0.491 . . . . 53.44 112.326 -175.963 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 89.5 t -88.21 -49.57 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 111.509 0.189 . . . . 63.51 111.509 -179.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 79.9 p -87.81 -6.53 58.09 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 120.387 -0.525 . . . . 74.43 110.642 -175.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 50.2 m -104.91 12.15 32.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.825 -0.625 . . . . 73.22 110.313 174.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 50.3 t -60.55 90.25 0.02 OUTLIER 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.22 0.534 . . . . 62.14 111.452 -176.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -94.05 6.44 48.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.545 -0.752 . . . . 70.23 109.226 175.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -74.26 -20.85 60.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.282 -0.872 . . . . 63.24 111.056 -175.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.6 m120 69.39 15.04 8.45 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.864 -0.607 . . . . 71.21 111.078 -176.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 37.7 mt -93.64 141.15 15.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.733 -0.667 . . . . 74.52 109.549 174.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.718 HD23 ' HE1' ' A' ' 101' ' ' MET . 64.6 tp -75.18 114.04 13.22 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.318 -0.401 . . . . 74.32 110.312 -178.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.483 HG21 ' CD2' ' A' ' 77' ' ' TYR . 44.0 mt -97.53 116.47 40.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.941 -0.572 . . . . 75.35 110.317 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.47 HD11 ' N ' ' A' ' 45' ' ' LEU . 3.3 mp -107.13 102.88 12.17 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.808 -0.442 . . . . 72.54 109.808 179.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.483 HG23 ' HB2' ' A' ' 77' ' ' TYR . 58.0 t -95.84 112.16 27.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.282 -0.417 . . . . 71.44 109.946 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -98.5 125.69 43.79 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.55 0.691 . . . . 64.5 110.385 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.409 ' HE1' ' HB2' ' A' ' 100' ' ' LEU . 70.2 m-85 . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 115.063 -0.971 . . . . 73.03 109.826 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo . . . . . 0 CA--C 1.531 0.344 0 N-CA-C 111.528 -0.22 . . . . 71.23 111.528 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.723 ' HB3' HG12 ' A' ' 119' ' ' ILE . 4.3 mp0 -50.98 -57.68 7.96 Favored 'General case' 0 C--O 1.252 1.197 0 CA-C-O 121.737 0.779 . . . . 74.1 111.312 -175.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.497 HD13 HD13 ' A' ' 99' ' ' ILE . 46.3 mt -54.54 -48.77 71.59 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 114.588 -1.187 . . . . 74.22 110.909 -174.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.618 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 50.1 mt-10 -75.0 -32.56 61.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.981 -0.554 . . . . 74.41 110.68 -176.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -56.24 -46.55 79.54 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.333 -0.394 . . . . 71.31 110.056 176.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.502 HD12 HD13 ' A' ' 123' ' ' ILE . 12.9 mt -82.6 -33.63 27.92 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.098 -0.501 . . . . 73.24 111.116 178.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.706 ' HB3' ' HG3' ' A' ' 22' ' ' MET . . . -59.74 -39.01 83.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.074 -0.512 . . . . 61.5 111.888 -175.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.618 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 77.7 mt-30 -56.78 -31.12 64.32 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.133 0.492 . . . . 70.24 110.515 -179.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -93.66 -51.47 4.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.367 -0.833 . . . . 65.55 111.003 -174.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.435 ' O ' HG21 ' A' ' 74' ' ' VAL . 7.2 m-85 -104.37 23.18 13.58 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.716 -0.675 . . . . 75.23 111.583 -168.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.458 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 8.7 t -52.65 -27.1 15.77 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 111.977 0.362 . . . . 74.33 111.977 -177.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -60.87 -27.6 68.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.875 0.369 . . . . 53.34 111.232 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -121.48 0.32 9.94 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.047 -0.524 . . . . 72.31 110.68 -174.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.435 HG21 ' O ' ' A' ' 70' ' ' TYR . 21.4 m -133.05 146.13 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 121.034 0.445 . . . . 73.54 110.883 176.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.681 ' HE3' ' HA ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -141.86 129.57 21.6 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.204 -0.665 . . . . 63.31 109.204 177.224 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.488 ' HB ' HD12 ' A' ' 23' ' ' ILE . 2.6 mp -106.04 138.18 32.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 120.653 0.263 . . . . 74.42 110.397 -177.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.483 ' HB2' HG23 ' A' ' 46' ' ' VAL . 84.4 m-85 -134.25 137.86 44.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 72.2 110.923 -175.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 41.8 mttp -112.19 122.31 47.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.544 -0.753 . . . . 72.22 109.211 173.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.6 tp . . . . . 0 C--N 1.325 -0.472 0 CA-C-N 116.012 -0.54 . . . . 72.5 111.457 -173.312 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.296 0 CA-C-O 121.1 0.476 . . . . 73.53 110.158 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.6 m -68.7 -31.98 71.45 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.809 -0.632 . . . . 71.01 110.511 177.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -59.25 -49.88 76.15 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.208 -0.451 . . . . 72.23 110.239 177.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -72.05 -17.33 62.02 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.24 -0.436 . . . . 74.44 110.565 176.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.54 48.88 5.7 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 121.189 -0.529 . . . . 71.21 112.538 177.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 88.2 t -68.56 104.83 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.892 0.377 . . . . 73.5 110.27 176.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.8 p -73.53 -40.91 63.65 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.938 -0.574 . . . . 73.31 111.341 -178.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -150.86 164.9 35.18 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.565 -0.289 . . . . 73.13 111.171 -178.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.59 ' HB ' ' HA ' ' A' ' 97' ' ' PRO . 2.7 pp -97.56 164.16 18.16 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 116.126 -0.488 . . . . 72.43 110.448 178.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.59 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 91.0 Cg_endo -78.09 165.5 83.0 Favored 'Cis proline' 0 C--N 1.355 0.91 0 C-N-CA 124.264 -1.14 . . . . 65.31 112.537 -0.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 13.0 m -129.65 122.44 29.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.051 -0.522 . . . . 71.12 110.298 -178.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.794 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 45.0 mt -115.4 108.19 24.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.345 -0.613 . . . . 75.35 109.345 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.48 ' HG ' ' HG3' ' A' ' 110' ' ' GLN . 2.4 tt -99.34 124.34 44.36 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.933 -0.395 . . . . 74.23 109.933 -176.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.74 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 65.0 mtp -93.45 112.01 23.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.927 -0.579 . . . . 74.11 111.155 -177.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -107.24 147.14 30.56 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.007 0.523 . . . . 74.43 110.446 175.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.678 ' HB3' HD23 ' A' ' 108' ' ' LEU . 28.7 ttpp -169.81 133.63 1.26 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.294 -0.632 . . . . 63.31 109.294 173.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.3 t30 61.43 24.82 14.87 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.266 0.555 . . . . 65.24 110.498 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 76.98 10.97 85.98 Favored Glycine 0 CA--C 1.522 0.5 0 CA-C-N 115.982 -0.554 . . . . 53.51 112.959 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -125.15 152.4 44.51 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.488 -0.56 . . . . 51.24 109.488 179.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.723 ' HD3' HE22 ' A' ' 110' ' ' GLN . 0.0 OUTLIER -84.71 142.9 29.53 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.447 -0.575 . . . . 60.31 109.447 177.842 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.678 HD23 ' HB3' ' A' ' 103' ' ' LYS . 2.4 mm? -106.32 -53.22 2.66 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.271 -0.27 . . . . 72.55 110.271 178.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.74 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 66.4 m -153.82 165.83 34.81 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 116.182 -0.463 . . . . 74.54 111.101 -178.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLN . . . . . 0.723 HE22 ' HD3' ' A' ' 107' ' ' LYS . 24.2 mp0 -128.44 102.44 6.64 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.533 -0.758 . . . . 75.32 109.443 177.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.794 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 50.6 t -80.35 107.04 12.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.517 -0.549 . . . . 64.25 109.517 177.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 52.5 mt -109.59 128.57 65.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.632 -0.507 . . . . 75.11 109.632 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.77 -123.09 6.36 Favored Glycine 0 N--CA 1.452 -0.269 0 N-CA-C 111.504 -0.639 . . . . 74.41 111.504 -176.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.52 101.94 1.87 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.955 0.377 . . . . 71.33 110.74 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -136.58 102.29 4.88 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 120.956 0.407 . . . . 74.42 110.861 179.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.587 HD12 HD12 ' A' ' 119' ' ' ILE . 7.9 tp -61.91 -38.39 80.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 115.895 -0.593 . . . . 73.12 110.383 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 37.7 t -61.57 -41.69 97.76 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.342 0.591 . . . . 71.15 110.316 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.448 ' O ' ' HG2' ' A' ' 122' ' ' GLU . 16.7 tppt? -63.92 -56.35 15.86 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.393 -0.821 . . . . 71.04 109.908 -179.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.723 HG12 ' HB3' ' A' ' 62' ' ' GLN . 2.2 pp -61.81 -43.33 97.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 115.455 -0.793 . . . . 71.22 111.979 -173.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.487 HD11 ' N ' ' A' ' 121' ' ' SER . 2.8 pp -63.0 -33.33 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 120.392 -0.523 . . . . 75.31 110.209 -178.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.487 ' N ' HD11 ' A' ' 120' ' ' ILE . 42.5 t -70.84 -52.3 21.22 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.07 -0.514 . . . . 62.24 110.997 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 118' ' ' LYS . 3.8 pt-20 -77.8 -37.67 48.26 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.391 0.886 . . . . 74.32 113.391 -175.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . 0.502 HD13 HD12 ' A' ' 66' ' ' LEU . 65.7 mt -61.39 -56.99 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 O-C-N 121.949 -0.469 . . . . 72.53 110.281 177.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -63.5 -20.46 65.62 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.845 -0.616 . . . . 72.01 111.174 -178.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -65.77 -35.24 80.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.052 -0.522 . . . . 63.32 110.452 175.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -95.59 -39.59 9.86 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.083 -0.508 . . . . 73.11 111.732 -175.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 38.9 pt -85.53 168.0 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.589 -0.278 . . . . 71.04 110.656 -178.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.9 p30 . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.258 -0.877 . . . . 74.44 110.95 -175.696 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 N--CA 1.483 1.208 0 N-CA-C 111.62 0.23 . . . . 64.12 111.62 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.55 84.63 0.18 Allowed 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.981 0.42 . . . . 74.33 111.632 -176.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 47.1 p-80 -113.47 121.9 45.67 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.08 -0.711 . . . . 73.01 109.08 173.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -165.76 96.6 0.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.085 0.469 . . . . 75.42 110.663 -175.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 66.5 t60 -148.38 110.22 4.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 74.22 110.219 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 31.6 m80 -87.31 -173.24 4.3 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.627 -0.508 . . . . 75.11 109.627 177.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 18.0 p-80 -151.64 99.27 2.58 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.174 0.512 . . . . 65.21 110.919 176.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 35.7 p80 -98.12 29.51 3.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.802 -0.635 . . . . 71.34 109.898 177.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 63.6 mtt -59.63 -29.7 68.2 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.578 -0.737 . . . . 61.33 110.919 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.57 -162.24 32.78 Favored Glycine 0 C--N 1.332 0.306 0 N-CA-C 111.66 -0.576 . . . . 54.42 111.66 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.1 t -123.73 157.44 33.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.666 0.269 . . . . 74.43 110.361 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.698 ' HB3' ' HA ' ' A' ' 52' ' ' TRP . 61.7 tp -158.2 115.01 2.85 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.413 -0.588 . . . . 75.13 109.413 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -107.71 147.91 30.13 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.121 -0.491 . . . . 74.12 110.782 -177.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -153.75 47.62 0.64 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.828 -0.624 . . . . 75.44 110.019 178.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -65.0 86.16 0.05 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.418 0.628 . . . . 71.2 110.718 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 t -67.62 -32.64 73.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.623 -0.717 . . . . 74.34 110.317 178.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -135.96 146.41 47.24 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 109.105 -0.702 . . . . 73.13 109.105 178.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -152.62 -80.62 0.03 OUTLIER Glycine 0 C--O 1.236 0.258 0 C-N-CA 120.859 -0.686 . . . . 72.22 112.4 -177.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -62.13 100.05 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.891 2.394 . . . . 73.22 112.203 -175.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 125.33 -19.32 6.77 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.883 -0.599 . . . . 71.45 112.582 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 73.4 p -87.0 -73.87 0.45 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.008 0.432 . . . . 64.02 111.182 -177.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.585 ' HG3' HG13 ' A' ' 23' ' ' ILE . 22.1 ptp -173.37 -30.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.86 -0.609 . . . . 73.25 110.379 -175.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.585 HG13 ' HG3' ' A' ' 22' ' ' MET . 60.8 mt -104.97 99.65 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 115.982 -0.553 . . . . 74.4 110.226 177.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.549 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 10.6 tp10 -101.22 155.23 18.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.83 -0.623 . . . . 71.41 109.699 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -106.69 134.7 49.44 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.025 -0.361 . . . . 65.14 110.025 176.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.505 HD13 ' HA ' ' A' ' 31' ' ' PHE . 32.1 pt -129.19 157.01 42.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-O 120.971 0.415 . . . . 73.54 111.134 -175.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -106.81 -171.45 22.63 Favored Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.93 -0.577 . . . . 13.31 112.284 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -67.92 -50.34 56.62 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.27 0.47 . . . . 75.21 112.27 -176.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.5 p -73.34 -11.95 60.66 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.425 0.528 . . . . 64.12 112.425 -171.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.407 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 1.7 pm0 -117.09 -6.71 11.37 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 116.668 -0.242 . . . . 71.55 111.069 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.505 ' HA ' HD13 ' A' ' 26' ' ' ILE . 93.4 t80 -51.77 -70.58 0.08 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.293 -0.412 . . . . 65.21 110.327 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -62.43 -35.18 78.46 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.136 0.493 . . . . 71.43 109.771 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -51.88 -47.6 64.46 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.104 -0.953 . . . . 73.12 111.565 -176.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.483 ' HZ1' ' HB2' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -102.52 -18.32 15.35 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.981 0.363 . . . . 53.44 111.981 -177.137 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.1 t -88.39 -59.74 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 111.947 0.351 . . . . 63.51 111.947 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 34.3 p -78.05 -33.08 51.12 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.818 0.342 . . . . 74.43 111.168 -172.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.9 m -84.57 11.84 8.08 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.253 -0.431 . . . . 73.22 111.351 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.516 ' SG ' HG21 ' A' ' 42' ' ' ILE . 44.9 t -75.76 103.07 5.68 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 120.863 0.363 . . . . 62.14 110.339 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -103.15 12.3 35.93 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.137 0.494 . . . . 70.23 110.327 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -81.7 1.65 33.34 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.082 -0.508 . . . . 63.24 111.256 -178.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 59.22 13.42 3.03 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.495 0.554 . . . . 71.21 112.495 -178.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.516 HG21 ' SG ' ' A' ' 38' ' ' CYS . 10.5 tt -78.85 153.09 4.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.182 -0.673 . . . . 74.52 109.182 176.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.772 HD23 ' HE3' ' A' ' 101' ' ' MET . 57.2 tp -93.4 111.55 23.23 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.281 0.562 . . . . 74.32 110.425 -177.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 101' ' ' MET . 71.6 mt -96.39 129.46 46.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.496 -0.774 . . . . 75.35 110.429 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.459 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 5.3 mp -117.72 103.83 10.4 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.923 -0.399 . . . . 72.54 109.923 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.521 HG12 ' HB2' ' A' ' 77' ' ' TYR . 29.6 m -93.78 127.88 45.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 110.242 -0.281 . . . . 71.44 110.242 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.488 ' CG ' ' HZ1' ' A' ' 78' ' ' LYS . 2.0 p-10 -125.07 153.24 43.22 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.925 0.393 . . . . 64.5 110.779 -177.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -77.81 -80.49 0.11 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.006 -0.543 . . . . 73.03 111.51 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -133.36 178.15 7.13 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.948 0.404 . . . . 75.11 111.392 -175.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.713 ' HB3' ' HB3' ' A' ' 53' ' ' CYS . . . -113.83 113.89 47.03 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.594 -0.73 . . . . 60.02 110.035 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.537 ' HG3' ' HD3' ' A' ' 97' ' ' PRO . 71.2 Cg_endo -72.24 82.91 1.28 Allowed 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.75 2.3 . . . . 74.34 112.025 -177.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.698 ' HA ' ' HB3' ' A' ' 12' ' ' LEU . 79.4 m95 60.76 22.94 12.88 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.931 -0.577 . . . . 74.15 110.877 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.713 ' HB3' ' HB3' ' A' ' 50' ' ' ALA . 52.6 t -81.99 66.6 7.64 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.735 -0.666 . . . . 72.24 110.106 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -120.69 156.18 16.11 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.459 -0.791 . . . . 63.14 111.657 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -65.4 -5.45 11.39 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.877 2.384 . . . . 62.11 112.734 -176.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 63.8 m -116.21 22.85 12.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.528 -0.305 . . . . 70.01 110.752 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.451 ' HG3' ' HE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER -152.9 -60.4 0.14 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.744 -0.465 . . . . 75.25 109.744 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 48.2 t -172.68 75.11 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.917 0.389 . . . . 52.33 110.634 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 52.3 tp -82.47 85.56 6.91 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.274 -0.639 . . . . 73.5 109.274 175.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -156.38 66.21 4.17 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 115.95 -0.568 . . . . 73.14 110.814 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.447 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 61.5 Cg_endo -92.12 155.66 3.22 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.698 2.265 . . . . 71.23 112.186 174.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 13.8 mp0 -62.32 -33.71 75.21 Favored 'General case' 0 C--O 1.248 1.01 0 CA-C-O 122.105 0.955 . . . . 74.1 109.598 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -56.98 -48.6 78.02 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-N 113.906 -1.497 . . . . 74.22 110.952 -174.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.447 ' HG3' ' HG2' ' A' ' 61' ' ' PRO . 45.2 mt-10 -59.31 -51.64 69.05 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.051 0.453 . . . . 74.41 109.886 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -51.28 -50.87 58.44 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.184 -0.916 . . . . 71.31 111.633 -176.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.586 HD13 HD12 ' A' ' 123' ' ' ILE . 13.2 mt -80.25 -39.22 29.4 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.024 -0.67 . . . . 73.24 112.346 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.56 -38.54 90.45 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.654 0.264 . . . . 61.5 111.31 -176.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.415 ' HA ' ' HE2' ' A' ' 22' ' ' MET . 73.2 mt-30 -54.6 -30.46 54.73 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.788 0.328 . . . . 70.24 111.177 178.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -90.45 -48.51 7.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.311 0.577 . . . . 65.55 110.837 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.512 ' O ' HG22 ' A' ' 74' ' ' VAL . 16.9 m-85 -98.31 23.18 8.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.547 -0.751 . . . . 75.23 112.118 -170.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.4 t -52.37 -42.01 63.58 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 112.234 0.457 . . . . 74.33 112.234 -172.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -72.99 -16.85 61.5 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.032 -0.418 . . . . 53.34 111.382 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.31 -8.04 16.5 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.536 -0.302 . . . . 72.31 111.225 -176.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.512 HG22 ' O ' ' A' ' 70' ' ' TYR . 28.3 m -133.73 151.17 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 O-C-N 121.923 -0.485 . . . . 73.54 111.032 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm -140.58 116.17 10.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.011 -0.54 . . . . 63.31 109.941 175.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.488 ' N ' HD12 ' A' ' 76' ' ' ILE . 2.7 mp -92.85 130.22 42.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.253 -0.647 . . . . 74.42 109.253 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.549 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 22.2 m-85 -124.46 128.81 49.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.745 0.307 . . . . 72.2 111.049 -178.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.488 ' HZ1' ' CG ' ' A' ' 47' ' ' ASP . 0.3 OUTLIER -77.96 114.07 16.47 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.273 -0.64 . . . . 72.22 109.273 174.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.56 HD13 ' HG3' ' A' ' 85' ' ' GLN . 10.6 tt -77.28 101.99 3.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.028 0.442 . . . . 72.5 110.058 177.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -64.4 -33.8 76.69 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.153 -0.476 . . . . 55.21 111.155 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.425 ' O ' HG12 ' A' ' 81' ' ' ILE . 10.9 tt -83.36 57.25 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 122.234 1.016 . . . . 61.14 110.015 178.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.65 -19.96 30.15 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.158 -0.928 . . . . 71.24 110.616 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -75.0 -19.91 59.88 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.377 -0.829 . . . . 64.43 111.493 -176.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -149.69 74.53 1.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.807 -0.357 . . . . 73.35 111.452 -174.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.56 ' HG3' HD13 ' A' ' 79' ' ' ILE . 21.7 mm-40 -144.7 111.27 5.68 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.861 -0.422 . . . . 74.21 109.861 172.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -79.1 9.17 4.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.599 -0.273 . . . . 61.45 111.412 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.3 t -55.95 -37.69 49.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.358 0.599 . . . . 75.03 109.532 174.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.21 -35.11 80.06 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.723 -0.671 . . . . 73.53 110.311 176.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.6 m -69.6 -32.95 71.98 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.907 -0.588 . . . . 71.01 109.756 176.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -63.17 -46.15 88.48 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.839 -0.619 . . . . 72.23 109.616 176.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.441 ' OH ' ' HE2' ' A' ' 107' ' ' LYS . 31.1 m-85 -77.11 -17.08 58.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.716 -0.675 . . . . 74.44 110.955 175.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 62.94 37.77 95.48 Favored Glycine 0 C--N 1.331 0.279 0 CA-C-N 116.203 -0.453 . . . . 71.21 112.197 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.7 p -86.23 144.73 8.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.889 0.376 . . . . 73.5 111.16 -175.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 31.9 t -136.58 84.66 2.09 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.868 -0.79 . . . . 73.31 108.868 173.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -163.85 161.6 23.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.659 -0.7 . . . . 73.13 109.975 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.435 ' HA ' ' HA ' ' A' ' 97' ' ' PRO . 0.0 OUTLIER -129.64 113.41 17.85 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 109.333 -0.617 . . . . 72.43 109.333 178.58 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.537 ' HD3' ' HG3' ' A' ' 51' ' ' PRO . 35.0 Cg_endo -98.6 -155.09 0.27 Allowed 'Cis proline' 0 C--N 1.348 0.544 0 C-N-CA 124.359 -1.101 . . . . 65.31 112.146 -2.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 37.7 m -145.26 139.52 27.18 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 109.256 -0.646 . . . . 71.12 109.256 174.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.701 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 3.6 mp -122.96 132.94 70.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 109.442 -0.577 . . . . 75.35 109.442 -178.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 7.9 mp -110.82 146.48 36.36 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.497 0.189 . . . . 74.23 110.602 178.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.772 ' HE3' HD23 ' A' ' 43' ' ' LEU . 59.0 mtp -115.82 118.5 33.19 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.995 -0.548 . . . . 74.11 111.256 -176.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -118.9 150.72 39.4 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.934 -0.575 . . . . 74.43 110.683 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.788 ' HB3' HD22 ' A' ' 108' ' ' LEU . 13.8 ttmm -165.58 125.67 1.8 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.75 -0.659 . . . . 63.31 109.474 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 63.34 27.1 15.27 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.514 0.673 . . . . 65.24 110.329 175.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 75.31 13.84 82.46 Favored Glycine 0 C--N 1.333 0.379 0 CA-C-N 115.683 -0.69 . . . . 53.51 111.991 -178.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -113.01 156.67 22.64 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 122.83 0.452 . . . . 51.24 110.232 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.441 ' HE2' ' OH ' ' A' ' 91' ' ' TYR . 14.7 ptmm? -101.22 125.39 47.84 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.287 -0.634 . . . . 60.31 109.287 176.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.788 HD22 ' HB3' ' A' ' 103' ' ' LYS . 2.1 mm? -104.87 -53.2 2.72 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 111.909 0.337 . . . . 72.55 111.909 -173.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.687 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 50.4 m -162.97 172.14 15.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.192 -0.458 . . . . 74.54 110.247 -172.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -147.59 127.14 13.26 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.016 0.436 . . . . 75.32 110.797 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.701 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 84.4 t -81.57 107.36 13.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 115.97 -0.559 . . . . 64.25 109.924 178.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.495 ' H ' ' HE3' ' A' ' 118' ' ' LYS . 65.6 mt -107.95 115.19 48.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 116.029 -0.532 . . . . 75.11 110.131 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.07 -135.57 13.19 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 116.097 -0.502 . . . . 74.41 112.108 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -145.39 77.05 1.5 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.182 0.515 . . . . 71.33 110.767 -178.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.529 ' O ' HG22 ' A' ' 119' ' ' ILE . 1.7 m-20 -124.21 91.11 3.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.789 -0.642 . . . . 74.42 109.895 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.435 ' O ' HG13 ' A' ' 119' ' ' ILE . 6.8 tp -54.45 -41.34 53.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 120.798 0.332 . . . . 73.12 111.187 -176.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 43.8 t -59.32 -34.8 72.78 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.17 0.51 . . . . 71.15 111.07 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.495 ' HE3' ' H ' ' A' ' 112' ' ' ILE . 2.4 tmtm? -79.38 -44.14 22.08 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.92 -0.582 . . . . 71.04 110.715 -178.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.529 HG22 ' O ' ' A' ' 115' ' ' ASP . 1.5 pp -66.41 -38.53 81.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 71.22 110.862 -175.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.428 HD12 ' N ' ' A' ' 121' ' ' SER . 2.7 pp -67.39 -31.81 54.51 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.078 0 C-N-CA 120.569 -0.452 . . . . 75.31 109.788 177.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.428 ' N ' HD12 ' A' ' 120' ' ' ILE . 34.7 t -67.48 -47.04 71.21 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.928 -0.578 . . . . 62.24 110.152 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.475 ' CD ' ' HZ2' ' A' ' 118' ' ' LYS . 15.0 pt-20 -76.74 -42.31 41.67 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.27 -0.423 . . . . 74.32 111.765 -177.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.586 HD12 HD13 ' A' ' 66' ' ' LEU . 68.3 mt -66.3 -52.23 49.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 O-C-N 122.335 -0.228 . . . . 72.53 111.046 -178.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -62.64 -20.28 64.64 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.927 0.394 . . . . 72.01 111.035 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -68.58 -34.14 75.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.075 -0.512 . . . . 63.32 110.423 176.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -103.9 -8.14 19.92 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.474 0.546 . . . . 73.11 112.474 -172.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 43.0 pt -139.11 167.85 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 120.796 0.332 . . . . 71.04 110.647 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.371 -0.823 . . . . 74.44 111.122 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.417 ' C ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 120.776 0.322 . . . . 64.12 110.615 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -168.39 97.11 0.41 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.833 -0.622 . . . . 74.33 109.544 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -151.09 101.28 2.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.357 -0.383 . . . . 73.01 110.19 -177.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -140.9 161.72 37.15 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 110.161 -0.311 . . . . 75.42 110.161 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.434 ' HB2' ' HA ' ' A' ' 90' ' ' GLN . 69.1 m80 -113.45 178.33 4.32 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.618 -0.512 . . . . 74.22 109.618 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 29.1 m80 -75.0 -78.29 0.11 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.33 -0.248 . . . . 75.11 110.33 -177.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.419 ' HB2' ' OD2' ' A' ' 86' ' ' ASP . 3.1 p80 178.22 -172.76 0.13 Allowed 'General case' 0 C--O 1.233 0.201 0 N-CA-C 109.537 -0.542 . . . . 65.21 109.537 -177.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.657 ' HD2' ' HG2' ' A' ' 9' ' ' MET . 4.9 t60 -124.51 -72.63 0.67 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.461 -0.57 . . . . 71.34 109.461 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.657 ' HG2' ' HD2' ' A' ' 8' ' ' HIS . 21.4 ptp 176.16 143.36 0.07 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 122.861 0.464 . . . . 61.33 110.34 176.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.54 80.9 0.32 Allowed Glycine 0 C--N 1.329 0.19 0 N-CA-C 110.359 -1.096 . . . . 54.42 110.359 173.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 19.8 p -80.53 2.13 26.67 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.51 0.93 . . . . 74.43 113.51 -167.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 30.6 tp 63.32 23.73 13.92 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.244 0.545 . . . . 75.13 111.022 175.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -86.47 49.33 1.78 Allowed 'General case' 0 C--N 1.329 -0.306 0 O-C-N 122.111 -0.368 . . . . 74.12 111.266 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -173.55 139.37 0.73 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.99 -0.55 . . . . 75.44 110.183 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -160.36 115.07 2.23 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.076 -0.713 . . . . 71.2 109.076 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 86.6 m -153.53 115.7 4.35 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.231 0.538 . . . . 74.34 111.761 -174.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.427 ' OE1' ' NZ ' ' A' ' 34' ' ' LYS . 4.8 tp60 -129.77 116.15 18.33 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.582 -0.736 . . . . 73.13 109.477 174.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 158.82 70.65 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 111.401 -0.68 . . . . 72.22 111.401 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.578 ' HA ' ' HG2' ' A' ' 24' ' ' GLU . 71.7 Cg_endo -72.82 162.39 41.25 Favored 'Trans proline' 0 C--O 1.237 0.434 0 C-N-CA 122.577 2.185 . . . . 73.22 112.563 -177.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -176.31 -35.63 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.9 -0.591 . . . . 71.45 111.695 178.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.0 m -95.99 158.65 15.35 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 122.458 0.303 . . . . 64.02 110.307 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -71.89 -28.62 63.63 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.729 -0.471 . . . . 73.25 109.729 176.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.3 mm -107.55 89.66 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 108.142 -1.059 . . . . 74.4 108.142 171.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.633 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 9.3 tp10 -108.78 155.46 20.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.566 -0.288 . . . . 71.41 110.483 -174.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.407 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 29.7 pt20 -105.29 147.65 27.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.919 0.39 . . . . 65.14 110.481 176.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 30.5 pt -129.56 -178.93 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.979 -0.555 . . . . 73.54 109.97 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.31 175.34 18.92 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.841 -0.695 . . . . 13.31 113.514 -175.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -67.76 -34.68 77.29 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.626 0.77 . . . . 75.21 110.949 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.2 t -79.88 -39.21 31.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 64.12 111.285 -171.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -95.12 0.25 54.07 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.998 -0.546 . . . . 71.55 111.304 -175.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -47.84 -71.19 0.07 Allowed 'General case' 0 CA--C 1.53 0.189 0 O-C-N 123.418 0.448 . . . . 65.21 111.186 -177.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -65.86 -32.88 74.65 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.375 -0.602 . . . . 71.43 109.375 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.475 ' O ' ' HB2' ' A' ' 37' ' ' SER . 3.4 t-20 -51.85 -39.17 58.44 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 114.762 -1.108 . . . . 73.12 111.333 -175.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.427 ' NZ ' ' OE1' ' A' ' 17' ' ' GLN . 10.9 ptmt -109.76 -25.8 10.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 53.44 112.122 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.5 t -80.11 -53.23 13.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 111.721 0.267 . . . . 63.51 111.721 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.0 p -83.75 -36.2 23.81 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.342 0.591 . . . . 74.43 110.067 -175.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.475 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 39.0 m -83.89 12.73 5.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.478 -0.783 . . . . 73.22 111.134 178.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 40.1 t -53.63 91.92 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.133 0.492 . . . . 62.14 110.979 176.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -80.84 -7.23 59.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.771 -0.65 . . . . 70.23 110.962 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -73.5 -16.54 61.28 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.247 -0.433 . . . . 63.24 110.643 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 65.89 21.69 11.4 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.744 -0.662 . . . . 71.21 111.443 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.546 HD12 ' HG2' ' A' ' 75' ' ' LYS . 17.6 tt -94.96 151.71 3.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.113 -0.699 . . . . 74.52 109.113 175.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.714 HD23 ' HE3' ' A' ' 101' ' ' MET . 64.8 tp -79.71 111.76 16.32 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.976 0.417 . . . . 74.32 110.474 -176.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 49.4 mt -91.31 122.91 43.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.615 -0.72 . . . . 75.35 110.498 177.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.571 HD13 HD11 ' A' ' 63' ' ' LEU . 58.8 mt -103.8 102.04 11.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.628 -0.715 . . . . 72.54 109.475 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 74.2 t -86.66 120.2 35.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.209 -0.451 . . . . 71.44 110.844 -177.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.487 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 13.7 t70 -95.24 154.91 16.96 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.925 0.393 . . . . 64.5 110.695 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -71.18 -63.64 1.07 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.762 -0.654 . . . . 73.03 112.301 -174.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 27.7 t90 -163.72 52.84 0.16 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.04 0.448 . . . . 75.11 110.916 -171.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 69.2 120.77 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 115.696 -0.683 . . . . 60.02 111.822 175.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.447 ' HG2' ' HG3' ' A' ' 61' ' ' PRO . 19.2 Cg_exo -68.14 69.37 0.93 Allowed 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.867 2.378 . . . . 74.34 112.152 175.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.434 ' HB2' ' HB3' ' A' ' 58' ' ' SER . 16.1 m95 62.29 103.23 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.672 0.789 . . . . 74.15 111.792 177.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 19.8 p -75.56 139.37 42.07 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.956 -0.565 . . . . 72.24 110.761 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 159.75 177.09 32.53 Favored Glycine 0 N--CA 1.452 -0.269 0 N-CA-C 111.699 -0.56 . . . . 63.14 111.699 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.03 75.08 0.68 Allowed 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 122.842 2.361 . . . . 62.11 112.432 -177.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.633 ' HA ' ' HB3' ' A' ' 59' ' ' LEU . 85.5 m 52.45 18.98 1.04 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.806 -0.634 . . . . 70.01 112.254 177.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.1 tpp180 -60.18 -68.73 0.27 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.793 0.33 . . . . 75.25 110.895 -176.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.434 ' HB3' ' HB2' ' A' ' 52' ' ' TRP . 27.7 t -105.29 7.49 33.46 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.546 -0.539 . . . . 52.33 109.546 176.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.633 ' HB3' ' HA ' ' A' ' 56' ' ' CYS . 32.4 tp -78.32 76.53 4.83 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.395 0.617 . . . . 73.5 110.041 -178.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -165.86 53.07 0.28 Allowed Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 114.858 -1.065 . . . . 73.14 108.305 177.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.447 ' HG3' ' HG2' ' A' ' 51' ' ' PRO . 87.3 Cg_endo -76.76 172.07 16.87 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.437 2.091 . . . . 71.23 112.571 -172.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.553 ' NE2' ' HA ' ' A' ' 114' ' ' ALA . 12.1 mp0 -52.15 -38.62 58.18 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.468 -0.787 . . . . 74.1 110.179 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.571 HD11 HD13 ' A' ' 45' ' ' LEU . 2.7 mm? -60.36 -48.7 80.62 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.672 -1.149 . . . . 74.22 110.326 -173.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -74.16 -36.54 64.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.179 -0.464 . . . . 74.41 109.997 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -52.33 -45.95 65.83 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.752 -0.658 . . . . 71.31 109.822 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.704 HD11 HD12 ' A' ' 123' ' ' ILE . 25.7 mt -84.78 -38.82 19.15 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 111.741 0.275 . . . . 73.24 111.741 177.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.517 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -55.98 -37.34 68.95 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.572 0.225 . . . . 61.5 111.464 -176.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -50.61 -32.35 18.62 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.948 0.404 . . . . 70.24 110.898 178.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -94.44 -59.02 2.04 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.833 -0.622 . . . . 65.55 111.27 175.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.533 ' O ' HG21 ' A' ' 74' ' ' VAL . 17.1 m-85 -91.1 21.03 4.51 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.156 0.798 . . . . 75.23 113.156 -168.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.517 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 11.2 t -54.52 -26.82 34.06 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.174 0.512 . . . . 74.33 110.976 -178.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -62.72 -20.13 64.6 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.752 -0.658 . . . . 53.34 112.239 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -131.93 7.78 4.39 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 111.661 0.245 . . . . 72.31 111.661 -175.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.533 HG21 ' O ' ' A' ' 70' ' ' TYR . 34.4 m -137.04 140.34 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 120.958 0.409 . . . . 73.54 110.992 177.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.546 ' HG2' HD12 ' A' ' 42' ' ' ILE . 33.6 mmtp -129.85 123.15 30.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.776 -0.647 . . . . 63.31 109.312 176.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.519 HG13 ' HB2' ' A' ' 45' ' ' LEU . 2.8 mp -98.99 132.48 44.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.694 -0.484 . . . . 74.42 109.694 -178.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.633 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 52.2 m-85 -134.52 129.34 34.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.076 -0.511 . . . . 72.2 109.786 -178.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.487 ' HB3' ' HB3' ' A' ' 47' ' ' ASP . 57.1 pttt -125.4 170.55 11.26 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.037 -0.357 . . . . 72.22 110.037 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.475 ' HB ' HG13 ' A' ' 81' ' ' ILE . 50.7 mt -137.36 152.85 27.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.485 -0.561 . . . . 72.5 109.485 176.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -77.51 69.75 3.8 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.105 -0.702 . . . . 55.21 109.105 170.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.475 HG13 ' HB ' ' A' ' 79' ' ' ILE . 69.9 mt -76.67 109.43 10.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.246 -0.888 . . . . 61.14 110.813 -177.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -82.79 -72.47 0.45 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.086 -0.709 . . . . 71.24 109.086 175.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -125.4 -6.75 7.0 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.009 -0.541 . . . . 64.43 110.795 172.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.4 ' HA ' ' O ' ' A' ' 9' ' ' MET . 15.6 p-10 -81.16 67.66 7.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.304 0.573 . . . . 73.35 111.881 -173.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.533 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 4.8 pp0? -144.87 122.96 12.11 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.668 -0.696 . . . . 74.21 109.568 171.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.419 ' OD2' ' HB2' ' A' ' 7' ' ' HIS . 59.1 m-20 -90.62 -22.85 21.01 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.853 0.359 . . . . 61.45 110.414 173.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 82.5 t -62.62 -55.7 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 115.652 -0.703 . . . . 75.03 112.795 -169.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.01 -44.42 92.65 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.968 0.413 . . . . 73.53 110.589 -174.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 45.2 m -62.3 -42.52 99.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.754 -0.657 . . . . 71.01 110.661 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.434 ' HA ' ' HB2' ' A' ' 5' ' ' HIS . 32.8 tt0 -65.1 -49.86 68.34 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.187 -0.46 . . . . 72.23 110.972 -176.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -74.0 -17.31 61.01 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.5 -0.318 . . . . 74.44 110.92 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.97 49.27 10.01 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.174 -0.536 . . . . 71.21 112.139 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 46.5 t -90.77 143.03 12.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 110.218 -0.289 . . . . 73.5 110.218 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.9 p -117.04 -58.48 2.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.299 -0.41 . . . . 73.31 110.996 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.59 108.35 2.41 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.105 -0.498 . . . . 73.13 111.479 -178.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.463 ' HB ' ' HA ' ' A' ' 97' ' ' PRO . 2.9 pp -107.42 158.38 33.34 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 116.11 -0.496 . . . . 72.43 109.876 176.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.463 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 61.3 Cg_endo -70.23 153.96 94.36 Favored 'Cis proline' 0 C--N 1.355 0.912 0 C-N-CA 124.039 -1.234 . . . . 65.31 113.03 2.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 28.7 m -120.17 135.3 55.02 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.381 -0.827 . . . . 71.12 109.799 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.583 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 3.8 mp -118.24 138.04 50.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.764 -0.458 . . . . 75.35 109.764 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.486 HD21 ' H ' ' A' ' 101' ' ' MET . 1.1 tt -121.79 137.23 54.85 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.115 -0.698 . . . . 74.23 109.115 176.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.756 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 61.4 mtp -101.62 118.47 37.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.065 -0.516 . . . . 74.11 110.879 -173.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -121.21 147.32 45.77 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.574 -0.284 . . . . 74.43 110.607 178.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.57 ' HB3' HD21 ' A' ' 108' ' ' LEU . 39.7 ttpt -159.16 116.09 2.69 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.099 -0.5 . . . . 63.31 110.137 176.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 48.64 54.75 10.09 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.73 -0.668 . . . . 65.24 111.309 177.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 80.82 -12.76 33.89 Favored Glycine 0 CA--C 1.519 0.328 0 CA-C-N 115.671 -0.695 . . . . 53.51 113.901 175.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -100.98 131.83 46.67 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 117.357 0.579 . . . . 51.24 110.735 -177.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -91.26 112.58 24.55 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.0 -0.741 . . . . 60.31 109.0 173.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.57 HD21 ' HB3' ' A' ' 103' ' ' LYS . 2.3 mm? -80.95 -53.37 6.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.126 -0.488 . . . . 72.55 111.26 -170.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.756 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 56.1 m -161.15 171.72 18.01 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.857 -0.61 . . . . 74.54 110.343 -172.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.492 HE21 HD13 ' A' ' 112' ' ' ILE . 29.5 tt0 -141.82 126.65 18.15 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 120.579 0.228 . . . . 75.32 110.704 -177.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.583 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 59.6 t -91.19 125.53 43.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 123.025 0.53 . . . . 64.25 110.633 178.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.492 HD13 HE21 ' A' ' 110' ' ' GLN . 62.0 mt -126.58 106.82 16.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.468 -0.333 . . . . 75.11 110.113 176.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 99.91 -143.34 16.37 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 121.082 -0.58 . . . . 74.41 112.388 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.553 ' HA ' ' NE2' ' A' ' 62' ' ' GLN . . . -126.49 56.85 1.44 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.251 0.548 . . . . 71.33 111.03 -176.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.492 ' O ' HG23 ' A' ' 119' ' ' ILE . 4.4 m-20 -93.38 71.15 4.39 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.022 -0.535 . . . . 74.42 110.147 179.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.576 ' O ' HG13 ' A' ' 119' ' ' ILE . 6.3 tp -54.57 -44.66 69.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 121.065 0.459 . . . . 73.12 111.432 -177.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.4 p -63.86 -28.89 70.16 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-O 121.212 0.529 . . . . 71.15 111.378 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.497 ' HZ2' ' CD ' ' A' ' 122' ' ' GLU . 14.5 tmtt? -80.03 -45.03 19.08 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 116.062 -0.517 . . . . 71.04 110.84 177.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 116' ' ' ILE . 2.0 pp -64.6 -38.09 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.47 -0.332 . . . . 71.22 111.01 -175.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.544 HG21 HD21 ' A' ' 66' ' ' LEU . 2.9 pp -60.5 -31.72 49.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-O 121.195 0.521 . . . . 75.31 110.051 176.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.422 ' N ' HD11 ' A' ' 120' ' ' ILE . 23.6 m -70.47 -51.68 27.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.977 -0.556 . . . . 62.24 110.734 177.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.567 ' HG2' ' HA ' ' A' ' 119' ' ' ILE . 15.6 pt-20 -72.38 -42.04 65.67 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.387 0.514 . . . . 74.32 112.387 -173.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.704 HD12 HD11 ' A' ' 66' ' ' LEU . 70.6 mt -64.07 -59.05 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 O-C-N 122.113 -0.367 . . . . 72.53 110.498 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -58.91 -20.75 54.66 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.046 -0.525 . . . . 72.01 110.943 -178.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -70.63 -39.14 73.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.811 -0.632 . . . . 63.32 110.885 176.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -103.61 -2.26 26.92 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.355 0.502 . . . . 73.11 112.355 -173.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 123' ' ' ILE . 29.6 pt -109.01 167.92 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 110.018 -0.364 . . . . 71.04 110.018 171.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.403 ' N ' HD21 ' A' ' 128' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.582 -0.723 . . . . 74.44 111.036 -175.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 110.207 -0.294 . . . . 64.12 110.207 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.49 101.76 0.2 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.308 -0.406 . . . . 74.33 110.788 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -86.15 134.17 33.82 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.277 -0.419 . . . . 73.01 110.249 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.408 ' O ' ' HG3' ' A' ' 90' ' ' GLN . 56.7 p-80 -122.33 119.26 30.58 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.671 -0.492 . . . . 75.42 109.671 174.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.8 p80 -128.02 123.65 35.21 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.145 -0.48 . . . . 74.22 109.74 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 52.1 t60 -173.16 137.17 0.67 Allowed 'General case' 0 C--N 1.329 -0.289 0 O-C-N 123.403 0.439 . . . . 75.11 110.363 -173.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.619 ' HA ' ' HB2' ' A' ' 86' ' ' ASP . 34.1 p-80 -164.35 118.1 1.4 Allowed 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.692 -0.484 . . . . 65.21 109.692 173.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.0 p-80 -76.17 157.97 32.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.106 -0.497 . . . . 71.34 110.495 -178.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 21.3 mmt -102.18 128.33 48.73 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.829 -0.804 . . . . 61.33 108.829 174.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.38 -136.62 2.46 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.964 -0.636 . . . . 54.42 111.687 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.2 m -151.61 65.84 0.87 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.625 0.726 . . . . 74.43 109.781 177.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -107.05 175.4 5.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.308 -0.86 . . . . 75.13 110.474 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -151.72 105.15 3.1 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.672 -0.695 . . . . 74.12 109.159 175.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -116.47 88.72 2.95 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.092 0.473 . . . . 75.44 110.659 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -86.06 133.25 33.91 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.997 -0.742 . . . . 71.2 108.997 173.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.1 t -127.08 174.57 8.78 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.824 0.345 . . . . 74.34 111.269 -175.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -160.9 103.29 1.31 Allowed 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.797 -0.638 . . . . 73.13 110.135 -177.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 178.85 70.81 0.06 OUTLIER Glycine 0 CA--C 1.519 0.325 0 N-CA-C 111.193 -0.763 . . . . 72.22 111.193 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -56.31 153.83 32.08 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.313 2.675 . . . . 73.22 112.938 -173.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 -66.27 2.72 Favored Glycine 0 C--O 1.239 0.419 0 N-CA-C 110.57 -1.012 . . . . 71.45 110.57 -174.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.6 m 62.0 154.47 0.04 OUTLIER 'General case' 0 C--O 1.237 0.418 0 CA-C-O 122.083 0.944 . . . . 64.02 113.455 170.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.603 ' HG2' HG12 ' A' ' 23' ' ' ILE . 1.4 pmm? -143.02 -50.64 0.35 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.908 -1.042 . . . . 73.25 108.437 170.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.603 HG12 ' HG2' ' A' ' 22' ' ' MET . 22.8 mm -121.18 84.07 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 108.06 -1.089 . . . . 74.4 108.06 173.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -86.25 154.74 21.06 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.102 0.477 . . . . 71.41 111.177 -172.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.419 ' HA ' ' HG2' ' A' ' 78' ' ' LYS . 8.6 pt20 -101.44 126.42 48.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.862 -0.608 . . . . 65.14 110.696 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.494 HD11 ' HA ' ' A' ' 31' ' ' PHE . 35.1 pt -131.86 174.62 12.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 120.736 0.303 . . . . 73.54 110.259 175.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -121.11 -166.8 13.09 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 116.016 -0.538 . . . . 13.31 112.486 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.79 -50.3 57.7 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 122.893 0.477 . . . . 75.21 112.023 -176.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 39.7 m -76.67 -31.44 57.29 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 120.901 0.381 . . . . 64.12 111.928 -169.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.481 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 2.1 pm0 -89.93 -15.29 32.37 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.967 -0.56 . . . . 71.55 110.882 -178.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.494 ' HA ' HD11 ' A' ' 26' ' ' ILE . 46.3 t80 -48.77 -70.86 0.08 Allowed 'General case' 0 C--O 1.226 -0.159 0 O-C-N 123.399 0.437 . . . . 65.21 110.285 178.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -56.45 -43.3 79.39 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-O 121.146 0.498 . . . . 71.43 109.748 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.62 ' O ' ' HB3' ' A' ' 37' ' ' SER . 23.1 t-20 -52.3 -41.28 62.79 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 114.209 -1.36 . . . . 73.12 112.449 -171.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.542 ' HZ1' ' HB2' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -112.96 -20.15 11.66 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.257 0.466 . . . . 53.44 112.257 -176.802 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 77.6 t -81.05 -48.97 18.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 O-C-N 122.331 -0.231 . . . . 63.51 111.233 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.8 p -88.2 -35.83 17.13 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.218 0.532 . . . . 74.43 110.242 -177.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.62 ' HB3' ' O ' ' A' ' 33' ' ' ASN . 33.9 t -84.67 12.38 7.27 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.875 -0.602 . . . . 73.22 110.904 178.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.452 ' SG ' ' HB2' ' A' ' 40' ' ' ASP . 43.6 t -53.71 103.24 0.07 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.955 0.407 . . . . 62.14 111.369 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -82.23 -8.9 59.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.871 -0.604 . . . . 70.23 110.372 176.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.452 ' HB2' ' SG ' ' A' ' 38' ' ' CYS . 21.2 m-20 -63.69 -30.76 71.82 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.219 -0.446 . . . . 63.24 110.561 -179.049 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 40' ' ' ASP . 17.9 m120 71.52 12.9 6.48 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.509 -0.768 . . . . 71.21 110.99 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.5 tt -88.62 161.57 2.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 109.223 -0.658 . . . . 74.52 109.223 177.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.4 HD11 HG23 ' A' ' 127' ' ' ILE . 26.9 mt -78.93 109.24 13.03 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.06 0.457 . . . . 74.32 110.662 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.603 HG21 ' CD2' ' A' ' 77' ' ' TYR . 45.2 mt -94.27 107.61 19.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.649 -0.705 . . . . 75.35 110.163 175.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.572 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 6.4 mp -97.2 107.18 19.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.934 -0.575 . . . . 72.54 109.583 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 28.5 m -94.97 129.92 44.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 110.091 -0.337 . . . . 71.44 110.091 179.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -104.29 139.78 38.81 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.11 0.481 . . . . 64.5 110.208 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.465 ' HE2' HD13 ' A' ' 100' ' ' LEU . 40.8 m-85 -93.22 67.75 4.19 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.842 -0.617 . . . . 73.03 110.066 176.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 92.0 m95 71.59 87.64 0.11 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.398 -1.274 . . . . 75.11 112.731 172.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -112.63 81.17 4.09 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.194 -0.912 . . . . 60.02 109.074 166.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.435 ' HB2' ' SG ' ' A' ' 53' ' ' CYS . 1.2 Cg_endo -84.69 6.33 5.79 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.132 2.554 . . . . 74.34 113.118 -171.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 20.1 m-90 60.21 6.97 1.11 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.359 0.503 . . . . 74.15 112.359 177.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.435 ' SG ' ' HB2' ' A' ' 51' ' ' PRO . 16.8 p -91.33 -13.93 31.67 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.593 0.235 . . . . 72.24 111.38 -175.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.6 174.48 42.23 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 121.19 -0.528 . . . . 63.14 112.753 -177.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -78.38 38.29 0.69 Allowed 'Trans proline' 0 CA--C 1.532 0.406 0 C-N-CA 123.225 2.617 . . . . 62.11 112.166 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 61.2 m -67.11 120.86 14.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 70.01 110.291 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -83.38 40.8 0.74 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 75.25 111.022 -176.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.6 t -136.98 174.04 11.05 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.11 -0.496 . . . . 52.33 110.024 -178.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.464 HD23 ' N ' ' A' ' 59' ' ' LEU . 2.6 mm? -101.85 -15.2 16.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.903 -0.59 . . . . 73.5 109.775 177.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -165.26 138.76 3.78 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 115.846 -0.616 . . . . 73.14 110.261 -176.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -79.57 -174.01 2.1 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.775 2.317 . . . . 71.23 112.408 177.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.576 ' HB3' HG12 ' A' ' 119' ' ' ILE . 13.8 mp0 -63.12 -48.32 79.0 Favored 'General case' 0 C--O 1.247 0.932 0 CA-C-O 121.583 0.706 . . . . 74.1 110.574 -174.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.552 HD13 ' N ' ' A' ' 64' ' ' GLU . 4.0 pp -57.38 -39.56 76.32 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 114.844 -1.071 . . . . 74.22 111.33 -176.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.552 ' N ' HD13 ' A' ' 63' ' ' LEU . 29.7 mt-10 -70.45 -43.25 70.26 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 120.809 -0.356 . . . . 74.41 110.048 177.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.2 mmtt -50.81 -52.95 36.24 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.133 -0.485 . . . . 71.31 111.528 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.738 HD12 HD12 ' A' ' 123' ' ' ILE . 14.8 mt -85.72 -42.83 13.9 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.198 0.814 . . . . 73.24 113.198 -176.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.18 -32.38 72.12 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.195 0.443 . . . . 61.5 112.195 -172.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -53.28 -33.44 53.2 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.884 0.373 . . . . 70.24 110.764 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -94.0 -53.4 4.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.005 -0.543 . . . . 65.55 110.85 176.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.516 ' O ' HG21 ' A' ' 74' ' ' VAL . 22.7 m-85 -85.35 14.83 4.89 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 113.149 0.796 . . . . 75.23 113.149 -169.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.8 t -52.94 -31.6 41.1 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.344 0.52 . . . . 74.33 111.441 -177.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -66.65 -16.9 64.53 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.283 -0.417 . . . . 53.34 111.553 -178.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -125.1 -7.04 7.15 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.375 -0.375 . . . . 72.31 110.627 -176.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.516 HG21 ' O ' ' A' ' 70' ' ' TYR . 19.6 m -141.83 150.69 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 109.979 -0.378 . . . . 73.54 109.979 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.9 tppt? -144.9 127.25 15.85 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.845 -0.428 . . . . 63.31 109.845 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.572 ' HA ' ' O ' ' A' ' 45' ' ' LEU . 1.9 mp -95.94 142.82 13.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.583 0.23 . . . . 74.42 110.398 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.603 ' CD2' HG21 ' A' ' 44' ' ' ILE . 83.6 m-85 -135.46 131.56 36.29 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.211 -0.45 . . . . 72.2 110.339 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.419 ' HG2' ' HA ' ' A' ' 25' ' ' GLN . 22.3 ptmt -87.21 134.56 33.52 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 120.734 0.302 . . . . 72.22 110.477 177.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.403 HG13 ' N ' ' A' ' 80' ' ' ASN . 7.8 tp -92.48 160.03 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 115.819 -0.628 . . . . 72.5 110.769 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.403 ' N ' HG13 ' A' ' 79' ' ' ILE . 18.2 t-20 -66.44 178.73 1.16 Allowed 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 109.573 -0.528 . . . . 55.21 109.573 174.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.594 ' HB ' ' ND2' ' A' ' 84' ' ' ASN . 64.6 mt -45.18 126.8 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 120.856 0.36 . . . . 61.14 111.494 -176.339 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.408 ' HG3' ' N ' ' A' ' 83' ' ' ASP . 13.8 pt-20 -43.79 -50.34 7.8 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.037 0.935 . . . . 71.24 113.508 -170.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.408 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 29.0 t70 -76.0 2.07 13.69 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 112.176 0.436 . . . . 64.43 112.176 -169.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.594 ' ND2' ' HB ' ' A' ' 81' ' ' ILE . 48.0 m-80 -93.33 -4.79 50.99 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.85 0.357 . . . . 73.35 111.12 178.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 40.9 mm-40 -129.29 117.76 21.2 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.962 -0.563 . . . . 74.21 109.932 176.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.619 ' HB2' ' HA ' ' A' ' 7' ' ' HIS . 10.1 m-20 -67.29 -4.54 11.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.564 -0.744 . . . . 61.45 111.146 -176.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.6 t -52.46 -43.24 41.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.168 0.508 . . . . 75.03 110.588 177.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.62 -42.87 99.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.774 -0.648 . . . . 73.53 110.168 178.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.9 m -67.86 -31.24 70.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.805 -0.634 . . . . 71.01 110.406 178.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' A' ' 4' ' ' HIS . 46.0 tt0 -65.4 -55.83 15.92 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.492 -0.776 . . . . 72.23 110.67 -179.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -80.12 -9.01 59.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.32 -0.4 . . . . 74.44 111.153 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.26 47.82 21.66 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.165 -0.54 . . . . 71.21 112.6 176.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.5 t -65.32 105.55 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.948 0.404 . . . . 73.5 110.42 178.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.2 p -107.49 0.43 22.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.082 -0.508 . . . . 73.31 111.06 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.62 125.98 10.83 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.61 -0.268 . . . . 73.13 110.847 -177.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 32.4 pt -100.1 150.94 37.33 Favored Pre-proline 0 C--O 1.238 0.466 0 CA-C-N 116.113 -0.494 . . . . 72.43 110.193 177.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -79.82 178.61 32.57 Favored 'Cis proline' 0 C--N 1.352 0.722 0 C-N-CA 123.663 -1.39 . . . . 65.31 112.507 0.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 27.6 m -148.03 133.3 18.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.194 -0.457 . . . . 71.12 110.243 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 62.2 mt -119.76 134.25 63.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.752 -0.462 . . . . 75.35 109.752 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.465 HD13 ' HE2' ' A' ' 48' ' ' PHE . 11.2 mp -118.0 130.81 56.41 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 120.619 0.247 . . . . 74.23 110.402 177.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 87.0 mtp -95.42 108.46 20.66 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.846 -0.616 . . . . 74.11 110.327 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -110.04 146.95 34.46 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.869 0.366 . . . . 74.43 110.989 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -153.37 108.13 3.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.73 -0.668 . . . . 63.31 109.595 174.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.61 29.78 18.36 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.009 -0.541 . . . . 65.24 110.424 177.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.04 -10.69 74.34 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.235 -0.507 . . . . 53.51 112.741 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -96.74 119.43 35.2 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.761 -0.459 . . . . 51.24 109.761 177.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.21 128.34 34.5 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.508 -0.553 . . . . 60.31 109.508 177.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.48 HD23 ' N ' ' A' ' 108' ' ' LEU . 2.4 mm? -87.89 -47.26 8.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.983 0.421 . . . . 72.55 110.54 -176.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 23.5 t -160.22 171.81 18.53 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.869 -0.605 . . . . 74.54 110.678 -175.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -149.04 129.73 14.09 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.718 -0.674 . . . . 75.32 110.906 -175.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.44 ' CG2' HG21 ' A' ' 119' ' ' ILE . 22.2 t -96.66 111.49 26.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 123.158 0.583 . . . . 64.25 110.067 178.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 59.8 mt -107.57 106.79 21.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.856 -0.424 . . . . 75.11 109.856 177.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 105.68 -112.39 3.93 Favored Glycine 0 C--N 1.33 0.226 0 N-CA-C 111.399 -0.68 . . . . 74.41 111.399 -176.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.51 57.16 0.5 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.396 0.617 . . . . 71.33 110.685 177.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.56 ' O ' HG23 ' A' ' 119' ' ' ILE . 3.0 m-20 -85.17 75.63 10.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.801 -0.636 . . . . 74.42 110.601 -179.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.547 ' O ' HG13 ' A' ' 119' ' ' ILE . 5.8 tp -52.56 -41.88 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 116.315 -0.402 . . . . 73.12 111.316 -178.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.9 p -62.15 -29.51 70.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.47 . . . . 71.15 111.075 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.418 ' HB2' ' HB3' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -79.41 -42.0 26.44 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.341 -0.614 . . . . 71.04 109.341 178.669 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.576 HG12 ' HB3' ' A' ' 62' ' ' GLN . 1.3 pp -64.68 -43.03 96.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.324 -0.398 . . . . 71.22 111.002 -174.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.504 HD11 ' N ' ' A' ' 121' ' ' SER . 2.9 pp -63.47 -32.26 56.0 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.096 0 C-N-CA 120.623 -0.431 . . . . 75.31 110.39 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.504 ' N ' HD11 ' A' ' 120' ' ' ILE . 47.9 m -71.15 -51.53 24.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.037 -0.529 . . . . 62.24 111.08 177.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.461 ' HG2' ' HA ' ' A' ' 119' ' ' ILE . 10.7 pt-20 -69.44 -41.13 76.71 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.526 -0.306 . . . . 74.32 111.458 -171.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.738 HD12 HD12 ' A' ' 66' ' ' LEU . 74.9 mt -67.33 -57.7 8.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 110.409 -0.219 . . . . 72.53 110.409 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -59.77 -23.39 63.22 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.952 0.406 . . . . 72.01 110.866 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -67.48 -29.29 68.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.943 -0.571 . . . . 63.32 111.391 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -111.82 -1.17 15.65 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.154 0.428 . . . . 73.11 112.154 -174.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 123' ' ' ILE . 47.5 pt -131.83 168.32 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 121.236 0.541 . . . . 71.04 111.299 177.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.1 p30 . . . . . 0 C--O 1.25 1.113 0 CA-C-N 115.116 -0.947 . . . . 74.44 110.485 -178.039 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.0 mtm . . . . . 0 N--CA 1.484 1.235 0 CA-C-O 120.63 0.252 . . . . 64.12 110.774 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.46 -43.42 39.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.348 0.594 . . . . 74.33 109.452 173.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -86.44 100.72 12.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.414 -0.812 . . . . 73.01 109.821 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 67.8 m80 -88.21 119.44 28.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.967 -0.56 . . . . 75.42 109.769 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 25.7 p80 -55.02 128.38 33.38 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.908 0.385 . . . . 74.22 111.257 -177.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -102.43 126.76 49.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.06 -0.518 . . . . 75.11 110.112 177.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -66.52 144.05 56.69 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.395 -0.366 . . . . 65.21 110.456 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -71.37 151.78 43.78 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.537 -0.542 . . . . 71.34 109.537 176.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -91.77 -28.25 17.5 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.731 0.3 . . . . 61.33 111.106 -177.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -128.17 -86.36 0.51 Allowed Glycine 0 C--N 1.329 0.175 0 CA-C-N 116.211 -0.45 . . . . 54.42 112.038 -178.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.6 m -71.53 112.49 7.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.68 0.276 . . . . 74.43 110.505 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 pp -76.63 -172.26 2.15 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.355 -0.384 . . . . 75.13 111.245 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -162.22 -62.98 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.196 0.522 . . . . 74.12 109.804 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -93.98 -179.35 4.94 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.645 -0.707 . . . . 75.44 110.683 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -70.55 101.72 2.08 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.282 -0.417 . . . . 71.2 110.851 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.3 m -65.97 155.28 37.03 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.706 -0.679 . . . . 74.34 110.207 174.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -54.48 130.47 39.75 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 110.01 -0.367 . . . . 73.13 110.01 175.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -165.21 80.73 0.12 Allowed Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 111.523 -0.631 . . . . 72.22 111.523 -175.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -68.05 -179.31 2.1 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 122.865 2.376 . . . . 73.22 112.824 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -52.79 121.91 17.53 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-N 115.647 -0.706 . . . . 71.45 112.503 -178.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.5 m -95.47 152.2 18.62 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 122.28 0.232 . . . . 64.02 111.013 -176.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.474 ' N ' ' SD ' ' A' ' 22' ' ' MET . 3.6 mpp? -64.89 -48.31 74.67 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.218 -0.446 . . . . 73.25 110.065 175.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.466 HG21 ' HE3' ' A' ' 78' ' ' LYS . 7.9 mm -101.08 92.48 2.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 108.595 -0.891 . . . . 74.4 108.595 175.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.601 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 34.4 tt0 -112.9 148.39 35.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.899 -0.591 . . . . 71.41 110.788 -168.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.545 ' HB3' ' HZ2' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -99.4 147.56 25.11 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 110.092 -0.336 . . . . 65.14 110.092 179.341 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.429 HD11 ' HA ' ' A' ' 31' ' ' PHE . 31.8 pt -137.91 162.36 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 121.012 0.434 . . . . 73.54 111.409 -176.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.62 171.23 19.97 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.335 -0.848 . . . . 13.31 111.758 177.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -67.78 -30.05 69.39 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.707 0.253 . . . . 75.21 111.459 -177.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 28.8 t -68.7 -36.66 78.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.713 0.292 . . . . 64.12 111.044 -177.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.434 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 4.3 pm0 -98.35 -9.85 24.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 71.55 111.188 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.483 ' HE1' HG11 ' A' ' 46' ' ' VAL . 93.3 t80 -46.75 -71.11 0.08 Allowed 'General case' 0 N--CA 1.467 0.399 0 O-C-N 123.317 0.385 . . . . 65.21 111.259 -175.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -65.79 -35.63 81.24 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 109.593 -0.521 . . . . 71.43 109.593 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -53.59 -33.75 55.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.807 -1.088 . . . . 73.12 111.881 -174.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 0.2 OUTLIER -114.82 -18.53 11.31 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 121.03 -0.268 . . . . 53.44 111.68 -179.822 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 72.7 t -88.44 -57.09 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 111.746 0.276 . . . . 63.51 111.746 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 58.2 p -76.32 -23.33 54.29 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.107 0.48 . . . . 74.43 110.537 -175.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.8 m -86.27 11.68 11.59 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.676 -0.693 . . . . 73.22 111.083 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.482 ' HB2' HD12 ' A' ' 44' ' ' ILE . 41.8 t -57.96 91.11 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.037 0.446 . . . . 62.14 110.962 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -101.33 -6.7 23.77 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.816 -0.629 . . . . 70.23 109.989 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -77.91 -5.23 50.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.361 -0.836 . . . . 63.24 111.778 -174.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.571 ' ND2' HD22 ' A' ' 104' ' ' ASN . 20.6 m120 66.83 16.56 10.4 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.336 -0.393 . . . . 71.21 110.856 -176.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.0 tt -87.18 142.87 12.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.33 -0.619 . . . . 74.52 109.33 177.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.769 HD22 ' HE2' ' A' ' 101' ' ' MET . 68.1 tp -82.46 116.91 22.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.889 0.376 . . . . 74.32 110.314 -178.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.482 HD12 ' HB2' ' A' ' 38' ' ' CYS . 56.3 mt -102.61 117.67 48.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.872 -0.603 . . . . 75.35 110.533 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.508 ' HB2' HG13 ' A' ' 76' ' ' ILE . 4.1 mp -106.06 103.84 13.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.051 -0.522 . . . . 72.54 109.748 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.499 HG21 ' HB2' ' A' ' 77' ' ' TYR . 45.7 t -109.41 123.76 65.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 111.43 0.159 . . . . 71.44 111.43 -177.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.466 ' HB2' HG13 ' A' ' 99' ' ' ILE . 14.2 t70 -91.82 149.52 21.54 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.661 -0.866 . . . . 64.5 108.661 170.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.424 ' O ' ' HB2' ' A' ' 49' ' ' TRP . 76.7 m-85 -64.28 -44.19 92.48 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.46 0.17 . . . . 73.03 111.46 -177.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.424 ' HB2' ' O ' ' A' ' 48' ' ' PHE . 38.2 t-105 166.49 -26.21 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 O-C-N 123.792 0.682 . . . . 75.11 110.04 -176.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 68.24 90.23 0.09 OUTLIER Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 115.409 -0.814 . . . . 60.02 110.474 -174.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -48.73 -32.97 23.38 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 123.21 2.606 . . . . 74.34 113.414 -176.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 39.1 p-90 -159.85 -54.75 0.06 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.735 0.302 . . . . 74.15 110.645 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.533 ' HB3' HG12 ' A' ' 96' ' ' ILE . 33.7 t -85.51 101.45 12.67 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.742 -0.466 . . . . 72.24 109.742 178.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -119.05 -160.7 11.45 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.225 -0.512 . . . . 63.14 112.267 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -77.32 24.81 0.49 Allowed 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 122.986 2.458 . . . . 62.11 112.599 -179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 7.1 p -66.87 94.95 0.34 Allowed 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.513 -0.312 . . . . 70.01 110.64 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 57' ' ' ARG . 16.6 mtp180 -145.92 162.14 38.45 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.814 -0.63 . . . . 75.25 110.157 -179.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.6 t -102.43 -41.67 6.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.329 -0.396 . . . . 52.33 110.115 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -93.67 72.75 4.3 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.506 -0.316 . . . . 73.5 110.747 -179.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 41.39 98.49 0.04 OUTLIER Pre-proline 0 N--CA 1.473 0.677 0 N-CA-C 114.015 1.117 . . . . 73.14 114.015 171.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.8 172.12 12.23 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.001 1.801 . . . . 71.23 110.931 168.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.523 ' HB3' HG12 ' A' ' 119' ' ' ILE . 6.8 mp0 -48.99 -57.62 6.21 Favored 'General case' 0 C--O 1.247 0.974 0 CA-C-O 121.627 0.727 . . . . 74.1 111.491 -173.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.585 HD11 ' N ' ' A' ' 64' ' ' GLU . 2.1 pp -62.31 -38.81 90.85 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.117 -0.947 . . . . 74.22 111.654 -174.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.585 ' N ' HD11 ' A' ' 63' ' ' LEU . 37.8 mt-10 -70.9 -35.47 72.32 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 110.003 -0.369 . . . . 74.41 110.003 177.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -57.37 -56.73 18.09 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.004 -0.544 . . . . 71.31 110.642 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.642 HD12 HD12 ' A' ' 123' ' ' ILE . 28.5 mt -80.1 -30.79 39.2 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.364 0.505 . . . . 73.24 112.364 -175.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.413 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -62.38 -33.27 74.42 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 111.585 0.217 . . . . 61.5 111.585 -177.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.553 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 78.6 mt-30 -64.07 -30.92 71.96 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.003 0.43 . . . . 70.24 110.657 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 68.8 mm-40 -89.28 -59.11 2.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.009 -0.541 . . . . 65.55 110.776 -176.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.498 ' O ' HG23 ' A' ' 74' ' ' VAL . 17.1 m-85 -87.8 23.49 2.0 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.56 -0.746 . . . . 75.23 111.892 -173.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.413 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 6.6 t -52.0 -38.79 58.01 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.063 0.764 . . . . 74.33 113.063 -167.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -73.45 -16.52 61.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.774 0.321 . . . . 53.34 111.181 -176.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -113.14 -4.31 13.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.317 -0.402 . . . . 72.31 110.951 -177.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.498 HG23 ' O ' ' A' ' 70' ' ' TYR . 32.8 m -133.19 137.15 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.254 0.55 . . . . 73.54 111.072 178.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.434 ' HD2' ' CZ ' ' A' ' 77' ' ' TYR . 7.7 mmtt -128.79 115.13 17.47 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.96 -0.755 . . . . 63.31 108.96 177.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.508 HG13 ' HB2' ' A' ' 45' ' ' LEU . 2.3 mp -99.68 134.68 38.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.411 -0.588 . . . . 74.42 109.411 -177.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.601 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 71.3 m-85 -132.49 155.58 48.33 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.393 -0.367 . . . . 72.2 110.363 -178.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.545 ' HZ2' ' HB3' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -144.02 128.59 18.09 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.722 -0.844 . . . . 72.22 108.722 170.635 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.1 tt -104.45 150.89 7.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.102 -0.499 . . . . 72.5 110.023 -175.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.43 67.86 10.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.927 0.394 . . . . 55.21 110.754 -175.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 53.8 mt -126.51 110.22 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.453 -0.573 . . . . 61.14 109.453 175.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -60.0 -72.38 0.11 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 120.961 0.41 . . . . 71.24 111.558 -171.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -125.48 -19.37 5.03 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.173 -0.467 . . . . 64.43 111.702 -176.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -70.78 76.53 0.62 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.059 -0.518 . . . . 73.35 111.824 -170.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -144.7 107.19 4.4 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.342 -0.39 . . . . 74.21 110.959 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -56.04 -36.17 67.71 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.212 0.529 . . . . 61.45 109.751 174.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 45.9 t -52.8 -44.68 48.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.045 -0.98 . . . . 75.03 111.181 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.77 -45.28 92.76 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.981 -0.554 . . . . 73.53 110.934 -177.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.9 m -73.9 -31.38 63.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.795 -0.638 . . . . 71.01 110.683 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -63.97 -43.94 94.24 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.765 -0.652 . . . . 72.23 110.573 -178.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -86.58 -14.3 43.27 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.196 -0.456 . . . . 74.44 110.48 175.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 65.03 55.59 20.97 Favored Glycine 0 C--O 1.237 0.282 0 CA-C-N 116.002 -0.545 . . . . 71.21 112.182 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.434 HG23 ' OG1' ' A' ' 98' ' ' THR . 7.9 p -73.93 131.73 34.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.766 0.317 . . . . 73.5 110.728 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.6 t -121.83 -0.88 9.5 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.456 -0.338 . . . . 73.31 111.141 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.456 ' HB1' HG23 ' A' ' 112' ' ' ILE . . . -135.98 128.73 30.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.697 0.285 . . . . 73.13 110.904 -177.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.697 HD11 ' H ' ' A' ' 96' ' ' ILE . 0.2 OUTLIER -113.06 154.85 44.95 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 115.866 -0.606 . . . . 72.43 109.938 179.781 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.67 177.54 28.29 Favored 'Cis proline' 0 C--N 1.356 0.967 0 C-N-CA 124.183 -1.174 . . . . 65.31 112.442 1.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.434 ' OG1' HG23 ' A' ' 93' ' ' VAL . 18.5 m -146.99 115.19 6.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.072 0.463 . . . . 71.12 110.521 -176.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.5 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 3.7 mp -117.88 129.55 74.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.5 -0.773 . . . . 75.35 110.095 -176.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.9 mp -104.54 132.57 50.63 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.835 -0.431 . . . . 74.23 109.835 174.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.769 ' HE2' HD22 ' A' ' 43' ' ' LEU . 53.0 mtp -101.46 112.91 25.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.959 -0.564 . . . . 74.11 110.696 -176.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -112.49 147.51 36.39 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.879 0.371 . . . . 74.43 110.861 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.805 ' HB3' HD23 ' A' ' 108' ' ' LEU . 28.2 ttpp -161.5 131.96 5.05 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.849 -0.614 . . . . 63.31 109.344 176.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.571 HD22 ' ND2' ' A' ' 41' ' ' ASN . 18.6 m120 58.34 32.33 21.95 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.238 0.542 . . . . 65.24 110.703 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.31 21.36 75.83 Favored Glycine 0 C--N 1.334 0.417 0 CA-C-N 115.509 -0.769 . . . . 53.51 112.727 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -137.05 133.53 35.54 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.436 -0.579 . . . . 51.24 109.436 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.9 pptp? -82.8 137.15 34.44 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.68 -0.489 . . . . 60.31 109.68 -177.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.805 HD23 ' HB3' ' A' ' 103' ' ' LYS . 2.1 mm? -99.13 -52.97 3.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.128 -0.487 . . . . 72.55 110.47 -177.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.634 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 16.8 m -150.31 172.1 15.92 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 115.679 -0.691 . . . . 74.54 110.795 -170.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.29 122.15 11.27 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.171 0.51 . . . . 75.32 110.858 -174.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.52 HG23 HG23 ' A' ' 119' ' ' ILE . 49.6 t -85.46 107.17 15.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.062 -0.517 . . . . 64.25 109.905 176.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.456 HG23 ' HB1' ' A' ' 95' ' ' ALA . 54.2 mt -106.32 106.95 21.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-O 120.987 0.423 . . . . 75.11 110.349 178.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.06 -134.76 12.65 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.766 -0.652 . . . . 74.41 112.096 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -132.82 81.67 1.96 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.87 0.367 . . . . 71.33 110.919 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.44 ' HB3' ' HB2' ' A' ' 118' ' ' LYS . 1.0 OUTLIER -122.53 94.41 4.28 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.928 -0.578 . . . . 74.42 110.519 -179.712 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.532 ' O ' HG13 ' A' ' 119' ' ' ILE . 7.8 tp -62.24 -41.38 91.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 CA-C-N 116.306 -0.406 . . . . 73.12 110.927 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.1 t -65.37 -28.9 69.6 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.12 -0.491 . . . . 71.15 110.449 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.44 ' HB2' ' HB3' ' A' ' 115' ' ' ASP . 0.2 OUTLIER -72.71 -55.36 6.9 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 108.689 -0.856 . . . . 71.04 108.689 176.879 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.532 HG13 ' O ' ' A' ' 116' ' ' ILE . 2.2 pp -60.92 -38.49 79.39 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-N 115.757 -0.656 . . . . 71.22 112.065 -171.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.508 HD12 ' N ' ' A' ' 121' ' ' SER . 2.9 pp -64.96 -33.01 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 C-N-CA 120.216 -0.594 . . . . 75.31 110.538 179.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.508 ' N ' HD12 ' A' ' 120' ' ' ILE . 42.0 t -70.92 -51.94 23.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.801 0.334 . . . . 62.24 110.258 177.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.511 ' HG2' ' HA ' ' A' ' 119' ' ' ILE . 15.6 pt-20 -71.78 -35.3 69.98 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.29 -0.413 . . . . 74.32 111.833 -170.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.642 HD12 HD12 ' A' ' 66' ' ' LEU . 71.4 mt -71.02 -53.91 19.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.628 0.251 . . . . 72.53 110.638 177.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -61.87 -23.03 66.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.328 -0.396 . . . . 72.01 111.386 -177.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -62.86 -48.96 76.79 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.461 -0.336 . . . . 63.32 111.361 176.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.559 ' OD1' HD21 ' A' ' 43' ' ' LEU . 9.3 p30 -88.38 -30.37 19.56 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 112.189 0.44 . . . . 73.11 112.189 -170.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.495 HG21 ' OD1' ' A' ' 126' ' ' ASN . 41.8 pt -106.59 168.14 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.864 0.364 . . . . 71.04 110.98 177.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.251 1.138 0 CA-C-O 118.376 -0.821 . . . . 74.44 110.985 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.55 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.126 0 N-CA-C 109.619 -0.511 . . . . 64.12 109.619 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.35 85.22 0.65 Allowed 'General case' 0 C--O 1.235 0.322 0 N-CA-C 112.317 0.488 . . . . 74.33 112.317 -176.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 25.7 p-80 -139.29 122.15 16.58 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.884 -1.154 . . . . 73.01 107.884 166.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.42 ' C ' ' H ' ' A' ' 6' ' ' HIS . 11.1 m170 -67.19 77.13 0.14 Allowed 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.499 0.555 . . . . 75.42 112.499 -166.241 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 53.86 0.04 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.791 1.236 . . . . 74.22 114.21 171.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.42 ' H ' ' C ' ' A' ' 4' ' ' HIS . 29.0 m80 -89.28 128.74 35.89 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 121.971 -0.456 . . . . 75.11 110.514 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . 0.506 ' ND1' ' SD ' ' A' ' 9' ' ' MET . 24.5 t-80 -127.87 145.21 51.02 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.182 -0.673 . . . . 65.21 109.182 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -93.82 93.52 8.0 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.94 0.4 . . . . 71.34 111.26 -176.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.506 ' SD ' ' ND1' ' A' ' 7' ' ' HIS . 4.3 mpp? -93.44 166.91 12.04 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.561 -0.533 . . . . 61.33 109.561 174.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -157.8 -162.97 12.12 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 121.206 -0.521 . . . . 54.42 111.886 178.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.9 t -164.62 135.26 4.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.818 0.342 . . . . 74.43 110.579 178.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.9 tt -87.67 104.71 16.79 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.435 -0.95 . . . . 75.13 108.435 175.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -132.97 121.56 22.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 74.12 109.851 -175.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -136.01 122.83 21.2 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.158 -0.474 . . . . 75.44 110.192 -178.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -85.07 99.2 10.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 71.2 110.957 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.2 p -116.86 97.89 6.2 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.826 -0.625 . . . . 74.34 109.654 174.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -73.02 172.61 10.67 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.211 -0.449 . . . . 73.13 111.093 -175.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -173.16 82.77 0.08 OUTLIER Glycine 0 CA--C 1.52 0.4 0 C-N-CA 121.233 -0.508 . . . . 72.22 112.169 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -77.16 126.98 8.93 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.925 2.416 . . . . 73.22 112.122 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.6 67.13 3.41 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.979 -0.629 . . . . 71.45 112.418 178.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.8 t -139.48 179.16 6.71 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 110.154 -0.313 . . . . 64.02 110.154 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.573 ' HG3' HG13 ' A' ' 23' ' ' ILE . 24.6 ptp -112.17 -34.43 5.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.524 -0.307 . . . . 73.25 110.293 176.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.573 HG13 ' HG3' ' A' ' 22' ' ' MET . 65.1 mt -134.3 118.98 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 116.28 -0.418 . . . . 74.4 109.881 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.543 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 8.4 tp10 -131.89 155.13 48.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.908 0.385 . . . . 71.41 111.019 -178.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -109.7 129.2 55.63 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.425 -0.583 . . . . 65.14 109.425 174.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.491 HG21 ' HD3' ' A' ' 34' ' ' LYS . 22.0 pt -122.59 173.65 8.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 116.5 -0.318 . . . . 73.54 111.438 -175.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -112.14 -176.48 19.93 Favored Glycine 0 C--N 1.333 0.371 0 CA-C-N 115.85 -0.614 . . . . 13.31 112.859 -176.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -58.62 -49.94 75.65 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.454 0.702 . . . . 75.21 112.339 -175.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.0 m -74.03 -16.99 61.03 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.657 0.614 . . . . 64.12 112.657 -168.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.401 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 2.1 pm0 -113.52 -7.89 13.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.575 -0.284 . . . . 71.55 111.471 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.486 ' HA ' HD12 ' A' ' 26' ' ' ILE . 30.5 t80 -49.25 -70.79 0.08 Allowed 'General case' 0 N--CA 1.461 0.106 0 O-C-N 123.32 0.387 . . . . 65.21 110.743 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -62.63 -37.67 87.25 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.644 -0.502 . . . . 71.43 109.644 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.508 ' O ' ' HB2' ' A' ' 37' ' ' SER . 20.7 t-20 -52.59 -42.9 64.95 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.789 -1.096 . . . . 73.12 112.051 -173.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.491 ' HD3' HG21 ' A' ' 26' ' ' ILE . 12.7 ptmt -111.52 -15.38 13.52 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.326 0.491 . . . . 53.44 112.326 -177.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.1 t -88.51 -56.37 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 111.681 0.252 . . . . 63.51 111.681 177.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 39.9 p -84.38 -32.09 24.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.911 0.386 . . . . 74.43 110.882 -173.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.508 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 18.0 m -83.81 8.92 13.26 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.083 -0.508 . . . . 73.22 111.516 -177.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.444 ' SG ' HG23 ' A' ' 42' ' ' ILE . 50.2 t -72.27 95.58 1.72 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.946 0.403 . . . . 62.14 110.449 -178.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -76.41 -9.32 58.56 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.934 -0.575 . . . . 70.23 110.796 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -59.05 -25.35 63.64 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.122 -0.49 . . . . 63.24 111.257 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.469 ' HA ' ' HB2' ' A' ' 103' ' ' LYS . 66.4 m-20 65.47 15.92 10.26 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.755 -0.657 . . . . 71.21 111.074 -176.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.444 HG23 ' SG ' ' A' ' 38' ' ' CYS . 10.6 tt -65.33 166.26 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 108.669 -0.863 . . . . 74.52 108.669 172.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.512 HD23 ' HE1' ' A' ' 101' ' ' MET . 49.7 tp -92.35 101.65 14.13 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 121.651 -0.656 . . . . 74.32 110.677 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 50.5 mt -87.32 131.89 34.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.522 -0.763 . . . . 75.35 109.795 174.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.521 ' HB2' HG13 ' A' ' 76' ' ' ILE . 89.0 mt -117.44 104.6 11.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.129 -0.487 . . . . 72.54 109.701 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 23.5 m -95.43 119.53 43.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.965 -0.294 . . . . 71.44 110.72 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.676 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 31.8 t70 -99.27 161.5 13.59 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 116.18 -0.464 . . . . 64.5 110.25 -178.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 25.9 p90 -65.46 -170.19 0.06 Allowed 'General case' 0 C--O 1.239 0.546 0 CA-C-O 121.397 0.617 . . . . 73.03 112.07 -174.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.519 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 3.6 m-90 -64.68 -166.24 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.236 -0.893 . . . . 75.11 111.759 -176.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 60.94 97.38 0.04 OUTLIER Pre-proline 0 CA--C 1.529 0.138 0 CA-C-N 115.489 -0.778 . . . . 60.02 110.54 -179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -61.56 -11.42 20.03 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.768 2.312 . . . . 74.34 112.843 -176.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -116.38 101.89 9.05 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.972 -0.381 . . . . 74.15 109.972 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 66.4 m -83.79 115.02 22.03 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.996 -0.372 . . . . 72.24 109.996 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.95 -65.23 1.18 Allowed Glycine 0 CA--C 1.525 0.683 0 C-N-CA 121.335 -0.46 . . . . 63.14 113.874 -174.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_exo -52.17 100.09 0.05 OUTLIER 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.051 2.501 . . . . 62.11 113.753 -173.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 82.9 m -101.06 92.88 5.2 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.119 -0.491 . . . . 70.01 109.831 175.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 29.5 mmm180 -65.44 -49.35 69.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.907 -0.588 . . . . 75.25 111.185 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.6 p -103.57 -168.8 1.55 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.76 -0.654 . . . . 52.33 110.166 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.408 ' O ' ' HB2' ' A' ' 60' ' ' GLU . 82.7 mt -66.99 103.49 1.17 Allowed 'General case' 0 C--O 1.233 0.207 0 N-CA-C 107.936 -1.135 . . . . 73.5 107.936 170.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 59' ' ' LEU . 2.9 mp0 65.93 157.45 0.13 Allowed Pre-proline 0 CA--C 1.541 0.615 0 O-C-N 123.629 0.58 . . . . 73.14 109.937 -170.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -67.06 160.11 48.85 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 121.728 1.619 . . . . 71.23 110.259 172.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.528 ' HB3' HG12 ' A' ' 119' ' ' ILE . 10.3 mp0 -51.46 -43.93 62.25 Favored 'General case' 0 C--O 1.246 0.918 0 CA-C-O 121.608 0.718 . . . . 74.1 110.294 -173.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.429 HD12 HG12 ' A' ' 99' ' ' ILE . 6.4 mp -56.92 -48.74 77.56 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 114.488 -1.233 . . . . 74.22 110.491 -175.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.424 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 49.0 mt-10 -70.74 -42.51 70.41 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 123.212 0.32 . . . . 74.41 110.249 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.5 tmtp? -50.76 -46.17 59.23 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.807 -0.633 . . . . 71.31 109.834 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.64 HD12 HD11 ' A' ' 123' ' ' ILE . 17.6 mt -86.18 -41.87 14.31 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.571 0.582 . . . . 73.24 112.571 177.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.87 -39.88 78.87 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 111.934 0.346 . . . . 61.5 111.934 -173.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 97.9 mt-30 -53.69 -33.2 54.61 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.269 0.557 . . . . 70.24 110.313 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 53.1 mm-40 -93.82 -41.39 9.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.445 -0.798 . . . . 65.55 111.465 -177.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.544 ' O ' HG23 ' A' ' 74' ' ' VAL . 17.3 m-85 -107.17 22.38 16.07 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.748 0.647 . . . . 75.23 112.748 -169.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.1 t -52.8 -34.05 51.75 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.13 0.419 . . . . 74.33 112.13 -176.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -68.3 -16.5 63.97 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 111.576 0.213 . . . . 53.34 111.576 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -122.52 -4.77 8.76 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.539 0.209 . . . . 72.31 111.047 -177.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 70' ' ' TYR . 27.7 m -136.82 147.48 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 O-C-N 122.071 -0.393 . . . . 73.54 110.444 178.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.434 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 7.0 tppt? -142.13 116.59 9.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.718 0.295 . . . . 63.31 110.208 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.521 HG13 ' HB2' ' A' ' 45' ' ' LEU . 2.0 mp -93.14 134.23 31.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.078 -0.51 . . . . 74.42 110.762 -175.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.543 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 97.1 m-85 -129.12 128.6 43.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.885 -0.598 . . . . 72.2 109.616 174.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.676 ' HG2' ' HB3' ' A' ' 47' ' ' ASP . 25.6 mtpp -103.29 143.2 32.97 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.787 -0.449 . . . . 72.22 109.787 176.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.519 ' O ' ' HA ' ' A' ' 49' ' ' TRP . 40.9 mm -96.99 131.34 44.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.848 -0.615 . . . . 72.5 111.059 -175.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.471 ' N ' HD21 ' A' ' 80' ' ' ASN . 0.1 OUTLIER -60.06 147.72 38.29 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.28 -0.418 . . . . 55.21 110.445 175.085 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 13.7 tt -66.21 -24.98 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 120.899 0.38 . . . . 61.14 110.884 -175.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -57.75 -25.18 60.1 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.847 -0.615 . . . . 71.24 111.12 -178.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.47 ' HB2' HD22 ' A' ' 80' ' ' ASN . 35.9 t70 -76.01 -25.37 55.68 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 119.205 -0.426 . . . . 64.43 112.075 -171.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.435 ' C ' ' O ' ' A' ' 83' ' ' ASP . 49.5 t30 2.33 102.73 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 124.524 1.14 . . . . 73.35 112.95 -176.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.54 146.91 47.75 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.284 0.564 . . . . 74.21 111.116 -168.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -53.97 -28.7 39.21 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 114.794 -1.094 . . . . 61.45 111.471 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 62.1 t -50.05 -34.71 10.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-N 115.82 -0.627 . . . . 75.03 111.161 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.23 -51.01 70.77 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.068 -0.514 . . . . 73.53 110.845 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.9 m -67.69 -30.72 70.32 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.259 -0.428 . . . . 71.01 110.727 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -59.56 -55.99 27.52 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.929 -0.578 . . . . 72.23 110.341 178.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -75.33 -15.82 60.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.391 -0.368 . . . . 74.44 110.937 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.46 61.01 2.39 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.306 -0.473 . . . . 71.21 112.661 175.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.432 HG22 HG22 ' A' ' 98' ' ' THR . 59.7 t -69.51 85.32 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-O 121.361 0.601 . . . . 73.5 110.137 176.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.2 t -116.03 9.76 14.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.507 -0.77 . . . . 73.31 110.144 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.443 ' HB1' HG21 ' A' ' 112' ' ' ILE . . . -152.66 142.63 22.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 73.13 109.973 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 29.9 pt -113.43 149.62 41.85 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.375 -0.375 . . . . 72.43 110.774 -177.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -76.54 -176.02 17.76 Favored 'Cis proline' 0 C--N 1.353 0.792 0 C-N-CA 124.005 -1.248 . . . . 65.31 112.442 -1.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 43.6 m -142.54 115.36 8.69 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.091 -0.337 . . . . 71.12 110.091 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.481 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 4.0 mp -129.14 142.84 42.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.979 -0.555 . . . . 75.35 109.837 -178.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.6 mp -118.92 140.84 49.32 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.697 0.284 . . . . 74.23 110.361 174.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.824 ' SD ' ' HB3' ' A' ' 109' ' ' SER . 89.8 mtp -96.72 114.11 25.73 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.841 -0.618 . . . . 74.11 110.46 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -115.12 144.5 43.57 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.072 0.463 . . . . 74.43 112.13 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.769 ' HG2' HD23 ' A' ' 108' ' ' LEU . 0.4 OUTLIER -157.8 119.23 3.59 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 108.913 -0.773 . . . . 63.31 108.913 163.617 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 58.94 25.03 13.23 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.543 0.687 . . . . 65.24 110.207 -176.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 87.45 -6.21 83.77 Favored Glycine 0 CA--C 1.52 0.349 0 CA-C-N 115.798 -0.637 . . . . 53.51 112.511 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -77.84 128.97 34.83 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.511 -0.552 . . . . 51.24 109.511 177.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 101' ' ' MET . 3.1 mppt? -90.49 109.41 20.55 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.32 -0.622 . . . . 60.31 109.32 174.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.769 HD23 ' HG2' ' A' ' 103' ' ' LYS . 2.3 mm? -77.92 -36.63 49.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.142 -0.481 . . . . 72.55 110.545 -175.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.824 ' HB3' ' SD ' ' A' ' 101' ' ' MET . 17.2 t -178.64 171.9 1.46 Allowed 'General case' 0 C--O 1.24 0.598 0 CA-C-N 115.593 -0.731 . . . . 74.54 109.05 -176.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.04 141.14 36.28 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.251 0.548 . . . . 75.32 111.106 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 98' ' ' THR . 46.6 t -103.57 107.1 21.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.169 -0.923 . . . . 64.25 109.772 176.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.443 HG21 ' HB1' ' A' ' 95' ' ' ALA . 45.1 mt -118.84 106.31 19.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.466 -0.938 . . . . 75.11 108.466 172.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 108.65 174.26 21.58 Favored Glycine 0 CA--C 1.519 0.322 0 N-CA-C 111.041 -0.824 . . . . 74.41 111.041 -170.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -96.59 56.99 1.57 Allowed 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.179 0.514 . . . . 71.33 110.77 -177.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.545 ' O ' HG23 ' A' ' 119' ' ' ILE . 1.9 m-20 -90.19 73.78 7.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.875 -0.602 . . . . 74.42 110.906 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.534 ' O ' HG13 ' A' ' 119' ' ' ILE . 6.3 tp -54.74 -40.37 51.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 CA-C-O 121.108 0.48 . . . . 73.12 110.823 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.2 p -62.62 -29.08 70.36 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.853 -0.612 . . . . 71.15 111.182 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.457 ' HB2' ' HB3' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -79.28 -48.66 13.75 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.306 -0.627 . . . . 71.04 109.306 177.409 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.545 HG23 ' O ' ' A' ' 115' ' ' ASP . 1.6 pp -61.84 -40.77 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 116.132 -0.486 . . . . 71.22 111.421 -172.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.532 HD12 ' N ' ' A' ' 121' ' ' SER . 2.9 pp -63.19 -31.97 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 C-N-CA 120.437 -0.505 . . . . 75.31 110.399 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.532 ' N ' HD12 ' A' ' 120' ' ' ILE . 33.6 t -70.46 -51.92 25.78 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.994 -0.548 . . . . 62.24 110.854 178.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.495 ' HG2' ' HA ' ' A' ' 119' ' ' ILE . 12.8 pt-20 -70.75 -43.67 68.36 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.085 -0.507 . . . . 74.32 111.325 -172.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.64 HD11 HD12 ' A' ' 66' ' ' LEU . 78.8 mt -64.41 -53.86 37.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.352 0.12 . . . . 72.53 110.958 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -59.79 -26.65 65.9 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.775 0.322 . . . . 72.01 111.263 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -77.34 -14.87 59.64 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 111.741 0.274 . . . . 63.32 111.741 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -118.14 9.72 12.74 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 111.656 0.243 . . . . 73.11 111.656 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.506 HG12 ' O ' ' A' ' 123' ' ' ILE . 43.6 pt -134.74 168.33 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 109.921 -0.4 . . . . 71.04 109.921 173.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.366 -0.826 . . . . 74.44 110.969 -176.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 mmt . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 109.76 -0.459 . . . . 64.12 109.76 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.49 153.97 24.08 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.723 0.296 . . . . 74.33 110.752 -177.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 20.1 t60 -76.25 151.72 36.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.119 -0.491 . . . . 73.01 109.793 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -45.27 125.38 5.43 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 123.43 0.456 . . . . 75.42 110.586 176.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.3 m170 -59.52 124.21 19.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.916 -0.584 . . . . 74.22 110.522 -175.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -135.56 139.1 43.64 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.046 -0.524 . . . . 75.11 109.862 -171.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -87.76 173.79 8.77 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.84 0.353 . . . . 65.21 111.166 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.438 ' HB3' ' O ' ' A' ' 49' ' ' TRP . 10.3 p-80 -93.72 156.77 16.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.963 -0.562 . . . . 71.34 111.221 -177.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 66.3 mtt -130.65 -73.61 0.54 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.78 -0.822 . . . . 61.33 108.78 167.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.03 -50.42 3.68 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 121.42 -0.419 . . . . 54.42 113.588 172.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 34.2 p 50.37 75.7 0.17 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.308 0.575 . . . . 74.43 111.591 -177.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.578 HD12 HG22 ' A' ' 79' ' ' ILE . 4.4 pp -160.49 150.31 17.74 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.329 -0.85 . . . . 75.13 109.676 178.219 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 30.5 tp10 -147.04 108.84 4.37 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.675 -0.491 . . . . 74.12 109.675 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -131.16 122.98 27.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 75.44 110.72 -176.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -82.09 108.08 15.29 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.013 -0.54 . . . . 71.2 109.715 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 99.5 m -95.44 148.31 22.6 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.921 -0.581 . . . . 74.34 111.756 -172.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 71.2 mm-40 -71.58 -164.26 0.11 Allowed 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.863 -0.608 . . . . 73.13 110.778 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -99.51 -70.96 0.96 Allowed Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.815 -0.63 . . . . 72.22 111.717 175.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.73 87.31 0.83 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.269 1.98 . . . . 73.22 112.246 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -129.43 -140.43 4.85 Favored Glycine 0 C--O 1.235 0.182 0 CA-C-N 115.87 -0.605 . . . . 71.45 111.869 177.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.9 m -69.49 156.43 38.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.624 0.249 . . . . 64.02 110.824 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.625 ' HG3' HG13 ' A' ' 23' ' ' ILE . 21.2 ptp -59.71 -33.42 71.59 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.764 -0.458 . . . . 73.25 109.764 175.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.625 HG13 ' HG3' ' A' ' 22' ' ' MET . 23.2 mt -127.09 101.65 8.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 108.673 -0.862 . . . . 74.4 108.673 174.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.452 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 9.4 tp10 -124.01 149.64 45.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.813 0.34 . . . . 71.41 110.377 -175.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -82.15 149.74 27.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.169 -0.468 . . . . 65.14 110.26 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.47 HD12 ' HA ' ' A' ' 31' ' ' PHE . 25.4 pt -130.01 177.4 6.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.603 -0.271 . . . . 73.54 110.512 178.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.18 158.55 18.21 Favored Glycine 0 C--O 1.237 0.32 0 CA-C-N 116.102 -0.499 . . . . 13.31 112.324 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -59.81 -39.15 84.07 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.203 0.525 . . . . 75.21 110.433 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.4 t -63.33 -32.83 74.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.424 -0.807 . . . . 64.12 111.529 -176.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.413 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 10.0 pt-20 -105.28 -1.06 25.71 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 112.324 0.49 . . . . 71.55 112.324 -174.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.47 ' HA ' HD12 ' A' ' 26' ' ' ILE . 57.9 t80 -47.15 -71.61 0.07 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.793 0.33 . . . . 65.21 111.192 -178.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -64.43 -36.43 84.15 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.351 -0.611 . . . . 71.43 109.351 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -52.43 -38.55 59.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.436 -1.256 . . . . 73.12 111.891 -173.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 15.8 ptmt -114.34 -18.27 11.6 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.094 0.405 . . . . 53.44 112.094 -177.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 72.7 t -85.22 -49.59 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 111.851 0.315 . . . . 63.51 111.851 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 64.9 p -83.06 -28.83 29.28 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.075 0.464 . . . . 74.43 111.04 -173.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.1 m -80.1 12.02 3.08 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.914 -0.585 . . . . 73.22 111.992 -177.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 24.6 p -76.8 87.33 3.4 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.824 0.345 . . . . 62.14 111.817 -176.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -75.22 -5.93 47.04 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.14 0.495 . . . . 70.23 110.397 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.522 ' O ' ' HB2' ' A' ' 41' ' ' ASN . 2.1 m-20 -52.82 -30.26 32.43 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.633 -0.712 . . . . 63.24 112.062 -177.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.522 ' HB2' ' O ' ' A' ' 40' ' ' ASP . 0.9 OUTLIER 75.11 11.47 3.55 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 123.691 0.619 . . . . 71.21 110.34 -171.669 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.454 HG23 ' HB2' ' A' ' 40' ' ' ASP . 10.0 tt -81.94 158.53 4.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 115.624 -0.716 . . . . 74.52 109.113 176.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.459 HD12 ' HB2' ' A' ' 126' ' ' ASN . 54.5 mt -84.92 112.53 20.65 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 120.916 -0.314 . . . . 74.32 110.604 179.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 20.0 mt -102.41 105.91 18.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.036 0.446 . . . . 75.35 109.945 173.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.5 ' HB2' HG12 ' A' ' 76' ' ' ILE . 5.1 mp -93.38 136.96 33.15 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.988 -0.745 . . . . 72.54 108.988 177.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.485 HG13 ' HB2' ' A' ' 77' ' ' TYR . 27.4 m -130.17 138.67 53.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.749 -0.463 . . . . 71.44 109.749 178.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -111.33 143.75 41.63 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.857 0.36 . . . . 64.5 111.036 177.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.559 ' HZ ' HG21 ' A' ' 96' ' ' ILE . 13.7 p90 -73.8 144.12 45.71 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.543 -0.54 . . . . 73.03 109.543 176.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.679 ' HB2' ' HA ' ' A' ' 79' ' ' ILE . 39.0 t-105 -84.91 159.93 20.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.921 0.391 . . . . 75.11 110.896 -176.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.448 ' HB3' ' SG ' ' A' ' 53' ' ' CYS . . . -143.0 150.81 54.22 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.275 -0.639 . . . . 60.02 109.275 177.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -61.52 -64.88 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.066 1.844 . . . . 74.34 111.639 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -148.44 -57.46 0.22 Allowed 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 109.301 -0.629 . . . . 74.15 109.301 177.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.448 ' SG ' ' HB3' ' A' ' 50' ' ' ALA . 81.8 m 68.95 -68.95 0.17 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.394 -0.821 . . . . 72.24 111.582 177.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -156.78 164.76 32.82 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 121.152 -0.547 . . . . 63.14 112.066 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.19 126.28 17.53 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.826 2.351 . . . . 62.11 112.083 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 56.7 m -62.74 94.67 0.07 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.247 -0.433 . . . . 70.01 110.82 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -104.35 164.58 11.64 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.122 -0.49 . . . . 75.25 109.824 177.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 26.1 t 61.14 90.7 0.06 Allowed 'General case' 0 CA--C 1.531 0.217 0 O-C-N 123.565 0.541 . . . . 52.33 110.407 -177.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.44 ' N ' HD21 ' A' ' 59' ' ' LEU . 2.9 mm? -84.45 34.5 0.53 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.062 -0.517 . . . . 73.5 110.887 -175.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -144.56 74.34 15.24 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.174 -0.466 . . . . 73.14 110.222 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -88.17 170.02 6.04 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.839 2.359 . . . . 71.23 112.314 178.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.576 ' HB3' HG12 ' A' ' 119' ' ' ILE . 9.6 mp0 -61.9 -57.51 11.49 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.351 0.596 . . . . 74.1 111.097 -173.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.478 ' HB2' HD11 ' A' ' 76' ' ' ILE . 2.3 pt? -54.37 -47.17 72.93 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.068 -0.969 . . . . 74.22 111.611 -174.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.511 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 37.2 mt-10 -65.66 -43.72 88.53 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 120.888 -0.325 . . . . 74.41 110.255 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -53.14 -48.66 67.73 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.891 -0.595 . . . . 71.31 110.982 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.554 HD11 HD11 ' A' ' 123' ' ' ILE . 17.7 mt -79.43 -37.73 36.37 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 111.967 0.358 . . . . 73.24 111.967 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.4 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -59.81 -31.42 69.69 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.457 0.17 . . . . 61.5 111.307 -176.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.511 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 74.8 mt-30 -54.52 -34.95 62.62 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.951 0.405 . . . . 70.24 111.051 177.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -94.1 -45.23 7.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.192 0.52 . . . . 65.55 111.019 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.558 ' O ' HG22 ' A' ' 74' ' ' VAL . 20.4 m-85 -92.85 14.92 15.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.807 -0.633 . . . . 75.23 112.285 -171.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.4 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 8.8 t -52.48 -35.99 53.92 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.05 0.452 . . . . 74.33 111.442 -174.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -63.96 -28.43 69.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.83 -0.623 . . . . 53.34 111.841 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -116.48 3.19 13.21 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.52 -0.309 . . . . 72.31 111.17 -173.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 70' ' ' TYR . 23.6 m -133.68 141.34 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 121.088 0.47 . . . . 73.54 110.556 177.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.709 ' HE3' ' HA ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -128.15 116.53 20.07 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.523 -0.762 . . . . 63.31 108.969 174.925 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.527 ' HB ' HG12 ' A' ' 23' ' ' ILE . 39.9 mt -109.49 134.7 50.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.725 0.298 . . . . 74.42 110.413 -177.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.485 ' HB2' HG13 ' A' ' 46' ' ' VAL . 51.3 m-85 -120.72 134.5 55.28 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 115.982 -0.554 . . . . 72.2 110.08 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.0 ptmm? -112.89 161.5 16.91 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.25 -0.886 . . . . 72.22 110.62 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.679 ' HA ' ' HB2' ' A' ' 49' ' ' TRP . 30.9 mt 67.43 66.86 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 115.561 -0.745 . . . . 72.5 109.892 -174.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -115.1 161.17 18.75 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.674 -0.694 . . . . 55.21 110.557 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 2.7 pp -89.33 24.35 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.898 -0.592 . . . . 61.14 110.782 178.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.4 ' CD ' HD12 ' A' ' 100' ' ' LEU . 33.3 tt0 -53.53 -40.66 65.67 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.305 -0.861 . . . . 71.24 111.53 -177.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -74.81 -18.16 60.5 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.146 -0.479 . . . . 64.43 110.884 -177.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -91.24 13.86 16.01 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.356 0.598 . . . . 73.35 109.818 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -110.19 132.51 54.1 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.673 -0.694 . . . . 74.21 109.94 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -57.67 -29.06 64.33 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.164 0.507 . . . . 61.45 109.791 173.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 56.7 t -54.96 -37.34 41.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 115.344 -0.843 . . . . 75.03 110.824 178.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.08 -52.21 65.87 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.089 0.471 . . . . 73.53 109.876 178.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.8 m -60.67 -32.05 71.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.83 -0.623 . . . . 71.01 110.53 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -66.12 -37.83 86.7 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.036 -0.529 . . . . 72.23 110.592 177.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -77.26 -5.66 50.22 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.463 -0.335 . . . . 74.44 111.099 176.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.85 21.0 64.33 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 121.082 -0.58 . . . . 71.21 112.077 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 97.9 t -65.93 102.92 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.045 0.45 . . . . 73.5 110.309 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.7 t -143.79 21.03 1.81 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.61 0.719 . . . . 73.31 109.174 178.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -129.01 160.9 31.28 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.567 -0.742 . . . . 73.13 110.29 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.559 HG21 ' HZ ' ' A' ' 48' ' ' PHE . 26.8 pt -118.67 130.61 24.7 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.304 -0.407 . . . . 72.43 110.603 -178.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 96' ' ' ILE . 47.7 Cg_endo -91.62 -170.05 3.96 Favored 'Cis proline' 0 C--N 1.35 0.616 0 C-N-CA 124.05 -1.229 . . . . 65.31 112.336 -4.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.558 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 88.5 m -147.83 139.81 24.12 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.034 -0.53 . . . . 71.12 109.677 175.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 36.9 mt -136.83 114.49 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 115.957 -0.565 . . . . 75.35 110.019 -176.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.4 HD12 ' CD ' ' A' ' 82' ' ' GLU . 8.2 mp -91.5 146.36 23.86 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.019 0.437 . . . . 74.23 111.152 178.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.478 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 90.5 mtp -108.63 118.97 38.16 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.994 -0.548 . . . . 74.11 110.663 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.419 ' CE2' ' HG2' ' A' ' 107' ' ' LYS . 79.3 m-85 -115.55 149.05 38.8 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.231 0.539 . . . . 74.43 111.482 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.617 ' HB3' HD23 ' A' ' 108' ' ' LEU . 30.8 ttmt -155.65 111.1 3.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.933 -1.031 . . . . 63.31 109.078 177.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.9 t30 60.7 25.06 14.87 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.458 0.647 . . . . 65.24 110.192 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.88 -14.89 62.06 Favored Glycine 0 C--N 1.334 0.458 0 CA-C-N 115.572 -0.74 . . . . 53.51 112.259 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -81.11 144.43 31.7 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.836 -0.431 . . . . 51.24 109.836 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.419 ' HG2' ' CE2' ' A' ' 102' ' ' PHE . 46.2 mttp -102.56 115.3 30.3 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.803 -0.444 . . . . 60.31 109.803 -176.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.617 HD23 ' HB3' ' A' ' 103' ' ' LYS . 2.8 mm? -85.85 -53.4 5.14 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.857 0.361 . . . . 72.55 111.249 -174.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.478 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 20.5 m -160.02 171.89 18.52 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.882 -0.599 . . . . 74.54 110.205 -172.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -143.88 124.04 13.71 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.024 -0.535 . . . . 75.32 110.568 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.563 HG21 HG21 ' A' ' 119' ' ' ILE . 61.2 t -80.43 107.13 12.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.83 -0.623 . . . . 64.25 109.471 175.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 58.7 mt -108.28 107.03 21.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 109.865 -0.42 . . . . 75.11 109.865 178.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.32 -132.53 10.98 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.811 -0.631 . . . . 74.41 111.604 -178.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -142.37 75.74 1.5 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.92 0.39 . . . . 71.33 110.387 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.487 ' O ' HG23 ' A' ' 119' ' ' ILE . 2.6 m-20 -115.47 97.5 6.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.917 -0.583 . . . . 74.42 110.611 -177.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.521 ' O ' HG13 ' A' ' 119' ' ' ILE . 6.7 tp -64.5 -41.08 91.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 116.411 -0.358 . . . . 73.12 111.342 -176.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 15.1 m -64.58 -29.85 70.87 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.454 0.645 . . . . 71.15 110.456 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.452 ' HG3' ' OE2' ' A' ' 122' ' ' GLU . 27.9 tptp -73.88 -50.64 19.29 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.453 -0.794 . . . . 71.04 110.453 178.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.576 HG12 ' HB3' ' A' ' 62' ' ' GLN . 2.1 pp -65.34 -41.32 91.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.814 -0.63 . . . . 71.22 111.519 -174.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.463 HG23 HD12 ' A' ' 66' ' ' LEU . 2.8 pp -62.32 -31.82 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 121.127 0.489 . . . . 75.31 109.837 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.535 ' O ' ' HB2' ' A' ' 125' ' ' ASN . 23.0 t -70.44 -51.56 28.47 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.85 -0.614 . . . . 62.24 110.55 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.452 ' OE2' ' HG3' ' A' ' 118' ' ' LYS . 10.7 pt-20 -73.52 -33.41 64.75 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 111.924 0.342 . . . . 74.32 111.924 -172.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.554 HD11 HD11 ' A' ' 66' ' ' LEU . 71.7 mt -73.59 -57.37 6.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-O 120.567 0.223 . . . . 72.53 110.654 178.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -63.67 -20.12 65.45 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.115 0.483 . . . . 72.01 110.609 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.535 ' HB2' ' O ' ' A' ' 121' ' ' SER . 26.7 t-20 -54.04 -29.8 45.3 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.717 -0.674 . . . . 63.32 110.76 176.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.459 ' HB2' HD12 ' A' ' 43' ' ' LEU . 33.8 m-80 -107.99 -45.21 4.02 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.872 -0.604 . . . . 73.11 111.233 -176.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 48.4 pt -105.46 167.78 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 120.819 0.343 . . . . 71.04 111.274 -175.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.543 ' N ' HD21 ' A' ' 128' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.38 -0.819 . . . . 74.44 112.137 -177.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.5 mtt . . . . . 0 N--CA 1.482 1.145 0 CA-C-O 120.773 0.32 . . . . 64.12 110.653 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.79 -97.6 0.06 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.464 -0.789 . . . . 74.33 111.584 177.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.426 ' O ' ' CG ' ' A' ' 3' ' ' HIS . 14.2 t-80 53.33 24.29 3.76 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.674 0.749 . . . . 73.01 110.121 -173.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 32.3 m80 -111.65 84.48 1.96 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.216 0.531 . . . . 75.42 111.29 -177.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -134.25 9.74 3.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.211 -0.904 . . . . 74.22 109.009 170.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 75.9 t60 -115.1 108.73 17.04 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.543 -0.753 . . . . 75.11 110.385 -174.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -148.67 156.8 42.88 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.164 -0.471 . . . . 65.21 109.903 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -110.69 98.38 7.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.363 0.601 . . . . 71.34 110.183 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 91.4 mtp -100.78 177.61 4.93 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.759 -0.655 . . . . 61.33 110.019 177.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.67 172.34 21.28 Favored Glycine 0 N--CA 1.452 -0.262 0 N-CA-C 111.844 -0.502 . . . . 54.42 111.844 -178.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.523 HG21 ' HA ' ' A' ' 57' ' ' ARG . 86.1 m -149.04 100.31 3.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.925 0.393 . . . . 74.43 110.248 177.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.429 HD13 HD13 ' A' ' 59' ' ' LEU . 8.8 mp -80.31 124.14 28.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.952 -0.567 . . . . 75.13 109.769 177.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -88.51 131.53 34.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.07 -0.514 . . . . 74.12 110.621 -179.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 63.2 95.71 0.04 OUTLIER 'General case' 0 C--O 1.233 0.216 0 O-C-N 123.941 0.775 . . . . 75.44 112.49 175.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.42 HE22 ' HG3' ' A' ' 64' ' ' GLU . 64.3 tt0 -67.43 119.24 11.93 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 107.828 -1.175 . . . . 71.2 107.828 169.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 29.2 p -48.88 -79.91 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.545 0.572 . . . . 74.34 112.545 -170.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -157.92 176.07 13.02 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 122.553 0.341 . . . . 73.13 110.417 -178.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -159.36 64.23 0.29 Allowed Glycine 0 CA--C 1.52 0.362 0 CA-C-N 115.824 -0.625 . . . . 72.22 111.773 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -92.38 135.84 1.48 Allowed 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 123.006 2.471 . . . . 73.22 112.455 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 52.78 52.92 35.71 Favored Glycine 0 CA--C 1.521 0.423 0 CA-C-N 116.333 -0.394 . . . . 71.45 112.967 177.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 40.1 m -141.81 -157.58 0.78 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.582 -0.525 . . . . 64.02 109.582 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.515 ' SD ' ' HA ' ' A' ' 68' ' ' GLN . 49.5 mtm -49.26 -35.71 18.46 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.638 0.733 . . . . 73.25 109.475 172.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.4 mm -92.67 128.83 43.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 114.38 -1.282 . . . . 74.4 108.641 171.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.401 ' HG2' ' CE1' ' A' ' 77' ' ' TYR . 9.1 tp10 -124.84 153.15 43.0 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.746 0.308 . . . . 71.41 110.426 -176.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.29 124.4 40.26 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.503 -0.554 . . . . 65.14 109.503 177.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.516 ' O ' HD12 ' A' ' 79' ' ' ILE . 32.5 pt -131.69 -176.93 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.047 -0.524 . . . . 73.54 110.533 -172.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -111.79 170.55 13.72 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 121.506 -0.378 . . . . 13.31 112.219 178.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -67.5 -38.15 83.9 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 122.575 0.35 . . . . 75.21 111.71 -178.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.2 m -60.32 -39.09 85.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.003 0.43 . . . . 64.12 111.177 -176.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.456 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 1.7 pm0 -103.38 -0.98 29.35 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.779 -0.646 . . . . 71.55 111.159 -177.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -53.04 -70.55 0.09 Allowed 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 109.775 -0.454 . . . . 65.21 109.775 177.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -49.75 -42.78 47.17 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 116.074 -0.512 . . . . 71.43 110.03 176.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.403 ' O ' ' HB2' ' A' ' 37' ' ' SER . 66.1 t30 -52.19 -54.32 32.29 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 114.655 -1.157 . . . . 73.12 111.481 -172.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.526 ' HZ3' ' HB2' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -101.23 -15.93 17.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.245 -0.434 . . . . 53.44 111.936 -172.921 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 73.1 t -88.58 -57.06 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 111.962 0.356 . . . . 63.51 111.962 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.9 p -88.01 -42.09 12.67 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.047 0.451 . . . . 74.43 110.716 -171.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 18.4 m -76.73 12.07 1.46 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.823 -0.626 . . . . 73.22 111.473 -178.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.427 ' SG ' ' HB2' ' A' ' 40' ' ' ASP . 50.1 t -81.21 99.96 8.86 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.999 0.428 . . . . 62.14 110.334 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -87.25 14.87 7.02 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.181 0.515 . . . . 70.23 110.661 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.427 ' HB2' ' SG ' ' A' ' 38' ' ' CYS . 5.5 m-20 -75.36 -8.8 57.64 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.066 -0.515 . . . . 63.24 111.041 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.1 m120 68.47 0.05 2.42 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.483 0.549 . . . . 71.21 112.483 177.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.9 tt -71.49 145.42 12.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 109.095 -0.706 . . . . 74.52 109.095 177.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.672 HD22 ' HE2' ' A' ' 101' ' ' MET . 61.1 tp -80.76 109.74 15.61 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.263 0.554 . . . . 74.32 110.071 -177.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.48 HG23 ' CD2' ' A' ' 77' ' ' TYR . 61.5 mt -94.99 114.54 31.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.357 -0.838 . . . . 75.35 110.386 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.454 HD13 ' N ' ' A' ' 45' ' ' LEU . 5.5 mp -98.6 101.99 13.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.04 -0.527 . . . . 72.54 110.114 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.603 HG23 ' HB2' ' A' ' 100' ' ' LEU . 16.3 m -96.9 109.92 23.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.685 -0.487 . . . . 71.44 109.685 176.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . 3.9 p30 -101.36 146.77 27.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.465 0.65 . . . . 64.5 111.79 -174.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -89.95 96.34 10.63 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 107.614 -1.254 . . . . 73.03 107.614 169.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 67.1 t-105 -58.75 145.39 40.54 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.702 -0.681 . . . . 75.11 111.052 -174.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.67 110.17 37.46 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.076 -0.511 . . . . 60.02 110.585 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -78.27 8.22 3.68 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.722 2.281 . . . . 74.34 112.234 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 65.6 t-105 -134.53 130.75 37.08 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.388 -0.597 . . . . 74.15 109.388 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 9.0 p -73.41 74.52 1.39 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.152 0.501 . . . . 72.24 111.339 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.66 -73.93 1.2 Allowed Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 111.222 -0.751 . . . . 63.14 111.222 175.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -70.5 126.34 12.72 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.794 2.329 . . . . 62.11 111.407 175.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 57' ' ' ARG . 48.2 t -163.92 -167.21 1.31 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.572 -0.529 . . . . 70.01 109.572 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.523 ' HA ' HG21 ' A' ' 11' ' ' THR . 33.2 mtm105 71.66 -2.65 2.39 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 122.971 0.508 . . . . 75.25 112.016 175.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.8 m -88.17 11.48 16.24 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.619 0.247 . . . . 52.33 111.315 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.429 HD13 HD13 ' A' ' 12' ' ' LEU . 3.3 mm? 63.86 -81.81 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.913 -0.585 . . . . 73.5 110.093 -174.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -106.92 139.02 19.99 Favored Pre-proline 0 C--O 1.234 0.274 0 N-CA-C 109.153 -0.684 . . . . 73.14 109.153 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.738 ' HG2' ' HB2' ' A' ' 64' ' ' GLU . 56.4 Cg_endo -68.14 156.84 64.28 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 121.475 1.45 . . . . 71.23 109.633 171.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.52 ' HB3' HG12 ' A' ' 119' ' ' ILE . 9.6 mp0 -57.21 -50.57 72.45 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-O 121.254 0.549 . . . . 74.1 110.401 -170.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.649 HD11 ' N ' ' A' ' 64' ' ' GLU . 3.4 pp -54.33 -40.36 67.95 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.142 -0.935 . . . . 74.22 111.282 -177.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.738 ' HB2' ' HG2' ' A' ' 61' ' ' PRO . 2.3 mm-40 -75.61 -39.89 57.21 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.101 0.477 . . . . 74.41 110.005 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -53.54 -45.81 69.97 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.409 -0.814 . . . . 71.31 109.427 -177.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.496 HD12 HD11 ' A' ' 123' ' ' ILE . 16.1 mt -84.69 -37.86 20.45 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.129 -0.487 . . . . 73.24 111.661 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -53.97 -46.03 71.55 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.783 0.325 . . . . 61.5 111.048 -177.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.515 ' HA ' ' SD ' ' A' ' 22' ' ' MET . 73.1 mt-30 -49.3 -34.86 16.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.724 -0.671 . . . . 70.24 111.516 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -94.01 -57.93 2.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.227 0.537 . . . . 65.55 111.088 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.507 ' O ' HG22 ' A' ' 74' ' ' VAL . 16.6 m-85 -90.44 21.26 4.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.679 -0.691 . . . . 75.23 112.731 -171.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.8 t -52.71 -28.49 22.17 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.167 0.508 . . . . 74.33 111.424 -177.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -65.71 -16.76 64.07 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.73 -0.668 . . . . 53.34 111.127 -177.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -129.05 -5.35 4.99 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.182 -0.463 . . . . 72.31 110.438 -176.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.507 HG22 ' O ' ' A' ' 70' ' ' TYR . 22.9 m -132.66 140.43 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.089 0.471 . . . . 73.54 110.659 178.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -137.25 123.18 20.16 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.813 -0.63 . . . . 63.31 109.475 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.452 HD13 ' N ' ' A' ' 76' ' ' ILE . 2.0 mp -95.62 141.06 15.83 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-O 120.537 0.208 . . . . 74.42 110.65 -175.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.518 ' HB2' HG11 ' A' ' 46' ' ' VAL . 88.2 m-85 -141.06 157.77 44.85 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.347 0.659 . . . . 72.2 109.638 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.39 166.67 16.38 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.935 0.398 . . . . 72.22 110.964 170.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.516 HD12 ' O ' ' A' ' 26' ' ' ILE . 3.9 tp -146.31 83.68 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.106 -0.952 . . . . 72.5 108.669 174.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -99.93 74.08 1.79 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.775 -0.648 . . . . 55.21 111.141 -173.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.626 HG13 ' H ' ' A' ' 83' ' ' ASP . 30.7 pt -144.79 -163.76 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.277 -1.008 . . . . 61.14 108.277 173.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -62.55 -12.87 25.25 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.654 0.264 . . . . 71.24 111.527 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.626 ' H ' HG13 ' A' ' 81' ' ' ILE . 4.6 m-20 -82.75 7.01 16.19 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.391 -0.368 . . . . 64.43 110.95 174.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -57.65 137.73 56.12 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.004 0.431 . . . . 73.35 110.664 -178.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.504 ' HB3' HG22 ' A' ' 87' ' ' VAL . 88.7 mt-30 -89.31 118.85 29.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.977 -0.556 . . . . 74.21 110.142 -175.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -64.63 0.55 1.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.697 -0.683 . . . . 61.45 111.869 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.504 HG22 ' HB3' ' A' ' 85' ' ' GLN . 41.6 t -51.94 -37.67 21.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 120.803 0.335 . . . . 75.03 110.969 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.47 -39.38 94.3 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.385 0.612 . . . . 73.53 110.58 177.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 51.3 m -70.77 -29.49 65.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.719 -0.673 . . . . 71.01 109.955 176.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -70.66 -35.63 72.96 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.171 -0.468 . . . . 72.23 110.151 177.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.466 ' CE1' HG12 ' A' ' 87' ' ' VAL . 30.3 m-85 -68.78 -17.2 63.99 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.387 -0.598 . . . . 74.44 109.387 171.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.86 42.22 9.95 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.397 -0.819 . . . . 71.21 112.417 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.525 HG22 ' OG1' ' A' ' 98' ' ' THR . 14.9 p -67.95 131.83 33.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.983 0.391 . . . . 73.5 110.385 177.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.3 p -101.82 -36.43 8.68 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.177 -0.465 . . . . 73.31 111.65 -177.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -127.98 143.6 51.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.649 0.262 . . . . 73.13 111.062 -175.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.457 ' HB ' ' HA ' ' A' ' 97' ' ' PRO . 2.5 pp -100.02 160.84 26.11 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 115.957 -0.565 . . . . 72.43 110.669 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.457 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 98.6 Cg_endo -82.36 -177.96 20.11 Favored 'Cis proline' 0 C--N 1.353 0.813 0 C-N-CA 124.03 -1.238 . . . . 65.31 112.223 -0.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.66 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 17.7 m -144.06 115.41 8.03 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.439 -0.346 . . . . 71.12 110.567 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.488 ' N ' HD13 ' A' ' 99' ' ' ILE . 3.3 mp -108.06 115.22 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.673 -0.24 . . . . 75.35 110.365 -177.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.603 ' HB2' HG23 ' A' ' 46' ' ' VAL . 8.9 mp -91.89 139.98 30.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.826 0.346 . . . . 74.23 110.54 178.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.672 ' HE2' HD22 ' A' ' 43' ' ' LEU . 81.7 mtp -109.37 116.44 31.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.921 -0.581 . . . . 74.11 110.534 -177.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -116.99 154.04 31.6 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.952 0.406 . . . . 74.43 111.035 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.811 ' HB3' HD22 ' A' ' 108' ' ' LEU . 16.1 ttmm -169.27 115.37 0.58 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.437 -0.801 . . . . 63.31 109.617 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.9 t30 60.35 31.08 20.29 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.334 0.588 . . . . 65.24 110.987 172.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.91 -14.45 63.28 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 121.314 -0.47 . . . . 53.51 113.163 178.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -97.04 146.11 25.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.598 0.237 . . . . 51.24 110.589 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -99.06 126.02 44.69 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.242 -0.651 . . . . 60.31 109.242 174.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.811 HD22 ' HB3' ' A' ' 103' ' ' LYS . 3.1 mm? -87.07 -47.39 8.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.525 -0.307 . . . . 72.55 111.15 -174.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.608 ' HB3' ' SD ' ' A' ' 101' ' ' MET . 27.9 t -167.01 171.8 10.77 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.738 0.304 . . . . 74.54 110.927 -175.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -136.69 130.82 32.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.702 -0.681 . . . . 75.32 110.014 175.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.702 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 60.2 t -94.43 107.3 19.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.991 -0.549 . . . . 64.25 110.292 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 61.6 mt -104.26 109.87 28.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 110.022 -0.362 . . . . 75.11 110.022 176.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 106.87 -142.85 15.74 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 121.204 -0.522 . . . . 74.41 112.093 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -138.96 80.16 1.77 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.03 0.443 . . . . 71.33 110.595 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.48 ' O ' HG22 ' A' ' 119' ' ' ILE . 3.0 m-20 -118.67 94.29 4.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.799 -0.637 . . . . 74.42 110.595 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.549 HD12 HD11 ' A' ' 119' ' ' ILE . 7.2 tp -65.07 -39.01 84.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.186 -0.461 . . . . 73.12 111.088 -176.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 27.0 t -64.81 -39.77 94.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.242 0.544 . . . . 71.15 110.445 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.702 ' HE3' ' HA ' ' A' ' 111' ' ' VAL . 0.7 OUTLIER -64.68 -51.7 61.11 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 115.779 -0.646 . . . . 71.04 110.629 178.326 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.549 HD11 HD12 ' A' ' 116' ' ' ILE . 2.2 pp -63.61 -42.04 94.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 116.209 -0.45 . . . . 71.22 111.51 -175.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.493 HG22 HD23 ' A' ' 66' ' ' LEU . 2.8 pp -64.33 -31.76 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 120.738 -0.385 . . . . 75.31 110.254 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.441 ' N ' HD12 ' A' ' 120' ' ' ILE . 23.0 t -69.75 -51.65 32.26 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.187 -0.46 . . . . 62.24 110.523 -178.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.409 ' OE1' ' NZ ' ' A' ' 118' ' ' LYS . 7.9 pt-20 -77.12 -40.68 44.86 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.806 0.669 . . . . 74.32 112.806 -176.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.496 HD11 HD12 ' A' ' 66' ' ' LEU . 69.5 mt -62.7 -53.7 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 O-C-N 122.046 -0.409 . . . . 72.53 110.696 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -59.86 -20.23 55.85 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.117 0.484 . . . . 72.01 110.85 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -78.81 -12.84 60.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.915 -0.584 . . . . 63.32 111.144 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -126.42 9.47 7.22 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.547 -0.297 . . . . 73.11 111.554 -178.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.486 HG12 ' O ' ' A' ' 123' ' ' ILE . 45.7 pt -138.99 168.09 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 109.871 -0.418 . . . . 71.04 109.871 175.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.418 ' N ' HD21 ' A' ' 128' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.163 0 CA-C-O 118.585 -0.722 . . . . 74.44 111.094 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.1 mmm . . . . . 0 N--CA 1.484 1.236 0 N-CA-C 110.224 -0.287 . . . . 64.12 110.224 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.47 137.05 58.0 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.143 -0.481 . . . . 74.33 111.047 -178.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -76.07 124.13 26.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.017 -0.538 . . . . 73.01 109.961 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -63.87 125.72 25.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.583 -0.281 . . . . 75.42 110.335 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.6 p-80 -65.44 158.62 26.27 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 110.042 -0.355 . . . . 74.22 110.042 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -156.12 140.09 16.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.593 -0.276 . . . . 75.11 111.038 -174.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -151.72 121.15 6.85 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.984 0.421 . . . . 65.21 109.944 176.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -114.17 -177.53 3.15 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.961 -0.563 . . . . 71.34 110.504 -178.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 14.5 tpt -134.26 126.76 30.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.053 -0.521 . . . . 61.33 109.623 176.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.12 158.62 15.98 Favored Glycine 0 C--N 1.329 0.194 0 C-N-CA 121.092 -0.575 . . . . 54.42 112.858 -177.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.422 HG22 HD23 ' A' ' 12' ' ' LEU . 36.7 m -140.97 126.97 19.37 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.71 -0.848 . . . . 74.43 108.71 176.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.422 HD23 HG22 ' A' ' 11' ' ' THR . 4.5 mm? 62.38 12.98 5.68 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.213 0.53 . . . . 75.13 110.432 -170.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -81.65 103.09 11.12 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.623 -0.717 . . . . 74.12 109.608 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 60.32 22.17 11.65 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.207 0.527 . . . . 75.44 110.946 -177.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.414 ' HB3' ' HA ' ' A' ' 12' ' ' LEU . 34.2 tt0 -104.76 124.11 48.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.586 -0.734 . . . . 71.2 110.489 -175.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.1 p -109.54 -176.57 3.05 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.988 -0.551 . . . . 74.34 111.011 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -98.76 -178.57 4.02 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.961 0.41 . . . . 73.13 111.206 -175.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -171.95 59.37 0.16 Allowed Glycine 0 CA--C 1.522 0.507 0 CA-C-N 115.791 -0.641 . . . . 72.22 112.116 175.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -86.66 164.37 9.21 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.779 2.319 . . . . 73.22 112.326 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.65 172.41 36.22 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 121.28 -0.486 . . . . 71.45 112.112 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.3 m -92.81 104.64 16.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.846 0.355 . . . . 64.02 110.565 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.701 ' SD ' HG13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -98.19 9.89 41.87 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.195 0.521 . . . . 73.25 110.231 176.104 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.701 HG13 ' SD ' ' A' ' 22' ' ' MET . 49.7 mt -115.82 106.36 20.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-N 115.283 -0.871 . . . . 74.4 109.321 175.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.461 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 11.3 tp10 -105.7 136.92 44.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.737 0.303 . . . . 71.41 110.791 -176.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -90.6 128.46 36.6 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 122.379 0.272 . . . . 65.14 110.383 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.456 HG21 ' HD3' ' A' ' 34' ' ' LYS . 33.9 pt -128.0 149.9 33.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 120.851 0.358 . . . . 73.54 111.243 -178.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.51 179.09 53.23 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.616 -0.72 . . . . 13.31 112.789 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -63.7 -50.36 69.47 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 122.767 0.427 . . . . 75.21 111.262 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.9 m -64.43 -39.12 93.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.994 -0.548 . . . . 64.12 111.803 -172.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.531 ' HA ' ' HB3' ' A' ' 33' ' ' ASN . 16.3 pt-20 -85.37 -9.33 57.72 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 116.507 -0.315 . . . . 71.55 111.691 -174.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -47.8 -71.0 0.08 Allowed 'General case' 0 N--CA 1.464 0.25 0 O-C-N 123.192 0.307 . . . . 65.21 111.088 -177.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -66.57 -34.58 78.21 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.276 -0.638 . . . . 71.43 109.276 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.531 ' HB3' ' HA ' ' A' ' 30' ' ' GLU . 7.7 t30 -52.42 -33.82 45.59 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 114.487 -1.233 . . . . 73.12 111.989 -176.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.456 ' HD3' HG21 ' A' ' 26' ' ' ILE . 14.4 ptmt -114.95 -19.35 10.98 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.214 0.45 . . . . 53.44 112.214 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.4 t -88.43 -55.25 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 111.973 0.36 . . . . 63.51 111.973 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 39.9 p -72.83 -18.52 61.45 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.11 0.481 . . . . 74.43 111.033 -173.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.9 p -90.8 11.93 20.9 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.704 -0.68 . . . . 73.22 111.028 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 51.8 t -59.63 117.01 4.43 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.258 -0.428 . . . . 62.14 111.292 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -117.43 3.73 12.5 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.548 0.69 . . . . 70.23 109.349 172.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.59 ' HB2' HG22 ' A' ' 42' ' ' ILE . 1.8 m-20 -70.64 -31.85 68.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.963 -1.017 . . . . 63.24 110.684 -176.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 40' ' ' ASP . 27.7 m-80 73.26 13.4 4.7 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.301 -0.863 . . . . 71.21 111.04 -175.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.59 HG22 ' HB2' ' A' ' 40' ' ' ASP . 15.1 tt -85.99 146.64 6.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 108.828 -0.804 . . . . 74.52 108.828 172.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.698 HD23 ' HE1' ' A' ' 101' ' ' MET . 63.4 tp -79.52 106.59 11.66 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-O 121.556 0.693 . . . . 74.32 110.312 -177.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.481 HG22 ' CD2' ' A' ' 77' ' ' TYR . 65.6 mt -88.68 107.53 17.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.801 -1.09 . . . . 75.35 110.364 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 70.3 mt -90.56 101.82 14.56 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.963 -0.562 . . . . 72.54 109.787 178.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.459 HG13 HG23 ' A' ' 44' ' ' ILE . 27.6 m -95.96 121.53 46.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.031 0.443 . . . . 71.44 110.849 -178.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -95.49 133.71 39.16 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.915 -0.584 . . . . 64.5 111.02 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -104.66 91.25 3.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.436 0.636 . . . . 73.03 111.495 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 11.7 t90 65.87 64.02 0.57 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 114.652 -1.158 . . . . 75.11 112.839 173.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -130.98 78.24 73.8 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 108.109 -1.071 . . . . 60.02 108.109 163.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.407 ' HB2' ' H ' ' A' ' 52' ' ' TRP . 82.5 Cg_exo -44.96 -80.87 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.588 2.859 . . . . 74.34 114.452 -167.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.407 ' H ' ' HB2' ' A' ' 51' ' ' PRO . 47.7 t90 -174.13 159.46 3.23 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 109.625 -0.509 . . . . 74.15 109.625 -174.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 67.3 m -142.53 118.02 10.31 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.995 -0.372 . . . . 72.24 109.995 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -62.39 -71.83 0.75 Allowed Glycine 0 C--N 1.332 0.336 0 C-N-CA 121.201 -0.523 . . . . 63.14 112.013 178.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -75.26 72.5 4.79 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 122.311 2.007 . . . . 62.11 111.489 175.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 53.3 t -67.4 114.15 5.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.899 -0.591 . . . . 70.01 110.438 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.01 15.37 2.8 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.272 -0.422 . . . . 75.25 111.549 -179.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.1 m -127.95 132.05 49.26 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.227 -0.442 . . . . 52.33 110.078 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.678 ' H ' HD22 ' A' ' 59' ' ' LEU . 1.7 pt? -69.74 76.45 0.44 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.257 0.551 . . . . 73.5 110.215 177.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.593 ' HG2' ' NE2' ' A' ' 68' ' ' GLN . 2.4 mp0 62.97 110.36 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 115.022 -0.99 . . . . 73.14 111.587 -177.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 60' ' ' GLU . 19.1 Cg_endo -57.59 167.62 3.74 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.458 2.105 . . . . 71.23 111.104 175.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.462 ' NE2' ' HA ' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -45.3 -49.7 12.5 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 116.162 -0.472 . . . . 74.1 111.469 -171.813 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.705 ' HB3' HG12 ' A' ' 76' ' ' ILE . 71.6 mt -56.78 -48.88 76.9 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.225 -0.898 . . . . 74.22 111.012 -175.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.542 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 34.4 mt-10 -70.6 -44.33 67.5 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.24 -0.437 . . . . 74.41 109.959 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.3 tptp -54.57 -42.74 71.36 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.378 -0.828 . . . . 71.31 110.986 -174.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.502 HD22 HG21 ' A' ' 120' ' ' ILE . 13.9 mt -81.51 -39.5 24.62 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 120.795 -0.362 . . . . 73.24 111.171 176.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.479 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -55.19 -33.49 63.07 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.587 0.232 . . . . 61.5 111.295 -178.551 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.593 ' NE2' ' HG2' ' A' ' 60' ' ' GLU . 96.4 mt-30 -51.06 -42.46 60.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.99 0.424 . . . . 70.24 110.794 177.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -94.02 -55.17 3.31 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.684 -0.689 . . . . 65.55 111.592 -177.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.533 ' O ' HG21 ' A' ' 74' ' ' VAL . 12.0 m-85 -94.86 22.17 6.75 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.727 0.639 . . . . 75.23 112.727 -167.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.479 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 8.2 t -52.5 -27.33 15.9 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.9 0.381 . . . . 74.33 111.585 -177.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -63.58 -24.25 67.72 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.246 -0.434 . . . . 53.34 111.832 -178.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.55 9.2 5.97 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.485 0.183 . . . . 72.31 111.183 -177.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.533 HG21 ' O ' ' A' ' 70' ' ' TYR . 27.2 m -138.33 140.29 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 O-C-N 121.779 -0.575 . . . . 73.54 110.565 175.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 39.2 mmtm -141.07 135.25 30.82 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.135 -0.484 . . . . 63.31 110.031 174.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.705 HG12 ' HB3' ' A' ' 63' ' ' LEU . 3.4 mp -103.94 144.49 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.391 -0.368 . . . . 74.42 110.146 -176.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.481 ' CD2' HG22 ' A' ' 44' ' ' ILE . 81.2 m-85 -129.38 138.46 51.53 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.276 0.56 . . . . 72.2 111.537 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.463 ' HE2' ' HA ' ' A' ' 78' ' ' LYS . 9.6 mmpt? -99.01 100.22 11.36 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.284 -0.871 . . . . 72.22 108.804 174.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.777 HG21 ' H ' ' A' ' 81' ' ' ILE . 2.4 mp -83.95 138.69 18.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 110.249 -0.278 . . . . 72.5 110.249 -175.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.42 ' N ' HD21 ' A' ' 80' ' ' ASN . 0.9 OUTLIER -75.4 -8.29 56.31 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.382 -0.372 . . . . 55.21 111.822 -177.16 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.777 ' H ' HG21 ' A' ' 79' ' ' ILE . 68.7 mt -68.12 85.04 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.21 0.529 . . . . 61.14 109.845 176.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -82.75 -72.58 0.44 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.813 -0.63 . . . . 71.24 111.49 -175.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -90.52 -25.09 20.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.341 -0.39 . . . . 64.43 111.475 -174.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -82.4 58.31 4.05 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.027 0.441 . . . . 73.35 110.567 -175.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -109.31 104.38 13.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.859 0.361 . . . . 74.21 111.039 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -90.38 -27.98 18.98 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.733 -0.84 . . . . 61.45 108.733 170.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 67.7 t -51.49 -45.7 35.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 114.946 -1.024 . . . . 75.03 111.364 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.84 -42.18 88.7 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.19 -0.459 . . . . 73.53 110.919 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.0 m -74.32 -30.18 61.94 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.71 -0.677 . . . . 71.01 110.554 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -61.64 -55.49 29.98 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.677 -0.692 . . . . 72.23 110.445 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.42 ' HE2' ' HE2' ' A' ' 107' ' ' LYS . 97.4 m-85 -77.08 -13.31 59.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.956 -0.565 . . . . 74.44 110.343 178.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.46 39.25 61.55 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 115.748 -0.66 . . . . 71.21 112.875 174.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 14.6 p -72.43 -37.37 57.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.657 0.265 . . . . 73.5 110.502 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.8 t 67.43 -67.43 0.18 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.67 -0.696 . . . . 73.31 111.294 -178.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.58 134.9 48.06 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.49 -0.323 . . . . 73.13 111.057 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.455 ' HB ' ' HA ' ' A' ' 97' ' ' PRO . 29.4 pt -113.87 158.67 38.5 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 116.062 -0.517 . . . . 72.43 110.107 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.455 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 95.4 Cg_endo -82.96 177.55 31.45 Favored 'Cis proline' 0 C--N 1.35 0.645 0 C-N-CA 123.889 -1.296 . . . . 65.31 112.352 -1.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.1 m -140.8 131.22 25.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.113 -0.494 . . . . 71.12 109.843 178.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.59 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 26.6 mt -109.33 116.93 53.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.333 -0.394 . . . . 75.35 109.999 -176.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.2 mp -94.55 144.57 25.48 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.144 0.497 . . . . 74.23 110.777 -178.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.764 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 70.3 mtp -106.38 114.58 28.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.606 -0.725 . . . . 74.11 109.923 -179.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -115.83 140.63 49.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.76 0.314 . . . . 74.43 110.453 177.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.722 ' HB3' HD21 ' A' ' 108' ' ' LEU . 38.1 ttpt -156.79 128.32 7.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.997 -0.547 . . . . 63.31 109.561 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.7 t30 60.0 24.84 14.01 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.324 0.583 . . . . 65.24 110.686 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.28 -1.13 82.08 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 116.058 -0.519 . . . . 53.51 113.266 177.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -108.2 160.92 15.45 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.99 0.395 . . . . 51.24 110.49 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.42 ' HE2' ' HE2' ' A' ' 91' ' ' TYR . 20.2 pttp -92.69 139.92 30.07 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.472 -0.936 . . . . 60.31 108.472 170.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.722 HD21 ' HB3' ' A' ' 103' ' ' LYS . 3.0 mm? -105.72 -52.98 2.72 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 110.087 -0.338 . . . . 72.55 110.087 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.764 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 23.4 m -157.59 170.96 21.21 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.865 -0.607 . . . . 74.54 110.171 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.7 pm0 -128.85 123.87 33.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.932 -0.576 . . . . 75.32 109.831 172.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.59 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 63.6 t -80.66 113.93 20.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.822 -0.626 . . . . 64.25 110.25 176.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 42.1 mt -100.2 123.06 52.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.427 -0.583 . . . . 75.11 109.427 175.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.76 -129.89 14.0 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.957 -0.639 . . . . 74.41 111.985 -179.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.462 ' HA ' ' NE2' ' A' ' 62' ' ' GLN . . . -142.65 57.36 1.43 Allowed 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.012 0.434 . . . . 71.33 111.117 -178.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.539 ' O ' ' HG3' ' A' ' 118' ' ' LYS . 7.7 m-20 -88.32 86.42 7.06 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-O 121.681 0.753 . . . . 74.42 110.21 177.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.551 ' O ' HG13 ' A' ' 119' ' ' ILE . 7.9 tp -53.09 -35.68 23.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.003 -0.999 . . . . 73.12 110.636 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.6 m -67.07 -37.0 83.22 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.846 -0.615 . . . . 71.15 111.215 -177.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.539 ' HG3' ' O ' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -76.04 -41.62 50.22 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.642 -0.503 . . . . 71.04 109.642 -179.325 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.551 HG13 ' O ' ' A' ' 116' ' ' ILE . 1.9 pp -65.7 -42.35 92.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 116.286 -0.415 . . . . 71.22 110.943 -176.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.502 HG21 HD22 ' A' ' 66' ' ' LEU . 2.8 pp -66.8 -31.85 55.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 121.123 0.487 . . . . 75.31 109.957 177.21 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.408 ' N ' HD11 ' A' ' 120' ' ' ILE . 47.2 t -63.58 -51.01 67.2 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.73 -0.668 . . . . 62.24 110.686 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.481 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 11.6 pt-20 -77.85 -46.17 22.2 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.14 0.422 . . . . 74.32 112.14 -178.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.508 ' O ' HG12 ' A' ' 127' ' ' ILE . 67.5 mt -60.04 -51.0 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 117.903 0.319 . . . . 72.53 111.555 -176.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -59.11 -30.86 68.42 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.073 0.463 . . . . 72.01 110.922 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -83.17 -20.82 33.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.413 0.625 . . . . 63.32 110.282 177.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.481 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 1.8 t-20 -88.61 -37.37 15.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.689 -0.687 . . . . 73.11 111.524 -173.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.508 HG12 ' O ' ' A' ' 123' ' ' ILE . 46.8 pt -100.99 168.61 1.87 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 116.266 -0.424 . . . . 71.04 111.159 -177.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.3 p30 . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.432 -0.794 . . . . 74.44 111.297 -174.921 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.589 ' SD ' ' N ' ' A' ' 2' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.482 1.166 0 N-CA-C 109.53 -0.544 . . . . 64.12 109.53 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.589 ' N ' ' SD ' ' A' ' 1' ' ' MET . . . -58.73 89.51 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.176 0.512 . . . . 74.33 112.193 -176.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.518 ' CD2' ' SD ' ' A' ' 1' ' ' MET . 94.5 m-70 -138.41 41.68 2.22 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.393 -0.966 . . . . 73.01 108.393 173.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 45.5 t60 -62.31 161.17 11.88 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.754 -1.112 . . . . 75.42 111.798 -170.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 64.63 12.62 7.68 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.257 1.023 . . . . 74.22 112.234 173.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.401 ' O ' ' CG ' ' A' ' 6' ' ' HIS . 6.8 p80 -75.57 74.51 2.59 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.559 0.695 . . . . 75.11 110.952 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 30.3 p-80 -157.84 83.13 0.88 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.61 0.719 . . . . 65.21 110.79 176.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.5 p-80 -138.43 36.99 2.26 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.375 -0.83 . . . . 71.34 108.886 171.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -97.2 178.24 5.31 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.663 -1.153 . . . . 61.33 110.222 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.22 -11.88 60.22 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 121.151 -0.547 . . . . 54.42 112.163 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.7 m -73.55 72.32 1.4 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.428 0.632 . . . . 74.43 109.998 178.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 52.3 tp -81.74 100.71 9.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.793 -0.64 . . . . 75.13 110.746 -176.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.33 108.56 5.79 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.285 -1.006 . . . . 74.12 108.285 173.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -152.42 53.54 0.79 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.211 -0.449 . . . . 75.44 110.702 -175.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -62.83 92.01 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.438 0.637 . . . . 71.2 110.004 176.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.0 m -101.04 9.33 42.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.734 0.778 . . . . 74.34 110.313 -176.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -120.03 -172.32 2.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.413 -0.812 . . . . 73.13 110.103 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.63 82.72 0.76 Allowed Glycine 0 C--N 1.331 0.273 0 N-CA-C 111.01 -0.836 . . . . 72.22 111.01 -173.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -77.96 51.28 3.58 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 123.056 2.504 . . . . 73.22 113.319 -172.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.6 10.76 64.29 Favored Glycine 0 C--N 1.332 0.327 0 CA-C-N 116.222 -0.445 . . . . 71.45 112.92 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.4 m -77.72 99.83 6.01 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.777 0.322 . . . . 64.02 110.183 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.521 ' N ' ' SD ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -68.24 -26.21 65.58 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.124 -0.489 . . . . 73.25 110.165 178.934 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.519 HG12 ' HG2' ' A' ' 22' ' ' MET . 14.3 mm -115.66 78.33 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 115.532 -0.758 . . . . 74.4 109.092 174.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.623 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 10.8 tp10 -96.99 153.17 18.07 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.21 -0.45 . . . . 71.41 110.016 -176.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.84 138.88 34.53 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.613 -0.514 . . . . 65.14 109.613 177.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 39.2 pt -122.76 153.75 27.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-O 121.189 0.518 . . . . 73.54 111.095 -177.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.489 ' HA2' ' HB2' ' A' ' 80' ' ' ASN . . . -76.58 150.71 38.62 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.408 -0.815 . . . . 13.31 111.729 176.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -63.64 -34.98 79.05 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.981 0.419 . . . . 75.21 110.469 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.1 m -72.99 -16.38 61.51 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.734 -0.667 . . . . 64.12 111.63 -176.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -113.79 3.02 15.34 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.398 -0.364 . . . . 71.55 110.907 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -47.08 -71.15 0.08 Allowed 'General case' 0 N--CA 1.464 0.241 0 O-C-N 123.46 0.475 . . . . 65.21 110.951 -177.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -65.15 -34.82 79.3 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.861 -0.422 . . . . 71.43 109.861 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -52.04 -41.06 61.98 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.221 -0.9 . . . . 73.12 111.215 -174.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -106.81 -25.2 11.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.195 -0.457 . . . . 53.44 112.104 -177.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 79.1 t -84.12 -50.83 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 112.073 0.397 . . . . 63.51 112.073 -175.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.3 p -76.83 -32.54 57.65 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.987 0.422 . . . . 74.43 110.81 -175.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.8 m -80.59 12.41 3.11 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.765 -0.652 . . . . 73.22 111.695 -177.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.624 ' SG ' HG23 ' A' ' 42' ' ' ILE . 37.1 t -59.24 90.9 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.879 0.371 . . . . 62.14 111.182 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -80.58 -22.0 41.12 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.944 0.402 . . . . 70.23 111.185 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -72.86 2.57 6.52 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.535 -0.302 . . . . 63.24 111.742 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 63.0 21.91 13.17 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.422 -0.354 . . . . 71.21 111.777 172.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.624 HG23 ' SG ' ' A' ' 38' ' ' CYS . 6.8 tt -87.9 144.63 8.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 109.388 -0.597 . . . . 74.52 109.388 177.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.488 ' O ' ' HA ' ' A' ' 74' ' ' VAL . 42.1 tp -81.14 115.53 20.61 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.008 0.433 . . . . 74.32 109.979 -177.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 62.1 mt -102.58 123.28 55.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.91 -0.586 . . . . 75.35 110.263 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.536 ' HG ' ' HG2' ' A' ' 101' ' ' MET . 3.3 mp -114.23 106.02 13.86 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.049 -0.523 . . . . 72.54 109.753 -178.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.511 HG21 ' HB2' ' A' ' 77' ' ' TYR . 43.5 t -102.12 125.54 56.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.598 -0.274 . . . . 71.44 110.566 -178.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -98.01 138.49 35.25 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.17 0.51 . . . . 64.5 109.894 178.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -100.89 25.25 8.2 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.578 -0.737 . . . . 73.03 110.009 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 6.1 t90 -92.0 -41.16 10.7 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.898 -0.592 . . . . 75.11 109.486 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.606 ' HB2' ' HD2' ' A' ' 51' ' ' PRO . . . 64.68 170.56 0.09 OUTLIER Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 115.683 -0.69 . . . . 60.02 111.517 175.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.606 ' HD2' ' HB2' ' A' ' 50' ' ' ALA . 73.7 Cg_endo -75.08 56.18 4.22 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.279 1.986 . . . . 74.34 111.746 173.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 71.2 t-105 -74.6 148.15 41.01 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.843 -0.617 . . . . 74.15 110.752 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 25.2 p -67.76 86.81 0.22 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.09 0.472 . . . . 72.24 110.57 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -159.59 133.98 3.54 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.851 -0.613 . . . . 63.14 111.907 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -59.78 97.07 0.1 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.672 2.248 . . . . 62.11 111.785 178.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 55.6 m -62.76 -36.28 82.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.839 -0.618 . . . . 70.01 110.647 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 72.94 -33.35 0.27 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.596 -0.729 . . . . 75.25 112.234 176.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.9 t -90.32 123.26 33.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.829 0.347 . . . . 52.33 110.401 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.407 HD23 ' N ' ' A' ' 59' ' ' LEU . 3.0 mm? -101.31 11.52 39.11 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.132 -0.485 . . . . 73.5 109.869 176.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.3 tp10 -151.63 73.42 8.1 Favored Pre-proline 0 C--O 1.236 0.349 0 N-CA-C 109.171 -0.678 . . . . 73.14 109.171 -177.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.526 ' HG2' ' HB2' ' A' ' 64' ' ' GLU . 85.4 Cg_endo -75.45 156.52 41.01 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.702 2.268 . . . . 71.23 112.485 -176.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.598 ' HB3' HG12 ' A' ' 119' ' ' ILE . 9.9 mp0 -55.34 -55.93 25.94 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-O 121.592 0.711 . . . . 74.1 111.27 -173.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.501 HD11 HG23 ' A' ' 111' ' ' VAL . 3.2 mm? -59.33 -48.39 81.82 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 114.844 -1.071 . . . . 74.22 110.952 -171.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.576 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 48.4 mt-10 -68.38 -32.48 72.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.067 -0.515 . . . . 74.41 110.427 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 61' ' ' PRO . 2.8 tmtm? -59.09 -52.46 65.63 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.803 -0.443 . . . . 71.31 109.803 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.682 HD13 HD12 ' A' ' 123' ' ' ILE . 29.3 mt -70.88 -33.46 70.62 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 120.903 -0.319 . . . . 73.24 111.347 177.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.19 -27.13 66.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.334 -0.394 . . . . 61.5 111.47 -178.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.576 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 76.1 mt-30 -56.93 -35.79 69.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.843 0.354 . . . . 70.24 110.738 177.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -93.83 -55.94 3.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.401 0.619 . . . . 65.55 110.468 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.5 ' O ' HG22 ' A' ' 74' ' ' VAL . 23.4 m-85 -84.74 22.51 1.33 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.58 -0.736 . . . . 75.23 112.69 -172.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.433 ' O ' ' NZ ' ' A' ' 75' ' ' LYS . 4.4 t -52.28 -44.54 65.05 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.369 0.507 . . . . 74.33 112.369 -170.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -73.14 -16.21 61.45 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 122.04 -0.412 . . . . 53.34 111.316 -176.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -101.6 -20.47 15.03 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 110.078 -0.342 . . . . 72.31 110.078 178.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 70' ' ' TYR . 25.4 m -136.91 122.06 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 121.298 0.571 . . . . 73.54 110.64 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.433 ' NZ ' ' O ' ' A' ' 71' ' ' THR . 38.0 mmtm -119.29 124.75 47.44 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.639 -0.504 . . . . 63.31 109.639 177.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.519 HG13 ' HB2' ' A' ' 45' ' ' LEU . 2.1 mp -97.37 137.48 24.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 74.42 110.054 -175.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.623 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 20.2 m-85 -126.58 134.45 50.81 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.116 -0.493 . . . . 72.2 110.368 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 19.1 mtpp -96.31 122.51 39.26 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.181 -0.674 . . . . 72.22 109.181 176.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.6 tp -64.13 145.74 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-O 120.908 0.385 . . . . 72.5 111.18 -176.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.489 ' HB2' ' HA2' ' A' ' 27' ' ' GLY . 52.9 t30 -60.22 -66.2 0.56 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.007 -0.542 . . . . 55.21 110.801 177.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.434 ' O ' ' HG2' ' A' ' 85' ' ' GLN . 59.0 mt -105.69 119.78 55.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.898 -0.592 . . . . 61.14 109.669 -179.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.466 ' HG2' ' N ' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -85.73 -57.79 2.91 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.795 0.665 . . . . 71.24 112.795 -172.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.466 ' N ' ' HG2' ' A' ' 82' ' ' GLU . 26.9 t70 -75.13 -21.61 58.72 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.274 0.472 . . . . 64.43 112.274 -166.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -87.86 0.95 55.15 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.962 0.411 . . . . 73.35 111.336 -177.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.434 ' HG2' ' O ' ' A' ' 81' ' ' ILE . 84.1 mm-40 -78.61 104.07 8.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.951 0.405 . . . . 74.21 110.184 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -63.32 -17.93 63.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.82 -0.627 . . . . 61.45 110.581 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.4 t -54.17 -46.3 67.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 115.869 -0.605 . . . . 75.03 110.705 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.4 -43.41 98.92 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.922 -0.581 . . . . 73.53 110.76 -178.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.4 m -74.52 -28.11 60.83 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.741 -0.663 . . . . 71.01 110.964 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -64.49 -51.11 64.67 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.067 0.46 . . . . 72.23 109.928 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -79.01 -6.71 57.03 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.684 -0.689 . . . . 74.44 110.36 176.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 61.95 53.32 43.85 Favored Glycine 0 C--N 1.331 0.281 0 CA-C-N 115.84 -0.618 . . . . 71.21 113.19 172.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.409 HG22 ' H ' ' A' ' 95' ' ' ALA . 10.0 p -80.01 133.67 29.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.908 0.385 . . . . 73.5 110.671 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.4 t -128.17 27.12 5.68 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.107 0.48 . . . . 73.31 110.329 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.418 ' HB3' HG22 ' A' ' 112' ' ' ILE . . . -145.03 130.38 18.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.01 -0.541 . . . . 73.13 110.157 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.708 ' H ' HD13 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -110.37 148.14 37.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 72.43 110.242 -178.153 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -77.07 -178.12 23.21 Favored 'Cis proline' 0 C--N 1.351 0.687 0 C-N-CA 123.758 -1.351 . . . . 65.31 112.512 -1.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.0 m -137.81 115.64 11.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.105 -0.498 . . . . 71.12 110.039 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.451 HD11 ' N ' ' A' ' 99' ' ' ILE . 3.9 mp -121.6 123.16 68.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-N 116.216 -0.447 . . . . 75.35 109.84 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.5 mp -101.24 141.77 33.64 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.243 -0.28 . . . . 74.23 110.243 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.733 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 56.5 mtp -116.91 115.48 25.58 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 116.398 -0.364 . . . . 74.11 110.872 -175.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -117.38 154.29 31.58 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.049 -0.523 . . . . 74.43 110.511 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.758 ' HB3' HD23 ' A' ' 108' ' ' LEU . 28.1 ttpp -168.23 122.89 0.94 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.747 -0.661 . . . . 63.31 109.78 178.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.2 t30 53.82 45.95 26.77 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.545 0.688 . . . . 65.24 110.845 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 73.87 3.83 65.07 Favored Glycine 0 CA--C 1.52 0.392 0 CA-C-N 115.578 -0.737 . . . . 53.51 113.719 176.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -111.41 142.87 43.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 117.134 0.467 . . . . 51.24 110.589 -178.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.474 ' O ' ' HG3' ' A' ' 107' ' ' LYS . 12.5 ptmm? -95.51 112.39 24.12 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.082 -0.71 . . . . 60.31 109.082 172.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.758 HD23 ' HB3' ' A' ' 103' ' ' LYS . 1.5 mm? -89.33 -53.18 4.67 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.088 0.471 . . . . 72.55 110.904 -172.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.733 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 22.8 m -150.08 172.02 15.93 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.517 -0.765 . . . . 74.54 110.458 -169.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.27 121.28 2.65 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.092 0.472 . . . . 75.32 111.116 -177.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.501 HG23 HD11 ' A' ' 63' ' ' LEU . 59.8 t -80.43 107.47 12.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.607 -0.724 . . . . 64.25 110.037 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.418 HG22 ' HB3' ' A' ' 95' ' ' ALA . 65.7 mt -110.58 106.91 21.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.344 -0.613 . . . . 75.11 109.344 177.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 96.51 -141.33 15.55 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 111.398 -0.681 . . . . 74.41 111.398 -176.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -141.54 88.58 2.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.914 0.357 . . . . 71.33 110.65 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.535 ' O ' HG22 ' A' ' 119' ' ' ILE . 11.7 m-20 -132.9 97.08 3.93 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.101 -0.499 . . . . 74.42 110.14 178.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.511 ' O ' HG13 ' A' ' 119' ' ' ILE . 7.1 tp -58.49 -40.25 77.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 120.846 0.355 . . . . 73.12 111.13 -177.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.3 t -67.24 -28.64 68.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.164 0.507 . . . . 71.15 110.74 -178.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.525 ' HZ1' ' CD ' ' A' ' 122' ' ' GLU . 1.9 tmtm? -79.27 -43.77 23.05 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.985 -0.552 . . . . 71.04 110.75 179.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.598 HG12 ' HB3' ' A' ' 62' ' ' GLN . 1.8 pp -67.64 -41.53 85.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 71.22 110.613 -177.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.64 HG23 HD11 ' A' ' 66' ' ' LEU . 2.7 pp -62.21 -31.64 52.17 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 109.693 -0.484 . . . . 75.31 109.693 177.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 23.1 t -69.71 -51.23 36.25 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.712 -0.676 . . . . 62.24 110.083 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.525 ' CD ' ' HZ1' ' A' ' 118' ' ' LYS . 16.4 pt-20 -74.12 -33.93 63.73 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 112.109 0.411 . . . . 74.32 112.109 -175.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.682 HD12 HD13 ' A' ' 66' ' ' LEU . 64.6 mt -67.13 -58.05 7.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 O-C-N 122.264 -0.272 . . . . 72.53 110.518 178.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -63.16 -19.98 64.97 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.073 0.463 . . . . 72.01 110.932 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.404 ' HB3' ' O ' ' A' ' 122' ' ' GLU . 7.3 t30 -60.69 -31.45 70.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.067 -0.515 . . . . 63.32 111.219 176.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -114.22 -3.15 13.22 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.075 0.398 . . . . 73.11 112.075 -173.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.43 HG12 ' O ' ' A' ' 123' ' ' ILE . 33.9 pt -135.64 168.56 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 110.372 -0.233 . . . . 71.04 110.372 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.383 -0.818 . . . . 74.44 111.104 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ttt . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 121.166 0.508 . . . . 64.12 110.167 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.97 82.07 7.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.921 -0.581 . . . . 74.33 110.485 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 61.2 t60 -91.73 31.75 1.18 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.355 0.598 . . . . 73.01 109.898 -178.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -79.89 53.53 1.68 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.595 -0.73 . . . . 75.42 111.453 -174.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -160.13 142.02 12.86 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.708 0.29 . . . . 74.22 110.581 176.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -148.02 -156.44 0.72 Allowed 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.25 -1.019 . . . . 75.11 108.25 175.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -139.36 136.78 35.13 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.19 -0.67 . . . . 65.21 109.19 174.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -132.55 78.04 1.78 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.068 0.461 . . . . 71.34 110.435 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 46.0 tpp -175.31 99.31 0.08 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.588 -0.733 . . . . 61.33 109.324 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.428 ' O ' ' HB3' ' A' ' 13' ' ' GLU . . . 121.84 -9.82 9.72 Favored Glycine 0 C--N 1.33 0.217 0 N-CA-C 111.267 -0.733 . . . . 54.42 111.267 -175.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.636 HG22 HD12 ' A' ' 12' ' ' LEU . 7.6 t -68.23 -21.59 64.83 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.391 0.276 . . . . 74.43 111.295 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.636 HD12 HG22 ' A' ' 11' ' ' THR . 8.7 mp -85.85 62.07 7.23 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.954 -0.758 . . . . 75.13 108.954 171.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.428 ' HB3' ' O ' ' A' ' 10' ' ' GLY . 14.8 tp10 -172.32 -54.09 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.349 -0.841 . . . . 74.12 109.231 -174.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -119.87 103.14 9.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.356 -0.838 . . . . 75.44 110.035 177.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -141.5 22.13 2.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.673 -0.694 . . . . 71.2 109.745 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.7 p -71.56 88.69 0.94 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.541 -0.754 . . . . 74.34 110.476 -177.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -75.46 87.66 2.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.569 0.699 . . . . 73.13 110.941 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.61 60.25 0.25 Allowed Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 114.853 -1.067 . . . . 72.22 110.796 176.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.41 ' HA ' ' OE1' ' A' ' 24' ' ' GLU . 46.4 Cg_endo -66.97 141.02 56.7 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.804 2.336 . . . . 73.22 112.505 -173.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 158.9 -12.33 0.21 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.824 -0.703 . . . . 71.45 113.246 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.703 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 32.5 t -70.44 147.83 49.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.207 0.504 . . . . 64.02 110.25 179.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -70.27 -27.29 64.31 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.7 -0.481 . . . . 73.25 109.7 176.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.443 HG12 ' HB ' ' A' ' 76' ' ' ILE . 51.1 mt -133.79 106.6 9.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 108.927 -0.768 . . . . 74.4 108.927 173.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.703 ' HB2' ' HB3' ' A' ' 21' ' ' SER . 36.9 tt0 -131.94 118.61 20.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.604 -0.271 . . . . 71.41 111.083 -171.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.498 ' NE2' ' H ' ' A' ' 25' ' ' GLN . 0.6 OUTLIER -81.62 132.73 35.31 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.209 -0.664 . . . . 65.14 109.209 173.454 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.46 HG22 ' HZ2' ' A' ' 34' ' ' LYS . 25.8 pt -126.44 175.32 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 120.983 0.42 . . . . 73.54 111.952 -170.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.45 154.13 26.97 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.646 -0.707 . . . . 13.31 112.369 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -67.41 -31.2 71.24 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.961 0.41 . . . . 75.21 110.957 -177.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.3 p -71.02 -39.29 72.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.999 -0.546 . . . . 64.12 110.877 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.415 ' HA ' ' HB3' ' A' ' 33' ' ' ASN . 13.1 pt-20 -91.48 -3.77 56.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.999 -0.546 . . . . 71.55 110.991 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -46.34 -71.02 0.08 Allowed 'General case' 0 N--CA 1.464 0.26 0 O-C-N 123.622 0.576 . . . . 65.21 111.161 -176.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.552 ' HB2' ' HG1' ' A' ' 36' ' ' THR . 5.9 p-10 -68.04 -35.17 77.81 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 109.396 -0.594 . . . . 71.43 109.396 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.415 ' HB3' ' HA ' ' A' ' 30' ' ' GLU . 6.2 t30 -52.53 -34.27 49.08 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 114.586 -1.188 . . . . 73.12 111.816 -175.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.46 ' HZ2' HG22 ' A' ' 26' ' ' ILE . 16.2 ptmt -111.69 -27.52 8.49 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.774 -0.194 . . . . 53.44 111.426 -178.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 71.7 t -84.57 -56.66 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 111.745 0.276 . . . . 63.51 111.745 -177.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.552 ' HG1' ' HB2' ' A' ' 32' ' ' ASP . 75.8 p -80.01 -23.77 41.29 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.011 0.434 . . . . 74.43 110.444 -173.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.1 m -83.66 6.08 22.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.733 -0.667 . . . . 73.22 111.027 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.616 ' SG ' HG22 ' A' ' 42' ' ' ILE . 48.0 t -66.88 98.92 0.58 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.887 0.375 . . . . 62.14 110.427 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -88.9 -2.94 58.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.102 -0.499 . . . . 70.23 110.318 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -71.56 -6.62 42.05 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.175 -0.466 . . . . 63.24 110.67 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 60.54 23.3 12.99 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.88 -0.6 . . . . 71.21 111.42 176.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.616 HG22 ' SG ' ' A' ' 38' ' ' CYS . 12.4 tt -84.9 152.61 3.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.754 -0.832 . . . . 74.52 108.754 174.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.643 HD23 ' HE3' ' A' ' 101' ' ' MET . 58.9 tp -85.09 110.2 18.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.606 0.241 . . . . 74.32 110.45 -175.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 101' ' ' MET . 54.4 mt -100.62 136.68 31.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.472 -0.331 . . . . 75.35 110.591 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.537 ' HG ' ' HG2' ' A' ' 101' ' ' MET . 3.7 mp -122.67 109.45 14.28 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.572 -0.529 . . . . 72.54 109.572 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 30.1 m -95.27 127.35 47.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.717 0.294 . . . . 71.44 110.606 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.419 ' HB3' ' HE2' ' A' ' 78' ' ' LYS . 3.1 t70 -125.63 149.42 48.43 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.322 0.582 . . . . 64.5 112.231 -171.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.525 ' CZ ' ' HB ' ' A' ' 98' ' ' THR . 22.5 p90 -134.75 95.21 3.3 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.493 -0.929 . . . . 73.03 108.493 164.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.412 ' HA ' ' HB3' ' A' ' 97' ' ' PRO . 10.9 p90 -74.56 177.16 6.24 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 114.539 -1.21 . . . . 75.11 112.138 -172.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 72.93 146.54 0.12 Allowed Pre-proline 0 N--CA 1.464 0.271 0 CA-C-N 115.148 -0.933 . . . . 60.02 111.472 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.649 ' HA ' HG12 ' A' ' 96' ' ' ILE . 32.1 Cg_endo -64.02 -27.34 65.93 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.349 2.033 . . . . 74.34 111.307 177.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.402 ' HB2' ' O ' ' A' ' 51' ' ' PRO . 20.6 t90 171.93 -43.85 0.01 OUTLIER 'General case' 0 C--O 1.234 0.272 0 CA-C-N 114.727 -1.124 . . . . 74.15 108.113 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 13.8 p -176.32 150.08 0.89 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-N 114.79 -1.096 . . . . 72.24 109.311 175.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.62 -148.27 16.9 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 121.128 -0.558 . . . . 63.14 112.354 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.86 157.61 47.33 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.722 2.281 . . . . 62.11 112.44 -178.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 73.9 m -147.62 -39.19 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 70.01 110.706 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.2 ttm180 62.03 76.99 0.35 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.337 0.589 . . . . 75.25 110.227 -177.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.0 m -96.32 129.72 43.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.836 -0.62 . . . . 52.33 110.99 -176.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 54.9 tp -169.39 89.65 0.2 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.355 -0.384 . . . . 73.5 109.991 175.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 56.41 75.12 0.61 Allowed Pre-proline 0 N--CA 1.467 0.42 0 CA-C-N 115.771 -0.649 . . . . 73.14 111.733 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -73.0 -178.08 3.32 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.488 2.126 . . . . 71.23 111.396 173.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.556 ' HB3' HG12 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -49.9 -50.21 46.92 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 121.359 0.6 . . . . 74.1 110.966 -176.734 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.675 HD21 HG23 ' A' ' 99' ' ' ILE . 8.8 mp -60.36 -48.85 79.99 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.258 -0.883 . . . . 74.22 111.524 -174.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.609 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 40.2 mt-10 -67.92 -36.35 80.01 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.804 -0.443 . . . . 74.41 109.804 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -54.93 -51.13 67.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.797 -0.638 . . . . 71.31 110.23 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.472 HD12 HG22 ' A' ' 120' ' ' ILE . 22.9 mt -78.3 -34.79 48.58 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.517 -0.31 . . . . 73.24 111.802 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.487 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.37 -28.05 69.73 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 111.345 0.128 . . . . 61.5 111.345 -175.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.609 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 78.9 mt-30 -53.0 -32.4 46.36 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.284 0.564 . . . . 70.24 109.993 175.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -93.55 -59.08 2.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.562 -0.745 . . . . 65.55 110.427 175.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.572 ' O ' HG22 ' A' ' 74' ' ' VAL . 19.0 m-85 -87.55 17.78 4.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.32 -0.855 . . . . 75.23 113.134 -168.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.487 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 9.3 t -52.95 -36.08 59.57 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.147 0.43 . . . . 74.33 111.552 -176.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -70.8 -17.18 62.78 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.826 0.346 . . . . 53.34 111.493 -178.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -112.21 -10.57 13.84 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.269 -0.423 . . . . 72.31 110.6 -176.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.572 HG22 ' O ' ' A' ' 70' ' ' TYR . 32.6 m -131.08 151.07 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 O-C-N 122.174 -0.329 . . . . 73.54 110.872 -179.126 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.606 ' HE3' ' HA ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -134.1 127.04 31.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.912 -0.585 . . . . 63.31 109.484 177.662 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.443 ' HB ' HG12 ' A' ' 23' ' ' ILE . 51.6 mt -102.21 130.31 52.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 120.788 0.328 . . . . 74.42 110.232 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 74.7 m-85 -131.13 151.44 51.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 72.2 109.779 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.419 ' HE2' ' HB3' ' A' ' 47' ' ' ASP . 1.3 mptm? -126.28 173.07 9.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.751 0.31 . . . . 72.22 111.302 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 61.7 mt 71.81 93.86 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 114.992 -1.004 . . . . 72.5 109.824 -174.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -120.4 -68.64 0.89 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.218 -0.901 . . . . 55.21 109.747 -176.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.3 pt -146.69 128.18 6.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.501 -0.772 . . . . 61.14 109.985 -176.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -85.61 -73.05 0.46 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.939 0.399 . . . . 71.24 110.224 175.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -125.63 -25.85 3.63 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.177 -0.465 . . . . 64.43 111.28 177.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -89.7 95.4 10.24 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.908 -0.587 . . . . 73.35 110.31 -175.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.536 ' OE1' ' HB1' ' A' ' 88' ' ' ALA . 0.5 OUTLIER -145.01 138.77 26.99 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.953 0.723 . . . . 74.21 112.953 -177.584 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -90.92 -44.12 9.56 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.057 -0.72 . . . . 61.45 109.057 162.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.4 p -52.12 -54.85 12.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 114.576 -1.193 . . . . 75.03 113.185 -170.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.536 ' HB1' ' OE1' ' A' ' 85' ' ' GLN . . . -61.09 -49.68 76.34 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.714 0.293 . . . . 73.53 110.839 -174.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.3 m -65.03 -32.67 74.5 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.281 -0.418 . . . . 71.01 111.081 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -66.32 -40.05 89.67 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.978 0.418 . . . . 72.23 110.202 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -81.88 -17.07 48.55 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.187 -0.461 . . . . 74.44 110.321 175.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.47 23.26 60.87 Favored Glycine 0 CA--C 1.519 0.327 0 CA-C-N 115.986 -0.552 . . . . 71.21 112.821 177.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.1 t -61.03 133.56 26.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 120.59 0.233 . . . . 73.5 110.721 -178.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 29.2 t -137.37 11.98 3.01 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.194 -0.457 . . . . 73.31 110.72 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -134.49 140.18 46.01 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.355 -0.384 . . . . 73.13 110.49 -177.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.649 HG12 ' HA ' ' A' ' 51' ' ' PRO . 2.7 pp -112.63 155.05 44.47 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 116.102 -0.499 . . . . 72.43 111.156 -176.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.412 ' HB3' ' HA ' ' A' ' 49' ' ' TRP . 89.8 Cg_endo -79.04 165.31 81.81 Favored 'Cis proline' 0 C--N 1.354 0.848 0 C-N-CA 123.611 -1.412 . . . . 65.31 111.582 -3.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.525 ' HB ' ' CZ ' ' A' ' 48' ' ' PHE . 22.8 m -117.54 120.79 39.14 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.817 -0.438 . . . . 71.12 109.817 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.691 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 27.6 mt -126.24 112.54 30.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.715 -0.675 . . . . 75.35 109.734 -175.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.39 134.18 42.62 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.056 -0.35 . . . . 74.23 110.056 -176.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.756 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 61.8 mtp -101.82 117.54 35.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.448 . . . . 74.11 110.912 -175.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -115.39 156.49 25.46 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 120.972 0.415 . . . . 74.43 111.235 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.73 ' HB3' HD22 ' A' ' 108' ' ' LEU . 37.7 ttmt -169.55 122.38 0.74 Allowed 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.279 -0.873 . . . . 63.31 109.598 177.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 60.56 26.08 15.75 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.327 0.584 . . . . 65.24 111.099 174.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.8 -14.45 61.65 Favored Glycine 0 CA--C 1.52 0.368 0 CA-C-N 115.971 -0.559 . . . . 53.51 112.681 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -94.73 139.54 31.1 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 122.591 0.356 . . . . 51.24 110.071 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.53 ' H ' ' HD3' ' A' ' 107' ' ' LYS . 0.1 OUTLIER -93.93 130.41 40.03 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.002 -0.74 . . . . 60.31 109.002 173.069 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.73 HD22 ' HB3' ' A' ' 103' ' ' LYS . 2.1 mm? -94.42 -53.16 4.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.166 -0.47 . . . . 72.55 110.737 -174.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.756 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 49.6 m -151.25 171.94 16.63 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.551 -0.75 . . . . 74.54 110.345 -172.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -145.15 114.87 7.29 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.153 0.502 . . . . 75.32 110.685 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.691 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 51.5 t -80.15 107.42 12.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.623 -0.717 . . . . 64.25 109.98 178.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 60.5 mt -110.18 106.73 21.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.243 -0.435 . . . . 75.11 110.202 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 93.3 -134.55 12.19 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 116.109 -0.496 . . . . 74.41 112.051 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -137.81 76.53 1.58 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.149 0.499 . . . . 71.33 110.78 -177.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -114.03 97.48 6.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.912 -0.586 . . . . 74.42 110.336 177.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.584 HD11 HD11 ' A' ' 119' ' ' ILE . 7.9 tp -62.54 -39.86 86.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-O 121.089 0.471 . . . . 73.12 110.038 178.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.4 m -63.27 -39.71 95.34 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.571 -0.741 . . . . 71.15 110.554 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -64.49 -56.17 15.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.757 -0.656 . . . . 71.04 110.617 177.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.584 HD11 HD11 ' A' ' 116' ' ' ILE . 2.4 pp -62.68 -39.94 86.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.121 -0.491 . . . . 71.22 111.816 -171.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.472 HG22 HD12 ' A' ' 66' ' ' LEU . 2.8 pp -64.08 -31.82 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 120.314 -0.554 . . . . 75.31 110.078 178.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.427 ' N ' HD13 ' A' ' 120' ' ' ILE . 33.1 t -70.67 -51.8 25.35 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.717 -0.674 . . . . 62.24 110.797 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -77.53 -43.11 33.08 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.544 0.572 . . . . 74.32 112.544 -174.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.424 HD12 HD11 ' A' ' 66' ' ' LEU . 79.7 mt -60.72 -57.62 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 O-C-N 122.187 -0.321 . . . . 72.53 110.813 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -59.58 -20.16 53.86 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.379 -0.373 . . . . 72.01 111.293 -177.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -76.24 -33.63 59.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.993 0.425 . . . . 63.32 110.349 176.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -98.73 -0.34 42.97 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.222 -0.445 . . . . 73.11 112.087 -175.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.413 HG12 ' O ' ' A' ' 123' ' ' ILE . 37.2 pt -133.71 168.27 24.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.763 -0.458 . . . . 71.04 109.763 172.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.481 -0.771 . . . . 74.44 110.861 -174.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptt? . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 120.699 0.285 . . . . 64.12 110.564 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.51 54.78 1.82 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.147 0.425 . . . . 74.33 112.147 -174.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.407 ' CG ' ' O ' ' A' ' 3' ' ' HIS . 36.5 t-80 58.05 14.02 2.49 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.036 0.534 . . . . 73.01 112.291 173.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -88.04 134.16 33.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.998 0.428 . . . . 75.42 111.177 -177.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -85.68 116.83 24.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.773 -0.649 . . . . 74.22 109.408 173.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -69.96 93.42 0.78 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.015 0.436 . . . . 75.11 110.566 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 65.6 t60 -99.47 119.53 38.15 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.042 -0.526 . . . . 65.21 109.819 176.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -60.57 125.47 23.82 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.809 -0.441 . . . . 71.34 109.809 176.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.4 ptm -134.5 149.83 50.73 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.336 -0.393 . . . . 61.33 110.357 -175.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.06 -164.3 39.93 Favored Glycine 0 N--CA 1.451 -0.332 0 N-CA-C 111.701 -0.56 . . . . 54.42 111.701 177.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.5 m 65.32 8.38 4.9 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.449 0.642 . . . . 74.43 110.836 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 62.4 tp -79.78 118.43 21.56 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.086 -0.506 . . . . 75.13 109.683 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 66.69 22.72 10.35 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 123.547 0.529 . . . . 74.12 110.551 -178.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.67 83.08 1.15 Allowed 'General case' 0 C--O 1.232 0.148 0 N-CA-C 109.385 -0.598 . . . . 75.44 109.385 176.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -125.0 132.73 53.21 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.905 -0.776 . . . . 71.2 108.905 -177.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.2 m -72.1 82.98 0.98 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.048 0.451 . . . . 74.34 110.897 -177.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -81.78 82.85 7.33 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.32 0.581 . . . . 73.13 109.911 177.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 170.79 72.31 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.438 -0.801 . . . . 72.22 111.668 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -81.11 -176.02 2.94 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.983 2.455 . . . . 73.22 112.011 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.78 78.28 0.38 Allowed Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 111.645 -0.582 . . . . 71.45 111.645 177.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.575 ' HB2' HG12 ' A' ' 23' ' ' ILE . 20.6 p -92.16 -47.88 7.0 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.737 0.303 . . . . 64.02 110.969 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 21.8 mmt 57.67 43.35 22.39 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 121.234 0.54 . . . . 73.25 110.94 -178.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.575 HG12 ' HB2' ' A' ' 21' ' ' SER . 13.2 mm -89.08 86.98 2.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-N 115.233 -0.894 . . . . 74.4 108.597 172.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.534 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 9.6 tp10 -95.06 134.87 37.28 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.376 -0.374 . . . . 71.41 110.726 -176.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.93 132.14 43.78 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.753 -0.462 . . . . 65.14 109.753 177.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.484 HD13 ' HA ' ' A' ' 31' ' ' PHE . 34.4 pt -123.97 175.14 6.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.417 -0.356 . . . . 73.54 111.383 -172.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.44 170.87 33.01 Favored Glycine 0 C--N 1.331 0.265 0 CA-C-N 115.802 -0.635 . . . . 13.31 112.998 -177.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -67.5 -42.37 82.97 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.058 0.543 . . . . 75.21 111.286 -177.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 24.7 t -76.44 -47.32 23.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 64.12 111.188 -174.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -73.47 -9.43 58.68 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.543 -0.299 . . . . 71.55 111.401 -179.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.59 ' HE1' HG13 ' A' ' 46' ' ' VAL . 50.8 t80 -44.21 -71.09 0.08 Allowed 'General case' 0 CA--C 1.529 0.163 0 O-C-N 123.451 0.47 . . . . 65.21 111.136 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -65.69 -32.87 74.67 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.04 -0.356 . . . . 71.43 110.04 -178.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.499 ' O ' ' HB3' ' A' ' 37' ' ' SER . 7.1 t30 -52.35 -41.02 62.68 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.232 -0.894 . . . . 73.12 111.16 -177.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 38' ' ' CYS . 13.1 ptmt -108.83 -15.89 14.29 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.227 -0.442 . . . . 53.44 111.905 -176.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.6 t -88.52 -60.99 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 111.867 0.321 . . . . 63.51 111.867 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.9 p -81.88 -28.85 32.73 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.814 0.34 . . . . 74.43 111.093 -172.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.499 ' HB3' ' O ' ' A' ' 33' ' ' ASN . 46.5 t -91.16 12.29 20.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.959 -0.564 . . . . 73.22 110.191 177.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 34' ' ' LYS . 51.2 t -67.48 95.65 0.47 Allowed 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 120.96 0.409 . . . . 62.14 111.157 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -89.71 14.41 11.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.33 0.586 . . . . 70.23 109.811 174.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -74.74 -6.02 46.55 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.858 -0.61 . . . . 63.24 110.392 -179.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.431 ' HA ' ' HB2' ' A' ' 104' ' ' ASN . 2.1 t-20 62.82 4.96 1.6 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.989 0.737 . . . . 71.21 112.989 174.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.652 HG22 ' HE2' ' A' ' 75' ' ' LYS . 13.2 tt -90.12 159.13 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.983 -0.377 . . . . 74.52 109.983 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.437 HD11 ' HB3' ' A' ' 101' ' ' MET . 64.7 tp -85.41 107.71 17.52 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.264 0.554 . . . . 74.32 109.94 178.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.482 HD12 ' HG ' ' A' ' 38' ' ' CYS . 65.6 mt -92.97 132.06 38.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.37 -0.832 . . . . 75.35 110.309 177.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.634 HD13 HD12 ' A' ' 63' ' ' LEU . 40.3 mt -111.04 101.84 10.35 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.267 -0.642 . . . . 72.54 109.267 177.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.59 HG13 ' HE1' ' A' ' 31' ' ' PHE . 61.3 t -91.5 116.3 32.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.564 -0.532 . . . . 71.44 109.564 178.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.494 ' HB2' ' CD1' ' A' ' 49' ' ' TRP . 2.0 p30 -97.1 148.34 23.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.199 0.523 . . . . 64.5 111.351 -173.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -126.24 65.26 1.23 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.323 -0.853 . . . . 73.03 109.803 175.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.494 ' CD1' ' HB2' ' A' ' 47' ' ' ASP . 64.3 p-90 -144.32 130.39 19.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.465 -0.789 . . . . 75.11 109.276 173.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -147.67 92.5 4.74 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.009 0.433 . . . . 60.02 111.277 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.407 ' HD3' ' HE3' ' A' ' 49' ' ' TRP . 1.9 Cg_endo -81.89 76.82 4.11 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.624 2.216 . . . . 74.34 109.786 171.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 7.4 m-90 -51.23 -47.33 62.39 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.814 -0.63 . . . . 74.15 110.171 -177.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 80.4 m -96.02 84.77 3.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.826 -0.625 . . . . 72.24 109.346 173.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -122.42 -168.74 13.29 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.949 -0.569 . . . . 63.14 112.606 -175.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -84.26 12.76 2.93 Favored 'Trans proline' 0 CA--C 1.533 0.442 0 C-N-CA 122.992 2.461 . . . . 62.11 112.76 -177.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 56.7 m 59.37 16.26 4.97 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.061 0.458 . . . . 70.01 111.287 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 20.4 tpp180 -103.81 148.15 26.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.976 -0.556 . . . . 75.25 110.542 -176.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.8 p -64.25 101.71 0.45 Allowed 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.735 -0.839 . . . . 52.33 108.735 170.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 55.1 tp -52.56 -33.55 46.26 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.147 -0.478 . . . . 73.5 111.187 -174.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 56.18 65.32 4.31 Favored Pre-proline 0 C--O 1.236 0.343 0 CA-C-N 115.861 -0.609 . . . . 73.14 110.634 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.18 178.11 6.41 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.087 1.858 . . . . 71.23 111.25 174.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.412 ' CD ' ' H ' ' A' ' 62' ' ' GLN . 11.7 mp0 -55.09 -48.29 73.76 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-O 121.871 0.843 . . . . 74.1 110.366 -178.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.634 HD12 HD13 ' A' ' 45' ' ' LEU . 2.9 mm? -61.39 -47.97 83.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.449 -1.251 . . . . 74.22 110.449 -174.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.54 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 45.9 tt0 -63.69 -44.05 94.86 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.235 -0.439 . . . . 74.41 109.941 178.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.642 ' HA ' ' HE3' ' A' ' 65' ' ' LYS . 0.1 OUTLIER -50.89 -51.66 49.6 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.602 -0.726 . . . . 71.31 111.033 -179.874 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.601 HD11 HG22 ' A' ' 120' ' ' ILE . 32.9 mt -71.99 -35.29 69.44 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.646 -0.422 . . . . 73.24 110.851 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.41 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -57.27 -40.06 76.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.026 -0.534 . . . . 61.5 111.227 -178.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.54 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 86.9 mt-30 -50.2 -33.4 19.19 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.983 0.42 . . . . 70.24 110.85 -177.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -94.09 -56.47 2.84 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.75 -0.659 . . . . 65.55 111.067 178.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.465 ' O ' HG23 ' A' ' 74' ' ' VAL . 17.3 m-85 -88.79 20.33 3.56 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.684 -0.689 . . . . 75.23 112.671 -170.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.41 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 13.8 t -53.35 -30.47 39.6 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.11 0.481 . . . . 74.33 112.28 -176.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -70.21 -16.78 63.11 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.381 -0.372 . . . . 53.34 111.324 -177.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -118.6 -6.5 10.67 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.489 -0.323 . . . . 72.31 110.458 -178.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 70' ' ' TYR . 30.1 m -137.1 135.39 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 121.143 0.497 . . . . 73.54 110.879 178.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.652 ' HE2' HG22 ' A' ' 42' ' ' ILE . 64.8 mttm -112.46 158.57 19.71 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.972 -0.751 . . . . 63.31 108.972 174.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.501 HG13 ' HB2' ' A' ' 45' ' ' LEU . 3.7 mp -125.56 139.4 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 C-N-CA 120.333 -0.547 . . . . 74.42 110.117 171.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.534 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 12.4 m-85 -125.04 129.1 49.6 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.9 -0.591 . . . . 72.2 110.094 177.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.45 ' HD3' ' N ' ' A' ' 79' ' ' ILE . 5.7 tmtm? -111.77 124.33 52.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.194 -0.912 . . . . 72.22 109.201 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.68 ' H ' HD13 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -113.46 151.02 15.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.775 -0.454 . . . . 72.5 109.775 176.032 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -102.12 178.47 4.59 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.502 -0.555 . . . . 55.21 109.502 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.414 ' O ' HG21 ' A' ' 81' ' ' ILE . 27.1 mt 66.13 39.26 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 122.479 1.133 . . . . 61.14 109.067 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.529 ' HA ' ' HG2' ' A' ' 85' ' ' GLN . 5.7 mt-10 -71.22 0.06 8.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.529 -1.214 . . . . 71.24 111.205 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -74.17 -25.14 59.55 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.944 -0.571 . . . . 64.43 109.787 177.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -112.47 25.93 11.03 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.263 -0.88 . . . . 73.35 111.226 -171.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.529 ' HG2' ' HA ' ' A' ' 82' ' ' GLU . 80.8 mm-40 -96.91 104.39 16.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.995 0.426 . . . . 74.21 110.317 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -84.08 -8.05 59.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.808 -0.633 . . . . 61.45 110.251 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.1 t -49.76 -35.12 9.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.545 -0.752 . . . . 75.03 110.926 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.91 -56.02 25.68 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.924 -0.58 . . . . 73.53 110.367 177.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.0 m -64.22 -35.04 79.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.269 -0.423 . . . . 71.01 110.454 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -57.65 -38.6 75.35 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.766 -0.652 . . . . 72.23 110.389 178.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -88.76 -17.2 30.35 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.502 -0.317 . . . . 74.44 111.501 176.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.55 25.25 39.69 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 121.018 -0.61 . . . . 71.21 112.223 -177.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 70.7 t -64.26 127.19 24.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.724 0.297 . . . . 73.5 110.296 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.5 p -91.3 -17.0 26.63 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.393 0.516 . . . . 73.31 112.393 -174.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -157.89 146.86 19.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.83 0.348 . . . . 73.13 111.572 -176.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.56 ' HB ' ' HA ' ' A' ' 97' ' ' PRO . 2.7 pp -98.71 162.04 23.03 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 115.923 -0.58 . . . . 72.43 110.036 176.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.56 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 98.5 Cg_endo -80.95 174.25 47.74 Favored 'Cis proline' 0 C--N 1.355 0.87 0 C-N-CA 124.133 -1.195 . . . . 65.31 112.83 2.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.541 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 27.8 m -145.68 134.18 22.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.951 -0.568 . . . . 71.12 110.042 179.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.593 HG23 ' HG ' ' A' ' 63' ' ' LEU . 3.5 mp -116.44 125.2 73.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 N-CA-C 109.71 -0.478 . . . . 75.35 109.71 178.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.7 mp -91.49 134.18 34.86 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.815 0.34 . . . . 74.23 110.738 -178.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.531 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 72.2 mtp -108.98 114.38 28.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.926 -0.579 . . . . 74.11 110.231 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -118.91 148.36 43.01 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.179 0.3 . . . . 74.43 110.271 178.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.6 ' HB3' HD22 ' A' ' 108' ' ' LEU . 62.4 tttm -152.56 115.22 4.54 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.025 -0.731 . . . . 63.31 109.025 176.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.431 ' HB2' ' HA ' ' A' ' 41' ' ' ASN . 5.8 t30 58.52 30.28 19.54 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.362 0.601 . . . . 65.24 110.279 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.18 -9.08 78.55 Favored Glycine 0 CA--C 1.521 0.434 0 CA-C-N 115.696 -0.684 . . . . 53.51 113.355 177.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -95.2 131.17 41.54 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 117.053 0.426 . . . . 51.24 111.031 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.722 ' HZ1' ' HB2' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -80.39 116.87 20.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 60.31 110.043 174.77 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.6 HD22 ' HB3' ' A' ' 103' ' ' LYS . 3.1 mm? -82.06 -52.57 6.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.442 -0.344 . . . . 72.55 110.317 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.531 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 74.6 m -159.35 171.82 19.09 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.81 -0.632 . . . . 74.54 110.759 -176.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 8.4 pm0 -133.35 119.12 19.3 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.428 -0.805 . . . . 75.32 109.346 172.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.541 ' O ' ' HA ' ' A' ' 98' ' ' THR . 61.3 t -79.99 110.33 15.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 64.25 110.048 -178.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 59.0 mt -107.98 118.54 55.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 110.036 -0.357 . . . . 75.11 110.036 -177.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.36 -115.36 4.21 Favored Glycine 0 N--CA 1.453 -0.206 0 N-CA-C 111.682 -0.567 . . . . 74.41 111.682 -178.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.55 89.19 1.02 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.89 0.345 . . . . 71.33 111.017 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.452 ' O ' HG23 ' A' ' 119' ' ' ILE . 12.5 m-20 -118.99 88.76 2.99 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.41 -0.359 . . . . 74.42 110.448 178.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.497 HD11 HD11 ' A' ' 119' ' ' ILE . 8.2 tp -62.73 -44.89 99.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 120.814 0.34 . . . . 73.12 110.902 -178.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.2 m -68.55 -27.06 65.75 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.34 -0.391 . . . . 71.15 111.336 -176.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.439 ' HZ2' ' CD ' ' A' ' 122' ' ' GLU . 0.8 OUTLIER -79.32 -45.27 19.98 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 120.839 0.352 . . . . 71.04 110.076 178.822 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.508 ' HA ' ' HG2' ' A' ' 122' ' ' GLU . 2.4 pp -68.43 -37.37 77.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.384 -0.371 . . . . 71.22 111.601 -176.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.601 HG22 HD11 ' A' ' 66' ' ' LEU . 2.7 pp -63.66 -31.79 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 121.3 0.571 . . . . 75.31 109.681 176.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.8 t -70.47 -47.89 58.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.446 -0.797 . . . . 62.24 110.568 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.508 ' HG2' ' HA ' ' A' ' 119' ' ' ILE . 21.1 pt-20 -76.96 -44.75 30.14 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.235 0.457 . . . . 74.32 112.235 -176.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.549 HD12 HD13 ' A' ' 66' ' ' LEU . 67.2 mt -61.43 -57.23 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 O-C-N 122.185 -0.322 . . . . 72.53 110.992 -178.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -60.59 -20.37 60.36 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.068 0.461 . . . . 72.01 111.227 -176.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -77.66 -34.49 53.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.753 -0.658 . . . . 63.32 110.576 176.123 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -83.27 -39.38 20.93 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.077 -0.51 . . . . 73.11 111.012 -177.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.431 HG12 ' O ' ' A' ' 123' ' ' ILE . 47.2 pt -91.78 168.15 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.283 -0.417 . . . . 71.04 110.2 178.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 6.4 p30 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.499 -0.762 . . . . 74.44 110.716 -172.651 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.492 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.2 pmm? . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 120.514 0.197 . . . . 64.12 111.111 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.94 102.62 2.03 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.952 0.406 . . . . 74.33 111.209 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.6 m170 -89.19 8.17 31.58 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.08 -0.509 . . . . 73.01 111.113 177.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 66.4 t60 -64.03 106.93 1.13 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.686 -0.487 . . . . 75.42 109.686 174.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 62.7 m80 -66.25 120.72 13.76 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.107 -0.497 . . . . 74.22 110.356 -175.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 21.4 p-80 -81.67 60.88 4.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.567 0.698 . . . . 75.11 110.381 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 38.9 t60 -65.26 121.82 15.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.267 -0.879 . . . . 65.21 110.73 -178.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -164.36 147.04 9.0 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.081 -0.508 . . . . 71.34 110.625 179.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -156.47 150.33 24.94 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.886 -0.597 . . . . 61.33 109.762 177.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.88 103.93 0.56 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.047 -0.597 . . . . 54.42 112.038 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.2 m -97.94 124.52 42.43 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.144 -0.317 . . . . 74.43 110.144 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.52 ' O ' HD11 ' A' ' 12' ' ' LEU . 4.1 pp -81.16 137.74 35.9 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.127 0.489 . . . . 75.13 110.715 178.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.78 23.15 10.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.802 -0.635 . . . . 74.12 109.955 179.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.37 146.14 7.46 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.649 -0.705 . . . . 75.44 110.765 177.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -95.62 97.12 9.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.456 0.646 . . . . 71.2 111.16 -175.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.1 t -123.5 -160.85 0.93 Allowed 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.804 -0.813 . . . . 74.34 108.804 175.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.549 ' HG3' ' H ' ' A' ' 18' ' ' GLY . 6.2 tp-100 -164.99 179.01 6.68 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 109.976 -0.379 . . . . 73.13 109.976 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.549 ' H ' ' HG3' ' A' ' 17' ' ' GLN . . . -123.45 77.65 0.36 Allowed Glycine 0 C--N 1.33 0.247 0 N-CA-C 111.464 -0.654 . . . . 72.22 111.464 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -79.41 -2.05 11.98 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.232 2.622 . . . . 73.22 111.682 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.73 -83.94 1.69 Allowed Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 110.631 -0.988 . . . . 71.45 110.631 174.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.3 m -77.23 150.57 35.38 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.437 -0.579 . . . . 64.02 109.437 171.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 16.0 tpt -67.85 77.52 0.21 Allowed 'General case' 0 C--O 1.238 0.487 0 CA-C-O 120.994 0.426 . . . . 73.25 110.508 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.5 HD13 ' HB ' ' A' ' 76' ' ' ILE . 16.9 mm -117.17 124.8 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 115.726 -0.67 . . . . 74.4 110.427 -177.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 45.6 tt0 -131.97 140.93 49.13 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.693 0.282 . . . . 71.41 110.316 173.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -95.8 126.85 41.35 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.786 -0.45 . . . . 65.14 109.786 176.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.487 HD12 ' HA ' ' A' ' 31' ' ' PHE . 44.5 pt -129.26 165.3 29.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-O 121.075 0.464 . . . . 73.54 111.525 -174.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.5 164.07 18.91 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.52 -0.764 . . . . 13.31 111.575 176.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -63.58 -29.88 71.07 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.575 0.226 . . . . 75.21 110.704 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.9 t -62.06 -22.33 65.67 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.17 -0.468 . . . . 64.12 111.627 -178.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -121.29 -3.23 9.48 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.788 -0.187 . . . . 71.55 110.836 -178.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.487 ' HA ' HD12 ' A' ' 26' ' ' ILE . 90.6 t80 -51.29 -70.96 0.07 Allowed 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.232 -0.44 . . . . 65.21 110.363 -177.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -62.71 -34.35 76.99 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.431 -0.581 . . . . 71.43 109.431 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.464 ' O ' ' HB3' ' A' ' 37' ' ' SER . 6.6 t30 -52.18 -39.71 60.48 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.116 -0.947 . . . . 73.12 111.477 -176.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.485 ' HD3' HG23 ' A' ' 26' ' ' ILE . 14.1 ptmt -110.23 -18.04 13.39 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 111.793 0.294 . . . . 53.44 111.793 -177.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 72.2 t -87.58 -54.4 8.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 111.661 0.245 . . . . 63.51 111.661 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 72.0 p -77.47 -27.33 52.0 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.302 0.572 . . . . 74.43 110.0 -176.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.464 ' HB3' ' O ' ' A' ' 33' ' ' ASN . 34.3 t -89.71 12.59 16.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.249 -0.887 . . . . 73.22 110.828 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.421 ' HB2' HD12 ' A' ' 44' ' ' ILE . 43.9 t -46.02 99.58 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.949 0.404 . . . . 62.14 111.672 -178.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -95.4 9.05 41.37 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.804 -0.635 . . . . 70.23 110.296 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -86.28 -15.39 40.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.011 -0.54 . . . . 63.24 110.774 -178.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.4 m120 62.99 16.54 9.35 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.482 0.658 . . . . 71.21 109.673 -171.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 21.7 mt -96.66 141.4 15.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 115.147 -0.933 . . . . 74.52 110.46 -177.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.609 HD23 ' HE2' ' A' ' 101' ' ' MET . 62.7 tp -71.56 103.92 3.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.85 -0.614 . . . . 74.32 110.087 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.421 HD12 ' HB2' ' A' ' 38' ' ' CYS . 44.3 mt -84.7 116.59 28.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.928 -0.578 . . . . 75.35 110.695 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.787 HD12 HD12 ' A' ' 63' ' ' LEU . 44.9 mt -100.63 109.98 22.08 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.475 -0.784 . . . . 72.54 109.217 179.112 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.3 m -100.97 115.02 41.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-O 120.866 0.365 . . . . 71.44 110.309 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.5 121.03 32.83 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.786 -0.643 . . . . 64.5 111.049 -175.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -101.0 96.44 7.25 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 109.593 -0.521 . . . . 73.03 109.593 175.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.5 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 56.3 t-105 -170.22 140.58 1.93 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.636 -0.711 . . . . 75.11 110.112 -178.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.92 103.09 2.47 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 110.152 -0.314 . . . . 60.02 110.152 175.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' A' ' 49' ' ' TRP . 86.4 Cg_endo -82.18 60.93 7.6 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.692 2.261 . . . . 74.34 112.946 -173.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -69.09 86.63 0.38 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.189 0.519 . . . . 74.15 110.467 176.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 53.4 t -147.1 -45.59 0.18 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.544 -0.753 . . . . 72.24 109.795 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 141.26 -127.14 3.27 Favored Glycine 0 C--N 1.331 0.304 0 N-CA-C 111.317 -0.713 . . . . 63.14 111.317 178.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.29 -159.77 0.1 Allowed 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 122.795 2.33 . . . . 62.11 111.625 176.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 49.5 t -66.99 79.85 0.12 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.055 0.455 . . . . 70.01 110.423 178.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 43.8 mtt180 -135.25 105.22 6.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.625 -0.716 . . . . 75.25 109.603 178.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 34.2 p -126.05 174.23 8.6 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.162 -0.472 . . . . 52.33 110.711 -179.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 76.4 mt -103.81 31.1 4.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.913 -0.585 . . . . 73.5 110.102 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.861 ' HB3' ' HE2' ' A' ' 65' ' ' LYS . 23.2 mm-40 63.12 75.61 0.4 Allowed Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 115.538 -0.756 . . . . 73.14 110.703 -177.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -80.63 162.11 21.76 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.5 2.133 . . . . 71.23 111.59 178.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.653 ' HB3' HG12 ' A' ' 119' ' ' ILE . 8.2 mp0 -52.47 -48.34 65.96 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 121.551 0.691 . . . . 74.1 110.986 -176.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.787 HD12 HD12 ' A' ' 45' ' ' LEU . 3.0 mm? -57.89 -48.07 80.93 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.655 -1.157 . . . . 74.22 110.35 -173.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.543 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 41.2 mt-10 -71.73 -34.94 69.98 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.432 -0.349 . . . . 74.41 110.9 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.861 ' HE2' ' HB3' ' A' ' 60' ' ' GLU . 49.6 mmtt -52.85 -52.96 55.26 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.768 0.318 . . . . 71.31 110.52 177.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.577 HD12 HD12 ' A' ' 123' ' ' ILE . 25.5 mt -76.51 -30.22 57.12 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.532 -0.467 . . . . 73.24 111.091 178.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.472 ' HB3' ' HA ' ' A' ' 64' ' ' GLU . . . -59.58 -37.68 79.16 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.743 -0.208 . . . . 61.5 111.412 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.543 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 79.2 mt-30 -54.09 -35.46 62.13 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.989 0.423 . . . . 70.24 110.982 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 66.8 mm-40 -93.86 -53.09 4.14 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.99 -0.55 . . . . 65.55 111.262 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.472 ' O ' HG21 ' A' ' 74' ' ' VAL . 14.3 m-85 -92.74 22.58 4.67 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.815 -0.63 . . . . 75.23 112.047 -171.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.441 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 9.5 t -52.91 -31.52 40.38 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.722 0.296 . . . . 74.33 111.775 -177.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -70.6 -16.47 62.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.991 0.425 . . . . 53.34 111.155 -177.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -123.43 0.79 8.92 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.164 -0.471 . . . . 72.31 110.761 -175.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.472 HG21 ' O ' ' A' ' 70' ' ' TYR . 29.1 m -131.29 147.55 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 120.939 0.4 . . . . 73.54 110.469 177.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -141.86 116.73 9.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.964 -0.562 . . . . 63.31 109.723 -178.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.5 ' HB ' HD13 ' A' ' 23' ' ' ILE . 3.0 mp -99.05 143.44 13.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 120.633 0.254 . . . . 74.42 110.811 -173.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.446 ' OH ' ' HE2' ' A' ' 34' ' ' LYS . 21.0 m-85 -130.75 130.05 43.27 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.988 0.423 . . . . 72.2 111.655 -179.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -96.21 115.17 27.01 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.69 -0.856 . . . . 72.22 108.69 170.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.698 HG12 ' H ' ' A' ' 81' ' ' ILE . 12.1 tt -101.53 160.98 3.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.864 -0.421 . . . . 72.5 109.864 178.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -85.54 -20.97 28.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.825 0.345 . . . . 55.21 110.74 178.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.698 ' H ' HG12 ' A' ' 79' ' ' ILE . 43.4 mm -89.25 97.91 7.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.796 -0.446 . . . . 61.14 109.796 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -85.33 -71.06 0.55 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.846 -0.615 . . . . 71.24 111.832 -174.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -124.27 -25.0 4.19 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.715 -0.675 . . . . 64.43 111.703 -169.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -78.11 60.72 2.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.188 0.518 . . . . 73.35 109.984 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -145.04 159.43 42.96 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.137 -0.483 . . . . 74.21 111.042 -176.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -66.23 -40.81 90.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.547 -0.751 . . . . 61.45 110.958 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 51.6 t -51.97 -49.49 37.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 116.08 -0.509 . . . . 75.03 111.354 -176.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -57.63 -50.54 72.81 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.787 -0.642 . . . . 73.53 110.283 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.3 m -60.06 -37.07 78.77 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.786 -0.643 . . . . 71.01 110.89 178.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -62.44 -47.0 85.99 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.566 -0.743 . . . . 72.23 110.683 -177.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -87.77 6.58 34.48 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.177 -0.465 . . . . 74.44 111.523 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.01 27.65 73.52 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 116.106 -0.497 . . . . 71.21 112.965 175.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 77.7 t -69.27 98.35 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.247 0.546 . . . . 73.5 110.732 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.2 m -101.98 -14.3 17.23 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.059 -0.519 . . . . 73.31 110.51 176.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -123.1 115.85 22.49 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.778 -0.647 . . . . 73.13 110.494 -177.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.585 ' HB ' ' HA ' ' A' ' 97' ' ' PRO . 30.3 pt -96.26 162.2 24.47 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 115.936 -0.574 . . . . 72.43 110.153 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.585 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 83.7 Cg_endo -81.71 171.91 54.9 Favored 'Cis proline' 0 C--N 1.353 0.794 0 C-N-CA 124.136 -1.193 . . . . 65.31 112.986 0.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 97.9 m -147.34 129.25 15.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.913 -0.585 . . . . 71.12 110.474 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.528 HD11 ' N ' ' A' ' 99' ' ' ILE . 3.6 mp -110.46 145.83 16.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.88 -0.785 . . . . 75.35 108.88 177.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.472 HD21 ' H ' ' A' ' 101' ' ' MET . 0.8 OUTLIER -121.56 137.81 54.57 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.755 -0.461 . . . . 74.23 109.755 178.825 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.695 ' SD ' ' HB3' ' A' ' 109' ' ' SER . 64.0 mtp -103.14 111.68 24.17 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.892 -0.594 . . . . 74.11 111.039 -174.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -115.46 153.72 30.59 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.736 0.303 . . . . 74.43 110.655 177.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.475 ' HB3' HD21 ' A' ' 108' ' ' LEU . 39.3 ttpt -166.77 116.92 0.91 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.314 -0.403 . . . . 63.31 110.051 175.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 8.1 t30 50.92 52.14 15.58 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.622 0.725 . . . . 65.24 110.957 178.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 76.46 -14.95 6.18 Favored Glycine 0 CA--C 1.521 0.43 0 CA-C-N 115.436 -0.802 . . . . 53.51 113.666 176.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -100.29 123.47 44.55 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 117.08 0.44 . . . . 51.24 110.398 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 30.6 pttt -89.24 122.61 32.68 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.517 -0.549 . . . . 60.31 109.517 174.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.48 HD23 ' N ' ' A' ' 108' ' ' LEU . 2.5 mm? -82.63 -52.62 6.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.612 -0.722 . . . . 72.55 111.281 -172.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.695 ' HB3' ' SD ' ' A' ' 101' ' ' MET . 22.0 t -162.42 172.01 16.24 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.995 -0.548 . . . . 74.54 110.845 -171.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -133.41 129.26 37.1 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.199 -0.455 . . . . 75.32 110.369 178.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.687 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 83.7 t -92.64 107.11 18.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.994 -0.548 . . . . 64.25 110.28 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 59.9 mt -110.32 119.19 58.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.722 -0.473 . . . . 75.11 109.722 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 95.74 -126.9 8.95 Favored Glycine 0 CA--C 1.519 0.322 0 N-CA-C 111.922 -0.471 . . . . 74.41 111.922 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.47 83.73 0.91 Allowed 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.895 0.379 . . . . 71.33 110.305 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.403 ' O ' HG22 ' A' ' 119' ' ' ILE . 4.9 m-20 -125.7 97.42 5.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.06 -0.518 . . . . 74.42 110.407 -178.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.509 ' O ' HG13 ' A' ' 119' ' ' ILE . 7.7 tp -60.64 -41.67 88.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-N 116.511 -0.313 . . . . 73.12 111.158 -177.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 30.4 t -62.74 -33.04 74.32 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.302 0.572 . . . . 71.15 110.853 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.687 ' HE3' ' HA ' ' A' ' 111' ' ' VAL . 0.9 OUTLIER -75.94 -47.67 24.25 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.648 -0.706 . . . . 71.04 110.656 -179.188 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.653 HG12 ' HB3' ' A' ' 62' ' ' GLN . 2.1 pp -64.97 -40.82 90.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.227 -0.442 . . . . 71.22 111.066 -177.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.455 HG22 HD13 ' A' ' 66' ' ' LEU . 2.8 pp -65.73 -31.71 54.94 Favored 'Isoleucine or valine' 0 C--N 1.34 0.169 0 N-CA-C 109.65 -0.5 . . . . 75.31 109.65 178.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 43.2 t -65.15 -51.62 60.05 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.632 -0.713 . . . . 62.24 110.482 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.439 ' CD ' ' HZ3' ' A' ' 118' ' ' LYS . 5.1 pt-20 -77.15 -38.73 51.24 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.635 0.605 . . . . 74.32 112.635 -176.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.577 HD12 HD12 ' A' ' 66' ' ' LEU . 56.8 mt -66.02 -53.2 40.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 O-C-N 122.167 -0.333 . . . . 72.53 111.011 -178.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -61.85 -20.34 63.59 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.14 0.495 . . . . 72.01 110.499 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -70.73 -32.58 69.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.981 -0.554 . . . . 63.32 111.436 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.533 ' OD1' HD22 ' A' ' 43' ' ' LEU . 9.3 p30 -106.39 -17.97 14.12 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.083 0.401 . . . . 73.11 112.083 -174.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.526 HG21 ' OD1' ' A' ' 126' ' ' ASN . 42.2 pt -125.39 167.69 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 120.846 0.355 . . . . 71.04 111.135 177.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.406 ' N ' HD21 ' A' ' 128' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.353 -0.832 . . . . 74.44 110.781 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 N--CA 1.483 1.186 0 CA-C-O 120.678 0.275 . . . . 64.12 110.648 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -165.88 149.39 7.77 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.033 -0.53 . . . . 74.33 109.964 178.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -97.56 62.5 1.69 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.537 0.684 . . . . 73.01 110.378 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -86.29 111.13 20.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.233 -0.894 . . . . 75.42 109.964 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -93.32 160.65 14.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.089 0.471 . . . . 74.22 111.268 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -78.81 107.84 11.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.463 -0.79 . . . . 75.11 109.773 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 40.3 t60 -71.2 -51.83 22.52 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.938 0.399 . . . . 65.21 111.219 -175.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 58.6 t60 -73.86 121.22 20.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.105 -0.498 . . . . 71.34 110.147 -178.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -100.76 -171.04 1.94 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.52 -0.309 . . . . 61.33 110.203 -178.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -150.93 138.74 6.79 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 121.198 -0.525 . . . . 54.42 112.34 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.7 p -95.72 132.89 40.45 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 122.404 0.281 . . . . 74.43 110.815 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.8 pp -87.29 175.67 7.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.771 0.32 . . . . 75.13 110.505 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -124.03 159.0 30.83 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.673 -0.492 . . . . 74.12 109.673 -177.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -147.34 101.47 3.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.685 0.278 . . . . 75.44 111.035 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -91.09 171.39 9.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.308 -0.405 . . . . 71.2 110.053 176.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 87.2 m -147.13 92.56 2.13 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.866 -0.42 . . . . 74.34 109.866 177.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -82.36 172.59 12.9 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.882 -0.599 . . . . 73.13 110.359 -178.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -145.32 70.27 0.38 Allowed Glycine 0 N--CA 1.453 -0.217 0 N-CA-C 111.876 -0.49 . . . . 72.22 111.876 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -72.79 175.78 9.85 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 122.56 2.174 . . . . 73.22 112.045 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 167.85 -166.56 39.48 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 116.21 -0.45 . . . . 71.45 112.025 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 40.1 m -150.66 170.05 20.12 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.968 -0.382 . . . . 64.02 109.968 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.475 ' N ' ' SD ' ' A' ' 22' ' ' MET . 3.7 mpp? -92.24 -43.88 9.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.454 -0.339 . . . . 73.25 111.57 -174.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.1 mt -108.44 123.59 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 121.018 0.437 . . . . 74.4 111.626 -174.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.633 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 8.7 tp10 -131.97 155.22 48.35 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.834 -0.802 . . . . 71.41 108.834 174.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -100.59 147.83 25.5 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.71 0.29 . . . . 65.14 110.263 174.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.504 HD12 ' HA ' ' A' ' 31' ' ' PHE . 34.9 pt -131.07 -176.95 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.464 -0.334 . . . . 73.54 110.691 -176.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -141.03 -173.83 13.77 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.403 -0.427 . . . . 13.31 112.902 -177.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -55.03 -50.73 68.34 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.92 0.888 . . . . 75.21 112.605 -175.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 24.9 t -73.4 -19.09 61.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.102 -0.499 . . . . 64.12 111.807 -169.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.502 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 1.7 pm0 -111.74 -15.24 13.46 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 111.874 0.324 . . . . 71.55 111.874 -177.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.504 ' HA ' HD12 ' A' ' 26' ' ' ILE . 61.6 t80 -48.2 -71.01 0.08 Allowed 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.41 0.444 . . . . 65.21 111.239 -176.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -63.44 -40.09 96.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.358 0.599 . . . . 71.43 109.636 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.514 ' O ' ' HB3' ' A' ' 37' ' ' SER . 1.8 m-80 -53.13 -34.08 55.18 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.445 -1.252 . . . . 73.12 112.58 -172.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.545 ' HZ3' ' HB2' ' A' ' 34' ' ' LYS . 0.0 OUTLIER -114.84 -25.02 8.39 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.577 -0.449 . . . . 53.44 112.16 179.754 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.4 t -82.74 -51.62 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 N-CA-C 111.51 0.189 . . . . 63.51 111.51 -178.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 44.3 p -85.86 -23.03 27.27 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.025 0.44 . . . . 74.43 110.265 -176.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.514 ' HB3' ' O ' ' A' ' 33' ' ' ASN . 28.5 t -92.76 12.05 24.82 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.679 -0.691 . . . . 73.22 110.384 177.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 41.3 t -60.19 90.73 0.02 OUTLIER 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.128 0.489 . . . . 62.14 110.961 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -90.27 -4.0 57.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.872 -0.604 . . . . 70.23 110.543 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -71.02 -8.2 51.71 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.075 -0.511 . . . . 63.24 110.875 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 57.15 22.68 7.76 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.961 -0.563 . . . . 71.21 111.246 -176.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.9 tt -94.16 148.68 4.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.951 -0.759 . . . . 74.52 108.951 177.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.535 HD11 ' HB3' ' A' ' 101' ' ' MET . 63.7 tp -82.46 113.25 20.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.04 0.448 . . . . 74.32 110.634 -175.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.41 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 58.2 mt -98.34 123.97 51.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.522 -0.763 . . . . 75.35 110.58 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.429 HD11 ' N ' ' A' ' 45' ' ' LEU . 5.1 mp -106.71 112.11 24.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.221 -0.445 . . . . 72.54 109.867 177.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.582 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 27.5 m -98.04 121.87 49.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-O 121.031 0.444 . . . . 71.44 110.957 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.433 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 2.3 t70 -96.87 128.05 43.44 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.684 -0.689 . . . . 64.5 110.819 -179.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.434 ' CE1' HD13 ' A' ' 100' ' ' LEU . 44.2 m-85 -82.43 76.82 9.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.07 0.462 . . . . 73.03 110.43 175.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 45.0 p90 35.83 76.13 0.05 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 114.341 -1.3 . . . . 75.11 113.588 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.712 ' HA ' ' HB3' ' A' ' 97' ' ' PRO . . . -52.03 115.2 6.33 Favored Pre-proline 0 C--O 1.236 0.361 0 CA-C-N 115.774 -0.648 . . . . 60.02 109.843 170.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.54 ' O ' ' N ' ' A' ' 53' ' ' CYS . 22.0 Cg_exo -64.24 85.86 0.15 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.657 2.238 . . . . 74.34 112.313 -176.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 33.3 p-90 40.34 -74.27 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.814 1.246 . . . . 74.15 113.346 178.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 51' ' ' PRO . 52.2 t 64.92 -76.55 0.04 OUTLIER 'General case' 0 C--O 1.235 0.306 0 C-N-CA 123.34 0.656 . . . . 72.24 111.394 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 57.83 75.73 0.24 Allowed Glycine 0 C--N 1.333 0.378 0 N-CA-C 111.414 -0.675 . . . . 63.14 111.414 -174.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.61 94.16 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.802 2.335 . . . . 62.11 111.992 -175.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 59.6 m -72.16 78.78 0.96 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.808 -0.633 . . . . 70.01 110.541 -178.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -156.94 7.21 0.17 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.605 -0.725 . . . . 75.25 109.815 178.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.9 t 69.66 18.68 7.54 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.684 -0.689 . . . . 52.33 110.811 -178.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -109.55 149.06 30.2 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.096 -0.502 . . . . 73.5 110.583 178.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -102.22 149.65 36.81 Favored Pre-proline 0 C--O 1.234 0.284 0 CA-C-N 116.0 -0.546 . . . . 73.14 109.976 178.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.53 165.21 23.5 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.526 2.151 . . . . 71.23 111.837 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.613 ' HB3' HG12 ' A' ' 119' ' ' ILE . 8.9 mp0 -51.13 -49.47 60.73 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-O 121.566 0.698 . . . . 74.1 110.533 -176.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.735 HD23 HG12 ' A' ' 99' ' ' ILE . 10.3 mp -54.44 -48.87 71.19 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.617 -1.174 . . . . 74.22 111.49 -175.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -73.42 -32.79 64.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.818 0.342 . . . . 74.41 110.296 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.0 tptp -60.31 -46.77 88.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.752 -0.658 . . . . 71.31 110.358 -176.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.528 HD13 HD11 ' A' ' 123' ' ' ILE . 17.4 mt -85.79 -40.69 15.77 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.082 0.401 . . . . 73.24 112.082 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.26 -37.15 69.41 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.193 0.442 . . . . 61.5 112.193 -173.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -58.47 -30.84 67.29 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.766 0.317 . . . . 70.24 111.201 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 19.2 mm-40 -90.55 -54.2 4.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.09 0.472 . . . . 65.55 110.595 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.513 ' O ' HG21 ' A' ' 74' ' ' VAL . 19.4 m-85 -88.1 22.48 2.4 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.762 -0.654 . . . . 75.23 112.043 -172.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.9 t -52.63 -32.71 43.21 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.175 0.435 . . . . 74.33 112.175 -172.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -72.03 -22.62 61.37 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 121.225 -0.19 . . . . 53.34 111.487 -175.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.04 -4.14 16.04 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.636 -0.256 . . . . 72.31 110.751 -177.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.513 HG21 ' O ' ' A' ' 70' ' ' TYR . 23.2 m -135.46 148.1 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.134 0.493 . . . . 73.54 111.568 -178.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 75' ' ' LYS . 36.6 mmtm -140.81 131.43 25.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.706 -0.679 . . . . 63.31 109.259 171.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.476 HD13 ' HB3' ' A' ' 63' ' ' LEU . 61.5 mt -110.24 127.68 67.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.366 -0.379 . . . . 74.42 110.521 -175.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.633 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 57.7 m-85 -124.84 128.74 49.17 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.592 -0.521 . . . . 72.2 109.592 178.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.433 ' HG2' ' HB3' ' A' ' 47' ' ' ASP . 9.2 mtmp? -100.52 142.74 31.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.874 0.369 . . . . 72.22 110.636 -177.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 32.8 mm -99.69 156.02 4.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.42 -0.809 . . . . 72.5 110.789 -174.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.403 ' OD1' ' N ' ' A' ' 81' ' ' ILE . 48.7 t-20 -104.53 153.46 21.13 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.462 -0.94 . . . . 55.21 108.462 172.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.403 ' N ' ' OD1' ' A' ' 80' ' ' ASN . 36.2 pt -51.79 -22.22 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 112.111 0.411 . . . . 61.14 112.111 -176.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -62.98 -48.72 77.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.243 -0.435 . . . . 71.24 111.56 -177.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -78.31 -12.44 60.0 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.129 -0.487 . . . . 64.43 111.901 -171.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -40.77 132.37 2.25 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 123.251 0.344 . . . . 73.35 111.754 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -122.49 139.42 53.9 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.758 -0.46 . . . . 74.21 109.758 -174.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -59.12 -12.36 4.93 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.671 -0.695 . . . . 61.45 112.013 -177.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.514 HG11 ' CE1' ' A' ' 91' ' ' TYR . 37.4 t -56.67 -41.42 74.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-O 121.247 0.546 . . . . 75.03 109.673 175.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.94 -44.31 97.03 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.715 -0.675 . . . . 73.53 109.95 176.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.9 m -59.33 -37.6 78.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.652 -0.704 . . . . 71.01 110.34 176.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -65.92 -36.56 83.72 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.068 -0.515 . . . . 72.23 110.064 177.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.514 ' CE1' HG11 ' A' ' 87' ' ' VAL . 23.3 m-85 -73.42 -4.2 32.14 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.384 -0.371 . . . . 74.44 111.123 175.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.0 9.33 82.67 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 121.276 -0.488 . . . . 71.21 112.099 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 89.2 t -75.24 83.76 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.425 0.631 . . . . 73.5 110.653 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.0 p -117.85 12.07 13.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.45 -0.795 . . . . 73.31 109.727 174.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -83.34 -68.39 0.71 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.695 -0.684 . . . . 73.13 110.978 -178.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 69.2 mt 68.44 128.1 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.554 0 O-C-N 123.506 0.503 . . . . 72.43 110.362 -178.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.712 ' HB3' ' HA ' ' A' ' 50' ' ' ALA . 85.9 Cg_endo -79.38 156.94 90.39 Favored 'Cis proline' 0 C--N 1.353 0.794 0 C-N-CA 123.923 -1.282 . . . . 65.31 112.686 2.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 39.6 m -149.27 134.08 17.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.985 -0.552 . . . . 71.12 109.858 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.735 HG12 HD23 ' A' ' 63' ' ' LEU . 3.5 mp -114.99 124.96 72.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.381 -0.372 . . . . 75.35 110.265 -176.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.434 HD13 ' CE1' ' A' ' 48' ' ' PHE . 10.3 mp -103.3 141.87 35.16 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.654 -0.499 . . . . 74.23 109.654 175.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.681 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 53.4 mtp -112.6 116.13 29.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.517 -0.31 . . . . 74.11 110.724 -173.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -114.07 152.57 30.85 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.212 -0.449 . . . . 74.43 110.851 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.637 ' HB3' HD21 ' A' ' 108' ' ' LEU . 39.1 ttpt -168.38 133.09 1.67 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.304 -0.628 . . . . 63.31 109.304 176.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 56.7 29.17 15.35 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.251 0.548 . . . . 65.24 109.817 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 87.79 -14.49 58.36 Favored Glycine 0 CA--C 1.52 0.358 0 CA-C-N 115.862 -0.608 . . . . 53.51 113.331 177.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -96.52 150.91 20.1 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 117.072 0.436 . . . . 51.24 110.803 -177.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 10.0 ptpt -91.96 118.2 30.54 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.07 -0.715 . . . . 60.31 109.07 171.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.637 HD21 ' HB3' ' A' ' 103' ' ' LYS . 2.2 mm? -89.8 -52.96 4.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.024 0.44 . . . . 72.55 111.057 -173.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.681 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 15.8 m -151.75 171.77 17.18 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 115.731 -0.668 . . . . 74.54 110.329 -170.283 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -149.89 123.44 9.12 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.286 0.565 . . . . 75.32 111.488 -176.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.424 HG23 HG22 ' A' ' 119' ' ' ILE . 40.4 t -86.26 107.08 16.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.674 -0.694 . . . . 64.25 109.618 175.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 12.8 mt -116.8 106.83 20.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 109.296 -0.631 . . . . 75.11 109.296 178.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 115.52 -127.25 7.51 Favored Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 111.574 -0.61 . . . . 74.41 111.574 -176.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.61 57.27 0.49 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.486 0.66 . . . . 71.33 109.651 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.448 ' O ' HG21 ' A' ' 119' ' ' ILE . 1.6 m-20 -105.58 99.54 9.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.384 -0.825 . . . . 74.42 110.882 -174.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.567 ' O ' HG13 ' A' ' 119' ' ' ILE . 7.0 tp -63.37 -38.87 83.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.171 -0.468 . . . . 73.12 111.079 -178.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.5 m -68.14 -26.85 65.98 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.11 0.481 . . . . 71.15 110.621 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 24.6 tptp -73.2 -52.02 15.64 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.678 -0.692 . . . . 71.04 110.041 176.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.613 HG12 ' HB3' ' A' ' 62' ' ' GLN . 2.0 pp -63.9 -40.81 90.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 115.68 -0.691 . . . . 71.22 111.461 -175.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.433 HD12 ' N ' ' A' ' 121' ' ' SER . 2.8 pp -63.14 -33.13 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 120.434 -0.506 . . . . 75.31 110.284 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.433 ' N ' HD12 ' A' ' 120' ' ' ILE . 35.9 t -70.71 -51.57 26.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.029 -0.532 . . . . 62.24 110.78 179.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.434 ' OE2' ' HB3' ' A' ' 109' ' ' SER . 15.9 pt-20 -75.86 -38.43 57.96 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.082 0.401 . . . . 74.32 112.082 -172.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.533 ' O ' HG12 ' A' ' 127' ' ' ILE . 69.9 mt -65.1 -55.8 18.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 O-C-N 122.32 -0.238 . . . . 72.53 110.442 178.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -60.37 -27.32 67.31 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.281 -0.418 . . . . 72.01 110.728 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -65.36 -31.48 72.62 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.28 -0.418 . . . . 63.32 110.74 176.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -104.43 -4.61 22.57 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.979 -0.555 . . . . 73.11 111.975 -172.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.533 HG12 ' O ' ' A' ' 123' ' ' ILE . 48.5 pt -131.56 168.94 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 122.166 0.186 . . . . 71.04 110.59 178.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.252 1.185 0 CA-C-O 118.462 -0.78 . . . . 74.44 112.796 -176.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 N--CA 1.482 1.161 0 CA-C-O 120.73 0.3 . . . . 64.12 110.368 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -123.33 143.8 49.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.45 . . . . 74.33 110.08 178.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -97.04 93.89 6.85 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.813 0.339 . . . . 73.01 110.315 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -85.05 94.73 8.9 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.572 -0.529 . . . . 75.42 109.572 177.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -61.43 118.91 7.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.985 -0.552 . . . . 74.22 110.991 -177.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 44.4 p-80 -174.79 154.78 1.99 Allowed 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 109.307 -0.627 . . . . 75.11 109.307 177.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 21.4 p-80 -56.87 92.12 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.305 0.574 . . . . 65.21 110.405 177.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -67.82 110.26 3.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.022 -0.535 . . . . 71.34 110.24 -178.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 20.5 ptp -152.89 10.58 0.47 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.577 -0.738 . . . . 61.33 110.017 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.12 60.56 4.88 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.775 -0.648 . . . . 54.42 112.234 -176.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 30.8 p -69.87 96.96 1.05 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.659 -0.497 . . . . 74.43 109.659 176.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.6 tt -81.56 60.68 4.65 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.312 0.577 . . . . 75.13 109.75 -175.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -89.2 84.25 6.51 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.621 -0.881 . . . . 74.12 108.621 177.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -132.86 144.16 50.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.956 -0.565 . . . . 75.44 111.075 -176.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -89.24 71.29 8.26 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 121.363 0.602 . . . . 71.2 110.65 -179.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.4 m -73.63 72.18 1.43 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.296 0.57 . . . . 74.34 110.649 178.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.96 95.95 4.76 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.961 -0.563 . . . . 73.13 110.146 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -92.01 -89.46 1.47 Allowed Glycine 0 N--CA 1.452 -0.286 0 N-CA-C 111.335 -0.706 . . . . 72.22 111.335 178.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -80.44 141.15 13.95 Favored 'Trans proline' 0 C--O 1.237 0.435 0 C-N-CA 122.763 2.309 . . . . 73.22 111.134 174.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.62 32.42 57.46 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.643 -0.789 . . . . 71.45 111.429 -175.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.4 p -85.84 -43.56 13.18 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.024 -0.361 . . . . 64.02 110.024 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 67.1 mtt -60.53 -55.88 28.09 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.02 -0.537 . . . . 73.25 109.995 178.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.8 mt -113.89 122.62 68.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 109.218 -0.66 . . . . 74.4 109.218 176.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 -125.54 124.76 42.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.834 0.35 . . . . 71.41 111.056 -174.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.431 ' HG3' ' HB3' ' A' ' 78' ' ' LYS . 1.1 mp0 -81.49 125.97 31.11 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.464 -0.569 . . . . 65.14 109.464 178.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.497 HG21 ' HD3' ' A' ' 34' ' ' LYS . 33.8 pt -131.58 176.39 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.744 0.307 . . . . 73.54 110.936 -176.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -108.86 174.83 18.86 Favored Glycine 0 C--N 1.331 0.278 0 N-CA-C 111.629 -0.588 . . . . 13.31 111.629 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -67.84 -33.43 74.75 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.58 0.229 . . . . 75.21 111.34 -176.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.0 t -68.79 -34.62 75.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.769 0.319 . . . . 64.12 111.145 -174.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -101.35 -6.11 24.52 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.145 -0.479 . . . . 71.55 110.799 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.464 ' HA ' HD13 ' A' ' 26' ' ' ILE . 59.5 t80 -50.45 -70.81 0.08 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.359 -0.382 . . . . 65.21 110.248 177.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -59.67 -36.93 77.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.095 0.474 . . . . 71.43 109.969 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.508 ' O ' ' HB2' ' A' ' 37' ' ' SER . 24.7 t-20 -52.41 -47.73 66.13 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.118 -0.946 . . . . 73.12 111.782 -175.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.497 ' HD3' HG21 ' A' ' 26' ' ' ILE . 0.2 OUTLIER -101.93 -19.18 15.36 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.687 0.255 . . . . 53.44 111.687 -176.01 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.7 t -88.25 -59.54 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 112.038 0.385 . . . . 63.51 112.038 -179.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 66.1 p -79.99 -28.1 39.53 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.135 0.493 . . . . 74.43 110.66 -172.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.508 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 39.8 m -94.6 12.48 27.4 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.69 -0.686 . . . . 73.22 110.958 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.547 ' SG ' HG21 ' A' ' 42' ' ' ILE . 50.9 t -53.68 92.1 0.01 OUTLIER 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.047 0.451 . . . . 62.14 112.043 -177.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -67.47 -19.28 65.32 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.04 -0.527 . . . . 70.23 110.951 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -62.46 -25.27 67.9 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.356 -0.384 . . . . 63.24 111.372 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.436 ' N ' HD21 ' A' ' 41' ' ' ASN . 0.9 OUTLIER 62.49 23.67 14.06 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.972 -0.558 . . . . 71.21 110.235 -175.305 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.547 HG21 ' SG ' ' A' ' 38' ' ' CYS . 12.3 tt -82.38 157.76 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.757 -0.656 . . . . 74.52 109.291 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.434 ' HB3' HG12 ' A' ' 74' ' ' VAL . 48.7 tp -78.21 102.7 7.72 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 109.586 -0.524 . . . . 74.32 109.586 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 101' ' ' MET . 32.5 mt -90.5 126.34 43.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.889 -0.596 . . . . 75.35 111.108 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.526 ' HG ' ' HG2' ' A' ' 101' ' ' MET . 3.5 mp -115.05 101.91 9.44 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.263 -0.644 . . . . 72.54 109.263 177.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.524 HG11 ' HB2' ' A' ' 77' ' ' TYR . 29.1 m -94.79 120.9 44.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.725 -0.472 . . . . 71.44 109.725 178.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -98.09 121.36 39.92 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.527 0.68 . . . . 64.5 109.385 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.587 ' HB3' ' HB2' ' A' ' 82' ' ' GLU . 90.4 m-85 -87.85 121.72 30.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.285 -0.87 . . . . 73.03 109.242 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.458 ' O ' ' HA ' ' A' ' 80' ' ' ASN . 54.9 t-105 -124.34 106.88 10.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.272 -0.422 . . . . 75.11 110.657 -177.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.06 120.46 81.76 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 116.597 -0.274 . . . . 60.02 110.566 174.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.438 ' O ' ' HB3' ' A' ' 52' ' ' TRP . 21.1 Cg_exo -66.7 -171.5 0.27 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.806 2.337 . . . . 74.34 111.824 175.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . 0.438 ' HB3' ' O ' ' A' ' 51' ' ' PRO . 44.9 t90 73.23 9.14 5.26 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.732 0.777 . . . . 74.15 110.13 -179.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 5.2 p -91.61 164.28 13.82 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.362 -0.836 . . . . 72.24 110.398 177.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.11 -141.98 5.77 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 121.44 -0.409 . . . . 63.14 113.281 -175.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -77.67 42.01 1.09 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.285 2.656 . . . . 62.11 113.213 -175.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 10.1 p -91.24 116.62 28.96 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.975 -0.38 . . . . 70.01 109.975 177.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 63.8 mtm180 -112.59 -176.85 3.0 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.463 -0.335 . . . . 75.25 110.696 179.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.0 m -63.19 -39.75 95.53 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.013 -0.539 . . . . 52.33 111.213 -178.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.7 mt 54.95 36.08 26.0 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.111 -0.495 . . . . 73.5 111.374 176.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 57.64 78.3 0.37 Allowed Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 115.562 -0.744 . . . . 73.14 110.56 -178.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.406 ' HG2' ' HB2' ' A' ' 64' ' ' GLU . 72.6 Cg_endo -75.98 161.24 36.14 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.581 2.187 . . . . 71.23 112.674 -176.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.582 ' HB3' HG12 ' A' ' 119' ' ' ILE . 15.7 mp0 -56.16 -40.89 74.59 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.353 -0.84 . . . . 74.1 110.758 -177.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.621 HD13 HG22 ' A' ' 111' ' ' VAL . 2.3 mm? -61.93 -41.0 97.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.87 -1.059 . . . . 74.22 109.868 -176.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.406 ' HB2' ' HG2' ' A' ' 61' ' ' PRO . 8.7 tm-20 -70.53 -36.66 73.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.63 -0.714 . . . . 74.41 109.174 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -56.87 -51.53 68.68 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.433 -0.803 . . . . 71.31 109.909 178.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.607 HD11 HD11 ' A' ' 123' ' ' ILE . 22.3 mt -80.63 -30.61 36.69 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.073 0.397 . . . . 73.24 112.073 -178.496 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.47 -34.95 69.55 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.789 0.328 . . . . 61.5 110.892 -178.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -56.57 -30.83 63.61 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.163 -0.471 . . . . 70.24 111.372 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -93.62 -48.37 6.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.235 -0.439 . . . . 65.55 110.886 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.533 ' O ' HG23 ' A' ' 74' ' ' VAL . 21.9 m-85 -93.92 21.21 6.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.033 -0.531 . . . . 75.23 112.154 -174.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.1 t -53.01 -36.38 60.43 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.035 0.383 . . . . 74.33 112.035 -174.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -71.24 -16.98 62.52 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.505 -0.316 . . . . 53.34 111.455 -177.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -117.16 -1.37 11.87 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.404 -0.362 . . . . 72.31 111.036 -175.344 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 70' ' ' TYR . 26.4 m -135.16 150.65 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 121.008 0.432 . . . . 73.54 111.55 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -137.57 115.2 11.27 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.094 -0.706 . . . . 63.31 109.094 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 45' ' ' LEU . 61.0 mt -98.21 140.63 17.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.692 0.282 . . . . 74.42 110.326 -178.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.524 ' HB2' HG11 ' A' ' 46' ' ' VAL . 95.1 m-85 -129.35 138.21 51.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.409 -0.359 . . . . 72.2 110.487 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.431 ' HB3' ' HG3' ' A' ' 25' ' ' GLN . 53.3 tptt -101.24 114.76 29.02 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.402 -0.817 . . . . 72.22 110.115 -178.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.44 ' N ' HD13 ' A' ' 79' ' ' ILE . 2.3 mp -133.62 144.54 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 120.765 0.317 . . . . 72.5 110.374 178.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.458 ' HA ' ' O ' ' A' ' 49' ' ' TRP . 4.4 p-10 -107.12 30.85 5.82 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.973 0.416 . . . . 55.21 111.281 -178.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 13.8 tt -98.04 15.99 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.103 0.478 . . . . 61.14 110.958 -176.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.587 ' HB2' ' HB3' ' A' ' 48' ' ' PHE . 36.7 tt0 -52.21 -58.63 6.03 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.117 -0.492 . . . . 71.24 112.13 -174.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -75.29 11.34 1.23 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.971 -0.559 . . . . 64.43 111.987 -173.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -124.27 -2.58 8.05 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.082 0.468 . . . . 73.35 111.08 -177.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -99.76 113.95 26.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.943 0.401 . . . . 74.21 111.542 -175.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -56.9 -27.06 60.23 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.663 -0.699 . . . . 61.45 109.63 173.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.5 t -51.3 -42.63 27.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 114.728 -1.124 . . . . 75.03 111.31 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.47 -49.75 76.32 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.032 -0.531 . . . . 73.53 110.777 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.2 m -66.88 -33.48 75.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.802 -0.635 . . . . 71.01 110.413 178.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -66.6 -36.3 82.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.658 -0.701 . . . . 72.23 110.82 -178.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -89.29 -0.77 57.72 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.844 0.354 . . . . 74.44 110.857 176.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.65 41.66 42.42 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-N 115.787 -0.642 . . . . 71.21 113.7 170.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.0 p -98.45 152.79 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.978 0.389 . . . . 73.5 110.076 176.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.9 t -148.01 35.54 0.83 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.184 0.516 . . . . 73.31 109.806 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -133.21 149.34 52.01 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.009 -0.541 . . . . 73.13 110.813 -178.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 68.6 mt -118.96 128.48 25.93 Favored Pre-proline 0 C--O 1.237 0.42 0 CA-C-N 115.826 -0.625 . . . . 72.43 109.88 176.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -92.98 167.03 23.0 Favored 'Cis proline' 0 C--N 1.349 0.575 0 C-N-CA 124.177 -1.176 . . . . 65.31 112.966 -1.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 62.1 m -120.48 128.63 53.32 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.017 -0.538 . . . . 71.12 110.906 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.665 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 3.4 mp -106.85 138.91 30.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.46 -0.57 . . . . 75.35 109.46 178.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.512 HD11 ' HB3' ' A' ' 110' ' ' GLN . 34.5 tp -127.56 145.93 50.7 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.797 -0.446 . . . . 74.23 109.797 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.792 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 72.7 mtp -118.26 116.21 26.31 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 120.874 0.368 . . . . 74.11 111.979 -173.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -109.41 157.78 18.59 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.736 -0.665 . . . . 74.43 111.363 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.478 ' CB ' HD23 ' A' ' 108' ' ' LEU . 39.4 ttmt -151.22 102.86 2.97 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.566 -0.901 . . . . 63.31 108.566 169.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.8 t30 53.73 38.76 29.18 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.394 0.616 . . . . 65.24 110.762 -177.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.81 -6.48 81.95 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 116.107 -0.497 . . . . 53.51 113.272 177.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -90.15 134.86 34.02 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 122.434 0.293 . . . . 51.24 110.248 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 40.2 tttm -89.42 120.95 31.19 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 110.013 -0.366 . . . . 60.31 110.013 176.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.528 ' N ' HD22 ' A' ' 108' ' ' LEU . 2.0 mm? -98.49 -53.11 3.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.244 -0.434 . . . . 72.55 110.514 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.792 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 16.7 m -156.78 172.41 18.68 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 115.172 -0.922 . . . . 74.54 110.007 -169.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.512 ' HB3' HD11 ' A' ' 100' ' ' LEU . 12.4 pt20 -158.4 131.57 7.39 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.88 0.371 . . . . 75.32 110.452 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.665 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 38.8 t -98.5 107.21 19.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.957 -0.565 . . . . 64.25 110.242 -176.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 68.6 mt -95.46 114.4 31.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.335 -0.393 . . . . 75.11 109.973 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.36 -109.9 2.9 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.726 -0.749 . . . . 74.41 111.966 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.61 104.22 1.97 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.658 0.229 . . . . 71.33 111.264 -178.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.505 ' O ' HG23 ' A' ' 119' ' ' ILE . 37.3 m-20 -140.55 96.05 2.97 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.624 0.25 . . . . 74.42 110.43 176.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.513 HD12 HD11 ' A' ' 119' ' ' ILE . 6.6 tp -60.15 -42.48 90.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 CA-C-O 120.933 0.397 . . . . 73.12 110.503 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 36.8 t -61.62 -30.18 70.53 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.715 -0.675 . . . . 71.15 110.694 -178.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.05 -53.73 6.72 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.183 -0.673 . . . . 71.04 109.183 179.144 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.582 HG12 ' HB3' ' A' ' 62' ' ' GLN . 2.1 pp -59.08 -40.41 80.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.692 -0.685 . . . . 71.22 111.701 -172.01 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.524 HD13 ' N ' ' A' ' 121' ' ' SER . 2.8 pp -59.2 -36.89 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 C-N-CA 119.935 -0.706 . . . . 75.31 110.142 178.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.524 ' N ' HD13 ' A' ' 120' ' ' ILE . 28.1 t -70.69 -50.62 34.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.19 -0.459 . . . . 62.24 110.865 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.551 ' HG2' ' HA ' ' A' ' 119' ' ' ILE . 16.4 pt-20 -76.36 -29.02 57.02 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 112.081 0.4 . . . . 74.32 112.081 -170.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.607 HD11 HD11 ' A' ' 66' ' ' LEU . 65.2 mt -72.08 -56.86 8.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-O 120.903 0.382 . . . . 72.53 110.004 174.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -61.88 -20.31 63.59 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.847 -0.615 . . . . 72.01 110.993 -178.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -66.87 -27.99 67.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.08 -0.509 . . . . 63.32 111.231 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -120.46 -1.12 10.2 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.497 0.554 . . . . 73.11 112.497 -171.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 31.4 pt -139.27 167.65 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 110.237 -0.283 . . . . 71.04 110.237 170.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.458 ' N ' HD21 ' A' ' 128' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.327 -0.845 . . . . 74.44 110.869 -179.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 tpt . . . . . 0 N--CA 1.48 1.055 0 CA-C-O 121.01 0.433 . . . . 64.12 110.358 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.05 99.61 4.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.919 -0.582 . . . . 74.33 109.946 176.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 25.0 t-80 -148.75 71.7 1.16 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.318 0.58 . . . . 73.01 109.98 -178.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 18.3 p80 -69.25 151.35 46.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.254 -0.884 . . . . 75.42 110.961 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 18.4 t60 -150.14 79.17 1.35 Allowed 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.308 -0.627 . . . . 74.22 109.308 176.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 29.4 t60 -60.94 115.81 4.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.875 -0.602 . . . . 75.11 110.528 -177.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -142.14 143.19 32.88 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.491 -0.559 . . . . 65.21 109.491 -179.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -144.1 16.43 1.73 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.875 0.369 . . . . 71.34 110.775 -179.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.6 mmt -110.4 111.27 22.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 61.33 109.98 176.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.2 66.21 3.48 Favored Glycine 0 N--CA 1.453 -0.199 0 N-CA-C 111.583 -0.607 . . . . 54.42 111.583 176.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.2 m -58.67 133.47 55.93 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 122.49 0.316 . . . . 74.43 110.907 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.7 tt -153.34 106.12 2.93 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 109.187 -0.672 . . . . 75.13 109.187 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -88.15 134.33 33.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.269 -0.423 . . . . 74.12 110.42 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.4 77.12 3.93 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.626 -0.509 . . . . 75.44 109.626 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -73.4 131.04 41.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.49 -0.777 . . . . 71.2 110.44 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.465 ' HG1' ' HG2' ' A' ' 24' ' ' GLU . 49.1 m -61.61 132.09 52.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.411 -0.359 . . . . 74.34 110.636 177.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.411 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 25.4 pt20 -93.93 90.0 6.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.368 0.604 . . . . 73.13 109.961 178.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 179.69 80.49 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.893 -0.67 . . . . 72.22 112.377 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.23 76.04 0.24 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.72 2.28 . . . . 73.22 110.981 177.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 168.54 -23.56 0.1 Allowed Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.291 -0.868 . . . . 71.45 111.618 -177.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 45.0 m -61.06 92.29 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.899 0.38 . . . . 64.02 110.338 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.728 ' HG2' HG13 ' A' ' 23' ' ' ILE . 1.6 pmm? -74.45 -25.6 59.51 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 109.786 -0.45 . . . . 73.25 109.786 176.279 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.728 HG13 ' HG2' ' A' ' 22' ' ' MET . 47.1 mt -129.04 118.15 45.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 115.729 -0.669 . . . . 74.4 109.408 177.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.465 ' HG2' ' HG1' ' A' ' 16' ' ' THR . 13.7 tp10 -131.83 155.11 48.37 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.275 -0.269 . . . . 71.41 110.275 -176.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.414 ' HG3' ' HE3' ' A' ' 78' ' ' LYS . 0.7 OUTLIER -92.2 147.67 22.75 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 110.399 -0.223 . . . . 65.14 110.399 -178.759 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 42.7 pt -135.02 -176.76 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 120.638 0.256 . . . . 73.54 110.401 176.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -118.41 167.17 12.94 Favored Glycine 0 C--N 1.331 0.281 0 N-CA-C 111.847 -0.501 . . . . 13.31 111.847 177.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -67.41 -40.79 85.61 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.864 0.32 . . . . 75.21 111.864 -174.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 83.4 p -80.16 -28.77 38.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.919 0.39 . . . . 64.12 111.43 -176.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.426 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 2.3 pm0 -91.48 -6.79 52.07 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 116.379 -0.373 . . . . 71.55 110.484 178.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.442 ' HE1' HG21 ' A' ' 46' ' ' VAL . 37.9 t80 -49.13 -70.8 0.08 Allowed 'General case' 0 C--O 1.227 -0.12 0 CA-C-N 115.871 -0.604 . . . . 65.21 110.174 175.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -58.22 -38.49 76.9 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 109.65 -0.5 . . . . 71.43 109.65 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -51.7 -46.43 63.91 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.035 -0.984 . . . . 73.12 111.321 -172.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.517 ' HZ2' ' HB2' ' A' ' 34' ' ' LYS . 0.1 OUTLIER -108.04 -21.16 12.92 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.107 0.41 . . . . 53.44 112.107 -176.643 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 89.7 t -88.17 -50.57 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 N-CA-C 111.722 0.268 . . . . 63.51 111.722 -177.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 66.4 p -80.18 -25.61 39.64 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 120.244 -0.582 . . . . 74.43 109.834 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.6 m -88.3 11.99 15.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.452 -0.795 . . . . 73.22 110.867 177.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.559 ' O ' ' HA ' ' A' ' 104' ' ' ASN . 44.2 t -59.3 104.49 0.26 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.66 0.267 . . . . 62.14 110.916 -178.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -81.55 -17.65 47.69 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.879 0.371 . . . . 70.23 110.293 176.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -65.92 -20.74 66.32 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.842 -0.617 . . . . 63.24 111.349 -177.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 64.44 11.48 6.57 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.058 0.543 . . . . 71.21 111.86 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.4 tt -73.35 163.29 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 109.442 -0.577 . . . . 74.52 109.442 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.637 HD21 ' HE1' ' A' ' 101' ' ' MET . 62.6 tp -87.65 110.61 20.53 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.109 0.48 . . . . 74.32 110.202 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.3 mt -96.0 119.66 44.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.747 -0.661 . . . . 75.35 110.204 178.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.676 HD12 HD11 ' A' ' 63' ' ' LEU . 71.5 mt -98.87 109.61 22.34 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.696 -0.853 . . . . 72.54 108.696 177.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.442 HG21 ' HE1' ' A' ' 31' ' ' PHE . 47.1 t -103.04 109.33 26.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.874 -0.148 . . . . 71.44 111.119 -176.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.446 ' HB3' ' HD1' ' A' ' 49' ' ' TRP . 1.2 m-20 -81.21 134.28 35.59 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.586 -0.524 . . . . 64.5 109.586 173.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.41 ' HE2' ' HA ' ' A' ' 97' ' ' PRO . 10.7 p90 -61.33 -28.68 69.38 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.517 0.675 . . . . 73.03 110.169 178.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.542 ' HD1' ' H ' ' A' ' 49' ' ' TRP . 0.2 OUTLIER -110.41 -164.0 0.89 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.127 -0.942 . . . . 75.11 109.858 -177.604 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.44 ' HA ' ' HB3' ' A' ' 78' ' ' LYS . . . -131.81 87.73 44.25 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.848 -0.16 . . . . 60.02 111.262 178.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -60.97 112.62 1.42 Allowed 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.252 1.968 . . . . 74.34 110.677 170.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -95.94 -76.01 0.51 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.853 -0.158 . . . . 74.15 111.212 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 52.8 t -172.14 160.22 5.13 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.076 -0.342 . . . . 72.24 110.076 -178.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -101.2 154.89 19.11 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 111.521 -0.632 . . . . 63.14 111.521 176.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.89 -29.35 89.25 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.711 2.274 . . . . 62.11 111.667 176.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 49.0 t -123.06 158.41 30.66 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.936 -0.575 . . . . 70.01 109.726 176.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 ttt180 -74.93 88.59 2.34 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 109.764 -0.458 . . . . 75.25 109.764 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.4 p -84.22 -171.81 3.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.873 -0.603 . . . . 52.33 110.964 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.402 ' N ' HD23 ' A' ' 59' ' ' LEU . 3.0 mm? -73.5 131.41 41.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 73.5 109.877 177.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -68.19 134.26 91.46 Favored Pre-proline 0 C--O 1.237 0.438 0 N-CA-C 109.593 -0.521 . . . . 73.14 109.593 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.01 172.43 11.92 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.469 2.113 . . . . 71.23 112.138 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.497 ' HB3' HG12 ' A' ' 119' ' ' ILE . 14.1 mp0 -47.06 -56.09 7.13 Favored 'General case' 0 C--O 1.249 1.067 0 CA-C-O 121.927 0.87 . . . . 74.1 110.953 -178.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.676 HD11 HD12 ' A' ' 45' ' ' LEU . 3.2 mm? -57.48 -48.14 80.0 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 114.215 -1.357 . . . . 74.22 110.758 -172.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 35.7 mt-10 -69.77 -38.92 76.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.601 -0.272 . . . . 74.41 110.853 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 26.7 mmtm -50.75 -50.18 56.24 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.852 0.358 . . . . 71.31 110.408 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.628 HD13 HD12 ' A' ' 123' ' ' ILE . 32.4 mt -77.73 -37.34 49.53 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 120.542 -0.463 . . . . 73.24 111.695 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.87 -31.32 72.33 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 111.729 0.27 . . . . 61.5 111.729 -175.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.464 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 75.4 mt-30 -54.44 -37.55 65.3 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.861 0.362 . . . . 70.24 110.882 178.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -93.57 -46.22 7.39 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.924 -0.58 . . . . 65.55 110.803 -177.248 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.516 ' O ' HG23 ' A' ' 74' ' ' VAL . 17.6 m-85 -93.32 22.32 5.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.761 -0.654 . . . . 75.23 112.366 -173.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.4 t -52.17 -38.55 58.05 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.206 0.447 . . . . 74.33 112.206 -173.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -71.06 -22.53 62.11 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 122.183 -0.323 . . . . 53.34 111.832 -177.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.34 -8.63 21.03 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.579 0.228 . . . . 72.31 110.773 -175.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 70' ' ' TYR . 35.2 m -133.11 151.16 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 O-C-N 121.944 -0.472 . . . . 73.54 111.412 -178.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.441 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 35.9 mmtm -139.09 115.34 10.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.773 -0.649 . . . . 63.31 109.563 174.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.515 ' HB ' HG12 ' A' ' 23' ' ' ILE . 56.4 mt -90.12 109.96 21.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.857 -0.61 . . . . 74.42 110.386 -178.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.459 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 7.7 m-85 -97.79 134.03 41.5 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.799 -0.445 . . . . 72.2 109.799 176.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.461 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 57.1 mtmt -107.28 155.6 19.78 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.845 -0.616 . . . . 72.22 110.677 -176.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.461 ' HB ' ' O ' ' A' ' 78' ' ' LYS . 41.4 mm 85.85 95.22 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 O-C-N 124.47 1.106 . . . . 72.5 111.665 178.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -153.34 87.05 1.24 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.589 -1.187 . . . . 55.21 108.186 173.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 40.8 mm -61.46 92.29 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.85 -0.614 . . . . 61.14 112.155 -170.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.633 ' HG2' ' HB1' ' A' ' 88' ' ' ALA . 3.5 tm-20 -53.89 -31.47 50.03 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.338 -0.846 . . . . 71.24 109.966 175.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.82 -7.59 53.88 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.179 -0.919 . . . . 64.43 111.813 -175.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -132.28 6.61 4.18 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 122.285 -0.259 . . . . 73.35 111.554 -176.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -112.68 115.77 29.09 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.939 0.399 . . . . 74.21 110.783 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -60.67 -29.24 69.17 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.801 -0.636 . . . . 61.45 111.054 -177.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 62.6 t -56.96 -44.23 82.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 CA-C-O 121.226 0.536 . . . . 75.03 110.305 178.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.633 ' HB1' ' HG2' ' A' ' 82' ' ' GLU . . . -68.17 -36.29 79.38 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.702 -0.681 . . . . 73.53 110.533 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.5 m -64.02 -40.67 96.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.364 -0.835 . . . . 71.01 110.297 176.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 54.7 tp60 -63.93 -43.65 95.26 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.841 -0.618 . . . . 72.23 110.207 178.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -70.68 -17.25 62.85 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.311 -0.404 . . . . 74.44 110.82 175.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 58.87 42.16 96.51 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 110.819 -0.912 . . . . 71.21 110.819 -175.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.6 p -93.65 17.6 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-O 120.973 0.416 . . . . 73.5 111.43 -171.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.6 m -66.81 81.27 0.11 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.264 0.554 . . . . 73.31 110.873 178.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -157.3 91.1 1.15 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.513 -0.921 . . . . 73.13 108.513 176.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.7 pp -83.52 149.32 57.37 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.426 -0.807 . . . . 72.43 111.52 -171.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.437 ' HD2' ' O ' ' A' ' 113' ' ' GLY . 15.5 Cg_exo -69.94 161.08 87.44 Favored 'Cis proline' 0 C--N 1.357 0.995 0 C-N-CA 124.268 -1.138 . . . . 65.31 112.657 -3.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.6 m -141.1 118.36 11.36 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.07 -0.514 . . . . 71.12 110.97 -175.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.659 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 3.2 mp -120.93 133.71 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.884 -0.598 . . . . 75.35 109.977 178.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.7 mp -109.95 139.61 44.86 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 110.182 -0.303 . . . . 74.23 110.182 176.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.657 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 71.7 mtp -104.65 116.2 31.65 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.305 -0.407 . . . . 74.11 110.492 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -114.96 142.16 47.0 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.165 0.507 . . . . 74.43 111.536 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.529 ' CB ' HD21 ' A' ' 108' ' ' LEU . 23.2 ttmm -143.09 107.08 4.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.17 -0.923 . . . . 63.31 109.036 174.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.559 ' HA ' ' O ' ' A' ' 38' ' ' CYS . 3.8 t-20 59.74 28.45 17.91 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.471 0.653 . . . . 65.24 110.461 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.25 -14.41 63.77 Favored Glycine 0 C--N 1.332 0.356 0 CA-C-N 115.819 -0.628 . . . . 53.51 113.181 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.484 ' HD2' HD13 ' A' ' 108' ' ' LEU . 0.9 OUTLIER -87.7 116.97 26.21 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.703 -0.851 . . . . 51.24 108.703 176.425 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 101' ' ' MET . 25.5 pttm -77.84 119.34 21.19 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.69 -0.485 . . . . 60.31 109.69 177.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.529 HD21 ' CB ' ' A' ' 103' ' ' LYS . 1.8 mm? -78.06 -52.06 9.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.335 0.588 . . . . 72.55 109.951 -175.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.657 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 72.1 m -160.69 172.47 17.04 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 114.944 -1.025 . . . . 74.54 110.11 -170.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.02 126.56 17.84 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.124 -0.489 . . . . 75.32 111.044 -174.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.659 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 44.2 t -85.88 106.97 15.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.316 -0.624 . . . . 64.25 109.316 174.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 32.7 mt -113.66 109.89 30.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.509 -0.552 . . . . 75.11 109.509 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.437 ' O ' ' HD2' ' A' ' 97' ' ' PRO . . . 100.74 -121.27 7.18 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.147 -0.549 . . . . 74.41 111.867 -177.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.21 57.37 0.51 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.349 0.595 . . . . 71.33 110.276 -177.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.528 ' O ' HG23 ' A' ' 119' ' ' ILE . 2.5 m-20 -103.51 95.54 6.14 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.719 -0.673 . . . . 74.42 110.86 -173.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.572 ' O ' HG13 ' A' ' 119' ' ' ILE . 6.0 tp -63.24 -43.99 99.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 116.126 -0.488 . . . . 73.12 112.074 -175.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.8 t -65.69 -28.2 68.9 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.13 0.49 . . . . 71.15 110.139 -178.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -75.67 -46.74 29.63 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.884 -0.598 . . . . 71.04 109.529 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.634 ' HA ' ' HG2' ' A' ' 122' ' ' GLU . 2.2 pp -66.67 -39.42 83.73 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.095 0 CA-C-N 116.325 -0.398 . . . . 71.22 111.713 -175.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.442 HD13 ' N ' ' A' ' 121' ' ' SER . 2.8 pp -62.5 -31.75 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 C-N-CA 120.385 -0.526 . . . . 75.31 109.768 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.442 ' N ' HD13 ' A' ' 120' ' ' ILE . 35.0 t -70.62 -51.37 28.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.877 -0.601 . . . . 62.24 110.657 176.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.634 ' HG2' ' HA ' ' A' ' 119' ' ' ILE . 16.7 pt-20 -71.28 -40.82 70.68 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 112.025 0.38 . . . . 74.32 112.025 -172.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.628 HD12 HD13 ' A' ' 66' ' ' LEU . 82.1 mt -70.71 -59.67 3.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.607 -0.27 . . . . 72.53 111.101 -177.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -58.02 -26.26 62.2 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.148 0.499 . . . . 72.01 111.022 -176.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -63.58 -28.94 70.27 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.859 -0.61 . . . . 63.32 111.223 178.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -115.0 9.92 16.13 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.244 0.461 . . . . 73.11 112.244 -174.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.452 HG12 ' O ' ' A' ' 123' ' ' ILE . 42.7 pt -139.08 168.92 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 110.212 -0.292 . . . . 71.04 110.212 175.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.252 1.214 0 CA-C-O 118.444 -0.788 . . . . 74.44 111.983 -176.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.474 ' HG3' ' H ' ' A' ' 3' ' ' HIS . 29.7 tpp . . . . . 0 N--CA 1.48 1.07 0 CA-C-O 120.691 0.282 . . . . 64.12 110.428 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -93.21 -3.8 53.14 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.428 0.529 . . . . 74.33 112.428 -173.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.474 ' H ' ' HG3' ' A' ' 1' ' ' MET . 14.2 m-70 -72.73 77.6 1.11 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.922 0.392 . . . . 73.01 110.56 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -91.1 135.86 33.48 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.027 -0.533 . . . . 75.42 110.211 178.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -84.85 22.57 1.34 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.157 -0.474 . . . . 74.22 112.076 -172.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -128.9 100.31 5.63 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.874 -0.417 . . . . 75.11 109.874 176.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 10.2 p80 -126.83 164.44 21.38 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.9 -0.407 . . . . 65.21 109.9 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -111.6 174.05 6.06 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.647 -0.251 . . . . 71.34 110.394 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.439 ' HA ' ' HG2' ' A' ' 51' ' ' PRO . 68.9 mtm -137.82 84.87 2.07 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.844 0.355 . . . . 61.33 110.53 179.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.02 52.58 52.53 Favored Glycine 0 C--N 1.333 0.394 0 CA-C-N 115.902 -0.59 . . . . 54.42 112.943 178.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 21.3 p -79.7 -62.21 1.76 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.844 0.354 . . . . 74.43 111.673 -178.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.91 -72.62 0.35 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.217 -0.447 . . . . 75.13 110.349 -176.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -147.16 148.4 31.5 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.158 -0.473 . . . . 74.12 110.589 -177.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -152.72 101.11 2.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.048 -0.524 . . . . 75.44 109.803 176.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -161.11 150.4 16.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.301 -0.408 . . . . 71.2 110.333 -177.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.0 t -122.33 116.55 24.26 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.589 -0.522 . . . . 74.34 109.589 174.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -101.5 89.06 3.6 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.726 -0.472 . . . . 73.13 109.726 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 152.01 89.65 0.07 OUTLIER Glycine 0 CA--C 1.519 0.332 0 CA-C-N 115.813 -0.63 . . . . 72.22 111.63 -178.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.8 93.04 0.21 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.618 2.212 . . . . 73.22 111.823 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 151.05 50.77 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.22 0 N-CA-C 111.273 -0.731 . . . . 71.45 111.273 -178.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.1 m -88.76 150.33 23.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.63 0.252 . . . . 64.02 110.819 -176.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.559 ' N ' ' SD ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -65.19 -19.37 65.94 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.031 0.443 . . . . 73.25 109.885 175.254 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 46.0 mt -103.32 84.55 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 115.365 -0.834 . . . . 74.4 108.966 172.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.491 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 10.0 tp10 -86.74 155.44 20.35 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.14 -0.482 . . . . 71.41 110.549 -175.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -97.34 143.79 27.75 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.742 0.306 . . . . 65.14 110.294 178.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.505 HD11 ' HA ' ' A' ' 31' ' ' PHE . 29.9 pt -133.65 163.67 36.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-N 116.324 -0.398 . . . . 73.54 110.639 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -98.12 155.6 20.34 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.899 -0.591 . . . . 13.31 111.654 176.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -60.3 -30.35 69.42 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.896 0.379 . . . . 75.21 110.902 -178.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.7 p -61.84 -30.98 71.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.879 -0.601 . . . . 64.12 111.337 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.408 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 10.8 pt-20 -114.24 4.14 15.38 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.216 -0.447 . . . . 71.55 111.954 -175.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.505 ' HA ' HD11 ' A' ' 26' ' ' ILE . 81.3 t80 -52.85 -71.63 0.07 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.733 0.301 . . . . 65.21 110.703 -177.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.538 ' O ' HG23 ' A' ' 36' ' ' THR . 7.3 p-10 -65.27 -34.06 77.46 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.617 -0.512 . . . . 71.43 109.617 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -52.28 -44.72 65.14 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.7 -1.136 . . . . 73.12 111.55 -176.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.421 ' HZ2' HG21 ' A' ' 26' ' ' ILE . 16.7 ptmt -100.9 -25.79 13.97 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.568 -0.287 . . . . 53.44 111.139 -177.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.3 t -78.49 -61.45 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 112.12 0.415 . . . . 63.51 112.12 -176.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 32' ' ' ASP . 11.9 t -84.32 0.35 49.47 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.005 0.431 . . . . 74.43 110.889 -170.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.6 m -98.82 -4.74 32.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.339 -0.392 . . . . 73.22 111.044 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.538 ' SG ' HG23 ' A' ' 42' ' ' ILE . 47.8 t -71.97 100.06 2.38 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.024 0.44 . . . . 62.14 111.034 -175.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -93.18 2.32 56.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.391 0.615 . . . . 70.23 109.548 176.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -63.09 -14.56 49.92 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.479 -0.782 . . . . 63.24 111.168 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.573 ' O ' ' HE3' ' A' ' 103' ' ' LYS . 32.8 m-80 69.21 19.63 7.81 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.749 -0.659 . . . . 71.21 110.946 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.538 HG23 ' SG ' ' A' ' 38' ' ' CYS . 10.9 tt -88.97 146.63 5.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 108.495 -0.928 . . . . 74.52 108.495 172.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.652 HD11 ' HB3' ' A' ' 101' ' ' MET . 68.7 tp -85.6 113.6 21.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.251 0.548 . . . . 74.32 110.648 -176.499 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 57.4 mt -94.64 123.62 46.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.199 -0.909 . . . . 75.35 110.331 177.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.504 ' HB2' HG12 ' A' ' 76' ' ' ILE . 2.2 mm? -104.74 104.36 14.15 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.334 -0.617 . . . . 72.54 109.334 178.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 35.9 m -99.1 130.29 48.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 110.357 -0.238 . . . . 71.44 110.357 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.492 ' HB2' HG13 ' A' ' 99' ' ' ILE . 27.0 t70 -122.62 141.29 51.88 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 120.923 0.392 . . . . 64.5 111.434 -177.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -79.85 100.4 7.99 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.699 -0.852 . . . . 73.03 108.699 172.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 72.5 t90 -40.09 104.96 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 O-C-N 124.248 0.967 . . . . 75.11 112.454 -171.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -157.3 148.05 16.29 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 115.725 -0.671 . . . . 60.02 110.29 177.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.439 ' HG2' ' HA ' ' A' ' 9' ' ' MET . 45.9 Cg_exo -57.72 109.13 0.44 Allowed 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.788 2.326 . . . . 74.34 112.549 179.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 13.0 p90 -70.06 83.77 0.51 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.795 -0.639 . . . . 74.15 112.028 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 84.7 m 72.56 -62.22 0.47 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.518 0.727 . . . . 72.24 112.698 173.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -73.3 -147.54 0.95 Allowed Glycine 0 CA--C 1.521 0.446 0 C-N-CA 121.482 -0.39 . . . . 63.14 113.031 -176.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.45 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 29.7 Cg_endo -64.2 -69.73 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.342 2.028 . . . . 62.11 111.68 178.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 55' ' ' PRO . 49.2 t 172.51 26.83 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 O-C-N 123.492 0.495 . . . . 70.01 109.913 178.182 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . 0.46 ' HG2' ' N ' ' A' ' 58' ' ' SER . 47.4 ttp180 -130.5 163.46 26.96 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.461 -0.336 . . . . 75.25 110.129 -175.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.46 ' N ' ' HG2' ' A' ' 57' ' ' ARG . 32.5 t -54.42 120.9 7.25 Favored 'General case' 0 C--O 1.239 0.519 0 O-C-N 123.386 0.429 . . . . 52.33 110.29 176.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 35.9 tp -134.0 34.79 3.33 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.423 0.63 . . . . 73.5 109.354 -176.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 55.29 55.0 10.22 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 115.321 -0.854 . . . . 73.14 111.014 -174.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.433 ' HD2' ' HB2' ' A' ' 64' ' ' GLU . 86.4 Cg_endo -81.37 165.3 18.76 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.262 1.975 . . . . 71.23 111.4 178.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.666 ' NE2' ' HA ' ' A' ' 114' ' ' ALA . 0.4 OUTLIER -45.15 -57.56 3.83 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.179 0.592 . . . . 74.1 111.931 -173.636 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.422 ' HG ' HG12 ' A' ' 99' ' ' ILE . 3.5 mm? -60.71 -48.6 81.07 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.392 -0.822 . . . . 74.22 111.25 -172.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.501 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 39.7 mt-10 -66.0 -37.66 86.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.965 0.412 . . . . 74.41 110.221 178.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 42.2 tptt -60.71 -45.07 95.63 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.501 -0.772 . . . . 71.31 110.405 -174.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.715 HD13 HD12 ' A' ' 123' ' ' ILE . 23.9 mt -79.95 -30.31 39.83 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.515 -0.312 . . . . 73.24 110.988 176.137 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.68 -33.62 74.31 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.699 0.285 . . . . 61.5 110.847 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.501 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 78.4 mt-30 -56.07 -31.79 63.53 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.048 0.452 . . . . 70.24 110.547 177.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -93.9 -53.78 3.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.74 -0.663 . . . . 65.55 111.041 -178.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.494 ' O ' HG23 ' A' ' 74' ' ' VAL . 14.4 m-85 -95.73 23.11 6.48 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.604 -0.725 . . . . 75.23 112.822 -168.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.7 t -52.78 -28.64 23.34 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.77 0.319 . . . . 74.33 111.69 -176.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -71.03 -18.71 62.57 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.603 -0.272 . . . . 53.34 111.642 -177.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -120.65 1.07 10.54 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.654 0.264 . . . . 72.31 110.554 -176.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 70' ' ' TYR . 27.9 m -133.57 145.79 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 O-C-N 122.019 -0.426 . . . . 73.54 111.312 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -141.09 124.43 16.6 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.143 -0.688 . . . . 63.31 109.143 172.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.504 HG12 ' HB2' ' A' ' 45' ' ' LEU . 49.5 mt -103.26 135.14 42.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 110.084 -0.339 . . . . 74.42 110.084 -175.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.491 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 74.1 m-85 -126.29 128.68 47.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.884 0.374 . . . . 72.2 110.242 178.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -97.54 139.29 33.67 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.719 -0.845 . . . . 72.22 108.719 176.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 20.6 tt -136.7 141.72 40.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.862 -0.422 . . . . 72.5 109.862 176.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -62.55 167.88 4.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.942 -0.572 . . . . 55.21 111.512 -173.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 29.7 pt -55.98 -12.67 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 115.66 -0.7 . . . . 61.14 111.831 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -49.12 -40.37 32.09 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.821 -0.627 . . . . 71.24 111.132 173.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.601 ' O ' ' HG3' ' A' ' 85' ' ' GLN . 24.8 t70 -77.03 12.48 1.38 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.034 -0.53 . . . . 64.43 112.115 -172.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -55.86 103.62 0.11 Allowed 'General case' 0 C--N 1.327 -0.38 0 O-C-N 121.793 -0.567 . . . . 73.35 109.695 172.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.601 ' HG3' ' O ' ' A' ' 83' ' ' ASP . 24.3 mt-30 -109.49 174.21 5.97 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.001 -0.74 . . . . 74.21 109.001 -178.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -71.61 -31.64 67.13 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.993 -1.003 . . . . 61.45 109.564 174.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.0 t -55.63 -34.98 37.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 115.057 -0.974 . . . . 75.03 111.024 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.12 -52.48 65.15 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.21 0.528 . . . . 73.53 110.398 178.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 29.7 m -67.44 -28.32 67.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.748 -0.66 . . . . 71.01 110.389 178.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -63.41 -42.69 98.76 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.875 -0.602 . . . . 72.23 110.19 178.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -74.89 -17.19 60.62 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.274 -0.421 . . . . 74.44 110.725 176.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 86.9 36.73 8.93 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 121.226 -0.512 . . . . 71.21 112.395 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 99.3 t -70.34 92.52 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-O 121.126 0.488 . . . . 73.5 110.028 176.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.7 m -70.53 -33.39 71.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.56 -0.745 . . . . 73.31 111.367 -178.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -148.11 145.8 28.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.881 0.372 . . . . 73.13 111.187 -176.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.538 ' HB ' ' HA ' ' A' ' 97' ' ' PRO . 17.3 pt -101.43 161.68 22.83 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 115.46 -0.791 . . . . 72.43 109.626 177.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.538 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 93.9 Cg_endo -74.49 169.97 72.62 Favored 'Cis proline' 0 C--N 1.357 0.999 0 C-N-CA 124.585 -1.006 . . . . 65.31 113.243 3.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 96.7 m -155.29 122.03 5.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.483 -0.781 . . . . 71.12 109.699 -175.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.505 HD11 ' N ' ' A' ' 99' ' ' ILE . 3.5 mp -106.7 108.95 26.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.123 -0.489 . . . . 75.35 110.277 -174.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.438 HD23 ' H ' ' A' ' 101' ' ' MET . 1.0 OUTLIER -92.9 136.49 33.21 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.88 -0.785 . . . . 74.23 108.88 177.755 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.886 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 69.0 mtp -101.34 117.52 35.13 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.244 -0.434 . . . . 74.11 110.943 -174.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -117.55 146.9 43.27 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 122.657 0.383 . . . . 74.43 110.524 178.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.808 ' HB3' HD22 ' A' ' 108' ' ' LEU . 84.1 tttt -166.68 135.37 2.84 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.973 -0.751 . . . . 63.31 108.973 -179.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 12.1 t30 60.24 24.91 14.3 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.575 0.702 . . . . 65.24 110.508 177.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.93 17.61 76.73 Favored Glycine 0 CA--C 1.517 0.16 0 CA-C-N 115.789 -0.641 . . . . 53.51 113.392 178.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -136.44 157.53 46.56 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 117.059 0.429 . . . . 51.24 110.265 178.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.636 ' HD2' ' H ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -83.36 142.47 31.01 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.363 -0.38 . . . . 60.31 110.085 176.62 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.808 HD22 ' HB3' ' A' ' 103' ' ' LYS . 2.9 mm? -111.47 -53.03 2.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.308 -0.406 . . . . 72.55 110.928 -178.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.886 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 14.2 m -158.26 172.17 18.87 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.949 -0.569 . . . . 74.54 110.124 -171.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -142.82 140.32 31.26 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.157 0.503 . . . . 75.32 111.76 -175.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.563 HG23 HG23 ' A' ' 119' ' ' ILE . 32.8 t -115.81 134.44 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 115.613 -0.721 . . . . 64.25 109.677 178.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 43.2 mt -126.15 106.89 16.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.899 0.381 . . . . 75.11 109.987 178.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 71.96 -85.86 0.47 Allowed Glycine 0 CA--C 1.521 0.425 0 CA-C-N 116.109 -0.496 . . . . 74.41 112.98 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.666 ' HA ' ' NE2' ' A' ' 62' ' ' GLN . . . -151.49 103.08 2.94 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 122.723 -0.28 . . . . 71.33 111.292 -174.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.449 ' O ' HG22 ' A' ' 119' ' ' ILE . 20.3 m-20 -132.49 63.28 1.63 Allowed 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 109.596 -0.52 . . . . 74.42 109.596 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.545 ' O ' HG13 ' A' ' 119' ' ' ILE . 6.8 tp -53.49 -51.57 40.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 N-CA-C 112.359 0.503 . . . . 73.12 112.359 -172.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.3 p -63.87 -28.1 69.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.33 0.586 . . . . 71.15 111.193 -178.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.412 ' HE2' ' HB2' ' A' ' 115' ' ' ASP . 3.0 tmmm? -79.47 -45.34 19.58 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.628 -0.715 . . . . 71.04 109.865 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.563 HG23 HG23 ' A' ' 111' ' ' VAL . 2.5 pp -69.26 -37.37 75.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 115.778 -0.647 . . . . 71.22 111.204 -174.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.466 HD12 ' N ' ' A' ' 121' ' ' SER . 2.9 pp -63.28 -31.92 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 C-N-CA 120.08 -0.648 . . . . 75.31 110.036 177.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.466 ' N ' HD12 ' A' ' 120' ' ' ILE . 45.0 t -70.52 -51.51 28.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.98 -0.555 . . . . 62.24 110.916 178.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.563 ' HG2' ' HA ' ' A' ' 119' ' ' ILE . 24.2 pt-20 -72.1 -48.93 40.28 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.151 0.426 . . . . 74.32 112.151 -174.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.715 HD12 HD13 ' A' ' 66' ' ' LEU . 83.4 mt -59.38 -55.81 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.597 0.237 . . . . 72.53 110.852 -177.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -58.77 -20.31 48.58 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.991 0.425 . . . . 72.01 111.044 -178.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -84.12 -35.55 23.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.032 -0.531 . . . . 63.32 111.06 177.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -91.69 -9.34 44.22 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.192 -0.458 . . . . 73.11 111.929 -172.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 123' ' ' ILE . 45.4 pt -133.94 168.19 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 120.689 0.28 . . . . 71.04 110.691 175.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.245 0.857 0 CA-C-O 118.802 -0.618 . . . . 74.44 110.624 -175.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.63 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.13 0 CA-C-O 121.102 0.477 . . . . 64.12 110.615 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -175.44 159.2 2.4 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.03 -0.532 . . . . 74.33 110.728 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -129.73 150.26 51.11 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.698 -0.853 . . . . 73.01 108.698 175.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -82.0 62.33 5.71 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.437 0.637 . . . . 75.42 111.117 -177.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.7 m80 -148.8 106.94 3.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.174 -0.921 . . . . 74.22 108.621 173.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -136.49 -50.67 0.68 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.899 0.381 . . . . 75.11 110.198 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 19.6 p80 -75.18 144.72 42.58 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.085 -0.507 . . . . 65.21 109.762 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -85.95 178.43 7.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.374 -0.375 . . . . 71.34 110.376 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 69.6 mtm -140.94 -173.98 3.86 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.971 -0.381 . . . . 61.33 109.971 179.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.05 150.81 22.84 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 121.272 -0.489 . . . . 54.42 112.169 178.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 26.1 p -108.22 101.11 10.35 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 122.472 0.309 . . . . 74.43 110.23 178.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.6 pp -82.17 179.45 7.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.317 -0.402 . . . . 75.13 110.486 -179.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -117.87 145.3 44.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.847 0.356 . . . . 74.12 110.293 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -146.83 134.36 20.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.034 -0.53 . . . . 75.44 110.002 179.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -98.5 75.5 2.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.347 0.594 . . . . 71.2 109.682 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 32.3 p -130.49 -73.02 0.55 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.525 -0.761 . . . . 74.34 110.422 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.02 155.99 28.5 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.281 -0.418 . . . . 73.13 110.128 178.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -130.23 -79.0 0.2 Allowed Glycine 0 CA--C 1.518 0.249 0 C-N-CA 121.155 -0.545 . . . . 72.22 112.106 178.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -69.48 103.88 1.18 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.794 2.329 . . . . 73.22 111.943 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -112.54 -4.71 24.86 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 121.321 -0.466 . . . . 71.45 112.33 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 44.5 t -97.5 107.4 19.89 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.529 -0.545 . . . . 64.02 109.529 178.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.512 ' N ' ' SD ' ' A' ' 22' ' ' MET . 1.4 mpt? -61.9 -38.25 87.65 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.126 -0.488 . . . . 73.25 111.105 -176.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.9 mt -111.66 128.11 68.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 115.898 -0.592 . . . . 74.4 110.337 -175.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.455 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 0.9 OUTLIER -122.0 144.22 49.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.326 -0.397 . . . . 71.41 109.952 -179.556 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.41 137.79 33.13 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 110.223 -0.288 . . . . 65.14 110.223 177.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.477 HG21 ' HD3' ' A' ' 34' ' ' LYS . 36.2 pt -140.22 172.96 11.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 121.337 0.589 . . . . 73.54 111.399 -176.664 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -110.73 173.91 16.61 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.236 -0.893 . . . . 13.31 111.809 177.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -67.29 -33.68 75.81 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.684 0.253 . . . . 75.21 111.684 -177.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 44.6 m -64.48 -47.56 78.52 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.091 0.472 . . . . 64.12 110.804 -178.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.514 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 3.8 pm0 -84.29 -14.46 49.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.762 -0.654 . . . . 71.55 111.072 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.591 ' HE1' HG13 ' A' ' 46' ' ' VAL . 92.4 t80 -46.23 -70.08 0.11 Allowed 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.384 0.427 . . . . 65.21 110.726 -178.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -61.68 -39.85 92.9 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 121.128 0.489 . . . . 71.43 109.726 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.421 ' O ' ' HB2' ' A' ' 37' ' ' SER . 9.4 t-20 -56.35 -33.76 65.98 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.617 -1.174 . . . . 73.12 112.216 -171.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.514 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 18.7 ptmt -115.16 -21.85 9.76 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.711 0.263 . . . . 53.44 111.711 -177.68 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 93.6 t -88.5 -55.63 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 111.727 0.269 . . . . 63.51 111.727 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 30.8 p -85.87 -25.24 26.32 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.076 0.465 . . . . 74.43 110.796 -173.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 16.0 m -84.67 12.03 7.91 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.997 -0.547 . . . . 73.22 110.547 176.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 43.5 t -75.22 94.73 3.02 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.868 0.366 . . . . 62.14 110.548 178.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -91.88 1.31 57.26 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.138 -0.483 . . . . 70.23 110.563 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -72.22 -7.79 51.22 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.197 -0.456 . . . . 63.24 111.499 -176.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 64.39 15.82 9.77 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.18 -0.464 . . . . 71.21 111.397 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.9 tt -85.04 147.82 5.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 108.507 -0.923 . . . . 74.52 108.507 173.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.716 HD21 ' HE3' ' A' ' 101' ' ' MET . 61.2 tp -85.31 120.68 27.07 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.338 0.589 . . . . 74.32 110.682 -175.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 51.1 mt -106.98 126.02 63.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.379 -0.828 . . . . 75.35 110.392 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.423 HD11 ' N ' ' A' ' 45' ' ' LEU . 5.8 mp -108.81 110.13 21.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.317 -0.401 . . . . 72.54 110.067 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.591 HG13 ' HE1' ' A' ' 31' ' ' PHE . 59.3 t -96.96 111.26 26.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.812 -0.44 . . . . 71.44 109.812 176.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.424 ' OD1' ' NZ ' ' A' ' 78' ' ' LYS . 1.7 p30 -91.24 154.64 19.14 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.077 0.465 . . . . 64.5 110.62 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -109.92 26.33 10.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.664 -0.698 . . . . 73.03 110.173 178.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 76.5 t90 -75.69 115.76 15.71 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.724 -0.843 . . . . 75.11 108.724 175.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -47.14 115.9 3.78 Favored Pre-proline 0 CA--C 1.531 0.218 0 O-C-N 123.84 0.712 . . . . 60.02 111.697 -175.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.454 ' HG3' ' HE3' ' A' ' 78' ' ' LYS . 18.8 Cg_exo -65.78 78.41 0.28 Allowed 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.808 2.339 . . . . 74.34 111.423 177.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 55.2 t-105 -150.77 142.55 23.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.713 -0.676 . . . . 74.15 109.808 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 52.1 t -79.53 84.81 5.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.144 0.497 . . . . 72.24 110.317 -179.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -173.73 67.03 0.11 Allowed Glycine 0 N--CA 1.453 -0.208 0 CA-C-N 115.729 -0.668 . . . . 63.14 112.172 177.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -92.1 10.91 2.41 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.029 2.486 . . . . 62.11 112.663 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 45.8 t 65.02 -73.7 0.06 Allowed 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 122.957 0.503 . . . . 70.01 109.82 -174.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.8 ttp180 -127.51 118.18 23.51 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.784 -0.821 . . . . 75.25 108.784 174.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.6 p -69.1 141.77 54.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.372 -0.376 . . . . 52.33 111.141 -177.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.09 155.67 23.4 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.99 -0.55 . . . . 73.5 109.529 176.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -83.15 111.57 31.73 Favored Pre-proline 0 C--O 1.235 0.3 0 N-CA-C 109.907 -0.405 . . . . 73.14 109.907 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -76.9 -174.29 2.11 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.628 2.219 . . . . 71.23 111.911 178.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.408 ' HB3' ' CD1' ' A' ' 119' ' ' ILE . 13.9 mp0 -57.74 -48.45 79.58 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.599 0.714 . . . . 74.1 110.466 -175.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.579 HD23 HG12 ' A' ' 99' ' ' ILE . 8.1 mp -55.55 -49.08 73.61 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 114.586 -1.188 . . . . 74.22 111.627 -174.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -71.15 -36.45 72.06 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.224 -0.287 . . . . 74.41 110.224 -177.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 65' ' ' LYS . 41.3 mmtt -55.58 -51.67 66.33 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.234 -0.439 . . . . 71.31 111.248 178.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.619 HD12 HD12 ' A' ' 123' ' ' ILE . 28.5 mt -76.38 -40.9 49.75 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 120.368 -0.533 . . . . 73.24 111.493 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.417 ' HB3' ' HB3' ' A' ' 22' ' ' MET . . . -59.68 -38.3 81.13 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 111.714 0.265 . . . . 61.5 111.714 -175.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -53.93 -33.07 55.71 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.751 0.31 . . . . 70.24 110.901 179.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 70.5 mm-40 -93.89 -41.09 9.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.031 -0.531 . . . . 65.55 111.17 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.478 ' O ' HG21 ' A' ' 74' ' ' VAL . 19.3 m-85 -107.42 17.46 22.75 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.957 0.725 . . . . 75.23 112.957 -168.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.0 t -53.95 -32.73 54.71 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.312 0.506 . . . . 74.33 112.188 -174.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -68.43 -16.69 64.0 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.804 0.335 . . . . 53.34 111.302 -178.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -114.47 -13.96 12.18 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.173 -0.467 . . . . 72.31 110.321 -178.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.478 HG21 ' O ' ' A' ' 70' ' ' TYR . 26.8 m -134.98 127.31 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 120.934 0.397 . . . . 73.54 110.688 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -118.42 122.83 43.75 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.57 -0.53 . . . . 63.31 109.57 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.446 HD12 ' HB3' ' A' ' 63' ' ' LEU . 60.7 mt -98.97 141.0 17.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.911 0.386 . . . . 74.42 110.913 -175.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.455 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 87.6 m-85 -133.63 157.93 44.52 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.076 -0.713 . . . . 72.2 109.076 175.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.454 ' HE3' ' HG3' ' A' ' 51' ' ' PRO . 0.4 OUTLIER -141.33 148.82 40.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.872 0.367 . . . . 72.22 110.799 179.244 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.4 pp -135.32 179.74 3.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.525 -0.761 . . . . 72.5 110.423 -179.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -137.03 89.09 2.41 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.877 0.37 . . . . 55.21 110.522 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.5 HG22 ' HB3' ' A' ' 84' ' ' ASN . 66.8 mt -145.85 111.01 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 108.962 -0.755 . . . . 61.14 108.962 177.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.3 mp0 -84.93 -72.43 0.48 Allowed 'General case' 0 C--O 1.235 0.342 0 N-CA-C 111.684 0.253 . . . . 71.24 111.684 -174.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -106.14 -8.3 17.5 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.502 -0.317 . . . . 64.43 111.54 -172.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.5 ' HB3' HG22 ' A' ' 81' ' ' ILE . 17.2 t-20 -84.83 18.62 2.35 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.377 0.608 . . . . 73.35 110.604 -177.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -126.02 136.95 53.56 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.074 -0.512 . . . . 74.21 110.572 -177.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -69.74 -31.74 69.9 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.846 -0.427 . . . . 61.45 109.846 174.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 97.0 t -47.22 -53.23 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 115.446 -0.797 . . . . 75.03 112.396 -173.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.68 -52.89 62.31 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.434 -0.348 . . . . 73.53 111.431 -176.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.1 m -72.3 -28.16 62.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 71.01 110.931 -179.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -65.6 -40.78 93.03 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.97 -0.559 . . . . 72.23 110.092 -178.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . 0.502 ' HH ' HD13 ' A' ' 100' ' ' LEU . 80.4 m-85 -88.23 -17.17 31.37 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.564 -0.744 . . . . 74.44 110.363 175.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 63.43 50.56 61.38 Favored Glycine 0 C--N 1.333 0.412 0 N-CA-C 111.19 -0.764 . . . . 71.21 111.19 -175.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.7 p -56.25 115.18 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.242 0.544 . . . . 73.5 111.187 -176.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.9 m -96.96 -14.26 21.82 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.813 -0.631 . . . . 73.31 110.855 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.77 131.66 15.15 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.705 0.288 . . . . 73.13 111.208 -177.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.521 ' HB ' ' HA ' ' A' ' 97' ' ' PRO . 2.8 pp -96.11 161.7 26.29 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 116.038 -0.528 . . . . 72.43 110.123 175.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.521 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 3.3 Cg_exo -76.83 176.52 43.59 Favored 'Cis proline' 0 C--N 1.355 0.888 0 C-N-CA 124.389 -1.088 . . . . 65.31 112.314 -0.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 15.9 m -134.32 121.35 21.11 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.221 -0.445 . . . . 71.12 110.098 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.632 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 3.7 mp -117.07 125.8 74.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.331 -0.618 . . . . 75.35 109.331 179.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.502 HD13 ' HH ' ' A' ' 91' ' ' TYR . 0.8 OUTLIER -106.92 128.9 54.72 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.794 0.331 . . . . 74.23 110.129 -177.566 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.741 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 65.9 mtp -100.74 113.26 25.99 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.117 -0.492 . . . . 74.11 110.772 -177.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -111.42 146.61 36.88 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.076 -0.511 . . . . 74.43 110.749 178.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.783 ' HB3' HD21 ' A' ' 108' ' ' LEU . 33.9 ttpt -160.06 130.89 5.68 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.889 -0.782 . . . . 63.31 108.889 177.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 31.5 t-20 55.11 31.61 16.63 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.681 0.753 . . . . 65.24 110.101 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 74.84 20.93 79.26 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.313 -0.858 . . . . 53.51 113.42 176.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -129.3 155.2 45.97 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.758 0.279 . . . . 51.24 110.663 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.53 120.14 32.69 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.765 0.317 . . . . 60.31 110.168 177.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.783 HD21 ' HB3' ' A' ' 103' ' ' LYS . 2.0 mm? -92.89 -51.87 4.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.332 -0.395 . . . . 72.55 110.323 -178.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.741 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 49.7 m -153.96 171.54 18.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.59 -0.732 . . . . 74.54 110.592 -175.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -146.16 124.89 12.57 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.992 -0.549 . . . . 75.32 110.546 176.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.632 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 52.5 t -82.55 107.12 14.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.697 -0.483 . . . . 64.25 109.697 176.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 64.5 mt -109.18 108.67 25.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.813 -0.44 . . . . 75.11 109.813 178.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.0 -122.9 7.74 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.18 -0.534 . . . . 74.41 111.783 -178.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.24 88.15 1.0 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.779 0.323 . . . . 71.33 110.27 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.471 ' O ' HG21 ' A' ' 119' ' ' ILE . 3.6 m-20 -126.7 86.58 2.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.274 -0.421 . . . . 74.42 110.282 -177.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.512 ' O ' HG13 ' A' ' 119' ' ' ILE . 7.7 tp -55.57 -44.76 77.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 116.242 -0.435 . . . . 73.12 111.807 -176.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.5 t -68.09 -26.48 65.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.07 0.462 . . . . 71.15 110.655 -175.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.485 ' HZ1' ' CD ' ' A' ' 122' ' ' GLU . 14.7 tmtt? -79.71 -45.6 18.64 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 116.086 -0.506 . . . . 71.04 110.269 179.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.512 HG13 ' O ' ' A' ' 116' ' ' ILE . 2.1 pp -67.87 -40.27 83.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 115.853 -0.612 . . . . 71.22 111.088 -175.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.467 HG21 HD13 ' A' ' 66' ' ' LEU . 2.8 pp -61.79 -32.23 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 120.439 -0.505 . . . . 75.31 110.029 178.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.465 ' N ' HD13 ' A' ' 120' ' ' ILE . 27.9 t -70.29 -51.77 27.89 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.867 -0.606 . . . . 62.24 110.379 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.522 ' HB2' ' HG ' ' A' ' 109' ' ' SER . 21.0 pt-20 -72.02 -34.33 68.75 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.186 0.439 . . . . 74.32 112.186 -175.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.619 HD12 HD12 ' A' ' 66' ' ' LEU . 66.8 mt -71.02 -47.97 58.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-O 120.661 0.267 . . . . 72.53 110.795 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -66.77 -20.12 65.89 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.948 0.404 . . . . 72.01 111.247 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -74.02 -6.13 45.57 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.458 -0.337 . . . . 63.32 111.172 174.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -113.93 -49.0 2.88 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.826 0.346 . . . . 73.11 110.648 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 33.6 pt -100.38 168.03 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.779 -0.646 . . . . 71.04 110.665 -177.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.449 ' N ' HD21 ' A' ' 128' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.161 0 CA-C-O 118.355 -0.831 . . . . 74.44 110.723 178.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.2 ttp . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 110.328 -0.249 . . . . 64.12 110.328 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 74.83 -51.3 0.67 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.418 0.687 . . . . 74.33 112.474 176.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -63.88 103.82 0.62 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.782 0.325 . . . . 73.01 111.331 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -82.79 154.49 24.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.263 -0.426 . . . . 75.42 109.983 178.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -90.62 157.1 17.66 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.303 -0.258 . . . . 74.22 110.303 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 49.1 m80 69.31 152.45 0.1 Allowed 'General case' 0 N--CA 1.466 0.363 0 O-C-N 123.642 0.588 . . . . 75.11 111.088 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -157.83 75.0 0.75 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.628 -0.714 . . . . 65.21 110.226 -177.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -99.2 81.55 2.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.038 0.447 . . . . 71.34 110.569 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.416 ' N ' ' SD ' ' A' ' 9' ' ' MET . 3.7 mpp? -69.21 91.51 0.52 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.388 -0.597 . . . . 61.33 109.388 175.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.74 -7.95 87.96 Favored Glycine 0 N--CA 1.453 -0.171 0 CA-C-N 115.813 -0.63 . . . . 54.42 112.88 -177.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 34.4 p -71.58 95.94 1.49 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.887 0.375 . . . . 74.43 110.283 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 59.6 tp -130.41 101.79 5.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 75.13 110.943 -177.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -171.19 116.4 0.43 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.586 -0.734 . . . . 74.12 109.333 174.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -168.05 131.39 1.59 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.34 -0.391 . . . . 75.44 110.796 -178.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -62.99 105.92 0.75 Allowed 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.044 -0.525 . . . . 71.2 110.056 176.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.3 p -69.74 89.65 0.56 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.26 0.552 . . . . 74.34 111.695 -176.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -96.15 147.37 23.81 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.794 -0.639 . . . . 73.13 110.301 176.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -54.83 -75.62 0.23 Allowed Glycine 0 CA--C 1.522 0.484 0 CA-C-N 116.012 -0.54 . . . . 72.22 113.701 -175.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -66.25 -4.47 10.57 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.797 2.331 . . . . 73.22 112.913 -176.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -86.9 -45.21 5.49 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 111.722 -0.551 . . . . 71.45 111.722 177.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 41.9 t -92.58 91.72 7.7 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.085 -0.339 . . . . 64.02 110.085 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.718 ' HG3' HG12 ' A' ' 23' ' ' ILE . 25.3 ptt? -72.02 -39.09 69.42 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.415 -0.357 . . . . 73.25 110.655 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.718 HG12 ' HG3' ' A' ' 22' ' ' MET . 14.6 mm -113.78 108.82 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 N-CA-C 109.043 -0.725 . . . . 74.4 109.043 178.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.567 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 36.1 tt0 -122.73 131.98 54.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.733 0.301 . . . . 71.41 110.536 -172.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -90.22 128.89 36.5 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.641 -0.503 . . . . 65.14 109.641 178.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.454 HG21 ' HD3' ' A' ' 34' ' ' LYS . 47.5 pt -130.9 165.94 29.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-O 121.056 0.455 . . . . 73.54 111.492 -175.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -111.79 169.26 13.07 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.576 -0.738 . . . . 13.31 112.845 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -52.25 -38.85 59.35 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 122.824 0.45 . . . . 75.21 111.407 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.5 t -59.36 -21.88 60.5 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.821 -0.627 . . . . 64.12 112.251 -175.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.465 ' HA ' ' HB2' ' A' ' 33' ' ' ASN . 11.3 pt-20 -125.64 -3.34 7.24 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 111.679 0.251 . . . . 71.55 111.679 -175.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -51.61 -70.8 0.08 Allowed 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.192 0.308 . . . . 65.21 111.152 -177.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -58.8 -42.71 89.75 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.638 0.733 . . . . 71.43 109.429 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.465 ' HB2' ' HA ' ' A' ' 30' ' ' GLU . 1.5 m-80 -52.44 -38.25 58.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 113.829 -1.532 . . . . 73.12 112.795 -172.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.454 ' HD3' HG21 ' A' ' 26' ' ' ILE . 16.1 ptmt -111.31 -19.58 12.59 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.023 0.379 . . . . 53.44 112.023 -177.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.6 t -88.26 -55.32 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 111.928 0.344 . . . . 63.51 111.928 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 45.7 p -77.92 -38.3 45.89 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.171 0.51 . . . . 74.43 110.78 -173.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.7 m -79.89 9.29 5.47 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.854 -0.612 . . . . 73.22 111.511 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 53.2 t -75.44 111.38 10.66 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.798 0.332 . . . . 62.14 111.066 -178.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -116.69 15.1 15.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.026 -0.534 . . . . 70.23 110.317 178.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -68.96 -2.46 9.87 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.828 -0.624 . . . . 63.24 112.08 -177.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . 0.435 ' O ' ' HE3' ' A' ' 103' ' ' LYS . 18.3 m120 70.18 6.26 5.69 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 122.954 0.502 . . . . 71.21 111.071 -177.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.3 tt -89.09 157.08 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.331 -0.618 . . . . 74.52 109.331 178.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.446 HD22 ' HE3' ' A' ' 101' ' ' MET . 63.7 tp -96.26 118.23 32.41 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.155 -0.313 . . . . 74.32 110.155 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 101' ' ' MET . 48.8 mt -97.96 124.79 51.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.163 -0.471 . . . . 75.35 110.703 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.514 ' HB2' HG13 ' A' ' 76' ' ' ILE . 3.3 mp -115.7 105.77 13.12 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.654 -0.499 . . . . 72.54 109.654 178.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.52 HG12 ' HB2' ' A' ' 77' ' ' TYR . 30.9 m -97.01 121.69 47.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 CA-C-N 116.625 -0.261 . . . . 71.44 110.32 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.414 ' OD1' ' HG2' ' A' ' 78' ' ' LYS . 5.8 p-10 -104.63 125.42 50.73 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.391 0.615 . . . . 64.5 109.823 176.525 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -75.25 100.65 4.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.414 -0.812 . . . . 73.03 111.497 -176.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.561 ' NE1' ' HA ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER 35.95 84.47 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 O-C-N 124.487 1.117 . . . . 75.11 113.639 171.97 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.97 154.85 49.95 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 115.582 -0.736 . . . . 60.02 110.04 174.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -53.91 155.16 15.22 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.925 2.416 . . . . 74.34 112.579 178.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 18.0 p90 -73.03 178.69 4.17 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.039 -0.528 . . . . 74.15 111.632 -176.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.509 ' SG ' ' N ' ' A' ' 54' ' ' GLY . 54.1 t -135.03 179.05 6.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.7 -0.682 . . . . 72.24 110.401 -176.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.509 ' N ' ' SG ' ' A' ' 53' ' ' CYS . . . -85.16 -177.41 50.81 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 111.726 -0.55 . . . . 63.14 111.726 175.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -57.49 -34.07 97.43 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.04 2.494 . . . . 62.11 112.663 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 25.8 p -115.87 142.79 46.3 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.216 -0.447 . . . . 70.01 109.898 177.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -75.27 82.37 2.4 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.743 -0.466 . . . . 75.25 109.743 -178.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.5 t -62.46 -32.45 73.33 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.74 -0.663 . . . . 52.33 110.468 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.4 pp -159.7 151.34 20.14 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.493 -0.776 . . . . 73.5 109.71 176.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.426 ' HB2' ' HB2' ' A' ' 64' ' ' GLU . 1.0 OUTLIER -137.26 150.8 70.14 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.828 -0.624 . . . . 73.14 109.975 -179.734 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -65.91 177.88 2.69 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.79 2.327 . . . . 71.23 112.952 -177.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.693 ' HB3' HG12 ' A' ' 119' ' ' ILE . 11.5 mp0 -51.18 -49.03 61.74 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 115.316 -0.857 . . . . 74.1 111.65 -173.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.511 HD13 HG21 ' A' ' 111' ' ' VAL . 2.5 mm? -64.25 -46.13 85.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.852 -1.067 . . . . 74.22 110.124 -172.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.574 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 55.0 mt-10 -68.0 -32.51 72.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.747 -0.66 . . . . 74.41 110.449 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -58.41 -56.66 19.23 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.342 -0.39 . . . . 71.31 110.634 176.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.565 HD13 HD13 ' A' ' 123' ' ' ILE . 22.5 mt -69.13 -30.11 68.29 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 120.825 -0.35 . . . . 73.24 110.861 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.21 -36.35 70.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.419 -0.355 . . . . 61.5 111.278 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.574 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 84.2 mt-30 -56.25 -32.98 65.0 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.286 -0.415 . . . . 70.24 111.006 -178.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -94.01 -56.59 2.81 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.322 0.582 . . . . 65.55 110.826 178.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.515 ' O ' HG23 ' A' ' 74' ' ' VAL . 22.2 m-85 -82.52 21.69 0.94 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.645 -0.707 . . . . 75.23 112.336 -173.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.445 ' OG1' ' HB3' ' A' ' 22' ' ' MET . 8.8 t -52.46 -31.26 33.92 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.976 0.417 . . . . 74.33 111.698 -176.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -70.13 -18.96 63.25 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.103 -0.498 . . . . 53.34 111.542 -175.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.41 6.24 8.35 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.732 0.301 . . . . 72.31 110.815 -173.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 70' ' ' TYR . 23.1 m -137.46 145.07 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 121.117 0.484 . . . . 73.54 111.583 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.5 mmtt -129.14 114.86 16.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.528 -0.76 . . . . 63.31 108.959 174.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.514 HG13 ' HB2' ' A' ' 45' ' ' LEU . 2.3 mp -100.5 138.43 24.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.559 -0.534 . . . . 74.42 109.559 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.567 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 41.2 m-85 -130.55 134.26 46.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.247 -0.433 . . . . 72.2 110.885 -177.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.414 ' HG2' ' OD1' ' A' ' 47' ' ' ASP . 55.9 mttm -109.19 111.86 23.7 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.257 -0.646 . . . . 72.22 109.257 174.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 32.0 pt -86.93 142.11 13.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.958 -0.564 . . . . 72.5 111.25 -175.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.7 p30 -90.12 -11.55 40.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.878 -0.601 . . . . 55.21 111.788 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 12.8 tt -75.01 87.19 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 121.871 0.843 . . . . 61.14 110.338 179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.561 ' HA ' ' NE1' ' A' ' 49' ' ' TRP . 9.0 pt-20 -85.44 -40.43 16.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.21 -0.905 . . . . 71.24 112.667 -174.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -84.81 -1.42 56.38 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.392 0.515 . . . . 64.43 112.392 -168.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -144.85 113.53 6.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.739 0.304 . . . . 73.35 110.826 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -144.7 104.07 3.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.462 0.649 . . . . 74.21 110.246 174.113 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -70.3 -58.4 3.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.601 -0.727 . . . . 61.45 111.082 -177.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 35.0 t -56.72 -41.78 75.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.709 -0.678 . . . . 75.03 111.182 -174.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.29 -41.39 94.18 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 116.252 -0.431 . . . . 73.53 111.001 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 88.5 m -65.76 -36.43 83.53 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.209 -0.45 . . . . 71.01 110.118 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -65.77 -37.34 86.05 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.159 -0.473 . . . . 72.23 110.228 177.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -70.72 -15.25 62.68 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.192 -0.458 . . . . 74.44 110.656 174.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.07 38.88 46.84 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.192 -0.528 . . . . 71.21 112.059 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.8 p -51.98 120.22 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 121.104 0.478 . . . . 73.5 111.168 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.4 m -124.37 6.57 8.37 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.782 -0.645 . . . . 73.31 110.609 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -156.38 126.77 6.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.09 -0.505 . . . . 73.13 110.606 -179.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.435 ' HB ' ' HA ' ' A' ' 97' ' ' PRO . 29.7 pt -101.69 156.14 35.55 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.986 -0.552 . . . . 72.43 109.755 177.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.435 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 84.5 Cg_endo -79.47 163.04 84.98 Favored 'Cis proline' 0 C--N 1.352 0.721 0 C-N-CA 123.822 -1.324 . . . . 65.31 112.709 1.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.469 HG23 HG12 ' A' ' 112' ' ' ILE . 30.6 m -128.19 115.62 18.65 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.733 -0.667 . . . . 71.12 109.36 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.602 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 3.4 mp -110.36 124.13 66.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.364 -0.38 . . . . 75.35 110.502 -176.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.4 mp -103.5 133.81 47.92 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.793 -0.447 . . . . 74.23 109.793 176.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.752 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 66.3 mtp -112.04 108.56 17.91 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.312 -0.404 . . . . 74.11 110.595 -175.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -108.76 154.83 21.49 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.162 -0.472 . . . . 74.43 111.272 -178.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.754 ' HB3' HD21 ' A' ' 108' ' ' LEU . 87.7 tttt -162.86 117.32 1.73 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.401 -0.962 . . . . 63.31 108.401 179.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 62.42 25.19 15.02 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.528 0.68 . . . . 65.24 110.416 -178.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.69 -0.44 89.19 Favored Glycine 0 C--N 1.331 0.291 0 CA-C-N 115.881 -0.599 . . . . 53.51 112.763 179.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -100.62 137.56 38.85 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.829 -0.434 . . . . 51.24 109.829 177.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.86 126.92 33.88 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.306 -0.627 . . . . 60.31 109.306 174.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.754 HD21 ' HB3' ' A' ' 103' ' ' LYS . 2.0 mm? -98.16 -51.09 4.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.224 -0.443 . . . . 72.55 110.108 -178.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.752 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 18.8 m -149.47 155.68 40.78 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.655 -0.702 . . . . 74.54 111.122 -171.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -131.04 118.85 21.16 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.802 -0.635 . . . . 75.32 109.835 175.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.602 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 50.4 t -89.78 107.09 17.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.707 -0.479 . . . . 64.25 109.707 176.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.469 HG12 HG23 ' A' ' 98' ' ' THR . 60.9 mt -112.72 117.33 55.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.613 -0.514 . . . . 75.11 109.613 179.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.75 -126.04 8.78 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 111.687 -0.565 . . . . 74.41 111.687 -178.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.52 91.46 1.16 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.711 0.291 . . . . 71.33 110.861 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -132.54 99.74 4.75 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.1 0.476 . . . . 74.42 111.155 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.628 HD12 HD12 ' A' ' 119' ' ' ILE . 7.1 tp -62.97 -40.39 88.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 115.671 -0.695 . . . . 73.12 110.58 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 32.3 t -64.8 -32.04 73.55 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.132 0.491 . . . . 71.15 110.257 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.99 -53.66 10.61 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 109.266 -0.642 . . . . 71.04 109.266 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.693 HG12 ' HB3' ' A' ' 62' ' ' GLN . 2.4 pp -62.07 -39.42 83.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 115.661 -0.7 . . . . 71.22 111.566 -173.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.443 HD13 ' N ' ' A' ' 121' ' ' SER . 2.8 pp -62.52 -31.52 52.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 120.087 -0.645 . . . . 75.31 110.208 178.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.443 ' N ' HD13 ' A' ' 120' ' ' ILE . 29.2 m -70.89 -51.43 26.29 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.194 -0.457 . . . . 62.24 110.806 178.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.477 ' OE2' ' HB3' ' A' ' 109' ' ' SER . 13.1 pt-20 -77.32 -41.91 38.82 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.603 0.594 . . . . 74.32 112.603 -173.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.565 HD13 HD13 ' A' ' 66' ' ' LEU . 74.2 mt -61.82 -55.14 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 O-C-N 122.144 -0.347 . . . . 72.53 110.611 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -59.26 -20.05 51.01 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.094 0.473 . . . . 72.01 110.816 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -79.08 -34.17 43.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.917 -0.583 . . . . 63.32 110.87 176.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -93.43 -20.87 19.9 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.372 -0.377 . . . . 73.11 111.611 -173.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.422 HG12 ' O ' ' A' ' 123' ' ' ILE . 48.5 pt -120.32 168.36 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 110.173 -0.306 . . . . 71.04 110.173 175.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.514 ' N ' HD21 ' A' ' 128' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.224 -0.893 . . . . 74.44 111.977 -176.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.567 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 110.237 -0.282 . . . . 64.12 110.237 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.35 133.0 55.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.375 -0.375 . . . . 74.33 110.56 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -97.93 164.94 12.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.032 -0.531 . . . . 73.01 110.258 178.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -84.16 131.11 34.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.284 -0.417 . . . . 75.42 111.041 -176.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -89.31 113.68 24.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.0 -0.546 . . . . 74.22 109.941 -178.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 38.4 m-70 -63.98 103.77 0.63 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.032 -0.531 . . . . 75.11 111.417 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -80.07 153.95 28.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.55 -0.75 . . . . 65.21 110.269 175.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -105.36 134.04 49.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.508 -0.315 . . . . 71.34 110.277 179.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 48.5 ttm -88.39 107.65 18.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.219 -0.446 . . . . 61.33 110.268 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -120.54 73.06 0.34 Allowed Glycine 0 C--N 1.332 0.328 0 C-N-CA 121.363 -0.446 . . . . 54.42 112.95 -177.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 62.4 m -81.18 104.49 11.69 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 110.064 -0.347 . . . . 74.43 110.064 175.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 97.6 mt -127.7 112.0 14.33 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.603 -0.271 . . . . 75.13 110.718 -178.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -175.32 145.15 0.74 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.072 -0.513 . . . . 74.12 109.904 176.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.88 128.35 35.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.445 -0.343 . . . . 75.44 110.54 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -147.87 148.65 31.08 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.465 -0.334 . . . . 71.2 110.337 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.8 t -101.7 154.15 19.14 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.331 -0.395 . . . . 74.34 110.33 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -163.74 138.21 5.94 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.702 -0.481 . . . . 73.13 109.702 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 178.49 86.53 0.07 OUTLIER Glycine 0 CA--C 1.519 0.319 0 C-N-CA 121.107 -0.568 . . . . 72.22 112.314 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.527 ' HB3' ' HG2' ' A' ' 68' ' ' GLN . 96.1 Cg_endo -82.68 174.97 9.21 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 122.883 2.389 . . . . 73.22 112.345 178.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.91 -175.08 23.63 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 121.313 -0.47 . . . . 71.45 112.439 178.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.8 p -94.84 88.32 5.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.367 0.603 . . . . 64.02 111.496 -178.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.578 ' HG3' ' HB2' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -111.82 4.75 18.59 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.639 -0.709 . . . . 73.25 109.176 170.115 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.412 HD11 ' HB ' ' A' ' 76' ' ' ILE . 8.6 mm -110.57 106.44 20.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 114.797 -1.092 . . . . 74.4 108.923 178.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.46 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 7.9 tp10 -121.1 141.4 50.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.888 0.375 . . . . 71.41 111.058 -178.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -95.58 124.15 39.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.886 -0.597 . . . . 65.14 109.535 177.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.51 HD12 ' HA ' ' A' ' 31' ' ' PHE . 27.0 pt -121.67 157.53 25.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 116.221 -0.445 . . . . 73.54 111.214 -175.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.25 170.15 37.05 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.875 -0.602 . . . . 13.31 112.107 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -66.2 -30.17 70.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.23 0.538 . . . . 75.21 110.449 -176.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.1 m -70.29 -48.76 55.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.575 -0.739 . . . . 64.12 111.156 -177.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -87.64 -13.55 42.4 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.45 -0.341 . . . . 71.55 111.274 -177.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.51 ' HA ' HD12 ' A' ' 26' ' ' ILE . 47.8 t80 -48.8 -70.15 0.1 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.873 0.368 . . . . 65.21 110.298 175.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -53.75 -43.26 68.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.946 -0.57 . . . . 71.43 109.663 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.557 ' O ' ' HB2' ' A' ' 37' ' ' SER . 0.2 OUTLIER -53.16 -50.11 65.24 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 114.734 -1.121 . . . . 73.12 111.762 -173.45 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.17 -17.08 17.56 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.195 0.443 . . . . 53.44 112.195 -173.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.5 t -88.29 -52.14 11.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 111.655 0.243 . . . . 63.51 111.655 -178.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.0 p -75.49 -45.27 39.38 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.545 0.688 . . . . 74.43 109.806 -177.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.557 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 19.9 m -77.06 12.78 1.27 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.47 -0.786 . . . . 73.22 111.107 176.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 36.1 t -28.93 101.17 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.184 0.993 . . . . 62.14 113.061 -178.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -89.62 -18.21 26.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.622 -0.717 . . . . 70.23 109.556 175.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.489 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . 2.8 m-20 -53.91 -40.33 66.57 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.685 -0.688 . . . . 63.24 110.833 -179.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 60.8 19.48 9.66 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.903 0.859 . . . . 71.21 109.636 -170.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.489 ' HB ' ' HB3' ' A' ' 40' ' ' ASP . 7.8 mt -101.02 154.24 4.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 114.086 -1.415 . . . . 74.52 108.613 175.207 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.717 HD22 ' HE3' ' A' ' 101' ' ' MET . 49.3 tp -70.15 104.9 2.74 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.505 -0.554 . . . . 74.32 109.505 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 48.1 mt -93.09 105.05 16.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.864 -0.607 . . . . 75.35 110.664 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.548 HD23 HD22 ' A' ' 63' ' ' LEU . 2.0 mp -100.28 102.98 14.38 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.434 -0.58 . . . . 72.54 109.434 178.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.499 HG21 ' HB2' ' A' ' 77' ' ' TYR . 33.2 t -99.66 123.74 52.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.422 -0.584 . . . . 71.44 109.422 178.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -108.75 131.6 54.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.529 0.681 . . . . 64.5 110.959 -178.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -85.68 88.11 7.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.091 -0.959 . . . . 73.03 109.312 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . 0.474 ' NE1' ' HB3' ' A' ' 78' ' ' LYS . 4.2 p-90 -96.51 160.82 14.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.343 -0.844 . . . . 75.11 110.683 -176.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -94.58 134.96 24.48 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.938 -0.574 . . . . 60.02 109.514 175.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -53.28 -35.27 73.65 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.769 2.313 . . . . 74.34 112.555 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -76.33 -5.73 48.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.878 -0.601 . . . . 74.15 111.338 -177.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . 0.403 ' HG ' ' HB3' ' A' ' 56' ' ' CYS . 47.6 t -91.33 9.47 31.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.387 -0.37 . . . . 72.24 110.501 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -52.23 -58.63 10.38 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 121.38 -0.438 . . . . 63.14 112.229 176.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -76.82 48.64 2.51 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.185 2.59 . . . . 62.11 111.696 174.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . 0.403 ' HB3' ' HG ' ' A' ' 53' ' ' CYS . 15.9 p -58.59 130.47 46.97 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.249 -0.432 . . . . 70.01 111.379 -179.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -80.89 76.01 7.83 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.58 -0.526 . . . . 75.25 109.58 177.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.8 t -170.4 175.56 4.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.508 -0.315 . . . . 52.33 110.234 -178.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.434 ' N ' HD21 ' A' ' 59' ' ' LEU . 2.3 pt? -163.3 154.51 16.9 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.975 -0.557 . . . . 73.5 110.006 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 56.14 63.87 5.54 Favored Pre-proline 0 C--O 1.238 0.45 0 O-C-N 123.694 0.621 . . . . 73.14 111.839 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.9 159.25 38.25 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.469 2.112 . . . . 71.23 110.923 175.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.458 ' HB3' HG12 ' A' ' 119' ' ' ILE . 7.3 mp0 -50.84 -57.46 8.4 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 121.165 0.507 . . . . 74.1 111.493 -172.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.795 HD11 HD12 ' A' ' 99' ' ' ILE . 21.7 mt -57.71 -48.84 78.45 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.461 -0.79 . . . . 74.22 111.437 -172.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.57 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 51.0 mt-10 -71.71 -32.49 67.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.961 -0.563 . . . . 74.41 110.244 -177.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -61.17 -46.23 91.35 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.974 -0.557 . . . . 71.31 110.051 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.436 HD13 HD12 ' A' ' 123' ' ' ILE . 37.6 mt -74.56 -37.22 63.03 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.447 -0.342 . . . . 73.24 110.919 175.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.578 ' HB2' ' HG3' ' A' ' 22' ' ' MET . . . -58.14 -31.11 66.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 61.5 111.603 -177.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.57 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 77.9 mt-30 -54.56 -33.26 59.86 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.862 0.363 . . . . 70.24 110.712 177.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -94.36 -42.25 8.99 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.051 -0.522 . . . . 65.55 111.592 177.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.525 ' O ' HG22 ' A' ' 74' ' ' VAL . 11.5 m-85 -103.41 22.34 14.39 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.461 0.541 . . . . 75.23 112.461 -168.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.44 ' OG1' ' HB3' ' A' ' 22' ' ' MET . 5.3 t -52.28 -35.04 49.14 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.412 0.523 . . . . 74.33 112.412 -172.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -71.35 -16.11 62.42 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.212 0.449 . . . . 53.34 112.212 -175.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.428 ' O ' HG21 ' A' ' 42' ' ' ILE . 0.2 OUTLIER -125.77 11.5 7.83 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.587 0.232 . . . . 72.31 111.218 -176.743 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 70' ' ' TYR . 34.1 m -136.76 137.43 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 O-C-N 121.733 -0.604 . . . . 73.54 111.275 176.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 28.1 mmtp -119.98 115.26 23.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.538 -0.755 . . . . 63.31 109.511 177.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.469 HD13 ' N ' ' A' ' 76' ' ' ILE . 2.9 mp -105.27 122.79 58.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 108.869 -0.789 . . . . 74.42 108.869 177.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.499 ' HB2' HG21 ' A' ' 46' ' ' VAL . 39.5 m-85 -119.37 132.32 55.83 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.229 0.538 . . . . 72.2 111.667 -174.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.474 ' HB3' ' NE1' ' A' ' 49' ' ' TRP . 73.2 mmtt -91.19 110.22 21.49 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.711 -1.132 . . . . 72.22 108.696 173.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 80' ' ' ASN . 6.6 tp -97.26 146.83 7.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.845 0.355 . . . . 72.5 110.999 -177.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.475 ' O ' HG13 ' A' ' 79' ' ' ILE . 40.2 t30 -79.3 158.76 27.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.788 -0.642 . . . . 55.21 109.93 173.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.2 tt -115.97 76.33 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.534 0.683 . . . . 61.14 109.614 176.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -73.41 -68.95 0.46 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.796 -0.638 . . . . 71.24 110.216 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -95.47 -16.82 21.97 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.926 -0.579 . . . . 64.43 111.125 -177.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 75.5 143.44 0.08 Allowed 'General case' 0 N--CA 1.473 0.695 0 O-C-N 123.8 0.688 . . . . 73.35 109.925 -176.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -103.45 121.15 42.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.097 -0.501 . . . . 74.21 111.356 -173.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -69.85 -15.0 63.02 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.89 -0.595 . . . . 61.45 110.391 176.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 62.6 t -48.91 -38.04 10.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 115.986 -0.552 . . . . 75.03 110.774 177.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.97 -49.3 76.65 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.813 -0.63 . . . . 73.53 110.242 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.5 m -64.19 -33.6 76.16 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.818 -0.628 . . . . 71.01 110.387 179.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -63.04 -46.95 85.13 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.823 -0.626 . . . . 72.23 110.306 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 22.4 m-30 -83.01 5.24 22.85 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.062 -0.517 . . . . 74.44 111.324 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 65.0 34.72 90.63 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 121.31 -0.471 . . . . 71.21 112.8 175.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.44 HG11 ' OG1' ' A' ' 98' ' ' THR . 64.7 t -61.71 98.9 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.978 0.418 . . . . 73.5 110.068 177.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.3 m -100.49 8.75 43.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.898 -0.592 . . . . 73.31 111.553 -174.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -147.6 164.82 32.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.601 0.238 . . . . 73.13 110.631 -178.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.4 pp -129.93 156.89 78.37 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.225 -0.443 . . . . 72.43 110.596 -178.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.17 169.35 74.45 Favored 'Cis proline' 0 C--N 1.354 0.827 0 C-N-CA 123.784 -1.34 . . . . 65.31 112.213 -0.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.44 ' OG1' HG11 ' A' ' 93' ' ' VAL . 15.0 m -112.15 124.5 52.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.108 -0.496 . . . . 71.12 110.502 -179.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.828 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 36.0 mt -126.62 135.75 62.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.341 -0.614 . . . . 75.35 109.341 178.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.19 133.77 52.64 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.964 -0.384 . . . . 74.23 109.964 -178.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.768 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 50.1 mtp -106.1 117.93 35.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.896 -0.593 . . . . 74.11 110.776 -176.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -118.34 155.72 30.16 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 122.646 0.378 . . . . 74.43 110.677 178.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.576 ' HB3' HD21 ' A' ' 108' ' ' LEU . 38.1 ttpt -166.31 123.04 1.32 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.844 -0.616 . . . . 63.31 109.774 176.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 46.2 t30 58.04 25.02 11.82 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.771 0.795 . . . . 65.24 110.812 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.85 -2.34 79.64 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 115.991 -0.549 . . . . 53.51 113.381 175.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 54.0 tttm -102.77 145.07 30.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.908 0.354 . . . . 51.24 110.135 177.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -82.19 139.22 34.43 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.804 -0.813 . . . . 60.31 108.804 171.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.576 HD21 ' HB3' ' A' ' 103' ' ' LYS . 2.7 mm? -107.14 -53.26 2.64 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.885 0.374 . . . . 72.55 110.231 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.768 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 54.5 m -153.72 164.46 38.27 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 116.019 -0.537 . . . . 74.54 111.086 -175.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -129.48 106.44 8.76 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.715 -0.675 . . . . 75.32 109.298 177.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.828 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 77.0 t -84.04 107.28 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.463 -0.569 . . . . 64.25 109.463 -179.304 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 62.5 mt -120.15 108.76 23.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.858 -0.61 . . . . 75.11 110.19 -176.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 108.67 -117.33 4.97 Favored Glycine 0 CA--C 1.518 0.265 0 N-CA-C 111.831 -0.508 . . . . 74.41 111.831 -178.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.41 57.22 0.5 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.392 0.615 . . . . 71.33 110.032 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.73 81.8 5.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.464 -0.789 . . . . 74.42 110.399 -178.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.525 HD12 HD12 ' A' ' 119' ' ' ILE . 6.3 tp -61.89 -42.58 95.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 115.847 -0.615 . . . . 73.12 110.928 -177.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 45.4 t -62.67 -31.59 72.51 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.036 0.446 . . . . 71.15 110.633 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -74.05 -52.2 13.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.971 -0.559 . . . . 71.04 110.225 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.525 HD12 HD12 ' A' ' 116' ' ' ILE . 2.3 pp -63.84 -39.3 84.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.159 -0.473 . . . . 71.22 111.552 -173.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.482 HD13 ' N ' ' A' ' 121' ' ' SER . 2.9 pp -64.81 -33.86 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 C-N-CA 120.303 -0.559 . . . . 75.31 109.946 178.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.482 ' N ' HD13 ' A' ' 120' ' ' ILE . 23.1 t -70.42 -47.62 59.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.933 -0.576 . . . . 62.24 110.584 -178.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.485 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 13.0 pt-20 -77.2 -43.06 35.09 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.676 -0.238 . . . . 74.32 111.48 -175.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.436 HD12 HD13 ' A' ' 66' ' ' LEU . 82.4 mt -64.11 -51.59 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 117.657 0.208 . . . . 72.53 111.143 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -58.65 -24.07 60.41 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.065 0.459 . . . . 72.01 110.609 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -91.94 -21.25 20.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.943 -0.571 . . . . 63.32 110.963 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 3.7 t-20 -85.81 -36.78 19.85 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.086 -0.506 . . . . 73.11 111.152 -175.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 47.2 pt -107.93 168.77 3.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 115.759 -0.655 . . . . 71.04 110.032 178.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.2 p30 . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.409 -0.805 . . . . 74.44 110.638 -173.533 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.504 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 120.813 0.34 . . . . 64.12 110.196 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.66 148.43 33.06 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.786 -0.45 . . . . 74.33 109.786 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -77.24 138.12 39.23 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.782 -0.451 . . . . 73.01 109.782 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -73.83 96.55 2.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.387 -0.37 . . . . 75.42 110.431 -176.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -61.67 125.81 25.14 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.068 -0.515 . . . . 74.22 109.671 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -81.39 156.13 25.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.445 -0.343 . . . . 75.11 110.498 -176.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -111.89 -177.73 3.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.287 -0.415 . . . . 65.21 110.15 -176.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -129.81 -171.27 2.48 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.404 -0.591 . . . . 71.34 109.404 177.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 48.2 ttm -135.99 119.52 17.01 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.032 -0.359 . . . . 61.33 110.032 178.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -118.75 48.43 0.94 Allowed Glycine 0 C--N 1.333 0.367 0 C-N-CA 121.424 -0.417 . . . . 54.42 112.602 -175.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.9 m -70.63 99.75 1.72 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 109.554 -0.535 . . . . 74.43 109.554 176.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.521 HD23 ' HB2' ' A' ' 13' ' ' GLU . 9.8 tt -118.43 135.77 54.17 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.01 -0.541 . . . . 75.13 110.619 -171.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.521 ' HB2' HD23 ' A' ' 12' ' ' LEU . 8.8 tp10 70.03 115.8 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.783 0.833 . . . . 74.12 111.396 178.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.47 -174.84 3.45 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.103 -0.499 . . . . 75.44 110.864 -177.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -130.8 152.07 50.55 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.15 -0.477 . . . . 71.2 109.996 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.2 t -61.8 113.21 2.63 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.589 0.709 . . . . 74.34 110.442 176.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -116.02 129.87 56.56 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.748 -0.834 . . . . 73.13 108.748 -177.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -165.15 87.99 0.1 Allowed Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.478 -0.868 . . . . 72.22 113.178 -172.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -96.55 -162.85 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.442 2.761 . . . . 73.22 111.498 171.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.405 ' O ' ' SD ' ' A' ' 22' ' ' MET . . . -87.33 154.68 26.46 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 110.455 -1.058 . . . . 71.45 110.455 173.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.2 p -69.25 80.25 0.36 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.284 0.564 . . . . 64.02 111.014 -177.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.706 ' HG3' ' HB3' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -92.75 -0.2 57.31 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.825 -0.625 . . . . 73.25 111.362 -177.254 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.501 HD11 ' HG2' ' A' ' 64' ' ' GLU . 22.9 mm -104.65 126.15 59.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.972 -0.558 . . . . 74.4 109.536 178.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.473 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 9.7 tp10 -129.23 137.29 51.01 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.025 -0.361 . . . . 71.41 110.025 178.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.647 ' NE2' ' H ' ' A' ' 25' ' ' GLN . 0.6 OUTLIER -105.81 114.62 28.88 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.614 -0.514 . . . . 65.14 109.614 176.771 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.528 HG23 ' HD3' ' A' ' 34' ' ' LYS . 28.2 pt -114.45 154.22 15.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.044 -0.526 . . . . 73.54 111.476 -172.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.56 178.22 45.66 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.455 -0.793 . . . . 13.31 112.115 176.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -63.25 -36.47 83.76 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.18 0.514 . . . . 75.21 111.213 -176.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.7 m -69.61 -42.67 74.05 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.756 -0.656 . . . . 64.12 111.525 -173.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -85.38 -12.31 52.42 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.562 -0.29 . . . . 71.55 111.692 -176.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.511 ' HA ' HD12 ' A' ' 26' ' ' ILE . 90.1 t80 -47.36 -69.9 0.11 Allowed 'General case' 0 N--CA 1.462 0.173 0 O-C-N 123.425 0.453 . . . . 65.21 110.263 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -55.63 -43.78 76.5 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 116.46 -0.336 . . . . 71.43 110.78 177.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.414 ' O ' ' HB2' ' A' ' 37' ' ' SER . 0.2 OUTLIER -52.22 -44.39 64.76 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.113 -0.949 . . . . 73.12 111.399 -170.557 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.528 ' HD3' HG23 ' A' ' 26' ' ' ILE . 0.2 OUTLIER -110.94 -21.71 11.88 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.326 0.491 . . . . 53.44 112.326 -175.963 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 89.5 t -88.21 -49.57 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 111.509 0.189 . . . . 63.51 111.509 -179.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 79.9 p -87.81 -6.53 58.09 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 120.387 -0.525 . . . . 74.43 110.642 -175.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 50.2 m -104.91 12.15 32.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.825 -0.625 . . . . 73.22 110.313 174.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 50.3 t -60.55 90.25 0.02 OUTLIER 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.22 0.534 . . . . 62.14 111.452 -176.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -94.05 6.44 48.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.545 -0.752 . . . . 70.23 109.226 175.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -74.26 -20.85 60.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.282 -0.872 . . . . 63.24 111.056 -175.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.6 m120 69.39 15.04 8.45 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.864 -0.607 . . . . 71.21 111.078 -176.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 37.7 mt -93.64 141.15 15.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.733 -0.667 . . . . 74.52 109.549 174.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.718 HD23 ' HE1' ' A' ' 101' ' ' MET . 64.6 tp -75.18 114.04 13.22 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.318 -0.401 . . . . 74.32 110.312 -178.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.483 HG21 ' CD2' ' A' ' 77' ' ' TYR . 44.0 mt -97.53 116.47 40.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.941 -0.572 . . . . 75.35 110.317 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.47 HD11 ' N ' ' A' ' 45' ' ' LEU . 3.3 mp -107.13 102.88 12.17 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.808 -0.442 . . . . 72.54 109.808 179.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.483 HG23 ' HB2' ' A' ' 77' ' ' TYR . 58.0 t -95.84 112.16 27.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.282 -0.417 . . . . 71.44 109.946 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -98.5 125.69 43.79 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.55 0.691 . . . . 64.5 110.385 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.409 ' HE1' ' HB2' ' A' ' 100' ' ' LEU . 70.2 m-85 -86.69 119.36 26.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.063 -0.971 . . . . 73.03 109.826 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 1.5 p-90 -132.91 169.4 16.84 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.292 -0.413 . . . . 75.11 110.593 -175.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.04 138.88 36.81 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.994 -0.548 . . . . 60.02 110.467 177.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.9 -30.55 93.36 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.823 2.349 . . . . 74.34 112.991 -175.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 10.1 m0 -98.51 15.6 24.41 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.783 0.325 . . . . 74.15 111.282 -178.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 49.0 t -89.38 20.03 4.09 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 120.785 0.326 . . . . 72.24 110.485 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -53.88 -54.04 33.21 Favored Glycine 0 CA--C 1.525 0.666 0 CA-C-N 115.955 -0.566 . . . . 63.14 113.142 179.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -71.21 62.33 2.63 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.008 2.472 . . . . 62.11 111.804 174.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 21.3 p -87.94 99.19 11.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.915 -0.584 . . . . 70.01 110.285 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -68.72 108.69 3.5 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.472 -0.566 . . . . 75.25 109.472 177.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 27.0 t -163.43 179.17 7.5 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.991 -0.374 . . . . 52.33 109.991 -178.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.475 ' N ' HD21 ' A' ' 59' ' ' LEU . 2.0 pt? -154.36 127.28 8.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.42 -0.354 . . . . 73.5 110.269 -179.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 39.59 73.4 0.83 Allowed Pre-proline 0 C--O 1.237 0.416 0 C-N-CA 123.888 0.875 . . . . 73.14 112.724 176.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.56 168.76 21.68 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.478 2.118 . . . . 71.23 111.528 177.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.723 ' HB3' HG12 ' A' ' 119' ' ' ILE . 4.3 mp0 -50.98 -57.68 7.96 Favored 'General case' 0 C--O 1.252 1.197 0 CA-C-O 121.737 0.779 . . . . 74.1 111.312 -175.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.497 HD13 HD13 ' A' ' 99' ' ' ILE . 46.3 mt -54.54 -48.77 71.59 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 114.588 -1.187 . . . . 74.22 110.909 -174.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.618 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 50.1 mt-10 -75.0 -32.56 61.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.981 -0.554 . . . . 74.41 110.68 -176.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -56.24 -46.55 79.54 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.333 -0.394 . . . . 71.31 110.056 176.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.502 HD12 HD13 ' A' ' 123' ' ' ILE . 12.9 mt -82.6 -33.63 27.92 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.098 -0.501 . . . . 73.24 111.116 178.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.706 ' HB3' ' HG3' ' A' ' 22' ' ' MET . . . -59.74 -39.01 83.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.074 -0.512 . . . . 61.5 111.888 -175.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.618 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 77.7 mt-30 -56.78 -31.12 64.32 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.133 0.492 . . . . 70.24 110.515 -179.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -93.66 -51.47 4.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.367 -0.833 . . . . 65.55 111.003 -174.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.435 ' O ' HG21 ' A' ' 74' ' ' VAL . 7.2 m-85 -104.37 23.18 13.58 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.716 -0.675 . . . . 75.23 111.583 -168.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.458 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 8.7 t -52.65 -27.1 15.77 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 111.977 0.362 . . . . 74.33 111.977 -177.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -60.87 -27.6 68.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.875 0.369 . . . . 53.34 111.232 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -121.48 0.32 9.94 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.047 -0.524 . . . . 72.31 110.68 -174.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.435 HG21 ' O ' ' A' ' 70' ' ' TYR . 21.4 m -133.05 146.13 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 121.034 0.445 . . . . 73.54 110.883 176.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.681 ' HE3' ' HA ' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -141.86 129.57 21.6 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.204 -0.665 . . . . 63.31 109.204 177.224 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.488 ' HB ' HD12 ' A' ' 23' ' ' ILE . 2.6 mp -106.04 138.18 32.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 120.653 0.263 . . . . 74.42 110.397 -177.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.483 ' HB2' HG23 ' A' ' 46' ' ' VAL . 84.4 m-85 -134.25 137.86 44.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 72.2 110.923 -175.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 41.8 mttp -112.19 122.31 47.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.544 -0.753 . . . . 72.22 109.211 173.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.6 tp -93.7 141.62 14.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.012 -0.54 . . . . 72.5 111.457 -173.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -73.83 121.1 20.35 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.88 -0.6 . . . . 55.21 109.382 172.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.0 tt -90.08 98.68 8.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.118 0.485 . . . . 61.14 110.989 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -81.92 -66.05 0.94 Allowed 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.635 -0.505 . . . . 71.24 109.635 175.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -125.05 4.75 7.94 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.097 -0.501 . . . . 64.43 110.982 178.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 63.8 -170.27 0.19 Allowed 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 109.622 -0.51 . . . . 73.35 109.622 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -144.52 136.65 26.2 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 122.163 -0.335 . . . . 74.21 110.589 -179.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -65.45 -11.92 47.52 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.231 -0.44 . . . . 61.45 110.856 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 52.3 t -52.5 -34.51 19.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-O 121.284 0.564 . . . . 75.03 110.13 175.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.3 -45.53 91.02 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.613 -0.721 . . . . 73.53 110.158 176.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.6 m -68.7 -31.98 71.45 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.809 -0.632 . . . . 71.01 110.511 177.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -59.25 -49.88 76.15 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.208 -0.451 . . . . 72.23 110.239 177.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -72.05 -17.33 62.02 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.24 -0.436 . . . . 74.44 110.565 176.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.54 48.88 5.7 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 121.189 -0.529 . . . . 71.21 112.538 177.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 88.2 t -68.56 104.83 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.892 0.377 . . . . 73.5 110.27 176.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.8 p -73.53 -40.91 63.65 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.938 -0.574 . . . . 73.31 111.341 -178.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -150.86 164.9 35.18 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.565 -0.289 . . . . 73.13 111.171 -178.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.59 ' HB ' ' HA ' ' A' ' 97' ' ' PRO . 2.7 pp -97.56 164.16 18.16 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 116.126 -0.488 . . . . 72.43 110.448 178.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.59 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 91.0 Cg_endo -78.09 165.5 83.0 Favored 'Cis proline' 0 C--N 1.355 0.91 0 C-N-CA 124.264 -1.14 . . . . 65.31 112.537 -0.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 13.0 m -129.65 122.44 29.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.051 -0.522 . . . . 71.12 110.298 -178.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.794 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 45.0 mt -115.4 108.19 24.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.345 -0.613 . . . . 75.35 109.345 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.48 ' HG ' ' HG3' ' A' ' 110' ' ' GLN . 2.4 tt -99.34 124.34 44.36 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.933 -0.395 . . . . 74.23 109.933 -176.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.74 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 65.0 mtp -93.45 112.01 23.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.927 -0.579 . . . . 74.11 111.155 -177.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -107.24 147.14 30.56 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.007 0.523 . . . . 74.43 110.446 175.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.678 ' HB3' HD23 ' A' ' 108' ' ' LEU . 28.7 ttpp -169.81 133.63 1.26 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.294 -0.632 . . . . 63.31 109.294 173.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.3 t30 61.43 24.82 14.87 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.266 0.555 . . . . 65.24 110.498 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 76.98 10.97 85.98 Favored Glycine 0 CA--C 1.522 0.5 0 CA-C-N 115.982 -0.554 . . . . 53.51 112.959 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -125.15 152.4 44.51 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.488 -0.56 . . . . 51.24 109.488 179.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.723 ' HD3' HE22 ' A' ' 110' ' ' GLN . 0.0 OUTLIER -84.71 142.9 29.53 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.447 -0.575 . . . . 60.31 109.447 177.842 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.678 HD23 ' HB3' ' A' ' 103' ' ' LYS . 2.4 mm? -106.32 -53.22 2.66 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.271 -0.27 . . . . 72.55 110.271 178.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.74 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 66.4 m -153.82 165.83 34.81 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 116.182 -0.463 . . . . 74.54 111.101 -178.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . 0.723 HE22 ' HD3' ' A' ' 107' ' ' LYS . 24.2 mp0 -128.44 102.44 6.64 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.533 -0.758 . . . . 75.32 109.443 177.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.794 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 50.6 t -80.35 107.04 12.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.517 -0.549 . . . . 64.25 109.517 177.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 52.5 mt -109.59 128.57 65.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.632 -0.507 . . . . 75.11 109.632 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.77 -123.09 6.36 Favored Glycine 0 N--CA 1.452 -0.269 0 N-CA-C 111.504 -0.639 . . . . 74.41 111.504 -176.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.52 101.94 1.87 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.955 0.377 . . . . 71.33 110.74 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -136.58 102.29 4.88 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 120.956 0.407 . . . . 74.42 110.861 179.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.587 HD12 HD12 ' A' ' 119' ' ' ILE . 7.9 tp -61.91 -38.39 80.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 115.895 -0.593 . . . . 73.12 110.383 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 37.7 t -61.57 -41.69 97.76 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.342 0.591 . . . . 71.15 110.316 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.448 ' O ' ' HG2' ' A' ' 122' ' ' GLU . 16.7 tppt? -63.92 -56.35 15.86 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.393 -0.821 . . . . 71.04 109.908 -179.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.723 HG12 ' HB3' ' A' ' 62' ' ' GLN . 2.2 pp -61.81 -43.33 97.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 115.455 -0.793 . . . . 71.22 111.979 -173.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.487 HD11 ' N ' ' A' ' 121' ' ' SER . 2.8 pp -63.0 -33.33 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 120.392 -0.523 . . . . 75.31 110.209 -178.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.487 ' N ' HD11 ' A' ' 120' ' ' ILE . 42.5 t -70.84 -52.3 21.22 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.07 -0.514 . . . . 62.24 110.997 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 118' ' ' LYS . 3.8 pt-20 -77.8 -37.67 48.26 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.391 0.886 . . . . 74.32 113.391 -175.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . 0.502 HD13 HD12 ' A' ' 66' ' ' LEU . 65.7 mt -61.39 -56.99 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 O-C-N 121.949 -0.469 . . . . 72.53 110.281 177.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -63.5 -20.46 65.62 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.845 -0.616 . . . . 72.01 111.174 -178.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -65.77 -35.24 80.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.052 -0.522 . . . . 63.32 110.452 175.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -95.59 -39.59 9.86 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.083 -0.508 . . . . 73.11 111.732 -175.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 38.9 pt -85.53 168.0 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.589 -0.278 . . . . 71.04 110.656 -178.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.9 p30 . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.258 -0.877 . . . . 74.44 110.95 -175.696 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.617 ' HG3' HG13 ' A' ' 23' ' ' ILE . 22.1 ptp . . . . . 0 N--CA 1.464 0.23 0 CA-C-O 120.762 0.315 . . . . 73.25 110.379 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.617 HG13 ' HG3' ' A' ' 22' ' ' MET . 60.8 mt -104.97 99.65 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 115.982 -0.553 . . . . 74.400000000000006 110.226 177.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.556 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 10.6 tp10 -101.22 155.23 18.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.83 -0.623 . . . . 71.409999999999997 109.699 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -106.69 134.7 49.44 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.025 -0.361 . . . . 65.140000000000001 110.025 176.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.523 HD12 ' HA ' ' A' ' 31' ' ' PHE . 32.1 pt -129.19 157.01 42.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-O 120.971 0.415 . . . . 64.230000000000004 111.134 -175.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -106.81 -171.45 22.63 Favored Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.93 -0.577 . . . . 13.31 112.284 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -67.92 -50.34 56.62 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.27 0.47 . . . . 73.329999999999998 112.27 -176.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.5 p -73.34 -11.95 60.66 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.425 0.528 . . . . 64.120000000000005 112.425 -171.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -117.09 -6.71 11.37 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 116.668 -0.242 . . . . 71.549999999999997 111.069 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.523 ' HA ' HD12 ' A' ' 26' ' ' ILE . 93.4 t80 -51.77 -70.58 0.08 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.293 -0.412 . . . . 65.209999999999994 110.327 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -62.43 -35.18 78.46 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.136 0.493 . . . . 71.430000000000007 109.771 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -51.88 -47.6 64.46 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.104 -0.953 . . . . 63.409999999999997 111.565 -176.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.52 -18.32 15.35 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.981 0.363 . . . . 53.439999999999998 111.981 -177.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.1 t -88.39 -59.74 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 111.947 0.351 . . . . 61.520000000000003 111.947 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 34.3 p -78.05 -33.08 51.12 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.818 0.342 . . . . 74.430000000000007 111.168 -172.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.9 m -84.57 11.84 8.08 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.253 -0.431 . . . . 73.219999999999999 111.351 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.518 ' SG ' HG22 ' A' ' 42' ' ' ILE . 44.9 t -75.76 103.07 5.68 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 120.863 0.363 . . . . 60.130000000000003 110.339 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -103.15 12.3 35.93 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.137 0.494 . . . . 70.230000000000004 110.327 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -81.7 1.65 33.34 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.082 -0.508 . . . . 63.240000000000002 111.256 -178.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 59.22 13.42 3.03 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.495 0.554 . . . . 71.209999999999994 112.495 -178.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.518 HG22 ' SG ' ' A' ' 38' ' ' CYS . 10.5 tt -78.85 153.09 4.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.182 -0.673 . . . . 74.519999999999996 109.182 176.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.785 HD21 ' HE3' ' A' ' 101' ' ' MET . 57.2 tp -93.4 111.55 23.23 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.281 0.562 . . . . 74.319999999999993 110.425 -177.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 101' ' ' MET . 71.6 mt -96.39 129.46 46.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.496 -0.774 . . . . 75.349999999999994 110.429 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 5.3 mp -117.72 103.83 10.4 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.923 -0.399 . . . . 41.200000000000003 109.923 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.557 HG12 ' HB2' ' A' ' 77' ' ' TYR . 29.6 m -93.78 127.88 45.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 110.242 -0.281 . . . . 71.439999999999998 110.242 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.488 ' O ' HG22 ' A' ' 79' ' ' ILE . 2.0 p-10 -125.07 153.24 43.22 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.925 0.393 . . . . 64.5 110.779 -177.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 . . . . . 0 CA--C 1.539 0.522 0 CA-C-N 116.006 -0.543 . . . . 73.030000000000001 111.51 178.224 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.469 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 61.5 Cg_endo . . . . . 0 N--CA 1.453 -0.895 0 CA-C-O 121.261 0.442 . . . . 71.140000000000001 112.186 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.474 ' H ' ' CD ' ' A' ' 62' ' ' GLN . 13.8 mp0 -62.32 -33.71 75.21 Favored 'General case' 0 C--O 1.248 1.01 0 CA-C-O 122.105 0.955 . . . . 74.099999999999994 109.598 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.418 ' H ' HD22 ' A' ' 63' ' ' LEU . 3.3 mm? -56.98 -48.6 78.02 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-N 113.906 -1.497 . . . . 74.219999999999999 110.952 -174.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.469 ' HG3' ' HG2' ' A' ' 61' ' ' PRO . 45.2 mt-10 -59.31 -51.64 69.05 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.051 0.453 . . . . 74.409999999999997 109.886 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -51.28 -50.87 58.44 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.184 -0.916 . . . . 71.310000000000002 111.633 -176.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.613 HD12 HD12 ' A' ' 123' ' ' ILE . 13.2 mt -80.25 -39.22 29.4 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.024 -0.67 . . . . 73.239999999999995 112.346 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.56 -38.54 90.45 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.654 0.264 . . . . 61.5 111.31 -176.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -54.6 -30.46 54.73 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.788 0.328 . . . . 70.239999999999995 111.177 178.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -90.45 -48.51 7.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.311 0.577 . . . . 65.549999999999997 110.837 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.522 ' O ' HG22 ' A' ' 74' ' ' VAL . 16.9 m-85 -98.31 23.18 8.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.547 -0.751 . . . . 75.230000000000004 112.118 -170.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.4 t -52.37 -42.01 63.58 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 112.234 0.457 . . . . 74.329999999999998 112.234 -172.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -72.99 -16.85 61.5 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.032 -0.418 . . . . 53.340000000000003 111.382 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.31 -8.04 16.5 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.536 -0.302 . . . . 72.310000000000002 111.225 -176.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.522 HG22 ' O ' ' A' ' 70' ' ' TYR . 28.3 m -133.73 151.17 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 O-C-N 121.923 -0.485 . . . . 55.140000000000001 111.032 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 42.5 mmtm -140.58 116.17 10.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.011 -0.54 . . . . 63.310000000000002 109.941 175.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.514 ' N ' HD12 ' A' ' 76' ' ' ILE . 2.7 mp -92.85 130.22 42.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.253 -0.647 . . . . 74.420000000000002 109.253 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.557 ' HB2' HG12 ' A' ' 46' ' ' VAL . 22.2 m-85 -124.46 128.81 49.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.745 0.307 . . . . 72.200000000000003 111.049 -178.002 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.534 ' HZ2' ' HA ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -77.96 114.07 16.47 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.273 -0.64 . . . . 72.219999999999999 109.273 174.918 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.488 HG22 ' O ' ' A' ' 47' ' ' ASP . 10.6 tt . . . . . 0 C--N 1.326 -0.433 0 CA-C-O 121.028 0.442 . . . . 72.5 110.058 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.206 0 CA-C-O 120.827 0.346 . . . . 73.530000000000001 110.311 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.6 m -69.6 -32.95 71.98 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.907 -0.588 . . . . 71.010000000000005 109.756 176.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -63.17 -46.15 88.48 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.839 -0.619 . . . . 72.230000000000004 109.616 176.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.459 ' OH ' ' HE2' ' A' ' 107' ' ' LYS . 31.1 m-85 -77.11 -17.08 58.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.716 -0.675 . . . . 74.030000000000001 110.955 175.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 62.94 37.77 95.48 Favored Glycine 0 C--N 1.331 0.279 0 CA-C-N 116.203 -0.453 . . . . 71.209999999999994 112.197 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.7 p -86.23 144.73 8.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.889 0.376 . . . . 73.5 111.16 -175.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 31.9 t -136.58 84.66 2.09 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.868 -0.79 . . . . 73.310000000000002 108.868 173.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -163.85 161.6 23.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.659 -0.7 . . . . 73.129999999999995 109.975 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.471 ' HA ' ' HA ' ' A' ' 97' ' ' PRO . 0.0 OUTLIER -129.64 113.41 17.85 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 109.333 -0.617 . . . . 72.430000000000007 109.333 178.58 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 96' ' ' ILE . 35.0 Cg_endo -98.6 -155.09 0.27 Allowed 'Cis proline' 0 C--N 1.348 0.544 0 C-N-CA 124.359 -1.101 . . . . 65.310000000000002 112.146 -2.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 37.7 m -145.26 139.52 27.18 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 109.256 -0.646 . . . . 71.120000000000005 109.256 174.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.722 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 3.6 mp -122.96 132.94 70.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 109.442 -0.577 . . . . 53.43 109.442 -178.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 7.9 mp -110.82 146.48 36.36 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.497 0.189 . . . . 73.120000000000005 110.602 178.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.785 ' HE3' HD21 ' A' ' 43' ' ' LEU . 59.0 mtp -115.82 118.5 33.19 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.995 -0.548 . . . . 74.109999999999999 111.256 -176.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -118.9 150.72 39.4 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.934 -0.575 . . . . 74.430000000000007 110.683 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.799 ' HB3' HD21 ' A' ' 108' ' ' LEU . 13.8 ttmm -165.58 125.67 1.8 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.75 -0.659 . . . . 63.310000000000002 109.474 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 53.3 t30 63.34 27.1 15.27 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.514 0.673 . . . . 65.239999999999995 110.329 175.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 75.31 13.84 82.46 Favored Glycine 0 C--N 1.333 0.379 0 CA-C-N 115.683 -0.69 . . . . 53.509999999999998 111.991 -178.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -113.01 156.67 22.64 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 122.83 0.452 . . . . 51.240000000000002 110.232 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.459 ' HE2' ' OH ' ' A' ' 91' ' ' TYR . 14.7 ptmm? -101.22 125.39 47.84 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.287 -0.634 . . . . 45.119999999999997 109.287 176.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.799 HD21 ' HB3' ' A' ' 103' ' ' LYS . 2.1 mm? -104.87 -53.2 2.72 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 111.909 0.337 . . . . 72.549999999999997 111.909 -173.109 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.709 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 50.4 m -162.97 172.14 15.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.192 -0.458 . . . . 74.540000000000006 110.247 -172.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.59 127.14 13.26 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.016 0.436 . . . . 75.319999999999993 110.797 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.722 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 84.4 t -81.57 107.36 13.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 115.97 -0.559 . . . . 64.25 109.924 178.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.537 ' H ' ' HE3' ' A' ' 118' ' ' LYS . 65.6 mt -107.95 115.19 48.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 116.029 -0.532 . . . . 75.109999999999999 110.131 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.07 -135.57 13.19 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 116.097 -0.502 . . . . 74.409999999999997 112.108 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -145.39 77.05 1.5 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.182 0.515 . . . . 71.329999999999998 110.767 -178.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.54 ' O ' HG23 ' A' ' 119' ' ' ILE . 1.7 m-20 -124.21 91.11 3.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.789 -0.642 . . . . 62.439999999999998 109.895 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.448 ' O ' HG13 ' A' ' 119' ' ' ILE . 6.8 tp -54.45 -41.34 53.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 120.798 0.332 . . . . 73.120000000000005 111.187 -176.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 43.8 t -59.32 -34.8 72.78 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.17 0.51 . . . . 71.150000000000006 111.07 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.537 ' HE3' ' H ' ' A' ' 112' ' ' ILE . 2.4 tmtm? -79.38 -44.14 22.08 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.92 -0.582 . . . . 71.040000000000006 110.715 -178.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.581 HG22 HG13 ' A' ' 111' ' ' VAL . 1.5 pp -66.41 -38.53 81.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 71.219999999999999 110.862 -175.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.435 HD12 ' N ' ' A' ' 121' ' ' SER . 2.7 pp -67.39 -31.81 54.51 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.078 0 C-N-CA 120.569 -0.452 . . . . 75.310000000000002 109.788 177.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.435 ' N ' HD12 ' A' ' 120' ' ' ILE . 34.7 t -67.48 -47.04 71.21 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.928 -0.578 . . . . 62.240000000000002 110.152 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.428 ' OE1' ' HB3' ' A' ' 109' ' ' SER . 15.0 pt-20 -76.74 -42.31 41.67 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.27 -0.423 . . . . 74.319999999999993 111.765 -177.157 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.613 HD12 HD12 ' A' ' 66' ' ' LEU . 68.3 mt -66.3 -52.23 49.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 O-C-N 122.335 -0.228 . . . . 72.530000000000001 111.046 -178.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -62.64 -20.28 64.64 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.927 0.394 . . . . 72.010000000000005 111.035 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -68.58 -34.14 75.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.075 -0.512 . . . . 60.229999999999997 110.423 176.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -103.9 -8.14 19.92 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.474 0.546 . . . . 73.109999999999999 112.474 -172.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 43.0 pt -139.11 167.85 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 120.796 0.332 . . . . 71.040000000000006 110.647 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.371 -0.823 . . . . 74.439999999999998 111.122 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 C--O 1.238 0.451 0 N-CA-C 109.729 -0.471 . . . . 73.25 109.729 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.409 HD13 ' HB ' ' A' ' 76' ' ' ILE . 10.3 mm -107.55 89.66 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 108.142 -1.059 . . . . 74.400000000000006 108.142 171.107 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.633 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 9.3 tp10 -108.78 155.46 20.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.566 -0.288 . . . . 71.409999999999997 110.483 -174.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.419 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 29.7 pt20 -105.29 147.65 27.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.919 0.39 . . . . 65.140000000000001 110.481 176.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.415 HD12 ' HA ' ' A' ' 31' ' ' PHE . 30.5 pt -129.56 -178.93 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.979 -0.555 . . . . 64.230000000000004 109.97 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.31 175.34 18.92 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.841 -0.695 . . . . 13.31 113.514 -175.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -67.76 -34.68 77.29 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.626 0.77 . . . . 73.329999999999998 110.949 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.2 t -79.88 -39.21 31.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 64.120000000000005 111.285 -171.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -95.12 0.25 54.07 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.998 -0.546 . . . . 71.549999999999997 111.304 -175.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.423 ' HE1' HG11 ' A' ' 46' ' ' VAL . 66.1 t80 -47.84 -71.19 0.07 Allowed 'General case' 0 CA--C 1.53 0.189 0 O-C-N 123.418 0.448 . . . . 65.209999999999994 111.186 -177.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -65.86 -32.88 74.65 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.375 -0.602 . . . . 71.430000000000007 109.375 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.486 ' O ' ' HB2' ' A' ' 37' ' ' SER . 64.5 t30 -51.85 -39.17 58.44 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 114.762 -1.108 . . . . 63.409999999999997 111.333 -175.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.9 ptmt -109.76 -25.8 10.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 53.439999999999998 112.122 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.5 t -80.11 -53.23 13.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 111.721 0.267 . . . . 61.520000000000003 111.721 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.0 p -83.75 -36.2 23.81 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.342 0.591 . . . . 74.430000000000007 110.067 -175.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.486 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 39.0 m -83.89 12.73 5.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.478 -0.783 . . . . 73.219999999999999 111.134 178.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 40.1 t -53.63 91.92 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.133 0.492 . . . . 60.130000000000003 110.979 176.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -80.84 -7.23 59.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.771 -0.65 . . . . 70.230000000000004 110.962 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -73.5 -16.54 61.28 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.247 -0.433 . . . . 63.240000000000002 110.643 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 65.89 21.69 11.4 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.744 -0.662 . . . . 71.209999999999994 111.443 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.571 HD13 ' HG2' ' A' ' 75' ' ' LYS . 17.6 tt -94.96 151.71 3.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.113 -0.699 . . . . 74.519999999999996 109.113 175.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.678 HD21 ' HE3' ' A' ' 101' ' ' MET . 64.8 tp -79.71 111.76 16.32 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.976 0.417 . . . . 74.319999999999993 110.474 -176.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 49.4 mt -91.31 122.91 43.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.615 -0.72 . . . . 75.349999999999994 110.498 177.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.587 HD13 HD12 ' A' ' 63' ' ' LEU . 58.8 mt -103.8 102.04 11.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.628 -0.715 . . . . 41.200000000000003 109.475 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 74.2 t -86.66 120.2 35.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.209 -0.451 . . . . 71.439999999999998 110.844 -177.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.506 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 13.7 t70 -95.24 154.91 16.96 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.925 0.393 . . . . 64.5 110.695 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 72.7 t80 . . . . . 0 CA--C 1.535 0.39 0 CA-C-N 115.762 -0.654 . . . . 73.030000000000001 112.301 -174.834 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo . . . . . 0 N--CA 1.463 -0.291 0 CA-C-O 120.89 0.287 . . . . 71.140000000000001 112.571 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.563 ' NE2' ' HA ' ' A' ' 114' ' ' ALA . 12.1 mp0 -52.15 -38.62 58.18 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.468 -0.787 . . . . 74.099999999999994 110.179 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.587 HD12 HD13 ' A' ' 45' ' ' LEU . 2.7 mm? -60.36 -48.7 80.62 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.672 -1.149 . . . . 74.219999999999999 110.326 -173.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -74.16 -36.54 64.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.179 -0.464 . . . . 74.409999999999997 109.997 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -52.33 -45.95 65.83 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.752 -0.658 . . . . 71.310000000000002 109.822 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.719 HD12 HD12 ' A' ' 123' ' ' ILE . 25.7 mt -84.78 -38.82 19.15 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 111.741 0.275 . . . . 73.239999999999995 111.741 177.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.541 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -55.98 -37.34 68.95 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.572 0.225 . . . . 61.5 111.464 -176.313 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -50.61 -32.35 18.62 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.948 0.404 . . . . 70.239999999999995 110.898 178.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -94.44 -59.02 2.04 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.833 -0.622 . . . . 65.549999999999997 111.27 175.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.544 ' O ' HG22 ' A' ' 74' ' ' VAL . 17.1 m-85 -91.1 21.03 4.51 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.156 0.798 . . . . 75.230000000000004 113.156 -168.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.541 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 11.2 t -54.52 -26.82 34.06 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.174 0.512 . . . . 74.329999999999998 110.976 -178.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -62.72 -20.13 64.6 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.752 -0.658 . . . . 53.340000000000003 112.239 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -131.93 7.78 4.39 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 111.661 0.245 . . . . 72.310000000000002 111.661 -175.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.544 HG22 ' O ' ' A' ' 70' ' ' TYR . 34.4 m -137.04 140.34 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 120.958 0.409 . . . . 55.140000000000001 110.992 177.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.571 ' HG2' HD13 ' A' ' 42' ' ' ILE . 33.6 mmtp -129.85 123.15 30.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.776 -0.647 . . . . 63.310000000000002 109.312 176.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.543 HG13 ' HB2' ' A' ' 45' ' ' LEU . 2.8 mp -98.99 132.48 44.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.694 -0.484 . . . . 74.420000000000002 109.694 -178.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.633 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 52.2 m-85 -134.52 129.34 34.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.076 -0.511 . . . . 72.200000000000003 109.786 -178.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.506 ' HB3' ' HB3' ' A' ' 47' ' ' ASP . 57.1 pttt -125.4 170.55 11.26 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.037 -0.357 . . . . 72.219999999999999 110.037 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 50.7 mt . . . . . 0 C--N 1.327 -0.385 0 N-CA-C 109.485 -0.561 . . . . 72.5 109.485 176.829 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.366 0 CA-C-O 120.968 0.413 . . . . 73.530000000000001 110.589 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 45.2 m -62.3 -42.52 99.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.754 -0.657 . . . . 71.010000000000005 110.661 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -65.1 -49.86 68.34 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.187 -0.46 . . . . 72.230000000000004 110.972 -176.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -74.0 -17.31 61.01 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.5 -0.318 . . . . 74.030000000000001 110.92 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.97 49.27 10.01 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.174 -0.536 . . . . 71.209999999999994 112.139 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 46.5 t -90.77 143.03 12.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 110.218 -0.289 . . . . 73.5 110.218 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.9 p -117.04 -58.48 2.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.299 -0.41 . . . . 73.310000000000002 110.996 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.59 108.35 2.41 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.105 -0.498 . . . . 73.129999999999995 111.479 -178.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.489 ' HB ' ' HA ' ' A' ' 97' ' ' PRO . 2.9 pp -107.42 158.38 33.34 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 116.11 -0.496 . . . . 72.430000000000007 109.876 176.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.489 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 61.3 Cg_endo -70.23 153.96 94.36 Favored 'Cis proline' 0 C--N 1.355 0.912 0 C-N-CA 124.039 -1.234 . . . . 65.310000000000002 113.03 2.358 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 28.7 m -120.17 135.3 55.02 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.381 -0.827 . . . . 71.120000000000005 109.799 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.607 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 3.8 mp -118.24 138.04 50.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.764 -0.458 . . . . 53.43 109.764 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.499 HD23 ' H ' ' A' ' 101' ' ' MET . 1.1 tt -121.79 137.23 54.85 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.115 -0.698 . . . . 73.120000000000005 109.115 176.235 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.769 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 61.4 mtp -101.62 118.47 37.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.065 -0.516 . . . . 74.109999999999999 110.879 -173.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -121.21 147.32 45.77 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.574 -0.284 . . . . 74.430000000000007 110.607 178.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.598 ' HB3' HD21 ' A' ' 108' ' ' LEU . 39.7 ttpt -159.16 116.09 2.69 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.099 -0.5 . . . . 63.310000000000002 110.137 176.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 61.8 t30 48.64 54.75 10.09 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.73 -0.668 . . . . 65.239999999999995 111.309 177.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 80.82 -12.76 33.89 Favored Glycine 0 CA--C 1.519 0.328 0 CA-C-N 115.671 -0.695 . . . . 53.509999999999998 113.901 175.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -100.98 131.83 46.67 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 117.357 0.579 . . . . 51.240000000000002 110.735 -177.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -91.26 112.58 24.55 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.0 -0.741 . . . . 45.119999999999997 109.0 173.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.598 HD21 ' HB3' ' A' ' 103' ' ' LYS . 2.3 mm? -80.95 -53.37 6.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.126 -0.488 . . . . 72.549999999999997 111.26 -170.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.769 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 56.1 m -161.15 171.72 18.01 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.857 -0.61 . . . . 74.540000000000006 110.343 -172.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -141.82 126.65 18.15 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 120.579 0.228 . . . . 75.319999999999993 110.704 -177.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.607 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 59.6 t -91.19 125.53 43.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 123.025 0.53 . . . . 64.25 110.633 178.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 62.0 mt -126.58 106.82 16.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.468 -0.333 . . . . 75.109999999999999 110.113 176.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 99.91 -143.34 16.37 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 121.082 -0.58 . . . . 74.409999999999997 112.388 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.563 ' HA ' ' NE2' ' A' ' 62' ' ' GLN . . . -126.49 56.85 1.44 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.251 0.548 . . . . 71.329999999999998 111.03 -176.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.505 ' O ' HG23 ' A' ' 119' ' ' ILE . 4.4 m-20 -93.38 71.15 4.39 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.022 -0.535 . . . . 62.439999999999998 110.147 179.095 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.586 ' O ' HG13 ' A' ' 119' ' ' ILE . 6.3 tp -54.57 -44.66 69.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 121.065 0.459 . . . . 73.120000000000005 111.432 -177.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.4 p -63.86 -28.89 70.16 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-O 121.212 0.529 . . . . 71.150000000000006 111.378 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.439 ' HB3' ' HB3' ' A' ' 115' ' ' ASP . 14.5 tmtt? -80.03 -45.03 19.08 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 116.062 -0.517 . . . . 71.040000000000006 110.84 177.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.586 HG13 ' O ' ' A' ' 116' ' ' ILE . 2.0 pp -64.6 -38.09 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.47 -0.332 . . . . 71.219999999999999 111.01 -175.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.566 HG22 HD21 ' A' ' 66' ' ' LEU . 2.9 pp -60.5 -31.72 49.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-O 121.195 0.521 . . . . 75.310000000000002 110.051 176.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.43 ' N ' HD12 ' A' ' 120' ' ' ILE . 23.6 m -70.47 -51.68 27.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.977 -0.556 . . . . 62.240000000000002 110.734 177.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.561 ' HG2' ' HA ' ' A' ' 119' ' ' ILE . 15.6 pt-20 -72.38 -42.04 65.67 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.387 0.514 . . . . 74.319999999999993 112.387 -173.185 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.719 HD12 HD12 ' A' ' 66' ' ' LEU . 70.6 mt -64.07 -59.05 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 O-C-N 122.113 -0.367 . . . . 72.530000000000001 110.498 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -58.91 -20.75 54.66 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.046 -0.525 . . . . 72.010000000000005 110.943 -178.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -70.63 -39.14 73.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.811 -0.632 . . . . 60.229999999999997 110.885 176.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -103.61 -2.26 26.92 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.355 0.502 . . . . 73.109999999999999 112.355 -173.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 123' ' ' ILE . 29.6 pt -109.01 167.92 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 110.018 -0.364 . . . . 71.040000000000006 110.018 171.15 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.582 -0.723 . . . . 74.439999999999998 111.036 -175.787 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.625 ' HG2' HG12 ' A' ' 23' ' ' ILE . 1.4 pmm? . . . . . 0 C--O 1.236 0.373 0 N-CA-C 108.437 -0.949 . . . . 73.25 108.437 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.625 HG12 ' HG2' ' A' ' 22' ' ' MET . 22.8 mm -121.18 84.07 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 108.06 -1.089 . . . . 74.400000000000006 108.06 173.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -86.25 154.74 21.06 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.102 0.477 . . . . 71.409999999999997 111.177 -172.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.441 ' HA ' ' HG2' ' A' ' 78' ' ' LYS . 8.6 pt20 -101.44 126.42 48.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.862 -0.608 . . . . 65.140000000000001 110.696 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.515 HD12 ' HA ' ' A' ' 31' ' ' PHE . 35.1 pt -131.86 174.62 12.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 120.736 0.303 . . . . 64.230000000000004 110.259 175.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.419 ' H ' ' HG2' ' A' ' 30' ' ' GLU . . . -121.11 -166.8 13.09 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 116.016 -0.538 . . . . 13.31 112.486 -179.019 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.79 -50.3 57.7 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 122.893 0.477 . . . . 73.329999999999998 112.023 -176.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 39.7 m -76.67 -31.44 57.29 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 120.901 0.381 . . . . 64.120000000000005 111.928 -169.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.477 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 2.1 pm0 -89.93 -15.29 32.37 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.967 -0.56 . . . . 71.549999999999997 110.882 -178.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.515 ' HA ' HD12 ' A' ' 26' ' ' ILE . 46.3 t80 -48.77 -70.86 0.08 Allowed 'General case' 0 C--O 1.226 -0.159 0 O-C-N 123.399 0.437 . . . . 65.209999999999994 110.285 178.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -56.45 -43.3 79.39 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-O 121.146 0.498 . . . . 71.430000000000007 109.748 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.631 ' O ' ' HB3' ' A' ' 37' ' ' SER . 23.1 t-20 -52.3 -41.28 62.79 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 114.209 -1.36 . . . . 63.409999999999997 112.449 -171.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -112.96 -20.15 11.66 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.257 0.466 . . . . 53.439999999999998 112.257 -176.802 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 77.6 t -81.05 -48.97 18.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 O-C-N 122.331 -0.231 . . . . 61.520000000000003 111.233 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.8 p -88.2 -35.83 17.13 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.218 0.532 . . . . 74.430000000000007 110.242 -177.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.631 ' HB3' ' O ' ' A' ' 33' ' ' ASN . 33.9 t -84.67 12.38 7.27 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.875 -0.602 . . . . 73.219999999999999 110.904 178.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 40' ' ' ASP . 43.6 t -53.71 103.24 0.07 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.955 0.407 . . . . 60.130000000000003 111.369 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -82.23 -8.9 59.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.871 -0.604 . . . . 70.230000000000004 110.372 176.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.448 ' HB2' ' SG ' ' A' ' 38' ' ' CYS . 21.2 m-20 -63.69 -30.76 71.82 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.219 -0.446 . . . . 63.240000000000002 110.561 -179.049 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 71.52 12.9 6.48 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.509 -0.768 . . . . 71.209999999999994 110.99 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.5 tt -88.62 161.57 2.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 109.223 -0.658 . . . . 74.519999999999996 109.223 177.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.436 HD12 HG23 ' A' ' 127' ' ' ILE . 26.9 mt -78.93 109.24 13.03 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.06 0.457 . . . . 74.319999999999993 110.662 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.619 HG23 ' CD2' ' A' ' 77' ' ' TYR . 45.2 mt -94.27 107.61 19.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.649 -0.705 . . . . 75.349999999999994 110.163 175.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.571 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 6.4 mp -97.2 107.18 19.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.934 -0.575 . . . . 41.200000000000003 109.583 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.404 HG12 ' HB2' ' A' ' 77' ' ' TYR . 28.5 m -94.97 129.92 44.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 110.091 -0.337 . . . . 71.439999999999998 110.091 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -104.29 139.78 38.81 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.11 0.481 . . . . 64.5 110.208 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.475 ' HE2' HD13 ' A' ' 100' ' ' LEU . 40.8 m-85 . . . . . 0 C--N 1.324 -0.512 0 CA-C-N 115.842 -0.617 . . . . 73.030000000000001 110.066 176.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.409 ' HD2' ' OE1' ' A' ' 64' ' ' GLU . 98.6 Cg_endo . . . . . 0 N--CA 1.462 -0.382 0 CA-C-O 121.06 0.358 . . . . 71.140000000000001 112.408 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.555 ' HB3' HG12 ' A' ' 119' ' ' ILE . 13.8 mp0 -63.12 -48.32 79.0 Favored 'General case' 0 C--O 1.247 0.932 0 CA-C-O 121.583 0.706 . . . . 74.099999999999994 110.574 -174.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.561 HD12 ' N ' ' A' ' 64' ' ' GLU . 4.0 pp -57.38 -39.56 76.32 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 114.844 -1.071 . . . . 74.219999999999999 111.33 -176.109 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.561 ' N ' HD12 ' A' ' 63' ' ' LEU . 29.7 mt-10 -70.45 -43.25 70.26 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 120.809 -0.356 . . . . 74.409999999999997 110.048 177.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.2 mmtt -50.81 -52.95 36.24 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.133 -0.485 . . . . 71.310000000000002 111.528 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.735 HD12 HD12 ' A' ' 123' ' ' ILE . 14.8 mt -85.72 -42.83 13.9 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.198 0.814 . . . . 73.239999999999995 113.198 -176.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.18 -32.38 72.12 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.195 0.443 . . . . 61.5 112.195 -172.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -53.28 -33.44 53.2 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.884 0.373 . . . . 70.239999999999995 110.764 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -94.0 -53.4 4.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.005 -0.543 . . . . 65.549999999999997 110.85 176.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.53 ' O ' HG22 ' A' ' 74' ' ' VAL . 22.7 m-85 -85.35 14.83 4.89 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 113.149 0.796 . . . . 75.230000000000004 113.149 -169.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.8 t -52.94 -31.6 41.1 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.344 0.52 . . . . 74.329999999999998 111.441 -177.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -66.65 -16.9 64.53 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.283 -0.417 . . . . 53.340000000000003 111.553 -178.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -125.1 -7.04 7.15 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.375 -0.375 . . . . 72.310000000000002 110.627 -176.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 70' ' ' TYR . 19.6 m -141.83 150.69 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 109.979 -0.378 . . . . 55.140000000000001 109.979 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.9 tppt? -144.9 127.25 15.85 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.845 -0.428 . . . . 63.310000000000002 109.845 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.571 ' HA ' ' O ' ' A' ' 45' ' ' LEU . 1.9 mp -95.94 142.82 13.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.583 0.23 . . . . 74.420000000000002 110.398 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.619 ' CD2' HG23 ' A' ' 44' ' ' ILE . 83.6 m-85 -135.46 131.56 36.29 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.211 -0.45 . . . . 72.200000000000003 110.339 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.441 ' HG2' ' HA ' ' A' ' 25' ' ' GLN . 22.3 ptmt -87.21 134.56 33.52 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 120.734 0.302 . . . . 72.219999999999999 110.477 177.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.41 HD13 ' CD1' ' A' ' 31' ' ' PHE . 7.8 tp . . . . . 0 CA--C 1.534 0.351 0 CA-C-N 115.819 -0.628 . . . . 72.5 110.769 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.128 0 CA-C-O 121.025 0.441 . . . . 73.530000000000001 110.168 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.9 m -67.86 -31.24 70.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.805 -0.634 . . . . 71.010000000000005 110.406 178.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -65.4 -55.83 15.92 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.492 -0.776 . . . . 72.230000000000004 110.67 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -80.12 -9.01 59.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.32 -0.4 . . . . 74.030000000000001 111.153 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.26 47.82 21.66 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.165 -0.54 . . . . 71.209999999999994 112.6 176.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.5 t -65.32 105.55 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.948 0.404 . . . . 73.5 110.42 178.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.2 p -107.49 0.43 22.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.082 -0.508 . . . . 73.310000000000002 111.06 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.62 125.98 10.83 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.61 -0.268 . . . . 73.129999999999995 110.847 -177.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 32.4 pt -100.1 150.94 37.33 Favored Pre-proline 0 C--O 1.238 0.466 0 CA-C-N 116.113 -0.494 . . . . 72.430000000000007 110.193 177.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -79.82 178.61 32.57 Favored 'Cis proline' 0 C--N 1.352 0.722 0 C-N-CA 123.663 -1.39 . . . . 65.310000000000002 112.507 0.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 27.6 m -148.03 133.3 18.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.194 -0.457 . . . . 71.120000000000005 110.243 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 62.2 mt -119.76 134.25 63.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.752 -0.462 . . . . 53.43 109.752 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.475 HD13 ' HE2' ' A' ' 48' ' ' PHE . 11.2 mp -118.0 130.81 56.41 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 120.619 0.247 . . . . 73.120000000000005 110.402 177.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.41 ' SD ' ' HB3' ' A' ' 109' ' ' SER . 87.0 mtp -95.42 108.46 20.66 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.846 -0.616 . . . . 74.109999999999999 110.327 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -110.04 146.95 34.46 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.869 0.366 . . . . 74.430000000000007 110.989 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.409 ' HB3' HD21 ' A' ' 108' ' ' LEU . 28.4 ttpp -153.37 108.13 3.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.73 -0.668 . . . . 63.310000000000002 109.595 174.186 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 61.61 29.78 18.36 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.009 -0.541 . . . . 65.239999999999995 110.424 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.04 -10.69 74.34 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.235 -0.507 . . . . 53.509999999999998 112.741 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -96.74 119.43 35.2 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.761 -0.459 . . . . 51.240000000000002 109.761 177.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.21 128.34 34.5 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.508 -0.553 . . . . 45.119999999999997 109.508 177.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.478 ' N ' HD22 ' A' ' 108' ' ' LEU . 2.4 mm? -87.89 -47.26 8.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.983 0.421 . . . . 72.549999999999997 110.54 -176.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.41 ' HB3' ' SD ' ' A' ' 101' ' ' MET . 23.5 t -160.22 171.81 18.53 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.869 -0.605 . . . . 74.540000000000006 110.678 -175.26 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -149.04 129.73 14.09 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.718 -0.674 . . . . 75.319999999999993 110.906 -175.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.498 ' CG2' HG22 ' A' ' 119' ' ' ILE . 22.2 t -96.66 111.49 26.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 123.158 0.583 . . . . 64.25 110.067 178.22 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 59.8 mt -107.57 106.79 21.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.856 -0.424 . . . . 75.109999999999999 109.856 177.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 105.68 -112.39 3.93 Favored Glycine 0 C--N 1.33 0.226 0 N-CA-C 111.399 -0.68 . . . . 74.409999999999997 111.399 -176.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.51 57.16 0.5 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.396 0.617 . . . . 71.329999999999998 110.685 177.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.593 ' O ' HG23 ' A' ' 119' ' ' ILE . 3.0 m-20 -85.17 75.63 10.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.801 -0.636 . . . . 62.439999999999998 110.601 -179.025 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.568 ' O ' HG13 ' A' ' 119' ' ' ILE . 5.8 tp -52.56 -41.88 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 116.315 -0.402 . . . . 73.120000000000005 111.316 -178.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.9 p -62.15 -29.51 70.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.47 . . . . 71.150000000000006 111.075 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.454 ' HB2' ' HB3' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -79.41 -42.0 26.44 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.341 -0.614 . . . . 71.040000000000006 109.341 178.669 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.593 HG23 ' O ' ' A' ' 115' ' ' ASP . 1.3 pp -64.68 -43.03 96.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.324 -0.398 . . . . 71.219999999999999 111.002 -174.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.507 HD12 ' N ' ' A' ' 121' ' ' SER . 2.9 pp -63.47 -32.26 56.0 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.096 0 C-N-CA 120.623 -0.431 . . . . 75.310000000000002 110.39 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.507 ' N ' HD12 ' A' ' 120' ' ' ILE . 47.9 m -71.15 -51.53 24.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.037 -0.529 . . . . 62.240000000000002 111.08 177.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.448 ' HG2' ' HA ' ' A' ' 119' ' ' ILE . 10.7 pt-20 -69.44 -41.13 76.71 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.526 -0.306 . . . . 74.319999999999993 111.458 -171.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.735 HD12 HD12 ' A' ' 66' ' ' LEU . 74.9 mt -67.33 -57.7 8.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 110.409 -0.219 . . . . 72.530000000000001 110.409 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -59.77 -23.39 63.22 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.952 0.406 . . . . 72.010000000000005 110.866 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -67.48 -29.29 68.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.943 -0.571 . . . . 60.229999999999997 111.391 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -111.82 -1.17 15.65 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.154 0.428 . . . . 73.109999999999999 112.154 -174.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.518 HG12 ' O ' ' A' ' 123' ' ' ILE . 47.5 pt -131.83 168.32 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 121.236 0.541 . . . . 71.040000000000006 111.299 177.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 . . . . . 0 C--O 1.25 1.113 0 CA-C-N 115.116 -0.947 . . . . 74.439999999999998 110.485 -178.039 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.474 ' N ' ' SD ' ' A' ' 22' ' ' MET . 3.6 mpp? . . . . . 0 C--O 1.236 0.36 0 CA-C-O 120.925 0.393 . . . . 73.25 110.065 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.48 HG22 ' HE3' ' A' ' 78' ' ' LYS . 7.9 mm -101.08 92.48 2.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 108.595 -0.891 . . . . 74.400000000000006 108.595 175.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.603 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 34.4 tt0 -112.9 148.39 35.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.899 -0.591 . . . . 71.409999999999997 110.788 -168.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.509 ' HB3' ' NZ ' ' A' ' 78' ' ' LYS . 5.3 pp0? -99.4 147.56 25.11 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 110.092 -0.336 . . . . 65.140000000000001 110.092 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.448 HD12 ' HA ' ' A' ' 31' ' ' PHE . 31.8 pt -137.91 162.36 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 121.012 0.434 . . . . 64.230000000000004 111.409 -176.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.62 171.23 19.97 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.335 -0.848 . . . . 13.31 111.758 177.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -67.78 -30.05 69.39 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.707 0.253 . . . . 73.329999999999998 111.459 -177.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 28.8 t -68.7 -36.66 78.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.713 0.292 . . . . 64.120000000000005 111.044 -177.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.431 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 4.3 pm0 -98.35 -9.85 24.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 71.549999999999997 111.188 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.482 ' HE1' HG11 ' A' ' 46' ' ' VAL . 93.3 t80 -46.75 -71.11 0.08 Allowed 'General case' 0 N--CA 1.467 0.399 0 O-C-N 123.317 0.385 . . . . 65.209999999999994 111.259 -175.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -65.79 -35.63 81.24 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 109.593 -0.521 . . . . 71.430000000000007 109.593 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -53.59 -33.75 55.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.807 -1.088 . . . . 63.409999999999997 111.881 -174.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.431 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 0.2 OUTLIER -114.82 -18.53 11.31 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 121.03 -0.268 . . . . 53.439999999999998 111.68 -179.822 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 72.7 t -88.44 -57.09 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 111.746 0.276 . . . . 61.520000000000003 111.746 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 58.2 p -76.32 -23.33 54.29 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.107 0.48 . . . . 74.430000000000007 110.537 -175.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.8 m -86.27 11.68 11.59 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.676 -0.693 . . . . 73.219999999999999 111.083 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.503 ' HB2' HD12 ' A' ' 44' ' ' ILE . 41.8 t -57.96 91.11 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.037 0.446 . . . . 60.130000000000003 110.962 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -101.33 -6.7 23.77 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.816 -0.629 . . . . 70.230000000000004 109.989 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -77.91 -5.23 50.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.361 -0.836 . . . . 63.240000000000002 111.778 -174.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 66.83 16.56 10.4 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.336 -0.393 . . . . 71.209999999999994 110.856 -176.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.0 tt -87.18 142.87 12.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.33 -0.619 . . . . 74.519999999999996 109.33 177.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.727 HD21 ' HE3' ' A' ' 101' ' ' MET . 68.1 tp -82.46 116.91 22.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.889 0.376 . . . . 74.319999999999993 110.314 -178.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.503 HD12 ' HB2' ' A' ' 38' ' ' CYS . 56.3 mt -102.61 117.67 48.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.872 -0.603 . . . . 75.349999999999994 110.533 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.525 ' HB2' HG13 ' A' ' 76' ' ' ILE . 4.1 mp -106.06 103.84 13.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.051 -0.522 . . . . 41.200000000000003 109.748 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.513 HG22 ' HB2' ' A' ' 77' ' ' TYR . 45.7 t -109.41 123.76 65.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 111.43 0.159 . . . . 71.439999999999998 111.43 -177.026 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.465 ' HB2' HG13 ' A' ' 99' ' ' ILE . 14.2 t70 -91.82 149.52 21.54 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.661 -0.866 . . . . 64.5 108.661 170.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 . . . . . 0 C--N 1.326 -0.444 0 N-CA-C 111.46 0.17 . . . . 73.030000000000001 111.46 -177.457 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo . . . . . 0 CA--C 1.533 0.458 0 N-CA-C 110.931 -0.45 . . . . 71.140000000000001 110.931 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.512 ' HB3' HG12 ' A' ' 119' ' ' ILE . 6.8 mp0 -48.99 -57.62 6.21 Favored 'General case' 0 C--O 1.247 0.974 0 CA-C-O 121.627 0.727 . . . . 74.099999999999994 111.491 -173.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.599 HD12 ' N ' ' A' ' 64' ' ' GLU . 2.1 pp -62.31 -38.81 90.85 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.117 -0.947 . . . . 74.219999999999999 111.654 -174.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.599 ' N ' HD12 ' A' ' 63' ' ' LEU . 37.8 mt-10 -70.9 -35.47 72.32 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 110.003 -0.369 . . . . 74.409999999999997 110.003 177.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -57.37 -56.73 18.09 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.004 -0.544 . . . . 71.310000000000002 110.642 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.661 HD12 HD12 ' A' ' 123' ' ' ILE . 28.5 mt -80.1 -30.79 39.2 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.364 0.505 . . . . 73.239999999999995 112.364 -175.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.428 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -62.38 -33.27 74.42 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 111.585 0.217 . . . . 61.5 111.585 -177.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.551 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 78.6 mt-30 -64.07 -30.92 71.96 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.003 0.43 . . . . 70.239999999999995 110.657 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 68.8 mm-40 -89.28 -59.11 2.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.009 -0.541 . . . . 65.549999999999997 110.776 -176.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.508 ' O ' HG22 ' A' ' 74' ' ' VAL . 17.1 m-85 -87.8 23.49 2.0 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.56 -0.746 . . . . 75.230000000000004 111.892 -173.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.428 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 6.6 t -52.0 -38.79 58.01 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.063 0.764 . . . . 74.329999999999998 113.063 -167.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -73.45 -16.52 61.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.774 0.321 . . . . 53.340000000000003 111.181 -176.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -113.14 -4.31 13.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.317 -0.402 . . . . 72.310000000000002 110.951 -177.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 70' ' ' TYR . 32.8 m -133.19 137.15 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.254 0.55 . . . . 55.140000000000001 111.072 178.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.432 ' HD2' ' CZ ' ' A' ' 77' ' ' TYR . 7.7 mmtt -128.79 115.13 17.47 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.96 -0.755 . . . . 63.310000000000002 108.96 177.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.525 HG13 ' HB2' ' A' ' 45' ' ' LEU . 2.3 mp -99.68 134.68 38.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.411 -0.588 . . . . 74.420000000000002 109.411 -177.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.603 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 71.3 m-85 -132.49 155.58 48.33 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.393 -0.367 . . . . 72.200000000000003 110.363 -178.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.509 ' NZ ' ' HB3' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -144.02 128.59 18.09 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.722 -0.844 . . . . 72.219999999999999 108.722 170.635 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.1 tt . . . . . 0 C--N 1.325 -0.457 0 CA-C-N 116.102 -0.499 . . . . 72.5 110.023 -175.466 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.38 0 CA-C-O 120.986 0.422 . . . . 73.530000000000001 110.934 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.9 m -73.9 -31.38 63.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.795 -0.638 . . . . 71.010000000000005 110.683 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -63.97 -43.94 94.24 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.765 -0.652 . . . . 72.230000000000004 110.573 -178.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -86.58 -14.3 43.27 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.196 -0.456 . . . . 74.030000000000001 110.48 175.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 65.03 55.59 20.97 Favored Glycine 0 C--O 1.237 0.282 0 CA-C-N 116.002 -0.545 . . . . 71.209999999999994 112.182 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.438 HG21 ' OG1' ' A' ' 98' ' ' THR . 7.9 p -73.93 131.73 34.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.766 0.317 . . . . 73.5 110.728 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.6 t -121.83 -0.88 9.5 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.456 -0.338 . . . . 73.310000000000002 111.141 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.459 ' HB3' HG22 ' A' ' 112' ' ' ILE . . . -135.98 128.73 30.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.697 0.285 . . . . 73.129999999999995 110.904 -177.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.786 HD13 ' H ' ' A' ' 96' ' ' ILE . 0.2 OUTLIER -113.06 154.85 44.95 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 115.866 -0.606 . . . . 72.430000000000007 109.938 179.781 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.67 177.54 28.29 Favored 'Cis proline' 0 C--N 1.356 0.967 0 C-N-CA 124.183 -1.174 . . . . 65.310000000000002 112.442 1.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.438 ' OG1' HG21 ' A' ' 93' ' ' VAL . 18.5 m -146.99 115.19 6.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.072 0.463 . . . . 71.120000000000005 110.521 -176.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.525 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 3.7 mp -117.88 129.55 74.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.5 -0.773 . . . . 53.43 110.095 -176.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.9 mp -104.54 132.57 50.63 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.835 -0.431 . . . . 73.120000000000005 109.835 174.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.727 ' HE3' HD21 ' A' ' 43' ' ' LEU . 53.0 mtp -101.46 112.91 25.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.959 -0.564 . . . . 74.109999999999999 110.696 -176.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -112.49 147.51 36.39 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.879 0.371 . . . . 74.430000000000007 110.861 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.829 ' HB3' HD21 ' A' ' 108' ' ' LEU . 28.2 ttpp -161.5 131.96 5.05 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.849 -0.614 . . . . 63.310000000000002 109.344 176.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 18.6 m120 58.34 32.33 21.95 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.238 0.542 . . . . 65.239999999999995 110.703 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.31 21.36 75.83 Favored Glycine 0 C--N 1.334 0.417 0 CA-C-N 115.509 -0.769 . . . . 53.509999999999998 112.727 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -137.05 133.53 35.54 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.436 -0.579 . . . . 51.240000000000002 109.436 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.9 pptp? -82.8 137.15 34.44 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.68 -0.489 . . . . 45.119999999999997 109.68 -177.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.829 HD21 ' HB3' ' A' ' 103' ' ' LYS . 2.1 mm? -99.13 -52.97 3.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.128 -0.487 . . . . 72.549999999999997 110.47 -177.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.653 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 16.8 m -150.31 172.1 15.92 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 115.679 -0.691 . . . . 74.540000000000006 110.795 -170.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.29 122.15 11.27 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.171 0.51 . . . . 75.319999999999993 110.858 -174.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.551 HG22 HG22 ' A' ' 119' ' ' ILE . 49.6 t -85.46 107.17 15.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.062 -0.517 . . . . 64.25 109.905 176.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.459 HG22 ' HB3' ' A' ' 95' ' ' ALA . 54.2 mt -106.32 106.95 21.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-O 120.987 0.423 . . . . 75.109999999999999 110.349 178.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.06 -134.76 12.65 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.766 -0.652 . . . . 74.409999999999997 112.096 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -132.82 81.67 1.96 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.87 0.367 . . . . 71.329999999999998 110.919 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.478 ' HB3' ' HB2' ' A' ' 118' ' ' LYS . 1.0 OUTLIER -122.53 94.41 4.28 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.928 -0.578 . . . . 62.439999999999998 110.519 -179.712 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.538 ' O ' HG13 ' A' ' 119' ' ' ILE . 7.8 tp -62.24 -41.38 91.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 CA-C-N 116.306 -0.406 . . . . 73.120000000000005 110.927 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.1 t -65.37 -28.9 69.6 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.12 -0.491 . . . . 71.150000000000006 110.449 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.478 ' HB2' ' HB3' ' A' ' 115' ' ' ASP . 0.2 OUTLIER -72.71 -55.36 6.9 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 108.689 -0.856 . . . . 71.040000000000006 108.689 176.879 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.551 HG22 HG22 ' A' ' 111' ' ' VAL . 2.2 pp -60.92 -38.49 79.39 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-N 115.757 -0.656 . . . . 71.219999999999999 112.065 -171.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.519 HD12 ' N ' ' A' ' 121' ' ' SER . 2.9 pp -64.96 -33.01 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 C-N-CA 120.216 -0.594 . . . . 75.310000000000002 110.538 179.021 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.519 ' N ' HD12 ' A' ' 120' ' ' ILE . 42.0 t -70.92 -51.94 23.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.801 0.334 . . . . 62.240000000000002 110.258 177.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.518 ' HG2' ' HA ' ' A' ' 119' ' ' ILE . 15.6 pt-20 -71.78 -35.3 69.98 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.29 -0.413 . . . . 74.319999999999993 111.833 -170.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.661 HD12 HD12 ' A' ' 66' ' ' LEU . 71.4 mt -71.02 -53.91 19.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.628 0.251 . . . . 72.530000000000001 110.638 177.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -61.87 -23.03 66.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.328 -0.396 . . . . 72.010000000000005 111.386 -177.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -62.86 -48.96 76.79 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.461 -0.336 . . . . 60.229999999999997 111.361 176.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.554 ' OD1' HD22 ' A' ' 43' ' ' LEU . 9.3 p30 -88.38 -30.37 19.56 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 112.189 0.44 . . . . 73.109999999999999 112.189 -170.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.514 HG23 ' OD1' ' A' ' 126' ' ' ASN . 41.8 pt -106.59 168.14 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.864 0.364 . . . . 71.040000000000006 110.98 177.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.251 1.138 0 CA-C-O 118.376 -0.821 . . . . 74.439999999999998 110.985 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.581 ' HG3' HG13 ' A' ' 23' ' ' ILE . 24.6 ptp . . . . . 0 C--O 1.233 0.197 0 CA-C-O 120.674 0.273 . . . . 73.25 110.293 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.581 HG13 ' HG3' ' A' ' 22' ' ' MET . 65.1 mt -134.3 118.98 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 116.28 -0.418 . . . . 74.400000000000006 109.881 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.545 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 8.4 tp10 -131.89 155.13 48.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.908 0.385 . . . . 71.409999999999997 111.019 -178.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -109.7 129.2 55.63 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.425 -0.583 . . . . 65.140000000000001 109.425 174.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.516 HD12 ' HA ' ' A' ' 31' ' ' PHE . 22.0 pt -122.59 173.65 8.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 116.5 -0.318 . . . . 64.230000000000004 111.438 -175.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -112.14 -176.48 19.93 Favored Glycine 0 C--N 1.333 0.371 0 CA-C-N 115.85 -0.614 . . . . 13.31 112.859 -176.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -58.62 -49.94 75.65 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.454 0.702 . . . . 73.329999999999998 112.339 -175.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.0 m -74.03 -16.99 61.03 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.657 0.614 . . . . 64.120000000000005 112.657 -168.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -113.52 -7.89 13.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.575 -0.284 . . . . 71.549999999999997 111.471 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.516 ' HA ' HD12 ' A' ' 26' ' ' ILE . 30.5 t80 -49.25 -70.79 0.08 Allowed 'General case' 0 N--CA 1.461 0.106 0 O-C-N 123.32 0.387 . . . . 65.209999999999994 110.743 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -62.63 -37.67 87.25 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.644 -0.502 . . . . 71.430000000000007 109.644 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.513 ' O ' ' HB2' ' A' ' 37' ' ' SER . 20.7 t-20 -52.59 -42.9 64.95 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.789 -1.096 . . . . 63.409999999999997 112.051 -173.242 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.502 ' HD3' HG21 ' A' ' 26' ' ' ILE . 12.7 ptmt -111.52 -15.38 13.52 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.326 0.491 . . . . 53.439999999999998 112.326 -177.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.1 t -88.51 -56.37 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 111.681 0.252 . . . . 61.520000000000003 111.681 177.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 39.9 p -84.38 -32.09 24.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.911 0.386 . . . . 74.430000000000007 110.882 -173.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.513 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 18.0 m -83.81 8.92 13.26 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.083 -0.508 . . . . 73.219999999999999 111.516 -177.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.458 ' SG ' HG22 ' A' ' 42' ' ' ILE . 50.2 t -72.27 95.58 1.72 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.946 0.403 . . . . 60.130000000000003 110.449 -178.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -76.41 -9.32 58.56 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.934 -0.575 . . . . 70.230000000000004 110.796 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -59.05 -25.35 63.64 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.122 -0.49 . . . . 63.240000000000002 111.257 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.474 ' HA ' ' HB2' ' A' ' 103' ' ' LYS . 66.4 m-20 65.47 15.92 10.26 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.755 -0.657 . . . . 71.209999999999994 111.074 -176.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.458 HG22 ' SG ' ' A' ' 38' ' ' CYS . 10.6 tt -65.33 166.26 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 108.669 -0.863 . . . . 74.519999999999996 108.669 172.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.591 HD21 ' HE3' ' A' ' 101' ' ' MET . 49.7 tp -92.35 101.65 14.13 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 121.651 -0.656 . . . . 74.319999999999993 110.677 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 50.5 mt -87.32 131.89 34.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.522 -0.763 . . . . 75.349999999999994 109.795 174.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.541 ' HB2' HG13 ' A' ' 76' ' ' ILE . 89.0 mt -117.44 104.6 11.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.129 -0.487 . . . . 41.200000000000003 109.701 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 23.5 m -95.43 119.53 43.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.965 -0.294 . . . . 71.439999999999998 110.72 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.698 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 31.8 t70 -99.27 161.5 13.59 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 116.18 -0.464 . . . . 64.5 110.25 -178.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.407 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 25.9 p90 . . . . . 0 C--O 1.239 0.546 0 CA-C-O 121.397 0.617 . . . . 73.030000000000001 112.07 -174.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo . . . . . 0 C--O 1.234 0.322 0 N-CA-C 110.259 -0.708 . . . . 71.140000000000001 110.259 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.499 ' HB3' HG12 ' A' ' 119' ' ' ILE . 10.3 mp0 -51.46 -43.93 62.25 Favored 'General case' 0 C--O 1.246 0.918 0 CA-C-O 121.608 0.718 . . . . 74.099999999999994 110.294 -173.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.443 HD11 HG12 ' A' ' 99' ' ' ILE . 6.4 mp -56.92 -48.74 77.56 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 114.488 -1.233 . . . . 74.219999999999999 110.491 -175.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.417 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 49.0 mt-10 -70.74 -42.51 70.41 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 123.212 0.32 . . . . 74.409999999999997 110.249 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.5 tmtp? -50.76 -46.17 59.23 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.807 -0.633 . . . . 71.310000000000002 109.834 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.652 HD12 HD12 ' A' ' 123' ' ' ILE . 17.6 mt -86.18 -41.87 14.31 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.571 0.582 . . . . 73.239999999999995 112.571 177.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.87 -39.88 78.87 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 111.934 0.346 . . . . 61.5 111.934 -173.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.417 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 97.9 mt-30 -53.69 -33.2 54.61 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.269 0.557 . . . . 70.239999999999995 110.313 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 53.1 mm-40 -93.82 -41.39 9.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.445 -0.798 . . . . 65.549999999999997 111.465 -177.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.555 ' O ' HG22 ' A' ' 74' ' ' VAL . 17.3 m-85 -107.17 22.38 16.07 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.748 0.647 . . . . 75.230000000000004 112.748 -169.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.1 t -52.8 -34.05 51.75 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.13 0.419 . . . . 74.329999999999998 112.13 -176.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -68.3 -16.5 63.97 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 111.576 0.213 . . . . 53.340000000000003 111.576 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -122.52 -4.77 8.76 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.539 0.209 . . . . 72.310000000000002 111.047 -177.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.555 HG22 ' O ' ' A' ' 70' ' ' TYR . 27.7 m -136.82 147.48 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 O-C-N 122.071 -0.393 . . . . 55.140000000000001 110.444 178.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.434 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 7.0 tppt? -142.13 116.59 9.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.718 0.295 . . . . 63.310000000000002 110.208 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.541 HG13 ' HB2' ' A' ' 45' ' ' LEU . 2.0 mp -93.14 134.23 31.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.078 -0.51 . . . . 74.420000000000002 110.762 -175.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.545 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 97.1 m-85 -129.12 128.6 43.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.885 -0.598 . . . . 72.200000000000003 109.616 174.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.698 ' HG2' ' HB3' ' A' ' 47' ' ' ASP . 25.6 mtpp -103.29 143.2 32.97 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.787 -0.449 . . . . 72.219999999999999 109.787 176.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 40.9 mm . . . . . 0 C--N 1.326 -0.453 0 CA-C-N 115.848 -0.615 . . . . 72.5 111.059 -175.507 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.291 0 CA-C-O 120.916 0.389 . . . . 73.530000000000001 110.845 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.9 m -67.69 -30.72 70.32 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.259 -0.428 . . . . 71.010000000000005 110.727 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -59.56 -55.99 27.52 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.929 -0.578 . . . . 72.230000000000004 110.341 178.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -75.33 -15.82 60.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.391 -0.368 . . . . 74.030000000000001 110.937 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.46 61.01 2.39 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.306 -0.473 . . . . 71.209999999999994 112.661 175.355 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.52 HG22 HG21 ' A' ' 98' ' ' THR . 59.7 t -69.51 85.32 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-O 121.361 0.601 . . . . 73.5 110.137 176.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.2 t -116.03 9.76 14.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.507 -0.77 . . . . 73.310000000000002 110.144 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.467 ' HB3' HG22 ' A' ' 112' ' ' ILE . . . -152.66 142.63 22.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 73.129999999999995 109.973 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 29.9 pt -113.43 149.62 41.85 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.375 -0.375 . . . . 72.430000000000007 110.774 -177.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -76.54 -176.02 17.76 Favored 'Cis proline' 0 C--N 1.353 0.792 0 C-N-CA 124.005 -1.248 . . . . 65.310000000000002 112.442 -1.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.52 HG21 HG22 ' A' ' 93' ' ' VAL . 43.6 m -142.54 115.36 8.69 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.091 -0.337 . . . . 71.120000000000005 110.091 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.471 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 4.0 mp -129.14 142.84 42.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.979 -0.555 . . . . 53.43 109.837 -178.075 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.6 mp -118.92 140.84 49.32 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.697 0.284 . . . . 73.120000000000005 110.361 174.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.843 ' SD ' ' HB3' ' A' ' 109' ' ' SER . 89.8 mtp -96.72 114.11 25.73 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.841 -0.618 . . . . 74.109999999999999 110.46 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -115.12 144.5 43.57 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.072 0.463 . . . . 74.430000000000007 112.13 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.81 ' HG2' HD21 ' A' ' 108' ' ' LEU . 0.4 OUTLIER -157.8 119.23 3.59 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 108.913 -0.773 . . . . 63.310000000000002 108.913 163.617 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 58.94 25.03 13.23 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.543 0.687 . . . . 65.239999999999995 110.207 -176.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 87.45 -6.21 83.77 Favored Glycine 0 CA--C 1.52 0.349 0 CA-C-N 115.798 -0.637 . . . . 53.509999999999998 112.511 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -77.84 128.97 34.83 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.511 -0.552 . . . . 51.240000000000002 109.511 177.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 101' ' ' MET . 3.1 mppt? -90.49 109.41 20.55 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.32 -0.622 . . . . 45.119999999999997 109.32 174.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.81 HD21 ' HG2' ' A' ' 103' ' ' LYS . 2.3 mm? -77.92 -36.63 49.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.142 -0.481 . . . . 72.549999999999997 110.545 -175.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.843 ' HB3' ' SD ' ' A' ' 101' ' ' MET . 17.2 t -178.64 171.9 1.46 Allowed 'General case' 0 C--O 1.24 0.598 0 CA-C-N 115.593 -0.731 . . . . 74.540000000000006 109.05 -176.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.04 141.14 36.28 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.251 0.548 . . . . 75.319999999999993 111.106 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 98' ' ' THR . 46.6 t -103.57 107.1 21.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.169 -0.923 . . . . 64.25 109.772 176.204 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.467 HG22 ' HB3' ' A' ' 95' ' ' ALA . 45.1 mt -118.84 106.31 19.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.466 -0.938 . . . . 75.109999999999999 108.466 172.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 108.65 174.26 21.58 Favored Glycine 0 CA--C 1.519 0.322 0 N-CA-C 111.041 -0.824 . . . . 74.409999999999997 111.041 -170.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -96.59 56.99 1.57 Allowed 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.179 0.514 . . . . 71.329999999999998 110.77 -177.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.548 ' O ' HG23 ' A' ' 119' ' ' ILE . 1.9 m-20 -90.19 73.78 7.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.875 -0.602 . . . . 62.439999999999998 110.906 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.551 ' O ' HG13 ' A' ' 119' ' ' ILE . 6.3 tp -54.74 -40.37 51.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 CA-C-O 121.108 0.48 . . . . 73.120000000000005 110.823 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.2 p -62.62 -29.08 70.36 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.853 -0.612 . . . . 71.150000000000006 111.182 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.498 ' HB2' ' HB3' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -79.28 -48.66 13.75 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.306 -0.627 . . . . 71.040000000000006 109.306 177.409 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.551 HG13 ' O ' ' A' ' 116' ' ' ILE . 1.6 pp -61.84 -40.77 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 116.132 -0.486 . . . . 71.219999999999999 111.421 -172.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.542 HD12 ' N ' ' A' ' 121' ' ' SER . 2.9 pp -63.19 -31.97 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 C-N-CA 120.437 -0.505 . . . . 75.310000000000002 110.399 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.542 ' N ' HD12 ' A' ' 120' ' ' ILE . 33.6 t -70.46 -51.92 25.78 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.994 -0.548 . . . . 62.240000000000002 110.854 178.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.5 ' HG2' ' HA ' ' A' ' 119' ' ' ILE . 12.8 pt-20 -70.75 -43.67 68.36 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.085 -0.507 . . . . 74.319999999999993 111.325 -172.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.652 HD12 HD12 ' A' ' 66' ' ' LEU . 78.8 mt -64.41 -53.86 37.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.352 0.12 . . . . 72.530000000000001 110.958 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -59.79 -26.65 65.9 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.775 0.322 . . . . 72.010000000000005 111.263 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -77.34 -14.87 59.64 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 111.741 0.274 . . . . 60.229999999999997 111.741 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -118.14 9.72 12.74 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 111.656 0.243 . . . . 73.109999999999999 111.656 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.522 HG12 ' O ' ' A' ' 123' ' ' ILE . 43.6 pt -134.74 168.33 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 109.921 -0.4 . . . . 71.040000000000006 109.921 173.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.366 -0.826 . . . . 74.439999999999998 110.969 -176.15 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.635 ' HG3' HG13 ' A' ' 23' ' ' ILE . 21.2 ptp . . . . . 0 N--CA 1.467 0.376 0 N-CA-C 109.764 -0.458 . . . . 73.25 109.764 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.635 HG13 ' HG3' ' A' ' 22' ' ' MET . 23.2 mt -127.09 101.65 8.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 108.673 -0.862 . . . . 74.400000000000006 108.673 174.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 9.4 tp10 -124.01 149.64 45.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.813 0.34 . . . . 71.409999999999997 110.377 -175.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -82.15 149.74 27.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.169 -0.468 . . . . 65.140000000000001 110.26 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.481 HD12 ' HA ' ' A' ' 31' ' ' PHE . 25.4 pt -130.01 177.4 6.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.603 -0.271 . . . . 64.230000000000004 110.512 178.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.18 158.55 18.21 Favored Glycine 0 C--O 1.237 0.32 0 CA-C-N 116.102 -0.499 . . . . 13.31 112.324 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -59.81 -39.15 84.07 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.203 0.525 . . . . 73.329999999999998 110.433 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.4 t -63.33 -32.83 74.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.424 -0.807 . . . . 64.120000000000005 111.529 -176.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.403 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 10.0 pt-20 -105.28 -1.06 25.71 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 112.324 0.49 . . . . 71.549999999999997 112.324 -174.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.481 ' HA ' HD12 ' A' ' 26' ' ' ILE . 57.9 t80 -47.15 -71.61 0.07 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.793 0.33 . . . . 65.209999999999994 111.192 -178.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -64.43 -36.43 84.15 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.351 -0.611 . . . . 71.430000000000007 109.351 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -52.43 -38.55 59.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.436 -1.256 . . . . 63.409999999999997 111.891 -173.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 15.8 ptmt -114.34 -18.27 11.6 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.094 0.405 . . . . 53.439999999999998 112.094 -177.245 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 72.7 t -85.22 -49.59 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 111.851 0.315 . . . . 61.520000000000003 111.851 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 64.9 p -83.06 -28.83 29.28 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.075 0.464 . . . . 74.430000000000007 111.04 -173.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.1 m -80.1 12.02 3.08 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.914 -0.585 . . . . 73.219999999999999 111.992 -177.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 24.6 p -76.8 87.33 3.4 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.824 0.345 . . . . 60.130000000000003 111.817 -176.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -75.22 -5.93 47.04 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.14 0.495 . . . . 70.230000000000004 110.397 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.526 ' O ' ' HB2' ' A' ' 41' ' ' ASN . 2.1 m-20 -52.82 -30.26 32.43 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.633 -0.712 . . . . 63.240000000000002 112.062 -177.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.526 ' HB2' ' O ' ' A' ' 40' ' ' ASP . 3.9 m-20 75.11 11.47 3.55 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 123.691 0.619 . . . . 71.209999999999994 110.34 -171.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.518 HG22 ' HB2' ' A' ' 40' ' ' ASP . 10.0 tt -81.94 158.53 4.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 115.624 -0.716 . . . . 74.519999999999996 109.113 176.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.489 HD11 ' HB2' ' A' ' 126' ' ' ASN . 54.5 mt -84.92 112.53 20.65 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 120.916 -0.314 . . . . 74.319999999999993 110.604 179.348 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.0 mt -102.41 105.91 18.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.036 0.446 . . . . 75.349999999999994 109.945 173.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.515 ' HB2' HG12 ' A' ' 76' ' ' ILE . 5.1 mp -93.38 136.96 33.15 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.988 -0.745 . . . . 41.200000000000003 108.988 177.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.502 HG12 ' HB2' ' A' ' 77' ' ' TYR . 27.4 m -130.17 138.67 53.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.749 -0.463 . . . . 71.439999999999998 109.749 178.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -111.33 143.75 41.63 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.857 0.36 . . . . 64.5 111.036 177.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.565 ' HZ ' HG22 ' A' ' 96' ' ' ILE . 13.7 p90 . . . . . 0 C--O 1.234 0.263 0 N-CA-C 109.543 -0.54 . . . . 73.030000000000001 109.543 176.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo . . . . . 0 N--CA 1.459 -0.543 0 CA-C-O 120.929 0.304 . . . . 71.140000000000001 112.314 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.557 ' HB3' HG12 ' A' ' 119' ' ' ILE . 9.6 mp0 -61.9 -57.51 11.49 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.351 0.596 . . . . 74.099999999999994 111.097 -173.315 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.494 ' HB2' HD13 ' A' ' 76' ' ' ILE . 2.3 pt? -54.37 -47.17 72.93 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.068 -0.969 . . . . 74.219999999999999 111.611 -174.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.511 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 37.2 mt-10 -65.66 -43.72 88.53 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 120.888 -0.325 . . . . 74.409999999999997 110.255 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -53.14 -48.66 67.73 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.891 -0.595 . . . . 71.310000000000002 110.982 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.582 HD12 HD12 ' A' ' 123' ' ' ILE . 17.7 mt -79.43 -37.73 36.37 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 111.967 0.358 . . . . 73.239999999999995 111.967 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.419 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -59.81 -31.42 69.69 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.457 0.17 . . . . 61.5 111.307 -176.152 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.511 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 74.8 mt-30 -54.52 -34.95 62.62 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.951 0.405 . . . . 70.239999999999995 111.051 177.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -94.1 -45.23 7.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.192 0.52 . . . . 65.549999999999997 111.019 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.573 ' O ' HG22 ' A' ' 74' ' ' VAL . 20.4 m-85 -92.85 14.92 15.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.807 -0.633 . . . . 75.230000000000004 112.285 -171.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.419 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 8.8 t -52.48 -35.99 53.92 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.05 0.452 . . . . 74.329999999999998 111.442 -174.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -63.96 -28.43 69.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.83 -0.623 . . . . 53.340000000000003 111.841 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -116.48 3.19 13.21 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.52 -0.309 . . . . 72.310000000000002 111.17 -173.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.573 HG22 ' O ' ' A' ' 70' ' ' TYR . 23.6 m -133.68 141.34 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 121.088 0.47 . . . . 55.140000000000001 110.556 177.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.728 ' HA ' ' HE3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -128.15 116.53 20.07 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.523 -0.762 . . . . 63.310000000000002 108.969 174.925 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.555 ' HB ' HG12 ' A' ' 23' ' ' ILE . 39.9 mt -109.49 134.7 50.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.725 0.298 . . . . 74.420000000000002 110.413 -177.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.502 ' HB2' HG12 ' A' ' 46' ' ' VAL . 51.3 m-85 -120.72 134.5 55.28 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 115.982 -0.554 . . . . 72.200000000000003 110.08 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.0 ptmm? -112.89 161.5 16.91 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.25 -0.886 . . . . 72.219999999999999 110.62 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 30.9 mt . . . . . 0 N--CA 1.464 0.24 0 CA-C-N 115.561 -0.745 . . . . 72.5 109.892 -174.111 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.187 0 CA-C-O 121.089 0.471 . . . . 73.530000000000001 109.876 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.8 m -60.67 -32.05 71.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.83 -0.623 . . . . 71.010000000000005 110.53 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -66.12 -37.83 86.7 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.036 -0.529 . . . . 72.230000000000004 110.592 177.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -77.26 -5.66 50.22 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.463 -0.335 . . . . 74.030000000000001 111.099 176.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.85 21.0 64.33 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 121.082 -0.58 . . . . 71.209999999999994 112.077 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 97.9 t -65.93 102.92 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.045 0.45 . . . . 73.5 110.309 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.7 t -143.79 21.03 1.81 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.61 0.719 . . . . 73.310000000000002 109.174 178.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -129.01 160.9 31.28 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.567 -0.742 . . . . 73.129999999999995 110.29 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.565 HG22 ' HZ ' ' A' ' 48' ' ' PHE . 26.8 pt -118.67 130.61 24.7 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.304 -0.407 . . . . 72.430000000000007 110.603 -178.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 96' ' ' ILE . 47.7 Cg_endo -91.62 -170.05 3.96 Favored 'Cis proline' 0 C--N 1.35 0.616 0 C-N-CA 124.05 -1.229 . . . . 65.310000000000002 112.336 -4.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 88.5 m -147.83 139.81 24.12 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.034 -0.53 . . . . 71.120000000000005 109.677 175.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 36.9 mt -136.83 114.49 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 115.957 -0.565 . . . . 53.43 110.019 -176.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.2 mp -91.5 146.36 23.86 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.019 0.437 . . . . 73.120000000000005 111.152 178.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.488 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 90.5 mtp -108.63 118.97 38.16 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.994 -0.548 . . . . 74.109999999999999 110.663 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.43 ' CE2' ' HG2' ' A' ' 107' ' ' LYS . 79.3 m-85 -115.55 149.05 38.8 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.231 0.539 . . . . 74.430000000000007 111.482 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.642 ' HB3' HD21 ' A' ' 108' ' ' LEU . 30.8 ttmt -155.65 111.1 3.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.933 -1.031 . . . . 63.310000000000002 109.078 177.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.9 t30 60.7 25.06 14.87 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.458 0.647 . . . . 65.239999999999995 110.192 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.88 -14.89 62.06 Favored Glycine 0 C--N 1.334 0.458 0 CA-C-N 115.572 -0.74 . . . . 53.509999999999998 112.259 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -81.11 144.43 31.7 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.836 -0.431 . . . . 51.240000000000002 109.836 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.43 ' HG2' ' CE2' ' A' ' 102' ' ' PHE . 46.2 mttp -102.56 115.3 30.3 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.803 -0.444 . . . . 45.119999999999997 109.803 -176.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.642 HD21 ' HB3' ' A' ' 103' ' ' LYS . 2.8 mm? -85.85 -53.4 5.14 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.857 0.361 . . . . 72.549999999999997 111.249 -174.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.488 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 20.5 m -160.02 171.89 18.52 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.882 -0.599 . . . . 74.540000000000006 110.205 -172.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.88 124.04 13.71 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.024 -0.535 . . . . 75.319999999999993 110.568 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.574 HG22 HG22 ' A' ' 119' ' ' ILE . 61.2 t -80.43 107.13 12.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.83 -0.623 . . . . 64.25 109.471 175.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 58.7 mt -108.28 107.03 21.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 109.865 -0.42 . . . . 75.109999999999999 109.865 178.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.32 -132.53 10.98 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.811 -0.631 . . . . 74.409999999999997 111.604 -178.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -142.37 75.74 1.5 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.92 0.39 . . . . 71.329999999999998 110.387 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.49 ' O ' HG23 ' A' ' 119' ' ' ILE . 2.6 m-20 -115.47 97.5 6.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.917 -0.583 . . . . 62.439999999999998 110.611 -177.274 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.528 ' O ' HG13 ' A' ' 119' ' ' ILE . 6.7 tp -64.5 -41.08 91.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 116.411 -0.358 . . . . 73.120000000000005 111.342 -176.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 15.1 m -64.58 -29.85 70.87 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.454 0.645 . . . . 71.150000000000006 110.456 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.463 ' HG3' ' OE2' ' A' ' 122' ' ' GLU . 27.9 tptp -73.88 -50.64 19.29 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.453 -0.794 . . . . 71.040000000000006 110.453 178.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.574 HG22 HG22 ' A' ' 111' ' ' VAL . 2.1 pp -65.34 -41.32 91.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.814 -0.63 . . . . 71.219999999999999 111.519 -174.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.472 HG22 HD11 ' A' ' 66' ' ' LEU . 2.8 pp -62.32 -31.82 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 121.127 0.489 . . . . 75.310000000000002 109.837 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.556 ' O ' ' HB2' ' A' ' 125' ' ' ASN . 23.0 t -70.44 -51.56 28.47 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.85 -0.614 . . . . 62.240000000000002 110.55 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.463 ' OE2' ' HG3' ' A' ' 118' ' ' LYS . 10.7 pt-20 -73.52 -33.41 64.75 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 111.924 0.342 . . . . 74.319999999999993 111.924 -172.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.582 HD12 HD12 ' A' ' 66' ' ' LEU . 71.7 mt -73.59 -57.37 6.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-O 120.567 0.223 . . . . 72.530000000000001 110.654 178.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -63.67 -20.12 65.45 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.115 0.483 . . . . 72.010000000000005 110.609 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.556 ' HB2' ' O ' ' A' ' 121' ' ' SER . 26.7 t-20 -54.04 -29.8 45.3 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.717 -0.674 . . . . 60.229999999999997 110.76 176.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.489 ' HB2' HD11 ' A' ' 43' ' ' LEU . 33.8 m-80 -107.99 -45.21 4.02 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.872 -0.604 . . . . 73.109999999999999 111.233 -176.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 48.4 pt -105.46 167.78 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 120.819 0.343 . . . . 71.040000000000006 111.274 -175.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 34.5 p-10 . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.38 -0.819 . . . . 74.439999999999998 112.137 -177.705 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.522 ' SD ' ' HA ' ' A' ' 68' ' ' GLN . 49.5 mtm . . . . . 0 N--CA 1.473 0.697 0 CA-C-O 121.638 0.733 . . . . 73.25 109.475 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.4 mm -92.67 128.83 43.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 114.38 -1.282 . . . . 74.400000000000006 108.641 171.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.413 ' HG2' ' CE1' ' A' ' 77' ' ' TYR . 9.1 tp10 -124.84 153.15 43.0 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.746 0.308 . . . . 71.409999999999997 110.426 -176.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -126.29 124.4 40.26 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.503 -0.554 . . . . 65.140000000000001 109.503 177.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.518 ' O ' HD13 ' A' ' 79' ' ' ILE . 32.5 pt -131.69 -176.93 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.047 -0.524 . . . . 64.230000000000004 110.533 -172.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -111.79 170.55 13.72 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 121.506 -0.378 . . . . 13.31 112.219 178.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -67.5 -38.15 83.9 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 122.575 0.35 . . . . 73.329999999999998 111.71 -178.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.2 m -60.32 -39.09 85.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.003 0.43 . . . . 64.120000000000005 111.177 -176.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.453 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 1.7 pm0 -103.38 -0.98 29.35 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.779 -0.646 . . . . 71.549999999999997 111.159 -177.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.405 ' HA ' HD12 ' A' ' 26' ' ' ILE . 69.2 t80 -53.04 -70.55 0.09 Allowed 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 109.775 -0.454 . . . . 65.209999999999994 109.775 177.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -49.75 -42.78 47.17 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 116.074 -0.512 . . . . 71.430000000000007 110.03 176.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.408 ' O ' ' HB2' ' A' ' 37' ' ' SER . 66.1 t30 -52.19 -54.32 32.29 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 114.655 -1.157 . . . . 63.409999999999997 111.481 -172.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.465 ' HE3' ' CE1' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -101.23 -15.93 17.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.245 -0.434 . . . . 53.439999999999998 111.936 -172.921 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 73.1 t -88.58 -57.06 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 111.962 0.356 . . . . 61.520000000000003 111.962 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.9 p -88.01 -42.09 12.67 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.047 0.451 . . . . 74.430000000000007 110.716 -171.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 18.4 m -76.73 12.07 1.46 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.823 -0.626 . . . . 73.219999999999999 111.473 -178.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.421 ' SG ' ' HB2' ' A' ' 40' ' ' ASP . 50.1 t -81.21 99.96 8.86 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.999 0.428 . . . . 60.130000000000003 110.334 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -87.25 14.87 7.02 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.181 0.515 . . . . 70.230000000000004 110.661 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.421 ' HB2' ' SG ' ' A' ' 38' ' ' CYS . 5.5 m-20 -75.36 -8.8 57.64 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.066 -0.515 . . . . 63.240000000000002 111.041 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.1 m120 68.47 0.05 2.42 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.483 0.549 . . . . 71.209999999999994 112.483 177.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.9 tt -71.49 145.42 12.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 109.095 -0.706 . . . . 74.519999999999996 109.095 177.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.601 HD11 ' HB3' ' A' ' 101' ' ' MET . 61.1 tp -80.76 109.74 15.61 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.263 0.554 . . . . 74.319999999999993 110.071 -177.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.485 HG23 ' CD2' ' A' ' 77' ' ' TYR . 61.5 mt -94.99 114.54 31.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.357 -0.838 . . . . 75.349999999999994 110.386 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.458 ' N ' HD12 ' A' ' 45' ' ' LEU . 5.5 mp -98.6 101.99 13.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.04 -0.527 . . . . 41.200000000000003 110.114 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.62 HG23 ' HB2' ' A' ' 100' ' ' LEU . 16.3 m -96.9 109.92 23.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.685 -0.487 . . . . 71.439999999999998 109.685 176.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . 3.9 p30 -101.36 146.77 27.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.465 0.65 . . . . 64.5 111.79 -174.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 66.4 t80 . . . . . 0 C--N 1.323 -0.548 0 N-CA-C 107.614 -1.254 . . . . 73.030000000000001 107.614 169.581 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.745 ' HG2' ' HB2' ' A' ' 64' ' ' GLU . 56.4 Cg_endo . . . . . 0 N--CA 1.464 -0.222 0 N-CA-C 109.633 -0.949 . . . . 71.140000000000001 109.633 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.506 ' HB3' HG12 ' A' ' 119' ' ' ILE . 9.6 mp0 -57.21 -50.57 72.45 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-O 121.254 0.549 . . . . 74.099999999999994 110.401 -170.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.663 HD12 ' N ' ' A' ' 64' ' ' GLU . 3.4 pp -54.33 -40.36 67.95 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.142 -0.935 . . . . 74.219999999999999 111.282 -177.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.745 ' HB2' ' HG2' ' A' ' 61' ' ' PRO . 2.3 mm-40 -75.61 -39.89 57.21 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.101 0.477 . . . . 74.409999999999997 110.005 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -53.54 -45.81 69.97 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.409 -0.814 . . . . 71.310000000000002 109.427 -177.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.505 HD12 HD12 ' A' ' 123' ' ' ILE . 16.1 mt -84.69 -37.86 20.45 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.129 -0.487 . . . . 73.239999999999995 111.661 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.406 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -53.97 -46.03 71.55 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.783 0.325 . . . . 61.5 111.048 -177.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.522 ' HA ' ' SD ' ' A' ' 22' ' ' MET . 73.1 mt-30 -49.3 -34.86 16.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.724 -0.671 . . . . 70.239999999999995 111.516 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -94.01 -57.93 2.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.227 0.537 . . . . 65.549999999999997 111.088 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.522 ' O ' HG22 ' A' ' 74' ' ' VAL . 16.6 m-85 -90.44 21.26 4.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.679 -0.691 . . . . 75.230000000000004 112.731 -171.066 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 8.8 t -52.71 -28.49 22.17 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.167 0.508 . . . . 74.329999999999998 111.424 -177.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -65.71 -16.76 64.07 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.73 -0.668 . . . . 53.340000000000003 111.127 -177.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -129.05 -5.35 4.99 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.182 -0.463 . . . . 72.310000000000002 110.438 -176.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.522 HG22 ' O ' ' A' ' 70' ' ' TYR . 22.9 m -132.66 140.43 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.089 0.471 . . . . 55.140000000000001 110.659 178.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -137.25 123.18 20.16 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.813 -0.63 . . . . 63.310000000000002 109.475 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.478 ' N ' HD12 ' A' ' 76' ' ' ILE . 2.0 mp -95.62 141.06 15.83 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-O 120.537 0.208 . . . . 74.420000000000002 110.65 -175.262 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.576 ' HB2' HG12 ' A' ' 46' ' ' VAL . 88.2 m-85 -141.06 157.77 44.85 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.347 0.659 . . . . 72.200000000000003 109.638 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.39 166.67 16.38 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.935 0.398 . . . . 72.219999999999999 110.964 170.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.518 HD13 ' O ' ' A' ' 26' ' ' ILE . 3.9 tp . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 115.106 -0.952 . . . . 72.5 108.669 174.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.551 0 CA-C-O 121.385 0.612 . . . . 73.530000000000001 110.58 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 51.3 m -70.77 -29.49 65.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.719 -0.673 . . . . 71.010000000000005 109.955 176.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -70.66 -35.63 72.96 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.171 -0.468 . . . . 72.230000000000004 110.151 177.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -68.78 -17.2 63.99 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.387 -0.598 . . . . 74.030000000000001 109.387 171.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.86 42.22 9.95 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.397 -0.819 . . . . 71.209999999999994 112.417 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.528 HG21 ' OG1' ' A' ' 98' ' ' THR . 14.9 p -67.95 131.83 33.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.983 0.391 . . . . 73.5 110.385 177.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.3 p -101.82 -36.43 8.68 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.177 -0.465 . . . . 73.310000000000002 111.65 -177.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -127.98 143.6 51.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.649 0.262 . . . . 73.129999999999995 111.062 -175.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.411 ' O ' HD12 ' A' ' 96' ' ' ILE . 2.5 pp -100.02 160.84 26.11 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 115.957 -0.565 . . . . 72.430000000000007 110.669 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.405 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 98.6 Cg_endo -82.36 -177.96 20.11 Favored 'Cis proline' 0 C--N 1.353 0.813 0 C-N-CA 124.03 -1.238 . . . . 65.310000000000002 112.223 -0.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.668 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 17.7 m -144.06 115.41 8.03 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.439 -0.346 . . . . 71.120000000000005 110.567 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.503 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.3 mp -108.06 115.22 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.673 -0.24 . . . . 53.43 110.365 -177.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.62 ' HB2' HG23 ' A' ' 46' ' ' VAL . 8.9 mp -91.89 139.98 30.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.826 0.346 . . . . 73.120000000000005 110.54 178.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.623 ' SD ' ' HB3' ' A' ' 109' ' ' SER . 81.7 mtp -109.37 116.44 31.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.921 -0.581 . . . . 74.109999999999999 110.534 -177.129 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -116.99 154.04 31.6 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.952 0.406 . . . . 74.430000000000007 111.035 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.84 ' HB3' HD21 ' A' ' 108' ' ' LEU . 16.1 ttmm -169.27 115.37 0.58 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.437 -0.801 . . . . 63.310000000000002 109.617 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.9 t30 60.35 31.08 20.29 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.334 0.588 . . . . 65.239999999999995 110.987 172.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.91 -14.45 63.28 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 121.314 -0.47 . . . . 53.509999999999998 113.163 178.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -97.04 146.11 25.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.598 0.237 . . . . 51.240000000000002 110.589 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -99.06 126.02 44.69 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.242 -0.651 . . . . 45.119999999999997 109.242 174.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.84 HD21 ' HB3' ' A' ' 103' ' ' LYS . 3.1 mm? -87.07 -47.39 8.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.525 -0.307 . . . . 72.549999999999997 111.15 -174.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.623 ' HB3' ' SD ' ' A' ' 101' ' ' MET . 27.9 t -167.01 171.8 10.77 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.738 0.304 . . . . 74.540000000000006 110.927 -175.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -136.69 130.82 32.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.702 -0.681 . . . . 75.319999999999993 110.014 175.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.721 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 60.2 t -94.43 107.3 19.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.991 -0.549 . . . . 64.25 110.292 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 61.6 mt -104.26 109.87 28.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 110.022 -0.362 . . . . 75.109999999999999 110.022 176.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 106.87 -142.85 15.74 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 121.204 -0.522 . . . . 74.409999999999997 112.093 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -138.96 80.16 1.77 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.03 0.443 . . . . 71.329999999999998 110.595 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.49 ' O ' HG23 ' A' ' 119' ' ' ILE . 3.0 m-20 -118.67 94.29 4.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.799 -0.637 . . . . 62.439999999999998 110.595 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.57 HD12 HD11 ' A' ' 119' ' ' ILE . 7.2 tp -65.07 -39.01 84.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.186 -0.461 . . . . 73.120000000000005 111.088 -176.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 27.0 t -64.81 -39.77 94.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.242 0.544 . . . . 71.150000000000006 110.445 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.721 ' HE3' ' HA ' ' A' ' 111' ' ' VAL . 0.7 OUTLIER -64.68 -51.7 61.11 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 115.779 -0.646 . . . . 71.040000000000006 110.629 178.326 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.57 HD11 HD12 ' A' ' 116' ' ' ILE . 2.2 pp -63.61 -42.04 94.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 116.209 -0.45 . . . . 71.219999999999999 111.51 -175.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.494 HG22 HD21 ' A' ' 66' ' ' LEU . 2.8 pp -64.33 -31.76 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 120.738 -0.385 . . . . 75.310000000000002 110.254 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.45 ' N ' HD12 ' A' ' 120' ' ' ILE . 23.0 t -69.75 -51.65 32.26 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.187 -0.46 . . . . 62.240000000000002 110.523 -178.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.402 ' OE1' ' NZ ' ' A' ' 118' ' ' LYS . 7.9 pt-20 -77.12 -40.68 44.86 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.806 0.669 . . . . 74.319999999999993 112.806 -176.434 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.505 HD12 HD12 ' A' ' 66' ' ' LEU . 69.5 mt -62.7 -53.7 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 O-C-N 122.046 -0.409 . . . . 72.530000000000001 110.696 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -59.86 -20.23 55.85 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.117 0.484 . . . . 72.010000000000005 110.85 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -78.81 -12.84 60.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.915 -0.584 . . . . 60.229999999999997 111.144 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -126.42 9.47 7.22 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.547 -0.297 . . . . 73.109999999999999 111.554 -178.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 123' ' ' ILE . 45.7 pt -138.99 168.09 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 109.871 -0.418 . . . . 71.040000000000006 109.871 175.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 . . . . . 0 C--O 1.251 1.163 0 CA-C-O 118.585 -0.722 . . . . 74.439999999999998 111.094 -179.46 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.721 ' SD ' HG13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.382 0 CA-C-O 121.195 0.521 . . . . 73.25 110.231 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.721 HG13 ' SD ' ' A' ' 22' ' ' MET . 49.7 mt -115.82 106.36 20.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-N 115.283 -0.871 . . . . 74.400000000000006 109.321 175.253 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.467 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 11.3 tp10 -105.7 136.92 44.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.737 0.303 . . . . 71.409999999999997 110.791 -176.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -90.6 128.46 36.6 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 122.379 0.272 . . . . 65.140000000000001 110.383 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.458 HG21 ' HD3' ' A' ' 34' ' ' LYS . 33.9 pt -128.0 149.9 33.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 120.851 0.358 . . . . 64.230000000000004 111.243 -178.034 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.51 179.09 53.23 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.616 -0.72 . . . . 13.31 112.789 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -63.7 -50.36 69.47 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 122.767 0.427 . . . . 73.329999999999998 111.262 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.9 m -64.43 -39.12 93.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.994 -0.548 . . . . 64.120000000000005 111.803 -172.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.559 ' HA ' ' HB3' ' A' ' 33' ' ' ASN . 16.3 pt-20 -85.37 -9.33 57.72 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 116.507 -0.315 . . . . 71.549999999999997 111.691 -174.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.408 ' HA ' HD12 ' A' ' 26' ' ' ILE . 34.6 t80 -47.8 -71.0 0.08 Allowed 'General case' 0 N--CA 1.464 0.25 0 O-C-N 123.192 0.307 . . . . 65.209999999999994 111.088 -177.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -66.57 -34.58 78.21 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.276 -0.638 . . . . 71.430000000000007 109.276 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.559 ' HB3' ' HA ' ' A' ' 30' ' ' GLU . 7.7 t30 -52.42 -33.82 45.59 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 114.487 -1.233 . . . . 63.409999999999997 111.989 -176.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.458 ' HD3' HG21 ' A' ' 26' ' ' ILE . 14.4 ptmt -114.95 -19.35 10.98 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.214 0.45 . . . . 53.439999999999998 112.214 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.4 t -88.43 -55.25 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 111.973 0.36 . . . . 61.520000000000003 111.973 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 39.9 p -72.83 -18.52 61.45 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.11 0.481 . . . . 74.430000000000007 111.033 -173.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.9 p -90.8 11.93 20.9 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.704 -0.68 . . . . 73.219999999999999 111.028 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 51.8 t -59.63 117.01 4.43 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.258 -0.428 . . . . 60.130000000000003 111.292 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -117.43 3.73 12.5 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.548 0.69 . . . . 70.230000000000004 109.349 172.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.628 ' HB2' HG22 ' A' ' 42' ' ' ILE . 1.8 m-20 -70.64 -31.85 68.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.963 -1.017 . . . . 63.240000000000002 110.684 -176.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' ' 40' ' ' ASP . 27.7 m-80 73.26 13.4 4.7 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.301 -0.863 . . . . 71.209999999999994 111.04 -175.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.628 HG22 ' HB2' ' A' ' 40' ' ' ASP . 15.1 tt -85.99 146.64 6.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 108.828 -0.804 . . . . 74.519999999999996 108.828 172.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.693 HD11 ' HB3' ' A' ' 101' ' ' MET . 63.4 tp -79.52 106.59 11.66 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-O 121.556 0.693 . . . . 74.319999999999993 110.312 -177.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.49 HG23 ' CD2' ' A' ' 77' ' ' TYR . 65.6 mt -88.68 107.53 17.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.801 -1.09 . . . . 75.349999999999994 110.364 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.4 HD13 HD22 ' A' ' 63' ' ' LEU . 70.3 mt -90.56 101.82 14.56 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.963 -0.562 . . . . 41.200000000000003 109.787 178.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.463 HG13 HG22 ' A' ' 44' ' ' ILE . 27.6 m -95.96 121.53 46.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.031 0.443 . . . . 71.439999999999998 110.849 -178.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -95.49 133.71 39.16 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.915 -0.584 . . . . 64.5 111.02 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 . . . . . 0 C--N 1.33 -0.269 0 CA-C-O 121.436 0.636 . . . . 73.030000000000001 111.495 -178.924 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo . . . . . 0 CA--C 1.528 0.216 0 N-CA-C 111.104 -0.383 . . . . 71.140000000000001 111.104 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.469 ' NE2' ' HA ' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -45.3 -49.7 12.5 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 116.162 -0.472 . . . . 74.099999999999994 111.469 -171.813 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.726 ' HB3' HG12 ' A' ' 76' ' ' ILE . 71.6 mt -56.78 -48.88 76.9 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.225 -0.898 . . . . 74.219999999999999 111.012 -175.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.544 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 34.4 mt-10 -70.6 -44.33 67.5 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.24 -0.437 . . . . 74.409999999999997 109.959 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.411 ' HD2' ' HA ' ' A' ' 65' ' ' LYS . 12.3 tptp -54.57 -42.74 71.36 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.378 -0.828 . . . . 71.310000000000002 110.986 -174.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.505 HD21 HG22 ' A' ' 120' ' ' ILE . 13.9 mt -81.51 -39.5 24.62 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 120.795 -0.362 . . . . 73.239999999999995 111.171 176.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.496 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -55.19 -33.49 63.07 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.587 0.232 . . . . 61.5 111.295 -178.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.544 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 96.4 mt-30 -51.06 -42.46 60.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.99 0.424 . . . . 70.239999999999995 110.794 177.193 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -94.02 -55.17 3.31 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.684 -0.689 . . . . 65.549999999999997 111.592 -177.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.542 ' O ' HG22 ' A' ' 74' ' ' VAL . 12.0 m-85 -94.86 22.17 6.75 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.727 0.639 . . . . 75.230000000000004 112.727 -167.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.496 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 8.2 t -52.5 -27.33 15.9 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.9 0.381 . . . . 74.329999999999998 111.585 -177.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -63.58 -24.25 67.72 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.246 -0.434 . . . . 53.340000000000003 111.832 -178.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.55 9.2 5.97 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.485 0.183 . . . . 72.310000000000002 111.183 -177.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.542 HG22 ' O ' ' A' ' 70' ' ' TYR . 27.2 m -138.33 140.29 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 O-C-N 121.779 -0.575 . . . . 55.140000000000001 110.565 175.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 39.2 mmtm -141.07 135.25 30.82 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.135 -0.484 . . . . 63.310000000000002 110.031 174.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.726 HG12 ' HB3' ' A' ' 63' ' ' LEU . 3.4 mp -103.94 144.49 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.391 -0.368 . . . . 74.420000000000002 110.146 -176.129 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.49 ' CD2' HG23 ' A' ' 44' ' ' ILE . 81.2 m-85 -129.38 138.46 51.53 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.276 0.56 . . . . 72.200000000000003 111.537 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.507 ' HA ' ' HE2' ' A' ' 78' ' ' LYS . 9.6 mmpt? -99.01 100.22 11.36 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.284 -0.871 . . . . 72.219999999999999 108.804 174.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.588 ' N ' HD12 ' A' ' 79' ' ' ILE . 2.4 mp . . . . . 0 C--N 1.323 -0.568 0 N-CA-C 110.249 -0.278 . . . . 72.5 110.249 -175.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.29 0 CA-C-O 121.058 0.456 . . . . 73.530000000000001 110.919 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.0 m -74.32 -30.18 61.94 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.71 -0.677 . . . . 71.010000000000005 110.554 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -61.64 -55.49 29.98 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.677 -0.692 . . . . 72.230000000000004 110.445 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.418 ' HE2' ' HE2' ' A' ' 107' ' ' LYS . 97.4 m-85 -77.08 -13.31 59.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.956 -0.565 . . . . 74.030000000000001 110.343 178.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.46 39.25 61.55 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 115.748 -0.66 . . . . 71.209999999999994 112.875 174.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 14.6 p -72.43 -37.37 57.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.657 0.265 . . . . 73.5 110.502 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.8 t 67.43 -67.43 0.18 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.67 -0.696 . . . . 73.310000000000002 111.294 -178.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.58 134.9 48.06 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.49 -0.323 . . . . 73.129999999999995 111.057 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.422 ' HB ' ' HA ' ' A' ' 97' ' ' PRO . 29.4 pt -113.87 158.67 38.5 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 116.062 -0.517 . . . . 72.430000000000007 110.107 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.422 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 95.4 Cg_endo -82.96 177.55 31.45 Favored 'Cis proline' 0 C--N 1.35 0.645 0 C-N-CA 123.889 -1.296 . . . . 65.310000000000002 112.352 -1.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.1 m -140.8 131.22 25.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.113 -0.494 . . . . 71.120000000000005 109.843 178.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.608 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 26.6 mt -109.33 116.93 53.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.333 -0.394 . . . . 53.43 109.999 -176.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.2 mp -94.55 144.57 25.48 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.144 0.497 . . . . 73.120000000000005 110.777 -178.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.773 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 70.3 mtp -106.38 114.58 28.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.606 -0.725 . . . . 74.109999999999999 109.923 -179.12 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -115.83 140.63 49.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.76 0.314 . . . . 74.430000000000007 110.453 177.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.741 ' HB3' HD21 ' A' ' 108' ' ' LEU . 38.1 ttpt -156.79 128.32 7.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.997 -0.547 . . . . 63.310000000000002 109.561 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.7 t30 60.0 24.84 14.01 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.324 0.583 . . . . 65.239999999999995 110.686 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.28 -1.13 82.08 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 116.058 -0.519 . . . . 53.509999999999998 113.266 177.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -108.2 160.92 15.45 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.99 0.395 . . . . 51.240000000000002 110.49 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.418 ' HE2' ' HE2' ' A' ' 91' ' ' TYR . 20.2 pttp -92.69 139.92 30.07 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.472 -0.936 . . . . 45.119999999999997 108.472 170.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.741 HD21 ' HB3' ' A' ' 103' ' ' LYS . 3.0 mm? -105.72 -52.98 2.72 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 110.087 -0.338 . . . . 72.549999999999997 110.087 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.773 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 23.4 m -157.59 170.96 21.21 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.865 -0.607 . . . . 74.540000000000006 110.171 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.7 pm0 -128.85 123.87 33.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.932 -0.576 . . . . 75.319999999999993 109.831 172.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.608 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 63.6 t -80.66 113.93 20.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.822 -0.626 . . . . 64.25 110.25 176.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 42.1 mt -100.2 123.06 52.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.427 -0.583 . . . . 75.109999999999999 109.427 175.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.76 -129.89 14.0 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.957 -0.639 . . . . 74.409999999999997 111.985 -179.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.469 ' HA ' ' NE2' ' A' ' 62' ' ' GLN . . . -142.65 57.36 1.43 Allowed 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.012 0.434 . . . . 71.329999999999998 111.117 -178.227 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.553 ' O ' ' HG3' ' A' ' 118' ' ' LYS . 7.7 m-20 -88.32 86.42 7.06 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-O 121.681 0.753 . . . . 62.439999999999998 110.21 177.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.559 ' O ' HG13 ' A' ' 119' ' ' ILE . 7.9 tp -53.09 -35.68 23.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.003 -0.999 . . . . 73.120000000000005 110.636 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.6 m -67.07 -37.0 83.22 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.846 -0.615 . . . . 71.150000000000006 111.215 -177.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.553 ' HG3' ' O ' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -76.04 -41.62 50.22 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.642 -0.503 . . . . 71.040000000000006 109.642 -179.325 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.559 HG13 ' O ' ' A' ' 116' ' ' ILE . 1.9 pp -65.7 -42.35 92.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 116.286 -0.415 . . . . 71.219999999999999 110.943 -176.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.505 HG22 HD21 ' A' ' 66' ' ' LEU . 2.8 pp -66.8 -31.85 55.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 121.123 0.487 . . . . 75.310000000000002 109.957 177.21 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.412 ' N ' HD12 ' A' ' 120' ' ' ILE . 47.2 t -63.58 -51.01 67.2 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.73 -0.668 . . . . 62.240000000000002 110.686 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.493 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 11.6 pt-20 -77.85 -46.17 22.2 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.14 0.422 . . . . 74.319999999999993 112.14 -178.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.532 ' O ' HG12 ' A' ' 127' ' ' ILE . 67.5 mt -60.04 -51.0 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 117.903 0.319 . . . . 72.530000000000001 111.555 -176.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -59.11 -30.86 68.42 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.073 0.463 . . . . 72.010000000000005 110.922 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -83.17 -20.82 33.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.413 0.625 . . . . 60.229999999999997 110.282 177.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.493 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 1.8 t-20 -88.61 -37.37 15.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.689 -0.687 . . . . 73.109999999999999 111.524 -173.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.532 HG12 ' O ' ' A' ' 123' ' ' ILE . 46.8 pt -100.99 168.61 1.87 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 116.266 -0.424 . . . . 71.040000000000006 111.159 -177.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.3 p30 . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.432 -0.794 . . . . 74.439999999999998 111.297 -174.921 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.521 ' N ' ' SD ' ' A' ' 22' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.341 0 CA-C-O 120.901 0.381 . . . . 73.25 110.165 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.512 HG12 ' HG2' ' A' ' 22' ' ' MET . 14.3 mm -115.66 78.33 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 115.532 -0.758 . . . . 74.400000000000006 109.092 174.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.623 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 10.8 tp10 -96.99 153.17 18.07 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.21 -0.45 . . . . 71.409999999999997 110.016 -176.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -97.84 138.88 34.53 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.613 -0.514 . . . . 65.140000000000001 109.613 177.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 39.2 pt -122.76 153.75 27.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-O 121.189 0.518 . . . . 64.230000000000004 111.095 -177.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.58 150.71 38.62 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.408 -0.815 . . . . 13.31 111.729 176.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -63.64 -34.98 79.05 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.981 0.419 . . . . 73.329999999999998 110.469 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.1 m -72.99 -16.38 61.51 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.734 -0.667 . . . . 64.120000000000005 111.63 -176.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -113.79 3.02 15.34 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.398 -0.364 . . . . 71.549999999999997 110.907 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -47.08 -71.15 0.08 Allowed 'General case' 0 N--CA 1.464 0.241 0 O-C-N 123.46 0.475 . . . . 65.209999999999994 110.951 -177.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -65.15 -34.82 79.3 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.861 -0.422 . . . . 71.430000000000007 109.861 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -52.04 -41.06 61.98 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.221 -0.9 . . . . 63.409999999999997 111.215 -174.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -106.81 -25.2 11.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.195 -0.457 . . . . 53.439999999999998 112.104 -177.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.4 HG21 HG21 ' A' ' 46' ' ' VAL . 79.1 t -84.12 -50.83 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 112.073 0.397 . . . . 61.520000000000003 112.073 -175.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.3 p -76.83 -32.54 57.65 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.987 0.422 . . . . 74.430000000000007 110.81 -175.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.8 m -80.59 12.41 3.11 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.765 -0.652 . . . . 73.219999999999999 111.695 -177.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.625 ' SG ' HG22 ' A' ' 42' ' ' ILE . 37.1 t -59.24 90.9 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.879 0.371 . . . . 60.130000000000003 111.182 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -80.58 -22.0 41.12 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.944 0.402 . . . . 70.230000000000004 111.185 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -72.86 2.57 6.52 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.535 -0.302 . . . . 63.240000000000002 111.742 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 63.0 21.91 13.17 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.422 -0.354 . . . . 71.209999999999994 111.777 172.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.625 HG22 ' SG ' ' A' ' 38' ' ' CYS . 6.8 tt -87.9 144.63 8.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 109.388 -0.597 . . . . 74.519999999999996 109.388 177.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.487 HD21 ' CE ' ' A' ' 101' ' ' MET . 42.1 tp -81.14 115.53 20.61 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.008 0.433 . . . . 74.319999999999993 109.979 -177.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 62.1 mt -102.58 123.28 55.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.91 -0.586 . . . . 75.349999999999994 110.263 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.548 ' HG ' ' HG2' ' A' ' 101' ' ' MET . 3.3 mp -114.23 106.02 13.86 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.049 -0.523 . . . . 41.200000000000003 109.753 -178.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.531 HG22 ' HB2' ' A' ' 77' ' ' TYR . 43.5 t -102.12 125.54 56.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.598 -0.274 . . . . 71.439999999999998 110.566 -178.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -98.01 138.49 35.25 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.17 0.51 . . . . 64.5 109.894 178.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 . . . . . 0 C--N 1.324 -0.505 0 CA-C-N 115.578 -0.737 . . . . 73.030000000000001 110.009 179.406 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.53 ' HG2' ' HB2' ' A' ' 64' ' ' GLU . 85.4 Cg_endo . . . . . 0 CA--C 1.531 0.325 0 CA-C-O 120.802 0.251 . . . . 71.140000000000001 112.485 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.585 ' HB3' HG12 ' A' ' 119' ' ' ILE . 9.9 mp0 -55.34 -55.93 25.94 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-O 121.592 0.711 . . . . 74.099999999999994 111.27 -173.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.558 HD11 HG21 ' A' ' 111' ' ' VAL . 3.2 mm? -59.33 -48.39 81.82 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 114.844 -1.071 . . . . 74.219999999999999 110.952 -171.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.585 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 48.4 mt-10 -68.38 -32.48 72.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.067 -0.515 . . . . 74.409999999999997 110.427 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 61' ' ' PRO . 2.8 tmtm? -59.09 -52.46 65.63 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.803 -0.443 . . . . 71.310000000000002 109.803 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.694 HD12 HD12 ' A' ' 123' ' ' ILE . 29.3 mt -70.88 -33.46 70.62 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 120.903 -0.319 . . . . 73.239999999999995 111.347 177.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.407 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -60.19 -27.13 66.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.334 -0.394 . . . . 61.5 111.47 -178.114 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.585 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 76.1 mt-30 -56.93 -35.79 69.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.843 0.354 . . . . 70.239999999999995 110.738 177.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -93.83 -55.94 3.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.401 0.619 . . . . 65.549999999999997 110.468 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.513 ' O ' HG22 ' A' ' 74' ' ' VAL . 23.4 m-85 -84.74 22.51 1.33 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.58 -0.736 . . . . 75.230000000000004 112.69 -172.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.433 ' O ' ' NZ ' ' A' ' 75' ' ' LYS . 4.4 t -52.28 -44.54 65.05 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.369 0.507 . . . . 74.329999999999998 112.369 -170.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -73.14 -16.21 61.45 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 122.04 -0.412 . . . . 53.340000000000003 111.316 -176.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -101.6 -20.47 15.03 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 110.078 -0.342 . . . . 72.310000000000002 110.078 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 70' ' ' TYR . 25.4 m -136.91 122.06 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 121.298 0.571 . . . . 55.140000000000001 110.64 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.433 ' NZ ' ' O ' ' A' ' 71' ' ' THR . 38.0 mmtm -119.29 124.75 47.44 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.639 -0.504 . . . . 63.310000000000002 109.639 177.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.536 HG13 ' HB2' ' A' ' 45' ' ' LEU . 2.1 mp -97.37 137.48 24.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 74.420000000000002 110.054 -175.186 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.623 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 20.2 m-85 -126.58 134.45 50.81 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.116 -0.493 . . . . 72.200000000000003 110.368 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 19.1 mtpp -96.31 122.51 39.26 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.181 -0.674 . . . . 72.219999999999999 109.181 176.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.6 tp . . . . . 0 CA--C 1.534 0.356 0 CA-C-O 120.908 0.385 . . . . 72.5 111.18 -176.531 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.355 0 CA-C-O 121.064 0.459 . . . . 73.530000000000001 110.76 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.4 m -74.52 -28.11 60.83 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.741 -0.663 . . . . 71.010000000000005 110.964 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -64.49 -51.11 64.67 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.067 0.46 . . . . 72.230000000000004 109.928 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -79.01 -6.71 57.03 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.684 -0.689 . . . . 74.030000000000001 110.36 176.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 61.95 53.32 43.85 Favored Glycine 0 C--N 1.331 0.281 0 CA-C-N 115.84 -0.618 . . . . 71.209999999999994 113.19 172.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.473 HG22 ' H ' ' A' ' 95' ' ' ALA . 10.0 p -80.01 133.67 29.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.908 0.385 . . . . 73.5 110.671 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.4 t -128.17 27.12 5.68 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.107 0.48 . . . . 73.310000000000002 110.329 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.473 ' H ' HG22 ' A' ' 93' ' ' VAL . . . -145.03 130.38 18.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.01 -0.541 . . . . 73.129999999999995 110.157 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.805 HD13 ' H ' ' A' ' 96' ' ' ILE . 0.2 OUTLIER -110.37 148.14 37.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 72.430000000000007 110.242 -178.153 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -77.07 -178.12 23.21 Favored 'Cis proline' 0 C--N 1.351 0.687 0 C-N-CA 123.758 -1.351 . . . . 65.310000000000002 112.512 -1.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.0 m -137.81 115.64 11.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.105 -0.498 . . . . 71.120000000000005 110.039 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.445 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.9 mp -121.6 123.16 68.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-N 116.216 -0.447 . . . . 53.43 109.84 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.5 mp -101.24 141.77 33.64 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.243 -0.28 . . . . 73.120000000000005 110.243 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.76 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 56.5 mtp -116.91 115.48 25.58 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 116.398 -0.364 . . . . 74.109999999999999 110.872 -175.101 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -117.38 154.29 31.58 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.049 -0.523 . . . . 74.430000000000007 110.511 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.749 ' HB3' HD21 ' A' ' 108' ' ' LEU . 28.1 ttpp -168.23 122.89 0.94 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.747 -0.661 . . . . 63.310000000000002 109.78 178.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.2 t30 53.82 45.95 26.77 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.545 0.688 . . . . 65.239999999999995 110.845 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 73.87 3.83 65.07 Favored Glycine 0 CA--C 1.52 0.392 0 CA-C-N 115.578 -0.737 . . . . 53.509999999999998 113.719 176.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -111.41 142.87 43.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 117.134 0.467 . . . . 51.240000000000002 110.589 -178.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.477 ' O ' ' HG3' ' A' ' 107' ' ' LYS . 12.5 ptmm? -95.51 112.39 24.12 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.082 -0.71 . . . . 45.119999999999997 109.082 172.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.749 HD21 ' HB3' ' A' ' 103' ' ' LYS . 1.5 mm? -89.33 -53.18 4.67 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.088 0.471 . . . . 72.549999999999997 110.904 -172.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.76 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 22.8 m -150.08 172.02 15.93 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.517 -0.765 . . . . 74.540000000000006 110.458 -169.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.27 121.28 2.65 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.092 0.472 . . . . 75.319999999999993 111.116 -177.011 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.558 HG21 HD11 ' A' ' 63' ' ' LEU . 59.8 t -80.43 107.47 12.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.607 -0.724 . . . . 64.25 110.037 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.425 HG22 ' HB3' ' A' ' 95' ' ' ALA . 65.7 mt -110.58 106.91 21.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.344 -0.613 . . . . 75.109999999999999 109.344 177.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 96.51 -141.33 15.55 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 111.398 -0.681 . . . . 74.409999999999997 111.398 -176.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -141.54 88.58 2.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.914 0.357 . . . . 71.329999999999998 110.65 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.538 ' O ' HG23 ' A' ' 119' ' ' ILE . 11.7 m-20 -132.9 97.08 3.93 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.101 -0.499 . . . . 62.439999999999998 110.14 178.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.52 ' O ' HG13 ' A' ' 119' ' ' ILE . 7.1 tp -58.49 -40.25 77.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 120.846 0.355 . . . . 73.120000000000005 111.13 -177.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.3 t -67.24 -28.64 68.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.164 0.507 . . . . 71.150000000000006 110.74 -178.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -79.27 -43.77 23.05 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.985 -0.552 . . . . 71.040000000000006 110.75 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.585 HG12 ' HB3' ' A' ' 62' ' ' GLN . 1.8 pp -67.64 -41.53 85.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 71.219999999999999 110.613 -177.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.65 HG22 HD11 ' A' ' 66' ' ' LEU . 2.7 pp -62.21 -31.64 52.17 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 109.693 -0.484 . . . . 75.310000000000002 109.693 177.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 23.1 t -69.71 -51.23 36.25 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.712 -0.676 . . . . 62.240000000000002 110.083 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.437 ' OE1' ' HB3' ' A' ' 109' ' ' SER . 16.4 pt-20 -74.12 -33.93 63.73 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 112.109 0.411 . . . . 74.319999999999993 112.109 -175.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.694 HD12 HD12 ' A' ' 66' ' ' LEU . 64.6 mt -67.13 -58.05 7.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 O-C-N 122.264 -0.272 . . . . 72.530000000000001 110.518 178.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -63.16 -19.98 64.97 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.073 0.463 . . . . 72.010000000000005 110.932 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.417 ' HB3' ' O ' ' A' ' 122' ' ' GLU . 27.2 t-20 -60.69 -31.45 70.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.067 -0.515 . . . . 60.229999999999997 111.219 176.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -114.22 -3.15 13.22 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.075 0.398 . . . . 73.109999999999999 112.075 -173.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.442 HG12 ' O ' ' A' ' 123' ' ' ILE . 33.9 pt -135.64 168.56 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 110.372 -0.233 . . . . 71.040000000000006 110.372 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.7 p30 . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.383 -0.818 . . . . 74.439999999999998 111.104 178.492 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 C--O 1.23 0.069 0 N-CA-C 109.7 -0.481 . . . . 73.25 109.7 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.472 HG12 ' HB ' ' A' ' 76' ' ' ILE . 51.1 mt -133.79 106.6 9.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 108.927 -0.768 . . . . 74.400000000000006 108.927 173.264 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.425 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 36.9 tt0 -131.94 118.61 20.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.604 -0.271 . . . . 71.409999999999997 111.083 -171.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.423 ' CD ' ' H ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -81.62 132.73 35.31 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.209 -0.664 . . . . 65.140000000000001 109.209 173.454 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 25.8 pt -126.44 175.32 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 120.983 0.42 . . . . 64.230000000000004 111.952 -170.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.45 154.13 26.97 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.646 -0.707 . . . . 13.31 112.369 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -67.41 -31.2 71.24 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.961 0.41 . . . . 73.329999999999998 110.957 -177.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.3 p -71.02 -39.29 72.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.999 -0.546 . . . . 64.120000000000005 110.877 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.437 ' HA ' ' HB3' ' A' ' 33' ' ' ASN . 13.1 pt-20 -91.48 -3.77 56.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.999 -0.546 . . . . 71.549999999999997 110.991 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -46.34 -71.02 0.08 Allowed 'General case' 0 N--CA 1.464 0.26 0 O-C-N 123.622 0.576 . . . . 65.209999999999994 111.161 -176.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -68.04 -35.17 77.81 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 109.396 -0.594 . . . . 71.430000000000007 109.396 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.437 ' HB3' ' HA ' ' A' ' 30' ' ' GLU . 6.2 t30 -52.53 -34.27 49.08 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 114.586 -1.188 . . . . 63.409999999999997 111.816 -175.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.2 ptmt -111.69 -27.52 8.49 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.774 -0.194 . . . . 53.439999999999998 111.426 -178.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 71.7 t -84.57 -56.66 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 111.745 0.276 . . . . 61.520000000000003 111.745 -177.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.8 p -80.01 -23.77 41.29 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.011 0.434 . . . . 74.430000000000007 110.444 -173.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.1 m -83.66 6.08 22.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.733 -0.667 . . . . 73.219999999999999 111.027 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.614 ' SG ' HG22 ' A' ' 42' ' ' ILE . 48.0 t -66.88 98.92 0.58 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.887 0.375 . . . . 60.130000000000003 110.427 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -88.9 -2.94 58.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.102 -0.499 . . . . 70.230000000000004 110.318 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -71.56 -6.62 42.05 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.175 -0.466 . . . . 63.240000000000002 110.67 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 60.54 23.3 12.99 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.88 -0.6 . . . . 71.209999999999994 111.42 176.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.614 HG22 ' SG ' ' A' ' 38' ' ' CYS . 12.4 tt -84.9 152.61 3.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.754 -0.832 . . . . 74.519999999999996 108.754 174.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.563 HD21 ' HE3' ' A' ' 101' ' ' MET . 58.9 tp -85.09 110.2 18.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.606 0.241 . . . . 74.319999999999993 110.45 -175.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 101' ' ' MET . 54.4 mt -100.62 136.68 31.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.472 -0.331 . . . . 75.349999999999994 110.591 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.555 ' HG ' ' HG2' ' A' ' 101' ' ' MET . 3.7 mp -122.67 109.45 14.28 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.572 -0.529 . . . . 41.200000000000003 109.572 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 30.1 m -95.27 127.35 47.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.717 0.294 . . . . 71.439999999999998 110.606 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.419 ' HB3' ' HE2' ' A' ' 78' ' ' LYS . 3.1 t70 -125.63 149.42 48.43 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.322 0.582 . . . . 64.5 112.231 -171.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.522 ' CZ ' ' HB ' ' A' ' 98' ' ' THR . 22.5 p90 . . . . . 0 C--N 1.327 -0.389 0 N-CA-C 108.493 -0.929 . . . . 73.030000000000001 108.493 164.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo . . . . . 0 C--O 1.233 0.249 0 N-CA-C 111.396 -0.271 . . . . 71.140000000000001 111.396 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.541 ' HB3' HG12 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -49.9 -50.21 46.92 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 121.359 0.6 . . . . 74.099999999999994 110.966 -176.734 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.701 HD21 HG21 ' A' ' 99' ' ' ILE . 8.8 mp -60.36 -48.85 79.99 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.258 -0.883 . . . . 74.219999999999999 111.524 -174.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.616 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 40.2 mt-10 -67.92 -36.35 80.01 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.804 -0.443 . . . . 74.409999999999997 109.804 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -54.93 -51.13 67.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.797 -0.638 . . . . 71.310000000000002 110.23 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.463 HD11 HG22 ' A' ' 120' ' ' ILE . 22.9 mt -78.3 -34.79 48.58 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.517 -0.31 . . . . 73.239999999999995 111.802 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.503 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.37 -28.05 69.73 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 111.345 0.128 . . . . 61.5 111.345 -175.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.616 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 78.9 mt-30 -53.0 -32.4 46.36 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.284 0.564 . . . . 70.239999999999995 109.993 175.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -93.55 -59.08 2.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.562 -0.745 . . . . 65.549999999999997 110.427 175.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.583 ' O ' HG22 ' A' ' 74' ' ' VAL . 19.0 m-85 -87.55 17.78 4.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.32 -0.855 . . . . 75.230000000000004 113.134 -168.101 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.503 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 9.3 t -52.95 -36.08 59.57 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.147 0.43 . . . . 74.329999999999998 111.552 -176.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -70.8 -17.18 62.78 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.826 0.346 . . . . 53.340000000000003 111.493 -178.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -112.21 -10.57 13.84 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.269 -0.423 . . . . 72.310000000000002 110.6 -176.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 70' ' ' TYR . 32.6 m -131.08 151.07 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 O-C-N 122.174 -0.329 . . . . 55.140000000000001 110.872 -179.126 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.621 ' HA ' ' HE3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -134.1 127.04 31.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.912 -0.585 . . . . 63.310000000000002 109.484 177.662 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.472 ' HB ' HG12 ' A' ' 23' ' ' ILE . 51.6 mt -102.21 130.31 52.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 120.788 0.328 . . . . 74.420000000000002 110.232 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.425 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 74.7 m-85 -131.13 151.44 51.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 72.200000000000003 109.779 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.419 ' HE2' ' HB3' ' A' ' 47' ' ' ASP . 1.3 mptm? -126.28 173.07 9.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.751 0.31 . . . . 72.219999999999999 111.302 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 61.7 mt . . . . . 0 N--CA 1.463 0.192 0 CA-C-N 114.992 -1.004 . . . . 72.5 109.824 -174.292 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.269 0 CA-C-O 120.714 0.293 . . . . 73.530000000000001 110.839 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.3 m -65.03 -32.67 74.5 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.281 -0.418 . . . . 71.010000000000005 111.081 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -66.32 -40.05 89.67 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.978 0.418 . . . . 72.230000000000004 110.202 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -81.88 -17.07 48.55 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.187 -0.461 . . . . 74.030000000000001 110.321 175.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.47 23.26 60.87 Favored Glycine 0 CA--C 1.519 0.327 0 CA-C-N 115.986 -0.552 . . . . 71.209999999999994 112.821 177.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.1 t -61.03 133.56 26.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 120.59 0.233 . . . . 73.5 110.721 -178.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 29.2 t -137.37 11.98 3.01 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.194 -0.457 . . . . 73.310000000000002 110.72 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -134.49 140.18 46.01 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.355 -0.384 . . . . 73.129999999999995 110.49 -177.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.438 ' O ' HD12 ' A' ' 96' ' ' ILE . 2.7 pp -112.63 155.05 44.47 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 116.102 -0.499 . . . . 72.430000000000007 111.156 -176.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -79.04 165.31 81.81 Favored 'Cis proline' 0 C--N 1.354 0.848 0 C-N-CA 123.611 -1.412 . . . . 65.310000000000002 111.582 -3.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.522 ' HB ' ' CZ ' ' A' ' 48' ' ' PHE . 22.8 m -117.54 120.79 39.14 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.817 -0.438 . . . . 71.120000000000005 109.817 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.704 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 27.6 mt -126.24 112.54 30.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.715 -0.675 . . . . 53.43 109.734 -175.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.39 134.18 42.62 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.056 -0.35 . . . . 73.120000000000005 110.056 -176.036 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.776 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 61.8 mtp -101.82 117.54 35.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.448 . . . . 74.109999999999999 110.912 -175.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -115.39 156.49 25.46 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 120.972 0.415 . . . . 74.430000000000007 111.235 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.755 ' HB3' HD21 ' A' ' 108' ' ' LEU . 37.7 ttmt -169.55 122.38 0.74 Allowed 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.279 -0.873 . . . . 63.310000000000002 109.598 177.019 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 63.3 t30 60.56 26.08 15.75 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.327 0.584 . . . . 65.239999999999995 111.099 174.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.8 -14.45 61.65 Favored Glycine 0 CA--C 1.52 0.368 0 CA-C-N 115.971 -0.559 . . . . 53.509999999999998 112.681 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -94.73 139.54 31.1 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 122.591 0.356 . . . . 51.240000000000002 110.071 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.629 ' HD3' ' H ' ' A' ' 107' ' ' LYS . 0.1 OUTLIER -93.93 130.41 40.03 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.002 -0.74 . . . . 45.119999999999997 109.002 173.069 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.755 HD21 ' HB3' ' A' ' 103' ' ' LYS . 2.1 mm? -94.42 -53.16 4.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.166 -0.47 . . . . 72.549999999999997 110.737 -174.02 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.776 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 49.6 m -151.25 171.94 16.63 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.551 -0.75 . . . . 74.540000000000006 110.345 -172.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -145.15 114.87 7.29 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.153 0.502 . . . . 75.319999999999993 110.685 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.704 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 51.5 t -80.15 107.42 12.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.623 -0.717 . . . . 64.25 109.98 178.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 60.5 mt -110.18 106.73 21.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.243 -0.435 . . . . 75.109999999999999 110.202 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 93.3 -134.55 12.19 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 116.109 -0.496 . . . . 74.409999999999997 112.051 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -137.81 76.53 1.58 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.149 0.499 . . . . 71.329999999999998 110.78 -177.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -114.03 97.48 6.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.912 -0.586 . . . . 62.439999999999998 110.336 177.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.609 HD12 HD11 ' A' ' 119' ' ' ILE . 7.9 tp -62.54 -39.86 86.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-O 121.089 0.471 . . . . 73.120000000000005 110.038 178.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.4 m -63.27 -39.71 95.34 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.571 -0.741 . . . . 71.150000000000006 110.554 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -64.49 -56.17 15.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.757 -0.656 . . . . 71.040000000000006 110.617 177.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.609 HD11 HD12 ' A' ' 116' ' ' ILE . 2.4 pp -62.68 -39.94 86.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.121 -0.491 . . . . 71.219999999999999 111.816 -171.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.463 HG22 HD11 ' A' ' 66' ' ' LEU . 2.8 pp -64.08 -31.82 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 120.314 -0.554 . . . . 75.310000000000002 110.078 178.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.438 ' N ' HD12 ' A' ' 120' ' ' ILE . 33.1 t -70.67 -51.8 25.35 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.717 -0.674 . . . . 62.240000000000002 110.797 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -77.53 -43.11 33.08 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.544 0.572 . . . . 74.319999999999993 112.544 -174.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.443 ' O ' HG12 ' A' ' 127' ' ' ILE . 79.7 mt -60.72 -57.62 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 O-C-N 122.187 -0.321 . . . . 72.530000000000001 110.813 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -59.58 -20.16 53.86 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.379 -0.373 . . . . 72.010000000000005 111.293 -177.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -76.24 -33.63 59.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.993 0.425 . . . . 60.229999999999997 110.349 176.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -98.73 -0.34 42.97 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.222 -0.445 . . . . 73.109999999999999 112.087 -175.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.443 HG12 ' O ' ' A' ' 123' ' ' ILE . 37.2 pt -133.71 168.27 24.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.763 -0.458 . . . . 71.040000000000006 109.763 172.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.481 -0.771 . . . . 74.439999999999998 110.861 -174.843 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 21.8 mmt . . . . . 0 C--O 1.242 0.666 0 CA-C-O 121.234 0.54 . . . . 73.25 110.94 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.2 mm -89.08 86.98 2.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-N 115.233 -0.894 . . . . 74.400000000000006 108.597 172.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.537 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 9.6 tp10 -95.06 134.87 37.28 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.376 -0.374 . . . . 71.409999999999997 110.726 -176.385 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.1 pp0? -97.93 132.14 43.78 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.753 -0.462 . . . . 65.140000000000001 109.753 177.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.497 HD12 ' HA ' ' A' ' 31' ' ' PHE . 34.4 pt -123.97 175.14 6.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.417 -0.356 . . . . 64.230000000000004 111.383 -172.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.44 170.87 33.01 Favored Glycine 0 C--N 1.331 0.265 0 CA-C-N 115.802 -0.635 . . . . 13.31 112.998 -177.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -67.5 -42.37 82.97 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.058 0.543 . . . . 73.329999999999998 111.286 -177.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 24.7 t -76.44 -47.32 23.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 64.120000000000005 111.188 -174.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -73.47 -9.43 58.68 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.543 -0.299 . . . . 71.549999999999997 111.401 -179.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.606 ' HE1' HG11 ' A' ' 46' ' ' VAL . 50.8 t80 -44.21 -71.09 0.08 Allowed 'General case' 0 CA--C 1.529 0.163 0 O-C-N 123.451 0.47 . . . . 65.209999999999994 111.136 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -65.69 -32.87 74.67 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.04 -0.356 . . . . 71.430000000000007 110.04 -178.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.51 ' O ' ' HB3' ' A' ' 37' ' ' SER . 7.1 t30 -52.35 -41.02 62.68 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.232 -0.894 . . . . 63.409999999999997 111.16 -177.391 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 38' ' ' CYS . 13.1 ptmt -108.83 -15.89 14.29 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.227 -0.442 . . . . 53.439999999999998 111.905 -176.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.6 t -88.52 -60.99 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 111.867 0.321 . . . . 61.520000000000003 111.867 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.9 p -81.88 -28.85 32.73 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.814 0.34 . . . . 74.430000000000007 111.093 -172.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.51 ' HB3' ' O ' ' A' ' 33' ' ' ASN . 46.5 t -91.16 12.29 20.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.959 -0.564 . . . . 73.219999999999999 110.191 177.167 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 34' ' ' LYS . 51.2 t -67.48 95.65 0.47 Allowed 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 120.96 0.409 . . . . 60.130000000000003 111.157 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -89.71 14.41 11.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.33 0.586 . . . . 70.230000000000004 109.811 174.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -74.74 -6.02 46.55 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.858 -0.61 . . . . 63.240000000000002 110.392 -179.065 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.43 ' HA ' ' HB2' ' A' ' 104' ' ' ASN . 2.1 t-20 62.82 4.96 1.6 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.989 0.737 . . . . 71.209999999999994 112.989 174.092 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.678 HG21 ' HE2' ' A' ' 75' ' ' LYS . 13.2 tt -90.12 159.13 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.983 -0.377 . . . . 74.519999999999996 109.983 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.459 HD11 ' HB3' ' A' ' 101' ' ' MET . 64.7 tp -85.41 107.71 17.52 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.264 0.554 . . . . 74.319999999999993 109.94 178.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.415 HD11 ' SG ' ' A' ' 38' ' ' CYS . 65.6 mt -92.97 132.06 38.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.37 -0.832 . . . . 75.349999999999994 110.309 177.318 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.654 HD13 HD12 ' A' ' 63' ' ' LEU . 40.3 mt -111.04 101.84 10.35 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.267 -0.642 . . . . 41.200000000000003 109.267 177.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.606 HG11 ' HE1' ' A' ' 31' ' ' PHE . 61.3 t -91.5 116.3 32.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.564 -0.532 . . . . 71.439999999999998 109.564 178.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -97.1 148.34 23.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.199 0.523 . . . . 64.5 111.351 -173.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.407 ' CE2' HD13 ' A' ' 100' ' ' LEU . 81.4 m-85 . . . . . 0 C--O 1.235 0.333 0 CA-C-N 115.323 -0.853 . . . . 73.030000000000001 109.803 175.045 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 N--CA 1.463 -0.318 0 N-CA-C 111.25 -0.327 . . . . 71.140000000000001 111.25 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.498 ' H ' ' CD ' ' A' ' 62' ' ' GLN . 11.7 mp0 -55.09 -48.29 73.76 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-O 121.871 0.843 . . . . 74.099999999999994 110.366 -178.41 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.654 HD12 HD13 ' A' ' 45' ' ' LEU . 2.9 mm? -61.39 -47.97 83.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.449 -1.251 . . . . 74.219999999999999 110.449 -174.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.552 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 45.9 tt0 -63.69 -44.05 94.86 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.235 -0.439 . . . . 74.409999999999997 109.941 178.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.652 ' HE3' ' HA ' ' A' ' 65' ' ' LYS . 0.1 OUTLIER -50.89 -51.66 49.6 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.602 -0.726 . . . . 71.310000000000002 111.033 -179.874 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.604 HD11 HG22 ' A' ' 120' ' ' ILE . 32.9 mt -71.99 -35.29 69.44 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.646 -0.422 . . . . 73.239999999999995 110.851 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.427 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -57.27 -40.06 76.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.026 -0.534 . . . . 61.5 111.227 -178.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.552 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 86.9 mt-30 -50.2 -33.4 19.19 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.983 0.42 . . . . 70.239999999999995 110.85 -177.543 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -94.09 -56.47 2.84 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.75 -0.659 . . . . 65.549999999999997 111.067 178.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.48 ' O ' HG22 ' A' ' 74' ' ' VAL . 17.3 m-85 -88.79 20.33 3.56 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.684 -0.689 . . . . 75.230000000000004 112.671 -170.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.427 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 13.8 t -53.35 -30.47 39.6 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.11 0.481 . . . . 74.329999999999998 112.28 -176.21 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -70.21 -16.78 63.11 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.381 -0.372 . . . . 53.340000000000003 111.324 -177.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -118.6 -6.5 10.67 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.489 -0.323 . . . . 72.310000000000002 110.458 -178.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.48 HG22 ' O ' ' A' ' 70' ' ' TYR . 30.1 m -137.1 135.39 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 121.143 0.497 . . . . 55.140000000000001 110.879 178.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.678 ' HE2' HG21 ' A' ' 42' ' ' ILE . 64.8 mttm -112.46 158.57 19.71 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.972 -0.751 . . . . 63.310000000000002 108.972 174.039 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.522 HG13 ' HB2' ' A' ' 45' ' ' LEU . 3.7 mp -125.56 139.4 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 C-N-CA 120.333 -0.547 . . . . 74.420000000000002 110.117 171.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.537 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 12.4 m-85 -125.04 129.1 49.6 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.9 -0.591 . . . . 72.200000000000003 110.094 177.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.456 ' HD3' ' N ' ' A' ' 79' ' ' ILE . 5.7 tmtm? -111.77 124.33 52.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.194 -0.912 . . . . 72.219999999999999 109.201 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.769 ' H ' HD13 ' A' ' 79' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.41 0 N-CA-C 109.775 -0.454 . . . . 72.5 109.775 176.032 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.137 0 CA-C-O 120.822 0.344 . . . . 73.530000000000001 110.367 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.0 m -64.22 -35.04 79.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.269 -0.423 . . . . 71.010000000000005 110.454 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -57.65 -38.6 75.35 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.766 -0.652 . . . . 72.230000000000004 110.389 178.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -88.76 -17.2 30.35 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.502 -0.317 . . . . 74.030000000000001 111.501 176.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.55 25.25 39.69 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 121.018 -0.61 . . . . 71.209999999999994 112.223 -177.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 70.7 t -64.26 127.19 24.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.724 0.297 . . . . 73.5 110.296 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.5 p -91.3 -17.0 26.63 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.393 0.516 . . . . 73.310000000000002 112.393 -174.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -157.89 146.86 19.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.83 0.348 . . . . 73.129999999999995 111.572 -176.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.559 ' HB ' ' HA ' ' A' ' 97' ' ' PRO . 2.7 pp -98.71 162.04 23.03 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 115.923 -0.58 . . . . 72.430000000000007 110.036 176.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.559 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 98.5 Cg_endo -80.95 174.25 47.74 Favored 'Cis proline' 0 C--N 1.355 0.87 0 C-N-CA 124.133 -1.195 . . . . 65.310000000000002 112.83 2.123 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.547 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 27.8 m -145.68 134.18 22.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.951 -0.568 . . . . 71.120000000000005 110.042 179.324 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.597 HG21 ' HG ' ' A' ' 63' ' ' LEU . 3.5 mp -116.44 125.2 73.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 N-CA-C 109.71 -0.478 . . . . 53.43 109.71 178.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.407 HD13 ' CE2' ' A' ' 48' ' ' PHE . 9.7 mp -91.49 134.18 34.86 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.815 0.34 . . . . 73.120000000000005 110.738 -178.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.546 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 72.2 mtp -108.98 114.38 28.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.926 -0.579 . . . . 74.109999999999999 110.231 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -118.91 148.36 43.01 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.179 0.3 . . . . 74.430000000000007 110.271 178.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.625 ' HB3' HD21 ' A' ' 108' ' ' LEU . 62.4 tttm -152.56 115.22 4.54 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.025 -0.731 . . . . 63.310000000000002 109.025 176.301 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.43 ' HB2' ' HA ' ' A' ' 41' ' ' ASN . 5.8 t30 58.52 30.28 19.54 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.362 0.601 . . . . 65.239999999999995 110.279 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.18 -9.08 78.55 Favored Glycine 0 CA--C 1.521 0.434 0 CA-C-N 115.696 -0.684 . . . . 53.509999999999998 113.355 177.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -95.2 131.17 41.54 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 117.053 0.426 . . . . 51.240000000000002 111.031 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.68 ' HZ2' ' HB2' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -80.39 116.87 20.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 45.119999999999997 110.043 174.77 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.625 HD21 ' HB3' ' A' ' 103' ' ' LYS . 3.1 mm? -82.06 -52.57 6.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.442 -0.344 . . . . 72.549999999999997 110.317 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.546 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 74.6 m -159.35 171.82 19.09 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.81 -0.632 . . . . 74.540000000000006 110.759 -176.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 8.4 pm0 -133.35 119.12 19.3 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.428 -0.805 . . . . 75.319999999999993 109.346 172.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 98' ' ' THR . 61.3 t -79.99 110.33 15.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 64.25 110.048 -178.504 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 59.0 mt -107.98 118.54 55.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 110.036 -0.357 . . . . 75.109999999999999 110.036 -177.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.36 -115.36 4.21 Favored Glycine 0 N--CA 1.453 -0.206 0 N-CA-C 111.682 -0.567 . . . . 74.409999999999997 111.682 -178.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.55 89.19 1.02 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.89 0.345 . . . . 71.329999999999998 111.017 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.465 ' O ' HG23 ' A' ' 119' ' ' ILE . 12.5 m-20 -118.99 88.76 2.99 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.41 -0.359 . . . . 62.439999999999998 110.448 178.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.505 HD12 HD11 ' A' ' 119' ' ' ILE . 8.2 tp -62.73 -44.89 99.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 120.814 0.34 . . . . 73.120000000000005 110.902 -178.168 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.2 m -68.55 -27.06 65.75 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.34 -0.391 . . . . 71.150000000000006 111.336 -176.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.32 -45.27 19.98 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 120.839 0.352 . . . . 71.040000000000006 110.076 178.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.521 ' HA ' ' HG2' ' A' ' 122' ' ' GLU . 2.4 pp -68.43 -37.37 77.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.384 -0.371 . . . . 71.219999999999999 111.601 -176.149 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.604 HG22 HD11 ' A' ' 66' ' ' LEU . 2.7 pp -63.66 -31.79 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 121.3 0.571 . . . . 75.310000000000002 109.681 176.009 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.8 t -70.47 -47.89 58.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.446 -0.797 . . . . 62.240000000000002 110.568 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.521 ' HG2' ' HA ' ' A' ' 119' ' ' ILE . 21.1 pt-20 -76.96 -44.75 30.14 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.235 0.457 . . . . 74.319999999999993 112.235 -176.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.572 HD12 HD12 ' A' ' 66' ' ' LEU . 67.2 mt -61.43 -57.23 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 O-C-N 122.185 -0.322 . . . . 72.530000000000001 110.992 -178.509 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -60.59 -20.37 60.36 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.068 0.461 . . . . 72.010000000000005 111.227 -176.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -77.66 -34.49 53.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.753 -0.658 . . . . 60.229999999999997 110.576 176.123 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -83.27 -39.38 20.93 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.077 -0.51 . . . . 73.109999999999999 111.012 -177.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.455 HG12 ' O ' ' A' ' 123' ' ' ILE . 47.2 pt -91.78 168.15 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.283 -0.417 . . . . 71.040000000000006 110.2 178.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 6.4 p30 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.499 -0.762 . . . . 74.439999999999998 110.716 -172.651 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 16.0 tpt . . . . . 0 C--O 1.238 0.487 0 CA-C-O 120.994 0.426 . . . . 73.25 110.508 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.53 HD13 ' HB ' ' A' ' 76' ' ' ILE . 16.9 mm -117.17 124.8 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 115.726 -0.67 . . . . 74.400000000000006 110.427 -177.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 45.6 tt0 -131.97 140.93 49.13 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.693 0.282 . . . . 71.409999999999997 110.316 173.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -95.8 126.85 41.35 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.786 -0.45 . . . . 65.140000000000001 109.786 176.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.514 HD12 ' HA ' ' A' ' 31' ' ' PHE . 44.5 pt -129.26 165.3 29.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-O 121.075 0.464 . . . . 64.230000000000004 111.525 -174.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.5 164.07 18.91 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.52 -0.764 . . . . 13.31 111.575 176.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -63.58 -29.88 71.07 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.575 0.226 . . . . 73.329999999999998 110.704 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.9 t -62.06 -22.33 65.67 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.17 -0.468 . . . . 64.120000000000005 111.627 -178.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -121.29 -3.23 9.48 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.788 -0.187 . . . . 71.549999999999997 110.836 -178.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.514 ' HA ' HD12 ' A' ' 26' ' ' ILE . 90.6 t80 -51.29 -70.96 0.07 Allowed 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.232 -0.44 . . . . 65.209999999999994 110.363 -177.399 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -62.71 -34.35 76.99 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.431 -0.581 . . . . 71.430000000000007 109.431 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.483 ' O ' ' HB3' ' A' ' 37' ' ' SER . 6.6 t30 -52.18 -39.71 60.48 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.116 -0.947 . . . . 63.409999999999997 111.477 -176.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.512 ' HD3' HG21 ' A' ' 26' ' ' ILE . 14.1 ptmt -110.23 -18.04 13.39 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 111.793 0.294 . . . . 53.439999999999998 111.793 -177.529 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 72.2 t -87.58 -54.4 8.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 111.661 0.245 . . . . 61.520000000000003 111.661 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 72.0 p -77.47 -27.33 52.0 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.302 0.572 . . . . 74.430000000000007 110.0 -176.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.483 ' HB3' ' O ' ' A' ' 33' ' ' ASN . 34.3 t -89.71 12.59 16.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.249 -0.887 . . . . 73.219999999999999 110.828 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.404 ' HB2' HD12 ' A' ' 44' ' ' ILE . 43.9 t -46.02 99.58 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.949 0.404 . . . . 60.130000000000003 111.672 -178.622 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -95.4 9.05 41.37 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.804 -0.635 . . . . 70.230000000000004 110.296 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -86.28 -15.39 40.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.011 -0.54 . . . . 63.240000000000002 110.774 -178.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.4 m120 62.99 16.54 9.35 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.482 0.658 . . . . 71.209999999999994 109.673 -171.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 21.7 mt -96.66 141.4 15.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 115.147 -0.933 . . . . 74.519999999999996 110.46 -177.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.677 HD21 ' HE3' ' A' ' 101' ' ' MET . 62.7 tp -71.56 103.92 3.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.85 -0.614 . . . . 74.319999999999993 110.087 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.404 HD12 ' HB2' ' A' ' 38' ' ' CYS . 44.3 mt -84.7 116.59 28.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.928 -0.578 . . . . 75.349999999999994 110.695 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.801 HD13 HD12 ' A' ' 63' ' ' LEU . 44.9 mt -100.63 109.98 22.08 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.475 -0.784 . . . . 41.200000000000003 109.217 179.112 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.3 m -100.97 115.02 41.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-O 120.866 0.365 . . . . 71.439999999999998 110.309 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.5 121.03 32.83 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.786 -0.643 . . . . 64.5 111.049 -175.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 . . . . . 0 C--O 1.239 0.534 0 N-CA-C 109.593 -0.521 . . . . 73.030000000000001 109.593 175.366 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo . . . . . 0 N--CA 1.463 -0.323 0 N-CA-C 111.59 -0.196 . . . . 71.140000000000001 111.59 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.634 ' HB3' HG12 ' A' ' 119' ' ' ILE . 8.2 mp0 -52.47 -48.34 65.96 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 121.551 0.691 . . . . 74.099999999999994 110.986 -176.511 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.801 HD12 HD13 ' A' ' 45' ' ' LEU . 3.0 mm? -57.89 -48.07 80.93 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.655 -1.157 . . . . 74.219999999999999 110.35 -173.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.546 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 41.2 mt-10 -71.73 -34.94 69.98 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.432 -0.349 . . . . 74.409999999999997 110.9 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 49.6 mmtt -52.85 -52.96 55.26 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.768 0.318 . . . . 71.310000000000002 110.52 177.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.597 HD12 HD12 ' A' ' 123' ' ' ILE . 25.5 mt -76.51 -30.22 57.12 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.532 -0.467 . . . . 73.239999999999995 111.091 178.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.516 ' HB3' ' HA ' ' A' ' 64' ' ' GLU . . . -59.58 -37.68 79.16 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.743 -0.208 . . . . 61.5 111.412 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.546 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 79.2 mt-30 -54.09 -35.46 62.13 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.989 0.423 . . . . 70.239999999999995 110.982 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 66.8 mm-40 -93.86 -53.09 4.14 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.99 -0.55 . . . . 65.549999999999997 111.262 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.489 ' O ' HG22 ' A' ' 74' ' ' VAL . 14.3 m-85 -92.74 22.58 4.67 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.815 -0.63 . . . . 75.230000000000004 112.047 -171.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.46 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 9.5 t -52.91 -31.52 40.38 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.722 0.296 . . . . 74.329999999999998 111.775 -177.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -70.6 -16.47 62.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.991 0.425 . . . . 53.340000000000003 111.155 -177.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -123.43 0.79 8.92 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.164 -0.471 . . . . 72.310000000000002 110.761 -175.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 70' ' ' TYR . 29.1 m -131.29 147.55 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 120.939 0.4 . . . . 55.140000000000001 110.469 177.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -141.86 116.73 9.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.964 -0.562 . . . . 63.310000000000002 109.723 -178.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.53 ' HB ' HD13 ' A' ' 23' ' ' ILE . 3.0 mp -99.05 143.44 13.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 120.633 0.254 . . . . 74.420000000000002 110.811 -173.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.457 ' OH ' ' HE2' ' A' ' 34' ' ' LYS . 21.0 m-85 -130.75 130.05 43.27 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.988 0.423 . . . . 72.200000000000003 111.655 -179.445 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -96.21 115.17 27.01 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.69 -0.856 . . . . 72.219999999999999 108.69 170.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.432 HD12 ' CD1' ' A' ' 31' ' ' PHE . 12.1 tt . . . . . 0 C--N 1.325 -0.469 0 N-CA-C 109.864 -0.421 . . . . 72.5 109.864 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.185 0 CA-C-O 121.031 0.444 . . . . 73.530000000000001 110.283 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.3 m -60.06 -37.07 78.77 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.786 -0.643 . . . . 71.010000000000005 110.89 178.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -62.44 -47.0 85.99 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.566 -0.743 . . . . 72.230000000000004 110.683 -177.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -87.77 6.58 34.48 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.177 -0.465 . . . . 74.030000000000001 111.523 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.01 27.65 73.52 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 116.106 -0.497 . . . . 71.209999999999994 112.965 175.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 77.7 t -69.27 98.35 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.247 0.546 . . . . 73.5 110.732 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.2 m -101.98 -14.3 17.23 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.059 -0.519 . . . . 73.310000000000002 110.51 176.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -123.1 115.85 22.49 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.778 -0.647 . . . . 73.129999999999995 110.494 -177.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.57 ' HB ' ' HA ' ' A' ' 97' ' ' PRO . 30.3 pt -96.26 162.2 24.47 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 115.936 -0.574 . . . . 72.430000000000007 110.153 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.57 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 83.7 Cg_endo -81.71 171.91 54.9 Favored 'Cis proline' 0 C--N 1.353 0.794 0 C-N-CA 124.136 -1.193 . . . . 65.310000000000002 112.986 0.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 97.9 m -147.34 129.25 15.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.913 -0.585 . . . . 71.120000000000005 110.474 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.53 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 3.6 mp -110.46 145.83 16.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.88 -0.785 . . . . 53.43 108.88 177.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.463 HD23 ' H ' ' A' ' 101' ' ' MET . 0.8 OUTLIER -121.56 137.81 54.57 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.755 -0.461 . . . . 73.120000000000005 109.755 178.825 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.702 ' SD ' ' HB3' ' A' ' 109' ' ' SER . 64.0 mtp -103.14 111.68 24.17 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.892 -0.594 . . . . 74.109999999999999 111.039 -174.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -115.46 153.72 30.59 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.736 0.303 . . . . 74.430000000000007 110.655 177.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.499 ' HB3' HD21 ' A' ' 108' ' ' LEU . 39.3 ttpt -166.77 116.92 0.91 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.314 -0.403 . . . . 63.310000000000002 110.051 175.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 8.1 t30 50.92 52.14 15.58 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.622 0.725 . . . . 65.239999999999995 110.957 178.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 76.46 -14.95 6.18 Favored Glycine 0 CA--C 1.521 0.43 0 CA-C-N 115.436 -0.802 . . . . 53.509999999999998 113.666 176.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -100.29 123.47 44.55 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 117.08 0.44 . . . . 51.240000000000002 110.398 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.402 ' H ' ' HG2' ' A' ' 107' ' ' LYS . 30.6 pttt -89.24 122.61 32.68 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.517 -0.549 . . . . 45.119999999999997 109.517 174.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.508 ' N ' HD22 ' A' ' 108' ' ' LEU . 2.5 mm? -82.63 -52.62 6.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.612 -0.722 . . . . 72.549999999999997 111.281 -172.259 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.702 ' HB3' ' SD ' ' A' ' 101' ' ' MET . 22.0 t -162.42 172.01 16.24 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.995 -0.548 . . . . 74.540000000000006 110.845 -171.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -133.41 129.26 37.1 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.199 -0.455 . . . . 75.319999999999993 110.369 178.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.688 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 83.7 t -92.64 107.11 18.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.994 -0.548 . . . . 64.25 110.28 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 59.9 mt -110.32 119.19 58.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.722 -0.473 . . . . 75.109999999999999 109.722 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 95.74 -126.9 8.95 Favored Glycine 0 CA--C 1.519 0.322 0 N-CA-C 111.922 -0.471 . . . . 74.409999999999997 111.922 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.47 83.73 0.91 Allowed 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.895 0.379 . . . . 71.329999999999998 110.305 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.41 ' O ' HG23 ' A' ' 119' ' ' ILE . 4.9 m-20 -125.7 97.42 5.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.06 -0.518 . . . . 62.439999999999998 110.407 -178.367 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.518 ' O ' HG13 ' A' ' 119' ' ' ILE . 7.7 tp -60.64 -41.67 88.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-N 116.511 -0.313 . . . . 73.120000000000005 111.158 -177.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 30.4 t -62.74 -33.04 74.32 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.302 0.572 . . . . 71.150000000000006 110.853 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.688 ' HE3' ' HA ' ' A' ' 111' ' ' VAL . 0.9 OUTLIER -75.94 -47.67 24.25 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.648 -0.706 . . . . 71.040000000000006 110.656 -179.188 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.634 HG12 ' HB3' ' A' ' 62' ' ' GLN . 2.1 pp -64.97 -40.82 90.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.227 -0.442 . . . . 71.219999999999999 111.066 -177.287 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.436 HG22 HD11 ' A' ' 66' ' ' LEU . 2.8 pp -65.73 -31.71 54.94 Favored 'Isoleucine or valine' 0 C--N 1.34 0.169 0 N-CA-C 109.65 -0.5 . . . . 75.310000000000002 109.65 178.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 43.2 t -65.15 -51.62 60.05 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.632 -0.713 . . . . 62.240000000000002 110.482 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -77.15 -38.73 51.24 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.635 0.605 . . . . 74.319999999999993 112.635 -176.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.597 HD12 HD12 ' A' ' 66' ' ' LEU . 56.8 mt -66.02 -53.2 40.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 O-C-N 122.167 -0.333 . . . . 72.530000000000001 111.011 -178.324 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -61.85 -20.34 63.59 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.14 0.495 . . . . 72.010000000000005 110.499 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -70.73 -32.58 69.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.981 -0.554 . . . . 60.229999999999997 111.436 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.545 ' OD1' HG23 ' A' ' 127' ' ' ILE . 9.3 p30 -106.39 -17.97 14.12 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.083 0.401 . . . . 73.109999999999999 112.083 -174.015 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.545 HG23 ' OD1' ' A' ' 126' ' ' ASN . 42.2 pt -125.39 167.69 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 120.846 0.355 . . . . 71.040000000000006 111.135 177.327 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.353 -0.832 . . . . 74.439999999999998 110.781 179.266 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.475 ' N ' ' SD ' ' A' ' 22' ' ' MET . 3.7 mpp? . . . . . 0 C--O 1.232 0.155 0 N-CA-C 111.57 0.211 . . . . 73.25 111.57 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.1 mt -108.44 123.59 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 121.018 0.437 . . . . 74.400000000000006 111.626 -174.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.642 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 8.7 tp10 -131.97 155.22 48.35 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.834 -0.802 . . . . 71.409999999999997 108.834 174.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -100.59 147.83 25.5 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.71 0.29 . . . . 65.140000000000001 110.263 174.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.518 HD12 ' HA ' ' A' ' 31' ' ' PHE . 34.9 pt -131.07 -176.95 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.464 -0.334 . . . . 64.230000000000004 110.691 -176.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.415 ' H ' ' HG2' ' A' ' 30' ' ' GLU . . . -141.03 -173.83 13.77 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.403 -0.427 . . . . 13.31 112.902 -177.393 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -55.03 -50.73 68.34 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.92 0.888 . . . . 73.329999999999998 112.605 -175.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 24.9 t -73.4 -19.09 61.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.102 -0.499 . . . . 64.120000000000005 111.807 -169.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.493 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 1.7 pm0 -111.74 -15.24 13.46 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 111.874 0.324 . . . . 71.549999999999997 111.874 -177.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.518 ' HA ' HD12 ' A' ' 26' ' ' ILE . 61.6 t80 -48.2 -71.01 0.08 Allowed 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.41 0.444 . . . . 65.209999999999994 111.239 -176.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -63.44 -40.09 96.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.358 0.599 . . . . 71.430000000000007 109.636 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.526 ' O ' ' HB3' ' A' ' 37' ' ' SER . 1.8 m-80 -53.13 -34.08 55.18 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.445 -1.252 . . . . 63.409999999999997 112.58 -172.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -114.84 -25.02 8.39 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.577 -0.449 . . . . 53.439999999999998 112.16 179.754 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.4 t -82.74 -51.62 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 N-CA-C 111.51 0.189 . . . . 61.520000000000003 111.51 -178.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 44.3 p -85.86 -23.03 27.27 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.025 0.44 . . . . 74.430000000000007 110.265 -176.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.526 ' HB3' ' O ' ' A' ' 33' ' ' ASN . 28.5 t -92.76 12.05 24.82 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.679 -0.691 . . . . 73.219999999999999 110.384 177.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 41.3 t -60.19 90.73 0.02 OUTLIER 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.128 0.489 . . . . 60.130000000000003 110.961 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -90.27 -4.0 57.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.872 -0.604 . . . . 70.230000000000004 110.543 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -71.02 -8.2 51.71 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.075 -0.511 . . . . 63.240000000000002 110.875 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 57.15 22.68 7.76 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.961 -0.563 . . . . 71.209999999999994 111.246 -176.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.9 tt -94.16 148.68 4.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.951 -0.759 . . . . 74.519999999999996 108.951 177.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.561 HD11 ' HB3' ' A' ' 101' ' ' MET . 63.7 tp -82.46 113.25 20.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.04 0.448 . . . . 74.319999999999993 110.634 -175.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.411 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 58.2 mt -98.34 123.97 51.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.522 -0.763 . . . . 75.349999999999994 110.58 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.451 ' N ' HD12 ' A' ' 45' ' ' LEU . 5.1 mp -106.71 112.11 24.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.221 -0.445 . . . . 41.200000000000003 109.867 177.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 27.5 m -98.04 121.87 49.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-O 121.031 0.444 . . . . 71.439999999999998 110.957 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.442 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 2.3 t70 -96.87 128.05 43.44 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.684 -0.689 . . . . 64.5 110.819 -179.087 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.458 ' CE1' HD13 ' A' ' 100' ' ' LEU . 44.2 m-85 . . . . . 0 C--N 1.328 -0.352 0 CA-C-O 121.07 0.462 . . . . 73.030000000000001 110.43 175.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo . . . . . 0 C--O 1.235 0.358 0 CA-C-O 120.446 0.103 . . . . 71.140000000000001 111.837 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.59 ' HB3' HG12 ' A' ' 119' ' ' ILE . 8.9 mp0 -51.13 -49.47 60.73 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-O 121.566 0.698 . . . . 74.099999999999994 110.533 -176.267 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.764 HD21 HG12 ' A' ' 99' ' ' ILE . 10.3 mp -54.44 -48.87 71.19 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.617 -1.174 . . . . 74.219999999999999 111.49 -175.409 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -73.42 -32.79 64.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.818 0.342 . . . . 74.409999999999997 110.296 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.0 tptp -60.31 -46.77 88.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.752 -0.658 . . . . 71.310000000000002 110.358 -176.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.526 HD12 HD12 ' A' ' 123' ' ' ILE . 17.4 mt -85.79 -40.69 15.77 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.082 0.401 . . . . 73.239999999999995 112.082 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.26 -37.15 69.41 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.193 0.442 . . . . 61.5 112.193 -173.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -58.47 -30.84 67.29 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.766 0.317 . . . . 70.239999999999995 111.201 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 19.2 mm-40 -90.55 -54.2 4.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.09 0.472 . . . . 65.549999999999997 110.595 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.525 ' O ' HG22 ' A' ' 74' ' ' VAL . 19.4 m-85 -88.1 22.48 2.4 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.762 -0.654 . . . . 75.230000000000004 112.043 -172.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.9 t -52.63 -32.71 43.21 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.175 0.435 . . . . 74.329999999999998 112.175 -172.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -72.03 -22.62 61.37 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 121.225 -0.19 . . . . 53.340000000000003 111.487 -175.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.04 -4.14 16.04 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.636 -0.256 . . . . 72.310000000000002 110.751 -177.309 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 70' ' ' TYR . 23.2 m -135.46 148.1 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.134 0.493 . . . . 55.140000000000001 111.568 -178.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 36.6 mmtm -140.81 131.43 25.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.706 -0.679 . . . . 63.310000000000002 109.259 171.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.488 HD13 ' HB3' ' A' ' 63' ' ' LEU . 61.5 mt -110.24 127.68 67.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.366 -0.379 . . . . 74.420000000000002 110.521 -175.177 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.642 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 57.7 m-85 -124.84 128.74 49.17 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.592 -0.521 . . . . 72.200000000000003 109.592 178.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.442 ' HG2' ' HB3' ' A' ' 47' ' ' ASP . 9.2 mtmp? -100.52 142.74 31.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.874 0.369 . . . . 72.219999999999999 110.636 -177.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 32.8 mm . . . . . 0 C--N 1.326 -0.436 0 CA-C-N 115.42 -0.809 . . . . 72.5 110.789 -174.651 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.233 0 CA-C-O 121.119 0.485 . . . . 73.530000000000001 109.95 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.9 m -59.33 -37.6 78.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.652 -0.704 . . . . 71.010000000000005 110.34 176.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -65.92 -36.56 83.72 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.068 -0.515 . . . . 72.230000000000004 110.064 177.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -73.42 -4.2 32.14 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.384 -0.371 . . . . 74.030000000000001 111.123 175.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.0 9.33 82.67 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 121.276 -0.488 . . . . 71.209999999999994 112.099 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 89.2 t -75.24 83.76 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.425 0.631 . . . . 73.5 110.653 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.0 p -117.85 12.07 13.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.45 -0.795 . . . . 73.310000000000002 109.727 174.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -83.34 -68.39 0.71 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.695 -0.684 . . . . 73.129999999999995 110.978 -178.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 69.2 mt 68.44 128.1 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.554 0 O-C-N 123.506 0.503 . . . . 72.430000000000007 110.362 -178.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -79.38 156.94 90.39 Favored 'Cis proline' 0 C--N 1.353 0.794 0 C-N-CA 123.923 -1.282 . . . . 65.310000000000002 112.686 2.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 39.6 m -149.27 134.08 17.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.985 -0.552 . . . . 71.120000000000005 109.858 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.764 HG12 HD21 ' A' ' 63' ' ' LEU . 3.5 mp -114.99 124.96 72.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.381 -0.372 . . . . 53.43 110.265 -176.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.458 HD13 ' CE1' ' A' ' 48' ' ' PHE . 10.3 mp -103.3 141.87 35.16 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.654 -0.499 . . . . 73.120000000000005 109.654 175.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.7 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 53.4 mtp -112.6 116.13 29.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.517 -0.31 . . . . 74.109999999999999 110.724 -173.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -114.07 152.57 30.85 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.212 -0.449 . . . . 74.430000000000007 110.851 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.641 ' HB3' HD21 ' A' ' 108' ' ' LEU . 39.1 ttpt -168.38 133.09 1.67 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.304 -0.628 . . . . 63.310000000000002 109.304 176.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 56.7 29.17 15.35 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.251 0.548 . . . . 65.239999999999995 109.817 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 87.79 -14.49 58.36 Favored Glycine 0 CA--C 1.52 0.358 0 CA-C-N 115.862 -0.608 . . . . 53.509999999999998 113.331 177.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -96.52 150.91 20.1 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 117.072 0.436 . . . . 51.240000000000002 110.803 -177.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 10.0 ptpt -91.96 118.2 30.54 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.07 -0.715 . . . . 45.119999999999997 109.07 171.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.641 HD21 ' HB3' ' A' ' 103' ' ' LYS . 2.2 mm? -89.8 -52.96 4.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.024 0.44 . . . . 72.549999999999997 111.057 -173.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.7 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 15.8 m -151.75 171.77 17.18 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 115.731 -0.668 . . . . 74.540000000000006 110.329 -170.283 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -149.89 123.44 9.12 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.286 0.565 . . . . 75.319999999999993 111.488 -176.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.44 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 40.4 t -86.26 107.08 16.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.674 -0.694 . . . . 64.25 109.618 175.091 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 12.8 mt -116.8 106.83 20.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 109.296 -0.631 . . . . 75.109999999999999 109.296 178.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 115.52 -127.25 7.51 Favored Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 111.574 -0.61 . . . . 74.409999999999997 111.574 -176.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.61 57.27 0.49 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.486 0.66 . . . . 71.329999999999998 109.651 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.452 ' O ' HG23 ' A' ' 119' ' ' ILE . 1.6 m-20 -105.58 99.54 9.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.384 -0.825 . . . . 62.439999999999998 110.882 -174.497 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.577 ' O ' HG13 ' A' ' 119' ' ' ILE . 7.0 tp -63.37 -38.87 83.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.171 -0.468 . . . . 73.120000000000005 111.079 -178.258 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.5 m -68.14 -26.85 65.98 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.11 0.481 . . . . 71.150000000000006 110.621 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.441 ' HB3' ' HB2' ' A' ' 115' ' ' ASP . 24.6 tptp -73.2 -52.02 15.64 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.678 -0.692 . . . . 71.040000000000006 110.041 176.326 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.59 HG12 ' HB3' ' A' ' 62' ' ' GLN . 2.0 pp -63.9 -40.81 90.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 115.68 -0.691 . . . . 71.219999999999999 111.461 -175.361 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.442 HD12 ' N ' ' A' ' 121' ' ' SER . 2.8 pp -63.14 -33.13 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 120.434 -0.506 . . . . 75.310000000000002 110.284 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.442 ' N ' HD12 ' A' ' 120' ' ' ILE . 35.9 t -70.71 -51.57 26.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.029 -0.532 . . . . 62.240000000000002 110.78 179.23 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.458 ' OE2' ' HB3' ' A' ' 109' ' ' SER . 15.9 pt-20 -75.86 -38.43 57.96 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.082 0.401 . . . . 74.319999999999993 112.082 -172.675 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.554 ' O ' HG12 ' A' ' 127' ' ' ILE . 69.9 mt -65.1 -55.8 18.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 O-C-N 122.32 -0.238 . . . . 72.530000000000001 110.442 178.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -60.37 -27.32 67.31 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.281 -0.418 . . . . 72.010000000000005 110.728 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -65.36 -31.48 72.62 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.28 -0.418 . . . . 60.229999999999997 110.74 176.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -104.43 -4.61 22.57 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.979 -0.555 . . . . 73.109999999999999 111.975 -172.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.554 HG12 ' O ' ' A' ' 123' ' ' ILE . 48.5 pt -131.56 168.94 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 122.166 0.186 . . . . 71.040000000000006 110.59 178.458 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.252 1.185 0 CA-C-O 118.462 -0.78 . . . . 74.439999999999998 112.796 -176.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 67.1 mtt . . . . . 0 N--CA 1.463 0.192 0 N-CA-C 109.995 -0.372 . . . . 73.25 109.995 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.8 mt -113.89 122.62 68.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 109.218 -0.66 . . . . 74.400000000000006 109.218 176.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 -125.54 124.76 42.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.834 0.35 . . . . 71.409999999999997 111.056 -174.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.442 ' HG3' ' HB3' ' A' ' 78' ' ' LYS . 1.1 mp0 -81.49 125.97 31.11 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.464 -0.569 . . . . 65.140000000000001 109.464 178.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.509 HG21 ' HD3' ' A' ' 34' ' ' LYS . 33.8 pt -131.58 176.39 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.744 0.307 . . . . 64.230000000000004 110.936 -176.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -108.86 174.83 18.86 Favored Glycine 0 C--N 1.331 0.278 0 N-CA-C 111.629 -0.588 . . . . 13.31 111.629 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -67.84 -33.43 74.75 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.58 0.229 . . . . 73.329999999999998 111.34 -176.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.0 t -68.79 -34.62 75.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.769 0.319 . . . . 64.120000000000005 111.145 -174.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -101.35 -6.11 24.52 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.145 -0.479 . . . . 71.549999999999997 110.799 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.494 ' HA ' HD12 ' A' ' 26' ' ' ILE . 59.5 t80 -50.45 -70.81 0.08 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.359 -0.382 . . . . 65.209999999999994 110.248 177.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -59.67 -36.93 77.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.095 0.474 . . . . 71.430000000000007 109.969 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.518 ' O ' ' HB2' ' A' ' 37' ' ' SER . 24.7 t-20 -52.41 -47.73 66.13 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.118 -0.946 . . . . 63.409999999999997 111.782 -175.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.509 ' HD3' HG21 ' A' ' 26' ' ' ILE . 0.2 OUTLIER -101.93 -19.18 15.36 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.687 0.255 . . . . 53.439999999999998 111.687 -176.01 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.7 t -88.25 -59.54 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 112.038 0.385 . . . . 61.520000000000003 112.038 -179.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 66.1 p -79.99 -28.1 39.53 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.135 0.493 . . . . 74.430000000000007 110.66 -172.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.518 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 39.8 m -94.6 12.48 27.4 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.69 -0.686 . . . . 73.219999999999999 110.958 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.556 ' SG ' HG22 ' A' ' 42' ' ' ILE . 50.9 t -53.68 92.1 0.01 OUTLIER 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.047 0.451 . . . . 60.130000000000003 112.043 -177.049 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -67.47 -19.28 65.32 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.04 -0.527 . . . . 70.230000000000004 110.951 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -62.46 -25.27 67.9 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.356 -0.384 . . . . 63.240000000000002 111.372 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 62.49 23.67 14.06 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.972 -0.558 . . . . 71.209999999999994 110.235 -175.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.556 HG22 ' SG ' ' A' ' 38' ' ' CYS . 12.3 tt -82.38 157.76 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.757 -0.656 . . . . 74.519999999999996 109.291 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.423 ' HB3' HG12 ' A' ' 74' ' ' VAL . 48.7 tp -78.21 102.7 7.72 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 109.586 -0.524 . . . . 74.319999999999993 109.586 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.464 ' O ' ' HA ' ' A' ' 101' ' ' MET . 32.5 mt -90.5 126.34 43.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.889 -0.596 . . . . 75.349999999999994 111.108 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.545 HD23 HD12 ' A' ' 63' ' ' LEU . 3.5 mp -115.05 101.91 9.44 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.263 -0.644 . . . . 41.200000000000003 109.263 177.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.54 HG12 ' HB2' ' A' ' 77' ' ' TYR . 29.1 m -94.79 120.9 44.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.725 -0.472 . . . . 71.439999999999998 109.725 178.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -98.09 121.36 39.92 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.527 0.68 . . . . 64.5 109.385 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 . . . . . 0 C--N 1.321 -0.641 0 CA-C-N 115.285 -0.87 . . . . 73.030000000000001 109.242 178.992 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.438 ' HG2' ' HB2' ' A' ' 64' ' ' GLU . 72.6 Cg_endo . . . . . 0 N--CA 1.463 -0.318 0 CA-C-O 121.18 0.408 . . . . 71.140000000000001 112.674 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.571 ' HB3' HG12 ' A' ' 119' ' ' ILE . 15.7 mp0 -56.16 -40.89 74.59 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.353 -0.84 . . . . 74.099999999999994 110.758 -177.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.679 HD11 HG21 ' A' ' 111' ' ' VAL . 2.3 mm? -61.93 -41.0 97.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.87 -1.059 . . . . 74.219999999999999 109.868 -176.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.438 ' HB2' ' HG2' ' A' ' 61' ' ' PRO . 8.7 tm-20 -70.53 -36.66 73.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.63 -0.714 . . . . 74.409999999999997 109.174 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -56.87 -51.53 68.68 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.433 -0.803 . . . . 71.310000000000002 109.909 178.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.605 HD12 HD12 ' A' ' 123' ' ' ILE . 22.3 mt -80.63 -30.61 36.69 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.073 0.397 . . . . 73.239999999999995 112.073 -178.496 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.47 -34.95 69.55 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.789 0.328 . . . . 61.5 110.892 -178.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -56.57 -30.83 63.61 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.163 -0.471 . . . . 70.239999999999995 111.372 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -93.62 -48.37 6.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.235 -0.439 . . . . 65.549999999999997 110.886 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.543 ' O ' HG22 ' A' ' 74' ' ' VAL . 21.9 m-85 -93.92 21.21 6.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.033 -0.531 . . . . 75.230000000000004 112.154 -174.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.1 t -53.01 -36.38 60.43 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.035 0.383 . . . . 74.329999999999998 112.035 -174.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -71.24 -16.98 62.52 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.505 -0.316 . . . . 53.340000000000003 111.455 -177.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -117.16 -1.37 11.87 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.404 -0.362 . . . . 72.310000000000002 111.036 -175.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.543 HG22 ' O ' ' A' ' 70' ' ' TYR . 26.4 m -135.16 150.65 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 121.008 0.432 . . . . 55.140000000000001 111.55 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -137.57 115.2 11.27 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.094 -0.706 . . . . 63.310000000000002 109.094 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.472 HG12 ' HB2' ' A' ' 45' ' ' LEU . 61.0 mt -98.21 140.63 17.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.692 0.282 . . . . 74.420000000000002 110.326 -178.557 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.54 ' HB2' HG12 ' A' ' 46' ' ' VAL . 95.1 m-85 -129.35 138.21 51.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.409 -0.359 . . . . 72.200000000000003 110.487 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.442 ' HB3' ' HG3' ' A' ' 25' ' ' GLN . 53.3 tptt -101.24 114.76 29.02 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.402 -0.817 . . . . 72.219999999999999 110.115 -178.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.444 ' N ' HD12 ' A' ' 79' ' ' ILE . 2.3 mp . . . . . 0 N--CA 1.468 0.431 0 CA-C-O 120.765 0.317 . . . . 72.5 110.374 178.027 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.406 ' O ' HG12 ' A' ' 93' ' ' VAL . . . . . . . . 0 C--O 1.235 0.327 0 CA-C-O 121.168 0.508 . . . . 73.530000000000001 110.777 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.2 m -66.88 -33.48 75.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.802 -0.635 . . . . 71.010000000000005 110.413 178.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -66.6 -36.3 82.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.658 -0.701 . . . . 72.230000000000004 110.82 -178.302 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -89.29 -0.77 57.72 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.844 0.354 . . . . 74.030000000000001 110.857 176.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.65 41.66 42.42 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-N 115.787 -0.642 . . . . 71.209999999999994 113.7 170.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 88' ' ' ALA . 10.0 p -98.45 152.79 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.978 0.389 . . . . 73.5 110.076 176.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.9 t -148.01 35.54 0.83 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.184 0.516 . . . . 73.310000000000002 109.806 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.405 ' H ' HG22 ' A' ' 93' ' ' VAL . . . -133.21 149.34 52.01 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.009 -0.541 . . . . 73.129999999999995 110.813 -178.375 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 97' ' ' PRO . 68.6 mt -118.96 128.48 25.93 Favored Pre-proline 0 C--O 1.237 0.42 0 CA-C-N 115.826 -0.625 . . . . 72.430000000000007 109.88 176.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 96' ' ' ILE . 57.2 Cg_endo -92.98 167.03 23.0 Favored 'Cis proline' 0 C--N 1.349 0.575 0 C-N-CA 124.177 -1.176 . . . . 65.310000000000002 112.966 -1.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 62.1 m -120.48 128.63 53.32 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.017 -0.538 . . . . 71.120000000000005 110.906 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.676 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 3.4 mp -106.85 138.91 30.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.46 -0.57 . . . . 53.43 109.46 178.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.541 HD12 ' HB3' ' A' ' 110' ' ' GLN . 34.5 tp -127.56 145.93 50.7 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.797 -0.446 . . . . 73.120000000000005 109.797 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.816 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 72.7 mtp -118.26 116.21 26.31 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 120.874 0.368 . . . . 74.109999999999999 111.979 -173.399 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -109.41 157.78 18.59 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.736 -0.665 . . . . 74.430000000000007 111.363 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.479 ' CB ' HD21 ' A' ' 108' ' ' LEU . 39.4 ttmt -151.22 102.86 2.97 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.566 -0.901 . . . . 63.310000000000002 108.566 169.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.8 t30 53.73 38.76 29.18 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.394 0.616 . . . . 65.239999999999995 110.762 -177.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.81 -6.48 81.95 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 116.107 -0.497 . . . . 53.509999999999998 113.272 177.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -90.15 134.86 34.02 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 122.434 0.293 . . . . 51.240000000000002 110.248 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 40.2 tttm -89.42 120.95 31.19 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 110.013 -0.366 . . . . 45.119999999999997 110.013 176.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.548 ' N ' HD22 ' A' ' 108' ' ' LEU . 2.0 mm? -98.49 -53.11 3.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.244 -0.434 . . . . 72.549999999999997 110.514 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.816 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 16.7 m -156.78 172.41 18.68 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 115.172 -0.922 . . . . 74.540000000000006 110.007 -169.543 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.541 ' HB3' HD12 ' A' ' 100' ' ' LEU . 12.4 pt20 -158.4 131.57 7.39 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.88 0.371 . . . . 75.319999999999993 110.452 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.679 HG21 HD11 ' A' ' 63' ' ' LEU . 38.8 t -98.5 107.21 19.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.957 -0.565 . . . . 64.25 110.242 -176.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 68.6 mt -95.46 114.4 31.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.335 -0.393 . . . . 75.109999999999999 109.973 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.36 -109.9 2.9 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.726 -0.749 . . . . 74.409999999999997 111.966 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.61 104.22 1.97 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.658 0.229 . . . . 71.329999999999998 111.264 -178.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.5 ' O ' HG23 ' A' ' 119' ' ' ILE . 37.3 m-20 -140.55 96.05 2.97 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.624 0.25 . . . . 62.439999999999998 110.43 176.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.518 HD12 HD11 ' A' ' 119' ' ' ILE . 6.6 tp -60.15 -42.48 90.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 CA-C-O 120.933 0.397 . . . . 73.120000000000005 110.503 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 36.8 t -61.62 -30.18 70.53 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.715 -0.675 . . . . 71.150000000000006 110.694 -178.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.05 -53.73 6.72 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.183 -0.673 . . . . 71.040000000000006 109.183 179.144 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.571 HG12 ' HB3' ' A' ' 62' ' ' GLN . 2.1 pp -59.08 -40.41 80.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.692 -0.685 . . . . 71.219999999999999 111.701 -172.01 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.534 HD12 ' N ' ' A' ' 121' ' ' SER . 2.8 pp -59.2 -36.89 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 C-N-CA 119.935 -0.706 . . . . 75.310000000000002 110.142 178.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.534 ' N ' HD12 ' A' ' 120' ' ' ILE . 28.1 t -70.69 -50.62 34.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.19 -0.459 . . . . 62.240000000000002 110.865 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.562 ' HG2' ' HA ' ' A' ' 119' ' ' ILE . 16.4 pt-20 -76.36 -29.02 57.02 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 112.081 0.4 . . . . 74.319999999999993 112.081 -170.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.605 HD12 HD12 ' A' ' 66' ' ' LEU . 65.2 mt -72.08 -56.86 8.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-O 120.903 0.382 . . . . 72.530000000000001 110.004 174.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -61.88 -20.31 63.59 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.847 -0.615 . . . . 72.010000000000005 110.993 -178.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -66.87 -27.99 67.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.08 -0.509 . . . . 60.229999999999997 111.231 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -120.46 -1.12 10.2 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.497 0.554 . . . . 73.109999999999999 112.497 -171.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 31.4 pt -139.27 167.65 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 110.237 -0.283 . . . . 71.040000000000006 110.237 170.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.327 -0.845 . . . . 74.439999999999998 110.869 -179.181 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.757 ' HG2' HG13 ' A' ' 23' ' ' ILE . 1.6 pmm? . . . . . 0 N--CA 1.461 0.108 0 N-CA-C 109.786 -0.45 . . . . 73.25 109.786 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.757 HG13 ' HG2' ' A' ' 22' ' ' MET . 47.1 mt -129.04 118.15 45.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 115.729 -0.669 . . . . 74.400000000000006 109.408 177.185 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 13.7 tp10 -131.83 155.11 48.37 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.275 -0.269 . . . . 71.409999999999997 110.275 -176.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.443 ' HG3' ' HE3' ' A' ' 78' ' ' LYS . 0.8 OUTLIER -92.2 147.67 22.75 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 110.399 -0.223 . . . . 65.140000000000001 110.399 -178.759 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 42.7 pt -135.02 -176.76 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 120.638 0.256 . . . . 64.230000000000004 110.401 176.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -118.41 167.17 12.94 Favored Glycine 0 C--N 1.331 0.281 0 N-CA-C 111.847 -0.501 . . . . 13.31 111.847 177.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -67.41 -40.79 85.61 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.864 0.32 . . . . 73.329999999999998 111.864 -174.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 83.4 p -80.16 -28.77 38.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.919 0.39 . . . . 64.120000000000005 111.43 -176.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.426 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 2.3 pm0 -91.48 -6.79 52.07 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 116.379 -0.373 . . . . 71.549999999999997 110.484 178.225 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.442 ' HE1' HG21 ' A' ' 46' ' ' VAL . 37.9 t80 -49.13 -70.8 0.08 Allowed 'General case' 0 C--O 1.227 -0.12 0 CA-C-N 115.871 -0.604 . . . . 65.209999999999994 110.174 175.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -58.22 -38.49 76.9 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 109.65 -0.5 . . . . 71.430000000000007 109.65 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -51.7 -46.43 63.91 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.035 -0.984 . . . . 63.409999999999997 111.321 -172.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -108.04 -21.16 12.92 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.107 0.41 . . . . 53.439999999999998 112.107 -176.643 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 89.7 t -88.17 -50.57 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 N-CA-C 111.722 0.268 . . . . 61.520000000000003 111.722 -177.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 66.4 p -80.18 -25.61 39.64 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 120.244 -0.582 . . . . 74.430000000000007 109.834 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.6 m -88.3 11.99 15.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.452 -0.795 . . . . 73.219999999999999 110.867 177.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.564 ' O ' ' HA ' ' A' ' 104' ' ' ASN . 44.2 t -59.3 104.49 0.26 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.66 0.267 . . . . 60.130000000000003 110.916 -178.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -81.55 -17.65 47.69 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.879 0.371 . . . . 70.230000000000004 110.293 176.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -65.92 -20.74 66.32 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.842 -0.617 . . . . 63.240000000000002 111.349 -177.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 64.44 11.48 6.57 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.058 0.543 . . . . 71.209999999999994 111.86 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.4 tt -73.35 163.29 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 109.442 -0.577 . . . . 74.519999999999996 109.442 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.661 HD21 ' HE3' ' A' ' 101' ' ' MET . 62.6 tp -87.65 110.61 20.53 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.109 0.48 . . . . 74.319999999999993 110.202 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.3 mt -96.0 119.66 44.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.747 -0.661 . . . . 75.349999999999994 110.204 178.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.688 HD13 HD12 ' A' ' 63' ' ' LEU . 71.5 mt -98.87 109.61 22.34 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.696 -0.853 . . . . 41.200000000000003 108.696 177.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.442 HG21 ' HE1' ' A' ' 31' ' ' PHE . 47.1 t -103.04 109.33 26.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.874 -0.148 . . . . 71.439999999999998 111.119 -176.154 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.21 134.28 35.59 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.586 -0.524 . . . . 64.5 109.586 173.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.4 ' HE2' ' HA ' ' A' ' 97' ' ' PRO . 10.7 p90 . . . . . 0 CA--C 1.533 0.301 0 CA-C-O 121.517 0.675 . . . . 73.030000000000001 110.169 178.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 CA--C 1.531 0.345 0 CA-C-O 120.511 0.129 . . . . 71.140000000000001 112.138 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.478 ' HB3' HG12 ' A' ' 119' ' ' ILE . 14.1 mp0 -47.06 -56.09 7.13 Favored 'General case' 0 C--O 1.249 1.067 0 CA-C-O 121.927 0.87 . . . . 74.099999999999994 110.953 -178.183 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.688 HD12 HD13 ' A' ' 45' ' ' LEU . 3.2 mm? -57.48 -48.14 80.0 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 114.215 -1.357 . . . . 74.219999999999999 110.758 -172.412 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 35.7 mt-10 -69.77 -38.92 76.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.601 -0.272 . . . . 74.409999999999997 110.853 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 26.7 mmtm -50.75 -50.18 56.24 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.852 0.358 . . . . 71.310000000000002 110.408 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.617 HD12 HD12 ' A' ' 123' ' ' ILE . 32.4 mt -77.73 -37.34 49.53 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 120.542 -0.463 . . . . 73.239999999999995 111.695 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.87 -31.32 72.33 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 111.729 0.27 . . . . 61.5 111.729 -175.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.462 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 75.4 mt-30 -54.44 -37.55 65.3 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.861 0.362 . . . . 70.239999999999995 110.882 178.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -93.57 -46.22 7.39 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.924 -0.58 . . . . 65.549999999999997 110.803 -177.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.528 ' O ' HG22 ' A' ' 74' ' ' VAL . 17.6 m-85 -93.32 22.32 5.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.761 -0.654 . . . . 75.230000000000004 112.366 -173.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.4 t -52.17 -38.55 58.05 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.206 0.447 . . . . 74.329999999999998 112.206 -173.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -71.06 -22.53 62.11 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 122.183 -0.323 . . . . 53.340000000000003 111.832 -177.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.34 -8.63 21.03 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.579 0.228 . . . . 72.310000000000002 110.773 -175.262 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 70' ' ' TYR . 35.2 m -133.11 151.16 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 O-C-N 121.944 -0.472 . . . . 55.140000000000001 111.412 -178.636 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.463 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 35.9 mmtm -139.09 115.34 10.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.773 -0.649 . . . . 63.310000000000002 109.563 174.094 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.55 ' HB ' HG12 ' A' ' 23' ' ' ILE . 56.4 mt -90.12 109.96 21.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.857 -0.61 . . . . 74.420000000000002 110.386 -178.014 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.463 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 7.7 m-85 -97.79 134.03 41.5 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.799 -0.445 . . . . 72.200000000000003 109.799 176.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.469 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 57.1 mtmt -107.28 155.6 19.78 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.845 -0.616 . . . . 72.219999999999999 110.677 -176.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.469 ' HB ' ' O ' ' A' ' 78' ' ' LYS . 41.4 mm . . . . . 0 N--CA 1.47 0.571 0 O-C-N 124.47 1.106 . . . . 72.5 111.665 178.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.627 0 CA-C-O 120.905 0.383 . . . . 73.530000000000001 110.533 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.5 m -64.02 -40.67 96.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.364 -0.835 . . . . 71.010000000000005 110.297 176.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 54.7 tp60 -63.93 -43.65 95.26 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.841 -0.618 . . . . 72.230000000000004 110.207 178.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -70.68 -17.25 62.85 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.311 -0.404 . . . . 74.030000000000001 110.82 175.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 58.87 42.16 96.51 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 110.819 -0.912 . . . . 71.209999999999994 110.819 -175.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.6 p -93.65 17.6 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-O 120.973 0.416 . . . . 73.5 111.43 -171.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.6 m -66.81 81.27 0.11 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.264 0.554 . . . . 73.310000000000002 110.873 178.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -157.3 91.1 1.15 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.513 -0.921 . . . . 73.129999999999995 108.513 176.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.7 pp -83.52 149.32 57.37 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.426 -0.807 . . . . 72.430000000000007 111.52 -171.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.438 ' HD2' ' O ' ' A' ' 113' ' ' GLY . 15.5 Cg_exo -69.94 161.08 87.44 Favored 'Cis proline' 0 C--N 1.357 0.995 0 C-N-CA 124.268 -1.138 . . . . 65.310000000000002 112.657 -3.233 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.6 m -141.1 118.36 11.36 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.07 -0.514 . . . . 71.120000000000005 110.97 -175.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.687 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 3.2 mp -120.93 133.71 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.884 -0.598 . . . . 53.43 109.977 178.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.7 mp -109.95 139.61 44.86 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 110.182 -0.303 . . . . 73.120000000000005 110.182 176.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.673 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 71.7 mtp -104.65 116.2 31.65 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.305 -0.407 . . . . 74.109999999999999 110.492 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -114.96 142.16 47.0 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.165 0.507 . . . . 74.430000000000007 111.536 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.622 ' CB ' HD21 ' A' ' 108' ' ' LEU . 23.2 ttmm -143.09 107.08 4.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.17 -0.923 . . . . 63.310000000000002 109.036 174.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.564 ' HA ' ' O ' ' A' ' 38' ' ' CYS . 3.8 t-20 59.74 28.45 17.91 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.471 0.653 . . . . 65.239999999999995 110.461 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.25 -14.41 63.77 Favored Glycine 0 C--N 1.332 0.356 0 CA-C-N 115.819 -0.628 . . . . 53.509999999999998 113.181 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.505 ' HD2' HD13 ' A' ' 108' ' ' LEU . 0.9 OUTLIER -87.7 116.97 26.21 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.703 -0.851 . . . . 51.240000000000002 108.703 176.425 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 101' ' ' MET . 25.5 pttm -77.84 119.34 21.19 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.69 -0.485 . . . . 45.119999999999997 109.69 177.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.622 HD21 ' CB ' ' A' ' 103' ' ' LYS . 1.8 mm? -78.06 -52.06 9.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.335 0.588 . . . . 72.549999999999997 109.951 -175.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.673 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 72.1 m -160.69 172.47 17.04 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 114.944 -1.025 . . . . 74.540000000000006 110.11 -170.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.02 126.56 17.84 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.124 -0.489 . . . . 75.319999999999993 111.044 -174.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.687 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 44.2 t -85.88 106.97 15.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.316 -0.624 . . . . 64.25 109.316 174.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 32.7 mt -113.66 109.89 30.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.509 -0.552 . . . . 75.109999999999999 109.509 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.438 ' O ' ' HD2' ' A' ' 97' ' ' PRO . . . 100.74 -121.27 7.18 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.147 -0.549 . . . . 74.409999999999997 111.867 -177.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.21 57.37 0.51 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.349 0.595 . . . . 71.329999999999998 110.276 -177.215 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.528 ' O ' HG23 ' A' ' 119' ' ' ILE . 2.5 m-20 -103.51 95.54 6.14 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.719 -0.673 . . . . 62.439999999999998 110.86 -173.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.582 ' O ' HG13 ' A' ' 119' ' ' ILE . 6.0 tp -63.24 -43.99 99.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 116.126 -0.488 . . . . 73.120000000000005 112.074 -175.36 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.8 t -65.69 -28.2 68.9 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.13 0.49 . . . . 71.150000000000006 110.139 -178.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -75.67 -46.74 29.63 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.884 -0.598 . . . . 71.040000000000006 109.529 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.634 ' HA ' ' HG2' ' A' ' 122' ' ' GLU . 2.2 pp -66.67 -39.42 83.73 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.095 0 CA-C-N 116.325 -0.398 . . . . 71.219999999999999 111.713 -175.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.455 HD12 ' N ' ' A' ' 121' ' ' SER . 2.8 pp -62.5 -31.75 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 C-N-CA 120.385 -0.526 . . . . 75.310000000000002 109.768 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.455 ' N ' HD12 ' A' ' 120' ' ' ILE . 35.0 t -70.62 -51.37 28.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.877 -0.601 . . . . 62.240000000000002 110.657 176.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.634 ' HG2' ' HA ' ' A' ' 119' ' ' ILE . 16.7 pt-20 -71.28 -40.82 70.68 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 112.025 0.38 . . . . 74.319999999999993 112.025 -172.318 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.617 HD12 HD12 ' A' ' 66' ' ' LEU . 82.1 mt -70.71 -59.67 3.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.607 -0.27 . . . . 72.530000000000001 111.101 -177.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -58.02 -26.26 62.2 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.148 0.499 . . . . 72.010000000000005 111.022 -176.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -63.58 -28.94 70.27 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.859 -0.61 . . . . 60.229999999999997 111.223 178.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -115.0 9.92 16.13 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.244 0.461 . . . . 73.109999999999999 112.244 -174.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.473 HG12 ' O ' ' A' ' 123' ' ' ILE . 42.7 pt -139.08 168.92 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 110.212 -0.292 . . . . 71.040000000000006 110.212 175.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.252 1.214 0 CA-C-O 118.444 -0.788 . . . . 74.439999999999998 111.983 -176.387 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.559 ' N ' ' SD ' ' A' ' 22' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.352 0 CA-C-O 121.031 0.443 . . . . 73.25 109.885 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.427 HG12 ' HB ' ' A' ' 76' ' ' ILE . 46.0 mt -103.32 84.55 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 115.365 -0.834 . . . . 74.400000000000006 108.966 172.246 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 10.0 tp10 -86.74 155.44 20.35 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.14 -0.482 . . . . 71.409999999999997 110.549 -175.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -97.34 143.79 27.75 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.742 0.306 . . . . 65.140000000000001 110.294 178.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.512 HD12 ' HA ' ' A' ' 31' ' ' PHE . 29.9 pt -133.65 163.67 36.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-N 116.324 -0.398 . . . . 64.230000000000004 110.639 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -98.12 155.6 20.34 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.899 -0.591 . . . . 13.31 111.654 176.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -60.3 -30.35 69.42 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.896 0.379 . . . . 73.329999999999998 110.902 -178.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.7 p -61.84 -30.98 71.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.879 -0.601 . . . . 64.120000000000005 111.337 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -114.24 4.14 15.38 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.216 -0.447 . . . . 71.549999999999997 111.954 -175.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.512 ' HA ' HD12 ' A' ' 26' ' ' ILE . 81.3 t80 -52.85 -71.63 0.07 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.733 0.301 . . . . 65.209999999999994 110.703 -177.359 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.553 ' O ' HG22 ' A' ' 36' ' ' THR . 7.3 p-10 -65.27 -34.06 77.46 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.617 -0.512 . . . . 71.430000000000007 109.617 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -52.28 -44.72 65.14 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.7 -1.136 . . . . 63.409999999999997 111.55 -176.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt -100.9 -25.79 13.97 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.568 -0.287 . . . . 53.439999999999998 111.139 -177.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.3 t -78.49 -61.45 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 112.12 0.415 . . . . 61.520000000000003 112.12 -176.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.553 HG22 ' O ' ' A' ' 32' ' ' ASP . 11.9 t -84.32 0.35 49.47 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.005 0.431 . . . . 74.430000000000007 110.889 -170.327 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.6 m -98.82 -4.74 32.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.339 -0.392 . . . . 73.219999999999999 111.044 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.549 ' SG ' HG22 ' A' ' 42' ' ' ILE . 47.8 t -71.97 100.06 2.38 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.024 0.44 . . . . 60.130000000000003 111.034 -175.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -93.18 2.32 56.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.391 0.615 . . . . 70.230000000000004 109.548 176.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -63.09 -14.56 49.92 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.479 -0.782 . . . . 63.240000000000002 111.168 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.581 ' O ' ' HE3' ' A' ' 103' ' ' LYS . 32.8 m-80 69.21 19.63 7.81 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.749 -0.659 . . . . 71.209999999999994 110.946 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.549 HG22 ' SG ' ' A' ' 38' ' ' CYS . 10.9 tt -88.97 146.63 5.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 108.495 -0.928 . . . . 74.519999999999996 108.495 172.05 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.667 HD11 ' HB3' ' A' ' 101' ' ' MET . 68.7 tp -85.6 113.6 21.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.251 0.548 . . . . 74.319999999999993 110.648 -176.499 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 57.4 mt -94.64 123.62 46.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.199 -0.909 . . . . 75.349999999999994 110.331 177.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.529 ' HB2' HG12 ' A' ' 76' ' ' ILE . 2.2 mm? -104.74 104.36 14.15 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.334 -0.617 . . . . 41.200000000000003 109.334 178.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 35.9 m -99.1 130.29 48.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 110.357 -0.238 . . . . 71.439999999999998 110.357 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.499 ' HB2' HG13 ' A' ' 99' ' ' ILE . 27.0 t70 -122.62 141.29 51.88 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 120.923 0.392 . . . . 64.5 111.434 -177.366 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 C--N 1.329 -0.319 0 N-CA-C 108.699 -0.852 . . . . 73.030000000000001 108.699 172.774 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.424 ' HD2' ' HB2' ' A' ' 64' ' ' GLU . 86.4 Cg_endo . . . . . 0 N--CA 1.459 -0.514 0 N-CA-C 111.4 -0.269 . . . . 71.140000000000001 111.4 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.675 ' NE2' ' HA ' ' A' ' 114' ' ' ALA . 0.4 OUTLIER -45.15 -57.56 3.83 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.179 0.592 . . . . 74.099999999999994 111.931 -173.636 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.437 HD22 ' HB2' ' A' ' 62' ' ' GLN . 3.5 mm? -60.71 -48.6 81.07 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.392 -0.822 . . . . 74.219999999999999 111.25 -172.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.502 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 39.7 mt-10 -66.0 -37.66 86.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.965 0.412 . . . . 74.409999999999997 110.221 178.398 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.427 ' HD2' ' HA ' ' A' ' 65' ' ' LYS . 42.2 tptt -60.71 -45.07 95.63 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.501 -0.772 . . . . 71.310000000000002 110.405 -174.579 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.712 HD12 HD12 ' A' ' 123' ' ' ILE . 23.9 mt -79.95 -30.31 39.83 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.515 -0.312 . . . . 73.239999999999995 110.988 176.137 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.68 -33.62 74.31 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.699 0.285 . . . . 61.5 110.847 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.502 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 78.4 mt-30 -56.07 -31.79 63.53 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.048 0.452 . . . . 70.239999999999995 110.547 177.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -93.9 -53.78 3.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.74 -0.663 . . . . 65.549999999999997 111.041 -178.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.512 ' O ' HG22 ' A' ' 74' ' ' VAL . 14.4 m-85 -95.73 23.11 6.48 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.604 -0.725 . . . . 75.230000000000004 112.822 -168.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.7 t -52.78 -28.64 23.34 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.77 0.319 . . . . 74.329999999999998 111.69 -176.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -71.03 -18.71 62.57 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.603 -0.272 . . . . 53.340000000000003 111.642 -177.01 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -120.65 1.07 10.54 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.654 0.264 . . . . 72.310000000000002 110.554 -176.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.512 HG22 ' O ' ' A' ' 70' ' ' TYR . 27.9 m -133.57 145.79 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 O-C-N 122.019 -0.426 . . . . 55.140000000000001 111.312 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 75' ' ' LYS . 41.7 mmtm -141.09 124.43 16.6 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.143 -0.688 . . . . 63.310000000000002 109.143 172.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.529 HG12 ' HB2' ' A' ' 45' ' ' LEU . 49.5 mt -103.26 135.14 42.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 110.084 -0.339 . . . . 74.420000000000002 110.084 -175.476 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.494 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 74.1 m-85 -126.29 128.68 47.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.884 0.374 . . . . 72.200000000000003 110.242 178.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -97.54 139.29 33.67 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.719 -0.845 . . . . 72.219999999999999 108.719 176.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 20.6 tt . . . . . 0 C--N 1.321 -0.641 0 N-CA-C 109.862 -0.422 . . . . 72.5 109.862 176.024 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.296 0 CA-C-O 121.21 0.528 . . . . 73.530000000000001 110.398 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 29.7 m -67.44 -28.32 67.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.748 -0.66 . . . . 71.010000000000005 110.389 178.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -63.41 -42.69 98.76 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.875 -0.602 . . . . 72.230000000000004 110.19 178.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -74.89 -17.19 60.62 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.274 -0.421 . . . . 74.030000000000001 110.725 176.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 86.9 36.73 8.93 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 121.226 -0.512 . . . . 71.209999999999994 112.395 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 99.3 t -70.34 92.52 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-O 121.126 0.488 . . . . 73.5 110.028 176.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.7 m -70.53 -33.39 71.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.56 -0.745 . . . . 73.310000000000002 111.367 -178.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -148.11 145.8 28.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.881 0.372 . . . . 73.129999999999995 111.187 -176.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.542 ' HB ' ' HA ' ' A' ' 97' ' ' PRO . 17.3 pt -101.43 161.68 22.83 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 115.46 -0.791 . . . . 72.430000000000007 109.626 177.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.542 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 93.9 Cg_endo -74.49 169.97 72.62 Favored 'Cis proline' 0 C--N 1.357 0.999 0 C-N-CA 124.585 -1.006 . . . . 65.310000000000002 113.243 3.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 96.7 m -155.29 122.03 5.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.483 -0.781 . . . . 71.120000000000005 109.699 -175.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.51 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.5 mp -106.7 108.95 26.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.123 -0.489 . . . . 53.43 110.277 -174.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.426 HD23 ' H ' ' A' ' 101' ' ' MET . 1.0 OUTLIER -92.9 136.49 33.21 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.88 -0.785 . . . . 73.120000000000005 108.88 177.755 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.901 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 69.0 mtp -101.34 117.52 35.13 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.244 -0.434 . . . . 74.109999999999999 110.943 -174.099 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -117.55 146.9 43.27 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 122.657 0.383 . . . . 74.430000000000007 110.524 178.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.812 ' HB3' HD21 ' A' ' 108' ' ' LEU . 84.1 tttt -166.68 135.37 2.84 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.973 -0.751 . . . . 63.310000000000002 108.973 -179.044 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 60.24 24.91 14.3 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.575 0.702 . . . . 65.239999999999995 110.508 177.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.93 17.61 76.73 Favored Glycine 0 CA--C 1.517 0.16 0 CA-C-N 115.789 -0.641 . . . . 53.509999999999998 113.392 178.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -136.44 157.53 46.56 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 117.059 0.429 . . . . 51.240000000000002 110.265 178.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.703 ' H ' ' HD2' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -83.36 142.47 31.01 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.363 -0.38 . . . . 45.119999999999997 110.085 176.62 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.812 HD21 ' HB3' ' A' ' 103' ' ' LYS . 2.9 mm? -111.47 -53.03 2.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.308 -0.406 . . . . 72.549999999999997 110.928 -178.251 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.901 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 14.2 m -158.26 172.17 18.87 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.949 -0.569 . . . . 74.540000000000006 110.124 -171.495 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -142.82 140.32 31.26 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.157 0.503 . . . . 75.319999999999993 111.76 -175.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.599 HG22 HG22 ' A' ' 119' ' ' ILE . 32.8 t -115.81 134.44 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 115.613 -0.721 . . . . 64.25 109.677 178.329 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 43.2 mt -126.15 106.89 16.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.899 0.381 . . . . 75.109999999999999 109.987 178.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 71.96 -85.86 0.47 Allowed Glycine 0 CA--C 1.521 0.425 0 CA-C-N 116.109 -0.496 . . . . 74.409999999999997 112.98 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.675 ' HA ' ' NE2' ' A' ' 62' ' ' GLN . . . -151.49 103.08 2.94 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 122.723 -0.28 . . . . 71.329999999999998 111.292 -174.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.45 ' O ' HG23 ' A' ' 119' ' ' ILE . 20.3 m-20 -132.49 63.28 1.63 Allowed 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 109.596 -0.52 . . . . 62.439999999999998 109.596 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.55 ' O ' HG13 ' A' ' 119' ' ' ILE . 6.8 tp -53.49 -51.57 40.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 N-CA-C 112.359 0.503 . . . . 73.120000000000005 112.359 -172.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.3 p -63.87 -28.1 69.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.33 0.586 . . . . 71.150000000000006 111.193 -178.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.429 ' HE2' ' HB2' ' A' ' 115' ' ' ASP . 3.0 tmmm? -79.47 -45.34 19.58 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.628 -0.715 . . . . 71.040000000000006 109.865 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.599 HG22 HG22 ' A' ' 111' ' ' VAL . 2.5 pp -69.26 -37.37 75.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 115.778 -0.647 . . . . 71.219999999999999 111.204 -174.427 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.474 HD12 ' N ' ' A' ' 121' ' ' SER . 2.9 pp -63.28 -31.92 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 C-N-CA 120.08 -0.648 . . . . 75.310000000000002 110.036 177.299 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.474 ' N ' HD12 ' A' ' 120' ' ' ILE . 45.0 t -70.52 -51.51 28.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.98 -0.555 . . . . 62.240000000000002 110.916 178.446 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.561 ' HG2' ' HA ' ' A' ' 119' ' ' ILE . 24.2 pt-20 -72.1 -48.93 40.28 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.151 0.426 . . . . 74.319999999999993 112.151 -174.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.712 HD12 HD12 ' A' ' 66' ' ' LEU . 83.4 mt -59.38 -55.81 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.597 0.237 . . . . 72.530000000000001 110.852 -177.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -58.77 -20.31 48.58 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.991 0.425 . . . . 72.010000000000005 111.044 -178.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -84.12 -35.55 23.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.032 -0.531 . . . . 60.229999999999997 111.06 177.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -91.69 -9.34 44.22 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.192 -0.458 . . . . 73.109999999999999 111.929 -172.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.479 HG12 ' O ' ' A' ' 123' ' ' ILE . 45.4 pt -133.94 168.19 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 120.689 0.28 . . . . 71.040000000000006 110.691 175.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 . . . . . 0 C--O 1.245 0.857 0 CA-C-O 118.802 -0.618 . . . . 74.439999999999998 110.624 -175.432 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.515 ' N ' ' SD ' ' A' ' 22' ' ' MET . 1.4 mpt? . . . . . 0 C--O 1.235 0.302 0 CA-C-O 120.799 0.333 . . . . 73.25 111.105 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.9 mt -111.66 128.11 68.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 115.898 -0.592 . . . . 74.400000000000006 110.337 -175.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 0.9 OUTLIER -122.0 144.22 49.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.326 -0.397 . . . . 71.409999999999997 109.952 -179.556 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -94.41 137.79 33.13 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 110.223 -0.288 . . . . 65.140000000000001 110.223 177.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.494 HD12 ' HA ' ' A' ' 31' ' ' PHE . 36.2 pt -140.22 172.96 11.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 121.337 0.589 . . . . 64.230000000000004 111.399 -176.664 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -110.73 173.91 16.61 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.236 -0.893 . . . . 13.31 111.809 177.06 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -67.29 -33.68 75.81 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.684 0.253 . . . . 73.329999999999998 111.684 -177.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 44.6 m -64.48 -47.56 78.52 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.091 0.472 . . . . 64.120000000000005 110.804 -178.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.509 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 3.8 pm0 -84.29 -14.46 49.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.762 -0.654 . . . . 71.549999999999997 111.072 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.604 ' HE1' HG11 ' A' ' 46' ' ' VAL . 92.4 t80 -46.23 -70.08 0.11 Allowed 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.384 0.427 . . . . 65.209999999999994 110.726 -178.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -61.68 -39.85 92.9 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 121.128 0.489 . . . . 71.430000000000007 109.726 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.421 ' O ' ' HB2' ' A' ' 37' ' ' SER . 9.4 t-20 -56.35 -33.76 65.98 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.617 -1.174 . . . . 63.409999999999997 112.216 -171.421 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 18.7 ptmt -115.16 -21.85 9.76 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.711 0.263 . . . . 53.439999999999998 111.711 -177.68 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 93.6 t -88.5 -55.63 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 111.727 0.269 . . . . 61.520000000000003 111.727 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 30.8 p -85.87 -25.24 26.32 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.076 0.465 . . . . 74.430000000000007 110.796 -173.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 16.0 m -84.67 12.03 7.91 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.997 -0.547 . . . . 73.219999999999999 110.547 176.443 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 43.5 t -75.22 94.73 3.02 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.868 0.366 . . . . 60.130000000000003 110.548 178.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -91.88 1.31 57.26 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.138 -0.483 . . . . 70.230000000000004 110.563 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -72.22 -7.79 51.22 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.197 -0.456 . . . . 63.240000000000002 111.499 -176.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 64.39 15.82 9.77 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.18 -0.464 . . . . 71.209999999999994 111.397 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.9 tt -85.04 147.82 5.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 108.507 -0.923 . . . . 74.519999999999996 108.507 173.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.657 HD21 ' HE3' ' A' ' 101' ' ' MET . 61.2 tp -85.31 120.68 27.07 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.338 0.589 . . . . 74.319999999999993 110.682 -175.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 51.1 mt -106.98 126.02 63.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.379 -0.828 . . . . 75.349999999999994 110.392 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 45' ' ' LEU . 5.8 mp -108.81 110.13 21.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.317 -0.401 . . . . 41.200000000000003 110.067 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.604 HG11 ' HE1' ' A' ' 31' ' ' PHE . 59.3 t -96.96 111.26 26.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.812 -0.44 . . . . 71.439999999999998 109.812 176.332 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.424 ' OD1' ' NZ ' ' A' ' 78' ' ' LYS . 1.7 p30 -91.24 154.64 19.14 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.077 0.465 . . . . 64.5 110.62 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.7 t80 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 115.664 -0.698 . . . . 73.030000000000001 110.173 178.824 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo . . . . . 0 C--O 1.235 0.329 0 CA-C-O 120.763 0.235 . . . . 71.140000000000001 111.911 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.454 ' H ' ' CD ' ' A' ' 62' ' ' GLN . 13.9 mp0 -57.74 -48.45 79.58 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.599 0.714 . . . . 74.099999999999994 110.466 -175.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.63 HD21 HG12 ' A' ' 99' ' ' ILE . 8.1 mp -55.55 -49.08 73.61 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 114.586 -1.188 . . . . 74.219999999999999 111.627 -174.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -71.15 -36.45 72.06 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.224 -0.287 . . . . 74.409999999999997 110.224 -177.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.439 ' HA ' ' HD3' ' A' ' 65' ' ' LYS . 41.3 mmtt -55.58 -51.67 66.33 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.234 -0.439 . . . . 71.310000000000002 111.248 178.507 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.591 HD12 HD12 ' A' ' 123' ' ' ILE . 28.5 mt -76.38 -40.9 49.75 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 120.368 -0.533 . . . . 73.239999999999995 111.493 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.467 ' HB1' ' HB3' ' A' ' 22' ' ' MET . . . -59.68 -38.3 81.13 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 111.714 0.265 . . . . 61.5 111.714 -175.552 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -53.93 -33.07 55.71 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.751 0.31 . . . . 70.239999999999995 110.901 179.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 70.5 mm-40 -93.89 -41.09 9.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.031 -0.531 . . . . 65.549999999999997 111.17 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.494 ' O ' HG22 ' A' ' 74' ' ' VAL . 19.3 m-85 -107.42 17.46 22.75 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.957 0.725 . . . . 75.230000000000004 112.957 -168.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.0 t -53.95 -32.73 54.71 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.312 0.506 . . . . 74.329999999999998 112.188 -174.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -68.43 -16.69 64.0 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.804 0.335 . . . . 53.340000000000003 111.302 -178.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -114.47 -13.96 12.18 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.173 -0.467 . . . . 72.310000000000002 110.321 -178.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 70' ' ' TYR . 26.8 m -134.98 127.31 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 120.934 0.397 . . . . 55.140000000000001 110.688 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -118.42 122.83 43.75 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.57 -0.53 . . . . 63.310000000000002 109.57 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.476 HD13 ' HB3' ' A' ' 63' ' ' LEU . 60.7 mt -98.97 141.0 17.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.911 0.386 . . . . 74.420000000000002 110.913 -175.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.459 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 87.6 m-85 -133.63 157.93 44.52 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.076 -0.713 . . . . 72.200000000000003 109.076 175.488 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.424 ' NZ ' ' OD1' ' A' ' 47' ' ' ASP . 0.4 OUTLIER -141.33 148.82 40.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.872 0.367 . . . . 72.219999999999999 110.799 179.244 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.4 pp . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 115.525 -0.761 . . . . 72.5 110.423 -179.181 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.387 0 CA-C-O 120.815 0.34 . . . . 73.530000000000001 111.431 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.1 m -72.3 -28.16 62.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 71.010000000000005 110.931 -179.029 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -65.6 -40.78 93.03 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.97 -0.559 . . . . 72.230000000000004 110.092 -178.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -88.23 -17.17 31.37 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.564 -0.744 . . . . 74.030000000000001 110.363 175.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 63.43 50.56 61.38 Favored Glycine 0 C--N 1.333 0.412 0 N-CA-C 111.19 -0.764 . . . . 71.209999999999994 111.19 -175.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.7 p -56.25 115.18 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.242 0.544 . . . . 73.5 111.187 -176.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.9 m -96.96 -14.26 21.82 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.813 -0.631 . . . . 73.310000000000002 110.855 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.77 131.66 15.15 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.705 0.288 . . . . 73.129999999999995 111.208 -177.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.532 ' HB ' ' HA ' ' A' ' 97' ' ' PRO . 2.8 pp -96.11 161.7 26.29 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 116.038 -0.528 . . . . 72.430000000000007 110.123 175.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.532 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 3.3 Cg_exo -76.83 176.52 43.59 Favored 'Cis proline' 0 C--N 1.355 0.888 0 C-N-CA 124.389 -1.088 . . . . 65.310000000000002 112.314 -0.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 15.9 m -134.32 121.35 21.11 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.221 -0.445 . . . . 71.120000000000005 110.098 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.655 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 3.7 mp -117.07 125.8 74.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.331 -0.618 . . . . 53.43 109.331 179.099 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -106.92 128.9 54.72 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.794 0.331 . . . . 73.120000000000005 110.129 -177.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.756 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 65.9 mtp -100.74 113.26 25.99 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.117 -0.492 . . . . 74.109999999999999 110.772 -177.272 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -111.42 146.61 36.88 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.076 -0.511 . . . . 74.430000000000007 110.749 178.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.802 ' HB3' HD21 ' A' ' 108' ' ' LEU . 33.9 ttpt -160.06 130.89 5.68 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.889 -0.782 . . . . 63.310000000000002 108.889 177.059 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 31.5 t-20 55.11 31.61 16.63 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.681 0.753 . . . . 65.239999999999995 110.101 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 74.84 20.93 79.26 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.313 -0.858 . . . . 53.509999999999998 113.42 176.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -129.3 155.2 45.97 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.758 0.279 . . . . 51.240000000000002 110.663 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.53 120.14 32.69 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.765 0.317 . . . . 45.119999999999997 110.168 177.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.802 HD21 ' HB3' ' A' ' 103' ' ' LYS . 2.0 mm? -92.89 -51.87 4.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.332 -0.395 . . . . 72.549999999999997 110.323 -178.287 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.756 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 49.7 m -153.96 171.54 18.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.59 -0.732 . . . . 74.540000000000006 110.592 -175.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -146.16 124.89 12.57 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.992 -0.549 . . . . 75.319999999999993 110.546 176.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.655 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 52.5 t -82.55 107.12 14.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.697 -0.483 . . . . 64.25 109.697 176.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 64.5 mt -109.18 108.67 25.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.813 -0.44 . . . . 75.109999999999999 109.813 178.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.0 -122.9 7.74 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.18 -0.534 . . . . 74.409999999999997 111.783 -178.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.24 88.15 1.0 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.779 0.323 . . . . 71.329999999999998 110.27 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.479 ' O ' HG23 ' A' ' 119' ' ' ILE . 3.6 m-20 -126.7 86.58 2.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.274 -0.421 . . . . 62.439999999999998 110.282 -177.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.52 ' O ' HG13 ' A' ' 119' ' ' ILE . 7.7 tp -55.57 -44.76 77.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 116.242 -0.435 . . . . 73.120000000000005 111.807 -176.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.5 t -68.09 -26.48 65.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.07 0.462 . . . . 71.150000000000006 110.655 -175.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -79.71 -45.6 18.64 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 116.086 -0.506 . . . . 71.040000000000006 110.269 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.52 HG13 ' O ' ' A' ' 116' ' ' ILE . 2.1 pp -67.87 -40.27 83.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 115.853 -0.612 . . . . 71.219999999999999 111.088 -175.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.485 HG22 HD11 ' A' ' 66' ' ' LEU . 2.8 pp -61.79 -32.23 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 120.439 -0.505 . . . . 75.310000000000002 110.029 178.104 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.468 ' N ' HD12 ' A' ' 120' ' ' ILE . 27.9 t -70.29 -51.77 27.89 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.867 -0.606 . . . . 62.240000000000002 110.379 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.477 ' HG2' ' HA ' ' A' ' 119' ' ' ILE . 21.0 pt-20 -72.02 -34.33 68.75 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.186 0.439 . . . . 74.319999999999993 112.186 -175.14 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.591 HD12 HD12 ' A' ' 66' ' ' LEU . 66.8 mt -71.02 -47.97 58.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-O 120.661 0.267 . . . . 72.530000000000001 110.795 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -66.77 -20.12 65.89 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.948 0.404 . . . . 72.010000000000005 111.247 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -74.02 -6.13 45.57 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.458 -0.337 . . . . 60.229999999999997 111.172 174.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -113.93 -49.0 2.88 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.826 0.346 . . . . 73.109999999999999 110.648 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 33.6 pt -100.38 168.03 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.779 -0.646 . . . . 71.040000000000006 110.665 -177.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 . . . . . 0 C--O 1.251 1.161 0 CA-C-O 118.355 -0.831 . . . . 74.439999999999998 110.723 178.164 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.728 ' HG3' HG12 ' A' ' 23' ' ' ILE . 25.3 ptt? . . . . . 0 N--CA 1.463 0.208 0 CA-C-O 120.666 0.27 . . . . 73.25 110.655 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.728 HG12 ' HG3' ' A' ' 22' ' ' MET . 14.6 mm -113.78 108.82 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 N-CA-C 109.043 -0.725 . . . . 74.400000000000006 109.043 178.438 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.568 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 36.1 tt0 -122.73 131.98 54.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.733 0.301 . . . . 71.409999999999997 110.536 -172.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -90.22 128.89 36.5 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.641 -0.503 . . . . 65.140000000000001 109.641 178.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.449 HG21 ' HD3' ' A' ' 34' ' ' LYS . 47.5 pt -130.9 165.94 29.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-O 121.056 0.455 . . . . 64.230000000000004 111.492 -175.088 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -111.79 169.26 13.07 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.576 -0.738 . . . . 13.31 112.845 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -52.25 -38.85 59.35 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 122.824 0.45 . . . . 73.329999999999998 111.407 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.5 t -59.36 -21.88 60.5 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.821 -0.627 . . . . 64.120000000000005 112.251 -175.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.51 ' HA ' ' HB2' ' A' ' 33' ' ' ASN . 11.3 pt-20 -125.64 -3.34 7.24 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 111.679 0.251 . . . . 71.549999999999997 111.679 -175.472 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -51.61 -70.8 0.08 Allowed 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.192 0.308 . . . . 65.209999999999994 111.152 -177.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -58.8 -42.71 89.75 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.638 0.733 . . . . 71.430000000000007 109.429 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.51 ' HB2' ' HA ' ' A' ' 30' ' ' GLU . 1.5 m-80 -52.44 -38.25 58.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 113.829 -1.532 . . . . 63.409999999999997 112.795 -172.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.449 ' HD3' HG21 ' A' ' 26' ' ' ILE . 16.1 ptmt -111.31 -19.58 12.59 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.023 0.379 . . . . 53.439999999999998 112.023 -177.45 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.6 t -88.26 -55.32 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 111.928 0.344 . . . . 61.520000000000003 111.928 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 45.7 p -77.92 -38.3 45.89 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.171 0.51 . . . . 74.430000000000007 110.78 -173.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.7 m -79.89 9.29 5.47 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.854 -0.612 . . . . 73.219999999999999 111.511 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 53.2 t -75.44 111.38 10.66 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.798 0.332 . . . . 60.130000000000003 111.066 -178.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -116.69 15.1 15.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.026 -0.534 . . . . 70.230000000000004 110.317 178.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -68.96 -2.46 9.87 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.828 -0.624 . . . . 63.240000000000002 112.08 -177.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.454 ' O ' ' HE3' ' A' ' 103' ' ' LYS . 89.8 m-20 70.18 6.26 5.69 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 122.954 0.502 . . . . 71.209999999999994 111.071 -177.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.3 tt -89.09 157.08 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.331 -0.618 . . . . 74.519999999999996 109.331 178.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.503 HD21 ' HE2' ' A' ' 101' ' ' MET . 63.7 tp -96.26 118.23 32.41 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.155 -0.313 . . . . 74.319999999999993 110.155 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 101' ' ' MET . 48.8 mt -97.96 124.79 51.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.163 -0.471 . . . . 75.349999999999994 110.703 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.532 ' HB2' HG13 ' A' ' 76' ' ' ILE . 3.3 mp -115.7 105.77 13.12 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.654 -0.499 . . . . 41.200000000000003 109.654 178.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.548 HG12 ' HB2' ' A' ' 77' ' ' TYR . 30.9 m -97.01 121.69 47.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 CA-C-N 116.625 -0.261 . . . . 71.439999999999998 110.32 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.432 ' OD1' ' HG2' ' A' ' 78' ' ' LYS . 5.8 p-10 -104.63 125.42 50.73 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.391 0.615 . . . . 64.5 109.823 176.525 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.414 -0.812 . . . . 73.030000000000001 111.497 -176.735 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo . . . . . 0 CA--C 1.534 0.502 0 CA-C-O 121.15 0.396 . . . . 71.140000000000001 112.952 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.688 ' HB3' HG12 ' A' ' 119' ' ' ILE . 11.5 mp0 -51.18 -49.03 61.74 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 115.316 -0.857 . . . . 74.099999999999994 111.65 -173.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.559 ' H ' HD22 ' A' ' 63' ' ' LEU . 2.5 mm? -64.25 -46.13 85.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.852 -1.067 . . . . 74.219999999999999 110.124 -172.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.588 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 55.0 mt-10 -68.0 -32.51 72.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.747 -0.66 . . . . 74.409999999999997 110.449 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -58.41 -56.66 19.23 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.342 -0.39 . . . . 71.310000000000002 110.634 176.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.595 HD12 HD12 ' A' ' 123' ' ' ILE . 22.5 mt -69.13 -30.11 68.29 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 120.825 -0.35 . . . . 73.239999999999995 110.861 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.21 -36.35 70.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.419 -0.355 . . . . 61.5 111.278 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.588 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 84.2 mt-30 -56.25 -32.98 65.0 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.286 -0.415 . . . . 70.239999999999995 111.006 -178.232 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -94.01 -56.59 2.81 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.322 0.582 . . . . 65.549999999999997 110.826 178.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.521 ' O ' HG22 ' A' ' 74' ' ' VAL . 22.2 m-85 -82.52 21.69 0.94 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.645 -0.707 . . . . 75.230000000000004 112.336 -173.215 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.461 ' OG1' ' HB3' ' A' ' 22' ' ' MET . 8.8 t -52.46 -31.26 33.92 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.976 0.417 . . . . 74.329999999999998 111.698 -176.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -70.13 -18.96 63.25 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.103 -0.498 . . . . 53.340000000000003 111.542 -175.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.41 6.24 8.35 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.732 0.301 . . . . 72.310000000000002 110.815 -173.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 70' ' ' TYR . 23.1 m -137.46 145.07 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 121.117 0.484 . . . . 55.140000000000001 111.583 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.5 mmtt -129.14 114.86 16.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.528 -0.76 . . . . 63.310000000000002 108.959 174.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.532 HG13 ' HB2' ' A' ' 45' ' ' LEU . 2.3 mp -100.5 138.43 24.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.559 -0.534 . . . . 74.420000000000002 109.559 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.568 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 41.2 m-85 -130.55 134.26 46.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.247 -0.433 . . . . 72.200000000000003 110.885 -177.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.432 ' HG2' ' OD1' ' A' ' 47' ' ' ASP . 55.9 mttm -109.19 111.86 23.7 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.257 -0.646 . . . . 72.219999999999999 109.257 174.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 32.0 pt . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 115.958 -0.564 . . . . 72.5 111.25 -175.882 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.554 0 CA-C-O 120.915 0.388 . . . . 73.530000000000001 111.001 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 88.5 m -65.76 -36.43 83.53 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.209 -0.45 . . . . 71.010000000000005 110.118 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -65.77 -37.34 86.05 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.159 -0.473 . . . . 72.230000000000004 110.228 177.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -70.72 -15.25 62.68 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.192 -0.458 . . . . 74.030000000000001 110.656 174.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.07 38.88 46.84 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.192 -0.528 . . . . 71.209999999999994 112.059 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.8 p -51.98 120.22 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 121.104 0.478 . . . . 73.5 111.168 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.4 m -124.37 6.57 8.37 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.782 -0.645 . . . . 73.310000000000002 110.609 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -156.38 126.77 6.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.09 -0.505 . . . . 73.129999999999995 110.606 -179.002 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.42 ' HB ' ' HA ' ' A' ' 97' ' ' PRO . 29.7 pt -101.69 156.14 35.55 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.986 -0.552 . . . . 72.430000000000007 109.755 177.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.42 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 84.5 Cg_endo -79.47 163.04 84.98 Favored 'Cis proline' 0 C--N 1.352 0.721 0 C-N-CA 123.822 -1.324 . . . . 65.310000000000002 112.709 1.11 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.484 HG23 HG12 ' A' ' 112' ' ' ILE . 30.6 m -128.19 115.62 18.65 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.733 -0.667 . . . . 71.120000000000005 109.36 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.623 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 3.4 mp -110.36 124.13 66.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.364 -0.38 . . . . 53.43 110.502 -176.269 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.4 mp -103.5 133.81 47.92 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.793 -0.447 . . . . 73.120000000000005 109.793 176.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.768 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 66.3 mtp -112.04 108.56 17.91 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.312 -0.404 . . . . 74.109999999999999 110.595 -175.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -108.76 154.83 21.49 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.162 -0.472 . . . . 74.430000000000007 111.272 -178.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.768 ' HB3' HD21 ' A' ' 108' ' ' LEU . 87.7 tttt -162.86 117.32 1.73 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.401 -0.962 . . . . 63.310000000000002 108.401 179.15 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 62.42 25.19 15.02 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.528 0.68 . . . . 65.239999999999995 110.416 -178.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.69 -0.44 89.19 Favored Glycine 0 C--N 1.331 0.291 0 CA-C-N 115.881 -0.599 . . . . 53.509999999999998 112.763 179.109 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -100.62 137.56 38.85 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.829 -0.434 . . . . 51.240000000000002 109.829 177.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.86 126.92 33.88 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.306 -0.627 . . . . 45.119999999999997 109.306 174.041 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.768 HD21 ' HB3' ' A' ' 103' ' ' LYS . 2.0 mm? -98.16 -51.09 4.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.224 -0.443 . . . . 72.549999999999997 110.108 -178.079 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.768 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 18.8 m -149.47 155.68 40.78 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.655 -0.702 . . . . 74.540000000000006 111.122 -171.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -131.04 118.85 21.16 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.802 -0.635 . . . . 75.319999999999993 109.835 175.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.623 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 50.4 t -89.78 107.09 17.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.707 -0.479 . . . . 64.25 109.707 176.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.484 HG12 HG23 ' A' ' 98' ' ' THR . 60.9 mt -112.72 117.33 55.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.613 -0.514 . . . . 75.109999999999999 109.613 179.163 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.75 -126.04 8.78 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 111.687 -0.565 . . . . 74.409999999999997 111.687 -178.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.52 91.46 1.16 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.711 0.291 . . . . 71.329999999999998 110.861 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.403 ' HB3' ' HB2' ' A' ' 118' ' ' LYS . 8.1 m-20 -132.54 99.74 4.75 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.1 0.476 . . . . 62.439999999999998 111.155 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.652 HD12 HD11 ' A' ' 119' ' ' ILE . 7.1 tp -62.97 -40.39 88.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 115.671 -0.695 . . . . 73.120000000000005 110.58 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 32.3 t -64.8 -32.04 73.55 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.132 0.491 . . . . 71.150000000000006 110.257 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.403 ' HB2' ' HB3' ' A' ' 115' ' ' ASP . 0.3 OUTLIER -72.99 -53.66 10.61 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 109.266 -0.642 . . . . 71.040000000000006 109.266 179.527 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.688 HG12 ' HB3' ' A' ' 62' ' ' GLN . 2.4 pp -62.07 -39.42 83.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 115.661 -0.7 . . . . 71.219999999999999 111.566 -173.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.448 HD12 ' N ' ' A' ' 121' ' ' SER . 2.8 pp -62.52 -31.52 52.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 120.087 -0.645 . . . . 75.310000000000002 110.208 178.349 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.448 ' N ' HD12 ' A' ' 120' ' ' ILE . 29.2 m -70.89 -51.43 26.29 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.194 -0.457 . . . . 62.240000000000002 110.806 178.529 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.488 ' OE2' ' HB3' ' A' ' 109' ' ' SER . 13.1 pt-20 -77.32 -41.91 38.82 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.603 0.594 . . . . 74.319999999999993 112.603 -173.564 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.595 HD12 HD12 ' A' ' 66' ' ' LEU . 74.2 mt -61.82 -55.14 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 O-C-N 122.144 -0.347 . . . . 72.530000000000001 110.611 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -59.26 -20.05 51.01 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.094 0.473 . . . . 72.010000000000005 110.816 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -79.08 -34.17 43.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.917 -0.583 . . . . 60.229999999999997 110.87 176.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -93.43 -20.87 19.9 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.372 -0.377 . . . . 73.109999999999999 111.611 -173.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.449 HG12 ' O ' ' A' ' 123' ' ' ILE . 48.5 pt -120.32 168.36 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 110.173 -0.306 . . . . 71.040000000000006 110.173 175.261 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 33.7 p-10 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.224 -0.893 . . . . 74.439999999999998 111.977 -176.698 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.611 ' HG3' ' HB1' ' A' ' 67' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.521 0 N-CA-C 109.176 -0.676 . . . . 73.25 109.176 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.441 HD13 ' HB ' ' A' ' 76' ' ' ILE . 8.6 mm -110.57 106.44 20.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 114.797 -1.092 . . . . 74.400000000000006 108.923 178.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.46 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 7.9 tp10 -121.1 141.4 50.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.888 0.375 . . . . 71.409999999999997 111.058 -178.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -95.58 124.15 39.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.886 -0.597 . . . . 65.140000000000001 109.535 177.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.556 HD12 ' HA ' ' A' ' 31' ' ' PHE . 27.0 pt -121.67 157.53 25.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 116.221 -0.445 . . . . 64.230000000000004 111.214 -175.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.25 170.15 37.05 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.875 -0.602 . . . . 13.31 112.107 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -66.2 -30.17 70.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.23 0.538 . . . . 73.329999999999998 110.449 -176.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.1 m -70.29 -48.76 55.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.575 -0.739 . . . . 64.120000000000005 111.156 -177.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -87.64 -13.55 42.4 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.45 -0.341 . . . . 71.549999999999997 111.274 -177.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.556 ' HA ' HD12 ' A' ' 26' ' ' ILE . 47.8 t80 -48.8 -70.15 0.1 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.873 0.368 . . . . 65.209999999999994 110.298 175.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -53.75 -43.26 68.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.946 -0.57 . . . . 71.430000000000007 109.663 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.557 ' O ' ' HB2' ' A' ' 37' ' ' SER . 33.8 t-20 -53.16 -50.11 65.24 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 114.734 -1.121 . . . . 63.409999999999997 111.762 -173.45 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.17 -17.08 17.56 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.195 0.443 . . . . 53.439999999999998 112.195 -173.228 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.5 t -88.29 -52.14 11.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 111.655 0.243 . . . . 61.520000000000003 111.655 -178.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.0 p -75.49 -45.27 39.38 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.545 0.688 . . . . 74.430000000000007 109.806 -177.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.557 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 19.9 m -77.06 12.78 1.27 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.47 -0.786 . . . . 73.219999999999999 111.107 176.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 36.1 t -28.93 101.17 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.184 0.993 . . . . 60.130000000000003 113.061 -178.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -89.62 -18.21 26.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.622 -0.717 . . . . 70.230000000000004 109.556 175.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.504 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . 2.8 m-20 -53.91 -40.33 66.57 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.685 -0.688 . . . . 63.240000000000002 110.833 -179.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 60.8 19.48 9.66 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.903 0.859 . . . . 71.209999999999994 109.636 -170.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.504 ' HB ' ' HB3' ' A' ' 40' ' ' ASP . 7.8 mt -101.02 154.24 4.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 114.086 -1.415 . . . . 74.519999999999996 108.613 175.207 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.617 HD11 ' HE3' ' A' ' 101' ' ' MET . 49.3 tp -70.15 104.9 2.74 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.505 -0.554 . . . . 74.319999999999993 109.505 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 48.1 mt -93.09 105.05 16.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.864 -0.607 . . . . 75.349999999999994 110.664 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.584 HD22 HD22 ' A' ' 63' ' ' LEU . 2.0 mp -100.28 102.98 14.38 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.434 -0.58 . . . . 41.200000000000003 109.434 178.191 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.51 HG22 ' HB2' ' A' ' 77' ' ' TYR . 33.2 t -99.66 123.74 52.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.422 -0.584 . . . . 71.439999999999998 109.422 178.422 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.407 ' CB ' HG12 ' A' ' 99' ' ' ILE . 6.1 p-10 -108.75 131.6 54.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.529 0.681 . . . . 64.5 110.959 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 115.091 -0.959 . . . . 73.030000000000001 109.312 -179.614 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo . . . . . 0 N--CA 1.464 -0.254 0 N-CA-C 110.923 -0.453 . . . . 71.140000000000001 110.923 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.444 ' HB3' HG12 ' A' ' 119' ' ' ILE . 7.3 mp0 -50.84 -57.46 8.4 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 121.165 0.507 . . . . 74.099999999999994 111.493 -172.291 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.819 HD11 HD13 ' A' ' 99' ' ' ILE . 21.7 mt -57.71 -48.84 78.45 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.461 -0.79 . . . . 74.219999999999999 111.437 -172.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.576 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 51.0 mt-10 -71.71 -32.49 67.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.961 -0.563 . . . . 74.409999999999997 110.244 -177.348 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -61.17 -46.23 91.35 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.974 -0.557 . . . . 71.310000000000002 110.051 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.452 HD12 HD12 ' A' ' 123' ' ' ILE . 37.6 mt -74.56 -37.22 63.03 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.447 -0.342 . . . . 73.239999999999995 110.919 175.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.611 ' HB1' ' HG3' ' A' ' 22' ' ' MET . . . -58.14 -31.11 66.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 61.5 111.603 -177.347 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.576 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 77.9 mt-30 -54.56 -33.26 59.86 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.862 0.363 . . . . 70.239999999999995 110.712 177.299 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -94.36 -42.25 8.99 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.051 -0.522 . . . . 65.549999999999997 111.592 177.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.533 ' O ' HG22 ' A' ' 74' ' ' VAL . 11.5 m-85 -103.41 22.34 14.39 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.461 0.541 . . . . 75.230000000000004 112.461 -168.068 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.449 ' OG1' ' HB3' ' A' ' 22' ' ' MET . 5.3 t -52.28 -35.04 49.14 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.412 0.523 . . . . 74.329999999999998 112.412 -172.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -71.35 -16.11 62.42 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.212 0.449 . . . . 53.340000000000003 112.212 -175.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.441 ' O ' HG23 ' A' ' 42' ' ' ILE . 0.2 OUTLIER -125.77 11.5 7.83 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.587 0.232 . . . . 72.310000000000002 111.218 -176.743 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 70' ' ' TYR . 34.1 m -136.76 137.43 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 O-C-N 121.733 -0.604 . . . . 55.140000000000001 111.275 176.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 28.1 mmtp -119.98 115.26 23.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.538 -0.755 . . . . 63.310000000000002 109.511 177.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.494 ' N ' HD12 ' A' ' 76' ' ' ILE . 2.9 mp -105.27 122.79 58.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 108.869 -0.789 . . . . 74.420000000000002 108.869 177.274 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.51 ' HB2' HG22 ' A' ' 46' ' ' VAL . 39.5 m-85 -119.37 132.32 55.83 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.229 0.538 . . . . 72.200000000000003 111.667 -174.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -91.19 110.22 21.49 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.711 -1.132 . . . . 72.219999999999999 108.696 173.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.402 HD13 ' HB2' ' A' ' 31' ' ' PHE . 6.6 tp . . . . . 0 C--N 1.323 -0.579 0 CA-C-O 120.845 0.355 . . . . 72.5 110.999 -177.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.156 0 CA-C-O 121.092 0.473 . . . . 73.530000000000001 110.242 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.5 m -64.19 -33.6 76.16 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.818 -0.628 . . . . 71.010000000000005 110.387 179.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -63.04 -46.95 85.13 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.823 -0.626 . . . . 72.230000000000004 110.306 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 22.4 m-30 -83.01 5.24 22.85 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.062 -0.517 . . . . 74.030000000000001 111.324 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 65.0 34.72 90.63 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 121.31 -0.471 . . . . 71.209999999999994 112.8 175.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.448 HG11 ' OG1' ' A' ' 98' ' ' THR . 64.7 t -61.71 98.9 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.978 0.418 . . . . 73.5 110.068 177.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.3 m -100.49 8.75 43.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.898 -0.592 . . . . 73.310000000000002 111.553 -174.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -147.6 164.82 32.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.601 0.238 . . . . 73.129999999999995 110.631 -178.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.405 HD12 ' O ' ' A' ' 96' ' ' ILE . 2.4 pp -129.93 156.89 78.37 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.225 -0.443 . . . . 72.430000000000007 110.596 -178.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.17 169.35 74.45 Favored 'Cis proline' 0 C--N 1.354 0.827 0 C-N-CA 123.784 -1.34 . . . . 65.310000000000002 112.213 -0.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.448 ' OG1' HG11 ' A' ' 93' ' ' VAL . 15.0 m -112.15 124.5 52.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.108 -0.496 . . . . 71.120000000000005 110.502 -179.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.85 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 36.0 mt -126.62 135.75 62.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.341 -0.614 . . . . 53.43 109.341 178.468 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.19 133.77 52.64 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.964 -0.384 . . . . 73.120000000000005 109.964 -178.381 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.788 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 50.1 mtp -106.1 117.93 35.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.896 -0.593 . . . . 74.109999999999999 110.776 -176.106 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -118.34 155.72 30.16 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 122.646 0.378 . . . . 74.430000000000007 110.677 178.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.596 ' HB3' HD21 ' A' ' 108' ' ' LEU . 38.1 ttpt -166.31 123.04 1.32 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.844 -0.616 . . . . 63.310000000000002 109.774 176.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 46.2 t30 58.04 25.02 11.82 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.771 0.795 . . . . 65.239999999999995 110.812 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.85 -2.34 79.64 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 115.991 -0.549 . . . . 53.509999999999998 113.381 175.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 54.0 tttm -102.77 145.07 30.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.908 0.354 . . . . 51.240000000000002 110.135 177.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -82.19 139.22 34.43 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.804 -0.813 . . . . 45.119999999999997 108.804 171.501 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.596 HD21 ' HB3' ' A' ' 103' ' ' LYS . 2.7 mm? -107.14 -53.26 2.64 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.885 0.374 . . . . 72.549999999999997 110.231 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.788 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 54.5 m -153.72 164.46 38.27 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 116.019 -0.537 . . . . 74.540000000000006 111.086 -175.573 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -129.48 106.44 8.76 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.715 -0.675 . . . . 75.319999999999993 109.298 177.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.85 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 77.0 t -84.04 107.28 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.463 -0.569 . . . . 64.25 109.463 -179.304 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 62.5 mt -120.15 108.76 23.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.858 -0.61 . . . . 75.109999999999999 110.19 -176.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 108.67 -117.33 4.97 Favored Glycine 0 CA--C 1.518 0.265 0 N-CA-C 111.831 -0.508 . . . . 74.409999999999997 111.831 -178.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.41 57.22 0.5 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.392 0.615 . . . . 71.329999999999998 110.032 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.73 81.8 5.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.464 -0.789 . . . . 62.439999999999998 110.399 -178.473 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.537 HD12 HD11 ' A' ' 119' ' ' ILE . 6.3 tp -61.89 -42.58 95.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 115.847 -0.615 . . . . 73.120000000000005 110.928 -177.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 45.4 t -62.67 -31.59 72.51 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.036 0.446 . . . . 71.150000000000006 110.633 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -74.05 -52.2 13.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.971 -0.559 . . . . 71.040000000000006 110.225 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.537 HD11 HD12 ' A' ' 116' ' ' ILE . 2.3 pp -63.84 -39.3 84.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.159 -0.473 . . . . 71.219999999999999 111.552 -173.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.487 HD12 ' N ' ' A' ' 121' ' ' SER . 2.9 pp -64.81 -33.86 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 C-N-CA 120.303 -0.559 . . . . 75.310000000000002 109.946 178.281 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.487 ' N ' HD12 ' A' ' 120' ' ' ILE . 23.1 t -70.42 -47.62 59.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.933 -0.576 . . . . 62.240000000000002 110.584 -178.412 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.502 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 13.0 pt-20 -77.2 -43.06 35.09 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.676 -0.238 . . . . 74.319999999999993 111.48 -175.181 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.452 HD12 HD12 ' A' ' 66' ' ' LEU . 82.4 mt -64.11 -51.59 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 117.657 0.208 . . . . 72.530000000000001 111.143 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -58.65 -24.07 60.41 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.065 0.459 . . . . 72.010000000000005 110.609 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -91.94 -21.25 20.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.943 -0.571 . . . . 60.229999999999997 110.963 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.502 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 3.7 t-20 -85.81 -36.78 19.85 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.086 -0.506 . . . . 73.109999999999999 111.152 -175.182 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ILE . . . . . 0.411 HG12 ' O ' ' A' ' 123' ' ' ILE . 47.2 pt -107.93 168.77 3.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 115.759 -0.655 . . . . 71.040000000000006 110.032 178.547 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.2 p30 . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.409 -0.805 . . . . 74.439999999999998 110.638 -173.533 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.765 ' HG3' ' HB1' ' A' ' 67' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.524 0 CA-C-O 120.587 0.232 . . . . 73.25 111.362 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.527 HD11 ' HG2' ' A' ' 64' ' ' GLU . 22.9 mm -104.65 126.15 59.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.972 -0.558 . . . . 74.400000000000006 109.536 178.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 9.7 tp10 -129.23 137.29 51.01 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.025 -0.361 . . . . 71.409999999999997 110.025 178.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -105.81 114.62 28.88 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.614 -0.514 . . . . 65.140000000000001 109.614 176.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.528 HD12 ' HA ' ' A' ' 31' ' ' PHE . 28.2 pt -114.45 154.22 15.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.044 -0.526 . . . . 64.230000000000004 111.476 -172.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.56 178.22 45.66 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.455 -0.793 . . . . 13.31 112.115 176.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -63.25 -36.47 83.76 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.18 0.514 . . . . 73.329999999999998 111.213 -176.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.7 m -69.61 -42.67 74.05 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.756 -0.656 . . . . 64.120000000000005 111.525 -173.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -85.38 -12.31 52.42 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.562 -0.29 . . . . 71.549999999999997 111.692 -176.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.528 ' HA ' HD12 ' A' ' 26' ' ' ILE . 90.1 t80 -47.36 -69.9 0.11 Allowed 'General case' 0 N--CA 1.462 0.173 0 O-C-N 123.425 0.453 . . . . 65.209999999999994 110.263 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -55.63 -43.78 76.5 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 116.46 -0.336 . . . . 71.430000000000007 110.78 177.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.414 ' O ' ' HB2' ' A' ' 37' ' ' SER . 0.2 OUTLIER -52.22 -44.39 64.76 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.113 -0.949 . . . . 63.409999999999997 111.399 -170.557 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.514 ' HD3' HG21 ' A' ' 26' ' ' ILE . 0.2 OUTLIER -110.94 -21.71 11.88 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.326 0.491 . . . . 53.439999999999998 112.326 -175.963 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 89.5 t -88.21 -49.57 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 111.509 0.189 . . . . 61.520000000000003 111.509 -179.003 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 79.9 p -87.81 -6.53 58.09 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 120.387 -0.525 . . . . 74.430000000000007 110.642 -175.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 50.2 m -104.91 12.15 32.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.825 -0.625 . . . . 73.219999999999999 110.313 174.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 50.3 t -60.55 90.25 0.02 OUTLIER 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.22 0.534 . . . . 60.130000000000003 111.452 -176.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -94.05 6.44 48.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.545 -0.752 . . . . 70.230000000000004 109.226 175.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -74.26 -20.85 60.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.282 -0.872 . . . . 63.240000000000002 111.056 -175.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.6 m120 69.39 15.04 8.45 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.864 -0.607 . . . . 71.209999999999994 111.078 -176.163 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 37.7 mt -93.64 141.15 15.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.733 -0.667 . . . . 74.519999999999996 109.549 174.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.478 HD11 ' HB3' ' A' ' 101' ' ' MET . 64.6 tp -75.18 114.04 13.22 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.318 -0.401 . . . . 74.319999999999993 110.312 -178.154 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.495 HG23 ' CD2' ' A' ' 77' ' ' TYR . 44.0 mt -97.53 116.47 40.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.941 -0.572 . . . . 75.349999999999994 110.317 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.472 HD22 HD22 ' A' ' 63' ' ' LEU . 3.3 mp -107.13 102.88 12.17 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.808 -0.442 . . . . 41.200000000000003 109.808 179.253 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.5 HG22 ' HB2' ' A' ' 77' ' ' TYR . 58.0 t -95.84 112.16 27.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.282 -0.417 . . . . 71.439999999999998 109.946 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -98.5 125.69 43.79 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.55 0.691 . . . . 64.5 110.385 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.424 ' HE1' ' HB2' ' A' ' 100' ' ' LEU . 70.2 m-85 . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 115.063 -0.971 . . . . 73.030000000000001 109.826 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo . . . . . 0 CA--C 1.531 0.344 0 N-CA-C 111.528 -0.22 . . . . 71.140000000000001 111.528 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.72 ' HB3' HG12 ' A' ' 119' ' ' ILE . 4.3 mp0 -50.98 -57.68 7.96 Favored 'General case' 0 C--O 1.252 1.197 0 CA-C-O 121.737 0.779 . . . . 74.099999999999994 111.312 -175.147 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.521 HD11 HD13 ' A' ' 99' ' ' ILE . 46.3 mt -54.54 -48.77 71.59 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 114.588 -1.187 . . . . 74.219999999999999 110.909 -174.183 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.625 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 50.1 mt-10 -75.0 -32.56 61.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.981 -0.554 . . . . 74.409999999999997 110.68 -176.115 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -56.24 -46.55 79.54 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.333 -0.394 . . . . 71.310000000000002 110.056 176.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.537 HD12 HD12 ' A' ' 123' ' ' ILE . 12.9 mt -82.6 -33.63 27.92 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.098 -0.501 . . . . 73.239999999999995 111.116 178.626 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.765 ' HB1' ' HG3' ' A' ' 22' ' ' MET . . . -59.74 -39.01 83.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.074 -0.512 . . . . 61.5 111.888 -175.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.625 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 77.7 mt-30 -56.78 -31.12 64.32 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.133 0.492 . . . . 70.239999999999995 110.515 -179.012 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -93.66 -51.47 4.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.367 -0.833 . . . . 65.549999999999997 111.003 -174.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.443 ' O ' HG22 ' A' ' 74' ' ' VAL . 7.2 m-85 -104.37 23.18 13.58 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.716 -0.675 . . . . 75.230000000000004 111.583 -168.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.475 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 8.7 t -52.65 -27.1 15.77 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 111.977 0.362 . . . . 74.329999999999998 111.977 -177.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -60.87 -27.6 68.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.875 0.369 . . . . 53.340000000000003 111.232 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -121.48 0.32 9.94 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.047 -0.524 . . . . 72.310000000000002 110.68 -174.16 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 70' ' ' TYR . 21.4 m -133.05 146.13 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 121.034 0.445 . . . . 55.140000000000001 110.883 176.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.706 ' HA ' ' HE3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -141.86 129.57 21.6 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.204 -0.665 . . . . 63.310000000000002 109.204 177.224 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.507 ' HB ' HD13 ' A' ' 23' ' ' ILE . 2.6 mp -106.04 138.18 32.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 120.653 0.263 . . . . 74.420000000000002 110.397 -177.391 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.5 ' HB2' HG22 ' A' ' 46' ' ' VAL . 84.4 m-85 -134.25 137.86 44.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 72.200000000000003 110.923 -175.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 41.8 mttp -112.19 122.31 47.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.544 -0.753 . . . . 72.219999999999999 109.211 173.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.6 tp . . . . . 0 C--N 1.325 -0.472 0 CA-C-N 116.012 -0.54 . . . . 72.5 111.457 -173.312 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.296 0 CA-C-O 121.1 0.476 . . . . 73.530000000000001 110.158 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.6 m -68.7 -31.98 71.45 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.809 -0.632 . . . . 71.010000000000005 110.511 177.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -59.25 -49.88 76.15 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.208 -0.451 . . . . 72.230000000000004 110.239 177.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -72.05 -17.33 62.02 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.24 -0.436 . . . . 74.030000000000001 110.565 176.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.54 48.88 5.7 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 121.189 -0.529 . . . . 71.209999999999994 112.538 177.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 88.2 t -68.56 104.83 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.892 0.377 . . . . 73.5 110.27 176.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.8 p -73.53 -40.91 63.65 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.938 -0.574 . . . . 73.310000000000002 111.341 -178.085 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -150.86 164.9 35.18 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.565 -0.289 . . . . 73.129999999999995 111.171 -178.151 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.564 ' HB ' ' HA ' ' A' ' 97' ' ' PRO . 2.7 pp -97.56 164.16 18.16 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 116.126 -0.488 . . . . 72.430000000000007 110.448 178.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.564 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 91.0 Cg_endo -78.09 165.5 83.0 Favored 'Cis proline' 0 C--N 1.355 0.91 0 C-N-CA 124.264 -1.14 . . . . 65.310000000000002 112.537 -0.38 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 13.0 m -129.65 122.44 29.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.051 -0.522 . . . . 71.120000000000005 110.298 -178.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.811 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 45.0 mt -115.4 108.19 24.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.345 -0.613 . . . . 53.43 109.345 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.503 ' HG ' ' HG3' ' A' ' 110' ' ' GLN . 2.4 tt -99.34 124.34 44.36 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.933 -0.395 . . . . 73.120000000000005 109.933 -176.11 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.753 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 65.0 mtp -93.45 112.01 23.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.927 -0.579 . . . . 74.109999999999999 111.155 -177.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -107.24 147.14 30.56 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.007 0.523 . . . . 74.430000000000007 110.446 175.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.731 ' HB3' HD21 ' A' ' 108' ' ' LEU . 28.7 ttpp -169.81 133.63 1.26 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.294 -0.632 . . . . 63.310000000000002 109.294 173.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.3 t30 61.43 24.82 14.87 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.266 0.555 . . . . 65.239999999999995 110.498 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 76.98 10.97 85.98 Favored Glycine 0 CA--C 1.522 0.5 0 CA-C-N 115.982 -0.554 . . . . 53.509999999999998 112.959 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -125.15 152.4 44.51 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.488 -0.56 . . . . 51.240000000000002 109.488 179.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.71 142.9 29.53 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.447 -0.575 . . . . 45.119999999999997 109.447 177.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.731 HD21 ' HB3' ' A' ' 103' ' ' LYS . 2.4 mm? -106.32 -53.22 2.66 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.271 -0.27 . . . . 72.549999999999997 110.271 178.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.753 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 66.4 m -153.82 165.83 34.81 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 116.182 -0.463 . . . . 74.540000000000006 111.101 -178.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLN . . . . . 0.503 ' HG3' ' HG ' ' A' ' 100' ' ' LEU . 1.6 mp0 -128.44 102.44 6.64 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.533 -0.758 . . . . 75.319999999999993 109.443 177.562 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.811 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 50.6 t -80.35 107.04 12.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.517 -0.549 . . . . 64.25 109.517 177.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 52.5 mt -109.59 128.57 65.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.632 -0.507 . . . . 75.109999999999999 109.632 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.77 -123.09 6.36 Favored Glycine 0 N--CA 1.452 -0.269 0 N-CA-C 111.504 -0.639 . . . . 74.409999999999997 111.504 -176.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.52 101.94 1.87 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.955 0.377 . . . . 71.329999999999998 110.74 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -136.58 102.29 4.88 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 120.956 0.407 . . . . 62.439999999999998 110.861 179.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.587 HD12 HD11 ' A' ' 119' ' ' ILE . 7.9 tp -61.91 -38.39 80.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 115.895 -0.593 . . . . 73.120000000000005 110.383 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 37.7 t -61.57 -41.69 97.76 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.342 0.591 . . . . 71.150000000000006 110.316 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.447 ' O ' ' HG2' ' A' ' 122' ' ' GLU . 16.7 tppt? -63.92 -56.35 15.86 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.393 -0.821 . . . . 71.040000000000006 109.908 -179.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.72 HG12 ' HB3' ' A' ' 62' ' ' GLN . 2.2 pp -61.81 -43.33 97.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 115.455 -0.793 . . . . 71.219999999999999 111.979 -173.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.498 HD12 ' N ' ' A' ' 121' ' ' SER . 2.8 pp -63.0 -33.33 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 120.392 -0.523 . . . . 75.310000000000002 110.209 -178.466 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.498 ' N ' HD12 ' A' ' 120' ' ' ILE . 42.5 t -70.84 -52.3 21.22 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.07 -0.514 . . . . 62.240000000000002 110.997 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 118' ' ' LYS . 3.8 pt-20 -77.8 -37.67 48.26 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.391 0.886 . . . . 74.319999999999993 113.391 -175.145 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ILE . . . . . 0.537 HD12 HD12 ' A' ' 66' ' ' LEU . 65.7 mt -61.39 -56.99 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 O-C-N 121.949 -0.469 . . . . 72.530000000000001 110.281 177.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -63.5 -20.46 65.62 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.845 -0.616 . . . . 72.010000000000005 111.174 -178.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -65.77 -35.24 80.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.052 -0.522 . . . . 60.229999999999997 110.452 175.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.409 ' HB3' ' HE2' ' A' ' 103' ' ' LYS . 48.7 m-80 -95.59 -39.59 9.86 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.083 -0.508 . . . . 73.109999999999999 111.732 -175.313 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 38.9 pt -85.53 168.0 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.589 -0.278 . . . . 71.040000000000006 110.656 -178.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.9 p30 . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.258 -0.877 . . . . 74.439999999999998 110.95 -175.696 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 N--CA 1.483 1.208 0 N-CA-C 111.62 0.23 . . . . 51.399999999999999 111.62 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.55 84.63 0.18 Allowed 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.981 0.42 . . . . 74.329999999999998 111.632 -176.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 47.1 p-80 -113.47 121.9 45.67 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.08 -0.711 . . . . 73.010000000000005 109.08 173.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -165.76 96.6 0.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.085 0.469 . . . . 75.420000000000002 110.663 -175.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 66.5 t60 -148.38 110.22 4.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 74.219999999999999 110.219 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 31.6 m80 -87.31 -173.24 4.3 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.627 -0.508 . . . . 71.200000000000003 109.627 177.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 18.0 p-80 -151.64 99.27 2.58 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.174 0.512 . . . . 65.209999999999994 110.919 176.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 35.7 p80 -98.12 29.51 3.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.802 -0.635 . . . . 71.340000000000003 109.898 177.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 63.6 mtt -59.63 -29.7 68.2 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.578 -0.737 . . . . 61.329999999999998 110.919 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.57 -162.24 32.78 Favored Glycine 0 C--N 1.332 0.306 0 N-CA-C 111.66 -0.576 . . . . 54.420000000000002 111.66 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.1 t -123.73 157.44 33.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.666 0.269 . . . . 62.43 110.361 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.713 ' HB3' ' HA ' ' A' ' 52' ' ' TRP . 61.7 tp -158.2 115.01 2.85 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.413 -0.588 . . . . 75.129999999999995 109.413 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -107.71 147.91 30.13 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.121 -0.491 . . . . 62.409999999999997 110.782 -177.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -153.75 47.62 0.64 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.828 -0.624 . . . . 64.340000000000003 110.019 178.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 15' ' ' GLN . 8.5 pt20 -65.0 86.16 0.05 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.418 0.628 . . . . 71.200000000000003 110.718 -179.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 t -67.62 -32.64 73.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.623 -0.717 . . . . 74.340000000000003 110.317 178.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -135.96 146.41 47.24 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 109.105 -0.702 . . . . 73.129999999999995 109.105 178.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -152.62 -80.62 0.03 OUTLIER Glycine 0 C--O 1.236 0.258 0 C-N-CA 120.859 -0.686 . . . . 72.219999999999999 112.4 -177.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -62.13 100.05 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.891 2.394 . . . . 73.219999999999999 112.203 -175.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 125.33 -19.32 6.77 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.883 -0.599 . . . . 71.450000000000003 112.582 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 73.4 p -87.0 -73.87 0.45 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.008 0.432 . . . . 64.019999999999996 111.182 -177.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.617 ' HG3' HG13 ' A' ' 23' ' ' ILE . 22.1 ptp -173.37 -30.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.86 -0.609 . . . . 73.25 110.379 -175.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.617 HG13 ' HG3' ' A' ' 22' ' ' MET . 60.8 mt -104.97 99.65 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 115.982 -0.553 . . . . 74.400000000000006 110.226 177.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.556 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 10.6 tp10 -101.22 155.23 18.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.83 -0.623 . . . . 71.409999999999997 109.699 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -106.69 134.7 49.44 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.025 -0.361 . . . . 65.140000000000001 110.025 176.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.523 HD12 ' HA ' ' A' ' 31' ' ' PHE . 32.1 pt -129.19 157.01 42.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-O 120.971 0.415 . . . . 64.230000000000004 111.134 -175.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -106.81 -171.45 22.63 Favored Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.93 -0.577 . . . . 13.31 112.284 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -67.92 -50.34 56.62 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.27 0.47 . . . . 73.329999999999998 112.27 -176.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.5 p -73.34 -11.95 60.66 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.425 0.528 . . . . 64.120000000000005 112.425 -171.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -117.09 -6.71 11.37 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 116.668 -0.242 . . . . 71.549999999999997 111.069 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.523 ' HA ' HD12 ' A' ' 26' ' ' ILE . 93.4 t80 -51.77 -70.58 0.08 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.293 -0.412 . . . . 65.209999999999994 110.327 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -62.43 -35.18 78.46 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.136 0.493 . . . . 71.430000000000007 109.771 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -51.88 -47.6 64.46 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.104 -0.953 . . . . 63.409999999999997 111.565 -176.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.52 -18.32 15.35 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.981 0.363 . . . . 53.439999999999998 111.981 -177.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.1 t -88.39 -59.74 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 111.947 0.351 . . . . 61.520000000000003 111.947 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 34.3 p -78.05 -33.08 51.12 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.818 0.342 . . . . 74.430000000000007 111.168 -172.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.9 m -84.57 11.84 8.08 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.253 -0.431 . . . . 73.219999999999999 111.351 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.518 ' SG ' HG22 ' A' ' 42' ' ' ILE . 44.9 t -75.76 103.07 5.68 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 120.863 0.363 . . . . 60.130000000000003 110.339 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -103.15 12.3 35.93 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.137 0.494 . . . . 70.230000000000004 110.327 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -81.7 1.65 33.34 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.082 -0.508 . . . . 63.240000000000002 111.256 -178.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 59.22 13.42 3.03 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.495 0.554 . . . . 71.209999999999994 112.495 -178.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.518 HG22 ' SG ' ' A' ' 38' ' ' CYS . 10.5 tt -78.85 153.09 4.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.182 -0.673 . . . . 74.519999999999996 109.182 176.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.785 HD21 ' HE3' ' A' ' 101' ' ' MET . 57.2 tp -93.4 111.55 23.23 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.281 0.562 . . . . 74.319999999999993 110.425 -177.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 101' ' ' MET . 71.6 mt -96.39 129.46 46.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.496 -0.774 . . . . 75.349999999999994 110.429 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 5.3 mp -117.72 103.83 10.4 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.923 -0.399 . . . . 41.200000000000003 109.923 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.557 HG12 ' HB2' ' A' ' 77' ' ' TYR . 29.6 m -93.78 127.88 45.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 110.242 -0.281 . . . . 71.439999999999998 110.242 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.488 ' O ' HG22 ' A' ' 79' ' ' ILE . 2.0 p-10 -125.07 153.24 43.22 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.925 0.393 . . . . 64.5 110.779 -177.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -77.81 -80.49 0.11 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.006 -0.543 . . . . 73.030000000000001 111.51 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -133.36 178.15 7.13 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.948 0.404 . . . . 72.239999999999995 111.392 -175.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.737 ' HB1' ' HB3' ' A' ' 53' ' ' CYS . . . -113.83 113.89 47.03 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.594 -0.73 . . . . 53.439999999999998 110.035 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.543 ' HG3' ' HD3' ' A' ' 97' ' ' PRO . 71.2 Cg_endo -72.24 82.91 1.28 Allowed 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.75 2.3 . . . . 74.340000000000003 112.025 -177.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.713 ' HA ' ' HB3' ' A' ' 12' ' ' LEU . 79.4 m95 60.76 22.94 12.88 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.931 -0.577 . . . . 74.150000000000006 110.877 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.737 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 52.6 t -81.99 66.6 7.64 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.735 -0.666 . . . . 72.239999999999995 110.106 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -120.69 156.18 16.11 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.459 -0.791 . . . . 63.140000000000001 111.657 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -65.4 -5.45 11.39 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.877 2.384 . . . . 62.109999999999999 112.734 -176.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 63.8 m -116.21 22.85 12.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.528 -0.305 . . . . 70.010000000000005 110.752 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.461 ' HG3' ' HE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER -152.9 -60.4 0.14 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.744 -0.465 . . . . 74.519999999999996 109.744 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' A' ' 53' ' ' CYS . 48.2 t -172.68 75.11 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.917 0.389 . . . . 52.329999999999998 110.634 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 52.3 tp -82.47 85.56 6.91 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.274 -0.639 . . . . 73.329999999999998 109.274 175.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -156.38 66.21 4.17 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 115.95 -0.568 . . . . 73.140000000000001 110.814 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.469 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 61.5 Cg_endo -92.12 155.66 3.22 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.698 2.265 . . . . 71.140000000000001 112.186 174.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.474 ' H ' ' CD ' ' A' ' 62' ' ' GLN . 13.8 mp0 -62.32 -33.71 75.21 Favored 'General case' 0 C--O 1.248 1.01 0 CA-C-O 122.105 0.955 . . . . 74.099999999999994 109.598 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.418 ' H ' HD22 ' A' ' 63' ' ' LEU . 3.3 mm? -56.98 -48.6 78.02 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-N 113.906 -1.497 . . . . 74.219999999999999 110.952 -174.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.469 ' HG3' ' HG2' ' A' ' 61' ' ' PRO . 45.2 mt-10 -59.31 -51.64 69.05 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.051 0.453 . . . . 74.409999999999997 109.886 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -51.28 -50.87 58.44 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.184 -0.916 . . . . 71.310000000000002 111.633 -176.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.613 HD12 HD12 ' A' ' 123' ' ' ILE . 13.2 mt -80.25 -39.22 29.4 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.024 -0.67 . . . . 73.239999999999995 112.346 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.56 -38.54 90.45 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.654 0.264 . . . . 61.5 111.31 -176.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -54.6 -30.46 54.73 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.788 0.328 . . . . 70.239999999999995 111.177 178.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -90.45 -48.51 7.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.311 0.577 . . . . 65.549999999999997 110.837 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.522 ' O ' HG22 ' A' ' 74' ' ' VAL . 16.9 m-85 -98.31 23.18 8.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.547 -0.751 . . . . 75.230000000000004 112.118 -170.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.4 t -52.37 -42.01 63.58 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 112.234 0.457 . . . . 74.329999999999998 112.234 -172.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -72.99 -16.85 61.5 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.032 -0.418 . . . . 53.340000000000003 111.382 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.31 -8.04 16.5 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.536 -0.302 . . . . 72.310000000000002 111.225 -176.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.522 HG22 ' O ' ' A' ' 70' ' ' TYR . 28.3 m -133.73 151.17 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 O-C-N 121.923 -0.485 . . . . 55.140000000000001 111.032 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 42.5 mmtm -140.58 116.17 10.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.011 -0.54 . . . . 63.310000000000002 109.941 175.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.514 ' N ' HD12 ' A' ' 76' ' ' ILE . 2.7 mp -92.85 130.22 42.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.253 -0.647 . . . . 74.420000000000002 109.253 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.557 ' HB2' HG12 ' A' ' 46' ' ' VAL . 22.2 m-85 -124.46 128.81 49.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.745 0.307 . . . . 72.200000000000003 111.049 -178.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.534 ' HZ2' ' HA ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -77.96 114.07 16.47 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.273 -0.64 . . . . 72.219999999999999 109.273 174.918 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.586 HD11 ' HG3' ' A' ' 85' ' ' GLN . 10.6 tt -77.28 101.99 3.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.028 0.442 . . . . 72.5 110.058 177.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -64.4 -33.8 76.69 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.153 -0.476 . . . . 55.210000000000001 111.155 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.439 HG12 ' O ' ' A' ' 81' ' ' ILE . 10.9 tt -83.36 57.25 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 122.234 1.016 . . . . 61.140000000000001 110.015 178.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.65 -19.96 30.15 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.158 -0.928 . . . . 71.239999999999995 110.616 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -75.0 -19.91 59.88 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.377 -0.829 . . . . 64.430000000000007 111.493 -176.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -149.69 74.53 1.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.807 -0.357 . . . . 73.349999999999994 111.452 -174.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.586 ' HG3' HD11 ' A' ' 79' ' ' ILE . 21.7 mm-40 -144.7 111.27 5.68 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.861 -0.422 . . . . 74.209999999999994 109.861 172.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -79.1 9.17 4.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.599 -0.273 . . . . 61.450000000000003 111.412 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.3 t -55.95 -37.69 49.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.358 0.599 . . . . 75.030000000000001 109.532 174.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.21 -35.11 80.06 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.723 -0.671 . . . . 73.530000000000001 110.311 176.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.6 m -69.6 -32.95 71.98 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.907 -0.588 . . . . 71.010000000000005 109.756 176.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -63.17 -46.15 88.48 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.839 -0.619 . . . . 72.230000000000004 109.616 176.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.459 ' OH ' ' HE2' ' A' ' 107' ' ' LYS . 31.1 m-85 -77.11 -17.08 58.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.716 -0.675 . . . . 74.030000000000001 110.955 175.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 62.94 37.77 95.48 Favored Glycine 0 C--N 1.331 0.279 0 CA-C-N 116.203 -0.453 . . . . 71.209999999999994 112.197 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.7 p -86.23 144.73 8.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.889 0.376 . . . . 73.5 111.16 -175.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 31.9 t -136.58 84.66 2.09 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.868 -0.79 . . . . 73.310000000000002 108.868 173.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -163.85 161.6 23.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.659 -0.7 . . . . 73.129999999999995 109.975 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.471 ' HA ' ' HA ' ' A' ' 97' ' ' PRO . 0.0 OUTLIER -129.64 113.41 17.85 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 109.333 -0.617 . . . . 72.430000000000007 109.333 178.58 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.543 ' HD3' ' HG3' ' A' ' 51' ' ' PRO . 35.0 Cg_endo -98.6 -155.09 0.27 Allowed 'Cis proline' 0 C--N 1.348 0.544 0 C-N-CA 124.359 -1.101 . . . . 65.310000000000002 112.146 -2.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 37.7 m -145.26 139.52 27.18 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 109.256 -0.646 . . . . 71.120000000000005 109.256 174.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.722 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 3.6 mp -122.96 132.94 70.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 109.442 -0.577 . . . . 53.43 109.442 -178.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 7.9 mp -110.82 146.48 36.36 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.497 0.189 . . . . 73.120000000000005 110.602 178.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.785 ' HE3' HD21 ' A' ' 43' ' ' LEU . 59.0 mtp -115.82 118.5 33.19 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.995 -0.548 . . . . 74.109999999999999 111.256 -176.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -118.9 150.72 39.4 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.934 -0.575 . . . . 74.430000000000007 110.683 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.799 ' HB3' HD21 ' A' ' 108' ' ' LEU . 13.8 ttmm -165.58 125.67 1.8 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.75 -0.659 . . . . 63.310000000000002 109.474 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 53.3 t30 63.34 27.1 15.27 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.514 0.673 . . . . 65.239999999999995 110.329 175.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 75.31 13.84 82.46 Favored Glycine 0 C--N 1.333 0.379 0 CA-C-N 115.683 -0.69 . . . . 53.509999999999998 111.991 -178.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -113.01 156.67 22.64 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 122.83 0.452 . . . . 51.240000000000002 110.232 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.459 ' HE2' ' OH ' ' A' ' 91' ' ' TYR . 14.7 ptmm? -101.22 125.39 47.84 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.287 -0.634 . . . . 45.119999999999997 109.287 176.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.799 HD21 ' HB3' ' A' ' 103' ' ' LYS . 2.1 mm? -104.87 -53.2 2.72 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 111.909 0.337 . . . . 72.549999999999997 111.909 -173.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.709 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 50.4 m -162.97 172.14 15.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.192 -0.458 . . . . 74.540000000000006 110.247 -172.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.59 127.14 13.26 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.016 0.436 . . . . 75.319999999999993 110.797 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.722 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 84.4 t -81.57 107.36 13.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 115.97 -0.559 . . . . 64.25 109.924 178.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.537 ' H ' ' HE3' ' A' ' 118' ' ' LYS . 65.6 mt -107.95 115.19 48.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 116.029 -0.532 . . . . 75.109999999999999 110.131 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.07 -135.57 13.19 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 116.097 -0.502 . . . . 74.409999999999997 112.108 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -145.39 77.05 1.5 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.182 0.515 . . . . 71.329999999999998 110.767 -178.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.54 ' O ' HG23 ' A' ' 119' ' ' ILE . 1.7 m-20 -124.21 91.11 3.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.789 -0.642 . . . . 62.439999999999998 109.895 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.448 ' O ' HG13 ' A' ' 119' ' ' ILE . 6.8 tp -54.45 -41.34 53.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 120.798 0.332 . . . . 73.120000000000005 111.187 -176.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 43.8 t -59.32 -34.8 72.78 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.17 0.51 . . . . 71.150000000000006 111.07 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.537 ' HE3' ' H ' ' A' ' 112' ' ' ILE . 2.4 tmtm? -79.38 -44.14 22.08 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.92 -0.582 . . . . 71.040000000000006 110.715 -178.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.581 HG22 HG13 ' A' ' 111' ' ' VAL . 1.5 pp -66.41 -38.53 81.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 71.219999999999999 110.862 -175.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.435 HD12 ' N ' ' A' ' 121' ' ' SER . 2.7 pp -67.39 -31.81 54.51 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.078 0 C-N-CA 120.569 -0.452 . . . . 75.310000000000002 109.788 177.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.435 ' N ' HD12 ' A' ' 120' ' ' ILE . 34.7 t -67.48 -47.04 71.21 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.928 -0.578 . . . . 62.240000000000002 110.152 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.428 ' OE1' ' HB3' ' A' ' 109' ' ' SER . 15.0 pt-20 -76.74 -42.31 41.67 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.27 -0.423 . . . . 74.319999999999993 111.765 -177.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.613 HD12 HD12 ' A' ' 66' ' ' LEU . 68.3 mt -66.3 -52.23 49.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 O-C-N 122.335 -0.228 . . . . 72.530000000000001 111.046 -178.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -62.64 -20.28 64.64 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.927 0.394 . . . . 72.010000000000005 111.035 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -68.58 -34.14 75.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.075 -0.512 . . . . 60.229999999999997 110.423 176.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -103.9 -8.14 19.92 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.474 0.546 . . . . 73.109999999999999 112.474 -172.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 43.0 pt -139.11 167.85 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 120.796 0.332 . . . . 71.040000000000006 110.647 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.371 -0.823 . . . . 74.439999999999998 111.122 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.417 ' C ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 120.776 0.322 . . . . 51.399999999999999 110.615 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -168.39 97.11 0.41 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.833 -0.622 . . . . 74.329999999999998 109.544 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -151.09 101.28 2.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.357 -0.383 . . . . 73.010000000000005 110.19 -177.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -140.9 161.72 37.15 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 110.161 -0.311 . . . . 75.420000000000002 110.161 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.459 ' HB2' ' HA ' ' A' ' 90' ' ' GLN . 69.1 m80 -113.45 178.33 4.32 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.618 -0.512 . . . . 74.219999999999999 109.618 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 29.1 m80 -75.0 -78.29 0.11 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.33 -0.248 . . . . 71.200000000000003 110.33 -177.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.415 ' HB2' ' OD2' ' A' ' 86' ' ' ASP . 3.1 p80 178.22 -172.76 0.13 Allowed 'General case' 0 C--O 1.233 0.201 0 N-CA-C 109.537 -0.542 . . . . 65.209999999999994 109.537 -177.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.659 ' HD2' ' HG2' ' A' ' 9' ' ' MET . 4.9 t60 -124.51 -72.63 0.67 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.461 -0.57 . . . . 71.340000000000003 109.461 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.659 ' HG2' ' HD2' ' A' ' 8' ' ' HIS . 21.4 ptp 176.16 143.36 0.07 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 122.861 0.464 . . . . 61.329999999999998 110.34 176.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.54 80.9 0.32 Allowed Glycine 0 C--N 1.329 0.19 0 N-CA-C 110.359 -1.096 . . . . 54.420000000000002 110.359 173.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 19.8 p -80.53 2.13 26.67 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.51 0.93 . . . . 62.43 113.51 -167.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.411 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 30.6 tp 63.32 23.73 13.92 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.244 0.545 . . . . 75.129999999999995 111.022 175.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -86.47 49.33 1.78 Allowed 'General case' 0 C--N 1.329 -0.306 0 O-C-N 122.111 -0.368 . . . . 62.409999999999997 111.266 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -173.55 139.37 0.73 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.99 -0.55 . . . . 64.340000000000003 110.183 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -160.36 115.07 2.23 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.076 -0.713 . . . . 71.200000000000003 109.076 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 86.6 m -153.53 115.7 4.35 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.231 0.538 . . . . 74.340000000000003 111.761 -174.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.427 ' OE1' ' NZ ' ' A' ' 34' ' ' LYS . 4.8 tp60 -129.77 116.15 18.33 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.582 -0.736 . . . . 73.129999999999995 109.477 174.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 158.82 70.65 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 111.401 -0.68 . . . . 72.219999999999999 111.401 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.545 ' HA ' ' HG2' ' A' ' 24' ' ' GLU . 71.7 Cg_endo -72.82 162.39 41.25 Favored 'Trans proline' 0 C--O 1.237 0.434 0 C-N-CA 122.577 2.185 . . . . 73.219999999999999 112.563 -177.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -176.31 -35.63 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.9 -0.591 . . . . 71.450000000000003 111.695 178.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.0 m -95.99 158.65 15.35 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 122.458 0.303 . . . . 64.019999999999996 110.307 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -71.89 -28.62 63.63 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.729 -0.471 . . . . 73.25 109.729 176.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.409 HD13 ' HB ' ' A' ' 76' ' ' ILE . 10.3 mm -107.55 89.66 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 108.142 -1.059 . . . . 74.400000000000006 108.142 171.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.633 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 9.3 tp10 -108.78 155.46 20.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.566 -0.288 . . . . 71.409999999999997 110.483 -174.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.419 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 29.7 pt20 -105.29 147.65 27.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.919 0.39 . . . . 65.140000000000001 110.481 176.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.415 HD12 ' HA ' ' A' ' 31' ' ' PHE . 30.5 pt -129.56 -178.93 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.979 -0.555 . . . . 64.230000000000004 109.97 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.31 175.34 18.92 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.841 -0.695 . . . . 13.31 113.514 -175.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -67.76 -34.68 77.29 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.626 0.77 . . . . 73.329999999999998 110.949 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.2 t -79.88 -39.21 31.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 64.120000000000005 111.285 -171.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -95.12 0.25 54.07 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.998 -0.546 . . . . 71.549999999999997 111.304 -175.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.423 ' HE1' HG11 ' A' ' 46' ' ' VAL . 66.1 t80 -47.84 -71.19 0.07 Allowed 'General case' 0 CA--C 1.53 0.189 0 O-C-N 123.418 0.448 . . . . 65.209999999999994 111.186 -177.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -65.86 -32.88 74.65 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.375 -0.602 . . . . 71.430000000000007 109.375 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.486 ' O ' ' HB2' ' A' ' 37' ' ' SER . 64.5 t30 -51.85 -39.17 58.44 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 114.762 -1.108 . . . . 63.409999999999997 111.333 -175.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.427 ' NZ ' ' OE1' ' A' ' 17' ' ' GLN . 10.9 ptmt -109.76 -25.8 10.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 53.439999999999998 112.122 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.5 t -80.11 -53.23 13.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 111.721 0.267 . . . . 61.520000000000003 111.721 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.0 p -83.75 -36.2 23.81 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.342 0.591 . . . . 74.430000000000007 110.067 -175.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.486 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 39.0 m -83.89 12.73 5.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.478 -0.783 . . . . 73.219999999999999 111.134 178.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 40.1 t -53.63 91.92 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.133 0.492 . . . . 60.130000000000003 110.979 176.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -80.84 -7.23 59.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.771 -0.65 . . . . 70.230000000000004 110.962 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -73.5 -16.54 61.28 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.247 -0.433 . . . . 63.240000000000002 110.643 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 65.89 21.69 11.4 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.744 -0.662 . . . . 71.209999999999994 111.443 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.571 HD13 ' HG2' ' A' ' 75' ' ' LYS . 17.6 tt -94.96 151.71 3.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.113 -0.699 . . . . 74.519999999999996 109.113 175.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.678 HD21 ' HE3' ' A' ' 101' ' ' MET . 64.8 tp -79.71 111.76 16.32 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.976 0.417 . . . . 74.319999999999993 110.474 -176.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 49.4 mt -91.31 122.91 43.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.615 -0.72 . . . . 75.349999999999994 110.498 177.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.587 HD13 HD12 ' A' ' 63' ' ' LEU . 58.8 mt -103.8 102.04 11.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.628 -0.715 . . . . 41.200000000000003 109.475 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 74.2 t -86.66 120.2 35.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.209 -0.451 . . . . 71.439999999999998 110.844 -177.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.506 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 13.7 t70 -95.24 154.91 16.96 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.925 0.393 . . . . 64.5 110.695 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -71.18 -63.64 1.07 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.762 -0.654 . . . . 73.030000000000001 112.301 -174.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 27.7 t90 -163.72 52.84 0.16 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.04 0.448 . . . . 72.239999999999995 110.916 -171.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . . . 69.2 120.77 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 115.696 -0.683 . . . . 53.439999999999998 111.822 175.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.46 ' HG2' ' HG3' ' A' ' 61' ' ' PRO . 19.2 Cg_exo -68.14 69.37 0.93 Allowed 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.867 2.378 . . . . 74.340000000000003 112.152 175.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.453 ' HB2' ' HB3' ' A' ' 58' ' ' SER . 16.1 m95 62.29 103.23 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.672 0.789 . . . . 74.150000000000006 111.792 177.254 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 19.8 p -75.56 139.37 42.07 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.956 -0.565 . . . . 72.239999999999995 110.761 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 159.75 177.09 32.53 Favored Glycine 0 N--CA 1.452 -0.269 0 N-CA-C 111.699 -0.56 . . . . 63.140000000000001 111.699 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.03 75.08 0.68 Allowed 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 122.842 2.361 . . . . 62.109999999999999 112.432 -177.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.666 ' HA ' ' HB3' ' A' ' 59' ' ' LEU . 85.5 m 52.45 18.98 1.04 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.806 -0.634 . . . . 70.010000000000005 112.254 177.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.1 tpp180 -60.18 -68.73 0.27 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.793 0.33 . . . . 74.519999999999996 110.895 -176.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.453 ' HB3' ' HB2' ' A' ' 52' ' ' TRP . 27.7 t -105.29 7.49 33.46 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.546 -0.539 . . . . 52.329999999999998 109.546 176.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.666 ' HB3' ' HA ' ' A' ' 56' ' ' CYS . 32.4 tp -78.32 76.53 4.83 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.395 0.617 . . . . 73.329999999999998 110.041 -178.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -165.86 53.07 0.28 Allowed Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 114.858 -1.065 . . . . 73.140000000000001 108.305 177.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.46 ' HG3' ' HG2' ' A' ' 51' ' ' PRO . 87.3 Cg_endo -76.76 172.07 16.87 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.437 2.091 . . . . 71.140000000000001 112.571 -172.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.563 ' NE2' ' HA ' ' A' ' 114' ' ' ALA . 12.1 mp0 -52.15 -38.62 58.18 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.468 -0.787 . . . . 74.099999999999994 110.179 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.587 HD12 HD13 ' A' ' 45' ' ' LEU . 2.7 mm? -60.36 -48.7 80.62 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.672 -1.149 . . . . 74.219999999999999 110.326 -173.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -74.16 -36.54 64.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.179 -0.464 . . . . 74.409999999999997 109.997 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -52.33 -45.95 65.83 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.752 -0.658 . . . . 71.310000000000002 109.822 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.719 HD12 HD12 ' A' ' 123' ' ' ILE . 25.7 mt -84.78 -38.82 19.15 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 111.741 0.275 . . . . 73.239999999999995 111.741 177.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.541 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -55.98 -37.34 68.95 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.572 0.225 . . . . 61.5 111.464 -176.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -50.61 -32.35 18.62 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.948 0.404 . . . . 70.239999999999995 110.898 178.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -94.44 -59.02 2.04 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.833 -0.622 . . . . 65.549999999999997 111.27 175.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.544 ' O ' HG22 ' A' ' 74' ' ' VAL . 17.1 m-85 -91.1 21.03 4.51 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.156 0.798 . . . . 75.230000000000004 113.156 -168.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.541 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 11.2 t -54.52 -26.82 34.06 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.174 0.512 . . . . 74.329999999999998 110.976 -178.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -62.72 -20.13 64.6 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.752 -0.658 . . . . 53.340000000000003 112.239 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -131.93 7.78 4.39 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 111.661 0.245 . . . . 72.310000000000002 111.661 -175.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.544 HG22 ' O ' ' A' ' 70' ' ' TYR . 34.4 m -137.04 140.34 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 120.958 0.409 . . . . 55.140000000000001 110.992 177.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.571 ' HG2' HD13 ' A' ' 42' ' ' ILE . 33.6 mmtp -129.85 123.15 30.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.776 -0.647 . . . . 63.310000000000002 109.312 176.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.543 HG13 ' HB2' ' A' ' 45' ' ' LEU . 2.8 mp -98.99 132.48 44.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.694 -0.484 . . . . 74.420000000000002 109.694 -178.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.633 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 52.2 m-85 -134.52 129.34 34.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.076 -0.511 . . . . 72.200000000000003 109.786 -178.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.506 ' HB3' ' HB3' ' A' ' 47' ' ' ASP . 57.1 pttt -125.4 170.55 11.26 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.037 -0.357 . . . . 72.219999999999999 110.037 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.491 ' HB ' HG13 ' A' ' 81' ' ' ILE . 50.7 mt -137.36 152.85 27.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.485 -0.561 . . . . 72.5 109.485 176.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -77.51 69.75 3.8 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.105 -0.702 . . . . 55.210000000000001 109.105 170.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.491 HG13 ' HB ' ' A' ' 79' ' ' ILE . 69.9 mt -76.67 109.43 10.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.246 -0.888 . . . . 61.140000000000001 110.813 -177.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -82.79 -72.47 0.45 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.086 -0.709 . . . . 71.239999999999995 109.086 175.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -125.4 -6.75 7.0 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.009 -0.541 . . . . 64.430000000000007 110.795 172.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.406 ' HA ' ' O ' ' A' ' 9' ' ' MET . 15.6 p-10 -81.16 67.66 7.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.304 0.573 . . . . 73.349999999999994 111.881 -173.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.545 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 4.8 pp0? -144.87 122.96 12.11 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.668 -0.696 . . . . 74.209999999999994 109.568 171.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.415 ' OD2' ' HB2' ' A' ' 7' ' ' HIS . 59.1 m-20 -90.62 -22.85 21.01 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.853 0.359 . . . . 61.450000000000003 110.414 173.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 82.5 t -62.62 -55.7 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 115.652 -0.703 . . . . 75.030000000000001 112.795 -169.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.01 -44.42 92.65 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.968 0.413 . . . . 73.530000000000001 110.589 -174.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 45.2 m -62.3 -42.52 99.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.754 -0.657 . . . . 71.010000000000005 110.661 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.459 ' HA ' ' HB2' ' A' ' 5' ' ' HIS . 32.8 tt0 -65.1 -49.86 68.34 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.187 -0.46 . . . . 72.230000000000004 110.972 -176.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -74.0 -17.31 61.01 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.5 -0.318 . . . . 74.030000000000001 110.92 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.97 49.27 10.01 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.174 -0.536 . . . . 71.209999999999994 112.139 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 46.5 t -90.77 143.03 12.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 110.218 -0.289 . . . . 73.5 110.218 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.9 p -117.04 -58.48 2.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.299 -0.41 . . . . 73.310000000000002 110.996 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.59 108.35 2.41 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.105 -0.498 . . . . 73.129999999999995 111.479 -178.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.489 ' HB ' ' HA ' ' A' ' 97' ' ' PRO . 2.9 pp -107.42 158.38 33.34 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 116.11 -0.496 . . . . 72.430000000000007 109.876 176.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.489 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 61.3 Cg_endo -70.23 153.96 94.36 Favored 'Cis proline' 0 C--N 1.355 0.912 0 C-N-CA 124.039 -1.234 . . . . 65.310000000000002 113.03 2.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 28.7 m -120.17 135.3 55.02 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.381 -0.827 . . . . 71.120000000000005 109.799 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.607 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 3.8 mp -118.24 138.04 50.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.764 -0.458 . . . . 53.43 109.764 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.499 HD23 ' H ' ' A' ' 101' ' ' MET . 1.1 tt -121.79 137.23 54.85 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.115 -0.698 . . . . 73.120000000000005 109.115 176.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.769 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 61.4 mtp -101.62 118.47 37.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.065 -0.516 . . . . 74.109999999999999 110.879 -173.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -121.21 147.32 45.77 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.574 -0.284 . . . . 74.430000000000007 110.607 178.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.598 ' HB3' HD21 ' A' ' 108' ' ' LEU . 39.7 ttpt -159.16 116.09 2.69 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.099 -0.5 . . . . 63.310000000000002 110.137 176.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 61.8 t30 48.64 54.75 10.09 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.73 -0.668 . . . . 65.239999999999995 111.309 177.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 80.82 -12.76 33.89 Favored Glycine 0 CA--C 1.519 0.328 0 CA-C-N 115.671 -0.695 . . . . 53.509999999999998 113.901 175.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -100.98 131.83 46.67 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 117.357 0.579 . . . . 51.240000000000002 110.735 -177.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -91.26 112.58 24.55 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.0 -0.741 . . . . 45.119999999999997 109.0 173.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.598 HD21 ' HB3' ' A' ' 103' ' ' LYS . 2.3 mm? -80.95 -53.37 6.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.126 -0.488 . . . . 72.549999999999997 111.26 -170.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.769 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 56.1 m -161.15 171.72 18.01 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.857 -0.61 . . . . 74.540000000000006 110.343 -172.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -141.82 126.65 18.15 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 120.579 0.228 . . . . 75.319999999999993 110.704 -177.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.607 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 59.6 t -91.19 125.53 43.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 123.025 0.53 . . . . 64.25 110.633 178.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 62.0 mt -126.58 106.82 16.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.468 -0.333 . . . . 75.109999999999999 110.113 176.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 99.91 -143.34 16.37 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 121.082 -0.58 . . . . 74.409999999999997 112.388 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.563 ' HA ' ' NE2' ' A' ' 62' ' ' GLN . . . -126.49 56.85 1.44 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.251 0.548 . . . . 71.329999999999998 111.03 -176.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.505 ' O ' HG23 ' A' ' 119' ' ' ILE . 4.4 m-20 -93.38 71.15 4.39 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.022 -0.535 . . . . 62.439999999999998 110.147 179.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.586 ' O ' HG13 ' A' ' 119' ' ' ILE . 6.3 tp -54.57 -44.66 69.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 121.065 0.459 . . . . 73.120000000000005 111.432 -177.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.4 p -63.86 -28.89 70.16 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-O 121.212 0.529 . . . . 71.150000000000006 111.378 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.439 ' HB3' ' HB3' ' A' ' 115' ' ' ASP . 14.5 tmtt? -80.03 -45.03 19.08 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 116.062 -0.517 . . . . 71.040000000000006 110.84 177.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.586 HG13 ' O ' ' A' ' 116' ' ' ILE . 2.0 pp -64.6 -38.09 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.47 -0.332 . . . . 71.219999999999999 111.01 -175.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.566 HG22 HD21 ' A' ' 66' ' ' LEU . 2.9 pp -60.5 -31.72 49.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-O 121.195 0.521 . . . . 75.310000000000002 110.051 176.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.43 ' N ' HD12 ' A' ' 120' ' ' ILE . 23.6 m -70.47 -51.68 27.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.977 -0.556 . . . . 62.240000000000002 110.734 177.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.561 ' HG2' ' HA ' ' A' ' 119' ' ' ILE . 15.6 pt-20 -72.38 -42.04 65.67 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.387 0.514 . . . . 74.319999999999993 112.387 -173.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.719 HD12 HD12 ' A' ' 66' ' ' LEU . 70.6 mt -64.07 -59.05 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 O-C-N 122.113 -0.367 . . . . 72.530000000000001 110.498 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -58.91 -20.75 54.66 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.046 -0.525 . . . . 72.010000000000005 110.943 -178.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -70.63 -39.14 73.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.811 -0.632 . . . . 60.229999999999997 110.885 176.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -103.61 -2.26 26.92 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.355 0.502 . . . . 73.109999999999999 112.355 -173.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 123' ' ' ILE . 29.6 pt -109.01 167.92 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 110.018 -0.364 . . . . 71.040000000000006 110.018 171.15 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 31.7 p-10 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.582 -0.723 . . . . 74.439999999999998 111.036 -175.787 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 110.207 -0.294 . . . . 51.399999999999999 110.207 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.49 101.76 0.2 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.308 -0.406 . . . . 74.329999999999998 110.788 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -86.15 134.17 33.82 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.277 -0.419 . . . . 73.010000000000005 110.249 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.421 ' O ' ' HG3' ' A' ' 90' ' ' GLN . 56.7 p-80 -122.33 119.26 30.58 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.671 -0.492 . . . . 75.420000000000002 109.671 174.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.8 p80 -128.02 123.65 35.21 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.145 -0.48 . . . . 74.219999999999999 109.74 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 52.1 t60 -173.16 137.17 0.67 Allowed 'General case' 0 C--N 1.329 -0.289 0 O-C-N 123.403 0.439 . . . . 71.200000000000003 110.363 -173.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.635 ' HA ' ' HB2' ' A' ' 86' ' ' ASP . 34.1 p-80 -164.35 118.1 1.4 Allowed 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.692 -0.484 . . . . 65.209999999999994 109.692 173.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.0 p-80 -76.17 157.97 32.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.106 -0.497 . . . . 71.340000000000003 110.495 -178.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 21.3 mmt -102.18 128.33 48.73 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.829 -0.804 . . . . 61.329999999999998 108.829 174.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.38 -136.62 2.46 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.964 -0.636 . . . . 54.420000000000002 111.687 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.2 m -151.61 65.84 0.87 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.625 0.726 . . . . 62.43 109.781 177.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -107.05 175.4 5.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.308 -0.86 . . . . 75.129999999999995 110.474 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -151.72 105.15 3.1 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.672 -0.695 . . . . 62.409999999999997 109.159 175.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -116.47 88.72 2.95 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.092 0.473 . . . . 64.340000000000003 110.659 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -86.06 133.25 33.91 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.997 -0.742 . . . . 71.200000000000003 108.997 173.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.1 t -127.08 174.57 8.78 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.824 0.345 . . . . 74.340000000000003 111.269 -175.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -160.9 103.29 1.31 Allowed 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.797 -0.638 . . . . 73.129999999999995 110.135 -177.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 178.85 70.81 0.06 OUTLIER Glycine 0 CA--C 1.519 0.325 0 N-CA-C 111.193 -0.763 . . . . 72.219999999999999 111.193 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -56.31 153.83 32.08 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.313 2.675 . . . . 73.219999999999999 112.938 -173.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 -66.27 2.72 Favored Glycine 0 C--O 1.239 0.419 0 N-CA-C 110.57 -1.012 . . . . 71.450000000000003 110.57 -174.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.6 m 62.0 154.47 0.04 OUTLIER 'General case' 0 C--O 1.237 0.418 0 CA-C-O 122.083 0.944 . . . . 64.019999999999996 113.455 170.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.625 ' HG2' HG12 ' A' ' 23' ' ' ILE . 1.4 pmm? -143.02 -50.64 0.35 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.908 -1.042 . . . . 73.25 108.437 170.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.625 HG12 ' HG2' ' A' ' 22' ' ' MET . 22.8 mm -121.18 84.07 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 108.06 -1.089 . . . . 74.400000000000006 108.06 173.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -86.25 154.74 21.06 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.102 0.477 . . . . 71.409999999999997 111.177 -172.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.441 ' HA ' ' HG2' ' A' ' 78' ' ' LYS . 8.6 pt20 -101.44 126.42 48.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.862 -0.608 . . . . 65.140000000000001 110.696 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.515 HD12 ' HA ' ' A' ' 31' ' ' PHE . 35.1 pt -131.86 174.62 12.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 120.736 0.303 . . . . 64.230000000000004 110.259 175.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.419 ' H ' ' HG2' ' A' ' 30' ' ' GLU . . . -121.11 -166.8 13.09 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 116.016 -0.538 . . . . 13.31 112.486 -179.019 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.79 -50.3 57.7 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 122.893 0.477 . . . . 73.329999999999998 112.023 -176.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 39.7 m -76.67 -31.44 57.29 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 120.901 0.381 . . . . 64.120000000000005 111.928 -169.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.477 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 2.1 pm0 -89.93 -15.29 32.37 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.967 -0.56 . . . . 71.549999999999997 110.882 -178.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.515 ' HA ' HD12 ' A' ' 26' ' ' ILE . 46.3 t80 -48.77 -70.86 0.08 Allowed 'General case' 0 C--O 1.226 -0.159 0 O-C-N 123.399 0.437 . . . . 65.209999999999994 110.285 178.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -56.45 -43.3 79.39 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-O 121.146 0.498 . . . . 71.430000000000007 109.748 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.631 ' O ' ' HB3' ' A' ' 37' ' ' SER . 23.1 t-20 -52.3 -41.28 62.79 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 114.209 -1.36 . . . . 63.409999999999997 112.449 -171.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -112.96 -20.15 11.66 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.257 0.466 . . . . 53.439999999999998 112.257 -176.802 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 77.6 t -81.05 -48.97 18.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 O-C-N 122.331 -0.231 . . . . 61.520000000000003 111.233 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.8 p -88.2 -35.83 17.13 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.218 0.532 . . . . 74.430000000000007 110.242 -177.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.631 ' HB3' ' O ' ' A' ' 33' ' ' ASN . 33.9 t -84.67 12.38 7.27 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.875 -0.602 . . . . 73.219999999999999 110.904 178.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 40' ' ' ASP . 43.6 t -53.71 103.24 0.07 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.955 0.407 . . . . 60.130000000000003 111.369 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -82.23 -8.9 59.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.871 -0.604 . . . . 70.230000000000004 110.372 176.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.448 ' HB2' ' SG ' ' A' ' 38' ' ' CYS . 21.2 m-20 -63.69 -30.76 71.82 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.219 -0.446 . . . . 63.240000000000002 110.561 -179.049 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 71.52 12.9 6.48 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.509 -0.768 . . . . 71.209999999999994 110.99 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.5 tt -88.62 161.57 2.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 109.223 -0.658 . . . . 74.519999999999996 109.223 177.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.436 HD12 HG23 ' A' ' 127' ' ' ILE . 26.9 mt -78.93 109.24 13.03 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.06 0.457 . . . . 74.319999999999993 110.662 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.619 HG23 ' CD2' ' A' ' 77' ' ' TYR . 45.2 mt -94.27 107.61 19.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.649 -0.705 . . . . 75.349999999999994 110.163 175.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.571 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 6.4 mp -97.2 107.18 19.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.934 -0.575 . . . . 41.200000000000003 109.583 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.404 HG12 ' HB2' ' A' ' 77' ' ' TYR . 28.5 m -94.97 129.92 44.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 110.091 -0.337 . . . . 71.439999999999998 110.091 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -104.29 139.78 38.81 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.11 0.481 . . . . 64.5 110.208 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.475 ' HE2' HD13 ' A' ' 100' ' ' LEU . 40.8 m-85 -93.22 67.75 4.19 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.842 -0.617 . . . . 73.030000000000001 110.066 176.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 92.0 m95 71.59 87.64 0.11 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.398 -1.274 . . . . 72.239999999999995 112.731 172.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -112.63 81.17 4.09 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.194 -0.912 . . . . 53.439999999999998 109.074 166.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.44 ' HB2' ' SG ' ' A' ' 53' ' ' CYS . 1.2 Cg_endo -84.69 6.33 5.79 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.132 2.554 . . . . 74.340000000000003 113.118 -171.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 20.1 m-90 60.21 6.97 1.11 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.359 0.503 . . . . 74.150000000000006 112.359 177.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.44 ' SG ' ' HB2' ' A' ' 51' ' ' PRO . 16.8 p -91.33 -13.93 31.67 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.593 0.235 . . . . 72.239999999999995 111.38 -175.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.6 174.48 42.23 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 121.19 -0.528 . . . . 63.140000000000001 112.753 -177.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -78.38 38.29 0.69 Allowed 'Trans proline' 0 CA--C 1.532 0.406 0 C-N-CA 123.225 2.617 . . . . 62.109999999999999 112.166 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 61.2 m -67.11 120.86 14.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 70.010000000000005 110.291 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -83.38 40.8 0.74 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 74.519999999999996 111.022 -176.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.6 t -136.98 174.04 11.05 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.11 -0.496 . . . . 52.329999999999998 110.024 -178.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.478 ' N ' HD22 ' A' ' 59' ' ' LEU . 2.6 mm? -101.85 -15.2 16.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.903 -0.59 . . . . 73.329999999999998 109.775 177.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -165.26 138.76 3.78 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 115.846 -0.616 . . . . 73.140000000000001 110.261 -176.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.409 ' HD2' ' OE1' ' A' ' 64' ' ' GLU . 98.6 Cg_endo -79.57 -174.01 2.1 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.775 2.317 . . . . 71.140000000000001 112.408 177.229 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.555 ' HB3' HG12 ' A' ' 119' ' ' ILE . 13.8 mp0 -63.12 -48.32 79.0 Favored 'General case' 0 C--O 1.247 0.932 0 CA-C-O 121.583 0.706 . . . . 74.099999999999994 110.574 -174.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.561 HD12 ' N ' ' A' ' 64' ' ' GLU . 4.0 pp -57.38 -39.56 76.32 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 114.844 -1.071 . . . . 74.219999999999999 111.33 -176.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.561 ' N ' HD12 ' A' ' 63' ' ' LEU . 29.7 mt-10 -70.45 -43.25 70.26 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 120.809 -0.356 . . . . 74.409999999999997 110.048 177.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.2 mmtt -50.81 -52.95 36.24 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.133 -0.485 . . . . 71.310000000000002 111.528 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.735 HD12 HD12 ' A' ' 123' ' ' ILE . 14.8 mt -85.72 -42.83 13.9 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.198 0.814 . . . . 73.239999999999995 113.198 -176.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.18 -32.38 72.12 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.195 0.443 . . . . 61.5 112.195 -172.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -53.28 -33.44 53.2 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.884 0.373 . . . . 70.239999999999995 110.764 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -94.0 -53.4 4.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.005 -0.543 . . . . 65.549999999999997 110.85 176.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.53 ' O ' HG22 ' A' ' 74' ' ' VAL . 22.7 m-85 -85.35 14.83 4.89 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 113.149 0.796 . . . . 75.230000000000004 113.149 -169.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.8 t -52.94 -31.6 41.1 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.344 0.52 . . . . 74.329999999999998 111.441 -177.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -66.65 -16.9 64.53 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.283 -0.417 . . . . 53.340000000000003 111.553 -178.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -125.1 -7.04 7.15 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.375 -0.375 . . . . 72.310000000000002 110.627 -176.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 70' ' ' TYR . 19.6 m -141.83 150.69 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 109.979 -0.378 . . . . 55.140000000000001 109.979 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.9 tppt? -144.9 127.25 15.85 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.845 -0.428 . . . . 63.310000000000002 109.845 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.571 ' HA ' ' O ' ' A' ' 45' ' ' LEU . 1.9 mp -95.94 142.82 13.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.583 0.23 . . . . 74.420000000000002 110.398 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.619 ' CD2' HG23 ' A' ' 44' ' ' ILE . 83.6 m-85 -135.46 131.56 36.29 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.211 -0.45 . . . . 72.200000000000003 110.339 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.441 ' HG2' ' HA ' ' A' ' 25' ' ' GLN . 22.3 ptmt -87.21 134.56 33.52 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 120.734 0.302 . . . . 72.219999999999999 110.477 177.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.41 HD13 ' CD1' ' A' ' 31' ' ' PHE . 7.8 tp -92.48 160.03 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 115.819 -0.628 . . . . 72.5 110.769 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -66.44 178.73 1.16 Allowed 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 109.573 -0.528 . . . . 55.210000000000001 109.573 174.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.463 ' HB ' ' OD1' ' A' ' 84' ' ' ASN . 64.6 mt -45.18 126.8 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 120.856 0.36 . . . . 61.140000000000001 111.494 -176.339 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.418 ' HG3' ' N ' ' A' ' 83' ' ' ASP . 13.8 pt-20 -43.79 -50.34 7.8 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.037 0.935 . . . . 71.239999999999995 113.508 -170.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.418 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 29.0 t70 -76.0 2.07 13.69 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 112.176 0.436 . . . . 64.430000000000007 112.176 -169.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.463 ' OD1' ' HB ' ' A' ' 81' ' ' ILE . 18.1 m120 -93.33 -4.79 50.99 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.85 0.357 . . . . 73.349999999999994 111.12 178.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 40.9 mm-40 -129.29 117.76 21.2 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.962 -0.563 . . . . 74.209999999999994 109.932 176.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.635 ' HB2' ' HA ' ' A' ' 7' ' ' HIS . 10.1 m-20 -67.29 -4.54 11.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.564 -0.744 . . . . 61.450000000000003 111.146 -176.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.6 t -52.46 -43.24 41.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.168 0.508 . . . . 75.030000000000001 110.588 177.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.62 -42.87 99.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.774 -0.648 . . . . 73.530000000000001 110.168 178.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.9 m -67.86 -31.24 70.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.805 -0.634 . . . . 71.010000000000005 110.406 178.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.421 ' HG3' ' O ' ' A' ' 4' ' ' HIS . 46.0 tt0 -65.4 -55.83 15.92 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.492 -0.776 . . . . 72.230000000000004 110.67 -179.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -80.12 -9.01 59.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.32 -0.4 . . . . 74.030000000000001 111.153 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.26 47.82 21.66 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.165 -0.54 . . . . 71.209999999999994 112.6 176.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.5 t -65.32 105.55 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.948 0.404 . . . . 73.5 110.42 178.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.2 p -107.49 0.43 22.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.082 -0.508 . . . . 73.310000000000002 111.06 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.62 125.98 10.83 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.61 -0.268 . . . . 73.129999999999995 110.847 -177.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 32.4 pt -100.1 150.94 37.33 Favored Pre-proline 0 C--O 1.238 0.466 0 CA-C-N 116.113 -0.494 . . . . 72.430000000000007 110.193 177.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -79.82 178.61 32.57 Favored 'Cis proline' 0 C--N 1.352 0.722 0 C-N-CA 123.663 -1.39 . . . . 65.310000000000002 112.507 0.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 27.6 m -148.03 133.3 18.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.194 -0.457 . . . . 71.120000000000005 110.243 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 62.2 mt -119.76 134.25 63.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.752 -0.462 . . . . 53.43 109.752 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.475 HD13 ' HE2' ' A' ' 48' ' ' PHE . 11.2 mp -118.0 130.81 56.41 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 120.619 0.247 . . . . 73.120000000000005 110.402 177.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.41 ' SD ' ' HB3' ' A' ' 109' ' ' SER . 87.0 mtp -95.42 108.46 20.66 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.846 -0.616 . . . . 74.109999999999999 110.327 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -110.04 146.95 34.46 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.869 0.366 . . . . 74.430000000000007 110.989 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.409 ' HB3' HD21 ' A' ' 108' ' ' LEU . 28.4 ttpp -153.37 108.13 3.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.73 -0.668 . . . . 63.310000000000002 109.595 174.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 61.61 29.78 18.36 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.009 -0.541 . . . . 65.239999999999995 110.424 177.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.04 -10.69 74.34 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.235 -0.507 . . . . 53.509999999999998 112.741 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -96.74 119.43 35.2 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.761 -0.459 . . . . 51.240000000000002 109.761 177.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.21 128.34 34.5 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.508 -0.553 . . . . 45.119999999999997 109.508 177.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.478 ' N ' HD22 ' A' ' 108' ' ' LEU . 2.4 mm? -87.89 -47.26 8.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.983 0.421 . . . . 72.549999999999997 110.54 -176.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.41 ' HB3' ' SD ' ' A' ' 101' ' ' MET . 23.5 t -160.22 171.81 18.53 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.869 -0.605 . . . . 74.540000000000006 110.678 -175.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -149.04 129.73 14.09 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.718 -0.674 . . . . 75.319999999999993 110.906 -175.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.498 ' CG2' HG22 ' A' ' 119' ' ' ILE . 22.2 t -96.66 111.49 26.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 123.158 0.583 . . . . 64.25 110.067 178.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 59.8 mt -107.57 106.79 21.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.856 -0.424 . . . . 75.109999999999999 109.856 177.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 105.68 -112.39 3.93 Favored Glycine 0 C--N 1.33 0.226 0 N-CA-C 111.399 -0.68 . . . . 74.409999999999997 111.399 -176.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.51 57.16 0.5 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.396 0.617 . . . . 71.329999999999998 110.685 177.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.593 ' O ' HG23 ' A' ' 119' ' ' ILE . 3.0 m-20 -85.17 75.63 10.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.801 -0.636 . . . . 62.439999999999998 110.601 -179.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.568 ' O ' HG13 ' A' ' 119' ' ' ILE . 5.8 tp -52.56 -41.88 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 116.315 -0.402 . . . . 73.120000000000005 111.316 -178.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.9 p -62.15 -29.51 70.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.47 . . . . 71.150000000000006 111.075 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.454 ' HB2' ' HB3' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -79.41 -42.0 26.44 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.341 -0.614 . . . . 71.040000000000006 109.341 178.669 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.593 HG23 ' O ' ' A' ' 115' ' ' ASP . 1.3 pp -64.68 -43.03 96.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.324 -0.398 . . . . 71.219999999999999 111.002 -174.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.507 HD12 ' N ' ' A' ' 121' ' ' SER . 2.9 pp -63.47 -32.26 56.0 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.096 0 C-N-CA 120.623 -0.431 . . . . 75.310000000000002 110.39 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.507 ' N ' HD12 ' A' ' 120' ' ' ILE . 47.9 m -71.15 -51.53 24.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.037 -0.529 . . . . 62.240000000000002 111.08 177.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.448 ' HG2' ' HA ' ' A' ' 119' ' ' ILE . 10.7 pt-20 -69.44 -41.13 76.71 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.526 -0.306 . . . . 74.319999999999993 111.458 -171.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.735 HD12 HD12 ' A' ' 66' ' ' LEU . 74.9 mt -67.33 -57.7 8.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 110.409 -0.219 . . . . 72.530000000000001 110.409 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -59.77 -23.39 63.22 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.952 0.406 . . . . 72.010000000000005 110.866 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -67.48 -29.29 68.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.943 -0.571 . . . . 60.229999999999997 111.391 178.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 48.9 m-80 -111.82 -1.17 15.65 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.154 0.428 . . . . 73.109999999999999 112.154 -174.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.518 HG12 ' O ' ' A' ' 123' ' ' ILE . 47.5 pt -131.83 168.32 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 121.236 0.541 . . . . 71.040000000000006 111.299 177.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 . . . . . 0 C--O 1.25 1.113 0 CA-C-N 115.116 -0.947 . . . . 74.439999999999998 110.485 -178.039 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.0 mtm . . . . . 0 N--CA 1.484 1.235 0 CA-C-O 120.63 0.252 . . . . 51.399999999999999 110.774 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.46 -43.42 39.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.348 0.594 . . . . 74.329999999999998 109.452 173.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -86.44 100.72 12.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.414 -0.812 . . . . 73.010000000000005 109.821 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 67.8 m80 -88.21 119.44 28.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.967 -0.56 . . . . 75.420000000000002 109.769 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 25.7 p80 -55.02 128.38 33.38 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.908 0.385 . . . . 74.219999999999999 111.257 -177.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -102.43 126.76 49.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.06 -0.518 . . . . 71.200000000000003 110.112 177.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -66.52 144.05 56.69 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.395 -0.366 . . . . 65.209999999999994 110.456 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -71.37 151.78 43.78 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.537 -0.542 . . . . 71.340000000000003 109.537 176.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -91.77 -28.25 17.5 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.731 0.3 . . . . 61.329999999999998 111.106 -177.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -128.17 -86.36 0.51 Allowed Glycine 0 C--N 1.329 0.175 0 CA-C-N 116.211 -0.45 . . . . 54.420000000000002 112.038 -178.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.6 m -71.53 112.49 7.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.68 0.276 . . . . 62.43 110.505 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 pp -76.63 -172.26 2.15 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.355 -0.384 . . . . 75.129999999999995 111.245 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -162.22 -62.98 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.196 0.522 . . . . 62.409999999999997 109.804 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -93.98 -179.35 4.94 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.645 -0.707 . . . . 64.340000000000003 110.683 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -70.55 101.72 2.08 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.282 -0.417 . . . . 71.200000000000003 110.851 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.3 m -65.97 155.28 37.03 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.706 -0.679 . . . . 74.340000000000003 110.207 174.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -54.48 130.47 39.75 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 110.01 -0.367 . . . . 73.129999999999995 110.01 175.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -165.21 80.73 0.12 Allowed Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 111.523 -0.631 . . . . 72.219999999999999 111.523 -175.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -68.05 -179.31 2.1 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 122.865 2.376 . . . . 73.219999999999999 112.824 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -52.79 121.91 17.53 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-N 115.647 -0.706 . . . . 71.450000000000003 112.503 -178.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.5 m -95.47 152.2 18.62 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 122.28 0.232 . . . . 64.019999999999996 111.013 -176.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.474 ' N ' ' SD ' ' A' ' 22' ' ' MET . 3.6 mpp? -64.89 -48.31 74.67 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.218 -0.446 . . . . 73.25 110.065 175.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.48 HG22 ' HE3' ' A' ' 78' ' ' LYS . 7.9 mm -101.08 92.48 2.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 108.595 -0.891 . . . . 74.400000000000006 108.595 175.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.603 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 34.4 tt0 -112.9 148.39 35.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.899 -0.591 . . . . 71.409999999999997 110.788 -168.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.509 ' HB3' ' NZ ' ' A' ' 78' ' ' LYS . 5.3 pp0? -99.4 147.56 25.11 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 110.092 -0.336 . . . . 65.140000000000001 110.092 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.448 HD12 ' HA ' ' A' ' 31' ' ' PHE . 31.8 pt -137.91 162.36 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 121.012 0.434 . . . . 64.230000000000004 111.409 -176.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.62 171.23 19.97 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.335 -0.848 . . . . 13.31 111.758 177.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -67.78 -30.05 69.39 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.707 0.253 . . . . 73.329999999999998 111.459 -177.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 28.8 t -68.7 -36.66 78.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.713 0.292 . . . . 64.120000000000005 111.044 -177.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.431 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 4.3 pm0 -98.35 -9.85 24.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 71.549999999999997 111.188 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.482 ' HE1' HG11 ' A' ' 46' ' ' VAL . 93.3 t80 -46.75 -71.11 0.08 Allowed 'General case' 0 N--CA 1.467 0.399 0 O-C-N 123.317 0.385 . . . . 65.209999999999994 111.259 -175.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -65.79 -35.63 81.24 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 109.593 -0.521 . . . . 71.430000000000007 109.593 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -53.59 -33.75 55.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.807 -1.088 . . . . 63.409999999999997 111.881 -174.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.431 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 0.2 OUTLIER -114.82 -18.53 11.31 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 121.03 -0.268 . . . . 53.439999999999998 111.68 -179.822 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 72.7 t -88.44 -57.09 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 111.746 0.276 . . . . 61.520000000000003 111.746 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 58.2 p -76.32 -23.33 54.29 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.107 0.48 . . . . 74.430000000000007 110.537 -175.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.8 m -86.27 11.68 11.59 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.676 -0.693 . . . . 73.219999999999999 111.083 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.503 ' HB2' HD12 ' A' ' 44' ' ' ILE . 41.8 t -57.96 91.11 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.037 0.446 . . . . 60.130000000000003 110.962 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -101.33 -6.7 23.77 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.816 -0.629 . . . . 70.230000000000004 109.989 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -77.91 -5.23 50.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.361 -0.836 . . . . 63.240000000000002 111.778 -174.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 53.5 m-80 66.83 16.56 10.4 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.336 -0.393 . . . . 71.209999999999994 110.856 -176.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.0 tt -87.18 142.87 12.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.33 -0.619 . . . . 74.519999999999996 109.33 177.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.727 HD21 ' HE3' ' A' ' 101' ' ' MET . 68.1 tp -82.46 116.91 22.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.889 0.376 . . . . 74.319999999999993 110.314 -178.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.503 HD12 ' HB2' ' A' ' 38' ' ' CYS . 56.3 mt -102.61 117.67 48.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.872 -0.603 . . . . 75.349999999999994 110.533 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.525 ' HB2' HG13 ' A' ' 76' ' ' ILE . 4.1 mp -106.06 103.84 13.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.051 -0.522 . . . . 41.200000000000003 109.748 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.513 HG22 ' HB2' ' A' ' 77' ' ' TYR . 45.7 t -109.41 123.76 65.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 111.43 0.159 . . . . 71.439999999999998 111.43 -177.026 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.465 ' HB2' HG13 ' A' ' 99' ' ' ILE . 14.2 t70 -91.82 149.52 21.54 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.661 -0.866 . . . . 64.5 108.661 170.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.444 ' O ' ' HB2' ' A' ' 49' ' ' TRP . 76.7 m-85 -64.28 -44.19 92.48 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.46 0.17 . . . . 73.030000000000001 111.46 -177.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.444 ' HB2' ' O ' ' A' ' 48' ' ' PHE . 38.2 t-105 166.49 -26.21 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 O-C-N 123.792 0.682 . . . . 72.239999999999995 110.04 -176.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 68.24 90.23 0.09 OUTLIER Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 115.409 -0.814 . . . . 53.439999999999998 110.474 -174.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -48.73 -32.97 23.38 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 123.21 2.606 . . . . 74.340000000000003 113.414 -176.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 39.1 p-90 -159.85 -54.75 0.06 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.735 0.302 . . . . 74.150000000000006 110.645 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.562 ' HB3' HG12 ' A' ' 96' ' ' ILE . 33.7 t -85.51 101.45 12.67 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.742 -0.466 . . . . 72.239999999999995 109.742 178.155 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -119.05 -160.7 11.45 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.225 -0.512 . . . . 63.140000000000001 112.267 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -77.32 24.81 0.49 Allowed 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 122.986 2.458 . . . . 62.109999999999999 112.599 -179.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 7.1 p -66.87 94.95 0.34 Allowed 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.513 -0.312 . . . . 70.010000000000005 110.64 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 57' ' ' ARG . 16.6 mtp180 -145.92 162.14 38.45 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.814 -0.63 . . . . 74.519999999999996 110.157 -179.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.6 t -102.43 -41.67 6.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.329 -0.396 . . . . 52.329999999999998 110.115 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.421 ' N ' HD22 ' A' ' 59' ' ' LEU . 3.1 mm? -93.67 72.75 4.3 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.506 -0.316 . . . . 73.329999999999998 110.747 -179.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 41.39 98.49 0.04 OUTLIER Pre-proline 0 N--CA 1.473 0.677 0 N-CA-C 114.015 1.117 . . . . 73.140000000000001 114.015 171.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.8 172.12 12.23 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.001 1.801 . . . . 71.140000000000001 110.931 168.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.512 ' HB3' HG12 ' A' ' 119' ' ' ILE . 6.8 mp0 -48.99 -57.62 6.21 Favored 'General case' 0 C--O 1.247 0.974 0 CA-C-O 121.627 0.727 . . . . 74.099999999999994 111.491 -173.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.599 HD12 ' N ' ' A' ' 64' ' ' GLU . 2.1 pp -62.31 -38.81 90.85 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.117 -0.947 . . . . 74.219999999999999 111.654 -174.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.599 ' N ' HD12 ' A' ' 63' ' ' LEU . 37.8 mt-10 -70.9 -35.47 72.32 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 110.003 -0.369 . . . . 74.409999999999997 110.003 177.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -57.37 -56.73 18.09 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.004 -0.544 . . . . 71.310000000000002 110.642 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.661 HD12 HD12 ' A' ' 123' ' ' ILE . 28.5 mt -80.1 -30.79 39.2 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.364 0.505 . . . . 73.239999999999995 112.364 -175.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.428 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -62.38 -33.27 74.42 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 111.585 0.217 . . . . 61.5 111.585 -177.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.551 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 78.6 mt-30 -64.07 -30.92 71.96 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.003 0.43 . . . . 70.239999999999995 110.657 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 68.8 mm-40 -89.28 -59.11 2.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.009 -0.541 . . . . 65.549999999999997 110.776 -176.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.508 ' O ' HG22 ' A' ' 74' ' ' VAL . 17.1 m-85 -87.8 23.49 2.0 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.56 -0.746 . . . . 75.230000000000004 111.892 -173.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.428 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 6.6 t -52.0 -38.79 58.01 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.063 0.764 . . . . 74.329999999999998 113.063 -167.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -73.45 -16.52 61.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.774 0.321 . . . . 53.340000000000003 111.181 -176.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -113.14 -4.31 13.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.317 -0.402 . . . . 72.310000000000002 110.951 -177.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 70' ' ' TYR . 32.8 m -133.19 137.15 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.254 0.55 . . . . 55.140000000000001 111.072 178.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.432 ' HD2' ' CZ ' ' A' ' 77' ' ' TYR . 7.7 mmtt -128.79 115.13 17.47 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.96 -0.755 . . . . 63.310000000000002 108.96 177.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.525 HG13 ' HB2' ' A' ' 45' ' ' LEU . 2.3 mp -99.68 134.68 38.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.411 -0.588 . . . . 74.420000000000002 109.411 -177.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.603 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 71.3 m-85 -132.49 155.58 48.33 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.393 -0.367 . . . . 72.200000000000003 110.363 -178.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.509 ' NZ ' ' HB3' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -144.02 128.59 18.09 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.722 -0.844 . . . . 72.219999999999999 108.722 170.635 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.1 tt -104.45 150.89 7.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.102 -0.499 . . . . 72.5 110.023 -175.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -85.43 67.86 10.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.927 0.394 . . . . 55.210000000000001 110.754 -175.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 53.8 mt -126.51 110.22 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.453 -0.573 . . . . 61.140000000000001 109.453 175.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -60.0 -72.38 0.11 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 120.961 0.41 . . . . 71.239999999999995 111.558 -171.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -125.48 -19.37 5.03 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.173 -0.467 . . . . 64.430000000000007 111.702 -176.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -70.78 76.53 0.62 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.059 -0.518 . . . . 73.349999999999994 111.824 -170.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -144.7 107.19 4.4 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.342 -0.39 . . . . 74.209999999999994 110.959 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -56.04 -36.17 67.71 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.212 0.529 . . . . 61.450000000000003 109.751 174.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 45.9 t -52.8 -44.68 48.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.045 -0.98 . . . . 75.030000000000001 111.181 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.77 -45.28 92.76 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.981 -0.554 . . . . 73.530000000000001 110.934 -177.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.9 m -73.9 -31.38 63.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.795 -0.638 . . . . 71.010000000000005 110.683 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -63.97 -43.94 94.24 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.765 -0.652 . . . . 72.230000000000004 110.573 -178.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -86.58 -14.3 43.27 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.196 -0.456 . . . . 74.030000000000001 110.48 175.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 65.03 55.59 20.97 Favored Glycine 0 C--O 1.237 0.282 0 CA-C-N 116.002 -0.545 . . . . 71.209999999999994 112.182 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.438 HG21 ' OG1' ' A' ' 98' ' ' THR . 7.9 p -73.93 131.73 34.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.766 0.317 . . . . 73.5 110.728 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.6 t -121.83 -0.88 9.5 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.456 -0.338 . . . . 73.310000000000002 111.141 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.459 ' HB3' HG22 ' A' ' 112' ' ' ILE . . . -135.98 128.73 30.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.697 0.285 . . . . 73.129999999999995 110.904 -177.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.786 HD13 ' H ' ' A' ' 96' ' ' ILE . 0.2 OUTLIER -113.06 154.85 44.95 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 115.866 -0.606 . . . . 72.430000000000007 109.938 179.781 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.67 177.54 28.29 Favored 'Cis proline' 0 C--N 1.356 0.967 0 C-N-CA 124.183 -1.174 . . . . 65.310000000000002 112.442 1.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.438 ' OG1' HG21 ' A' ' 93' ' ' VAL . 18.5 m -146.99 115.19 6.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.072 0.463 . . . . 71.120000000000005 110.521 -176.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.525 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 3.7 mp -117.88 129.55 74.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.5 -0.773 . . . . 53.43 110.095 -176.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.9 mp -104.54 132.57 50.63 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.835 -0.431 . . . . 73.120000000000005 109.835 174.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.727 ' HE3' HD21 ' A' ' 43' ' ' LEU . 53.0 mtp -101.46 112.91 25.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.959 -0.564 . . . . 74.109999999999999 110.696 -176.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -112.49 147.51 36.39 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.879 0.371 . . . . 74.430000000000007 110.861 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.829 ' HB3' HD21 ' A' ' 108' ' ' LEU . 28.2 ttpp -161.5 131.96 5.05 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.849 -0.614 . . . . 63.310000000000002 109.344 176.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 18.6 m120 58.34 32.33 21.95 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.238 0.542 . . . . 65.239999999999995 110.703 -178.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.31 21.36 75.83 Favored Glycine 0 C--N 1.334 0.417 0 CA-C-N 115.509 -0.769 . . . . 53.509999999999998 112.727 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -137.05 133.53 35.54 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.436 -0.579 . . . . 51.240000000000002 109.436 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.9 pptp? -82.8 137.15 34.44 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.68 -0.489 . . . . 45.119999999999997 109.68 -177.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.829 HD21 ' HB3' ' A' ' 103' ' ' LYS . 2.1 mm? -99.13 -52.97 3.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.128 -0.487 . . . . 72.549999999999997 110.47 -177.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.653 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 16.8 m -150.31 172.1 15.92 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 115.679 -0.691 . . . . 74.540000000000006 110.795 -170.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.29 122.15 11.27 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.171 0.51 . . . . 75.319999999999993 110.858 -174.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.551 HG22 HG22 ' A' ' 119' ' ' ILE . 49.6 t -85.46 107.17 15.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.062 -0.517 . . . . 64.25 109.905 176.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.459 HG22 ' HB3' ' A' ' 95' ' ' ALA . 54.2 mt -106.32 106.95 21.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-O 120.987 0.423 . . . . 75.109999999999999 110.349 178.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.06 -134.76 12.65 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.766 -0.652 . . . . 74.409999999999997 112.096 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -132.82 81.67 1.96 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.87 0.367 . . . . 71.329999999999998 110.919 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.478 ' HB3' ' HB2' ' A' ' 118' ' ' LYS . 1.0 OUTLIER -122.53 94.41 4.28 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.928 -0.578 . . . . 62.439999999999998 110.519 -179.712 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.538 ' O ' HG13 ' A' ' 119' ' ' ILE . 7.8 tp -62.24 -41.38 91.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 CA-C-N 116.306 -0.406 . . . . 73.120000000000005 110.927 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.1 t -65.37 -28.9 69.6 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.12 -0.491 . . . . 71.150000000000006 110.449 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.478 ' HB2' ' HB3' ' A' ' 115' ' ' ASP . 0.2 OUTLIER -72.71 -55.36 6.9 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 108.689 -0.856 . . . . 71.040000000000006 108.689 176.879 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.551 HG22 HG22 ' A' ' 111' ' ' VAL . 2.2 pp -60.92 -38.49 79.39 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-N 115.757 -0.656 . . . . 71.219999999999999 112.065 -171.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.519 HD12 ' N ' ' A' ' 121' ' ' SER . 2.9 pp -64.96 -33.01 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 C-N-CA 120.216 -0.594 . . . . 75.310000000000002 110.538 179.021 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.519 ' N ' HD12 ' A' ' 120' ' ' ILE . 42.0 t -70.92 -51.94 23.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.801 0.334 . . . . 62.240000000000002 110.258 177.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.518 ' HG2' ' HA ' ' A' ' 119' ' ' ILE . 15.6 pt-20 -71.78 -35.3 69.98 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.29 -0.413 . . . . 74.319999999999993 111.833 -170.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.661 HD12 HD12 ' A' ' 66' ' ' LEU . 71.4 mt -71.02 -53.91 19.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.628 0.251 . . . . 72.530000000000001 110.638 177.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -61.87 -23.03 66.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.328 -0.396 . . . . 72.010000000000005 111.386 -177.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -62.86 -48.96 76.79 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.461 -0.336 . . . . 60.229999999999997 111.361 176.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.554 ' OD1' HD22 ' A' ' 43' ' ' LEU . 9.3 p30 -88.38 -30.37 19.56 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 112.189 0.44 . . . . 73.109999999999999 112.189 -170.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.514 HG23 ' OD1' ' A' ' 126' ' ' ASN . 41.8 pt -106.59 168.14 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.864 0.364 . . . . 71.040000000000006 110.98 177.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.251 1.138 0 CA-C-O 118.376 -0.821 . . . . 74.439999999999998 110.985 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.527 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.126 0 N-CA-C 109.619 -0.511 . . . . 51.399999999999999 109.619 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.35 85.22 0.65 Allowed 'General case' 0 C--O 1.235 0.322 0 N-CA-C 112.317 0.488 . . . . 74.329999999999998 112.317 -176.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 25.7 p-80 -139.29 122.15 16.58 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.884 -1.154 . . . . 73.010000000000005 107.884 166.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.413 ' O ' ' N ' ' A' ' 6' ' ' HIS . 11.1 m170 -67.19 77.13 0.14 Allowed 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.499 0.555 . . . . 75.420000000000002 112.499 -166.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 53.86 0.04 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.791 1.236 . . . . 74.219999999999999 114.21 171.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.413 ' N ' ' O ' ' A' ' 4' ' ' HIS . 29.0 m80 -89.28 128.74 35.89 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 121.971 -0.456 . . . . 71.200000000000003 110.514 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' HIS . . . . . 0.496 ' ND1' ' SD ' ' A' ' 9' ' ' MET . 24.5 t-80 -127.87 145.21 51.02 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.182 -0.673 . . . . 65.209999999999994 109.182 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -93.82 93.52 8.0 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.94 0.4 . . . . 71.340000000000003 111.26 -176.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.496 ' SD ' ' ND1' ' A' ' 7' ' ' HIS . 4.3 mpp? -93.44 166.91 12.04 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.561 -0.533 . . . . 61.329999999999998 109.561 174.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -157.8 -162.97 12.12 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 121.206 -0.521 . . . . 54.420000000000002 111.886 178.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.9 t -164.62 135.26 4.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.818 0.342 . . . . 62.43 110.579 178.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.9 tt -87.67 104.71 16.79 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.435 -0.95 . . . . 75.129999999999995 108.435 175.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -132.97 121.56 22.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 62.409999999999997 109.851 -175.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -136.01 122.83 21.2 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.158 -0.474 . . . . 64.340000000000003 110.192 -178.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -85.07 99.2 10.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 71.200000000000003 110.957 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.2 p -116.86 97.89 6.2 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.826 -0.625 . . . . 74.340000000000003 109.654 174.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -73.02 172.61 10.67 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.211 -0.449 . . . . 73.129999999999995 111.093 -175.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -173.16 82.77 0.08 OUTLIER Glycine 0 CA--C 1.52 0.4 0 C-N-CA 121.233 -0.508 . . . . 72.219999999999999 112.169 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -77.16 126.98 8.93 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.925 2.416 . . . . 73.219999999999999 112.122 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.6 67.13 3.41 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.979 -0.629 . . . . 71.450000000000003 112.418 178.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.8 t -139.48 179.16 6.71 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 110.154 -0.313 . . . . 64.019999999999996 110.154 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.581 ' HG3' HG13 ' A' ' 23' ' ' ILE . 24.6 ptp -112.17 -34.43 5.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.524 -0.307 . . . . 73.25 110.293 176.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.581 HG13 ' HG3' ' A' ' 22' ' ' MET . 65.1 mt -134.3 118.98 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 116.28 -0.418 . . . . 74.400000000000006 109.881 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.545 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 8.4 tp10 -131.89 155.13 48.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.908 0.385 . . . . 71.409999999999997 111.019 -178.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -109.7 129.2 55.63 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.425 -0.583 . . . . 65.140000000000001 109.425 174.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.516 HD12 ' HA ' ' A' ' 31' ' ' PHE . 22.0 pt -122.59 173.65 8.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 116.5 -0.318 . . . . 64.230000000000004 111.438 -175.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -112.14 -176.48 19.93 Favored Glycine 0 C--N 1.333 0.371 0 CA-C-N 115.85 -0.614 . . . . 13.31 112.859 -176.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -58.62 -49.94 75.65 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.454 0.702 . . . . 73.329999999999998 112.339 -175.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.0 m -74.03 -16.99 61.03 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.657 0.614 . . . . 64.120000000000005 112.657 -168.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -113.52 -7.89 13.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.575 -0.284 . . . . 71.549999999999997 111.471 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.516 ' HA ' HD12 ' A' ' 26' ' ' ILE . 30.5 t80 -49.25 -70.79 0.08 Allowed 'General case' 0 N--CA 1.461 0.106 0 O-C-N 123.32 0.387 . . . . 65.209999999999994 110.743 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -62.63 -37.67 87.25 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.644 -0.502 . . . . 71.430000000000007 109.644 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.513 ' O ' ' HB2' ' A' ' 37' ' ' SER . 20.7 t-20 -52.59 -42.9 64.95 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.789 -1.096 . . . . 63.409999999999997 112.051 -173.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.502 ' HD3' HG21 ' A' ' 26' ' ' ILE . 12.7 ptmt -111.52 -15.38 13.52 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.326 0.491 . . . . 53.439999999999998 112.326 -177.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.1 t -88.51 -56.37 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 111.681 0.252 . . . . 61.520000000000003 111.681 177.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 39.9 p -84.38 -32.09 24.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.911 0.386 . . . . 74.430000000000007 110.882 -173.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.513 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 18.0 m -83.81 8.92 13.26 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.083 -0.508 . . . . 73.219999999999999 111.516 -177.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.458 ' SG ' HG22 ' A' ' 42' ' ' ILE . 50.2 t -72.27 95.58 1.72 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.946 0.403 . . . . 60.130000000000003 110.449 -178.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -76.41 -9.32 58.56 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.934 -0.575 . . . . 70.230000000000004 110.796 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -59.05 -25.35 63.64 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.122 -0.49 . . . . 63.240000000000002 111.257 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.474 ' HA ' ' HB2' ' A' ' 103' ' ' LYS . 66.4 m-20 65.47 15.92 10.26 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.755 -0.657 . . . . 71.209999999999994 111.074 -176.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.458 HG22 ' SG ' ' A' ' 38' ' ' CYS . 10.6 tt -65.33 166.26 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 108.669 -0.863 . . . . 74.519999999999996 108.669 172.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.591 HD21 ' HE3' ' A' ' 101' ' ' MET . 49.7 tp -92.35 101.65 14.13 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 121.651 -0.656 . . . . 74.319999999999993 110.677 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 50.5 mt -87.32 131.89 34.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.522 -0.763 . . . . 75.349999999999994 109.795 174.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.541 ' HB2' HG13 ' A' ' 76' ' ' ILE . 89.0 mt -117.44 104.6 11.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.129 -0.487 . . . . 41.200000000000003 109.701 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 23.5 m -95.43 119.53 43.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.965 -0.294 . . . . 71.439999999999998 110.72 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.698 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 31.8 t70 -99.27 161.5 13.59 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 116.18 -0.464 . . . . 64.5 110.25 -178.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.407 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 25.9 p90 -65.46 -170.19 0.06 Allowed 'General case' 0 C--O 1.239 0.546 0 CA-C-O 121.397 0.617 . . . . 73.030000000000001 112.07 -174.06 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.53 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 3.6 m-90 -64.68 -166.24 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.236 -0.893 . . . . 72.239999999999995 111.759 -176.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.429 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . . . 60.94 97.38 0.04 OUTLIER Pre-proline 0 CA--C 1.529 0.138 0 CA-C-N 115.489 -0.778 . . . . 53.439999999999998 110.54 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 50' ' ' ALA . 28.1 Cg_endo -61.56 -11.42 20.03 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.768 2.312 . . . . 74.340000000000003 112.843 -176.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -116.38 101.89 9.05 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.972 -0.381 . . . . 74.150000000000006 109.972 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 66.4 m -83.79 115.02 22.03 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.996 -0.372 . . . . 72.239999999999995 109.996 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.95 -65.23 1.18 Allowed Glycine 0 CA--C 1.525 0.683 0 C-N-CA 121.335 -0.46 . . . . 63.140000000000001 113.874 -174.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_exo -52.17 100.09 0.05 OUTLIER 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.051 2.501 . . . . 62.109999999999999 113.753 -173.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 82.9 m -101.06 92.88 5.2 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.119 -0.491 . . . . 70.010000000000005 109.831 175.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 29.5 mmm180 -65.44 -49.35 69.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.907 -0.588 . . . . 74.519999999999996 111.185 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.6 p -103.57 -168.8 1.55 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.76 -0.654 . . . . 52.329999999999998 110.166 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.41 ' O ' ' HB2' ' A' ' 60' ' ' GLU . 82.7 mt -66.99 103.49 1.17 Allowed 'General case' 0 C--O 1.233 0.207 0 N-CA-C 107.936 -1.135 . . . . 73.329999999999998 107.936 170.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 59' ' ' LEU . 2.9 mp0 65.93 157.45 0.13 Allowed Pre-proline 0 CA--C 1.541 0.615 0 O-C-N 123.629 0.58 . . . . 73.140000000000001 109.937 -170.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -67.06 160.11 48.85 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 121.728 1.619 . . . . 71.140000000000001 110.259 172.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.499 ' HB3' HG12 ' A' ' 119' ' ' ILE . 10.3 mp0 -51.46 -43.93 62.25 Favored 'General case' 0 C--O 1.246 0.918 0 CA-C-O 121.608 0.718 . . . . 74.099999999999994 110.294 -173.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.443 HD11 HG12 ' A' ' 99' ' ' ILE . 6.4 mp -56.92 -48.74 77.56 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 114.488 -1.233 . . . . 74.219999999999999 110.491 -175.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.417 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 49.0 mt-10 -70.74 -42.51 70.41 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 123.212 0.32 . . . . 74.409999999999997 110.249 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.5 tmtp? -50.76 -46.17 59.23 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.807 -0.633 . . . . 71.310000000000002 109.834 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.652 HD12 HD12 ' A' ' 123' ' ' ILE . 17.6 mt -86.18 -41.87 14.31 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.571 0.582 . . . . 73.239999999999995 112.571 177.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.87 -39.88 78.87 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 111.934 0.346 . . . . 61.5 111.934 -173.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.417 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 97.9 mt-30 -53.69 -33.2 54.61 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.269 0.557 . . . . 70.239999999999995 110.313 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 53.1 mm-40 -93.82 -41.39 9.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.445 -0.798 . . . . 65.549999999999997 111.465 -177.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.555 ' O ' HG22 ' A' ' 74' ' ' VAL . 17.3 m-85 -107.17 22.38 16.07 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.748 0.647 . . . . 75.230000000000004 112.748 -169.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.1 t -52.8 -34.05 51.75 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.13 0.419 . . . . 74.329999999999998 112.13 -176.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -68.3 -16.5 63.97 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 111.576 0.213 . . . . 53.340000000000003 111.576 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -122.52 -4.77 8.76 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.539 0.209 . . . . 72.310000000000002 111.047 -177.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.555 HG22 ' O ' ' A' ' 70' ' ' TYR . 27.7 m -136.82 147.48 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 O-C-N 122.071 -0.393 . . . . 55.140000000000001 110.444 178.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.434 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 7.0 tppt? -142.13 116.59 9.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.718 0.295 . . . . 63.310000000000002 110.208 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.541 HG13 ' HB2' ' A' ' 45' ' ' LEU . 2.0 mp -93.14 134.23 31.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.078 -0.51 . . . . 74.420000000000002 110.762 -175.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.545 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 97.1 m-85 -129.12 128.6 43.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.885 -0.598 . . . . 72.200000000000003 109.616 174.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.698 ' HG2' ' HB3' ' A' ' 47' ' ' ASP . 25.6 mtpp -103.29 143.2 32.97 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.787 -0.449 . . . . 72.219999999999999 109.787 176.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.53 ' O ' ' HA ' ' A' ' 49' ' ' TRP . 40.9 mm -96.99 131.34 44.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.848 -0.615 . . . . 72.5 111.059 -175.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.411 ' ND2' ' HB2' ' A' ' 82' ' ' GLU . 30.1 p-10 -60.06 147.72 38.29 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.28 -0.418 . . . . 55.210000000000001 110.445 175.085 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 13.7 tt -66.21 -24.98 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 120.899 0.38 . . . . 61.140000000000001 110.884 -175.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.411 ' HB2' ' ND2' ' A' ' 80' ' ' ASN . 44.2 mm-40 -57.75 -25.18 60.1 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.847 -0.615 . . . . 71.239999999999995 111.12 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.435 ' O ' ' C ' ' A' ' 84' ' ' ASN . 35.9 t70 -76.01 -25.37 55.68 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 119.205 -0.426 . . . . 64.430000000000007 112.075 -171.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.435 ' C ' ' O ' ' A' ' 83' ' ' ASP . 49.5 t30 2.33 102.73 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 124.524 1.14 . . . . 73.349999999999994 112.95 -176.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.414 ' HG2' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -123.54 146.91 47.75 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.284 0.564 . . . . 74.209999999999994 111.116 -168.81 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -53.97 -28.7 39.21 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 114.794 -1.094 . . . . 61.450000000000003 111.471 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.414 ' HB ' ' HG2' ' A' ' 85' ' ' GLN . 62.1 t -50.05 -34.71 10.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-N 115.82 -0.627 . . . . 75.030000000000001 111.161 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.23 -51.01 70.77 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.068 -0.514 . . . . 73.530000000000001 110.845 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.9 m -67.69 -30.72 70.32 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.259 -0.428 . . . . 71.010000000000005 110.727 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -59.56 -55.99 27.52 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.929 -0.578 . . . . 72.230000000000004 110.341 178.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -75.33 -15.82 60.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.391 -0.368 . . . . 74.030000000000001 110.937 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.46 61.01 2.39 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.306 -0.473 . . . . 71.209999999999994 112.661 175.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.52 HG22 HG21 ' A' ' 98' ' ' THR . 59.7 t -69.51 85.32 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-O 121.361 0.601 . . . . 73.5 110.137 176.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.2 t -116.03 9.76 14.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.507 -0.77 . . . . 73.310000000000002 110.144 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.467 ' HB3' HG22 ' A' ' 112' ' ' ILE . . . -152.66 142.63 22.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 73.129999999999995 109.973 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 29.9 pt -113.43 149.62 41.85 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.375 -0.375 . . . . 72.430000000000007 110.774 -177.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -76.54 -176.02 17.76 Favored 'Cis proline' 0 C--N 1.353 0.792 0 C-N-CA 124.005 -1.248 . . . . 65.310000000000002 112.442 -1.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.52 HG21 HG22 ' A' ' 93' ' ' VAL . 43.6 m -142.54 115.36 8.69 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.091 -0.337 . . . . 71.120000000000005 110.091 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.471 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 4.0 mp -129.14 142.84 42.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.979 -0.555 . . . . 53.43 109.837 -178.075 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.6 mp -118.92 140.84 49.32 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.697 0.284 . . . . 73.120000000000005 110.361 174.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.843 ' SD ' ' HB3' ' A' ' 109' ' ' SER . 89.8 mtp -96.72 114.11 25.73 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.841 -0.618 . . . . 74.109999999999999 110.46 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -115.12 144.5 43.57 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.072 0.463 . . . . 74.430000000000007 112.13 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.81 ' HG2' HD21 ' A' ' 108' ' ' LEU . 0.4 OUTLIER -157.8 119.23 3.59 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 108.913 -0.773 . . . . 63.310000000000002 108.913 163.617 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 58.94 25.03 13.23 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.543 0.687 . . . . 65.239999999999995 110.207 -176.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 87.45 -6.21 83.77 Favored Glycine 0 CA--C 1.52 0.349 0 CA-C-N 115.798 -0.637 . . . . 53.509999999999998 112.511 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -77.84 128.97 34.83 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.511 -0.552 . . . . 51.240000000000002 109.511 177.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 101' ' ' MET . 3.1 mppt? -90.49 109.41 20.55 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.32 -0.622 . . . . 45.119999999999997 109.32 174.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.81 HD21 ' HG2' ' A' ' 103' ' ' LYS . 2.3 mm? -77.92 -36.63 49.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.142 -0.481 . . . . 72.549999999999997 110.545 -175.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.843 ' HB3' ' SD ' ' A' ' 101' ' ' MET . 17.2 t -178.64 171.9 1.46 Allowed 'General case' 0 C--O 1.24 0.598 0 CA-C-N 115.593 -0.731 . . . . 74.540000000000006 109.05 -176.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.04 141.14 36.28 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.251 0.548 . . . . 75.319999999999993 111.106 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 98' ' ' THR . 46.6 t -103.57 107.1 21.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.169 -0.923 . . . . 64.25 109.772 176.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.467 HG22 ' HB3' ' A' ' 95' ' ' ALA . 45.1 mt -118.84 106.31 19.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.466 -0.938 . . . . 75.109999999999999 108.466 172.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 108.65 174.26 21.58 Favored Glycine 0 CA--C 1.519 0.322 0 N-CA-C 111.041 -0.824 . . . . 74.409999999999997 111.041 -170.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -96.59 56.99 1.57 Allowed 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.179 0.514 . . . . 71.329999999999998 110.77 -177.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.548 ' O ' HG23 ' A' ' 119' ' ' ILE . 1.9 m-20 -90.19 73.78 7.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.875 -0.602 . . . . 62.439999999999998 110.906 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.551 ' O ' HG13 ' A' ' 119' ' ' ILE . 6.3 tp -54.74 -40.37 51.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 CA-C-O 121.108 0.48 . . . . 73.120000000000005 110.823 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.2 p -62.62 -29.08 70.36 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.853 -0.612 . . . . 71.150000000000006 111.182 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.498 ' HB2' ' HB3' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -79.28 -48.66 13.75 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.306 -0.627 . . . . 71.040000000000006 109.306 177.409 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.551 HG13 ' O ' ' A' ' 116' ' ' ILE . 1.6 pp -61.84 -40.77 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 116.132 -0.486 . . . . 71.219999999999999 111.421 -172.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.542 HD12 ' N ' ' A' ' 121' ' ' SER . 2.9 pp -63.19 -31.97 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 C-N-CA 120.437 -0.505 . . . . 75.310000000000002 110.399 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.542 ' N ' HD12 ' A' ' 120' ' ' ILE . 33.6 t -70.46 -51.92 25.78 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.994 -0.548 . . . . 62.240000000000002 110.854 178.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.5 ' HG2' ' HA ' ' A' ' 119' ' ' ILE . 12.8 pt-20 -70.75 -43.67 68.36 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.085 -0.507 . . . . 74.319999999999993 111.325 -172.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.652 HD12 HD12 ' A' ' 66' ' ' LEU . 78.8 mt -64.41 -53.86 37.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.352 0.12 . . . . 72.530000000000001 110.958 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -59.79 -26.65 65.9 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.775 0.322 . . . . 72.010000000000005 111.263 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -77.34 -14.87 59.64 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 111.741 0.274 . . . . 60.229999999999997 111.741 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -118.14 9.72 12.74 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 111.656 0.243 . . . . 73.109999999999999 111.656 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.522 HG12 ' O ' ' A' ' 123' ' ' ILE . 43.6 pt -134.74 168.33 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 109.921 -0.4 . . . . 71.040000000000006 109.921 173.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 21.2 p-10 . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.366 -0.826 . . . . 74.439999999999998 110.969 -176.15 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 mmt . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 109.76 -0.459 . . . . 51.399999999999999 109.76 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.49 153.97 24.08 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.723 0.296 . . . . 74.329999999999998 110.752 -177.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 -76.25 151.72 36.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.119 -0.491 . . . . 73.010000000000005 109.793 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -45.27 125.38 5.43 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 123.43 0.456 . . . . 75.420000000000002 110.586 176.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.3 m170 -59.52 124.21 19.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.916 -0.584 . . . . 74.219999999999999 110.522 -175.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -135.56 139.1 43.64 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.046 -0.524 . . . . 71.200000000000003 109.862 -171.159 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -87.76 173.79 8.77 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.84 0.353 . . . . 65.209999999999994 111.166 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.46 ' HB3' ' O ' ' A' ' 49' ' ' TRP . 10.3 p-80 -93.72 156.77 16.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.963 -0.562 . . . . 71.340000000000003 111.221 -177.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 66.3 mtt -130.65 -73.61 0.54 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.78 -0.822 . . . . 61.329999999999998 108.78 167.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.03 -50.42 3.68 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 121.42 -0.419 . . . . 54.420000000000002 113.588 172.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 34.2 p 50.37 75.7 0.17 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.308 0.575 . . . . 62.43 111.591 -177.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.593 HD11 HG21 ' A' ' 79' ' ' ILE . 4.4 pp -160.49 150.31 17.74 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.329 -0.85 . . . . 75.129999999999995 109.676 178.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 30.5 tp10 -147.04 108.84 4.37 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.675 -0.491 . . . . 62.409999999999997 109.675 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -131.16 122.98 27.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 64.340000000000003 110.72 -176.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -82.09 108.08 15.29 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.013 -0.54 . . . . 71.200000000000003 109.715 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 99.5 m -95.44 148.31 22.6 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.921 -0.581 . . . . 74.340000000000003 111.756 -172.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 71.2 mm-40 -71.58 -164.26 0.11 Allowed 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.863 -0.608 . . . . 73.129999999999995 110.778 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -99.51 -70.96 0.96 Allowed Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.815 -0.63 . . . . 72.219999999999999 111.717 175.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.73 87.31 0.83 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.269 1.98 . . . . 73.219999999999999 112.246 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -129.43 -140.43 4.85 Favored Glycine 0 C--O 1.235 0.182 0 CA-C-N 115.87 -0.605 . . . . 71.450000000000003 111.869 177.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.9 m -69.49 156.43 38.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.624 0.249 . . . . 64.019999999999996 110.824 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.635 ' HG3' HG13 ' A' ' 23' ' ' ILE . 21.2 ptp -59.71 -33.42 71.59 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.764 -0.458 . . . . 73.25 109.764 175.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.635 HG13 ' HG3' ' A' ' 22' ' ' MET . 23.2 mt -127.09 101.65 8.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 108.673 -0.862 . . . . 74.400000000000006 108.673 174.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 9.4 tp10 -124.01 149.64 45.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.813 0.34 . . . . 71.409999999999997 110.377 -175.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -82.15 149.74 27.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.169 -0.468 . . . . 65.140000000000001 110.26 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.481 HD12 ' HA ' ' A' ' 31' ' ' PHE . 25.4 pt -130.01 177.4 6.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.603 -0.271 . . . . 64.230000000000004 110.512 178.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.18 158.55 18.21 Favored Glycine 0 C--O 1.237 0.32 0 CA-C-N 116.102 -0.499 . . . . 13.31 112.324 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -59.81 -39.15 84.07 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.203 0.525 . . . . 73.329999999999998 110.433 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.4 t -63.33 -32.83 74.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.424 -0.807 . . . . 64.120000000000005 111.529 -176.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.403 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 10.0 pt-20 -105.28 -1.06 25.71 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 112.324 0.49 . . . . 71.549999999999997 112.324 -174.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.481 ' HA ' HD12 ' A' ' 26' ' ' ILE . 57.9 t80 -47.15 -71.61 0.07 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.793 0.33 . . . . 65.209999999999994 111.192 -178.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -64.43 -36.43 84.15 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.351 -0.611 . . . . 71.430000000000007 109.351 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -52.43 -38.55 59.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.436 -1.256 . . . . 63.409999999999997 111.891 -173.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 15.8 ptmt -114.34 -18.27 11.6 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.094 0.405 . . . . 53.439999999999998 112.094 -177.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 72.7 t -85.22 -49.59 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 111.851 0.315 . . . . 61.520000000000003 111.851 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 64.9 p -83.06 -28.83 29.28 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.075 0.464 . . . . 74.430000000000007 111.04 -173.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.1 m -80.1 12.02 3.08 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.914 -0.585 . . . . 73.219999999999999 111.992 -177.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 24.6 p -76.8 87.33 3.4 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.824 0.345 . . . . 60.130000000000003 111.817 -176.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -75.22 -5.93 47.04 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.14 0.495 . . . . 70.230000000000004 110.397 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.526 ' O ' ' HB2' ' A' ' 41' ' ' ASN . 2.1 m-20 -52.82 -30.26 32.43 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.633 -0.712 . . . . 63.240000000000002 112.062 -177.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.526 ' HB2' ' O ' ' A' ' 40' ' ' ASP . 3.9 m-20 75.11 11.47 3.55 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 123.691 0.619 . . . . 71.209999999999994 110.34 -171.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.518 HG22 ' HB2' ' A' ' 40' ' ' ASP . 10.0 tt -81.94 158.53 4.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 115.624 -0.716 . . . . 74.519999999999996 109.113 176.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.489 HD11 ' HB2' ' A' ' 126' ' ' ASN . 54.5 mt -84.92 112.53 20.65 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 120.916 -0.314 . . . . 74.319999999999993 110.604 179.348 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.0 mt -102.41 105.91 18.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.036 0.446 . . . . 75.349999999999994 109.945 173.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.515 ' HB2' HG12 ' A' ' 76' ' ' ILE . 5.1 mp -93.38 136.96 33.15 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.988 -0.745 . . . . 41.200000000000003 108.988 177.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.502 HG12 ' HB2' ' A' ' 77' ' ' TYR . 27.4 m -130.17 138.67 53.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.749 -0.463 . . . . 71.439999999999998 109.749 178.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -111.33 143.75 41.63 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.857 0.36 . . . . 64.5 111.036 177.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.565 ' HZ ' HG22 ' A' ' 96' ' ' ILE . 13.7 p90 -73.8 144.12 45.71 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.543 -0.54 . . . . 73.030000000000001 109.543 176.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.649 ' HB2' ' HA ' ' A' ' 79' ' ' ILE . 39.0 t-105 -84.91 159.93 20.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.921 0.391 . . . . 72.239999999999995 110.896 -176.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.457 ' HB1' ' SG ' ' A' ' 53' ' ' CYS . . . -143.0 150.81 54.22 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.275 -0.639 . . . . 53.439999999999998 109.275 177.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -61.52 -64.88 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.066 1.844 . . . . 74.340000000000003 111.639 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -148.44 -57.46 0.22 Allowed 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 109.301 -0.629 . . . . 74.150000000000006 109.301 177.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.457 ' SG ' ' HB1' ' A' ' 50' ' ' ALA . 81.8 m 68.95 -68.95 0.17 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.394 -0.821 . . . . 72.239999999999995 111.582 177.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -156.78 164.76 32.82 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 121.152 -0.547 . . . . 63.140000000000001 112.066 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.19 126.28 17.53 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.826 2.351 . . . . 62.109999999999999 112.083 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 56.7 m -62.74 94.67 0.07 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.247 -0.433 . . . . 70.010000000000005 110.82 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 57' ' ' ARG . 2.0 ptm180 -104.35 164.58 11.64 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.122 -0.49 . . . . 74.519999999999996 109.824 177.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 26.1 t 61.14 90.7 0.06 Allowed 'General case' 0 CA--C 1.531 0.217 0 O-C-N 123.565 0.541 . . . . 52.329999999999998 110.407 -177.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.452 ' N ' HD22 ' A' ' 59' ' ' LEU . 2.9 mm? -84.45 34.5 0.53 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.062 -0.517 . . . . 73.329999999999998 110.887 -175.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -144.56 74.34 15.24 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.174 -0.466 . . . . 73.140000000000001 110.222 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -88.17 170.02 6.04 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.839 2.359 . . . . 71.140000000000001 112.314 178.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.557 ' HB3' HG12 ' A' ' 119' ' ' ILE . 9.6 mp0 -61.9 -57.51 11.49 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.351 0.596 . . . . 74.099999999999994 111.097 -173.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.494 ' HB2' HD13 ' A' ' 76' ' ' ILE . 2.3 pt? -54.37 -47.17 72.93 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.068 -0.969 . . . . 74.219999999999999 111.611 -174.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.511 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 37.2 mt-10 -65.66 -43.72 88.53 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 120.888 -0.325 . . . . 74.409999999999997 110.255 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -53.14 -48.66 67.73 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.891 -0.595 . . . . 71.310000000000002 110.982 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.582 HD12 HD12 ' A' ' 123' ' ' ILE . 17.7 mt -79.43 -37.73 36.37 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 111.967 0.358 . . . . 73.239999999999995 111.967 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.419 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -59.81 -31.42 69.69 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.457 0.17 . . . . 61.5 111.307 -176.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.511 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 74.8 mt-30 -54.52 -34.95 62.62 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.951 0.405 . . . . 70.239999999999995 111.051 177.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -94.1 -45.23 7.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.192 0.52 . . . . 65.549999999999997 111.019 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.573 ' O ' HG22 ' A' ' 74' ' ' VAL . 20.4 m-85 -92.85 14.92 15.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.807 -0.633 . . . . 75.230000000000004 112.285 -171.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.419 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 8.8 t -52.48 -35.99 53.92 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.05 0.452 . . . . 74.329999999999998 111.442 -174.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -63.96 -28.43 69.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.83 -0.623 . . . . 53.340000000000003 111.841 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -116.48 3.19 13.21 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.52 -0.309 . . . . 72.310000000000002 111.17 -173.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.573 HG22 ' O ' ' A' ' 70' ' ' TYR . 23.6 m -133.68 141.34 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 121.088 0.47 . . . . 55.140000000000001 110.556 177.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.728 ' HA ' ' HE3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -128.15 116.53 20.07 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.523 -0.762 . . . . 63.310000000000002 108.969 174.925 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.555 ' HB ' HG12 ' A' ' 23' ' ' ILE . 39.9 mt -109.49 134.7 50.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.725 0.298 . . . . 74.420000000000002 110.413 -177.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.502 ' HB2' HG12 ' A' ' 46' ' ' VAL . 51.3 m-85 -120.72 134.5 55.28 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 115.982 -0.554 . . . . 72.200000000000003 110.08 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.0 ptmm? -112.89 161.5 16.91 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.25 -0.886 . . . . 72.219999999999999 110.62 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.649 ' HA ' ' HB2' ' A' ' 49' ' ' TRP . 30.9 mt 67.43 66.86 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 115.561 -0.745 . . . . 72.5 109.892 -174.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -115.1 161.17 18.75 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.674 -0.694 . . . . 55.210000000000001 110.557 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.45 ' H ' HG13 ' A' ' 81' ' ' ILE . 2.7 pp -89.33 24.35 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.898 -0.592 . . . . 61.140000000000001 110.782 178.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.412 ' CD ' HD13 ' A' ' 100' ' ' LEU . 33.3 tt0 -53.53 -40.66 65.67 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.305 -0.861 . . . . 71.239999999999995 111.53 -177.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -74.81 -18.16 60.5 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.146 -0.479 . . . . 64.430000000000007 110.884 -177.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -91.24 13.86 16.01 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.356 0.598 . . . . 73.349999999999994 109.818 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -110.19 132.51 54.1 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.673 -0.694 . . . . 74.209999999999994 109.94 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -57.67 -29.06 64.33 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.164 0.507 . . . . 61.450000000000003 109.791 173.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 56.7 t -54.96 -37.34 41.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 115.344 -0.843 . . . . 75.030000000000001 110.824 178.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.08 -52.21 65.87 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.089 0.471 . . . . 73.530000000000001 109.876 178.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.8 m -60.67 -32.05 71.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.83 -0.623 . . . . 71.010000000000005 110.53 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -66.12 -37.83 86.7 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.036 -0.529 . . . . 72.230000000000004 110.592 177.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -77.26 -5.66 50.22 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.463 -0.335 . . . . 74.030000000000001 111.099 176.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.85 21.0 64.33 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 121.082 -0.58 . . . . 71.209999999999994 112.077 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 97.9 t -65.93 102.92 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.045 0.45 . . . . 73.5 110.309 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.7 t -143.79 21.03 1.81 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.61 0.719 . . . . 73.310000000000002 109.174 178.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -129.01 160.9 31.28 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.567 -0.742 . . . . 73.129999999999995 110.29 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.565 HG22 ' HZ ' ' A' ' 48' ' ' PHE . 26.8 pt -118.67 130.61 24.7 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.304 -0.407 . . . . 72.430000000000007 110.603 -178.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 96' ' ' ILE . 47.7 Cg_endo -91.62 -170.05 3.96 Favored 'Cis proline' 0 C--N 1.35 0.616 0 C-N-CA 124.05 -1.229 . . . . 65.310000000000002 112.336 -4.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 88.5 m -147.83 139.81 24.12 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.034 -0.53 . . . . 71.120000000000005 109.677 175.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 36.9 mt -136.83 114.49 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 115.957 -0.565 . . . . 53.43 110.019 -176.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.412 HD13 ' CD ' ' A' ' 82' ' ' GLU . 8.2 mp -91.5 146.36 23.86 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.019 0.437 . . . . 73.120000000000005 111.152 178.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.488 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 90.5 mtp -108.63 118.97 38.16 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.994 -0.548 . . . . 74.109999999999999 110.663 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.43 ' CE2' ' HG2' ' A' ' 107' ' ' LYS . 79.3 m-85 -115.55 149.05 38.8 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.231 0.539 . . . . 74.430000000000007 111.482 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.642 ' HB3' HD21 ' A' ' 108' ' ' LEU . 30.8 ttmt -155.65 111.1 3.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.933 -1.031 . . . . 63.310000000000002 109.078 177.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.9 t30 60.7 25.06 14.87 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.458 0.647 . . . . 65.239999999999995 110.192 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.88 -14.89 62.06 Favored Glycine 0 C--N 1.334 0.458 0 CA-C-N 115.572 -0.74 . . . . 53.509999999999998 112.259 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -81.11 144.43 31.7 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.836 -0.431 . . . . 51.240000000000002 109.836 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.43 ' HG2' ' CE2' ' A' ' 102' ' ' PHE . 46.2 mttp -102.56 115.3 30.3 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.803 -0.444 . . . . 45.119999999999997 109.803 -176.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.642 HD21 ' HB3' ' A' ' 103' ' ' LYS . 2.8 mm? -85.85 -53.4 5.14 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.857 0.361 . . . . 72.549999999999997 111.249 -174.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.488 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 20.5 m -160.02 171.89 18.52 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.882 -0.599 . . . . 74.540000000000006 110.205 -172.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.88 124.04 13.71 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.024 -0.535 . . . . 75.319999999999993 110.568 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.574 HG22 HG22 ' A' ' 119' ' ' ILE . 61.2 t -80.43 107.13 12.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.83 -0.623 . . . . 64.25 109.471 175.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 58.7 mt -108.28 107.03 21.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 109.865 -0.42 . . . . 75.109999999999999 109.865 178.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.32 -132.53 10.98 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.811 -0.631 . . . . 74.409999999999997 111.604 -178.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -142.37 75.74 1.5 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.92 0.39 . . . . 71.329999999999998 110.387 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.49 ' O ' HG23 ' A' ' 119' ' ' ILE . 2.6 m-20 -115.47 97.5 6.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.917 -0.583 . . . . 62.439999999999998 110.611 -177.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.528 ' O ' HG13 ' A' ' 119' ' ' ILE . 6.7 tp -64.5 -41.08 91.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 116.411 -0.358 . . . . 73.120000000000005 111.342 -176.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 15.1 m -64.58 -29.85 70.87 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.454 0.645 . . . . 71.150000000000006 110.456 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.463 ' HG3' ' OE2' ' A' ' 122' ' ' GLU . 27.9 tptp -73.88 -50.64 19.29 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.453 -0.794 . . . . 71.040000000000006 110.453 178.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.574 HG22 HG22 ' A' ' 111' ' ' VAL . 2.1 pp -65.34 -41.32 91.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.814 -0.63 . . . . 71.219999999999999 111.519 -174.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.472 HG22 HD11 ' A' ' 66' ' ' LEU . 2.8 pp -62.32 -31.82 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 121.127 0.489 . . . . 75.310000000000002 109.837 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.556 ' O ' ' HB2' ' A' ' 125' ' ' ASN . 23.0 t -70.44 -51.56 28.47 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.85 -0.614 . . . . 62.240000000000002 110.55 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.463 ' OE2' ' HG3' ' A' ' 118' ' ' LYS . 10.7 pt-20 -73.52 -33.41 64.75 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 111.924 0.342 . . . . 74.319999999999993 111.924 -172.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.582 HD12 HD12 ' A' ' 66' ' ' LEU . 71.7 mt -73.59 -57.37 6.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-O 120.567 0.223 . . . . 72.530000000000001 110.654 178.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -63.67 -20.12 65.45 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.115 0.483 . . . . 72.010000000000005 110.609 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.556 ' HB2' ' O ' ' A' ' 121' ' ' SER . 26.7 t-20 -54.04 -29.8 45.3 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.717 -0.674 . . . . 60.229999999999997 110.76 176.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.489 ' HB2' HD11 ' A' ' 43' ' ' LEU . 33.8 m-80 -107.99 -45.21 4.02 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.872 -0.604 . . . . 73.109999999999999 111.233 -176.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 48.4 pt -105.46 167.78 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 120.819 0.343 . . . . 71.040000000000006 111.274 -175.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 34.5 p-10 . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.38 -0.819 . . . . 74.439999999999998 112.137 -177.705 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.5 mtt . . . . . 0 N--CA 1.482 1.145 0 CA-C-O 120.773 0.32 . . . . 51.399999999999999 110.653 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.79 -97.6 0.06 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.464 -0.789 . . . . 74.329999999999998 111.584 177.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.426 ' O ' ' CG ' ' A' ' 3' ' ' HIS . 14.2 t-80 53.33 24.29 3.76 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.674 0.749 . . . . 73.010000000000005 110.121 -173.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 32.3 m80 -111.65 84.48 1.96 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.216 0.531 . . . . 75.420000000000002 111.29 -177.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -134.25 9.74 3.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.211 -0.904 . . . . 74.219999999999999 109.009 170.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 75.9 t60 -115.1 108.73 17.04 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.543 -0.753 . . . . 71.200000000000003 110.385 -174.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -148.67 156.8 42.88 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.164 -0.471 . . . . 65.209999999999994 109.903 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -110.69 98.38 7.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.363 0.601 . . . . 71.340000000000003 110.183 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 91.4 mtp -100.78 177.61 4.93 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.759 -0.655 . . . . 61.329999999999998 110.019 177.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.67 172.34 21.28 Favored Glycine 0 N--CA 1.452 -0.262 0 N-CA-C 111.844 -0.502 . . . . 54.420000000000002 111.844 -178.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.543 HG23 ' HA ' ' A' ' 57' ' ' ARG . 86.1 m -149.04 100.31 3.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.925 0.393 . . . . 62.43 110.248 177.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.448 HD13 HD12 ' A' ' 59' ' ' LEU . 8.8 mp -80.31 124.14 28.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.952 -0.567 . . . . 75.129999999999995 109.769 177.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -88.51 131.53 34.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.07 -0.514 . . . . 62.409999999999997 110.621 -179.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 63.2 95.71 0.04 OUTLIER 'General case' 0 C--O 1.233 0.216 0 O-C-N 123.941 0.775 . . . . 64.340000000000003 112.49 175.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -67.43 119.24 11.93 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 107.828 -1.175 . . . . 71.200000000000003 107.828 169.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 29.2 p -48.88 -79.91 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.545 0.572 . . . . 74.340000000000003 112.545 -170.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -157.92 176.07 13.02 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 122.553 0.341 . . . . 73.129999999999995 110.417 -178.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -159.36 64.23 0.29 Allowed Glycine 0 CA--C 1.52 0.362 0 CA-C-N 115.824 -0.625 . . . . 72.219999999999999 111.773 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -92.38 135.84 1.48 Allowed 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 123.006 2.471 . . . . 73.219999999999999 112.455 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 52.78 52.92 35.71 Favored Glycine 0 CA--C 1.521 0.423 0 CA-C-N 116.333 -0.394 . . . . 71.450000000000003 112.967 177.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 40.1 m -141.81 -157.58 0.78 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.582 -0.525 . . . . 64.019999999999996 109.582 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.522 ' SD ' ' HA ' ' A' ' 68' ' ' GLN . 49.5 mtm -49.26 -35.71 18.46 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.638 0.733 . . . . 73.25 109.475 172.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.4 mm -92.67 128.83 43.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 114.38 -1.282 . . . . 74.400000000000006 108.641 171.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.413 ' HG2' ' CE1' ' A' ' 77' ' ' TYR . 9.1 tp10 -124.84 153.15 43.0 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.746 0.308 . . . . 71.409999999999997 110.426 -176.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.29 124.4 40.26 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.503 -0.554 . . . . 65.140000000000001 109.503 177.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.518 ' O ' HD13 ' A' ' 79' ' ' ILE . 32.5 pt -131.69 -176.93 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.047 -0.524 . . . . 64.230000000000004 110.533 -172.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -111.79 170.55 13.72 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 121.506 -0.378 . . . . 13.31 112.219 178.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -67.5 -38.15 83.9 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 122.575 0.35 . . . . 73.329999999999998 111.71 -178.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.2 m -60.32 -39.09 85.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.003 0.43 . . . . 64.120000000000005 111.177 -176.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.453 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 1.7 pm0 -103.38 -0.98 29.35 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.779 -0.646 . . . . 71.549999999999997 111.159 -177.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.405 ' HA ' HD12 ' A' ' 26' ' ' ILE . 69.2 t80 -53.04 -70.55 0.09 Allowed 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 109.775 -0.454 . . . . 65.209999999999994 109.775 177.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -49.75 -42.78 47.17 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 116.074 -0.512 . . . . 71.430000000000007 110.03 176.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.408 ' O ' ' HB2' ' A' ' 37' ' ' SER . 66.1 t30 -52.19 -54.32 32.29 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 114.655 -1.157 . . . . 63.409999999999997 111.481 -172.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.465 ' HE3' ' CE1' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -101.23 -15.93 17.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.245 -0.434 . . . . 53.439999999999998 111.936 -172.921 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 73.1 t -88.58 -57.06 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 111.962 0.356 . . . . 61.520000000000003 111.962 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.9 p -88.01 -42.09 12.67 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.047 0.451 . . . . 74.430000000000007 110.716 -171.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 18.4 m -76.73 12.07 1.46 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.823 -0.626 . . . . 73.219999999999999 111.473 -178.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.421 ' SG ' ' HB2' ' A' ' 40' ' ' ASP . 50.1 t -81.21 99.96 8.86 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.999 0.428 . . . . 60.130000000000003 110.334 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -87.25 14.87 7.02 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.181 0.515 . . . . 70.230000000000004 110.661 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.421 ' HB2' ' SG ' ' A' ' 38' ' ' CYS . 5.5 m-20 -75.36 -8.8 57.64 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.066 -0.515 . . . . 63.240000000000002 111.041 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.1 m120 68.47 0.05 2.42 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.483 0.549 . . . . 71.209999999999994 112.483 177.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.9 tt -71.49 145.42 12.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 109.095 -0.706 . . . . 74.519999999999996 109.095 177.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.601 HD11 ' HB3' ' A' ' 101' ' ' MET . 61.1 tp -80.76 109.74 15.61 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.263 0.554 . . . . 74.319999999999993 110.071 -177.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.485 HG23 ' CD2' ' A' ' 77' ' ' TYR . 61.5 mt -94.99 114.54 31.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.357 -0.838 . . . . 75.349999999999994 110.386 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.458 ' N ' HD12 ' A' ' 45' ' ' LEU . 5.5 mp -98.6 101.99 13.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.04 -0.527 . . . . 41.200000000000003 110.114 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.62 HG23 ' HB2' ' A' ' 100' ' ' LEU . 16.3 m -96.9 109.92 23.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.685 -0.487 . . . . 71.439999999999998 109.685 176.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . 3.9 p30 -101.36 146.77 27.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.465 0.65 . . . . 64.5 111.79 -174.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -89.95 96.34 10.63 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 107.614 -1.254 . . . . 73.030000000000001 107.614 169.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 67.1 t-105 -58.75 145.39 40.54 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.702 -0.681 . . . . 72.239999999999995 111.052 -174.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.67 110.17 37.46 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.076 -0.511 . . . . 53.439999999999998 110.585 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -78.27 8.22 3.68 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.722 2.281 . . . . 74.340000000000003 112.234 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 65.6 t-105 -134.53 130.75 37.08 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.388 -0.597 . . . . 74.150000000000006 109.388 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 9.0 p -73.41 74.52 1.39 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.152 0.501 . . . . 72.239999999999995 111.339 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.66 -73.93 1.2 Allowed Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 111.222 -0.751 . . . . 63.140000000000001 111.222 175.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -70.5 126.34 12.72 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.794 2.329 . . . . 62.109999999999999 111.407 175.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 57' ' ' ARG . 48.2 t -163.92 -167.21 1.31 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.572 -0.529 . . . . 70.010000000000005 109.572 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.543 ' HA ' HG23 ' A' ' 11' ' ' THR . 33.2 mtm105 71.66 -2.65 2.39 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 122.971 0.508 . . . . 74.519999999999996 112.016 175.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.8 m -88.17 11.48 16.24 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.619 0.247 . . . . 52.329999999999998 111.315 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.448 HD12 HD13 ' A' ' 12' ' ' LEU . 3.3 mm? 63.86 -81.81 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.913 -0.585 . . . . 73.329999999999998 110.093 -174.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -106.92 139.02 19.99 Favored Pre-proline 0 C--O 1.234 0.274 0 N-CA-C 109.153 -0.684 . . . . 73.140000000000001 109.153 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.745 ' HG2' ' HB2' ' A' ' 64' ' ' GLU . 56.4 Cg_endo -68.14 156.84 64.28 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 121.475 1.45 . . . . 71.140000000000001 109.633 171.059 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.506 ' HB3' HG12 ' A' ' 119' ' ' ILE . 9.6 mp0 -57.21 -50.57 72.45 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-O 121.254 0.549 . . . . 74.099999999999994 110.401 -170.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.663 HD12 ' N ' ' A' ' 64' ' ' GLU . 3.4 pp -54.33 -40.36 67.95 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.142 -0.935 . . . . 74.219999999999999 111.282 -177.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.745 ' HB2' ' HG2' ' A' ' 61' ' ' PRO . 2.3 mm-40 -75.61 -39.89 57.21 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.101 0.477 . . . . 74.409999999999997 110.005 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -53.54 -45.81 69.97 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.409 -0.814 . . . . 71.310000000000002 109.427 -177.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.505 HD12 HD12 ' A' ' 123' ' ' ILE . 16.1 mt -84.69 -37.86 20.45 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.129 -0.487 . . . . 73.239999999999995 111.661 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.406 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -53.97 -46.03 71.55 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.783 0.325 . . . . 61.5 111.048 -177.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.522 ' HA ' ' SD ' ' A' ' 22' ' ' MET . 73.1 mt-30 -49.3 -34.86 16.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.724 -0.671 . . . . 70.239999999999995 111.516 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -94.01 -57.93 2.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.227 0.537 . . . . 65.549999999999997 111.088 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.522 ' O ' HG22 ' A' ' 74' ' ' VAL . 16.6 m-85 -90.44 21.26 4.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.679 -0.691 . . . . 75.230000000000004 112.731 -171.066 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 8.8 t -52.71 -28.49 22.17 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.167 0.508 . . . . 74.329999999999998 111.424 -177.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -65.71 -16.76 64.07 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.73 -0.668 . . . . 53.340000000000003 111.127 -177.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -129.05 -5.35 4.99 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.182 -0.463 . . . . 72.310000000000002 110.438 -176.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.522 HG22 ' O ' ' A' ' 70' ' ' TYR . 22.9 m -132.66 140.43 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.089 0.471 . . . . 55.140000000000001 110.659 178.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -137.25 123.18 20.16 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.813 -0.63 . . . . 63.310000000000002 109.475 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.478 ' N ' HD12 ' A' ' 76' ' ' ILE . 2.0 mp -95.62 141.06 15.83 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-O 120.537 0.208 . . . . 74.420000000000002 110.65 -175.262 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.576 ' HB2' HG12 ' A' ' 46' ' ' VAL . 88.2 m-85 -141.06 157.77 44.85 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.347 0.659 . . . . 72.200000000000003 109.638 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.39 166.67 16.38 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.935 0.398 . . . . 72.219999999999999 110.964 170.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.518 HD13 ' O ' ' A' ' 26' ' ' ILE . 3.9 tp -146.31 83.68 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.106 -0.952 . . . . 72.5 108.669 174.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -99.93 74.08 1.79 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.775 -0.648 . . . . 55.210000000000001 111.141 -173.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.689 HG13 ' H ' ' A' ' 83' ' ' ASP . 30.7 pt -144.79 -163.76 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.277 -1.008 . . . . 61.140000000000001 108.277 173.011 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -62.55 -12.87 25.25 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.654 0.264 . . . . 71.239999999999995 111.527 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.689 ' H ' HG13 ' A' ' 81' ' ' ILE . 4.6 m-20 -82.75 7.01 16.19 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.391 -0.368 . . . . 64.430000000000007 110.95 174.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -57.65 137.73 56.12 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.004 0.431 . . . . 73.349999999999994 110.664 -178.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.533 ' HB3' HG23 ' A' ' 87' ' ' VAL . 88.7 mt-30 -89.31 118.85 29.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.977 -0.556 . . . . 74.209999999999994 110.142 -175.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -64.63 0.55 1.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.697 -0.683 . . . . 61.450000000000003 111.869 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.533 HG23 ' HB3' ' A' ' 85' ' ' GLN . 41.6 t -51.94 -37.67 21.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 120.803 0.335 . . . . 75.030000000000001 110.969 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.47 -39.38 94.3 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.385 0.612 . . . . 73.530000000000001 110.58 177.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 51.3 m -70.77 -29.49 65.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.719 -0.673 . . . . 71.010000000000005 109.955 176.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -70.66 -35.63 72.96 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.171 -0.468 . . . . 72.230000000000004 110.151 177.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.49 ' CE1' HG12 ' A' ' 87' ' ' VAL . 30.3 m-85 -68.78 -17.2 63.99 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.387 -0.598 . . . . 74.030000000000001 109.387 171.097 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.86 42.22 9.95 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.397 -0.819 . . . . 71.209999999999994 112.417 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.528 HG21 ' OG1' ' A' ' 98' ' ' THR . 14.9 p -67.95 131.83 33.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.983 0.391 . . . . 73.5 110.385 177.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.3 p -101.82 -36.43 8.68 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.177 -0.465 . . . . 73.310000000000002 111.65 -177.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -127.98 143.6 51.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.649 0.262 . . . . 73.129999999999995 111.062 -175.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.411 ' O ' HD12 ' A' ' 96' ' ' ILE . 2.5 pp -100.02 160.84 26.11 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 115.957 -0.565 . . . . 72.430000000000007 110.669 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.405 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 98.6 Cg_endo -82.36 -177.96 20.11 Favored 'Cis proline' 0 C--N 1.353 0.813 0 C-N-CA 124.03 -1.238 . . . . 65.310000000000002 112.223 -0.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.668 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 17.7 m -144.06 115.41 8.03 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.439 -0.346 . . . . 71.120000000000005 110.567 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.503 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.3 mp -108.06 115.22 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.673 -0.24 . . . . 53.43 110.365 -177.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.62 ' HB2' HG23 ' A' ' 46' ' ' VAL . 8.9 mp -91.89 139.98 30.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.826 0.346 . . . . 73.120000000000005 110.54 178.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.623 ' SD ' ' HB3' ' A' ' 109' ' ' SER . 81.7 mtp -109.37 116.44 31.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.921 -0.581 . . . . 74.109999999999999 110.534 -177.129 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -116.99 154.04 31.6 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.952 0.406 . . . . 74.430000000000007 111.035 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.84 ' HB3' HD21 ' A' ' 108' ' ' LEU . 16.1 ttmm -169.27 115.37 0.58 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.437 -0.801 . . . . 63.310000000000002 109.617 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.9 t30 60.35 31.08 20.29 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.334 0.588 . . . . 65.239999999999995 110.987 172.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.91 -14.45 63.28 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 121.314 -0.47 . . . . 53.509999999999998 113.163 178.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -97.04 146.11 25.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.598 0.237 . . . . 51.240000000000002 110.589 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -99.06 126.02 44.69 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.242 -0.651 . . . . 45.119999999999997 109.242 174.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.84 HD21 ' HB3' ' A' ' 103' ' ' LYS . 3.1 mm? -87.07 -47.39 8.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.525 -0.307 . . . . 72.549999999999997 111.15 -174.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.623 ' HB3' ' SD ' ' A' ' 101' ' ' MET . 27.9 t -167.01 171.8 10.77 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.738 0.304 . . . . 74.540000000000006 110.927 -175.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -136.69 130.82 32.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.702 -0.681 . . . . 75.319999999999993 110.014 175.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.721 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 60.2 t -94.43 107.3 19.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.991 -0.549 . . . . 64.25 110.292 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 61.6 mt -104.26 109.87 28.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 110.022 -0.362 . . . . 75.109999999999999 110.022 176.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 106.87 -142.85 15.74 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 121.204 -0.522 . . . . 74.409999999999997 112.093 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -138.96 80.16 1.77 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.03 0.443 . . . . 71.329999999999998 110.595 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.49 ' O ' HG23 ' A' ' 119' ' ' ILE . 3.0 m-20 -118.67 94.29 4.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.799 -0.637 . . . . 62.439999999999998 110.595 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.57 HD12 HD11 ' A' ' 119' ' ' ILE . 7.2 tp -65.07 -39.01 84.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.186 -0.461 . . . . 73.120000000000005 111.088 -176.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 27.0 t -64.81 -39.77 94.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.242 0.544 . . . . 71.150000000000006 110.445 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.721 ' HE3' ' HA ' ' A' ' 111' ' ' VAL . 0.7 OUTLIER -64.68 -51.7 61.11 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 115.779 -0.646 . . . . 71.040000000000006 110.629 178.326 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.57 HD11 HD12 ' A' ' 116' ' ' ILE . 2.2 pp -63.61 -42.04 94.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 116.209 -0.45 . . . . 71.219999999999999 111.51 -175.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.494 HG22 HD21 ' A' ' 66' ' ' LEU . 2.8 pp -64.33 -31.76 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 120.738 -0.385 . . . . 75.310000000000002 110.254 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.45 ' N ' HD12 ' A' ' 120' ' ' ILE . 23.0 t -69.75 -51.65 32.26 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.187 -0.46 . . . . 62.240000000000002 110.523 -178.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.402 ' OE1' ' NZ ' ' A' ' 118' ' ' LYS . 7.9 pt-20 -77.12 -40.68 44.86 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.806 0.669 . . . . 74.319999999999993 112.806 -176.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.505 HD12 HD12 ' A' ' 66' ' ' LEU . 69.5 mt -62.7 -53.7 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 O-C-N 122.046 -0.409 . . . . 72.530000000000001 110.696 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 13.1 m120 -59.86 -20.23 55.85 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.117 0.484 . . . . 72.010000000000005 110.85 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -78.81 -12.84 60.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.915 -0.584 . . . . 60.229999999999997 111.144 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -126.42 9.47 7.22 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.547 -0.297 . . . . 73.109999999999999 111.554 -178.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 123' ' ' ILE . 45.7 pt -138.99 168.09 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 109.871 -0.418 . . . . 71.040000000000006 109.871 175.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 . . . . . 0 C--O 1.251 1.163 0 CA-C-O 118.585 -0.722 . . . . 74.439999999999998 111.094 -179.46 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.1 mmm . . . . . 0 N--CA 1.484 1.236 0 N-CA-C 110.224 -0.287 . . . . 51.399999999999999 110.224 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.47 137.05 58.0 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.143 -0.481 . . . . 74.329999999999998 111.047 -178.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -76.07 124.13 26.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.017 -0.538 . . . . 73.010000000000005 109.961 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -63.87 125.72 25.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.583 -0.281 . . . . 75.420000000000002 110.335 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.6 p-80 -65.44 158.62 26.27 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 110.042 -0.355 . . . . 74.219999999999999 110.042 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -156.12 140.09 16.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.593 -0.276 . . . . 71.200000000000003 111.038 -174.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -151.72 121.15 6.85 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.984 0.421 . . . . 65.209999999999994 109.944 176.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -114.17 -177.53 3.15 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.961 -0.563 . . . . 71.340000000000003 110.504 -178.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 14.5 tpt -134.26 126.76 30.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.053 -0.521 . . . . 61.329999999999998 109.623 176.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.12 158.62 15.98 Favored Glycine 0 C--N 1.329 0.194 0 C-N-CA 121.092 -0.575 . . . . 54.420000000000002 112.858 -177.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.428 HG22 HD23 ' A' ' 12' ' ' LEU . 36.7 m -140.97 126.97 19.37 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.71 -0.848 . . . . 62.43 108.71 176.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.428 HD23 HG22 ' A' ' 11' ' ' THR . 4.5 mm? 62.38 12.98 5.68 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.213 0.53 . . . . 75.129999999999995 110.432 -170.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -81.65 103.09 11.12 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.623 -0.717 . . . . 62.409999999999997 109.608 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 60.32 22.17 11.65 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.207 0.527 . . . . 64.340000000000003 110.946 -177.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.407 ' HB3' ' HA ' ' A' ' 12' ' ' LEU . 34.2 tt0 -104.76 124.11 48.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.586 -0.734 . . . . 71.200000000000003 110.489 -175.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.1 p -109.54 -176.57 3.05 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.988 -0.551 . . . . 74.340000000000003 111.011 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -98.76 -178.57 4.02 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.961 0.41 . . . . 73.129999999999995 111.206 -175.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -171.95 59.37 0.16 Allowed Glycine 0 CA--C 1.522 0.507 0 CA-C-N 115.791 -0.641 . . . . 72.219999999999999 112.116 175.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -86.66 164.37 9.21 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.779 2.319 . . . . 73.219999999999999 112.326 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.65 172.41 36.22 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 121.28 -0.486 . . . . 71.450000000000003 112.112 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.3 m -92.81 104.64 16.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.846 0.355 . . . . 64.019999999999996 110.565 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.721 ' SD ' HG13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -98.19 9.89 41.87 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.195 0.521 . . . . 73.25 110.231 176.104 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.721 HG13 ' SD ' ' A' ' 22' ' ' MET . 49.7 mt -115.82 106.36 20.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-N 115.283 -0.871 . . . . 74.400000000000006 109.321 175.253 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.467 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 11.3 tp10 -105.7 136.92 44.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.737 0.303 . . . . 71.409999999999997 110.791 -176.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -90.6 128.46 36.6 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 122.379 0.272 . . . . 65.140000000000001 110.383 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.458 HG21 ' HD3' ' A' ' 34' ' ' LYS . 33.9 pt -128.0 149.9 33.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 120.851 0.358 . . . . 64.230000000000004 111.243 -178.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.51 179.09 53.23 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.616 -0.72 . . . . 13.31 112.789 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -63.7 -50.36 69.47 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 122.767 0.427 . . . . 73.329999999999998 111.262 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.9 m -64.43 -39.12 93.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.994 -0.548 . . . . 64.120000000000005 111.803 -172.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.559 ' HA ' ' HB3' ' A' ' 33' ' ' ASN . 16.3 pt-20 -85.37 -9.33 57.72 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 116.507 -0.315 . . . . 71.549999999999997 111.691 -174.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.408 ' HA ' HD12 ' A' ' 26' ' ' ILE . 34.6 t80 -47.8 -71.0 0.08 Allowed 'General case' 0 N--CA 1.464 0.25 0 O-C-N 123.192 0.307 . . . . 65.209999999999994 111.088 -177.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -66.57 -34.58 78.21 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.276 -0.638 . . . . 71.430000000000007 109.276 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.559 ' HB3' ' HA ' ' A' ' 30' ' ' GLU . 7.7 t30 -52.42 -33.82 45.59 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 114.487 -1.233 . . . . 63.409999999999997 111.989 -176.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.458 ' HD3' HG21 ' A' ' 26' ' ' ILE . 14.4 ptmt -114.95 -19.35 10.98 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.214 0.45 . . . . 53.439999999999998 112.214 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.4 t -88.43 -55.25 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 111.973 0.36 . . . . 61.520000000000003 111.973 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 39.9 p -72.83 -18.52 61.45 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.11 0.481 . . . . 74.430000000000007 111.033 -173.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.9 p -90.8 11.93 20.9 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.704 -0.68 . . . . 73.219999999999999 111.028 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 51.8 t -59.63 117.01 4.43 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.258 -0.428 . . . . 60.130000000000003 111.292 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -117.43 3.73 12.5 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.548 0.69 . . . . 70.230000000000004 109.349 172.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.628 ' HB2' HG22 ' A' ' 42' ' ' ILE . 1.8 m-20 -70.64 -31.85 68.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.963 -1.017 . . . . 63.240000000000002 110.684 -176.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' ' 40' ' ' ASP . 27.7 m-80 73.26 13.4 4.7 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.301 -0.863 . . . . 71.209999999999994 111.04 -175.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.628 HG22 ' HB2' ' A' ' 40' ' ' ASP . 15.1 tt -85.99 146.64 6.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 108.828 -0.804 . . . . 74.519999999999996 108.828 172.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.693 HD11 ' HB3' ' A' ' 101' ' ' MET . 63.4 tp -79.52 106.59 11.66 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-O 121.556 0.693 . . . . 74.319999999999993 110.312 -177.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.49 HG23 ' CD2' ' A' ' 77' ' ' TYR . 65.6 mt -88.68 107.53 17.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.801 -1.09 . . . . 75.349999999999994 110.364 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.4 HD13 HD22 ' A' ' 63' ' ' LEU . 70.3 mt -90.56 101.82 14.56 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.963 -0.562 . . . . 41.200000000000003 109.787 178.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.463 HG13 HG22 ' A' ' 44' ' ' ILE . 27.6 m -95.96 121.53 46.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.031 0.443 . . . . 71.439999999999998 110.849 -178.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -95.49 133.71 39.16 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.915 -0.584 . . . . 64.5 111.02 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -104.66 91.25 3.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.436 0.636 . . . . 73.030000000000001 111.495 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 11.7 t90 65.87 64.02 0.57 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 114.652 -1.158 . . . . 72.239999999999995 112.839 173.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -130.98 78.24 73.8 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 108.109 -1.071 . . . . 53.439999999999998 108.109 163.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -44.96 -80.87 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.588 2.859 . . . . 74.340000000000003 114.452 -167.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 47.7 t90 -174.13 159.46 3.23 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 109.625 -0.509 . . . . 74.150000000000006 109.625 -174.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 67.3 m -142.53 118.02 10.31 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.995 -0.372 . . . . 72.239999999999995 109.995 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -62.39 -71.83 0.75 Allowed Glycine 0 C--N 1.332 0.336 0 C-N-CA 121.201 -0.523 . . . . 63.140000000000001 112.013 178.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -75.26 72.5 4.79 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 122.311 2.007 . . . . 62.109999999999999 111.489 175.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 53.3 t -67.4 114.15 5.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.899 -0.591 . . . . 70.010000000000005 110.438 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.01 15.37 2.8 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.272 -0.422 . . . . 74.519999999999996 111.549 -179.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.1 m -127.95 132.05 49.26 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.227 -0.442 . . . . 52.329999999999998 110.078 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.764 HD23 ' H ' ' A' ' 59' ' ' LEU . 1.7 pt? -69.74 76.45 0.44 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.257 0.551 . . . . 73.329999999999998 110.215 177.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.596 ' HG2' ' NE2' ' A' ' 68' ' ' GLN . 2.4 mp0 62.97 110.36 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 115.022 -0.99 . . . . 73.140000000000001 111.587 -177.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 60' ' ' GLU . 19.1 Cg_endo -57.59 167.62 3.74 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.458 2.105 . . . . 71.140000000000001 111.104 175.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.469 ' NE2' ' HA ' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -45.3 -49.7 12.5 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 116.162 -0.472 . . . . 74.099999999999994 111.469 -171.813 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.726 ' HB3' HG12 ' A' ' 76' ' ' ILE . 71.6 mt -56.78 -48.88 76.9 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.225 -0.898 . . . . 74.219999999999999 111.012 -175.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.544 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 34.4 mt-10 -70.6 -44.33 67.5 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.24 -0.437 . . . . 74.409999999999997 109.959 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.411 ' HD2' ' HA ' ' A' ' 65' ' ' LYS . 12.3 tptp -54.57 -42.74 71.36 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.378 -0.828 . . . . 71.310000000000002 110.986 -174.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.505 HD21 HG22 ' A' ' 120' ' ' ILE . 13.9 mt -81.51 -39.5 24.62 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 120.795 -0.362 . . . . 73.239999999999995 111.171 176.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.496 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -55.19 -33.49 63.07 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.587 0.232 . . . . 61.5 111.295 -178.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.596 ' NE2' ' HG2' ' A' ' 60' ' ' GLU . 96.4 mt-30 -51.06 -42.46 60.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.99 0.424 . . . . 70.239999999999995 110.794 177.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -94.02 -55.17 3.31 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.684 -0.689 . . . . 65.549999999999997 111.592 -177.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.542 ' O ' HG22 ' A' ' 74' ' ' VAL . 12.0 m-85 -94.86 22.17 6.75 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.727 0.639 . . . . 75.230000000000004 112.727 -167.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.496 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 8.2 t -52.5 -27.33 15.9 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.9 0.381 . . . . 74.329999999999998 111.585 -177.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -63.58 -24.25 67.72 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.246 -0.434 . . . . 53.340000000000003 111.832 -178.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.55 9.2 5.97 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.485 0.183 . . . . 72.310000000000002 111.183 -177.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.542 HG22 ' O ' ' A' ' 70' ' ' TYR . 27.2 m -138.33 140.29 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 O-C-N 121.779 -0.575 . . . . 55.140000000000001 110.565 175.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 39.2 mmtm -141.07 135.25 30.82 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.135 -0.484 . . . . 63.310000000000002 110.031 174.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.726 HG12 ' HB3' ' A' ' 63' ' ' LEU . 3.4 mp -103.94 144.49 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.391 -0.368 . . . . 74.420000000000002 110.146 -176.129 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.49 ' CD2' HG23 ' A' ' 44' ' ' ILE . 81.2 m-85 -129.38 138.46 51.53 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.276 0.56 . . . . 72.200000000000003 111.537 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.507 ' HA ' ' HE2' ' A' ' 78' ' ' LYS . 9.6 mmpt? -99.01 100.22 11.36 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.284 -0.871 . . . . 72.219999999999999 108.804 174.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.841 HG22 ' H ' ' A' ' 81' ' ' ILE . 2.4 mp -83.95 138.69 18.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 110.249 -0.278 . . . . 72.5 110.249 -175.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -75.4 -8.29 56.31 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.382 -0.372 . . . . 55.210000000000001 111.822 -177.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.841 ' H ' HG22 ' A' ' 79' ' ' ILE . 68.7 mt -68.12 85.04 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.21 0.529 . . . . 61.140000000000001 109.845 176.086 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -82.75 -72.58 0.44 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.813 -0.63 . . . . 71.239999999999995 111.49 -175.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -90.52 -25.09 20.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.341 -0.39 . . . . 64.430000000000007 111.475 -174.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -82.4 58.31 4.05 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.027 0.441 . . . . 73.349999999999994 110.567 -175.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -109.31 104.38 13.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.859 0.361 . . . . 74.209999999999994 111.039 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -90.38 -27.98 18.98 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.733 -0.84 . . . . 61.450000000000003 108.733 170.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 67.7 t -51.49 -45.7 35.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 114.946 -1.024 . . . . 75.030000000000001 111.364 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.84 -42.18 88.7 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.19 -0.459 . . . . 73.530000000000001 110.919 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.0 m -74.32 -30.18 61.94 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.71 -0.677 . . . . 71.010000000000005 110.554 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -61.64 -55.49 29.98 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.677 -0.692 . . . . 72.230000000000004 110.445 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.418 ' HE2' ' HE2' ' A' ' 107' ' ' LYS . 97.4 m-85 -77.08 -13.31 59.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.956 -0.565 . . . . 74.030000000000001 110.343 178.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.46 39.25 61.55 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 115.748 -0.66 . . . . 71.209999999999994 112.875 174.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 14.6 p -72.43 -37.37 57.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.657 0.265 . . . . 73.5 110.502 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.8 t 67.43 -67.43 0.18 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.67 -0.696 . . . . 73.310000000000002 111.294 -178.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.58 134.9 48.06 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.49 -0.323 . . . . 73.129999999999995 111.057 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.422 ' HB ' ' HA ' ' A' ' 97' ' ' PRO . 29.4 pt -113.87 158.67 38.5 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 116.062 -0.517 . . . . 72.430000000000007 110.107 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.422 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 95.4 Cg_endo -82.96 177.55 31.45 Favored 'Cis proline' 0 C--N 1.35 0.645 0 C-N-CA 123.889 -1.296 . . . . 65.310000000000002 112.352 -1.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.1 m -140.8 131.22 25.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.113 -0.494 . . . . 71.120000000000005 109.843 178.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.608 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 26.6 mt -109.33 116.93 53.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.333 -0.394 . . . . 53.43 109.999 -176.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.2 mp -94.55 144.57 25.48 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.144 0.497 . . . . 73.120000000000005 110.777 -178.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.773 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 70.3 mtp -106.38 114.58 28.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.606 -0.725 . . . . 74.109999999999999 109.923 -179.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -115.83 140.63 49.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.76 0.314 . . . . 74.430000000000007 110.453 177.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.741 ' HB3' HD21 ' A' ' 108' ' ' LEU . 38.1 ttpt -156.79 128.32 7.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.997 -0.547 . . . . 63.310000000000002 109.561 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.7 t30 60.0 24.84 14.01 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.324 0.583 . . . . 65.239999999999995 110.686 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.28 -1.13 82.08 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 116.058 -0.519 . . . . 53.509999999999998 113.266 177.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -108.2 160.92 15.45 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.99 0.395 . . . . 51.240000000000002 110.49 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.418 ' HE2' ' HE2' ' A' ' 91' ' ' TYR . 20.2 pttp -92.69 139.92 30.07 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.472 -0.936 . . . . 45.119999999999997 108.472 170.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.741 HD21 ' HB3' ' A' ' 103' ' ' LYS . 3.0 mm? -105.72 -52.98 2.72 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 110.087 -0.338 . . . . 72.549999999999997 110.087 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.773 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 23.4 m -157.59 170.96 21.21 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.865 -0.607 . . . . 74.540000000000006 110.171 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.7 pm0 -128.85 123.87 33.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.932 -0.576 . . . . 75.319999999999993 109.831 172.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.608 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 63.6 t -80.66 113.93 20.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.822 -0.626 . . . . 64.25 110.25 176.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 42.1 mt -100.2 123.06 52.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.427 -0.583 . . . . 75.109999999999999 109.427 175.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.76 -129.89 14.0 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.957 -0.639 . . . . 74.409999999999997 111.985 -179.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.469 ' HA ' ' NE2' ' A' ' 62' ' ' GLN . . . -142.65 57.36 1.43 Allowed 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.012 0.434 . . . . 71.329999999999998 111.117 -178.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.553 ' O ' ' HG3' ' A' ' 118' ' ' LYS . 7.7 m-20 -88.32 86.42 7.06 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-O 121.681 0.753 . . . . 62.439999999999998 110.21 177.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.559 ' O ' HG13 ' A' ' 119' ' ' ILE . 7.9 tp -53.09 -35.68 23.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.003 -0.999 . . . . 73.120000000000005 110.636 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.6 m -67.07 -37.0 83.22 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.846 -0.615 . . . . 71.150000000000006 111.215 -177.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.553 ' HG3' ' O ' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -76.04 -41.62 50.22 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.642 -0.503 . . . . 71.040000000000006 109.642 -179.325 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.559 HG13 ' O ' ' A' ' 116' ' ' ILE . 1.9 pp -65.7 -42.35 92.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 116.286 -0.415 . . . . 71.219999999999999 110.943 -176.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.505 HG22 HD21 ' A' ' 66' ' ' LEU . 2.8 pp -66.8 -31.85 55.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 121.123 0.487 . . . . 75.310000000000002 109.957 177.21 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.412 ' N ' HD12 ' A' ' 120' ' ' ILE . 47.2 t -63.58 -51.01 67.2 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.73 -0.668 . . . . 62.240000000000002 110.686 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.493 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 11.6 pt-20 -77.85 -46.17 22.2 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.14 0.422 . . . . 74.319999999999993 112.14 -178.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.532 ' O ' HG12 ' A' ' 127' ' ' ILE . 67.5 mt -60.04 -51.0 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 117.903 0.319 . . . . 72.530000000000001 111.555 -176.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -59.11 -30.86 68.42 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.073 0.463 . . . . 72.010000000000005 110.922 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -83.17 -20.82 33.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.413 0.625 . . . . 60.229999999999997 110.282 177.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.493 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 1.8 t-20 -88.61 -37.37 15.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.689 -0.687 . . . . 73.109999999999999 111.524 -173.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.532 HG12 ' O ' ' A' ' 123' ' ' ILE . 46.8 pt -100.99 168.61 1.87 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 116.266 -0.424 . . . . 71.040000000000006 111.159 -177.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.3 p30 . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.432 -0.794 . . . . 74.439999999999998 111.297 -174.921 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.589 ' SD ' ' N ' ' A' ' 2' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.482 1.166 0 N-CA-C 109.53 -0.544 . . . . 51.399999999999999 109.53 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.589 ' N ' ' SD ' ' A' ' 1' ' ' MET . . . -58.73 89.51 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.176 0.512 . . . . 74.329999999999998 112.193 -176.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.518 ' CD2' ' SD ' ' A' ' 1' ' ' MET . 94.5 m-70 -138.41 41.68 2.22 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.393 -0.966 . . . . 73.010000000000005 108.393 173.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 45.5 t60 -62.31 161.17 11.88 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.754 -1.112 . . . . 75.420000000000002 111.798 -170.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 64.63 12.62 7.68 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.257 1.023 . . . . 74.219999999999999 112.234 173.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.401 ' O ' ' CG ' ' A' ' 6' ' ' HIS . 6.8 p80 -75.57 74.51 2.59 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.559 0.695 . . . . 71.200000000000003 110.952 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 25.3 p80 -157.84 83.13 0.88 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.61 0.719 . . . . 65.209999999999994 110.79 176.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.5 p-80 -138.43 36.99 2.26 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.375 -0.83 . . . . 71.340000000000003 108.886 171.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -97.2 178.24 5.31 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.663 -1.153 . . . . 61.329999999999998 110.222 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.22 -11.88 60.22 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 121.151 -0.547 . . . . 54.420000000000002 112.163 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.7 m -73.55 72.32 1.4 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.428 0.632 . . . . 62.43 109.998 178.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 52.3 tp -81.74 100.71 9.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.793 -0.64 . . . . 75.129999999999995 110.746 -176.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.33 108.56 5.79 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.285 -1.006 . . . . 62.409999999999997 108.285 173.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -152.42 53.54 0.79 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.211 -0.449 . . . . 64.340000000000003 110.702 -175.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -62.83 92.01 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.438 0.637 . . . . 71.200000000000003 110.004 176.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.0 m -101.04 9.33 42.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.734 0.778 . . . . 74.340000000000003 110.313 -176.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -120.03 -172.32 2.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.413 -0.812 . . . . 73.129999999999995 110.103 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.63 82.72 0.76 Allowed Glycine 0 C--N 1.331 0.273 0 N-CA-C 111.01 -0.836 . . . . 72.219999999999999 111.01 -173.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -77.96 51.28 3.58 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 123.056 2.504 . . . . 73.219999999999999 113.319 -172.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.6 10.76 64.29 Favored Glycine 0 C--N 1.332 0.327 0 CA-C-N 116.222 -0.445 . . . . 71.450000000000003 112.92 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.4 m -77.72 99.83 6.01 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.777 0.322 . . . . 64.019999999999996 110.183 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.521 ' N ' ' SD ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -68.24 -26.21 65.58 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.124 -0.489 . . . . 73.25 110.165 178.934 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.512 HG12 ' HG2' ' A' ' 22' ' ' MET . 14.3 mm -115.66 78.33 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 115.532 -0.758 . . . . 74.400000000000006 109.092 174.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.623 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 10.8 tp10 -96.99 153.17 18.07 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.21 -0.45 . . . . 71.409999999999997 110.016 -176.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.2 pp0? -97.84 138.88 34.53 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.613 -0.514 . . . . 65.140000000000001 109.613 177.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 39.2 pt -122.76 153.75 27.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-O 121.189 0.518 . . . . 64.230000000000004 111.095 -177.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.507 ' HA2' ' HB2' ' A' ' 80' ' ' ASN . . . -76.58 150.71 38.62 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.408 -0.815 . . . . 13.31 111.729 176.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -63.64 -34.98 79.05 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.981 0.419 . . . . 73.329999999999998 110.469 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.1 m -72.99 -16.38 61.51 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.734 -0.667 . . . . 64.120000000000005 111.63 -176.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -113.79 3.02 15.34 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.398 -0.364 . . . . 71.549999999999997 110.907 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -47.08 -71.15 0.08 Allowed 'General case' 0 N--CA 1.464 0.241 0 O-C-N 123.46 0.475 . . . . 65.209999999999994 110.951 -177.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -65.15 -34.82 79.3 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.861 -0.422 . . . . 71.430000000000007 109.861 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -52.04 -41.06 61.98 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.221 -0.9 . . . . 63.409999999999997 111.215 -174.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -106.81 -25.2 11.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.195 -0.457 . . . . 53.439999999999998 112.104 -177.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.4 HG21 HG21 ' A' ' 46' ' ' VAL . 79.1 t -84.12 -50.83 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 112.073 0.397 . . . . 61.520000000000003 112.073 -175.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.3 p -76.83 -32.54 57.65 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.987 0.422 . . . . 74.430000000000007 110.81 -175.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.8 m -80.59 12.41 3.11 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.765 -0.652 . . . . 73.219999999999999 111.695 -177.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.625 ' SG ' HG22 ' A' ' 42' ' ' ILE . 37.1 t -59.24 90.9 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.879 0.371 . . . . 60.130000000000003 111.182 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -80.58 -22.0 41.12 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.944 0.402 . . . . 70.230000000000004 111.185 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -72.86 2.57 6.52 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.535 -0.302 . . . . 63.240000000000002 111.742 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 63.0 21.91 13.17 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.422 -0.354 . . . . 71.209999999999994 111.777 172.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.625 HG22 ' SG ' ' A' ' 38' ' ' CYS . 6.8 tt -87.9 144.63 8.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 109.388 -0.597 . . . . 74.519999999999996 109.388 177.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.487 HD21 ' CE ' ' A' ' 101' ' ' MET . 42.1 tp -81.14 115.53 20.61 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.008 0.433 . . . . 74.319999999999993 109.979 -177.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 62.1 mt -102.58 123.28 55.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.91 -0.586 . . . . 75.349999999999994 110.263 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.548 ' HG ' ' HG2' ' A' ' 101' ' ' MET . 3.3 mp -114.23 106.02 13.86 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.049 -0.523 . . . . 41.200000000000003 109.753 -178.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.531 HG22 ' HB2' ' A' ' 77' ' ' TYR . 43.5 t -102.12 125.54 56.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.598 -0.274 . . . . 71.439999999999998 110.566 -178.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -98.01 138.49 35.25 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.17 0.51 . . . . 64.5 109.894 178.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -100.89 25.25 8.2 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.578 -0.737 . . . . 73.030000000000001 110.009 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 6.1 t90 -92.0 -41.16 10.7 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.898 -0.592 . . . . 72.239999999999995 109.486 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.634 ' HB1' ' HD2' ' A' ' 51' ' ' PRO . . . 64.68 170.56 0.09 OUTLIER Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 115.683 -0.69 . . . . 53.439999999999998 111.517 175.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.634 ' HD2' ' HB1' ' A' ' 50' ' ' ALA . 73.7 Cg_endo -75.08 56.18 4.22 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.279 1.986 . . . . 74.340000000000003 111.746 173.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 71.2 t-105 -74.6 148.15 41.01 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.843 -0.617 . . . . 74.150000000000006 110.752 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 25.2 p -67.76 86.81 0.22 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.09 0.472 . . . . 72.239999999999995 110.57 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -159.59 133.98 3.54 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.851 -0.613 . . . . 63.140000000000001 111.907 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -59.78 97.07 0.1 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.672 2.248 . . . . 62.109999999999999 111.785 178.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 55.6 m -62.76 -36.28 82.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.839 -0.618 . . . . 70.010000000000005 110.647 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 72.94 -33.35 0.27 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.596 -0.729 . . . . 74.519999999999996 112.234 176.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.9 t -90.32 123.26 33.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.829 0.347 . . . . 52.329999999999998 110.401 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.426 ' N ' HD22 ' A' ' 59' ' ' LEU . 3.0 mm? -101.31 11.52 39.11 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.132 -0.485 . . . . 73.329999999999998 109.869 176.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.3 tp10 -151.63 73.42 8.1 Favored Pre-proline 0 C--O 1.236 0.349 0 N-CA-C 109.171 -0.678 . . . . 73.140000000000001 109.171 -177.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.53 ' HG2' ' HB2' ' A' ' 64' ' ' GLU . 85.4 Cg_endo -75.45 156.52 41.01 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.702 2.268 . . . . 71.140000000000001 112.485 -176.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.585 ' HB3' HG12 ' A' ' 119' ' ' ILE . 9.9 mp0 -55.34 -55.93 25.94 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-O 121.592 0.711 . . . . 74.099999999999994 111.27 -173.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.558 HD11 HG21 ' A' ' 111' ' ' VAL . 3.2 mm? -59.33 -48.39 81.82 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 114.844 -1.071 . . . . 74.219999999999999 110.952 -171.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.585 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 48.4 mt-10 -68.38 -32.48 72.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.067 -0.515 . . . . 74.409999999999997 110.427 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 61' ' ' PRO . 2.8 tmtm? -59.09 -52.46 65.63 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.803 -0.443 . . . . 71.310000000000002 109.803 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.694 HD12 HD12 ' A' ' 123' ' ' ILE . 29.3 mt -70.88 -33.46 70.62 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 120.903 -0.319 . . . . 73.239999999999995 111.347 177.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.407 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -60.19 -27.13 66.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.334 -0.394 . . . . 61.5 111.47 -178.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.585 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 76.1 mt-30 -56.93 -35.79 69.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.843 0.354 . . . . 70.239999999999995 110.738 177.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -93.83 -55.94 3.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.401 0.619 . . . . 65.549999999999997 110.468 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.513 ' O ' HG22 ' A' ' 74' ' ' VAL . 23.4 m-85 -84.74 22.51 1.33 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.58 -0.736 . . . . 75.230000000000004 112.69 -172.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.433 ' O ' ' NZ ' ' A' ' 75' ' ' LYS . 4.4 t -52.28 -44.54 65.05 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.369 0.507 . . . . 74.329999999999998 112.369 -170.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -73.14 -16.21 61.45 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 122.04 -0.412 . . . . 53.340000000000003 111.316 -176.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -101.6 -20.47 15.03 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 110.078 -0.342 . . . . 72.310000000000002 110.078 178.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 70' ' ' TYR . 25.4 m -136.91 122.06 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 121.298 0.571 . . . . 55.140000000000001 110.64 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.433 ' NZ ' ' O ' ' A' ' 71' ' ' THR . 38.0 mmtm -119.29 124.75 47.44 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.639 -0.504 . . . . 63.310000000000002 109.639 177.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.536 HG13 ' HB2' ' A' ' 45' ' ' LEU . 2.1 mp -97.37 137.48 24.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 74.420000000000002 110.054 -175.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.623 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 20.2 m-85 -126.58 134.45 50.81 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.116 -0.493 . . . . 72.200000000000003 110.368 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 19.1 mtpp -96.31 122.51 39.26 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.181 -0.674 . . . . 72.219999999999999 109.181 176.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.6 tp -64.13 145.74 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-O 120.908 0.385 . . . . 72.5 111.18 -176.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.507 ' HB2' ' HA2' ' A' ' 27' ' ' GLY . 52.9 t30 -60.22 -66.2 0.56 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.007 -0.542 . . . . 55.210000000000001 110.801 177.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.452 ' O ' ' HG2' ' A' ' 85' ' ' GLN . 59.0 mt -105.69 119.78 55.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.898 -0.592 . . . . 61.140000000000001 109.669 -179.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.505 ' CD ' ' H ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -85.73 -57.79 2.91 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.795 0.665 . . . . 71.239999999999995 112.795 -172.997 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.453 ' N ' ' HG2' ' A' ' 82' ' ' GLU . 26.9 t70 -75.13 -21.61 58.72 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.274 0.472 . . . . 64.430000000000007 112.274 -166.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -87.86 0.95 55.15 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.962 0.411 . . . . 73.349999999999994 111.336 -177.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.452 ' HG2' ' O ' ' A' ' 81' ' ' ILE . 84.1 mm-40 -78.61 104.07 8.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.951 0.405 . . . . 74.209999999999994 110.184 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -63.32 -17.93 63.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.82 -0.627 . . . . 61.450000000000003 110.581 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.4 t -54.17 -46.3 67.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 115.869 -0.605 . . . . 75.030000000000001 110.705 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.4 -43.41 98.92 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.922 -0.581 . . . . 73.530000000000001 110.76 -178.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.4 m -74.52 -28.11 60.83 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.741 -0.663 . . . . 71.010000000000005 110.964 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -64.49 -51.11 64.67 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.067 0.46 . . . . 72.230000000000004 109.928 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -79.01 -6.71 57.03 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.684 -0.689 . . . . 74.030000000000001 110.36 176.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 61.95 53.32 43.85 Favored Glycine 0 C--N 1.331 0.281 0 CA-C-N 115.84 -0.618 . . . . 71.209999999999994 113.19 172.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.473 HG22 ' H ' ' A' ' 95' ' ' ALA . 10.0 p -80.01 133.67 29.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.908 0.385 . . . . 73.5 110.671 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.4 t -128.17 27.12 5.68 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.107 0.48 . . . . 73.310000000000002 110.329 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.473 ' H ' HG22 ' A' ' 93' ' ' VAL . . . -145.03 130.38 18.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.01 -0.541 . . . . 73.129999999999995 110.157 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.805 HD13 ' H ' ' A' ' 96' ' ' ILE . 0.2 OUTLIER -110.37 148.14 37.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 72.430000000000007 110.242 -178.153 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -77.07 -178.12 23.21 Favored 'Cis proline' 0 C--N 1.351 0.687 0 C-N-CA 123.758 -1.351 . . . . 65.310000000000002 112.512 -1.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.0 m -137.81 115.64 11.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.105 -0.498 . . . . 71.120000000000005 110.039 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.445 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.9 mp -121.6 123.16 68.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-N 116.216 -0.447 . . . . 53.43 109.84 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.5 mp -101.24 141.77 33.64 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.243 -0.28 . . . . 73.120000000000005 110.243 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.76 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 56.5 mtp -116.91 115.48 25.58 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 116.398 -0.364 . . . . 74.109999999999999 110.872 -175.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -117.38 154.29 31.58 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.049 -0.523 . . . . 74.430000000000007 110.511 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.749 ' HB3' HD21 ' A' ' 108' ' ' LEU . 28.1 ttpp -168.23 122.89 0.94 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.747 -0.661 . . . . 63.310000000000002 109.78 178.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.2 t30 53.82 45.95 26.77 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.545 0.688 . . . . 65.239999999999995 110.845 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 73.87 3.83 65.07 Favored Glycine 0 CA--C 1.52 0.392 0 CA-C-N 115.578 -0.737 . . . . 53.509999999999998 113.719 176.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -111.41 142.87 43.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 117.134 0.467 . . . . 51.240000000000002 110.589 -178.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.477 ' O ' ' HG3' ' A' ' 107' ' ' LYS . 12.5 ptmm? -95.51 112.39 24.12 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.082 -0.71 . . . . 45.119999999999997 109.082 172.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.749 HD21 ' HB3' ' A' ' 103' ' ' LYS . 1.5 mm? -89.33 -53.18 4.67 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.088 0.471 . . . . 72.549999999999997 110.904 -172.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.76 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 22.8 m -150.08 172.02 15.93 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.517 -0.765 . . . . 74.540000000000006 110.458 -169.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.27 121.28 2.65 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.092 0.472 . . . . 75.319999999999993 111.116 -177.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.558 HG21 HD11 ' A' ' 63' ' ' LEU . 59.8 t -80.43 107.47 12.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.607 -0.724 . . . . 64.25 110.037 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.425 HG22 ' HB3' ' A' ' 95' ' ' ALA . 65.7 mt -110.58 106.91 21.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.344 -0.613 . . . . 75.109999999999999 109.344 177.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 96.51 -141.33 15.55 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 111.398 -0.681 . . . . 74.409999999999997 111.398 -176.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -141.54 88.58 2.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.914 0.357 . . . . 71.329999999999998 110.65 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.538 ' O ' HG23 ' A' ' 119' ' ' ILE . 11.7 m-20 -132.9 97.08 3.93 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.101 -0.499 . . . . 62.439999999999998 110.14 178.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.52 ' O ' HG13 ' A' ' 119' ' ' ILE . 7.1 tp -58.49 -40.25 77.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 120.846 0.355 . . . . 73.120000000000005 111.13 -177.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.3 t -67.24 -28.64 68.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.164 0.507 . . . . 71.150000000000006 110.74 -178.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -79.27 -43.77 23.05 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.985 -0.552 . . . . 71.040000000000006 110.75 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.585 HG12 ' HB3' ' A' ' 62' ' ' GLN . 1.8 pp -67.64 -41.53 85.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 71.219999999999999 110.613 -177.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.65 HG22 HD11 ' A' ' 66' ' ' LEU . 2.7 pp -62.21 -31.64 52.17 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 109.693 -0.484 . . . . 75.310000000000002 109.693 177.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 23.1 t -69.71 -51.23 36.25 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.712 -0.676 . . . . 62.240000000000002 110.083 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.437 ' OE1' ' HB3' ' A' ' 109' ' ' SER . 16.4 pt-20 -74.12 -33.93 63.73 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 112.109 0.411 . . . . 74.319999999999993 112.109 -175.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.694 HD12 HD12 ' A' ' 66' ' ' LEU . 64.6 mt -67.13 -58.05 7.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 O-C-N 122.264 -0.272 . . . . 72.530000000000001 110.518 178.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -63.16 -19.98 64.97 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.073 0.463 . . . . 72.010000000000005 110.932 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.417 ' HB3' ' O ' ' A' ' 122' ' ' GLU . 27.2 t-20 -60.69 -31.45 70.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.067 -0.515 . . . . 60.229999999999997 111.219 176.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -114.22 -3.15 13.22 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.075 0.398 . . . . 73.109999999999999 112.075 -173.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.442 HG12 ' O ' ' A' ' 123' ' ' ILE . 33.9 pt -135.64 168.56 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 110.372 -0.233 . . . . 71.040000000000006 110.372 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.7 p30 . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.383 -0.818 . . . . 74.439999999999998 111.104 178.492 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ttt . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 121.166 0.508 . . . . 51.399999999999999 110.167 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.97 82.07 7.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.921 -0.581 . . . . 74.329999999999998 110.485 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 61.2 t60 -91.73 31.75 1.18 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.355 0.598 . . . . 73.010000000000005 109.898 -178.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -79.89 53.53 1.68 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.595 -0.73 . . . . 75.420000000000002 111.453 -174.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -160.13 142.02 12.86 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.708 0.29 . . . . 74.219999999999999 110.581 176.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -148.02 -156.44 0.72 Allowed 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.25 -1.019 . . . . 71.200000000000003 108.25 175.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -139.36 136.78 35.13 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.19 -0.67 . . . . 65.209999999999994 109.19 174.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -132.55 78.04 1.78 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.068 0.461 . . . . 71.340000000000003 110.435 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 46.0 tpp -175.31 99.31 0.08 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.588 -0.733 . . . . 61.329999999999998 109.324 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.442 ' O ' ' HB3' ' A' ' 13' ' ' GLU . . . 121.84 -9.82 9.72 Favored Glycine 0 C--N 1.33 0.217 0 N-CA-C 111.267 -0.733 . . . . 54.420000000000002 111.267 -175.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.657 HG23 HD12 ' A' ' 12' ' ' LEU . 7.6 t -68.23 -21.59 64.83 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.391 0.276 . . . . 62.43 111.295 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.657 HD12 HG23 ' A' ' 11' ' ' THR . 8.7 mp -85.85 62.07 7.23 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.954 -0.758 . . . . 75.129999999999995 108.954 171.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.442 ' HB3' ' O ' ' A' ' 10' ' ' GLY . 14.8 tp10 -172.32 -54.09 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.349 -0.841 . . . . 62.409999999999997 109.231 -174.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -119.87 103.14 9.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.356 -0.838 . . . . 64.340000000000003 110.035 177.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -141.5 22.13 2.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.673 -0.694 . . . . 71.200000000000003 109.745 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.7 p -71.56 88.69 0.94 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.541 -0.754 . . . . 74.340000000000003 110.476 -177.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.406 ' OE1' ' HA ' ' A' ' 17' ' ' GLN . 19.8 mm-40 -75.46 87.66 2.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.569 0.699 . . . . 73.129999999999995 110.941 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.61 60.25 0.25 Allowed Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 114.853 -1.067 . . . . 72.219999999999999 110.796 176.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.453 ' HA ' ' OE1' ' A' ' 24' ' ' GLU . 46.4 Cg_endo -66.97 141.02 56.7 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.804 2.336 . . . . 73.219999999999999 112.505 -173.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 158.9 -12.33 0.21 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.824 -0.703 . . . . 71.450000000000003 113.246 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.708 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 32.5 t -70.44 147.83 49.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.207 0.504 . . . . 64.019999999999996 110.25 179.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -70.27 -27.29 64.31 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.7 -0.481 . . . . 73.25 109.7 176.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.472 HG12 ' HB ' ' A' ' 76' ' ' ILE . 51.1 mt -133.79 106.6 9.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 108.927 -0.768 . . . . 74.400000000000006 108.927 173.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.708 ' HB2' ' HB3' ' A' ' 21' ' ' SER . 36.9 tt0 -131.94 118.61 20.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.604 -0.271 . . . . 71.409999999999997 111.083 -171.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.423 ' CD ' ' H ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -81.62 132.73 35.31 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.209 -0.664 . . . . 65.140000000000001 109.209 173.454 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 25.8 pt -126.44 175.32 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 120.983 0.42 . . . . 64.230000000000004 111.952 -170.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.45 154.13 26.97 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.646 -0.707 . . . . 13.31 112.369 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -67.41 -31.2 71.24 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.961 0.41 . . . . 73.329999999999998 110.957 -177.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.3 p -71.02 -39.29 72.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.999 -0.546 . . . . 64.120000000000005 110.877 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.437 ' HA ' ' HB3' ' A' ' 33' ' ' ASN . 13.1 pt-20 -91.48 -3.77 56.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.999 -0.546 . . . . 71.549999999999997 110.991 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -46.34 -71.02 0.08 Allowed 'General case' 0 N--CA 1.464 0.26 0 O-C-N 123.622 0.576 . . . . 65.209999999999994 111.161 -176.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -68.04 -35.17 77.81 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 109.396 -0.594 . . . . 71.430000000000007 109.396 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.437 ' HB3' ' HA ' ' A' ' 30' ' ' GLU . 6.2 t30 -52.53 -34.27 49.08 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 114.586 -1.188 . . . . 63.409999999999997 111.816 -175.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.2 ptmt -111.69 -27.52 8.49 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.774 -0.194 . . . . 53.439999999999998 111.426 -178.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 71.7 t -84.57 -56.66 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 111.745 0.276 . . . . 61.520000000000003 111.745 -177.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.8 p -80.01 -23.77 41.29 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.011 0.434 . . . . 74.430000000000007 110.444 -173.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.1 m -83.66 6.08 22.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.733 -0.667 . . . . 73.219999999999999 111.027 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.614 ' SG ' HG22 ' A' ' 42' ' ' ILE . 48.0 t -66.88 98.92 0.58 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.887 0.375 . . . . 60.130000000000003 110.427 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -88.9 -2.94 58.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.102 -0.499 . . . . 70.230000000000004 110.318 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -71.56 -6.62 42.05 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.175 -0.466 . . . . 63.240000000000002 110.67 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 60.54 23.3 12.99 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.88 -0.6 . . . . 71.209999999999994 111.42 176.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.614 HG22 ' SG ' ' A' ' 38' ' ' CYS . 12.4 tt -84.9 152.61 3.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.754 -0.832 . . . . 74.519999999999996 108.754 174.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.563 HD21 ' HE3' ' A' ' 101' ' ' MET . 58.9 tp -85.09 110.2 18.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.606 0.241 . . . . 74.319999999999993 110.45 -175.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 101' ' ' MET . 54.4 mt -100.62 136.68 31.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.472 -0.331 . . . . 75.349999999999994 110.591 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.555 ' HG ' ' HG2' ' A' ' 101' ' ' MET . 3.7 mp -122.67 109.45 14.28 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.572 -0.529 . . . . 41.200000000000003 109.572 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 30.1 m -95.27 127.35 47.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.717 0.294 . . . . 71.439999999999998 110.606 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.419 ' HB3' ' HE2' ' A' ' 78' ' ' LYS . 3.1 t70 -125.63 149.42 48.43 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.322 0.582 . . . . 64.5 112.231 -171.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.522 ' CZ ' ' HB ' ' A' ' 98' ' ' THR . 22.5 p90 -134.75 95.21 3.3 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.493 -0.929 . . . . 73.030000000000001 108.493 164.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.446 ' HA ' ' HB3' ' A' ' 97' ' ' PRO . 10.9 p90 -74.56 177.16 6.24 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 114.539 -1.21 . . . . 72.239999999999995 112.138 -172.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 72.93 146.54 0.12 Allowed Pre-proline 0 N--CA 1.464 0.271 0 CA-C-N 115.148 -0.933 . . . . 53.439999999999998 111.472 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.627 ' HA ' HG12 ' A' ' 96' ' ' ILE . 32.1 Cg_endo -64.02 -27.34 65.93 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.349 2.033 . . . . 74.340000000000003 111.307 177.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.419 ' HB2' ' O ' ' A' ' 51' ' ' PRO . 20.6 t90 171.93 -43.85 0.01 OUTLIER 'General case' 0 C--O 1.234 0.272 0 CA-C-N 114.727 -1.124 . . . . 74.150000000000006 108.113 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 13.8 p -176.32 150.08 0.89 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-N 114.79 -1.096 . . . . 72.239999999999995 109.311 175.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.62 -148.27 16.9 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 121.128 -0.558 . . . . 63.140000000000001 112.354 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.86 157.61 47.33 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.722 2.281 . . . . 62.109999999999999 112.44 -178.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 73.9 m -147.62 -39.19 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 70.010000000000005 110.706 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.2 ttm180 62.03 76.99 0.35 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.337 0.589 . . . . 74.519999999999996 110.227 -177.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.0 m -96.32 129.72 43.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.836 -0.62 . . . . 52.329999999999998 110.99 -176.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 54.9 tp -169.39 89.65 0.2 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.355 -0.384 . . . . 73.329999999999998 109.991 175.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 56.41 75.12 0.61 Allowed Pre-proline 0 N--CA 1.467 0.42 0 CA-C-N 115.771 -0.649 . . . . 73.140000000000001 111.733 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -73.0 -178.08 3.32 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.488 2.126 . . . . 71.140000000000001 111.396 173.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.541 ' HB3' HG12 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -49.9 -50.21 46.92 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 121.359 0.6 . . . . 74.099999999999994 110.966 -176.734 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.701 HD21 HG21 ' A' ' 99' ' ' ILE . 8.8 mp -60.36 -48.85 79.99 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.258 -0.883 . . . . 74.219999999999999 111.524 -174.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.616 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 40.2 mt-10 -67.92 -36.35 80.01 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.804 -0.443 . . . . 74.409999999999997 109.804 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -54.93 -51.13 67.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.797 -0.638 . . . . 71.310000000000002 110.23 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.463 HD11 HG22 ' A' ' 120' ' ' ILE . 22.9 mt -78.3 -34.79 48.58 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.517 -0.31 . . . . 73.239999999999995 111.802 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.503 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.37 -28.05 69.73 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 111.345 0.128 . . . . 61.5 111.345 -175.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.616 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 78.9 mt-30 -53.0 -32.4 46.36 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.284 0.564 . . . . 70.239999999999995 109.993 175.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -93.55 -59.08 2.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.562 -0.745 . . . . 65.549999999999997 110.427 175.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.583 ' O ' HG22 ' A' ' 74' ' ' VAL . 19.0 m-85 -87.55 17.78 4.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.32 -0.855 . . . . 75.230000000000004 113.134 -168.101 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.503 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 9.3 t -52.95 -36.08 59.57 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.147 0.43 . . . . 74.329999999999998 111.552 -176.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -70.8 -17.18 62.78 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.826 0.346 . . . . 53.340000000000003 111.493 -178.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -112.21 -10.57 13.84 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.269 -0.423 . . . . 72.310000000000002 110.6 -176.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 70' ' ' TYR . 32.6 m -131.08 151.07 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 O-C-N 122.174 -0.329 . . . . 55.140000000000001 110.872 -179.126 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.621 ' HA ' ' HE3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -134.1 127.04 31.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.912 -0.585 . . . . 63.310000000000002 109.484 177.662 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.472 ' HB ' HG12 ' A' ' 23' ' ' ILE . 51.6 mt -102.21 130.31 52.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 120.788 0.328 . . . . 74.420000000000002 110.232 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.425 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 74.7 m-85 -131.13 151.44 51.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 72.200000000000003 109.779 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.419 ' HE2' ' HB3' ' A' ' 47' ' ' ASP . 1.3 mptm? -126.28 173.07 9.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.751 0.31 . . . . 72.219999999999999 111.302 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 61.7 mt 71.81 93.86 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 114.992 -1.004 . . . . 72.5 109.824 -174.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -120.4 -68.64 0.89 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.218 -0.901 . . . . 55.210000000000001 109.747 -176.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.3 pt -146.69 128.18 6.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.501 -0.772 . . . . 61.140000000000001 109.985 -176.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -85.61 -73.05 0.46 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.939 0.399 . . . . 71.239999999999995 110.224 175.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -125.63 -25.85 3.63 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.177 -0.465 . . . . 64.430000000000007 111.28 177.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -89.7 95.4 10.24 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.908 -0.587 . . . . 73.349999999999994 110.31 -175.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.539 ' OE1' ' HB3' ' A' ' 88' ' ' ALA . 0.5 OUTLIER -145.01 138.77 26.99 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.953 0.723 . . . . 74.209999999999994 112.953 -177.584 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -90.92 -44.12 9.56 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.057 -0.72 . . . . 61.450000000000003 109.057 162.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.4 p -52.12 -54.85 12.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 114.576 -1.193 . . . . 75.030000000000001 113.185 -170.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.539 ' HB3' ' OE1' ' A' ' 85' ' ' GLN . . . -61.09 -49.68 76.34 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.714 0.293 . . . . 73.530000000000001 110.839 -174.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.3 m -65.03 -32.67 74.5 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.281 -0.418 . . . . 71.010000000000005 111.081 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -66.32 -40.05 89.67 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.978 0.418 . . . . 72.230000000000004 110.202 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -81.88 -17.07 48.55 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.187 -0.461 . . . . 74.030000000000001 110.321 175.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.47 23.26 60.87 Favored Glycine 0 CA--C 1.519 0.327 0 CA-C-N 115.986 -0.552 . . . . 71.209999999999994 112.821 177.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.1 t -61.03 133.56 26.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 120.59 0.233 . . . . 73.5 110.721 -178.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 29.2 t -137.37 11.98 3.01 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.194 -0.457 . . . . 73.310000000000002 110.72 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -134.49 140.18 46.01 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.355 -0.384 . . . . 73.129999999999995 110.49 -177.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.627 HG12 ' HA ' ' A' ' 51' ' ' PRO . 2.7 pp -112.63 155.05 44.47 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 116.102 -0.499 . . . . 72.430000000000007 111.156 -176.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.446 ' HB3' ' HA ' ' A' ' 49' ' ' TRP . 89.8 Cg_endo -79.04 165.31 81.81 Favored 'Cis proline' 0 C--N 1.354 0.848 0 C-N-CA 123.611 -1.412 . . . . 65.310000000000002 111.582 -3.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.522 ' HB ' ' CZ ' ' A' ' 48' ' ' PHE . 22.8 m -117.54 120.79 39.14 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.817 -0.438 . . . . 71.120000000000005 109.817 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.704 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 27.6 mt -126.24 112.54 30.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.715 -0.675 . . . . 53.43 109.734 -175.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.39 134.18 42.62 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.056 -0.35 . . . . 73.120000000000005 110.056 -176.036 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.776 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 61.8 mtp -101.82 117.54 35.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.448 . . . . 74.109999999999999 110.912 -175.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -115.39 156.49 25.46 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 120.972 0.415 . . . . 74.430000000000007 111.235 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.755 ' HB3' HD21 ' A' ' 108' ' ' LEU . 37.7 ttmt -169.55 122.38 0.74 Allowed 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.279 -0.873 . . . . 63.310000000000002 109.598 177.019 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 63.3 t30 60.56 26.08 15.75 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.327 0.584 . . . . 65.239999999999995 111.099 174.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.8 -14.45 61.65 Favored Glycine 0 CA--C 1.52 0.368 0 CA-C-N 115.971 -0.559 . . . . 53.509999999999998 112.681 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -94.73 139.54 31.1 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 122.591 0.356 . . . . 51.240000000000002 110.071 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.629 ' HD3' ' H ' ' A' ' 107' ' ' LYS . 0.1 OUTLIER -93.93 130.41 40.03 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.002 -0.74 . . . . 45.119999999999997 109.002 173.069 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.755 HD21 ' HB3' ' A' ' 103' ' ' LYS . 2.1 mm? -94.42 -53.16 4.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.166 -0.47 . . . . 72.549999999999997 110.737 -174.02 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.776 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 49.6 m -151.25 171.94 16.63 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.551 -0.75 . . . . 74.540000000000006 110.345 -172.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -145.15 114.87 7.29 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.153 0.502 . . . . 75.319999999999993 110.685 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.704 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 51.5 t -80.15 107.42 12.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.623 -0.717 . . . . 64.25 109.98 178.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 60.5 mt -110.18 106.73 21.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.243 -0.435 . . . . 75.109999999999999 110.202 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 93.3 -134.55 12.19 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 116.109 -0.496 . . . . 74.409999999999997 112.051 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -137.81 76.53 1.58 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.149 0.499 . . . . 71.329999999999998 110.78 -177.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -114.03 97.48 6.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.912 -0.586 . . . . 62.439999999999998 110.336 177.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.609 HD12 HD11 ' A' ' 119' ' ' ILE . 7.9 tp -62.54 -39.86 86.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-O 121.089 0.471 . . . . 73.120000000000005 110.038 178.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.4 m -63.27 -39.71 95.34 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.571 -0.741 . . . . 71.150000000000006 110.554 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -64.49 -56.17 15.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.757 -0.656 . . . . 71.040000000000006 110.617 177.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.609 HD11 HD12 ' A' ' 116' ' ' ILE . 2.4 pp -62.68 -39.94 86.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.121 -0.491 . . . . 71.219999999999999 111.816 -171.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.463 HG22 HD11 ' A' ' 66' ' ' LEU . 2.8 pp -64.08 -31.82 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 120.314 -0.554 . . . . 75.310000000000002 110.078 178.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.438 ' N ' HD12 ' A' ' 120' ' ' ILE . 33.1 t -70.67 -51.8 25.35 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.717 -0.674 . . . . 62.240000000000002 110.797 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -77.53 -43.11 33.08 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.544 0.572 . . . . 74.319999999999993 112.544 -174.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.443 ' O ' HG12 ' A' ' 127' ' ' ILE . 79.7 mt -60.72 -57.62 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 O-C-N 122.187 -0.321 . . . . 72.530000000000001 110.813 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -59.58 -20.16 53.86 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.379 -0.373 . . . . 72.010000000000005 111.293 -177.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -76.24 -33.63 59.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.993 0.425 . . . . 60.229999999999997 110.349 176.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -98.73 -0.34 42.97 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.222 -0.445 . . . . 73.109999999999999 112.087 -175.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.443 HG12 ' O ' ' A' ' 123' ' ' ILE . 37.2 pt -133.71 168.27 24.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.763 -0.458 . . . . 71.040000000000006 109.763 172.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 25.7 p-10 . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.481 -0.771 . . . . 74.439999999999998 110.861 -174.843 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptt? . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 120.699 0.285 . . . . 51.399999999999999 110.564 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.51 54.78 1.82 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.147 0.425 . . . . 74.329999999999998 112.147 -174.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.407 ' CG ' ' O ' ' A' ' 3' ' ' HIS . 36.5 t-80 58.05 14.02 2.49 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.036 0.534 . . . . 73.010000000000005 112.291 173.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -88.04 134.16 33.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.998 0.428 . . . . 75.420000000000002 111.177 -177.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -85.68 116.83 24.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.773 -0.649 . . . . 74.219999999999999 109.408 173.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -69.96 93.42 0.78 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.015 0.436 . . . . 71.200000000000003 110.566 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 65.6 t60 -99.47 119.53 38.15 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.042 -0.526 . . . . 65.209999999999994 109.819 176.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -60.57 125.47 23.82 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.809 -0.441 . . . . 71.340000000000003 109.809 176.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.4 ptm -134.5 149.83 50.73 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.336 -0.393 . . . . 61.329999999999998 110.357 -175.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.06 -164.3 39.93 Favored Glycine 0 N--CA 1.451 -0.332 0 N-CA-C 111.701 -0.56 . . . . 54.420000000000002 111.701 177.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.5 m 65.32 8.38 4.9 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.449 0.642 . . . . 62.43 110.836 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 62.4 tp -79.78 118.43 21.56 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.086 -0.506 . . . . 75.129999999999995 109.683 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 66.69 22.72 10.35 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 123.547 0.529 . . . . 62.409999999999997 110.551 -178.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.67 83.08 1.15 Allowed 'General case' 0 C--O 1.232 0.148 0 N-CA-C 109.385 -0.598 . . . . 64.340000000000003 109.385 176.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -125.0 132.73 53.21 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.905 -0.776 . . . . 71.200000000000003 108.905 -177.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.2 m -72.1 82.98 0.98 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.048 0.451 . . . . 74.340000000000003 110.897 -177.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -81.78 82.85 7.33 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.32 0.581 . . . . 73.129999999999995 109.911 177.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 170.79 72.31 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.438 -0.801 . . . . 72.219999999999999 111.668 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -81.11 -176.02 2.94 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.983 2.455 . . . . 73.219999999999999 112.011 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.78 78.28 0.38 Allowed Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 111.645 -0.582 . . . . 71.450000000000003 111.645 177.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.584 ' HB2' HG12 ' A' ' 23' ' ' ILE . 20.6 p -92.16 -47.88 7.0 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.737 0.303 . . . . 64.019999999999996 110.969 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 21.8 mmt 57.67 43.35 22.39 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 121.234 0.54 . . . . 73.25 110.94 -178.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.584 HG12 ' HB2' ' A' ' 21' ' ' SER . 13.2 mm -89.08 86.98 2.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-N 115.233 -0.894 . . . . 74.400000000000006 108.597 172.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.537 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 9.6 tp10 -95.06 134.87 37.28 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.376 -0.374 . . . . 71.409999999999997 110.726 -176.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.1 pp0? -97.93 132.14 43.78 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.753 -0.462 . . . . 65.140000000000001 109.753 177.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.497 HD12 ' HA ' ' A' ' 31' ' ' PHE . 34.4 pt -123.97 175.14 6.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.417 -0.356 . . . . 64.230000000000004 111.383 -172.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.44 170.87 33.01 Favored Glycine 0 C--N 1.331 0.265 0 CA-C-N 115.802 -0.635 . . . . 13.31 112.998 -177.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -67.5 -42.37 82.97 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.058 0.543 . . . . 73.329999999999998 111.286 -177.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 24.7 t -76.44 -47.32 23.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 64.120000000000005 111.188 -174.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -73.47 -9.43 58.68 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.543 -0.299 . . . . 71.549999999999997 111.401 -179.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.606 ' HE1' HG11 ' A' ' 46' ' ' VAL . 50.8 t80 -44.21 -71.09 0.08 Allowed 'General case' 0 CA--C 1.529 0.163 0 O-C-N 123.451 0.47 . . . . 65.209999999999994 111.136 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -65.69 -32.87 74.67 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.04 -0.356 . . . . 71.430000000000007 110.04 -178.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.51 ' O ' ' HB3' ' A' ' 37' ' ' SER . 7.1 t30 -52.35 -41.02 62.68 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.232 -0.894 . . . . 63.409999999999997 111.16 -177.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 38' ' ' CYS . 13.1 ptmt -108.83 -15.89 14.29 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.227 -0.442 . . . . 53.439999999999998 111.905 -176.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.6 t -88.52 -60.99 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 111.867 0.321 . . . . 61.520000000000003 111.867 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.9 p -81.88 -28.85 32.73 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.814 0.34 . . . . 74.430000000000007 111.093 -172.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.51 ' HB3' ' O ' ' A' ' 33' ' ' ASN . 46.5 t -91.16 12.29 20.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.959 -0.564 . . . . 73.219999999999999 110.191 177.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 34' ' ' LYS . 51.2 t -67.48 95.65 0.47 Allowed 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 120.96 0.409 . . . . 60.130000000000003 111.157 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 58.3 t30 -89.71 14.41 11.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.33 0.586 . . . . 70.230000000000004 109.811 174.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -74.74 -6.02 46.55 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.858 -0.61 . . . . 63.240000000000002 110.392 -179.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.43 ' HA ' ' HB2' ' A' ' 104' ' ' ASN . 2.1 t-20 62.82 4.96 1.6 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.989 0.737 . . . . 71.209999999999994 112.989 174.092 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.678 HG21 ' HE2' ' A' ' 75' ' ' LYS . 13.2 tt -90.12 159.13 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.983 -0.377 . . . . 74.519999999999996 109.983 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.459 HD11 ' HB3' ' A' ' 101' ' ' MET . 64.7 tp -85.41 107.71 17.52 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.264 0.554 . . . . 74.319999999999993 109.94 178.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.415 HD11 ' SG ' ' A' ' 38' ' ' CYS . 65.6 mt -92.97 132.06 38.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.37 -0.832 . . . . 75.349999999999994 110.309 177.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.654 HD13 HD12 ' A' ' 63' ' ' LEU . 40.3 mt -111.04 101.84 10.35 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.267 -0.642 . . . . 41.200000000000003 109.267 177.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.606 HG11 ' HE1' ' A' ' 31' ' ' PHE . 61.3 t -91.5 116.3 32.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.564 -0.532 . . . . 71.439999999999998 109.564 178.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.498 ' HB2' ' CD1' ' A' ' 49' ' ' TRP . 2.0 p30 -97.1 148.34 23.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.199 0.523 . . . . 64.5 111.351 -173.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.407 ' CE2' HD13 ' A' ' 100' ' ' LEU . 81.4 m-85 -126.24 65.26 1.23 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.323 -0.853 . . . . 73.030000000000001 109.803 175.045 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.498 ' CD1' ' HB2' ' A' ' 47' ' ' ASP . 64.3 p-90 -144.32 130.39 19.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.465 -0.789 . . . . 72.239999999999995 109.276 173.026 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -147.67 92.5 4.74 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.009 0.433 . . . . 53.439999999999998 111.277 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.412 ' HD3' ' HE3' ' A' ' 49' ' ' TRP . 1.9 Cg_endo -81.89 76.82 4.11 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.624 2.216 . . . . 74.340000000000003 109.786 171.334 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 7.4 m-90 -51.23 -47.33 62.39 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.814 -0.63 . . . . 74.150000000000006 110.171 -177.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 80.4 m -96.02 84.77 3.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.826 -0.625 . . . . 72.239999999999995 109.346 173.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -122.42 -168.74 13.29 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.949 -0.569 . . . . 63.140000000000001 112.606 -175.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -84.26 12.76 2.93 Favored 'Trans proline' 0 CA--C 1.533 0.442 0 C-N-CA 122.992 2.461 . . . . 62.109999999999999 112.76 -177.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 56.7 m 59.37 16.26 4.97 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.061 0.458 . . . . 70.010000000000005 111.287 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 20.4 tpp180 -103.81 148.15 26.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.976 -0.556 . . . . 74.519999999999996 110.542 -176.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.8 p -64.25 101.71 0.45 Allowed 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.735 -0.839 . . . . 52.329999999999998 108.735 170.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 55.1 tp -52.56 -33.55 46.26 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.147 -0.478 . . . . 73.329999999999998 111.187 -174.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 56.18 65.32 4.31 Favored Pre-proline 0 C--O 1.236 0.343 0 CA-C-N 115.861 -0.609 . . . . 73.140000000000001 110.634 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.18 178.11 6.41 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.087 1.858 . . . . 71.140000000000001 111.25 174.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.498 ' H ' ' CD ' ' A' ' 62' ' ' GLN . 11.7 mp0 -55.09 -48.29 73.76 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-O 121.871 0.843 . . . . 74.099999999999994 110.366 -178.41 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.654 HD12 HD13 ' A' ' 45' ' ' LEU . 2.9 mm? -61.39 -47.97 83.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.449 -1.251 . . . . 74.219999999999999 110.449 -174.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.552 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 45.9 tt0 -63.69 -44.05 94.86 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.235 -0.439 . . . . 74.409999999999997 109.941 178.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.652 ' HE3' ' HA ' ' A' ' 65' ' ' LYS . 0.1 OUTLIER -50.89 -51.66 49.6 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.602 -0.726 . . . . 71.310000000000002 111.033 -179.874 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.604 HD11 HG22 ' A' ' 120' ' ' ILE . 32.9 mt -71.99 -35.29 69.44 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.646 -0.422 . . . . 73.239999999999995 110.851 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.427 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -57.27 -40.06 76.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.026 -0.534 . . . . 61.5 111.227 -178.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.552 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 86.9 mt-30 -50.2 -33.4 19.19 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.983 0.42 . . . . 70.239999999999995 110.85 -177.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -94.09 -56.47 2.84 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.75 -0.659 . . . . 65.549999999999997 111.067 178.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.48 ' O ' HG22 ' A' ' 74' ' ' VAL . 17.3 m-85 -88.79 20.33 3.56 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.684 -0.689 . . . . 75.230000000000004 112.671 -170.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.427 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 13.8 t -53.35 -30.47 39.6 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.11 0.481 . . . . 74.329999999999998 112.28 -176.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -70.21 -16.78 63.11 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.381 -0.372 . . . . 53.340000000000003 111.324 -177.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -118.6 -6.5 10.67 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.489 -0.323 . . . . 72.310000000000002 110.458 -178.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.48 HG22 ' O ' ' A' ' 70' ' ' TYR . 30.1 m -137.1 135.39 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 121.143 0.497 . . . . 55.140000000000001 110.879 178.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.678 ' HE2' HG21 ' A' ' 42' ' ' ILE . 64.8 mttm -112.46 158.57 19.71 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.972 -0.751 . . . . 63.310000000000002 108.972 174.039 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.522 HG13 ' HB2' ' A' ' 45' ' ' LEU . 3.7 mp -125.56 139.4 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 C-N-CA 120.333 -0.547 . . . . 74.420000000000002 110.117 171.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.537 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 12.4 m-85 -125.04 129.1 49.6 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.9 -0.591 . . . . 72.200000000000003 110.094 177.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.456 ' HD3' ' N ' ' A' ' 79' ' ' ILE . 5.7 tmtm? -111.77 124.33 52.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.194 -0.912 . . . . 72.219999999999999 109.201 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.769 ' H ' HD13 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -113.46 151.02 15.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.775 -0.454 . . . . 72.5 109.775 176.032 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -102.12 178.47 4.59 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.502 -0.555 . . . . 55.210000000000001 109.502 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.416 ' O ' HG22 ' A' ' 81' ' ' ILE . 27.1 mt 66.13 39.26 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 122.479 1.133 . . . . 61.140000000000001 109.067 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.579 ' HA ' ' HG2' ' A' ' 85' ' ' GLN . 5.7 mt-10 -71.22 0.06 8.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.529 -1.214 . . . . 71.239999999999995 111.205 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -74.17 -25.14 59.55 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.944 -0.571 . . . . 64.430000000000007 109.787 177.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -112.47 25.93 11.03 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.263 -0.88 . . . . 73.349999999999994 111.226 -171.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.579 ' HG2' ' HA ' ' A' ' 82' ' ' GLU . 80.8 mm-40 -96.91 104.39 16.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.995 0.426 . . . . 74.209999999999994 110.317 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -84.08 -8.05 59.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.808 -0.633 . . . . 61.450000000000003 110.251 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.1 t -49.76 -35.12 9.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.545 -0.752 . . . . 75.030000000000001 110.926 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.91 -56.02 25.68 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.924 -0.58 . . . . 73.530000000000001 110.367 177.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.0 m -64.22 -35.04 79.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.269 -0.423 . . . . 71.010000000000005 110.454 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -57.65 -38.6 75.35 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.766 -0.652 . . . . 72.230000000000004 110.389 178.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -88.76 -17.2 30.35 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.502 -0.317 . . . . 74.030000000000001 111.501 176.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.55 25.25 39.69 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 121.018 -0.61 . . . . 71.209999999999994 112.223 -177.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 70.7 t -64.26 127.19 24.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.724 0.297 . . . . 73.5 110.296 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.5 p -91.3 -17.0 26.63 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.393 0.516 . . . . 73.310000000000002 112.393 -174.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -157.89 146.86 19.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.83 0.348 . . . . 73.129999999999995 111.572 -176.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.559 ' HB ' ' HA ' ' A' ' 97' ' ' PRO . 2.7 pp -98.71 162.04 23.03 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 115.923 -0.58 . . . . 72.430000000000007 110.036 176.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.559 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 98.5 Cg_endo -80.95 174.25 47.74 Favored 'Cis proline' 0 C--N 1.355 0.87 0 C-N-CA 124.133 -1.195 . . . . 65.310000000000002 112.83 2.123 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.547 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 27.8 m -145.68 134.18 22.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.951 -0.568 . . . . 71.120000000000005 110.042 179.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.597 HG21 ' HG ' ' A' ' 63' ' ' LEU . 3.5 mp -116.44 125.2 73.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 N-CA-C 109.71 -0.478 . . . . 53.43 109.71 178.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.407 HD13 ' CE2' ' A' ' 48' ' ' PHE . 9.7 mp -91.49 134.18 34.86 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.815 0.34 . . . . 73.120000000000005 110.738 -178.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.546 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 72.2 mtp -108.98 114.38 28.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.926 -0.579 . . . . 74.109999999999999 110.231 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -118.91 148.36 43.01 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.179 0.3 . . . . 74.430000000000007 110.271 178.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.625 ' HB3' HD21 ' A' ' 108' ' ' LEU . 62.4 tttm -152.56 115.22 4.54 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.025 -0.731 . . . . 63.310000000000002 109.025 176.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.43 ' HB2' ' HA ' ' A' ' 41' ' ' ASN . 5.8 t30 58.52 30.28 19.54 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.362 0.601 . . . . 65.239999999999995 110.279 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.18 -9.08 78.55 Favored Glycine 0 CA--C 1.521 0.434 0 CA-C-N 115.696 -0.684 . . . . 53.509999999999998 113.355 177.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -95.2 131.17 41.54 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 117.053 0.426 . . . . 51.240000000000002 111.031 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.68 ' HZ2' ' HB2' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -80.39 116.87 20.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 45.119999999999997 110.043 174.77 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.625 HD21 ' HB3' ' A' ' 103' ' ' LYS . 3.1 mm? -82.06 -52.57 6.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.442 -0.344 . . . . 72.549999999999997 110.317 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.546 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 74.6 m -159.35 171.82 19.09 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.81 -0.632 . . . . 74.540000000000006 110.759 -176.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 8.4 pm0 -133.35 119.12 19.3 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.428 -0.805 . . . . 75.319999999999993 109.346 172.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 98' ' ' THR . 61.3 t -79.99 110.33 15.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 64.25 110.048 -178.504 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 59.0 mt -107.98 118.54 55.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 110.036 -0.357 . . . . 75.109999999999999 110.036 -177.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.36 -115.36 4.21 Favored Glycine 0 N--CA 1.453 -0.206 0 N-CA-C 111.682 -0.567 . . . . 74.409999999999997 111.682 -178.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.55 89.19 1.02 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.89 0.345 . . . . 71.329999999999998 111.017 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.465 ' O ' HG23 ' A' ' 119' ' ' ILE . 12.5 m-20 -118.99 88.76 2.99 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.41 -0.359 . . . . 62.439999999999998 110.448 178.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.505 HD12 HD11 ' A' ' 119' ' ' ILE . 8.2 tp -62.73 -44.89 99.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 120.814 0.34 . . . . 73.120000000000005 110.902 -178.168 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.2 m -68.55 -27.06 65.75 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.34 -0.391 . . . . 71.150000000000006 111.336 -176.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.32 -45.27 19.98 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 120.839 0.352 . . . . 71.040000000000006 110.076 178.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.521 ' HA ' ' HG2' ' A' ' 122' ' ' GLU . 2.4 pp -68.43 -37.37 77.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.384 -0.371 . . . . 71.219999999999999 111.601 -176.149 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.604 HG22 HD11 ' A' ' 66' ' ' LEU . 2.7 pp -63.66 -31.79 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 121.3 0.571 . . . . 75.310000000000002 109.681 176.009 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.8 t -70.47 -47.89 58.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.446 -0.797 . . . . 62.240000000000002 110.568 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.521 ' HG2' ' HA ' ' A' ' 119' ' ' ILE . 21.1 pt-20 -76.96 -44.75 30.14 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.235 0.457 . . . . 74.319999999999993 112.235 -176.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.572 HD12 HD12 ' A' ' 66' ' ' LEU . 67.2 mt -61.43 -57.23 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 O-C-N 122.185 -0.322 . . . . 72.530000000000001 110.992 -178.509 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -60.59 -20.37 60.36 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.068 0.461 . . . . 72.010000000000005 111.227 -176.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -77.66 -34.49 53.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.753 -0.658 . . . . 60.229999999999997 110.576 176.123 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -83.27 -39.38 20.93 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.077 -0.51 . . . . 73.109999999999999 111.012 -177.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.455 HG12 ' O ' ' A' ' 123' ' ' ILE . 47.2 pt -91.78 168.15 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.283 -0.417 . . . . 71.040000000000006 110.2 178.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 6.4 p30 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.499 -0.762 . . . . 74.439999999999998 110.716 -172.651 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.492 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.2 pmm? . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 120.514 0.197 . . . . 51.399999999999999 111.111 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.94 102.62 2.03 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.952 0.406 . . . . 74.329999999999998 111.209 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.6 m170 -89.19 8.17 31.58 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.08 -0.509 . . . . 73.010000000000005 111.113 177.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 66.4 t60 -64.03 106.93 1.13 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.686 -0.487 . . . . 75.420000000000002 109.686 174.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 62.7 m80 -66.25 120.72 13.76 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.107 -0.497 . . . . 74.219999999999999 110.356 -175.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 21.4 p-80 -81.67 60.88 4.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.567 0.698 . . . . 71.200000000000003 110.381 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 38.9 t60 -65.26 121.82 15.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.267 -0.879 . . . . 65.209999999999994 110.73 -178.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -164.36 147.04 9.0 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.081 -0.508 . . . . 71.340000000000003 110.625 179.104 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -156.47 150.33 24.94 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.886 -0.597 . . . . 61.329999999999998 109.762 177.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.88 103.93 0.56 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.047 -0.597 . . . . 54.420000000000002 112.038 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.2 m -97.94 124.52 42.43 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.144 -0.317 . . . . 62.43 110.144 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.54 ' O ' HD12 ' A' ' 12' ' ' LEU . 4.1 pp -81.16 137.74 35.9 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.127 0.489 . . . . 75.129999999999995 110.715 178.259 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.78 23.15 10.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.802 -0.635 . . . . 62.409999999999997 109.955 179.052 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.37 146.14 7.46 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.649 -0.705 . . . . 64.340000000000003 110.765 177.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -95.62 97.12 9.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.456 0.646 . . . . 71.200000000000003 111.16 -175.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.1 t -123.5 -160.85 0.93 Allowed 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.804 -0.813 . . . . 74.340000000000003 108.804 175.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.529 ' HG3' ' H ' ' A' ' 18' ' ' GLY . 6.2 tp-100 -164.99 179.01 6.68 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 109.976 -0.379 . . . . 73.129999999999995 109.976 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.529 ' H ' ' HG3' ' A' ' 17' ' ' GLN . . . -123.45 77.65 0.36 Allowed Glycine 0 C--N 1.33 0.247 0 N-CA-C 111.464 -0.654 . . . . 72.219999999999999 111.464 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -79.41 -2.05 11.98 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.232 2.622 . . . . 73.219999999999999 111.682 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.73 -83.94 1.69 Allowed Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 110.631 -0.988 . . . . 71.450000000000003 110.631 174.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.3 m -77.23 150.57 35.38 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.437 -0.579 . . . . 64.019999999999996 109.437 171.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 16.0 tpt -67.85 77.52 0.21 Allowed 'General case' 0 C--O 1.238 0.487 0 CA-C-O 120.994 0.426 . . . . 73.25 110.508 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.53 HD13 ' HB ' ' A' ' 76' ' ' ILE . 16.9 mm -117.17 124.8 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 115.726 -0.67 . . . . 74.400000000000006 110.427 -177.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 45.6 tt0 -131.97 140.93 49.13 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.693 0.282 . . . . 71.409999999999997 110.316 173.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -95.8 126.85 41.35 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.786 -0.45 . . . . 65.140000000000001 109.786 176.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.514 HD12 ' HA ' ' A' ' 31' ' ' PHE . 44.5 pt -129.26 165.3 29.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-O 121.075 0.464 . . . . 64.230000000000004 111.525 -174.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.5 164.07 18.91 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.52 -0.764 . . . . 13.31 111.575 176.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -63.58 -29.88 71.07 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.575 0.226 . . . . 73.329999999999998 110.704 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.9 t -62.06 -22.33 65.67 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.17 -0.468 . . . . 64.120000000000005 111.627 -178.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -121.29 -3.23 9.48 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.788 -0.187 . . . . 71.549999999999997 110.836 -178.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.514 ' HA ' HD12 ' A' ' 26' ' ' ILE . 90.6 t80 -51.29 -70.96 0.07 Allowed 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.232 -0.44 . . . . 65.209999999999994 110.363 -177.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -62.71 -34.35 76.99 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.431 -0.581 . . . . 71.430000000000007 109.431 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.483 ' O ' ' HB3' ' A' ' 37' ' ' SER . 6.6 t30 -52.18 -39.71 60.48 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.116 -0.947 . . . . 63.409999999999997 111.477 -176.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.512 ' HD3' HG21 ' A' ' 26' ' ' ILE . 14.1 ptmt -110.23 -18.04 13.39 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 111.793 0.294 . . . . 53.439999999999998 111.793 -177.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 72.2 t -87.58 -54.4 8.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 111.661 0.245 . . . . 61.520000000000003 111.661 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 72.0 p -77.47 -27.33 52.0 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.302 0.572 . . . . 74.430000000000007 110.0 -176.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.483 ' HB3' ' O ' ' A' ' 33' ' ' ASN . 34.3 t -89.71 12.59 16.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.249 -0.887 . . . . 73.219999999999999 110.828 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.404 ' HB2' HD12 ' A' ' 44' ' ' ILE . 43.9 t -46.02 99.58 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.949 0.404 . . . . 60.130000000000003 111.672 -178.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -95.4 9.05 41.37 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.804 -0.635 . . . . 70.230000000000004 110.296 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -86.28 -15.39 40.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.011 -0.54 . . . . 63.240000000000002 110.774 -178.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.4 m120 62.99 16.54 9.35 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.482 0.658 . . . . 71.209999999999994 109.673 -171.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 21.7 mt -96.66 141.4 15.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 115.147 -0.933 . . . . 74.519999999999996 110.46 -177.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.677 HD21 ' HE3' ' A' ' 101' ' ' MET . 62.7 tp -71.56 103.92 3.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.85 -0.614 . . . . 74.319999999999993 110.087 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.404 HD12 ' HB2' ' A' ' 38' ' ' CYS . 44.3 mt -84.7 116.59 28.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.928 -0.578 . . . . 75.349999999999994 110.695 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.801 HD13 HD12 ' A' ' 63' ' ' LEU . 44.9 mt -100.63 109.98 22.08 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.475 -0.784 . . . . 41.200000000000003 109.217 179.112 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.3 m -100.97 115.02 41.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-O 120.866 0.365 . . . . 71.439999999999998 110.309 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.5 121.03 32.83 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.786 -0.643 . . . . 64.5 111.049 -175.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -101.0 96.44 7.25 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 109.593 -0.521 . . . . 73.030000000000001 109.593 175.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.503 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 56.3 t-105 -170.22 140.58 1.93 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.636 -0.711 . . . . 72.239999999999995 110.112 -178.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.92 103.09 2.47 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 110.152 -0.314 . . . . 53.439999999999998 110.152 175.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' A' ' 49' ' ' TRP . 86.4 Cg_endo -82.18 60.93 7.6 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.692 2.261 . . . . 74.340000000000003 112.946 -173.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -69.09 86.63 0.38 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.189 0.519 . . . . 74.150000000000006 110.467 176.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 53.4 t -147.1 -45.59 0.18 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.544 -0.753 . . . . 72.239999999999995 109.795 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.412 ' HA3' ' HD3' ' A' ' 55' ' ' PRO . . . 141.26 -127.14 3.27 Favored Glycine 0 C--N 1.331 0.304 0 N-CA-C 111.317 -0.713 . . . . 63.140000000000001 111.317 178.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.412 ' HD3' ' HA3' ' A' ' 54' ' ' GLY . 2.7 Cg_exo -76.29 -159.77 0.1 Allowed 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 122.795 2.33 . . . . 62.109999999999999 111.625 176.376 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 49.5 t -66.99 79.85 0.12 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.055 0.455 . . . . 70.010000000000005 110.423 178.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.403 ' HD3' HH11 ' A' ' 57' ' ' ARG . 43.8 mtt180 -135.25 105.22 6.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.625 -0.716 . . . . 74.519999999999996 109.603 178.12 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 34.2 p -126.05 174.23 8.6 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.162 -0.472 . . . . 52.329999999999998 110.711 -179.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 76.4 mt -103.81 31.1 4.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.913 -0.585 . . . . 73.329999999999998 110.102 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.88 ' HB3' ' HE2' ' A' ' 65' ' ' LYS . 23.2 mm-40 63.12 75.61 0.4 Allowed Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 115.538 -0.756 . . . . 73.140000000000001 110.703 -177.014 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -80.63 162.11 21.76 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.5 2.133 . . . . 71.140000000000001 111.59 178.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.634 ' HB3' HG12 ' A' ' 119' ' ' ILE . 8.2 mp0 -52.47 -48.34 65.96 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 121.551 0.691 . . . . 74.099999999999994 110.986 -176.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.801 HD12 HD13 ' A' ' 45' ' ' LEU . 3.0 mm? -57.89 -48.07 80.93 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.655 -1.157 . . . . 74.219999999999999 110.35 -173.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.546 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 41.2 mt-10 -71.73 -34.94 69.98 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.432 -0.349 . . . . 74.409999999999997 110.9 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.88 ' HE2' ' HB3' ' A' ' 60' ' ' GLU . 49.6 mmtt -52.85 -52.96 55.26 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.768 0.318 . . . . 71.310000000000002 110.52 177.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.597 HD12 HD12 ' A' ' 123' ' ' ILE . 25.5 mt -76.51 -30.22 57.12 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.532 -0.467 . . . . 73.239999999999995 111.091 178.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.516 ' HB3' ' HA ' ' A' ' 64' ' ' GLU . . . -59.58 -37.68 79.16 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.743 -0.208 . . . . 61.5 111.412 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.546 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 79.2 mt-30 -54.09 -35.46 62.13 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.989 0.423 . . . . 70.239999999999995 110.982 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 66.8 mm-40 -93.86 -53.09 4.14 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.99 -0.55 . . . . 65.549999999999997 111.262 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.489 ' O ' HG22 ' A' ' 74' ' ' VAL . 14.3 m-85 -92.74 22.58 4.67 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.815 -0.63 . . . . 75.230000000000004 112.047 -171.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.46 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 9.5 t -52.91 -31.52 40.38 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.722 0.296 . . . . 74.329999999999998 111.775 -177.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -70.6 -16.47 62.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.991 0.425 . . . . 53.340000000000003 111.155 -177.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -123.43 0.79 8.92 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.164 -0.471 . . . . 72.310000000000002 110.761 -175.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 70' ' ' TYR . 29.1 m -131.29 147.55 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 120.939 0.4 . . . . 55.140000000000001 110.469 177.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -141.86 116.73 9.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.964 -0.562 . . . . 63.310000000000002 109.723 -178.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.53 ' HB ' HD13 ' A' ' 23' ' ' ILE . 3.0 mp -99.05 143.44 13.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 120.633 0.254 . . . . 74.420000000000002 110.811 -173.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.457 ' OH ' ' HE2' ' A' ' 34' ' ' LYS . 21.0 m-85 -130.75 130.05 43.27 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.988 0.423 . . . . 72.200000000000003 111.655 -179.445 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -96.21 115.17 27.01 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.69 -0.856 . . . . 72.219999999999999 108.69 170.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.723 HG12 ' H ' ' A' ' 81' ' ' ILE . 12.1 tt -101.53 160.98 3.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.864 -0.421 . . . . 72.5 109.864 178.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.421 ' N ' HG12 ' A' ' 79' ' ' ILE . 90.1 m-20 -85.54 -20.97 28.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.825 0.345 . . . . 55.210000000000001 110.74 178.131 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.723 ' H ' HG12 ' A' ' 79' ' ' ILE . 43.4 mm -89.25 97.91 7.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.796 -0.446 . . . . 61.140000000000001 109.796 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -85.33 -71.06 0.55 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.846 -0.615 . . . . 71.239999999999995 111.832 -174.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -124.27 -25.0 4.19 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.715 -0.675 . . . . 64.430000000000007 111.703 -169.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -78.11 60.72 2.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.188 0.518 . . . . 73.349999999999994 109.984 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.455 ' HG3' ' H ' ' A' ' 88' ' ' ALA . 24.8 pt20 -145.04 159.43 42.96 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.137 -0.483 . . . . 74.209999999999994 111.042 -176.265 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -66.23 -40.81 90.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.547 -0.751 . . . . 61.450000000000003 110.958 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 51.6 t -51.97 -49.49 37.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 116.08 -0.509 . . . . 75.030000000000001 111.354 -176.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.455 ' H ' ' HG3' ' A' ' 85' ' ' GLN . . . -57.63 -50.54 72.81 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.787 -0.642 . . . . 73.530000000000001 110.283 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.3 m -60.06 -37.07 78.77 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.786 -0.643 . . . . 71.010000000000005 110.89 178.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -62.44 -47.0 85.99 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.566 -0.743 . . . . 72.230000000000004 110.683 -177.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -87.77 6.58 34.48 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.177 -0.465 . . . . 74.030000000000001 111.523 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.01 27.65 73.52 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 116.106 -0.497 . . . . 71.209999999999994 112.965 175.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 77.7 t -69.27 98.35 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.247 0.546 . . . . 73.5 110.732 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.2 m -101.98 -14.3 17.23 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.059 -0.519 . . . . 73.310000000000002 110.51 176.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -123.1 115.85 22.49 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.778 -0.647 . . . . 73.129999999999995 110.494 -177.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.57 ' HB ' ' HA ' ' A' ' 97' ' ' PRO . 30.3 pt -96.26 162.2 24.47 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 115.936 -0.574 . . . . 72.430000000000007 110.153 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.57 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 83.7 Cg_endo -81.71 171.91 54.9 Favored 'Cis proline' 0 C--N 1.353 0.794 0 C-N-CA 124.136 -1.193 . . . . 65.310000000000002 112.986 0.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 97.9 m -147.34 129.25 15.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.913 -0.585 . . . . 71.120000000000005 110.474 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.53 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 3.6 mp -110.46 145.83 16.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.88 -0.785 . . . . 53.43 108.88 177.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.463 HD23 ' H ' ' A' ' 101' ' ' MET . 0.8 OUTLIER -121.56 137.81 54.57 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.755 -0.461 . . . . 73.120000000000005 109.755 178.825 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.702 ' SD ' ' HB3' ' A' ' 109' ' ' SER . 64.0 mtp -103.14 111.68 24.17 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.892 -0.594 . . . . 74.109999999999999 111.039 -174.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -115.46 153.72 30.59 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.736 0.303 . . . . 74.430000000000007 110.655 177.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.499 ' HB3' HD21 ' A' ' 108' ' ' LEU . 39.3 ttpt -166.77 116.92 0.91 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.314 -0.403 . . . . 63.310000000000002 110.051 175.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 8.1 t30 50.92 52.14 15.58 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.622 0.725 . . . . 65.239999999999995 110.957 178.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 76.46 -14.95 6.18 Favored Glycine 0 CA--C 1.521 0.43 0 CA-C-N 115.436 -0.802 . . . . 53.509999999999998 113.666 176.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -100.29 123.47 44.55 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 117.08 0.44 . . . . 51.240000000000002 110.398 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.402 ' H ' ' HG2' ' A' ' 107' ' ' LYS . 30.6 pttt -89.24 122.61 32.68 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.517 -0.549 . . . . 45.119999999999997 109.517 174.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.508 ' N ' HD22 ' A' ' 108' ' ' LEU . 2.5 mm? -82.63 -52.62 6.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.612 -0.722 . . . . 72.549999999999997 111.281 -172.259 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.702 ' HB3' ' SD ' ' A' ' 101' ' ' MET . 22.0 t -162.42 172.01 16.24 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.995 -0.548 . . . . 74.540000000000006 110.845 -171.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -133.41 129.26 37.1 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.199 -0.455 . . . . 75.319999999999993 110.369 178.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.688 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 83.7 t -92.64 107.11 18.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.994 -0.548 . . . . 64.25 110.28 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 59.9 mt -110.32 119.19 58.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.722 -0.473 . . . . 75.109999999999999 109.722 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 95.74 -126.9 8.95 Favored Glycine 0 CA--C 1.519 0.322 0 N-CA-C 111.922 -0.471 . . . . 74.409999999999997 111.922 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.47 83.73 0.91 Allowed 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.895 0.379 . . . . 71.329999999999998 110.305 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.41 ' O ' HG23 ' A' ' 119' ' ' ILE . 4.9 m-20 -125.7 97.42 5.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.06 -0.518 . . . . 62.439999999999998 110.407 -178.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.518 ' O ' HG13 ' A' ' 119' ' ' ILE . 7.7 tp -60.64 -41.67 88.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-N 116.511 -0.313 . . . . 73.120000000000005 111.158 -177.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 30.4 t -62.74 -33.04 74.32 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.302 0.572 . . . . 71.150000000000006 110.853 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.688 ' HE3' ' HA ' ' A' ' 111' ' ' VAL . 0.9 OUTLIER -75.94 -47.67 24.25 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.648 -0.706 . . . . 71.040000000000006 110.656 -179.188 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.634 HG12 ' HB3' ' A' ' 62' ' ' GLN . 2.1 pp -64.97 -40.82 90.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.227 -0.442 . . . . 71.219999999999999 111.066 -177.287 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.436 HG22 HD11 ' A' ' 66' ' ' LEU . 2.8 pp -65.73 -31.71 54.94 Favored 'Isoleucine or valine' 0 C--N 1.34 0.169 0 N-CA-C 109.65 -0.5 . . . . 75.310000000000002 109.65 178.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 43.2 t -65.15 -51.62 60.05 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.632 -0.713 . . . . 62.240000000000002 110.482 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -77.15 -38.73 51.24 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.635 0.605 . . . . 74.319999999999993 112.635 -176.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.597 HD12 HD12 ' A' ' 66' ' ' LEU . 56.8 mt -66.02 -53.2 40.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 O-C-N 122.167 -0.333 . . . . 72.530000000000001 111.011 -178.324 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -61.85 -20.34 63.59 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.14 0.495 . . . . 72.010000000000005 110.499 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -70.73 -32.58 69.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.981 -0.554 . . . . 60.229999999999997 111.436 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.545 ' OD1' HG23 ' A' ' 127' ' ' ILE . 9.3 p30 -106.39 -17.97 14.12 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.083 0.401 . . . . 73.109999999999999 112.083 -174.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.545 HG23 ' OD1' ' A' ' 126' ' ' ASN . 42.2 pt -125.39 167.69 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 120.846 0.355 . . . . 71.040000000000006 111.135 177.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.353 -0.832 . . . . 74.439999999999998 110.781 179.266 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 N--CA 1.483 1.186 0 CA-C-O 120.678 0.275 . . . . 51.399999999999999 110.648 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -165.88 149.39 7.77 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.033 -0.53 . . . . 74.329999999999998 109.964 178.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -97.56 62.5 1.69 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.537 0.684 . . . . 73.010000000000005 110.378 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -86.29 111.13 20.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.233 -0.894 . . . . 75.420000000000002 109.964 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -93.32 160.65 14.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.089 0.471 . . . . 74.219999999999999 111.268 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -78.81 107.84 11.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.463 -0.79 . . . . 71.200000000000003 109.773 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 40.3 t60 -71.2 -51.83 22.52 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.938 0.399 . . . . 65.209999999999994 111.219 -175.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 58.6 t60 -73.86 121.22 20.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.105 -0.498 . . . . 71.340000000000003 110.147 -178.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -100.76 -171.04 1.94 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.52 -0.309 . . . . 61.329999999999998 110.203 -178.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -150.93 138.74 6.79 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 121.198 -0.525 . . . . 54.420000000000002 112.34 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.7 p -95.72 132.89 40.45 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 122.404 0.281 . . . . 62.43 110.815 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.8 pp -87.29 175.67 7.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.771 0.32 . . . . 75.129999999999995 110.505 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -124.03 159.0 30.83 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.673 -0.492 . . . . 62.409999999999997 109.673 -177.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -147.34 101.47 3.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.685 0.278 . . . . 64.340000000000003 111.035 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -91.09 171.39 9.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.308 -0.405 . . . . 71.200000000000003 110.053 176.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 87.2 m -147.13 92.56 2.13 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.866 -0.42 . . . . 74.340000000000003 109.866 177.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -82.36 172.59 12.9 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.882 -0.599 . . . . 73.129999999999995 110.359 -178.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -145.32 70.27 0.38 Allowed Glycine 0 N--CA 1.453 -0.217 0 N-CA-C 111.876 -0.49 . . . . 72.219999999999999 111.876 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -72.79 175.78 9.85 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 122.56 2.174 . . . . 73.219999999999999 112.045 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 167.85 -166.56 39.48 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 116.21 -0.45 . . . . 71.450000000000003 112.025 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 40.1 m -150.66 170.05 20.12 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.968 -0.382 . . . . 64.019999999999996 109.968 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.475 ' N ' ' SD ' ' A' ' 22' ' ' MET . 3.7 mpp? -92.24 -43.88 9.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.454 -0.339 . . . . 73.25 111.57 -174.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.1 mt -108.44 123.59 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 121.018 0.437 . . . . 74.400000000000006 111.626 -174.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.642 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 8.7 tp10 -131.97 155.22 48.35 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.834 -0.802 . . . . 71.409999999999997 108.834 174.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -100.59 147.83 25.5 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.71 0.29 . . . . 65.140000000000001 110.263 174.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.518 HD12 ' HA ' ' A' ' 31' ' ' PHE . 34.9 pt -131.07 -176.95 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.464 -0.334 . . . . 64.230000000000004 110.691 -176.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.415 ' H ' ' HG2' ' A' ' 30' ' ' GLU . . . -141.03 -173.83 13.77 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.403 -0.427 . . . . 13.31 112.902 -177.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -55.03 -50.73 68.34 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.92 0.888 . . . . 73.329999999999998 112.605 -175.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 24.9 t -73.4 -19.09 61.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.102 -0.499 . . . . 64.120000000000005 111.807 -169.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.493 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 1.7 pm0 -111.74 -15.24 13.46 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 111.874 0.324 . . . . 71.549999999999997 111.874 -177.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.518 ' HA ' HD12 ' A' ' 26' ' ' ILE . 61.6 t80 -48.2 -71.01 0.08 Allowed 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.41 0.444 . . . . 65.209999999999994 111.239 -176.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -63.44 -40.09 96.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.358 0.599 . . . . 71.430000000000007 109.636 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.526 ' O ' ' HB3' ' A' ' 37' ' ' SER . 1.8 m-80 -53.13 -34.08 55.18 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.445 -1.252 . . . . 63.409999999999997 112.58 -172.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -114.84 -25.02 8.39 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.577 -0.449 . . . . 53.439999999999998 112.16 179.754 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.4 t -82.74 -51.62 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 N-CA-C 111.51 0.189 . . . . 61.520000000000003 111.51 -178.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 44.3 p -85.86 -23.03 27.27 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.025 0.44 . . . . 74.430000000000007 110.265 -176.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.526 ' HB3' ' O ' ' A' ' 33' ' ' ASN . 28.5 t -92.76 12.05 24.82 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.679 -0.691 . . . . 73.219999999999999 110.384 177.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 41.3 t -60.19 90.73 0.02 OUTLIER 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.128 0.489 . . . . 60.130000000000003 110.961 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -90.27 -4.0 57.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.872 -0.604 . . . . 70.230000000000004 110.543 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -71.02 -8.2 51.71 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.075 -0.511 . . . . 63.240000000000002 110.875 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 57.15 22.68 7.76 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.961 -0.563 . . . . 71.209999999999994 111.246 -176.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.9 tt -94.16 148.68 4.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.951 -0.759 . . . . 74.519999999999996 108.951 177.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.561 HD11 ' HB3' ' A' ' 101' ' ' MET . 63.7 tp -82.46 113.25 20.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.04 0.448 . . . . 74.319999999999993 110.634 -175.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.411 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 58.2 mt -98.34 123.97 51.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.522 -0.763 . . . . 75.349999999999994 110.58 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.451 ' N ' HD12 ' A' ' 45' ' ' LEU . 5.1 mp -106.71 112.11 24.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.221 -0.445 . . . . 41.200000000000003 109.867 177.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 27.5 m -98.04 121.87 49.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-O 121.031 0.444 . . . . 71.439999999999998 110.957 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.442 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 2.3 t70 -96.87 128.05 43.44 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.684 -0.689 . . . . 64.5 110.819 -179.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.458 ' CE1' HD13 ' A' ' 100' ' ' LEU . 44.2 m-85 -82.43 76.82 9.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.07 0.462 . . . . 73.030000000000001 110.43 175.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 45.0 p90 35.83 76.13 0.05 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 114.341 -1.3 . . . . 72.239999999999995 113.588 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.732 ' HA ' ' HB3' ' A' ' 97' ' ' PRO . . . -52.03 115.2 6.33 Favored Pre-proline 0 C--O 1.236 0.361 0 CA-C-N 115.774 -0.648 . . . . 53.439999999999998 109.843 170.133 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.54 ' O ' ' N ' ' A' ' 53' ' ' CYS . 22.0 Cg_exo -64.24 85.86 0.15 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.657 2.238 . . . . 74.340000000000003 112.313 -176.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 33.3 p-90 40.34 -74.27 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.814 1.246 . . . . 74.150000000000006 113.346 178.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 51' ' ' PRO . 52.2 t 64.92 -76.55 0.04 OUTLIER 'General case' 0 C--O 1.235 0.306 0 C-N-CA 123.34 0.656 . . . . 72.239999999999995 111.394 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 57.83 75.73 0.24 Allowed Glycine 0 C--N 1.333 0.378 0 N-CA-C 111.414 -0.675 . . . . 63.140000000000001 111.414 -174.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.61 94.16 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.802 2.335 . . . . 62.109999999999999 111.992 -175.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 59.6 m -72.16 78.78 0.96 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.808 -0.633 . . . . 70.010000000000005 110.541 -178.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -156.94 7.21 0.17 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.605 -0.725 . . . . 74.519999999999996 109.815 178.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.9 t 69.66 18.68 7.54 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.684 -0.689 . . . . 52.329999999999998 110.811 -178.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -109.55 149.06 30.2 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.096 -0.502 . . . . 73.329999999999998 110.583 178.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -102.22 149.65 36.81 Favored Pre-proline 0 C--O 1.234 0.284 0 CA-C-N 116.0 -0.546 . . . . 73.140000000000001 109.976 178.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.53 165.21 23.5 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.526 2.151 . . . . 71.140000000000001 111.837 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.59 ' HB3' HG12 ' A' ' 119' ' ' ILE . 8.9 mp0 -51.13 -49.47 60.73 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-O 121.566 0.698 . . . . 74.099999999999994 110.533 -176.267 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.764 HD21 HG12 ' A' ' 99' ' ' ILE . 10.3 mp -54.44 -48.87 71.19 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.617 -1.174 . . . . 74.219999999999999 111.49 -175.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -73.42 -32.79 64.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.818 0.342 . . . . 74.409999999999997 110.296 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.0 tptp -60.31 -46.77 88.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.752 -0.658 . . . . 71.310000000000002 110.358 -176.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.526 HD12 HD12 ' A' ' 123' ' ' ILE . 17.4 mt -85.79 -40.69 15.77 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.082 0.401 . . . . 73.239999999999995 112.082 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.26 -37.15 69.41 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.193 0.442 . . . . 61.5 112.193 -173.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -58.47 -30.84 67.29 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.766 0.317 . . . . 70.239999999999995 111.201 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 19.2 mm-40 -90.55 -54.2 4.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.09 0.472 . . . . 65.549999999999997 110.595 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.525 ' O ' HG22 ' A' ' 74' ' ' VAL . 19.4 m-85 -88.1 22.48 2.4 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.762 -0.654 . . . . 75.230000000000004 112.043 -172.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.9 t -52.63 -32.71 43.21 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.175 0.435 . . . . 74.329999999999998 112.175 -172.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -72.03 -22.62 61.37 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 121.225 -0.19 . . . . 53.340000000000003 111.487 -175.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.04 -4.14 16.04 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.636 -0.256 . . . . 72.310000000000002 110.751 -177.309 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 70' ' ' TYR . 23.2 m -135.46 148.1 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.134 0.493 . . . . 55.140000000000001 111.568 -178.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 36.6 mmtm -140.81 131.43 25.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.706 -0.679 . . . . 63.310000000000002 109.259 171.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.488 HD13 ' HB3' ' A' ' 63' ' ' LEU . 61.5 mt -110.24 127.68 67.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.366 -0.379 . . . . 74.420000000000002 110.521 -175.177 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.642 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 57.7 m-85 -124.84 128.74 49.17 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.592 -0.521 . . . . 72.200000000000003 109.592 178.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.442 ' HG2' ' HB3' ' A' ' 47' ' ' ASP . 9.2 mtmp? -100.52 142.74 31.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.874 0.369 . . . . 72.219999999999999 110.636 -177.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 32.8 mm -99.69 156.02 4.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.42 -0.809 . . . . 72.5 110.789 -174.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.403 ' OD1' ' N ' ' A' ' 81' ' ' ILE . 48.7 t-20 -104.53 153.46 21.13 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.462 -0.94 . . . . 55.210000000000001 108.462 172.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.403 ' N ' ' OD1' ' A' ' 80' ' ' ASN . 36.2 pt -51.79 -22.22 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 112.111 0.411 . . . . 61.140000000000001 112.111 -176.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -62.98 -48.72 77.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.243 -0.435 . . . . 71.239999999999995 111.56 -177.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -78.31 -12.44 60.0 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.129 -0.487 . . . . 64.430000000000007 111.901 -171.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -40.77 132.37 2.25 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 123.251 0.344 . . . . 73.349999999999994 111.754 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -122.49 139.42 53.9 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.758 -0.46 . . . . 74.209999999999994 109.758 -174.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -59.12 -12.36 4.93 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.671 -0.695 . . . . 61.450000000000003 112.013 -177.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.528 HG12 ' CE1' ' A' ' 91' ' ' TYR . 37.4 t -56.67 -41.42 74.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-O 121.247 0.546 . . . . 75.030000000000001 109.673 175.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.94 -44.31 97.03 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.715 -0.675 . . . . 73.530000000000001 109.95 176.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.9 m -59.33 -37.6 78.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.652 -0.704 . . . . 71.010000000000005 110.34 176.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -65.92 -36.56 83.72 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.068 -0.515 . . . . 72.230000000000004 110.064 177.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.528 ' CE1' HG12 ' A' ' 87' ' ' VAL . 23.3 m-85 -73.42 -4.2 32.14 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.384 -0.371 . . . . 74.030000000000001 111.123 175.001 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.0 9.33 82.67 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 121.276 -0.488 . . . . 71.209999999999994 112.099 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 89.2 t -75.24 83.76 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.425 0.631 . . . . 73.5 110.653 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.0 p -117.85 12.07 13.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.45 -0.795 . . . . 73.310000000000002 109.727 174.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -83.34 -68.39 0.71 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.695 -0.684 . . . . 73.129999999999995 110.978 -178.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 69.2 mt 68.44 128.1 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.554 0 O-C-N 123.506 0.503 . . . . 72.430000000000007 110.362 -178.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.732 ' HB3' ' HA ' ' A' ' 50' ' ' ALA . 85.9 Cg_endo -79.38 156.94 90.39 Favored 'Cis proline' 0 C--N 1.353 0.794 0 C-N-CA 123.923 -1.282 . . . . 65.310000000000002 112.686 2.324 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 39.6 m -149.27 134.08 17.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.985 -0.552 . . . . 71.120000000000005 109.858 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.764 HG12 HD21 ' A' ' 63' ' ' LEU . 3.5 mp -114.99 124.96 72.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.381 -0.372 . . . . 53.43 110.265 -176.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.458 HD13 ' CE1' ' A' ' 48' ' ' PHE . 10.3 mp -103.3 141.87 35.16 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.654 -0.499 . . . . 73.120000000000005 109.654 175.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.7 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 53.4 mtp -112.6 116.13 29.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.517 -0.31 . . . . 74.109999999999999 110.724 -173.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -114.07 152.57 30.85 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.212 -0.449 . . . . 74.430000000000007 110.851 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.641 ' HB3' HD21 ' A' ' 108' ' ' LEU . 39.1 ttpt -168.38 133.09 1.67 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.304 -0.628 . . . . 63.310000000000002 109.304 176.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 56.7 29.17 15.35 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.251 0.548 . . . . 65.239999999999995 109.817 -179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 87.79 -14.49 58.36 Favored Glycine 0 CA--C 1.52 0.358 0 CA-C-N 115.862 -0.608 . . . . 53.509999999999998 113.331 177.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -96.52 150.91 20.1 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 117.072 0.436 . . . . 51.240000000000002 110.803 -177.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 10.0 ptpt -91.96 118.2 30.54 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.07 -0.715 . . . . 45.119999999999997 109.07 171.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.641 HD21 ' HB3' ' A' ' 103' ' ' LYS . 2.2 mm? -89.8 -52.96 4.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.024 0.44 . . . . 72.549999999999997 111.057 -173.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.7 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 15.8 m -151.75 171.77 17.18 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 115.731 -0.668 . . . . 74.540000000000006 110.329 -170.283 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -149.89 123.44 9.12 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.286 0.565 . . . . 75.319999999999993 111.488 -176.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.44 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 40.4 t -86.26 107.08 16.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.674 -0.694 . . . . 64.25 109.618 175.091 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 12.8 mt -116.8 106.83 20.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 109.296 -0.631 . . . . 75.109999999999999 109.296 178.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 115.52 -127.25 7.51 Favored Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 111.574 -0.61 . . . . 74.409999999999997 111.574 -176.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.61 57.27 0.49 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.486 0.66 . . . . 71.329999999999998 109.651 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.452 ' O ' HG23 ' A' ' 119' ' ' ILE . 1.6 m-20 -105.58 99.54 9.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.384 -0.825 . . . . 62.439999999999998 110.882 -174.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.577 ' O ' HG13 ' A' ' 119' ' ' ILE . 7.0 tp -63.37 -38.87 83.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.171 -0.468 . . . . 73.120000000000005 111.079 -178.258 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.5 m -68.14 -26.85 65.98 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.11 0.481 . . . . 71.150000000000006 110.621 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.441 ' HB3' ' HB2' ' A' ' 115' ' ' ASP . 24.6 tptp -73.2 -52.02 15.64 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.678 -0.692 . . . . 71.040000000000006 110.041 176.326 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.59 HG12 ' HB3' ' A' ' 62' ' ' GLN . 2.0 pp -63.9 -40.81 90.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 115.68 -0.691 . . . . 71.219999999999999 111.461 -175.361 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.442 HD12 ' N ' ' A' ' 121' ' ' SER . 2.8 pp -63.14 -33.13 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 120.434 -0.506 . . . . 75.310000000000002 110.284 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.442 ' N ' HD12 ' A' ' 120' ' ' ILE . 35.9 t -70.71 -51.57 26.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.029 -0.532 . . . . 62.240000000000002 110.78 179.23 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.458 ' OE2' ' HB3' ' A' ' 109' ' ' SER . 15.9 pt-20 -75.86 -38.43 57.96 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.082 0.401 . . . . 74.319999999999993 112.082 -172.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.554 ' O ' HG12 ' A' ' 127' ' ' ILE . 69.9 mt -65.1 -55.8 18.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 O-C-N 122.32 -0.238 . . . . 72.530000000000001 110.442 178.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -60.37 -27.32 67.31 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.281 -0.418 . . . . 72.010000000000005 110.728 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -65.36 -31.48 72.62 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.28 -0.418 . . . . 60.229999999999997 110.74 176.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -104.43 -4.61 22.57 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.979 -0.555 . . . . 73.109999999999999 111.975 -172.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.554 HG12 ' O ' ' A' ' 123' ' ' ILE . 48.5 pt -131.56 168.94 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 122.166 0.186 . . . . 71.040000000000006 110.59 178.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.252 1.185 0 CA-C-O 118.462 -0.78 . . . . 74.439999999999998 112.796 -176.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 N--CA 1.482 1.161 0 CA-C-O 120.73 0.3 . . . . 51.399999999999999 110.368 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -123.33 143.8 49.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.45 . . . . 74.329999999999998 110.08 178.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -97.04 93.89 6.85 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.813 0.339 . . . . 73.010000000000005 110.315 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -85.05 94.73 8.9 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.572 -0.529 . . . . 75.420000000000002 109.572 177.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -61.43 118.91 7.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.985 -0.552 . . . . 74.219999999999999 110.991 -177.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 44.4 p-80 -174.79 154.78 1.99 Allowed 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 109.307 -0.627 . . . . 71.200000000000003 109.307 177.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 24.2 p80 -56.87 92.12 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.305 0.574 . . . . 65.209999999999994 110.405 177.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -67.82 110.26 3.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.022 -0.535 . . . . 71.340000000000003 110.24 -178.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 20.5 ptp -152.89 10.58 0.47 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.577 -0.738 . . . . 61.329999999999998 110.017 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.12 60.56 4.88 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.775 -0.648 . . . . 54.420000000000002 112.234 -176.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 30.8 p -69.87 96.96 1.05 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.659 -0.497 . . . . 62.43 109.659 176.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.6 tt -81.56 60.68 4.65 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.312 0.577 . . . . 75.129999999999995 109.75 -175.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -89.2 84.25 6.51 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.621 -0.881 . . . . 62.409999999999997 108.621 177.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -132.86 144.16 50.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.956 -0.565 . . . . 64.340000000000003 111.075 -176.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -89.24 71.29 8.26 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 121.363 0.602 . . . . 71.200000000000003 110.65 -179.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.4 m -73.63 72.18 1.43 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.296 0.57 . . . . 74.340000000000003 110.649 178.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.96 95.95 4.76 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.961 -0.563 . . . . 73.129999999999995 110.146 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -92.01 -89.46 1.47 Allowed Glycine 0 N--CA 1.452 -0.286 0 N-CA-C 111.335 -0.706 . . . . 72.219999999999999 111.335 178.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -80.44 141.15 13.95 Favored 'Trans proline' 0 C--O 1.237 0.435 0 C-N-CA 122.763 2.309 . . . . 73.219999999999999 111.134 174.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.62 32.42 57.46 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.643 -0.789 . . . . 71.450000000000003 111.429 -175.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.4 p -85.84 -43.56 13.18 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.024 -0.361 . . . . 64.019999999999996 110.024 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 67.1 mtt -60.53 -55.88 28.09 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.02 -0.537 . . . . 73.25 109.995 178.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.8 mt -113.89 122.62 68.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 109.218 -0.66 . . . . 74.400000000000006 109.218 176.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 -125.54 124.76 42.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.834 0.35 . . . . 71.409999999999997 111.056 -174.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.442 ' HG3' ' HB3' ' A' ' 78' ' ' LYS . 1.1 mp0 -81.49 125.97 31.11 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.464 -0.569 . . . . 65.140000000000001 109.464 178.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.509 HG21 ' HD3' ' A' ' 34' ' ' LYS . 33.8 pt -131.58 176.39 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.744 0.307 . . . . 64.230000000000004 110.936 -176.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -108.86 174.83 18.86 Favored Glycine 0 C--N 1.331 0.278 0 N-CA-C 111.629 -0.588 . . . . 13.31 111.629 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -67.84 -33.43 74.75 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.58 0.229 . . . . 73.329999999999998 111.34 -176.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.0 t -68.79 -34.62 75.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.769 0.319 . . . . 64.120000000000005 111.145 -174.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -101.35 -6.11 24.52 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.145 -0.479 . . . . 71.549999999999997 110.799 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.494 ' HA ' HD12 ' A' ' 26' ' ' ILE . 59.5 t80 -50.45 -70.81 0.08 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.359 -0.382 . . . . 65.209999999999994 110.248 177.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -59.67 -36.93 77.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.095 0.474 . . . . 71.430000000000007 109.969 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.518 ' O ' ' HB2' ' A' ' 37' ' ' SER . 24.7 t-20 -52.41 -47.73 66.13 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.118 -0.946 . . . . 63.409999999999997 111.782 -175.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.509 ' HD3' HG21 ' A' ' 26' ' ' ILE . 0.2 OUTLIER -101.93 -19.18 15.36 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.687 0.255 . . . . 53.439999999999998 111.687 -176.01 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.7 t -88.25 -59.54 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 112.038 0.385 . . . . 61.520000000000003 112.038 -179.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 66.1 p -79.99 -28.1 39.53 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.135 0.493 . . . . 74.430000000000007 110.66 -172.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.518 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 39.8 m -94.6 12.48 27.4 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.69 -0.686 . . . . 73.219999999999999 110.958 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.556 ' SG ' HG22 ' A' ' 42' ' ' ILE . 50.9 t -53.68 92.1 0.01 OUTLIER 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.047 0.451 . . . . 60.130000000000003 112.043 -177.049 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -67.47 -19.28 65.32 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.04 -0.527 . . . . 70.230000000000004 110.951 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -62.46 -25.27 67.9 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.356 -0.384 . . . . 63.240000000000002 111.372 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 62.49 23.67 14.06 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.972 -0.558 . . . . 71.209999999999994 110.235 -175.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.556 HG22 ' SG ' ' A' ' 38' ' ' CYS . 12.3 tt -82.38 157.76 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.757 -0.656 . . . . 74.519999999999996 109.291 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.423 ' HB3' HG12 ' A' ' 74' ' ' VAL . 48.7 tp -78.21 102.7 7.72 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 109.586 -0.524 . . . . 74.319999999999993 109.586 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.464 ' O ' ' HA ' ' A' ' 101' ' ' MET . 32.5 mt -90.5 126.34 43.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.889 -0.596 . . . . 75.349999999999994 111.108 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.545 HD23 HD12 ' A' ' 63' ' ' LEU . 3.5 mp -115.05 101.91 9.44 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.263 -0.644 . . . . 41.200000000000003 109.263 177.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.54 HG12 ' HB2' ' A' ' 77' ' ' TYR . 29.1 m -94.79 120.9 44.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.725 -0.472 . . . . 71.439999999999998 109.725 178.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -98.09 121.36 39.92 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.527 0.68 . . . . 64.5 109.385 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.598 ' HB3' ' HB2' ' A' ' 82' ' ' GLU . 90.4 m-85 -87.85 121.72 30.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.285 -0.87 . . . . 73.030000000000001 109.242 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.463 ' O ' ' HA ' ' A' ' 80' ' ' ASN . 54.9 t-105 -124.34 106.88 10.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.272 -0.422 . . . . 72.239999999999995 110.657 -177.232 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.06 120.46 81.76 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 116.597 -0.274 . . . . 53.439999999999998 110.566 174.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.453 ' O ' ' HB3' ' A' ' 52' ' ' TRP . 21.1 Cg_exo -66.7 -171.5 0.27 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.806 2.337 . . . . 74.340000000000003 111.824 175.083 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' TRP . . . . . 0.453 ' HB3' ' O ' ' A' ' 51' ' ' PRO . 44.9 t90 73.23 9.14 5.26 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.732 0.777 . . . . 74.150000000000006 110.13 -179.271 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 5.2 p -91.61 164.28 13.82 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.362 -0.836 . . . . 72.239999999999995 110.398 177.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.11 -141.98 5.77 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 121.44 -0.409 . . . . 63.140000000000001 113.281 -175.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -77.67 42.01 1.09 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.285 2.656 . . . . 62.109999999999999 113.213 -175.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 10.1 p -91.24 116.62 28.96 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.975 -0.38 . . . . 70.010000000000005 109.975 177.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 63.8 mtm180 -112.59 -176.85 3.0 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.463 -0.335 . . . . 74.519999999999996 110.696 179.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.0 m -63.19 -39.75 95.53 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.013 -0.539 . . . . 52.329999999999998 111.213 -178.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.7 mt 54.95 36.08 26.0 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.111 -0.495 . . . . 73.329999999999998 111.374 176.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 57.64 78.3 0.37 Allowed Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 115.562 -0.744 . . . . 73.140000000000001 110.56 -178.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.438 ' HG2' ' HB2' ' A' ' 64' ' ' GLU . 72.6 Cg_endo -75.98 161.24 36.14 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.581 2.187 . . . . 71.140000000000001 112.674 -176.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.571 ' HB3' HG12 ' A' ' 119' ' ' ILE . 15.7 mp0 -56.16 -40.89 74.59 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.353 -0.84 . . . . 74.099999999999994 110.758 -177.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.679 HD11 HG21 ' A' ' 111' ' ' VAL . 2.3 mm? -61.93 -41.0 97.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.87 -1.059 . . . . 74.219999999999999 109.868 -176.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.438 ' HB2' ' HG2' ' A' ' 61' ' ' PRO . 8.7 tm-20 -70.53 -36.66 73.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.63 -0.714 . . . . 74.409999999999997 109.174 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -56.87 -51.53 68.68 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.433 -0.803 . . . . 71.310000000000002 109.909 178.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.605 HD12 HD12 ' A' ' 123' ' ' ILE . 22.3 mt -80.63 -30.61 36.69 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.073 0.397 . . . . 73.239999999999995 112.073 -178.496 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.47 -34.95 69.55 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.789 0.328 . . . . 61.5 110.892 -178.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -56.57 -30.83 63.61 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.163 -0.471 . . . . 70.239999999999995 111.372 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -93.62 -48.37 6.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.235 -0.439 . . . . 65.549999999999997 110.886 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.543 ' O ' HG22 ' A' ' 74' ' ' VAL . 21.9 m-85 -93.92 21.21 6.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.033 -0.531 . . . . 75.230000000000004 112.154 -174.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.1 t -53.01 -36.38 60.43 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.035 0.383 . . . . 74.329999999999998 112.035 -174.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -71.24 -16.98 62.52 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.505 -0.316 . . . . 53.340000000000003 111.455 -177.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -117.16 -1.37 11.87 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.404 -0.362 . . . . 72.310000000000002 111.036 -175.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.543 HG22 ' O ' ' A' ' 70' ' ' TYR . 26.4 m -135.16 150.65 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 121.008 0.432 . . . . 55.140000000000001 111.55 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -137.57 115.2 11.27 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.094 -0.706 . . . . 63.310000000000002 109.094 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.472 HG12 ' HB2' ' A' ' 45' ' ' LEU . 61.0 mt -98.21 140.63 17.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.692 0.282 . . . . 74.420000000000002 110.326 -178.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.54 ' HB2' HG12 ' A' ' 46' ' ' VAL . 95.1 m-85 -129.35 138.21 51.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.409 -0.359 . . . . 72.200000000000003 110.487 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.442 ' HB3' ' HG3' ' A' ' 25' ' ' GLN . 53.3 tptt -101.24 114.76 29.02 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.402 -0.817 . . . . 72.219999999999999 110.115 -178.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.444 ' N ' HD12 ' A' ' 79' ' ' ILE . 2.3 mp -133.62 144.54 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 120.765 0.317 . . . . 72.5 110.374 178.027 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.463 ' HA ' ' O ' ' A' ' 49' ' ' TRP . 4.4 p-10 -107.12 30.85 5.82 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.973 0.416 . . . . 55.210000000000001 111.281 -178.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 13.8 tt -98.04 15.99 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.103 0.478 . . . . 61.140000000000001 110.958 -176.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.598 ' HB2' ' HB3' ' A' ' 48' ' ' PHE . 36.7 tt0 -52.21 -58.63 6.03 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.117 -0.492 . . . . 71.239999999999995 112.13 -174.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -75.29 11.34 1.23 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.971 -0.559 . . . . 64.430000000000007 111.987 -173.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -124.27 -2.58 8.05 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.082 0.468 . . . . 73.349999999999994 111.08 -177.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -99.76 113.95 26.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.943 0.401 . . . . 74.209999999999994 111.542 -175.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -56.9 -27.06 60.23 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.663 -0.699 . . . . 61.450000000000003 109.63 173.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.5 t -51.3 -42.63 27.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 114.728 -1.124 . . . . 75.030000000000001 111.31 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.406 ' O ' HG12 ' A' ' 93' ' ' VAL . . . -60.47 -49.75 76.32 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.032 -0.531 . . . . 73.530000000000001 110.777 -179.161 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.2 m -66.88 -33.48 75.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.802 -0.635 . . . . 71.010000000000005 110.413 178.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -66.6 -36.3 82.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.658 -0.701 . . . . 72.230000000000004 110.82 -178.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -89.29 -0.77 57.72 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.844 0.354 . . . . 74.030000000000001 110.857 176.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.65 41.66 42.42 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-N 115.787 -0.642 . . . . 71.209999999999994 113.7 170.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 88' ' ' ALA . 10.0 p -98.45 152.79 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.978 0.389 . . . . 73.5 110.076 176.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.9 t -148.01 35.54 0.83 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.184 0.516 . . . . 73.310000000000002 109.806 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.405 ' H ' HG22 ' A' ' 93' ' ' VAL . . . -133.21 149.34 52.01 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.009 -0.541 . . . . 73.129999999999995 110.813 -178.375 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 97' ' ' PRO . 68.6 mt -118.96 128.48 25.93 Favored Pre-proline 0 C--O 1.237 0.42 0 CA-C-N 115.826 -0.625 . . . . 72.430000000000007 109.88 176.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 96' ' ' ILE . 57.2 Cg_endo -92.98 167.03 23.0 Favored 'Cis proline' 0 C--N 1.349 0.575 0 C-N-CA 124.177 -1.176 . . . . 65.310000000000002 112.966 -1.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 62.1 m -120.48 128.63 53.32 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.017 -0.538 . . . . 71.120000000000005 110.906 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.676 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 3.4 mp -106.85 138.91 30.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.46 -0.57 . . . . 53.43 109.46 178.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.541 HD12 ' HB3' ' A' ' 110' ' ' GLN . 34.5 tp -127.56 145.93 50.7 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.797 -0.446 . . . . 73.120000000000005 109.797 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.816 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 72.7 mtp -118.26 116.21 26.31 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 120.874 0.368 . . . . 74.109999999999999 111.979 -173.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -109.41 157.78 18.59 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.736 -0.665 . . . . 74.430000000000007 111.363 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.479 ' CB ' HD21 ' A' ' 108' ' ' LEU . 39.4 ttmt -151.22 102.86 2.97 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.566 -0.901 . . . . 63.310000000000002 108.566 169.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.8 t30 53.73 38.76 29.18 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.394 0.616 . . . . 65.239999999999995 110.762 -177.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.81 -6.48 81.95 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 116.107 -0.497 . . . . 53.509999999999998 113.272 177.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -90.15 134.86 34.02 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 122.434 0.293 . . . . 51.240000000000002 110.248 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 40.2 tttm -89.42 120.95 31.19 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 110.013 -0.366 . . . . 45.119999999999997 110.013 176.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.548 ' N ' HD22 ' A' ' 108' ' ' LEU . 2.0 mm? -98.49 -53.11 3.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.244 -0.434 . . . . 72.549999999999997 110.514 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.816 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 16.7 m -156.78 172.41 18.68 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 115.172 -0.922 . . . . 74.540000000000006 110.007 -169.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.541 ' HB3' HD12 ' A' ' 100' ' ' LEU . 12.4 pt20 -158.4 131.57 7.39 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.88 0.371 . . . . 75.319999999999993 110.452 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.679 HG21 HD11 ' A' ' 63' ' ' LEU . 38.8 t -98.5 107.21 19.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.957 -0.565 . . . . 64.25 110.242 -176.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 68.6 mt -95.46 114.4 31.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.335 -0.393 . . . . 75.109999999999999 109.973 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.36 -109.9 2.9 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.726 -0.749 . . . . 74.409999999999997 111.966 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.61 104.22 1.97 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.658 0.229 . . . . 71.329999999999998 111.264 -178.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.5 ' O ' HG23 ' A' ' 119' ' ' ILE . 37.3 m-20 -140.55 96.05 2.97 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.624 0.25 . . . . 62.439999999999998 110.43 176.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.518 HD12 HD11 ' A' ' 119' ' ' ILE . 6.6 tp -60.15 -42.48 90.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 CA-C-O 120.933 0.397 . . . . 73.120000000000005 110.503 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 36.8 t -61.62 -30.18 70.53 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.715 -0.675 . . . . 71.150000000000006 110.694 -178.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.05 -53.73 6.72 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.183 -0.673 . . . . 71.040000000000006 109.183 179.144 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.571 HG12 ' HB3' ' A' ' 62' ' ' GLN . 2.1 pp -59.08 -40.41 80.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.692 -0.685 . . . . 71.219999999999999 111.701 -172.01 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.534 HD12 ' N ' ' A' ' 121' ' ' SER . 2.8 pp -59.2 -36.89 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 C-N-CA 119.935 -0.706 . . . . 75.310000000000002 110.142 178.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.534 ' N ' HD12 ' A' ' 120' ' ' ILE . 28.1 t -70.69 -50.62 34.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.19 -0.459 . . . . 62.240000000000002 110.865 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.562 ' HG2' ' HA ' ' A' ' 119' ' ' ILE . 16.4 pt-20 -76.36 -29.02 57.02 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 112.081 0.4 . . . . 74.319999999999993 112.081 -170.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.605 HD12 HD12 ' A' ' 66' ' ' LEU . 65.2 mt -72.08 -56.86 8.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-O 120.903 0.382 . . . . 72.530000000000001 110.004 174.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -61.88 -20.31 63.59 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.847 -0.615 . . . . 72.010000000000005 110.993 -178.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -66.87 -27.99 67.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.08 -0.509 . . . . 60.229999999999997 111.231 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -120.46 -1.12 10.2 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.497 0.554 . . . . 73.109999999999999 112.497 -171.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 31.4 pt -139.27 167.65 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 110.237 -0.283 . . . . 71.040000000000006 110.237 170.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.327 -0.845 . . . . 74.439999999999998 110.869 -179.181 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 tpt . . . . . 0 N--CA 1.48 1.055 0 CA-C-O 121.01 0.433 . . . . 51.399999999999999 110.358 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.05 99.61 4.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.919 -0.582 . . . . 74.329999999999998 109.946 176.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 25.0 t-80 -148.75 71.7 1.16 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.318 0.58 . . . . 73.010000000000005 109.98 -178.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 18.3 p80 -69.25 151.35 46.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.254 -0.884 . . . . 75.420000000000002 110.961 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 18.4 t60 -150.14 79.17 1.35 Allowed 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.308 -0.627 . . . . 74.219999999999999 109.308 176.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 29.4 t60 -60.94 115.81 4.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.875 -0.602 . . . . 71.200000000000003 110.528 -177.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -142.14 143.19 32.88 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.491 -0.559 . . . . 65.209999999999994 109.491 -179.312 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -144.1 16.43 1.73 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.875 0.369 . . . . 71.340000000000003 110.775 -179.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.6 mmt -110.4 111.27 22.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 61.329999999999998 109.98 176.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.2 66.21 3.48 Favored Glycine 0 N--CA 1.453 -0.199 0 N-CA-C 111.583 -0.607 . . . . 54.420000000000002 111.583 176.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.2 m -58.67 133.47 55.93 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 122.49 0.316 . . . . 62.43 110.907 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.7 tt -153.34 106.12 2.93 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 109.187 -0.672 . . . . 75.129999999999995 109.187 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -88.15 134.33 33.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.269 -0.423 . . . . 62.409999999999997 110.42 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.4 77.12 3.93 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.626 -0.509 . . . . 64.340000000000003 109.626 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -73.4 131.04 41.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.49 -0.777 . . . . 71.200000000000003 110.44 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 49.1 m -61.61 132.09 52.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.411 -0.359 . . . . 74.340000000000003 110.636 177.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.414 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 25.4 pt20 -93.93 90.0 6.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.368 0.604 . . . . 73.129999999999995 109.961 178.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 179.69 80.49 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.893 -0.67 . . . . 72.219999999999999 112.377 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.23 76.04 0.24 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.72 2.28 . . . . 73.219999999999999 110.981 177.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 168.54 -23.56 0.1 Allowed Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.291 -0.868 . . . . 71.450000000000003 111.618 -177.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 45.0 m -61.06 92.29 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.899 0.38 . . . . 64.019999999999996 110.338 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.757 ' HG2' HG13 ' A' ' 23' ' ' ILE . 1.6 pmm? -74.45 -25.6 59.51 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 109.786 -0.45 . . . . 73.25 109.786 176.279 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.757 HG13 ' HG2' ' A' ' 22' ' ' MET . 47.1 mt -129.04 118.15 45.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 115.729 -0.669 . . . . 74.400000000000006 109.408 177.185 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 13.7 tp10 -131.83 155.11 48.37 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.275 -0.269 . . . . 71.409999999999997 110.275 -176.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.443 ' HG3' ' HE3' ' A' ' 78' ' ' LYS . 0.8 OUTLIER -92.2 147.67 22.75 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 110.399 -0.223 . . . . 65.140000000000001 110.399 -178.759 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 42.7 pt -135.02 -176.76 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 120.638 0.256 . . . . 64.230000000000004 110.401 176.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -118.41 167.17 12.94 Favored Glycine 0 C--N 1.331 0.281 0 N-CA-C 111.847 -0.501 . . . . 13.31 111.847 177.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -67.41 -40.79 85.61 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.864 0.32 . . . . 73.329999999999998 111.864 -174.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 83.4 p -80.16 -28.77 38.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.919 0.39 . . . . 64.120000000000005 111.43 -176.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.426 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 2.3 pm0 -91.48 -6.79 52.07 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 116.379 -0.373 . . . . 71.549999999999997 110.484 178.225 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.442 ' HE1' HG21 ' A' ' 46' ' ' VAL . 37.9 t80 -49.13 -70.8 0.08 Allowed 'General case' 0 C--O 1.227 -0.12 0 CA-C-N 115.871 -0.604 . . . . 65.209999999999994 110.174 175.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -58.22 -38.49 76.9 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 109.65 -0.5 . . . . 71.430000000000007 109.65 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -51.7 -46.43 63.91 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.035 -0.984 . . . . 63.409999999999997 111.321 -172.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -108.04 -21.16 12.92 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.107 0.41 . . . . 53.439999999999998 112.107 -176.643 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 89.7 t -88.17 -50.57 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 N-CA-C 111.722 0.268 . . . . 61.520000000000003 111.722 -177.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 66.4 p -80.18 -25.61 39.64 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 120.244 -0.582 . . . . 74.430000000000007 109.834 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.6 m -88.3 11.99 15.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.452 -0.795 . . . . 73.219999999999999 110.867 177.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.564 ' O ' ' HA ' ' A' ' 104' ' ' ASN . 44.2 t -59.3 104.49 0.26 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.66 0.267 . . . . 60.130000000000003 110.916 -178.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -81.55 -17.65 47.69 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.879 0.371 . . . . 70.230000000000004 110.293 176.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -65.92 -20.74 66.32 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.842 -0.617 . . . . 63.240000000000002 111.349 -177.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 64.44 11.48 6.57 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.058 0.543 . . . . 71.209999999999994 111.86 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.4 tt -73.35 163.29 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 109.442 -0.577 . . . . 74.519999999999996 109.442 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.661 HD21 ' HE3' ' A' ' 101' ' ' MET . 62.6 tp -87.65 110.61 20.53 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.109 0.48 . . . . 74.319999999999993 110.202 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.3 mt -96.0 119.66 44.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.747 -0.661 . . . . 75.349999999999994 110.204 178.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.688 HD13 HD12 ' A' ' 63' ' ' LEU . 71.5 mt -98.87 109.61 22.34 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.696 -0.853 . . . . 41.200000000000003 108.696 177.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.442 HG21 ' HE1' ' A' ' 31' ' ' PHE . 47.1 t -103.04 109.33 26.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.874 -0.148 . . . . 71.439999999999998 111.119 -176.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.447 ' HB3' ' HD1' ' A' ' 49' ' ' TRP . 1.2 m-20 -81.21 134.28 35.59 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.586 -0.524 . . . . 64.5 109.586 173.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.41 ' HA ' ' HB3' ' A' ' 80' ' ' ASN . 10.7 p90 -61.33 -28.68 69.38 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.517 0.675 . . . . 73.030000000000001 110.169 178.106 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.606 ' H ' ' HD1' ' A' ' 49' ' ' TRP . 0.2 OUTLIER -110.41 -164.0 0.89 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.127 -0.942 . . . . 72.239999999999995 109.858 -177.604 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.441 ' HA ' ' HB3' ' A' ' 78' ' ' LYS . . . -131.81 87.73 44.25 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.848 -0.16 . . . . 53.439999999999998 111.262 178.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -60.97 112.62 1.42 Allowed 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.252 1.968 . . . . 74.340000000000003 110.677 170.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -95.94 -76.01 0.51 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.853 -0.158 . . . . 74.150000000000006 111.212 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 52.8 t -172.14 160.22 5.13 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.076 -0.342 . . . . 72.239999999999995 110.076 -178.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -101.2 154.89 19.11 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 111.521 -0.632 . . . . 63.140000000000001 111.521 176.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.89 -29.35 89.25 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.711 2.274 . . . . 62.109999999999999 111.667 176.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 49.0 t -123.06 158.41 30.66 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.936 -0.575 . . . . 70.010000000000005 109.726 176.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 ttt180 -74.93 88.59 2.34 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 109.764 -0.458 . . . . 74.519999999999996 109.764 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.4 p -84.22 -171.81 3.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.873 -0.603 . . . . 52.329999999999998 110.964 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.437 ' N ' HD22 ' A' ' 59' ' ' LEU . 3.0 mm? -73.5 131.41 41.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 73.329999999999998 109.877 177.13 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -68.19 134.26 91.46 Favored Pre-proline 0 C--O 1.237 0.438 0 N-CA-C 109.593 -0.521 . . . . 73.140000000000001 109.593 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.01 172.43 11.92 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.469 2.113 . . . . 71.140000000000001 112.138 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.478 ' HB3' HG12 ' A' ' 119' ' ' ILE . 14.1 mp0 -47.06 -56.09 7.13 Favored 'General case' 0 C--O 1.249 1.067 0 CA-C-O 121.927 0.87 . . . . 74.099999999999994 110.953 -178.183 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.688 HD12 HD13 ' A' ' 45' ' ' LEU . 3.2 mm? -57.48 -48.14 80.0 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 114.215 -1.357 . . . . 74.219999999999999 110.758 -172.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 35.7 mt-10 -69.77 -38.92 76.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.601 -0.272 . . . . 74.409999999999997 110.853 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 26.7 mmtm -50.75 -50.18 56.24 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.852 0.358 . . . . 71.310000000000002 110.408 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.617 HD12 HD12 ' A' ' 123' ' ' ILE . 32.4 mt -77.73 -37.34 49.53 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 120.542 -0.463 . . . . 73.239999999999995 111.695 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.87 -31.32 72.33 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 111.729 0.27 . . . . 61.5 111.729 -175.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.462 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 75.4 mt-30 -54.44 -37.55 65.3 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.861 0.362 . . . . 70.239999999999995 110.882 178.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -93.57 -46.22 7.39 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.924 -0.58 . . . . 65.549999999999997 110.803 -177.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.528 ' O ' HG22 ' A' ' 74' ' ' VAL . 17.6 m-85 -93.32 22.32 5.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.761 -0.654 . . . . 75.230000000000004 112.366 -173.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.4 t -52.17 -38.55 58.05 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.206 0.447 . . . . 74.329999999999998 112.206 -173.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -71.06 -22.53 62.11 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 122.183 -0.323 . . . . 53.340000000000003 111.832 -177.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.34 -8.63 21.03 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.579 0.228 . . . . 72.310000000000002 110.773 -175.262 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 70' ' ' TYR . 35.2 m -133.11 151.16 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 O-C-N 121.944 -0.472 . . . . 55.140000000000001 111.412 -178.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.463 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 35.9 mmtm -139.09 115.34 10.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.773 -0.649 . . . . 63.310000000000002 109.563 174.094 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.55 ' HB ' HG12 ' A' ' 23' ' ' ILE . 56.4 mt -90.12 109.96 21.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.857 -0.61 . . . . 74.420000000000002 110.386 -178.014 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.463 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 7.7 m-85 -97.79 134.03 41.5 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.799 -0.445 . . . . 72.200000000000003 109.799 176.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.469 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 57.1 mtmt -107.28 155.6 19.78 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.845 -0.616 . . . . 72.219999999999999 110.677 -176.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.469 ' HB ' ' O ' ' A' ' 78' ' ' LYS . 41.4 mm 85.85 95.22 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 O-C-N 124.47 1.106 . . . . 72.5 111.665 178.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.41 ' HB3' ' HA ' ' A' ' 48' ' ' PHE . 25.9 t-20 -153.34 87.05 1.24 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.589 -1.187 . . . . 55.210000000000001 108.186 173.177 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 40.8 mm -61.46 92.29 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.85 -0.614 . . . . 61.140000000000001 112.155 -170.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.643 ' HG2' ' HB1' ' A' ' 88' ' ' ALA . 3.5 tm-20 -53.89 -31.47 50.03 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.338 -0.846 . . . . 71.239999999999995 109.966 175.124 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.82 -7.59 53.88 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.179 -0.919 . . . . 64.430000000000007 111.813 -175.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -132.28 6.61 4.18 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 122.285 -0.259 . . . . 73.349999999999994 111.554 -176.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -112.68 115.77 29.09 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.939 0.399 . . . . 74.209999999999994 110.783 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -60.67 -29.24 69.17 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.801 -0.636 . . . . 61.450000000000003 111.054 -177.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 62.6 t -56.96 -44.23 82.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 CA-C-O 121.226 0.536 . . . . 75.030000000000001 110.305 178.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.643 ' HB1' ' HG2' ' A' ' 82' ' ' GLU . . . -68.17 -36.29 79.38 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.702 -0.681 . . . . 73.530000000000001 110.533 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.5 m -64.02 -40.67 96.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.364 -0.835 . . . . 71.010000000000005 110.297 176.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 54.7 tp60 -63.93 -43.65 95.26 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.841 -0.618 . . . . 72.230000000000004 110.207 178.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -70.68 -17.25 62.85 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.311 -0.404 . . . . 74.030000000000001 110.82 175.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 58.87 42.16 96.51 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 110.819 -0.912 . . . . 71.209999999999994 110.819 -175.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.6 p -93.65 17.6 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-O 120.973 0.416 . . . . 73.5 111.43 -171.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.6 m -66.81 81.27 0.11 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.264 0.554 . . . . 73.310000000000002 110.873 178.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -157.3 91.1 1.15 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.513 -0.921 . . . . 73.129999999999995 108.513 176.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.7 pp -83.52 149.32 57.37 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.426 -0.807 . . . . 72.430000000000007 111.52 -171.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.438 ' HD2' ' O ' ' A' ' 113' ' ' GLY . 15.5 Cg_exo -69.94 161.08 87.44 Favored 'Cis proline' 0 C--N 1.357 0.995 0 C-N-CA 124.268 -1.138 . . . . 65.310000000000002 112.657 -3.233 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.6 m -141.1 118.36 11.36 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.07 -0.514 . . . . 71.120000000000005 110.97 -175.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.687 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 3.2 mp -120.93 133.71 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.884 -0.598 . . . . 53.43 109.977 178.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.7 mp -109.95 139.61 44.86 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 110.182 -0.303 . . . . 73.120000000000005 110.182 176.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.673 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 71.7 mtp -104.65 116.2 31.65 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.305 -0.407 . . . . 74.109999999999999 110.492 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -114.96 142.16 47.0 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.165 0.507 . . . . 74.430000000000007 111.536 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.622 ' CB ' HD21 ' A' ' 108' ' ' LEU . 23.2 ttmm -143.09 107.08 4.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.17 -0.923 . . . . 63.310000000000002 109.036 174.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.564 ' HA ' ' O ' ' A' ' 38' ' ' CYS . 3.8 t-20 59.74 28.45 17.91 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.471 0.653 . . . . 65.239999999999995 110.461 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.25 -14.41 63.77 Favored Glycine 0 C--N 1.332 0.356 0 CA-C-N 115.819 -0.628 . . . . 53.509999999999998 113.181 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.505 ' HD2' HD13 ' A' ' 108' ' ' LEU . 0.9 OUTLIER -87.7 116.97 26.21 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.703 -0.851 . . . . 51.240000000000002 108.703 176.425 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 101' ' ' MET . 25.5 pttm -77.84 119.34 21.19 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.69 -0.485 . . . . 45.119999999999997 109.69 177.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.622 HD21 ' CB ' ' A' ' 103' ' ' LYS . 1.8 mm? -78.06 -52.06 9.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.335 0.588 . . . . 72.549999999999997 109.951 -175.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.673 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 72.1 m -160.69 172.47 17.04 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 114.944 -1.025 . . . . 74.540000000000006 110.11 -170.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.02 126.56 17.84 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.124 -0.489 . . . . 75.319999999999993 111.044 -174.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.687 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 44.2 t -85.88 106.97 15.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.316 -0.624 . . . . 64.25 109.316 174.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 32.7 mt -113.66 109.89 30.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.509 -0.552 . . . . 75.109999999999999 109.509 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.438 ' O ' ' HD2' ' A' ' 97' ' ' PRO . . . 100.74 -121.27 7.18 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.147 -0.549 . . . . 74.409999999999997 111.867 -177.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.21 57.37 0.51 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.349 0.595 . . . . 71.329999999999998 110.276 -177.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.528 ' O ' HG23 ' A' ' 119' ' ' ILE . 2.5 m-20 -103.51 95.54 6.14 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.719 -0.673 . . . . 62.439999999999998 110.86 -173.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.582 ' O ' HG13 ' A' ' 119' ' ' ILE . 6.0 tp -63.24 -43.99 99.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 116.126 -0.488 . . . . 73.120000000000005 112.074 -175.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.8 t -65.69 -28.2 68.9 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.13 0.49 . . . . 71.150000000000006 110.139 -178.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -75.67 -46.74 29.63 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.884 -0.598 . . . . 71.040000000000006 109.529 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.634 ' HA ' ' HG2' ' A' ' 122' ' ' GLU . 2.2 pp -66.67 -39.42 83.73 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.095 0 CA-C-N 116.325 -0.398 . . . . 71.219999999999999 111.713 -175.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.455 HD12 ' N ' ' A' ' 121' ' ' SER . 2.8 pp -62.5 -31.75 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 C-N-CA 120.385 -0.526 . . . . 75.310000000000002 109.768 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.455 ' N ' HD12 ' A' ' 120' ' ' ILE . 35.0 t -70.62 -51.37 28.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.877 -0.601 . . . . 62.240000000000002 110.657 176.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.634 ' HG2' ' HA ' ' A' ' 119' ' ' ILE . 16.7 pt-20 -71.28 -40.82 70.68 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 112.025 0.38 . . . . 74.319999999999993 112.025 -172.318 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.617 HD12 HD12 ' A' ' 66' ' ' LEU . 82.1 mt -70.71 -59.67 3.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.607 -0.27 . . . . 72.530000000000001 111.101 -177.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -58.02 -26.26 62.2 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.148 0.499 . . . . 72.010000000000005 111.022 -176.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -63.58 -28.94 70.27 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.859 -0.61 . . . . 60.229999999999997 111.223 178.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -115.0 9.92 16.13 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.244 0.461 . . . . 73.109999999999999 112.244 -174.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.473 HG12 ' O ' ' A' ' 123' ' ' ILE . 42.7 pt -139.08 168.92 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 110.212 -0.292 . . . . 71.040000000000006 110.212 175.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.252 1.214 0 CA-C-O 118.444 -0.788 . . . . 74.439999999999998 111.983 -176.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.519 ' HG3' ' H ' ' A' ' 3' ' ' HIS . 29.7 tpp . . . . . 0 N--CA 1.48 1.07 0 CA-C-O 120.691 0.282 . . . . 51.399999999999999 110.428 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -93.21 -3.8 53.14 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.428 0.529 . . . . 74.329999999999998 112.428 -173.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.519 ' H ' ' HG3' ' A' ' 1' ' ' MET . 14.2 m-70 -72.73 77.6 1.11 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.922 0.392 . . . . 73.010000000000005 110.56 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.4 ' H ' ' CD2' ' A' ' 4' ' ' HIS . 3.8 p80 -91.1 135.86 33.48 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.027 -0.533 . . . . 75.420000000000002 110.211 178.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -84.85 22.57 1.34 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.157 -0.474 . . . . 74.219999999999999 112.076 -172.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -128.9 100.31 5.63 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.874 -0.417 . . . . 71.200000000000003 109.874 176.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 10.2 p80 -126.83 164.44 21.38 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.9 -0.407 . . . . 65.209999999999994 109.9 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -111.6 174.05 6.06 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.647 -0.251 . . . . 71.340000000000003 110.394 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.466 ' HA ' ' HG2' ' A' ' 51' ' ' PRO . 68.9 mtm -137.82 84.87 2.07 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.844 0.355 . . . . 61.329999999999998 110.53 179.174 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.02 52.58 52.53 Favored Glycine 0 C--N 1.333 0.394 0 CA-C-N 115.902 -0.59 . . . . 54.420000000000002 112.943 178.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 21.3 p -79.7 -62.21 1.76 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.844 0.354 . . . . 62.43 111.673 -178.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.91 -72.62 0.35 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.217 -0.447 . . . . 75.129999999999995 110.349 -176.121 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -147.16 148.4 31.5 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.158 -0.473 . . . . 62.409999999999997 110.589 -177.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -152.72 101.11 2.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.048 -0.524 . . . . 64.340000000000003 109.803 176.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -161.11 150.4 16.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.301 -0.408 . . . . 71.200000000000003 110.333 -177.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.0 t -122.33 116.55 24.26 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.589 -0.522 . . . . 74.340000000000003 109.589 174.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -101.5 89.06 3.6 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.726 -0.472 . . . . 73.129999999999995 109.726 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 152.01 89.65 0.07 OUTLIER Glycine 0 CA--C 1.519 0.332 0 CA-C-N 115.813 -0.63 . . . . 72.219999999999999 111.63 -178.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.8 93.04 0.21 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.618 2.212 . . . . 73.219999999999999 111.823 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 151.05 50.77 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.22 0 N-CA-C 111.273 -0.731 . . . . 71.450000000000003 111.273 -178.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.1 m -88.76 150.33 23.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.63 0.252 . . . . 64.019999999999996 110.819 -176.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.559 ' N ' ' SD ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -65.19 -19.37 65.94 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.031 0.443 . . . . 73.25 109.885 175.254 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.427 HG12 ' HB ' ' A' ' 76' ' ' ILE . 46.0 mt -103.32 84.55 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 115.365 -0.834 . . . . 74.400000000000006 108.966 172.246 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 10.0 tp10 -86.74 155.44 20.35 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.14 -0.482 . . . . 71.409999999999997 110.549 -175.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -97.34 143.79 27.75 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.742 0.306 . . . . 65.140000000000001 110.294 178.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.512 HD12 ' HA ' ' A' ' 31' ' ' PHE . 29.9 pt -133.65 163.67 36.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-N 116.324 -0.398 . . . . 64.230000000000004 110.639 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -98.12 155.6 20.34 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.899 -0.591 . . . . 13.31 111.654 176.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -60.3 -30.35 69.42 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.896 0.379 . . . . 73.329999999999998 110.902 -178.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.7 p -61.84 -30.98 71.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.879 -0.601 . . . . 64.120000000000005 111.337 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -114.24 4.14 15.38 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.216 -0.447 . . . . 71.549999999999997 111.954 -175.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.512 ' HA ' HD12 ' A' ' 26' ' ' ILE . 81.3 t80 -52.85 -71.63 0.07 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.733 0.301 . . . . 65.209999999999994 110.703 -177.359 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.553 ' O ' HG22 ' A' ' 36' ' ' THR . 7.3 p-10 -65.27 -34.06 77.46 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.617 -0.512 . . . . 71.430000000000007 109.617 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -52.28 -44.72 65.14 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.7 -1.136 . . . . 63.409999999999997 111.55 -176.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt -100.9 -25.79 13.97 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.568 -0.287 . . . . 53.439999999999998 111.139 -177.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.3 t -78.49 -61.45 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 112.12 0.415 . . . . 61.520000000000003 112.12 -176.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.553 HG22 ' O ' ' A' ' 32' ' ' ASP . 11.9 t -84.32 0.35 49.47 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.005 0.431 . . . . 74.430000000000007 110.889 -170.327 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.6 m -98.82 -4.74 32.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.339 -0.392 . . . . 73.219999999999999 111.044 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.549 ' SG ' HG22 ' A' ' 42' ' ' ILE . 47.8 t -71.97 100.06 2.38 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.024 0.44 . . . . 60.130000000000003 111.034 -175.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -93.18 2.32 56.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.391 0.615 . . . . 70.230000000000004 109.548 176.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -63.09 -14.56 49.92 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.479 -0.782 . . . . 63.240000000000002 111.168 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.581 ' O ' ' HE3' ' A' ' 103' ' ' LYS . 32.8 m-80 69.21 19.63 7.81 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.749 -0.659 . . . . 71.209999999999994 110.946 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.549 HG22 ' SG ' ' A' ' 38' ' ' CYS . 10.9 tt -88.97 146.63 5.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 108.495 -0.928 . . . . 74.519999999999996 108.495 172.05 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.667 HD11 ' HB3' ' A' ' 101' ' ' MET . 68.7 tp -85.6 113.6 21.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.251 0.548 . . . . 74.319999999999993 110.648 -176.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 57.4 mt -94.64 123.62 46.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.199 -0.909 . . . . 75.349999999999994 110.331 177.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.529 ' HB2' HG12 ' A' ' 76' ' ' ILE . 2.2 mm? -104.74 104.36 14.15 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.334 -0.617 . . . . 41.200000000000003 109.334 178.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 35.9 m -99.1 130.29 48.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 110.357 -0.238 . . . . 71.439999999999998 110.357 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.499 ' HB2' HG13 ' A' ' 99' ' ' ILE . 27.0 t70 -122.62 141.29 51.88 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 120.923 0.392 . . . . 64.5 111.434 -177.366 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -79.85 100.4 7.99 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.699 -0.852 . . . . 73.030000000000001 108.699 172.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 72.5 t90 -40.09 104.96 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 O-C-N 124.248 0.967 . . . . 72.239999999999995 112.454 -171.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -157.3 148.05 16.29 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 115.725 -0.671 . . . . 53.439999999999998 110.29 177.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.466 ' HG2' ' HA ' ' A' ' 9' ' ' MET . 45.9 Cg_exo -57.72 109.13 0.44 Allowed 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.788 2.326 . . . . 74.340000000000003 112.549 179.003 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 13.0 p90 -70.06 83.77 0.51 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.795 -0.639 . . . . 74.150000000000006 112.028 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 84.7 m 72.56 -62.22 0.47 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.518 0.727 . . . . 72.239999999999995 112.698 173.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -73.3 -147.54 0.95 Allowed Glycine 0 CA--C 1.521 0.446 0 C-N-CA 121.482 -0.39 . . . . 63.140000000000001 113.031 -176.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.464 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 29.7 Cg_endo -64.2 -69.73 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.342 2.028 . . . . 62.109999999999999 111.68 178.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' CYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 55' ' ' PRO . 49.2 t 172.51 26.83 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 O-C-N 123.492 0.495 . . . . 70.010000000000005 109.913 178.182 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.466 ' HG2' ' N ' ' A' ' 58' ' ' SER . 47.4 ttp180 -130.5 163.46 26.96 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.461 -0.336 . . . . 74.519999999999996 110.129 -175.226 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.466 ' N ' ' HG2' ' A' ' 57' ' ' ARG . 32.5 t -54.42 120.9 7.25 Favored 'General case' 0 C--O 1.239 0.519 0 O-C-N 123.386 0.429 . . . . 52.329999999999998 110.29 176.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.454 ' H ' ' HD3' ' A' ' 61' ' ' PRO . 35.9 tp -134.0 34.79 3.33 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.423 0.63 . . . . 73.329999999999998 109.354 -176.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 55.29 55.0 10.22 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 115.321 -0.854 . . . . 73.140000000000001 111.014 -174.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.454 ' HD3' ' H ' ' A' ' 59' ' ' LEU . 86.4 Cg_endo -81.37 165.3 18.76 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.262 1.975 . . . . 71.140000000000001 111.4 178.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.675 ' NE2' ' HA ' ' A' ' 114' ' ' ALA . 0.4 OUTLIER -45.15 -57.56 3.83 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.179 0.592 . . . . 74.099999999999994 111.931 -173.636 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.437 HD22 ' HB2' ' A' ' 62' ' ' GLN . 3.5 mm? -60.71 -48.6 81.07 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.392 -0.822 . . . . 74.219999999999999 111.25 -172.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.502 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 39.7 mt-10 -66.0 -37.66 86.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.965 0.412 . . . . 74.409999999999997 110.221 178.398 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.427 ' HD2' ' HA ' ' A' ' 65' ' ' LYS . 42.2 tptt -60.71 -45.07 95.63 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.501 -0.772 . . . . 71.310000000000002 110.405 -174.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.712 HD12 HD12 ' A' ' 123' ' ' ILE . 23.9 mt -79.95 -30.31 39.83 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.515 -0.312 . . . . 73.239999999999995 110.988 176.137 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.68 -33.62 74.31 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.699 0.285 . . . . 61.5 110.847 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.502 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 78.4 mt-30 -56.07 -31.79 63.53 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.048 0.452 . . . . 70.239999999999995 110.547 177.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -93.9 -53.78 3.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.74 -0.663 . . . . 65.549999999999997 111.041 -178.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.512 ' O ' HG22 ' A' ' 74' ' ' VAL . 14.4 m-85 -95.73 23.11 6.48 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.604 -0.725 . . . . 75.230000000000004 112.822 -168.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.7 t -52.78 -28.64 23.34 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.77 0.319 . . . . 74.329999999999998 111.69 -176.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -71.03 -18.71 62.57 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.603 -0.272 . . . . 53.340000000000003 111.642 -177.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -120.65 1.07 10.54 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.654 0.264 . . . . 72.310000000000002 110.554 -176.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.512 HG22 ' O ' ' A' ' 70' ' ' TYR . 27.9 m -133.57 145.79 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 O-C-N 122.019 -0.426 . . . . 55.140000000000001 111.312 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 75' ' ' LYS . 41.7 mmtm -141.09 124.43 16.6 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.143 -0.688 . . . . 63.310000000000002 109.143 172.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.529 HG12 ' HB2' ' A' ' 45' ' ' LEU . 49.5 mt -103.26 135.14 42.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 110.084 -0.339 . . . . 74.420000000000002 110.084 -175.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.494 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 74.1 m-85 -126.29 128.68 47.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.884 0.374 . . . . 72.200000000000003 110.242 178.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -97.54 139.29 33.67 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.719 -0.845 . . . . 72.219999999999999 108.719 176.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 20.6 tt -136.7 141.72 40.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.862 -0.422 . . . . 72.5 109.862 176.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -62.55 167.88 4.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.942 -0.572 . . . . 55.210000000000001 111.512 -173.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 29.7 pt -55.98 -12.67 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 115.66 -0.7 . . . . 61.140000000000001 111.831 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -49.12 -40.37 32.09 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.821 -0.627 . . . . 71.239999999999995 111.132 173.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.626 ' O ' ' HG3' ' A' ' 85' ' ' GLN . 24.8 t70 -77.03 12.48 1.38 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.034 -0.53 . . . . 64.430000000000007 112.115 -172.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -55.86 103.62 0.11 Allowed 'General case' 0 C--N 1.327 -0.38 0 O-C-N 121.793 -0.567 . . . . 73.349999999999994 109.695 172.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.626 ' HG3' ' O ' ' A' ' 83' ' ' ASP . 24.3 mt-30 -109.49 174.21 5.97 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.001 -0.74 . . . . 74.209999999999994 109.001 -178.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -71.61 -31.64 67.13 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.993 -1.003 . . . . 61.450000000000003 109.564 174.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.0 t -55.63 -34.98 37.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 115.057 -0.974 . . . . 75.030000000000001 111.024 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.12 -52.48 65.15 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.21 0.528 . . . . 73.530000000000001 110.398 178.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 29.7 m -67.44 -28.32 67.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.748 -0.66 . . . . 71.010000000000005 110.389 178.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -63.41 -42.69 98.76 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.875 -0.602 . . . . 72.230000000000004 110.19 178.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -74.89 -17.19 60.62 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.274 -0.421 . . . . 74.030000000000001 110.725 176.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 86.9 36.73 8.93 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 121.226 -0.512 . . . . 71.209999999999994 112.395 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 99.3 t -70.34 92.52 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-O 121.126 0.488 . . . . 73.5 110.028 176.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.7 m -70.53 -33.39 71.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.56 -0.745 . . . . 73.310000000000002 111.367 -178.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -148.11 145.8 28.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.881 0.372 . . . . 73.129999999999995 111.187 -176.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.542 ' HB ' ' HA ' ' A' ' 97' ' ' PRO . 17.3 pt -101.43 161.68 22.83 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 115.46 -0.791 . . . . 72.430000000000007 109.626 177.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.542 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 93.9 Cg_endo -74.49 169.97 72.62 Favored 'Cis proline' 0 C--N 1.357 0.999 0 C-N-CA 124.585 -1.006 . . . . 65.310000000000002 113.243 3.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 96.7 m -155.29 122.03 5.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.483 -0.781 . . . . 71.120000000000005 109.699 -175.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.51 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.5 mp -106.7 108.95 26.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.123 -0.489 . . . . 53.43 110.277 -174.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.426 HD23 ' H ' ' A' ' 101' ' ' MET . 1.0 OUTLIER -92.9 136.49 33.21 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.88 -0.785 . . . . 73.120000000000005 108.88 177.755 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.901 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 69.0 mtp -101.34 117.52 35.13 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.244 -0.434 . . . . 74.109999999999999 110.943 -174.099 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -117.55 146.9 43.27 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 122.657 0.383 . . . . 74.430000000000007 110.524 178.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.812 ' HB3' HD21 ' A' ' 108' ' ' LEU . 84.1 tttt -166.68 135.37 2.84 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.973 -0.751 . . . . 63.310000000000002 108.973 -179.044 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 60.24 24.91 14.3 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.575 0.702 . . . . 65.239999999999995 110.508 177.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.93 17.61 76.73 Favored Glycine 0 CA--C 1.517 0.16 0 CA-C-N 115.789 -0.641 . . . . 53.509999999999998 113.392 178.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -136.44 157.53 46.56 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 117.059 0.429 . . . . 51.240000000000002 110.265 178.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.703 ' H ' ' HD2' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -83.36 142.47 31.01 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.363 -0.38 . . . . 45.119999999999997 110.085 176.62 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.812 HD21 ' HB3' ' A' ' 103' ' ' LYS . 2.9 mm? -111.47 -53.03 2.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.308 -0.406 . . . . 72.549999999999997 110.928 -178.251 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.901 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 14.2 m -158.26 172.17 18.87 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.949 -0.569 . . . . 74.540000000000006 110.124 -171.495 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -142.82 140.32 31.26 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.157 0.503 . . . . 75.319999999999993 111.76 -175.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.599 HG22 HG22 ' A' ' 119' ' ' ILE . 32.8 t -115.81 134.44 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 115.613 -0.721 . . . . 64.25 109.677 178.329 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 43.2 mt -126.15 106.89 16.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.899 0.381 . . . . 75.109999999999999 109.987 178.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 71.96 -85.86 0.47 Allowed Glycine 0 CA--C 1.521 0.425 0 CA-C-N 116.109 -0.496 . . . . 74.409999999999997 112.98 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.675 ' HA ' ' NE2' ' A' ' 62' ' ' GLN . . . -151.49 103.08 2.94 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 122.723 -0.28 . . . . 71.329999999999998 111.292 -174.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.45 ' O ' HG23 ' A' ' 119' ' ' ILE . 20.3 m-20 -132.49 63.28 1.63 Allowed 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 109.596 -0.52 . . . . 62.439999999999998 109.596 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.55 ' O ' HG13 ' A' ' 119' ' ' ILE . 6.8 tp -53.49 -51.57 40.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 N-CA-C 112.359 0.503 . . . . 73.120000000000005 112.359 -172.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.3 p -63.87 -28.1 69.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.33 0.586 . . . . 71.150000000000006 111.193 -178.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.429 ' HE2' ' HB2' ' A' ' 115' ' ' ASP . 3.0 tmmm? -79.47 -45.34 19.58 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.628 -0.715 . . . . 71.040000000000006 109.865 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.599 HG22 HG22 ' A' ' 111' ' ' VAL . 2.5 pp -69.26 -37.37 75.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 115.778 -0.647 . . . . 71.219999999999999 111.204 -174.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.474 HD12 ' N ' ' A' ' 121' ' ' SER . 2.9 pp -63.28 -31.92 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 C-N-CA 120.08 -0.648 . . . . 75.310000000000002 110.036 177.299 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.474 ' N ' HD12 ' A' ' 120' ' ' ILE . 45.0 t -70.52 -51.51 28.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.98 -0.555 . . . . 62.240000000000002 110.916 178.446 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.561 ' HG2' ' HA ' ' A' ' 119' ' ' ILE . 24.2 pt-20 -72.1 -48.93 40.28 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.151 0.426 . . . . 74.319999999999993 112.151 -174.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.712 HD12 HD12 ' A' ' 66' ' ' LEU . 83.4 mt -59.38 -55.81 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.597 0.237 . . . . 72.530000000000001 110.852 -177.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -58.77 -20.31 48.58 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.991 0.425 . . . . 72.010000000000005 111.044 -178.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -84.12 -35.55 23.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.032 -0.531 . . . . 60.229999999999997 111.06 177.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -91.69 -9.34 44.22 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.192 -0.458 . . . . 73.109999999999999 111.929 -172.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.479 HG12 ' O ' ' A' ' 123' ' ' ILE . 45.4 pt -133.94 168.19 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 120.689 0.28 . . . . 71.040000000000006 110.691 175.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 . . . . . 0 C--O 1.245 0.857 0 CA-C-O 118.802 -0.618 . . . . 74.439999999999998 110.624 -175.432 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.568 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.13 0 CA-C-O 121.102 0.477 . . . . 51.399999999999999 110.615 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -175.44 159.2 2.4 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.03 -0.532 . . . . 74.329999999999998 110.728 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -129.73 150.26 51.11 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.698 -0.853 . . . . 73.010000000000005 108.698 175.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -82.0 62.33 5.71 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.437 0.637 . . . . 75.420000000000002 111.117 -177.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.7 m80 -148.8 106.94 3.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.174 -0.921 . . . . 74.219999999999999 108.621 173.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -136.49 -50.67 0.68 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.899 0.381 . . . . 71.200000000000003 110.198 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 19.6 p80 -75.18 144.72 42.58 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.085 -0.507 . . . . 65.209999999999994 109.762 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -85.95 178.43 7.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.374 -0.375 . . . . 71.340000000000003 110.376 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 69.6 mtm -140.94 -173.98 3.86 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.971 -0.381 . . . . 61.329999999999998 109.971 179.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.05 150.81 22.84 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 121.272 -0.489 . . . . 54.420000000000002 112.169 178.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 26.1 p -108.22 101.11 10.35 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 122.472 0.309 . . . . 62.43 110.23 178.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.6 pp -82.17 179.45 7.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.317 -0.402 . . . . 75.129999999999995 110.486 -179.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -117.87 145.3 44.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.847 0.356 . . . . 62.409999999999997 110.293 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -146.83 134.36 20.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.034 -0.53 . . . . 64.340000000000003 110.002 179.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -98.5 75.5 2.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.347 0.594 . . . . 71.200000000000003 109.682 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 32.3 p -130.49 -73.02 0.55 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.525 -0.761 . . . . 74.340000000000003 110.422 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -159.02 155.99 28.5 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.281 -0.418 . . . . 73.129999999999995 110.128 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -130.23 -79.0 0.2 Allowed Glycine 0 CA--C 1.518 0.249 0 C-N-CA 121.155 -0.545 . . . . 72.219999999999999 112.106 178.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -69.48 103.88 1.18 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.794 2.329 . . . . 73.219999999999999 111.943 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -112.54 -4.71 24.86 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 121.321 -0.466 . . . . 71.450000000000003 112.33 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 44.5 t -97.5 107.4 19.89 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.529 -0.545 . . . . 64.019999999999996 109.529 178.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.512 ' N ' ' SD ' ' A' ' 22' ' ' MET . 1.4 mpt? -61.9 -38.25 87.65 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.126 -0.488 . . . . 73.25 111.105 -176.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.9 mt -111.66 128.11 68.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 115.898 -0.592 . . . . 74.400000000000006 110.337 -175.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 0.9 OUTLIER -122.0 144.22 49.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.326 -0.397 . . . . 71.409999999999997 109.952 -179.556 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.2 pp0? -94.41 137.79 33.13 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 110.223 -0.288 . . . . 65.140000000000001 110.223 177.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.494 HD12 ' HA ' ' A' ' 31' ' ' PHE . 36.2 pt -140.22 172.96 11.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 121.337 0.589 . . . . 64.230000000000004 111.399 -176.664 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -110.73 173.91 16.61 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.236 -0.893 . . . . 13.31 111.809 177.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -67.29 -33.68 75.81 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.684 0.253 . . . . 73.329999999999998 111.684 -177.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 44.6 m -64.48 -47.56 78.52 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.091 0.472 . . . . 64.120000000000005 110.804 -178.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.509 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 3.8 pm0 -84.29 -14.46 49.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.762 -0.654 . . . . 71.549999999999997 111.072 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.604 ' HE1' HG11 ' A' ' 46' ' ' VAL . 92.4 t80 -46.23 -70.08 0.11 Allowed 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.384 0.427 . . . . 65.209999999999994 110.726 -178.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -61.68 -39.85 92.9 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 121.128 0.489 . . . . 71.430000000000007 109.726 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.421 ' O ' ' HB2' ' A' ' 37' ' ' SER . 9.4 t-20 -56.35 -33.76 65.98 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.617 -1.174 . . . . 63.409999999999997 112.216 -171.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 18.7 ptmt -115.16 -21.85 9.76 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.711 0.263 . . . . 53.439999999999998 111.711 -177.68 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 93.6 t -88.5 -55.63 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 111.727 0.269 . . . . 61.520000000000003 111.727 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 30.8 p -85.87 -25.24 26.32 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.076 0.465 . . . . 74.430000000000007 110.796 -173.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 16.0 m -84.67 12.03 7.91 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.997 -0.547 . . . . 73.219999999999999 110.547 176.443 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 43.5 t -75.22 94.73 3.02 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.868 0.366 . . . . 60.130000000000003 110.548 178.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -91.88 1.31 57.26 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.138 -0.483 . . . . 70.230000000000004 110.563 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -72.22 -7.79 51.22 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.197 -0.456 . . . . 63.240000000000002 111.499 -176.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 64.39 15.82 9.77 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.18 -0.464 . . . . 71.209999999999994 111.397 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.9 tt -85.04 147.82 5.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 108.507 -0.923 . . . . 74.519999999999996 108.507 173.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.657 HD21 ' HE3' ' A' ' 101' ' ' MET . 61.2 tp -85.31 120.68 27.07 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.338 0.589 . . . . 74.319999999999993 110.682 -175.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 51.1 mt -106.98 126.02 63.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.379 -0.828 . . . . 75.349999999999994 110.392 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 45' ' ' LEU . 5.8 mp -108.81 110.13 21.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.317 -0.401 . . . . 41.200000000000003 110.067 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.604 HG11 ' HE1' ' A' ' 31' ' ' PHE . 59.3 t -96.96 111.26 26.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.812 -0.44 . . . . 71.439999999999998 109.812 176.332 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.424 ' OD1' ' NZ ' ' A' ' 78' ' ' LYS . 1.7 p30 -91.24 154.64 19.14 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.077 0.465 . . . . 64.5 110.62 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -109.92 26.33 10.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.664 -0.698 . . . . 73.030000000000001 110.173 178.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 76.5 t90 -75.69 115.76 15.71 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.724 -0.843 . . . . 72.239999999999995 108.724 175.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -47.14 115.9 3.78 Favored Pre-proline 0 CA--C 1.531 0.218 0 O-C-N 123.84 0.712 . . . . 53.439999999999998 111.697 -175.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.451 ' HG3' ' HE3' ' A' ' 78' ' ' LYS . 18.8 Cg_exo -65.78 78.41 0.28 Allowed 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.808 2.339 . . . . 74.340000000000003 111.423 177.368 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 55.2 t-105 -150.77 142.55 23.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.713 -0.676 . . . . 74.150000000000006 109.808 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 52.1 t -79.53 84.81 5.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.144 0.497 . . . . 72.239999999999995 110.317 -179.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -173.73 67.03 0.11 Allowed Glycine 0 N--CA 1.453 -0.208 0 CA-C-N 115.729 -0.668 . . . . 63.140000000000001 112.172 177.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -92.1 10.91 2.41 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.029 2.486 . . . . 62.109999999999999 112.663 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 45.8 t 65.02 -73.7 0.06 Allowed 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 122.957 0.503 . . . . 70.010000000000005 109.82 -174.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.8 ttp180 -127.51 118.18 23.51 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.784 -0.821 . . . . 74.519999999999996 108.784 174.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.6 p -69.1 141.77 54.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.372 -0.376 . . . . 52.329999999999998 111.141 -177.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.09 155.67 23.4 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.99 -0.55 . . . . 73.329999999999998 109.529 176.15 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -83.15 111.57 31.73 Favored Pre-proline 0 C--O 1.235 0.3 0 N-CA-C 109.907 -0.405 . . . . 73.140000000000001 109.907 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -76.9 -174.29 2.11 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.628 2.219 . . . . 71.140000000000001 111.911 178.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.454 ' H ' ' CD ' ' A' ' 62' ' ' GLN . 13.9 mp0 -57.74 -48.45 79.58 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.599 0.714 . . . . 74.099999999999994 110.466 -175.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.63 HD21 HG12 ' A' ' 99' ' ' ILE . 8.1 mp -55.55 -49.08 73.61 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 114.586 -1.188 . . . . 74.219999999999999 111.627 -174.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -71.15 -36.45 72.06 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.224 -0.287 . . . . 74.409999999999997 110.224 -177.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.439 ' HA ' ' HD3' ' A' ' 65' ' ' LYS . 41.3 mmtt -55.58 -51.67 66.33 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.234 -0.439 . . . . 71.310000000000002 111.248 178.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.591 HD12 HD12 ' A' ' 123' ' ' ILE . 28.5 mt -76.38 -40.9 49.75 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 120.368 -0.533 . . . . 73.239999999999995 111.493 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.467 ' HB1' ' HB3' ' A' ' 22' ' ' MET . . . -59.68 -38.3 81.13 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 111.714 0.265 . . . . 61.5 111.714 -175.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -53.93 -33.07 55.71 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.751 0.31 . . . . 70.239999999999995 110.901 179.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 70.5 mm-40 -93.89 -41.09 9.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.031 -0.531 . . . . 65.549999999999997 111.17 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.494 ' O ' HG22 ' A' ' 74' ' ' VAL . 19.3 m-85 -107.42 17.46 22.75 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.957 0.725 . . . . 75.230000000000004 112.957 -168.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.0 t -53.95 -32.73 54.71 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.312 0.506 . . . . 74.329999999999998 112.188 -174.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -68.43 -16.69 64.0 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.804 0.335 . . . . 53.340000000000003 111.302 -178.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 -114.47 -13.96 12.18 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.173 -0.467 . . . . 72.310000000000002 110.321 -178.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 70' ' ' TYR . 26.8 m -134.98 127.31 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 120.934 0.397 . . . . 55.140000000000001 110.688 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -118.42 122.83 43.75 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.57 -0.53 . . . . 63.310000000000002 109.57 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.476 HD13 ' HB3' ' A' ' 63' ' ' LEU . 60.7 mt -98.97 141.0 17.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.911 0.386 . . . . 74.420000000000002 110.913 -175.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.459 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 87.6 m-85 -133.63 157.93 44.52 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.076 -0.713 . . . . 72.200000000000003 109.076 175.488 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.451 ' HE3' ' HG3' ' A' ' 51' ' ' PRO . 0.4 OUTLIER -141.33 148.82 40.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.872 0.367 . . . . 72.219999999999999 110.799 179.244 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.4 pp -135.32 179.74 3.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.525 -0.761 . . . . 72.5 110.423 -179.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -137.03 89.09 2.41 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.877 0.37 . . . . 55.210000000000001 110.522 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.515 HG23 ' HB3' ' A' ' 84' ' ' ASN . 66.8 mt -145.85 111.01 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 108.962 -0.755 . . . . 61.140000000000001 108.962 177.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.3 mp0 -84.93 -72.43 0.48 Allowed 'General case' 0 C--O 1.235 0.342 0 N-CA-C 111.684 0.253 . . . . 71.239999999999995 111.684 -174.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -106.14 -8.3 17.5 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.502 -0.317 . . . . 64.430000000000007 111.54 -172.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.515 ' HB3' HG23 ' A' ' 81' ' ' ILE . 17.2 t-20 -84.83 18.62 2.35 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.377 0.608 . . . . 73.349999999999994 110.604 -177.041 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -126.02 136.95 53.56 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.074 -0.512 . . . . 74.209999999999994 110.572 -177.572 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -69.74 -31.74 69.9 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.846 -0.427 . . . . 61.450000000000003 109.846 174.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 97.0 t -47.22 -53.23 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 115.446 -0.797 . . . . 75.030000000000001 112.396 -173.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.68 -52.89 62.31 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.434 -0.348 . . . . 73.530000000000001 111.431 -176.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.1 m -72.3 -28.16 62.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 71.010000000000005 110.931 -179.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -65.6 -40.78 93.03 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.97 -0.559 . . . . 72.230000000000004 110.092 -178.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -88.23 -17.17 31.37 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.564 -0.744 . . . . 74.030000000000001 110.363 175.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 63.43 50.56 61.38 Favored Glycine 0 C--N 1.333 0.412 0 N-CA-C 111.19 -0.764 . . . . 71.209999999999994 111.19 -175.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.7 p -56.25 115.18 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.242 0.544 . . . . 73.5 111.187 -176.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.9 m -96.96 -14.26 21.82 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.813 -0.631 . . . . 73.310000000000002 110.855 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.77 131.66 15.15 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.705 0.288 . . . . 73.129999999999995 111.208 -177.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.532 ' HB ' ' HA ' ' A' ' 97' ' ' PRO . 2.8 pp -96.11 161.7 26.29 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 116.038 -0.528 . . . . 72.430000000000007 110.123 175.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.532 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 3.3 Cg_exo -76.83 176.52 43.59 Favored 'Cis proline' 0 C--N 1.355 0.888 0 C-N-CA 124.389 -1.088 . . . . 65.310000000000002 112.314 -0.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 15.9 m -134.32 121.35 21.11 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.221 -0.445 . . . . 71.120000000000005 110.098 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.655 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 3.7 mp -117.07 125.8 74.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.331 -0.618 . . . . 53.43 109.331 179.099 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -106.92 128.9 54.72 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.794 0.331 . . . . 73.120000000000005 110.129 -177.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.756 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 65.9 mtp -100.74 113.26 25.99 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.117 -0.492 . . . . 74.109999999999999 110.772 -177.272 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -111.42 146.61 36.88 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.076 -0.511 . . . . 74.430000000000007 110.749 178.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.802 ' HB3' HD21 ' A' ' 108' ' ' LEU . 33.9 ttpt -160.06 130.89 5.68 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.889 -0.782 . . . . 63.310000000000002 108.889 177.059 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 31.5 t-20 55.11 31.61 16.63 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.681 0.753 . . . . 65.239999999999995 110.101 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 74.84 20.93 79.26 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.313 -0.858 . . . . 53.509999999999998 113.42 176.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -129.3 155.2 45.97 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.758 0.279 . . . . 51.240000000000002 110.663 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.53 120.14 32.69 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.765 0.317 . . . . 45.119999999999997 110.168 177.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.802 HD21 ' HB3' ' A' ' 103' ' ' LYS . 2.0 mm? -92.89 -51.87 4.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.332 -0.395 . . . . 72.549999999999997 110.323 -178.287 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.756 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 49.7 m -153.96 171.54 18.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.59 -0.732 . . . . 74.540000000000006 110.592 -175.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -146.16 124.89 12.57 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.992 -0.549 . . . . 75.319999999999993 110.546 176.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.655 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 52.5 t -82.55 107.12 14.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.697 -0.483 . . . . 64.25 109.697 176.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 64.5 mt -109.18 108.67 25.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.813 -0.44 . . . . 75.109999999999999 109.813 178.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.0 -122.9 7.74 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.18 -0.534 . . . . 74.409999999999997 111.783 -178.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.24 88.15 1.0 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.779 0.323 . . . . 71.329999999999998 110.27 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.479 ' O ' HG23 ' A' ' 119' ' ' ILE . 3.6 m-20 -126.7 86.58 2.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.274 -0.421 . . . . 62.439999999999998 110.282 -177.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.52 ' O ' HG13 ' A' ' 119' ' ' ILE . 7.7 tp -55.57 -44.76 77.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 116.242 -0.435 . . . . 73.120000000000005 111.807 -176.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.5 t -68.09 -26.48 65.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.07 0.462 . . . . 71.150000000000006 110.655 -175.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -79.71 -45.6 18.64 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 116.086 -0.506 . . . . 71.040000000000006 110.269 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.52 HG13 ' O ' ' A' ' 116' ' ' ILE . 2.1 pp -67.87 -40.27 83.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 115.853 -0.612 . . . . 71.219999999999999 111.088 -175.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.485 HG22 HD11 ' A' ' 66' ' ' LEU . 2.8 pp -61.79 -32.23 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 120.439 -0.505 . . . . 75.310000000000002 110.029 178.104 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.468 ' N ' HD12 ' A' ' 120' ' ' ILE . 27.9 t -70.29 -51.77 27.89 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.867 -0.606 . . . . 62.240000000000002 110.379 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.477 ' HG2' ' HA ' ' A' ' 119' ' ' ILE . 21.0 pt-20 -72.02 -34.33 68.75 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.186 0.439 . . . . 74.319999999999993 112.186 -175.14 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.591 HD12 HD12 ' A' ' 66' ' ' LEU . 66.8 mt -71.02 -47.97 58.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-O 120.661 0.267 . . . . 72.530000000000001 110.795 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -66.77 -20.12 65.89 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.948 0.404 . . . . 72.010000000000005 111.247 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -74.02 -6.13 45.57 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.458 -0.337 . . . . 60.229999999999997 111.172 174.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -113.93 -49.0 2.88 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.826 0.346 . . . . 73.109999999999999 110.648 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 33.6 pt -100.38 168.03 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.779 -0.646 . . . . 71.040000000000006 110.665 -177.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 . . . . . 0 C--O 1.251 1.161 0 CA-C-O 118.355 -0.831 . . . . 74.439999999999998 110.723 178.164 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.2 ttp . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 110.328 -0.249 . . . . 51.399999999999999 110.328 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 74.83 -51.3 0.67 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.418 0.687 . . . . 74.329999999999998 112.474 176.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -63.88 103.82 0.62 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.782 0.325 . . . . 73.010000000000005 111.331 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -82.79 154.49 24.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.263 -0.426 . . . . 75.420000000000002 109.983 178.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -90.62 157.1 17.66 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.303 -0.258 . . . . 74.219999999999999 110.303 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 49.1 m80 69.31 152.45 0.1 Allowed 'General case' 0 N--CA 1.466 0.363 0 O-C-N 123.642 0.588 . . . . 71.200000000000003 111.088 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -157.83 75.0 0.75 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.628 -0.714 . . . . 65.209999999999994 110.226 -177.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -99.2 81.55 2.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.038 0.447 . . . . 71.340000000000003 110.569 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.416 ' N ' ' SD ' ' A' ' 9' ' ' MET . 3.7 mpp? -69.21 91.51 0.52 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.388 -0.597 . . . . 61.329999999999998 109.388 175.118 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.74 -7.95 87.96 Favored Glycine 0 N--CA 1.453 -0.171 0 CA-C-N 115.813 -0.63 . . . . 54.420000000000002 112.88 -177.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 34.4 p -71.58 95.94 1.49 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.887 0.375 . . . . 62.43 110.283 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 59.6 tp -130.41 101.79 5.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 75.129999999999995 110.943 -177.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -171.19 116.4 0.43 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.586 -0.734 . . . . 62.409999999999997 109.333 174.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -168.05 131.39 1.59 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.34 -0.391 . . . . 64.340000000000003 110.796 -178.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -62.99 105.92 0.75 Allowed 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.044 -0.525 . . . . 71.200000000000003 110.056 176.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.3 p -69.74 89.65 0.56 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.26 0.552 . . . . 74.340000000000003 111.695 -176.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -96.15 147.37 23.81 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.794 -0.639 . . . . 73.129999999999995 110.301 176.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -54.83 -75.62 0.23 Allowed Glycine 0 CA--C 1.522 0.484 0 CA-C-N 116.012 -0.54 . . . . 72.219999999999999 113.701 -175.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -66.25 -4.47 10.57 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.797 2.331 . . . . 73.219999999999999 112.913 -176.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -86.9 -45.21 5.49 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 111.722 -0.551 . . . . 71.450000000000003 111.722 177.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 41.9 t -92.58 91.72 7.7 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.085 -0.339 . . . . 64.019999999999996 110.085 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.728 ' HG3' HG12 ' A' ' 23' ' ' ILE . 25.3 ptt? -72.02 -39.09 69.42 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.415 -0.357 . . . . 73.25 110.655 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.728 HG12 ' HG3' ' A' ' 22' ' ' MET . 14.6 mm -113.78 108.82 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 N-CA-C 109.043 -0.725 . . . . 74.400000000000006 109.043 178.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.568 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 36.1 tt0 -122.73 131.98 54.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.733 0.301 . . . . 71.409999999999997 110.536 -172.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -90.22 128.89 36.5 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.641 -0.503 . . . . 65.140000000000001 109.641 178.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.449 HG21 ' HD3' ' A' ' 34' ' ' LYS . 47.5 pt -130.9 165.94 29.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-O 121.056 0.455 . . . . 64.230000000000004 111.492 -175.088 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -111.79 169.26 13.07 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.576 -0.738 . . . . 13.31 112.845 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -52.25 -38.85 59.35 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 122.824 0.45 . . . . 73.329999999999998 111.407 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.5 t -59.36 -21.88 60.5 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.821 -0.627 . . . . 64.120000000000005 112.251 -175.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.51 ' HA ' ' HB2' ' A' ' 33' ' ' ASN . 11.3 pt-20 -125.64 -3.34 7.24 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 111.679 0.251 . . . . 71.549999999999997 111.679 -175.472 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -51.61 -70.8 0.08 Allowed 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.192 0.308 . . . . 65.209999999999994 111.152 -177.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -58.8 -42.71 89.75 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.638 0.733 . . . . 71.430000000000007 109.429 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.51 ' HB2' ' HA ' ' A' ' 30' ' ' GLU . 1.5 m-80 -52.44 -38.25 58.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 113.829 -1.532 . . . . 63.409999999999997 112.795 -172.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.449 ' HD3' HG21 ' A' ' 26' ' ' ILE . 16.1 ptmt -111.31 -19.58 12.59 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.023 0.379 . . . . 53.439999999999998 112.023 -177.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.6 t -88.26 -55.32 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 111.928 0.344 . . . . 61.520000000000003 111.928 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 45.7 p -77.92 -38.3 45.89 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.171 0.51 . . . . 74.430000000000007 110.78 -173.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.7 m -79.89 9.29 5.47 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.854 -0.612 . . . . 73.219999999999999 111.511 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 53.2 t -75.44 111.38 10.66 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.798 0.332 . . . . 60.130000000000003 111.066 -178.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -116.69 15.1 15.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.026 -0.534 . . . . 70.230000000000004 110.317 178.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -68.96 -2.46 9.87 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.828 -0.624 . . . . 63.240000000000002 112.08 -177.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.454 ' O ' ' HE3' ' A' ' 103' ' ' LYS . 89.8 m-20 70.18 6.26 5.69 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 122.954 0.502 . . . . 71.209999999999994 111.071 -177.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.3 tt -89.09 157.08 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.331 -0.618 . . . . 74.519999999999996 109.331 178.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.503 HD21 ' HE2' ' A' ' 101' ' ' MET . 63.7 tp -96.26 118.23 32.41 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.155 -0.313 . . . . 74.319999999999993 110.155 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 101' ' ' MET . 48.8 mt -97.96 124.79 51.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.163 -0.471 . . . . 75.349999999999994 110.703 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.532 ' HB2' HG13 ' A' ' 76' ' ' ILE . 3.3 mp -115.7 105.77 13.12 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.654 -0.499 . . . . 41.200000000000003 109.654 178.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.548 HG12 ' HB2' ' A' ' 77' ' ' TYR . 30.9 m -97.01 121.69 47.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 CA-C-N 116.625 -0.261 . . . . 71.439999999999998 110.32 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.432 ' OD1' ' HG2' ' A' ' 78' ' ' LYS . 5.8 p-10 -104.63 125.42 50.73 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.391 0.615 . . . . 64.5 109.823 176.525 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -75.25 100.65 4.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.414 -0.812 . . . . 73.030000000000001 111.497 -176.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.572 ' NE1' ' HA ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER 35.95 84.47 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 O-C-N 124.487 1.117 . . . . 72.239999999999995 113.639 171.97 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.97 154.85 49.95 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 115.582 -0.736 . . . . 53.439999999999998 110.04 174.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -53.91 155.16 15.22 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.925 2.416 . . . . 74.340000000000003 112.579 178.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 18.0 p90 -73.03 178.69 4.17 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.039 -0.528 . . . . 74.150000000000006 111.632 -176.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' CYS . . . . . 0.509 ' SG ' ' N ' ' A' ' 54' ' ' GLY . 54.1 t -135.03 179.05 6.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.7 -0.682 . . . . 72.239999999999995 110.401 -176.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.509 ' N ' ' SG ' ' A' ' 53' ' ' CYS . . . -85.16 -177.41 50.81 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 111.726 -0.55 . . . . 63.140000000000001 111.726 175.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -57.49 -34.07 97.43 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.04 2.494 . . . . 62.109999999999999 112.663 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 25.8 p -115.87 142.79 46.3 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.216 -0.447 . . . . 70.010000000000005 109.898 177.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -75.27 82.37 2.4 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.743 -0.466 . . . . 74.519999999999996 109.743 -178.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.5 t -62.46 -32.45 73.33 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.74 -0.663 . . . . 52.329999999999998 110.468 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.4 HD12 ' O ' ' A' ' 59' ' ' LEU . 3.4 pp -159.7 151.34 20.14 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.493 -0.776 . . . . 73.329999999999998 109.71 176.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.439 ' HB2' ' HB2' ' A' ' 64' ' ' GLU . 1.0 OUTLIER -137.26 150.8 70.14 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.828 -0.624 . . . . 73.140000000000001 109.975 -179.734 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -65.91 177.88 2.69 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.79 2.327 . . . . 71.140000000000001 112.952 -177.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.688 ' HB3' HG12 ' A' ' 119' ' ' ILE . 11.5 mp0 -51.18 -49.03 61.74 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 115.316 -0.857 . . . . 74.099999999999994 111.65 -173.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.559 ' H ' HD22 ' A' ' 63' ' ' LEU . 2.5 mm? -64.25 -46.13 85.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.852 -1.067 . . . . 74.219999999999999 110.124 -172.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.588 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 55.0 mt-10 -68.0 -32.51 72.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.747 -0.66 . . . . 74.409999999999997 110.449 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -58.41 -56.66 19.23 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.342 -0.39 . . . . 71.310000000000002 110.634 176.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.595 HD12 HD12 ' A' ' 123' ' ' ILE . 22.5 mt -69.13 -30.11 68.29 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 120.825 -0.35 . . . . 73.239999999999995 110.861 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.21 -36.35 70.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.419 -0.355 . . . . 61.5 111.278 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.588 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 84.2 mt-30 -56.25 -32.98 65.0 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.286 -0.415 . . . . 70.239999999999995 111.006 -178.232 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -94.01 -56.59 2.81 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.322 0.582 . . . . 65.549999999999997 110.826 178.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.521 ' O ' HG22 ' A' ' 74' ' ' VAL . 22.2 m-85 -82.52 21.69 0.94 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.645 -0.707 . . . . 75.230000000000004 112.336 -173.215 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.461 ' OG1' ' HB3' ' A' ' 22' ' ' MET . 8.8 t -52.46 -31.26 33.92 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.976 0.417 . . . . 74.329999999999998 111.698 -176.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -70.13 -18.96 63.25 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.103 -0.498 . . . . 53.340000000000003 111.542 -175.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.41 6.24 8.35 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.732 0.301 . . . . 72.310000000000002 110.815 -173.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 70' ' ' TYR . 23.1 m -137.46 145.07 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 121.117 0.484 . . . . 55.140000000000001 111.583 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.5 mmtt -129.14 114.86 16.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.528 -0.76 . . . . 63.310000000000002 108.959 174.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.532 HG13 ' HB2' ' A' ' 45' ' ' LEU . 2.3 mp -100.5 138.43 24.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.559 -0.534 . . . . 74.420000000000002 109.559 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.568 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 41.2 m-85 -130.55 134.26 46.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.247 -0.433 . . . . 72.200000000000003 110.885 -177.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.432 ' HG2' ' OD1' ' A' ' 47' ' ' ASP . 55.9 mttm -109.19 111.86 23.7 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.257 -0.646 . . . . 72.219999999999999 109.257 174.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 32.0 pt -86.93 142.11 13.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.958 -0.564 . . . . 72.5 111.25 -175.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.7 p30 -90.12 -11.55 40.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.878 -0.601 . . . . 55.210000000000001 111.788 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.405 HG23 ' O ' ' A' ' 81' ' ' ILE . 12.8 tt -75.01 87.19 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 121.871 0.843 . . . . 61.140000000000001 110.338 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.572 ' HA ' ' NE1' ' A' ' 49' ' ' TRP . 9.0 pt-20 -85.44 -40.43 16.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.21 -0.905 . . . . 71.239999999999995 112.667 -174.474 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -84.81 -1.42 56.38 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.392 0.515 . . . . 64.430000000000007 112.392 -168.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -144.85 113.53 6.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.739 0.304 . . . . 73.349999999999994 110.826 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -144.7 104.07 3.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.462 0.649 . . . . 74.209999999999994 110.246 174.113 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -70.3 -58.4 3.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.601 -0.727 . . . . 61.450000000000003 111.082 -177.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 35.0 t -56.72 -41.78 75.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.709 -0.678 . . . . 75.030000000000001 111.182 -174.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.29 -41.39 94.18 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 116.252 -0.431 . . . . 73.530000000000001 111.001 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 88.5 m -65.76 -36.43 83.53 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.209 -0.45 . . . . 71.010000000000005 110.118 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -65.77 -37.34 86.05 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.159 -0.473 . . . . 72.230000000000004 110.228 177.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -70.72 -15.25 62.68 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.192 -0.458 . . . . 74.030000000000001 110.656 174.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.07 38.88 46.84 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.192 -0.528 . . . . 71.209999999999994 112.059 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.8 p -51.98 120.22 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 121.104 0.478 . . . . 73.5 111.168 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.4 m -124.37 6.57 8.37 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.782 -0.645 . . . . 73.310000000000002 110.609 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -156.38 126.77 6.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.09 -0.505 . . . . 73.129999999999995 110.606 -179.002 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.42 ' HB ' ' HA ' ' A' ' 97' ' ' PRO . 29.7 pt -101.69 156.14 35.55 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.986 -0.552 . . . . 72.430000000000007 109.755 177.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.42 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 84.5 Cg_endo -79.47 163.04 84.98 Favored 'Cis proline' 0 C--N 1.352 0.721 0 C-N-CA 123.822 -1.324 . . . . 65.310000000000002 112.709 1.11 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.484 HG23 HG12 ' A' ' 112' ' ' ILE . 30.6 m -128.19 115.62 18.65 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.733 -0.667 . . . . 71.120000000000005 109.36 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.623 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 3.4 mp -110.36 124.13 66.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.364 -0.38 . . . . 53.43 110.502 -176.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.4 mp -103.5 133.81 47.92 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.793 -0.447 . . . . 73.120000000000005 109.793 176.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.768 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 66.3 mtp -112.04 108.56 17.91 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.312 -0.404 . . . . 74.109999999999999 110.595 -175.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -108.76 154.83 21.49 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.162 -0.472 . . . . 74.430000000000007 111.272 -178.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.768 ' HB3' HD21 ' A' ' 108' ' ' LEU . 87.7 tttt -162.86 117.32 1.73 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.401 -0.962 . . . . 63.310000000000002 108.401 179.15 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 62.42 25.19 15.02 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.528 0.68 . . . . 65.239999999999995 110.416 -178.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.69 -0.44 89.19 Favored Glycine 0 C--N 1.331 0.291 0 CA-C-N 115.881 -0.599 . . . . 53.509999999999998 112.763 179.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -100.62 137.56 38.85 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.829 -0.434 . . . . 51.240000000000002 109.829 177.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.86 126.92 33.88 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.306 -0.627 . . . . 45.119999999999997 109.306 174.041 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.768 HD21 ' HB3' ' A' ' 103' ' ' LYS . 2.0 mm? -98.16 -51.09 4.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.224 -0.443 . . . . 72.549999999999997 110.108 -178.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.768 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 18.8 m -149.47 155.68 40.78 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.655 -0.702 . . . . 74.540000000000006 111.122 -171.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -131.04 118.85 21.16 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.802 -0.635 . . . . 75.319999999999993 109.835 175.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.623 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 50.4 t -89.78 107.09 17.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.707 -0.479 . . . . 64.25 109.707 176.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.484 HG12 HG23 ' A' ' 98' ' ' THR . 60.9 mt -112.72 117.33 55.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.613 -0.514 . . . . 75.109999999999999 109.613 179.163 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.75 -126.04 8.78 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 111.687 -0.565 . . . . 74.409999999999997 111.687 -178.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.52 91.46 1.16 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.711 0.291 . . . . 71.329999999999998 110.861 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.403 ' HB3' ' HB2' ' A' ' 118' ' ' LYS . 8.1 m-20 -132.54 99.74 4.75 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.1 0.476 . . . . 62.439999999999998 111.155 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.652 HD12 HD11 ' A' ' 119' ' ' ILE . 7.1 tp -62.97 -40.39 88.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 115.671 -0.695 . . . . 73.120000000000005 110.58 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 32.3 t -64.8 -32.04 73.55 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.132 0.491 . . . . 71.150000000000006 110.257 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.403 ' HB2' ' HB3' ' A' ' 115' ' ' ASP . 0.3 OUTLIER -72.99 -53.66 10.61 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 109.266 -0.642 . . . . 71.040000000000006 109.266 179.527 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.688 HG12 ' HB3' ' A' ' 62' ' ' GLN . 2.4 pp -62.07 -39.42 83.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 115.661 -0.7 . . . . 71.219999999999999 111.566 -173.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.448 HD12 ' N ' ' A' ' 121' ' ' SER . 2.8 pp -62.52 -31.52 52.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 120.087 -0.645 . . . . 75.310000000000002 110.208 178.349 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.448 ' N ' HD12 ' A' ' 120' ' ' ILE . 29.2 m -70.89 -51.43 26.29 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.194 -0.457 . . . . 62.240000000000002 110.806 178.529 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.488 ' OE2' ' HB3' ' A' ' 109' ' ' SER . 13.1 pt-20 -77.32 -41.91 38.82 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.603 0.594 . . . . 74.319999999999993 112.603 -173.564 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.595 HD12 HD12 ' A' ' 66' ' ' LEU . 74.2 mt -61.82 -55.14 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 O-C-N 122.144 -0.347 . . . . 72.530000000000001 110.611 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -59.26 -20.05 51.01 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.094 0.473 . . . . 72.010000000000005 110.816 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -79.08 -34.17 43.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.917 -0.583 . . . . 60.229999999999997 110.87 176.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -93.43 -20.87 19.9 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.372 -0.377 . . . . 73.109999999999999 111.611 -173.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.449 HG12 ' O ' ' A' ' 123' ' ' ILE . 48.5 pt -120.32 168.36 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 110.173 -0.306 . . . . 71.040000000000006 110.173 175.261 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 33.7 p-10 . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.224 -0.893 . . . . 74.439999999999998 111.977 -176.698 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.462 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 110.237 -0.282 . . . . 51.399999999999999 110.237 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.35 133.0 55.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.375 -0.375 . . . . 74.329999999999998 110.56 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -97.93 164.94 12.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.032 -0.531 . . . . 73.010000000000005 110.258 178.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -84.16 131.11 34.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.284 -0.417 . . . . 75.420000000000002 111.041 -176.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -89.31 113.68 24.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.0 -0.546 . . . . 74.219999999999999 109.941 -178.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 38.4 m-70 -63.98 103.77 0.63 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.032 -0.531 . . . . 71.200000000000003 111.417 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -80.07 153.95 28.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.55 -0.75 . . . . 65.209999999999994 110.269 175.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -105.36 134.04 49.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.508 -0.315 . . . . 71.340000000000003 110.277 179.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 48.5 ttm -88.39 107.65 18.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.219 -0.446 . . . . 61.329999999999998 110.268 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -120.54 73.06 0.34 Allowed Glycine 0 C--N 1.332 0.328 0 C-N-CA 121.363 -0.446 . . . . 54.420000000000002 112.95 -177.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 62.4 m -81.18 104.49 11.69 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 110.064 -0.347 . . . . 62.43 110.064 175.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 97.6 mt -127.7 112.0 14.33 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.603 -0.271 . . . . 75.129999999999995 110.718 -178.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -175.32 145.15 0.74 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.072 -0.513 . . . . 62.409999999999997 109.904 176.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.88 128.35 35.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.445 -0.343 . . . . 64.340000000000003 110.54 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -147.87 148.65 31.08 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.465 -0.334 . . . . 71.200000000000003 110.337 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.8 t -101.7 154.15 19.14 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.331 -0.395 . . . . 74.340000000000003 110.33 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -163.74 138.21 5.94 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.702 -0.481 . . . . 73.129999999999995 109.702 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 178.49 86.53 0.07 OUTLIER Glycine 0 CA--C 1.519 0.319 0 C-N-CA 121.107 -0.568 . . . . 72.219999999999999 112.314 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.562 ' HB3' ' HG2' ' A' ' 68' ' ' GLN . 96.1 Cg_endo -82.68 174.97 9.21 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 122.883 2.389 . . . . 73.219999999999999 112.345 178.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.91 -175.08 23.63 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 121.313 -0.47 . . . . 71.450000000000003 112.439 178.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.8 p -94.84 88.32 5.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.367 0.603 . . . . 64.019999999999996 111.496 -178.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.611 ' HG3' ' HB1' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -111.82 4.75 18.59 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.639 -0.709 . . . . 73.25 109.176 170.115 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.441 HD13 ' HB ' ' A' ' 76' ' ' ILE . 8.6 mm -110.57 106.44 20.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 114.797 -1.092 . . . . 74.400000000000006 108.923 178.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.46 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 7.9 tp10 -121.1 141.4 50.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.888 0.375 . . . . 71.409999999999997 111.058 -178.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -95.58 124.15 39.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.886 -0.597 . . . . 65.140000000000001 109.535 177.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.556 HD12 ' HA ' ' A' ' 31' ' ' PHE . 27.0 pt -121.67 157.53 25.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 116.221 -0.445 . . . . 64.230000000000004 111.214 -175.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.25 170.15 37.05 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.875 -0.602 . . . . 13.31 112.107 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -66.2 -30.17 70.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.23 0.538 . . . . 73.329999999999998 110.449 -176.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.1 m -70.29 -48.76 55.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.575 -0.739 . . . . 64.120000000000005 111.156 -177.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -87.64 -13.55 42.4 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.45 -0.341 . . . . 71.549999999999997 111.274 -177.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.556 ' HA ' HD12 ' A' ' 26' ' ' ILE . 47.8 t80 -48.8 -70.15 0.1 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.873 0.368 . . . . 65.209999999999994 110.298 175.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -53.75 -43.26 68.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.946 -0.57 . . . . 71.430000000000007 109.663 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.557 ' O ' ' HB2' ' A' ' 37' ' ' SER . 33.8 t-20 -53.16 -50.11 65.24 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 114.734 -1.121 . . . . 63.409999999999997 111.762 -173.45 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.17 -17.08 17.56 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.195 0.443 . . . . 53.439999999999998 112.195 -173.228 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.5 t -88.29 -52.14 11.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 111.655 0.243 . . . . 61.520000000000003 111.655 -178.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.0 p -75.49 -45.27 39.38 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.545 0.688 . . . . 74.430000000000007 109.806 -177.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.557 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 19.9 m -77.06 12.78 1.27 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.47 -0.786 . . . . 73.219999999999999 111.107 176.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 36.1 t -28.93 101.17 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.184 0.993 . . . . 60.130000000000003 113.061 -178.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -89.62 -18.21 26.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.622 -0.717 . . . . 70.230000000000004 109.556 175.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.504 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . 2.8 m-20 -53.91 -40.33 66.57 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.685 -0.688 . . . . 63.240000000000002 110.833 -179.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 60.8 19.48 9.66 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.903 0.859 . . . . 71.209999999999994 109.636 -170.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.504 ' HB ' ' HB3' ' A' ' 40' ' ' ASP . 7.8 mt -101.02 154.24 4.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 114.086 -1.415 . . . . 74.519999999999996 108.613 175.207 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.617 HD11 ' HE3' ' A' ' 101' ' ' MET . 49.3 tp -70.15 104.9 2.74 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.505 -0.554 . . . . 74.319999999999993 109.505 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 48.1 mt -93.09 105.05 16.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.864 -0.607 . . . . 75.349999999999994 110.664 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.584 HD22 HD22 ' A' ' 63' ' ' LEU . 2.0 mp -100.28 102.98 14.38 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.434 -0.58 . . . . 41.200000000000003 109.434 178.191 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.51 HG22 ' HB2' ' A' ' 77' ' ' TYR . 33.2 t -99.66 123.74 52.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.422 -0.584 . . . . 71.439999999999998 109.422 178.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.407 ' CB ' HG12 ' A' ' 99' ' ' ILE . 6.1 p-10 -108.75 131.6 54.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.529 0.681 . . . . 64.5 110.959 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -85.68 88.11 7.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.091 -0.959 . . . . 73.030000000000001 109.312 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' TRP . . . . . 0.481 ' NE1' ' HB3' ' A' ' 78' ' ' LYS . 4.2 p-90 -96.51 160.82 14.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.343 -0.844 . . . . 72.239999999999995 110.683 -176.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -94.58 134.96 24.48 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.938 -0.574 . . . . 53.439999999999998 109.514 175.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -53.28 -35.27 73.65 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.769 2.313 . . . . 74.340000000000003 112.555 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -76.33 -5.73 48.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.878 -0.601 . . . . 74.150000000000006 111.338 -177.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 47.6 t -91.33 9.47 31.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.387 -0.37 . . . . 72.239999999999995 110.501 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -52.23 -58.63 10.38 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 121.38 -0.438 . . . . 63.140000000000001 112.229 176.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -76.82 48.64 2.51 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.185 2.59 . . . . 62.109999999999999 111.696 174.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 15.9 p -58.59 130.47 46.97 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.249 -0.432 . . . . 70.010000000000005 111.379 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -80.89 76.01 7.83 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.58 -0.526 . . . . 74.519999999999996 109.58 177.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.8 t -170.4 175.56 4.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.508 -0.315 . . . . 52.329999999999998 110.234 -178.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.42 HD23 ' N ' ' A' ' 59' ' ' LEU . 2.3 pt? -163.3 154.51 16.9 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.975 -0.557 . . . . 73.329999999999998 110.006 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 56.14 63.87 5.54 Favored Pre-proline 0 C--O 1.238 0.45 0 O-C-N 123.694 0.621 . . . . 73.140000000000001 111.839 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.9 159.25 38.25 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.469 2.112 . . . . 71.140000000000001 110.923 175.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.444 ' HB3' HG12 ' A' ' 119' ' ' ILE . 7.3 mp0 -50.84 -57.46 8.4 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 121.165 0.507 . . . . 74.099999999999994 111.493 -172.291 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.819 HD11 HD13 ' A' ' 99' ' ' ILE . 21.7 mt -57.71 -48.84 78.45 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.461 -0.79 . . . . 74.219999999999999 111.437 -172.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.576 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 51.0 mt-10 -71.71 -32.49 67.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.961 -0.563 . . . . 74.409999999999997 110.244 -177.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -61.17 -46.23 91.35 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.974 -0.557 . . . . 71.310000000000002 110.051 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.452 HD12 HD12 ' A' ' 123' ' ' ILE . 37.6 mt -74.56 -37.22 63.03 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.447 -0.342 . . . . 73.239999999999995 110.919 175.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.611 ' HB1' ' HG3' ' A' ' 22' ' ' MET . . . -58.14 -31.11 66.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 61.5 111.603 -177.347 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.576 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 77.9 mt-30 -54.56 -33.26 59.86 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.862 0.363 . . . . 70.239999999999995 110.712 177.299 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -94.36 -42.25 8.99 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.051 -0.522 . . . . 65.549999999999997 111.592 177.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.533 ' O ' HG22 ' A' ' 74' ' ' VAL . 11.5 m-85 -103.41 22.34 14.39 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.461 0.541 . . . . 75.230000000000004 112.461 -168.068 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.449 ' OG1' ' HB3' ' A' ' 22' ' ' MET . 5.3 t -52.28 -35.04 49.14 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.412 0.523 . . . . 74.329999999999998 112.412 -172.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -71.35 -16.11 62.42 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.212 0.449 . . . . 53.340000000000003 112.212 -175.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.441 ' O ' HG23 ' A' ' 42' ' ' ILE . 0.2 OUTLIER -125.77 11.5 7.83 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.587 0.232 . . . . 72.310000000000002 111.218 -176.743 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 70' ' ' TYR . 34.1 m -136.76 137.43 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 O-C-N 121.733 -0.604 . . . . 55.140000000000001 111.275 176.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 28.1 mmtp -119.98 115.26 23.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.538 -0.755 . . . . 63.310000000000002 109.511 177.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.494 ' N ' HD12 ' A' ' 76' ' ' ILE . 2.9 mp -105.27 122.79 58.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 108.869 -0.789 . . . . 74.420000000000002 108.869 177.274 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.51 ' HB2' HG22 ' A' ' 46' ' ' VAL . 39.5 m-85 -119.37 132.32 55.83 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.229 0.538 . . . . 72.200000000000003 111.667 -174.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.481 ' HB3' ' NE1' ' A' ' 49' ' ' TRP . 73.2 mmtt -91.19 110.22 21.49 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.711 -1.132 . . . . 72.219999999999999 108.696 173.203 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 80' ' ' ASN . 6.6 tp -97.26 146.83 7.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.845 0.355 . . . . 72.5 110.999 -177.168 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.481 ' O ' HG13 ' A' ' 79' ' ' ILE . 40.2 t30 -79.3 158.76 27.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.788 -0.642 . . . . 55.210000000000001 109.93 173.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.2 tt -115.97 76.33 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.534 0.683 . . . . 61.140000000000001 109.614 176.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -73.41 -68.95 0.46 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.796 -0.638 . . . . 71.239999999999995 110.216 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -95.47 -16.82 21.97 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.926 -0.579 . . . . 64.430000000000007 111.125 -177.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 75.5 143.44 0.08 Allowed 'General case' 0 N--CA 1.473 0.695 0 O-C-N 123.8 0.688 . . . . 73.349999999999994 109.925 -176.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.462 ' H ' ' CD ' ' A' ' 85' ' ' GLN . 4.9 pm0 -103.45 121.15 42.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.097 -0.501 . . . . 74.209999999999994 111.356 -173.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -69.85 -15.0 63.02 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.89 -0.595 . . . . 61.450000000000003 110.391 176.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 62.6 t -48.91 -38.04 10.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 115.986 -0.552 . . . . 75.030000000000001 110.774 177.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.97 -49.3 76.65 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.813 -0.63 . . . . 73.530000000000001 110.242 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.5 m -64.19 -33.6 76.16 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.818 -0.628 . . . . 71.010000000000005 110.387 179.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -63.04 -46.95 85.13 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.823 -0.626 . . . . 72.230000000000004 110.306 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 22.4 m-30 -83.01 5.24 22.85 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.062 -0.517 . . . . 74.030000000000001 111.324 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 65.0 34.72 90.63 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 121.31 -0.471 . . . . 71.209999999999994 112.8 175.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.448 HG11 ' OG1' ' A' ' 98' ' ' THR . 64.7 t -61.71 98.9 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.978 0.418 . . . . 73.5 110.068 177.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.3 m -100.49 8.75 43.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.898 -0.592 . . . . 73.310000000000002 111.553 -174.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -147.6 164.82 32.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.601 0.238 . . . . 73.129999999999995 110.631 -178.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.405 HD12 ' O ' ' A' ' 96' ' ' ILE . 2.4 pp -129.93 156.89 78.37 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.225 -0.443 . . . . 72.430000000000007 110.596 -178.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.17 169.35 74.45 Favored 'Cis proline' 0 C--N 1.354 0.827 0 C-N-CA 123.784 -1.34 . . . . 65.310000000000002 112.213 -0.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.448 ' OG1' HG11 ' A' ' 93' ' ' VAL . 15.0 m -112.15 124.5 52.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.108 -0.496 . . . . 71.120000000000005 110.502 -179.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.85 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 36.0 mt -126.62 135.75 62.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.341 -0.614 . . . . 53.43 109.341 178.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.19 133.77 52.64 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.964 -0.384 . . . . 73.120000000000005 109.964 -178.381 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.788 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 50.1 mtp -106.1 117.93 35.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.896 -0.593 . . . . 74.109999999999999 110.776 -176.106 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -118.34 155.72 30.16 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 122.646 0.378 . . . . 74.430000000000007 110.677 178.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.596 ' HB3' HD21 ' A' ' 108' ' ' LEU . 38.1 ttpt -166.31 123.04 1.32 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.844 -0.616 . . . . 63.310000000000002 109.774 176.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 46.2 t30 58.04 25.02 11.82 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.771 0.795 . . . . 65.239999999999995 110.812 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.85 -2.34 79.64 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 115.991 -0.549 . . . . 53.509999999999998 113.381 175.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 54.0 tttm -102.77 145.07 30.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.908 0.354 . . . . 51.240000000000002 110.135 177.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -82.19 139.22 34.43 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.804 -0.813 . . . . 45.119999999999997 108.804 171.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.596 HD21 ' HB3' ' A' ' 103' ' ' LYS . 2.7 mm? -107.14 -53.26 2.64 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.885 0.374 . . . . 72.549999999999997 110.231 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.788 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 54.5 m -153.72 164.46 38.27 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 116.019 -0.537 . . . . 74.540000000000006 111.086 -175.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -129.48 106.44 8.76 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.715 -0.675 . . . . 75.319999999999993 109.298 177.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.85 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 77.0 t -84.04 107.28 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.463 -0.569 . . . . 64.25 109.463 -179.304 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 62.5 mt -120.15 108.76 23.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.858 -0.61 . . . . 75.109999999999999 110.19 -176.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 108.67 -117.33 4.97 Favored Glycine 0 CA--C 1.518 0.265 0 N-CA-C 111.831 -0.508 . . . . 74.409999999999997 111.831 -178.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.41 57.22 0.5 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.392 0.615 . . . . 71.329999999999998 110.032 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.73 81.8 5.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.464 -0.789 . . . . 62.439999999999998 110.399 -178.473 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.537 HD12 HD11 ' A' ' 119' ' ' ILE . 6.3 tp -61.89 -42.58 95.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 115.847 -0.615 . . . . 73.120000000000005 110.928 -177.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 45.4 t -62.67 -31.59 72.51 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.036 0.446 . . . . 71.150000000000006 110.633 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -74.05 -52.2 13.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.971 -0.559 . . . . 71.040000000000006 110.225 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.537 HD11 HD12 ' A' ' 116' ' ' ILE . 2.3 pp -63.84 -39.3 84.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.159 -0.473 . . . . 71.219999999999999 111.552 -173.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.487 HD12 ' N ' ' A' ' 121' ' ' SER . 2.9 pp -64.81 -33.86 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 C-N-CA 120.303 -0.559 . . . . 75.310000000000002 109.946 178.281 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.487 ' N ' HD12 ' A' ' 120' ' ' ILE . 23.1 t -70.42 -47.62 59.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.933 -0.576 . . . . 62.240000000000002 110.584 -178.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.502 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 13.0 pt-20 -77.2 -43.06 35.09 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.676 -0.238 . . . . 74.319999999999993 111.48 -175.181 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.452 HD12 HD12 ' A' ' 66' ' ' LEU . 82.4 mt -64.11 -51.59 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 117.657 0.208 . . . . 72.530000000000001 111.143 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -58.65 -24.07 60.41 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.065 0.459 . . . . 72.010000000000005 110.609 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -91.94 -21.25 20.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.943 -0.571 . . . . 60.229999999999997 110.963 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.502 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 3.7 t-20 -85.81 -36.78 19.85 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.086 -0.506 . . . . 73.109999999999999 111.152 -175.182 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.411 HG12 ' O ' ' A' ' 123' ' ' ILE . 47.2 pt -107.93 168.77 3.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 115.759 -0.655 . . . . 71.040000000000006 110.032 178.547 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.2 p30 . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.409 -0.805 . . . . 74.439999999999998 110.638 -173.533 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.453 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 120.813 0.34 . . . . 51.399999999999999 110.196 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.66 148.43 33.06 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.786 -0.45 . . . . 74.329999999999998 109.786 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -77.24 138.12 39.23 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.782 -0.451 . . . . 73.010000000000005 109.782 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -73.83 96.55 2.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.387 -0.37 . . . . 75.420000000000002 110.431 -176.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -61.67 125.81 25.14 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.068 -0.515 . . . . 74.219999999999999 109.671 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -81.39 156.13 25.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.445 -0.343 . . . . 71.200000000000003 110.498 -176.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -111.89 -177.73 3.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.287 -0.415 . . . . 65.209999999999994 110.15 -176.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -129.81 -171.27 2.48 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.404 -0.591 . . . . 71.340000000000003 109.404 177.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 48.2 ttm -135.99 119.52 17.01 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.032 -0.359 . . . . 61.329999999999998 110.032 178.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -118.75 48.43 0.94 Allowed Glycine 0 C--N 1.333 0.367 0 C-N-CA 121.424 -0.417 . . . . 54.420000000000002 112.602 -175.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.9 m -70.63 99.75 1.72 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 109.554 -0.535 . . . . 62.43 109.554 176.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.541 HD23 ' HB2' ' A' ' 13' ' ' GLU . 9.8 tt -118.43 135.77 54.17 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.01 -0.541 . . . . 75.129999999999995 110.619 -171.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.541 ' HB2' HD23 ' A' ' 12' ' ' LEU . 8.8 tp10 70.03 115.8 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.783 0.833 . . . . 62.409999999999997 111.396 178.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.47 -174.84 3.45 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.103 -0.499 . . . . 64.340000000000003 110.864 -177.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -130.8 152.07 50.55 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.15 -0.477 . . . . 71.200000000000003 109.996 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.2 t -61.8 113.21 2.63 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.589 0.709 . . . . 74.340000000000003 110.442 176.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.402 ' OE1' ' HD3' ' A' ' 19' ' ' PRO . 1.5 tm0? -116.02 129.87 56.56 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.748 -0.834 . . . . 73.129999999999995 108.748 -177.401 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -165.15 87.99 0.1 Allowed Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.478 -0.868 . . . . 72.219999999999999 113.178 -172.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.402 ' HD3' ' OE1' ' A' ' 17' ' ' GLN . 86.6 Cg_endo -96.55 -162.85 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.442 2.761 . . . . 73.219999999999999 111.498 171.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.405 ' O ' ' SD ' ' A' ' 22' ' ' MET . . . -87.33 154.68 26.46 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 110.455 -1.058 . . . . 71.450000000000003 110.455 173.153 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.2 p -69.25 80.25 0.36 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.284 0.564 . . . . 64.019999999999996 111.014 -177.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.765 ' HG3' ' HB1' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -92.75 -0.2 57.31 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.825 -0.625 . . . . 73.25 111.362 -177.254 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.527 HD11 ' HG2' ' A' ' 64' ' ' GLU . 22.9 mm -104.65 126.15 59.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.972 -0.558 . . . . 74.400000000000006 109.536 178.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 9.7 tp10 -129.23 137.29 51.01 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.025 -0.361 . . . . 71.409999999999997 110.025 178.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -105.81 114.62 28.88 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.614 -0.514 . . . . 65.140000000000001 109.614 176.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.528 HD12 ' HA ' ' A' ' 31' ' ' PHE . 28.2 pt -114.45 154.22 15.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.044 -0.526 . . . . 64.230000000000004 111.476 -172.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.56 178.22 45.66 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.455 -0.793 . . . . 13.31 112.115 176.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -63.25 -36.47 83.76 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.18 0.514 . . . . 73.329999999999998 111.213 -176.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.7 m -69.61 -42.67 74.05 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.756 -0.656 . . . . 64.120000000000005 111.525 -173.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -85.38 -12.31 52.42 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.562 -0.29 . . . . 71.549999999999997 111.692 -176.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.528 ' HA ' HD12 ' A' ' 26' ' ' ILE . 90.1 t80 -47.36 -69.9 0.11 Allowed 'General case' 0 N--CA 1.462 0.173 0 O-C-N 123.425 0.453 . . . . 65.209999999999994 110.263 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -55.63 -43.78 76.5 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 116.46 -0.336 . . . . 71.430000000000007 110.78 177.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.414 ' O ' ' HB2' ' A' ' 37' ' ' SER . 0.2 OUTLIER -52.22 -44.39 64.76 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.113 -0.949 . . . . 63.409999999999997 111.399 -170.557 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.514 ' HD3' HG21 ' A' ' 26' ' ' ILE . 0.2 OUTLIER -110.94 -21.71 11.88 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.326 0.491 . . . . 53.439999999999998 112.326 -175.963 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 89.5 t -88.21 -49.57 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 111.509 0.189 . . . . 61.520000000000003 111.509 -179.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 79.9 p -87.81 -6.53 58.09 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 120.387 -0.525 . . . . 74.430000000000007 110.642 -175.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 50.2 m -104.91 12.15 32.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.825 -0.625 . . . . 73.219999999999999 110.313 174.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 50.3 t -60.55 90.25 0.02 OUTLIER 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.22 0.534 . . . . 60.130000000000003 111.452 -176.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -94.05 6.44 48.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.545 -0.752 . . . . 70.230000000000004 109.226 175.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -74.26 -20.85 60.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.282 -0.872 . . . . 63.240000000000002 111.056 -175.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.6 m120 69.39 15.04 8.45 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.864 -0.607 . . . . 71.209999999999994 111.078 -176.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 37.7 mt -93.64 141.15 15.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.733 -0.667 . . . . 74.519999999999996 109.549 174.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.478 HD11 ' HB3' ' A' ' 101' ' ' MET . 64.6 tp -75.18 114.04 13.22 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.318 -0.401 . . . . 74.319999999999993 110.312 -178.154 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.495 HG23 ' CD2' ' A' ' 77' ' ' TYR . 44.0 mt -97.53 116.47 40.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.941 -0.572 . . . . 75.349999999999994 110.317 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.472 HD22 HD22 ' A' ' 63' ' ' LEU . 3.3 mp -107.13 102.88 12.17 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.808 -0.442 . . . . 41.200000000000003 109.808 179.253 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.5 HG22 ' HB2' ' A' ' 77' ' ' TYR . 58.0 t -95.84 112.16 27.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.282 -0.417 . . . . 71.439999999999998 109.946 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -98.5 125.69 43.79 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.55 0.691 . . . . 64.5 110.385 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.424 ' HE1' ' HB2' ' A' ' 100' ' ' LEU . 70.2 m-85 -86.69 119.36 26.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.063 -0.971 . . . . 73.030000000000001 109.826 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 1.5 p-90 -132.91 169.4 16.84 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.292 -0.413 . . . . 72.239999999999995 110.593 -175.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.04 138.88 36.81 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.994 -0.548 . . . . 53.439999999999998 110.467 177.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.9 -30.55 93.36 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.823 2.349 . . . . 74.340000000000003 112.991 -175.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 10.1 m0 -98.51 15.6 24.41 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.783 0.325 . . . . 74.150000000000006 111.282 -178.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 49.0 t -89.38 20.03 4.09 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 120.785 0.326 . . . . 72.239999999999995 110.485 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -53.88 -54.04 33.21 Favored Glycine 0 CA--C 1.525 0.666 0 CA-C-N 115.955 -0.566 . . . . 63.140000000000001 113.142 179.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -71.21 62.33 2.63 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.008 2.472 . . . . 62.109999999999999 111.804 174.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 21.3 p -87.94 99.19 11.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.915 -0.584 . . . . 70.010000000000005 110.285 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -68.72 108.69 3.5 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.472 -0.566 . . . . 74.519999999999996 109.472 177.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 27.0 t -163.43 179.17 7.5 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.991 -0.374 . . . . 52.329999999999998 109.991 -178.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.474 HD23 ' N ' ' A' ' 59' ' ' LEU . 2.0 pt? -154.36 127.28 8.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.42 -0.354 . . . . 73.329999999999998 110.269 -179.416 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 39.59 73.4 0.83 Allowed Pre-proline 0 C--O 1.237 0.416 0 C-N-CA 123.888 0.875 . . . . 73.140000000000001 112.724 176.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.56 168.76 21.68 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.478 2.118 . . . . 71.140000000000001 111.528 177.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.72 ' HB3' HG12 ' A' ' 119' ' ' ILE . 4.3 mp0 -50.98 -57.68 7.96 Favored 'General case' 0 C--O 1.252 1.197 0 CA-C-O 121.737 0.779 . . . . 74.099999999999994 111.312 -175.147 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.521 HD11 HD13 ' A' ' 99' ' ' ILE . 46.3 mt -54.54 -48.77 71.59 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 114.588 -1.187 . . . . 74.219999999999999 110.909 -174.183 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.625 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 50.1 mt-10 -75.0 -32.56 61.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.981 -0.554 . . . . 74.409999999999997 110.68 -176.115 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -56.24 -46.55 79.54 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.333 -0.394 . . . . 71.310000000000002 110.056 176.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.537 HD12 HD12 ' A' ' 123' ' ' ILE . 12.9 mt -82.6 -33.63 27.92 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.098 -0.501 . . . . 73.239999999999995 111.116 178.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.765 ' HB1' ' HG3' ' A' ' 22' ' ' MET . . . -59.74 -39.01 83.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.074 -0.512 . . . . 61.5 111.888 -175.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.625 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 77.7 mt-30 -56.78 -31.12 64.32 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.133 0.492 . . . . 70.239999999999995 110.515 -179.012 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -93.66 -51.47 4.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.367 -0.833 . . . . 65.549999999999997 111.003 -174.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.443 ' O ' HG22 ' A' ' 74' ' ' VAL . 7.2 m-85 -104.37 23.18 13.58 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.716 -0.675 . . . . 75.230000000000004 111.583 -168.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.475 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 8.7 t -52.65 -27.1 15.77 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 111.977 0.362 . . . . 74.329999999999998 111.977 -177.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -60.87 -27.6 68.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.875 0.369 . . . . 53.340000000000003 111.232 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -121.48 0.32 9.94 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.047 -0.524 . . . . 72.310000000000002 110.68 -174.16 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 70' ' ' TYR . 21.4 m -133.05 146.13 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 121.034 0.445 . . . . 55.140000000000001 110.883 176.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.706 ' HA ' ' HE3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -141.86 129.57 21.6 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.204 -0.665 . . . . 63.310000000000002 109.204 177.224 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.507 ' HB ' HD13 ' A' ' 23' ' ' ILE . 2.6 mp -106.04 138.18 32.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 120.653 0.263 . . . . 74.420000000000002 110.397 -177.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.5 ' HB2' HG22 ' A' ' 46' ' ' VAL . 84.4 m-85 -134.25 137.86 44.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 72.200000000000003 110.923 -175.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 41.8 mttp -112.19 122.31 47.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.544 -0.753 . . . . 72.219999999999999 109.211 173.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.6 tp -93.7 141.62 14.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.012 -0.54 . . . . 72.5 111.457 -173.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -73.83 121.1 20.35 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.88 -0.6 . . . . 55.210000000000001 109.382 172.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.0 tt -90.08 98.68 8.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.118 0.485 . . . . 61.140000000000001 110.989 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -81.92 -66.05 0.94 Allowed 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.635 -0.505 . . . . 71.239999999999995 109.635 175.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -125.05 4.75 7.94 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.097 -0.501 . . . . 64.430000000000007 110.982 178.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 63.8 -170.27 0.19 Allowed 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 109.622 -0.51 . . . . 73.349999999999994 109.622 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -144.52 136.65 26.2 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 122.163 -0.335 . . . . 74.209999999999994 110.589 -179.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -65.45 -11.92 47.52 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.231 -0.44 . . . . 61.450000000000003 110.856 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 52.3 t -52.5 -34.51 19.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-O 121.284 0.564 . . . . 75.030000000000001 110.13 175.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.3 -45.53 91.02 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.613 -0.721 . . . . 73.530000000000001 110.158 176.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.6 m -68.7 -31.98 71.45 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.809 -0.632 . . . . 71.010000000000005 110.511 177.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -59.25 -49.88 76.15 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.208 -0.451 . . . . 72.230000000000004 110.239 177.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -72.05 -17.33 62.02 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.24 -0.436 . . . . 74.030000000000001 110.565 176.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.54 48.88 5.7 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 121.189 -0.529 . . . . 71.209999999999994 112.538 177.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 88.2 t -68.56 104.83 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.892 0.377 . . . . 73.5 110.27 176.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.8 p -73.53 -40.91 63.65 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.938 -0.574 . . . . 73.310000000000002 111.341 -178.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -150.86 164.9 35.18 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.565 -0.289 . . . . 73.129999999999995 111.171 -178.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.564 ' HB ' ' HA ' ' A' ' 97' ' ' PRO . 2.7 pp -97.56 164.16 18.16 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 116.126 -0.488 . . . . 72.430000000000007 110.448 178.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.564 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 91.0 Cg_endo -78.09 165.5 83.0 Favored 'Cis proline' 0 C--N 1.355 0.91 0 C-N-CA 124.264 -1.14 . . . . 65.310000000000002 112.537 -0.38 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 13.0 m -129.65 122.44 29.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.051 -0.522 . . . . 71.120000000000005 110.298 -178.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.811 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 45.0 mt -115.4 108.19 24.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.345 -0.613 . . . . 53.43 109.345 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.503 ' HG ' ' HG3' ' A' ' 110' ' ' GLN . 2.4 tt -99.34 124.34 44.36 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.933 -0.395 . . . . 73.120000000000005 109.933 -176.11 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.753 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 65.0 mtp -93.45 112.01 23.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.927 -0.579 . . . . 74.109999999999999 111.155 -177.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -107.24 147.14 30.56 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.007 0.523 . . . . 74.430000000000007 110.446 175.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.731 ' HB3' HD21 ' A' ' 108' ' ' LEU . 28.7 ttpp -169.81 133.63 1.26 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.294 -0.632 . . . . 63.310000000000002 109.294 173.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.3 t30 61.43 24.82 14.87 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.266 0.555 . . . . 65.239999999999995 110.498 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 76.98 10.97 85.98 Favored Glycine 0 CA--C 1.522 0.5 0 CA-C-N 115.982 -0.554 . . . . 53.509999999999998 112.959 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -125.15 152.4 44.51 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.488 -0.56 . . . . 51.240000000000002 109.488 179.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.71 142.9 29.53 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.447 -0.575 . . . . 45.119999999999997 109.447 177.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.731 HD21 ' HB3' ' A' ' 103' ' ' LYS . 2.4 mm? -106.32 -53.22 2.66 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.271 -0.27 . . . . 72.549999999999997 110.271 178.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.753 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 66.4 m -153.82 165.83 34.81 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 116.182 -0.463 . . . . 74.540000000000006 111.101 -178.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLN . . . . . 0.503 ' HG3' ' HG ' ' A' ' 100' ' ' LEU . 1.6 mp0 -128.44 102.44 6.64 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.533 -0.758 . . . . 75.319999999999993 109.443 177.562 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.811 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 50.6 t -80.35 107.04 12.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.517 -0.549 . . . . 64.25 109.517 177.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 52.5 mt -109.59 128.57 65.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.632 -0.507 . . . . 75.109999999999999 109.632 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.77 -123.09 6.36 Favored Glycine 0 N--CA 1.452 -0.269 0 N-CA-C 111.504 -0.639 . . . . 74.409999999999997 111.504 -176.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.52 101.94 1.87 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.955 0.377 . . . . 71.329999999999998 110.74 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -136.58 102.29 4.88 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 120.956 0.407 . . . . 62.439999999999998 110.861 179.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.587 HD12 HD11 ' A' ' 119' ' ' ILE . 7.9 tp -61.91 -38.39 80.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 115.895 -0.593 . . . . 73.120000000000005 110.383 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 37.7 t -61.57 -41.69 97.76 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.342 0.591 . . . . 71.150000000000006 110.316 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.447 ' O ' ' HG2' ' A' ' 122' ' ' GLU . 16.7 tppt? -63.92 -56.35 15.86 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.393 -0.821 . . . . 71.040000000000006 109.908 -179.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.72 HG12 ' HB3' ' A' ' 62' ' ' GLN . 2.2 pp -61.81 -43.33 97.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 115.455 -0.793 . . . . 71.219999999999999 111.979 -173.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.498 HD12 ' N ' ' A' ' 121' ' ' SER . 2.8 pp -63.0 -33.33 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 120.392 -0.523 . . . . 75.310000000000002 110.209 -178.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.498 ' N ' HD12 ' A' ' 120' ' ' ILE . 42.5 t -70.84 -52.3 21.22 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.07 -0.514 . . . . 62.240000000000002 110.997 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 118' ' ' LYS . 3.8 pt-20 -77.8 -37.67 48.26 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.391 0.886 . . . . 74.319999999999993 113.391 -175.145 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ILE . . . . . 0.537 HD12 HD12 ' A' ' 66' ' ' LEU . 65.7 mt -61.39 -56.99 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 O-C-N 121.949 -0.469 . . . . 72.530000000000001 110.281 177.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -63.5 -20.46 65.62 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.845 -0.616 . . . . 72.010000000000005 111.174 -178.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -65.77 -35.24 80.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.052 -0.522 . . . . 60.229999999999997 110.452 175.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.409 ' HB3' ' HE2' ' A' ' 103' ' ' LYS . 48.7 m-80 -95.59 -39.59 9.86 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.083 -0.508 . . . . 73.109999999999999 111.732 -175.313 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 38.9 pt -85.53 168.0 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.589 -0.278 . . . . 71.040000000000006 110.656 -178.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.9 p30 . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.258 -0.877 . . . . 74.439999999999998 110.95 -175.696 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.617 ' HG3' HG13 ' A' ' 23' ' ' ILE . 22.1 ptp . . . . . 0 N--CA 1.464 0.23 0 CA-C-O 120.762 0.315 . . . . 73.25 110.379 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.617 HG13 ' HG3' ' A' ' 22' ' ' MET . 60.8 mt -104.97 99.65 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 115.982 -0.553 . . . . 74.400000000000006 110.226 177.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.556 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 10.6 tp10 -101.22 155.23 18.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.83 -0.623 . . . . 71.409999999999997 109.699 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -106.69 134.7 49.44 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.025 -0.361 . . . . 65.140000000000001 110.025 176.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.523 HD12 ' HA ' ' A' ' 31' ' ' PHE . 32.1 pt -129.19 157.01 42.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-O 120.971 0.415 . . . . 64.230000000000004 111.134 -175.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -106.81 -171.45 22.63 Favored Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.93 -0.577 . . . . 13.31 112.284 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -67.92 -50.34 56.62 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.27 0.47 . . . . 73.329999999999998 112.27 -176.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.5 p -73.34 -11.95 60.66 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.425 0.528 . . . . 64.120000000000005 112.425 -171.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -117.09 -6.71 11.37 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 116.668 -0.242 . . . . 71.549999999999997 111.069 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.523 ' HA ' HD12 ' A' ' 26' ' ' ILE . 93.4 t80 -51.77 -70.58 0.08 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.293 -0.412 . . . . 65.209999999999994 110.327 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -62.43 -35.18 78.46 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.136 0.493 . . . . 71.430000000000007 109.771 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -51.88 -47.6 64.46 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.104 -0.953 . . . . 63.409999999999997 111.565 -176.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.52 -18.32 15.35 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.981 0.363 . . . . 53.439999999999998 111.981 -177.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.1 t -88.39 -59.74 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 111.947 0.351 . . . . 61.520000000000003 111.947 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 34.3 p -78.05 -33.08 51.12 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.818 0.342 . . . . 74.430000000000007 111.168 -172.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.9 m -84.57 11.84 8.08 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.253 -0.431 . . . . 73.219999999999999 111.351 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.518 ' SG ' HG22 ' A' ' 42' ' ' ILE . 44.9 t -75.76 103.07 5.68 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 120.863 0.363 . . . . 60.130000000000003 110.339 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -103.15 12.3 35.93 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.137 0.494 . . . . 70.230000000000004 110.327 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -81.7 1.65 33.34 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.082 -0.508 . . . . 63.240000000000002 111.256 -178.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 59.22 13.42 3.03 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.495 0.554 . . . . 71.209999999999994 112.495 -178.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.518 HG22 ' SG ' ' A' ' 38' ' ' CYS . 10.5 tt -78.85 153.09 4.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.182 -0.673 . . . . 74.519999999999996 109.182 176.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.785 HD21 ' HE3' ' A' ' 101' ' ' MET . 57.2 tp -93.4 111.55 23.23 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.281 0.562 . . . . 74.319999999999993 110.425 -177.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 101' ' ' MET . 71.6 mt -96.39 129.46 46.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.496 -0.774 . . . . 75.349999999999994 110.429 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 5.3 mp -117.72 103.83 10.4 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.923 -0.399 . . . . 41.200000000000003 109.923 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.557 HG12 ' HB2' ' A' ' 77' ' ' TYR . 29.6 m -93.78 127.88 45.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 110.242 -0.281 . . . . 71.439999999999998 110.242 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.488 ' O ' HG22 ' A' ' 79' ' ' ILE . 2.0 p-10 -125.07 153.24 43.22 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.925 0.393 . . . . 64.5 110.779 -177.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 . . . . . 0 CA--C 1.539 0.522 0 CA-C-N 116.006 -0.543 . . . . 73.030000000000001 111.51 178.224 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.469 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 61.5 Cg_endo . . . . . 0 N--CA 1.453 -0.895 0 CA-C-O 121.261 0.442 . . . . 71.140000000000001 112.186 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.474 ' H ' ' CD ' ' A' ' 62' ' ' GLN . 13.8 mp0 -62.32 -33.71 75.21 Favored 'General case' 0 C--O 1.248 1.01 0 CA-C-O 122.105 0.955 . . . . 74.099999999999994 109.598 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.418 ' H ' HD22 ' A' ' 63' ' ' LEU . 3.3 mm? -56.98 -48.6 78.02 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-N 113.906 -1.497 . . . . 74.219999999999999 110.952 -174.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.469 ' HG3' ' HG2' ' A' ' 61' ' ' PRO . 45.2 mt-10 -59.31 -51.64 69.05 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.051 0.453 . . . . 74.409999999999997 109.886 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -51.28 -50.87 58.44 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.184 -0.916 . . . . 71.310000000000002 111.633 -176.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.613 HD12 HD12 ' A' ' 123' ' ' ILE . 13.2 mt -80.25 -39.22 29.4 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.024 -0.67 . . . . 73.239999999999995 112.346 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.56 -38.54 90.45 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.654 0.264 . . . . 61.5 111.31 -176.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -54.6 -30.46 54.73 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.788 0.328 . . . . 70.239999999999995 111.177 178.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -90.45 -48.51 7.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.311 0.577 . . . . 65.549999999999997 110.837 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.522 ' O ' HG22 ' A' ' 74' ' ' VAL . 16.9 m-85 -98.31 23.18 8.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.547 -0.751 . . . . 75.230000000000004 112.118 -170.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.4 t -52.37 -42.01 63.58 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 112.234 0.457 . . . . 74.329999999999998 112.234 -172.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -72.99 -16.85 61.5 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.032 -0.418 . . . . 53.340000000000003 111.382 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.31 -8.04 16.5 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.536 -0.302 . . . . 72.310000000000002 111.225 -176.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.522 HG22 ' O ' ' A' ' 70' ' ' TYR . 28.3 m -133.73 151.17 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 O-C-N 121.923 -0.485 . . . . 55.140000000000001 111.032 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 42.5 mmtm -140.58 116.17 10.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.011 -0.54 . . . . 63.310000000000002 109.941 175.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.514 ' N ' HD12 ' A' ' 76' ' ' ILE . 2.7 mp -92.85 130.22 42.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.253 -0.647 . . . . 74.420000000000002 109.253 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.557 ' HB2' HG12 ' A' ' 46' ' ' VAL . 22.2 m-85 -124.46 128.81 49.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.745 0.307 . . . . 72.200000000000003 111.049 -178.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.534 ' HZ2' ' HA ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -77.96 114.07 16.47 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.273 -0.64 . . . . 72.219999999999999 109.273 174.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.488 HG22 ' O ' ' A' ' 47' ' ' ASP . 10.6 tt . . . . . 0 C--N 1.326 -0.433 0 CA-C-O 121.028 0.442 . . . . 72.5 110.058 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.206 0 CA-C-O 120.827 0.346 . . . . 73.530000000000001 110.311 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.6 m -69.6 -32.95 71.98 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.907 -0.588 . . . . 71.010000000000005 109.756 176.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -63.17 -46.15 88.48 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.839 -0.619 . . . . 72.230000000000004 109.616 176.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.459 ' OH ' ' HE2' ' A' ' 107' ' ' LYS . 31.1 m-85 -77.11 -17.08 58.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.716 -0.675 . . . . 74.030000000000001 110.955 175.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 62.94 37.77 95.48 Favored Glycine 0 C--N 1.331 0.279 0 CA-C-N 116.203 -0.453 . . . . 71.209999999999994 112.197 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.7 p -86.23 144.73 8.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.889 0.376 . . . . 73.5 111.16 -175.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 31.9 t -136.58 84.66 2.09 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.868 -0.79 . . . . 73.310000000000002 108.868 173.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -163.85 161.6 23.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.659 -0.7 . . . . 73.129999999999995 109.975 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.471 ' HA ' ' HA ' ' A' ' 97' ' ' PRO . 0.0 OUTLIER -129.64 113.41 17.85 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 109.333 -0.617 . . . . 72.430000000000007 109.333 178.58 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 96' ' ' ILE . 35.0 Cg_endo -98.6 -155.09 0.27 Allowed 'Cis proline' 0 C--N 1.348 0.544 0 C-N-CA 124.359 -1.101 . . . . 65.310000000000002 112.146 -2.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 37.7 m -145.26 139.52 27.18 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 109.256 -0.646 . . . . 71.120000000000005 109.256 174.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.722 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 3.6 mp -122.96 132.94 70.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 109.442 -0.577 . . . . 53.43 109.442 -178.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 7.9 mp -110.82 146.48 36.36 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.497 0.189 . . . . 73.120000000000005 110.602 178.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.785 ' HE3' HD21 ' A' ' 43' ' ' LEU . 59.0 mtp -115.82 118.5 33.19 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.995 -0.548 . . . . 74.109999999999999 111.256 -176.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -118.9 150.72 39.4 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.934 -0.575 . . . . 74.430000000000007 110.683 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.799 ' HB3' HD21 ' A' ' 108' ' ' LEU . 13.8 ttmm -165.58 125.67 1.8 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.75 -0.659 . . . . 63.310000000000002 109.474 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 63.34 27.1 15.27 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.514 0.673 . . . . 65.239999999999995 110.329 175.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 75.31 13.84 82.46 Favored Glycine 0 C--N 1.333 0.379 0 CA-C-N 115.683 -0.69 . . . . 53.509999999999998 111.991 -178.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -113.01 156.67 22.64 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 122.83 0.452 . . . . 51.240000000000002 110.232 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.459 ' HE2' ' OH ' ' A' ' 91' ' ' TYR . 14.7 ptmm? -101.22 125.39 47.84 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.287 -0.634 . . . . 45.119999999999997 109.287 176.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.799 HD21 ' HB3' ' A' ' 103' ' ' LYS . 2.1 mm? -104.87 -53.2 2.72 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 111.909 0.337 . . . . 72.549999999999997 111.909 -173.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.709 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 50.4 m -162.97 172.14 15.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.192 -0.458 . . . . 74.540000000000006 110.247 -172.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.449 ' NE2' ' H ' ' A' ' 110' ' ' GLN . 0.4 OUTLIER -147.59 127.14 13.26 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.016 0.436 . . . . 75.319999999999993 110.797 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.722 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 84.4 t -81.57 107.36 13.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 115.97 -0.559 . . . . 64.25 109.924 178.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.537 ' H ' ' HE3' ' A' ' 118' ' ' LYS . 65.6 mt -107.95 115.19 48.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 116.029 -0.532 . . . . 75.109999999999999 110.131 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.07 -135.57 13.19 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 116.097 -0.502 . . . . 74.409999999999997 112.108 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -145.39 77.05 1.5 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.182 0.515 . . . . 71.329999999999998 110.767 -178.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.54 ' O ' HG23 ' A' ' 119' ' ' ILE . 1.7 m-20 -124.21 91.11 3.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.789 -0.642 . . . . 62.439999999999998 109.895 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.448 ' O ' HG13 ' A' ' 119' ' ' ILE . 6.8 tp -54.45 -41.34 53.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 120.798 0.332 . . . . 73.120000000000005 111.187 -176.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 43.8 t -59.32 -34.8 72.78 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.17 0.51 . . . . 71.150000000000006 111.07 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.537 ' HE3' ' H ' ' A' ' 112' ' ' ILE . 2.4 tmtm? -79.38 -44.14 22.08 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.92 -0.582 . . . . 71.040000000000006 110.715 -178.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.581 HG22 HG13 ' A' ' 111' ' ' VAL . 1.5 pp -66.41 -38.53 81.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 71.219999999999999 110.862 -175.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.435 HD12 ' N ' ' A' ' 121' ' ' SER . 2.7 pp -67.39 -31.81 54.51 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.078 0 C-N-CA 120.569 -0.452 . . . . 75.310000000000002 109.788 177.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.435 ' N ' HD12 ' A' ' 120' ' ' ILE . 34.7 t -67.48 -47.04 71.21 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.928 -0.578 . . . . 62.240000000000002 110.152 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.428 ' OE1' ' HB3' ' A' ' 109' ' ' SER . 15.0 pt-20 -76.74 -42.31 41.67 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.27 -0.423 . . . . 74.319999999999993 111.765 -177.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.613 HD12 HD12 ' A' ' 66' ' ' LEU . 68.3 mt -66.3 -52.23 49.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 O-C-N 122.335 -0.228 . . . . 72.530000000000001 111.046 -178.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -62.64 -20.28 64.64 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.927 0.394 . . . . 72.010000000000005 111.035 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -68.58 -34.14 75.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.075 -0.512 . . . . 60.229999999999997 110.423 176.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -103.9 -8.14 19.92 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.474 0.546 . . . . 73.109999999999999 112.474 -172.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 43.0 pt -139.11 167.85 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 120.796 0.332 . . . . 71.040000000000006 110.647 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.371 -0.823 . . . . 74.439999999999998 111.122 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 27.0 ptt? . . . . . 0 C--O 1.238 0.451 0 N-CA-C 109.729 -0.471 . . . . 73.25 109.729 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.409 HD13 ' HB ' ' A' ' 76' ' ' ILE . 10.3 mm -107.55 89.66 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 108.142 -1.059 . . . . 74.400000000000006 108.142 171.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.633 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 9.3 tp10 -108.78 155.46 20.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.566 -0.288 . . . . 71.409999999999997 110.483 -174.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.419 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 29.7 pt20 -105.29 147.65 27.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.919 0.39 . . . . 65.140000000000001 110.481 176.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.415 HD12 ' HA ' ' A' ' 31' ' ' PHE . 30.5 pt -129.56 -178.93 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.979 -0.555 . . . . 64.230000000000004 109.97 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.31 175.34 18.92 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.841 -0.695 . . . . 13.31 113.514 -175.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -67.76 -34.68 77.29 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.626 0.77 . . . . 73.329999999999998 110.949 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.2 t -79.88 -39.21 31.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 64.120000000000005 111.285 -171.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -95.12 0.25 54.07 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.998 -0.546 . . . . 71.549999999999997 111.304 -175.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.423 ' HE1' HG11 ' A' ' 46' ' ' VAL . 66.1 t80 -47.84 -71.19 0.07 Allowed 'General case' 0 CA--C 1.53 0.189 0 O-C-N 123.418 0.448 . . . . 65.209999999999994 111.186 -177.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -65.86 -32.88 74.65 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.375 -0.602 . . . . 71.430000000000007 109.375 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.486 ' O ' ' HB2' ' A' ' 37' ' ' SER . 3.4 t-20 -51.85 -39.17 58.44 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 114.762 -1.108 . . . . 63.409999999999997 111.333 -175.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 10.9 ptmt -109.76 -25.8 10.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 53.439999999999998 112.122 -178.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.5 t -80.11 -53.23 13.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 111.721 0.267 . . . . 61.520000000000003 111.721 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.0 p -83.75 -36.2 23.81 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.342 0.591 . . . . 74.430000000000007 110.067 -175.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.486 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 39.0 m -83.89 12.73 5.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.478 -0.783 . . . . 73.219999999999999 111.134 178.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 40.1 t -53.63 91.92 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.133 0.492 . . . . 60.130000000000003 110.979 176.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -80.84 -7.23 59.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.771 -0.65 . . . . 70.230000000000004 110.962 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -73.5 -16.54 61.28 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.247 -0.433 . . . . 63.240000000000002 110.643 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 65.89 21.69 11.4 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.744 -0.662 . . . . 71.209999999999994 111.443 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.571 HD13 ' HG2' ' A' ' 75' ' ' LYS . 17.6 tt -94.96 151.71 3.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.113 -0.699 . . . . 74.519999999999996 109.113 175.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.678 HD21 ' HE3' ' A' ' 101' ' ' MET . 64.8 tp -79.71 111.76 16.32 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.976 0.417 . . . . 74.319999999999993 110.474 -176.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 49.4 mt -91.31 122.91 43.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.615 -0.72 . . . . 75.349999999999994 110.498 177.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.587 HD13 HD12 ' A' ' 63' ' ' LEU . 58.8 mt -103.8 102.04 11.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.628 -0.715 . . . . 41.200000000000003 109.475 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 74.2 t -86.66 120.2 35.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.209 -0.451 . . . . 71.439999999999998 110.844 -177.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.506 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 13.7 t70 -95.24 154.91 16.96 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.925 0.393 . . . . 64.5 110.695 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 72.7 t80 . . . . . 0 CA--C 1.535 0.39 0 CA-C-N 115.762 -0.654 . . . . 73.030000000000001 112.301 -174.834 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo . . . . . 0 N--CA 1.463 -0.291 0 CA-C-O 120.89 0.287 . . . . 71.140000000000001 112.571 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.563 ' NE2' ' HA ' ' A' ' 114' ' ' ALA . 12.1 mp0 -52.15 -38.62 58.18 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.468 -0.787 . . . . 74.099999999999994 110.179 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.587 HD12 HD13 ' A' ' 45' ' ' LEU . 2.7 mm? -60.36 -48.7 80.62 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.672 -1.149 . . . . 74.219999999999999 110.326 -173.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -74.16 -36.54 64.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.179 -0.464 . . . . 74.409999999999997 109.997 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -52.33 -45.95 65.83 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.752 -0.658 . . . . 71.310000000000002 109.822 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.719 HD12 HD12 ' A' ' 123' ' ' ILE . 25.7 mt -84.78 -38.82 19.15 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 111.741 0.275 . . . . 73.239999999999995 111.741 177.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.541 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -55.98 -37.34 68.95 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.572 0.225 . . . . 61.5 111.464 -176.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -50.61 -32.35 18.62 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.948 0.404 . . . . 70.239999999999995 110.898 178.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -94.44 -59.02 2.04 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.833 -0.622 . . . . 65.549999999999997 111.27 175.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.544 ' O ' HG22 ' A' ' 74' ' ' VAL . 17.1 m-85 -91.1 21.03 4.51 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.156 0.798 . . . . 75.230000000000004 113.156 -168.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.541 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 11.2 t -54.52 -26.82 34.06 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.174 0.512 . . . . 74.329999999999998 110.976 -178.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -62.72 -20.13 64.6 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.752 -0.658 . . . . 53.340000000000003 112.239 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -131.93 7.78 4.39 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 111.661 0.245 . . . . 72.310000000000002 111.661 -175.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.544 HG22 ' O ' ' A' ' 70' ' ' TYR . 34.4 m -137.04 140.34 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 120.958 0.409 . . . . 55.140000000000001 110.992 177.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.571 ' HG2' HD13 ' A' ' 42' ' ' ILE . 33.6 mmtp -129.85 123.15 30.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.776 -0.647 . . . . 63.310000000000002 109.312 176.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.543 HG13 ' HB2' ' A' ' 45' ' ' LEU . 2.8 mp -98.99 132.48 44.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.694 -0.484 . . . . 74.420000000000002 109.694 -178.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.633 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 52.2 m-85 -134.52 129.34 34.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.076 -0.511 . . . . 72.200000000000003 109.786 -178.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.506 ' HB3' ' HB3' ' A' ' 47' ' ' ASP . 57.1 pttt -125.4 170.55 11.26 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.037 -0.357 . . . . 72.219999999999999 110.037 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 50.7 mt . . . . . 0 C--N 1.327 -0.385 0 N-CA-C 109.485 -0.561 . . . . 72.5 109.485 176.829 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.366 0 CA-C-O 120.968 0.413 . . . . 73.530000000000001 110.589 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 45.2 m -62.3 -42.52 99.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.754 -0.657 . . . . 71.010000000000005 110.661 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -65.1 -49.86 68.34 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.187 -0.46 . . . . 72.230000000000004 110.972 -176.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -74.0 -17.31 61.01 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.5 -0.318 . . . . 74.030000000000001 110.92 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.97 49.27 10.01 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.174 -0.536 . . . . 71.209999999999994 112.139 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 46.5 t -90.77 143.03 12.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 110.218 -0.289 . . . . 73.5 110.218 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.9 p -117.04 -58.48 2.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.299 -0.41 . . . . 73.310000000000002 110.996 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.59 108.35 2.41 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.105 -0.498 . . . . 73.129999999999995 111.479 -178.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.489 ' HB ' ' HA ' ' A' ' 97' ' ' PRO . 2.9 pp -107.42 158.38 33.34 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 116.11 -0.496 . . . . 72.430000000000007 109.876 176.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.489 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 61.3 Cg_endo -70.23 153.96 94.36 Favored 'Cis proline' 0 C--N 1.355 0.912 0 C-N-CA 124.039 -1.234 . . . . 65.310000000000002 113.03 2.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 28.7 m -120.17 135.3 55.02 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.381 -0.827 . . . . 71.120000000000005 109.799 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.607 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 3.8 mp -118.24 138.04 50.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.764 -0.458 . . . . 53.43 109.764 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.499 HD23 ' H ' ' A' ' 101' ' ' MET . 1.1 tt -121.79 137.23 54.85 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.115 -0.698 . . . . 73.120000000000005 109.115 176.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.769 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 61.4 mtp -101.62 118.47 37.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.065 -0.516 . . . . 74.109999999999999 110.879 -173.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -121.21 147.32 45.77 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.574 -0.284 . . . . 74.430000000000007 110.607 178.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.598 ' HB3' HD21 ' A' ' 108' ' ' LEU . 39.7 ttpt -159.16 116.09 2.69 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.099 -0.5 . . . . 63.310000000000002 110.137 176.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 48.64 54.75 10.09 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.73 -0.668 . . . . 65.239999999999995 111.309 177.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 80.82 -12.76 33.89 Favored Glycine 0 CA--C 1.519 0.328 0 CA-C-N 115.671 -0.695 . . . . 53.509999999999998 113.901 175.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -100.98 131.83 46.67 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 117.357 0.579 . . . . 51.240000000000002 110.735 -177.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -91.26 112.58 24.55 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.0 -0.741 . . . . 45.119999999999997 109.0 173.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.598 HD21 ' HB3' ' A' ' 103' ' ' LYS . 2.3 mm? -80.95 -53.37 6.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.126 -0.488 . . . . 72.549999999999997 111.26 -170.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.769 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 56.1 m -161.15 171.72 18.01 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.857 -0.61 . . . . 74.540000000000006 110.343 -172.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.539 HE21 HD11 ' A' ' 112' ' ' ILE . 29.5 tt0 -141.82 126.65 18.15 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 120.579 0.228 . . . . 75.319999999999993 110.704 -177.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.607 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 59.6 t -91.19 125.53 43.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 123.025 0.53 . . . . 64.25 110.633 178.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.539 HD11 HE21 ' A' ' 110' ' ' GLN . 62.0 mt -126.58 106.82 16.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.468 -0.333 . . . . 75.109999999999999 110.113 176.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 99.91 -143.34 16.37 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 121.082 -0.58 . . . . 74.409999999999997 112.388 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.563 ' HA ' ' NE2' ' A' ' 62' ' ' GLN . . . -126.49 56.85 1.44 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.251 0.548 . . . . 71.329999999999998 111.03 -176.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.505 ' O ' HG23 ' A' ' 119' ' ' ILE . 4.4 m-20 -93.38 71.15 4.39 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.022 -0.535 . . . . 62.439999999999998 110.147 179.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.586 ' O ' HG13 ' A' ' 119' ' ' ILE . 6.3 tp -54.57 -44.66 69.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 121.065 0.459 . . . . 73.120000000000005 111.432 -177.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.4 p -63.86 -28.89 70.16 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-O 121.212 0.529 . . . . 71.150000000000006 111.378 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.439 ' HB3' ' HB3' ' A' ' 115' ' ' ASP . 14.5 tmtt? -80.03 -45.03 19.08 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 116.062 -0.517 . . . . 71.040000000000006 110.84 177.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.586 HG13 ' O ' ' A' ' 116' ' ' ILE . 2.0 pp -64.6 -38.09 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.47 -0.332 . . . . 71.219999999999999 111.01 -175.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.566 HG22 HD21 ' A' ' 66' ' ' LEU . 2.9 pp -60.5 -31.72 49.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-O 121.195 0.521 . . . . 75.310000000000002 110.051 176.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.43 ' N ' HD12 ' A' ' 120' ' ' ILE . 23.6 m -70.47 -51.68 27.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.977 -0.556 . . . . 62.240000000000002 110.734 177.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.561 ' HG2' ' HA ' ' A' ' 119' ' ' ILE . 15.6 pt-20 -72.38 -42.04 65.67 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.387 0.514 . . . . 74.319999999999993 112.387 -173.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.719 HD12 HD12 ' A' ' 66' ' ' LEU . 70.6 mt -64.07 -59.05 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 O-C-N 122.113 -0.367 . . . . 72.530000000000001 110.498 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -58.91 -20.75 54.66 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.046 -0.525 . . . . 72.010000000000005 110.943 -178.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -70.63 -39.14 73.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.811 -0.632 . . . . 60.229999999999997 110.885 176.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -103.61 -2.26 26.92 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.355 0.502 . . . . 73.109999999999999 112.355 -173.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 123' ' ' ILE . 29.6 pt -109.01 167.92 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 110.018 -0.364 . . . . 71.040000000000006 110.018 171.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.412 ' N ' HD22 ' A' ' 128' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.582 -0.723 . . . . 74.439999999999998 111.036 -175.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.625 ' HG2' HG12 ' A' ' 23' ' ' ILE . 1.4 pmm? . . . . . 0 C--O 1.236 0.373 0 N-CA-C 108.437 -0.949 . . . . 73.25 108.437 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.625 HG12 ' HG2' ' A' ' 22' ' ' MET . 22.8 mm -121.18 84.07 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 108.06 -1.089 . . . . 74.400000000000006 108.06 173.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -86.25 154.74 21.06 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.102 0.477 . . . . 71.409999999999997 111.177 -172.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.441 ' HA ' ' HG2' ' A' ' 78' ' ' LYS . 8.6 pt20 -101.44 126.42 48.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.862 -0.608 . . . . 65.140000000000001 110.696 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.515 HD12 ' HA ' ' A' ' 31' ' ' PHE . 35.1 pt -131.86 174.62 12.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 120.736 0.303 . . . . 64.230000000000004 110.259 175.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.419 ' H ' ' HG2' ' A' ' 30' ' ' GLU . . . -121.11 -166.8 13.09 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 116.016 -0.538 . . . . 13.31 112.486 -179.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.79 -50.3 57.7 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 122.893 0.477 . . . . 73.329999999999998 112.023 -176.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 39.7 m -76.67 -31.44 57.29 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 120.901 0.381 . . . . 64.120000000000005 111.928 -169.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.477 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 2.1 pm0 -89.93 -15.29 32.37 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.967 -0.56 . . . . 71.549999999999997 110.882 -178.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.515 ' HA ' HD12 ' A' ' 26' ' ' ILE . 46.3 t80 -48.77 -70.86 0.08 Allowed 'General case' 0 C--O 1.226 -0.159 0 O-C-N 123.399 0.437 . . . . 65.209999999999994 110.285 178.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -56.45 -43.3 79.39 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-O 121.146 0.498 . . . . 71.430000000000007 109.748 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.631 ' O ' ' HB3' ' A' ' 37' ' ' SER . 23.1 t-20 -52.3 -41.28 62.79 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 114.209 -1.36 . . . . 63.409999999999997 112.449 -171.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -112.96 -20.15 11.66 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.257 0.466 . . . . 53.439999999999998 112.257 -176.802 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 77.6 t -81.05 -48.97 18.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 O-C-N 122.331 -0.231 . . . . 61.520000000000003 111.233 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.8 p -88.2 -35.83 17.13 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.218 0.532 . . . . 74.430000000000007 110.242 -177.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.631 ' HB3' ' O ' ' A' ' 33' ' ' ASN . 33.9 t -84.67 12.38 7.27 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.875 -0.602 . . . . 73.219999999999999 110.904 178.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 40' ' ' ASP . 43.6 t -53.71 103.24 0.07 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.955 0.407 . . . . 60.130000000000003 111.369 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -82.23 -8.9 59.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.871 -0.604 . . . . 70.230000000000004 110.372 176.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.448 ' HB2' ' SG ' ' A' ' 38' ' ' CYS . 21.2 m-20 -63.69 -30.76 71.82 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.219 -0.446 . . . . 63.240000000000002 110.561 -179.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.9 m120 71.52 12.9 6.48 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.509 -0.768 . . . . 71.209999999999994 110.99 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.5 tt -88.62 161.57 2.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 109.223 -0.658 . . . . 74.519999999999996 109.223 177.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.436 HD12 HG23 ' A' ' 127' ' ' ILE . 26.9 mt -78.93 109.24 13.03 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.06 0.457 . . . . 74.319999999999993 110.662 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.619 HG23 ' CD2' ' A' ' 77' ' ' TYR . 45.2 mt -94.27 107.61 19.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.649 -0.705 . . . . 75.349999999999994 110.163 175.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.571 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 6.4 mp -97.2 107.18 19.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.934 -0.575 . . . . 41.200000000000003 109.583 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.404 HG12 ' HB2' ' A' ' 77' ' ' TYR . 28.5 m -94.97 129.92 44.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 110.091 -0.337 . . . . 71.439999999999998 110.091 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -104.29 139.78 38.81 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.11 0.481 . . . . 64.5 110.208 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.475 ' HE2' HD13 ' A' ' 100' ' ' LEU . 40.8 m-85 . . . . . 0 C--N 1.324 -0.512 0 CA-C-N 115.842 -0.617 . . . . 73.030000000000001 110.066 176.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.409 ' HD2' ' OE1' ' A' ' 64' ' ' GLU . 98.6 Cg_endo . . . . . 0 N--CA 1.462 -0.382 0 CA-C-O 121.06 0.358 . . . . 71.140000000000001 112.408 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.555 ' HB3' HG12 ' A' ' 119' ' ' ILE . 13.8 mp0 -63.12 -48.32 79.0 Favored 'General case' 0 C--O 1.247 0.932 0 CA-C-O 121.583 0.706 . . . . 74.099999999999994 110.574 -174.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.561 HD12 ' N ' ' A' ' 64' ' ' GLU . 4.0 pp -57.38 -39.56 76.32 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 114.844 -1.071 . . . . 74.219999999999999 111.33 -176.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.561 ' N ' HD12 ' A' ' 63' ' ' LEU . 29.7 mt-10 -70.45 -43.25 70.26 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 120.809 -0.356 . . . . 74.409999999999997 110.048 177.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.2 mmtt -50.81 -52.95 36.24 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.133 -0.485 . . . . 71.310000000000002 111.528 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.735 HD12 HD12 ' A' ' 123' ' ' ILE . 14.8 mt -85.72 -42.83 13.9 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.198 0.814 . . . . 73.239999999999995 113.198 -176.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.18 -32.38 72.12 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.195 0.443 . . . . 61.5 112.195 -172.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -53.28 -33.44 53.2 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.884 0.373 . . . . 70.239999999999995 110.764 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -94.0 -53.4 4.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.005 -0.543 . . . . 65.549999999999997 110.85 176.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.53 ' O ' HG22 ' A' ' 74' ' ' VAL . 22.7 m-85 -85.35 14.83 4.89 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 113.149 0.796 . . . . 75.230000000000004 113.149 -169.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.8 t -52.94 -31.6 41.1 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.344 0.52 . . . . 74.329999999999998 111.441 -177.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -66.65 -16.9 64.53 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.283 -0.417 . . . . 53.340000000000003 111.553 -178.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -125.1 -7.04 7.15 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.375 -0.375 . . . . 72.310000000000002 110.627 -176.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 70' ' ' TYR . 19.6 m -141.83 150.69 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 109.979 -0.378 . . . . 55.140000000000001 109.979 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.9 tppt? -144.9 127.25 15.85 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.845 -0.428 . . . . 63.310000000000002 109.845 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.571 ' HA ' ' O ' ' A' ' 45' ' ' LEU . 1.9 mp -95.94 142.82 13.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.583 0.23 . . . . 74.420000000000002 110.398 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.619 ' CD2' HG23 ' A' ' 44' ' ' ILE . 83.6 m-85 -135.46 131.56 36.29 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.211 -0.45 . . . . 72.200000000000003 110.339 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.441 ' HG2' ' HA ' ' A' ' 25' ' ' GLN . 22.3 ptmt -87.21 134.56 33.52 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 120.734 0.302 . . . . 72.219999999999999 110.477 177.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.41 HD13 ' CD1' ' A' ' 31' ' ' PHE . 7.8 tp . . . . . 0 CA--C 1.534 0.351 0 CA-C-N 115.819 -0.628 . . . . 72.5 110.769 -179.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.128 0 CA-C-O 121.025 0.441 . . . . 73.530000000000001 110.168 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.9 m -67.86 -31.24 70.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.805 -0.634 . . . . 71.010000000000005 110.406 178.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -65.4 -55.83 15.92 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.492 -0.776 . . . . 72.230000000000004 110.67 -179.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -80.12 -9.01 59.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.32 -0.4 . . . . 74.030000000000001 111.153 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.26 47.82 21.66 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.165 -0.54 . . . . 71.209999999999994 112.6 176.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.5 t -65.32 105.55 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.948 0.404 . . . . 73.5 110.42 178.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.2 p -107.49 0.43 22.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.082 -0.508 . . . . 73.310000000000002 111.06 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.62 125.98 10.83 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.61 -0.268 . . . . 73.129999999999995 110.847 -177.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 32.4 pt -100.1 150.94 37.33 Favored Pre-proline 0 C--O 1.238 0.466 0 CA-C-N 116.113 -0.494 . . . . 72.430000000000007 110.193 177.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -79.82 178.61 32.57 Favored 'Cis proline' 0 C--N 1.352 0.722 0 C-N-CA 123.663 -1.39 . . . . 65.310000000000002 112.507 0.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 27.6 m -148.03 133.3 18.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.194 -0.457 . . . . 71.120000000000005 110.243 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 62.2 mt -119.76 134.25 63.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.752 -0.462 . . . . 53.43 109.752 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.475 HD13 ' HE2' ' A' ' 48' ' ' PHE . 11.2 mp -118.0 130.81 56.41 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 120.619 0.247 . . . . 73.120000000000005 110.402 177.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.41 ' SD ' ' HB3' ' A' ' 109' ' ' SER . 87.0 mtp -95.42 108.46 20.66 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.846 -0.616 . . . . 74.109999999999999 110.327 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -110.04 146.95 34.46 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.869 0.366 . . . . 74.430000000000007 110.989 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.409 ' HB3' HD21 ' A' ' 108' ' ' LEU . 28.4 ttpp -153.37 108.13 3.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.73 -0.668 . . . . 63.310000000000002 109.595 174.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.61 29.78 18.36 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.009 -0.541 . . . . 65.239999999999995 110.424 177.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.04 -10.69 74.34 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.235 -0.507 . . . . 53.509999999999998 112.741 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -96.74 119.43 35.2 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.761 -0.459 . . . . 51.240000000000002 109.761 177.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.21 128.34 34.5 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.508 -0.553 . . . . 45.119999999999997 109.508 177.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.478 ' N ' HD22 ' A' ' 108' ' ' LEU . 2.4 mm? -87.89 -47.26 8.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.983 0.421 . . . . 72.549999999999997 110.54 -176.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.41 ' HB3' ' SD ' ' A' ' 101' ' ' MET . 23.5 t -160.22 171.81 18.53 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.869 -0.605 . . . . 74.540000000000006 110.678 -175.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -149.04 129.73 14.09 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.718 -0.674 . . . . 75.319999999999993 110.906 -175.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.498 ' CG2' HG22 ' A' ' 119' ' ' ILE . 22.2 t -96.66 111.49 26.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 123.158 0.583 . . . . 64.25 110.067 178.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 59.8 mt -107.57 106.79 21.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.856 -0.424 . . . . 75.109999999999999 109.856 177.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 105.68 -112.39 3.93 Favored Glycine 0 C--N 1.33 0.226 0 N-CA-C 111.399 -0.68 . . . . 74.409999999999997 111.399 -176.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.51 57.16 0.5 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.396 0.617 . . . . 71.329999999999998 110.685 177.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.593 ' O ' HG23 ' A' ' 119' ' ' ILE . 3.0 m-20 -85.17 75.63 10.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.801 -0.636 . . . . 62.439999999999998 110.601 -179.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.568 ' O ' HG13 ' A' ' 119' ' ' ILE . 5.8 tp -52.56 -41.88 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 116.315 -0.402 . . . . 73.120000000000005 111.316 -178.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.9 p -62.15 -29.51 70.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.47 . . . . 71.150000000000006 111.075 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.454 ' HB2' ' HB3' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -79.41 -42.0 26.44 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.341 -0.614 . . . . 71.040000000000006 109.341 178.669 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.593 HG23 ' O ' ' A' ' 115' ' ' ASP . 1.3 pp -64.68 -43.03 96.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.324 -0.398 . . . . 71.219999999999999 111.002 -174.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.507 HD12 ' N ' ' A' ' 121' ' ' SER . 2.9 pp -63.47 -32.26 56.0 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.096 0 C-N-CA 120.623 -0.431 . . . . 75.310000000000002 110.39 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.507 ' N ' HD12 ' A' ' 120' ' ' ILE . 47.9 m -71.15 -51.53 24.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.037 -0.529 . . . . 62.240000000000002 111.08 177.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.448 ' HG2' ' HA ' ' A' ' 119' ' ' ILE . 10.7 pt-20 -69.44 -41.13 76.71 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.526 -0.306 . . . . 74.319999999999993 111.458 -171.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.735 HD12 HD12 ' A' ' 66' ' ' LEU . 74.9 mt -67.33 -57.7 8.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 110.409 -0.219 . . . . 72.530000000000001 110.409 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -59.77 -23.39 63.22 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.952 0.406 . . . . 72.010000000000005 110.866 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.419 HD22 ' ND2' ' A' ' 126' ' ' ASN . 6.7 t30 -67.48 -29.29 68.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.943 -0.571 . . . . 60.229999999999997 111.391 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.419 ' ND2' HD22 ' A' ' 125' ' ' ASN . 48.9 m-80 -111.82 -1.17 15.65 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.154 0.428 . . . . 73.109999999999999 112.154 -174.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.518 HG12 ' O ' ' A' ' 123' ' ' ILE . 47.5 pt -131.83 168.32 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 121.236 0.541 . . . . 71.040000000000006 111.299 177.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.1 p30 . . . . . 0 C--O 1.25 1.113 0 CA-C-N 115.116 -0.947 . . . . 74.439999999999998 110.485 -178.039 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.474 ' N ' ' SD ' ' A' ' 22' ' ' MET . 3.6 mpp? . . . . . 0 C--O 1.236 0.36 0 CA-C-O 120.925 0.393 . . . . 73.25 110.065 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.48 HG22 ' HE3' ' A' ' 78' ' ' LYS . 7.9 mm -101.08 92.48 2.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 108.595 -0.891 . . . . 74.400000000000006 108.595 175.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.603 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 34.4 tt0 -112.9 148.39 35.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.899 -0.591 . . . . 71.409999999999997 110.788 -168.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.509 ' HB3' ' NZ ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -99.4 147.56 25.11 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 110.092 -0.336 . . . . 65.140000000000001 110.092 179.341 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.448 HD12 ' HA ' ' A' ' 31' ' ' PHE . 31.8 pt -137.91 162.36 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 121.012 0.434 . . . . 64.230000000000004 111.409 -176.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.62 171.23 19.97 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.335 -0.848 . . . . 13.31 111.758 177.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -67.78 -30.05 69.39 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.707 0.253 . . . . 73.329999999999998 111.459 -177.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 28.8 t -68.7 -36.66 78.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.713 0.292 . . . . 64.120000000000005 111.044 -177.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.431 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 4.3 pm0 -98.35 -9.85 24.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 71.549999999999997 111.188 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.482 ' HE1' HG11 ' A' ' 46' ' ' VAL . 93.3 t80 -46.75 -71.11 0.08 Allowed 'General case' 0 N--CA 1.467 0.399 0 O-C-N 123.317 0.385 . . . . 65.209999999999994 111.259 -175.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -65.79 -35.63 81.24 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 109.593 -0.521 . . . . 71.430000000000007 109.593 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -53.59 -33.75 55.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.807 -1.088 . . . . 63.409999999999997 111.881 -174.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.431 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 0.2 OUTLIER -114.82 -18.53 11.31 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 121.03 -0.268 . . . . 53.439999999999998 111.68 -179.822 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 72.7 t -88.44 -57.09 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 111.746 0.276 . . . . 61.520000000000003 111.746 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 58.2 p -76.32 -23.33 54.29 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.107 0.48 . . . . 74.430000000000007 110.537 -175.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.8 m -86.27 11.68 11.59 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.676 -0.693 . . . . 73.219999999999999 111.083 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.503 ' HB2' HD12 ' A' ' 44' ' ' ILE . 41.8 t -57.96 91.11 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.037 0.446 . . . . 60.130000000000003 110.962 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -101.33 -6.7 23.77 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.816 -0.629 . . . . 70.230000000000004 109.989 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -77.91 -5.23 50.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.361 -0.836 . . . . 63.240000000000002 111.778 -174.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.58 ' ND2' HD21 ' A' ' 104' ' ' ASN . 20.6 m120 66.83 16.56 10.4 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.336 -0.393 . . . . 71.209999999999994 110.856 -176.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.0 tt -87.18 142.87 12.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.33 -0.619 . . . . 74.519999999999996 109.33 177.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.727 HD21 ' HE3' ' A' ' 101' ' ' MET . 68.1 tp -82.46 116.91 22.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.889 0.376 . . . . 74.319999999999993 110.314 -178.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.503 HD12 ' HB2' ' A' ' 38' ' ' CYS . 56.3 mt -102.61 117.67 48.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.872 -0.603 . . . . 75.349999999999994 110.533 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.525 ' HB2' HG13 ' A' ' 76' ' ' ILE . 4.1 mp -106.06 103.84 13.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.051 -0.522 . . . . 41.200000000000003 109.748 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.513 HG22 ' HB2' ' A' ' 77' ' ' TYR . 45.7 t -109.41 123.76 65.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 111.43 0.159 . . . . 71.439999999999998 111.43 -177.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.465 ' HB2' HG13 ' A' ' 99' ' ' ILE . 14.2 t70 -91.82 149.52 21.54 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.661 -0.866 . . . . 64.5 108.661 170.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 . . . . . 0 C--N 1.326 -0.444 0 N-CA-C 111.46 0.17 . . . . 73.030000000000001 111.46 -177.457 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo . . . . . 0 CA--C 1.533 0.458 0 N-CA-C 110.931 -0.45 . . . . 71.140000000000001 110.931 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.512 ' HB3' HG12 ' A' ' 119' ' ' ILE . 6.8 mp0 -48.99 -57.62 6.21 Favored 'General case' 0 C--O 1.247 0.974 0 CA-C-O 121.627 0.727 . . . . 74.099999999999994 111.491 -173.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.599 HD12 ' N ' ' A' ' 64' ' ' GLU . 2.1 pp -62.31 -38.81 90.85 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.117 -0.947 . . . . 74.219999999999999 111.654 -174.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.599 ' N ' HD12 ' A' ' 63' ' ' LEU . 37.8 mt-10 -70.9 -35.47 72.32 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 110.003 -0.369 . . . . 74.409999999999997 110.003 177.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -57.37 -56.73 18.09 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.004 -0.544 . . . . 71.310000000000002 110.642 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.661 HD12 HD12 ' A' ' 123' ' ' ILE . 28.5 mt -80.1 -30.79 39.2 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.364 0.505 . . . . 73.239999999999995 112.364 -175.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.428 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -62.38 -33.27 74.42 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 111.585 0.217 . . . . 61.5 111.585 -177.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.551 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 78.6 mt-30 -64.07 -30.92 71.96 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.003 0.43 . . . . 70.239999999999995 110.657 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 68.8 mm-40 -89.28 -59.11 2.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.009 -0.541 . . . . 65.549999999999997 110.776 -176.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.508 ' O ' HG22 ' A' ' 74' ' ' VAL . 17.1 m-85 -87.8 23.49 2.0 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.56 -0.746 . . . . 75.230000000000004 111.892 -173.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.428 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 6.6 t -52.0 -38.79 58.01 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.063 0.764 . . . . 74.329999999999998 113.063 -167.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -73.45 -16.52 61.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.774 0.321 . . . . 53.340000000000003 111.181 -176.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -113.14 -4.31 13.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.317 -0.402 . . . . 72.310000000000002 110.951 -177.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 70' ' ' TYR . 32.8 m -133.19 137.15 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.254 0.55 . . . . 55.140000000000001 111.072 178.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.432 ' HD2' ' CZ ' ' A' ' 77' ' ' TYR . 7.7 mmtt -128.79 115.13 17.47 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.96 -0.755 . . . . 63.310000000000002 108.96 177.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.525 HG13 ' HB2' ' A' ' 45' ' ' LEU . 2.3 mp -99.68 134.68 38.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.411 -0.588 . . . . 74.420000000000002 109.411 -177.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.603 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 71.3 m-85 -132.49 155.58 48.33 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.393 -0.367 . . . . 72.200000000000003 110.363 -178.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.509 ' NZ ' ' HB3' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -144.02 128.59 18.09 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.722 -0.844 . . . . 72.219999999999999 108.722 170.635 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.1 tt . . . . . 0 C--N 1.325 -0.457 0 CA-C-N 116.102 -0.499 . . . . 72.5 110.023 -175.466 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.38 0 CA-C-O 120.986 0.422 . . . . 73.530000000000001 110.934 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.9 m -73.9 -31.38 63.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.795 -0.638 . . . . 71.010000000000005 110.683 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -63.97 -43.94 94.24 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.765 -0.652 . . . . 72.230000000000004 110.573 -178.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -86.58 -14.3 43.27 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.196 -0.456 . . . . 74.030000000000001 110.48 175.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 65.03 55.59 20.97 Favored Glycine 0 C--O 1.237 0.282 0 CA-C-N 116.002 -0.545 . . . . 71.209999999999994 112.182 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.438 HG21 ' OG1' ' A' ' 98' ' ' THR . 7.9 p -73.93 131.73 34.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.766 0.317 . . . . 73.5 110.728 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.6 t -121.83 -0.88 9.5 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.456 -0.338 . . . . 73.310000000000002 111.141 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.459 ' HB3' HG22 ' A' ' 112' ' ' ILE . . . -135.98 128.73 30.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.697 0.285 . . . . 73.129999999999995 110.904 -177.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.786 HD13 ' H ' ' A' ' 96' ' ' ILE . 0.2 OUTLIER -113.06 154.85 44.95 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 115.866 -0.606 . . . . 72.430000000000007 109.938 179.781 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.67 177.54 28.29 Favored 'Cis proline' 0 C--N 1.356 0.967 0 C-N-CA 124.183 -1.174 . . . . 65.310000000000002 112.442 1.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.438 ' OG1' HG21 ' A' ' 93' ' ' VAL . 18.5 m -146.99 115.19 6.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.072 0.463 . . . . 71.120000000000005 110.521 -176.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.525 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 3.7 mp -117.88 129.55 74.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.5 -0.773 . . . . 53.43 110.095 -176.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.9 mp -104.54 132.57 50.63 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.835 -0.431 . . . . 73.120000000000005 109.835 174.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.727 ' HE3' HD21 ' A' ' 43' ' ' LEU . 53.0 mtp -101.46 112.91 25.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.959 -0.564 . . . . 74.109999999999999 110.696 -176.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -112.49 147.51 36.39 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.879 0.371 . . . . 74.430000000000007 110.861 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.829 ' HB3' HD21 ' A' ' 108' ' ' LEU . 28.2 ttpp -161.5 131.96 5.05 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.849 -0.614 . . . . 63.310000000000002 109.344 176.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.58 HD21 ' ND2' ' A' ' 41' ' ' ASN . 18.6 m120 58.34 32.33 21.95 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.238 0.542 . . . . 65.239999999999995 110.703 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.31 21.36 75.83 Favored Glycine 0 C--N 1.334 0.417 0 CA-C-N 115.509 -0.769 . . . . 53.509999999999998 112.727 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -137.05 133.53 35.54 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.436 -0.579 . . . . 51.240000000000002 109.436 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.9 pptp? -82.8 137.15 34.44 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.68 -0.489 . . . . 45.119999999999997 109.68 -177.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.829 HD21 ' HB3' ' A' ' 103' ' ' LYS . 2.1 mm? -99.13 -52.97 3.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.128 -0.487 . . . . 72.549999999999997 110.47 -177.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.653 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 16.8 m -150.31 172.1 15.92 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 115.679 -0.691 . . . . 74.540000000000006 110.795 -170.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.29 122.15 11.27 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.171 0.51 . . . . 75.319999999999993 110.858 -174.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.551 HG22 HG22 ' A' ' 119' ' ' ILE . 49.6 t -85.46 107.17 15.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.062 -0.517 . . . . 64.25 109.905 176.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.459 HG22 ' HB3' ' A' ' 95' ' ' ALA . 54.2 mt -106.32 106.95 21.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-O 120.987 0.423 . . . . 75.109999999999999 110.349 178.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.06 -134.76 12.65 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.766 -0.652 . . . . 74.409999999999997 112.096 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -132.82 81.67 1.96 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.87 0.367 . . . . 71.329999999999998 110.919 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.478 ' HB3' ' HB2' ' A' ' 118' ' ' LYS . 1.0 OUTLIER -122.53 94.41 4.28 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.928 -0.578 . . . . 62.439999999999998 110.519 -179.712 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.538 ' O ' HG13 ' A' ' 119' ' ' ILE . 7.8 tp -62.24 -41.38 91.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 CA-C-N 116.306 -0.406 . . . . 73.120000000000005 110.927 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.1 t -65.37 -28.9 69.6 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.12 -0.491 . . . . 71.150000000000006 110.449 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.478 ' HB2' ' HB3' ' A' ' 115' ' ' ASP . 0.2 OUTLIER -72.71 -55.36 6.9 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 108.689 -0.856 . . . . 71.040000000000006 108.689 176.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.551 HG22 HG22 ' A' ' 111' ' ' VAL . 2.2 pp -60.92 -38.49 79.39 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-N 115.757 -0.656 . . . . 71.219999999999999 112.065 -171.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.519 HD12 ' N ' ' A' ' 121' ' ' SER . 2.9 pp -64.96 -33.01 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 C-N-CA 120.216 -0.594 . . . . 75.310000000000002 110.538 179.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.519 ' N ' HD12 ' A' ' 120' ' ' ILE . 42.0 t -70.92 -51.94 23.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.801 0.334 . . . . 62.240000000000002 110.258 177.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.518 ' HG2' ' HA ' ' A' ' 119' ' ' ILE . 15.6 pt-20 -71.78 -35.3 69.98 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.29 -0.413 . . . . 74.319999999999993 111.833 -170.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.661 HD12 HD12 ' A' ' 66' ' ' LEU . 71.4 mt -71.02 -53.91 19.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.628 0.251 . . . . 72.530000000000001 110.638 177.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -61.87 -23.03 66.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.328 -0.396 . . . . 72.010000000000005 111.386 -177.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -62.86 -48.96 76.79 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.461 -0.336 . . . . 60.229999999999997 111.361 176.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.554 ' OD1' HD22 ' A' ' 43' ' ' LEU . 9.3 p30 -88.38 -30.37 19.56 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 112.189 0.44 . . . . 73.109999999999999 112.189 -170.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.514 HG23 ' OD1' ' A' ' 126' ' ' ASN . 41.8 pt -106.59 168.14 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.864 0.364 . . . . 71.040000000000006 110.98 177.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.251 1.138 0 CA-C-O 118.376 -0.821 . . . . 74.439999999999998 110.985 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.581 ' HG3' HG13 ' A' ' 23' ' ' ILE . 24.6 ptp . . . . . 0 C--O 1.233 0.197 0 CA-C-O 120.674 0.273 . . . . 73.25 110.293 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.581 HG13 ' HG3' ' A' ' 22' ' ' MET . 65.1 mt -134.3 118.98 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 116.28 -0.418 . . . . 74.400000000000006 109.881 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.545 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 8.4 tp10 -131.89 155.13 48.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.908 0.385 . . . . 71.409999999999997 111.019 -178.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -109.7 129.2 55.63 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.425 -0.583 . . . . 65.140000000000001 109.425 174.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.516 HD12 ' HA ' ' A' ' 31' ' ' PHE . 22.0 pt -122.59 173.65 8.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 116.5 -0.318 . . . . 64.230000000000004 111.438 -175.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -112.14 -176.48 19.93 Favored Glycine 0 C--N 1.333 0.371 0 CA-C-N 115.85 -0.614 . . . . 13.31 112.859 -176.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -58.62 -49.94 75.65 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.454 0.702 . . . . 73.329999999999998 112.339 -175.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.0 m -74.03 -16.99 61.03 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.657 0.614 . . . . 64.120000000000005 112.657 -168.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -113.52 -7.89 13.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.575 -0.284 . . . . 71.549999999999997 111.471 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.516 ' HA ' HD12 ' A' ' 26' ' ' ILE . 30.5 t80 -49.25 -70.79 0.08 Allowed 'General case' 0 N--CA 1.461 0.106 0 O-C-N 123.32 0.387 . . . . 65.209999999999994 110.743 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -62.63 -37.67 87.25 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.644 -0.502 . . . . 71.430000000000007 109.644 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.513 ' O ' ' HB2' ' A' ' 37' ' ' SER . 20.7 t-20 -52.59 -42.9 64.95 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.789 -1.096 . . . . 63.409999999999997 112.051 -173.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.502 ' HD3' HG21 ' A' ' 26' ' ' ILE . 12.7 ptmt -111.52 -15.38 13.52 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.326 0.491 . . . . 53.439999999999998 112.326 -177.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.1 t -88.51 -56.37 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 111.681 0.252 . . . . 61.520000000000003 111.681 177.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 39.9 p -84.38 -32.09 24.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.911 0.386 . . . . 74.430000000000007 110.882 -173.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.513 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 18.0 m -83.81 8.92 13.26 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.083 -0.508 . . . . 73.219999999999999 111.516 -177.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.458 ' SG ' HG22 ' A' ' 42' ' ' ILE . 50.2 t -72.27 95.58 1.72 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.946 0.403 . . . . 60.130000000000003 110.449 -178.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -76.41 -9.32 58.56 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.934 -0.575 . . . . 70.230000000000004 110.796 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -59.05 -25.35 63.64 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.122 -0.49 . . . . 63.240000000000002 111.257 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.474 ' HA ' ' HB2' ' A' ' 103' ' ' LYS . 66.4 m-20 65.47 15.92 10.26 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.755 -0.657 . . . . 71.209999999999994 111.074 -176.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.458 HG22 ' SG ' ' A' ' 38' ' ' CYS . 10.6 tt -65.33 166.26 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 108.669 -0.863 . . . . 74.519999999999996 108.669 172.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.591 HD21 ' HE3' ' A' ' 101' ' ' MET . 49.7 tp -92.35 101.65 14.13 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 121.651 -0.656 . . . . 74.319999999999993 110.677 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 50.5 mt -87.32 131.89 34.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.522 -0.763 . . . . 75.349999999999994 109.795 174.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.541 ' HB2' HG13 ' A' ' 76' ' ' ILE . 89.0 mt -117.44 104.6 11.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.129 -0.487 . . . . 41.200000000000003 109.701 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 23.5 m -95.43 119.53 43.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.965 -0.294 . . . . 71.439999999999998 110.72 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.698 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 31.8 t70 -99.27 161.5 13.59 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 116.18 -0.464 . . . . 64.5 110.25 -178.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.407 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 25.9 p90 . . . . . 0 C--O 1.239 0.546 0 CA-C-O 121.397 0.617 . . . . 73.030000000000001 112.07 -174.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo . . . . . 0 C--O 1.234 0.322 0 N-CA-C 110.259 -0.708 . . . . 71.140000000000001 110.259 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.499 ' HB3' HG12 ' A' ' 119' ' ' ILE . 10.3 mp0 -51.46 -43.93 62.25 Favored 'General case' 0 C--O 1.246 0.918 0 CA-C-O 121.608 0.718 . . . . 74.099999999999994 110.294 -173.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.443 HD11 HG12 ' A' ' 99' ' ' ILE . 6.4 mp -56.92 -48.74 77.56 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 114.488 -1.233 . . . . 74.219999999999999 110.491 -175.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.417 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 49.0 mt-10 -70.74 -42.51 70.41 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 123.212 0.32 . . . . 74.409999999999997 110.249 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.5 tmtp? -50.76 -46.17 59.23 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.807 -0.633 . . . . 71.310000000000002 109.834 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.652 HD12 HD12 ' A' ' 123' ' ' ILE . 17.6 mt -86.18 -41.87 14.31 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.571 0.582 . . . . 73.239999999999995 112.571 177.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.87 -39.88 78.87 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 111.934 0.346 . . . . 61.5 111.934 -173.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.417 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 97.9 mt-30 -53.69 -33.2 54.61 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.269 0.557 . . . . 70.239999999999995 110.313 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 53.1 mm-40 -93.82 -41.39 9.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.445 -0.798 . . . . 65.549999999999997 111.465 -177.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.555 ' O ' HG22 ' A' ' 74' ' ' VAL . 17.3 m-85 -107.17 22.38 16.07 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.748 0.647 . . . . 75.230000000000004 112.748 -169.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.1 t -52.8 -34.05 51.75 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.13 0.419 . . . . 74.329999999999998 112.13 -176.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -68.3 -16.5 63.97 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 111.576 0.213 . . . . 53.340000000000003 111.576 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -122.52 -4.77 8.76 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.539 0.209 . . . . 72.310000000000002 111.047 -177.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.555 HG22 ' O ' ' A' ' 70' ' ' TYR . 27.7 m -136.82 147.48 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 O-C-N 122.071 -0.393 . . . . 55.140000000000001 110.444 178.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.434 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 7.0 tppt? -142.13 116.59 9.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.718 0.295 . . . . 63.310000000000002 110.208 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.541 HG13 ' HB2' ' A' ' 45' ' ' LEU . 2.0 mp -93.14 134.23 31.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.078 -0.51 . . . . 74.420000000000002 110.762 -175.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.545 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 97.1 m-85 -129.12 128.6 43.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.885 -0.598 . . . . 72.200000000000003 109.616 174.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.698 ' HG2' ' HB3' ' A' ' 47' ' ' ASP . 25.6 mtpp -103.29 143.2 32.97 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.787 -0.449 . . . . 72.219999999999999 109.787 176.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 40.9 mm . . . . . 0 C--N 1.326 -0.453 0 CA-C-N 115.848 -0.615 . . . . 72.5 111.059 -175.507 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.291 0 CA-C-O 120.916 0.389 . . . . 73.530000000000001 110.845 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.9 m -67.69 -30.72 70.32 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.259 -0.428 . . . . 71.010000000000005 110.727 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -59.56 -55.99 27.52 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.929 -0.578 . . . . 72.230000000000004 110.341 178.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -75.33 -15.82 60.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.391 -0.368 . . . . 74.030000000000001 110.937 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.46 61.01 2.39 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.306 -0.473 . . . . 71.209999999999994 112.661 175.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.52 HG22 HG21 ' A' ' 98' ' ' THR . 59.7 t -69.51 85.32 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-O 121.361 0.601 . . . . 73.5 110.137 176.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.2 t -116.03 9.76 14.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.507 -0.77 . . . . 73.310000000000002 110.144 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.467 ' HB3' HG22 ' A' ' 112' ' ' ILE . . . -152.66 142.63 22.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 73.129999999999995 109.973 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 29.9 pt -113.43 149.62 41.85 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.375 -0.375 . . . . 72.430000000000007 110.774 -177.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -76.54 -176.02 17.76 Favored 'Cis proline' 0 C--N 1.353 0.792 0 C-N-CA 124.005 -1.248 . . . . 65.310000000000002 112.442 -1.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.52 HG21 HG22 ' A' ' 93' ' ' VAL . 43.6 m -142.54 115.36 8.69 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.091 -0.337 . . . . 71.120000000000005 110.091 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.471 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 4.0 mp -129.14 142.84 42.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.979 -0.555 . . . . 53.43 109.837 -178.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.6 mp -118.92 140.84 49.32 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.697 0.284 . . . . 73.120000000000005 110.361 174.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.843 ' SD ' ' HB3' ' A' ' 109' ' ' SER . 89.8 mtp -96.72 114.11 25.73 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.841 -0.618 . . . . 74.109999999999999 110.46 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -115.12 144.5 43.57 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.072 0.463 . . . . 74.430000000000007 112.13 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.81 ' HG2' HD21 ' A' ' 108' ' ' LEU . 0.4 OUTLIER -157.8 119.23 3.59 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 108.913 -0.773 . . . . 63.310000000000002 108.913 163.617 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 58.94 25.03 13.23 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.543 0.687 . . . . 65.239999999999995 110.207 -176.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 87.45 -6.21 83.77 Favored Glycine 0 CA--C 1.52 0.349 0 CA-C-N 115.798 -0.637 . . . . 53.509999999999998 112.511 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -77.84 128.97 34.83 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.511 -0.552 . . . . 51.240000000000002 109.511 177.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 101' ' ' MET . 3.1 mppt? -90.49 109.41 20.55 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.32 -0.622 . . . . 45.119999999999997 109.32 174.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.81 HD21 ' HG2' ' A' ' 103' ' ' LYS . 2.3 mm? -77.92 -36.63 49.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.142 -0.481 . . . . 72.549999999999997 110.545 -175.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.843 ' HB3' ' SD ' ' A' ' 101' ' ' MET . 17.2 t -178.64 171.9 1.46 Allowed 'General case' 0 C--O 1.24 0.598 0 CA-C-N 115.593 -0.731 . . . . 74.540000000000006 109.05 -176.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.04 141.14 36.28 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.251 0.548 . . . . 75.319999999999993 111.106 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 98' ' ' THR . 46.6 t -103.57 107.1 21.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.169 -0.923 . . . . 64.25 109.772 176.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.467 HG22 ' HB3' ' A' ' 95' ' ' ALA . 45.1 mt -118.84 106.31 19.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.466 -0.938 . . . . 75.109999999999999 108.466 172.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 108.65 174.26 21.58 Favored Glycine 0 CA--C 1.519 0.322 0 N-CA-C 111.041 -0.824 . . . . 74.409999999999997 111.041 -170.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -96.59 56.99 1.57 Allowed 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.179 0.514 . . . . 71.329999999999998 110.77 -177.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.548 ' O ' HG23 ' A' ' 119' ' ' ILE . 1.9 m-20 -90.19 73.78 7.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.875 -0.602 . . . . 62.439999999999998 110.906 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.551 ' O ' HG13 ' A' ' 119' ' ' ILE . 6.3 tp -54.74 -40.37 51.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 CA-C-O 121.108 0.48 . . . . 73.120000000000005 110.823 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.2 p -62.62 -29.08 70.36 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.853 -0.612 . . . . 71.150000000000006 111.182 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.498 ' HB2' ' HB3' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -79.28 -48.66 13.75 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.306 -0.627 . . . . 71.040000000000006 109.306 177.409 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.551 HG13 ' O ' ' A' ' 116' ' ' ILE . 1.6 pp -61.84 -40.77 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 116.132 -0.486 . . . . 71.219999999999999 111.421 -172.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.542 HD12 ' N ' ' A' ' 121' ' ' SER . 2.9 pp -63.19 -31.97 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 C-N-CA 120.437 -0.505 . . . . 75.310000000000002 110.399 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.542 ' N ' HD12 ' A' ' 120' ' ' ILE . 33.6 t -70.46 -51.92 25.78 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.994 -0.548 . . . . 62.240000000000002 110.854 178.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.5 ' HG2' ' HA ' ' A' ' 119' ' ' ILE . 12.8 pt-20 -70.75 -43.67 68.36 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.085 -0.507 . . . . 74.319999999999993 111.325 -172.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.652 HD12 HD12 ' A' ' 66' ' ' LEU . 78.8 mt -64.41 -53.86 37.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.352 0.12 . . . . 72.530000000000001 110.958 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -59.79 -26.65 65.9 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.775 0.322 . . . . 72.010000000000005 111.263 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -77.34 -14.87 59.64 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 111.741 0.274 . . . . 60.229999999999997 111.741 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -118.14 9.72 12.74 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 111.656 0.243 . . . . 73.109999999999999 111.656 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.522 HG12 ' O ' ' A' ' 123' ' ' ILE . 43.6 pt -134.74 168.33 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 109.921 -0.4 . . . . 71.040000000000006 109.921 173.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.366 -0.826 . . . . 74.439999999999998 110.969 -176.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.635 ' HG3' HG13 ' A' ' 23' ' ' ILE . 21.2 ptp . . . . . 0 N--CA 1.467 0.376 0 N-CA-C 109.764 -0.458 . . . . 73.25 109.764 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.635 HG13 ' HG3' ' A' ' 22' ' ' MET . 23.2 mt -127.09 101.65 8.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 108.673 -0.862 . . . . 74.400000000000006 108.673 174.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 9.4 tp10 -124.01 149.64 45.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.813 0.34 . . . . 71.409999999999997 110.377 -175.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -82.15 149.74 27.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.169 -0.468 . . . . 65.140000000000001 110.26 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.481 HD12 ' HA ' ' A' ' 31' ' ' PHE . 25.4 pt -130.01 177.4 6.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.603 -0.271 . . . . 64.230000000000004 110.512 178.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.18 158.55 18.21 Favored Glycine 0 C--O 1.237 0.32 0 CA-C-N 116.102 -0.499 . . . . 13.31 112.324 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -59.81 -39.15 84.07 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.203 0.525 . . . . 73.329999999999998 110.433 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.4 t -63.33 -32.83 74.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.424 -0.807 . . . . 64.120000000000005 111.529 -176.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.403 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 10.0 pt-20 -105.28 -1.06 25.71 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 112.324 0.49 . . . . 71.549999999999997 112.324 -174.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.481 ' HA ' HD12 ' A' ' 26' ' ' ILE . 57.9 t80 -47.15 -71.61 0.07 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.793 0.33 . . . . 65.209999999999994 111.192 -178.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -64.43 -36.43 84.15 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.351 -0.611 . . . . 71.430000000000007 109.351 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -52.43 -38.55 59.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.436 -1.256 . . . . 63.409999999999997 111.891 -173.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 15.8 ptmt -114.34 -18.27 11.6 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.094 0.405 . . . . 53.439999999999998 112.094 -177.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 72.7 t -85.22 -49.59 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 111.851 0.315 . . . . 61.520000000000003 111.851 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 64.9 p -83.06 -28.83 29.28 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.075 0.464 . . . . 74.430000000000007 111.04 -173.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.1 m -80.1 12.02 3.08 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.914 -0.585 . . . . 73.219999999999999 111.992 -177.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 24.6 p -76.8 87.33 3.4 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.824 0.345 . . . . 60.130000000000003 111.817 -176.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -75.22 -5.93 47.04 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.14 0.495 . . . . 70.230000000000004 110.397 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.526 ' O ' ' HB2' ' A' ' 41' ' ' ASN . 2.1 m-20 -52.82 -30.26 32.43 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.633 -0.712 . . . . 63.240000000000002 112.062 -177.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.526 ' HB2' ' O ' ' A' ' 40' ' ' ASP . 0.9 OUTLIER 75.11 11.47 3.55 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 123.691 0.619 . . . . 71.209999999999994 110.34 -171.669 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.518 HG22 ' HB2' ' A' ' 40' ' ' ASP . 10.0 tt -81.94 158.53 4.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 115.624 -0.716 . . . . 74.519999999999996 109.113 176.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.489 HD11 ' HB2' ' A' ' 126' ' ' ASN . 54.5 mt -84.92 112.53 20.65 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 120.916 -0.314 . . . . 74.319999999999993 110.604 179.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.0 mt -102.41 105.91 18.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.036 0.446 . . . . 75.349999999999994 109.945 173.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.515 ' HB2' HG12 ' A' ' 76' ' ' ILE . 5.1 mp -93.38 136.96 33.15 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.988 -0.745 . . . . 41.200000000000003 108.988 177.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.502 HG12 ' HB2' ' A' ' 77' ' ' TYR . 27.4 m -130.17 138.67 53.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.749 -0.463 . . . . 71.439999999999998 109.749 178.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -111.33 143.75 41.63 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.857 0.36 . . . . 64.5 111.036 177.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.565 ' HZ ' HG22 ' A' ' 96' ' ' ILE . 13.7 p90 . . . . . 0 C--O 1.234 0.263 0 N-CA-C 109.543 -0.54 . . . . 73.030000000000001 109.543 176.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo . . . . . 0 N--CA 1.459 -0.543 0 CA-C-O 120.929 0.304 . . . . 71.140000000000001 112.314 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.557 ' HB3' HG12 ' A' ' 119' ' ' ILE . 9.6 mp0 -61.9 -57.51 11.49 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.351 0.596 . . . . 74.099999999999994 111.097 -173.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.494 ' HB2' HD13 ' A' ' 76' ' ' ILE . 2.3 pt? -54.37 -47.17 72.93 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.068 -0.969 . . . . 74.219999999999999 111.611 -174.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.511 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 37.2 mt-10 -65.66 -43.72 88.53 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 120.888 -0.325 . . . . 74.409999999999997 110.255 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -53.14 -48.66 67.73 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.891 -0.595 . . . . 71.310000000000002 110.982 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.582 HD12 HD12 ' A' ' 123' ' ' ILE . 17.7 mt -79.43 -37.73 36.37 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 111.967 0.358 . . . . 73.239999999999995 111.967 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.419 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -59.81 -31.42 69.69 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.457 0.17 . . . . 61.5 111.307 -176.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.511 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 74.8 mt-30 -54.52 -34.95 62.62 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.951 0.405 . . . . 70.239999999999995 111.051 177.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -94.1 -45.23 7.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.192 0.52 . . . . 65.549999999999997 111.019 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.573 ' O ' HG22 ' A' ' 74' ' ' VAL . 20.4 m-85 -92.85 14.92 15.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.807 -0.633 . . . . 75.230000000000004 112.285 -171.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.419 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 8.8 t -52.48 -35.99 53.92 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.05 0.452 . . . . 74.329999999999998 111.442 -174.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -63.96 -28.43 69.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.83 -0.623 . . . . 53.340000000000003 111.841 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -116.48 3.19 13.21 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.52 -0.309 . . . . 72.310000000000002 111.17 -173.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.573 HG22 ' O ' ' A' ' 70' ' ' TYR . 23.6 m -133.68 141.34 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 121.088 0.47 . . . . 55.140000000000001 110.556 177.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.728 ' HA ' ' HE3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -128.15 116.53 20.07 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.523 -0.762 . . . . 63.310000000000002 108.969 174.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.555 ' HB ' HG12 ' A' ' 23' ' ' ILE . 39.9 mt -109.49 134.7 50.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.725 0.298 . . . . 74.420000000000002 110.413 -177.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.502 ' HB2' HG12 ' A' ' 46' ' ' VAL . 51.3 m-85 -120.72 134.5 55.28 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 115.982 -0.554 . . . . 72.200000000000003 110.08 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.0 ptmm? -112.89 161.5 16.91 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.25 -0.886 . . . . 72.219999999999999 110.62 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 30.9 mt . . . . . 0 N--CA 1.464 0.24 0 CA-C-N 115.561 -0.745 . . . . 72.5 109.892 -174.111 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.187 0 CA-C-O 121.089 0.471 . . . . 73.530000000000001 109.876 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.8 m -60.67 -32.05 71.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.83 -0.623 . . . . 71.010000000000005 110.53 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -66.12 -37.83 86.7 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.036 -0.529 . . . . 72.230000000000004 110.592 177.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -77.26 -5.66 50.22 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.463 -0.335 . . . . 74.030000000000001 111.099 176.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.85 21.0 64.33 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 121.082 -0.58 . . . . 71.209999999999994 112.077 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 97.9 t -65.93 102.92 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.045 0.45 . . . . 73.5 110.309 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.7 t -143.79 21.03 1.81 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.61 0.719 . . . . 73.310000000000002 109.174 178.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -129.01 160.9 31.28 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.567 -0.742 . . . . 73.129999999999995 110.29 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.565 HG22 ' HZ ' ' A' ' 48' ' ' PHE . 26.8 pt -118.67 130.61 24.7 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.304 -0.407 . . . . 72.430000000000007 110.603 -178.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 96' ' ' ILE . 47.7 Cg_endo -91.62 -170.05 3.96 Favored 'Cis proline' 0 C--N 1.35 0.616 0 C-N-CA 124.05 -1.229 . . . . 65.310000000000002 112.336 -4.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 88.5 m -147.83 139.81 24.12 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.034 -0.53 . . . . 71.120000000000005 109.677 175.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 36.9 mt -136.83 114.49 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 115.957 -0.565 . . . . 53.43 110.019 -176.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.2 mp -91.5 146.36 23.86 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.019 0.437 . . . . 73.120000000000005 111.152 178.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.488 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 90.5 mtp -108.63 118.97 38.16 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.994 -0.548 . . . . 74.109999999999999 110.663 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.43 ' CE2' ' HG2' ' A' ' 107' ' ' LYS . 79.3 m-85 -115.55 149.05 38.8 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.231 0.539 . . . . 74.430000000000007 111.482 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.642 ' HB3' HD21 ' A' ' 108' ' ' LEU . 30.8 ttmt -155.65 111.1 3.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.933 -1.031 . . . . 63.310000000000002 109.078 177.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.9 t30 60.7 25.06 14.87 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.458 0.647 . . . . 65.239999999999995 110.192 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.88 -14.89 62.06 Favored Glycine 0 C--N 1.334 0.458 0 CA-C-N 115.572 -0.74 . . . . 53.509999999999998 112.259 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -81.11 144.43 31.7 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.836 -0.431 . . . . 51.240000000000002 109.836 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.43 ' HG2' ' CE2' ' A' ' 102' ' ' PHE . 46.2 mttp -102.56 115.3 30.3 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.803 -0.444 . . . . 45.119999999999997 109.803 -176.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.642 HD21 ' HB3' ' A' ' 103' ' ' LYS . 2.8 mm? -85.85 -53.4 5.14 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.857 0.361 . . . . 72.549999999999997 111.249 -174.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.488 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 20.5 m -160.02 171.89 18.52 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.882 -0.599 . . . . 74.540000000000006 110.205 -172.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.467 ' NE2' ' H ' ' A' ' 110' ' ' GLN . 0.4 OUTLIER -143.88 124.04 13.71 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.024 -0.535 . . . . 75.319999999999993 110.568 178.805 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.574 HG22 HG22 ' A' ' 119' ' ' ILE . 61.2 t -80.43 107.13 12.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.83 -0.623 . . . . 64.25 109.471 175.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 58.7 mt -108.28 107.03 21.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 109.865 -0.42 . . . . 75.109999999999999 109.865 178.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.32 -132.53 10.98 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.811 -0.631 . . . . 74.409999999999997 111.604 -178.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -142.37 75.74 1.5 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.92 0.39 . . . . 71.329999999999998 110.387 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.49 ' O ' HG23 ' A' ' 119' ' ' ILE . 2.6 m-20 -115.47 97.5 6.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.917 -0.583 . . . . 62.439999999999998 110.611 -177.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.528 ' O ' HG13 ' A' ' 119' ' ' ILE . 6.7 tp -64.5 -41.08 91.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 116.411 -0.358 . . . . 73.120000000000005 111.342 -176.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 15.1 m -64.58 -29.85 70.87 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.454 0.645 . . . . 71.150000000000006 110.456 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.463 ' HG3' ' OE2' ' A' ' 122' ' ' GLU . 27.9 tptp -73.88 -50.64 19.29 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.453 -0.794 . . . . 71.040000000000006 110.453 178.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.574 HG22 HG22 ' A' ' 111' ' ' VAL . 2.1 pp -65.34 -41.32 91.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.814 -0.63 . . . . 71.219999999999999 111.519 -174.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.472 HG22 HD11 ' A' ' 66' ' ' LEU . 2.8 pp -62.32 -31.82 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 121.127 0.489 . . . . 75.310000000000002 109.837 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.556 ' O ' ' HB2' ' A' ' 125' ' ' ASN . 23.0 t -70.44 -51.56 28.47 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.85 -0.614 . . . . 62.240000000000002 110.55 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.463 ' OE2' ' HG3' ' A' ' 118' ' ' LYS . 10.7 pt-20 -73.52 -33.41 64.75 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 111.924 0.342 . . . . 74.319999999999993 111.924 -172.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.582 HD12 HD12 ' A' ' 66' ' ' LEU . 71.7 mt -73.59 -57.37 6.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-O 120.567 0.223 . . . . 72.530000000000001 110.654 178.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -63.67 -20.12 65.45 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.115 0.483 . . . . 72.010000000000005 110.609 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.556 ' HB2' ' O ' ' A' ' 121' ' ' SER . 26.7 t-20 -54.04 -29.8 45.3 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.717 -0.674 . . . . 60.229999999999997 110.76 176.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.489 ' HB2' HD11 ' A' ' 43' ' ' LEU . 33.8 m-80 -107.99 -45.21 4.02 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.872 -0.604 . . . . 73.109999999999999 111.233 -176.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 48.4 pt -105.46 167.78 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 120.819 0.343 . . . . 71.040000000000006 111.274 -175.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.55 ' N ' HD22 ' A' ' 128' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.38 -0.819 . . . . 74.439999999999998 112.137 -177.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.522 ' SD ' ' HA ' ' A' ' 68' ' ' GLN . 49.5 mtm . . . . . 0 N--CA 1.473 0.697 0 CA-C-O 121.638 0.733 . . . . 73.25 109.475 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.4 mm -92.67 128.83 43.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 114.38 -1.282 . . . . 74.400000000000006 108.641 171.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.413 ' HG2' ' CE1' ' A' ' 77' ' ' TYR . 9.1 tp10 -124.84 153.15 43.0 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.746 0.308 . . . . 71.409999999999997 110.426 -176.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.29 124.4 40.26 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.503 -0.554 . . . . 65.140000000000001 109.503 177.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.518 ' O ' HD13 ' A' ' 79' ' ' ILE . 32.5 pt -131.69 -176.93 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.047 -0.524 . . . . 64.230000000000004 110.533 -172.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -111.79 170.55 13.72 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 121.506 -0.378 . . . . 13.31 112.219 178.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -67.5 -38.15 83.9 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 122.575 0.35 . . . . 73.329999999999998 111.71 -178.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.2 m -60.32 -39.09 85.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.003 0.43 . . . . 64.120000000000005 111.177 -176.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.453 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 1.7 pm0 -103.38 -0.98 29.35 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.779 -0.646 . . . . 71.549999999999997 111.159 -177.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.405 ' HA ' HD12 ' A' ' 26' ' ' ILE . 69.2 t80 -53.04 -70.55 0.09 Allowed 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 109.775 -0.454 . . . . 65.209999999999994 109.775 177.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -49.75 -42.78 47.17 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 116.074 -0.512 . . . . 71.430000000000007 110.03 176.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.408 ' O ' ' HB2' ' A' ' 37' ' ' SER . 66.1 t30 -52.19 -54.32 32.29 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 114.655 -1.157 . . . . 63.409999999999997 111.481 -172.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.465 ' HE3' ' CE1' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -101.23 -15.93 17.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.245 -0.434 . . . . 53.439999999999998 111.936 -172.921 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 73.1 t -88.58 -57.06 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 111.962 0.356 . . . . 61.520000000000003 111.962 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.9 p -88.01 -42.09 12.67 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.047 0.451 . . . . 74.430000000000007 110.716 -171.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 18.4 m -76.73 12.07 1.46 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.823 -0.626 . . . . 73.219999999999999 111.473 -178.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.421 ' SG ' ' HB2' ' A' ' 40' ' ' ASP . 50.1 t -81.21 99.96 8.86 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.999 0.428 . . . . 60.130000000000003 110.334 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -87.25 14.87 7.02 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.181 0.515 . . . . 70.230000000000004 110.661 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.421 ' HB2' ' SG ' ' A' ' 38' ' ' CYS . 5.5 m-20 -75.36 -8.8 57.64 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.066 -0.515 . . . . 63.240000000000002 111.041 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.1 m120 68.47 0.05 2.42 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.483 0.549 . . . . 71.209999999999994 112.483 177.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.9 tt -71.49 145.42 12.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 109.095 -0.706 . . . . 74.519999999999996 109.095 177.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.601 HD11 ' HB3' ' A' ' 101' ' ' MET . 61.1 tp -80.76 109.74 15.61 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.263 0.554 . . . . 74.319999999999993 110.071 -177.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.485 HG23 ' CD2' ' A' ' 77' ' ' TYR . 61.5 mt -94.99 114.54 31.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.357 -0.838 . . . . 75.349999999999994 110.386 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.458 ' N ' HD12 ' A' ' 45' ' ' LEU . 5.5 mp -98.6 101.99 13.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.04 -0.527 . . . . 41.200000000000003 110.114 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.62 HG23 ' HB2' ' A' ' 100' ' ' LEU . 16.3 m -96.9 109.92 23.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.685 -0.487 . . . . 71.439999999999998 109.685 176.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . 3.9 p30 -101.36 146.77 27.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.465 0.65 . . . . 64.5 111.79 -174.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 66.4 t80 . . . . . 0 C--N 1.323 -0.548 0 N-CA-C 107.614 -1.254 . . . . 73.030000000000001 107.614 169.581 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.745 ' HG2' ' HB2' ' A' ' 64' ' ' GLU . 56.4 Cg_endo . . . . . 0 N--CA 1.464 -0.222 0 N-CA-C 109.633 -0.949 . . . . 71.140000000000001 109.633 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.506 ' HB3' HG12 ' A' ' 119' ' ' ILE . 9.6 mp0 -57.21 -50.57 72.45 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-O 121.254 0.549 . . . . 74.099999999999994 110.401 -170.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.663 HD12 ' N ' ' A' ' 64' ' ' GLU . 3.4 pp -54.33 -40.36 67.95 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.142 -0.935 . . . . 74.219999999999999 111.282 -177.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.745 ' HB2' ' HG2' ' A' ' 61' ' ' PRO . 2.3 mm-40 -75.61 -39.89 57.21 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.101 0.477 . . . . 74.409999999999997 110.005 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -53.54 -45.81 69.97 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.409 -0.814 . . . . 71.310000000000002 109.427 -177.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.505 HD12 HD12 ' A' ' 123' ' ' ILE . 16.1 mt -84.69 -37.86 20.45 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.129 -0.487 . . . . 73.239999999999995 111.661 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.406 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -53.97 -46.03 71.55 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.783 0.325 . . . . 61.5 111.048 -177.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.522 ' HA ' ' SD ' ' A' ' 22' ' ' MET . 73.1 mt-30 -49.3 -34.86 16.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.724 -0.671 . . . . 70.239999999999995 111.516 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -94.01 -57.93 2.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.227 0.537 . . . . 65.549999999999997 111.088 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.522 ' O ' HG22 ' A' ' 74' ' ' VAL . 16.6 m-85 -90.44 21.26 4.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.679 -0.691 . . . . 75.230000000000004 112.731 -171.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 8.8 t -52.71 -28.49 22.17 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.167 0.508 . . . . 74.329999999999998 111.424 -177.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -65.71 -16.76 64.07 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.73 -0.668 . . . . 53.340000000000003 111.127 -177.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -129.05 -5.35 4.99 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.182 -0.463 . . . . 72.310000000000002 110.438 -176.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.522 HG22 ' O ' ' A' ' 70' ' ' TYR . 22.9 m -132.66 140.43 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.089 0.471 . . . . 55.140000000000001 110.659 178.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -137.25 123.18 20.16 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.813 -0.63 . . . . 63.310000000000002 109.475 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.478 ' N ' HD12 ' A' ' 76' ' ' ILE . 2.0 mp -95.62 141.06 15.83 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-O 120.537 0.208 . . . . 74.420000000000002 110.65 -175.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.576 ' HB2' HG12 ' A' ' 46' ' ' VAL . 88.2 m-85 -141.06 157.77 44.85 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.347 0.659 . . . . 72.200000000000003 109.638 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.39 166.67 16.38 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.935 0.398 . . . . 72.219999999999999 110.964 170.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.518 HD13 ' O ' ' A' ' 26' ' ' ILE . 3.9 tp . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 115.106 -0.952 . . . . 72.5 108.669 174.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.551 0 CA-C-O 121.385 0.612 . . . . 73.530000000000001 110.58 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 51.3 m -70.77 -29.49 65.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.719 -0.673 . . . . 71.010000000000005 109.955 176.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -70.66 -35.63 72.96 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.171 -0.468 . . . . 72.230000000000004 110.151 177.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -68.78 -17.2 63.99 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.387 -0.598 . . . . 74.030000000000001 109.387 171.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.86 42.22 9.95 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.397 -0.819 . . . . 71.209999999999994 112.417 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.528 HG21 ' OG1' ' A' ' 98' ' ' THR . 14.9 p -67.95 131.83 33.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.983 0.391 . . . . 73.5 110.385 177.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.3 p -101.82 -36.43 8.68 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.177 -0.465 . . . . 73.310000000000002 111.65 -177.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -127.98 143.6 51.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.649 0.262 . . . . 73.129999999999995 111.062 -175.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.411 ' O ' HD12 ' A' ' 96' ' ' ILE . 2.5 pp -100.02 160.84 26.11 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 115.957 -0.565 . . . . 72.430000000000007 110.669 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.405 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 98.6 Cg_endo -82.36 -177.96 20.11 Favored 'Cis proline' 0 C--N 1.353 0.813 0 C-N-CA 124.03 -1.238 . . . . 65.310000000000002 112.223 -0.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.668 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 17.7 m -144.06 115.41 8.03 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.439 -0.346 . . . . 71.120000000000005 110.567 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.503 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.3 mp -108.06 115.22 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.673 -0.24 . . . . 53.43 110.365 -177.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.62 ' HB2' HG23 ' A' ' 46' ' ' VAL . 8.9 mp -91.89 139.98 30.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.826 0.346 . . . . 73.120000000000005 110.54 178.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.623 ' SD ' ' HB3' ' A' ' 109' ' ' SER . 81.7 mtp -109.37 116.44 31.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.921 -0.581 . . . . 74.109999999999999 110.534 -177.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -116.99 154.04 31.6 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.952 0.406 . . . . 74.430000000000007 111.035 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.84 ' HB3' HD21 ' A' ' 108' ' ' LEU . 16.1 ttmm -169.27 115.37 0.58 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.437 -0.801 . . . . 63.310000000000002 109.617 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.9 t30 60.35 31.08 20.29 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.334 0.588 . . . . 65.239999999999995 110.987 172.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.91 -14.45 63.28 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 121.314 -0.47 . . . . 53.509999999999998 113.163 178.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -97.04 146.11 25.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.598 0.237 . . . . 51.240000000000002 110.589 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -99.06 126.02 44.69 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.242 -0.651 . . . . 45.119999999999997 109.242 174.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.84 HD21 ' HB3' ' A' ' 103' ' ' LYS . 3.1 mm? -87.07 -47.39 8.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.525 -0.307 . . . . 72.549999999999997 111.15 -174.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.623 ' HB3' ' SD ' ' A' ' 101' ' ' MET . 27.9 t -167.01 171.8 10.77 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.738 0.304 . . . . 74.540000000000006 110.927 -175.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -136.69 130.82 32.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.702 -0.681 . . . . 75.319999999999993 110.014 175.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.721 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 60.2 t -94.43 107.3 19.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.991 -0.549 . . . . 64.25 110.292 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 61.6 mt -104.26 109.87 28.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 110.022 -0.362 . . . . 75.109999999999999 110.022 176.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 106.87 -142.85 15.74 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 121.204 -0.522 . . . . 74.409999999999997 112.093 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -138.96 80.16 1.77 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.03 0.443 . . . . 71.329999999999998 110.595 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.49 ' O ' HG23 ' A' ' 119' ' ' ILE . 3.0 m-20 -118.67 94.29 4.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.799 -0.637 . . . . 62.439999999999998 110.595 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.57 HD12 HD11 ' A' ' 119' ' ' ILE . 7.2 tp -65.07 -39.01 84.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.186 -0.461 . . . . 73.120000000000005 111.088 -176.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 27.0 t -64.81 -39.77 94.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.242 0.544 . . . . 71.150000000000006 110.445 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.721 ' HE3' ' HA ' ' A' ' 111' ' ' VAL . 0.7 OUTLIER -64.68 -51.7 61.11 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 115.779 -0.646 . . . . 71.040000000000006 110.629 178.326 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.57 HD11 HD12 ' A' ' 116' ' ' ILE . 2.2 pp -63.61 -42.04 94.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 116.209 -0.45 . . . . 71.219999999999999 111.51 -175.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.494 HG22 HD21 ' A' ' 66' ' ' LEU . 2.8 pp -64.33 -31.76 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 120.738 -0.385 . . . . 75.310000000000002 110.254 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.45 ' N ' HD12 ' A' ' 120' ' ' ILE . 23.0 t -69.75 -51.65 32.26 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.187 -0.46 . . . . 62.240000000000002 110.523 -178.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.402 ' OE1' ' NZ ' ' A' ' 118' ' ' LYS . 7.9 pt-20 -77.12 -40.68 44.86 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.806 0.669 . . . . 74.319999999999993 112.806 -176.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.505 HD12 HD12 ' A' ' 66' ' ' LEU . 69.5 mt -62.7 -53.7 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 O-C-N 122.046 -0.409 . . . . 72.530000000000001 110.696 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -59.86 -20.23 55.85 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.117 0.484 . . . . 72.010000000000005 110.85 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -78.81 -12.84 60.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.915 -0.584 . . . . 60.229999999999997 111.144 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -126.42 9.47 7.22 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.547 -0.297 . . . . 73.109999999999999 111.554 -178.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 123' ' ' ILE . 45.7 pt -138.99 168.09 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 109.871 -0.418 . . . . 71.040000000000006 109.871 175.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.432 ' N ' HD22 ' A' ' 128' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.163 0 CA-C-O 118.585 -0.722 . . . . 74.439999999999998 111.094 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.721 ' SD ' HG13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.382 0 CA-C-O 121.195 0.521 . . . . 73.25 110.231 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.721 HG13 ' SD ' ' A' ' 22' ' ' MET . 49.7 mt -115.82 106.36 20.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-N 115.283 -0.871 . . . . 74.400000000000006 109.321 175.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.467 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 11.3 tp10 -105.7 136.92 44.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.737 0.303 . . . . 71.409999999999997 110.791 -176.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -90.6 128.46 36.6 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 122.379 0.272 . . . . 65.140000000000001 110.383 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.458 HG21 ' HD3' ' A' ' 34' ' ' LYS . 33.9 pt -128.0 149.9 33.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 120.851 0.358 . . . . 64.230000000000004 111.243 -178.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.51 179.09 53.23 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.616 -0.72 . . . . 13.31 112.789 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -63.7 -50.36 69.47 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 122.767 0.427 . . . . 73.329999999999998 111.262 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.9 m -64.43 -39.12 93.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.994 -0.548 . . . . 64.120000000000005 111.803 -172.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.559 ' HA ' ' HB3' ' A' ' 33' ' ' ASN . 16.3 pt-20 -85.37 -9.33 57.72 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 116.507 -0.315 . . . . 71.549999999999997 111.691 -174.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.408 ' HA ' HD12 ' A' ' 26' ' ' ILE . 34.6 t80 -47.8 -71.0 0.08 Allowed 'General case' 0 N--CA 1.464 0.25 0 O-C-N 123.192 0.307 . . . . 65.209999999999994 111.088 -177.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -66.57 -34.58 78.21 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.276 -0.638 . . . . 71.430000000000007 109.276 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.559 ' HB3' ' HA ' ' A' ' 30' ' ' GLU . 7.7 t30 -52.42 -33.82 45.59 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 114.487 -1.233 . . . . 63.409999999999997 111.989 -176.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.458 ' HD3' HG21 ' A' ' 26' ' ' ILE . 14.4 ptmt -114.95 -19.35 10.98 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.214 0.45 . . . . 53.439999999999998 112.214 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.4 t -88.43 -55.25 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 111.973 0.36 . . . . 61.520000000000003 111.973 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 39.9 p -72.83 -18.52 61.45 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.11 0.481 . . . . 74.430000000000007 111.033 -173.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.9 p -90.8 11.93 20.9 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.704 -0.68 . . . . 73.219999999999999 111.028 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 51.8 t -59.63 117.01 4.43 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.258 -0.428 . . . . 60.130000000000003 111.292 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -117.43 3.73 12.5 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.548 0.69 . . . . 70.230000000000004 109.349 172.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.628 ' HB2' HG22 ' A' ' 42' ' ' ILE . 1.8 m-20 -70.64 -31.85 68.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.963 -1.017 . . . . 63.240000000000002 110.684 -176.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' ' 40' ' ' ASP . 27.7 m-80 73.26 13.4 4.7 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.301 -0.863 . . . . 71.209999999999994 111.04 -175.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.628 HG22 ' HB2' ' A' ' 40' ' ' ASP . 15.1 tt -85.99 146.64 6.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 108.828 -0.804 . . . . 74.519999999999996 108.828 172.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.693 HD11 ' HB3' ' A' ' 101' ' ' MET . 63.4 tp -79.52 106.59 11.66 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-O 121.556 0.693 . . . . 74.319999999999993 110.312 -177.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.49 HG23 ' CD2' ' A' ' 77' ' ' TYR . 65.6 mt -88.68 107.53 17.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.801 -1.09 . . . . 75.349999999999994 110.364 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.4 HD13 HD22 ' A' ' 63' ' ' LEU . 70.3 mt -90.56 101.82 14.56 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.963 -0.562 . . . . 41.200000000000003 109.787 178.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.463 HG13 HG22 ' A' ' 44' ' ' ILE . 27.6 m -95.96 121.53 46.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.031 0.443 . . . . 71.439999999999998 110.849 -178.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -95.49 133.71 39.16 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.915 -0.584 . . . . 64.5 111.02 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 . . . . . 0 C--N 1.33 -0.269 0 CA-C-O 121.436 0.636 . . . . 73.030000000000001 111.495 -178.924 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo . . . . . 0 CA--C 1.528 0.216 0 N-CA-C 111.104 -0.383 . . . . 71.140000000000001 111.104 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.469 ' NE2' ' HA ' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -45.3 -49.7 12.5 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 116.162 -0.472 . . . . 74.099999999999994 111.469 -171.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.726 ' HB3' HG12 ' A' ' 76' ' ' ILE . 71.6 mt -56.78 -48.88 76.9 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.225 -0.898 . . . . 74.219999999999999 111.012 -175.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.544 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 34.4 mt-10 -70.6 -44.33 67.5 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.24 -0.437 . . . . 74.409999999999997 109.959 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.411 ' HD2' ' HA ' ' A' ' 65' ' ' LYS . 12.3 tptp -54.57 -42.74 71.36 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.378 -0.828 . . . . 71.310000000000002 110.986 -174.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.505 HD21 HG22 ' A' ' 120' ' ' ILE . 13.9 mt -81.51 -39.5 24.62 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 120.795 -0.362 . . . . 73.239999999999995 111.171 176.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.496 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -55.19 -33.49 63.07 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.587 0.232 . . . . 61.5 111.295 -178.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.544 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 96.4 mt-30 -51.06 -42.46 60.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.99 0.424 . . . . 70.239999999999995 110.794 177.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -94.02 -55.17 3.31 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.684 -0.689 . . . . 65.549999999999997 111.592 -177.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.542 ' O ' HG22 ' A' ' 74' ' ' VAL . 12.0 m-85 -94.86 22.17 6.75 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.727 0.639 . . . . 75.230000000000004 112.727 -167.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.496 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 8.2 t -52.5 -27.33 15.9 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.9 0.381 . . . . 74.329999999999998 111.585 -177.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -63.58 -24.25 67.72 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.246 -0.434 . . . . 53.340000000000003 111.832 -178.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.55 9.2 5.97 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.485 0.183 . . . . 72.310000000000002 111.183 -177.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.542 HG22 ' O ' ' A' ' 70' ' ' TYR . 27.2 m -138.33 140.29 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 O-C-N 121.779 -0.575 . . . . 55.140000000000001 110.565 175.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 39.2 mmtm -141.07 135.25 30.82 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.135 -0.484 . . . . 63.310000000000002 110.031 174.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.726 HG12 ' HB3' ' A' ' 63' ' ' LEU . 3.4 mp -103.94 144.49 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.391 -0.368 . . . . 74.420000000000002 110.146 -176.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.49 ' CD2' HG23 ' A' ' 44' ' ' ILE . 81.2 m-85 -129.38 138.46 51.53 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.276 0.56 . . . . 72.200000000000003 111.537 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.507 ' HA ' ' HE2' ' A' ' 78' ' ' LYS . 9.6 mmpt? -99.01 100.22 11.36 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.284 -0.871 . . . . 72.219999999999999 108.804 174.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.588 ' N ' HD12 ' A' ' 79' ' ' ILE . 2.4 mp . . . . . 0 C--N 1.323 -0.568 0 N-CA-C 110.249 -0.278 . . . . 72.5 110.249 -175.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.29 0 CA-C-O 121.058 0.456 . . . . 73.530000000000001 110.919 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.0 m -74.32 -30.18 61.94 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.71 -0.677 . . . . 71.010000000000005 110.554 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -61.64 -55.49 29.98 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.677 -0.692 . . . . 72.230000000000004 110.445 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.418 ' HE2' ' HE2' ' A' ' 107' ' ' LYS . 97.4 m-85 -77.08 -13.31 59.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.956 -0.565 . . . . 74.030000000000001 110.343 178.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.46 39.25 61.55 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 115.748 -0.66 . . . . 71.209999999999994 112.875 174.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 14.6 p -72.43 -37.37 57.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.657 0.265 . . . . 73.5 110.502 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.8 t 67.43 -67.43 0.18 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.67 -0.696 . . . . 73.310000000000002 111.294 -178.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.58 134.9 48.06 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.49 -0.323 . . . . 73.129999999999995 111.057 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.422 ' HB ' ' HA ' ' A' ' 97' ' ' PRO . 29.4 pt -113.87 158.67 38.5 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 116.062 -0.517 . . . . 72.430000000000007 110.107 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.422 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 95.4 Cg_endo -82.96 177.55 31.45 Favored 'Cis proline' 0 C--N 1.35 0.645 0 C-N-CA 123.889 -1.296 . . . . 65.310000000000002 112.352 -1.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.1 m -140.8 131.22 25.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.113 -0.494 . . . . 71.120000000000005 109.843 178.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.608 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 26.6 mt -109.33 116.93 53.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.333 -0.394 . . . . 53.43 109.999 -176.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.2 mp -94.55 144.57 25.48 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.144 0.497 . . . . 73.120000000000005 110.777 -178.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.773 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 70.3 mtp -106.38 114.58 28.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.606 -0.725 . . . . 74.109999999999999 109.923 -179.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -115.83 140.63 49.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.76 0.314 . . . . 74.430000000000007 110.453 177.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.741 ' HB3' HD21 ' A' ' 108' ' ' LEU . 38.1 ttpt -156.79 128.32 7.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.997 -0.547 . . . . 63.310000000000002 109.561 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.7 t30 60.0 24.84 14.01 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.324 0.583 . . . . 65.239999999999995 110.686 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.28 -1.13 82.08 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 116.058 -0.519 . . . . 53.509999999999998 113.266 177.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -108.2 160.92 15.45 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.99 0.395 . . . . 51.240000000000002 110.49 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.418 ' HE2' ' HE2' ' A' ' 91' ' ' TYR . 20.2 pttp -92.69 139.92 30.07 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.472 -0.936 . . . . 45.119999999999997 108.472 170.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.741 HD21 ' HB3' ' A' ' 103' ' ' LYS . 3.0 mm? -105.72 -52.98 2.72 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 110.087 -0.338 . . . . 72.549999999999997 110.087 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.773 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 23.4 m -157.59 170.96 21.21 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.865 -0.607 . . . . 74.540000000000006 110.171 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.7 pm0 -128.85 123.87 33.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.932 -0.576 . . . . 75.319999999999993 109.831 172.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.608 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 63.6 t -80.66 113.93 20.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.822 -0.626 . . . . 64.25 110.25 176.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 42.1 mt -100.2 123.06 52.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.427 -0.583 . . . . 75.109999999999999 109.427 175.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.76 -129.89 14.0 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.957 -0.639 . . . . 74.409999999999997 111.985 -179.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.469 ' HA ' ' NE2' ' A' ' 62' ' ' GLN . . . -142.65 57.36 1.43 Allowed 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.012 0.434 . . . . 71.329999999999998 111.117 -178.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.553 ' O ' ' HG3' ' A' ' 118' ' ' LYS . 7.7 m-20 -88.32 86.42 7.06 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-O 121.681 0.753 . . . . 62.439999999999998 110.21 177.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.559 ' O ' HG13 ' A' ' 119' ' ' ILE . 7.9 tp -53.09 -35.68 23.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.003 -0.999 . . . . 73.120000000000005 110.636 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.6 m -67.07 -37.0 83.22 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.846 -0.615 . . . . 71.150000000000006 111.215 -177.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.553 ' HG3' ' O ' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -76.04 -41.62 50.22 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.642 -0.503 . . . . 71.040000000000006 109.642 -179.325 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.559 HG13 ' O ' ' A' ' 116' ' ' ILE . 1.9 pp -65.7 -42.35 92.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 116.286 -0.415 . . . . 71.219999999999999 110.943 -176.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.505 HG22 HD21 ' A' ' 66' ' ' LEU . 2.8 pp -66.8 -31.85 55.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 121.123 0.487 . . . . 75.310000000000002 109.957 177.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.412 ' N ' HD12 ' A' ' 120' ' ' ILE . 47.2 t -63.58 -51.01 67.2 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.73 -0.668 . . . . 62.240000000000002 110.686 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.493 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 11.6 pt-20 -77.85 -46.17 22.2 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.14 0.422 . . . . 74.319999999999993 112.14 -178.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.532 ' O ' HG12 ' A' ' 127' ' ' ILE . 67.5 mt -60.04 -51.0 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 117.903 0.319 . . . . 72.530000000000001 111.555 -176.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -59.11 -30.86 68.42 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.073 0.463 . . . . 72.010000000000005 110.922 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -83.17 -20.82 33.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.413 0.625 . . . . 60.229999999999997 110.282 177.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.493 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 1.8 t-20 -88.61 -37.37 15.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.689 -0.687 . . . . 73.109999999999999 111.524 -173.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.532 HG12 ' O ' ' A' ' 123' ' ' ILE . 46.8 pt -100.99 168.61 1.87 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 116.266 -0.424 . . . . 71.040000000000006 111.159 -177.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.3 p30 . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.432 -0.794 . . . . 74.439999999999998 111.297 -174.921 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.521 ' N ' ' SD ' ' A' ' 22' ' ' MET . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.341 0 CA-C-O 120.901 0.381 . . . . 73.25 110.165 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.512 HG12 ' HG2' ' A' ' 22' ' ' MET . 14.3 mm -115.66 78.33 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 115.532 -0.758 . . . . 74.400000000000006 109.092 174.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.623 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 10.8 tp10 -96.99 153.17 18.07 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.21 -0.45 . . . . 71.409999999999997 110.016 -176.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.439 HE21 ' HB2' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -97.84 138.88 34.53 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.613 -0.514 . . . . 65.140000000000001 109.613 177.505 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 39.2 pt -122.76 153.75 27.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-O 121.189 0.518 . . . . 64.230000000000004 111.095 -177.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.58 150.71 38.62 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.408 -0.815 . . . . 13.31 111.729 176.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -63.64 -34.98 79.05 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.981 0.419 . . . . 73.329999999999998 110.469 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.1 m -72.99 -16.38 61.51 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.734 -0.667 . . . . 64.120000000000005 111.63 -176.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -113.79 3.02 15.34 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.398 -0.364 . . . . 71.549999999999997 110.907 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -47.08 -71.15 0.08 Allowed 'General case' 0 N--CA 1.464 0.241 0 O-C-N 123.46 0.475 . . . . 65.209999999999994 110.951 -177.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -65.15 -34.82 79.3 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.861 -0.422 . . . . 71.430000000000007 109.861 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -52.04 -41.06 61.98 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.221 -0.9 . . . . 63.409999999999997 111.215 -174.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -106.81 -25.2 11.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.195 -0.457 . . . . 53.439999999999998 112.104 -177.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.4 HG21 HG21 ' A' ' 46' ' ' VAL . 79.1 t -84.12 -50.83 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 112.073 0.397 . . . . 61.520000000000003 112.073 -175.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.3 p -76.83 -32.54 57.65 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.987 0.422 . . . . 74.430000000000007 110.81 -175.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.8 m -80.59 12.41 3.11 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.765 -0.652 . . . . 73.219999999999999 111.695 -177.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.625 ' SG ' HG22 ' A' ' 42' ' ' ILE . 37.1 t -59.24 90.9 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.879 0.371 . . . . 60.130000000000003 111.182 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -80.58 -22.0 41.12 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.944 0.402 . . . . 70.230000000000004 111.185 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -72.86 2.57 6.52 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.535 -0.302 . . . . 63.240000000000002 111.742 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 63.0 21.91 13.17 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.422 -0.354 . . . . 71.209999999999994 111.777 172.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.625 HG22 ' SG ' ' A' ' 38' ' ' CYS . 6.8 tt -87.9 144.63 8.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 109.388 -0.597 . . . . 74.519999999999996 109.388 177.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.487 HD21 ' CE ' ' A' ' 101' ' ' MET . 42.1 tp -81.14 115.53 20.61 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.008 0.433 . . . . 74.319999999999993 109.979 -177.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 62.1 mt -102.58 123.28 55.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.91 -0.586 . . . . 75.349999999999994 110.263 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.548 ' HG ' ' HG2' ' A' ' 101' ' ' MET . 3.3 mp -114.23 106.02 13.86 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.049 -0.523 . . . . 41.200000000000003 109.753 -178.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.531 HG22 ' HB2' ' A' ' 77' ' ' TYR . 43.5 t -102.12 125.54 56.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.598 -0.274 . . . . 71.439999999999998 110.566 -178.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -98.01 138.49 35.25 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.17 0.51 . . . . 64.5 109.894 178.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 . . . . . 0 C--N 1.324 -0.505 0 CA-C-N 115.578 -0.737 . . . . 73.030000000000001 110.009 179.406 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.53 ' HG2' ' HB2' ' A' ' 64' ' ' GLU . 85.4 Cg_endo . . . . . 0 CA--C 1.531 0.325 0 CA-C-O 120.802 0.251 . . . . 71.140000000000001 112.485 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.585 ' HB3' HG12 ' A' ' 119' ' ' ILE . 9.9 mp0 -55.34 -55.93 25.94 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-O 121.592 0.711 . . . . 74.099999999999994 111.27 -173.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.558 HD11 HG21 ' A' ' 111' ' ' VAL . 3.2 mm? -59.33 -48.39 81.82 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 114.844 -1.071 . . . . 74.219999999999999 110.952 -171.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.585 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 48.4 mt-10 -68.38 -32.48 72.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.067 -0.515 . . . . 74.409999999999997 110.427 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 61' ' ' PRO . 2.8 tmtm? -59.09 -52.46 65.63 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.803 -0.443 . . . . 71.310000000000002 109.803 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.694 HD12 HD12 ' A' ' 123' ' ' ILE . 29.3 mt -70.88 -33.46 70.62 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 120.903 -0.319 . . . . 73.239999999999995 111.347 177.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.407 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -60.19 -27.13 66.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.334 -0.394 . . . . 61.5 111.47 -178.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.585 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 76.1 mt-30 -56.93 -35.79 69.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.843 0.354 . . . . 70.239999999999995 110.738 177.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -93.83 -55.94 3.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.401 0.619 . . . . 65.549999999999997 110.468 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.513 ' O ' HG22 ' A' ' 74' ' ' VAL . 23.4 m-85 -84.74 22.51 1.33 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.58 -0.736 . . . . 75.230000000000004 112.69 -172.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.433 ' O ' ' NZ ' ' A' ' 75' ' ' LYS . 4.4 t -52.28 -44.54 65.05 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.369 0.507 . . . . 74.329999999999998 112.369 -170.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -73.14 -16.21 61.45 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 122.04 -0.412 . . . . 53.340000000000003 111.316 -176.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -101.6 -20.47 15.03 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 110.078 -0.342 . . . . 72.310000000000002 110.078 178.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 70' ' ' TYR . 25.4 m -136.91 122.06 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 121.298 0.571 . . . . 55.140000000000001 110.64 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.433 ' NZ ' ' O ' ' A' ' 71' ' ' THR . 38.0 mmtm -119.29 124.75 47.44 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.639 -0.504 . . . . 63.310000000000002 109.639 177.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.536 HG13 ' HB2' ' A' ' 45' ' ' LEU . 2.1 mp -97.37 137.48 24.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 74.420000000000002 110.054 -175.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.623 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 20.2 m-85 -126.58 134.45 50.81 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.116 -0.493 . . . . 72.200000000000003 110.368 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 19.1 mtpp -96.31 122.51 39.26 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.181 -0.674 . . . . 72.219999999999999 109.181 176.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.6 tp . . . . . 0 CA--C 1.534 0.356 0 CA-C-O 120.908 0.385 . . . . 72.5 111.18 -176.531 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.355 0 CA-C-O 121.064 0.459 . . . . 73.530000000000001 110.76 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.4 m -74.52 -28.11 60.83 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.741 -0.663 . . . . 71.010000000000005 110.964 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -64.49 -51.11 64.67 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.067 0.46 . . . . 72.230000000000004 109.928 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -79.01 -6.71 57.03 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.684 -0.689 . . . . 74.030000000000001 110.36 176.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 61.95 53.32 43.85 Favored Glycine 0 C--N 1.331 0.281 0 CA-C-N 115.84 -0.618 . . . . 71.209999999999994 113.19 172.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.473 HG22 ' H ' ' A' ' 95' ' ' ALA . 10.0 p -80.01 133.67 29.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.908 0.385 . . . . 73.5 110.671 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.4 t -128.17 27.12 5.68 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.107 0.48 . . . . 73.310000000000002 110.329 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.473 ' H ' HG22 ' A' ' 93' ' ' VAL . . . -145.03 130.38 18.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.01 -0.541 . . . . 73.129999999999995 110.157 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.805 HD13 ' H ' ' A' ' 96' ' ' ILE . 0.2 OUTLIER -110.37 148.14 37.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 72.430000000000007 110.242 -178.153 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -77.07 -178.12 23.21 Favored 'Cis proline' 0 C--N 1.351 0.687 0 C-N-CA 123.758 -1.351 . . . . 65.310000000000002 112.512 -1.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.0 m -137.81 115.64 11.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.105 -0.498 . . . . 71.120000000000005 110.039 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.445 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.9 mp -121.6 123.16 68.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-N 116.216 -0.447 . . . . 53.43 109.84 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.5 mp -101.24 141.77 33.64 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.243 -0.28 . . . . 73.120000000000005 110.243 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.76 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 56.5 mtp -116.91 115.48 25.58 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 116.398 -0.364 . . . . 74.109999999999999 110.872 -175.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -117.38 154.29 31.58 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.049 -0.523 . . . . 74.430000000000007 110.511 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.749 ' HB3' HD21 ' A' ' 108' ' ' LEU . 28.1 ttpp -168.23 122.89 0.94 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.747 -0.661 . . . . 63.310000000000002 109.78 178.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.2 t30 53.82 45.95 26.77 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.545 0.688 . . . . 65.239999999999995 110.845 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 73.87 3.83 65.07 Favored Glycine 0 CA--C 1.52 0.392 0 CA-C-N 115.578 -0.737 . . . . 53.509999999999998 113.719 176.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -111.41 142.87 43.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 117.134 0.467 . . . . 51.240000000000002 110.589 -178.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.477 ' O ' ' HG3' ' A' ' 107' ' ' LYS . 12.5 ptmm? -95.51 112.39 24.12 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.082 -0.71 . . . . 45.119999999999997 109.082 172.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.749 HD21 ' HB3' ' A' ' 103' ' ' LYS . 1.5 mm? -89.33 -53.18 4.67 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.088 0.471 . . . . 72.549999999999997 110.904 -172.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.76 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 22.8 m -150.08 172.02 15.93 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.517 -0.765 . . . . 74.540000000000006 110.458 -169.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.27 121.28 2.65 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.092 0.472 . . . . 75.319999999999993 111.116 -177.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.558 HG21 HD11 ' A' ' 63' ' ' LEU . 59.8 t -80.43 107.47 12.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.607 -0.724 . . . . 64.25 110.037 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.425 HG22 ' HB3' ' A' ' 95' ' ' ALA . 65.7 mt -110.58 106.91 21.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.344 -0.613 . . . . 75.109999999999999 109.344 177.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 96.51 -141.33 15.55 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 111.398 -0.681 . . . . 74.409999999999997 111.398 -176.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -141.54 88.58 2.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.914 0.357 . . . . 71.329999999999998 110.65 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.538 ' O ' HG23 ' A' ' 119' ' ' ILE . 11.7 m-20 -132.9 97.08 3.93 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.101 -0.499 . . . . 62.439999999999998 110.14 178.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.52 ' O ' HG13 ' A' ' 119' ' ' ILE . 7.1 tp -58.49 -40.25 77.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 120.846 0.355 . . . . 73.120000000000005 111.13 -177.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.3 t -67.24 -28.64 68.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.164 0.507 . . . . 71.150000000000006 110.74 -178.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -79.27 -43.77 23.05 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.985 -0.552 . . . . 71.040000000000006 110.75 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.585 HG12 ' HB3' ' A' ' 62' ' ' GLN . 1.8 pp -67.64 -41.53 85.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 71.219999999999999 110.613 -177.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.65 HG22 HD11 ' A' ' 66' ' ' LEU . 2.7 pp -62.21 -31.64 52.17 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 109.693 -0.484 . . . . 75.310000000000002 109.693 177.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 23.1 t -69.71 -51.23 36.25 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.712 -0.676 . . . . 62.240000000000002 110.083 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.437 ' OE1' ' HB3' ' A' ' 109' ' ' SER . 16.4 pt-20 -74.12 -33.93 63.73 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 112.109 0.411 . . . . 74.319999999999993 112.109 -175.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.694 HD12 HD12 ' A' ' 66' ' ' LEU . 64.6 mt -67.13 -58.05 7.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 O-C-N 122.264 -0.272 . . . . 72.530000000000001 110.518 178.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -63.16 -19.98 64.97 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.073 0.463 . . . . 72.010000000000005 110.932 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.422 HD22 ' ND2' ' A' ' 126' ' ' ASN . 7.3 t30 -60.69 -31.45 70.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.067 -0.515 . . . . 60.229999999999997 111.219 176.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.422 ' ND2' HD22 ' A' ' 125' ' ' ASN . 51.9 m-80 -114.22 -3.15 13.22 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.075 0.398 . . . . 73.109999999999999 112.075 -173.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.442 HG12 ' O ' ' A' ' 123' ' ' ILE . 33.9 pt -135.64 168.56 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 110.372 -0.233 . . . . 71.040000000000006 110.372 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.383 -0.818 . . . . 74.439999999999998 111.104 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 C--O 1.23 0.069 0 N-CA-C 109.7 -0.481 . . . . 73.25 109.7 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.472 HG12 ' HB ' ' A' ' 76' ' ' ILE . 51.1 mt -133.79 106.6 9.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 108.927 -0.768 . . . . 74.400000000000006 108.927 173.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.425 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 36.9 tt0 -131.94 118.61 20.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.604 -0.271 . . . . 71.409999999999997 111.083 -171.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.563 ' H ' ' NE2' ' A' ' 25' ' ' GLN . 0.6 OUTLIER -81.62 132.73 35.31 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.209 -0.664 . . . . 65.140000000000001 109.209 173.454 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 25.8 pt -126.44 175.32 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 120.983 0.42 . . . . 64.230000000000004 111.952 -170.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.45 154.13 26.97 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.646 -0.707 . . . . 13.31 112.369 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -67.41 -31.2 71.24 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.961 0.41 . . . . 73.329999999999998 110.957 -177.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.3 p -71.02 -39.29 72.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.999 -0.546 . . . . 64.120000000000005 110.877 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.437 ' HA ' ' HB3' ' A' ' 33' ' ' ASN . 13.1 pt-20 -91.48 -3.77 56.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.999 -0.546 . . . . 71.549999999999997 110.991 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -46.34 -71.02 0.08 Allowed 'General case' 0 N--CA 1.464 0.26 0 O-C-N 123.622 0.576 . . . . 65.209999999999994 111.161 -176.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -68.04 -35.17 77.81 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 109.396 -0.594 . . . . 71.430000000000007 109.396 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.437 ' HB3' ' HA ' ' A' ' 30' ' ' GLU . 6.2 t30 -52.53 -34.27 49.08 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 114.586 -1.188 . . . . 63.409999999999997 111.816 -175.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.2 ptmt -111.69 -27.52 8.49 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.774 -0.194 . . . . 53.439999999999998 111.426 -178.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 71.7 t -84.57 -56.66 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 111.745 0.276 . . . . 61.520000000000003 111.745 -177.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.8 p -80.01 -23.77 41.29 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.011 0.434 . . . . 74.430000000000007 110.444 -173.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.1 m -83.66 6.08 22.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.733 -0.667 . . . . 73.219999999999999 111.027 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.614 ' SG ' HG22 ' A' ' 42' ' ' ILE . 48.0 t -66.88 98.92 0.58 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.887 0.375 . . . . 60.130000000000003 110.427 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -88.9 -2.94 58.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.102 -0.499 . . . . 70.230000000000004 110.318 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -71.56 -6.62 42.05 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.175 -0.466 . . . . 63.240000000000002 110.67 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 60.54 23.3 12.99 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.88 -0.6 . . . . 71.209999999999994 111.42 176.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.614 HG22 ' SG ' ' A' ' 38' ' ' CYS . 12.4 tt -84.9 152.61 3.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.754 -0.832 . . . . 74.519999999999996 108.754 174.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.563 HD21 ' HE3' ' A' ' 101' ' ' MET . 58.9 tp -85.09 110.2 18.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.606 0.241 . . . . 74.319999999999993 110.45 -175.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 101' ' ' MET . 54.4 mt -100.62 136.68 31.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.472 -0.331 . . . . 75.349999999999994 110.591 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.555 ' HG ' ' HG2' ' A' ' 101' ' ' MET . 3.7 mp -122.67 109.45 14.28 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.572 -0.529 . . . . 41.200000000000003 109.572 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 30.1 m -95.27 127.35 47.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.717 0.294 . . . . 71.439999999999998 110.606 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.419 ' HB3' ' HE2' ' A' ' 78' ' ' LYS . 3.1 t70 -125.63 149.42 48.43 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.322 0.582 . . . . 64.5 112.231 -171.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.522 ' CZ ' ' HB ' ' A' ' 98' ' ' THR . 22.5 p90 . . . . . 0 C--N 1.327 -0.389 0 N-CA-C 108.493 -0.929 . . . . 73.030000000000001 108.493 164.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo . . . . . 0 C--O 1.233 0.249 0 N-CA-C 111.396 -0.271 . . . . 71.140000000000001 111.396 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.541 ' HB3' HG12 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -49.9 -50.21 46.92 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 121.359 0.6 . . . . 74.099999999999994 110.966 -176.734 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.701 HD21 HG21 ' A' ' 99' ' ' ILE . 8.8 mp -60.36 -48.85 79.99 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.258 -0.883 . . . . 74.219999999999999 111.524 -174.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.616 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 40.2 mt-10 -67.92 -36.35 80.01 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.804 -0.443 . . . . 74.409999999999997 109.804 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -54.93 -51.13 67.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.797 -0.638 . . . . 71.310000000000002 110.23 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.463 HD11 HG22 ' A' ' 120' ' ' ILE . 22.9 mt -78.3 -34.79 48.58 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.517 -0.31 . . . . 73.239999999999995 111.802 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.503 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.37 -28.05 69.73 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 111.345 0.128 . . . . 61.5 111.345 -175.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.616 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 78.9 mt-30 -53.0 -32.4 46.36 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.284 0.564 . . . . 70.239999999999995 109.993 175.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -93.55 -59.08 2.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.562 -0.745 . . . . 65.549999999999997 110.427 175.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.583 ' O ' HG22 ' A' ' 74' ' ' VAL . 19.0 m-85 -87.55 17.78 4.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.32 -0.855 . . . . 75.230000000000004 113.134 -168.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.503 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 9.3 t -52.95 -36.08 59.57 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.147 0.43 . . . . 74.329999999999998 111.552 -176.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -70.8 -17.18 62.78 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.826 0.346 . . . . 53.340000000000003 111.493 -178.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -112.21 -10.57 13.84 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.269 -0.423 . . . . 72.310000000000002 110.6 -176.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 70' ' ' TYR . 32.6 m -131.08 151.07 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 O-C-N 122.174 -0.329 . . . . 55.140000000000001 110.872 -179.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.621 ' HA ' ' HE3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -134.1 127.04 31.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.912 -0.585 . . . . 63.310000000000002 109.484 177.662 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.472 ' HB ' HG12 ' A' ' 23' ' ' ILE . 51.6 mt -102.21 130.31 52.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 120.788 0.328 . . . . 74.420000000000002 110.232 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.425 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 74.7 m-85 -131.13 151.44 51.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 72.200000000000003 109.779 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.419 ' HE2' ' HB3' ' A' ' 47' ' ' ASP . 1.3 mptm? -126.28 173.07 9.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.751 0.31 . . . . 72.219999999999999 111.302 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 61.7 mt . . . . . 0 N--CA 1.463 0.192 0 CA-C-N 114.992 -1.004 . . . . 72.5 109.824 -174.292 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.269 0 CA-C-O 120.714 0.293 . . . . 73.530000000000001 110.839 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.3 m -65.03 -32.67 74.5 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.281 -0.418 . . . . 71.010000000000005 111.081 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -66.32 -40.05 89.67 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.978 0.418 . . . . 72.230000000000004 110.202 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -81.88 -17.07 48.55 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.187 -0.461 . . . . 74.030000000000001 110.321 175.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.47 23.26 60.87 Favored Glycine 0 CA--C 1.519 0.327 0 CA-C-N 115.986 -0.552 . . . . 71.209999999999994 112.821 177.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.1 t -61.03 133.56 26.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 120.59 0.233 . . . . 73.5 110.721 -178.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 29.2 t -137.37 11.98 3.01 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.194 -0.457 . . . . 73.310000000000002 110.72 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -134.49 140.18 46.01 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.355 -0.384 . . . . 73.129999999999995 110.49 -177.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.438 ' O ' HD12 ' A' ' 96' ' ' ILE . 2.7 pp -112.63 155.05 44.47 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 116.102 -0.499 . . . . 72.430000000000007 111.156 -176.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -79.04 165.31 81.81 Favored 'Cis proline' 0 C--N 1.354 0.848 0 C-N-CA 123.611 -1.412 . . . . 65.310000000000002 111.582 -3.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.522 ' HB ' ' CZ ' ' A' ' 48' ' ' PHE . 22.8 m -117.54 120.79 39.14 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.817 -0.438 . . . . 71.120000000000005 109.817 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.704 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 27.6 mt -126.24 112.54 30.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.715 -0.675 . . . . 53.43 109.734 -175.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.39 134.18 42.62 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.056 -0.35 . . . . 73.120000000000005 110.056 -176.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.776 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 61.8 mtp -101.82 117.54 35.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.448 . . . . 74.109999999999999 110.912 -175.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -115.39 156.49 25.46 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 120.972 0.415 . . . . 74.430000000000007 111.235 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.755 ' HB3' HD21 ' A' ' 108' ' ' LEU . 37.7 ttmt -169.55 122.38 0.74 Allowed 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.279 -0.873 . . . . 63.310000000000002 109.598 177.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 60.56 26.08 15.75 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.327 0.584 . . . . 65.239999999999995 111.099 174.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.8 -14.45 61.65 Favored Glycine 0 CA--C 1.52 0.368 0 CA-C-N 115.971 -0.559 . . . . 53.509999999999998 112.681 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -94.73 139.54 31.1 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 122.591 0.356 . . . . 51.240000000000002 110.071 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.629 ' HD3' ' H ' ' A' ' 107' ' ' LYS . 0.1 OUTLIER -93.93 130.41 40.03 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.002 -0.74 . . . . 45.119999999999997 109.002 173.069 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.755 HD21 ' HB3' ' A' ' 103' ' ' LYS . 2.1 mm? -94.42 -53.16 4.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.166 -0.47 . . . . 72.549999999999997 110.737 -174.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.776 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 49.6 m -151.25 171.94 16.63 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.551 -0.75 . . . . 74.540000000000006 110.345 -172.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -145.15 114.87 7.29 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.153 0.502 . . . . 75.319999999999993 110.685 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.704 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 51.5 t -80.15 107.42 12.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.623 -0.717 . . . . 64.25 109.98 178.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 60.5 mt -110.18 106.73 21.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.243 -0.435 . . . . 75.109999999999999 110.202 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 93.3 -134.55 12.19 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 116.109 -0.496 . . . . 74.409999999999997 112.051 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -137.81 76.53 1.58 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.149 0.499 . . . . 71.329999999999998 110.78 -177.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -114.03 97.48 6.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.912 -0.586 . . . . 62.439999999999998 110.336 177.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.609 HD12 HD11 ' A' ' 119' ' ' ILE . 7.9 tp -62.54 -39.86 86.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-O 121.089 0.471 . . . . 73.120000000000005 110.038 178.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.4 m -63.27 -39.71 95.34 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.571 -0.741 . . . . 71.150000000000006 110.554 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -64.49 -56.17 15.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.757 -0.656 . . . . 71.040000000000006 110.617 177.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.609 HD11 HD12 ' A' ' 116' ' ' ILE . 2.4 pp -62.68 -39.94 86.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.121 -0.491 . . . . 71.219999999999999 111.816 -171.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.463 HG22 HD11 ' A' ' 66' ' ' LEU . 2.8 pp -64.08 -31.82 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 120.314 -0.554 . . . . 75.310000000000002 110.078 178.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.438 ' N ' HD12 ' A' ' 120' ' ' ILE . 33.1 t -70.67 -51.8 25.35 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.717 -0.674 . . . . 62.240000000000002 110.797 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -77.53 -43.11 33.08 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.544 0.572 . . . . 74.319999999999993 112.544 -174.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.443 ' O ' HG12 ' A' ' 127' ' ' ILE . 79.7 mt -60.72 -57.62 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 O-C-N 122.187 -0.321 . . . . 72.530000000000001 110.813 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -59.58 -20.16 53.86 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.379 -0.373 . . . . 72.010000000000005 111.293 -177.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -76.24 -33.63 59.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.993 0.425 . . . . 60.229999999999997 110.349 176.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -98.73 -0.34 42.97 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.222 -0.445 . . . . 73.109999999999999 112.087 -175.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.443 HG12 ' O ' ' A' ' 123' ' ' ILE . 37.2 pt -133.71 168.27 24.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.763 -0.458 . . . . 71.040000000000006 109.763 172.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.481 -0.771 . . . . 74.439999999999998 110.861 -174.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 21.8 mmt . . . . . 0 C--O 1.242 0.666 0 CA-C-O 121.234 0.54 . . . . 73.25 110.94 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.2 mm -89.08 86.98 2.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-N 115.233 -0.894 . . . . 74.400000000000006 108.597 172.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.537 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 9.6 tp10 -95.06 134.87 37.28 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.376 -0.374 . . . . 71.409999999999997 110.726 -176.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.415 HE21 ' HB2' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -97.93 132.14 43.78 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.753 -0.462 . . . . 65.140000000000001 109.753 177.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.497 HD12 ' HA ' ' A' ' 31' ' ' PHE . 34.4 pt -123.97 175.14 6.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.417 -0.356 . . . . 64.230000000000004 111.383 -172.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.44 170.87 33.01 Favored Glycine 0 C--N 1.331 0.265 0 CA-C-N 115.802 -0.635 . . . . 13.31 112.998 -177.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -67.5 -42.37 82.97 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.058 0.543 . . . . 73.329999999999998 111.286 -177.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 24.7 t -76.44 -47.32 23.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 64.120000000000005 111.188 -174.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -73.47 -9.43 58.68 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.543 -0.299 . . . . 71.549999999999997 111.401 -179.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.606 ' HE1' HG11 ' A' ' 46' ' ' VAL . 50.8 t80 -44.21 -71.09 0.08 Allowed 'General case' 0 CA--C 1.529 0.163 0 O-C-N 123.451 0.47 . . . . 65.209999999999994 111.136 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -65.69 -32.87 74.67 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.04 -0.356 . . . . 71.430000000000007 110.04 -178.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.51 ' O ' ' HB3' ' A' ' 37' ' ' SER . 7.1 t30 -52.35 -41.02 62.68 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.232 -0.894 . . . . 63.409999999999997 111.16 -177.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 38' ' ' CYS . 13.1 ptmt -108.83 -15.89 14.29 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.227 -0.442 . . . . 53.439999999999998 111.905 -176.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.6 t -88.52 -60.99 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 111.867 0.321 . . . . 61.520000000000003 111.867 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.9 p -81.88 -28.85 32.73 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.814 0.34 . . . . 74.430000000000007 111.093 -172.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.51 ' HB3' ' O ' ' A' ' 33' ' ' ASN . 46.5 t -91.16 12.29 20.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.959 -0.564 . . . . 73.219999999999999 110.191 177.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 34' ' ' LYS . 51.2 t -67.48 95.65 0.47 Allowed 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 120.96 0.409 . . . . 60.130000000000003 111.157 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -89.71 14.41 11.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.33 0.586 . . . . 70.230000000000004 109.811 174.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -74.74 -6.02 46.55 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.858 -0.61 . . . . 63.240000000000002 110.392 -179.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.43 ' HA ' ' HB2' ' A' ' 104' ' ' ASN . 2.1 t-20 62.82 4.96 1.6 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.989 0.737 . . . . 71.209999999999994 112.989 174.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.678 HG21 ' HE2' ' A' ' 75' ' ' LYS . 13.2 tt -90.12 159.13 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.983 -0.377 . . . . 74.519999999999996 109.983 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.459 HD11 ' HB3' ' A' ' 101' ' ' MET . 64.7 tp -85.41 107.71 17.52 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.264 0.554 . . . . 74.319999999999993 109.94 178.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.415 HD11 ' SG ' ' A' ' 38' ' ' CYS . 65.6 mt -92.97 132.06 38.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.37 -0.832 . . . . 75.349999999999994 110.309 177.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.654 HD13 HD12 ' A' ' 63' ' ' LEU . 40.3 mt -111.04 101.84 10.35 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.267 -0.642 . . . . 41.200000000000003 109.267 177.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.606 HG11 ' HE1' ' A' ' 31' ' ' PHE . 61.3 t -91.5 116.3 32.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.564 -0.532 . . . . 71.439999999999998 109.564 178.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -97.1 148.34 23.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.199 0.523 . . . . 64.5 111.351 -173.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.407 ' CE2' HD13 ' A' ' 100' ' ' LEU . 81.4 m-85 . . . . . 0 C--O 1.235 0.333 0 CA-C-N 115.323 -0.853 . . . . 73.030000000000001 109.803 175.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo . . . . . 0 N--CA 1.463 -0.318 0 N-CA-C 111.25 -0.327 . . . . 71.140000000000001 111.25 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.498 ' H ' ' CD ' ' A' ' 62' ' ' GLN . 11.7 mp0 -55.09 -48.29 73.76 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-O 121.871 0.843 . . . . 74.099999999999994 110.366 -178.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.654 HD12 HD13 ' A' ' 45' ' ' LEU . 2.9 mm? -61.39 -47.97 83.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.449 -1.251 . . . . 74.219999999999999 110.449 -174.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.552 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 45.9 tt0 -63.69 -44.05 94.86 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.235 -0.439 . . . . 74.409999999999997 109.941 178.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.652 ' HE3' ' HA ' ' A' ' 65' ' ' LYS . 0.1 OUTLIER -50.89 -51.66 49.6 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.602 -0.726 . . . . 71.310000000000002 111.033 -179.874 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.604 HD11 HG22 ' A' ' 120' ' ' ILE . 32.9 mt -71.99 -35.29 69.44 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.646 -0.422 . . . . 73.239999999999995 110.851 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.427 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -57.27 -40.06 76.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.026 -0.534 . . . . 61.5 111.227 -178.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.552 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 86.9 mt-30 -50.2 -33.4 19.19 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.983 0.42 . . . . 70.239999999999995 110.85 -177.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -94.09 -56.47 2.84 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.75 -0.659 . . . . 65.549999999999997 111.067 178.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.48 ' O ' HG22 ' A' ' 74' ' ' VAL . 17.3 m-85 -88.79 20.33 3.56 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.684 -0.689 . . . . 75.230000000000004 112.671 -170.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.427 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 13.8 t -53.35 -30.47 39.6 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.11 0.481 . . . . 74.329999999999998 112.28 -176.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -70.21 -16.78 63.11 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.381 -0.372 . . . . 53.340000000000003 111.324 -177.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -118.6 -6.5 10.67 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.489 -0.323 . . . . 72.310000000000002 110.458 -178.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.48 HG22 ' O ' ' A' ' 70' ' ' TYR . 30.1 m -137.1 135.39 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 121.143 0.497 . . . . 55.140000000000001 110.879 178.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.678 ' HE2' HG21 ' A' ' 42' ' ' ILE . 64.8 mttm -112.46 158.57 19.71 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.972 -0.751 . . . . 63.310000000000002 108.972 174.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.522 HG13 ' HB2' ' A' ' 45' ' ' LEU . 3.7 mp -125.56 139.4 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 C-N-CA 120.333 -0.547 . . . . 74.420000000000002 110.117 171.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.537 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 12.4 m-85 -125.04 129.1 49.6 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.9 -0.591 . . . . 72.200000000000003 110.094 177.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.456 ' HD3' ' N ' ' A' ' 79' ' ' ILE . 5.7 tmtm? -111.77 124.33 52.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.194 -0.912 . . . . 72.219999999999999 109.201 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.769 ' H ' HD13 ' A' ' 79' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.41 0 N-CA-C 109.775 -0.454 . . . . 72.5 109.775 176.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.137 0 CA-C-O 120.822 0.344 . . . . 73.530000000000001 110.367 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.0 m -64.22 -35.04 79.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.269 -0.423 . . . . 71.010000000000005 110.454 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -57.65 -38.6 75.35 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.766 -0.652 . . . . 72.230000000000004 110.389 178.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -88.76 -17.2 30.35 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.502 -0.317 . . . . 74.030000000000001 111.501 176.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.55 25.25 39.69 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 121.018 -0.61 . . . . 71.209999999999994 112.223 -177.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 70.7 t -64.26 127.19 24.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.724 0.297 . . . . 73.5 110.296 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.5 p -91.3 -17.0 26.63 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.393 0.516 . . . . 73.310000000000002 112.393 -174.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -157.89 146.86 19.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.83 0.348 . . . . 73.129999999999995 111.572 -176.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.559 ' HB ' ' HA ' ' A' ' 97' ' ' PRO . 2.7 pp -98.71 162.04 23.03 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 115.923 -0.58 . . . . 72.430000000000007 110.036 176.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.559 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 98.5 Cg_endo -80.95 174.25 47.74 Favored 'Cis proline' 0 C--N 1.355 0.87 0 C-N-CA 124.133 -1.195 . . . . 65.310000000000002 112.83 2.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.547 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 27.8 m -145.68 134.18 22.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.951 -0.568 . . . . 71.120000000000005 110.042 179.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.597 HG21 ' HG ' ' A' ' 63' ' ' LEU . 3.5 mp -116.44 125.2 73.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 N-CA-C 109.71 -0.478 . . . . 53.43 109.71 178.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.407 HD13 ' CE2' ' A' ' 48' ' ' PHE . 9.7 mp -91.49 134.18 34.86 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.815 0.34 . . . . 73.120000000000005 110.738 -178.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.546 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 72.2 mtp -108.98 114.38 28.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.926 -0.579 . . . . 74.109999999999999 110.231 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -118.91 148.36 43.01 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.179 0.3 . . . . 74.430000000000007 110.271 178.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.625 ' HB3' HD21 ' A' ' 108' ' ' LEU . 62.4 tttm -152.56 115.22 4.54 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.025 -0.731 . . . . 63.310000000000002 109.025 176.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.43 ' HB2' ' HA ' ' A' ' 41' ' ' ASN . 5.8 t30 58.52 30.28 19.54 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.362 0.601 . . . . 65.239999999999995 110.279 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.18 -9.08 78.55 Favored Glycine 0 CA--C 1.521 0.434 0 CA-C-N 115.696 -0.684 . . . . 53.509999999999998 113.355 177.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -95.2 131.17 41.54 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 117.053 0.426 . . . . 51.240000000000002 111.031 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.68 ' HZ2' ' HB2' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -80.39 116.87 20.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 45.119999999999997 110.043 174.77 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.625 HD21 ' HB3' ' A' ' 103' ' ' LYS . 3.1 mm? -82.06 -52.57 6.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.442 -0.344 . . . . 72.549999999999997 110.317 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.546 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 74.6 m -159.35 171.82 19.09 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.81 -0.632 . . . . 74.540000000000006 110.759 -176.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 8.4 pm0 -133.35 119.12 19.3 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.428 -0.805 . . . . 75.319999999999993 109.346 172.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 98' ' ' THR . 61.3 t -79.99 110.33 15.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 64.25 110.048 -178.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 59.0 mt -107.98 118.54 55.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 110.036 -0.357 . . . . 75.109999999999999 110.036 -177.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.36 -115.36 4.21 Favored Glycine 0 N--CA 1.453 -0.206 0 N-CA-C 111.682 -0.567 . . . . 74.409999999999997 111.682 -178.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.55 89.19 1.02 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.89 0.345 . . . . 71.329999999999998 111.017 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.465 ' O ' HG23 ' A' ' 119' ' ' ILE . 12.5 m-20 -118.99 88.76 2.99 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.41 -0.359 . . . . 62.439999999999998 110.448 178.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.505 HD12 HD11 ' A' ' 119' ' ' ILE . 8.2 tp -62.73 -44.89 99.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 120.814 0.34 . . . . 73.120000000000005 110.902 -178.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.2 m -68.55 -27.06 65.75 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.34 -0.391 . . . . 71.150000000000006 111.336 -176.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.32 -45.27 19.98 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 120.839 0.352 . . . . 71.040000000000006 110.076 178.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.521 ' HA ' ' HG2' ' A' ' 122' ' ' GLU . 2.4 pp -68.43 -37.37 77.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.384 -0.371 . . . . 71.219999999999999 111.601 -176.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.604 HG22 HD11 ' A' ' 66' ' ' LEU . 2.7 pp -63.66 -31.79 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 121.3 0.571 . . . . 75.310000000000002 109.681 176.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.8 t -70.47 -47.89 58.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.446 -0.797 . . . . 62.240000000000002 110.568 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.521 ' HG2' ' HA ' ' A' ' 119' ' ' ILE . 21.1 pt-20 -76.96 -44.75 30.14 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.235 0.457 . . . . 74.319999999999993 112.235 -176.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.572 HD12 HD12 ' A' ' 66' ' ' LEU . 67.2 mt -61.43 -57.23 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 O-C-N 122.185 -0.322 . . . . 72.530000000000001 110.992 -178.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -60.59 -20.37 60.36 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.068 0.461 . . . . 72.010000000000005 111.227 -176.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -77.66 -34.49 53.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.753 -0.658 . . . . 60.229999999999997 110.576 176.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -83.27 -39.38 20.93 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.077 -0.51 . . . . 73.109999999999999 111.012 -177.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.455 HG12 ' O ' ' A' ' 123' ' ' ILE . 47.2 pt -91.78 168.15 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.283 -0.417 . . . . 71.040000000000006 110.2 178.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 6.4 p30 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.499 -0.762 . . . . 74.439999999999998 110.716 -172.651 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 16.0 tpt . . . . . 0 C--O 1.238 0.487 0 CA-C-O 120.994 0.426 . . . . 73.25 110.508 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.53 HD13 ' HB ' ' A' ' 76' ' ' ILE . 16.9 mm -117.17 124.8 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 115.726 -0.67 . . . . 74.400000000000006 110.427 -177.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 45.6 tt0 -131.97 140.93 49.13 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.693 0.282 . . . . 71.409999999999997 110.316 173.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -95.8 126.85 41.35 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.786 -0.45 . . . . 65.140000000000001 109.786 176.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.514 HD12 ' HA ' ' A' ' 31' ' ' PHE . 44.5 pt -129.26 165.3 29.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-O 121.075 0.464 . . . . 64.230000000000004 111.525 -174.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.5 164.07 18.91 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.52 -0.764 . . . . 13.31 111.575 176.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -63.58 -29.88 71.07 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.575 0.226 . . . . 73.329999999999998 110.704 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.9 t -62.06 -22.33 65.67 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.17 -0.468 . . . . 64.120000000000005 111.627 -178.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -121.29 -3.23 9.48 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.788 -0.187 . . . . 71.549999999999997 110.836 -178.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.514 ' HA ' HD12 ' A' ' 26' ' ' ILE . 90.6 t80 -51.29 -70.96 0.07 Allowed 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.232 -0.44 . . . . 65.209999999999994 110.363 -177.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -62.71 -34.35 76.99 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.431 -0.581 . . . . 71.430000000000007 109.431 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.483 ' O ' ' HB3' ' A' ' 37' ' ' SER . 6.6 t30 -52.18 -39.71 60.48 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.116 -0.947 . . . . 63.409999999999997 111.477 -176.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.512 ' HD3' HG21 ' A' ' 26' ' ' ILE . 14.1 ptmt -110.23 -18.04 13.39 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 111.793 0.294 . . . . 53.439999999999998 111.793 -177.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 72.2 t -87.58 -54.4 8.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 111.661 0.245 . . . . 61.520000000000003 111.661 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 72.0 p -77.47 -27.33 52.0 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.302 0.572 . . . . 74.430000000000007 110.0 -176.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.483 ' HB3' ' O ' ' A' ' 33' ' ' ASN . 34.3 t -89.71 12.59 16.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.249 -0.887 . . . . 73.219999999999999 110.828 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.404 ' HB2' HD12 ' A' ' 44' ' ' ILE . 43.9 t -46.02 99.58 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.949 0.404 . . . . 60.130000000000003 111.672 -178.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -95.4 9.05 41.37 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.804 -0.635 . . . . 70.230000000000004 110.296 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -86.28 -15.39 40.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.011 -0.54 . . . . 63.240000000000002 110.774 -178.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.4 m120 62.99 16.54 9.35 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.482 0.658 . . . . 71.209999999999994 109.673 -171.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 21.7 mt -96.66 141.4 15.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 115.147 -0.933 . . . . 74.519999999999996 110.46 -177.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.677 HD21 ' HE3' ' A' ' 101' ' ' MET . 62.7 tp -71.56 103.92 3.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.85 -0.614 . . . . 74.319999999999993 110.087 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.404 HD12 ' HB2' ' A' ' 38' ' ' CYS . 44.3 mt -84.7 116.59 28.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.928 -0.578 . . . . 75.349999999999994 110.695 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.801 HD13 HD12 ' A' ' 63' ' ' LEU . 44.9 mt -100.63 109.98 22.08 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.475 -0.784 . . . . 41.200000000000003 109.217 179.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.3 m -100.97 115.02 41.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-O 120.866 0.365 . . . . 71.439999999999998 110.309 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.5 121.03 32.83 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.786 -0.643 . . . . 64.5 111.049 -175.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 . . . . . 0 C--O 1.239 0.534 0 N-CA-C 109.593 -0.521 . . . . 73.030000000000001 109.593 175.366 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo . . . . . 0 N--CA 1.463 -0.323 0 N-CA-C 111.59 -0.196 . . . . 71.140000000000001 111.59 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.634 ' HB3' HG12 ' A' ' 119' ' ' ILE . 8.2 mp0 -52.47 -48.34 65.96 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 121.551 0.691 . . . . 74.099999999999994 110.986 -176.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.801 HD12 HD13 ' A' ' 45' ' ' LEU . 3.0 mm? -57.89 -48.07 80.93 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.655 -1.157 . . . . 74.219999999999999 110.35 -173.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.546 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 41.2 mt-10 -71.73 -34.94 69.98 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.432 -0.349 . . . . 74.409999999999997 110.9 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 49.6 mmtt -52.85 -52.96 55.26 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.768 0.318 . . . . 71.310000000000002 110.52 177.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.597 HD12 HD12 ' A' ' 123' ' ' ILE . 25.5 mt -76.51 -30.22 57.12 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.532 -0.467 . . . . 73.239999999999995 111.091 178.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.516 ' HB3' ' HA ' ' A' ' 64' ' ' GLU . . . -59.58 -37.68 79.16 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.743 -0.208 . . . . 61.5 111.412 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.546 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 79.2 mt-30 -54.09 -35.46 62.13 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.989 0.423 . . . . 70.239999999999995 110.982 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 66.8 mm-40 -93.86 -53.09 4.14 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.99 -0.55 . . . . 65.549999999999997 111.262 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.489 ' O ' HG22 ' A' ' 74' ' ' VAL . 14.3 m-85 -92.74 22.58 4.67 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.815 -0.63 . . . . 75.230000000000004 112.047 -171.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.46 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 9.5 t -52.91 -31.52 40.38 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.722 0.296 . . . . 74.329999999999998 111.775 -177.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -70.6 -16.47 62.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.991 0.425 . . . . 53.340000000000003 111.155 -177.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -123.43 0.79 8.92 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.164 -0.471 . . . . 72.310000000000002 110.761 -175.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 70' ' ' TYR . 29.1 m -131.29 147.55 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 120.939 0.4 . . . . 55.140000000000001 110.469 177.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -141.86 116.73 9.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.964 -0.562 . . . . 63.310000000000002 109.723 -178.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.53 ' HB ' HD13 ' A' ' 23' ' ' ILE . 3.0 mp -99.05 143.44 13.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 120.633 0.254 . . . . 74.420000000000002 110.811 -173.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.457 ' OH ' ' HE2' ' A' ' 34' ' ' LYS . 21.0 m-85 -130.75 130.05 43.27 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.988 0.423 . . . . 72.200000000000003 111.655 -179.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -96.21 115.17 27.01 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.69 -0.856 . . . . 72.219999999999999 108.69 170.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.432 HD12 ' CD1' ' A' ' 31' ' ' PHE . 12.1 tt . . . . . 0 C--N 1.325 -0.469 0 N-CA-C 109.864 -0.421 . . . . 72.5 109.864 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.185 0 CA-C-O 121.031 0.444 . . . . 73.530000000000001 110.283 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.3 m -60.06 -37.07 78.77 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.786 -0.643 . . . . 71.010000000000005 110.89 178.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -62.44 -47.0 85.99 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.566 -0.743 . . . . 72.230000000000004 110.683 -177.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -87.77 6.58 34.48 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.177 -0.465 . . . . 74.030000000000001 111.523 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.01 27.65 73.52 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 116.106 -0.497 . . . . 71.209999999999994 112.965 175.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 77.7 t -69.27 98.35 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.247 0.546 . . . . 73.5 110.732 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.2 m -101.98 -14.3 17.23 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.059 -0.519 . . . . 73.310000000000002 110.51 176.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -123.1 115.85 22.49 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.778 -0.647 . . . . 73.129999999999995 110.494 -177.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.57 ' HB ' ' HA ' ' A' ' 97' ' ' PRO . 30.3 pt -96.26 162.2 24.47 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 115.936 -0.574 . . . . 72.430000000000007 110.153 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.57 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 83.7 Cg_endo -81.71 171.91 54.9 Favored 'Cis proline' 0 C--N 1.353 0.794 0 C-N-CA 124.136 -1.193 . . . . 65.310000000000002 112.986 0.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 97.9 m -147.34 129.25 15.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.913 -0.585 . . . . 71.120000000000005 110.474 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.53 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 3.6 mp -110.46 145.83 16.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.88 -0.785 . . . . 53.43 108.88 177.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.463 HD23 ' H ' ' A' ' 101' ' ' MET . 0.8 OUTLIER -121.56 137.81 54.57 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.755 -0.461 . . . . 73.120000000000005 109.755 178.825 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.702 ' SD ' ' HB3' ' A' ' 109' ' ' SER . 64.0 mtp -103.14 111.68 24.17 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.892 -0.594 . . . . 74.109999999999999 111.039 -174.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -115.46 153.72 30.59 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.736 0.303 . . . . 74.430000000000007 110.655 177.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.499 ' HB3' HD21 ' A' ' 108' ' ' LEU . 39.3 ttpt -166.77 116.92 0.91 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.314 -0.403 . . . . 63.310000000000002 110.051 175.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 8.1 t30 50.92 52.14 15.58 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.622 0.725 . . . . 65.239999999999995 110.957 178.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 76.46 -14.95 6.18 Favored Glycine 0 CA--C 1.521 0.43 0 CA-C-N 115.436 -0.802 . . . . 53.509999999999998 113.666 176.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -100.29 123.47 44.55 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 117.08 0.44 . . . . 51.240000000000002 110.398 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.402 ' H ' ' HG2' ' A' ' 107' ' ' LYS . 30.6 pttt -89.24 122.61 32.68 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.517 -0.549 . . . . 45.119999999999997 109.517 174.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.508 ' N ' HD22 ' A' ' 108' ' ' LEU . 2.5 mm? -82.63 -52.62 6.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.612 -0.722 . . . . 72.549999999999997 111.281 -172.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.702 ' HB3' ' SD ' ' A' ' 101' ' ' MET . 22.0 t -162.42 172.01 16.24 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.995 -0.548 . . . . 74.540000000000006 110.845 -171.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -133.41 129.26 37.1 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.199 -0.455 . . . . 75.319999999999993 110.369 178.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.688 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 83.7 t -92.64 107.11 18.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.994 -0.548 . . . . 64.25 110.28 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 59.9 mt -110.32 119.19 58.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.722 -0.473 . . . . 75.109999999999999 109.722 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 95.74 -126.9 8.95 Favored Glycine 0 CA--C 1.519 0.322 0 N-CA-C 111.922 -0.471 . . . . 74.409999999999997 111.922 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.47 83.73 0.91 Allowed 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.895 0.379 . . . . 71.329999999999998 110.305 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.41 ' O ' HG23 ' A' ' 119' ' ' ILE . 4.9 m-20 -125.7 97.42 5.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.06 -0.518 . . . . 62.439999999999998 110.407 -178.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.518 ' O ' HG13 ' A' ' 119' ' ' ILE . 7.7 tp -60.64 -41.67 88.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-N 116.511 -0.313 . . . . 73.120000000000005 111.158 -177.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 30.4 t -62.74 -33.04 74.32 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.302 0.572 . . . . 71.150000000000006 110.853 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.688 ' HE3' ' HA ' ' A' ' 111' ' ' VAL . 0.9 OUTLIER -75.94 -47.67 24.25 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.648 -0.706 . . . . 71.040000000000006 110.656 -179.188 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.634 HG12 ' HB3' ' A' ' 62' ' ' GLN . 2.1 pp -64.97 -40.82 90.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.227 -0.442 . . . . 71.219999999999999 111.066 -177.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.436 HG22 HD11 ' A' ' 66' ' ' LEU . 2.8 pp -65.73 -31.71 54.94 Favored 'Isoleucine or valine' 0 C--N 1.34 0.169 0 N-CA-C 109.65 -0.5 . . . . 75.310000000000002 109.65 178.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 43.2 t -65.15 -51.62 60.05 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.632 -0.713 . . . . 62.240000000000002 110.482 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -77.15 -38.73 51.24 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.635 0.605 . . . . 74.319999999999993 112.635 -176.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.597 HD12 HD12 ' A' ' 66' ' ' LEU . 56.8 mt -66.02 -53.2 40.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 O-C-N 122.167 -0.333 . . . . 72.530000000000001 111.011 -178.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -61.85 -20.34 63.59 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.14 0.495 . . . . 72.010000000000005 110.499 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -70.73 -32.58 69.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.981 -0.554 . . . . 60.229999999999997 111.436 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.545 ' OD1' HG23 ' A' ' 127' ' ' ILE . 9.3 p30 -106.39 -17.97 14.12 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.083 0.401 . . . . 73.109999999999999 112.083 -174.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.545 HG23 ' OD1' ' A' ' 126' ' ' ASN . 42.2 pt -125.39 167.69 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 120.846 0.355 . . . . 71.040000000000006 111.135 177.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.454 HD22 ' H ' ' A' ' 128' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.353 -0.832 . . . . 74.439999999999998 110.781 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.475 ' N ' ' SD ' ' A' ' 22' ' ' MET . 3.7 mpp? . . . . . 0 C--O 1.232 0.155 0 N-CA-C 111.57 0.211 . . . . 73.25 111.57 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.1 mt -108.44 123.59 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 121.018 0.437 . . . . 74.400000000000006 111.626 -174.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.642 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 8.7 tp10 -131.97 155.22 48.35 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.834 -0.802 . . . . 71.409999999999997 108.834 174.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -100.59 147.83 25.5 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.71 0.29 . . . . 65.140000000000001 110.263 174.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.518 HD12 ' HA ' ' A' ' 31' ' ' PHE . 34.9 pt -131.07 -176.95 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.464 -0.334 . . . . 64.230000000000004 110.691 -176.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.415 ' H ' ' HG2' ' A' ' 30' ' ' GLU . . . -141.03 -173.83 13.77 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.403 -0.427 . . . . 13.31 112.902 -177.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -55.03 -50.73 68.34 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.92 0.888 . . . . 73.329999999999998 112.605 -175.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 24.9 t -73.4 -19.09 61.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.102 -0.499 . . . . 64.120000000000005 111.807 -169.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.493 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 1.7 pm0 -111.74 -15.24 13.46 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 111.874 0.324 . . . . 71.549999999999997 111.874 -177.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.518 ' HA ' HD12 ' A' ' 26' ' ' ILE . 61.6 t80 -48.2 -71.01 0.08 Allowed 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.41 0.444 . . . . 65.209999999999994 111.239 -176.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -63.44 -40.09 96.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.358 0.599 . . . . 71.430000000000007 109.636 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.526 ' O ' ' HB3' ' A' ' 37' ' ' SER . 1.8 m-80 -53.13 -34.08 55.18 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.445 -1.252 . . . . 63.409999999999997 112.58 -172.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -114.84 -25.02 8.39 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.577 -0.449 . . . . 53.439999999999998 112.16 179.754 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.4 t -82.74 -51.62 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 N-CA-C 111.51 0.189 . . . . 61.520000000000003 111.51 -178.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 44.3 p -85.86 -23.03 27.27 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.025 0.44 . . . . 74.430000000000007 110.265 -176.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.526 ' HB3' ' O ' ' A' ' 33' ' ' ASN . 28.5 t -92.76 12.05 24.82 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.679 -0.691 . . . . 73.219999999999999 110.384 177.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 41.3 t -60.19 90.73 0.02 OUTLIER 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.128 0.489 . . . . 60.130000000000003 110.961 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -90.27 -4.0 57.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.872 -0.604 . . . . 70.230000000000004 110.543 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -71.02 -8.2 51.71 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.075 -0.511 . . . . 63.240000000000002 110.875 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 57.15 22.68 7.76 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.961 -0.563 . . . . 71.209999999999994 111.246 -176.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.9 tt -94.16 148.68 4.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.951 -0.759 . . . . 74.519999999999996 108.951 177.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.561 HD11 ' HB3' ' A' ' 101' ' ' MET . 63.7 tp -82.46 113.25 20.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.04 0.448 . . . . 74.319999999999993 110.634 -175.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.411 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 58.2 mt -98.34 123.97 51.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.522 -0.763 . . . . 75.349999999999994 110.58 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.451 ' N ' HD12 ' A' ' 45' ' ' LEU . 5.1 mp -106.71 112.11 24.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.221 -0.445 . . . . 41.200000000000003 109.867 177.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 27.5 m -98.04 121.87 49.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-O 121.031 0.444 . . . . 71.439999999999998 110.957 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.442 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 2.3 t70 -96.87 128.05 43.44 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.684 -0.689 . . . . 64.5 110.819 -179.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.458 ' CE1' HD13 ' A' ' 100' ' ' LEU . 44.2 m-85 . . . . . 0 C--N 1.328 -0.352 0 CA-C-O 121.07 0.462 . . . . 73.030000000000001 110.43 175.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo . . . . . 0 C--O 1.235 0.358 0 CA-C-O 120.446 0.103 . . . . 71.140000000000001 111.837 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.59 ' HB3' HG12 ' A' ' 119' ' ' ILE . 8.9 mp0 -51.13 -49.47 60.73 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-O 121.566 0.698 . . . . 74.099999999999994 110.533 -176.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.764 HD21 HG12 ' A' ' 99' ' ' ILE . 10.3 mp -54.44 -48.87 71.19 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.617 -1.174 . . . . 74.219999999999999 111.49 -175.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -73.42 -32.79 64.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.818 0.342 . . . . 74.409999999999997 110.296 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.0 tptp -60.31 -46.77 88.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.752 -0.658 . . . . 71.310000000000002 110.358 -176.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.526 HD12 HD12 ' A' ' 123' ' ' ILE . 17.4 mt -85.79 -40.69 15.77 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.082 0.401 . . . . 73.239999999999995 112.082 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.26 -37.15 69.41 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.193 0.442 . . . . 61.5 112.193 -173.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -58.47 -30.84 67.29 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.766 0.317 . . . . 70.239999999999995 111.201 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 19.2 mm-40 -90.55 -54.2 4.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.09 0.472 . . . . 65.549999999999997 110.595 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.525 ' O ' HG22 ' A' ' 74' ' ' VAL . 19.4 m-85 -88.1 22.48 2.4 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.762 -0.654 . . . . 75.230000000000004 112.043 -172.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.9 t -52.63 -32.71 43.21 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.175 0.435 . . . . 74.329999999999998 112.175 -172.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -72.03 -22.62 61.37 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 121.225 -0.19 . . . . 53.340000000000003 111.487 -175.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.04 -4.14 16.04 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.636 -0.256 . . . . 72.310000000000002 110.751 -177.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 70' ' ' TYR . 23.2 m -135.46 148.1 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.134 0.493 . . . . 55.140000000000001 111.568 -178.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 36.6 mmtm -140.81 131.43 25.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.706 -0.679 . . . . 63.310000000000002 109.259 171.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.488 HD13 ' HB3' ' A' ' 63' ' ' LEU . 61.5 mt -110.24 127.68 67.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.366 -0.379 . . . . 74.420000000000002 110.521 -175.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.642 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 57.7 m-85 -124.84 128.74 49.17 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.592 -0.521 . . . . 72.200000000000003 109.592 178.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.442 ' HG2' ' HB3' ' A' ' 47' ' ' ASP . 9.2 mtmp? -100.52 142.74 31.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.874 0.369 . . . . 72.219999999999999 110.636 -177.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 32.8 mm . . . . . 0 C--N 1.326 -0.436 0 CA-C-N 115.42 -0.809 . . . . 72.5 110.789 -174.651 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.233 0 CA-C-O 121.119 0.485 . . . . 73.530000000000001 109.95 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.9 m -59.33 -37.6 78.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.652 -0.704 . . . . 71.010000000000005 110.34 176.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -65.92 -36.56 83.72 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.068 -0.515 . . . . 72.230000000000004 110.064 177.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -73.42 -4.2 32.14 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.384 -0.371 . . . . 74.030000000000001 111.123 175.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.0 9.33 82.67 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 121.276 -0.488 . . . . 71.209999999999994 112.099 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 89.2 t -75.24 83.76 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.425 0.631 . . . . 73.5 110.653 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.0 p -117.85 12.07 13.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.45 -0.795 . . . . 73.310000000000002 109.727 174.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -83.34 -68.39 0.71 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.695 -0.684 . . . . 73.129999999999995 110.978 -178.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 69.2 mt 68.44 128.1 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.554 0 O-C-N 123.506 0.503 . . . . 72.430000000000007 110.362 -178.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -79.38 156.94 90.39 Favored 'Cis proline' 0 C--N 1.353 0.794 0 C-N-CA 123.923 -1.282 . . . . 65.310000000000002 112.686 2.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 39.6 m -149.27 134.08 17.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.985 -0.552 . . . . 71.120000000000005 109.858 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.764 HG12 HD21 ' A' ' 63' ' ' LEU . 3.5 mp -114.99 124.96 72.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.381 -0.372 . . . . 53.43 110.265 -176.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.458 HD13 ' CE1' ' A' ' 48' ' ' PHE . 10.3 mp -103.3 141.87 35.16 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.654 -0.499 . . . . 73.120000000000005 109.654 175.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.7 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 53.4 mtp -112.6 116.13 29.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.517 -0.31 . . . . 74.109999999999999 110.724 -173.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -114.07 152.57 30.85 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.212 -0.449 . . . . 74.430000000000007 110.851 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.641 ' HB3' HD21 ' A' ' 108' ' ' LEU . 39.1 ttpt -168.38 133.09 1.67 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.304 -0.628 . . . . 63.310000000000002 109.304 176.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 56.7 29.17 15.35 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.251 0.548 . . . . 65.239999999999995 109.817 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 87.79 -14.49 58.36 Favored Glycine 0 CA--C 1.52 0.358 0 CA-C-N 115.862 -0.608 . . . . 53.509999999999998 113.331 177.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -96.52 150.91 20.1 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 117.072 0.436 . . . . 51.240000000000002 110.803 -177.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 10.0 ptpt -91.96 118.2 30.54 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.07 -0.715 . . . . 45.119999999999997 109.07 171.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.641 HD21 ' HB3' ' A' ' 103' ' ' LYS . 2.2 mm? -89.8 -52.96 4.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.024 0.44 . . . . 72.549999999999997 111.057 -173.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.7 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 15.8 m -151.75 171.77 17.18 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 115.731 -0.668 . . . . 74.540000000000006 110.329 -170.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -149.89 123.44 9.12 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.286 0.565 . . . . 75.319999999999993 111.488 -176.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.44 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 40.4 t -86.26 107.08 16.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.674 -0.694 . . . . 64.25 109.618 175.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 12.8 mt -116.8 106.83 20.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 109.296 -0.631 . . . . 75.109999999999999 109.296 178.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 115.52 -127.25 7.51 Favored Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 111.574 -0.61 . . . . 74.409999999999997 111.574 -176.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.61 57.27 0.49 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.486 0.66 . . . . 71.329999999999998 109.651 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.452 ' O ' HG23 ' A' ' 119' ' ' ILE . 1.6 m-20 -105.58 99.54 9.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.384 -0.825 . . . . 62.439999999999998 110.882 -174.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.577 ' O ' HG13 ' A' ' 119' ' ' ILE . 7.0 tp -63.37 -38.87 83.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.171 -0.468 . . . . 73.120000000000005 111.079 -178.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.5 m -68.14 -26.85 65.98 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.11 0.481 . . . . 71.150000000000006 110.621 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.441 ' HB3' ' HB2' ' A' ' 115' ' ' ASP . 24.6 tptp -73.2 -52.02 15.64 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.678 -0.692 . . . . 71.040000000000006 110.041 176.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.59 HG12 ' HB3' ' A' ' 62' ' ' GLN . 2.0 pp -63.9 -40.81 90.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 115.68 -0.691 . . . . 71.219999999999999 111.461 -175.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.442 HD12 ' N ' ' A' ' 121' ' ' SER . 2.8 pp -63.14 -33.13 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 120.434 -0.506 . . . . 75.310000000000002 110.284 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.442 ' N ' HD12 ' A' ' 120' ' ' ILE . 35.9 t -70.71 -51.57 26.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.029 -0.532 . . . . 62.240000000000002 110.78 179.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.458 ' OE2' ' HB3' ' A' ' 109' ' ' SER . 15.9 pt-20 -75.86 -38.43 57.96 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.082 0.401 . . . . 74.319999999999993 112.082 -172.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.554 ' O ' HG12 ' A' ' 127' ' ' ILE . 69.9 mt -65.1 -55.8 18.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 O-C-N 122.32 -0.238 . . . . 72.530000000000001 110.442 178.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -60.37 -27.32 67.31 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.281 -0.418 . . . . 72.010000000000005 110.728 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -65.36 -31.48 72.62 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.28 -0.418 . . . . 60.229999999999997 110.74 176.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -104.43 -4.61 22.57 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.979 -0.555 . . . . 73.109999999999999 111.975 -172.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.554 HG12 ' O ' ' A' ' 123' ' ' ILE . 48.5 pt -131.56 168.94 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 122.166 0.186 . . . . 71.040000000000006 110.59 178.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.252 1.185 0 CA-C-O 118.462 -0.78 . . . . 74.439999999999998 112.796 -176.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 67.1 mtt . . . . . 0 N--CA 1.463 0.192 0 N-CA-C 109.995 -0.372 . . . . 73.25 109.995 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.8 mt -113.89 122.62 68.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 109.218 -0.66 . . . . 74.400000000000006 109.218 176.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 -125.54 124.76 42.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.834 0.35 . . . . 71.409999999999997 111.056 -174.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.442 ' HG3' ' HB3' ' A' ' 78' ' ' LYS . 1.1 mp0 -81.49 125.97 31.11 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.464 -0.569 . . . . 65.140000000000001 109.464 178.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.509 HG21 ' HD3' ' A' ' 34' ' ' LYS . 33.8 pt -131.58 176.39 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.744 0.307 . . . . 64.230000000000004 110.936 -176.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -108.86 174.83 18.86 Favored Glycine 0 C--N 1.331 0.278 0 N-CA-C 111.629 -0.588 . . . . 13.31 111.629 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -67.84 -33.43 74.75 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.58 0.229 . . . . 73.329999999999998 111.34 -176.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.0 t -68.79 -34.62 75.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.769 0.319 . . . . 64.120000000000005 111.145 -174.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -101.35 -6.11 24.52 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.145 -0.479 . . . . 71.549999999999997 110.799 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.494 ' HA ' HD12 ' A' ' 26' ' ' ILE . 59.5 t80 -50.45 -70.81 0.08 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.359 -0.382 . . . . 65.209999999999994 110.248 177.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -59.67 -36.93 77.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.095 0.474 . . . . 71.430000000000007 109.969 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.518 ' O ' ' HB2' ' A' ' 37' ' ' SER . 24.7 t-20 -52.41 -47.73 66.13 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.118 -0.946 . . . . 63.409999999999997 111.782 -175.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.509 ' HD3' HG21 ' A' ' 26' ' ' ILE . 0.2 OUTLIER -101.93 -19.18 15.36 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.687 0.255 . . . . 53.439999999999998 111.687 -176.01 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.7 t -88.25 -59.54 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 112.038 0.385 . . . . 61.520000000000003 112.038 -179.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 66.1 p -79.99 -28.1 39.53 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.135 0.493 . . . . 74.430000000000007 110.66 -172.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.518 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 39.8 m -94.6 12.48 27.4 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.69 -0.686 . . . . 73.219999999999999 110.958 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.556 ' SG ' HG22 ' A' ' 42' ' ' ILE . 50.9 t -53.68 92.1 0.01 OUTLIER 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.047 0.451 . . . . 60.130000000000003 112.043 -177.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -67.47 -19.28 65.32 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.04 -0.527 . . . . 70.230000000000004 110.951 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -62.46 -25.27 67.9 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.356 -0.384 . . . . 63.240000000000002 111.372 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.452 ' N ' HD22 ' A' ' 41' ' ' ASN . 0.9 OUTLIER 62.49 23.67 14.06 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.972 -0.558 . . . . 71.209999999999994 110.235 -175.305 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.556 HG22 ' SG ' ' A' ' 38' ' ' CYS . 12.3 tt -82.38 157.76 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.757 -0.656 . . . . 74.519999999999996 109.291 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.423 ' HB3' HG12 ' A' ' 74' ' ' VAL . 48.7 tp -78.21 102.7 7.72 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 109.586 -0.524 . . . . 74.319999999999993 109.586 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.464 ' O ' ' HA ' ' A' ' 101' ' ' MET . 32.5 mt -90.5 126.34 43.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.889 -0.596 . . . . 75.349999999999994 111.108 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.545 HD23 HD12 ' A' ' 63' ' ' LEU . 3.5 mp -115.05 101.91 9.44 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.263 -0.644 . . . . 41.200000000000003 109.263 177.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.54 HG12 ' HB2' ' A' ' 77' ' ' TYR . 29.1 m -94.79 120.9 44.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.725 -0.472 . . . . 71.439999999999998 109.725 178.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -98.09 121.36 39.92 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.527 0.68 . . . . 64.5 109.385 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 . . . . . 0 C--N 1.321 -0.641 0 CA-C-N 115.285 -0.87 . . . . 73.030000000000001 109.242 178.992 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.438 ' HG2' ' HB2' ' A' ' 64' ' ' GLU . 72.6 Cg_endo . . . . . 0 N--CA 1.463 -0.318 0 CA-C-O 121.18 0.408 . . . . 71.140000000000001 112.674 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.571 ' HB3' HG12 ' A' ' 119' ' ' ILE . 15.7 mp0 -56.16 -40.89 74.59 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.353 -0.84 . . . . 74.099999999999994 110.758 -177.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.679 HD11 HG21 ' A' ' 111' ' ' VAL . 2.3 mm? -61.93 -41.0 97.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.87 -1.059 . . . . 74.219999999999999 109.868 -176.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.438 ' HB2' ' HG2' ' A' ' 61' ' ' PRO . 8.7 tm-20 -70.53 -36.66 73.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.63 -0.714 . . . . 74.409999999999997 109.174 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -56.87 -51.53 68.68 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.433 -0.803 . . . . 71.310000000000002 109.909 178.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.605 HD12 HD12 ' A' ' 123' ' ' ILE . 22.3 mt -80.63 -30.61 36.69 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.073 0.397 . . . . 73.239999999999995 112.073 -178.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.47 -34.95 69.55 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.789 0.328 . . . . 61.5 110.892 -178.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -56.57 -30.83 63.61 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.163 -0.471 . . . . 70.239999999999995 111.372 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -93.62 -48.37 6.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.235 -0.439 . . . . 65.549999999999997 110.886 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.543 ' O ' HG22 ' A' ' 74' ' ' VAL . 21.9 m-85 -93.92 21.21 6.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.033 -0.531 . . . . 75.230000000000004 112.154 -174.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.1 t -53.01 -36.38 60.43 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.035 0.383 . . . . 74.329999999999998 112.035 -174.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -71.24 -16.98 62.52 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.505 -0.316 . . . . 53.340000000000003 111.455 -177.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -117.16 -1.37 11.87 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.404 -0.362 . . . . 72.310000000000002 111.036 -175.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.543 HG22 ' O ' ' A' ' 70' ' ' TYR . 26.4 m -135.16 150.65 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 121.008 0.432 . . . . 55.140000000000001 111.55 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -137.57 115.2 11.27 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.094 -0.706 . . . . 63.310000000000002 109.094 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.472 HG12 ' HB2' ' A' ' 45' ' ' LEU . 61.0 mt -98.21 140.63 17.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.692 0.282 . . . . 74.420000000000002 110.326 -178.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.54 ' HB2' HG12 ' A' ' 46' ' ' VAL . 95.1 m-85 -129.35 138.21 51.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.409 -0.359 . . . . 72.200000000000003 110.487 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.442 ' HB3' ' HG3' ' A' ' 25' ' ' GLN . 53.3 tptt -101.24 114.76 29.02 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.402 -0.817 . . . . 72.219999999999999 110.115 -178.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.444 ' N ' HD12 ' A' ' 79' ' ' ILE . 2.3 mp . . . . . 0 N--CA 1.468 0.431 0 CA-C-O 120.765 0.317 . . . . 72.5 110.374 178.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.406 ' O ' HG12 ' A' ' 93' ' ' VAL . . . . . . . . 0 C--O 1.235 0.327 0 CA-C-O 121.168 0.508 . . . . 73.530000000000001 110.777 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.2 m -66.88 -33.48 75.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.802 -0.635 . . . . 71.010000000000005 110.413 178.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -66.6 -36.3 82.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.658 -0.701 . . . . 72.230000000000004 110.82 -178.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -89.29 -0.77 57.72 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.844 0.354 . . . . 74.030000000000001 110.857 176.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.65 41.66 42.42 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-N 115.787 -0.642 . . . . 71.209999999999994 113.7 170.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 88' ' ' ALA . 10.0 p -98.45 152.79 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.978 0.389 . . . . 73.5 110.076 176.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.9 t -148.01 35.54 0.83 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.184 0.516 . . . . 73.310000000000002 109.806 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.405 ' H ' HG22 ' A' ' 93' ' ' VAL . . . -133.21 149.34 52.01 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.009 -0.541 . . . . 73.129999999999995 110.813 -178.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 97' ' ' PRO . 68.6 mt -118.96 128.48 25.93 Favored Pre-proline 0 C--O 1.237 0.42 0 CA-C-N 115.826 -0.625 . . . . 72.430000000000007 109.88 176.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 96' ' ' ILE . 57.2 Cg_endo -92.98 167.03 23.0 Favored 'Cis proline' 0 C--N 1.349 0.575 0 C-N-CA 124.177 -1.176 . . . . 65.310000000000002 112.966 -1.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 62.1 m -120.48 128.63 53.32 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.017 -0.538 . . . . 71.120000000000005 110.906 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.676 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 3.4 mp -106.85 138.91 30.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.46 -0.57 . . . . 53.43 109.46 178.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.541 HD12 ' HB3' ' A' ' 110' ' ' GLN . 34.5 tp -127.56 145.93 50.7 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.797 -0.446 . . . . 73.120000000000005 109.797 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.816 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 72.7 mtp -118.26 116.21 26.31 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 120.874 0.368 . . . . 74.109999999999999 111.979 -173.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -109.41 157.78 18.59 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.736 -0.665 . . . . 74.430000000000007 111.363 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.479 ' CB ' HD21 ' A' ' 108' ' ' LEU . 39.4 ttmt -151.22 102.86 2.97 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.566 -0.901 . . . . 63.310000000000002 108.566 169.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.8 t30 53.73 38.76 29.18 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.394 0.616 . . . . 65.239999999999995 110.762 -177.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.81 -6.48 81.95 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 116.107 -0.497 . . . . 53.509999999999998 113.272 177.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -90.15 134.86 34.02 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 122.434 0.293 . . . . 51.240000000000002 110.248 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 40.2 tttm -89.42 120.95 31.19 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 110.013 -0.366 . . . . 45.119999999999997 110.013 176.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.548 ' N ' HD22 ' A' ' 108' ' ' LEU . 2.0 mm? -98.49 -53.11 3.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.244 -0.434 . . . . 72.549999999999997 110.514 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.816 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 16.7 m -156.78 172.41 18.68 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 115.172 -0.922 . . . . 74.540000000000006 110.007 -169.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.541 ' HB3' HD12 ' A' ' 100' ' ' LEU . 12.4 pt20 -158.4 131.57 7.39 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.88 0.371 . . . . 75.319999999999993 110.452 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.679 HG21 HD11 ' A' ' 63' ' ' LEU . 38.8 t -98.5 107.21 19.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.957 -0.565 . . . . 64.25 110.242 -176.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 68.6 mt -95.46 114.4 31.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.335 -0.393 . . . . 75.109999999999999 109.973 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.36 -109.9 2.9 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.726 -0.749 . . . . 74.409999999999997 111.966 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.61 104.22 1.97 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.658 0.229 . . . . 71.329999999999998 111.264 -178.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.5 ' O ' HG23 ' A' ' 119' ' ' ILE . 37.3 m-20 -140.55 96.05 2.97 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.624 0.25 . . . . 62.439999999999998 110.43 176.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.518 HD12 HD11 ' A' ' 119' ' ' ILE . 6.6 tp -60.15 -42.48 90.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 CA-C-O 120.933 0.397 . . . . 73.120000000000005 110.503 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 36.8 t -61.62 -30.18 70.53 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.715 -0.675 . . . . 71.150000000000006 110.694 -178.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.05 -53.73 6.72 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.183 -0.673 . . . . 71.040000000000006 109.183 179.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.571 HG12 ' HB3' ' A' ' 62' ' ' GLN . 2.1 pp -59.08 -40.41 80.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.692 -0.685 . . . . 71.219999999999999 111.701 -172.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.534 HD12 ' N ' ' A' ' 121' ' ' SER . 2.8 pp -59.2 -36.89 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 C-N-CA 119.935 -0.706 . . . . 75.310000000000002 110.142 178.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.534 ' N ' HD12 ' A' ' 120' ' ' ILE . 28.1 t -70.69 -50.62 34.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.19 -0.459 . . . . 62.240000000000002 110.865 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.562 ' HG2' ' HA ' ' A' ' 119' ' ' ILE . 16.4 pt-20 -76.36 -29.02 57.02 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 112.081 0.4 . . . . 74.319999999999993 112.081 -170.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.605 HD12 HD12 ' A' ' 66' ' ' LEU . 65.2 mt -72.08 -56.86 8.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-O 120.903 0.382 . . . . 72.530000000000001 110.004 174.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -61.88 -20.31 63.59 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.847 -0.615 . . . . 72.010000000000005 110.993 -178.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -66.87 -27.99 67.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.08 -0.509 . . . . 60.229999999999997 111.231 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -120.46 -1.12 10.2 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.497 0.554 . . . . 73.109999999999999 112.497 -171.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 31.4 pt -139.27 167.65 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 110.237 -0.283 . . . . 71.040000000000006 110.237 170.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.53 HD22 ' H ' ' A' ' 128' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.327 -0.845 . . . . 74.439999999999998 110.869 -179.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.757 ' HG2' HG13 ' A' ' 23' ' ' ILE . 1.6 pmm? . . . . . 0 N--CA 1.461 0.108 0 N-CA-C 109.786 -0.45 . . . . 73.25 109.786 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.757 HG13 ' HG2' ' A' ' 22' ' ' MET . 47.1 mt -129.04 118.15 45.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 115.729 -0.669 . . . . 74.400000000000006 109.408 177.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 13.7 tp10 -131.83 155.11 48.37 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.275 -0.269 . . . . 71.409999999999997 110.275 -176.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.443 ' HG3' ' HE3' ' A' ' 78' ' ' LYS . 0.7 OUTLIER -92.2 147.67 22.75 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 110.399 -0.223 . . . . 65.140000000000001 110.399 -178.759 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 42.7 pt -135.02 -176.76 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 120.638 0.256 . . . . 64.230000000000004 110.401 176.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -118.41 167.17 12.94 Favored Glycine 0 C--N 1.331 0.281 0 N-CA-C 111.847 -0.501 . . . . 13.31 111.847 177.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -67.41 -40.79 85.61 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.864 0.32 . . . . 73.329999999999998 111.864 -174.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 83.4 p -80.16 -28.77 38.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.919 0.39 . . . . 64.120000000000005 111.43 -176.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.426 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 2.3 pm0 -91.48 -6.79 52.07 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 116.379 -0.373 . . . . 71.549999999999997 110.484 178.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.442 ' HE1' HG21 ' A' ' 46' ' ' VAL . 37.9 t80 -49.13 -70.8 0.08 Allowed 'General case' 0 C--O 1.227 -0.12 0 CA-C-N 115.871 -0.604 . . . . 65.209999999999994 110.174 175.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -58.22 -38.49 76.9 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 109.65 -0.5 . . . . 71.430000000000007 109.65 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -51.7 -46.43 63.91 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.035 -0.984 . . . . 63.409999999999997 111.321 -172.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -108.04 -21.16 12.92 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.107 0.41 . . . . 53.439999999999998 112.107 -176.643 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 89.7 t -88.17 -50.57 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 N-CA-C 111.722 0.268 . . . . 61.520000000000003 111.722 -177.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 66.4 p -80.18 -25.61 39.64 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 120.244 -0.582 . . . . 74.430000000000007 109.834 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.6 m -88.3 11.99 15.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.452 -0.795 . . . . 73.219999999999999 110.867 177.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.564 ' O ' ' HA ' ' A' ' 104' ' ' ASN . 44.2 t -59.3 104.49 0.26 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.66 0.267 . . . . 60.130000000000003 110.916 -178.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.405 ' N ' HD22 ' A' ' 39' ' ' ASN . 0.9 OUTLIER -81.55 -17.65 47.69 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.879 0.371 . . . . 70.230000000000004 110.293 176.372 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -65.92 -20.74 66.32 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.842 -0.617 . . . . 63.240000000000002 111.349 -177.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 64.44 11.48 6.57 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.058 0.543 . . . . 71.209999999999994 111.86 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.4 tt -73.35 163.29 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 109.442 -0.577 . . . . 74.519999999999996 109.442 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.661 HD21 ' HE3' ' A' ' 101' ' ' MET . 62.6 tp -87.65 110.61 20.53 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.109 0.48 . . . . 74.319999999999993 110.202 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.3 mt -96.0 119.66 44.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.747 -0.661 . . . . 75.349999999999994 110.204 178.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.688 HD13 HD12 ' A' ' 63' ' ' LEU . 71.5 mt -98.87 109.61 22.34 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.696 -0.853 . . . . 41.200000000000003 108.696 177.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.442 HG21 ' HE1' ' A' ' 31' ' ' PHE . 47.1 t -103.04 109.33 26.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.874 -0.148 . . . . 71.439999999999998 111.119 -176.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -81.21 134.28 35.59 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.586 -0.524 . . . . 64.5 109.586 173.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.4 ' HE2' ' HA ' ' A' ' 97' ' ' PRO . 10.7 p90 . . . . . 0 CA--C 1.533 0.301 0 CA-C-O 121.517 0.675 . . . . 73.030000000000001 110.169 178.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 CA--C 1.531 0.345 0 CA-C-O 120.511 0.129 . . . . 71.140000000000001 112.138 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.478 ' HB3' HG12 ' A' ' 119' ' ' ILE . 14.1 mp0 -47.06 -56.09 7.13 Favored 'General case' 0 C--O 1.249 1.067 0 CA-C-O 121.927 0.87 . . . . 74.099999999999994 110.953 -178.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.688 HD12 HD13 ' A' ' 45' ' ' LEU . 3.2 mm? -57.48 -48.14 80.0 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 114.215 -1.357 . . . . 74.219999999999999 110.758 -172.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 35.7 mt-10 -69.77 -38.92 76.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.601 -0.272 . . . . 74.409999999999997 110.853 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 26.7 mmtm -50.75 -50.18 56.24 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.852 0.358 . . . . 71.310000000000002 110.408 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.617 HD12 HD12 ' A' ' 123' ' ' ILE . 32.4 mt -77.73 -37.34 49.53 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 120.542 -0.463 . . . . 73.239999999999995 111.695 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.87 -31.32 72.33 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 111.729 0.27 . . . . 61.5 111.729 -175.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.462 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 75.4 mt-30 -54.44 -37.55 65.3 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.861 0.362 . . . . 70.239999999999995 110.882 178.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -93.57 -46.22 7.39 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.924 -0.58 . . . . 65.549999999999997 110.803 -177.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.528 ' O ' HG22 ' A' ' 74' ' ' VAL . 17.6 m-85 -93.32 22.32 5.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.761 -0.654 . . . . 75.230000000000004 112.366 -173.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.4 t -52.17 -38.55 58.05 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.206 0.447 . . . . 74.329999999999998 112.206 -173.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -71.06 -22.53 62.11 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 122.183 -0.323 . . . . 53.340000000000003 111.832 -177.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.34 -8.63 21.03 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.579 0.228 . . . . 72.310000000000002 110.773 -175.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 70' ' ' TYR . 35.2 m -133.11 151.16 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 O-C-N 121.944 -0.472 . . . . 55.140000000000001 111.412 -178.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.463 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 35.9 mmtm -139.09 115.34 10.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.773 -0.649 . . . . 63.310000000000002 109.563 174.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.55 ' HB ' HG12 ' A' ' 23' ' ' ILE . 56.4 mt -90.12 109.96 21.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.857 -0.61 . . . . 74.420000000000002 110.386 -178.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.463 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 7.7 m-85 -97.79 134.03 41.5 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.799 -0.445 . . . . 72.200000000000003 109.799 176.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.469 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 57.1 mtmt -107.28 155.6 19.78 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.845 -0.616 . . . . 72.219999999999999 110.677 -176.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.469 ' HB ' ' O ' ' A' ' 78' ' ' LYS . 41.4 mm . . . . . 0 N--CA 1.47 0.571 0 O-C-N 124.47 1.106 . . . . 72.5 111.665 178.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.627 0 CA-C-O 120.905 0.383 . . . . 73.530000000000001 110.533 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.5 m -64.02 -40.67 96.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.364 -0.835 . . . . 71.010000000000005 110.297 176.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 54.7 tp60 -63.93 -43.65 95.26 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.841 -0.618 . . . . 72.230000000000004 110.207 178.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -70.68 -17.25 62.85 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.311 -0.404 . . . . 74.030000000000001 110.82 175.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 58.87 42.16 96.51 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 110.819 -0.912 . . . . 71.209999999999994 110.819 -175.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.6 p -93.65 17.6 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-O 120.973 0.416 . . . . 73.5 111.43 -171.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.6 m -66.81 81.27 0.11 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.264 0.554 . . . . 73.310000000000002 110.873 178.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -157.3 91.1 1.15 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.513 -0.921 . . . . 73.129999999999995 108.513 176.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.7 pp -83.52 149.32 57.37 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.426 -0.807 . . . . 72.430000000000007 111.52 -171.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.438 ' HD2' ' O ' ' A' ' 113' ' ' GLY . 15.5 Cg_exo -69.94 161.08 87.44 Favored 'Cis proline' 0 C--N 1.357 0.995 0 C-N-CA 124.268 -1.138 . . . . 65.310000000000002 112.657 -3.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.6 m -141.1 118.36 11.36 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.07 -0.514 . . . . 71.120000000000005 110.97 -175.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.687 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 3.2 mp -120.93 133.71 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.884 -0.598 . . . . 53.43 109.977 178.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.7 mp -109.95 139.61 44.86 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 110.182 -0.303 . . . . 73.120000000000005 110.182 176.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.673 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 71.7 mtp -104.65 116.2 31.65 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.305 -0.407 . . . . 74.109999999999999 110.492 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -114.96 142.16 47.0 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.165 0.507 . . . . 74.430000000000007 111.536 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.622 ' CB ' HD21 ' A' ' 108' ' ' LEU . 23.2 ttmm -143.09 107.08 4.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.17 -0.923 . . . . 63.310000000000002 109.036 174.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.564 ' HA ' ' O ' ' A' ' 38' ' ' CYS . 3.8 t-20 59.74 28.45 17.91 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.471 0.653 . . . . 65.239999999999995 110.461 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.25 -14.41 63.77 Favored Glycine 0 C--N 1.332 0.356 0 CA-C-N 115.819 -0.628 . . . . 53.509999999999998 113.181 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.505 ' HD2' HD13 ' A' ' 108' ' ' LEU . 0.9 OUTLIER -87.7 116.97 26.21 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.703 -0.851 . . . . 51.240000000000002 108.703 176.425 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 101' ' ' MET . 25.5 pttm -77.84 119.34 21.19 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.69 -0.485 . . . . 45.119999999999997 109.69 177.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.622 HD21 ' CB ' ' A' ' 103' ' ' LYS . 1.8 mm? -78.06 -52.06 9.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.335 0.588 . . . . 72.549999999999997 109.951 -175.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.673 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 72.1 m -160.69 172.47 17.04 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 114.944 -1.025 . . . . 74.540000000000006 110.11 -170.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.02 126.56 17.84 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.124 -0.489 . . . . 75.319999999999993 111.044 -174.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.687 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 44.2 t -85.88 106.97 15.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.316 -0.624 . . . . 64.25 109.316 174.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 32.7 mt -113.66 109.89 30.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.509 -0.552 . . . . 75.109999999999999 109.509 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.438 ' O ' ' HD2' ' A' ' 97' ' ' PRO . . . 100.74 -121.27 7.18 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.147 -0.549 . . . . 74.409999999999997 111.867 -177.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.21 57.37 0.51 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.349 0.595 . . . . 71.329999999999998 110.276 -177.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.528 ' O ' HG23 ' A' ' 119' ' ' ILE . 2.5 m-20 -103.51 95.54 6.14 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.719 -0.673 . . . . 62.439999999999998 110.86 -173.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.582 ' O ' HG13 ' A' ' 119' ' ' ILE . 6.0 tp -63.24 -43.99 99.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 116.126 -0.488 . . . . 73.120000000000005 112.074 -175.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.8 t -65.69 -28.2 68.9 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.13 0.49 . . . . 71.150000000000006 110.139 -178.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -75.67 -46.74 29.63 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.884 -0.598 . . . . 71.040000000000006 109.529 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.634 ' HA ' ' HG2' ' A' ' 122' ' ' GLU . 2.2 pp -66.67 -39.42 83.73 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.095 0 CA-C-N 116.325 -0.398 . . . . 71.219999999999999 111.713 -175.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.455 HD12 ' N ' ' A' ' 121' ' ' SER . 2.8 pp -62.5 -31.75 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 C-N-CA 120.385 -0.526 . . . . 75.310000000000002 109.768 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.455 ' N ' HD12 ' A' ' 120' ' ' ILE . 35.0 t -70.62 -51.37 28.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.877 -0.601 . . . . 62.240000000000002 110.657 176.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.634 ' HG2' ' HA ' ' A' ' 119' ' ' ILE . 16.7 pt-20 -71.28 -40.82 70.68 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 112.025 0.38 . . . . 74.319999999999993 112.025 -172.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.617 HD12 HD12 ' A' ' 66' ' ' LEU . 82.1 mt -70.71 -59.67 3.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.607 -0.27 . . . . 72.530000000000001 111.101 -177.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -58.02 -26.26 62.2 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.148 0.499 . . . . 72.010000000000005 111.022 -176.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -63.58 -28.94 70.27 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.859 -0.61 . . . . 60.229999999999997 111.223 178.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -115.0 9.92 16.13 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.244 0.461 . . . . 73.109999999999999 112.244 -174.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.473 HG12 ' O ' ' A' ' 123' ' ' ILE . 42.7 pt -139.08 168.92 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 110.212 -0.292 . . . . 71.040000000000006 110.212 175.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.252 1.214 0 CA-C-O 118.444 -0.788 . . . . 74.439999999999998 111.983 -176.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.559 ' N ' ' SD ' ' A' ' 22' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.352 0 CA-C-O 121.031 0.443 . . . . 73.25 109.885 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.427 HG12 ' HB ' ' A' ' 76' ' ' ILE . 46.0 mt -103.32 84.55 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 115.365 -0.834 . . . . 74.400000000000006 108.966 172.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 10.0 tp10 -86.74 155.44 20.35 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.14 -0.482 . . . . 71.409999999999997 110.549 -175.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -97.34 143.79 27.75 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.742 0.306 . . . . 65.140000000000001 110.294 178.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.512 HD12 ' HA ' ' A' ' 31' ' ' PHE . 29.9 pt -133.65 163.67 36.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-N 116.324 -0.398 . . . . 64.230000000000004 110.639 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -98.12 155.6 20.34 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.899 -0.591 . . . . 13.31 111.654 176.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -60.3 -30.35 69.42 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.896 0.379 . . . . 73.329999999999998 110.902 -178.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.7 p -61.84 -30.98 71.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.879 -0.601 . . . . 64.120000000000005 111.337 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -114.24 4.14 15.38 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.216 -0.447 . . . . 71.549999999999997 111.954 -175.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.512 ' HA ' HD12 ' A' ' 26' ' ' ILE . 81.3 t80 -52.85 -71.63 0.07 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.733 0.301 . . . . 65.209999999999994 110.703 -177.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.553 ' O ' HG22 ' A' ' 36' ' ' THR . 7.3 p-10 -65.27 -34.06 77.46 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.617 -0.512 . . . . 71.430000000000007 109.617 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -52.28 -44.72 65.14 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.7 -1.136 . . . . 63.409999999999997 111.55 -176.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt -100.9 -25.79 13.97 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.568 -0.287 . . . . 53.439999999999998 111.139 -177.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.3 t -78.49 -61.45 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 112.12 0.415 . . . . 61.520000000000003 112.12 -176.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.553 HG22 ' O ' ' A' ' 32' ' ' ASP . 11.9 t -84.32 0.35 49.47 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.005 0.431 . . . . 74.430000000000007 110.889 -170.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.6 m -98.82 -4.74 32.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.339 -0.392 . . . . 73.219999999999999 111.044 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.549 ' SG ' HG22 ' A' ' 42' ' ' ILE . 47.8 t -71.97 100.06 2.38 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.024 0.44 . . . . 60.130000000000003 111.034 -175.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -93.18 2.32 56.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.391 0.615 . . . . 70.230000000000004 109.548 176.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -63.09 -14.56 49.92 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.479 -0.782 . . . . 63.240000000000002 111.168 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.581 ' O ' ' HE3' ' A' ' 103' ' ' LYS . 32.8 m-80 69.21 19.63 7.81 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.749 -0.659 . . . . 71.209999999999994 110.946 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.549 HG22 ' SG ' ' A' ' 38' ' ' CYS . 10.9 tt -88.97 146.63 5.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 108.495 -0.928 . . . . 74.519999999999996 108.495 172.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.667 HD11 ' HB3' ' A' ' 101' ' ' MET . 68.7 tp -85.6 113.6 21.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.251 0.548 . . . . 74.319999999999993 110.648 -176.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 57.4 mt -94.64 123.62 46.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.199 -0.909 . . . . 75.349999999999994 110.331 177.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.529 ' HB2' HG12 ' A' ' 76' ' ' ILE . 2.2 mm? -104.74 104.36 14.15 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.334 -0.617 . . . . 41.200000000000003 109.334 178.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 35.9 m -99.1 130.29 48.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 110.357 -0.238 . . . . 71.439999999999998 110.357 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.499 ' HB2' HG13 ' A' ' 99' ' ' ILE . 27.0 t70 -122.62 141.29 51.88 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 120.923 0.392 . . . . 64.5 111.434 -177.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 . . . . . 0 C--N 1.329 -0.319 0 N-CA-C 108.699 -0.852 . . . . 73.030000000000001 108.699 172.774 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.424 ' HD2' ' HB2' ' A' ' 64' ' ' GLU . 86.4 Cg_endo . . . . . 0 N--CA 1.459 -0.514 0 N-CA-C 111.4 -0.269 . . . . 71.140000000000001 111.4 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.675 ' NE2' ' HA ' ' A' ' 114' ' ' ALA . 0.4 OUTLIER -45.15 -57.56 3.83 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.179 0.592 . . . . 74.099999999999994 111.931 -173.636 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.437 HD22 ' HB2' ' A' ' 62' ' ' GLN . 3.5 mm? -60.71 -48.6 81.07 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.392 -0.822 . . . . 74.219999999999999 111.25 -172.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.502 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 39.7 mt-10 -66.0 -37.66 86.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.965 0.412 . . . . 74.409999999999997 110.221 178.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.427 ' HD2' ' HA ' ' A' ' 65' ' ' LYS . 42.2 tptt -60.71 -45.07 95.63 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.501 -0.772 . . . . 71.310000000000002 110.405 -174.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.712 HD12 HD12 ' A' ' 123' ' ' ILE . 23.9 mt -79.95 -30.31 39.83 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.515 -0.312 . . . . 73.239999999999995 110.988 176.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.68 -33.62 74.31 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.699 0.285 . . . . 61.5 110.847 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.502 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 78.4 mt-30 -56.07 -31.79 63.53 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.048 0.452 . . . . 70.239999999999995 110.547 177.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -93.9 -53.78 3.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.74 -0.663 . . . . 65.549999999999997 111.041 -178.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.512 ' O ' HG22 ' A' ' 74' ' ' VAL . 14.4 m-85 -95.73 23.11 6.48 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.604 -0.725 . . . . 75.230000000000004 112.822 -168.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.7 t -52.78 -28.64 23.34 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.77 0.319 . . . . 74.329999999999998 111.69 -176.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -71.03 -18.71 62.57 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.603 -0.272 . . . . 53.340000000000003 111.642 -177.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -120.65 1.07 10.54 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.654 0.264 . . . . 72.310000000000002 110.554 -176.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.512 HG22 ' O ' ' A' ' 70' ' ' TYR . 27.9 m -133.57 145.79 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 O-C-N 122.019 -0.426 . . . . 55.140000000000001 111.312 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 75' ' ' LYS . 41.7 mmtm -141.09 124.43 16.6 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.143 -0.688 . . . . 63.310000000000002 109.143 172.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.529 HG12 ' HB2' ' A' ' 45' ' ' LEU . 49.5 mt -103.26 135.14 42.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 110.084 -0.339 . . . . 74.420000000000002 110.084 -175.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.494 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 74.1 m-85 -126.29 128.68 47.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.884 0.374 . . . . 72.200000000000003 110.242 178.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -97.54 139.29 33.67 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.719 -0.845 . . . . 72.219999999999999 108.719 176.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 20.6 tt . . . . . 0 C--N 1.321 -0.641 0 N-CA-C 109.862 -0.422 . . . . 72.5 109.862 176.024 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.296 0 CA-C-O 121.21 0.528 . . . . 73.530000000000001 110.398 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 29.7 m -67.44 -28.32 67.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.748 -0.66 . . . . 71.010000000000005 110.389 178.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -63.41 -42.69 98.76 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.875 -0.602 . . . . 72.230000000000004 110.19 178.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -74.89 -17.19 60.62 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.274 -0.421 . . . . 74.030000000000001 110.725 176.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 86.9 36.73 8.93 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 121.226 -0.512 . . . . 71.209999999999994 112.395 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 99.3 t -70.34 92.52 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-O 121.126 0.488 . . . . 73.5 110.028 176.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.7 m -70.53 -33.39 71.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.56 -0.745 . . . . 73.310000000000002 111.367 -178.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -148.11 145.8 28.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.881 0.372 . . . . 73.129999999999995 111.187 -176.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.542 ' HB ' ' HA ' ' A' ' 97' ' ' PRO . 17.3 pt -101.43 161.68 22.83 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 115.46 -0.791 . . . . 72.430000000000007 109.626 177.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.542 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 93.9 Cg_endo -74.49 169.97 72.62 Favored 'Cis proline' 0 C--N 1.357 0.999 0 C-N-CA 124.585 -1.006 . . . . 65.310000000000002 113.243 3.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 96.7 m -155.29 122.03 5.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.483 -0.781 . . . . 71.120000000000005 109.699 -175.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.51 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.5 mp -106.7 108.95 26.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.123 -0.489 . . . . 53.43 110.277 -174.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.426 HD23 ' H ' ' A' ' 101' ' ' MET . 1.0 OUTLIER -92.9 136.49 33.21 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.88 -0.785 . . . . 73.120000000000005 108.88 177.755 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.901 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 69.0 mtp -101.34 117.52 35.13 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.244 -0.434 . . . . 74.109999999999999 110.943 -174.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -117.55 146.9 43.27 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 122.657 0.383 . . . . 74.430000000000007 110.524 178.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.812 ' HB3' HD21 ' A' ' 108' ' ' LEU . 84.1 tttt -166.68 135.37 2.84 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.973 -0.751 . . . . 63.310000000000002 108.973 -179.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 12.1 t30 60.24 24.91 14.3 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.575 0.702 . . . . 65.239999999999995 110.508 177.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.93 17.61 76.73 Favored Glycine 0 CA--C 1.517 0.16 0 CA-C-N 115.789 -0.641 . . . . 53.509999999999998 113.392 178.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -136.44 157.53 46.56 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 117.059 0.429 . . . . 51.240000000000002 110.265 178.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.703 ' H ' ' HD2' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -83.36 142.47 31.01 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.363 -0.38 . . . . 45.119999999999997 110.085 176.62 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.812 HD21 ' HB3' ' A' ' 103' ' ' LYS . 2.9 mm? -111.47 -53.03 2.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.308 -0.406 . . . . 72.549999999999997 110.928 -178.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.901 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 14.2 m -158.26 172.17 18.87 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.949 -0.569 . . . . 74.540000000000006 110.124 -171.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -142.82 140.32 31.26 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.157 0.503 . . . . 75.319999999999993 111.76 -175.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.599 HG22 HG22 ' A' ' 119' ' ' ILE . 32.8 t -115.81 134.44 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 115.613 -0.721 . . . . 64.25 109.677 178.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 43.2 mt -126.15 106.89 16.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.899 0.381 . . . . 75.109999999999999 109.987 178.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 71.96 -85.86 0.47 Allowed Glycine 0 CA--C 1.521 0.425 0 CA-C-N 116.109 -0.496 . . . . 74.409999999999997 112.98 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.675 ' HA ' ' NE2' ' A' ' 62' ' ' GLN . . . -151.49 103.08 2.94 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 122.723 -0.28 . . . . 71.329999999999998 111.292 -174.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.45 ' O ' HG23 ' A' ' 119' ' ' ILE . 20.3 m-20 -132.49 63.28 1.63 Allowed 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 109.596 -0.52 . . . . 62.439999999999998 109.596 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.55 ' O ' HG13 ' A' ' 119' ' ' ILE . 6.8 tp -53.49 -51.57 40.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 N-CA-C 112.359 0.503 . . . . 73.120000000000005 112.359 -172.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.3 p -63.87 -28.1 69.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.33 0.586 . . . . 71.150000000000006 111.193 -178.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.429 ' HE2' ' HB2' ' A' ' 115' ' ' ASP . 3.0 tmmm? -79.47 -45.34 19.58 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.628 -0.715 . . . . 71.040000000000006 109.865 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.599 HG22 HG22 ' A' ' 111' ' ' VAL . 2.5 pp -69.26 -37.37 75.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 115.778 -0.647 . . . . 71.219999999999999 111.204 -174.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.474 HD12 ' N ' ' A' ' 121' ' ' SER . 2.9 pp -63.28 -31.92 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 C-N-CA 120.08 -0.648 . . . . 75.310000000000002 110.036 177.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.474 ' N ' HD12 ' A' ' 120' ' ' ILE . 45.0 t -70.52 -51.51 28.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.98 -0.555 . . . . 62.240000000000002 110.916 178.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.561 ' HG2' ' HA ' ' A' ' 119' ' ' ILE . 24.2 pt-20 -72.1 -48.93 40.28 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.151 0.426 . . . . 74.319999999999993 112.151 -174.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.712 HD12 HD12 ' A' ' 66' ' ' LEU . 83.4 mt -59.38 -55.81 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.597 0.237 . . . . 72.530000000000001 110.852 -177.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -58.77 -20.31 48.58 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.991 0.425 . . . . 72.010000000000005 111.044 -178.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -84.12 -35.55 23.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.032 -0.531 . . . . 60.229999999999997 111.06 177.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -91.69 -9.34 44.22 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.192 -0.458 . . . . 73.109999999999999 111.929 -172.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.479 HG12 ' O ' ' A' ' 123' ' ' ILE . 45.4 pt -133.94 168.19 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 120.689 0.28 . . . . 71.040000000000006 110.691 175.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.245 0.857 0 CA-C-O 118.802 -0.618 . . . . 74.439999999999998 110.624 -175.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.515 ' N ' ' SD ' ' A' ' 22' ' ' MET . 1.4 mpt? . . . . . 0 C--O 1.235 0.302 0 CA-C-O 120.799 0.333 . . . . 73.25 111.105 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.9 mt -111.66 128.11 68.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 115.898 -0.592 . . . . 74.400000000000006 110.337 -175.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 0.9 OUTLIER -122.0 144.22 49.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.326 -0.397 . . . . 71.409999999999997 109.952 -179.556 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.41 137.79 33.13 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 110.223 -0.288 . . . . 65.140000000000001 110.223 177.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.494 HD12 ' HA ' ' A' ' 31' ' ' PHE . 36.2 pt -140.22 172.96 11.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 121.337 0.589 . . . . 64.230000000000004 111.399 -176.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -110.73 173.91 16.61 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.236 -0.893 . . . . 13.31 111.809 177.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -67.29 -33.68 75.81 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.684 0.253 . . . . 73.329999999999998 111.684 -177.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 44.6 m -64.48 -47.56 78.52 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.091 0.472 . . . . 64.120000000000005 110.804 -178.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.509 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 3.8 pm0 -84.29 -14.46 49.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.762 -0.654 . . . . 71.549999999999997 111.072 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.604 ' HE1' HG11 ' A' ' 46' ' ' VAL . 92.4 t80 -46.23 -70.08 0.11 Allowed 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.384 0.427 . . . . 65.209999999999994 110.726 -178.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -61.68 -39.85 92.9 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 121.128 0.489 . . . . 71.430000000000007 109.726 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.421 ' O ' ' HB2' ' A' ' 37' ' ' SER . 9.4 t-20 -56.35 -33.76 65.98 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.617 -1.174 . . . . 63.409999999999997 112.216 -171.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 18.7 ptmt -115.16 -21.85 9.76 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.711 0.263 . . . . 53.439999999999998 111.711 -177.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 93.6 t -88.5 -55.63 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 111.727 0.269 . . . . 61.520000000000003 111.727 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 30.8 p -85.87 -25.24 26.32 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.076 0.465 . . . . 74.430000000000007 110.796 -173.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 16.0 m -84.67 12.03 7.91 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.997 -0.547 . . . . 73.219999999999999 110.547 176.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 43.5 t -75.22 94.73 3.02 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.868 0.366 . . . . 60.130000000000003 110.548 178.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -91.88 1.31 57.26 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.138 -0.483 . . . . 70.230000000000004 110.563 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -72.22 -7.79 51.22 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.197 -0.456 . . . . 63.240000000000002 111.499 -176.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 64.39 15.82 9.77 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.18 -0.464 . . . . 71.209999999999994 111.397 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.9 tt -85.04 147.82 5.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 108.507 -0.923 . . . . 74.519999999999996 108.507 173.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.657 HD21 ' HE3' ' A' ' 101' ' ' MET . 61.2 tp -85.31 120.68 27.07 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.338 0.589 . . . . 74.319999999999993 110.682 -175.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 51.1 mt -106.98 126.02 63.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.379 -0.828 . . . . 75.349999999999994 110.392 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 45' ' ' LEU . 5.8 mp -108.81 110.13 21.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.317 -0.401 . . . . 41.200000000000003 110.067 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.604 HG11 ' HE1' ' A' ' 31' ' ' PHE . 59.3 t -96.96 111.26 26.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.812 -0.44 . . . . 71.439999999999998 109.812 176.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.424 ' OD1' ' NZ ' ' A' ' 78' ' ' LYS . 1.7 p30 -91.24 154.64 19.14 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.077 0.465 . . . . 64.5 110.62 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.7 t80 . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 115.664 -0.698 . . . . 73.030000000000001 110.173 178.824 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo . . . . . 0 C--O 1.235 0.329 0 CA-C-O 120.763 0.235 . . . . 71.140000000000001 111.911 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.454 ' H ' ' CD ' ' A' ' 62' ' ' GLN . 13.9 mp0 -57.74 -48.45 79.58 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.599 0.714 . . . . 74.099999999999994 110.466 -175.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.63 HD21 HG12 ' A' ' 99' ' ' ILE . 8.1 mp -55.55 -49.08 73.61 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 114.586 -1.188 . . . . 74.219999999999999 111.627 -174.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -71.15 -36.45 72.06 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.224 -0.287 . . . . 74.409999999999997 110.224 -177.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.439 ' HA ' ' HD3' ' A' ' 65' ' ' LYS . 41.3 mmtt -55.58 -51.67 66.33 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.234 -0.439 . . . . 71.310000000000002 111.248 178.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.591 HD12 HD12 ' A' ' 123' ' ' ILE . 28.5 mt -76.38 -40.9 49.75 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 120.368 -0.533 . . . . 73.239999999999995 111.493 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.467 ' HB1' ' HB3' ' A' ' 22' ' ' MET . . . -59.68 -38.3 81.13 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 111.714 0.265 . . . . 61.5 111.714 -175.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -53.93 -33.07 55.71 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.751 0.31 . . . . 70.239999999999995 110.901 179.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 70.5 mm-40 -93.89 -41.09 9.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.031 -0.531 . . . . 65.549999999999997 111.17 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.494 ' O ' HG22 ' A' ' 74' ' ' VAL . 19.3 m-85 -107.42 17.46 22.75 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.957 0.725 . . . . 75.230000000000004 112.957 -168.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.0 t -53.95 -32.73 54.71 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.312 0.506 . . . . 74.329999999999998 112.188 -174.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -68.43 -16.69 64.0 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.804 0.335 . . . . 53.340000000000003 111.302 -178.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -114.47 -13.96 12.18 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.173 -0.467 . . . . 72.310000000000002 110.321 -178.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 70' ' ' TYR . 26.8 m -134.98 127.31 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 120.934 0.397 . . . . 55.140000000000001 110.688 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -118.42 122.83 43.75 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.57 -0.53 . . . . 63.310000000000002 109.57 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.476 HD13 ' HB3' ' A' ' 63' ' ' LEU . 60.7 mt -98.97 141.0 17.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.911 0.386 . . . . 74.420000000000002 110.913 -175.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.459 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 87.6 m-85 -133.63 157.93 44.52 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.076 -0.713 . . . . 72.200000000000003 109.076 175.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.424 ' NZ ' ' OD1' ' A' ' 47' ' ' ASP . 0.4 OUTLIER -141.33 148.82 40.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.872 0.367 . . . . 72.219999999999999 110.799 179.244 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.4 pp . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 115.525 -0.761 . . . . 72.5 110.423 -179.181 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.387 0 CA-C-O 120.815 0.34 . . . . 73.530000000000001 111.431 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.1 m -72.3 -28.16 62.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 71.010000000000005 110.931 -179.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -65.6 -40.78 93.03 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.97 -0.559 . . . . 72.230000000000004 110.092 -178.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -88.23 -17.17 31.37 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.564 -0.744 . . . . 74.030000000000001 110.363 175.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 63.43 50.56 61.38 Favored Glycine 0 C--N 1.333 0.412 0 N-CA-C 111.19 -0.764 . . . . 71.209999999999994 111.19 -175.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.7 p -56.25 115.18 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.242 0.544 . . . . 73.5 111.187 -176.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.9 m -96.96 -14.26 21.82 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.813 -0.631 . . . . 73.310000000000002 110.855 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.77 131.66 15.15 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.705 0.288 . . . . 73.129999999999995 111.208 -177.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.532 ' HB ' ' HA ' ' A' ' 97' ' ' PRO . 2.8 pp -96.11 161.7 26.29 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 116.038 -0.528 . . . . 72.430000000000007 110.123 175.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.532 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 3.3 Cg_exo -76.83 176.52 43.59 Favored 'Cis proline' 0 C--N 1.355 0.888 0 C-N-CA 124.389 -1.088 . . . . 65.310000000000002 112.314 -0.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 15.9 m -134.32 121.35 21.11 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.221 -0.445 . . . . 71.120000000000005 110.098 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.655 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 3.7 mp -117.07 125.8 74.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.331 -0.618 . . . . 53.43 109.331 179.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -106.92 128.9 54.72 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.794 0.331 . . . . 73.120000000000005 110.129 -177.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.756 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 65.9 mtp -100.74 113.26 25.99 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.117 -0.492 . . . . 74.109999999999999 110.772 -177.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -111.42 146.61 36.88 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.076 -0.511 . . . . 74.430000000000007 110.749 178.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.802 ' HB3' HD21 ' A' ' 108' ' ' LEU . 33.9 ttpt -160.06 130.89 5.68 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.889 -0.782 . . . . 63.310000000000002 108.889 177.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 31.5 t-20 55.11 31.61 16.63 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.681 0.753 . . . . 65.239999999999995 110.101 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 74.84 20.93 79.26 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.313 -0.858 . . . . 53.509999999999998 113.42 176.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -129.3 155.2 45.97 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.758 0.279 . . . . 51.240000000000002 110.663 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.53 120.14 32.69 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.765 0.317 . . . . 45.119999999999997 110.168 177.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.802 HD21 ' HB3' ' A' ' 103' ' ' LYS . 2.0 mm? -92.89 -51.87 4.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.332 -0.395 . . . . 72.549999999999997 110.323 -178.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.756 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 49.7 m -153.96 171.54 18.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.59 -0.732 . . . . 74.540000000000006 110.592 -175.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -146.16 124.89 12.57 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.992 -0.549 . . . . 75.319999999999993 110.546 176.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.655 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 52.5 t -82.55 107.12 14.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.697 -0.483 . . . . 64.25 109.697 176.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 64.5 mt -109.18 108.67 25.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.813 -0.44 . . . . 75.109999999999999 109.813 178.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.0 -122.9 7.74 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.18 -0.534 . . . . 74.409999999999997 111.783 -178.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.24 88.15 1.0 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.779 0.323 . . . . 71.329999999999998 110.27 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.479 ' O ' HG23 ' A' ' 119' ' ' ILE . 3.6 m-20 -126.7 86.58 2.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.274 -0.421 . . . . 62.439999999999998 110.282 -177.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.52 ' O ' HG13 ' A' ' 119' ' ' ILE . 7.7 tp -55.57 -44.76 77.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 116.242 -0.435 . . . . 73.120000000000005 111.807 -176.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.5 t -68.09 -26.48 65.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.07 0.462 . . . . 71.150000000000006 110.655 -175.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -79.71 -45.6 18.64 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 116.086 -0.506 . . . . 71.040000000000006 110.269 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.52 HG13 ' O ' ' A' ' 116' ' ' ILE . 2.1 pp -67.87 -40.27 83.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 115.853 -0.612 . . . . 71.219999999999999 111.088 -175.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.485 HG22 HD11 ' A' ' 66' ' ' LEU . 2.8 pp -61.79 -32.23 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 120.439 -0.505 . . . . 75.310000000000002 110.029 178.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.468 ' N ' HD12 ' A' ' 120' ' ' ILE . 27.9 t -70.29 -51.77 27.89 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.867 -0.606 . . . . 62.240000000000002 110.379 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.477 ' HG2' ' HA ' ' A' ' 119' ' ' ILE . 21.0 pt-20 -72.02 -34.33 68.75 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.186 0.439 . . . . 74.319999999999993 112.186 -175.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.591 HD12 HD12 ' A' ' 66' ' ' LEU . 66.8 mt -71.02 -47.97 58.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-O 120.661 0.267 . . . . 72.530000000000001 110.795 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -66.77 -20.12 65.89 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.948 0.404 . . . . 72.010000000000005 111.247 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -74.02 -6.13 45.57 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.458 -0.337 . . . . 60.229999999999997 111.172 174.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -113.93 -49.0 2.88 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.826 0.346 . . . . 73.109999999999999 110.648 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 33.6 pt -100.38 168.03 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.779 -0.646 . . . . 71.040000000000006 110.665 -177.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.468 ' N ' HD22 ' A' ' 128' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.161 0 CA-C-O 118.355 -0.831 . . . . 74.439999999999998 110.723 178.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.728 ' HG3' HG12 ' A' ' 23' ' ' ILE . 25.3 ptt? . . . . . 0 N--CA 1.463 0.208 0 CA-C-O 120.666 0.27 . . . . 73.25 110.655 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.728 HG12 ' HG3' ' A' ' 22' ' ' MET . 14.6 mm -113.78 108.82 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 N-CA-C 109.043 -0.725 . . . . 74.400000000000006 109.043 178.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.568 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 36.1 tt0 -122.73 131.98 54.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.733 0.301 . . . . 71.409999999999997 110.536 -172.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -90.22 128.89 36.5 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.641 -0.503 . . . . 65.140000000000001 109.641 178.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.449 HG21 ' HD3' ' A' ' 34' ' ' LYS . 47.5 pt -130.9 165.94 29.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-O 121.056 0.455 . . . . 64.230000000000004 111.492 -175.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -111.79 169.26 13.07 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.576 -0.738 . . . . 13.31 112.845 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -52.25 -38.85 59.35 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 122.824 0.45 . . . . 73.329999999999998 111.407 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.5 t -59.36 -21.88 60.5 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.821 -0.627 . . . . 64.120000000000005 112.251 -175.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.51 ' HA ' ' HB2' ' A' ' 33' ' ' ASN . 11.3 pt-20 -125.64 -3.34 7.24 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 111.679 0.251 . . . . 71.549999999999997 111.679 -175.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -51.61 -70.8 0.08 Allowed 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.192 0.308 . . . . 65.209999999999994 111.152 -177.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -58.8 -42.71 89.75 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.638 0.733 . . . . 71.430000000000007 109.429 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.51 ' HB2' ' HA ' ' A' ' 30' ' ' GLU . 1.5 m-80 -52.44 -38.25 58.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 113.829 -1.532 . . . . 63.409999999999997 112.795 -172.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.449 ' HD3' HG21 ' A' ' 26' ' ' ILE . 16.1 ptmt -111.31 -19.58 12.59 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.023 0.379 . . . . 53.439999999999998 112.023 -177.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.6 t -88.26 -55.32 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 111.928 0.344 . . . . 61.520000000000003 111.928 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 45.7 p -77.92 -38.3 45.89 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.171 0.51 . . . . 74.430000000000007 110.78 -173.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.7 m -79.89 9.29 5.47 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.854 -0.612 . . . . 73.219999999999999 111.511 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 53.2 t -75.44 111.38 10.66 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.798 0.332 . . . . 60.130000000000003 111.066 -178.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -116.69 15.1 15.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.026 -0.534 . . . . 70.230000000000004 110.317 178.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -68.96 -2.46 9.87 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.828 -0.624 . . . . 63.240000000000002 112.08 -177.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.454 ' O ' ' HE3' ' A' ' 103' ' ' LYS . 18.3 m120 70.18 6.26 5.69 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 122.954 0.502 . . . . 71.209999999999994 111.071 -177.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.3 tt -89.09 157.08 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.331 -0.618 . . . . 74.519999999999996 109.331 178.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.503 HD21 ' HE2' ' A' ' 101' ' ' MET . 63.7 tp -96.26 118.23 32.41 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.155 -0.313 . . . . 74.319999999999993 110.155 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 101' ' ' MET . 48.8 mt -97.96 124.79 51.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.163 -0.471 . . . . 75.349999999999994 110.703 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.532 ' HB2' HG13 ' A' ' 76' ' ' ILE . 3.3 mp -115.7 105.77 13.12 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.654 -0.499 . . . . 41.200000000000003 109.654 178.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.548 HG12 ' HB2' ' A' ' 77' ' ' TYR . 30.9 m -97.01 121.69 47.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 CA-C-N 116.625 -0.261 . . . . 71.439999999999998 110.32 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.432 ' OD1' ' HG2' ' A' ' 78' ' ' LYS . 5.8 p-10 -104.63 125.42 50.73 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.391 0.615 . . . . 64.5 109.823 176.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 115.414 -0.812 . . . . 73.030000000000001 111.497 -176.735 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo . . . . . 0 CA--C 1.534 0.502 0 CA-C-O 121.15 0.396 . . . . 71.140000000000001 112.952 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.688 ' HB3' HG12 ' A' ' 119' ' ' ILE . 11.5 mp0 -51.18 -49.03 61.74 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 115.316 -0.857 . . . . 74.099999999999994 111.65 -173.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.559 ' H ' HD22 ' A' ' 63' ' ' LEU . 2.5 mm? -64.25 -46.13 85.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.852 -1.067 . . . . 74.219999999999999 110.124 -172.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.588 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 55.0 mt-10 -68.0 -32.51 72.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.747 -0.66 . . . . 74.409999999999997 110.449 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -58.41 -56.66 19.23 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.342 -0.39 . . . . 71.310000000000002 110.634 176.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.595 HD12 HD12 ' A' ' 123' ' ' ILE . 22.5 mt -69.13 -30.11 68.29 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 120.825 -0.35 . . . . 73.239999999999995 110.861 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.21 -36.35 70.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.419 -0.355 . . . . 61.5 111.278 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.588 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 84.2 mt-30 -56.25 -32.98 65.0 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.286 -0.415 . . . . 70.239999999999995 111.006 -178.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -94.01 -56.59 2.81 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.322 0.582 . . . . 65.549999999999997 110.826 178.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.521 ' O ' HG22 ' A' ' 74' ' ' VAL . 22.2 m-85 -82.52 21.69 0.94 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.645 -0.707 . . . . 75.230000000000004 112.336 -173.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.461 ' OG1' ' HB3' ' A' ' 22' ' ' MET . 8.8 t -52.46 -31.26 33.92 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.976 0.417 . . . . 74.329999999999998 111.698 -176.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -70.13 -18.96 63.25 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.103 -0.498 . . . . 53.340000000000003 111.542 -175.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.41 6.24 8.35 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.732 0.301 . . . . 72.310000000000002 110.815 -173.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 70' ' ' TYR . 23.1 m -137.46 145.07 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 121.117 0.484 . . . . 55.140000000000001 111.583 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.5 mmtt -129.14 114.86 16.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.528 -0.76 . . . . 63.310000000000002 108.959 174.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.532 HG13 ' HB2' ' A' ' 45' ' ' LEU . 2.3 mp -100.5 138.43 24.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.559 -0.534 . . . . 74.420000000000002 109.559 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.568 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 41.2 m-85 -130.55 134.26 46.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.247 -0.433 . . . . 72.200000000000003 110.885 -177.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.432 ' HG2' ' OD1' ' A' ' 47' ' ' ASP . 55.9 mttm -109.19 111.86 23.7 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.257 -0.646 . . . . 72.219999999999999 109.257 174.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 32.0 pt . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 115.958 -0.564 . . . . 72.5 111.25 -175.882 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.554 0 CA-C-O 120.915 0.388 . . . . 73.530000000000001 111.001 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 88.5 m -65.76 -36.43 83.53 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.209 -0.45 . . . . 71.010000000000005 110.118 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -65.77 -37.34 86.05 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.159 -0.473 . . . . 72.230000000000004 110.228 177.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -70.72 -15.25 62.68 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.192 -0.458 . . . . 74.030000000000001 110.656 174.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.07 38.88 46.84 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.192 -0.528 . . . . 71.209999999999994 112.059 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.8 p -51.98 120.22 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 121.104 0.478 . . . . 73.5 111.168 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.4 m -124.37 6.57 8.37 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.782 -0.645 . . . . 73.310000000000002 110.609 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -156.38 126.77 6.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.09 -0.505 . . . . 73.129999999999995 110.606 -179.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.42 ' HB ' ' HA ' ' A' ' 97' ' ' PRO . 29.7 pt -101.69 156.14 35.55 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.986 -0.552 . . . . 72.430000000000007 109.755 177.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.42 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 84.5 Cg_endo -79.47 163.04 84.98 Favored 'Cis proline' 0 C--N 1.352 0.721 0 C-N-CA 123.822 -1.324 . . . . 65.310000000000002 112.709 1.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.484 HG23 HG12 ' A' ' 112' ' ' ILE . 30.6 m -128.19 115.62 18.65 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.733 -0.667 . . . . 71.120000000000005 109.36 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.623 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 3.4 mp -110.36 124.13 66.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.364 -0.38 . . . . 53.43 110.502 -176.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.4 mp -103.5 133.81 47.92 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.793 -0.447 . . . . 73.120000000000005 109.793 176.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.768 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 66.3 mtp -112.04 108.56 17.91 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.312 -0.404 . . . . 74.109999999999999 110.595 -175.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -108.76 154.83 21.49 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.162 -0.472 . . . . 74.430000000000007 111.272 -178.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.768 ' HB3' HD21 ' A' ' 108' ' ' LEU . 87.7 tttt -162.86 117.32 1.73 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.401 -0.962 . . . . 63.310000000000002 108.401 179.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 62.42 25.19 15.02 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.528 0.68 . . . . 65.239999999999995 110.416 -178.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.69 -0.44 89.19 Favored Glycine 0 C--N 1.331 0.291 0 CA-C-N 115.881 -0.599 . . . . 53.509999999999998 112.763 179.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -100.62 137.56 38.85 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.829 -0.434 . . . . 51.240000000000002 109.829 177.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.86 126.92 33.88 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.306 -0.627 . . . . 45.119999999999997 109.306 174.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.768 HD21 ' HB3' ' A' ' 103' ' ' LYS . 2.0 mm? -98.16 -51.09 4.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.224 -0.443 . . . . 72.549999999999997 110.108 -178.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.768 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 18.8 m -149.47 155.68 40.78 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.655 -0.702 . . . . 74.540000000000006 111.122 -171.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -131.04 118.85 21.16 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.802 -0.635 . . . . 75.319999999999993 109.835 175.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.623 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 50.4 t -89.78 107.09 17.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.707 -0.479 . . . . 64.25 109.707 176.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.484 HG12 HG23 ' A' ' 98' ' ' THR . 60.9 mt -112.72 117.33 55.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.613 -0.514 . . . . 75.109999999999999 109.613 179.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.75 -126.04 8.78 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 111.687 -0.565 . . . . 74.409999999999997 111.687 -178.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.52 91.46 1.16 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.711 0.291 . . . . 71.329999999999998 110.861 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.403 ' HB3' ' HB2' ' A' ' 118' ' ' LYS . 8.1 m-20 -132.54 99.74 4.75 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.1 0.476 . . . . 62.439999999999998 111.155 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.652 HD12 HD11 ' A' ' 119' ' ' ILE . 7.1 tp -62.97 -40.39 88.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 115.671 -0.695 . . . . 73.120000000000005 110.58 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 32.3 t -64.8 -32.04 73.55 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.132 0.491 . . . . 71.150000000000006 110.257 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.403 ' HB2' ' HB3' ' A' ' 115' ' ' ASP . 0.3 OUTLIER -72.99 -53.66 10.61 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 109.266 -0.642 . . . . 71.040000000000006 109.266 179.527 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.688 HG12 ' HB3' ' A' ' 62' ' ' GLN . 2.4 pp -62.07 -39.42 83.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 115.661 -0.7 . . . . 71.219999999999999 111.566 -173.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.448 HD12 ' N ' ' A' ' 121' ' ' SER . 2.8 pp -62.52 -31.52 52.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 120.087 -0.645 . . . . 75.310000000000002 110.208 178.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.448 ' N ' HD12 ' A' ' 120' ' ' ILE . 29.2 m -70.89 -51.43 26.29 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.194 -0.457 . . . . 62.240000000000002 110.806 178.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.488 ' OE2' ' HB3' ' A' ' 109' ' ' SER . 13.1 pt-20 -77.32 -41.91 38.82 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.603 0.594 . . . . 74.319999999999993 112.603 -173.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.595 HD12 HD12 ' A' ' 66' ' ' LEU . 74.2 mt -61.82 -55.14 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 O-C-N 122.144 -0.347 . . . . 72.530000000000001 110.611 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -59.26 -20.05 51.01 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.094 0.473 . . . . 72.010000000000005 110.816 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -79.08 -34.17 43.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.917 -0.583 . . . . 60.229999999999997 110.87 176.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -93.43 -20.87 19.9 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.372 -0.377 . . . . 73.109999999999999 111.611 -173.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.449 HG12 ' O ' ' A' ' 123' ' ' ILE . 48.5 pt -120.32 168.36 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 110.173 -0.306 . . . . 71.040000000000006 110.173 175.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . 0.529 ' N ' HD22 ' A' ' 128' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.224 -0.893 . . . . 74.439999999999998 111.977 -176.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.611 ' HG3' ' HB1' ' A' ' 67' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.521 0 N-CA-C 109.176 -0.676 . . . . 73.25 109.176 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.441 HD13 ' HB ' ' A' ' 76' ' ' ILE . 8.6 mm -110.57 106.44 20.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 114.797 -1.092 . . . . 74.400000000000006 108.923 178.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.46 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 7.9 tp10 -121.1 141.4 50.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.888 0.375 . . . . 71.409999999999997 111.058 -178.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -95.58 124.15 39.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.886 -0.597 . . . . 65.140000000000001 109.535 177.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.556 HD12 ' HA ' ' A' ' 31' ' ' PHE . 27.0 pt -121.67 157.53 25.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 116.221 -0.445 . . . . 64.230000000000004 111.214 -175.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.25 170.15 37.05 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.875 -0.602 . . . . 13.31 112.107 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -66.2 -30.17 70.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.23 0.538 . . . . 73.329999999999998 110.449 -176.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.1 m -70.29 -48.76 55.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.575 -0.739 . . . . 64.120000000000005 111.156 -177.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -87.64 -13.55 42.4 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.45 -0.341 . . . . 71.549999999999997 111.274 -177.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.556 ' HA ' HD12 ' A' ' 26' ' ' ILE . 47.8 t80 -48.8 -70.15 0.1 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.873 0.368 . . . . 65.209999999999994 110.298 175.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -53.75 -43.26 68.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.946 -0.57 . . . . 71.430000000000007 109.663 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.557 ' O ' ' HB2' ' A' ' 37' ' ' SER . 0.2 OUTLIER -53.16 -50.11 65.24 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 114.734 -1.121 . . . . 63.409999999999997 111.762 -173.45 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.17 -17.08 17.56 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.195 0.443 . . . . 53.439999999999998 112.195 -173.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.5 t -88.29 -52.14 11.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 111.655 0.243 . . . . 61.520000000000003 111.655 -178.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.0 p -75.49 -45.27 39.38 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.545 0.688 . . . . 74.430000000000007 109.806 -177.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.557 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 19.9 m -77.06 12.78 1.27 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.47 -0.786 . . . . 73.219999999999999 111.107 176.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 36.1 t -28.93 101.17 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.184 0.993 . . . . 60.130000000000003 113.061 -178.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -89.62 -18.21 26.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.622 -0.717 . . . . 70.230000000000004 109.556 175.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.504 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . 2.8 m-20 -53.91 -40.33 66.57 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.685 -0.688 . . . . 63.240000000000002 110.833 -179.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 60.8 19.48 9.66 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.903 0.859 . . . . 71.209999999999994 109.636 -170.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.504 ' HB ' ' HB3' ' A' ' 40' ' ' ASP . 7.8 mt -101.02 154.24 4.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 114.086 -1.415 . . . . 74.519999999999996 108.613 175.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.617 HD11 ' HE3' ' A' ' 101' ' ' MET . 49.3 tp -70.15 104.9 2.74 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.505 -0.554 . . . . 74.319999999999993 109.505 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 48.1 mt -93.09 105.05 16.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.864 -0.607 . . . . 75.349999999999994 110.664 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.584 HD22 HD22 ' A' ' 63' ' ' LEU . 2.0 mp -100.28 102.98 14.38 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.434 -0.58 . . . . 41.200000000000003 109.434 178.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.51 HG22 ' HB2' ' A' ' 77' ' ' TYR . 33.2 t -99.66 123.74 52.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.422 -0.584 . . . . 71.439999999999998 109.422 178.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.407 ' CB ' HG12 ' A' ' 99' ' ' ILE . 6.1 p-10 -108.75 131.6 54.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.529 0.681 . . . . 64.5 110.959 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 . . . . . 0 C--N 1.328 -0.341 0 CA-C-N 115.091 -0.959 . . . . 73.030000000000001 109.312 -179.614 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo . . . . . 0 N--CA 1.464 -0.254 0 N-CA-C 110.923 -0.453 . . . . 71.140000000000001 110.923 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.444 ' HB3' HG12 ' A' ' 119' ' ' ILE . 7.3 mp0 -50.84 -57.46 8.4 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 121.165 0.507 . . . . 74.099999999999994 111.493 -172.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.819 HD11 HD13 ' A' ' 99' ' ' ILE . 21.7 mt -57.71 -48.84 78.45 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.461 -0.79 . . . . 74.219999999999999 111.437 -172.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.576 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 51.0 mt-10 -71.71 -32.49 67.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.961 -0.563 . . . . 74.409999999999997 110.244 -177.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -61.17 -46.23 91.35 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.974 -0.557 . . . . 71.310000000000002 110.051 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.452 HD12 HD12 ' A' ' 123' ' ' ILE . 37.6 mt -74.56 -37.22 63.03 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.447 -0.342 . . . . 73.239999999999995 110.919 175.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.611 ' HB1' ' HG3' ' A' ' 22' ' ' MET . . . -58.14 -31.11 66.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 61.5 111.603 -177.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.576 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 77.9 mt-30 -54.56 -33.26 59.86 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.862 0.363 . . . . 70.239999999999995 110.712 177.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -94.36 -42.25 8.99 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.051 -0.522 . . . . 65.549999999999997 111.592 177.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.533 ' O ' HG22 ' A' ' 74' ' ' VAL . 11.5 m-85 -103.41 22.34 14.39 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.461 0.541 . . . . 75.230000000000004 112.461 -168.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.449 ' OG1' ' HB3' ' A' ' 22' ' ' MET . 5.3 t -52.28 -35.04 49.14 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.412 0.523 . . . . 74.329999999999998 112.412 -172.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -71.35 -16.11 62.42 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.212 0.449 . . . . 53.340000000000003 112.212 -175.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.441 ' O ' HG23 ' A' ' 42' ' ' ILE . 0.2 OUTLIER -125.77 11.5 7.83 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.587 0.232 . . . . 72.310000000000002 111.218 -176.743 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 70' ' ' TYR . 34.1 m -136.76 137.43 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 O-C-N 121.733 -0.604 . . . . 55.140000000000001 111.275 176.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 28.1 mmtp -119.98 115.26 23.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.538 -0.755 . . . . 63.310000000000002 109.511 177.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.494 ' N ' HD12 ' A' ' 76' ' ' ILE . 2.9 mp -105.27 122.79 58.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 108.869 -0.789 . . . . 74.420000000000002 108.869 177.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.51 ' HB2' HG22 ' A' ' 46' ' ' VAL . 39.5 m-85 -119.37 132.32 55.83 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.229 0.538 . . . . 72.200000000000003 111.667 -174.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -91.19 110.22 21.49 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.711 -1.132 . . . . 72.219999999999999 108.696 173.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.402 HD13 ' HB2' ' A' ' 31' ' ' PHE . 6.6 tp . . . . . 0 C--N 1.323 -0.579 0 CA-C-O 120.845 0.355 . . . . 72.5 110.999 -177.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.156 0 CA-C-O 121.092 0.473 . . . . 73.530000000000001 110.242 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.5 m -64.19 -33.6 76.16 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.818 -0.628 . . . . 71.010000000000005 110.387 179.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -63.04 -46.95 85.13 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.823 -0.626 . . . . 72.230000000000004 110.306 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 22.4 m-30 -83.01 5.24 22.85 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.062 -0.517 . . . . 74.030000000000001 111.324 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 65.0 34.72 90.63 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 121.31 -0.471 . . . . 71.209999999999994 112.8 175.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.448 HG11 ' OG1' ' A' ' 98' ' ' THR . 64.7 t -61.71 98.9 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.978 0.418 . . . . 73.5 110.068 177.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.3 m -100.49 8.75 43.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.898 -0.592 . . . . 73.310000000000002 111.553 -174.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -147.6 164.82 32.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.601 0.238 . . . . 73.129999999999995 110.631 -178.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.405 HD12 ' O ' ' A' ' 96' ' ' ILE . 2.4 pp -129.93 156.89 78.37 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.225 -0.443 . . . . 72.430000000000007 110.596 -178.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.17 169.35 74.45 Favored 'Cis proline' 0 C--N 1.354 0.827 0 C-N-CA 123.784 -1.34 . . . . 65.310000000000002 112.213 -0.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.448 ' OG1' HG11 ' A' ' 93' ' ' VAL . 15.0 m -112.15 124.5 52.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.108 -0.496 . . . . 71.120000000000005 110.502 -179.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.85 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 36.0 mt -126.62 135.75 62.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.341 -0.614 . . . . 53.43 109.341 178.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.19 133.77 52.64 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.964 -0.384 . . . . 73.120000000000005 109.964 -178.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.788 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 50.1 mtp -106.1 117.93 35.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.896 -0.593 . . . . 74.109999999999999 110.776 -176.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -118.34 155.72 30.16 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 122.646 0.378 . . . . 74.430000000000007 110.677 178.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.596 ' HB3' HD21 ' A' ' 108' ' ' LEU . 38.1 ttpt -166.31 123.04 1.32 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.844 -0.616 . . . . 63.310000000000002 109.774 176.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 46.2 t30 58.04 25.02 11.82 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.771 0.795 . . . . 65.239999999999995 110.812 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.85 -2.34 79.64 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 115.991 -0.549 . . . . 53.509999999999998 113.381 175.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 54.0 tttm -102.77 145.07 30.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.908 0.354 . . . . 51.240000000000002 110.135 177.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -82.19 139.22 34.43 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.804 -0.813 . . . . 45.119999999999997 108.804 171.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.596 HD21 ' HB3' ' A' ' 103' ' ' LYS . 2.7 mm? -107.14 -53.26 2.64 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.885 0.374 . . . . 72.549999999999997 110.231 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.788 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 54.5 m -153.72 164.46 38.27 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 116.019 -0.537 . . . . 74.540000000000006 111.086 -175.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -129.48 106.44 8.76 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.715 -0.675 . . . . 75.319999999999993 109.298 177.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.85 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 77.0 t -84.04 107.28 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.463 -0.569 . . . . 64.25 109.463 -179.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 62.5 mt -120.15 108.76 23.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.858 -0.61 . . . . 75.109999999999999 110.19 -176.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 108.67 -117.33 4.97 Favored Glycine 0 CA--C 1.518 0.265 0 N-CA-C 111.831 -0.508 . . . . 74.409999999999997 111.831 -178.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.41 57.22 0.5 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.392 0.615 . . . . 71.329999999999998 110.032 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.73 81.8 5.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.464 -0.789 . . . . 62.439999999999998 110.399 -178.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.537 HD12 HD11 ' A' ' 119' ' ' ILE . 6.3 tp -61.89 -42.58 95.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 115.847 -0.615 . . . . 73.120000000000005 110.928 -177.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 45.4 t -62.67 -31.59 72.51 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.036 0.446 . . . . 71.150000000000006 110.633 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -74.05 -52.2 13.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.971 -0.559 . . . . 71.040000000000006 110.225 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.537 HD11 HD12 ' A' ' 116' ' ' ILE . 2.3 pp -63.84 -39.3 84.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.159 -0.473 . . . . 71.219999999999999 111.552 -173.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.487 HD12 ' N ' ' A' ' 121' ' ' SER . 2.9 pp -64.81 -33.86 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 C-N-CA 120.303 -0.559 . . . . 75.310000000000002 109.946 178.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.487 ' N ' HD12 ' A' ' 120' ' ' ILE . 23.1 t -70.42 -47.62 59.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.933 -0.576 . . . . 62.240000000000002 110.584 -178.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.502 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 13.0 pt-20 -77.2 -43.06 35.09 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.676 -0.238 . . . . 74.319999999999993 111.48 -175.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.452 HD12 HD12 ' A' ' 66' ' ' LEU . 82.4 mt -64.11 -51.59 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 117.657 0.208 . . . . 72.530000000000001 111.143 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -58.65 -24.07 60.41 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.065 0.459 . . . . 72.010000000000005 110.609 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -91.94 -21.25 20.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.943 -0.571 . . . . 60.229999999999997 110.963 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.502 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 3.7 t-20 -85.81 -36.78 19.85 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.086 -0.506 . . . . 73.109999999999999 111.152 -175.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . 0.411 HG12 ' O ' ' A' ' 123' ' ' ILE . 47.2 pt -107.93 168.77 3.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 115.759 -0.655 . . . . 71.040000000000006 110.032 178.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.2 p30 . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.409 -0.805 . . . . 74.439999999999998 110.638 -173.533 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.765 ' HG3' ' HB1' ' A' ' 67' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--O 1.239 0.524 0 CA-C-O 120.587 0.232 . . . . 73.25 111.362 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.527 HD11 ' HG2' ' A' ' 64' ' ' GLU . 22.9 mm -104.65 126.15 59.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.972 -0.558 . . . . 74.400000000000006 109.536 178.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 9.7 tp10 -129.23 137.29 51.01 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.025 -0.361 . . . . 71.409999999999997 110.025 178.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.711 ' H ' ' NE2' ' A' ' 25' ' ' GLN . 0.6 OUTLIER -105.81 114.62 28.88 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.614 -0.514 . . . . 65.140000000000001 109.614 176.771 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.528 HD12 ' HA ' ' A' ' 31' ' ' PHE . 28.2 pt -114.45 154.22 15.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.044 -0.526 . . . . 64.230000000000004 111.476 -172.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.56 178.22 45.66 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.455 -0.793 . . . . 13.31 112.115 176.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -63.25 -36.47 83.76 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.18 0.514 . . . . 73.329999999999998 111.213 -176.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.7 m -69.61 -42.67 74.05 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.756 -0.656 . . . . 64.120000000000005 111.525 -173.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -85.38 -12.31 52.42 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.562 -0.29 . . . . 71.549999999999997 111.692 -176.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.528 ' HA ' HD12 ' A' ' 26' ' ' ILE . 90.1 t80 -47.36 -69.9 0.11 Allowed 'General case' 0 N--CA 1.462 0.173 0 O-C-N 123.425 0.453 . . . . 65.209999999999994 110.263 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -55.63 -43.78 76.5 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 116.46 -0.336 . . . . 71.430000000000007 110.78 177.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.414 ' O ' ' HB2' ' A' ' 37' ' ' SER . 0.2 OUTLIER -52.22 -44.39 64.76 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.113 -0.949 . . . . 63.409999999999997 111.399 -170.557 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.514 ' HD3' HG21 ' A' ' 26' ' ' ILE . 0.2 OUTLIER -110.94 -21.71 11.88 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.326 0.491 . . . . 53.439999999999998 112.326 -175.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 89.5 t -88.21 -49.57 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 111.509 0.189 . . . . 61.520000000000003 111.509 -179.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 79.9 p -87.81 -6.53 58.09 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 120.387 -0.525 . . . . 74.430000000000007 110.642 -175.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 50.2 m -104.91 12.15 32.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.825 -0.625 . . . . 73.219999999999999 110.313 174.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 50.3 t -60.55 90.25 0.02 OUTLIER 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.22 0.534 . . . . 60.130000000000003 111.452 -176.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -94.05 6.44 48.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.545 -0.752 . . . . 70.230000000000004 109.226 175.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -74.26 -20.85 60.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.282 -0.872 . . . . 63.240000000000002 111.056 -175.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.6 m120 69.39 15.04 8.45 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.864 -0.607 . . . . 71.209999999999994 111.078 -176.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 37.7 mt -93.64 141.15 15.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.733 -0.667 . . . . 74.519999999999996 109.549 174.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.478 HD11 ' HB3' ' A' ' 101' ' ' MET . 64.6 tp -75.18 114.04 13.22 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.318 -0.401 . . . . 74.319999999999993 110.312 -178.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.495 HG23 ' CD2' ' A' ' 77' ' ' TYR . 44.0 mt -97.53 116.47 40.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.941 -0.572 . . . . 75.349999999999994 110.317 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.472 HD22 HD22 ' A' ' 63' ' ' LEU . 3.3 mp -107.13 102.88 12.17 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.808 -0.442 . . . . 41.200000000000003 109.808 179.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.5 HG22 ' HB2' ' A' ' 77' ' ' TYR . 58.0 t -95.84 112.16 27.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.282 -0.417 . . . . 71.439999999999998 109.946 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -98.5 125.69 43.79 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.55 0.691 . . . . 64.5 110.385 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.424 ' HE1' ' HB2' ' A' ' 100' ' ' LEU . 70.2 m-85 . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 115.063 -0.971 . . . . 73.030000000000001 109.826 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo . . . . . 0 CA--C 1.531 0.344 0 N-CA-C 111.528 -0.22 . . . . 71.140000000000001 111.528 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.72 ' HB3' HG12 ' A' ' 119' ' ' ILE . 4.3 mp0 -50.98 -57.68 7.96 Favored 'General case' 0 C--O 1.252 1.197 0 CA-C-O 121.737 0.779 . . . . 74.099999999999994 111.312 -175.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.521 HD11 HD13 ' A' ' 99' ' ' ILE . 46.3 mt -54.54 -48.77 71.59 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 114.588 -1.187 . . . . 74.219999999999999 110.909 -174.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.625 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 50.1 mt-10 -75.0 -32.56 61.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.981 -0.554 . . . . 74.409999999999997 110.68 -176.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -56.24 -46.55 79.54 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.333 -0.394 . . . . 71.310000000000002 110.056 176.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.537 HD12 HD12 ' A' ' 123' ' ' ILE . 12.9 mt -82.6 -33.63 27.92 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.098 -0.501 . . . . 73.239999999999995 111.116 178.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.765 ' HB1' ' HG3' ' A' ' 22' ' ' MET . . . -59.74 -39.01 83.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.074 -0.512 . . . . 61.5 111.888 -175.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.625 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 77.7 mt-30 -56.78 -31.12 64.32 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.133 0.492 . . . . 70.239999999999995 110.515 -179.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -93.66 -51.47 4.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.367 -0.833 . . . . 65.549999999999997 111.003 -174.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.443 ' O ' HG22 ' A' ' 74' ' ' VAL . 7.2 m-85 -104.37 23.18 13.58 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.716 -0.675 . . . . 75.230000000000004 111.583 -168.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.475 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 8.7 t -52.65 -27.1 15.77 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 111.977 0.362 . . . . 74.329999999999998 111.977 -177.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -60.87 -27.6 68.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.875 0.369 . . . . 53.340000000000003 111.232 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -121.48 0.32 9.94 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.047 -0.524 . . . . 72.310000000000002 110.68 -174.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 70' ' ' TYR . 21.4 m -133.05 146.13 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 121.034 0.445 . . . . 55.140000000000001 110.883 176.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.706 ' HA ' ' HE3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -141.86 129.57 21.6 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.204 -0.665 . . . . 63.310000000000002 109.204 177.224 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.507 ' HB ' HD13 ' A' ' 23' ' ' ILE . 2.6 mp -106.04 138.18 32.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 120.653 0.263 . . . . 74.420000000000002 110.397 -177.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.5 ' HB2' HG22 ' A' ' 46' ' ' VAL . 84.4 m-85 -134.25 137.86 44.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 72.200000000000003 110.923 -175.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 41.8 mttp -112.19 122.31 47.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.544 -0.753 . . . . 72.219999999999999 109.211 173.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.6 tp . . . . . 0 C--N 1.325 -0.472 0 CA-C-N 116.012 -0.54 . . . . 72.5 111.457 -173.312 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.296 0 CA-C-O 121.1 0.476 . . . . 73.530000000000001 110.158 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.6 m -68.7 -31.98 71.45 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.809 -0.632 . . . . 71.010000000000005 110.511 177.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -59.25 -49.88 76.15 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.208 -0.451 . . . . 72.230000000000004 110.239 177.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -72.05 -17.33 62.02 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.24 -0.436 . . . . 74.030000000000001 110.565 176.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.54 48.88 5.7 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 121.189 -0.529 . . . . 71.209999999999994 112.538 177.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 88.2 t -68.56 104.83 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.892 0.377 . . . . 73.5 110.27 176.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.8 p -73.53 -40.91 63.65 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.938 -0.574 . . . . 73.310000000000002 111.341 -178.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -150.86 164.9 35.18 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.565 -0.289 . . . . 73.129999999999995 111.171 -178.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.564 ' HB ' ' HA ' ' A' ' 97' ' ' PRO . 2.7 pp -97.56 164.16 18.16 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 116.126 -0.488 . . . . 72.430000000000007 110.448 178.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.564 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 91.0 Cg_endo -78.09 165.5 83.0 Favored 'Cis proline' 0 C--N 1.355 0.91 0 C-N-CA 124.264 -1.14 . . . . 65.310000000000002 112.537 -0.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 13.0 m -129.65 122.44 29.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.051 -0.522 . . . . 71.120000000000005 110.298 -178.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.811 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 45.0 mt -115.4 108.19 24.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.345 -0.613 . . . . 53.43 109.345 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.503 ' HG ' ' HG3' ' A' ' 110' ' ' GLN . 2.4 tt -99.34 124.34 44.36 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.933 -0.395 . . . . 73.120000000000005 109.933 -176.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.753 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 65.0 mtp -93.45 112.01 23.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.927 -0.579 . . . . 74.109999999999999 111.155 -177.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -107.24 147.14 30.56 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.007 0.523 . . . . 74.430000000000007 110.446 175.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.731 ' HB3' HD21 ' A' ' 108' ' ' LEU . 28.7 ttpp -169.81 133.63 1.26 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.294 -0.632 . . . . 63.310000000000002 109.294 173.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.3 t30 61.43 24.82 14.87 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.266 0.555 . . . . 65.239999999999995 110.498 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 76.98 10.97 85.98 Favored Glycine 0 CA--C 1.522 0.5 0 CA-C-N 115.982 -0.554 . . . . 53.509999999999998 112.959 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -125.15 152.4 44.51 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.488 -0.56 . . . . 51.240000000000002 109.488 179.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.75 ' HD3' HE22 ' A' ' 110' ' ' GLN . 0.0 OUTLIER -84.71 142.9 29.53 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.447 -0.575 . . . . 45.119999999999997 109.447 177.842 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.731 HD21 ' HB3' ' A' ' 103' ' ' LYS . 2.4 mm? -106.32 -53.22 2.66 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.271 -0.27 . . . . 72.549999999999997 110.271 178.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.753 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 66.4 m -153.82 165.83 34.81 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 116.182 -0.463 . . . . 74.540000000000006 111.101 -178.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLN . . . . . 0.75 HE22 ' HD3' ' A' ' 107' ' ' LYS . 24.2 mp0 -128.44 102.44 6.64 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.533 -0.758 . . . . 75.319999999999993 109.443 177.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.811 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 50.6 t -80.35 107.04 12.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.517 -0.549 . . . . 64.25 109.517 177.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 52.5 mt -109.59 128.57 65.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.632 -0.507 . . . . 75.109999999999999 109.632 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.77 -123.09 6.36 Favored Glycine 0 N--CA 1.452 -0.269 0 N-CA-C 111.504 -0.639 . . . . 74.409999999999997 111.504 -176.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.52 101.94 1.87 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.955 0.377 . . . . 71.329999999999998 110.74 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -136.58 102.29 4.88 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 120.956 0.407 . . . . 62.439999999999998 110.861 179.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.587 HD12 HD11 ' A' ' 119' ' ' ILE . 7.9 tp -61.91 -38.39 80.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 115.895 -0.593 . . . . 73.120000000000005 110.383 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 37.7 t -61.57 -41.69 97.76 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.342 0.591 . . . . 71.150000000000006 110.316 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.447 ' O ' ' HG2' ' A' ' 122' ' ' GLU . 16.7 tppt? -63.92 -56.35 15.86 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.393 -0.821 . . . . 71.040000000000006 109.908 -179.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.72 HG12 ' HB3' ' A' ' 62' ' ' GLN . 2.2 pp -61.81 -43.33 97.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 115.455 -0.793 . . . . 71.219999999999999 111.979 -173.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.498 HD12 ' N ' ' A' ' 121' ' ' SER . 2.8 pp -63.0 -33.33 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 120.392 -0.523 . . . . 75.310000000000002 110.209 -178.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.498 ' N ' HD12 ' A' ' 120' ' ' ILE . 42.5 t -70.84 -52.3 21.22 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.07 -0.514 . . . . 62.240000000000002 110.997 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 118' ' ' LYS . 3.8 pt-20 -77.8 -37.67 48.26 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.391 0.886 . . . . 74.319999999999993 113.391 -175.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . 0.537 HD12 HD12 ' A' ' 66' ' ' LEU . 65.7 mt -61.39 -56.99 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 O-C-N 121.949 -0.469 . . . . 72.530000000000001 110.281 177.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -63.5 -20.46 65.62 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.845 -0.616 . . . . 72.010000000000005 111.174 -178.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -65.77 -35.24 80.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.052 -0.522 . . . . 60.229999999999997 110.452 175.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.409 ' HB3' ' HE2' ' A' ' 103' ' ' LYS . 48.7 m-80 -95.59 -39.59 9.86 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.083 -0.508 . . . . 73.109999999999999 111.732 -175.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 38.9 pt -85.53 168.0 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.589 -0.278 . . . . 71.040000000000006 110.656 -178.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.9 p30 . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.258 -0.877 . . . . 74.439999999999998 110.95 -175.696 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 ptt? . . . . . 0 N--CA 1.483 1.208 0 N-CA-C 111.62 0.23 . . . . 51.399999999999999 111.62 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.55 84.63 0.18 Allowed 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 120.981 0.42 . . . . 74.329999999999998 111.632 -176.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 47.1 p-80 -113.47 121.9 45.67 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.08 -0.711 . . . . 73.010000000000005 109.08 173.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -165.76 96.6 0.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.085 0.469 . . . . 75.420000000000002 110.663 -175.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 66.5 t60 -148.38 110.22 4.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 74.219999999999999 110.219 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 31.6 m80 -87.31 -173.24 4.3 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.627 -0.508 . . . . 71.200000000000003 109.627 177.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 18.0 p-80 -151.64 99.27 2.58 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.174 0.512 . . . . 65.209999999999994 110.919 176.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 35.7 p80 -98.12 29.51 3.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.802 -0.635 . . . . 71.340000000000003 109.898 177.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 63.6 mtt -59.63 -29.7 68.2 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.578 -0.737 . . . . 61.329999999999998 110.919 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.57 -162.24 32.78 Favored Glycine 0 C--N 1.332 0.306 0 N-CA-C 111.66 -0.576 . . . . 54.420000000000002 111.66 -179.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.1 t -123.73 157.44 33.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.666 0.269 . . . . 62.43 110.361 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.713 ' HB3' ' HA ' ' A' ' 52' ' ' TRP . 61.7 tp -158.2 115.01 2.85 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.413 -0.588 . . . . 75.129999999999995 109.413 -179.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -107.71 147.91 30.13 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.121 -0.491 . . . . 62.409999999999997 110.782 -177.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -153.75 47.62 0.64 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.828 -0.624 . . . . 64.340000000000003 110.019 178.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 15' ' ' GLN . 8.5 pt20 -65.0 86.16 0.05 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.418 0.628 . . . . 71.200000000000003 110.718 -179.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.0 t -67.62 -32.64 73.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.623 -0.717 . . . . 74.340000000000003 110.317 178.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -135.96 146.41 47.24 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 109.105 -0.702 . . . . 73.129999999999995 109.105 178.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -152.62 -80.62 0.03 OUTLIER Glycine 0 C--O 1.236 0.258 0 C-N-CA 120.859 -0.686 . . . . 72.219999999999999 112.4 -177.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -62.13 100.05 0.2 Allowed 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.891 2.394 . . . . 73.219999999999999 112.203 -175.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 125.33 -19.32 6.77 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.883 -0.599 . . . . 71.450000000000003 112.582 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 73.4 p -87.0 -73.87 0.45 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.008 0.432 . . . . 64.019999999999996 111.182 -177.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.617 ' HG3' HG13 ' A' ' 23' ' ' ILE . 22.1 ptp -173.37 -30.9 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.86 -0.609 . . . . 73.25 110.379 -175.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.617 HG13 ' HG3' ' A' ' 22' ' ' MET . 60.8 mt -104.97 99.65 8.91 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 115.982 -0.553 . . . . 74.400000000000006 110.226 177.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.556 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 10.6 tp10 -101.22 155.23 18.14 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.83 -0.623 . . . . 71.409999999999997 109.699 -179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -106.69 134.7 49.44 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.025 -0.361 . . . . 65.140000000000001 110.025 176.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.523 HD12 ' HA ' ' A' ' 31' ' ' PHE . 32.1 pt -129.19 157.01 42.08 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-O 120.971 0.415 . . . . 64.230000000000004 111.134 -175.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -106.81 -171.45 22.63 Favored Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.93 -0.577 . . . . 13.31 112.284 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -67.92 -50.34 56.62 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.27 0.47 . . . . 73.329999999999998 112.27 -176.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.5 p -73.34 -11.95 60.66 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.425 0.528 . . . . 64.120000000000005 112.425 -171.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -117.09 -6.71 11.37 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 116.668 -0.242 . . . . 71.549999999999997 111.069 178.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.523 ' HA ' HD12 ' A' ' 26' ' ' ILE . 93.4 t80 -51.77 -70.58 0.08 Allowed 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.293 -0.412 . . . . 65.209999999999994 110.327 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -62.43 -35.18 78.46 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.136 0.493 . . . . 71.430000000000007 109.771 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -51.88 -47.6 64.46 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-N 115.104 -0.953 . . . . 63.409999999999997 111.565 -176.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.52 -18.32 15.35 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 111.981 0.363 . . . . 53.439999999999998 111.981 -177.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.1 t -88.39 -59.74 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 111.947 0.351 . . . . 61.520000000000003 111.947 -179.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 34.3 p -78.05 -33.08 51.12 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.818 0.342 . . . . 74.430000000000007 111.168 -172.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.9 m -84.57 11.84 8.08 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.253 -0.431 . . . . 73.219999999999999 111.351 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.518 ' SG ' HG22 ' A' ' 42' ' ' ILE . 44.9 t -75.76 103.07 5.68 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 120.863 0.363 . . . . 60.130000000000003 110.339 178.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -103.15 12.3 35.93 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-O 121.137 0.494 . . . . 70.230000000000004 110.327 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -81.7 1.65 33.34 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 116.082 -0.508 . . . . 63.240000000000002 111.256 -178.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 59.22 13.42 3.03 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 112.495 0.554 . . . . 71.209999999999994 112.495 -178.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.518 HG22 ' SG ' ' A' ' 38' ' ' CYS . 10.5 tt -78.85 153.09 4.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.182 -0.673 . . . . 74.519999999999996 109.182 176.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.785 HD21 ' HE3' ' A' ' 101' ' ' MET . 57.2 tp -93.4 111.55 23.23 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.281 0.562 . . . . 74.319999999999993 110.425 -177.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 101' ' ' MET . 71.6 mt -96.39 129.46 46.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.496 -0.774 . . . . 75.349999999999994 110.429 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 5.3 mp -117.72 103.83 10.4 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.923 -0.399 . . . . 41.200000000000003 109.923 179.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.557 HG12 ' HB2' ' A' ' 77' ' ' TYR . 29.6 m -93.78 127.88 45.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 110.242 -0.281 . . . . 71.439999999999998 110.242 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.488 ' O ' HG22 ' A' ' 79' ' ' ILE . 2.0 p-10 -125.07 153.24 43.22 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.925 0.393 . . . . 64.5 110.779 -177.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -77.81 -80.49 0.11 Allowed 'General case' 0 CA--C 1.539 0.522 0 CA-C-N 116.006 -0.543 . . . . 73.030000000000001 111.51 178.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -133.36 178.15 7.13 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 120.948 0.404 . . . . 72.239999999999995 111.392 -175.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.737 ' HB1' ' HB3' ' A' ' 53' ' ' CYS . . . -113.83 113.89 47.03 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.594 -0.73 . . . . 53.439999999999998 110.035 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.543 ' HG3' ' HD3' ' A' ' 97' ' ' PRO . 71.2 Cg_endo -72.24 82.91 1.28 Allowed 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 122.75 2.3 . . . . 74.340000000000003 112.025 -177.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.713 ' HA ' ' HB3' ' A' ' 12' ' ' LEU . 79.4 m95 60.76 22.94 12.88 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.931 -0.577 . . . . 74.150000000000006 110.877 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.737 ' HB3' ' HB1' ' A' ' 50' ' ' ALA . 52.6 t -81.99 66.6 7.64 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.735 -0.666 . . . . 72.239999999999995 110.106 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -120.69 156.18 16.11 Favored Glycine 0 N--CA 1.451 -0.363 0 CA-C-N 115.459 -0.791 . . . . 63.140000000000001 111.657 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -65.4 -5.45 11.39 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.877 2.384 . . . . 62.109999999999999 112.734 -176.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 63.8 m -116.21 22.85 12.59 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.528 -0.305 . . . . 70.010000000000005 110.752 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.461 ' HG3' ' HE3' ' A' ' 52' ' ' TRP . 0.0 OUTLIER -152.9 -60.4 0.14 Allowed 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 109.744 -0.465 . . . . 74.519999999999996 109.744 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' A' ' 53' ' ' CYS . 48.2 t -172.68 75.11 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.917 0.389 . . . . 52.329999999999998 110.634 -179.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 52.3 tp -82.47 85.56 6.91 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.274 -0.639 . . . . 73.329999999999998 109.274 175.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -156.38 66.21 4.17 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 115.95 -0.568 . . . . 73.140000000000001 110.814 -178.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.469 ' HG2' ' HG3' ' A' ' 64' ' ' GLU . 61.5 Cg_endo -92.12 155.66 3.22 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.698 2.265 . . . . 71.140000000000001 112.186 174.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.474 ' H ' ' CD ' ' A' ' 62' ' ' GLN . 13.8 mp0 -62.32 -33.71 75.21 Favored 'General case' 0 C--O 1.248 1.01 0 CA-C-O 122.105 0.955 . . . . 74.099999999999994 109.598 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.418 ' H ' HD22 ' A' ' 63' ' ' LEU . 3.3 mm? -56.98 -48.6 78.02 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-N 113.906 -1.497 . . . . 74.219999999999999 110.952 -174.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.469 ' HG3' ' HG2' ' A' ' 61' ' ' PRO . 45.2 mt-10 -59.31 -51.64 69.05 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.051 0.453 . . . . 74.409999999999997 109.886 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 41.6 mmtm -51.28 -50.87 58.44 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.184 -0.916 . . . . 71.310000000000002 111.633 -176.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.613 HD12 HD12 ' A' ' 123' ' ' ILE . 13.2 mt -80.25 -39.22 29.4 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.024 -0.67 . . . . 73.239999999999995 112.346 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.56 -38.54 90.45 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.654 0.264 . . . . 61.5 111.31 -176.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -54.6 -30.46 54.73 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.788 0.328 . . . . 70.239999999999995 111.177 178.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -90.45 -48.51 7.06 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.311 0.577 . . . . 65.549999999999997 110.837 178.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.522 ' O ' HG22 ' A' ' 74' ' ' VAL . 16.9 m-85 -98.31 23.18 8.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.547 -0.751 . . . . 75.230000000000004 112.118 -170.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.4 t -52.37 -42.01 63.58 Favored 'General case' 0 CA--C 1.539 0.519 0 N-CA-C 112.234 0.457 . . . . 74.329999999999998 112.234 -172.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -72.99 -16.85 61.5 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.032 -0.418 . . . . 53.340000000000003 111.382 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -107.31 -8.04 16.5 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.536 -0.302 . . . . 72.310000000000002 111.225 -176.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.522 HG22 ' O ' ' A' ' 70' ' ' TYR . 28.3 m -133.73 151.17 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 O-C-N 121.923 -0.485 . . . . 55.140000000000001 111.032 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.403 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 42.5 mmtm -140.58 116.17 10.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.011 -0.54 . . . . 63.310000000000002 109.941 175.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.514 ' N ' HD12 ' A' ' 76' ' ' ILE . 2.7 mp -92.85 130.22 42.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.253 -0.647 . . . . 74.420000000000002 109.253 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.557 ' HB2' HG12 ' A' ' 46' ' ' VAL . 22.2 m-85 -124.46 128.81 49.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.745 0.307 . . . . 72.200000000000003 111.049 -178.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.534 ' HZ2' ' HA ' ' A' ' 78' ' ' LYS . 0.3 OUTLIER -77.96 114.07 16.47 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.273 -0.64 . . . . 72.219999999999999 109.273 174.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.586 HD11 ' HG3' ' A' ' 85' ' ' GLN . 10.6 tt -77.28 101.99 3.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.028 0.442 . . . . 72.5 110.058 177.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -64.4 -33.8 76.69 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.153 -0.476 . . . . 55.210000000000001 111.155 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.439 HG12 ' O ' ' A' ' 81' ' ' ILE . 10.9 tt -83.36 57.25 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 122.234 1.016 . . . . 61.140000000000001 110.015 178.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.65 -19.96 30.15 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.158 -0.928 . . . . 71.239999999999995 110.616 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -75.0 -19.91 59.88 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.377 -0.829 . . . . 64.430000000000007 111.493 -176.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -149.69 74.53 1.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.807 -0.357 . . . . 73.349999999999994 111.452 -174.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.586 ' HG3' HD11 ' A' ' 79' ' ' ILE . 21.7 mm-40 -144.7 111.27 5.68 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.861 -0.422 . . . . 74.209999999999994 109.861 172.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.9 m-20 -79.1 9.17 4.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.599 -0.273 . . . . 61.450000000000003 111.412 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.3 t -55.95 -37.69 49.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.358 0.599 . . . . 75.030000000000001 109.532 174.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.21 -35.11 80.06 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.723 -0.671 . . . . 73.530000000000001 110.311 176.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.6 m -69.6 -32.95 71.98 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.907 -0.588 . . . . 71.010000000000005 109.756 176.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 59.0 tp60 -63.17 -46.15 88.48 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.839 -0.619 . . . . 72.230000000000004 109.616 176.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.459 ' OH ' ' HE2' ' A' ' 107' ' ' LYS . 31.1 m-85 -77.11 -17.08 58.93 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.716 -0.675 . . . . 74.030000000000001 110.955 175.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 62.94 37.77 95.48 Favored Glycine 0 C--N 1.331 0.279 0 CA-C-N 116.203 -0.453 . . . . 71.209999999999994 112.197 -179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.7 p -86.23 144.73 8.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.889 0.376 . . . . 73.5 111.16 -175.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 31.9 t -136.58 84.66 2.09 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.868 -0.79 . . . . 73.310000000000002 108.868 173.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -163.85 161.6 23.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.659 -0.7 . . . . 73.129999999999995 109.975 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.471 ' HA ' ' HA ' ' A' ' 97' ' ' PRO . 0.0 OUTLIER -129.64 113.41 17.85 Favored Pre-proline 0 C--N 1.324 -0.525 0 N-CA-C 109.333 -0.617 . . . . 72.430000000000007 109.333 178.58 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.543 ' HD3' ' HG3' ' A' ' 51' ' ' PRO . 35.0 Cg_endo -98.6 -155.09 0.27 Allowed 'Cis proline' 0 C--N 1.348 0.544 0 C-N-CA 124.359 -1.101 . . . . 65.310000000000002 112.146 -2.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 37.7 m -145.26 139.52 27.18 Favored 'General case' 0 C--O 1.238 0.481 0 N-CA-C 109.256 -0.646 . . . . 71.120000000000005 109.256 174.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.722 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 3.6 mp -122.96 132.94 70.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 109.442 -0.577 . . . . 53.43 109.442 -178.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 45' ' ' LEU . 7.9 mp -110.82 146.48 36.36 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 120.497 0.189 . . . . 73.120000000000005 110.602 178.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.785 ' HE3' HD21 ' A' ' 43' ' ' LEU . 59.0 mtp -115.82 118.5 33.19 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.995 -0.548 . . . . 74.109999999999999 111.256 -176.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -118.9 150.72 39.4 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 115.934 -0.575 . . . . 74.430000000000007 110.683 179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.799 ' HB3' HD21 ' A' ' 108' ' ' LEU . 13.8 ttmm -165.58 125.67 1.8 Allowed 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.75 -0.659 . . . . 63.310000000000002 109.474 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 63.34 27.1 15.27 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.514 0.673 . . . . 65.239999999999995 110.329 175.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 75.31 13.84 82.46 Favored Glycine 0 C--N 1.333 0.379 0 CA-C-N 115.683 -0.69 . . . . 53.509999999999998 111.991 -178.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -113.01 156.67 22.64 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 122.83 0.452 . . . . 51.240000000000002 110.232 -177.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.459 ' HE2' ' OH ' ' A' ' 91' ' ' TYR . 14.7 ptmm? -101.22 125.39 47.84 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.287 -0.634 . . . . 45.119999999999997 109.287 176.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.799 HD21 ' HB3' ' A' ' 103' ' ' LYS . 2.1 mm? -104.87 -53.2 2.72 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 111.909 0.337 . . . . 72.549999999999997 111.909 -173.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.709 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 50.4 m -162.97 172.14 15.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.192 -0.458 . . . . 74.540000000000006 110.247 -172.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.449 ' NE2' ' H ' ' A' ' 110' ' ' GLN . 0.4 OUTLIER -147.59 127.14 13.26 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-O 121.016 0.436 . . . . 75.319999999999993 110.797 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.722 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 84.4 t -81.57 107.36 13.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 115.97 -0.559 . . . . 64.25 109.924 178.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.537 ' H ' ' HE3' ' A' ' 118' ' ' LYS . 65.6 mt -107.95 115.19 48.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 CA-C-N 116.029 -0.532 . . . . 75.109999999999999 110.131 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.07 -135.57 13.19 Favored Glycine 0 N--CA 1.45 -0.382 0 CA-C-N 116.097 -0.502 . . . . 74.409999999999997 112.108 179.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -145.39 77.05 1.5 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.182 0.515 . . . . 71.329999999999998 110.767 -178.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.54 ' O ' HG23 ' A' ' 119' ' ' ILE . 1.7 m-20 -124.21 91.11 3.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.789 -0.642 . . . . 62.439999999999998 109.895 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.448 ' O ' HG13 ' A' ' 119' ' ' ILE . 6.8 tp -54.45 -41.34 53.37 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 120.798 0.332 . . . . 73.120000000000005 111.187 -176.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 43.8 t -59.32 -34.8 72.78 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-O 121.17 0.51 . . . . 71.150000000000006 111.07 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.537 ' HE3' ' H ' ' A' ' 112' ' ' ILE . 2.4 tmtm? -79.38 -44.14 22.08 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.92 -0.582 . . . . 71.040000000000006 110.715 -178.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.581 HG22 HG13 ' A' ' 111' ' ' VAL . 1.5 pp -66.41 -38.53 81.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.175 -0.466 . . . . 71.219999999999999 110.862 -175.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.435 HD12 ' N ' ' A' ' 121' ' ' SER . 2.7 pp -67.39 -31.81 54.51 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.078 0 C-N-CA 120.569 -0.452 . . . . 75.310000000000002 109.788 177.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.435 ' N ' HD12 ' A' ' 120' ' ' ILE . 34.7 t -67.48 -47.04 71.21 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.928 -0.578 . . . . 62.240000000000002 110.152 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.428 ' OE1' ' HB3' ' A' ' 109' ' ' SER . 15.0 pt-20 -76.74 -42.31 41.67 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.27 -0.423 . . . . 74.319999999999993 111.765 -177.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.613 HD12 HD12 ' A' ' 66' ' ' LEU . 68.3 mt -66.3 -52.23 49.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 O-C-N 122.335 -0.228 . . . . 72.530000000000001 111.046 -178.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -62.64 -20.28 64.64 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.927 0.394 . . . . 72.010000000000005 111.035 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -68.58 -34.14 75.28 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.075 -0.512 . . . . 60.229999999999997 110.423 176.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -103.9 -8.14 19.92 Favored 'General case' 0 N--CA 1.465 0.325 0 N-CA-C 112.474 0.546 . . . . 73.109999999999999 112.474 -172.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 43.0 pt -139.11 167.85 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 120.796 0.332 . . . . 71.040000000000006 110.647 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.975 0 CA-C-O 118.371 -0.823 . . . . 74.439999999999998 111.122 -178.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.417 ' C ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 120.776 0.322 . . . . 51.399999999999999 110.615 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -168.39 97.11 0.41 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.833 -0.622 . . . . 74.329999999999998 109.544 179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -151.09 101.28 2.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.357 -0.383 . . . . 73.010000000000005 110.19 -177.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -140.9 161.72 37.15 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 110.161 -0.311 . . . . 75.420000000000002 110.161 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.459 ' HB2' ' HA ' ' A' ' 90' ' ' GLN . 69.1 m80 -113.45 178.33 4.32 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.618 -0.512 . . . . 74.219999999999999 109.618 179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 29.1 m80 -75.0 -78.29 0.11 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 110.33 -0.248 . . . . 71.200000000000003 110.33 -177.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.415 ' HB2' ' OD2' ' A' ' 86' ' ' ASP . 3.1 p80 178.22 -172.76 0.13 Allowed 'General case' 0 C--O 1.233 0.201 0 N-CA-C 109.537 -0.542 . . . . 65.209999999999994 109.537 -177.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.659 ' HD2' ' HG2' ' A' ' 9' ' ' MET . 4.9 t60 -124.51 -72.63 0.67 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.461 -0.57 . . . . 71.340000000000003 109.461 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.659 ' HG2' ' HD2' ' A' ' 8' ' ' HIS . 21.4 ptp 176.16 143.36 0.07 Allowed 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 122.861 0.464 . . . . 61.329999999999998 110.34 176.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -119.54 80.9 0.32 Allowed Glycine 0 C--N 1.329 0.19 0 N-CA-C 110.359 -1.096 . . . . 54.420000000000002 110.359 173.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 19.8 p -80.53 2.13 26.67 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 113.51 0.93 . . . . 62.43 113.51 -167.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.411 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 30.6 tp 63.32 23.73 13.92 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.244 0.545 . . . . 75.129999999999995 111.022 175.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -86.47 49.33 1.78 Allowed 'General case' 0 C--N 1.329 -0.306 0 O-C-N 122.111 -0.368 . . . . 62.409999999999997 111.266 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -173.55 139.37 0.73 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.99 -0.55 . . . . 64.340000000000003 110.183 178.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -160.36 115.07 2.23 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.076 -0.713 . . . . 71.200000000000003 109.076 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 86.6 m -153.53 115.7 4.35 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.231 0.538 . . . . 74.340000000000003 111.761 -174.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.427 ' OE1' ' NZ ' ' A' ' 34' ' ' LYS . 4.8 tp60 -129.77 116.15 18.33 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 115.582 -0.736 . . . . 73.129999999999995 109.477 174.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 158.82 70.65 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 111.401 -0.68 . . . . 72.219999999999999 111.401 -178.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.545 ' HA ' ' HG2' ' A' ' 24' ' ' GLU . 71.7 Cg_endo -72.82 162.39 41.25 Favored 'Trans proline' 0 C--O 1.237 0.434 0 C-N-CA 122.577 2.185 . . . . 73.219999999999999 112.563 -177.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -176.31 -35.63 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.523 0 CA-C-N 115.9 -0.591 . . . . 71.450000000000003 111.695 178.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.0 m -95.99 158.65 15.35 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 122.458 0.303 . . . . 64.019999999999996 110.307 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -71.89 -28.62 63.63 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 109.729 -0.471 . . . . 73.25 109.729 176.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.409 HD13 ' HB ' ' A' ' 76' ' ' ILE . 10.3 mm -107.55 89.66 1.35 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.244 0 N-CA-C 108.142 -1.059 . . . . 74.400000000000006 108.142 171.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.633 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 9.3 tp10 -108.78 155.46 20.74 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.566 -0.288 . . . . 71.409999999999997 110.483 -174.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.419 ' HA ' ' O ' ' A' ' 78' ' ' LYS . 29.7 pt20 -105.29 147.65 27.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.919 0.39 . . . . 65.140000000000001 110.481 176.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.415 HD12 ' HA ' ' A' ' 31' ' ' PHE . 30.5 pt -129.56 -178.93 2.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.979 -0.555 . . . . 64.230000000000004 109.97 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.31 175.34 18.92 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.841 -0.695 . . . . 13.31 113.514 -175.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -67.76 -34.68 77.29 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.626 0.77 . . . . 73.329999999999998 110.949 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.2 t -79.88 -39.21 31.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 64.120000000000005 111.285 -171.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -95.12 0.25 54.07 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.998 -0.546 . . . . 71.549999999999997 111.304 -175.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.423 ' HE1' HG11 ' A' ' 46' ' ' VAL . 66.1 t80 -47.84 -71.19 0.07 Allowed 'General case' 0 CA--C 1.53 0.189 0 O-C-N 123.418 0.448 . . . . 65.209999999999994 111.186 -177.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -65.86 -32.88 74.65 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.375 -0.602 . . . . 71.430000000000007 109.375 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.486 ' O ' ' HB2' ' A' ' 37' ' ' SER . 3.4 t-20 -51.85 -39.17 58.44 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 114.762 -1.108 . . . . 63.409999999999997 111.333 -175.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.427 ' NZ ' ' OE1' ' A' ' 17' ' ' GLN . 10.9 ptmt -109.76 -25.8 10.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 53.439999999999998 112.122 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.5 t -80.11 -53.23 13.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 111.721 0.267 . . . . 61.520000000000003 111.721 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 56.0 p -83.75 -36.2 23.81 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 121.342 0.591 . . . . 74.430000000000007 110.067 -175.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.486 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 39.0 m -83.89 12.73 5.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.478 -0.783 . . . . 73.219999999999999 111.134 178.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 40.1 t -53.63 91.92 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.133 0.492 . . . . 60.130000000000003 110.979 176.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 24.3 p-10 -80.84 -7.23 59.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.771 -0.65 . . . . 70.230000000000004 110.962 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -73.5 -16.54 61.28 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.247 -0.433 . . . . 63.240000000000002 110.643 -178.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 43.6 m-80 65.89 21.69 11.4 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.744 -0.662 . . . . 71.209999999999994 111.443 178.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.571 HD13 ' HG2' ' A' ' 75' ' ' LYS . 17.6 tt -94.96 151.71 3.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.113 -0.699 . . . . 74.519999999999996 109.113 175.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.678 HD21 ' HE3' ' A' ' 101' ' ' MET . 64.8 tp -79.71 111.76 16.32 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.976 0.417 . . . . 74.319999999999993 110.474 -176.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 49.4 mt -91.31 122.91 43.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.615 -0.72 . . . . 75.349999999999994 110.498 177.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.587 HD13 HD12 ' A' ' 63' ' ' LEU . 58.8 mt -103.8 102.04 11.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.628 -0.715 . . . . 41.200000000000003 109.475 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 74.2 t -86.66 120.2 35.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.209 -0.451 . . . . 71.439999999999998 110.844 -177.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.506 ' HB3' ' HB3' ' A' ' 78' ' ' LYS . 13.7 t70 -95.24 154.91 16.96 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.925 0.393 . . . . 64.5 110.695 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -71.18 -63.64 1.07 Allowed 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.762 -0.654 . . . . 73.030000000000001 112.301 -174.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 27.7 t90 -163.72 52.84 0.16 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.04 0.448 . . . . 72.239999999999995 110.916 -171.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . . . 69.2 120.77 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 115.696 -0.683 . . . . 53.439999999999998 111.822 175.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.46 ' HG2' ' HG3' ' A' ' 61' ' ' PRO . 19.2 Cg_exo -68.14 69.37 0.93 Allowed 'Trans proline' 0 CA--C 1.535 0.561 0 C-N-CA 122.867 2.378 . . . . 74.340000000000003 112.152 175.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.453 ' HB2' ' HB3' ' A' ' 58' ' ' SER . 16.1 m95 62.29 103.23 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 123.672 0.789 . . . . 74.150000000000006 111.792 177.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 19.8 p -75.56 139.37 42.07 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 115.956 -0.565 . . . . 72.239999999999995 110.761 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 159.75 177.09 32.53 Favored Glycine 0 N--CA 1.452 -0.269 0 N-CA-C 111.699 -0.56 . . . . 63.140000000000001 111.699 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -68.03 75.08 0.68 Allowed 'Trans proline' 0 CA--C 1.535 0.552 0 C-N-CA 122.842 2.361 . . . . 62.109999999999999 112.432 -177.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.666 ' HA ' ' HB3' ' A' ' 59' ' ' LEU . 85.5 m 52.45 18.98 1.04 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.806 -0.634 . . . . 70.010000000000005 112.254 177.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.1 tpp180 -60.18 -68.73 0.27 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.793 0.33 . . . . 74.519999999999996 110.895 -176.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.453 ' HB3' ' HB2' ' A' ' 52' ' ' TRP . 27.7 t -105.29 7.49 33.46 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.546 -0.539 . . . . 52.329999999999998 109.546 176.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.666 ' HB3' ' HA ' ' A' ' 56' ' ' CYS . 32.4 tp -78.32 76.53 4.83 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.395 0.617 . . . . 73.329999999999998 110.041 -178.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -165.86 53.07 0.28 Allowed Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 114.858 -1.065 . . . . 73.140000000000001 108.305 177.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.46 ' HG3' ' HG2' ' A' ' 51' ' ' PRO . 87.3 Cg_endo -76.76 172.07 16.87 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.437 2.091 . . . . 71.140000000000001 112.571 -172.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.563 ' NE2' ' HA ' ' A' ' 114' ' ' ALA . 12.1 mp0 -52.15 -38.62 58.18 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-N 115.468 -0.787 . . . . 74.099999999999994 110.179 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.587 HD12 HD13 ' A' ' 45' ' ' LEU . 2.7 mm? -60.36 -48.7 80.62 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 114.672 -1.149 . . . . 74.219999999999999 110.326 -173.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -74.16 -36.54 64.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.179 -0.464 . . . . 74.409999999999997 109.997 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -52.33 -45.95 65.83 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.752 -0.658 . . . . 71.310000000000002 109.822 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.719 HD12 HD12 ' A' ' 123' ' ' ILE . 25.7 mt -84.78 -38.82 19.15 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 111.741 0.275 . . . . 73.239999999999995 111.741 177.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.541 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -55.98 -37.34 68.95 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 120.572 0.225 . . . . 61.5 111.464 -176.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -50.61 -32.35 18.62 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 120.948 0.404 . . . . 70.239999999999995 110.898 178.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -94.44 -59.02 2.04 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.833 -0.622 . . . . 65.549999999999997 111.27 175.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.544 ' O ' HG22 ' A' ' 74' ' ' VAL . 17.1 m-85 -91.1 21.03 4.51 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.156 0.798 . . . . 75.230000000000004 113.156 -168.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.541 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 11.2 t -54.52 -26.82 34.06 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 121.174 0.512 . . . . 74.329999999999998 110.976 -178.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -62.72 -20.13 64.6 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 115.752 -0.658 . . . . 53.340000000000003 112.239 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -131.93 7.78 4.39 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 111.661 0.245 . . . . 72.310000000000002 111.661 -175.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.544 HG22 ' O ' ' A' ' 70' ' ' TYR . 34.4 m -137.04 140.34 42.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-O 120.958 0.409 . . . . 55.140000000000001 110.992 177.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.571 ' HG2' HD13 ' A' ' 42' ' ' ILE . 33.6 mmtp -129.85 123.15 30.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.776 -0.647 . . . . 63.310000000000002 109.312 176.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.543 HG13 ' HB2' ' A' ' 45' ' ' LEU . 2.8 mp -98.99 132.48 44.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.694 -0.484 . . . . 74.420000000000002 109.694 -178.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.633 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 52.2 m-85 -134.52 129.34 34.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.076 -0.511 . . . . 72.200000000000003 109.786 -178.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.506 ' HB3' ' HB3' ' A' ' 47' ' ' ASP . 57.1 pttt -125.4 170.55 11.26 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 110.037 -0.357 . . . . 72.219999999999999 110.037 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.491 ' HB ' HG13 ' A' ' 81' ' ' ILE . 50.7 mt -137.36 152.85 27.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 N-CA-C 109.485 -0.561 . . . . 72.5 109.485 176.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -77.51 69.75 3.8 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.105 -0.702 . . . . 55.210000000000001 109.105 170.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.491 HG13 ' HB ' ' A' ' 79' ' ' ILE . 69.9 mt -76.67 109.43 10.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.246 -0.888 . . . . 61.140000000000001 110.813 -177.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -82.79 -72.47 0.45 Allowed 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.086 -0.709 . . . . 71.239999999999995 109.086 175.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -125.4 -6.75 7.0 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.009 -0.541 . . . . 64.430000000000007 110.795 172.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.406 ' HA ' ' O ' ' A' ' 9' ' ' MET . 15.6 p-10 -81.16 67.66 7.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.304 0.573 . . . . 73.349999999999994 111.881 -173.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.545 ' O ' ' HB3' ' A' ' 8' ' ' HIS . 4.8 pp0? -144.87 122.96 12.11 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.668 -0.696 . . . . 74.209999999999994 109.568 171.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.415 ' OD2' ' HB2' ' A' ' 7' ' ' HIS . 59.1 m-20 -90.62 -22.85 21.01 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.853 0.359 . . . . 61.450000000000003 110.414 173.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 82.5 t -62.62 -55.7 22.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 115.652 -0.703 . . . . 75.030000000000001 112.795 -169.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -64.01 -44.42 92.65 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 120.968 0.413 . . . . 73.530000000000001 110.589 -174.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 45.2 m -62.3 -42.52 99.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.754 -0.657 . . . . 71.010000000000005 110.661 179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.459 ' HA ' ' HB2' ' A' ' 5' ' ' HIS . 32.8 tt0 -65.1 -49.86 68.34 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.187 -0.46 . . . . 72.230000000000004 110.972 -176.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -74.0 -17.31 61.01 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.5 -0.318 . . . . 74.030000000000001 110.92 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.97 49.27 10.01 Favored Glycine 0 C--N 1.334 0.441 0 C-N-CA 121.174 -0.536 . . . . 71.209999999999994 112.139 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 46.5 t -90.77 143.03 12.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 110.218 -0.289 . . . . 73.5 110.218 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.9 p -117.04 -58.48 2.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.299 -0.41 . . . . 73.310000000000002 110.996 -178.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.59 108.35 2.41 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.105 -0.498 . . . . 73.129999999999995 111.479 -178.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.489 ' HB ' ' HA ' ' A' ' 97' ' ' PRO . 2.9 pp -107.42 158.38 33.34 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 116.11 -0.496 . . . . 72.430000000000007 109.876 176.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.489 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 61.3 Cg_endo -70.23 153.96 94.36 Favored 'Cis proline' 0 C--N 1.355 0.912 0 C-N-CA 124.039 -1.234 . . . . 65.310000000000002 113.03 2.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 28.7 m -120.17 135.3 55.02 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.381 -0.827 . . . . 71.120000000000005 109.799 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.607 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 3.8 mp -118.24 138.04 50.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.764 -0.458 . . . . 53.43 109.764 -179.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.499 HD23 ' H ' ' A' ' 101' ' ' MET . 1.1 tt -121.79 137.23 54.85 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.115 -0.698 . . . . 73.120000000000005 109.115 176.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.769 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 61.4 mtp -101.62 118.47 37.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.065 -0.516 . . . . 74.109999999999999 110.879 -173.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -121.21 147.32 45.77 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.574 -0.284 . . . . 74.430000000000007 110.607 178.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.598 ' HB3' HD21 ' A' ' 108' ' ' LEU . 39.7 ttpt -159.16 116.09 2.69 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.099 -0.5 . . . . 63.310000000000002 110.137 176.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 48.64 54.75 10.09 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-N 115.73 -0.668 . . . . 65.239999999999995 111.309 177.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 80.82 -12.76 33.89 Favored Glycine 0 CA--C 1.519 0.328 0 CA-C-N 115.671 -0.695 . . . . 53.509999999999998 113.901 175.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -100.98 131.83 46.67 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 117.357 0.579 . . . . 51.240000000000002 110.735 -177.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 57.4 pttt -91.26 112.58 24.55 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.0 -0.741 . . . . 45.119999999999997 109.0 173.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.598 HD21 ' HB3' ' A' ' 103' ' ' LYS . 2.3 mm? -80.95 -53.37 6.5 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.126 -0.488 . . . . 72.549999999999997 111.26 -170.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.769 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 56.1 m -161.15 171.72 18.01 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.857 -0.61 . . . . 74.540000000000006 110.343 -172.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.539 HE21 HD11 ' A' ' 112' ' ' ILE . 29.5 tt0 -141.82 126.65 18.15 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 120.579 0.228 . . . . 75.319999999999993 110.704 -177.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.607 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 59.6 t -91.19 125.53 43.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 123.025 0.53 . . . . 64.25 110.633 178.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.539 HD11 HE21 ' A' ' 110' ' ' GLN . 62.0 mt -126.58 106.82 16.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.468 -0.333 . . . . 75.109999999999999 110.113 176.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 99.91 -143.34 16.37 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 121.082 -0.58 . . . . 74.409999999999997 112.388 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.563 ' HA ' ' NE2' ' A' ' 62' ' ' GLN . . . -126.49 56.85 1.44 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.251 0.548 . . . . 71.329999999999998 111.03 -176.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.505 ' O ' HG23 ' A' ' 119' ' ' ILE . 4.4 m-20 -93.38 71.15 4.39 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.022 -0.535 . . . . 62.439999999999998 110.147 179.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.586 ' O ' HG13 ' A' ' 119' ' ' ILE . 6.3 tp -54.57 -44.66 69.81 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 121.065 0.459 . . . . 73.120000000000005 111.432 -177.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 9.4 p -63.86 -28.89 70.16 Favored 'General case' 0 CA--C 1.535 0.365 0 CA-C-O 121.212 0.529 . . . . 71.150000000000006 111.378 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.439 ' HB3' ' HB3' ' A' ' 115' ' ' ASP . 14.5 tmtt? -80.03 -45.03 19.08 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 116.062 -0.517 . . . . 71.040000000000006 110.84 177.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.586 HG13 ' O ' ' A' ' 116' ' ' ILE . 2.0 pp -64.6 -38.09 81.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 116.47 -0.332 . . . . 71.219999999999999 111.01 -175.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.566 HG22 HD21 ' A' ' 66' ' ' LEU . 2.9 pp -60.5 -31.72 49.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.192 0 CA-C-O 121.195 0.521 . . . . 75.310000000000002 110.051 176.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.43 ' N ' HD12 ' A' ' 120' ' ' ILE . 23.6 m -70.47 -51.68 27.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.977 -0.556 . . . . 62.240000000000002 110.734 177.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.561 ' HG2' ' HA ' ' A' ' 119' ' ' ILE . 15.6 pt-20 -72.38 -42.04 65.67 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.387 0.514 . . . . 74.319999999999993 112.387 -173.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.719 HD12 HD12 ' A' ' 66' ' ' LEU . 70.6 mt -64.07 -59.05 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 O-C-N 122.113 -0.367 . . . . 72.530000000000001 110.498 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -58.91 -20.75 54.66 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.046 -0.525 . . . . 72.010000000000005 110.943 -178.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -70.63 -39.14 73.89 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.811 -0.632 . . . . 60.229999999999997 110.885 176.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 51.5 m-80 -103.61 -2.26 26.92 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 112.355 0.502 . . . . 73.109999999999999 112.355 -173.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 123' ' ' ILE . 29.6 pt -109.01 167.92 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 N-CA-C 110.018 -0.364 . . . . 71.040000000000006 110.018 171.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.412 ' N ' HD22 ' A' ' 128' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.582 -0.723 . . . . 74.439999999999998 111.036 -175.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 N--CA 1.482 1.139 0 N-CA-C 110.207 -0.294 . . . . 51.399999999999999 110.207 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.49 101.76 0.2 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.308 -0.406 . . . . 74.329999999999998 110.788 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 74.6 m80 -86.15 134.17 33.82 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.277 -0.419 . . . . 73.010000000000005 110.249 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.421 ' O ' ' HG3' ' A' ' 90' ' ' GLN . 56.7 p-80 -122.33 119.26 30.58 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.671 -0.492 . . . . 75.420000000000002 109.671 174.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 13.8 p80 -128.02 123.65 35.21 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.145 -0.48 . . . . 74.219999999999999 109.74 -178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 52.1 t60 -173.16 137.17 0.67 Allowed 'General case' 0 C--N 1.329 -0.289 0 O-C-N 123.403 0.439 . . . . 71.200000000000003 110.363 -173.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.635 ' HA ' ' HB2' ' A' ' 86' ' ' ASP . 34.1 p-80 -164.35 118.1 1.4 Allowed 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.692 -0.484 . . . . 65.209999999999994 109.692 173.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 31.0 p-80 -76.17 157.97 32.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.106 -0.497 . . . . 71.340000000000003 110.495 -178.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 21.3 mmt -102.18 128.33 48.73 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.829 -0.804 . . . . 61.329999999999998 108.829 174.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.38 -136.62 2.46 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.964 -0.636 . . . . 54.420000000000002 111.687 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.2 m -151.61 65.84 0.87 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.625 0.726 . . . . 62.43 109.781 177.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -107.05 175.4 5.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.308 -0.86 . . . . 75.129999999999995 110.474 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -151.72 105.15 3.1 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.672 -0.695 . . . . 62.409999999999997 109.159 175.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -116.47 88.72 2.95 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.092 0.473 . . . . 64.340000000000003 110.659 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -86.06 133.25 33.91 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 108.997 -0.742 . . . . 71.200000000000003 108.997 173.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.1 t -127.08 174.57 8.78 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.824 0.345 . . . . 74.340000000000003 111.269 -175.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -160.9 103.29 1.31 Allowed 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.797 -0.638 . . . . 73.129999999999995 110.135 -177.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 178.85 70.81 0.06 OUTLIER Glycine 0 CA--C 1.519 0.325 0 N-CA-C 111.193 -0.763 . . . . 72.219999999999999 111.193 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -56.31 153.83 32.08 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 123.313 2.675 . . . . 73.219999999999999 112.938 -173.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.29 -66.27 2.72 Favored Glycine 0 C--O 1.239 0.419 0 N-CA-C 110.57 -1.012 . . . . 71.450000000000003 110.57 -174.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.6 m 62.0 154.47 0.04 OUTLIER 'General case' 0 C--O 1.237 0.418 0 CA-C-O 122.083 0.944 . . . . 64.019999999999996 113.455 170.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.625 ' HG2' HG12 ' A' ' 23' ' ' ILE . 1.4 pmm? -143.02 -50.64 0.35 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.908 -1.042 . . . . 73.25 108.437 170.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.625 HG12 ' HG2' ' A' ' 22' ' ' MET . 22.8 mm -121.18 84.07 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 108.06 -1.089 . . . . 74.400000000000006 108.06 173.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -86.25 154.74 21.06 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.102 0.477 . . . . 71.409999999999997 111.177 -172.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.441 ' HA ' ' HG2' ' A' ' 78' ' ' LYS . 8.6 pt20 -101.44 126.42 48.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.862 -0.608 . . . . 65.140000000000001 110.696 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.515 HD12 ' HA ' ' A' ' 31' ' ' PHE . 35.1 pt -131.86 174.62 12.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 120.736 0.303 . . . . 64.230000000000004 110.259 175.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.419 ' H ' ' HG2' ' A' ' 30' ' ' GLU . . . -121.11 -166.8 13.09 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 116.016 -0.538 . . . . 13.31 112.486 -179.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.79 -50.3 57.7 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 122.893 0.477 . . . . 73.329999999999998 112.023 -176.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 39.7 m -76.67 -31.44 57.29 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-O 120.901 0.381 . . . . 64.120000000000005 111.928 -169.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.477 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 2.1 pm0 -89.93 -15.29 32.37 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.967 -0.56 . . . . 71.549999999999997 110.882 -178.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.515 ' HA ' HD12 ' A' ' 26' ' ' ILE . 46.3 t80 -48.77 -70.86 0.08 Allowed 'General case' 0 C--O 1.226 -0.159 0 O-C-N 123.399 0.437 . . . . 65.209999999999994 110.285 178.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -56.45 -43.3 79.39 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-O 121.146 0.498 . . . . 71.430000000000007 109.748 179.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.631 ' O ' ' HB3' ' A' ' 37' ' ' SER . 23.1 t-20 -52.3 -41.28 62.79 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 114.209 -1.36 . . . . 63.409999999999997 112.449 -171.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -112.96 -20.15 11.66 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.257 0.466 . . . . 53.439999999999998 112.257 -176.802 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 77.6 t -81.05 -48.97 18.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 O-C-N 122.331 -0.231 . . . . 61.520000000000003 111.233 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 73.8 p -88.2 -35.83 17.13 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 121.218 0.532 . . . . 74.430000000000007 110.242 -177.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.631 ' HB3' ' O ' ' A' ' 33' ' ' ASN . 33.9 t -84.67 12.38 7.27 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.875 -0.602 . . . . 73.219999999999999 110.904 178.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 40' ' ' ASP . 43.6 t -53.71 103.24 0.07 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.955 0.407 . . . . 60.130000000000003 111.369 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -82.23 -8.9 59.65 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.871 -0.604 . . . . 70.230000000000004 110.372 176.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.448 ' HB2' ' SG ' ' A' ' 38' ' ' CYS . 21.2 m-20 -63.69 -30.76 71.82 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.219 -0.446 . . . . 63.240000000000002 110.561 -179.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 17.9 m120 71.52 12.9 6.48 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.509 -0.768 . . . . 71.209999999999994 110.99 -179.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.5 tt -88.62 161.57 2.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 N-CA-C 109.223 -0.658 . . . . 74.519999999999996 109.223 177.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.436 HD12 HG23 ' A' ' 127' ' ' ILE . 26.9 mt -78.93 109.24 13.03 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 121.06 0.457 . . . . 74.319999999999993 110.662 179.185 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.619 HG23 ' CD2' ' A' ' 77' ' ' TYR . 45.2 mt -94.27 107.61 19.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.649 -0.705 . . . . 75.349999999999994 110.163 175.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.571 ' O ' ' HA ' ' A' ' 76' ' ' ILE . 6.4 mp -97.2 107.18 19.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.934 -0.575 . . . . 41.200000000000003 109.583 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.404 HG12 ' HB2' ' A' ' 77' ' ' TYR . 28.5 m -94.97 129.92 44.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 110.091 -0.337 . . . . 71.439999999999998 110.091 179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -104.29 139.78 38.81 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 121.11 0.481 . . . . 64.5 110.208 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.475 ' HE2' HD13 ' A' ' 100' ' ' LEU . 40.8 m-85 -93.22 67.75 4.19 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.842 -0.617 . . . . 73.030000000000001 110.066 176.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 92.0 m95 71.59 87.64 0.11 Allowed 'General case' 0 C--O 1.235 0.292 0 CA-C-N 114.398 -1.274 . . . . 72.239999999999995 112.731 172.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -112.63 81.17 4.09 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.194 -0.912 . . . . 53.439999999999998 109.074 166.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.44 ' HB2' ' SG ' ' A' ' 53' ' ' CYS . 1.2 Cg_endo -84.69 6.33 5.79 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.132 2.554 . . . . 74.340000000000003 113.118 -171.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 20.1 m-90 60.21 6.97 1.11 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.359 0.503 . . . . 74.150000000000006 112.359 177.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.44 ' SG ' ' HB2' ' A' ' 51' ' ' PRO . 16.8 p -91.33 -13.93 31.67 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.593 0.235 . . . . 72.239999999999995 111.38 -175.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.6 174.48 42.23 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 121.19 -0.528 . . . . 63.140000000000001 112.753 -177.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -78.38 38.29 0.69 Allowed 'Trans proline' 0 CA--C 1.532 0.406 0 C-N-CA 123.225 2.617 . . . . 62.109999999999999 112.166 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 61.2 m -67.11 120.86 14.4 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.145 -0.48 . . . . 70.010000000000005 110.291 -179.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -83.38 40.8 0.74 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 74.519999999999996 111.022 -176.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 42.6 t -136.98 174.04 11.05 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.11 -0.496 . . . . 52.329999999999998 110.024 -178.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.478 ' N ' HD22 ' A' ' 59' ' ' LEU . 2.6 mm? -101.85 -15.2 16.97 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.903 -0.59 . . . . 73.329999999999998 109.775 177.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -165.26 138.76 3.78 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 115.846 -0.616 . . . . 73.140000000000001 110.261 -176.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.409 ' HD2' ' OE1' ' A' ' 64' ' ' GLU . 98.6 Cg_endo -79.57 -174.01 2.1 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.775 2.317 . . . . 71.140000000000001 112.408 177.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.555 ' HB3' HG12 ' A' ' 119' ' ' ILE . 13.8 mp0 -63.12 -48.32 79.0 Favored 'General case' 0 C--O 1.247 0.932 0 CA-C-O 121.583 0.706 . . . . 74.099999999999994 110.574 -174.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.561 HD12 ' N ' ' A' ' 64' ' ' GLU . 4.0 pp -57.38 -39.56 76.32 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 114.844 -1.071 . . . . 74.219999999999999 111.33 -176.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.561 ' N ' HD12 ' A' ' 63' ' ' LEU . 29.7 mt-10 -70.45 -43.25 70.26 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 120.809 -0.356 . . . . 74.409999999999997 110.048 177.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.2 mmtt -50.81 -52.95 36.24 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.133 -0.485 . . . . 71.310000000000002 111.528 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.735 HD12 HD12 ' A' ' 123' ' ' ILE . 14.8 mt -85.72 -42.83 13.9 Favored 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 113.198 0.814 . . . . 73.239999999999995 113.198 -176.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.18 -32.38 72.12 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.195 0.443 . . . . 61.5 112.195 -172.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 73.4 mt-30 -53.28 -33.44 53.2 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 120.884 0.373 . . . . 70.239999999999995 110.764 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -94.0 -53.4 4.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.005 -0.543 . . . . 65.549999999999997 110.85 176.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.53 ' O ' HG22 ' A' ' 74' ' ' VAL . 22.7 m-85 -85.35 14.83 4.89 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 113.149 0.796 . . . . 75.230000000000004 113.149 -169.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.8 t -52.94 -31.6 41.1 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 118.344 0.52 . . . . 74.329999999999998 111.441 -177.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -66.65 -16.9 64.53 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.283 -0.417 . . . . 53.340000000000003 111.553 -178.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -125.1 -7.04 7.15 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.375 -0.375 . . . . 72.310000000000002 110.627 -176.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 70' ' ' TYR . 19.6 m -141.83 150.69 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 N-CA-C 109.979 -0.378 . . . . 55.140000000000001 109.979 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.9 tppt? -144.9 127.25 15.85 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.845 -0.428 . . . . 63.310000000000002 109.845 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.571 ' HA ' ' O ' ' A' ' 45' ' ' LEU . 1.9 mp -95.94 142.82 13.19 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.583 0.23 . . . . 74.420000000000002 110.398 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.619 ' CD2' HG23 ' A' ' 44' ' ' ILE . 83.6 m-85 -135.46 131.56 36.29 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 116.211 -0.45 . . . . 72.200000000000003 110.339 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.441 ' HG2' ' HA ' ' A' ' 25' ' ' GLN . 22.3 ptmt -87.21 134.56 33.52 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 120.734 0.302 . . . . 72.219999999999999 110.477 177.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.41 HD13 ' CD1' ' A' ' 31' ' ' PHE . 7.8 tp -92.48 160.03 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 CA-C-N 115.819 -0.628 . . . . 72.5 110.769 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -66.44 178.73 1.16 Allowed 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 109.573 -0.528 . . . . 55.210000000000001 109.573 174.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.628 ' HB ' HD22 ' A' ' 84' ' ' ASN . 64.6 mt -45.18 126.8 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 CA-C-O 120.856 0.36 . . . . 61.140000000000001 111.494 -176.339 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.418 ' HG3' ' N ' ' A' ' 83' ' ' ASP . 13.8 pt-20 -43.79 -50.34 7.8 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.037 0.935 . . . . 71.239999999999995 113.508 -170.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.418 ' N ' ' HG3' ' A' ' 82' ' ' GLU . 29.0 t70 -76.0 2.07 13.69 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 112.176 0.436 . . . . 64.430000000000007 112.176 -169.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.628 HD22 ' HB ' ' A' ' 81' ' ' ILE . 48.0 m-80 -93.33 -4.79 50.99 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.85 0.357 . . . . 73.349999999999994 111.12 178.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 40.9 mm-40 -129.29 117.76 21.2 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.962 -0.563 . . . . 74.209999999999994 109.932 176.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.635 ' HB2' ' HA ' ' A' ' 7' ' ' HIS . 10.1 m-20 -67.29 -4.54 11.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.564 -0.744 . . . . 61.450000000000003 111.146 -176.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 60.6 t -52.46 -43.24 41.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 CA-C-O 121.168 0.508 . . . . 75.030000000000001 110.588 177.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.62 -42.87 99.5 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.774 -0.648 . . . . 73.530000000000001 110.168 178.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.9 m -67.86 -31.24 70.91 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.805 -0.634 . . . . 71.010000000000005 110.406 178.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.421 ' HG3' ' O ' ' A' ' 4' ' ' HIS . 46.0 tt0 -65.4 -55.83 15.92 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.492 -0.776 . . . . 72.230000000000004 110.67 -179.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -80.12 -9.01 59.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.32 -0.4 . . . . 74.030000000000001 111.153 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.26 47.82 21.66 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.165 -0.54 . . . . 71.209999999999994 112.6 176.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 96.5 t -65.32 105.55 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.948 0.404 . . . . 73.5 110.42 178.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.2 p -107.49 0.43 22.78 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.082 -0.508 . . . . 73.310000000000002 111.06 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.62 125.98 10.83 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.61 -0.268 . . . . 73.129999999999995 110.847 -177.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 32.4 pt -100.1 150.94 37.33 Favored Pre-proline 0 C--O 1.238 0.466 0 CA-C-N 116.113 -0.494 . . . . 72.430000000000007 110.193 177.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -79.82 178.61 32.57 Favored 'Cis proline' 0 C--N 1.352 0.722 0 C-N-CA 123.663 -1.39 . . . . 65.310000000000002 112.507 0.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 27.6 m -148.03 133.3 18.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.194 -0.457 . . . . 71.120000000000005 110.243 -179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 62.2 mt -119.76 134.25 63.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.752 -0.462 . . . . 53.43 109.752 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.475 HD13 ' HE2' ' A' ' 48' ' ' PHE . 11.2 mp -118.0 130.81 56.41 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-O 120.619 0.247 . . . . 73.120000000000005 110.402 177.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.41 ' SD ' ' HB3' ' A' ' 109' ' ' SER . 87.0 mtp -95.42 108.46 20.66 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 115.846 -0.616 . . . . 74.109999999999999 110.327 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -110.04 146.95 34.46 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.869 0.366 . . . . 74.430000000000007 110.989 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.409 ' HB3' HD21 ' A' ' 108' ' ' LEU . 28.4 ttpp -153.37 108.13 3.15 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.73 -0.668 . . . . 63.310000000000002 109.595 174.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 61.61 29.78 18.36 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.009 -0.541 . . . . 65.239999999999995 110.424 177.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.04 -10.69 74.34 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 121.235 -0.507 . . . . 53.509999999999998 112.741 179.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -96.74 119.43 35.2 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.761 -0.459 . . . . 51.240000000000002 109.761 177.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.21 128.34 34.5 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.508 -0.553 . . . . 45.119999999999997 109.508 177.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.478 ' N ' HD22 ' A' ' 108' ' ' LEU . 2.4 mm? -87.89 -47.26 8.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.983 0.421 . . . . 72.549999999999997 110.54 -176.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.41 ' HB3' ' SD ' ' A' ' 101' ' ' MET . 23.5 t -160.22 171.81 18.53 Favored 'General case' 0 C--O 1.24 0.555 0 CA-C-N 115.869 -0.605 . . . . 74.540000000000006 110.678 -175.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -149.04 129.73 14.09 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.718 -0.674 . . . . 75.319999999999993 110.906 -175.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.498 ' CG2' HG22 ' A' ' 119' ' ' ILE . 22.2 t -96.66 111.49 26.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 123.158 0.583 . . . . 64.25 110.067 178.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 59.8 mt -107.57 106.79 21.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.856 -0.424 . . . . 75.109999999999999 109.856 177.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 105.68 -112.39 3.93 Favored Glycine 0 C--N 1.33 0.226 0 N-CA-C 111.399 -0.68 . . . . 74.409999999999997 111.399 -176.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.51 57.16 0.5 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.396 0.617 . . . . 71.329999999999998 110.685 177.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.593 ' O ' HG23 ' A' ' 119' ' ' ILE . 3.0 m-20 -85.17 75.63 10.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.801 -0.636 . . . . 62.439999999999998 110.601 -179.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.568 ' O ' HG13 ' A' ' 119' ' ' ILE . 5.8 tp -52.56 -41.88 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 116.315 -0.402 . . . . 73.120000000000005 111.316 -178.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 2.9 p -62.15 -29.51 70.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.47 . . . . 71.150000000000006 111.075 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.454 ' HB2' ' HB3' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -79.41 -42.0 26.44 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 109.341 -0.614 . . . . 71.040000000000006 109.341 178.669 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.593 HG23 ' O ' ' A' ' 115' ' ' ASP . 1.3 pp -64.68 -43.03 96.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.324 -0.398 . . . . 71.219999999999999 111.002 -174.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.507 HD12 ' N ' ' A' ' 121' ' ' SER . 2.9 pp -63.47 -32.26 56.0 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.096 0 C-N-CA 120.623 -0.431 . . . . 75.310000000000002 110.39 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.507 ' N ' HD12 ' A' ' 120' ' ' ILE . 47.9 m -71.15 -51.53 24.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.037 -0.529 . . . . 62.240000000000002 111.08 177.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.448 ' HG2' ' HA ' ' A' ' 119' ' ' ILE . 10.7 pt-20 -69.44 -41.13 76.71 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.526 -0.306 . . . . 74.319999999999993 111.458 -171.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.735 HD12 HD12 ' A' ' 66' ' ' LEU . 74.9 mt -67.33 -57.7 8.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 110.409 -0.219 . . . . 72.530000000000001 110.409 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -59.77 -23.39 63.22 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.952 0.406 . . . . 72.010000000000005 110.866 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.419 HD22 ' ND2' ' A' ' 126' ' ' ASN . 6.7 t30 -67.48 -29.29 68.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.943 -0.571 . . . . 60.229999999999997 111.391 178.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.419 ' ND2' HD22 ' A' ' 125' ' ' ASN . 48.9 m-80 -111.82 -1.17 15.65 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.154 0.428 . . . . 73.109999999999999 112.154 -174.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.518 HG12 ' O ' ' A' ' 123' ' ' ILE . 47.5 pt -131.83 168.32 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-O 121.236 0.541 . . . . 71.040000000000006 111.299 177.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.1 p30 . . . . . 0 C--O 1.25 1.113 0 CA-C-N 115.116 -0.947 . . . . 74.439999999999998 110.485 -178.039 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.0 mtm . . . . . 0 N--CA 1.484 1.235 0 CA-C-O 120.63 0.252 . . . . 51.399999999999999 110.774 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.46 -43.42 39.98 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.348 0.594 . . . . 74.329999999999998 109.452 173.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 59.5 t-80 -86.44 100.72 12.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.414 -0.812 . . . . 73.010000000000005 109.821 179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 67.8 m80 -88.21 119.44 28.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.967 -0.56 . . . . 75.420000000000002 109.769 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 25.7 p80 -55.02 128.38 33.38 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.908 0.385 . . . . 74.219999999999999 111.257 -177.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -102.43 126.76 49.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.06 -0.518 . . . . 71.200000000000003 110.112 177.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 21.8 p80 -66.52 144.05 56.69 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.395 -0.366 . . . . 65.209999999999994 110.456 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -71.37 151.78 43.78 Favored 'General case' 0 C--O 1.236 0.357 0 N-CA-C 109.537 -0.542 . . . . 71.340000000000003 109.537 176.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -91.77 -28.25 17.5 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-O 120.731 0.3 . . . . 61.329999999999998 111.106 -177.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -128.17 -86.36 0.51 Allowed Glycine 0 C--N 1.329 0.175 0 CA-C-N 116.211 -0.45 . . . . 54.420000000000002 112.038 -178.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.6 m -71.53 112.49 7.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.68 0.276 . . . . 62.43 110.505 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.4 pp -76.63 -172.26 2.15 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.355 -0.384 . . . . 75.129999999999995 111.245 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -162.22 -62.98 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.196 0.522 . . . . 62.409999999999997 109.804 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -93.98 -179.35 4.94 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.645 -0.707 . . . . 64.340000000000003 110.683 179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -70.55 101.72 2.08 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.282 -0.417 . . . . 71.200000000000003 110.851 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.3 m -65.97 155.28 37.03 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 115.706 -0.679 . . . . 74.340000000000003 110.207 174.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 65.2 tt0 -54.48 130.47 39.75 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 110.01 -0.367 . . . . 73.129999999999995 110.01 175.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -165.21 80.73 0.12 Allowed Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 111.523 -0.631 . . . . 72.219999999999999 111.523 -175.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -68.05 -179.31 2.1 Favored 'Trans proline' 0 CA--C 1.535 0.533 0 C-N-CA 122.865 2.376 . . . . 73.219999999999999 112.824 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -52.79 121.91 17.53 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-N 115.647 -0.706 . . . . 71.450000000000003 112.503 -178.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.5 m -95.47 152.2 18.62 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 122.28 0.232 . . . . 64.019999999999996 111.013 -176.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.474 ' N ' ' SD ' ' A' ' 22' ' ' MET . 3.6 mpp? -64.89 -48.31 74.67 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 116.218 -0.446 . . . . 73.25 110.065 175.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.48 HG22 ' HE3' ' A' ' 78' ' ' LYS . 7.9 mm -101.08 92.48 2.46 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 N-CA-C 108.595 -0.891 . . . . 74.400000000000006 108.595 175.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.603 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 34.4 tt0 -112.9 148.39 35.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.899 -0.591 . . . . 71.409999999999997 110.788 -168.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.509 ' HB3' ' NZ ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -99.4 147.56 25.11 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 110.092 -0.336 . . . . 65.140000000000001 110.092 179.341 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.448 HD12 ' HA ' ' A' ' 31' ' ' PHE . 31.8 pt -137.91 162.36 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 121.012 0.434 . . . . 64.230000000000004 111.409 -176.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.62 171.23 19.97 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 115.335 -0.848 . . . . 13.31 111.758 177.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -67.78 -30.05 69.39 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 116.707 0.253 . . . . 73.329999999999998 111.459 -177.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 28.8 t -68.7 -36.66 78.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.713 0.292 . . . . 64.120000000000005 111.044 -177.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.431 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 4.3 pm0 -98.35 -9.85 24.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.241 -0.436 . . . . 71.549999999999997 111.188 -178.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.482 ' HE1' HG11 ' A' ' 46' ' ' VAL . 93.3 t80 -46.75 -71.11 0.08 Allowed 'General case' 0 N--CA 1.467 0.399 0 O-C-N 123.317 0.385 . . . . 65.209999999999994 111.259 -175.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -65.79 -35.63 81.24 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 109.593 -0.521 . . . . 71.430000000000007 109.593 179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -53.59 -33.75 55.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.807 -1.088 . . . . 63.409999999999997 111.881 -174.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.431 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 0.2 OUTLIER -114.82 -18.53 11.31 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 121.03 -0.268 . . . . 53.439999999999998 111.68 -179.822 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 72.7 t -88.44 -57.09 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 111.746 0.276 . . . . 61.520000000000003 111.746 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 58.2 p -76.32 -23.33 54.29 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 121.107 0.48 . . . . 74.430000000000007 110.537 -175.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.8 m -86.27 11.68 11.59 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.676 -0.693 . . . . 73.219999999999999 111.083 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.503 ' HB2' HD12 ' A' ' 44' ' ' ILE . 41.8 t -57.96 91.11 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.037 0.446 . . . . 60.130000000000003 110.962 178.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -101.33 -6.7 23.77 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.816 -0.629 . . . . 70.230000000000004 109.989 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -77.91 -5.23 50.38 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.361 -0.836 . . . . 63.240000000000002 111.778 -174.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.58 ' ND2' HD21 ' A' ' 104' ' ' ASN . 20.6 m120 66.83 16.56 10.4 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 116.336 -0.393 . . . . 71.209999999999994 110.856 -176.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.0 tt -87.18 142.87 12.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.33 -0.619 . . . . 74.519999999999996 109.33 177.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.727 HD21 ' HE3' ' A' ' 101' ' ' MET . 68.1 tp -82.46 116.91 22.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.889 0.376 . . . . 74.319999999999993 110.314 -178.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.503 HD12 ' HB2' ' A' ' 38' ' ' CYS . 56.3 mt -102.61 117.67 48.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.872 -0.603 . . . . 75.349999999999994 110.533 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.525 ' HB2' HG13 ' A' ' 76' ' ' ILE . 4.1 mp -106.06 103.84 13.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.051 -0.522 . . . . 41.200000000000003 109.748 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.513 HG22 ' HB2' ' A' ' 77' ' ' TYR . 45.7 t -109.41 123.76 65.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 111.43 0.159 . . . . 71.439999999999998 111.43 -177.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.465 ' HB2' HG13 ' A' ' 99' ' ' ILE . 14.2 t70 -91.82 149.52 21.54 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.661 -0.866 . . . . 64.5 108.661 170.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.444 ' O ' ' HB2' ' A' ' 49' ' ' TRP . 76.7 m-85 -64.28 -44.19 92.48 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.46 0.17 . . . . 73.030000000000001 111.46 -177.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.444 ' HB2' ' O ' ' A' ' 48' ' ' PHE . 38.2 t-105 166.49 -26.21 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 O-C-N 123.792 0.682 . . . . 72.239999999999995 110.04 -176.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 68.24 90.23 0.09 OUTLIER Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 115.409 -0.814 . . . . 53.439999999999998 110.474 -174.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -48.73 -32.97 23.38 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 123.21 2.606 . . . . 74.340000000000003 113.414 -176.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 39.1 p-90 -159.85 -54.75 0.06 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 120.735 0.302 . . . . 74.150000000000006 110.645 178.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.562 ' HB3' HG12 ' A' ' 96' ' ' ILE . 33.7 t -85.51 101.45 12.67 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.742 -0.466 . . . . 72.239999999999995 109.742 178.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -119.05 -160.7 11.45 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 121.225 -0.512 . . . . 63.140000000000001 112.267 179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -77.32 24.81 0.49 Allowed 'Trans proline' 0 CA--C 1.534 0.497 0 C-N-CA 122.986 2.458 . . . . 62.109999999999999 112.599 -179.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 7.1 p -66.87 94.95 0.34 Allowed 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.513 -0.312 . . . . 70.010000000000005 110.64 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 57' ' ' ARG . 16.6 mtp180 -145.92 162.14 38.45 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.814 -0.63 . . . . 74.519999999999996 110.157 -179.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.6 t -102.43 -41.67 6.23 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.329 -0.396 . . . . 52.329999999999998 110.115 177.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.421 ' N ' HD22 ' A' ' 59' ' ' LEU . 3.1 mm? -93.67 72.75 4.3 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.506 -0.316 . . . . 73.329999999999998 110.747 -179.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 41.39 98.49 0.04 OUTLIER Pre-proline 0 N--CA 1.473 0.677 0 N-CA-C 114.015 1.117 . . . . 73.140000000000001 114.015 171.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.8 172.12 12.23 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.001 1.801 . . . . 71.140000000000001 110.931 168.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.512 ' HB3' HG12 ' A' ' 119' ' ' ILE . 6.8 mp0 -48.99 -57.62 6.21 Favored 'General case' 0 C--O 1.247 0.974 0 CA-C-O 121.627 0.727 . . . . 74.099999999999994 111.491 -173.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.599 HD12 ' N ' ' A' ' 64' ' ' GLU . 2.1 pp -62.31 -38.81 90.85 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.117 -0.947 . . . . 74.219999999999999 111.654 -174.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.599 ' N ' HD12 ' A' ' 63' ' ' LEU . 37.8 mt-10 -70.9 -35.47 72.32 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 110.003 -0.369 . . . . 74.409999999999997 110.003 177.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.7 mmtt -57.37 -56.73 18.09 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 116.004 -0.544 . . . . 71.310000000000002 110.642 179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.661 HD12 HD12 ' A' ' 123' ' ' ILE . 28.5 mt -80.1 -30.79 39.2 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.364 0.505 . . . . 73.239999999999995 112.364 -175.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.428 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -62.38 -33.27 74.42 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 111.585 0.217 . . . . 61.5 111.585 -177.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.551 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 78.6 mt-30 -64.07 -30.92 71.96 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.003 0.43 . . . . 70.239999999999995 110.657 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 68.8 mm-40 -89.28 -59.11 2.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.009 -0.541 . . . . 65.549999999999997 110.776 -176.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.508 ' O ' HG22 ' A' ' 74' ' ' VAL . 17.1 m-85 -87.8 23.49 2.0 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.56 -0.746 . . . . 75.230000000000004 111.892 -173.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.428 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 6.6 t -52.0 -38.79 58.01 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 113.063 0.764 . . . . 74.329999999999998 113.063 -167.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -73.45 -16.52 61.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.774 0.321 . . . . 53.340000000000003 111.181 -176.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -113.14 -4.31 13.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.317 -0.402 . . . . 72.310000000000002 110.951 -177.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 70' ' ' TYR . 32.8 m -133.19 137.15 54.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 121.254 0.55 . . . . 55.140000000000001 111.072 178.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.432 ' HD2' ' CZ ' ' A' ' 77' ' ' TYR . 7.7 mmtt -128.79 115.13 17.47 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.96 -0.755 . . . . 63.310000000000002 108.96 177.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.525 HG13 ' HB2' ' A' ' 45' ' ' LEU . 2.3 mp -99.68 134.68 38.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.411 -0.588 . . . . 74.420000000000002 109.411 -177.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.603 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 71.3 m-85 -132.49 155.58 48.33 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.393 -0.367 . . . . 72.200000000000003 110.363 -178.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.509 ' NZ ' ' HB3' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -144.02 128.59 18.09 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.722 -0.844 . . . . 72.219999999999999 108.722 170.635 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.1 tt -104.45 150.89 7.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 116.102 -0.499 . . . . 72.5 110.023 -175.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -85.43 67.86 10.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.927 0.394 . . . . 55.210000000000001 110.754 -175.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 53.8 mt -126.51 110.22 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 N-CA-C 109.453 -0.573 . . . . 61.140000000000001 109.453 175.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -60.0 -72.38 0.11 Allowed 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 120.961 0.41 . . . . 71.239999999999995 111.558 -171.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -125.48 -19.37 5.03 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.173 -0.467 . . . . 64.430000000000007 111.702 -176.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -70.78 76.53 0.62 Allowed 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.059 -0.518 . . . . 73.349999999999994 111.824 -170.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.9 mm-40 -144.7 107.19 4.4 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.342 -0.39 . . . . 74.209999999999994 110.959 -179.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -56.04 -36.17 67.71 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.212 0.529 . . . . 61.450000000000003 109.751 174.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 45.9 t -52.8 -44.68 48.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.045 -0.98 . . . . 75.030000000000001 111.181 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.77 -45.28 92.76 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.981 -0.554 . . . . 73.530000000000001 110.934 -177.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 23.9 m -73.9 -31.38 63.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.795 -0.638 . . . . 71.010000000000005 110.683 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -63.97 -43.94 94.24 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.765 -0.652 . . . . 72.230000000000004 110.573 -178.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -86.58 -14.3 43.27 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.196 -0.456 . . . . 74.030000000000001 110.48 175.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 65.03 55.59 20.97 Favored Glycine 0 C--O 1.237 0.282 0 CA-C-N 116.002 -0.545 . . . . 71.209999999999994 112.182 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.438 HG21 ' OG1' ' A' ' 98' ' ' THR . 7.9 p -73.93 131.73 34.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.766 0.317 . . . . 73.5 110.728 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.6 t -121.83 -0.88 9.5 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.456 -0.338 . . . . 73.310000000000002 111.141 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.459 ' HB3' HG22 ' A' ' 112' ' ' ILE . . . -135.98 128.73 30.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.697 0.285 . . . . 73.129999999999995 110.904 -177.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.786 HD13 ' H ' ' A' ' 96' ' ' ILE . 0.2 OUTLIER -113.06 154.85 44.95 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 115.866 -0.606 . . . . 72.430000000000007 109.938 179.781 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -69.67 177.54 28.29 Favored 'Cis proline' 0 C--N 1.356 0.967 0 C-N-CA 124.183 -1.174 . . . . 65.310000000000002 112.442 1.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.438 ' OG1' HG21 ' A' ' 93' ' ' VAL . 18.5 m -146.99 115.19 6.6 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.072 0.463 . . . . 71.120000000000005 110.521 -176.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.525 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 3.7 mp -117.88 129.55 74.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.5 -0.773 . . . . 53.43 110.095 -176.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.9 mp -104.54 132.57 50.63 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.835 -0.431 . . . . 73.120000000000005 109.835 174.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.727 ' HE3' HD21 ' A' ' 43' ' ' LEU . 53.0 mtp -101.46 112.91 25.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.959 -0.564 . . . . 74.109999999999999 110.696 -176.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -112.49 147.51 36.39 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.879 0.371 . . . . 74.430000000000007 110.861 179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.829 ' HB3' HD21 ' A' ' 108' ' ' LEU . 28.2 ttpp -161.5 131.96 5.05 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.849 -0.614 . . . . 63.310000000000002 109.344 176.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.58 HD21 ' ND2' ' A' ' 41' ' ' ASN . 18.6 m120 58.34 32.33 21.95 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.238 0.542 . . . . 65.239999999999995 110.703 -178.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 69.31 21.36 75.83 Favored Glycine 0 C--N 1.334 0.417 0 CA-C-N 115.509 -0.769 . . . . 53.509999999999998 112.727 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -137.05 133.53 35.54 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.436 -0.579 . . . . 51.240000000000002 109.436 178.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.9 pptp? -82.8 137.15 34.44 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.68 -0.489 . . . . 45.119999999999997 109.68 -177.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.829 HD21 ' HB3' ' A' ' 103' ' ' LYS . 2.1 mm? -99.13 -52.97 3.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.128 -0.487 . . . . 72.549999999999997 110.47 -177.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.653 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 16.8 m -150.31 172.1 15.92 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 115.679 -0.691 . . . . 74.540000000000006 110.795 -170.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.29 122.15 11.27 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.171 0.51 . . . . 75.319999999999993 110.858 -174.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.551 HG22 HG22 ' A' ' 119' ' ' ILE . 49.6 t -85.46 107.17 15.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.062 -0.517 . . . . 64.25 109.905 176.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.459 HG22 ' HB3' ' A' ' 95' ' ' ALA . 54.2 mt -106.32 106.95 21.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-O 120.987 0.423 . . . . 75.109999999999999 110.349 178.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 88.06 -134.76 12.65 Favored Glycine 0 N--CA 1.451 -0.322 0 CA-C-N 115.766 -0.652 . . . . 74.409999999999997 112.096 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -132.82 81.67 1.96 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.87 0.367 . . . . 71.329999999999998 110.919 -178.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.478 ' HB3' ' HB2' ' A' ' 118' ' ' LYS . 1.0 OUTLIER -122.53 94.41 4.28 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.928 -0.578 . . . . 62.439999999999998 110.519 -179.712 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.538 ' O ' HG13 ' A' ' 119' ' ' ILE . 7.8 tp -62.24 -41.38 91.24 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 CA-C-N 116.306 -0.406 . . . . 73.120000000000005 110.927 -179.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.1 t -65.37 -28.9 69.6 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 116.12 -0.491 . . . . 71.150000000000006 110.449 -178.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.478 ' HB2' ' HB3' ' A' ' 115' ' ' ASP . 0.2 OUTLIER -72.71 -55.36 6.9 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 108.689 -0.856 . . . . 71.040000000000006 108.689 176.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.551 HG22 HG22 ' A' ' 111' ' ' VAL . 2.2 pp -60.92 -38.49 79.39 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 CA-C-N 115.757 -0.656 . . . . 71.219999999999999 112.065 -171.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.519 HD12 ' N ' ' A' ' 121' ' ' SER . 2.9 pp -64.96 -33.01 60.71 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 C-N-CA 120.216 -0.594 . . . . 75.310000000000002 110.538 179.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.519 ' N ' HD12 ' A' ' 120' ' ' ILE . 42.0 t -70.92 -51.94 23.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.801 0.334 . . . . 62.240000000000002 110.258 177.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.518 ' HG2' ' HA ' ' A' ' 119' ' ' ILE . 15.6 pt-20 -71.78 -35.3 69.98 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.29 -0.413 . . . . 74.319999999999993 111.833 -170.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.661 HD12 HD12 ' A' ' 66' ' ' LEU . 71.4 mt -71.02 -53.91 19.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.628 0.251 . . . . 72.530000000000001 110.638 177.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -61.87 -23.03 66.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.328 -0.396 . . . . 72.010000000000005 111.386 -177.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -62.86 -48.96 76.79 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.461 -0.336 . . . . 60.229999999999997 111.361 176.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.554 ' OD1' HD22 ' A' ' 43' ' ' LEU . 9.3 p30 -88.38 -30.37 19.56 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 112.189 0.44 . . . . 73.109999999999999 112.189 -170.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.514 HG23 ' OD1' ' A' ' 126' ' ' ASN . 41.8 pt -106.59 168.14 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.864 0.364 . . . . 71.040000000000006 110.98 177.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.251 1.138 0 CA-C-O 118.376 -0.821 . . . . 74.439999999999998 110.985 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.527 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.126 0 N-CA-C 109.619 -0.511 . . . . 51.399999999999999 109.619 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -161.35 85.22 0.65 Allowed 'General case' 0 C--O 1.235 0.322 0 N-CA-C 112.317 0.488 . . . . 74.329999999999998 112.317 -176.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 25.7 p-80 -139.29 122.15 16.58 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.884 -1.154 . . . . 73.010000000000005 107.884 166.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.413 ' O ' ' N ' ' A' ' 6' ' ' HIS . 11.1 m170 -67.19 77.13 0.14 Allowed 'General case' 0 N--CA 1.467 0.384 0 N-CA-C 112.499 0.555 . . . . 75.420000000000002 112.499 -166.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 53.86 0.04 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.791 1.236 . . . . 74.219999999999999 114.21 171.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.413 ' N ' ' O ' ' A' ' 4' ' ' HIS . 29.0 m80 -89.28 128.74 35.89 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 121.971 -0.456 . . . . 71.200000000000003 110.514 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . 0.496 ' ND1' ' SD ' ' A' ' 9' ' ' MET . 24.5 t-80 -127.87 145.21 51.02 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.182 -0.673 . . . . 65.209999999999994 109.182 178.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 23.9 m170 -93.82 93.52 8.0 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.94 0.4 . . . . 71.340000000000003 111.26 -176.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.496 ' SD ' ' ND1' ' A' ' 7' ' ' HIS . 4.3 mpp? -93.44 166.91 12.04 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.561 -0.533 . . . . 61.329999999999998 109.561 174.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -157.8 -162.97 12.12 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 121.206 -0.521 . . . . 54.420000000000002 111.886 178.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.9 t -164.62 135.26 4.09 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.818 0.342 . . . . 62.43 110.579 178.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.9 tt -87.67 104.71 16.79 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 108.435 -0.95 . . . . 75.129999999999995 108.435 175.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -132.97 121.56 22.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.225 -0.443 . . . . 62.409999999999997 109.851 -175.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -136.01 122.83 21.2 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.158 -0.474 . . . . 64.340000000000003 110.192 -178.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 86.1 mm-40 -85.07 99.2 10.88 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 71.200000000000003 110.957 -179.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.2 p -116.86 97.89 6.2 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.826 -0.625 . . . . 74.340000000000003 109.654 174.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -73.02 172.61 10.67 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 116.211 -0.449 . . . . 73.129999999999995 111.093 -175.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -173.16 82.77 0.08 OUTLIER Glycine 0 CA--C 1.52 0.4 0 C-N-CA 121.233 -0.508 . . . . 72.219999999999999 112.169 -178.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -77.16 126.98 8.93 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.925 2.416 . . . . 73.219999999999999 112.122 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -79.6 67.13 3.41 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.979 -0.629 . . . . 71.450000000000003 112.418 178.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.8 t -139.48 179.16 6.71 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 110.154 -0.313 . . . . 64.019999999999996 110.154 -178.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.581 ' HG3' HG13 ' A' ' 23' ' ' ILE . 24.6 ptp -112.17 -34.43 5.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.524 -0.307 . . . . 73.25 110.293 176.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.581 HG13 ' HG3' ' A' ' 22' ' ' MET . 65.1 mt -134.3 118.98 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 CA-C-N 116.28 -0.418 . . . . 74.400000000000006 109.881 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.545 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 8.4 tp10 -131.89 155.13 48.41 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.908 0.385 . . . . 71.409999999999997 111.019 -178.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -109.7 129.2 55.63 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.425 -0.583 . . . . 65.140000000000001 109.425 174.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.516 HD12 ' HA ' ' A' ' 31' ' ' PHE . 22.0 pt -122.59 173.65 8.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 CA-C-N 116.5 -0.318 . . . . 64.230000000000004 111.438 -175.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -112.14 -176.48 19.93 Favored Glycine 0 C--N 1.333 0.371 0 CA-C-N 115.85 -0.614 . . . . 13.31 112.859 -176.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -58.62 -49.94 75.65 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.454 0.702 . . . . 73.329999999999998 112.339 -175.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 25.0 m -74.03 -16.99 61.03 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.657 0.614 . . . . 64.120000000000005 112.657 -168.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -113.52 -7.89 13.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.575 -0.284 . . . . 71.549999999999997 111.471 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.516 ' HA ' HD12 ' A' ' 26' ' ' ILE . 30.5 t80 -49.25 -70.79 0.08 Allowed 'General case' 0 N--CA 1.461 0.106 0 O-C-N 123.32 0.387 . . . . 65.209999999999994 110.743 179.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -62.63 -37.67 87.25 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.644 -0.502 . . . . 71.430000000000007 109.644 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.513 ' O ' ' HB2' ' A' ' 37' ' ' SER . 20.7 t-20 -52.59 -42.9 64.95 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.789 -1.096 . . . . 63.409999999999997 112.051 -173.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.502 ' HD3' HG21 ' A' ' 26' ' ' ILE . 12.7 ptmt -111.52 -15.38 13.52 Favored 'General case' 0 CA--C 1.533 0.305 0 N-CA-C 112.326 0.491 . . . . 53.439999999999998 112.326 -177.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.1 t -88.51 -56.37 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 N-CA-C 111.681 0.252 . . . . 61.520000000000003 111.681 177.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 39.9 p -84.38 -32.09 24.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.911 0.386 . . . . 74.430000000000007 110.882 -173.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.513 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 18.0 m -83.81 8.92 13.26 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.083 -0.508 . . . . 73.219999999999999 111.516 -177.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.458 ' SG ' HG22 ' A' ' 42' ' ' ILE . 50.2 t -72.27 95.58 1.72 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-O 120.946 0.403 . . . . 60.130000000000003 110.449 -178.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -76.41 -9.32 58.56 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.934 -0.575 . . . . 70.230000000000004 110.796 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -59.05 -25.35 63.64 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 116.122 -0.49 . . . . 63.240000000000002 111.257 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.474 ' HA ' ' HB2' ' A' ' 103' ' ' LYS . 66.4 m-20 65.47 15.92 10.26 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.755 -0.657 . . . . 71.209999999999994 111.074 -176.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.458 HG22 ' SG ' ' A' ' 38' ' ' CYS . 10.6 tt -65.33 166.26 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 N-CA-C 108.669 -0.863 . . . . 74.519999999999996 108.669 172.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.591 HD21 ' HE3' ' A' ' 101' ' ' MET . 49.7 tp -92.35 101.65 14.13 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 121.651 -0.656 . . . . 74.319999999999993 110.677 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 50.5 mt -87.32 131.89 34.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.522 -0.763 . . . . 75.349999999999994 109.795 174.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.541 ' HB2' HG13 ' A' ' 76' ' ' ILE . 89.0 mt -117.44 104.6 11.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.129 -0.487 . . . . 41.200000000000003 109.701 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 23.5 m -95.43 119.53 43.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.965 -0.294 . . . . 71.439999999999998 110.72 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.698 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 31.8 t70 -99.27 161.5 13.59 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 116.18 -0.464 . . . . 64.5 110.25 -178.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.407 ' HB3' ' HB ' ' A' ' 98' ' ' THR . 25.9 p90 -65.46 -170.19 0.06 Allowed 'General case' 0 C--O 1.239 0.546 0 CA-C-O 121.397 0.617 . . . . 73.030000000000001 112.07 -174.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.53 ' HA ' ' O ' ' A' ' 79' ' ' ILE . 3.6 m-90 -64.68 -166.24 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 115.236 -0.893 . . . . 72.239999999999995 111.759 -176.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.429 ' HA ' ' HD2' ' A' ' 51' ' ' PRO . . . 60.94 97.38 0.04 OUTLIER Pre-proline 0 CA--C 1.529 0.138 0 CA-C-N 115.489 -0.778 . . . . 53.439999999999998 110.54 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 50' ' ' ALA . 28.1 Cg_endo -61.56 -11.42 20.03 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.768 2.312 . . . . 74.340000000000003 112.843 -176.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 80.4 m95 -116.38 101.89 9.05 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.972 -0.381 . . . . 74.150000000000006 109.972 179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 66.4 m -83.79 115.02 22.03 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.996 -0.372 . . . . 72.239999999999995 109.996 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -90.95 -65.23 1.18 Allowed Glycine 0 CA--C 1.525 0.683 0 C-N-CA 121.335 -0.46 . . . . 63.140000000000001 113.874 -174.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_exo -52.17 100.09 0.05 OUTLIER 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.051 2.501 . . . . 62.109999999999999 113.753 -173.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 82.9 m -101.06 92.88 5.2 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.119 -0.491 . . . . 70.010000000000005 109.831 175.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 29.5 mmm180 -65.44 -49.35 69.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.907 -0.588 . . . . 74.519999999999996 111.185 -178.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 11.6 p -103.57 -168.8 1.55 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.76 -0.654 . . . . 52.329999999999998 110.166 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.41 ' O ' ' HB2' ' A' ' 60' ' ' GLU . 82.7 mt -66.99 103.49 1.17 Allowed 'General case' 0 C--O 1.233 0.207 0 N-CA-C 107.936 -1.135 . . . . 73.329999999999998 107.936 170.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 59' ' ' LEU . 2.9 mp0 65.93 157.45 0.13 Allowed Pre-proline 0 CA--C 1.541 0.615 0 O-C-N 123.629 0.58 . . . . 73.140000000000001 109.937 -170.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -67.06 160.11 48.85 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 121.728 1.619 . . . . 71.140000000000001 110.259 172.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.499 ' HB3' HG12 ' A' ' 119' ' ' ILE . 10.3 mp0 -51.46 -43.93 62.25 Favored 'General case' 0 C--O 1.246 0.918 0 CA-C-O 121.608 0.718 . . . . 74.099999999999994 110.294 -173.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.443 HD11 HG12 ' A' ' 99' ' ' ILE . 6.4 mp -56.92 -48.74 77.56 Favored 'General case' 0 C--O 1.223 -0.34 0 CA-C-N 114.488 -1.233 . . . . 74.219999999999999 110.491 -175.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.417 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 49.0 mt-10 -70.74 -42.51 70.41 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 123.212 0.32 . . . . 74.409999999999997 110.249 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 3.5 tmtp? -50.76 -46.17 59.23 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.807 -0.633 . . . . 71.310000000000002 109.834 -177.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.652 HD12 HD12 ' A' ' 123' ' ' ILE . 17.6 mt -86.18 -41.87 14.31 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 112.571 0.582 . . . . 73.239999999999995 112.571 177.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.87 -39.88 78.87 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 111.934 0.346 . . . . 61.5 111.934 -173.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.417 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 97.9 mt-30 -53.69 -33.2 54.61 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.269 0.557 . . . . 70.239999999999995 110.313 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 53.1 mm-40 -93.82 -41.39 9.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.445 -0.798 . . . . 65.549999999999997 111.465 -177.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.555 ' O ' HG22 ' A' ' 74' ' ' VAL . 17.3 m-85 -107.17 22.38 16.07 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 112.748 0.647 . . . . 75.230000000000004 112.748 -169.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.1 t -52.8 -34.05 51.75 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 112.13 0.419 . . . . 74.329999999999998 112.13 -176.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -68.3 -16.5 63.97 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 111.576 0.213 . . . . 53.340000000000003 111.576 -178.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -122.52 -4.77 8.76 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.539 0.209 . . . . 72.310000000000002 111.047 -177.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.555 HG22 ' O ' ' A' ' 70' ' ' TYR . 27.7 m -136.82 147.48 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 O-C-N 122.071 -0.393 . . . . 55.140000000000001 110.444 178.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.434 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 7.0 tppt? -142.13 116.59 9.63 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.718 0.295 . . . . 63.310000000000002 110.208 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.541 HG13 ' HB2' ' A' ' 45' ' ' LEU . 2.0 mp -93.14 134.23 31.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.078 -0.51 . . . . 74.420000000000002 110.762 -175.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.545 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 97.1 m-85 -129.12 128.6 43.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.885 -0.598 . . . . 72.200000000000003 109.616 174.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.698 ' HG2' ' HB3' ' A' ' 47' ' ' ASP . 25.6 mtpp -103.29 143.2 32.97 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.787 -0.449 . . . . 72.219999999999999 109.787 176.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.53 ' O ' ' HA ' ' A' ' 49' ' ' TRP . 40.9 mm -96.99 131.34 44.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.848 -0.615 . . . . 72.5 111.059 -175.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.526 HD21 ' HB2' ' A' ' 83' ' ' ASP . 0.1 OUTLIER -60.06 147.72 38.29 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.28 -0.418 . . . . 55.210000000000001 110.445 175.085 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 13.7 tt -66.21 -24.98 34.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-O 120.899 0.38 . . . . 61.140000000000001 110.884 -175.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.2 mm-40 -57.75 -25.18 60.1 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.847 -0.615 . . . . 71.239999999999995 111.12 -178.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.526 ' HB2' HD21 ' A' ' 80' ' ' ASN . 35.9 t70 -76.01 -25.37 55.68 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 119.205 -0.426 . . . . 64.430000000000007 112.075 -171.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.435 ' C ' ' O ' ' A' ' 83' ' ' ASP . 49.5 t30 2.33 102.73 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 124.524 1.14 . . . . 73.349999999999994 112.95 -176.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.414 ' HG2' ' HB ' ' A' ' 87' ' ' VAL . 0.0 OUTLIER -123.54 146.91 47.75 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.284 0.564 . . . . 74.209999999999994 111.116 -168.81 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -53.97 -28.7 39.21 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 114.794 -1.094 . . . . 61.450000000000003 111.471 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.414 ' HB ' ' HG2' ' A' ' 85' ' ' GLN . 62.1 t -50.05 -34.71 10.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-N 115.82 -0.627 . . . . 75.030000000000001 111.161 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.23 -51.01 70.77 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.068 -0.514 . . . . 73.530000000000001 110.845 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.9 m -67.69 -30.72 70.32 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 116.259 -0.428 . . . . 71.010000000000005 110.727 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -59.56 -55.99 27.52 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 115.929 -0.578 . . . . 72.230000000000004 110.341 178.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 54.1 m-85 -75.33 -15.82 60.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.391 -0.368 . . . . 74.030000000000001 110.937 178.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 79.46 61.01 2.39 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.306 -0.473 . . . . 71.209999999999994 112.661 175.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.52 HG22 HG21 ' A' ' 98' ' ' THR . 59.7 t -69.51 85.32 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-O 121.361 0.601 . . . . 73.5 110.137 176.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.2 t -116.03 9.76 14.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.507 -0.77 . . . . 73.310000000000002 110.144 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.467 ' HB3' HG22 ' A' ' 112' ' ' ILE . . . -152.66 142.63 22.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.154 -0.475 . . . . 73.129999999999995 109.973 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 29.9 pt -113.43 149.62 41.85 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.375 -0.375 . . . . 72.430000000000007 110.774 -177.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -76.54 -176.02 17.76 Favored 'Cis proline' 0 C--N 1.353 0.792 0 C-N-CA 124.005 -1.248 . . . . 65.310000000000002 112.442 -1.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.52 HG21 HG22 ' A' ' 93' ' ' VAL . 43.6 m -142.54 115.36 8.69 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.091 -0.337 . . . . 71.120000000000005 110.091 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.471 ' HA ' ' O ' ' A' ' 46' ' ' VAL . 4.0 mp -129.14 142.84 42.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.979 -0.555 . . . . 53.43 109.837 -178.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 8.6 mp -118.92 140.84 49.32 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-O 120.697 0.284 . . . . 73.120000000000005 110.361 174.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.843 ' SD ' ' HB3' ' A' ' 109' ' ' SER . 89.8 mtp -96.72 114.11 25.73 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.841 -0.618 . . . . 74.109999999999999 110.46 -178.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -115.12 144.5 43.57 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 121.072 0.463 . . . . 74.430000000000007 112.13 -178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.81 ' HG2' HD21 ' A' ' 108' ' ' LEU . 0.4 OUTLIER -157.8 119.23 3.59 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 108.913 -0.773 . . . . 63.310000000000002 108.913 163.617 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 58.94 25.03 13.23 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-O 121.543 0.687 . . . . 65.239999999999995 110.207 -176.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 87.45 -6.21 83.77 Favored Glycine 0 CA--C 1.52 0.349 0 CA-C-N 115.798 -0.637 . . . . 53.509999999999998 112.511 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -77.84 128.97 34.83 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 109.511 -0.552 . . . . 51.240000000000002 109.511 177.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 101' ' ' MET . 3.1 mppt? -90.49 109.41 20.55 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.32 -0.622 . . . . 45.119999999999997 109.32 174.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.81 HD21 ' HG2' ' A' ' 103' ' ' LYS . 2.3 mm? -77.92 -36.63 49.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.142 -0.481 . . . . 72.549999999999997 110.545 -175.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.843 ' HB3' ' SD ' ' A' ' 101' ' ' MET . 17.2 t -178.64 171.9 1.46 Allowed 'General case' 0 C--O 1.24 0.598 0 CA-C-N 115.593 -0.731 . . . . 74.540000000000006 109.05 -176.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.04 141.14 36.28 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-O 121.251 0.548 . . . . 75.319999999999993 111.106 179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 98' ' ' THR . 46.6 t -103.57 107.1 21.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.169 -0.923 . . . . 64.25 109.772 176.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.467 HG22 ' HB3' ' A' ' 95' ' ' ALA . 45.1 mt -118.84 106.31 19.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 108.466 -0.938 . . . . 75.109999999999999 108.466 172.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 108.65 174.26 21.58 Favored Glycine 0 CA--C 1.519 0.322 0 N-CA-C 111.041 -0.824 . . . . 74.409999999999997 111.041 -170.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -96.59 56.99 1.57 Allowed 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.179 0.514 . . . . 71.329999999999998 110.77 -177.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.548 ' O ' HG23 ' A' ' 119' ' ' ILE . 1.9 m-20 -90.19 73.78 7.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.875 -0.602 . . . . 62.439999999999998 110.906 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.551 ' O ' HG13 ' A' ' 119' ' ' ILE . 6.3 tp -54.74 -40.37 51.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 CA-C-O 121.108 0.48 . . . . 73.120000000000005 110.823 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 5.2 p -62.62 -29.08 70.36 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.853 -0.612 . . . . 71.150000000000006 111.182 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.498 ' HB2' ' HB3' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -79.28 -48.66 13.75 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.306 -0.627 . . . . 71.040000000000006 109.306 177.409 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.551 HG13 ' O ' ' A' ' 116' ' ' ILE . 1.6 pp -61.84 -40.77 88.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 CA-C-N 116.132 -0.486 . . . . 71.219999999999999 111.421 -172.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.542 HD12 ' N ' ' A' ' 121' ' ' SER . 2.9 pp -63.19 -31.97 54.63 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.141 0 C-N-CA 120.437 -0.505 . . . . 75.310000000000002 110.399 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.542 ' N ' HD12 ' A' ' 120' ' ' ILE . 33.6 t -70.46 -51.92 25.78 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.994 -0.548 . . . . 62.240000000000002 110.854 178.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.5 ' HG2' ' HA ' ' A' ' 119' ' ' ILE . 12.8 pt-20 -70.75 -43.67 68.36 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.085 -0.507 . . . . 74.319999999999993 111.325 -172.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.652 HD12 HD12 ' A' ' 66' ' ' LEU . 78.8 mt -64.41 -53.86 37.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.352 0.12 . . . . 72.530000000000001 110.958 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -59.79 -26.65 65.9 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.775 0.322 . . . . 72.010000000000005 111.263 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 -77.34 -14.87 59.64 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 111.741 0.274 . . . . 60.229999999999997 111.741 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -118.14 9.72 12.74 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 111.656 0.243 . . . . 73.109999999999999 111.656 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.522 HG12 ' O ' ' A' ' 123' ' ' ILE . 43.6 pt -134.74 168.33 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 N-CA-C 109.921 -0.4 . . . . 71.040000000000006 109.921 173.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.366 -0.826 . . . . 74.439999999999998 110.969 -176.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 mmt . . . . . 0 N--CA 1.479 1.003 0 N-CA-C 109.76 -0.459 . . . . 51.399999999999999 109.76 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -159.49 153.97 24.08 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 120.723 0.296 . . . . 74.329999999999998 110.752 -177.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 20.1 t60 -76.25 151.72 36.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.119 -0.491 . . . . 73.010000000000005 109.793 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 47.9 t-80 -45.27 125.38 5.43 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 123.43 0.456 . . . . 75.420000000000002 110.586 176.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.3 m170 -59.52 124.21 19.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.916 -0.584 . . . . 74.219999999999999 110.522 -175.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 8.3 t-160 -135.56 139.1 43.64 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.046 -0.524 . . . . 71.200000000000003 109.862 -171.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -87.76 173.79 8.77 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 120.84 0.353 . . . . 65.209999999999994 111.166 179.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.46 ' HB3' ' O ' ' A' ' 49' ' ' TRP . 10.3 p-80 -93.72 156.77 16.5 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.963 -0.562 . . . . 71.340000000000003 111.221 -177.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 66.3 mtt -130.65 -73.61 0.54 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.78 -0.822 . . . . 61.329999999999998 108.78 167.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.03 -50.42 3.68 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 121.42 -0.419 . . . . 54.420000000000002 113.588 172.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 34.2 p 50.37 75.7 0.17 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.308 0.575 . . . . 62.43 111.591 -177.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.593 HD11 HG21 ' A' ' 79' ' ' ILE . 4.4 pp -160.49 150.31 17.74 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.329 -0.85 . . . . 75.129999999999995 109.676 178.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 30.5 tp10 -147.04 108.84 4.37 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.675 -0.491 . . . . 62.409999999999997 109.675 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -131.16 122.98 27.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.234 -0.439 . . . . 64.340000000000003 110.72 -176.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 23.3 mp0 -82.09 108.08 15.29 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.013 -0.54 . . . . 71.200000000000003 109.715 178.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 99.5 m -95.44 148.31 22.6 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.921 -0.581 . . . . 74.340000000000003 111.756 -172.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 71.2 mm-40 -71.58 -164.26 0.11 Allowed 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.863 -0.608 . . . . 73.129999999999995 110.778 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -99.51 -70.96 0.96 Allowed Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.815 -0.63 . . . . 72.219999999999999 111.717 175.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -71.73 87.31 0.83 Allowed 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.269 1.98 . . . . 73.219999999999999 112.246 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -129.43 -140.43 4.85 Favored Glycine 0 C--O 1.235 0.182 0 CA-C-N 115.87 -0.605 . . . . 71.450000000000003 111.869 177.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.9 m -69.49 156.43 38.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.624 0.249 . . . . 64.019999999999996 110.824 178.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.635 ' HG3' HG13 ' A' ' 23' ' ' ILE . 21.2 ptp -59.71 -33.42 71.59 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 109.764 -0.458 . . . . 73.25 109.764 175.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.635 HG13 ' HG3' ' A' ' 22' ' ' MET . 23.2 mt -127.09 101.65 8.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 108.673 -0.862 . . . . 74.400000000000006 108.673 174.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 9.4 tp10 -124.01 149.64 45.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.813 0.34 . . . . 71.409999999999997 110.377 -175.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -82.15 149.74 27.79 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.169 -0.468 . . . . 65.140000000000001 110.26 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.481 HD12 ' HA ' ' A' ' 31' ' ' PHE . 25.4 pt -130.01 177.4 6.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.603 -0.271 . . . . 64.230000000000004 110.512 178.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -102.18 158.55 18.21 Favored Glycine 0 C--O 1.237 0.32 0 CA-C-N 116.102 -0.499 . . . . 13.31 112.324 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -59.81 -39.15 84.07 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.203 0.525 . . . . 73.329999999999998 110.433 -178.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.4 t -63.33 -32.83 74.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.424 -0.807 . . . . 64.120000000000005 111.529 -176.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.403 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 10.0 pt-20 -105.28 -1.06 25.71 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 112.324 0.49 . . . . 71.549999999999997 112.324 -174.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.481 ' HA ' HD12 ' A' ' 26' ' ' ILE . 57.9 t80 -47.15 -71.61 0.07 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 120.793 0.33 . . . . 65.209999999999994 111.192 -178.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -64.43 -36.43 84.15 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.351 -0.611 . . . . 71.430000000000007 109.351 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -52.43 -38.55 59.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.436 -1.256 . . . . 63.409999999999997 111.891 -173.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 15.8 ptmt -114.34 -18.27 11.6 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.094 0.405 . . . . 53.439999999999998 112.094 -177.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 72.7 t -85.22 -49.59 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 111.851 0.315 . . . . 61.520000000000003 111.851 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 64.9 p -83.06 -28.83 29.28 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.075 0.464 . . . . 74.430000000000007 111.04 -173.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.1 m -80.1 12.02 3.08 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.914 -0.585 . . . . 73.219999999999999 111.992 -177.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 24.6 p -76.8 87.33 3.4 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-O 120.824 0.345 . . . . 60.130000000000003 111.817 -176.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -75.22 -5.93 47.04 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.14 0.495 . . . . 70.230000000000004 110.397 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.526 ' O ' ' HB2' ' A' ' 41' ' ' ASN . 2.1 m-20 -52.82 -30.26 32.43 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.633 -0.712 . . . . 63.240000000000002 112.062 -177.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.526 ' HB2' ' O ' ' A' ' 40' ' ' ASP . 0.9 OUTLIER 75.11 11.47 3.55 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 123.691 0.619 . . . . 71.209999999999994 110.34 -171.669 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.518 HG22 ' HB2' ' A' ' 40' ' ' ASP . 10.0 tt -81.94 158.53 4.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 CA-C-N 115.624 -0.716 . . . . 74.519999999999996 109.113 176.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.489 HD11 ' HB2' ' A' ' 126' ' ' ASN . 54.5 mt -84.92 112.53 20.65 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 120.916 -0.314 . . . . 74.319999999999993 110.604 179.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 20.0 mt -102.41 105.91 18.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.036 0.446 . . . . 75.349999999999994 109.945 173.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.515 ' HB2' HG12 ' A' ' 76' ' ' ILE . 5.1 mp -93.38 136.96 33.15 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.988 -0.745 . . . . 41.200000000000003 108.988 177.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.502 HG12 ' HB2' ' A' ' 77' ' ' TYR . 27.4 m -130.17 138.67 53.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 109.749 -0.463 . . . . 71.439999999999998 109.749 178.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -111.33 143.75 41.63 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.857 0.36 . . . . 64.5 111.036 177.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.565 ' HZ ' HG22 ' A' ' 96' ' ' ILE . 13.7 p90 -73.8 144.12 45.71 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 109.543 -0.54 . . . . 73.030000000000001 109.543 176.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.649 ' HB2' ' HA ' ' A' ' 79' ' ' ILE . 39.0 t-105 -84.91 159.93 20.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.921 0.391 . . . . 72.239999999999995 110.896 -176.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.457 ' HB1' ' SG ' ' A' ' 53' ' ' CYS . . . -143.0 150.81 54.22 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 109.275 -0.639 . . . . 53.439999999999998 109.275 177.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -61.52 -64.88 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.066 1.844 . . . . 74.340000000000003 111.639 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 95.3 m95 -148.44 -57.46 0.22 Allowed 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 109.301 -0.629 . . . . 74.150000000000006 109.301 177.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.457 ' SG ' ' HB1' ' A' ' 50' ' ' ALA . 81.8 m 68.95 -68.95 0.17 Allowed 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.394 -0.821 . . . . 72.239999999999995 111.582 177.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -156.78 164.76 32.82 Favored Glycine 0 CA--C 1.518 0.232 0 C-N-CA 121.152 -0.547 . . . . 63.140000000000001 112.066 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.19 126.28 17.53 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.826 2.351 . . . . 62.109999999999999 112.083 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 56.7 m -62.74 94.67 0.07 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.247 -0.433 . . . . 70.010000000000005 110.82 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 57' ' ' ARG . 2.0 ptm180 -104.35 164.58 11.64 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.122 -0.49 . . . . 74.519999999999996 109.824 177.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 26.1 t 61.14 90.7 0.06 Allowed 'General case' 0 CA--C 1.531 0.217 0 O-C-N 123.565 0.541 . . . . 52.329999999999998 110.407 -177.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.452 ' N ' HD22 ' A' ' 59' ' ' LEU . 2.9 mm? -84.45 34.5 0.53 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.062 -0.517 . . . . 73.329999999999998 110.887 -175.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -144.56 74.34 15.24 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.174 -0.466 . . . . 73.140000000000001 110.222 -179.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -88.17 170.02 6.04 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.839 2.359 . . . . 71.140000000000001 112.314 178.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.557 ' HB3' HG12 ' A' ' 119' ' ' ILE . 9.6 mp0 -61.9 -57.51 11.49 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.351 0.596 . . . . 74.099999999999994 111.097 -173.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.494 ' HB2' HD13 ' A' ' 76' ' ' ILE . 2.3 pt? -54.37 -47.17 72.93 Favored 'General case' 0 CA--C 1.53 0.186 0 CA-C-N 115.068 -0.969 . . . . 74.219999999999999 111.611 -174.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.511 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 37.2 mt-10 -65.66 -43.72 88.53 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 120.888 -0.325 . . . . 74.409999999999997 110.255 179.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -53.14 -48.66 67.73 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 115.891 -0.595 . . . . 71.310000000000002 110.982 -177.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.582 HD12 HD12 ' A' ' 123' ' ' ILE . 17.7 mt -79.43 -37.73 36.37 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 111.967 0.358 . . . . 73.239999999999995 111.967 -179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.419 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -59.81 -31.42 69.69 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.457 0.17 . . . . 61.5 111.307 -176.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.511 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 74.8 mt-30 -54.52 -34.95 62.62 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.951 0.405 . . . . 70.239999999999995 111.051 177.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -94.1 -45.23 7.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.192 0.52 . . . . 65.549999999999997 111.019 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.573 ' O ' HG22 ' A' ' 74' ' ' VAL . 20.4 m-85 -92.85 14.92 15.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.807 -0.633 . . . . 75.230000000000004 112.285 -171.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.419 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 8.8 t -52.48 -35.99 53.92 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.05 0.452 . . . . 74.329999999999998 111.442 -174.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -63.96 -28.43 69.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.83 -0.623 . . . . 53.340000000000003 111.841 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -116.48 3.19 13.21 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.52 -0.309 . . . . 72.310000000000002 111.17 -173.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.573 HG22 ' O ' ' A' ' 70' ' ' TYR . 23.6 m -133.68 141.34 44.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 121.088 0.47 . . . . 55.140000000000001 110.556 177.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.728 ' HA ' ' HE3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -128.15 116.53 20.07 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.523 -0.762 . . . . 63.310000000000002 108.969 174.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.555 ' HB ' HG12 ' A' ' 23' ' ' ILE . 39.9 mt -109.49 134.7 50.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.725 0.298 . . . . 74.420000000000002 110.413 -177.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.502 ' HB2' HG12 ' A' ' 46' ' ' VAL . 51.3 m-85 -120.72 134.5 55.28 Favored 'General case' 0 C--O 1.242 0.706 0 CA-C-N 115.982 -0.554 . . . . 72.200000000000003 110.08 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 8.0 ptmm? -112.89 161.5 16.91 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.25 -0.886 . . . . 72.219999999999999 110.62 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.649 ' HA ' ' HB2' ' A' ' 49' ' ' TRP . 30.9 mt 67.43 66.86 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 115.561 -0.745 . . . . 72.5 109.892 -174.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -115.1 161.17 18.75 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 115.674 -0.694 . . . . 55.210000000000001 110.557 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.45 ' H ' HG13 ' A' ' 81' ' ' ILE . 2.7 pp -89.33 24.35 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.898 -0.592 . . . . 61.140000000000001 110.782 178.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.412 ' CD ' HD13 ' A' ' 100' ' ' LEU . 33.3 tt0 -53.53 -40.66 65.67 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.305 -0.861 . . . . 71.239999999999995 111.53 -177.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -74.81 -18.16 60.5 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 116.146 -0.479 . . . . 64.430000000000007 110.884 -177.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -91.24 13.86 16.01 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.356 0.598 . . . . 73.349999999999994 109.818 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -110.19 132.51 54.1 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.673 -0.694 . . . . 74.209999999999994 109.94 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -57.67 -29.06 64.33 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.164 0.507 . . . . 61.450000000000003 109.791 173.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 56.7 t -54.96 -37.34 41.49 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 CA-C-N 115.344 -0.843 . . . . 75.030000000000001 110.824 178.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.08 -52.21 65.87 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.089 0.471 . . . . 73.530000000000001 109.876 178.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.8 m -60.67 -32.05 71.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.83 -0.623 . . . . 71.010000000000005 110.53 177.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 52.3 tt0 -66.12 -37.83 86.7 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.036 -0.529 . . . . 72.230000000000004 110.592 177.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -77.26 -5.66 50.22 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 116.463 -0.335 . . . . 74.030000000000001 111.099 176.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.85 21.0 64.33 Favored Glycine 0 C--N 1.33 0.211 0 C-N-CA 121.082 -0.58 . . . . 71.209999999999994 112.077 -178.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 97.9 t -65.93 102.92 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.045 0.45 . . . . 73.5 110.309 178.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.7 t -143.79 21.03 1.81 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.61 0.719 . . . . 73.310000000000002 109.174 178.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -129.01 160.9 31.28 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.567 -0.742 . . . . 73.129999999999995 110.29 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.565 HG22 ' HZ ' ' A' ' 48' ' ' PHE . 26.8 pt -118.67 130.61 24.7 Favored Pre-proline 0 CA--C 1.533 0.313 0 CA-C-N 116.304 -0.407 . . . . 72.430000000000007 110.603 -178.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 96' ' ' ILE . 47.7 Cg_endo -91.62 -170.05 3.96 Favored 'Cis proline' 0 C--N 1.35 0.616 0 C-N-CA 124.05 -1.229 . . . . 65.310000000000002 112.336 -4.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 88.5 m -147.83 139.81 24.12 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 116.034 -0.53 . . . . 71.120000000000005 109.677 175.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 36.9 mt -136.83 114.49 13.86 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 CA-C-N 115.957 -0.565 . . . . 53.43 110.019 -176.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.412 HD13 ' CD ' ' A' ' 82' ' ' GLU . 8.2 mp -91.5 146.36 23.86 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.019 0.437 . . . . 73.120000000000005 111.152 178.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.488 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 90.5 mtp -108.63 118.97 38.16 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.994 -0.548 . . . . 74.109999999999999 110.663 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.43 ' CE2' ' HG2' ' A' ' 107' ' ' LYS . 79.3 m-85 -115.55 149.05 38.8 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-O 121.231 0.539 . . . . 74.430000000000007 111.482 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.642 ' HB3' HD21 ' A' ' 108' ' ' LEU . 30.8 ttmt -155.65 111.1 3.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 114.933 -1.031 . . . . 63.310000000000002 109.078 177.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 9.9 t30 60.7 25.06 14.87 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.458 0.647 . . . . 65.239999999999995 110.192 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.88 -14.89 62.06 Favored Glycine 0 C--N 1.334 0.458 0 CA-C-N 115.572 -0.74 . . . . 53.509999999999998 112.259 -179.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -81.11 144.43 31.7 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.836 -0.431 . . . . 51.240000000000002 109.836 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.43 ' HG2' ' CE2' ' A' ' 102' ' ' PHE . 46.2 mttp -102.56 115.3 30.3 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.803 -0.444 . . . . 45.119999999999997 109.803 -176.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.642 HD21 ' HB3' ' A' ' 103' ' ' LYS . 2.8 mm? -85.85 -53.4 5.14 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 120.857 0.361 . . . . 72.549999999999997 111.249 -174.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.488 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 20.5 m -160.02 171.89 18.52 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.882 -0.599 . . . . 74.540000000000006 110.205 -172.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.467 ' NE2' ' H ' ' A' ' 110' ' ' GLN . 0.4 OUTLIER -143.88 124.04 13.71 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.024 -0.535 . . . . 75.319999999999993 110.568 178.805 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.574 HG22 HG22 ' A' ' 119' ' ' ILE . 61.2 t -80.43 107.13 12.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.83 -0.623 . . . . 64.25 109.471 175.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 58.7 mt -108.28 107.03 21.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 109.865 -0.42 . . . . 75.109999999999999 109.865 178.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 98.32 -132.53 10.98 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.811 -0.631 . . . . 74.409999999999997 111.604 -178.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -142.37 75.74 1.5 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.92 0.39 . . . . 71.329999999999998 110.387 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.49 ' O ' HG23 ' A' ' 119' ' ' ILE . 2.6 m-20 -115.47 97.5 6.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.917 -0.583 . . . . 62.439999999999998 110.611 -177.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.528 ' O ' HG13 ' A' ' 119' ' ' ILE . 6.7 tp -64.5 -41.08 91.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 116.411 -0.358 . . . . 73.120000000000005 111.342 -176.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 15.1 m -64.58 -29.85 70.87 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.454 0.645 . . . . 71.150000000000006 110.456 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.463 ' HG3' ' OE2' ' A' ' 122' ' ' GLU . 27.9 tptp -73.88 -50.64 19.29 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 115.453 -0.794 . . . . 71.040000000000006 110.453 178.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.574 HG22 HG22 ' A' ' 111' ' ' VAL . 2.1 pp -65.34 -41.32 91.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.814 -0.63 . . . . 71.219999999999999 111.519 -174.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.472 HG22 HD11 ' A' ' 66' ' ' LEU . 2.8 pp -62.32 -31.82 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-O 121.127 0.489 . . . . 75.310000000000002 109.837 178.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.556 ' O ' ' HB2' ' A' ' 125' ' ' ASN . 23.0 t -70.44 -51.56 28.47 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 115.85 -0.614 . . . . 62.240000000000002 110.55 179.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.463 ' OE2' ' HG3' ' A' ' 118' ' ' LYS . 10.7 pt-20 -73.52 -33.41 64.75 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 111.924 0.342 . . . . 74.319999999999993 111.924 -172.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.582 HD12 HD12 ' A' ' 66' ' ' LEU . 71.7 mt -73.59 -57.37 6.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 CA-C-O 120.567 0.223 . . . . 72.530000000000001 110.654 178.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -63.67 -20.12 65.45 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.115 0.483 . . . . 72.010000000000005 110.609 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.556 ' HB2' ' O ' ' A' ' 121' ' ' SER . 26.7 t-20 -54.04 -29.8 45.3 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.717 -0.674 . . . . 60.229999999999997 110.76 176.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.489 ' HB2' HD11 ' A' ' 43' ' ' LEU . 33.8 m-80 -107.99 -45.21 4.02 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.872 -0.604 . . . . 73.109999999999999 111.233 -176.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 48.4 pt -105.46 167.78 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-O 120.819 0.343 . . . . 71.040000000000006 111.274 -175.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.55 ' N ' HD22 ' A' ' 128' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.38 -0.819 . . . . 74.439999999999998 112.137 -177.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.5 mtt . . . . . 0 N--CA 1.482 1.145 0 CA-C-O 120.773 0.32 . . . . 51.399999999999999 110.653 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.79 -97.6 0.06 Allowed 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.464 -0.789 . . . . 74.329999999999998 111.584 177.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.426 ' O ' ' CG ' ' A' ' 3' ' ' HIS . 14.2 t-80 53.33 24.29 3.76 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.674 0.749 . . . . 73.010000000000005 110.121 -173.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 32.3 m80 -111.65 84.48 1.96 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.216 0.531 . . . . 75.420000000000002 111.29 -177.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -134.25 9.74 3.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.211 -0.904 . . . . 74.219999999999999 109.009 170.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 75.9 t60 -115.1 108.73 17.04 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 115.543 -0.753 . . . . 71.200000000000003 110.385 -174.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 3.8 p-80 -148.67 156.8 42.88 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.164 -0.471 . . . . 65.209999999999994 109.903 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -110.69 98.38 7.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.363 0.601 . . . . 71.340000000000003 110.183 179.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 91.4 mtp -100.78 177.61 4.93 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.759 -0.655 . . . . 61.329999999999998 110.019 177.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 108.67 172.34 21.28 Favored Glycine 0 N--CA 1.452 -0.262 0 N-CA-C 111.844 -0.502 . . . . 54.420000000000002 111.844 -178.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.543 HG23 ' HA ' ' A' ' 57' ' ' ARG . 86.1 m -149.04 100.31 3.05 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.925 0.393 . . . . 62.43 110.248 177.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.448 HD13 HD12 ' A' ' 59' ' ' LEU . 8.8 mp -80.31 124.14 28.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.952 -0.567 . . . . 75.129999999999995 109.769 177.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -88.51 131.53 34.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.07 -0.514 . . . . 62.409999999999997 110.621 -179.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 63.2 95.71 0.04 OUTLIER 'General case' 0 C--O 1.233 0.216 0 O-C-N 123.941 0.775 . . . . 64.340000000000003 112.49 175.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.471 HE22 ' HG3' ' A' ' 64' ' ' GLU . 64.3 tt0 -67.43 119.24 11.93 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 107.828 -1.175 . . . . 71.200000000000003 107.828 169.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 29.2 p -48.88 -79.91 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 112.545 0.572 . . . . 74.340000000000003 112.545 -170.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 21.3 mm-40 -157.92 176.07 13.02 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 122.553 0.341 . . . . 73.129999999999995 110.417 -178.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -159.36 64.23 0.29 Allowed Glycine 0 CA--C 1.52 0.362 0 CA-C-N 115.824 -0.625 . . . . 72.219999999999999 111.773 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -92.38 135.84 1.48 Allowed 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 123.006 2.471 . . . . 73.219999999999999 112.455 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 52.78 52.92 35.71 Favored Glycine 0 CA--C 1.521 0.423 0 CA-C-N 116.333 -0.394 . . . . 71.450000000000003 112.967 177.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 40.1 m -141.81 -157.58 0.78 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.582 -0.525 . . . . 64.019999999999996 109.582 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.522 ' SD ' ' HA ' ' A' ' 68' ' ' GLN . 49.5 mtm -49.26 -35.71 18.46 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.638 0.733 . . . . 73.25 109.475 172.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.4 mm -92.67 128.83 43.98 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 CA-C-N 114.38 -1.282 . . . . 74.400000000000006 108.641 171.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.413 ' HG2' ' CE1' ' A' ' 77' ' ' TYR . 9.1 tp10 -124.84 153.15 43.0 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.746 0.308 . . . . 71.409999999999997 110.426 -176.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.29 124.4 40.26 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.503 -0.554 . . . . 65.140000000000001 109.503 177.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.518 ' O ' HD13 ' A' ' 79' ' ' ILE . 32.5 pt -131.69 -176.93 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.047 -0.524 . . . . 64.230000000000004 110.533 -172.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -111.79 170.55 13.72 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 121.506 -0.378 . . . . 13.31 112.219 178.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -67.5 -38.15 83.9 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 122.575 0.35 . . . . 73.329999999999998 111.71 -178.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.2 m -60.32 -39.09 85.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.003 0.43 . . . . 64.120000000000005 111.177 -176.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.453 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 1.7 pm0 -103.38 -0.98 29.35 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.779 -0.646 . . . . 71.549999999999997 111.159 -177.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.405 ' HA ' HD12 ' A' ' 26' ' ' ILE . 69.2 t80 -53.04 -70.55 0.09 Allowed 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 109.775 -0.454 . . . . 65.209999999999994 109.775 177.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -49.75 -42.78 47.17 Favored 'General case' 0 C--O 1.24 0.574 0 CA-C-N 116.074 -0.512 . . . . 71.430000000000007 110.03 176.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.408 ' O ' ' HB2' ' A' ' 37' ' ' SER . 66.1 t30 -52.19 -54.32 32.29 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 114.655 -1.157 . . . . 63.409999999999997 111.481 -172.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.465 ' HE3' ' CE1' ' A' ' 77' ' ' TYR . 0.1 OUTLIER -101.23 -15.93 17.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.245 -0.434 . . . . 53.439999999999998 111.936 -172.921 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 73.1 t -88.58 -57.06 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 111.962 0.356 . . . . 61.520000000000003 111.962 -179.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.9 p -88.01 -42.09 12.67 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-O 121.047 0.451 . . . . 74.430000000000007 110.716 -171.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 18.4 m -76.73 12.07 1.46 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.823 -0.626 . . . . 73.219999999999999 111.473 -178.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.421 ' SG ' ' HB2' ' A' ' 40' ' ' ASP . 50.1 t -81.21 99.96 8.86 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.999 0.428 . . . . 60.130000000000003 110.334 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -87.25 14.87 7.02 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.181 0.515 . . . . 70.230000000000004 110.661 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.421 ' HB2' ' SG ' ' A' ' 38' ' ' CYS . 5.5 m-20 -75.36 -8.8 57.64 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.066 -0.515 . . . . 63.240000000000002 111.041 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 8.1 m120 68.47 0.05 2.42 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 112.483 0.549 . . . . 71.209999999999994 112.483 177.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.9 tt -71.49 145.42 12.46 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 109.095 -0.706 . . . . 74.519999999999996 109.095 177.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.601 HD11 ' HB3' ' A' ' 101' ' ' MET . 61.1 tp -80.76 109.74 15.61 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.263 0.554 . . . . 74.319999999999993 110.071 -177.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.485 HG23 ' CD2' ' A' ' 77' ' ' TYR . 61.5 mt -94.99 114.54 31.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.357 -0.838 . . . . 75.349999999999994 110.386 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.458 ' N ' HD12 ' A' ' 45' ' ' LEU . 5.5 mp -98.6 101.99 13.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.04 -0.527 . . . . 41.200000000000003 110.114 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.62 HG23 ' HB2' ' A' ' 100' ' ' LEU . 16.3 m -96.9 109.92 23.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.685 -0.487 . . . . 71.439999999999998 109.685 176.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 99' ' ' ILE . 3.9 p30 -101.36 146.77 27.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.465 0.65 . . . . 64.5 111.79 -174.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -89.95 96.34 10.63 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 107.614 -1.254 . . . . 73.030000000000001 107.614 169.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 67.1 t-105 -58.75 145.39 40.54 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.702 -0.681 . . . . 72.239999999999995 111.052 -174.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -89.67 110.17 37.46 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.076 -0.511 . . . . 53.439999999999998 110.585 -179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -78.27 8.22 3.68 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.722 2.281 . . . . 74.340000000000003 112.234 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 65.6 t-105 -134.53 130.75 37.08 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.388 -0.597 . . . . 74.150000000000006 109.388 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 9.0 p -73.41 74.52 1.39 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.152 0.501 . . . . 72.239999999999995 111.339 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.66 -73.93 1.2 Allowed Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 111.222 -0.751 . . . . 63.140000000000001 111.222 175.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -70.5 126.34 12.72 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.794 2.329 . . . . 62.109999999999999 111.407 175.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.505 ' SG ' ' N ' ' A' ' 57' ' ' ARG . 48.2 t -163.92 -167.21 1.31 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.572 -0.529 . . . . 70.010000000000005 109.572 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.543 ' HA ' HG23 ' A' ' 11' ' ' THR . 33.2 mtm105 71.66 -2.65 2.39 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 122.971 0.508 . . . . 74.519999999999996 112.016 175.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.8 m -88.17 11.48 16.24 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.619 0.247 . . . . 52.329999999999998 111.315 -177.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.448 HD12 HD13 ' A' ' 12' ' ' LEU . 3.3 mm? 63.86 -81.81 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 115.913 -0.585 . . . . 73.329999999999998 110.093 -174.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -106.92 139.02 19.99 Favored Pre-proline 0 C--O 1.234 0.274 0 N-CA-C 109.153 -0.684 . . . . 73.140000000000001 109.153 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.745 ' HG2' ' HB2' ' A' ' 64' ' ' GLU . 56.4 Cg_endo -68.14 156.84 64.28 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 121.475 1.45 . . . . 71.140000000000001 109.633 171.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.506 ' HB3' HG12 ' A' ' 119' ' ' ILE . 9.6 mp0 -57.21 -50.57 72.45 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-O 121.254 0.549 . . . . 74.099999999999994 110.401 -170.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.663 HD12 ' N ' ' A' ' 64' ' ' GLU . 3.4 pp -54.33 -40.36 67.95 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 115.142 -0.935 . . . . 74.219999999999999 111.282 -177.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.745 ' HB2' ' HG2' ' A' ' 61' ' ' PRO . 2.3 mm-40 -75.61 -39.89 57.21 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.101 0.477 . . . . 74.409999999999997 110.005 179.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -53.54 -45.81 69.97 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.409 -0.814 . . . . 71.310000000000002 109.427 -177.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.505 HD12 HD12 ' A' ' 123' ' ' ILE . 16.1 mt -84.69 -37.86 20.45 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.129 -0.487 . . . . 73.239999999999995 111.661 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.406 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -53.97 -46.03 71.55 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 120.783 0.325 . . . . 61.5 111.048 -177.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.522 ' HA ' ' SD ' ' A' ' 22' ' ' MET . 73.1 mt-30 -49.3 -34.86 16.47 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.724 -0.671 . . . . 70.239999999999995 111.516 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -94.01 -57.93 2.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.227 0.537 . . . . 65.549999999999997 111.088 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.522 ' O ' HG22 ' A' ' 74' ' ' VAL . 16.6 m-85 -90.44 21.26 4.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.679 -0.691 . . . . 75.230000000000004 112.731 -171.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.406 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 8.8 t -52.71 -28.49 22.17 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.167 0.508 . . . . 74.329999999999998 111.424 -177.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 29.3 mt-10 -65.71 -16.76 64.07 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.73 -0.668 . . . . 53.340000000000003 111.127 -177.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -129.05 -5.35 4.99 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 116.182 -0.463 . . . . 72.310000000000002 110.438 -176.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.522 HG22 ' O ' ' A' ' 70' ' ' TYR . 22.9 m -132.66 140.43 47.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-O 121.089 0.471 . . . . 55.140000000000001 110.659 178.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -137.25 123.18 20.16 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.813 -0.63 . . . . 63.310000000000002 109.475 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.478 ' N ' HD12 ' A' ' 76' ' ' ILE . 2.0 mp -95.62 141.06 15.83 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-O 120.537 0.208 . . . . 74.420000000000002 110.65 -175.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.576 ' HB2' HG12 ' A' ' 46' ' ' VAL . 88.2 m-85 -141.06 157.77 44.85 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 123.347 0.659 . . . . 72.200000000000003 109.638 -179.211 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -166.39 166.67 16.38 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.935 0.398 . . . . 72.219999999999999 110.964 170.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.518 HD13 ' O ' ' A' ' 26' ' ' ILE . 3.9 tp -146.31 83.68 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.106 -0.952 . . . . 72.5 108.669 174.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -99.93 74.08 1.79 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.775 -0.648 . . . . 55.210000000000001 111.141 -173.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.689 HG13 ' H ' ' A' ' 83' ' ' ASP . 30.7 pt -144.79 -163.76 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 108.277 -1.008 . . . . 61.140000000000001 108.277 173.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -62.55 -12.87 25.25 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.654 0.264 . . . . 71.239999999999995 111.527 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.689 ' H ' HG13 ' A' ' 81' ' ' ILE . 4.6 m-20 -82.75 7.01 16.19 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 116.391 -0.368 . . . . 64.430000000000007 110.95 174.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -57.65 137.73 56.12 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.004 0.431 . . . . 73.349999999999994 110.664 -178.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.533 ' HB3' HG23 ' A' ' 87' ' ' VAL . 88.7 mt-30 -89.31 118.85 29.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.977 -0.556 . . . . 74.209999999999994 110.142 -175.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -64.63 0.55 1.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.697 -0.683 . . . . 61.450000000000003 111.869 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.533 HG23 ' HB3' ' A' ' 85' ' ' GLN . 41.6 t -51.94 -37.67 21.8 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 120.803 0.335 . . . . 75.030000000000001 110.969 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.47 -39.38 94.3 Favored 'General case' 0 C--O 1.239 0.551 0 CA-C-O 121.385 0.612 . . . . 73.530000000000001 110.58 177.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 51.3 m -70.77 -29.49 65.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.719 -0.673 . . . . 71.010000000000005 109.955 176.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -70.66 -35.63 72.96 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.171 -0.468 . . . . 72.230000000000004 110.151 177.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.49 ' CE1' HG12 ' A' ' 87' ' ' VAL . 30.3 m-85 -68.78 -17.2 63.99 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 109.387 -0.598 . . . . 74.030000000000001 109.387 171.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.86 42.22 9.95 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.397 -0.819 . . . . 71.209999999999994 112.417 178.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.528 HG21 ' OG1' ' A' ' 98' ' ' THR . 14.9 p -67.95 131.83 33.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 CA-C-N 116.983 0.391 . . . . 73.5 110.385 177.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.3 p -101.82 -36.43 8.68 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.177 -0.465 . . . . 73.310000000000002 111.65 -177.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -127.98 143.6 51.09 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.649 0.262 . . . . 73.129999999999995 111.062 -175.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.411 ' O ' HD12 ' A' ' 96' ' ' ILE . 2.5 pp -100.02 160.84 26.11 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 115.957 -0.565 . . . . 72.430000000000007 110.669 179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.405 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 98.6 Cg_endo -82.36 -177.96 20.11 Favored 'Cis proline' 0 C--N 1.353 0.813 0 C-N-CA 124.03 -1.238 . . . . 65.310000000000002 112.223 -0.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.668 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 17.7 m -144.06 115.41 8.03 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.439 -0.346 . . . . 71.120000000000005 110.567 179.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.503 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.3 mp -108.06 115.22 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 CA-C-N 116.673 -0.24 . . . . 53.43 110.365 -177.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.62 ' HB2' HG23 ' A' ' 46' ' ' VAL . 8.9 mp -91.89 139.98 30.13 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.826 0.346 . . . . 73.120000000000005 110.54 178.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.623 ' SD ' ' HB3' ' A' ' 109' ' ' SER . 81.7 mtp -109.37 116.44 31.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.921 -0.581 . . . . 74.109999999999999 110.534 -177.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -116.99 154.04 31.6 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.952 0.406 . . . . 74.430000000000007 111.035 178.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.84 ' HB3' HD21 ' A' ' 108' ' ' LEU . 16.1 ttmm -169.27 115.37 0.58 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.437 -0.801 . . . . 63.310000000000002 109.617 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.9 t30 60.35 31.08 20.29 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.334 0.588 . . . . 65.239999999999995 110.987 172.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.91 -14.45 63.28 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 121.314 -0.47 . . . . 53.509999999999998 113.163 178.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -97.04 146.11 25.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.598 0.237 . . . . 51.240000000000002 110.589 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 9.5 ptpp? -99.06 126.02 44.69 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.242 -0.651 . . . . 45.119999999999997 109.242 174.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.84 HD21 ' HB3' ' A' ' 103' ' ' LYS . 3.1 mm? -87.07 -47.39 8.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.525 -0.307 . . . . 72.549999999999997 111.15 -174.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.623 ' HB3' ' SD ' ' A' ' 101' ' ' MET . 27.9 t -167.01 171.8 10.77 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 120.738 0.304 . . . . 74.540000000000006 110.927 -175.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -136.69 130.82 32.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.702 -0.681 . . . . 75.319999999999993 110.014 175.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.721 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 60.2 t -94.43 107.3 19.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.991 -0.549 . . . . 64.25 110.292 179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 61.6 mt -104.26 109.87 28.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 110.022 -0.362 . . . . 75.109999999999999 110.022 176.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 106.87 -142.85 15.74 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 121.204 -0.522 . . . . 74.409999999999997 112.093 -179.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -138.96 80.16 1.77 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.03 0.443 . . . . 71.329999999999998 110.595 -179.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.49 ' O ' HG23 ' A' ' 119' ' ' ILE . 3.0 m-20 -118.67 94.29 4.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.799 -0.637 . . . . 62.439999999999998 110.595 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.57 HD12 HD11 ' A' ' 119' ' ' ILE . 7.2 tp -65.07 -39.01 84.19 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.186 -0.461 . . . . 73.120000000000005 111.088 -176.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 27.0 t -64.81 -39.77 94.12 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.242 0.544 . . . . 71.150000000000006 110.445 179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.721 ' HE3' ' HA ' ' A' ' 111' ' ' VAL . 0.7 OUTLIER -64.68 -51.7 61.11 Favored 'General case' 0 C--O 1.242 0.668 0 CA-C-N 115.779 -0.646 . . . . 71.040000000000006 110.629 178.326 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.57 HD11 HD12 ' A' ' 116' ' ' ILE . 2.2 pp -63.61 -42.04 94.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 116.209 -0.45 . . . . 71.219999999999999 111.51 -175.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.494 HG22 HD21 ' A' ' 66' ' ' LEU . 2.8 pp -64.33 -31.76 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 C-N-CA 120.738 -0.385 . . . . 75.310000000000002 110.254 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.45 ' N ' HD12 ' A' ' 120' ' ' ILE . 23.0 t -69.75 -51.65 32.26 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 116.187 -0.46 . . . . 62.240000000000002 110.523 -178.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.402 ' OE1' ' NZ ' ' A' ' 118' ' ' LYS . 7.9 pt-20 -77.12 -40.68 44.86 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.806 0.669 . . . . 74.319999999999993 112.806 -176.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.505 HD12 HD12 ' A' ' 66' ' ' LEU . 69.5 mt -62.7 -53.7 43.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 O-C-N 122.046 -0.409 . . . . 72.530000000000001 110.696 -179.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -59.86 -20.23 55.85 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.117 0.484 . . . . 72.010000000000005 110.85 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -78.81 -12.84 60.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.915 -0.584 . . . . 60.229999999999997 111.144 -179.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 52.8 m-80 -126.42 9.47 7.22 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.547 -0.297 . . . . 73.109999999999999 111.554 -178.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.501 HG12 ' O ' ' A' ' 123' ' ' ILE . 45.7 pt -138.99 168.09 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 N-CA-C 109.871 -0.418 . . . . 71.040000000000006 109.871 175.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.432 ' N ' HD22 ' A' ' 128' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.163 0 CA-C-O 118.585 -0.722 . . . . 74.439999999999998 111.094 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 94.1 mmm . . . . . 0 N--CA 1.484 1.236 0 N-CA-C 110.224 -0.287 . . . . 51.399999999999999 110.224 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.47 137.05 58.0 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.143 -0.481 . . . . 74.329999999999998 111.047 -178.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -76.07 124.13 26.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.017 -0.538 . . . . 73.010000000000005 109.961 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -63.87 125.72 25.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.583 -0.281 . . . . 75.420000000000002 110.335 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.6 p-80 -65.44 158.62 26.27 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 110.042 -0.355 . . . . 74.219999999999999 110.042 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -156.12 140.09 16.32 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.593 -0.276 . . . . 71.200000000000003 111.038 -174.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -151.72 121.15 6.85 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.984 0.421 . . . . 65.209999999999994 109.944 176.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -114.17 -177.53 3.15 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.961 -0.563 . . . . 71.340000000000003 110.504 -178.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 14.5 tpt -134.26 126.76 30.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.053 -0.521 . . . . 61.329999999999998 109.623 176.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -105.12 158.62 15.98 Favored Glycine 0 C--N 1.329 0.194 0 C-N-CA 121.092 -0.575 . . . . 54.420000000000002 112.858 -177.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.428 HG22 HD23 ' A' ' 12' ' ' LEU . 36.7 m -140.97 126.97 19.37 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.71 -0.848 . . . . 62.43 108.71 176.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.428 HD23 HG22 ' A' ' 11' ' ' THR . 4.5 mm? 62.38 12.98 5.68 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-O 121.213 0.53 . . . . 75.129999999999995 110.432 -170.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -81.65 103.09 11.12 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.623 -0.717 . . . . 62.409999999999997 109.608 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . 60.32 22.17 11.65 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.207 0.527 . . . . 64.340000000000003 110.946 -177.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.407 ' HB3' ' HA ' ' A' ' 12' ' ' LEU . 34.2 tt0 -104.76 124.11 48.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.586 -0.734 . . . . 71.200000000000003 110.489 -175.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.1 p -109.54 -176.57 3.05 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.988 -0.551 . . . . 74.340000000000003 111.011 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -98.76 -178.57 4.02 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.961 0.41 . . . . 73.129999999999995 111.206 -175.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -171.95 59.37 0.16 Allowed Glycine 0 CA--C 1.522 0.507 0 CA-C-N 115.791 -0.641 . . . . 72.219999999999999 112.116 175.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -86.66 164.37 9.21 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.779 2.319 . . . . 73.219999999999999 112.326 -179.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.65 172.41 36.22 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 121.28 -0.486 . . . . 71.450000000000003 112.112 -179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 34.3 m -92.81 104.64 16.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.846 0.355 . . . . 64.019999999999996 110.565 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.721 ' SD ' HG13 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -98.19 9.89 41.87 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.195 0.521 . . . . 73.25 110.231 176.104 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.721 HG13 ' SD ' ' A' ' 22' ' ' MET . 49.7 mt -115.82 106.36 20.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 CA-C-N 115.283 -0.871 . . . . 74.400000000000006 109.321 175.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.467 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 11.3 tp10 -105.7 136.92 44.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.737 0.303 . . . . 71.409999999999997 110.791 -176.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -90.6 128.46 36.6 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 122.379 0.272 . . . . 65.140000000000001 110.383 -179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.458 HG21 ' HD3' ' A' ' 34' ' ' LYS . 33.9 pt -128.0 149.9 33.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 120.851 0.358 . . . . 64.230000000000004 111.243 -178.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -82.51 179.09 53.23 Favored Glycine 0 N--CA 1.45 -0.392 0 CA-C-N 115.616 -0.72 . . . . 13.31 112.789 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -63.7 -50.36 69.47 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 122.767 0.427 . . . . 73.329999999999998 111.262 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.9 m -64.43 -39.12 93.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.994 -0.548 . . . . 64.120000000000005 111.803 -172.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.559 ' HA ' ' HB3' ' A' ' 33' ' ' ASN . 16.3 pt-20 -85.37 -9.33 57.72 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 116.507 -0.315 . . . . 71.549999999999997 111.691 -174.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.408 ' HA ' HD12 ' A' ' 26' ' ' ILE . 34.6 t80 -47.8 -71.0 0.08 Allowed 'General case' 0 N--CA 1.464 0.25 0 O-C-N 123.192 0.307 . . . . 65.209999999999994 111.088 -177.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -66.57 -34.58 78.21 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.276 -0.638 . . . . 71.430000000000007 109.276 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.559 ' HB3' ' HA ' ' A' ' 30' ' ' GLU . 7.7 t30 -52.42 -33.82 45.59 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 114.487 -1.233 . . . . 63.409999999999997 111.989 -176.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.458 ' HD3' HG21 ' A' ' 26' ' ' ILE . 14.4 ptmt -114.95 -19.35 10.98 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.214 0.45 . . . . 53.439999999999998 112.214 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.4 t -88.43 -55.25 6.58 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 111.973 0.36 . . . . 61.520000000000003 111.973 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 39.9 p -72.83 -18.52 61.45 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.11 0.481 . . . . 74.430000000000007 111.033 -173.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.9 p -90.8 11.93 20.9 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.704 -0.68 . . . . 73.219999999999999 111.028 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 51.8 t -59.63 117.01 4.43 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.258 -0.428 . . . . 60.130000000000003 111.292 -178.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 20.5 p30 -117.43 3.73 12.5 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.548 0.69 . . . . 70.230000000000004 109.349 172.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.628 ' HB2' HG22 ' A' ' 42' ' ' ILE . 1.8 m-20 -70.64 -31.85 68.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 114.963 -1.017 . . . . 63.240000000000002 110.684 -176.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' ' 40' ' ' ASP . 27.7 m-80 73.26 13.4 4.7 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.301 -0.863 . . . . 71.209999999999994 111.04 -175.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.628 HG22 ' HB2' ' A' ' 40' ' ' ASP . 15.1 tt -85.99 146.64 6.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.332 0 N-CA-C 108.828 -0.804 . . . . 74.519999999999996 108.828 172.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.693 HD11 ' HB3' ' A' ' 101' ' ' MET . 63.4 tp -79.52 106.59 11.66 Favored 'General case' 0 C--O 1.241 0.655 0 CA-C-O 121.556 0.693 . . . . 74.319999999999993 110.312 -177.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.49 HG23 ' CD2' ' A' ' 77' ' ' TYR . 65.6 mt -88.68 107.53 17.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 114.801 -1.09 . . . . 75.349999999999994 110.364 179.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.4 HD13 HD22 ' A' ' 63' ' ' LEU . 70.3 mt -90.56 101.82 14.56 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.963 -0.562 . . . . 41.200000000000003 109.787 178.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.463 HG13 HG22 ' A' ' 44' ' ' ILE . 27.6 m -95.96 121.53 46.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.031 0.443 . . . . 71.439999999999998 110.849 -178.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -95.49 133.71 39.16 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.915 -0.584 . . . . 64.5 111.02 -179.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -104.66 91.25 3.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.436 0.636 . . . . 73.030000000000001 111.495 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 11.7 t90 65.87 64.02 0.57 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 114.652 -1.158 . . . . 72.239999999999995 112.839 173.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -130.98 78.24 73.8 Favored Pre-proline 0 C--N 1.324 -0.521 0 N-CA-C 108.109 -1.071 . . . . 53.439999999999998 108.109 163.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -44.96 -80.87 0.02 OUTLIER 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.588 2.859 . . . . 74.340000000000003 114.452 -167.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 47.7 t90 -174.13 159.46 3.23 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 109.625 -0.509 . . . . 74.150000000000006 109.625 -174.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 67.3 m -142.53 118.02 10.31 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.995 -0.372 . . . . 72.239999999999995 109.995 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -62.39 -71.83 0.75 Allowed Glycine 0 C--N 1.332 0.336 0 C-N-CA 121.201 -0.523 . . . . 63.140000000000001 112.013 178.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -75.26 72.5 4.79 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 122.311 2.007 . . . . 62.109999999999999 111.489 175.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 53.3 t -67.4 114.15 5.86 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.899 -0.591 . . . . 70.010000000000005 110.438 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.01 15.37 2.8 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.272 -0.422 . . . . 74.519999999999996 111.549 -179.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.1 m -127.95 132.05 49.26 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.227 -0.442 . . . . 52.329999999999998 110.078 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.764 HD23 ' H ' ' A' ' 59' ' ' LEU . 1.7 pt? -69.74 76.45 0.44 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.257 0.551 . . . . 73.329999999999998 110.215 177.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.596 ' HG2' ' NE2' ' A' ' 68' ' ' GLN . 2.4 mp0 62.97 110.36 0.03 OUTLIER Pre-proline 0 CA--C 1.531 0.236 0 CA-C-N 115.022 -0.99 . . . . 73.140000000000001 111.587 -177.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 60' ' ' GLU . 19.1 Cg_endo -57.59 167.62 3.74 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.458 2.105 . . . . 71.140000000000001 111.104 175.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.469 ' NE2' ' HA ' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -45.3 -49.7 12.5 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 116.162 -0.472 . . . . 74.099999999999994 111.469 -171.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.726 ' HB3' HG12 ' A' ' 76' ' ' ILE . 71.6 mt -56.78 -48.88 76.9 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.225 -0.898 . . . . 74.219999999999999 111.012 -175.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.544 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 34.4 mt-10 -70.6 -44.33 67.5 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.24 -0.437 . . . . 74.409999999999997 109.959 -179.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.411 ' HD2' ' HA ' ' A' ' 65' ' ' LYS . 12.3 tptp -54.57 -42.74 71.36 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 115.378 -0.828 . . . . 71.310000000000002 110.986 -174.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.505 HD21 HG22 ' A' ' 120' ' ' ILE . 13.9 mt -81.51 -39.5 24.62 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 120.795 -0.362 . . . . 73.239999999999995 111.171 176.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.496 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -55.19 -33.49 63.07 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.587 0.232 . . . . 61.5 111.295 -178.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.596 ' NE2' ' HG2' ' A' ' 60' ' ' GLU . 96.4 mt-30 -51.06 -42.46 60.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.99 0.424 . . . . 70.239999999999995 110.794 177.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 77.2 mm-40 -94.02 -55.17 3.31 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.684 -0.689 . . . . 65.549999999999997 111.592 -177.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.542 ' O ' HG22 ' A' ' 74' ' ' VAL . 12.0 m-85 -94.86 22.17 6.75 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.727 0.639 . . . . 75.230000000000004 112.727 -167.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.496 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 8.2 t -52.5 -27.33 15.9 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 120.9 0.381 . . . . 74.329999999999998 111.585 -177.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -63.58 -24.25 67.72 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.246 -0.434 . . . . 53.340000000000003 111.832 -178.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.55 9.2 5.97 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.485 0.183 . . . . 72.310000000000002 111.183 -177.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.542 HG22 ' O ' ' A' ' 70' ' ' TYR . 27.2 m -138.33 140.29 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 O-C-N 121.779 -0.575 . . . . 55.140000000000001 110.565 175.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 39.2 mmtm -141.07 135.25 30.82 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.135 -0.484 . . . . 63.310000000000002 110.031 174.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.726 HG12 ' HB3' ' A' ' 63' ' ' LEU . 3.4 mp -103.94 144.49 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.391 -0.368 . . . . 74.420000000000002 110.146 -176.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.49 ' CD2' HG23 ' A' ' 44' ' ' ILE . 81.2 m-85 -129.38 138.46 51.53 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-O 121.276 0.56 . . . . 72.200000000000003 111.537 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.507 ' HA ' ' HE2' ' A' ' 78' ' ' LYS . 9.6 mmpt? -99.01 100.22 11.36 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.284 -0.871 . . . . 72.219999999999999 108.804 174.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.841 HG22 ' H ' ' A' ' 81' ' ' ILE . 2.4 mp -83.95 138.69 18.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 110.249 -0.278 . . . . 72.5 110.249 -175.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.433 ' N ' HD22 ' A' ' 80' ' ' ASN . 0.9 OUTLIER -75.4 -8.29 56.31 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 116.382 -0.372 . . . . 55.210000000000001 111.822 -177.16 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.841 ' H ' HG22 ' A' ' 79' ' ' ILE . 68.7 mt -68.12 85.04 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 121.21 0.529 . . . . 61.140000000000001 109.845 176.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -82.75 -72.58 0.44 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.813 -0.63 . . . . 71.239999999999995 111.49 -175.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -90.52 -25.09 20.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.341 -0.39 . . . . 64.430000000000007 111.475 -174.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -82.4 58.31 4.05 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 121.027 0.441 . . . . 73.349999999999994 110.567 -175.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 75.8 mt-30 -109.31 104.38 13.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.859 0.361 . . . . 74.209999999999994 111.039 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -90.38 -27.98 18.98 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.733 -0.84 . . . . 61.450000000000003 108.733 170.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 67.7 t -51.49 -45.7 35.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-N 114.946 -1.024 . . . . 75.030000000000001 111.364 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -58.84 -42.18 88.7 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.19 -0.459 . . . . 73.530000000000001 110.919 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.0 m -74.32 -30.18 61.94 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.71 -0.677 . . . . 71.010000000000005 110.554 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -61.64 -55.49 29.98 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.677 -0.692 . . . . 72.230000000000004 110.445 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.418 ' HE2' ' HE2' ' A' ' 107' ' ' LYS . 97.4 m-85 -77.08 -13.31 59.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.956 -0.565 . . . . 74.030000000000001 110.343 178.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 71.46 39.25 61.55 Favored Glycine 0 C--N 1.334 0.427 0 CA-C-N 115.748 -0.66 . . . . 71.209999999999994 112.875 174.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 14.6 p -72.43 -37.37 57.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.657 0.265 . . . . 73.5 110.502 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.8 t 67.43 -67.43 0.18 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.67 -0.696 . . . . 73.310000000000002 111.294 -178.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.58 134.9 48.06 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.49 -0.323 . . . . 73.129999999999995 111.057 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.422 ' HB ' ' HA ' ' A' ' 97' ' ' PRO . 29.4 pt -113.87 158.67 38.5 Favored Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 116.062 -0.517 . . . . 72.430000000000007 110.107 -179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.422 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 95.4 Cg_endo -82.96 177.55 31.45 Favored 'Cis proline' 0 C--N 1.35 0.645 0 C-N-CA 123.889 -1.296 . . . . 65.310000000000002 112.352 -1.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 7.1 m -140.8 131.22 25.23 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.113 -0.494 . . . . 71.120000000000005 109.843 178.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.608 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 26.6 mt -109.33 116.93 53.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.333 -0.394 . . . . 53.43 109.999 -176.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 11.2 mp -94.55 144.57 25.48 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.144 0.497 . . . . 73.120000000000005 110.777 -178.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.773 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 70.3 mtp -106.38 114.58 28.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.606 -0.725 . . . . 74.109999999999999 109.923 -179.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -115.83 140.63 49.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.76 0.314 . . . . 74.430000000000007 110.453 177.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.741 ' HB3' HD21 ' A' ' 108' ' ' LEU . 38.1 ttpt -156.79 128.32 7.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.997 -0.547 . . . . 63.310000000000002 109.561 179.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.7 t30 60.0 24.84 14.01 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.324 0.583 . . . . 65.239999999999995 110.686 178.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.28 -1.13 82.08 Favored Glycine 0 C--N 1.333 0.395 0 CA-C-N 116.058 -0.519 . . . . 53.509999999999998 113.266 177.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -108.2 160.92 15.45 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 116.99 0.395 . . . . 51.240000000000002 110.49 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.418 ' HE2' ' HE2' ' A' ' 91' ' ' TYR . 20.2 pttp -92.69 139.92 30.07 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.472 -0.936 . . . . 45.119999999999997 108.472 170.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.741 HD21 ' HB3' ' A' ' 103' ' ' LYS . 3.0 mm? -105.72 -52.98 2.72 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 110.087 -0.338 . . . . 72.549999999999997 110.087 -179.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.773 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 23.4 m -157.59 170.96 21.21 Favored 'General case' 0 C--O 1.239 0.546 0 CA-C-N 115.865 -0.607 . . . . 74.540000000000006 110.171 -179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.7 pm0 -128.85 123.87 33.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.932 -0.576 . . . . 75.319999999999993 109.831 172.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.608 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 63.6 t -80.66 113.93 20.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.822 -0.626 . . . . 64.25 110.25 176.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 42.1 mt -100.2 123.06 52.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.427 -0.583 . . . . 75.109999999999999 109.427 175.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 72.76 -129.89 14.0 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.957 -0.639 . . . . 74.409999999999997 111.985 -179.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.469 ' HA ' ' NE2' ' A' ' 62' ' ' GLN . . . -142.65 57.36 1.43 Allowed 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.012 0.434 . . . . 71.329999999999998 111.117 -178.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.553 ' O ' ' HG3' ' A' ' 118' ' ' LYS . 7.7 m-20 -88.32 86.42 7.06 Favored 'General case' 0 C--O 1.244 0.813 0 CA-C-O 121.681 0.753 . . . . 62.439999999999998 110.21 177.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.559 ' O ' HG13 ' A' ' 119' ' ' ILE . 7.9 tp -53.09 -35.68 23.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.003 -0.999 . . . . 73.120000000000005 110.636 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.6 m -67.07 -37.0 83.22 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 115.846 -0.615 . . . . 71.150000000000006 111.215 -177.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.553 ' HG3' ' O ' ' A' ' 115' ' ' ASP . 0.0 OUTLIER -76.04 -41.62 50.22 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.642 -0.503 . . . . 71.040000000000006 109.642 -179.325 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.559 HG13 ' O ' ' A' ' 116' ' ' ILE . 1.9 pp -65.7 -42.35 92.41 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 116.286 -0.415 . . . . 71.219999999999999 110.943 -176.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.505 HG22 HD21 ' A' ' 66' ' ' LEU . 2.8 pp -66.8 -31.85 55.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-O 121.123 0.487 . . . . 75.310000000000002 109.957 177.21 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.412 ' N ' HD12 ' A' ' 120' ' ' ILE . 47.2 t -63.58 -51.01 67.2 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.73 -0.668 . . . . 62.240000000000002 110.686 -179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.493 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 11.6 pt-20 -77.85 -46.17 22.2 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.14 0.422 . . . . 74.319999999999993 112.14 -178.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.532 ' O ' HG12 ' A' ' 127' ' ' ILE . 67.5 mt -60.04 -51.0 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 117.903 0.319 . . . . 72.530000000000001 111.555 -176.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -59.11 -30.86 68.42 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.073 0.463 . . . . 72.010000000000005 110.922 -178.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 31.1 t30 -83.17 -20.82 33.97 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.413 0.625 . . . . 60.229999999999997 110.282 177.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.493 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 1.8 t-20 -88.61 -37.37 15.69 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.689 -0.687 . . . . 73.109999999999999 111.524 -173.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.532 HG12 ' O ' ' A' ' 123' ' ' ILE . 46.8 pt -100.99 168.61 1.87 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-N 116.266 -0.424 . . . . 71.040000000000006 111.159 -177.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.3 p30 . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.432 -0.794 . . . . 74.439999999999998 111.297 -174.921 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.589 ' SD ' ' N ' ' A' ' 2' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.482 1.166 0 N-CA-C 109.53 -0.544 . . . . 51.399999999999999 109.53 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.589 ' N ' ' SD ' ' A' ' 1' ' ' MET . . . -58.73 89.51 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.176 0.512 . . . . 74.329999999999998 112.193 -176.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.518 ' CD2' ' SD ' ' A' ' 1' ' ' MET . 94.5 m-70 -138.41 41.68 2.22 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 108.393 -0.966 . . . . 73.010000000000005 108.393 173.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 45.5 t60 -62.31 161.17 11.88 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.754 -1.112 . . . . 75.420000000000002 111.798 -170.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 64.63 12.62 7.68 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.257 1.023 . . . . 74.219999999999999 112.234 173.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.401 ' O ' ' CG ' ' A' ' 6' ' ' HIS . 6.8 p80 -75.57 74.51 2.59 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.559 0.695 . . . . 71.200000000000003 110.952 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 30.3 p-80 -157.84 83.13 0.88 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.61 0.719 . . . . 65.209999999999994 110.79 176.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 3.5 p-80 -138.43 36.99 2.26 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.375 -0.83 . . . . 71.340000000000003 108.886 171.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -97.2 178.24 5.31 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.663 -1.153 . . . . 61.329999999999998 110.222 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.22 -11.88 60.22 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 121.151 -0.547 . . . . 54.420000000000002 112.163 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.7 m -73.55 72.32 1.4 Allowed 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.428 0.632 . . . . 62.43 109.998 178.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 52.3 tp -81.74 100.71 9.67 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.793 -0.64 . . . . 75.129999999999995 110.746 -176.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -140.33 108.56 5.79 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.285 -1.006 . . . . 62.409999999999997 108.285 173.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -152.42 53.54 0.79 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.211 -0.449 . . . . 64.340000000000003 110.702 -175.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.3 pt20 -62.83 92.01 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.438 0.637 . . . . 71.200000000000003 110.004 176.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 12.0 m -101.04 9.33 42.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.734 0.778 . . . . 74.340000000000003 110.313 -176.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -120.03 -172.32 2.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.413 -0.812 . . . . 73.129999999999995 110.103 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.63 82.72 0.76 Allowed Glycine 0 C--N 1.331 0.273 0 N-CA-C 111.01 -0.836 . . . . 72.219999999999999 111.01 -173.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -77.96 51.28 3.58 Favored 'Trans proline' 0 CA--C 1.534 0.49 0 C-N-CA 123.056 2.504 . . . . 73.219999999999999 113.319 -172.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 69.6 10.76 64.29 Favored Glycine 0 C--N 1.332 0.327 0 CA-C-N 116.222 -0.445 . . . . 71.450000000000003 112.92 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.4 m -77.72 99.83 6.01 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.777 0.322 . . . . 64.019999999999996 110.183 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.521 ' N ' ' SD ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -68.24 -26.21 65.58 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.124 -0.489 . . . . 73.25 110.165 178.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.512 HG12 ' HG2' ' A' ' 22' ' ' MET . 14.3 mm -115.66 78.33 0.51 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 115.532 -0.758 . . . . 74.400000000000006 109.092 174.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.623 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 10.8 tp10 -96.99 153.17 18.07 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.21 -0.45 . . . . 71.409999999999997 110.016 -176.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.439 HE21 ' HB2' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -97.84 138.88 34.53 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.613 -0.514 . . . . 65.140000000000001 109.613 177.505 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 39.2 pt -122.76 153.75 27.73 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-O 121.189 0.518 . . . . 64.230000000000004 111.095 -177.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.507 ' HA2' ' HB2' ' A' ' 80' ' ' ASN . . . -76.58 150.71 38.62 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.408 -0.815 . . . . 13.31 111.729 176.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -63.64 -34.98 79.05 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.981 0.419 . . . . 73.329999999999998 110.469 179.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.1 m -72.99 -16.38 61.51 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.734 -0.667 . . . . 64.120000000000005 111.63 -176.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -113.79 3.02 15.34 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.398 -0.364 . . . . 71.549999999999997 110.907 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -47.08 -71.15 0.08 Allowed 'General case' 0 N--CA 1.464 0.241 0 O-C-N 123.46 0.475 . . . . 65.209999999999994 110.951 -177.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -65.15 -34.82 79.3 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.861 -0.422 . . . . 71.430000000000007 109.861 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -52.04 -41.06 61.98 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.221 -0.9 . . . . 63.409999999999997 111.215 -174.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.2 ptmt -106.81 -25.2 11.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.195 -0.457 . . . . 53.439999999999998 112.104 -177.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.4 HG21 HG21 ' A' ' 46' ' ' VAL . 79.1 t -84.12 -50.83 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 112.073 0.397 . . . . 61.520000000000003 112.073 -175.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 77.3 p -76.83 -32.54 57.65 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.987 0.422 . . . . 74.430000000000007 110.81 -175.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.8 m -80.59 12.41 3.11 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.765 -0.652 . . . . 73.219999999999999 111.695 -177.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.625 ' SG ' HG22 ' A' ' 42' ' ' ILE . 37.1 t -59.24 90.9 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 120.879 0.371 . . . . 60.130000000000003 111.182 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -80.58 -22.0 41.12 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 120.944 0.402 . . . . 70.230000000000004 111.185 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -72.86 2.57 6.52 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.535 -0.302 . . . . 63.240000000000002 111.742 -178.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 63.0 21.91 13.17 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 116.422 -0.354 . . . . 71.209999999999994 111.777 172.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.625 HG22 ' SG ' ' A' ' 38' ' ' CYS . 6.8 tt -87.9 144.63 8.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 N-CA-C 109.388 -0.597 . . . . 74.519999999999996 109.388 177.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.487 HD21 ' CE ' ' A' ' 101' ' ' MET . 42.1 tp -81.14 115.53 20.61 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.008 0.433 . . . . 74.319999999999993 109.979 -177.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 62.1 mt -102.58 123.28 55.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.91 -0.586 . . . . 75.349999999999994 110.263 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.548 ' HG ' ' HG2' ' A' ' 101' ' ' MET . 3.3 mp -114.23 106.02 13.86 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.049 -0.523 . . . . 41.200000000000003 109.753 -178.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.531 HG22 ' HB2' ' A' ' 77' ' ' TYR . 43.5 t -102.12 125.54 56.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.598 -0.274 . . . . 71.439999999999998 110.566 -178.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -98.01 138.49 35.25 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.17 0.51 . . . . 64.5 109.894 178.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -100.89 25.25 8.2 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.578 -0.737 . . . . 73.030000000000001 110.009 179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 6.1 t90 -92.0 -41.16 10.7 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.898 -0.592 . . . . 72.239999999999995 109.486 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.634 ' HB1' ' HD2' ' A' ' 51' ' ' PRO . . . 64.68 170.56 0.09 OUTLIER Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 115.683 -0.69 . . . . 53.439999999999998 111.517 175.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.634 ' HD2' ' HB1' ' A' ' 50' ' ' ALA . 73.7 Cg_endo -75.08 56.18 4.22 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.279 1.986 . . . . 74.340000000000003 111.746 173.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 71.2 t-105 -74.6 148.15 41.01 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.843 -0.617 . . . . 74.150000000000006 110.752 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 25.2 p -67.76 86.81 0.22 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.09 0.472 . . . . 72.239999999999995 110.57 178.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -159.59 133.98 3.54 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.851 -0.613 . . . . 63.140000000000001 111.907 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -59.78 97.07 0.1 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.672 2.248 . . . . 62.109999999999999 111.785 178.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 55.6 m -62.76 -36.28 82.55 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.839 -0.618 . . . . 70.010000000000005 110.647 179.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 72.94 -33.35 0.27 Allowed 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.596 -0.729 . . . . 74.519999999999996 112.234 176.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.9 t -90.32 123.26 33.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.829 0.347 . . . . 52.329999999999998 110.401 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.426 ' N ' HD22 ' A' ' 59' ' ' LEU . 3.0 mm? -101.31 11.52 39.11 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.132 -0.485 . . . . 73.329999999999998 109.869 176.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 25.3 tp10 -151.63 73.42 8.1 Favored Pre-proline 0 C--O 1.236 0.349 0 N-CA-C 109.171 -0.678 . . . . 73.140000000000001 109.171 -177.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.53 ' HG2' ' HB2' ' A' ' 64' ' ' GLU . 85.4 Cg_endo -75.45 156.52 41.01 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.702 2.268 . . . . 71.140000000000001 112.485 -176.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.585 ' HB3' HG12 ' A' ' 119' ' ' ILE . 9.9 mp0 -55.34 -55.93 25.94 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-O 121.592 0.711 . . . . 74.099999999999994 111.27 -173.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.558 HD11 HG21 ' A' ' 111' ' ' VAL . 3.2 mm? -59.33 -48.39 81.82 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 114.844 -1.071 . . . . 74.219999999999999 110.952 -171.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.585 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 48.4 mt-10 -68.38 -32.48 72.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.067 -0.515 . . . . 74.409999999999997 110.427 179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 61' ' ' PRO . 2.8 tmtm? -59.09 -52.46 65.63 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 109.803 -0.443 . . . . 71.310000000000002 109.803 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.694 HD12 HD12 ' A' ' 123' ' ' ILE . 29.3 mt -70.88 -33.46 70.62 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 120.903 -0.319 . . . . 73.239999999999995 111.347 177.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.407 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -60.19 -27.13 66.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.334 -0.394 . . . . 61.5 111.47 -178.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.585 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 76.1 mt-30 -56.93 -35.79 69.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.843 0.354 . . . . 70.239999999999995 110.738 177.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -93.83 -55.94 3.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.401 0.619 . . . . 65.549999999999997 110.468 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.513 ' O ' HG22 ' A' ' 74' ' ' VAL . 23.4 m-85 -84.74 22.51 1.33 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.58 -0.736 . . . . 75.230000000000004 112.69 -172.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.433 ' O ' ' NZ ' ' A' ' 75' ' ' LYS . 4.4 t -52.28 -44.54 65.05 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.369 0.507 . . . . 74.329999999999998 112.369 -170.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -73.14 -16.21 61.45 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 122.04 -0.412 . . . . 53.340000000000003 111.316 -176.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -101.6 -20.47 15.03 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 110.078 -0.342 . . . . 72.310000000000002 110.078 178.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 70' ' ' TYR . 25.4 m -136.91 122.06 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 121.298 0.571 . . . . 55.140000000000001 110.64 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.433 ' NZ ' ' O ' ' A' ' 71' ' ' THR . 38.0 mmtm -119.29 124.75 47.44 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.639 -0.504 . . . . 63.310000000000002 109.639 177.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.536 HG13 ' HB2' ' A' ' 45' ' ' LEU . 2.1 mp -97.37 137.48 24.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.148 -0.478 . . . . 74.420000000000002 110.054 -175.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.623 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 20.2 m-85 -126.58 134.45 50.81 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.116 -0.493 . . . . 72.200000000000003 110.368 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 19.1 mtpp -96.31 122.51 39.26 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.181 -0.674 . . . . 72.219999999999999 109.181 176.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 10.6 tp -64.13 145.74 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 CA-C-O 120.908 0.385 . . . . 72.5 111.18 -176.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.507 ' HB2' ' HA2' ' A' ' 27' ' ' GLY . 52.9 t30 -60.22 -66.2 0.56 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.007 -0.542 . . . . 55.210000000000001 110.801 177.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.452 ' O ' ' HG2' ' A' ' 85' ' ' GLN . 59.0 mt -105.69 119.78 55.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.898 -0.592 . . . . 61.140000000000001 109.669 -179.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.505 ' CD ' ' H ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -85.73 -57.79 2.91 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.795 0.665 . . . . 71.239999999999995 112.795 -172.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.453 ' N ' ' HG2' ' A' ' 82' ' ' GLU . 26.9 t70 -75.13 -21.61 58.72 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.274 0.472 . . . . 64.430000000000007 112.274 -166.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -87.86 0.95 55.15 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.962 0.411 . . . . 73.349999999999994 111.336 -177.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.452 ' HG2' ' O ' ' A' ' 81' ' ' ILE . 84.1 mm-40 -78.61 104.07 8.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.951 0.405 . . . . 74.209999999999994 110.184 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -63.32 -17.93 63.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.82 -0.627 . . . . 61.450000000000003 110.581 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.4 t -54.17 -46.3 67.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 CA-C-N 115.869 -0.605 . . . . 75.030000000000001 110.705 178.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.4 -43.41 98.92 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 115.922 -0.581 . . . . 73.530000000000001 110.76 -178.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.4 m -74.52 -28.11 60.83 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.741 -0.663 . . . . 71.010000000000005 110.964 179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 61.0 tt0 -64.49 -51.11 64.67 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.067 0.46 . . . . 72.230000000000004 109.928 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -79.01 -6.71 57.03 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.684 -0.689 . . . . 74.030000000000001 110.36 176.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 61.95 53.32 43.85 Favored Glycine 0 C--N 1.331 0.281 0 CA-C-N 115.84 -0.618 . . . . 71.209999999999994 113.19 172.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.473 HG22 ' H ' ' A' ' 95' ' ' ALA . 10.0 p -80.01 133.67 29.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.908 0.385 . . . . 73.5 110.671 179.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.4 t -128.17 27.12 5.68 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.107 0.48 . . . . 73.310000000000002 110.329 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.473 ' H ' HG22 ' A' ' 93' ' ' VAL . . . -145.03 130.38 18.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.01 -0.541 . . . . 73.129999999999995 110.157 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.805 HD13 ' H ' ' A' ' 96' ' ' ILE . 0.2 OUTLIER -110.37 148.14 37.79 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 72.430000000000007 110.242 -178.153 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -77.07 -178.12 23.21 Favored 'Cis proline' 0 C--N 1.351 0.687 0 C-N-CA 123.758 -1.351 . . . . 65.310000000000002 112.512 -1.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 18.0 m -137.81 115.64 11.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.105 -0.498 . . . . 71.120000000000005 110.039 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.445 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.9 mp -121.6 123.16 68.87 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-N 116.216 -0.447 . . . . 53.43 109.84 -179.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.5 mp -101.24 141.77 33.64 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.243 -0.28 . . . . 73.120000000000005 110.243 178.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.76 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 56.5 mtp -116.91 115.48 25.58 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 116.398 -0.364 . . . . 74.109999999999999 110.872 -175.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -117.38 154.29 31.58 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.049 -0.523 . . . . 74.430000000000007 110.511 -179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.749 ' HB3' HD21 ' A' ' 108' ' ' LEU . 28.1 ttpp -168.23 122.89 0.94 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.747 -0.661 . . . . 63.310000000000002 109.78 178.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.2 t30 53.82 45.95 26.77 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.545 0.688 . . . . 65.239999999999995 110.845 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 73.87 3.83 65.07 Favored Glycine 0 CA--C 1.52 0.392 0 CA-C-N 115.578 -0.737 . . . . 53.509999999999998 113.719 176.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 55.4 tptt -111.41 142.87 43.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 117.134 0.467 . . . . 51.240000000000002 110.589 -178.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.477 ' O ' ' HG3' ' A' ' 107' ' ' LYS . 12.5 ptmm? -95.51 112.39 24.12 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 109.082 -0.71 . . . . 45.119999999999997 109.082 172.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.749 HD21 ' HB3' ' A' ' 103' ' ' LYS . 1.5 mm? -89.33 -53.18 4.67 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.088 0.471 . . . . 72.549999999999997 110.904 -172.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.76 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 22.8 m -150.08 172.02 15.93 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.517 -0.765 . . . . 74.540000000000006 110.458 -169.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -161.27 121.28 2.65 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.092 0.472 . . . . 75.319999999999993 111.116 -177.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.558 HG21 HD11 ' A' ' 63' ' ' LEU . 59.8 t -80.43 107.47 12.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-N 115.607 -0.724 . . . . 64.25 110.037 178.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.425 HG22 ' HB3' ' A' ' 95' ' ' ALA . 65.7 mt -110.58 106.91 21.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.344 -0.613 . . . . 75.109999999999999 109.344 177.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 96.51 -141.33 15.55 Favored Glycine 0 N--CA 1.449 -0.449 0 N-CA-C 111.398 -0.681 . . . . 74.409999999999997 111.398 -176.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -141.54 88.58 2.15 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.914 0.357 . . . . 71.329999999999998 110.65 -178.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.538 ' O ' HG23 ' A' ' 119' ' ' ILE . 11.7 m-20 -132.9 97.08 3.93 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.101 -0.499 . . . . 62.439999999999998 110.14 178.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.52 ' O ' HG13 ' A' ' 119' ' ' ILE . 7.1 tp -58.49 -40.25 77.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 CA-C-O 120.846 0.355 . . . . 73.120000000000005 111.13 -177.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.3 t -67.24 -28.64 68.22 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.164 0.507 . . . . 71.150000000000006 110.74 -178.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.9 tmtm? -79.27 -43.77 23.05 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.985 -0.552 . . . . 71.040000000000006 110.75 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.585 HG12 ' HB3' ' A' ' 62' ' ' GLN . 1.8 pp -67.64 -41.53 85.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.118 -0.492 . . . . 71.219999999999999 110.613 -177.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.65 HG22 HD11 ' A' ' 66' ' ' LEU . 2.7 pp -62.21 -31.64 52.17 Favored 'Isoleucine or valine' 0 C--O 1.231 0.124 0 N-CA-C 109.693 -0.484 . . . . 75.310000000000002 109.693 177.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 23.1 t -69.71 -51.23 36.25 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.712 -0.676 . . . . 62.240000000000002 110.083 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.437 ' OE1' ' HB3' ' A' ' 109' ' ' SER . 16.4 pt-20 -74.12 -33.93 63.73 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 112.109 0.411 . . . . 74.319999999999993 112.109 -175.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.694 HD12 HD12 ' A' ' 66' ' ' LEU . 64.6 mt -67.13 -58.05 7.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 O-C-N 122.264 -0.272 . . . . 72.530000000000001 110.518 178.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 46.0 m-80 -63.16 -19.98 64.97 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.073 0.463 . . . . 72.010000000000005 110.932 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.422 HD22 ' ND2' ' A' ' 126' ' ' ASN . 7.3 t30 -60.69 -31.45 70.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.067 -0.515 . . . . 60.229999999999997 111.219 176.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.422 ' ND2' HD22 ' A' ' 125' ' ' ASN . 51.9 m-80 -114.22 -3.15 13.22 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.075 0.398 . . . . 73.109999999999999 112.075 -173.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.442 HG12 ' O ' ' A' ' 123' ' ' ILE . 33.9 pt -135.64 168.56 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 110.372 -0.233 . . . . 71.040000000000006 110.372 179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.383 -0.818 . . . . 74.439999999999998 111.104 178.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ttt . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 121.166 0.508 . . . . 51.399999999999999 110.167 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.97 82.07 7.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.921 -0.581 . . . . 74.329999999999998 110.485 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 61.2 t60 -91.73 31.75 1.18 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.355 0.598 . . . . 73.010000000000005 109.898 -178.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 52.0 t-80 -79.89 53.53 1.68 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.595 -0.73 . . . . 75.420000000000002 111.453 -174.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -160.13 142.02 12.86 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.708 0.29 . . . . 74.219999999999999 110.581 176.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -148.02 -156.44 0.72 Allowed 'General case' 0 N--CA 1.466 0.332 0 N-CA-C 108.25 -1.019 . . . . 71.200000000000003 108.25 175.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -139.36 136.78 35.13 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.19 -0.67 . . . . 65.209999999999994 109.19 174.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -132.55 78.04 1.78 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.068 0.461 . . . . 71.340000000000003 110.435 179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 46.0 tpp -175.31 99.31 0.08 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.588 -0.733 . . . . 61.329999999999998 109.324 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.442 ' O ' ' HB3' ' A' ' 13' ' ' GLU . . . 121.84 -9.82 9.72 Favored Glycine 0 C--N 1.33 0.217 0 N-CA-C 111.267 -0.733 . . . . 54.420000000000002 111.267 -175.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.657 HG23 HD12 ' A' ' 12' ' ' LEU . 7.6 t -68.23 -21.59 64.83 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.391 0.276 . . . . 62.43 111.295 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.657 HD12 HG23 ' A' ' 11' ' ' THR . 8.7 mp -85.85 62.07 7.23 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.954 -0.758 . . . . 75.129999999999995 108.954 171.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.442 ' HB3' ' O ' ' A' ' 10' ' ' GLY . 14.8 tp10 -172.32 -54.09 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.349 -0.841 . . . . 62.409999999999997 109.231 -174.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -119.87 103.14 9.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.356 -0.838 . . . . 64.340000000000003 110.035 177.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.0 pm0 -141.5 22.13 2.18 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.673 -0.694 . . . . 71.200000000000003 109.745 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 36.7 p -71.56 88.69 0.94 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.541 -0.754 . . . . 74.340000000000003 110.476 -177.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.406 ' OE1' ' HA ' ' A' ' 17' ' ' GLN . 19.8 mm-40 -75.46 87.66 2.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.569 0.699 . . . . 73.129999999999995 110.941 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -164.61 60.25 0.25 Allowed Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 114.853 -1.067 . . . . 72.219999999999999 110.796 176.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.453 ' HA ' ' OE1' ' A' ' 24' ' ' GLU . 46.4 Cg_endo -66.97 141.02 56.7 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.804 2.336 . . . . 73.219999999999999 112.505 -173.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 158.9 -12.33 0.21 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.824 -0.703 . . . . 71.450000000000003 113.246 178.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.708 ' HB3' ' HB2' ' A' ' 24' ' ' GLU . 32.5 t -70.44 147.83 49.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.207 0.504 . . . . 64.019999999999996 110.25 179.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -70.27 -27.29 64.31 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 109.7 -0.481 . . . . 73.25 109.7 176.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.472 HG12 ' HB ' ' A' ' 76' ' ' ILE . 51.1 mt -133.79 106.6 9.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 108.927 -0.768 . . . . 74.400000000000006 108.927 173.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.708 ' HB2' ' HB3' ' A' ' 21' ' ' SER . 36.9 tt0 -131.94 118.61 20.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.604 -0.271 . . . . 71.409999999999997 111.083 -171.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.563 ' H ' ' NE2' ' A' ' 25' ' ' GLN . 0.6 OUTLIER -81.62 132.73 35.31 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 109.209 -0.664 . . . . 65.140000000000001 109.209 173.454 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 25.8 pt -126.44 175.32 8.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 120.983 0.42 . . . . 64.230000000000004 111.952 -170.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.45 154.13 26.97 Favored Glycine 0 N--CA 1.449 -0.439 0 CA-C-N 115.646 -0.707 . . . . 13.31 112.369 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -67.41 -31.2 71.24 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.961 0.41 . . . . 73.329999999999998 110.957 -177.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.3 p -71.02 -39.29 72.45 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.999 -0.546 . . . . 64.120000000000005 110.877 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.437 ' HA ' ' HB3' ' A' ' 33' ' ' ASN . 13.1 pt-20 -91.48 -3.77 56.23 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.999 -0.546 . . . . 71.549999999999997 110.991 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -46.34 -71.02 0.08 Allowed 'General case' 0 N--CA 1.464 0.26 0 O-C-N 123.622 0.576 . . . . 65.209999999999994 111.161 -176.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -68.04 -35.17 77.81 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 109.396 -0.594 . . . . 71.430000000000007 109.396 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.437 ' HB3' ' HA ' ' A' ' 30' ' ' GLU . 6.2 t30 -52.53 -34.27 49.08 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 114.586 -1.188 . . . . 63.409999999999997 111.816 -175.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.2 ptmt -111.69 -27.52 8.49 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.774 -0.194 . . . . 53.439999999999998 111.426 -178.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 71.7 t -84.57 -56.66 5.24 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 111.745 0.276 . . . . 61.520000000000003 111.745 -177.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 75.8 p -80.01 -23.77 41.29 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.011 0.434 . . . . 74.430000000000007 110.444 -173.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.1 m -83.66 6.08 22.18 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.733 -0.667 . . . . 73.219999999999999 111.027 179.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.614 ' SG ' HG22 ' A' ' 42' ' ' ILE . 48.0 t -66.88 98.92 0.58 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-O 120.887 0.375 . . . . 60.130000000000003 110.427 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -88.9 -2.94 58.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.102 -0.499 . . . . 70.230000000000004 110.318 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -71.56 -6.62 42.05 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.175 -0.466 . . . . 63.240000000000002 110.67 178.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 60.54 23.3 12.99 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.88 -0.6 . . . . 71.209999999999994 111.42 176.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.614 HG22 ' SG ' ' A' ' 38' ' ' CYS . 12.4 tt -84.9 152.61 3.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 108.754 -0.832 . . . . 74.519999999999996 108.754 174.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.563 HD21 ' HE3' ' A' ' 101' ' ' MET . 58.9 tp -85.09 110.2 18.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.606 0.241 . . . . 74.319999999999993 110.45 -175.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 101' ' ' MET . 54.4 mt -100.62 136.68 31.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.472 -0.331 . . . . 75.349999999999994 110.591 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.555 ' HG ' ' HG2' ' A' ' 101' ' ' MET . 3.7 mp -122.67 109.45 14.28 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.572 -0.529 . . . . 41.200000000000003 109.572 179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 30.1 m -95.27 127.35 47.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.717 0.294 . . . . 71.439999999999998 110.606 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.419 ' HB3' ' HE2' ' A' ' 78' ' ' LYS . 3.1 t70 -125.63 149.42 48.43 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.322 0.582 . . . . 64.5 112.231 -171.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.522 ' CZ ' ' HB ' ' A' ' 98' ' ' THR . 22.5 p90 -134.75 95.21 3.3 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.493 -0.929 . . . . 73.030000000000001 108.493 164.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.446 ' HA ' ' HB3' ' A' ' 97' ' ' PRO . 10.9 p90 -74.56 177.16 6.24 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 114.539 -1.21 . . . . 72.239999999999995 112.138 -172.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . 72.93 146.54 0.12 Allowed Pre-proline 0 N--CA 1.464 0.271 0 CA-C-N 115.148 -0.933 . . . . 53.439999999999998 111.472 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.627 ' HA ' HG12 ' A' ' 96' ' ' ILE . 32.1 Cg_endo -64.02 -27.34 65.93 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.349 2.033 . . . . 74.340000000000003 111.307 177.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.419 ' HB2' ' O ' ' A' ' 51' ' ' PRO . 20.6 t90 171.93 -43.85 0.01 OUTLIER 'General case' 0 C--O 1.234 0.272 0 CA-C-N 114.727 -1.124 . . . . 74.150000000000006 108.113 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 13.8 p -176.32 150.08 0.89 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-N 114.79 -1.096 . . . . 72.239999999999995 109.311 175.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.62 -148.27 16.9 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 121.128 -0.558 . . . . 63.140000000000001 112.354 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.86 157.61 47.33 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.722 2.281 . . . . 62.109999999999999 112.44 -178.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 73.9 m -147.62 -39.19 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 70.010000000000005 110.706 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.2 ttm180 62.03 76.99 0.35 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.337 0.589 . . . . 74.519999999999996 110.227 -177.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.0 m -96.32 129.72 43.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.836 -0.62 . . . . 52.329999999999998 110.99 -176.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 54.9 tp -169.39 89.65 0.2 Allowed 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.355 -0.384 . . . . 73.329999999999998 109.991 175.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 56.41 75.12 0.61 Allowed Pre-proline 0 N--CA 1.467 0.42 0 CA-C-N 115.771 -0.649 . . . . 73.140000000000001 111.733 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -73.0 -178.08 3.32 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.488 2.126 . . . . 71.140000000000001 111.396 173.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.541 ' HB3' HG12 ' A' ' 119' ' ' ILE . 0.2 OUTLIER -49.9 -50.21 46.92 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 121.359 0.6 . . . . 74.099999999999994 110.966 -176.734 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.701 HD21 HG21 ' A' ' 99' ' ' ILE . 8.8 mp -60.36 -48.85 79.99 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.258 -0.883 . . . . 74.219999999999999 111.524 -174.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.616 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 40.2 mt-10 -67.92 -36.35 80.01 Favored 'General case' 0 C--N 1.333 -0.138 0 N-CA-C 109.804 -0.443 . . . . 74.409999999999997 109.804 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -54.93 -51.13 67.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.797 -0.638 . . . . 71.310000000000002 110.23 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.463 HD11 HG22 ' A' ' 120' ' ' ILE . 22.9 mt -78.3 -34.79 48.58 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.517 -0.31 . . . . 73.239999999999995 111.802 178.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.503 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -63.37 -28.05 69.73 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 111.345 0.128 . . . . 61.5 111.345 -175.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.616 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 78.9 mt-30 -53.0 -32.4 46.36 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.284 0.564 . . . . 70.239999999999995 109.993 175.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -93.55 -59.08 2.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.562 -0.745 . . . . 65.549999999999997 110.427 175.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.583 ' O ' HG22 ' A' ' 74' ' ' VAL . 19.0 m-85 -87.55 17.78 4.37 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.32 -0.855 . . . . 75.230000000000004 113.134 -168.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.503 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 9.3 t -52.95 -36.08 59.57 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 118.147 0.43 . . . . 74.329999999999998 111.552 -176.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.6 mm-40 -70.8 -17.18 62.78 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.826 0.346 . . . . 53.340000000000003 111.493 -178.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -112.21 -10.57 13.84 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 116.269 -0.423 . . . . 72.310000000000002 110.6 -176.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 70' ' ' TYR . 32.6 m -131.08 151.07 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 O-C-N 122.174 -0.329 . . . . 55.140000000000001 110.872 -179.126 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.621 ' HA ' ' HE3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -134.1 127.04 31.33 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.912 -0.585 . . . . 63.310000000000002 109.484 177.662 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.472 ' HB ' HG12 ' A' ' 23' ' ' ILE . 51.6 mt -102.21 130.31 52.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 120.788 0.328 . . . . 74.420000000000002 110.232 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.425 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 74.7 m-85 -131.13 151.44 51.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.193 -0.458 . . . . 72.200000000000003 109.779 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.419 ' HE2' ' HB3' ' A' ' 47' ' ' ASP . 1.3 mptm? -126.28 173.07 9.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.751 0.31 . . . . 72.219999999999999 111.302 179.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 61.7 mt 71.81 93.86 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 114.992 -1.004 . . . . 72.5 109.824 -174.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -120.4 -68.64 0.89 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.218 -0.901 . . . . 55.210000000000001 109.747 -176.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 8.3 pt -146.69 128.18 6.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 115.501 -0.772 . . . . 61.140000000000001 109.985 -176.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -85.61 -73.05 0.46 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.939 0.399 . . . . 71.239999999999995 110.224 175.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -125.63 -25.85 3.63 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 116.177 -0.465 . . . . 64.430000000000007 111.28 177.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -89.7 95.4 10.24 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.908 -0.587 . . . . 73.349999999999994 110.31 -175.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.539 ' OE1' ' HB3' ' A' ' 88' ' ' ALA . 0.5 OUTLIER -145.01 138.77 26.99 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 112.953 0.723 . . . . 74.209999999999994 112.953 -177.584 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -90.92 -44.12 9.56 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.057 -0.72 . . . . 61.450000000000003 109.057 162.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.4 p -52.12 -54.85 12.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 114.576 -1.193 . . . . 75.030000000000001 113.185 -170.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.539 ' HB3' ' OE1' ' A' ' 85' ' ' GLN . . . -61.09 -49.68 76.34 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.714 0.293 . . . . 73.530000000000001 110.839 -174.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.3 m -65.03 -32.67 74.5 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.281 -0.418 . . . . 71.010000000000005 111.081 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 24.0 tt0 -66.32 -40.05 89.67 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.978 0.418 . . . . 72.230000000000004 110.202 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 45.7 m-85 -81.88 -17.07 48.55 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.187 -0.461 . . . . 74.030000000000001 110.321 175.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.47 23.26 60.87 Favored Glycine 0 CA--C 1.519 0.327 0 CA-C-N 115.986 -0.552 . . . . 71.209999999999994 112.821 177.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 47.1 t -61.03 133.56 26.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-O 120.59 0.233 . . . . 73.5 110.721 -178.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 29.2 t -137.37 11.98 3.01 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 116.194 -0.457 . . . . 73.310000000000002 110.72 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -134.49 140.18 46.01 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.355 -0.384 . . . . 73.129999999999995 110.49 -177.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.627 HG12 ' HA ' ' A' ' 51' ' ' PRO . 2.7 pp -112.63 155.05 44.47 Favored Pre-proline 0 CA--C 1.536 0.405 0 CA-C-N 116.102 -0.499 . . . . 72.430000000000007 111.156 -176.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.446 ' HB3' ' HA ' ' A' ' 49' ' ' TRP . 89.8 Cg_endo -79.04 165.31 81.81 Favored 'Cis proline' 0 C--N 1.354 0.848 0 C-N-CA 123.611 -1.412 . . . . 65.310000000000002 111.582 -3.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.522 ' HB ' ' CZ ' ' A' ' 48' ' ' PHE . 22.8 m -117.54 120.79 39.14 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.817 -0.438 . . . . 71.120000000000005 109.817 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.704 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 27.6 mt -126.24 112.54 30.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.715 -0.675 . . . . 53.43 109.734 -175.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -99.39 134.18 42.62 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.056 -0.35 . . . . 73.120000000000005 110.056 -176.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.776 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 61.8 mtp -101.82 117.54 35.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.448 . . . . 74.109999999999999 110.912 -175.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -115.39 156.49 25.46 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 120.972 0.415 . . . . 74.430000000000007 111.235 -178.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.755 ' HB3' HD21 ' A' ' 108' ' ' LEU . 37.7 ttmt -169.55 122.38 0.74 Allowed 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.279 -0.873 . . . . 63.310000000000002 109.598 177.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 60.56 26.08 15.75 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.327 0.584 . . . . 65.239999999999995 111.099 174.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.8 -14.45 61.65 Favored Glycine 0 CA--C 1.52 0.368 0 CA-C-N 115.971 -0.559 . . . . 53.509999999999998 112.681 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -94.73 139.54 31.1 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 122.591 0.356 . . . . 51.240000000000002 110.071 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.629 ' HD3' ' H ' ' A' ' 107' ' ' LYS . 0.1 OUTLIER -93.93 130.41 40.03 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.002 -0.74 . . . . 45.119999999999997 109.002 173.069 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.755 HD21 ' HB3' ' A' ' 103' ' ' LYS . 2.1 mm? -94.42 -53.16 4.02 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.166 -0.47 . . . . 72.549999999999997 110.737 -174.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.776 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 49.6 m -151.25 171.94 16.63 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.551 -0.75 . . . . 74.540000000000006 110.345 -172.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -145.15 114.87 7.29 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.153 0.502 . . . . 75.319999999999993 110.685 -179.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.704 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 51.5 t -80.15 107.42 12.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.623 -0.717 . . . . 64.25 109.98 178.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 60.5 mt -110.18 106.73 21.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.243 -0.435 . . . . 75.109999999999999 110.202 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 93.3 -134.55 12.19 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 116.109 -0.496 . . . . 74.409999999999997 112.051 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -137.81 76.53 1.58 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-O 121.149 0.499 . . . . 71.329999999999998 110.78 -177.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -114.03 97.48 6.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.912 -0.586 . . . . 62.439999999999998 110.336 177.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.609 HD12 HD11 ' A' ' 119' ' ' ILE . 7.9 tp -62.54 -39.86 86.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-O 121.089 0.471 . . . . 73.120000000000005 110.038 178.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 4.4 m -63.27 -39.71 95.34 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.571 -0.741 . . . . 71.150000000000006 110.554 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 16.7 tppt? -64.49 -56.17 15.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.757 -0.656 . . . . 71.040000000000006 110.617 177.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.609 HD11 HD12 ' A' ' 116' ' ' ILE . 2.4 pp -62.68 -39.94 86.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.121 -0.491 . . . . 71.219999999999999 111.816 -171.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.463 HG22 HD11 ' A' ' 66' ' ' LEU . 2.8 pp -64.08 -31.82 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 C-N-CA 120.314 -0.554 . . . . 75.310000000000002 110.078 178.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.438 ' N ' HD12 ' A' ' 120' ' ' ILE . 33.1 t -70.67 -51.8 25.35 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.717 -0.674 . . . . 62.240000000000002 110.797 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 20.8 pt-20 -77.53 -43.11 33.08 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 112.544 0.572 . . . . 74.319999999999993 112.544 -174.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.443 ' O ' HG12 ' A' ' 127' ' ' ILE . 79.7 mt -60.72 -57.62 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 O-C-N 122.187 -0.321 . . . . 72.530000000000001 110.813 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -59.58 -20.16 53.86 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.379 -0.373 . . . . 72.010000000000005 111.293 -177.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -76.24 -33.63 59.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.993 0.425 . . . . 60.229999999999997 110.349 176.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -98.73 -0.34 42.97 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 116.222 -0.445 . . . . 73.109999999999999 112.087 -175.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.443 HG12 ' O ' ' A' ' 123' ' ' ILE . 37.2 pt -133.71 168.27 24.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.763 -0.458 . . . . 71.040000000000006 109.763 172.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.481 -0.771 . . . . 74.439999999999998 110.861 -174.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptt? . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 120.699 0.285 . . . . 51.399999999999999 110.564 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.51 54.78 1.82 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.147 0.425 . . . . 74.329999999999998 112.147 -174.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.407 ' CG ' ' O ' ' A' ' 3' ' ' HIS . 36.5 t-80 58.05 14.02 2.49 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.036 0.534 . . . . 73.010000000000005 112.291 173.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 33.0 m170 -88.04 134.16 33.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.998 0.428 . . . . 75.420000000000002 111.177 -177.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 25.4 t60 -85.68 116.83 24.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.773 -0.649 . . . . 74.219999999999999 109.408 173.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -69.96 93.42 0.78 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.015 0.436 . . . . 71.200000000000003 110.566 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 65.6 t60 -99.47 119.53 38.15 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.042 -0.526 . . . . 65.209999999999994 109.819 176.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -60.57 125.47 23.82 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.809 -0.441 . . . . 71.340000000000003 109.809 176.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.4 ptm -134.5 149.83 50.73 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.336 -0.393 . . . . 61.329999999999998 110.357 -175.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.06 -164.3 39.93 Favored Glycine 0 N--CA 1.451 -0.332 0 N-CA-C 111.701 -0.56 . . . . 54.420000000000002 111.701 177.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.5 m 65.32 8.38 4.9 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.449 0.642 . . . . 62.43 110.836 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 62.4 tp -79.78 118.43 21.56 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.086 -0.506 . . . . 75.129999999999995 109.683 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 66.69 22.72 10.35 Favored 'General case' 0 N--CA 1.467 0.413 0 O-C-N 123.547 0.529 . . . . 62.409999999999997 110.551 -178.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.67 83.08 1.15 Allowed 'General case' 0 C--O 1.232 0.148 0 N-CA-C 109.385 -0.598 . . . . 64.340000000000003 109.385 176.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -125.0 132.73 53.21 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.905 -0.776 . . . . 71.200000000000003 108.905 -177.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 25.2 m -72.1 82.98 0.98 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.048 0.451 . . . . 74.340000000000003 110.897 -177.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -81.78 82.85 7.33 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 121.32 0.581 . . . . 73.129999999999995 109.911 177.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 170.79 72.31 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 115.438 -0.801 . . . . 72.219999999999999 111.668 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -81.11 -176.02 2.94 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.983 2.455 . . . . 73.219999999999999 112.011 179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -69.78 78.28 0.38 Allowed Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 111.645 -0.582 . . . . 71.450000000000003 111.645 177.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.584 ' HB2' HG12 ' A' ' 23' ' ' ILE . 20.6 p -92.16 -47.88 7.0 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.737 0.303 . . . . 64.019999999999996 110.969 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 21.8 mmt 57.67 43.35 22.39 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 121.234 0.54 . . . . 73.25 110.94 -178.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.584 HG12 ' HB2' ' A' ' 21' ' ' SER . 13.2 mm -89.08 86.98 2.7 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-N 115.233 -0.894 . . . . 74.400000000000006 108.597 172.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.537 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 9.6 tp10 -95.06 134.87 37.28 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.376 -0.374 . . . . 71.409999999999997 110.726 -176.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.415 HE21 ' HB2' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -97.93 132.14 43.78 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.753 -0.462 . . . . 65.140000000000001 109.753 177.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.497 HD12 ' HA ' ' A' ' 31' ' ' PHE . 34.4 pt -123.97 175.14 6.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.417 -0.356 . . . . 64.230000000000004 111.383 -172.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.44 170.87 33.01 Favored Glycine 0 C--N 1.331 0.265 0 CA-C-N 115.802 -0.635 . . . . 13.31 112.998 -177.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -67.5 -42.37 82.97 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 123.058 0.543 . . . . 73.329999999999998 111.286 -177.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 24.7 t -76.44 -47.32 23.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 64.120000000000005 111.188 -174.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -73.47 -9.43 58.68 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-N 116.543 -0.299 . . . . 71.549999999999997 111.401 -179.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.606 ' HE1' HG11 ' A' ' 46' ' ' VAL . 50.8 t80 -44.21 -71.09 0.08 Allowed 'General case' 0 CA--C 1.529 0.163 0 O-C-N 123.451 0.47 . . . . 65.209999999999994 111.136 -179.158 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -65.69 -32.87 74.67 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 110.04 -0.356 . . . . 71.430000000000007 110.04 -178.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.51 ' O ' ' HB3' ' A' ' 37' ' ' SER . 7.1 t30 -52.35 -41.02 62.68 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.232 -0.894 . . . . 63.409999999999997 111.16 -177.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.485 ' O ' ' HB2' ' A' ' 38' ' ' CYS . 13.1 ptmt -108.83 -15.89 14.29 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.227 -0.442 . . . . 53.439999999999998 111.905 -176.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.6 t -88.52 -60.99 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 N-CA-C 111.867 0.321 . . . . 61.520000000000003 111.867 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 40.9 p -81.88 -28.85 32.73 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 120.814 0.34 . . . . 74.430000000000007 111.093 -172.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.51 ' HB3' ' O ' ' A' ' 33' ' ' ASN . 46.5 t -91.16 12.29 20.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.959 -0.564 . . . . 73.219999999999999 110.191 177.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 34' ' ' LYS . 51.2 t -67.48 95.65 0.47 Allowed 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 120.96 0.409 . . . . 60.130000000000003 111.157 179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -89.71 14.41 11.83 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.33 0.586 . . . . 70.230000000000004 109.811 174.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -74.74 -6.02 46.55 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 115.858 -0.61 . . . . 63.240000000000002 110.392 -179.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.43 ' HA ' ' HB2' ' A' ' 104' ' ' ASN . 2.1 t-20 62.82 4.96 1.6 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.989 0.737 . . . . 71.209999999999994 112.989 174.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.678 HG21 ' HE2' ' A' ' 75' ' ' LYS . 13.2 tt -90.12 159.13 2.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.983 -0.377 . . . . 74.519999999999996 109.983 -179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.459 HD11 ' HB3' ' A' ' 101' ' ' MET . 64.7 tp -85.41 107.71 17.52 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 121.264 0.554 . . . . 74.319999999999993 109.94 178.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.415 HD11 ' SG ' ' A' ' 38' ' ' CYS . 65.6 mt -92.97 132.06 38.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.37 -0.832 . . . . 75.349999999999994 110.309 177.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.654 HD13 HD12 ' A' ' 63' ' ' LEU . 40.3 mt -111.04 101.84 10.35 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.267 -0.642 . . . . 41.200000000000003 109.267 177.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.606 HG11 ' HE1' ' A' ' 31' ' ' PHE . 61.3 t -91.5 116.3 32.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.564 -0.532 . . . . 71.439999999999998 109.564 178.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.498 ' HB2' ' CD1' ' A' ' 49' ' ' TRP . 2.0 p30 -97.1 148.34 23.13 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.199 0.523 . . . . 64.5 111.351 -173.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.407 ' CE2' HD13 ' A' ' 100' ' ' LEU . 81.4 m-85 -126.24 65.26 1.23 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.323 -0.853 . . . . 73.030000000000001 109.803 175.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.498 ' CD1' ' HB2' ' A' ' 47' ' ' ASP . 64.3 p-90 -144.32 130.39 19.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.465 -0.789 . . . . 72.239999999999995 109.276 173.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -147.67 92.5 4.74 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.009 0.433 . . . . 53.439999999999998 111.277 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.412 ' HD3' ' HE3' ' A' ' 49' ' ' TRP . 1.9 Cg_endo -81.89 76.82 4.11 Favored 'Trans proline' 0 N--CA 1.45 -1.031 0 C-N-CA 122.624 2.216 . . . . 74.340000000000003 109.786 171.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 7.4 m-90 -51.23 -47.33 62.39 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 115.814 -0.63 . . . . 74.150000000000006 110.171 -177.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 80.4 m -96.02 84.77 3.89 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.826 -0.625 . . . . 72.239999999999995 109.346 173.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -122.42 -168.74 13.29 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.949 -0.569 . . . . 63.140000000000001 112.606 -175.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -84.26 12.76 2.93 Favored 'Trans proline' 0 CA--C 1.533 0.442 0 C-N-CA 122.992 2.461 . . . . 62.109999999999999 112.76 -177.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 56.7 m 59.37 16.26 4.97 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.061 0.458 . . . . 70.010000000000005 111.287 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 20.4 tpp180 -103.81 148.15 26.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.976 -0.556 . . . . 74.519999999999996 110.542 -176.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.8 p -64.25 101.71 0.45 Allowed 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 108.735 -0.839 . . . . 52.329999999999998 108.735 170.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 55.1 tp -52.56 -33.55 46.26 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.147 -0.478 . . . . 73.329999999999998 111.187 -174.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 56.18 65.32 4.31 Favored Pre-proline 0 C--O 1.236 0.343 0 CA-C-N 115.861 -0.609 . . . . 73.140000000000001 110.634 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.18 178.11 6.41 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.087 1.858 . . . . 71.140000000000001 111.25 174.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.498 ' H ' ' CD ' ' A' ' 62' ' ' GLN . 11.7 mp0 -55.09 -48.29 73.76 Favored 'General case' 0 C--O 1.245 0.867 0 CA-C-O 121.871 0.843 . . . . 74.099999999999994 110.366 -178.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.654 HD12 HD13 ' A' ' 45' ' ' LEU . 2.9 mm? -61.39 -47.97 83.39 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 114.449 -1.251 . . . . 74.219999999999999 110.449 -174.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.552 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 45.9 tt0 -63.69 -44.05 94.86 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.235 -0.439 . . . . 74.409999999999997 109.941 178.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.652 ' HE3' ' HA ' ' A' ' 65' ' ' LYS . 0.1 OUTLIER -50.89 -51.66 49.6 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.602 -0.726 . . . . 71.310000000000002 111.033 -179.874 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.604 HD11 HG22 ' A' ' 120' ' ' ILE . 32.9 mt -71.99 -35.29 69.44 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.646 -0.422 . . . . 73.239999999999995 110.851 179.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.427 ' O ' ' HB ' ' A' ' 71' ' ' THR . . . -57.27 -40.06 76.94 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.026 -0.534 . . . . 61.5 111.227 -178.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.552 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 86.9 mt-30 -50.2 -33.4 19.19 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.983 0.42 . . . . 70.239999999999995 110.85 -177.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -94.09 -56.47 2.84 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.75 -0.659 . . . . 65.549999999999997 111.067 178.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.48 ' O ' HG22 ' A' ' 74' ' ' VAL . 17.3 m-85 -88.79 20.33 3.56 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.684 -0.689 . . . . 75.230000000000004 112.671 -170.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.427 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 13.8 t -53.35 -30.47 39.6 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.11 0.481 . . . . 74.329999999999998 112.28 -176.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -70.21 -16.78 63.11 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.381 -0.372 . . . . 53.340000000000003 111.324 -177.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -118.6 -6.5 10.67 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.489 -0.323 . . . . 72.310000000000002 110.458 -178.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.48 HG22 ' O ' ' A' ' 70' ' ' TYR . 30.1 m -137.1 135.39 47.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-O 121.143 0.497 . . . . 55.140000000000001 110.879 178.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.678 ' HE2' HG21 ' A' ' 42' ' ' ILE . 64.8 mttm -112.46 158.57 19.71 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.972 -0.751 . . . . 63.310000000000002 108.972 174.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.522 HG13 ' HB2' ' A' ' 45' ' ' LEU . 3.7 mp -125.56 139.4 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 C-N-CA 120.333 -0.547 . . . . 74.420000000000002 110.117 171.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.537 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 12.4 m-85 -125.04 129.1 49.6 Favored 'General case' 0 C--O 1.238 0.493 0 CA-C-N 115.9 -0.591 . . . . 72.200000000000003 110.094 177.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.456 ' HD3' ' N ' ' A' ' 79' ' ' ILE . 5.7 tmtm? -111.77 124.33 52.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.194 -0.912 . . . . 72.219999999999999 109.201 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.769 ' H ' HD13 ' A' ' 79' ' ' ILE . 0.2 OUTLIER -113.46 151.02 15.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.775 -0.454 . . . . 72.5 109.775 176.032 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -102.12 178.47 4.59 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.502 -0.555 . . . . 55.210000000000001 109.502 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.416 ' O ' HG22 ' A' ' 81' ' ' ILE . 27.1 mt 66.13 39.26 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 122.479 1.133 . . . . 61.140000000000001 109.067 179.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.579 ' HA ' ' HG2' ' A' ' 85' ' ' GLN . 5.7 mt-10 -71.22 0.06 8.73 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.529 -1.214 . . . . 71.239999999999995 111.205 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -74.17 -25.14 59.55 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 115.944 -0.571 . . . . 64.430000000000007 109.787 177.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -112.47 25.93 11.03 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.263 -0.88 . . . . 73.349999999999994 111.226 -171.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.579 ' HG2' ' HA ' ' A' ' 82' ' ' GLU . 80.8 mm-40 -96.91 104.39 16.39 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.995 0.426 . . . . 74.209999999999994 110.317 179.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -84.08 -8.05 59.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.808 -0.633 . . . . 61.450000000000003 110.251 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.1 t -49.76 -35.12 9.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 115.545 -0.752 . . . . 75.030000000000001 110.926 179.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.91 -56.02 25.68 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.924 -0.58 . . . . 73.530000000000001 110.367 177.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.0 m -64.22 -35.04 79.5 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.269 -0.423 . . . . 71.010000000000005 110.454 179.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 65.1 tt0 -57.65 -38.6 75.35 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 115.766 -0.652 . . . . 72.230000000000004 110.389 178.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -88.76 -17.2 30.35 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.502 -0.317 . . . . 74.030000000000001 111.501 176.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 85.55 25.25 39.69 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 121.018 -0.61 . . . . 71.209999999999994 112.223 -177.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 70.7 t -64.26 127.19 24.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.724 0.297 . . . . 73.5 110.296 178.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.5 p -91.3 -17.0 26.63 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.393 0.516 . . . . 73.310000000000002 112.393 -174.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -157.89 146.86 19.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.83 0.348 . . . . 73.129999999999995 111.572 -176.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.559 ' HB ' ' HA ' ' A' ' 97' ' ' PRO . 2.7 pp -98.71 162.04 23.03 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 115.923 -0.58 . . . . 72.430000000000007 110.036 176.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.559 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 98.5 Cg_endo -80.95 174.25 47.74 Favored 'Cis proline' 0 C--N 1.355 0.87 0 C-N-CA 124.133 -1.195 . . . . 65.310000000000002 112.83 2.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.547 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 27.8 m -145.68 134.18 22.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.951 -0.568 . . . . 71.120000000000005 110.042 179.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.597 HG21 ' HG ' ' A' ' 63' ' ' LEU . 3.5 mp -116.44 125.2 73.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.137 0 N-CA-C 109.71 -0.478 . . . . 53.43 109.71 178.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.407 HD13 ' CE2' ' A' ' 48' ' ' PHE . 9.7 mp -91.49 134.18 34.86 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.815 0.34 . . . . 73.120000000000005 110.738 -178.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.546 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 72.2 mtp -108.98 114.38 28.07 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.926 -0.579 . . . . 74.109999999999999 110.231 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -118.91 148.36 43.01 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 123.179 0.3 . . . . 74.430000000000007 110.271 178.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.625 ' HB3' HD21 ' A' ' 108' ' ' LEU . 62.4 tttm -152.56 115.22 4.54 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.025 -0.731 . . . . 63.310000000000002 109.025 176.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.43 ' HB2' ' HA ' ' A' ' 41' ' ' ASN . 5.8 t30 58.52 30.28 19.54 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.362 0.601 . . . . 65.239999999999995 110.279 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.18 -9.08 78.55 Favored Glycine 0 CA--C 1.521 0.434 0 CA-C-N 115.696 -0.684 . . . . 53.509999999999998 113.355 177.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -95.2 131.17 41.54 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 117.053 0.426 . . . . 51.240000000000002 111.031 179.116 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.68 ' HZ2' ' HB2' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -80.39 116.87 20.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 45.119999999999997 110.043 174.77 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.625 HD21 ' HB3' ' A' ' 103' ' ' LYS . 3.1 mm? -82.06 -52.57 6.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.442 -0.344 . . . . 72.549999999999997 110.317 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.546 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 74.6 m -159.35 171.82 19.09 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.81 -0.632 . . . . 74.540000000000006 110.759 -176.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 8.4 pm0 -133.35 119.12 19.3 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.428 -0.805 . . . . 75.319999999999993 109.346 172.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 98' ' ' THR . 61.3 t -79.99 110.33 15.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 64.25 110.048 -178.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 59.0 mt -107.98 118.54 55.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 110.036 -0.357 . . . . 75.109999999999999 110.036 -177.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.36 -115.36 4.21 Favored Glycine 0 N--CA 1.453 -0.206 0 N-CA-C 111.682 -0.567 . . . . 74.409999999999997 111.682 -178.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.55 89.19 1.02 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.89 0.345 . . . . 71.329999999999998 111.017 -179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.465 ' O ' HG23 ' A' ' 119' ' ' ILE . 12.5 m-20 -118.99 88.76 2.99 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.41 -0.359 . . . . 62.439999999999998 110.448 178.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.505 HD12 HD11 ' A' ' 119' ' ' ILE . 8.2 tp -62.73 -44.89 99.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 CA-C-O 120.814 0.34 . . . . 73.120000000000005 110.902 -178.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 20.2 m -68.55 -27.06 65.75 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.34 -0.391 . . . . 71.150000000000006 111.336 -176.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.32 -45.27 19.98 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 120.839 0.352 . . . . 71.040000000000006 110.076 178.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.521 ' HA ' ' HG2' ' A' ' 122' ' ' GLU . 2.4 pp -68.43 -37.37 77.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.384 -0.371 . . . . 71.219999999999999 111.601 -176.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.604 HG22 HD11 ' A' ' 66' ' ' LEU . 2.7 pp -63.66 -31.79 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 121.3 0.571 . . . . 75.310000000000002 109.681 176.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.8 t -70.47 -47.89 58.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.446 -0.797 . . . . 62.240000000000002 110.568 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.521 ' HG2' ' HA ' ' A' ' 119' ' ' ILE . 21.1 pt-20 -76.96 -44.75 30.14 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.235 0.457 . . . . 74.319999999999993 112.235 -176.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.572 HD12 HD12 ' A' ' 66' ' ' LEU . 67.2 mt -61.43 -57.23 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 O-C-N 122.185 -0.322 . . . . 72.530000000000001 110.992 -178.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -60.59 -20.37 60.36 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-O 121.068 0.461 . . . . 72.010000000000005 111.227 -176.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -77.66 -34.49 53.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.753 -0.658 . . . . 60.229999999999997 110.576 176.123 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -83.27 -39.38 20.93 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.077 -0.51 . . . . 73.109999999999999 111.012 -177.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.455 HG12 ' O ' ' A' ' 123' ' ' ILE . 47.2 pt -91.78 168.15 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.283 -0.417 . . . . 71.040000000000006 110.2 178.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 6.4 p30 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.499 -0.762 . . . . 74.439999999999998 110.716 -172.651 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.492 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.2 pmm? . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 120.514 0.197 . . . . 51.399999999999999 111.111 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.94 102.62 2.03 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.952 0.406 . . . . 74.329999999999998 111.209 -179.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.6 m170 -89.19 8.17 31.58 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.08 -0.509 . . . . 73.010000000000005 111.113 177.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 66.4 t60 -64.03 106.93 1.13 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.686 -0.487 . . . . 75.420000000000002 109.686 174.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 62.7 m80 -66.25 120.72 13.76 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.107 -0.497 . . . . 74.219999999999999 110.356 -175.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 21.4 p-80 -81.67 60.88 4.81 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.567 0.698 . . . . 71.200000000000003 110.381 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 38.9 t60 -65.26 121.82 15.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.267 -0.879 . . . . 65.209999999999994 110.73 -178.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -164.36 147.04 9.0 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.081 -0.508 . . . . 71.340000000000003 110.625 179.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -156.47 150.33 24.94 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.886 -0.597 . . . . 61.329999999999998 109.762 177.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.88 103.93 0.56 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.047 -0.597 . . . . 54.420000000000002 112.038 -179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.2 m -97.94 124.52 42.43 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.144 -0.317 . . . . 62.43 110.144 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.54 ' O ' HD12 ' A' ' 12' ' ' LEU . 4.1 pp -81.16 137.74 35.9 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.127 0.489 . . . . 75.129999999999995 110.715 178.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.78 23.15 10.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.802 -0.635 . . . . 62.409999999999997 109.955 179.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.37 146.14 7.46 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.649 -0.705 . . . . 64.340000000000003 110.765 177.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -95.62 97.12 9.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.456 0.646 . . . . 71.200000000000003 111.16 -175.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.1 t -123.5 -160.85 0.93 Allowed 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.804 -0.813 . . . . 74.340000000000003 108.804 175.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.529 ' HG3' ' H ' ' A' ' 18' ' ' GLY . 6.2 tp-100 -164.99 179.01 6.68 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 109.976 -0.379 . . . . 73.129999999999995 109.976 -178.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.529 ' H ' ' HG3' ' A' ' 17' ' ' GLN . . . -123.45 77.65 0.36 Allowed Glycine 0 C--N 1.33 0.247 0 N-CA-C 111.464 -0.654 . . . . 72.219999999999999 111.464 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -79.41 -2.05 11.98 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.232 2.622 . . . . 73.219999999999999 111.682 -179.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.73 -83.94 1.69 Allowed Glycine 0 N--CA 1.45 -0.383 0 N-CA-C 110.631 -0.988 . . . . 71.450000000000003 110.631 174.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.3 m -77.23 150.57 35.38 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.437 -0.579 . . . . 64.019999999999996 109.437 171.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 16.0 tpt -67.85 77.52 0.21 Allowed 'General case' 0 C--O 1.238 0.487 0 CA-C-O 120.994 0.426 . . . . 73.25 110.508 -179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.53 HD13 ' HB ' ' A' ' 76' ' ' ILE . 16.9 mm -117.17 124.8 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 115.726 -0.67 . . . . 74.400000000000006 110.427 -177.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 45.6 tt0 -131.97 140.93 49.13 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.693 0.282 . . . . 71.409999999999997 110.316 173.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -95.8 126.85 41.35 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.786 -0.45 . . . . 65.140000000000001 109.786 176.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.514 HD12 ' HA ' ' A' ' 31' ' ' PHE . 44.5 pt -129.26 165.3 29.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-O 121.075 0.464 . . . . 64.230000000000004 111.525 -174.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.5 164.07 18.91 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.52 -0.764 . . . . 13.31 111.575 176.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -63.58 -29.88 71.07 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.575 0.226 . . . . 73.329999999999998 110.704 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.9 t -62.06 -22.33 65.67 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.17 -0.468 . . . . 64.120000000000005 111.627 -178.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -121.29 -3.23 9.48 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.788 -0.187 . . . . 71.549999999999997 110.836 -178.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.514 ' HA ' HD12 ' A' ' 26' ' ' ILE . 90.6 t80 -51.29 -70.96 0.07 Allowed 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.232 -0.44 . . . . 65.209999999999994 110.363 -177.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -62.71 -34.35 76.99 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.431 -0.581 . . . . 71.430000000000007 109.431 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.483 ' O ' ' HB3' ' A' ' 37' ' ' SER . 6.6 t30 -52.18 -39.71 60.48 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 115.116 -0.947 . . . . 63.409999999999997 111.477 -176.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.512 ' HD3' HG21 ' A' ' 26' ' ' ILE . 14.1 ptmt -110.23 -18.04 13.39 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 111.793 0.294 . . . . 53.439999999999998 111.793 -177.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 72.2 t -87.58 -54.4 8.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 111.661 0.245 . . . . 61.520000000000003 111.661 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 72.0 p -77.47 -27.33 52.0 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.302 0.572 . . . . 74.430000000000007 110.0 -176.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.483 ' HB3' ' O ' ' A' ' 33' ' ' ASN . 34.3 t -89.71 12.59 16.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.249 -0.887 . . . . 73.219999999999999 110.828 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.404 ' HB2' HD12 ' A' ' 44' ' ' ILE . 43.9 t -46.02 99.58 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.949 0.404 . . . . 60.130000000000003 111.672 -178.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -95.4 9.05 41.37 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 115.804 -0.635 . . . . 70.230000000000004 110.296 178.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -86.28 -15.39 40.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.011 -0.54 . . . . 63.240000000000002 110.774 -178.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.4 m120 62.99 16.54 9.35 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.482 0.658 . . . . 71.209999999999994 109.673 -171.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 21.7 mt -96.66 141.4 15.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 CA-C-N 115.147 -0.933 . . . . 74.519999999999996 110.46 -177.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.677 HD21 ' HE3' ' A' ' 101' ' ' MET . 62.7 tp -71.56 103.92 3.14 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.85 -0.614 . . . . 74.319999999999993 110.087 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.404 HD12 ' HB2' ' A' ' 38' ' ' CYS . 44.3 mt -84.7 116.59 28.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.928 -0.578 . . . . 75.349999999999994 110.695 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.801 HD13 HD12 ' A' ' 63' ' ' LEU . 44.9 mt -100.63 109.98 22.08 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.475 -0.784 . . . . 41.200000000000003 109.217 179.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.3 m -100.97 115.02 41.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-O 120.866 0.365 . . . . 71.439999999999998 110.309 179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.5 121.03 32.83 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.786 -0.643 . . . . 64.5 111.049 -175.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -101.0 96.44 7.25 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 109.593 -0.521 . . . . 73.030000000000001 109.593 175.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.503 ' O ' ' HD3' ' A' ' 51' ' ' PRO . 56.3 t-105 -170.22 140.58 1.93 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.636 -0.711 . . . . 72.239999999999995 110.112 -178.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -83.92 103.09 2.47 Favored Pre-proline 0 CA--C 1.536 0.41 0 N-CA-C 110.152 -0.314 . . . . 53.439999999999998 110.152 175.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' A' ' 49' ' ' TRP . 86.4 Cg_endo -82.18 60.93 7.6 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.692 2.261 . . . . 74.340000000000003 112.946 -173.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 91.1 m95 -69.09 86.63 0.38 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.189 0.519 . . . . 74.150000000000006 110.467 176.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 53.4 t -147.1 -45.59 0.18 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.544 -0.753 . . . . 72.239999999999995 109.795 179.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.412 ' HA3' ' HD3' ' A' ' 55' ' ' PRO . . . 141.26 -127.14 3.27 Favored Glycine 0 C--N 1.331 0.304 0 N-CA-C 111.317 -0.713 . . . . 63.140000000000001 111.317 178.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.412 ' HD3' ' HA3' ' A' ' 54' ' ' GLY . 2.7 Cg_exo -76.29 -159.77 0.1 Allowed 'Trans proline' 0 CA--C 1.532 0.383 0 C-N-CA 122.795 2.33 . . . . 62.109999999999999 111.625 176.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 49.5 t -66.99 79.85 0.12 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.055 0.455 . . . . 70.010000000000005 110.423 178.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.403 ' HD3' HH11 ' A' ' 57' ' ' ARG . 43.8 mtt180 -135.25 105.22 6.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.625 -0.716 . . . . 74.519999999999996 109.603 178.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 34.2 p -126.05 174.23 8.6 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.162 -0.472 . . . . 52.329999999999998 110.711 -179.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 76.4 mt -103.81 31.1 4.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.913 -0.585 . . . . 73.329999999999998 110.102 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.88 ' HB3' ' HE2' ' A' ' 65' ' ' LYS . 23.2 mm-40 63.12 75.61 0.4 Allowed Pre-proline 0 CA--C 1.534 0.361 0 CA-C-N 115.538 -0.756 . . . . 73.140000000000001 110.703 -177.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -80.63 162.11 21.76 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.5 2.133 . . . . 71.140000000000001 111.59 178.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.634 ' HB3' HG12 ' A' ' 119' ' ' ILE . 8.2 mp0 -52.47 -48.34 65.96 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-O 121.551 0.691 . . . . 74.099999999999994 110.986 -176.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.801 HD12 HD13 ' A' ' 45' ' ' LEU . 3.0 mm? -57.89 -48.07 80.93 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 114.655 -1.157 . . . . 74.219999999999999 110.35 -173.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.546 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 41.2 mt-10 -71.73 -34.94 69.98 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.432 -0.349 . . . . 74.409999999999997 110.9 179.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.88 ' HE2' ' HB3' ' A' ' 60' ' ' GLU . 49.6 mmtt -52.85 -52.96 55.26 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.768 0.318 . . . . 71.310000000000002 110.52 177.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.597 HD12 HD12 ' A' ' 123' ' ' ILE . 25.5 mt -76.51 -30.22 57.12 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.532 -0.467 . . . . 73.239999999999995 111.091 178.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.516 ' HB3' ' HA ' ' A' ' 64' ' ' GLU . . . -59.58 -37.68 79.16 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.743 -0.208 . . . . 61.5 111.412 -179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.546 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 79.2 mt-30 -54.09 -35.46 62.13 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.989 0.423 . . . . 70.239999999999995 110.982 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 66.8 mm-40 -93.86 -53.09 4.14 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.99 -0.55 . . . . 65.549999999999997 111.262 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.489 ' O ' HG22 ' A' ' 74' ' ' VAL . 14.3 m-85 -92.74 22.58 4.67 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.815 -0.63 . . . . 75.230000000000004 112.047 -171.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.46 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 9.5 t -52.91 -31.52 40.38 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.722 0.296 . . . . 74.329999999999998 111.775 -177.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -70.6 -16.47 62.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.991 0.425 . . . . 53.340000000000003 111.155 -177.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -123.43 0.79 8.92 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.164 -0.471 . . . . 72.310000000000002 110.761 -175.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.489 HG22 ' O ' ' A' ' 70' ' ' TYR . 29.1 m -131.29 147.55 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-O 120.939 0.4 . . . . 55.140000000000001 110.469 177.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -141.86 116.73 9.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.964 -0.562 . . . . 63.310000000000002 109.723 -178.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.53 ' HB ' HD13 ' A' ' 23' ' ' ILE . 3.0 mp -99.05 143.44 13.33 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 120.633 0.254 . . . . 74.420000000000002 110.811 -173.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.457 ' OH ' ' HE2' ' A' ' 34' ' ' LYS . 21.0 m-85 -130.75 130.05 43.27 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.988 0.423 . . . . 72.200000000000003 111.655 -179.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -96.21 115.17 27.01 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.69 -0.856 . . . . 72.219999999999999 108.69 170.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.723 HG12 ' H ' ' A' ' 81' ' ' ILE . 12.1 tt -101.53 160.98 3.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 N-CA-C 109.864 -0.421 . . . . 72.5 109.864 178.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.421 ' N ' HG12 ' A' ' 79' ' ' ILE . 90.1 m-20 -85.54 -20.97 28.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.825 0.345 . . . . 55.210000000000001 110.74 178.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.723 ' H ' HG12 ' A' ' 79' ' ' ILE . 43.4 mm -89.25 97.91 7.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 109.796 -0.446 . . . . 61.140000000000001 109.796 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -85.33 -71.06 0.55 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.846 -0.615 . . . . 71.239999999999995 111.832 -174.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -124.27 -25.0 4.19 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.715 -0.675 . . . . 64.430000000000007 111.703 -169.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -78.11 60.72 2.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.188 0.518 . . . . 73.349999999999994 109.984 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.455 ' HG3' ' H ' ' A' ' 88' ' ' ALA . 24.8 pt20 -145.04 159.43 42.96 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.137 -0.483 . . . . 74.209999999999994 111.042 -176.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -66.23 -40.81 90.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.547 -0.751 . . . . 61.450000000000003 110.958 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 51.6 t -51.97 -49.49 37.87 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-N 116.08 -0.509 . . . . 75.030000000000001 111.354 -176.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.455 ' H ' ' HG3' ' A' ' 85' ' ' GLN . . . -57.63 -50.54 72.81 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.787 -0.642 . . . . 73.530000000000001 110.283 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 27.3 m -60.06 -37.07 78.77 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.786 -0.643 . . . . 71.010000000000005 110.89 178.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -62.44 -47.0 85.99 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.566 -0.743 . . . . 72.230000000000004 110.683 -177.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -87.77 6.58 34.48 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.177 -0.465 . . . . 74.030000000000001 111.523 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 67.01 27.65 73.52 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 116.106 -0.497 . . . . 71.209999999999994 112.965 175.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 77.7 t -69.27 98.35 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.247 0.546 . . . . 73.5 110.732 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 39.2 m -101.98 -14.3 17.23 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.059 -0.519 . . . . 73.310000000000002 110.51 176.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -123.1 115.85 22.49 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.778 -0.647 . . . . 73.129999999999995 110.494 -177.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.57 ' HB ' ' HA ' ' A' ' 97' ' ' PRO . 30.3 pt -96.26 162.2 24.47 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 115.936 -0.574 . . . . 72.430000000000007 110.153 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.57 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 83.7 Cg_endo -81.71 171.91 54.9 Favored 'Cis proline' 0 C--N 1.353 0.794 0 C-N-CA 124.136 -1.193 . . . . 65.310000000000002 112.986 0.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 111' ' ' VAL . 97.9 m -147.34 129.25 15.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.913 -0.585 . . . . 71.120000000000005 110.474 178.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.53 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 3.6 mp -110.46 145.83 16.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 108.88 -0.785 . . . . 53.43 108.88 177.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.463 HD23 ' H ' ' A' ' 101' ' ' MET . 0.8 OUTLIER -121.56 137.81 54.57 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.755 -0.461 . . . . 73.120000000000005 109.755 178.825 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.702 ' SD ' ' HB3' ' A' ' 109' ' ' SER . 64.0 mtp -103.14 111.68 24.17 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.892 -0.594 . . . . 74.109999999999999 111.039 -174.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -115.46 153.72 30.59 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-O 120.736 0.303 . . . . 74.430000000000007 110.655 177.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.499 ' HB3' HD21 ' A' ' 108' ' ' LEU . 39.3 ttpt -166.77 116.92 0.91 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.314 -0.403 . . . . 63.310000000000002 110.051 175.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 8.1 t30 50.92 52.14 15.58 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 121.622 0.725 . . . . 65.239999999999995 110.957 178.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 76.46 -14.95 6.18 Favored Glycine 0 CA--C 1.521 0.43 0 CA-C-N 115.436 -0.802 . . . . 53.509999999999998 113.666 176.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.0 tptp -100.29 123.47 44.55 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 117.08 0.44 . . . . 51.240000000000002 110.398 -179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.402 ' H ' ' HG2' ' A' ' 107' ' ' LYS . 30.6 pttt -89.24 122.61 32.68 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.517 -0.549 . . . . 45.119999999999997 109.517 174.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.508 ' N ' HD22 ' A' ' 108' ' ' LEU . 2.5 mm? -82.63 -52.62 6.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.612 -0.722 . . . . 72.549999999999997 111.281 -172.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.702 ' HB3' ' SD ' ' A' ' 101' ' ' MET . 22.0 t -162.42 172.01 16.24 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.995 -0.548 . . . . 74.540000000000006 110.845 -171.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -133.41 129.26 37.1 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.199 -0.455 . . . . 75.319999999999993 110.369 178.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.688 ' HA ' ' HE3' ' A' ' 118' ' ' LYS . 83.7 t -92.64 107.11 18.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.994 -0.548 . . . . 64.25 110.28 178.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 59.9 mt -110.32 119.19 58.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 109.722 -0.473 . . . . 75.109999999999999 109.722 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 95.74 -126.9 8.95 Favored Glycine 0 CA--C 1.519 0.322 0 N-CA-C 111.922 -0.471 . . . . 74.409999999999997 111.922 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.47 83.73 0.91 Allowed 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.895 0.379 . . . . 71.329999999999998 110.305 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.41 ' O ' HG23 ' A' ' 119' ' ' ILE . 4.9 m-20 -125.7 97.42 5.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.06 -0.518 . . . . 62.439999999999998 110.407 -178.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.518 ' O ' HG13 ' A' ' 119' ' ' ILE . 7.7 tp -60.64 -41.67 88.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-N 116.511 -0.313 . . . . 73.120000000000005 111.158 -177.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 30.4 t -62.74 -33.04 74.32 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.302 0.572 . . . . 71.150000000000006 110.853 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.688 ' HE3' ' HA ' ' A' ' 111' ' ' VAL . 0.9 OUTLIER -75.94 -47.67 24.25 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 115.648 -0.706 . . . . 71.040000000000006 110.656 -179.188 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.634 HG12 ' HB3' ' A' ' 62' ' ' GLN . 2.1 pp -64.97 -40.82 90.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.227 -0.442 . . . . 71.219999999999999 111.066 -177.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.436 HG22 HD11 ' A' ' 66' ' ' LEU . 2.8 pp -65.73 -31.71 54.94 Favored 'Isoleucine or valine' 0 C--N 1.34 0.169 0 N-CA-C 109.65 -0.5 . . . . 75.310000000000002 109.65 178.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 43.2 t -65.15 -51.62 60.05 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.632 -0.713 . . . . 62.240000000000002 110.482 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -77.15 -38.73 51.24 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.635 0.605 . . . . 74.319999999999993 112.635 -176.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.597 HD12 HD12 ' A' ' 66' ' ' LEU . 56.8 mt -66.02 -53.2 40.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 O-C-N 122.167 -0.333 . . . . 72.530000000000001 111.011 -178.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -61.85 -20.34 63.59 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.14 0.495 . . . . 72.010000000000005 110.499 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -70.73 -32.58 69.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.981 -0.554 . . . . 60.229999999999997 111.436 -179.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.545 ' OD1' HG23 ' A' ' 127' ' ' ILE . 9.3 p30 -106.39 -17.97 14.12 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.083 0.401 . . . . 73.109999999999999 112.083 -174.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.545 HG23 ' OD1' ' A' ' 126' ' ' ASN . 42.2 pt -125.39 167.69 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 CA-C-O 120.846 0.355 . . . . 71.040000000000006 111.135 177.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.454 HD22 ' H ' ' A' ' 128' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.353 -0.832 . . . . 74.439999999999998 110.781 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 N--CA 1.483 1.186 0 CA-C-O 120.678 0.275 . . . . 51.399999999999999 110.648 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -165.88 149.39 7.77 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.033 -0.53 . . . . 74.329999999999998 109.964 178.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -97.56 62.5 1.69 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.537 0.684 . . . . 73.010000000000005 110.378 -179.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 50.4 t-80 -86.29 111.13 20.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.233 -0.894 . . . . 75.420000000000002 109.964 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -93.32 160.65 14.73 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.089 0.471 . . . . 74.219999999999999 111.268 -178.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -78.81 107.84 11.82 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.463 -0.79 . . . . 71.200000000000003 109.773 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 40.3 t60 -71.2 -51.83 22.52 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.938 0.399 . . . . 65.209999999999994 111.219 -175.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 58.6 t60 -73.86 121.22 20.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.105 -0.498 . . . . 71.340000000000003 110.147 -178.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -100.76 -171.04 1.94 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.52 -0.309 . . . . 61.329999999999998 110.203 -178.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -150.93 138.74 6.79 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 121.198 -0.525 . . . . 54.420000000000002 112.34 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 31.7 p -95.72 132.89 40.45 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 122.404 0.281 . . . . 62.43 110.815 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.8 pp -87.29 175.67 7.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.771 0.32 . . . . 75.129999999999995 110.505 178.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -124.03 159.0 30.83 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.673 -0.492 . . . . 62.409999999999997 109.673 -177.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -147.34 101.47 3.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.685 0.278 . . . . 64.340000000000003 111.035 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -91.09 171.39 9.29 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.308 -0.405 . . . . 71.200000000000003 110.053 176.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 87.2 m -147.13 92.56 2.13 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.866 -0.42 . . . . 74.340000000000003 109.866 177.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -82.36 172.59 12.9 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.882 -0.599 . . . . 73.129999999999995 110.359 -178.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -145.32 70.27 0.38 Allowed Glycine 0 N--CA 1.453 -0.217 0 N-CA-C 111.876 -0.49 . . . . 72.219999999999999 111.876 -179.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -72.79 175.78 9.85 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 122.56 2.174 . . . . 73.219999999999999 112.045 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 167.85 -166.56 39.48 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 116.21 -0.45 . . . . 71.450000000000003 112.025 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 40.1 m -150.66 170.05 20.12 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.968 -0.382 . . . . 64.019999999999996 109.968 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.475 ' N ' ' SD ' ' A' ' 22' ' ' MET . 3.7 mpp? -92.24 -43.88 9.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.454 -0.339 . . . . 73.25 111.57 -174.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.1 mt -108.44 123.59 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.222 0 CA-C-O 121.018 0.437 . . . . 74.400000000000006 111.626 -174.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.642 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 8.7 tp10 -131.97 155.22 48.35 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.834 -0.802 . . . . 71.409999999999997 108.834 174.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -100.59 147.83 25.5 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.71 0.29 . . . . 65.140000000000001 110.263 174.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.518 HD12 ' HA ' ' A' ' 31' ' ' PHE . 34.9 pt -131.07 -176.95 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.464 -0.334 . . . . 64.230000000000004 110.691 -176.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.415 ' H ' ' HG2' ' A' ' 30' ' ' GLU . . . -141.03 -173.83 13.77 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.403 -0.427 . . . . 13.31 112.902 -177.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -55.03 -50.73 68.34 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 123.92 0.888 . . . . 73.329999999999998 112.605 -175.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 24.9 t -73.4 -19.09 61.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.102 -0.499 . . . . 64.120000000000005 111.807 -169.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.493 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 1.7 pm0 -111.74 -15.24 13.46 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 111.874 0.324 . . . . 71.549999999999997 111.874 -177.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.518 ' HA ' HD12 ' A' ' 26' ' ' ILE . 61.6 t80 -48.2 -71.01 0.08 Allowed 'General case' 0 N--CA 1.468 0.437 0 O-C-N 123.41 0.444 . . . . 65.209999999999994 111.239 -176.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -63.44 -40.09 96.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.358 0.599 . . . . 71.430000000000007 109.636 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.526 ' O ' ' HB3' ' A' ' 37' ' ' SER . 1.8 m-80 -53.13 -34.08 55.18 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.445 -1.252 . . . . 63.409999999999997 112.58 -172.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.493 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -114.84 -25.02 8.39 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 120.577 -0.449 . . . . 53.439999999999998 112.16 179.754 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 92.4 t -82.74 -51.62 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 N-CA-C 111.51 0.189 . . . . 61.520000000000003 111.51 -178.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 44.3 p -85.86 -23.03 27.27 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.025 0.44 . . . . 74.430000000000007 110.265 -176.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.526 ' HB3' ' O ' ' A' ' 33' ' ' ASN . 28.5 t -92.76 12.05 24.82 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.679 -0.691 . . . . 73.219999999999999 110.384 177.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 41.3 t -60.19 90.73 0.02 OUTLIER 'General case' 0 C--O 1.234 0.246 0 CA-C-O 121.128 0.489 . . . . 60.130000000000003 110.961 179.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -90.27 -4.0 57.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.872 -0.604 . . . . 70.230000000000004 110.543 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -71.02 -8.2 51.71 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.075 -0.511 . . . . 63.240000000000002 110.875 179.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 57.15 22.68 7.76 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.961 -0.563 . . . . 71.209999999999994 111.246 -176.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 10.9 tt -94.16 148.68 4.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 108.951 -0.759 . . . . 74.519999999999996 108.951 177.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.561 HD11 ' HB3' ' A' ' 101' ' ' MET . 63.7 tp -82.46 113.25 20.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.04 0.448 . . . . 74.319999999999993 110.634 -175.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.411 ' HA ' ' O ' ' A' ' 75' ' ' LYS . 58.2 mt -98.34 123.97 51.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.522 -0.763 . . . . 75.349999999999994 110.58 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.451 ' N ' HD12 ' A' ' 45' ' ' LEU . 5.1 mp -106.71 112.11 24.94 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.221 -0.445 . . . . 41.200000000000003 109.867 177.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.585 ' HA ' ' O ' ' A' ' 77' ' ' TYR . 27.5 m -98.04 121.87 49.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-O 121.031 0.444 . . . . 71.439999999999998 110.957 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.442 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 2.3 t70 -96.87 128.05 43.44 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.684 -0.689 . . . . 64.5 110.819 -179.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.458 ' CE1' HD13 ' A' ' 100' ' ' LEU . 44.2 m-85 -82.43 76.82 9.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.07 0.462 . . . . 73.030000000000001 110.43 175.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 45.0 p90 35.83 76.13 0.05 Allowed 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 114.341 -1.3 . . . . 72.239999999999995 113.588 177.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.732 ' HA ' ' HB3' ' A' ' 97' ' ' PRO . . . -52.03 115.2 6.33 Favored Pre-proline 0 C--O 1.236 0.361 0 CA-C-N 115.774 -0.648 . . . . 53.439999999999998 109.843 170.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.54 ' O ' ' N ' ' A' ' 53' ' ' CYS . 22.0 Cg_exo -64.24 85.86 0.15 Allowed 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.657 2.238 . . . . 74.340000000000003 112.313 -176.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 33.3 p-90 40.34 -74.27 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.814 1.246 . . . . 74.150000000000006 113.346 178.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.54 ' N ' ' O ' ' A' ' 51' ' ' PRO . 52.2 t 64.92 -76.55 0.04 OUTLIER 'General case' 0 C--O 1.235 0.306 0 C-N-CA 123.34 0.656 . . . . 72.239999999999995 111.394 179.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 57.83 75.73 0.24 Allowed Glycine 0 C--N 1.333 0.378 0 N-CA-C 111.414 -0.675 . . . . 63.140000000000001 111.414 -174.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -56.61 94.16 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 122.802 2.335 . . . . 62.109999999999999 111.992 -175.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 59.6 m -72.16 78.78 0.96 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.808 -0.633 . . . . 70.010000000000005 110.541 -178.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 39.2 ttm180 -156.94 7.21 0.17 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.605 -0.725 . . . . 74.519999999999996 109.815 178.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.9 t 69.66 18.68 7.54 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 115.684 -0.689 . . . . 52.329999999999998 110.811 -178.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -109.55 149.06 30.2 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.096 -0.502 . . . . 73.329999999999998 110.583 178.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -102.22 149.65 36.81 Favored Pre-proline 0 C--O 1.234 0.284 0 CA-C-N 116.0 -0.546 . . . . 73.140000000000001 109.976 178.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -65.53 165.21 23.5 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 122.526 2.151 . . . . 71.140000000000001 111.837 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.59 ' HB3' HG12 ' A' ' 119' ' ' ILE . 8.9 mp0 -51.13 -49.47 60.73 Favored 'General case' 0 C--O 1.244 0.798 0 CA-C-O 121.566 0.698 . . . . 74.099999999999994 110.533 -176.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.764 HD21 HG12 ' A' ' 99' ' ' ILE . 10.3 mp -54.44 -48.87 71.19 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 114.617 -1.174 . . . . 74.219999999999999 111.49 -175.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -73.42 -32.79 64.62 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.818 0.342 . . . . 74.409999999999997 110.296 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.0 tptp -60.31 -46.77 88.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.752 -0.658 . . . . 71.310000000000002 110.358 -176.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.526 HD12 HD12 ' A' ' 123' ' ' ILE . 17.4 mt -85.79 -40.69 15.77 Favored 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 112.082 0.401 . . . . 73.239999999999995 112.082 179.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.26 -37.15 69.41 Favored 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.193 0.442 . . . . 61.5 112.193 -173.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -58.47 -30.84 67.29 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.766 0.317 . . . . 70.239999999999995 111.201 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 19.2 mm-40 -90.55 -54.2 4.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.09 0.472 . . . . 65.549999999999997 110.595 179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.525 ' O ' HG22 ' A' ' 74' ' ' VAL . 19.4 m-85 -88.1 22.48 2.4 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 115.762 -0.654 . . . . 75.230000000000004 112.043 -172.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.9 t -52.63 -32.71 43.21 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 112.175 0.435 . . . . 74.329999999999998 112.175 -172.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -72.03 -22.62 61.37 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 121.225 -0.19 . . . . 53.340000000000003 111.487 -175.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -110.04 -4.14 16.04 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.636 -0.256 . . . . 72.310000000000002 110.751 -177.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 70' ' ' TYR . 23.2 m -135.46 148.1 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 CA-C-O 121.134 0.493 . . . . 55.140000000000001 111.568 -178.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 36.6 mmtm -140.81 131.43 25.54 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.706 -0.679 . . . . 63.310000000000002 109.259 171.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.488 HD13 ' HB3' ' A' ' 63' ' ' LEU . 61.5 mt -110.24 127.68 67.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 116.366 -0.379 . . . . 74.420000000000002 110.521 -175.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.642 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 57.7 m-85 -124.84 128.74 49.17 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.592 -0.521 . . . . 72.200000000000003 109.592 178.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.442 ' HG2' ' HB3' ' A' ' 47' ' ' ASP . 9.2 mtmp? -100.52 142.74 31.58 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.874 0.369 . . . . 72.219999999999999 110.636 -177.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 32.8 mm -99.69 156.02 4.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.42 -0.809 . . . . 72.5 110.789 -174.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.403 ' OD1' ' N ' ' A' ' 81' ' ' ILE . 48.7 t-20 -104.53 153.46 21.13 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.462 -0.94 . . . . 55.210000000000001 108.462 172.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.403 ' N ' ' OD1' ' A' ' 80' ' ' ASN . 36.2 pt -51.79 -22.22 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 112.111 0.411 . . . . 61.140000000000001 112.111 -176.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -62.98 -48.72 77.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.243 -0.435 . . . . 71.239999999999995 111.56 -177.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -78.31 -12.44 60.0 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 116.129 -0.487 . . . . 64.430000000000007 111.901 -171.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -40.77 132.37 2.25 Favored 'General case' 0 N--CA 1.472 0.668 0 O-C-N 123.251 0.344 . . . . 73.349999999999994 111.754 -177.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -122.49 139.42 53.9 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 109.758 -0.46 . . . . 74.209999999999994 109.758 -174.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -59.12 -12.36 4.93 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 115.671 -0.695 . . . . 61.450000000000003 112.013 -177.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.528 HG12 ' CE1' ' A' ' 91' ' ' TYR . 37.4 t -56.67 -41.42 74.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-O 121.247 0.546 . . . . 75.030000000000001 109.673 175.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.94 -44.31 97.03 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.715 -0.675 . . . . 73.530000000000001 109.95 176.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.9 m -59.33 -37.6 78.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.652 -0.704 . . . . 71.010000000000005 110.34 176.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -65.92 -36.56 83.72 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.068 -0.515 . . . . 72.230000000000004 110.064 177.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.528 ' CE1' HG12 ' A' ' 87' ' ' VAL . 23.3 m-85 -73.42 -4.2 32.14 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 116.384 -0.371 . . . . 74.030000000000001 111.123 175.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.0 9.33 82.67 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 121.276 -0.488 . . . . 71.209999999999994 112.099 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 89.2 t -75.24 83.76 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.425 0.631 . . . . 73.5 110.653 -178.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 10.0 p -117.85 12.07 13.71 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.45 -0.795 . . . . 73.310000000000002 109.727 174.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -83.34 -68.39 0.71 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 115.695 -0.684 . . . . 73.129999999999995 110.978 -178.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 69.2 mt 68.44 128.1 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.554 0 O-C-N 123.506 0.503 . . . . 72.430000000000007 110.362 -178.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.732 ' HB3' ' HA ' ' A' ' 50' ' ' ALA . 85.9 Cg_endo -79.38 156.94 90.39 Favored 'Cis proline' 0 C--N 1.353 0.794 0 C-N-CA 123.923 -1.282 . . . . 65.310000000000002 112.686 2.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 39.6 m -149.27 134.08 17.89 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.985 -0.552 . . . . 71.120000000000005 109.858 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.764 HG12 HD21 ' A' ' 63' ' ' LEU . 3.5 mp -114.99 124.96 72.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.381 -0.372 . . . . 53.43 110.265 -176.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.458 HD13 ' CE1' ' A' ' 48' ' ' PHE . 10.3 mp -103.3 141.87 35.16 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.654 -0.499 . . . . 73.120000000000005 109.654 175.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.7 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 53.4 mtp -112.6 116.13 29.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.517 -0.31 . . . . 74.109999999999999 110.724 -173.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -114.07 152.57 30.85 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.212 -0.449 . . . . 74.430000000000007 110.851 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.641 ' HB3' HD21 ' A' ' 108' ' ' LEU . 39.1 ttpt -168.38 133.09 1.67 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.304 -0.628 . . . . 63.310000000000002 109.304 176.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 56.7 29.17 15.35 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.251 0.548 . . . . 65.239999999999995 109.817 -179.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 87.79 -14.49 58.36 Favored Glycine 0 CA--C 1.52 0.358 0 CA-C-N 115.862 -0.608 . . . . 53.509999999999998 113.331 177.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -96.52 150.91 20.1 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 117.072 0.436 . . . . 51.240000000000002 110.803 -177.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 10.0 ptpt -91.96 118.2 30.54 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.07 -0.715 . . . . 45.119999999999997 109.07 171.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.641 HD21 ' HB3' ' A' ' 103' ' ' LYS . 2.2 mm? -89.8 -52.96 4.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.024 0.44 . . . . 72.549999999999997 111.057 -173.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.7 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 15.8 m -151.75 171.77 17.18 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 115.731 -0.668 . . . . 74.540000000000006 110.329 -170.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -149.89 123.44 9.12 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-O 121.286 0.565 . . . . 75.319999999999993 111.488 -176.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.44 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 40.4 t -86.26 107.08 16.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.674 -0.694 . . . . 64.25 109.618 175.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 12.8 mt -116.8 106.83 20.98 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 109.296 -0.631 . . . . 75.109999999999999 109.296 178.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 115.52 -127.25 7.51 Favored Glycine 0 N--CA 1.452 -0.245 0 N-CA-C 111.574 -0.61 . . . . 74.409999999999997 111.574 -176.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.61 57.27 0.49 Allowed 'General case' 0 C--O 1.234 0.237 0 CA-C-O 121.486 0.66 . . . . 71.329999999999998 109.651 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.452 ' O ' HG23 ' A' ' 119' ' ' ILE . 1.6 m-20 -105.58 99.54 9.14 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.384 -0.825 . . . . 62.439999999999998 110.882 -174.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.577 ' O ' HG13 ' A' ' 119' ' ' ILE . 7.0 tp -63.37 -38.87 83.32 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.171 -0.468 . . . . 73.120000000000005 111.079 -178.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 19.5 m -68.14 -26.85 65.98 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.11 0.481 . . . . 71.150000000000006 110.621 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.441 ' HB3' ' HB2' ' A' ' 115' ' ' ASP . 24.6 tptp -73.2 -52.02 15.64 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.678 -0.692 . . . . 71.040000000000006 110.041 176.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.59 HG12 ' HB3' ' A' ' 62' ' ' GLN . 2.0 pp -63.9 -40.81 90.39 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 115.68 -0.691 . . . . 71.219999999999999 111.461 -175.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.442 HD12 ' N ' ' A' ' 121' ' ' SER . 2.8 pp -63.14 -33.13 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.337 0 C-N-CA 120.434 -0.506 . . . . 75.310000000000002 110.284 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.442 ' N ' HD12 ' A' ' 120' ' ' ILE . 35.9 t -70.71 -51.57 26.59 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.029 -0.532 . . . . 62.240000000000002 110.78 179.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.458 ' OE2' ' HB3' ' A' ' 109' ' ' SER . 15.9 pt-20 -75.86 -38.43 57.96 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.082 0.401 . . . . 74.319999999999993 112.082 -172.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.554 ' O ' HG12 ' A' ' 127' ' ' ILE . 69.9 mt -65.1 -55.8 18.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 O-C-N 122.32 -0.238 . . . . 72.530000000000001 110.442 178.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -60.37 -27.32 67.31 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.281 -0.418 . . . . 72.010000000000005 110.728 -179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -65.36 -31.48 72.62 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.28 -0.418 . . . . 60.229999999999997 110.74 176.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -104.43 -4.61 22.57 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.979 -0.555 . . . . 73.109999999999999 111.975 -172.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.554 HG12 ' O ' ' A' ' 123' ' ' ILE . 48.5 pt -131.56 168.94 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 122.166 0.186 . . . . 71.040000000000006 110.59 178.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.252 1.185 0 CA-C-O 118.462 -0.78 . . . . 74.439999999999998 112.796 -176.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 ptt? . . . . . 0 N--CA 1.482 1.161 0 CA-C-O 120.73 0.3 . . . . 51.399999999999999 110.368 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -123.33 143.8 49.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.211 -0.45 . . . . 74.329999999999998 110.08 178.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -97.04 93.89 6.85 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.813 0.339 . . . . 73.010000000000005 110.315 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -85.05 94.73 8.9 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.572 -0.529 . . . . 75.420000000000002 109.572 177.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 55.3 t-80 -61.43 118.91 7.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.985 -0.552 . . . . 74.219999999999999 110.991 -177.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 44.4 p-80 -174.79 154.78 1.99 Allowed 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 109.307 -0.627 . . . . 71.200000000000003 109.307 177.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 21.4 p-80 -56.87 92.12 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 121.305 0.574 . . . . 65.209999999999994 110.405 177.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.6 p80 -67.82 110.26 3.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.022 -0.535 . . . . 71.340000000000003 110.24 -178.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 20.5 ptp -152.89 10.58 0.47 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.577 -0.738 . . . . 61.329999999999998 110.017 178.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -83.12 60.56 4.88 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.775 -0.648 . . . . 54.420000000000002 112.234 -176.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 30.8 p -69.87 96.96 1.05 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.659 -0.497 . . . . 62.43 109.659 176.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.6 tt -81.56 60.68 4.65 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.312 0.577 . . . . 75.129999999999995 109.75 -175.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -89.2 84.25 6.51 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.621 -0.881 . . . . 62.409999999999997 108.621 177.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -132.86 144.16 50.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.956 -0.565 . . . . 64.340000000000003 111.075 -176.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.7 pt20 -89.24 71.29 8.26 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 121.363 0.602 . . . . 71.200000000000003 110.65 -179.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 20.4 m -73.63 72.18 1.43 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.296 0.57 . . . . 74.340000000000003 110.649 178.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 87.0 mt-30 -123.96 95.95 4.76 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.961 -0.563 . . . . 73.129999999999995 110.146 179.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -92.01 -89.46 1.47 Allowed Glycine 0 N--CA 1.452 -0.286 0 N-CA-C 111.335 -0.706 . . . . 72.219999999999999 111.335 178.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -80.44 141.15 13.95 Favored 'Trans proline' 0 C--O 1.237 0.435 0 C-N-CA 122.763 2.309 . . . . 73.219999999999999 111.134 174.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 74.62 32.42 57.46 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.643 -0.789 . . . . 71.450000000000003 111.429 -175.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.4 p -85.84 -43.56 13.18 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.024 -0.361 . . . . 64.019999999999996 110.024 178.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . . . . . . . . . 67.1 mtt -60.53 -55.88 28.09 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.02 -0.537 . . . . 73.25 109.995 178.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 50.8 mt -113.89 122.62 68.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 109.218 -0.66 . . . . 74.400000000000006 109.218 176.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 53.3 tt0 -125.54 124.76 42.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.834 0.35 . . . . 71.409999999999997 111.056 -174.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.442 ' HG3' ' HB3' ' A' ' 78' ' ' LYS . 1.1 mp0 -81.49 125.97 31.11 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.464 -0.569 . . . . 65.140000000000001 109.464 178.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.509 HG21 ' HD3' ' A' ' 34' ' ' LYS . 33.8 pt -131.58 176.39 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.744 0.307 . . . . 64.230000000000004 110.936 -176.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -108.86 174.83 18.86 Favored Glycine 0 C--N 1.331 0.278 0 N-CA-C 111.629 -0.588 . . . . 13.31 111.629 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -67.84 -33.43 74.75 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.58 0.229 . . . . 73.329999999999998 111.34 -176.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.0 t -68.79 -34.62 75.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.769 0.319 . . . . 64.120000000000005 111.145 -174.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -101.35 -6.11 24.52 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.145 -0.479 . . . . 71.549999999999997 110.799 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.494 ' HA ' HD12 ' A' ' 26' ' ' ILE . 59.5 t80 -50.45 -70.81 0.08 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.359 -0.382 . . . . 65.209999999999994 110.248 177.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -59.67 -36.93 77.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.095 0.474 . . . . 71.430000000000007 109.969 179.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.518 ' O ' ' HB2' ' A' ' 37' ' ' SER . 24.7 t-20 -52.41 -47.73 66.13 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.118 -0.946 . . . . 63.409999999999997 111.782 -175.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.509 ' HD3' HG21 ' A' ' 26' ' ' ILE . 0.2 OUTLIER -101.93 -19.18 15.36 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.687 0.255 . . . . 53.439999999999998 111.687 -176.01 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.7 t -88.25 -59.54 2.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 N-CA-C 112.038 0.385 . . . . 61.520000000000003 112.038 -179.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 66.1 p -79.99 -28.1 39.53 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.135 0.493 . . . . 74.430000000000007 110.66 -172.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.518 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 39.8 m -94.6 12.48 27.4 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.69 -0.686 . . . . 73.219999999999999 110.958 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.556 ' SG ' HG22 ' A' ' 42' ' ' ILE . 50.9 t -53.68 92.1 0.01 OUTLIER 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.047 0.451 . . . . 60.130000000000003 112.043 -177.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -67.47 -19.28 65.32 Favored 'General case' 0 CA--C 1.53 0.173 0 CA-C-N 116.04 -0.527 . . . . 70.230000000000004 110.951 178.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -62.46 -25.27 67.9 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.356 -0.384 . . . . 63.240000000000002 111.372 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.452 ' N ' HD22 ' A' ' 41' ' ' ASN . 0.9 OUTLIER 62.49 23.67 14.06 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.972 -0.558 . . . . 71.209999999999994 110.235 -175.305 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.556 HG22 ' SG ' ' A' ' 38' ' ' CYS . 12.3 tt -82.38 157.76 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.757 -0.656 . . . . 74.519999999999996 109.291 179.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.423 ' HB3' HG12 ' A' ' 74' ' ' VAL . 48.7 tp -78.21 102.7 7.72 Favored 'General case' 0 C--O 1.231 0.115 0 N-CA-C 109.586 -0.524 . . . . 74.319999999999993 109.586 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.464 ' O ' ' HA ' ' A' ' 101' ' ' MET . 32.5 mt -90.5 126.34 43.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.889 -0.596 . . . . 75.349999999999994 111.108 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.545 HD23 HD12 ' A' ' 63' ' ' LEU . 3.5 mp -115.05 101.91 9.44 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.263 -0.644 . . . . 41.200000000000003 109.263 177.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.54 HG12 ' HB2' ' A' ' 77' ' ' TYR . 29.1 m -94.79 120.9 44.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 109.725 -0.472 . . . . 71.439999999999998 109.725 178.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -98.09 121.36 39.92 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.527 0.68 . . . . 64.5 109.385 178.002 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.598 ' HB3' ' HB2' ' A' ' 82' ' ' GLU . 90.4 m-85 -87.85 121.72 30.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.285 -0.87 . . . . 73.030000000000001 109.242 178.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.463 ' O ' ' HA ' ' A' ' 80' ' ' ASN . 54.9 t-105 -124.34 106.88 10.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.272 -0.422 . . . . 72.239999999999995 110.657 -177.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.06 120.46 81.76 Favored Pre-proline 0 CA--C 1.535 0.372 0 CA-C-N 116.597 -0.274 . . . . 53.439999999999998 110.566 174.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.453 ' O ' ' HB3' ' A' ' 52' ' ' TRP . 21.1 Cg_exo -66.7 -171.5 0.27 Allowed 'Trans proline' 0 C--N 1.35 0.613 0 C-N-CA 122.806 2.337 . . . . 74.340000000000003 111.824 175.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . 0.453 ' HB3' ' O ' ' A' ' 51' ' ' PRO . 44.9 t90 73.23 9.14 5.26 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 121.732 0.777 . . . . 74.150000000000006 110.13 -179.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 5.2 p -91.61 164.28 13.82 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-N 115.362 -0.836 . . . . 72.239999999999995 110.398 177.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.11 -141.98 5.77 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 121.44 -0.409 . . . . 63.140000000000001 113.281 -175.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -77.67 42.01 1.09 Allowed 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.285 2.656 . . . . 62.109999999999999 113.213 -175.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 10.1 p -91.24 116.62 28.96 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.975 -0.38 . . . . 70.010000000000005 109.975 177.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 63.8 mtm180 -112.59 -176.85 3.0 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.463 -0.335 . . . . 74.519999999999996 110.696 179.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.0 m -63.19 -39.75 95.53 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.013 -0.539 . . . . 52.329999999999998 111.213 -178.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.7 mt 54.95 36.08 26.0 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.111 -0.495 . . . . 73.329999999999998 111.374 176.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 57.64 78.3 0.37 Allowed Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 115.562 -0.744 . . . . 73.140000000000001 110.56 -178.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.438 ' HG2' ' HB2' ' A' ' 64' ' ' GLU . 72.6 Cg_endo -75.98 161.24 36.14 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.581 2.187 . . . . 71.140000000000001 112.674 -176.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.571 ' HB3' HG12 ' A' ' 119' ' ' ILE . 15.7 mp0 -56.16 -40.89 74.59 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-N 115.353 -0.84 . . . . 74.099999999999994 110.758 -177.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.679 HD11 HG21 ' A' ' 111' ' ' VAL . 2.3 mm? -61.93 -41.0 97.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.87 -1.059 . . . . 74.219999999999999 109.868 -176.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.438 ' HB2' ' HG2' ' A' ' 61' ' ' PRO . 8.7 tm-20 -70.53 -36.66 73.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.63 -0.714 . . . . 74.409999999999997 109.174 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -56.87 -51.53 68.68 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 115.433 -0.803 . . . . 71.310000000000002 109.909 178.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.605 HD12 HD12 ' A' ' 123' ' ' ILE . 22.3 mt -80.63 -30.61 36.69 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.073 0.397 . . . . 73.239999999999995 112.073 -178.496 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.47 -34.95 69.55 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.789 0.328 . . . . 61.5 110.892 -178.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -56.57 -30.83 63.61 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.163 -0.471 . . . . 70.239999999999995 111.372 178.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 12.9 mm-40 -93.62 -48.37 6.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.235 -0.439 . . . . 65.549999999999997 110.886 -179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.543 ' O ' HG22 ' A' ' 74' ' ' VAL . 21.9 m-85 -93.92 21.21 6.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.033 -0.531 . . . . 75.230000000000004 112.154 -174.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.1 t -53.01 -36.38 60.43 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.035 0.383 . . . . 74.329999999999998 112.035 -174.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -71.24 -16.98 62.52 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 116.505 -0.316 . . . . 53.340000000000003 111.455 -177.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -117.16 -1.37 11.87 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.404 -0.362 . . . . 72.310000000000002 111.036 -175.344 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.543 HG22 ' O ' ' A' ' 70' ' ' TYR . 26.4 m -135.16 150.65 29.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 121.008 0.432 . . . . 55.140000000000001 111.55 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -137.57 115.2 11.27 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.094 -0.706 . . . . 63.310000000000002 109.094 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.472 HG12 ' HB2' ' A' ' 45' ' ' LEU . 61.0 mt -98.21 140.63 17.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.692 0.282 . . . . 74.420000000000002 110.326 -178.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.54 ' HB2' HG12 ' A' ' 46' ' ' VAL . 95.1 m-85 -129.35 138.21 51.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.409 -0.359 . . . . 72.200000000000003 110.487 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.442 ' HB3' ' HG3' ' A' ' 25' ' ' GLN . 53.3 tptt -101.24 114.76 29.02 Favored 'General case' 0 C--O 1.238 0.47 0 CA-C-N 115.402 -0.817 . . . . 72.219999999999999 110.115 -178.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.444 ' N ' HD12 ' A' ' 79' ' ' ILE . 2.3 mp -133.62 144.54 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 CA-C-O 120.765 0.317 . . . . 72.5 110.374 178.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.463 ' HA ' ' O ' ' A' ' 49' ' ' TRP . 4.4 p-10 -107.12 30.85 5.82 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.973 0.416 . . . . 55.210000000000001 111.281 -178.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 13.8 tt -98.04 15.99 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.103 0.478 . . . . 61.140000000000001 110.958 -176.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.598 ' HB2' ' HB3' ' A' ' 48' ' ' PHE . 36.7 tt0 -52.21 -58.63 6.03 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.117 -0.492 . . . . 71.239999999999995 112.13 -174.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -75.29 11.34 1.23 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.971 -0.559 . . . . 64.430000000000007 111.987 -173.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -124.27 -2.58 8.05 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-O 121.082 0.468 . . . . 73.349999999999994 111.08 -177.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -99.76 113.95 26.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.943 0.401 . . . . 74.209999999999994 111.542 -175.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -56.9 -27.06 60.23 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.663 -0.699 . . . . 61.450000000000003 109.63 173.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 58.5 t -51.3 -42.63 27.44 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-N 114.728 -1.124 . . . . 75.030000000000001 111.31 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.406 ' O ' HG12 ' A' ' 93' ' ' VAL . . . -60.47 -49.75 76.32 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.032 -0.531 . . . . 73.530000000000001 110.777 -179.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.2 m -66.88 -33.48 75.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.802 -0.635 . . . . 71.010000000000005 110.413 178.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -66.6 -36.3 82.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.658 -0.701 . . . . 72.230000000000004 110.82 -178.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -89.29 -0.77 57.72 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.844 0.354 . . . . 74.030000000000001 110.857 176.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 73.65 41.66 42.42 Favored Glycine 0 C--N 1.331 0.293 0 CA-C-N 115.787 -0.642 . . . . 71.209999999999994 113.7 170.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.406 HG12 ' O ' ' A' ' 88' ' ' ALA . 10.0 p -98.45 152.79 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.978 0.389 . . . . 73.5 110.076 176.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 22.9 t -148.01 35.54 0.83 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.184 0.516 . . . . 73.310000000000002 109.806 179.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.405 ' H ' HG22 ' A' ' 93' ' ' VAL . . . -133.21 149.34 52.01 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.009 -0.541 . . . . 73.129999999999995 110.813 -178.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 97' ' ' PRO . 68.6 mt -118.96 128.48 25.93 Favored Pre-proline 0 C--O 1.237 0.42 0 CA-C-N 115.826 -0.625 . . . . 72.430000000000007 109.88 176.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.427 ' HA ' ' HA ' ' A' ' 96' ' ' ILE . 57.2 Cg_endo -92.98 167.03 23.0 Favored 'Cis proline' 0 C--N 1.349 0.575 0 C-N-CA 124.177 -1.176 . . . . 65.310000000000002 112.966 -1.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 62.1 m -120.48 128.63 53.32 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.017 -0.538 . . . . 71.120000000000005 110.906 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.676 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 3.4 mp -106.85 138.91 30.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.46 -0.57 . . . . 53.43 109.46 178.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.541 HD12 ' HB3' ' A' ' 110' ' ' GLN . 34.5 tp -127.56 145.93 50.7 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.797 -0.446 . . . . 73.120000000000005 109.797 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.816 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 72.7 mtp -118.26 116.21 26.31 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 120.874 0.368 . . . . 74.109999999999999 111.979 -173.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -109.41 157.78 18.59 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.736 -0.665 . . . . 74.430000000000007 111.363 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.479 ' CB ' HD21 ' A' ' 108' ' ' LEU . 39.4 ttmt -151.22 102.86 2.97 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.566 -0.901 . . . . 63.310000000000002 108.566 169.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 64.8 t30 53.73 38.76 29.18 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 121.394 0.616 . . . . 65.239999999999995 110.762 -177.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.81 -6.48 81.95 Favored Glycine 0 CA--C 1.522 0.48 0 CA-C-N 116.107 -0.497 . . . . 53.509999999999998 113.272 177.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 64.3 tttp -90.15 134.86 34.02 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 122.434 0.293 . . . . 51.240000000000002 110.248 179.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 40.2 tttm -89.42 120.95 31.19 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 110.013 -0.366 . . . . 45.119999999999997 110.013 176.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.548 ' N ' HD22 ' A' ' 108' ' ' LEU . 2.0 mm? -98.49 -53.11 3.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.244 -0.434 . . . . 72.549999999999997 110.514 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.816 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 16.7 m -156.78 172.41 18.68 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-N 115.172 -0.922 . . . . 74.540000000000006 110.007 -169.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.541 ' HB3' HD12 ' A' ' 100' ' ' LEU . 12.4 pt20 -158.4 131.57 7.39 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.88 0.371 . . . . 75.319999999999993 110.452 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.679 HG21 HD11 ' A' ' 63' ' ' LEU . 38.8 t -98.5 107.21 19.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.957 -0.565 . . . . 64.25 110.242 -176.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 68.6 mt -95.46 114.4 31.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.335 -0.393 . . . . 75.109999999999999 109.973 178.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 76.36 -109.9 2.9 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.726 -0.749 . . . . 74.409999999999997 111.966 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.61 104.22 1.97 Allowed 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.658 0.229 . . . . 71.329999999999998 111.264 -178.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.5 ' O ' HG23 ' A' ' 119' ' ' ILE . 37.3 m-20 -140.55 96.05 2.97 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 120.624 0.25 . . . . 62.439999999999998 110.43 176.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.518 HD12 HD11 ' A' ' 119' ' ' ILE . 6.6 tp -60.15 -42.48 90.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.591 0 CA-C-O 120.933 0.397 . . . . 73.120000000000005 110.503 -179.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 36.8 t -61.62 -30.18 70.53 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.715 -0.675 . . . . 71.150000000000006 110.694 -178.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -79.05 -53.73 6.72 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.183 -0.673 . . . . 71.040000000000006 109.183 179.144 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.571 HG12 ' HB3' ' A' ' 62' ' ' GLN . 2.1 pp -59.08 -40.41 80.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.692 -0.685 . . . . 71.219999999999999 111.701 -172.01 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.534 HD12 ' N ' ' A' ' 121' ' ' SER . 2.8 pp -59.2 -36.89 65.54 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 C-N-CA 119.935 -0.706 . . . . 75.310000000000002 110.142 178.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.534 ' N ' HD12 ' A' ' 120' ' ' ILE . 28.1 t -70.69 -50.62 34.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.19 -0.459 . . . . 62.240000000000002 110.865 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.562 ' HG2' ' HA ' ' A' ' 119' ' ' ILE . 16.4 pt-20 -76.36 -29.02 57.02 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 112.081 0.4 . . . . 74.319999999999993 112.081 -170.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.605 HD12 HD12 ' A' ' 66' ' ' LEU . 65.2 mt -72.08 -56.86 8.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 CA-C-O 120.903 0.382 . . . . 72.530000000000001 110.004 174.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 92.3 m-20 -61.88 -20.31 63.59 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.847 -0.615 . . . . 72.010000000000005 110.993 -178.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -66.87 -27.99 67.97 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.08 -0.509 . . . . 60.229999999999997 111.231 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -120.46 -1.12 10.2 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.497 0.554 . . . . 73.109999999999999 112.497 -171.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 31.4 pt -139.27 167.65 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 N-CA-C 110.237 -0.283 . . . . 71.040000000000006 110.237 170.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.53 HD22 ' H ' ' A' ' 128' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.327 -0.845 . . . . 74.439999999999998 110.869 -179.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 tpt . . . . . 0 N--CA 1.48 1.055 0 CA-C-O 121.01 0.433 . . . . 51.399999999999999 110.358 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.05 99.61 4.62 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.919 -0.582 . . . . 74.329999999999998 109.946 176.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 25.0 t-80 -148.75 71.7 1.16 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.318 0.58 . . . . 73.010000000000005 109.98 -178.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 18.3 p80 -69.25 151.35 46.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.254 -0.884 . . . . 75.420000000000002 110.961 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 18.4 t60 -150.14 79.17 1.35 Allowed 'General case' 0 C--O 1.235 0.327 0 N-CA-C 109.308 -0.627 . . . . 74.219999999999999 109.308 176.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 29.4 t60 -60.94 115.81 4.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.875 -0.602 . . . . 71.200000000000003 110.528 -177.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -142.14 143.19 32.88 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.491 -0.559 . . . . 65.209999999999994 109.491 -179.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 25.0 p80 -144.1 16.43 1.73 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.875 0.369 . . . . 71.340000000000003 110.775 -179.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.6 mmt -110.4 111.27 22.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.25 -0.432 . . . . 61.329999999999998 109.98 176.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.2 66.21 3.48 Favored Glycine 0 N--CA 1.453 -0.199 0 N-CA-C 111.583 -0.607 . . . . 54.420000000000002 111.583 176.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.2 m -58.67 133.47 55.93 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 122.49 0.316 . . . . 62.43 110.907 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 5.7 tt -153.34 106.12 2.93 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 109.187 -0.672 . . . . 75.129999999999995 109.187 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 18.8 tp10 -88.15 134.33 33.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.269 -0.423 . . . . 62.409999999999997 110.42 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -77.4 77.12 3.93 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.626 -0.509 . . . . 64.340000000000003 109.626 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -73.4 131.04 41.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.49 -0.777 . . . . 71.200000000000003 110.44 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 49.1 m -61.61 132.09 52.16 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.411 -0.359 . . . . 74.340000000000003 110.636 177.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.414 ' O ' ' HG3' ' A' ' 17' ' ' GLN . 25.4 pt20 -93.93 90.0 6.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.368 0.604 . . . . 73.129999999999995 109.961 178.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 179.69 80.49 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.893 -0.67 . . . . 72.219999999999999 112.377 -179.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -65.23 76.04 0.24 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.72 2.28 . . . . 73.219999999999999 110.981 177.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 168.54 -23.56 0.1 Allowed Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.291 -0.868 . . . . 71.450000000000003 111.618 -177.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 45.0 m -61.06 92.29 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 120.899 0.38 . . . . 64.019999999999996 110.338 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.757 ' HG2' HG13 ' A' ' 23' ' ' ILE . 1.6 pmm? -74.45 -25.6 59.51 Favored 'General case' 0 C--N 1.332 -0.153 0 N-CA-C 109.786 -0.45 . . . . 73.25 109.786 176.279 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.757 HG13 ' HG2' ' A' ' 22' ' ' MET . 47.1 mt -129.04 118.15 45.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 115.729 -0.669 . . . . 74.400000000000006 109.408 177.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 13.7 tp10 -131.83 155.11 48.37 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.275 -0.269 . . . . 71.409999999999997 110.275 -176.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.443 ' HG3' ' HE3' ' A' ' 78' ' ' LYS . 0.7 OUTLIER -92.2 147.67 22.75 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 110.399 -0.223 . . . . 65.140000000000001 110.399 -178.759 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 42.7 pt -135.02 -176.76 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 120.638 0.256 . . . . 64.230000000000004 110.401 176.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -118.41 167.17 12.94 Favored Glycine 0 C--N 1.331 0.281 0 N-CA-C 111.847 -0.501 . . . . 13.31 111.847 177.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.4 p-10 -67.41 -40.79 85.61 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.864 0.32 . . . . 73.329999999999998 111.864 -174.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 83.4 p -80.16 -28.77 38.77 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.919 0.39 . . . . 64.120000000000005 111.43 -176.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.426 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 2.3 pm0 -91.48 -6.79 52.07 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 116.379 -0.373 . . . . 71.549999999999997 110.484 178.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.442 ' HE1' HG21 ' A' ' 46' ' ' VAL . 37.9 t80 -49.13 -70.8 0.08 Allowed 'General case' 0 C--O 1.227 -0.12 0 CA-C-N 115.871 -0.604 . . . . 65.209999999999994 110.174 175.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -58.22 -38.49 76.9 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 109.65 -0.5 . . . . 71.430000000000007 109.65 179.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -51.7 -46.43 63.91 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-N 115.035 -0.984 . . . . 63.409999999999997 111.321 -172.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -108.04 -21.16 12.92 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 112.107 0.41 . . . . 53.439999999999998 112.107 -176.643 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 89.7 t -88.17 -50.57 13.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 N-CA-C 111.722 0.268 . . . . 61.520000000000003 111.722 -177.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 66.4 p -80.18 -25.61 39.64 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 120.244 -0.582 . . . . 74.430000000000007 109.834 -176.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.6 m -88.3 11.99 15.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.452 -0.795 . . . . 73.219999999999999 110.867 177.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.564 ' O ' ' HA ' ' A' ' 104' ' ' ASN . 44.2 t -59.3 104.49 0.26 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.66 0.267 . . . . 60.130000000000003 110.916 -178.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.405 ' N ' HD22 ' A' ' 39' ' ' ASN . 0.9 OUTLIER -81.55 -17.65 47.69 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.879 0.371 . . . . 70.230000000000004 110.293 176.372 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -65.92 -20.74 66.32 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.842 -0.617 . . . . 63.240000000000002 111.349 -177.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 64.44 11.48 6.57 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.058 0.543 . . . . 71.209999999999994 111.86 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 9.4 tt -73.35 163.29 4.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 109.442 -0.577 . . . . 74.519999999999996 109.442 179.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.661 HD21 ' HE3' ' A' ' 101' ' ' MET . 62.6 tp -87.65 110.61 20.53 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.109 0.48 . . . . 74.319999999999993 110.202 179.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.3 mt -96.0 119.66 44.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.747 -0.661 . . . . 75.349999999999994 110.204 178.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.688 HD13 HD12 ' A' ' 63' ' ' LEU . 71.5 mt -98.87 109.61 22.34 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.696 -0.853 . . . . 41.200000000000003 108.696 177.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.442 HG21 ' HE1' ' A' ' 31' ' ' PHE . 47.1 t -103.04 109.33 26.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.874 -0.148 . . . . 71.439999999999998 111.119 -176.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.447 ' HB3' ' HD1' ' A' ' 49' ' ' TRP . 1.2 m-20 -81.21 134.28 35.59 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 109.586 -0.524 . . . . 64.5 109.586 173.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.41 ' HA ' ' HB3' ' A' ' 80' ' ' ASN . 10.7 p90 -61.33 -28.68 69.38 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.517 0.675 . . . . 73.030000000000001 110.169 178.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.606 ' H ' ' HD1' ' A' ' 49' ' ' TRP . 0.2 OUTLIER -110.41 -164.0 0.89 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.127 -0.942 . . . . 72.239999999999995 109.858 -177.604 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.441 ' HA ' ' HB3' ' A' ' 78' ' ' LYS . . . -131.81 87.73 44.25 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.848 -0.16 . . . . 53.439999999999998 111.262 178.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -60.97 112.62 1.42 Allowed 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.252 1.968 . . . . 74.340000000000003 110.677 170.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -95.94 -76.01 0.51 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.853 -0.158 . . . . 74.150000000000006 111.212 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 52.8 t -172.14 160.22 5.13 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.076 -0.342 . . . . 72.239999999999995 110.076 -178.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -101.2 154.89 19.11 Favored Glycine 0 N--CA 1.451 -0.351 0 N-CA-C 111.521 -0.632 . . . . 63.140000000000001 111.521 176.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.89 -29.35 89.25 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.711 2.274 . . . . 62.109999999999999 111.667 176.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 49.0 t -123.06 158.41 30.66 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.936 -0.575 . . . . 70.010000000000005 109.726 176.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 51.3 ttt180 -74.93 88.59 2.34 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 109.764 -0.458 . . . . 74.519999999999996 109.764 179.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.4 p -84.22 -171.81 3.82 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.873 -0.603 . . . . 52.329999999999998 110.964 179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.437 ' N ' HD22 ' A' ' 59' ' ' LEU . 3.0 mm? -73.5 131.41 41.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 73.329999999999998 109.877 177.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -68.19 134.26 91.46 Favored Pre-proline 0 C--O 1.237 0.438 0 N-CA-C 109.593 -0.521 . . . . 73.140000000000001 109.593 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -69.01 172.43 11.92 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.469 2.113 . . . . 71.140000000000001 112.138 -179.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.478 ' HB3' HG12 ' A' ' 119' ' ' ILE . 14.1 mp0 -47.06 -56.09 7.13 Favored 'General case' 0 C--O 1.249 1.067 0 CA-C-O 121.927 0.87 . . . . 74.099999999999994 110.953 -178.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.688 HD12 HD13 ' A' ' 45' ' ' LEU . 3.2 mm? -57.48 -48.14 80.0 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 114.215 -1.357 . . . . 74.219999999999999 110.758 -172.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.462 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 35.7 mt-10 -69.77 -38.92 76.9 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.601 -0.272 . . . . 74.409999999999997 110.853 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 26.7 mmtm -50.75 -50.18 56.24 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.852 0.358 . . . . 71.310000000000002 110.408 177.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.617 HD12 HD12 ' A' ' 123' ' ' ILE . 32.4 mt -77.73 -37.34 49.53 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 120.542 -0.463 . . . . 73.239999999999995 111.695 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.87 -31.32 72.33 Favored 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 111.729 0.27 . . . . 61.5 111.729 -175.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.462 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 75.4 mt-30 -54.44 -37.55 65.3 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.861 0.362 . . . . 70.239999999999995 110.882 178.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.6 mm-40 -93.57 -46.22 7.39 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.924 -0.58 . . . . 65.549999999999997 110.803 -177.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.528 ' O ' HG22 ' A' ' 74' ' ' VAL . 17.6 m-85 -93.32 22.32 5.31 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.761 -0.654 . . . . 75.230000000000004 112.366 -173.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.4 t -52.17 -38.55 58.05 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.206 0.447 . . . . 74.329999999999998 112.206 -173.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -71.06 -22.53 62.11 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 122.183 -0.323 . . . . 53.340000000000003 111.832 -177.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -102.34 -8.63 21.03 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.579 0.228 . . . . 72.310000000000002 110.773 -175.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 70' ' ' TYR . 35.2 m -133.11 151.16 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 O-C-N 121.944 -0.472 . . . . 55.140000000000001 111.412 -178.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.463 ' HD3' ' HA ' ' A' ' 75' ' ' LYS . 35.9 mmtm -139.09 115.34 10.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.773 -0.649 . . . . 63.310000000000002 109.563 174.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.55 ' HB ' HG12 ' A' ' 23' ' ' ILE . 56.4 mt -90.12 109.96 21.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.857 -0.61 . . . . 74.420000000000002 110.386 -178.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.463 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 7.7 m-85 -97.79 134.03 41.5 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.799 -0.445 . . . . 72.200000000000003 109.799 176.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.469 ' O ' ' HB ' ' A' ' 79' ' ' ILE . 57.1 mtmt -107.28 155.6 19.78 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.845 -0.616 . . . . 72.219999999999999 110.677 -176.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.469 ' HB ' ' O ' ' A' ' 78' ' ' LYS . 41.4 mm 85.85 95.22 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 O-C-N 124.47 1.106 . . . . 72.5 111.665 178.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.41 ' HB3' ' HA ' ' A' ' 48' ' ' PHE . 25.9 t-20 -153.34 87.05 1.24 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.589 -1.187 . . . . 55.210000000000001 108.186 173.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 40.8 mm -61.46 92.29 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.85 -0.614 . . . . 61.140000000000001 112.155 -170.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.643 ' HG2' ' HB1' ' A' ' 88' ' ' ALA . 3.5 tm-20 -53.89 -31.47 50.03 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.338 -0.846 . . . . 71.239999999999995 109.966 175.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -74.82 -7.59 53.88 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.179 -0.919 . . . . 64.430000000000007 111.813 -175.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -132.28 6.61 4.18 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 122.285 -0.259 . . . . 73.349999999999994 111.554 -176.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -112.68 115.77 29.09 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 120.939 0.399 . . . . 74.209999999999994 110.783 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -60.67 -29.24 69.17 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.801 -0.636 . . . . 61.450000000000003 111.054 -177.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 62.6 t -56.96 -44.23 82.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 CA-C-O 121.226 0.536 . . . . 75.030000000000001 110.305 178.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.643 ' HB1' ' HG2' ' A' ' 82' ' ' GLU . . . -68.17 -36.29 79.38 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 115.702 -0.681 . . . . 73.530000000000001 110.533 -179.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 21.5 m -64.02 -40.67 96.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.364 -0.835 . . . . 71.010000000000005 110.297 176.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 54.7 tp60 -63.93 -43.65 95.26 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 115.841 -0.618 . . . . 72.230000000000004 110.207 178.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -70.68 -17.25 62.85 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-N 116.311 -0.404 . . . . 74.030000000000001 110.82 175.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 58.87 42.16 96.51 Favored Glycine 0 C--N 1.335 0.503 0 N-CA-C 110.819 -0.912 . . . . 71.209999999999994 110.819 -175.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 9.6 p -93.65 17.6 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-O 120.973 0.416 . . . . 73.5 111.43 -171.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 50.6 m -66.81 81.27 0.11 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.264 0.554 . . . . 73.310000000000002 110.873 178.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -157.3 91.1 1.15 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.513 -0.921 . . . . 73.129999999999995 108.513 176.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 2.7 pp -83.52 149.32 57.37 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 115.426 -0.807 . . . . 72.430000000000007 111.52 -171.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.438 ' HD2' ' O ' ' A' ' 113' ' ' GLY . 15.5 Cg_exo -69.94 161.08 87.44 Favored 'Cis proline' 0 C--N 1.357 0.995 0 C-N-CA 124.268 -1.138 . . . . 65.310000000000002 112.657 -3.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 23.6 m -141.1 118.36 11.36 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.07 -0.514 . . . . 71.120000000000005 110.97 -175.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.687 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 3.2 mp -120.93 133.71 66.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 115.884 -0.598 . . . . 53.43 109.977 178.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 9.7 mp -109.95 139.61 44.86 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 110.182 -0.303 . . . . 73.120000000000005 110.182 176.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.673 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 71.7 mtp -104.65 116.2 31.65 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.305 -0.407 . . . . 74.109999999999999 110.492 -179.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -114.96 142.16 47.0 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 121.165 0.507 . . . . 74.430000000000007 111.536 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.622 ' CB ' HD21 ' A' ' 108' ' ' LEU . 23.2 ttmm -143.09 107.08 4.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.17 -0.923 . . . . 63.310000000000002 109.036 174.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.564 ' HA ' ' O ' ' A' ' 38' ' ' CYS . 3.8 t-20 59.74 28.45 17.91 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.471 0.653 . . . . 65.239999999999995 110.461 179.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.25 -14.41 63.77 Favored Glycine 0 C--N 1.332 0.356 0 CA-C-N 115.819 -0.628 . . . . 53.509999999999998 113.181 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.505 ' HD2' HD13 ' A' ' 108' ' ' LEU . 0.9 OUTLIER -87.7 116.97 26.21 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.703 -0.851 . . . . 51.240000000000002 108.703 176.425 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.443 ' HA ' ' O ' ' A' ' 101' ' ' MET . 25.5 pttm -77.84 119.34 21.19 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 109.69 -0.485 . . . . 45.119999999999997 109.69 177.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.622 HD21 ' CB ' ' A' ' 103' ' ' LYS . 1.8 mm? -78.06 -52.06 9.35 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.335 0.588 . . . . 72.549999999999997 109.951 -175.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.673 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 72.1 m -160.69 172.47 17.04 Favored 'General case' 0 C--O 1.241 0.652 0 CA-C-N 114.944 -1.025 . . . . 74.540000000000006 110.11 -170.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.02 126.56 17.84 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.124 -0.489 . . . . 75.319999999999993 111.044 -174.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.687 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 44.2 t -85.88 106.97 15.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.316 -0.624 . . . . 64.25 109.316 174.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 32.7 mt -113.66 109.89 30.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.509 -0.552 . . . . 75.109999999999999 109.509 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.438 ' O ' ' HD2' ' A' ' 97' ' ' PRO . . . 100.74 -121.27 7.18 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 121.147 -0.549 . . . . 74.409999999999997 111.867 -177.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.21 57.37 0.51 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.349 0.595 . . . . 71.329999999999998 110.276 -177.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.528 ' O ' HG23 ' A' ' 119' ' ' ILE . 2.5 m-20 -103.51 95.54 6.14 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.719 -0.673 . . . . 62.439999999999998 110.86 -173.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.582 ' O ' HG13 ' A' ' 119' ' ' ILE . 6.0 tp -63.24 -43.99 99.01 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 116.126 -0.488 . . . . 73.120000000000005 112.074 -175.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 33.8 t -65.69 -28.2 68.9 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.13 0.49 . . . . 71.150000000000006 110.139 -178.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -75.67 -46.74 29.63 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 115.884 -0.598 . . . . 71.040000000000006 109.529 179.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.634 ' HA ' ' HG2' ' A' ' 122' ' ' GLU . 2.2 pp -66.67 -39.42 83.73 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.095 0 CA-C-N 116.325 -0.398 . . . . 71.219999999999999 111.713 -175.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.455 HD12 ' N ' ' A' ' 121' ' ' SER . 2.8 pp -62.5 -31.75 52.94 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 C-N-CA 120.385 -0.526 . . . . 75.310000000000002 109.768 179.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.455 ' N ' HD12 ' A' ' 120' ' ' ILE . 35.0 t -70.62 -51.37 28.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.877 -0.601 . . . . 62.240000000000002 110.657 176.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.634 ' HG2' ' HA ' ' A' ' 119' ' ' ILE . 16.7 pt-20 -71.28 -40.82 70.68 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 112.025 0.38 . . . . 74.319999999999993 112.025 -172.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.617 HD12 HD12 ' A' ' 66' ' ' LEU . 82.1 mt -70.71 -59.67 3.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 116.607 -0.27 . . . . 72.530000000000001 111.101 -177.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -58.02 -26.26 62.2 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.148 0.499 . . . . 72.010000000000005 111.022 -176.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -63.58 -28.94 70.27 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.859 -0.61 . . . . 60.229999999999997 111.223 178.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 60.1 m-80 -115.0 9.92 16.13 Favored 'General case' 0 N--CA 1.465 0.289 0 N-CA-C 112.244 0.461 . . . . 73.109999999999999 112.244 -174.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.473 HG12 ' O ' ' A' ' 123' ' ' ILE . 42.7 pt -139.08 168.92 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 N-CA-C 110.212 -0.292 . . . . 71.040000000000006 110.212 175.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.252 1.214 0 CA-C-O 118.444 -0.788 . . . . 74.439999999999998 111.983 -176.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.519 ' HG3' ' H ' ' A' ' 3' ' ' HIS . 29.7 tpp . . . . . 0 N--CA 1.48 1.07 0 CA-C-O 120.691 0.282 . . . . 51.399999999999999 110.428 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -93.21 -3.8 53.14 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 112.428 0.529 . . . . 74.329999999999998 112.428 -173.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.519 ' H ' ' HG3' ' A' ' 1' ' ' MET . 14.2 m-70 -72.73 77.6 1.11 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.922 0.392 . . . . 73.010000000000005 110.56 179.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.4 ' H ' ' CD2' ' A' ' 4' ' ' HIS . 3.8 p80 -91.1 135.86 33.48 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.027 -0.533 . . . . 75.420000000000002 110.211 178.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.2 m170 -84.85 22.57 1.34 Allowed 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.157 -0.474 . . . . 74.219999999999999 112.076 -172.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -128.9 100.31 5.63 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 109.874 -0.417 . . . . 71.200000000000003 109.874 176.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 10.2 p80 -126.83 164.44 21.38 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 109.9 -0.407 . . . . 65.209999999999994 109.9 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -111.6 174.05 6.06 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.647 -0.251 . . . . 71.340000000000003 110.394 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.466 ' HA ' ' HG2' ' A' ' 51' ' ' PRO . 68.9 mtm -137.82 84.87 2.07 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.844 0.355 . . . . 61.329999999999998 110.53 179.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 59.02 52.58 52.53 Favored Glycine 0 C--N 1.333 0.394 0 CA-C-N 115.902 -0.59 . . . . 54.420000000000002 112.943 178.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 21.3 p -79.7 -62.21 1.76 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 120.844 0.354 . . . . 62.43 111.673 -178.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -77.91 -72.62 0.35 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.217 -0.447 . . . . 75.129999999999995 110.349 -176.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -147.16 148.4 31.5 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.158 -0.473 . . . . 62.409999999999997 110.589 -177.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -152.72 101.11 2.59 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.048 -0.524 . . . . 64.340000000000003 109.803 176.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -161.11 150.4 16.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.301 -0.408 . . . . 71.200000000000003 110.333 -177.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.0 t -122.33 116.55 24.26 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.589 -0.522 . . . . 74.340000000000003 109.589 174.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -101.5 89.06 3.6 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 109.726 -0.472 . . . . 73.129999999999995 109.726 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 152.01 89.65 0.07 OUTLIER Glycine 0 CA--C 1.519 0.332 0 CA-C-N 115.813 -0.63 . . . . 72.219999999999999 111.63 -178.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.8 93.04 0.21 Allowed 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.618 2.212 . . . . 73.219999999999999 111.823 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 151.05 50.77 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.22 0 N-CA-C 111.273 -0.731 . . . . 71.450000000000003 111.273 -178.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.1 m -88.76 150.33 23.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.63 0.252 . . . . 64.019999999999996 110.819 -176.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.559 ' N ' ' SD ' ' A' ' 22' ' ' MET . 0.0 OUTLIER -65.19 -19.37 65.94 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.031 0.443 . . . . 73.25 109.885 175.254 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.427 HG12 ' HB ' ' A' ' 76' ' ' ILE . 46.0 mt -103.32 84.55 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 115.365 -0.834 . . . . 74.400000000000006 108.966 172.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.494 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 10.0 tp10 -86.74 155.44 20.35 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.14 -0.482 . . . . 71.409999999999997 110.549 -175.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 -97.34 143.79 27.75 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.742 0.306 . . . . 65.140000000000001 110.294 178.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.512 HD12 ' HA ' ' A' ' 31' ' ' PHE . 29.9 pt -133.65 163.67 36.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-N 116.324 -0.398 . . . . 64.230000000000004 110.639 -179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -98.12 155.6 20.34 Favored Glycine 0 N--CA 1.451 -0.311 0 CA-C-N 115.899 -0.591 . . . . 13.31 111.654 176.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -60.3 -30.35 69.42 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.896 0.379 . . . . 73.329999999999998 110.902 -178.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.7 p -61.84 -30.98 71.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.879 -0.601 . . . . 64.120000000000005 111.337 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -114.24 4.14 15.38 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.216 -0.447 . . . . 71.549999999999997 111.954 -175.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.512 ' HA ' HD12 ' A' ' 26' ' ' ILE . 81.3 t80 -52.85 -71.63 0.07 Allowed 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.733 0.301 . . . . 65.209999999999994 110.703 -177.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.553 ' O ' HG22 ' A' ' 36' ' ' THR . 7.3 p-10 -65.27 -34.06 77.46 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.617 -0.512 . . . . 71.430000000000007 109.617 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -52.28 -44.72 65.14 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 114.7 -1.136 . . . . 63.409999999999997 111.55 -176.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 16.7 ptmt -100.9 -25.79 13.97 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.568 -0.287 . . . . 53.439999999999998 111.139 -177.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 54.3 t -78.49 -61.45 1.71 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 N-CA-C 112.12 0.415 . . . . 61.520000000000003 112.12 -176.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.553 HG22 ' O ' ' A' ' 32' ' ' ASP . 11.9 t -84.32 0.35 49.47 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.005 0.431 . . . . 74.430000000000007 110.889 -170.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.6 m -98.82 -4.74 32.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.339 -0.392 . . . . 73.219999999999999 111.044 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.549 ' SG ' HG22 ' A' ' 42' ' ' ILE . 47.8 t -71.97 100.06 2.38 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.024 0.44 . . . . 60.130000000000003 111.034 -175.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -93.18 2.32 56.72 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.391 0.615 . . . . 70.230000000000004 109.548 176.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -63.09 -14.56 49.92 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 115.479 -0.782 . . . . 63.240000000000002 111.168 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.581 ' O ' ' HE3' ' A' ' 103' ' ' LYS . 32.8 m-80 69.21 19.63 7.81 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 115.749 -0.659 . . . . 71.209999999999994 110.946 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.549 HG22 ' SG ' ' A' ' 38' ' ' CYS . 10.9 tt -88.97 146.63 5.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 108.495 -0.928 . . . . 74.519999999999996 108.495 172.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.667 HD11 ' HB3' ' A' ' 101' ' ' MET . 68.7 tp -85.6 113.6 21.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.251 0.548 . . . . 74.319999999999993 110.648 -176.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 57.4 mt -94.64 123.62 46.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.199 -0.909 . . . . 75.349999999999994 110.331 177.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.529 ' HB2' HG12 ' A' ' 76' ' ' ILE . 2.2 mm? -104.74 104.36 14.15 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.334 -0.617 . . . . 41.200000000000003 109.334 178.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 35.9 m -99.1 130.29 48.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 110.357 -0.238 . . . . 71.439999999999998 110.357 -179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.499 ' HB2' HG13 ' A' ' 99' ' ' ILE . 27.0 t70 -122.62 141.29 51.88 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 120.923 0.392 . . . . 64.5 111.434 -177.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -79.85 100.4 7.99 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.699 -0.852 . . . . 73.030000000000001 108.699 172.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 72.5 t90 -40.09 104.96 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 O-C-N 124.248 0.967 . . . . 72.239999999999995 112.454 -171.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -157.3 148.05 16.29 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 115.725 -0.671 . . . . 53.439999999999998 110.29 177.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.466 ' HG2' ' HA ' ' A' ' 9' ' ' MET . 45.9 Cg_exo -57.72 109.13 0.44 Allowed 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.788 2.326 . . . . 74.340000000000003 112.549 179.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 13.0 p90 -70.06 83.77 0.51 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.795 -0.639 . . . . 74.150000000000006 112.028 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 84.7 m 72.56 -62.22 0.47 Allowed 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.518 0.727 . . . . 72.239999999999995 112.698 173.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -73.3 -147.54 0.95 Allowed Glycine 0 CA--C 1.521 0.446 0 C-N-CA 121.482 -0.39 . . . . 63.140000000000001 113.031 -176.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.464 ' O ' ' HB2' ' A' ' 56' ' ' CYS . 29.7 Cg_endo -64.2 -69.73 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.342 2.028 . . . . 62.109999999999999 111.68 178.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 55' ' ' PRO . 49.2 t 172.51 26.83 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 O-C-N 123.492 0.495 . . . . 70.010000000000005 109.913 178.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.466 ' HG2' ' N ' ' A' ' 58' ' ' SER . 47.4 ttp180 -130.5 163.46 26.96 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.461 -0.336 . . . . 74.519999999999996 110.129 -175.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.466 ' N ' ' HG2' ' A' ' 57' ' ' ARG . 32.5 t -54.42 120.9 7.25 Favored 'General case' 0 C--O 1.239 0.519 0 O-C-N 123.386 0.429 . . . . 52.329999999999998 110.29 176.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.454 ' H ' ' HD3' ' A' ' 61' ' ' PRO . 35.9 tp -134.0 34.79 3.33 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.423 0.63 . . . . 73.329999999999998 109.354 -176.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 49.2 mm-40 55.29 55.0 10.22 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 115.321 -0.854 . . . . 73.140000000000001 111.014 -174.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.454 ' HD3' ' H ' ' A' ' 59' ' ' LEU . 86.4 Cg_endo -81.37 165.3 18.76 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.262 1.975 . . . . 71.140000000000001 111.4 178.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.675 ' NE2' ' HA ' ' A' ' 114' ' ' ALA . 0.4 OUTLIER -45.15 -57.56 3.83 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.179 0.592 . . . . 74.099999999999994 111.931 -173.636 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.437 HD22 ' HB2' ' A' ' 62' ' ' GLN . 3.5 mm? -60.71 -48.6 81.07 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.392 -0.822 . . . . 74.219999999999999 111.25 -172.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.502 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 39.7 mt-10 -66.0 -37.66 86.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.965 0.412 . . . . 74.409999999999997 110.221 178.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.427 ' HD2' ' HA ' ' A' ' 65' ' ' LYS . 42.2 tptt -60.71 -45.07 95.63 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.501 -0.772 . . . . 71.310000000000002 110.405 -174.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.712 HD12 HD12 ' A' ' 123' ' ' ILE . 23.9 mt -79.95 -30.31 39.83 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.515 -0.312 . . . . 73.239999999999995 110.988 176.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.68 -33.62 74.31 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.699 0.285 . . . . 61.5 110.847 179.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.502 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 78.4 mt-30 -56.07 -31.79 63.53 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.048 0.452 . . . . 70.239999999999995 110.547 177.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -93.9 -53.78 3.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.74 -0.663 . . . . 65.549999999999997 111.041 -178.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.512 ' O ' HG22 ' A' ' 74' ' ' VAL . 14.4 m-85 -95.73 23.11 6.48 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 115.604 -0.725 . . . . 75.230000000000004 112.822 -168.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.7 t -52.78 -28.64 23.34 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.77 0.319 . . . . 74.329999999999998 111.69 -176.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -71.03 -18.71 62.57 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-N 116.603 -0.272 . . . . 53.340000000000003 111.642 -177.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -120.65 1.07 10.54 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.654 0.264 . . . . 72.310000000000002 110.554 -176.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.512 HG22 ' O ' ' A' ' 70' ' ' TYR . 27.9 m -133.57 145.79 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 O-C-N 122.019 -0.426 . . . . 55.140000000000001 111.312 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 75' ' ' LYS . 41.7 mmtm -141.09 124.43 16.6 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.143 -0.688 . . . . 63.310000000000002 109.143 172.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.529 HG12 ' HB2' ' A' ' 45' ' ' LEU . 49.5 mt -103.26 135.14 42.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 110.084 -0.339 . . . . 74.420000000000002 110.084 -175.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.494 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 74.1 m-85 -126.29 128.68 47.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.884 0.374 . . . . 72.200000000000003 110.242 178.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -97.54 139.29 33.67 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.719 -0.845 . . . . 72.219999999999999 108.719 176.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 20.6 tt -136.7 141.72 40.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.862 -0.422 . . . . 72.5 109.862 176.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -62.55 167.88 4.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.942 -0.572 . . . . 55.210000000000001 111.512 -173.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 29.7 pt -55.98 -12.67 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 115.66 -0.7 . . . . 61.140000000000001 111.831 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -49.12 -40.37 32.09 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.821 -0.627 . . . . 71.239999999999995 111.132 173.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.626 ' O ' ' HG3' ' A' ' 85' ' ' GLN . 24.8 t70 -77.03 12.48 1.38 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.034 -0.53 . . . . 64.430000000000007 112.115 -172.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -55.86 103.62 0.11 Allowed 'General case' 0 C--N 1.327 -0.38 0 O-C-N 121.793 -0.567 . . . . 73.349999999999994 109.695 172.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.626 ' HG3' ' O ' ' A' ' 83' ' ' ASP . 24.3 mt-30 -109.49 174.21 5.97 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 109.001 -0.74 . . . . 74.209999999999994 109.001 -178.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -71.61 -31.64 67.13 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.993 -1.003 . . . . 61.450000000000003 109.564 174.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.0 t -55.63 -34.98 37.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 CA-C-N 115.057 -0.974 . . . . 75.030000000000001 111.024 179.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -60.12 -52.48 65.15 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 121.21 0.528 . . . . 73.530000000000001 110.398 178.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 29.7 m -67.44 -28.32 67.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.748 -0.66 . . . . 71.010000000000005 110.389 178.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -63.41 -42.69 98.76 Favored 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.875 -0.602 . . . . 72.230000000000004 110.19 178.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -74.89 -17.19 60.62 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.274 -0.421 . . . . 74.030000000000001 110.725 176.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 86.9 36.73 8.93 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 121.226 -0.512 . . . . 71.209999999999994 112.395 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 99.3 t -70.34 92.52 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-O 121.126 0.488 . . . . 73.5 110.028 176.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 23.7 m -70.53 -33.39 71.12 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.56 -0.745 . . . . 73.310000000000002 111.367 -178.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -148.11 145.8 28.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.881 0.372 . . . . 73.129999999999995 111.187 -176.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.542 ' HB ' ' HA ' ' A' ' 97' ' ' PRO . 17.3 pt -101.43 161.68 22.83 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-N 115.46 -0.791 . . . . 72.430000000000007 109.626 177.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.542 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 93.9 Cg_endo -74.49 169.97 72.62 Favored 'Cis proline' 0 C--N 1.357 0.999 0 C-N-CA 124.585 -1.006 . . . . 65.310000000000002 113.243 3.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 96.7 m -155.29 122.03 5.37 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.483 -0.781 . . . . 71.120000000000005 109.699 -175.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.51 ' N ' HD12 ' A' ' 99' ' ' ILE . 3.5 mp -106.7 108.95 26.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.123 -0.489 . . . . 53.43 110.277 -174.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.426 HD23 ' H ' ' A' ' 101' ' ' MET . 1.0 OUTLIER -92.9 136.49 33.21 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 108.88 -0.785 . . . . 73.120000000000005 108.88 177.755 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.901 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 69.0 mtp -101.34 117.52 35.13 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.244 -0.434 . . . . 74.109999999999999 110.943 -174.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -117.55 146.9 43.27 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 122.657 0.383 . . . . 74.430000000000007 110.524 178.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.812 ' HB3' HD21 ' A' ' 108' ' ' LEU . 84.1 tttt -166.68 135.37 2.84 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.973 -0.751 . . . . 63.310000000000002 108.973 -179.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 12.1 t30 60.24 24.91 14.3 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.575 0.702 . . . . 65.239999999999995 110.508 177.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 78.93 17.61 76.73 Favored Glycine 0 CA--C 1.517 0.16 0 CA-C-N 115.789 -0.641 . . . . 53.509999999999998 113.392 178.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -136.44 157.53 46.56 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 117.059 0.429 . . . . 51.240000000000002 110.265 178.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.703 ' H ' ' HD2' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -83.36 142.47 31.01 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.363 -0.38 . . . . 45.119999999999997 110.085 176.62 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.812 HD21 ' HB3' ' A' ' 103' ' ' LYS . 2.9 mm? -111.47 -53.03 2.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.308 -0.406 . . . . 72.549999999999997 110.928 -178.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.901 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 14.2 m -158.26 172.17 18.87 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 115.949 -0.569 . . . . 74.540000000000006 110.124 -171.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -142.82 140.32 31.26 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.157 0.503 . . . . 75.319999999999993 111.76 -175.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.599 HG22 HG22 ' A' ' 119' ' ' ILE . 32.8 t -115.81 134.44 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.19 0 CA-C-N 115.613 -0.721 . . . . 64.25 109.677 178.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 43.2 mt -126.15 106.89 16.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.899 0.381 . . . . 75.109999999999999 109.987 178.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 71.96 -85.86 0.47 Allowed Glycine 0 CA--C 1.521 0.425 0 CA-C-N 116.109 -0.496 . . . . 74.409999999999997 112.98 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.675 ' HA ' ' NE2' ' A' ' 62' ' ' GLN . . . -151.49 103.08 2.94 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 122.723 -0.28 . . . . 71.329999999999998 111.292 -174.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.45 ' O ' HG23 ' A' ' 119' ' ' ILE . 20.3 m-20 -132.49 63.28 1.63 Allowed 'General case' 0 C--O 1.224 -0.257 0 N-CA-C 109.596 -0.52 . . . . 62.439999999999998 109.596 178.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.55 ' O ' HG13 ' A' ' 119' ' ' ILE . 6.8 tp -53.49 -51.57 40.76 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.726 0 N-CA-C 112.359 0.503 . . . . 73.120000000000005 112.359 -172.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 8.3 p -63.87 -28.1 69.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.33 0.586 . . . . 71.150000000000006 111.193 -178.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.429 ' HE2' ' HB2' ' A' ' 115' ' ' ASP . 3.0 tmmm? -79.47 -45.34 19.58 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 115.628 -0.715 . . . . 71.040000000000006 109.865 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.599 HG22 HG22 ' A' ' 111' ' ' VAL . 2.5 pp -69.26 -37.37 75.87 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 CA-C-N 115.778 -0.647 . . . . 71.219999999999999 111.204 -174.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.474 HD12 ' N ' ' A' ' 121' ' ' SER . 2.9 pp -63.28 -31.92 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.143 0 C-N-CA 120.08 -0.648 . . . . 75.310000000000002 110.036 177.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.474 ' N ' HD12 ' A' ' 120' ' ' ILE . 45.0 t -70.52 -51.51 28.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.98 -0.555 . . . . 62.240000000000002 110.916 178.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.561 ' HG2' ' HA ' ' A' ' 119' ' ' ILE . 24.2 pt-20 -72.1 -48.93 40.28 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.151 0.426 . . . . 74.319999999999993 112.151 -174.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.712 HD12 HD12 ' A' ' 66' ' ' LEU . 83.4 mt -59.38 -55.81 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.597 0.237 . . . . 72.530000000000001 110.852 -177.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -58.77 -20.31 48.58 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.991 0.425 . . . . 72.010000000000005 111.044 -178.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -84.12 -35.55 23.58 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.032 -0.531 . . . . 60.229999999999997 111.06 177.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -91.69 -9.34 44.22 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-N 116.192 -0.458 . . . . 73.109999999999999 111.929 -172.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.479 HG12 ' O ' ' A' ' 123' ' ' ILE . 45.4 pt -133.94 168.19 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 120.689 0.28 . . . . 71.040000000000006 110.691 175.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.245 0.857 0 CA-C-O 118.802 -0.618 . . . . 74.439999999999998 110.624 -175.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.568 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.13 0 CA-C-O 121.102 0.477 . . . . 51.399999999999999 110.615 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -175.44 159.2 2.4 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.03 -0.532 . . . . 74.329999999999998 110.728 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -129.73 150.26 51.11 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.698 -0.853 . . . . 73.010000000000005 108.698 175.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -82.0 62.33 5.71 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.437 0.637 . . . . 75.420000000000002 111.117 -177.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 32.7 m80 -148.8 106.94 3.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.174 -0.921 . . . . 74.219999999999999 108.621 173.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 63.2 m80 -136.49 -50.67 0.68 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.899 0.381 . . . . 71.200000000000003 110.198 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 19.6 p80 -75.18 144.72 42.58 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.085 -0.507 . . . . 65.209999999999994 109.762 177.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -85.95 178.43 7.28 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.374 -0.375 . . . . 71.340000000000003 110.376 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 69.6 mtm -140.94 -173.98 3.86 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.971 -0.381 . . . . 61.329999999999998 109.971 179.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.05 150.81 22.84 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 121.272 -0.489 . . . . 54.420000000000002 112.169 178.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 26.1 p -108.22 101.11 10.35 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 122.472 0.309 . . . . 62.43 110.23 178.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 3.6 pp -82.17 179.45 7.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.317 -0.402 . . . . 75.129999999999995 110.486 -179.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -117.87 145.3 44.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.847 0.356 . . . . 62.409999999999997 110.293 179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -146.83 134.36 20.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.034 -0.53 . . . . 64.340000000000003 110.002 179.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 54.2 tp60 -98.5 75.5 2.2 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.347 0.594 . . . . 71.200000000000003 109.682 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 32.3 p -130.49 -73.02 0.55 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.525 -0.761 . . . . 74.340000000000003 110.422 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.02 155.99 28.5 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.281 -0.418 . . . . 73.129999999999995 110.128 178.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -130.23 -79.0 0.2 Allowed Glycine 0 CA--C 1.518 0.249 0 C-N-CA 121.155 -0.545 . . . . 72.219999999999999 112.106 178.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -69.48 103.88 1.18 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.794 2.329 . . . . 73.219999999999999 111.943 179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -112.54 -4.71 24.86 Favored Glycine 0 N--CA 1.453 -0.222 0 C-N-CA 121.321 -0.466 . . . . 71.450000000000003 112.33 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 44.5 t -97.5 107.4 19.89 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.529 -0.545 . . . . 64.019999999999996 109.529 178.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.512 ' N ' ' SD ' ' A' ' 22' ' ' MET . 1.4 mpt? -61.9 -38.25 87.65 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 116.126 -0.488 . . . . 73.25 111.105 -176.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 48.9 mt -111.66 128.11 68.4 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 115.898 -0.592 . . . . 74.400000000000006 110.337 -175.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 0.9 OUTLIER -122.0 144.22 49.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.326 -0.397 . . . . 71.409999999999997 109.952 -179.556 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.41 137.79 33.13 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 110.223 -0.288 . . . . 65.140000000000001 110.223 177.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.494 HD12 ' HA ' ' A' ' 31' ' ' PHE . 36.2 pt -140.22 172.96 11.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-O 121.337 0.589 . . . . 64.230000000000004 111.399 -176.664 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -110.73 173.91 16.61 Favored Glycine 0 N--CA 1.451 -0.33 0 CA-C-N 115.236 -0.893 . . . . 13.31 111.809 177.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -67.29 -33.68 75.81 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.684 0.253 . . . . 73.329999999999998 111.684 -177.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 44.6 m -64.48 -47.56 78.52 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.091 0.472 . . . . 64.120000000000005 110.804 -178.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.509 ' O ' ' HG2' ' A' ' 34' ' ' LYS . 3.8 pm0 -84.29 -14.46 49.72 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.762 -0.654 . . . . 71.549999999999997 111.072 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.604 ' HE1' HG11 ' A' ' 46' ' ' VAL . 92.4 t80 -46.23 -70.08 0.11 Allowed 'General case' 0 N--CA 1.464 0.259 0 O-C-N 123.384 0.427 . . . . 65.209999999999994 110.726 -178.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -61.68 -39.85 92.9 Favored 'General case' 0 C--O 1.24 0.581 0 CA-C-O 121.128 0.489 . . . . 71.430000000000007 109.726 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.421 ' O ' ' HB2' ' A' ' 37' ' ' SER . 9.4 t-20 -56.35 -33.76 65.98 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.617 -1.174 . . . . 63.409999999999997 112.216 -171.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 30' ' ' GLU . 18.7 ptmt -115.16 -21.85 9.76 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 111.711 0.263 . . . . 53.439999999999998 111.711 -177.68 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 93.6 t -88.5 -55.63 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 111.727 0.269 . . . . 61.520000000000003 111.727 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 30.8 p -85.87 -25.24 26.32 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.076 0.465 . . . . 74.430000000000007 110.796 -173.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 16.0 m -84.67 12.03 7.91 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.997 -0.547 . . . . 73.219999999999999 110.547 176.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 43.5 t -75.22 94.73 3.02 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.868 0.366 . . . . 60.130000000000003 110.548 178.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -91.88 1.31 57.26 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.138 -0.483 . . . . 70.230000000000004 110.563 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -72.22 -7.79 51.22 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.197 -0.456 . . . . 63.240000000000002 111.499 -176.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 41.2 m-80 64.39 15.82 9.77 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.18 -0.464 . . . . 71.209999999999994 111.397 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 7.9 tt -85.04 147.82 5.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 108.507 -0.923 . . . . 74.519999999999996 108.507 173.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.657 HD21 ' HE3' ' A' ' 101' ' ' MET . 61.2 tp -85.31 120.68 27.07 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-O 121.338 0.589 . . . . 74.319999999999993 110.682 -175.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 51.1 mt -106.98 126.02 63.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.379 -0.828 . . . . 75.349999999999994 110.392 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 45' ' ' LEU . 5.8 mp -108.81 110.13 21.42 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.317 -0.401 . . . . 41.200000000000003 110.067 179.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.604 HG11 ' HE1' ' A' ' 31' ' ' PHE . 59.3 t -96.96 111.26 26.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.812 -0.44 . . . . 71.439999999999998 109.812 176.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.424 ' OD1' ' NZ ' ' A' ' 78' ' ' LYS . 1.7 p30 -91.24 154.64 19.14 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.077 0.465 . . . . 64.5 110.62 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -109.92 26.33 10.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.664 -0.698 . . . . 73.030000000000001 110.173 178.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 76.5 t90 -75.69 115.76 15.71 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.724 -0.843 . . . . 72.239999999999995 108.724 175.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -47.14 115.9 3.78 Favored Pre-proline 0 CA--C 1.531 0.218 0 O-C-N 123.84 0.712 . . . . 53.439999999999998 111.697 -175.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.451 ' HG3' ' HE3' ' A' ' 78' ' ' LYS . 18.8 Cg_exo -65.78 78.41 0.28 Allowed 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.808 2.339 . . . . 74.340000000000003 111.423 177.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 55.2 t-105 -150.77 142.55 23.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.713 -0.676 . . . . 74.150000000000006 109.808 -179.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 52.1 t -79.53 84.81 5.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.144 0.497 . . . . 72.239999999999995 110.317 -179.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -173.73 67.03 0.11 Allowed Glycine 0 N--CA 1.453 -0.208 0 CA-C-N 115.729 -0.668 . . . . 63.140000000000001 112.172 177.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -92.1 10.91 2.41 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.029 2.486 . . . . 62.109999999999999 112.663 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 45.8 t 65.02 -73.7 0.06 Allowed 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 122.957 0.503 . . . . 70.010000000000005 109.82 -174.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.8 ttp180 -127.51 118.18 23.51 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 108.784 -0.821 . . . . 74.519999999999996 108.784 174.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 14.6 p -69.1 141.77 54.62 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.372 -0.376 . . . . 52.329999999999998 111.141 -177.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -161.09 155.67 23.4 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.99 -0.55 . . . . 73.329999999999998 109.529 176.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -83.15 111.57 31.73 Favored Pre-proline 0 C--O 1.235 0.3 0 N-CA-C 109.907 -0.405 . . . . 73.140000000000001 109.907 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -76.9 -174.29 2.11 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 122.628 2.219 . . . . 71.140000000000001 111.911 178.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.454 ' H ' ' CD ' ' A' ' 62' ' ' GLN . 13.9 mp0 -57.74 -48.45 79.58 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.599 0.714 . . . . 74.099999999999994 110.466 -175.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.63 HD21 HG12 ' A' ' 99' ' ' ILE . 8.1 mp -55.55 -49.08 73.61 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 114.586 -1.188 . . . . 74.219999999999999 111.627 -174.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -71.15 -36.45 72.06 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.224 -0.287 . . . . 74.409999999999997 110.224 -177.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.439 ' HA ' ' HD3' ' A' ' 65' ' ' LYS . 41.3 mmtt -55.58 -51.67 66.33 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.234 -0.439 . . . . 71.310000000000002 111.248 178.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.591 HD12 HD12 ' A' ' 123' ' ' ILE . 28.5 mt -76.38 -40.9 49.75 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 120.368 -0.533 . . . . 73.239999999999995 111.493 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.467 ' HB1' ' HB3' ' A' ' 22' ' ' MET . . . -59.68 -38.3 81.13 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 111.714 0.265 . . . . 61.5 111.714 -175.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -53.93 -33.07 55.71 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.751 0.31 . . . . 70.239999999999995 110.901 179.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 70.5 mm-40 -93.89 -41.09 9.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.031 -0.531 . . . . 65.549999999999997 111.17 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.494 ' O ' HG22 ' A' ' 74' ' ' VAL . 19.3 m-85 -107.42 17.46 22.75 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 112.957 0.725 . . . . 75.230000000000004 112.957 -168.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.0 t -53.95 -32.73 54.71 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.312 0.506 . . . . 74.329999999999998 112.188 -174.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -68.43 -16.69 64.0 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-O 120.804 0.335 . . . . 53.340000000000003 111.302 -178.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -114.47 -13.96 12.18 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.173 -0.467 . . . . 72.310000000000002 110.321 -178.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 70' ' ' TYR . 26.8 m -134.98 127.31 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 CA-C-O 120.934 0.397 . . . . 55.140000000000001 110.688 178.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -118.42 122.83 43.75 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.57 -0.53 . . . . 63.310000000000002 109.57 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.476 HD13 ' HB3' ' A' ' 63' ' ' LEU . 60.7 mt -98.97 141.0 17.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 120.911 0.386 . . . . 74.420000000000002 110.913 -175.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.459 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 87.6 m-85 -133.63 157.93 44.52 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.076 -0.713 . . . . 72.200000000000003 109.076 175.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.451 ' HE3' ' HG3' ' A' ' 51' ' ' PRO . 0.4 OUTLIER -141.33 148.82 40.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.872 0.367 . . . . 72.219999999999999 110.799 179.244 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.4 pp -135.32 179.74 3.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.525 -0.761 . . . . 72.5 110.423 -179.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -137.03 89.09 2.41 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.877 0.37 . . . . 55.210000000000001 110.522 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.515 HG23 ' HB3' ' A' ' 84' ' ' ASN . 66.8 mt -145.85 111.01 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 N-CA-C 108.962 -0.755 . . . . 61.140000000000001 108.962 177.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.3 mp0 -84.93 -72.43 0.48 Allowed 'General case' 0 C--O 1.235 0.342 0 N-CA-C 111.684 0.253 . . . . 71.239999999999995 111.684 -174.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -106.14 -8.3 17.5 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 116.502 -0.317 . . . . 64.430000000000007 111.54 -172.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.515 ' HB3' HG23 ' A' ' 81' ' ' ILE . 17.2 t-20 -84.83 18.62 2.35 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-O 121.377 0.608 . . . . 73.349999999999994 110.604 -177.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -126.02 136.95 53.56 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.074 -0.512 . . . . 74.209999999999994 110.572 -177.572 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -69.74 -31.74 69.9 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 109.846 -0.427 . . . . 61.450000000000003 109.846 174.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 97.0 t -47.22 -53.23 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-N 115.446 -0.797 . . . . 75.030000000000001 112.396 -173.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -55.68 -52.89 62.31 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.434 -0.348 . . . . 73.530000000000001 111.431 -176.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.1 m -72.3 -28.16 62.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.125 -0.489 . . . . 71.010000000000005 110.931 -179.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 21.4 tt0 -65.6 -40.78 93.03 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 115.97 -0.559 . . . . 72.230000000000004 110.092 -178.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -88.23 -17.17 31.37 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.564 -0.744 . . . . 74.030000000000001 110.363 175.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 63.43 50.56 61.38 Favored Glycine 0 C--N 1.333 0.412 0 N-CA-C 111.19 -0.764 . . . . 71.209999999999994 111.19 -175.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.7 p -56.25 115.18 0.72 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.242 0.544 . . . . 73.5 111.187 -176.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.9 m -96.96 -14.26 21.82 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.813 -0.631 . . . . 73.310000000000002 110.855 -179.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -149.77 131.66 15.15 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.705 0.288 . . . . 73.129999999999995 111.208 -177.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.532 ' HB ' ' HA ' ' A' ' 97' ' ' PRO . 2.8 pp -96.11 161.7 26.29 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 116.038 -0.528 . . . . 72.430000000000007 110.123 175.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.532 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 3.3 Cg_exo -76.83 176.52 43.59 Favored 'Cis proline' 0 C--N 1.355 0.888 0 C-N-CA 124.389 -1.088 . . . . 65.310000000000002 112.314 -0.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 15.9 m -134.32 121.35 21.11 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.221 -0.445 . . . . 71.120000000000005 110.098 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.655 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 3.7 mp -117.07 125.8 74.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 109.331 -0.618 . . . . 53.43 109.331 179.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -106.92 128.9 54.72 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.794 0.331 . . . . 73.120000000000005 110.129 -177.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.756 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 65.9 mtp -100.74 113.26 25.99 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.117 -0.492 . . . . 74.109999999999999 110.772 -177.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -111.42 146.61 36.88 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.076 -0.511 . . . . 74.430000000000007 110.749 178.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.802 ' HB3' HD21 ' A' ' 108' ' ' LEU . 33.9 ttpt -160.06 130.89 5.68 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 108.889 -0.782 . . . . 63.310000000000002 108.889 177.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 31.5 t-20 55.11 31.61 16.63 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.681 0.753 . . . . 65.239999999999995 110.101 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 74.84 20.93 79.26 Favored Glycine 0 C--N 1.333 0.367 0 CA-C-N 115.313 -0.858 . . . . 53.509999999999998 113.42 176.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -129.3 155.2 45.97 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.758 0.279 . . . . 51.240000000000002 110.663 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.53 120.14 32.69 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.765 0.317 . . . . 45.119999999999997 110.168 177.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.802 HD21 ' HB3' ' A' ' 103' ' ' LYS . 2.0 mm? -92.89 -51.87 4.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.332 -0.395 . . . . 72.549999999999997 110.323 -178.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.756 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 49.7 m -153.96 171.54 18.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.59 -0.732 . . . . 74.540000000000006 110.592 -175.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 3.1 pm0 -146.16 124.89 12.57 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 115.992 -0.549 . . . . 75.319999999999993 110.546 176.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.655 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 52.5 t -82.55 107.12 14.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.697 -0.483 . . . . 64.25 109.697 176.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 64.5 mt -109.18 108.67 25.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.813 -0.44 . . . . 75.109999999999999 109.813 178.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.0 -122.9 7.74 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.18 -0.534 . . . . 74.409999999999997 111.783 -178.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.24 88.15 1.0 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.779 0.323 . . . . 71.329999999999998 110.27 179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.479 ' O ' HG23 ' A' ' 119' ' ' ILE . 3.6 m-20 -126.7 86.58 2.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.274 -0.421 . . . . 62.439999999999998 110.282 -177.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.52 ' O ' HG13 ' A' ' 119' ' ' ILE . 7.7 tp -55.57 -44.76 77.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 CA-C-N 116.242 -0.435 . . . . 73.120000000000005 111.807 -176.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 10.5 t -68.09 -26.48 65.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.07 0.462 . . . . 71.150000000000006 110.655 -175.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -79.71 -45.6 18.64 Favored 'General case' 0 C--O 1.242 0.7 0 CA-C-N 116.086 -0.506 . . . . 71.040000000000006 110.269 179.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.52 HG13 ' O ' ' A' ' 116' ' ' ILE . 2.1 pp -67.87 -40.27 83.24 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.142 0 CA-C-N 115.853 -0.612 . . . . 71.219999999999999 111.088 -175.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.485 HG22 HD11 ' A' ' 66' ' ' LEU . 2.8 pp -61.79 -32.23 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 120.439 -0.505 . . . . 75.310000000000002 110.029 178.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.468 ' N ' HD12 ' A' ' 120' ' ' ILE . 27.9 t -70.29 -51.77 27.89 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.867 -0.606 . . . . 62.240000000000002 110.379 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.477 ' HG2' ' HA ' ' A' ' 119' ' ' ILE . 21.0 pt-20 -72.02 -34.33 68.75 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.186 0.439 . . . . 74.319999999999993 112.186 -175.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.591 HD12 HD12 ' A' ' 66' ' ' LEU . 66.8 mt -71.02 -47.97 58.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 CA-C-O 120.661 0.267 . . . . 72.530000000000001 110.795 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -66.77 -20.12 65.89 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-O 120.948 0.404 . . . . 72.010000000000005 111.247 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 8.9 m-20 -74.02 -6.13 45.57 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 116.458 -0.337 . . . . 60.229999999999997 111.172 174.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 -113.93 -49.0 2.88 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.826 0.346 . . . . 73.109999999999999 110.648 178.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 33.6 pt -100.38 168.03 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.779 -0.646 . . . . 71.040000000000006 110.665 -177.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.468 ' N ' HD22 ' A' ' 128' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.161 0 CA-C-O 118.355 -0.831 . . . . 74.439999999999998 110.723 178.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.2 ttp . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 110.328 -0.249 . . . . 51.399999999999999 110.328 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 74.83 -51.3 0.67 Allowed 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.418 0.687 . . . . 74.329999999999998 112.474 176.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -63.88 103.82 0.62 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 120.782 0.325 . . . . 73.010000000000005 111.331 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 46.0 t-80 -82.79 154.49 24.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.263 -0.426 . . . . 75.420000000000002 109.983 178.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -90.62 157.1 17.66 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 110.303 -0.258 . . . . 74.219999999999999 110.303 177.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 49.1 m80 69.31 152.45 0.1 Allowed 'General case' 0 N--CA 1.466 0.363 0 O-C-N 123.642 0.588 . . . . 71.200000000000003 111.088 -178.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 22.4 p80 -157.83 75.0 0.75 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.628 -0.714 . . . . 65.209999999999994 110.226 -177.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -99.2 81.55 2.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.038 0.447 . . . . 71.340000000000003 110.569 179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.416 ' N ' ' SD ' ' A' ' 9' ' ' MET . 3.7 mpp? -69.21 91.51 0.52 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.388 -0.597 . . . . 61.329999999999998 109.388 175.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.74 -7.95 87.96 Favored Glycine 0 N--CA 1.453 -0.171 0 CA-C-N 115.813 -0.63 . . . . 54.420000000000002 112.88 -177.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 34.4 p -71.58 95.94 1.49 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.887 0.375 . . . . 62.43 110.283 179.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 59.6 tp -130.41 101.79 5.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 75.129999999999995 110.943 -177.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -171.19 116.4 0.43 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.586 -0.734 . . . . 62.409999999999997 109.333 174.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -168.05 131.39 1.59 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.34 -0.391 . . . . 64.340000000000003 110.796 -178.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -62.99 105.92 0.75 Allowed 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.044 -0.525 . . . . 71.200000000000003 110.056 176.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.3 p -69.74 89.65 0.56 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.26 0.552 . . . . 74.340000000000003 111.695 -176.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -96.15 147.37 23.81 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.794 -0.639 . . . . 73.129999999999995 110.301 176.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -54.83 -75.62 0.23 Allowed Glycine 0 CA--C 1.522 0.484 0 CA-C-N 116.012 -0.54 . . . . 72.219999999999999 113.701 -175.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -66.25 -4.47 10.57 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 122.797 2.331 . . . . 73.219999999999999 112.913 -176.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -86.9 -45.21 5.49 Favored Glycine 0 N--CA 1.449 -0.44 0 N-CA-C 111.722 -0.551 . . . . 71.450000000000003 111.722 177.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 41.9 t -92.58 91.72 7.7 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.085 -0.339 . . . . 64.019999999999996 110.085 -179.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.728 ' HG3' HG12 ' A' ' 23' ' ' ILE . 25.3 ptt? -72.02 -39.09 69.42 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.415 -0.357 . . . . 73.25 110.655 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.728 HG12 ' HG3' ' A' ' 22' ' ' MET . 14.6 mm -113.78 108.82 26.47 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 N-CA-C 109.043 -0.725 . . . . 74.400000000000006 109.043 178.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.568 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 36.1 tt0 -122.73 131.98 54.03 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.733 0.301 . . . . 71.409999999999997 110.536 -172.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -90.22 128.89 36.5 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.641 -0.503 . . . . 65.140000000000001 109.641 178.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.449 HG21 ' HD3' ' A' ' 34' ' ' LYS . 47.5 pt -130.9 165.94 29.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-O 121.056 0.455 . . . . 64.230000000000004 111.492 -175.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -111.79 169.26 13.07 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.576 -0.738 . . . . 13.31 112.845 -179.343 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -52.25 -38.85 59.35 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 122.824 0.45 . . . . 73.329999999999998 111.407 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 34.5 t -59.36 -21.88 60.5 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.821 -0.627 . . . . 64.120000000000005 112.251 -175.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.51 ' HA ' ' HB2' ' A' ' 33' ' ' ASN . 11.3 pt-20 -125.64 -3.34 7.24 Favored 'General case' 0 C--O 1.234 0.238 0 N-CA-C 111.679 0.251 . . . . 71.549999999999997 111.679 -175.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -51.61 -70.8 0.08 Allowed 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.192 0.308 . . . . 65.209999999999994 111.152 -177.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.4 p-10 -58.8 -42.71 89.75 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.638 0.733 . . . . 71.430000000000007 109.429 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.51 ' HB2' ' HA ' ' A' ' 30' ' ' GLU . 1.5 m-80 -52.44 -38.25 58.79 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 113.829 -1.532 . . . . 63.409999999999997 112.795 -172.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.449 ' HD3' HG21 ' A' ' 26' ' ' ILE . 16.1 ptmt -111.31 -19.58 12.59 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.023 0.379 . . . . 53.439999999999998 112.023 -177.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 87.6 t -88.26 -55.32 6.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 N-CA-C 111.928 0.344 . . . . 61.520000000000003 111.928 -178.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 45.7 p -77.92 -38.3 45.89 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.171 0.51 . . . . 74.430000000000007 110.78 -173.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.7 m -79.89 9.29 5.47 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 115.854 -0.612 . . . . 73.219999999999999 111.511 -179.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 53.2 t -75.44 111.38 10.66 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.798 0.332 . . . . 60.130000000000003 111.066 -178.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -116.69 15.1 15.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.026 -0.534 . . . . 70.230000000000004 110.317 178.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -68.96 -2.46 9.87 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.828 -0.624 . . . . 63.240000000000002 112.08 -177.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.454 ' O ' ' HE3' ' A' ' 103' ' ' LYS . 18.3 m120 70.18 6.26 5.69 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 122.954 0.502 . . . . 71.209999999999994 111.071 -177.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 8.3 tt -89.09 157.08 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 N-CA-C 109.331 -0.618 . . . . 74.519999999999996 109.331 178.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.503 HD21 ' HE2' ' A' ' 101' ' ' MET . 63.7 tp -96.26 118.23 32.41 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.155 -0.313 . . . . 74.319999999999993 110.155 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 101' ' ' MET . 48.8 mt -97.96 124.79 51.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 116.163 -0.471 . . . . 75.349999999999994 110.703 179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.532 ' HB2' HG13 ' A' ' 76' ' ' ILE . 3.3 mp -115.7 105.77 13.12 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.654 -0.499 . . . . 41.200000000000003 109.654 178.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.548 HG12 ' HB2' ' A' ' 77' ' ' TYR . 30.9 m -97.01 121.69 47.77 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 CA-C-N 116.625 -0.261 . . . . 71.439999999999998 110.32 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.432 ' OD1' ' HG2' ' A' ' 78' ' ' LYS . 5.8 p-10 -104.63 125.42 50.73 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 121.391 0.615 . . . . 64.5 109.823 176.525 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 -75.25 100.65 4.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.414 -0.812 . . . . 73.030000000000001 111.497 -176.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.572 ' NE1' ' HA ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER 35.95 84.47 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.652 0 O-C-N 124.487 1.117 . . . . 72.239999999999995 113.639 171.97 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.97 154.85 49.95 Favored Pre-proline 0 CA--C 1.536 0.44 0 CA-C-N 115.582 -0.736 . . . . 53.439999999999998 110.04 174.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -53.91 155.16 15.22 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 122.925 2.416 . . . . 74.340000000000003 112.579 178.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 18.0 p90 -73.03 178.69 4.17 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.039 -0.528 . . . . 74.150000000000006 111.632 -176.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . 0.509 ' SG ' ' N ' ' A' ' 54' ' ' GLY . 54.1 t -135.03 179.05 6.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.7 -0.682 . . . . 72.239999999999995 110.401 -176.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.509 ' N ' ' SG ' ' A' ' 53' ' ' CYS . . . -85.16 -177.41 50.81 Favored Glycine 0 CA--C 1.52 0.404 0 N-CA-C 111.726 -0.55 . . . . 63.140000000000001 111.726 175.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_exo -57.49 -34.07 97.43 Favored 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 123.04 2.494 . . . . 62.109999999999999 112.663 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 25.8 p -115.87 142.79 46.3 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.216 -0.447 . . . . 70.010000000000005 109.898 177.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -75.27 82.37 2.4 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.743 -0.466 . . . . 74.519999999999996 109.743 -178.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 28.5 t -62.46 -32.45 73.33 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.74 -0.663 . . . . 52.329999999999998 110.468 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.4 HD12 ' O ' ' A' ' 59' ' ' LEU . 3.4 pp -159.7 151.34 20.14 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 115.493 -0.776 . . . . 73.329999999999998 109.71 176.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.439 ' HB2' ' HB2' ' A' ' 64' ' ' GLU . 1.0 OUTLIER -137.26 150.8 70.14 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.828 -0.624 . . . . 73.140000000000001 109.975 -179.734 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -65.91 177.88 2.69 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 122.79 2.327 . . . . 71.140000000000001 112.952 -177.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.688 ' HB3' HG12 ' A' ' 119' ' ' ILE . 11.5 mp0 -51.18 -49.03 61.74 Favored 'General case' 0 C--O 1.242 0.664 0 CA-C-N 115.316 -0.857 . . . . 74.099999999999994 111.65 -173.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.559 ' H ' HD22 ' A' ' 63' ' ' LEU . 2.5 mm? -64.25 -46.13 85.11 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.852 -1.067 . . . . 74.219999999999999 110.124 -172.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.588 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 55.0 mt-10 -68.0 -32.51 72.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.747 -0.66 . . . . 74.409999999999997 110.449 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -58.41 -56.66 19.23 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 116.342 -0.39 . . . . 71.310000000000002 110.634 176.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.595 HD12 HD12 ' A' ' 123' ' ' ILE . 22.5 mt -69.13 -30.11 68.29 Favored 'General case' 0 N--CA 1.462 0.143 0 C-N-CA 120.825 -0.35 . . . . 73.239999999999995 110.861 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.21 -36.35 70.75 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.419 -0.355 . . . . 61.5 111.278 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.588 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 84.2 mt-30 -56.25 -32.98 65.0 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 116.286 -0.415 . . . . 70.239999999999995 111.006 -178.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 12.0 mm-40 -94.01 -56.59 2.81 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-O 121.322 0.582 . . . . 65.549999999999997 110.826 178.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.521 ' O ' HG22 ' A' ' 74' ' ' VAL . 22.2 m-85 -82.52 21.69 0.94 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.645 -0.707 . . . . 75.230000000000004 112.336 -173.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.461 ' OG1' ' HB3' ' A' ' 22' ' ' MET . 8.8 t -52.46 -31.26 33.92 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.976 0.417 . . . . 74.329999999999998 111.698 -176.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -70.13 -18.96 63.25 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.103 -0.498 . . . . 53.340000000000003 111.542 -175.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.41 6.24 8.35 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 120.732 0.301 . . . . 72.310000000000002 110.815 -173.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.521 HG22 ' O ' ' A' ' 70' ' ' TYR . 23.1 m -137.46 145.07 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-O 121.117 0.484 . . . . 55.140000000000001 111.583 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.5 mmtt -129.14 114.86 16.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.528 -0.76 . . . . 63.310000000000002 108.959 174.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.532 HG13 ' HB2' ' A' ' 45' ' ' LEU . 2.3 mp -100.5 138.43 24.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.559 -0.534 . . . . 74.420000000000002 109.559 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.568 ' HA ' ' O ' ' A' ' 24' ' ' GLU . 41.2 m-85 -130.55 134.26 46.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.247 -0.433 . . . . 72.200000000000003 110.885 -177.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.432 ' HG2' ' OD1' ' A' ' 47' ' ' ASP . 55.9 mttm -109.19 111.86 23.7 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.257 -0.646 . . . . 72.219999999999999 109.257 174.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 32.0 pt -86.93 142.11 13.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.958 -0.564 . . . . 72.5 111.25 -175.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 29.7 p30 -90.12 -11.55 40.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.878 -0.601 . . . . 55.210000000000001 111.788 -179.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.405 HG23 ' O ' ' A' ' 81' ' ' ILE . 12.8 tt -75.01 87.19 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-O 121.871 0.843 . . . . 61.140000000000001 110.338 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.572 ' HA ' ' NE1' ' A' ' 49' ' ' TRP . 9.0 pt-20 -85.44 -40.43 16.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.21 -0.905 . . . . 71.239999999999995 112.667 -174.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -84.81 -1.42 56.38 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 112.392 0.515 . . . . 64.430000000000007 112.392 -168.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -144.85 113.53 6.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.739 0.304 . . . . 73.349999999999994 110.826 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -144.7 104.07 3.99 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.462 0.649 . . . . 74.209999999999994 110.246 174.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -70.3 -58.4 3.79 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.601 -0.727 . . . . 61.450000000000003 111.082 -177.389 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 35.0 t -56.72 -41.78 75.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.709 -0.678 . . . . 75.030000000000001 111.182 -174.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -65.29 -41.39 94.18 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-N 116.252 -0.431 . . . . 73.530000000000001 111.001 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 88.5 m -65.76 -36.43 83.53 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.209 -0.45 . . . . 71.010000000000005 110.118 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -65.77 -37.34 86.05 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.159 -0.473 . . . . 72.230000000000004 110.228 177.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -70.72 -15.25 62.68 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.192 -0.458 . . . . 74.030000000000001 110.656 174.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 74.07 38.88 46.84 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 121.192 -0.528 . . . . 71.209999999999994 112.059 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.8 p -51.98 120.22 1.4 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 121.104 0.478 . . . . 73.5 111.168 -179.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.4 m -124.37 6.57 8.37 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.782 -0.645 . . . . 73.310000000000002 110.609 179.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -156.38 126.77 6.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.09 -0.505 . . . . 73.129999999999995 110.606 -179.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.42 ' HB ' ' HA ' ' A' ' 97' ' ' PRO . 29.7 pt -101.69 156.14 35.55 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.986 -0.552 . . . . 72.430000000000007 109.755 177.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.42 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 84.5 Cg_endo -79.47 163.04 84.98 Favored 'Cis proline' 0 C--N 1.352 0.721 0 C-N-CA 123.822 -1.324 . . . . 65.310000000000002 112.709 1.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.484 HG23 HG12 ' A' ' 112' ' ' ILE . 30.6 m -128.19 115.62 18.65 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.733 -0.667 . . . . 71.120000000000005 109.36 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.623 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 3.4 mp -110.36 124.13 66.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.364 -0.38 . . . . 53.43 110.502 -176.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 10.4 mp -103.5 133.81 47.92 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.793 -0.447 . . . . 73.120000000000005 109.793 176.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.768 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 66.3 mtp -112.04 108.56 17.91 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.312 -0.404 . . . . 74.109999999999999 110.595 -175.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -108.76 154.83 21.49 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.162 -0.472 . . . . 74.430000000000007 111.272 -178.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.768 ' HB3' HD21 ' A' ' 108' ' ' LEU . 87.7 tttt -162.86 117.32 1.73 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.401 -0.962 . . . . 63.310000000000002 108.401 179.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 62.42 25.19 15.02 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.528 0.68 . . . . 65.239999999999995 110.416 -178.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 84.69 -0.44 89.19 Favored Glycine 0 C--N 1.331 0.291 0 CA-C-N 115.881 -0.599 . . . . 53.509999999999998 112.763 179.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 23.1 tptm -100.62 137.56 38.85 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.829 -0.434 . . . . 51.240000000000002 109.829 177.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.86 126.92 33.88 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 109.306 -0.627 . . . . 45.119999999999997 109.306 174.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.768 HD21 ' HB3' ' A' ' 103' ' ' LYS . 2.0 mm? -98.16 -51.09 4.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.224 -0.443 . . . . 72.549999999999997 110.108 -178.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.768 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 18.8 m -149.47 155.68 40.78 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.655 -0.702 . . . . 74.540000000000006 111.122 -171.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -131.04 118.85 21.16 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.802 -0.635 . . . . 75.319999999999993 109.835 175.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.623 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 50.4 t -89.78 107.09 17.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 N-CA-C 109.707 -0.479 . . . . 64.25 109.707 176.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.484 HG12 HG23 ' A' ' 98' ' ' THR . 60.9 mt -112.72 117.33 55.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 109.613 -0.514 . . . . 75.109999999999999 109.613 179.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 100.75 -126.04 8.78 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 111.687 -0.565 . . . . 74.409999999999997 111.687 -178.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.52 91.46 1.16 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.711 0.291 . . . . 71.329999999999998 110.861 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.403 ' HB3' ' HB2' ' A' ' 118' ' ' LYS . 8.1 m-20 -132.54 99.74 4.75 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-O 121.1 0.476 . . . . 62.439999999999998 111.155 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.652 HD12 HD11 ' A' ' 119' ' ' ILE . 7.1 tp -62.97 -40.39 88.79 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-N 115.671 -0.695 . . . . 73.120000000000005 110.58 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 32.3 t -64.8 -32.04 73.55 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.132 0.491 . . . . 71.150000000000006 110.257 -178.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.403 ' HB2' ' HB3' ' A' ' 115' ' ' ASP . 0.3 OUTLIER -72.99 -53.66 10.61 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 109.266 -0.642 . . . . 71.040000000000006 109.266 179.527 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.688 HG12 ' HB3' ' A' ' 62' ' ' GLN . 2.4 pp -62.07 -39.42 83.75 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.134 0 CA-C-N 115.661 -0.7 . . . . 71.219999999999999 111.566 -173.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.448 HD12 ' N ' ' A' ' 121' ' ' SER . 2.8 pp -62.52 -31.52 52.22 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 120.087 -0.645 . . . . 75.310000000000002 110.208 178.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.448 ' N ' HD12 ' A' ' 120' ' ' ILE . 29.2 m -70.89 -51.43 26.29 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 116.194 -0.457 . . . . 62.240000000000002 110.806 178.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.488 ' OE2' ' HB3' ' A' ' 109' ' ' SER . 13.1 pt-20 -77.32 -41.91 38.82 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.603 0.594 . . . . 74.319999999999993 112.603 -173.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.595 HD12 HD12 ' A' ' 66' ' ' LEU . 74.2 mt -61.82 -55.14 26.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.303 0 O-C-N 122.144 -0.347 . . . . 72.530000000000001 110.611 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -59.26 -20.05 51.01 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.094 0.473 . . . . 72.010000000000005 110.816 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -79.08 -34.17 43.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.917 -0.583 . . . . 60.229999999999997 110.87 176.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 -93.43 -20.87 19.9 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 116.372 -0.377 . . . . 73.109999999999999 111.611 -173.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.449 HG12 ' O ' ' A' ' 123' ' ' ILE . 48.5 pt -120.32 168.36 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 N-CA-C 110.173 -0.306 . . . . 71.040000000000006 110.173 175.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.529 ' N ' HD22 ' A' ' 128' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.224 -0.893 . . . . 74.439999999999998 111.977 -176.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.462 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.9 OUTLIER . . . . . 0 N--CA 1.48 1.059 0 N-CA-C 110.237 -0.282 . . . . 51.399999999999999 110.237 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -120.35 133.0 55.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.375 -0.375 . . . . 74.329999999999998 110.56 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -97.93 164.94 12.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.032 -0.531 . . . . 73.010000000000005 110.258 178.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -84.16 131.11 34.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.284 -0.417 . . . . 75.420000000000002 111.041 -176.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -89.31 113.68 24.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.0 -0.546 . . . . 74.219999999999999 109.941 -178.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 38.4 m-70 -63.98 103.77 0.63 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.032 -0.531 . . . . 71.200000000000003 111.417 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -80.07 153.95 28.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.55 -0.75 . . . . 65.209999999999994 110.269 175.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -105.36 134.04 49.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.508 -0.315 . . . . 71.340000000000003 110.277 179.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 48.5 ttm -88.39 107.65 18.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.219 -0.446 . . . . 61.329999999999998 110.268 -179.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -120.54 73.06 0.34 Allowed Glycine 0 C--N 1.332 0.328 0 C-N-CA 121.363 -0.446 . . . . 54.420000000000002 112.95 -177.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 62.4 m -81.18 104.49 11.69 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 110.064 -0.347 . . . . 62.43 110.064 175.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 97.6 mt -127.7 112.0 14.33 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.603 -0.271 . . . . 75.129999999999995 110.718 -178.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -175.32 145.15 0.74 Allowed 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.072 -0.513 . . . . 62.409999999999997 109.904 176.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -87.88 128.35 35.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.445 -0.343 . . . . 64.340000000000003 110.54 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -147.87 148.65 31.08 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.465 -0.334 . . . . 71.200000000000003 110.337 -179.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.8 t -101.7 154.15 19.14 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.331 -0.395 . . . . 74.340000000000003 110.33 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -163.74 138.21 5.94 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.702 -0.481 . . . . 73.129999999999995 109.702 -179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 178.49 86.53 0.07 OUTLIER Glycine 0 CA--C 1.519 0.319 0 C-N-CA 121.107 -0.568 . . . . 72.219999999999999 112.314 -179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.562 ' HB3' ' HG2' ' A' ' 68' ' ' GLN . 96.1 Cg_endo -82.68 174.97 9.21 Favored 'Trans proline' 0 CA--C 1.534 0.493 0 C-N-CA 122.883 2.389 . . . . 73.219999999999999 112.345 178.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -71.91 -175.08 23.63 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 121.313 -0.47 . . . . 71.450000000000003 112.439 178.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.8 p -94.84 88.32 5.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.367 0.603 . . . . 64.019999999999996 111.496 -178.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.611 ' HG3' ' HB1' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -111.82 4.75 18.59 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-N 115.639 -0.709 . . . . 73.25 109.176 170.115 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.441 HD13 ' HB ' ' A' ' 76' ' ' ILE . 8.6 mm -110.57 106.44 20.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 114.797 -1.092 . . . . 74.400000000000006 108.923 178.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.46 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 7.9 tp10 -121.1 141.4 50.82 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.888 0.375 . . . . 71.409999999999997 111.058 -178.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 24.0 pt20 -95.58 124.15 39.47 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.886 -0.597 . . . . 65.140000000000001 109.535 177.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.556 HD12 ' HA ' ' A' ' 31' ' ' PHE . 27.0 pt -121.67 157.53 25.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-N 116.221 -0.445 . . . . 64.230000000000004 111.214 -175.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.25 170.15 37.05 Favored Glycine 0 N--CA 1.45 -0.388 0 CA-C-N 115.875 -0.602 . . . . 13.31 112.107 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -66.2 -30.17 70.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.23 0.538 . . . . 73.329999999999998 110.449 -176.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.1 m -70.29 -48.76 55.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.575 -0.739 . . . . 64.120000000000005 111.156 -177.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -87.64 -13.55 42.4 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.45 -0.341 . . . . 71.549999999999997 111.274 -177.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.556 ' HA ' HD12 ' A' ' 26' ' ' ILE . 47.8 t80 -48.8 -70.15 0.1 Allowed 'General case' 0 N--CA 1.462 0.154 0 CA-C-O 120.873 0.368 . . . . 65.209999999999994 110.298 175.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -53.75 -43.26 68.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.946 -0.57 . . . . 71.430000000000007 109.663 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.557 ' O ' ' HB2' ' A' ' 37' ' ' SER . 0.2 OUTLIER -53.16 -50.11 65.24 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 114.734 -1.121 . . . . 63.409999999999997 111.762 -173.45 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.17 -17.08 17.56 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.195 0.443 . . . . 53.439999999999998 112.195 -173.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.5 t -88.29 -52.14 11.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 111.655 0.243 . . . . 61.520000000000003 111.655 -178.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 71.0 p -75.49 -45.27 39.38 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.545 0.688 . . . . 74.430000000000007 109.806 -177.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.557 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 19.9 m -77.06 12.78 1.27 Allowed 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.47 -0.786 . . . . 73.219999999999999 111.107 176.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 36.1 t -28.93 101.17 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.184 0.993 . . . . 60.130000000000003 113.061 -178.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -89.62 -18.21 26.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.622 -0.717 . . . . 70.230000000000004 109.556 175.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.504 ' HB3' ' HB ' ' A' ' 42' ' ' ILE . 2.8 m-20 -53.91 -40.33 66.57 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.685 -0.688 . . . . 63.240000000000002 110.833 -179.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 22.1 m-80 60.8 19.48 9.66 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 121.903 0.859 . . . . 71.209999999999994 109.636 -170.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.504 ' HB ' ' HB3' ' A' ' 40' ' ' ASP . 7.8 mt -101.02 154.24 4.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 114.086 -1.415 . . . . 74.519999999999996 108.613 175.207 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.617 HD11 ' HE3' ' A' ' 101' ' ' MET . 49.3 tp -70.15 104.9 2.74 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 109.505 -0.554 . . . . 74.319999999999993 109.505 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 48.1 mt -93.09 105.05 16.37 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.864 -0.607 . . . . 75.349999999999994 110.664 -178.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.584 HD22 HD22 ' A' ' 63' ' ' LEU . 2.0 mp -100.28 102.98 14.38 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.434 -0.58 . . . . 41.200000000000003 109.434 178.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.51 HG22 ' HB2' ' A' ' 77' ' ' TYR . 33.2 t -99.66 123.74 52.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.422 -0.584 . . . . 71.439999999999998 109.422 178.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.407 ' CB ' HG12 ' A' ' 99' ' ' ILE . 6.1 p-10 -108.75 131.6 54.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.529 0.681 . . . . 64.5 110.959 -178.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 56.4 m-85 -85.68 88.11 7.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.091 -0.959 . . . . 73.030000000000001 109.312 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . 0.481 ' NE1' ' HB3' ' A' ' 78' ' ' LYS . 4.2 p-90 -96.51 160.82 14.19 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.343 -0.844 . . . . 72.239999999999995 110.683 -176.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -94.58 134.96 24.48 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-N 115.938 -0.574 . . . . 53.439999999999998 109.514 175.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -53.28 -35.27 73.65 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.769 2.313 . . . . 74.340000000000003 112.555 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -76.33 -5.73 48.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.878 -0.601 . . . . 74.150000000000006 111.338 -177.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 47.6 t -91.33 9.47 31.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.387 -0.37 . . . . 72.239999999999995 110.501 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -52.23 -58.63 10.38 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 121.38 -0.438 . . . . 63.140000000000001 112.229 176.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -76.82 48.64 2.51 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.185 2.59 . . . . 62.109999999999999 111.696 174.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 15.9 p -58.59 130.47 46.97 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 116.249 -0.432 . . . . 70.010000000000005 111.379 -179.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 5.4 mpt_? -80.89 76.01 7.83 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 109.58 -0.526 . . . . 74.519999999999996 109.58 177.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.8 t -170.4 175.56 4.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.508 -0.315 . . . . 52.329999999999998 110.234 -178.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.42 HD23 ' N ' ' A' ' 59' ' ' LEU . 2.3 pt? -163.3 154.51 16.9 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.975 -0.557 . . . . 73.329999999999998 110.006 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 56.14 63.87 5.54 Favored Pre-proline 0 C--O 1.238 0.45 0 O-C-N 123.694 0.621 . . . . 73.140000000000001 111.839 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.9 159.25 38.25 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.469 2.112 . . . . 71.140000000000001 110.923 175.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.444 ' HB3' HG12 ' A' ' 119' ' ' ILE . 7.3 mp0 -50.84 -57.46 8.4 Favored 'General case' 0 C--O 1.242 0.703 0 CA-C-O 121.165 0.507 . . . . 74.099999999999994 111.493 -172.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.819 HD11 HD13 ' A' ' 99' ' ' ILE . 21.7 mt -57.71 -48.84 78.45 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.461 -0.79 . . . . 74.219999999999999 111.437 -172.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.576 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 51.0 mt-10 -71.71 -32.49 67.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.961 -0.563 . . . . 74.409999999999997 110.244 -177.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -61.17 -46.23 91.35 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.974 -0.557 . . . . 71.310000000000002 110.051 179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.452 HD12 HD12 ' A' ' 123' ' ' ILE . 37.6 mt -74.56 -37.22 63.03 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.447 -0.342 . . . . 73.239999999999995 110.919 175.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.611 ' HB1' ' HG3' ' A' ' 22' ' ' MET . . . -58.14 -31.11 66.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 61.5 111.603 -177.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.576 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 77.9 mt-30 -54.56 -33.26 59.86 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 120.862 0.363 . . . . 70.239999999999995 110.712 177.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -94.36 -42.25 8.99 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 116.051 -0.522 . . . . 65.549999999999997 111.592 177.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.533 ' O ' HG22 ' A' ' 74' ' ' VAL . 11.5 m-85 -103.41 22.34 14.39 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.461 0.541 . . . . 75.230000000000004 112.461 -168.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.449 ' OG1' ' HB3' ' A' ' 22' ' ' MET . 5.3 t -52.28 -35.04 49.14 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.412 0.523 . . . . 74.329999999999998 112.412 -172.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -71.35 -16.11 62.42 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.212 0.449 . . . . 53.340000000000003 112.212 -175.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.441 ' O ' HG23 ' A' ' 42' ' ' ILE . 0.2 OUTLIER -125.77 11.5 7.83 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.587 0.232 . . . . 72.310000000000002 111.218 -176.743 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 70' ' ' TYR . 34.1 m -136.76 137.43 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 O-C-N 121.733 -0.604 . . . . 55.140000000000001 111.275 176.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 28.1 mmtp -119.98 115.26 23.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.538 -0.755 . . . . 63.310000000000002 109.511 177.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.494 ' N ' HD12 ' A' ' 76' ' ' ILE . 2.9 mp -105.27 122.79 58.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 108.869 -0.789 . . . . 74.420000000000002 108.869 177.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.51 ' HB2' HG22 ' A' ' 46' ' ' VAL . 39.5 m-85 -119.37 132.32 55.83 Favored 'General case' 0 C--O 1.239 0.535 0 CA-C-O 121.229 0.538 . . . . 72.200000000000003 111.667 -174.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.481 ' HB3' ' NE1' ' A' ' 49' ' ' TRP . 73.2 mmtt -91.19 110.22 21.49 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 114.711 -1.132 . . . . 72.219999999999999 108.696 173.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 80' ' ' ASN . 6.6 tp -97.26 146.83 7.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 120.845 0.355 . . . . 72.5 110.999 -177.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.481 ' O ' HG13 ' A' ' 79' ' ' ILE . 40.2 t30 -79.3 158.76 27.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.788 -0.642 . . . . 55.210000000000001 109.93 173.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.2 tt -115.97 76.33 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.534 0.683 . . . . 61.140000000000001 109.614 176.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -73.41 -68.95 0.46 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.796 -0.638 . . . . 71.239999999999995 110.216 179.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -95.47 -16.82 21.97 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.926 -0.579 . . . . 64.430000000000007 111.125 -177.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 75.5 143.44 0.08 Allowed 'General case' 0 N--CA 1.473 0.695 0 O-C-N 123.8 0.688 . . . . 73.349999999999994 109.925 -176.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.462 ' H ' ' CD ' ' A' ' 85' ' ' GLN . 4.9 pm0 -103.45 121.15 42.23 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.097 -0.501 . . . . 74.209999999999994 111.356 -173.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -69.85 -15.0 63.02 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.89 -0.595 . . . . 61.450000000000003 110.391 176.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 62.6 t -48.91 -38.04 10.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 115.986 -0.552 . . . . 75.030000000000001 110.774 177.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -61.97 -49.3 76.65 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.813 -0.63 . . . . 73.530000000000001 110.242 178.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.5 m -64.19 -33.6 76.16 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.818 -0.628 . . . . 71.010000000000005 110.387 179.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -63.04 -46.95 85.13 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 115.823 -0.626 . . . . 72.230000000000004 110.306 178.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 22.4 m-30 -83.01 5.24 22.85 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.062 -0.517 . . . . 74.030000000000001 111.324 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 65.0 34.72 90.63 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 121.31 -0.471 . . . . 71.209999999999994 112.8 175.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.448 HG11 ' OG1' ' A' ' 98' ' ' THR . 64.7 t -61.71 98.9 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.978 0.418 . . . . 73.5 110.068 177.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.3 m -100.49 8.75 43.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.898 -0.592 . . . . 73.310000000000002 111.553 -174.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -147.6 164.82 32.28 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.601 0.238 . . . . 73.129999999999995 110.631 -178.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.405 HD12 ' O ' ' A' ' 96' ' ' ILE . 2.4 pp -129.93 156.89 78.37 Favored Pre-proline 0 CA--C 1.534 0.354 0 CA-C-N 116.225 -0.443 . . . . 72.430000000000007 110.596 -178.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.17 169.35 74.45 Favored 'Cis proline' 0 C--N 1.354 0.827 0 C-N-CA 123.784 -1.34 . . . . 65.310000000000002 112.213 -0.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.448 ' OG1' HG11 ' A' ' 93' ' ' VAL . 15.0 m -112.15 124.5 52.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.108 -0.496 . . . . 71.120000000000005 110.502 -179.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.85 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 36.0 mt -126.62 135.75 62.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.341 -0.614 . . . . 53.43 109.341 178.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -125.19 133.77 52.64 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.964 -0.384 . . . . 73.120000000000005 109.964 -178.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.788 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 50.1 mtp -106.1 117.93 35.31 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.896 -0.593 . . . . 74.109999999999999 110.776 -176.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -118.34 155.72 30.16 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 122.646 0.378 . . . . 74.430000000000007 110.677 178.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.596 ' HB3' HD21 ' A' ' 108' ' ' LEU . 38.1 ttpt -166.31 123.04 1.32 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 115.844 -0.616 . . . . 63.310000000000002 109.774 176.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 46.2 t30 58.04 25.02 11.82 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-O 121.771 0.795 . . . . 65.239999999999995 110.812 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 90.85 -2.34 79.64 Favored Glycine 0 C--N 1.331 0.303 0 CA-C-N 115.991 -0.549 . . . . 53.509999999999998 113.381 175.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 54.0 tttm -102.77 145.07 30.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.908 0.354 . . . . 51.240000000000002 110.135 177.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 61.8 pttt -82.19 139.22 34.43 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.804 -0.813 . . . . 45.119999999999997 108.804 171.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.596 HD21 ' HB3' ' A' ' 103' ' ' LYS . 2.7 mm? -107.14 -53.26 2.64 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.885 0.374 . . . . 72.549999999999997 110.231 179.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.788 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 54.5 m -153.72 164.46 38.27 Favored 'General case' 0 C--O 1.24 0.594 0 CA-C-N 116.019 -0.537 . . . . 74.540000000000006 111.086 -175.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 17.4 mp0 -129.48 106.44 8.76 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 115.715 -0.675 . . . . 75.319999999999993 109.298 177.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.85 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 77.0 t -84.04 107.28 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.463 -0.569 . . . . 64.25 109.463 -179.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 62.5 mt -120.15 108.76 23.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.858 -0.61 . . . . 75.109999999999999 110.19 -176.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 108.67 -117.33 4.97 Favored Glycine 0 CA--C 1.518 0.265 0 N-CA-C 111.831 -0.508 . . . . 74.409999999999997 111.831 -178.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.41 57.22 0.5 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.392 0.615 . . . . 71.329999999999998 110.032 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.73 81.8 5.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.464 -0.789 . . . . 62.439999999999998 110.399 -178.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.537 HD12 HD11 ' A' ' 119' ' ' ILE . 6.3 tp -61.89 -42.58 95.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 115.847 -0.615 . . . . 73.120000000000005 110.928 -177.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 45.4 t -62.67 -31.59 72.51 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.036 0.446 . . . . 71.150000000000006 110.633 -179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -74.05 -52.2 13.43 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.971 -0.559 . . . . 71.040000000000006 110.225 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.537 HD11 HD12 ' A' ' 116' ' ' ILE . 2.3 pp -63.84 -39.3 84.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.159 -0.473 . . . . 71.219999999999999 111.552 -173.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.487 HD12 ' N ' ' A' ' 121' ' ' SER . 2.9 pp -64.81 -33.86 66.31 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.162 0 C-N-CA 120.303 -0.559 . . . . 75.310000000000002 109.946 178.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.487 ' N ' HD12 ' A' ' 120' ' ' ILE . 23.1 t -70.42 -47.62 59.92 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.933 -0.576 . . . . 62.240000000000002 110.584 -178.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.502 ' O ' ' HB2' ' A' ' 126' ' ' ASN . 13.0 pt-20 -77.2 -43.06 35.09 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.676 -0.238 . . . . 74.319999999999993 111.48 -175.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.452 HD12 HD12 ' A' ' 66' ' ' LEU . 82.4 mt -64.11 -51.59 66.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 CA-C-N 117.657 0.208 . . . . 72.530000000000001 111.143 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 -58.65 -24.07 60.41 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 121.065 0.459 . . . . 72.010000000000005 110.609 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -91.94 -21.25 20.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.943 -0.571 . . . . 60.229999999999997 110.963 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.502 ' HB2' ' O ' ' A' ' 122' ' ' GLU . 3.7 t-20 -85.81 -36.78 19.85 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.086 -0.506 . . . . 73.109999999999999 111.152 -175.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.411 HG12 ' O ' ' A' ' 123' ' ' ILE . 47.2 pt -107.93 168.77 3.24 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 CA-C-N 115.759 -0.655 . . . . 71.040000000000006 110.032 178.547 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 3.2 p30 . . . . . 0 C--O 1.247 0.968 0 CA-C-O 118.409 -0.805 . . . . 74.439999999999998 110.638 -173.533 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.453 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 120.813 0.34 . . . . 51.399999999999999 110.196 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.66 148.43 33.06 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.786 -0.45 . . . . 74.329999999999998 109.786 179.445 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -77.24 138.12 39.23 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.782 -0.451 . . . . 73.010000000000005 109.782 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -73.83 96.55 2.6 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.387 -0.37 . . . . 75.420000000000002 110.431 -176.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -61.67 125.81 25.14 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.068 -0.515 . . . . 74.219999999999999 109.671 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -81.39 156.13 25.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.445 -0.343 . . . . 71.200000000000003 110.498 -176.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -111.89 -177.73 3.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.287 -0.415 . . . . 65.209999999999994 110.15 -176.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -129.81 -171.27 2.48 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.404 -0.591 . . . . 71.340000000000003 109.404 177.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 48.2 ttm -135.99 119.52 17.01 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.032 -0.359 . . . . 61.329999999999998 110.032 178.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -118.75 48.43 0.94 Allowed Glycine 0 C--N 1.333 0.367 0 C-N-CA 121.424 -0.417 . . . . 54.420000000000002 112.602 -175.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.9 m -70.63 99.75 1.72 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 109.554 -0.535 . . . . 62.43 109.554 176.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.541 HD23 ' HB2' ' A' ' 13' ' ' GLU . 9.8 tt -118.43 135.77 54.17 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.01 -0.541 . . . . 75.129999999999995 110.619 -171.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.541 ' HB2' HD23 ' A' ' 12' ' ' LEU . 8.8 tp10 70.03 115.8 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.783 0.833 . . . . 62.409999999999997 111.396 178.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -94.47 -174.84 3.45 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 116.103 -0.499 . . . . 64.340000000000003 110.864 -177.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -130.8 152.07 50.55 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.15 -0.477 . . . . 71.200000000000003 109.996 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.2 t -61.8 113.21 2.63 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-O 121.589 0.709 . . . . 74.340000000000003 110.442 176.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.402 ' OE1' ' HD3' ' A' ' 19' ' ' PRO . 1.5 tm0? -116.02 129.87 56.56 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.748 -0.834 . . . . 73.129999999999995 108.748 -177.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -165.15 87.99 0.1 Allowed Glycine 0 CA--C 1.519 0.33 0 C-N-CA 120.478 -0.868 . . . . 72.219999999999999 113.178 -172.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.402 ' HD3' ' OE1' ' A' ' 17' ' ' GLN . 86.6 Cg_endo -96.55 -162.85 0.08 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.442 2.761 . . . . 73.219999999999999 111.498 171.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.405 ' O ' ' SD ' ' A' ' 22' ' ' MET . . . -87.33 154.68 26.46 Favored Glycine 0 N--CA 1.444 -0.792 0 N-CA-C 110.455 -1.058 . . . . 71.450000000000003 110.455 173.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.2 p -69.25 80.25 0.36 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.284 0.564 . . . . 64.019999999999996 111.014 -177.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.765 ' HG3' ' HB1' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -92.75 -0.2 57.31 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-N 115.825 -0.625 . . . . 73.25 111.362 -177.254 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.527 HD11 ' HG2' ' A' ' 64' ' ' GLU . 22.9 mm -104.65 126.15 59.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.972 -0.558 . . . . 74.400000000000006 109.536 178.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 9.7 tp10 -129.23 137.29 51.01 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 110.025 -0.361 . . . . 71.409999999999997 110.025 178.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.711 ' H ' ' NE2' ' A' ' 25' ' ' GLN . 0.6 OUTLIER -105.81 114.62 28.88 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.614 -0.514 . . . . 65.140000000000001 109.614 176.771 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.528 HD12 ' HA ' ' A' ' 31' ' ' PHE . 28.2 pt -114.45 154.22 15.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.044 -0.526 . . . . 64.230000000000004 111.476 -172.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.56 178.22 45.66 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-N 115.455 -0.793 . . . . 13.31 112.115 176.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -63.25 -36.47 83.76 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.18 0.514 . . . . 73.329999999999998 111.213 -176.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.7 m -69.61 -42.67 74.05 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.756 -0.656 . . . . 64.120000000000005 111.525 -173.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -85.38 -12.31 52.42 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.562 -0.29 . . . . 71.549999999999997 111.692 -176.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.528 ' HA ' HD12 ' A' ' 26' ' ' ILE . 90.1 t80 -47.36 -69.9 0.11 Allowed 'General case' 0 N--CA 1.462 0.173 0 O-C-N 123.425 0.453 . . . . 65.209999999999994 110.263 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -55.63 -43.78 76.5 Favored 'General case' 0 C--O 1.24 0.596 0 CA-C-N 116.46 -0.336 . . . . 71.430000000000007 110.78 177.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.414 ' O ' ' HB2' ' A' ' 37' ' ' SER . 0.2 OUTLIER -52.22 -44.39 64.76 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 115.113 -0.949 . . . . 63.409999999999997 111.399 -170.557 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.514 ' HD3' HG21 ' A' ' 26' ' ' ILE . 0.2 OUTLIER -110.94 -21.71 11.88 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.326 0.491 . . . . 53.439999999999998 112.326 -175.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 89.5 t -88.21 -49.57 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 N-CA-C 111.509 0.189 . . . . 61.520000000000003 111.509 -179.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 79.9 p -87.81 -6.53 58.09 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 120.387 -0.525 . . . . 74.430000000000007 110.642 -175.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 33' ' ' ASN . 50.2 m -104.91 12.15 32.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.825 -0.625 . . . . 73.219999999999999 110.313 174.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . . . . . . . . . 50.3 t -60.55 90.25 0.02 OUTLIER 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.22 0.534 . . . . 60.130000000000003 111.452 -176.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -94.05 6.44 48.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.545 -0.752 . . . . 70.230000000000004 109.226 175.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -74.26 -20.85 60.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.282 -0.872 . . . . 63.240000000000002 111.056 -175.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.6 m120 69.39 15.04 8.45 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.864 -0.607 . . . . 71.209999999999994 111.078 -176.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 37.7 mt -93.64 141.15 15.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.733 -0.667 . . . . 74.519999999999996 109.549 174.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.478 HD11 ' HB3' ' A' ' 101' ' ' MET . 64.6 tp -75.18 114.04 13.22 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.318 -0.401 . . . . 74.319999999999993 110.312 -178.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.495 HG23 ' CD2' ' A' ' 77' ' ' TYR . 44.0 mt -97.53 116.47 40.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.941 -0.572 . . . . 75.349999999999994 110.317 179.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.472 HD22 HD22 ' A' ' 63' ' ' LEU . 3.3 mp -107.13 102.88 12.17 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.808 -0.442 . . . . 41.200000000000003 109.808 179.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.5 HG22 ' HB2' ' A' ' 77' ' ' TYR . 58.0 t -95.84 112.16 27.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.282 -0.417 . . . . 71.439999999999998 109.946 -179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -98.5 125.69 43.79 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.55 0.691 . . . . 64.5 110.385 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.424 ' HE1' ' HB2' ' A' ' 100' ' ' LEU . 70.2 m-85 -86.69 119.36 26.84 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.063 -0.971 . . . . 73.030000000000001 109.826 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' TRP . . . . . . . . . . . . . 1.5 p-90 -132.91 169.4 16.84 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.292 -0.413 . . . . 72.239999999999995 110.593 -175.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -85.04 138.88 36.81 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 115.994 -0.548 . . . . 53.439999999999998 110.467 177.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.9 -30.55 93.36 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.823 2.349 . . . . 74.340000000000003 112.991 -175.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' TRP . . . . . . . . . . . . . 10.1 m0 -98.51 15.6 24.41 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.783 0.325 . . . . 74.150000000000006 111.282 -178.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' CYS . . . . . . . . . . . . . 49.0 t -89.38 20.03 4.09 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 120.785 0.326 . . . . 72.239999999999995 110.485 178.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -53.88 -54.04 33.21 Favored Glycine 0 CA--C 1.525 0.666 0 CA-C-N 115.955 -0.566 . . . . 63.140000000000001 113.142 179.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -71.21 62.33 2.63 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.008 2.472 . . . . 62.109999999999999 111.804 174.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' CYS . . . . . . . . . . . . . 21.3 p -87.94 99.19 11.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.915 -0.584 . . . . 70.010000000000005 110.285 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -68.72 108.69 3.5 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.472 -0.566 . . . . 74.519999999999996 109.472 177.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 27.0 t -163.43 179.17 7.5 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.991 -0.374 . . . . 52.329999999999998 109.991 -178.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.474 HD23 ' N ' ' A' ' 59' ' ' LEU . 2.0 pt? -154.36 127.28 8.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.42 -0.354 . . . . 73.329999999999998 110.269 -179.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 39.59 73.4 0.83 Allowed Pre-proline 0 C--O 1.237 0.416 0 C-N-CA 123.888 0.875 . . . . 73.140000000000001 112.724 176.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -70.56 168.76 21.68 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 122.478 2.118 . . . . 71.140000000000001 111.528 177.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.72 ' HB3' HG12 ' A' ' 119' ' ' ILE . 4.3 mp0 -50.98 -57.68 7.96 Favored 'General case' 0 C--O 1.252 1.197 0 CA-C-O 121.737 0.779 . . . . 74.099999999999994 111.312 -175.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.521 HD11 HD13 ' A' ' 99' ' ' ILE . 46.3 mt -54.54 -48.77 71.59 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 114.588 -1.187 . . . . 74.219999999999999 110.909 -174.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.625 ' O ' ' HG3' ' A' ' 68' ' ' GLN . 50.1 mt-10 -75.0 -32.56 61.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.981 -0.554 . . . . 74.409999999999997 110.68 -176.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 19.6 tptm -56.24 -46.55 79.54 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 116.333 -0.394 . . . . 71.310000000000002 110.056 176.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.537 HD12 HD12 ' A' ' 123' ' ' ILE . 12.9 mt -82.6 -33.63 27.92 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-N 116.098 -0.501 . . . . 73.239999999999995 111.116 178.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.765 ' HB1' ' HG3' ' A' ' 22' ' ' MET . . . -59.74 -39.01 83.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.074 -0.512 . . . . 61.5 111.888 -175.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.625 ' HG3' ' O ' ' A' ' 64' ' ' GLU . 77.7 mt-30 -56.78 -31.12 64.32 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.133 0.492 . . . . 70.239999999999995 110.515 -179.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -93.66 -51.47 4.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.367 -0.833 . . . . 65.549999999999997 111.003 -174.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.443 ' O ' HG22 ' A' ' 74' ' ' VAL . 7.2 m-85 -104.37 23.18 13.58 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 115.716 -0.675 . . . . 75.230000000000004 111.583 -168.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.475 ' HB ' ' O ' ' A' ' 67' ' ' ALA . 8.7 t -52.65 -27.1 15.77 Favored 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 111.977 0.362 . . . . 74.329999999999998 111.977 -177.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -60.87 -27.6 68.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.875 0.369 . . . . 53.340000000000003 111.232 179.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -121.48 0.32 9.94 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 116.047 -0.524 . . . . 72.310000000000002 110.68 -174.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 70' ' ' TYR . 21.4 m -133.05 146.13 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 CA-C-O 121.034 0.445 . . . . 55.140000000000001 110.883 176.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.706 ' HA ' ' HE3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -141.86 129.57 21.6 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.204 -0.665 . . . . 63.310000000000002 109.204 177.224 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.507 ' HB ' HD13 ' A' ' 23' ' ' ILE . 2.6 mp -106.04 138.18 32.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 120.653 0.263 . . . . 74.420000000000002 110.397 -177.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.5 ' HB2' HG22 ' A' ' 46' ' ' VAL . 84.4 m-85 -134.25 137.86 44.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.176 -0.465 . . . . 72.200000000000003 110.923 -175.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 41.8 mttp -112.19 122.31 47.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.544 -0.753 . . . . 72.219999999999999 109.211 173.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.6 tp -93.7 141.62 14.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.012 -0.54 . . . . 72.5 111.457 -173.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -73.83 121.1 20.35 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.88 -0.6 . . . . 55.210000000000001 109.382 172.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 9.0 tt -90.08 98.68 8.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 121.118 0.485 . . . . 61.140000000000001 110.989 -178.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -81.92 -66.05 0.94 Allowed 'General case' 0 C--O 1.233 0.222 0 N-CA-C 109.635 -0.505 . . . . 71.239999999999995 109.635 175.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -125.05 4.75 7.94 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.097 -0.501 . . . . 64.430000000000007 110.982 178.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 63.8 -170.27 0.19 Allowed 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 109.622 -0.51 . . . . 73.349999999999994 109.622 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -144.52 136.65 26.2 Favored 'General case' 0 C--O 1.235 0.297 0 O-C-N 122.163 -0.335 . . . . 74.209999999999994 110.589 -179.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -65.45 -11.92 47.52 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.231 -0.44 . . . . 61.450000000000003 110.856 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 52.3 t -52.5 -34.51 19.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 CA-C-O 121.284 0.564 . . . . 75.030000000000001 110.13 175.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -59.3 -45.53 91.02 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.613 -0.721 . . . . 73.530000000000001 110.158 176.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 28.6 m -68.7 -31.98 71.45 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.809 -0.632 . . . . 71.010000000000005 110.511 177.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -59.25 -49.88 76.15 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.208 -0.451 . . . . 72.230000000000004 110.239 177.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -72.05 -17.33 62.02 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.24 -0.436 . . . . 74.030000000000001 110.565 176.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.54 48.88 5.7 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 121.189 -0.529 . . . . 71.209999999999994 112.538 177.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 88.2 t -68.56 104.83 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.892 0.377 . . . . 73.5 110.27 176.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.8 p -73.53 -40.91 63.65 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.938 -0.574 . . . . 73.310000000000002 111.341 -178.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -150.86 164.9 35.18 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.565 -0.289 . . . . 73.129999999999995 111.171 -178.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.564 ' HB ' ' HA ' ' A' ' 97' ' ' PRO . 2.7 pp -97.56 164.16 18.16 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 116.126 -0.488 . . . . 72.430000000000007 110.448 178.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.564 ' HA ' ' HB ' ' A' ' 96' ' ' ILE . 91.0 Cg_endo -78.09 165.5 83.0 Favored 'Cis proline' 0 C--N 1.355 0.91 0 C-N-CA 124.264 -1.14 . . . . 65.310000000000002 112.537 -0.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 13.0 m -129.65 122.44 29.01 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.051 -0.522 . . . . 71.120000000000005 110.298 -178.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.811 ' HB ' ' HB ' ' A' ' 111' ' ' VAL . 45.0 mt -115.4 108.19 24.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.345 -0.613 . . . . 53.43 109.345 -179.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.503 ' HG ' ' HG3' ' A' ' 110' ' ' GLN . 2.4 tt -99.34 124.34 44.36 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.933 -0.395 . . . . 73.120000000000005 109.933 -176.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.753 ' SD ' ' HB2' ' A' ' 109' ' ' SER . 65.0 mtp -93.45 112.01 23.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.927 -0.579 . . . . 74.109999999999999 111.155 -177.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -107.24 147.14 30.56 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 123.007 0.523 . . . . 74.430000000000007 110.446 175.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.731 ' HB3' HD21 ' A' ' 108' ' ' LEU . 28.7 ttpp -169.81 133.63 1.26 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.294 -0.632 . . . . 63.310000000000002 109.294 173.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 65.3 t30 61.43 24.82 14.87 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-O 121.266 0.555 . . . . 65.239999999999995 110.498 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 76.98 10.97 85.98 Favored Glycine 0 CA--C 1.522 0.5 0 CA-C-N 115.982 -0.554 . . . . 53.509999999999998 112.959 179.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 59.3 tttm -125.15 152.4 44.51 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 109.488 -0.56 . . . . 51.240000000000002 109.488 179.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.75 ' HD3' HE22 ' A' ' 110' ' ' GLN . 0.0 OUTLIER -84.71 142.9 29.53 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 109.447 -0.575 . . . . 45.119999999999997 109.447 177.842 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.731 HD21 ' HB3' ' A' ' 103' ' ' LYS . 2.4 mm? -106.32 -53.22 2.66 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 110.271 -0.27 . . . . 72.549999999999997 110.271 178.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.753 ' HB2' ' SD ' ' A' ' 101' ' ' MET . 66.4 m -153.82 165.83 34.81 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 116.182 -0.463 . . . . 74.540000000000006 111.101 -178.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . 0.75 HE22 ' HD3' ' A' ' 107' ' ' LYS . 24.2 mp0 -128.44 102.44 6.64 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 115.533 -0.758 . . . . 75.319999999999993 109.443 177.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.811 ' HB ' ' HB ' ' A' ' 99' ' ' ILE . 50.6 t -80.35 107.04 12.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 N-CA-C 109.517 -0.549 . . . . 64.25 109.517 177.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 52.5 mt -109.59 128.57 65.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.632 -0.507 . . . . 75.109999999999999 109.632 179.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 86.77 -123.09 6.36 Favored Glycine 0 N--CA 1.452 -0.269 0 N-CA-C 111.504 -0.639 . . . . 74.409999999999997 111.504 -176.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -157.52 101.94 1.87 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.955 0.377 . . . . 71.329999999999998 110.74 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -136.58 102.29 4.88 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 120.956 0.407 . . . . 62.439999999999998 110.861 179.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.587 HD12 HD11 ' A' ' 119' ' ' ILE . 7.9 tp -61.91 -38.39 80.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 115.895 -0.593 . . . . 73.120000000000005 110.383 179.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 37.7 t -61.57 -41.69 97.76 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 121.342 0.591 . . . . 71.150000000000006 110.316 178.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.447 ' O ' ' HG2' ' A' ' 122' ' ' GLU . 16.7 tppt? -63.92 -56.35 15.86 Favored 'General case' 0 C--O 1.241 0.65 0 CA-C-N 115.393 -0.821 . . . . 71.040000000000006 109.908 -179.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.72 HG12 ' HB3' ' A' ' 62' ' ' GLN . 2.2 pp -61.81 -43.33 97.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-N 115.455 -0.793 . . . . 71.219999999999999 111.979 -173.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.498 HD12 ' N ' ' A' ' 121' ' ' SER . 2.8 pp -63.0 -33.33 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 120.392 -0.523 . . . . 75.310000000000002 110.209 -178.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.498 ' N ' HD12 ' A' ' 120' ' ' ILE . 42.5 t -70.84 -52.3 21.22 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.07 -0.514 . . . . 62.240000000000002 110.997 -179.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 118' ' ' LYS . 3.8 pt-20 -77.8 -37.67 48.26 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.391 0.886 . . . . 74.319999999999993 113.391 -175.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . 0.537 HD12 HD12 ' A' ' 66' ' ' LEU . 65.7 mt -61.39 -56.99 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 O-C-N 121.949 -0.469 . . . . 72.530000000000001 110.281 177.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -63.5 -20.46 65.62 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.845 -0.616 . . . . 72.010000000000005 111.174 -178.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 34.3 t30 -65.77 -35.24 80.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.052 -0.522 . . . . 60.229999999999997 110.452 175.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.409 ' HB3' ' HE2' ' A' ' 103' ' ' LYS . 48.7 m-80 -95.59 -39.59 9.86 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.083 -0.508 . . . . 73.109999999999999 111.732 -175.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 38.9 pt -85.53 168.0 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.589 -0.278 . . . . 71.040000000000006 110.656 -178.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 8.9 p30 . . . . . 0 C--O 1.25 1.121 0 CA-C-O 118.258 -0.877 . . . . 74.439999999999998 110.95 -175.696 . . . . . . . . 0 0 . 1 stop_ save_